PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gaspar, C; Lopes-Cendes, I; Hayes, S; Goto, J; Arvidsson, K; Dias, A; Silveira, I; Maciel, P; Coutinho, P; Lima, M; Zhou, YX; Soong, BW; Watanabe, M; Giunti, P; Stevanin, G; Riess, O; Sasaki, H; Hsieh, M; Nicholson, GA; Brunt, E; Higgins, JJ; Lauritzen, M; Tranebjaerg, L; Volpini, V; Wood, N; Ranum, L; Tsuji, S; Brice, A; Sequeiros, J; Rouleau, GA				Gaspar, C; Lopes-Cendes, I; Hayes, S; Goto, J; Arvidsson, K; Dias, A; Silveira, I; Maciel, P; Coutinho, P; Lima, M; Zhou, YX; Soong, BW; Watanabe, M; Giunti, P; Stevanin, G; Riess, O; Sasaki, H; Hsieh, M; Nicholson, GA; Brunt, E; Higgins, JJ; Lauritzen, M; Tranebjaerg, L; Volpini, V; Wood, N; Ranum, L; Tsuji, S; Brice, A; Sequeiros, J; Rouleau, GA			Ancestral origins of the Machado-Joseph disease mutation: A worldwide haplotype study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; INTRAGENIC POLYMORPHISMS; GENETIC DISORDER; CAG EXPANSIONS; FAMILIES; DEGENERATION; DOMINANT; ATAXIA; INSTABILITY; MJD1	Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder originally described in families of Portuguese-Azorean ancestry. The cloning of the MJD1 gene allowed identification of the disease in many other populations, and MJD is now known to be the most common cause of dominant spinocerebellar ataxia. The hypothesis that its present world distribution could result from the spread of an original founder mutation has been raised, both at historical and molecular levels. In the present study, we tested this hypothesis by linkage-disequilibrium analysis of tightly linked polymorphisms and by haplotype comparison, in 249 families from different countries. We typed five microsatellite markers surrounding the MJD1 locus (D14S1015, D14S995, D14S973, D14S1016, and D14S977), and three intragenic single-base-pair polymorphisms ((A) under bar (669)TG/(G) under bar (669)TG, (C) under bar (987)GG/(G) under bar (987)GG, and TA (A) under bar (1118) /TA (C) under bar (1118)). The results show two different haplotypes, specific to the island of origin, in families of Azorean extraction. In families from mainland Portugal, both Azorean haplotypes can be found. The majority of the non-Portuguese families also share the same intragenic haplotype seen in the families coming from the island of Flores, but at least three other haplotypes were seen. These findings suggest two introductions of the mutation into the Portuguese population. Worldwide, the sharing of one intragenic haplotype by the majority of the families studied implies a founder mutation in MJD.	Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada; Univ Porto, Inst Mol Biol & Celular, UnIGENe, Porto, Portugal; Hosp Santo Antonio, Porto, Portugal; Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Unic Acores, Dept Biol, Ponta Delgada, Acores, Portugal; China Japan Friendship Hosp, Dept Neurol, Neurogenet Unit, Beijing, Peoples R China; Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; Gunma Univ, Sch Med, Dept Neurol, Gunma, Japan; Univ London, Inst Neurobiol, London WC1E 7HU, England; Hop La Pitie Salpetriere, INSERM, U289, Expt Med Lab, Paris, France; Ruhr Univ Bochum, Dept Human Mol Genet, D-4630 Bochum, Germany; Hokkaido Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido 060, Japan; Chung Shan Med & Dent Coll, Taichung, Taiwan; Univ Sydney, Concord Hosp, Dept Med, Mol Med Lab, Sydney, NSW 2006, Australia; Acad Ziekenhuis Groningen, Groningen, Netherlands; NINDS, Clin Neurogenet Unit, Med Neurol Branch, NIH, Bethesda, MD 20892 USA; Univ Copenhagen, Glostrup Hosp, Dept Clin Neurophysiol, DK-2600 Glostrup, Denmark; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Hosp Duran & Reynals, Med & Mol Genet Ctr IRO, Barcelona, Spain; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	McGill University; McGill University; Universidade do Porto; Niigata University; China-Japan Friendship Hospital; Gunma University; University of London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ruhr University Bochum; Hokkaido University; Chung Shan Medical University; Concord Repatriation General Hospital; University of Sydney; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Copenhagen; UiT The Arctic University of Tromso; University Hospital of North Norway; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Rouleau, GA (corresponding author), Montreal Gen Hosp, Res Inst, L7-224,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mi32@musica.mcgill.ca	Silveira, Isabel/D-6881-2012; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016; Maciel, Patricia/AAH-2102-2020; Giunti, Paola/E-5526-2012; Wood, Nicholas W/C-2505-2009; Maciel, Patrícia/B-5989-2009; brice, alexis/AAE-8275-2019; Coutinho, Paula/K-6053-2013; Lopes-Cendes, Iscia/B-9416-2013	Silveira, Isabel/0000-0002-2610-5260; Stevanin, Giovanni/0000-0001-9368-8657; Maciel, Patricia/0000-0002-0920-6350; Giunti, Paola/0000-0003-3508-4788; Wood, Nicholas W/0000-0002-9500-3348; Maciel, Patrícia/0000-0002-0920-6350; brice, alexis/0000-0002-0941-3990; Lopes-Cendes, Iscia/0000-0002-6221-6822; Coutinho, Paula/0000-0002-3461-230X; Lauritzen, Martin/0000-0002-1517-1131; Nicholson, Garth/0000-0001-9694-066X; Lima, Manuela/0000-0002-3357-3273	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031687] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31687] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; COUTINHO P, 1977, MEDICO, V82, P1; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Lima M, 1998, HUM BIOL, V70, P1011; Maciel P, 1999, EUR J HUM GENET, V7, P147, DOI 10.1038/sj.ejhg.5200264; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; RANUM LPW, 1995, AM J HUM GENET, V57, P603; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHOLS L, 1995, J NEUROL NEUROSUR PS, V59, P449, DOI 10.1136/jnnp.59.4.449; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; SEQUEIROS J, 1989, CLIN RES, V37, pA870; Silveira I, 1998, AM J MED GENET, V81, P134, DOI 10.1002/(SICI)1096-8628(19980328)81:2<134::AID-AJMG3>3.0.CO;2-W; Stevanin G, 1997, AM J HUM GENET, V60, P1548; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; WOODS BT, 1972, J NEUROL SCI, V17, P149, DOI 10.1016/0022-510X(72)90137-2	21	86	90	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					523	528		10.1086/318184	http://dx.doi.org/10.1086/318184			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133357	Green Published, Bronze			2022-12-18	WOS:000166524800024
J	Toivonen, HTT; Onkamo, P; Vasko, K; Ollikainen, V; Sevon, P; Mannila, H; Herr, M; Kere, J				Toivonen, HTT; Onkamo, P; Vasko, K; Ollikainen, V; Sevon, P; Mannila, H; Herr, M; Kere, J			Data mining applied to linkage disequilibrium mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; DISEASE GENES; LOCI; ASSOCIATION; POPULATIONS; LIKELIHOOD; EXAMPLE; FINLAND; TESTS	We introduce a new method for linkage disequilibrium mapping: haplotype pattern mining (HPM). The method, inspired by data mining methods, is based on discovery of recurrent patterns. We define a class of useful haplotype patterns in genetic case-control data and use the algorithm for finding disease-associated haplotypes. The haplotypes are ordered by their strength of association with the phenotype, and all haplotypes exceeding a given threshold level are used for prediction of disease susceptibility-gene location. The method is model-free, in the sense that it does not require land is unable to utilize) any assumptions about the inheritance model of the disease. The statistical model is nonparametric. The haplotypes are allowed to contain gaps, which improves the method's robustness to mutations and to missing and erroneous data. Experimental studies with simulated microsatellite and SNP data show that the method has good localization power in data sets with large degrees of phenocopies and with lots of missing and erroneous data. The power of HPM is roughly identical for marker maps at a density of 3 single-nucleotide polymorphisms/cM or 1 microsatellite/cM The capacity to handle high proportions of phenocopies makes the method promising for complex disease mapping. An example of correct disease susceptibility-gene localization with HPM is given with real marker data from families from the United Kingdom affected by type 1 diabetes. The method is extendable to include environmental covariates or phenotype measurements or to find several genes simultaneously.	Univ Helsinki, Rolf Nevanlinna Inst, FIN-00014 Helsinki, Finland; Univ Helsinki, Nokia Res Ctr, Helsinki, Finland; Univ Helsinki, Finnish Genome Ctr, Helsinki, Finland; Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland; Helsinki Univ Technol, Helsinki, Finland; Univ Cambridge, Dept Med Genet, Wellcome Trust Ctr Mol Mech Dis, Cambridge, England	University of Helsinki; Nokia Corporation; Nokia Finland; Siemens AG; Nokia Siemens Networks; University of Helsinki; University of Helsinki; University of Helsinki; Aalto University; University of Cambridge	Onkamo, P (corresponding author), Univ Helsinki, Rolf Nevanlinna Inst, POB 4,Yliopistonkatu 5, FIN-00014 Helsinki, Finland.		Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Toivonen, Hannu TT/A-3657-2012	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Toivonen, Hannu TT/0000-0003-1339-8022				Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1996, ADV KNOWLEDGE DISCOV, P307, DOI DOI 10.1007/978-3-319-31750-2.; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; CHURCHILL GA, 1994, GENETICS, V138, P963; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; Herr M, 2000, HUM MOL GENET, V9, P1291, DOI 10.1093/hmg/9.9.1291; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Laitinen T, 1997, HUM MOL GENET, V6, P2069, DOI 10.1093/hmg/6.12.2069; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; Long AD, 1998, GENETICS, V149, P999; Long AD, 1999, GENOME RES, V9, P720; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	29	86	93	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					133	145		10.1086/302954	http://dx.doi.org/10.1086/302954			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10848493	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000088926900016
J	Saunier, S; Calado, J; Benessy, F; Silbermann, F; Heilig, R; Weissenbach, J; Antignac, C				Saunier, S; Calado, J; Benessy, F; Silbermann, F; Heilig, R; Weissenbach, J; Antignac, C			Characterization of the NPHP1 locus: Mutational mechanism involved in deletions in familial juvenile nephronophthisis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOLOGOUS RECOMBINATION; GENE-CLUSTER; CHROMOSOME-2; INVERSION; CONSTRUCTION; FREQUENCY; DISORDERS; PROTEIN; DOMAIN; TYPE-1	Famial juvenile nephronophthisis is an autosomal recessive, genetically heterogeneous kidney disorder representing the most frequent inherited cause of chronic renal failure in children. A gene, NPHP1, responsible for similar to 85% of the purely renal form of nephronophthisis, has been mapped to 2q13 and characterized. The major NPHP1 gene defect is a large homozygous deletion found in similar to 80% of the patients. In this study, by large-scale genomic sequencing and pulsed-held gel electrophoresis analysis, we characterized the complex organization of the MPI;IPI locus and determined the mutational mechanism that results in the large deletion observed in most patients. We showed that the deletion is 290 kb in size and that NPHP1 is flanked by two large inverted repeats of similar to 330 kb. In addition, a second sequence of 45 kb located adjacent to the proximal 330-kb repeat was shown to be directly repeated 250 kb away within the distal 330-kb repeat deleting the sequence tag site (STS) 804H10R present in the proximal copy. The patients' deletion breakpoints appear to be located within the 45-kb repent, suggesting an unequal recombination between the two homologous copies of this smaller repeat. Moreover, we demonstrated a non-pathologic rearrangement involving the two 330-kb inverted repeats found in 11 patients and, in the homozygous state, in 2 (1.3%) control individuals. This could be explained by interchromosomal mispairing of the 330-kb inverted repeat, followed by double recombination or by a prior intrachromosomal mispairing of these repeats, leading to an inversion of the NPHP1 region, followed by an interchromosomal unequal crossover event. This complex rearrangement, as well as the common deletion found in most patients, illustrates the high level of rearrangements occurring in the centromeric region of chromosome 2.	Univ Paris 05, Hop Necker Enfants Malad, INSERM U423, F-75015 Paris, France; Ctr Natl Sequencage, GENOSCOPE, Evry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Antignac, C (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM U423, Tour Lavoisier 6e Etage,149 Rue de Sevres, F-75015 Paris, France.		ANTIGNAC, Corinne/H-8945-2017; Saunier, Sophie/G-6044-2015	ANTIGNAC, Corinne/0000-0002-9934-4940; Saunier, Sophie/0000-0002-1069-0047; legendre, flora/0000-0002-4149-1913; Calado, Joaquim/0000-0002-1194-3392				ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; ANTIGNAC C, 1998, CLIN NEPHROL, P2417; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; DJALALI M, 1986, HUM GENET, V72, P32, DOI 10.1007/BF00278814; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; HEIDET L, 1995, HUM MOL GENET, V4, P99, DOI 10.1093/hmg/4.1.99; Hildebrandt F, 1996, CYTOGENET CELL GENET, V73, P235, DOI 10.1159/000134346; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; HUBER C, 1990, NUCLEIC ACIDS RES, V18, P3475, DOI 10.1093/nar/18.12.3475; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Konrad M, 1996, HUM MOL GENET, V5, P367, DOI 10.1093/hmg/5.3.367; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LI M, 1992, NUCLEIC ACIDS RES, V20, P1117; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MACDONALD IM, 1985, HUM GENET, V69, P281, DOI 10.1007/BF00293042; MEDHIOUB M, 1994, GENOMICS, V22, P296, DOI 10.1006/geno.1994.1387; Nothwang HG, 1998, GENOMICS, V47, P383, DOI 10.1006/geno.1997.5119; Nothwang HG, 1998, GENOMICS, V47, P276, DOI 10.1006/geno.1997.5102; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; REINER O, 1995, GENOMICS, V30, P251, DOI 10.1006/geno.1995.9880; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; VEJERSLEV LO, 1984, PRENATAL DIAG, V4, P181, DOI 10.1002/pd.1970040304; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	32	86	87	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					778	789		10.1086/302819	http://dx.doi.org/10.1086/302819			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712196	Green Published, Bronze			2022-12-18	WOS:000088373200004
J	Service, SK; Lang, DWT; Freimer, NB; Sandkuijl, LA				Service, SK; Lang, DWT; Freimer, NB; Sandkuijl, LA			Linkage-disequilibrium mapping of disease genes by reconstruction of ancestral haplotypes in founder populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIKELIHOOD; GENOME; HETEROGENEITY; CHOLESTASIS; SEGMENTS; DESCENT	Linkage disequilibrium (LD) mapping may be a powerful means for genome screening to identify susceptibility loci for common diseases. Anew statistical approach for detection of LD around a disease gene is presented here. This method compares the distribution of haplotypes in affected individuals versus that expected for individuals descended from a common ancestor who carried a mutation of the disease gene. Simulations demonstrate that this method, which we term "ancestral haplotype reconstruction" (AHR), should be powerful for genome screening of phenotypes characterized by a high degree of etiologic heterogeneity, even with currently available marker maps; AHR is best suited to application in isolated populations where affected individuals are relatively recently descended (<similar to 25 generations) from a common disease mutation-bearing founder.	Univ Calif San Francisco, Neurogenet Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Dept Psychiat, San Francisco, CA 94143 USA; AT&T Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Leiden Univ, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Univ Groningen, Dept Med Genet, Groningen, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Alcatel-Lucent; Lucent Technologies; AT&T; Nokia Corporation; Nokia Bell Labs; Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC; University of Groningen	Freimer, NB (corresponding author), Univ Calif San Francisco, Neurogenet Lab, San Francisco, CA 94143 USA.							Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Durham LK, 1997, AM J HUM GENET, V61, P830, DOI 10.1086/514891; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Freimer NB, 1997, NAT GENET, V17, P371, DOI 10.1038/ng1297-371; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; Mathews CA, 1997, AM J HUM GENET, V61, pA401; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SANDA AI, 1986, NUCLEIC ACIDS RES, V14, P7265, DOI 10.1093/nar/14.18.7265; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SLATKIN M, 1991, GENETICS, V129, P555; STAM P, 1981, EUPHYTICA, V30, P227, DOI 10.1007/BF00033982; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VANGOOL WA, 1995, ANN NEUROL, V38, P225, DOI 10.1002/ana.410380215; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	28	86	89	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1728	1738		10.1086/302398	http://dx.doi.org/10.1086/302398			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330361	Green Published, Bronze			2022-12-18	WOS:000080696200026
J	Hardcastle, AJ; Thiselton, DL; Van Maldergem, L; Saha, BK; Jay, M; Plant, C; Taylor, R; Bird, AC; Bhattacharya, S				Hardcastle, AJ; Thiselton, DL; Van Maldergem, L; Saha, BK; Jay, M; Plant, C; Taylor, R; Bird, AC; Bhattacharya, S			Mutations in the RP2 gene cause disease in 10% of families with familial X-linked retinitis pigmentosa assessed in this study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NUCLEOTIDE-EXCHANGE FACTOR; POSITIONAL CLONING; PROXIMAL XP; RETINITIS-PIGMENTOSA-2; HOMOLOGY; LINKAGE; LOCUS; RPGR; RCC1; DNA		UCL, Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; UCL, Inst Ophthalmol, Dept Clin Ophthalmol, London, England; Inst Pathol & Genet ASBL, Gerpinnes, Belgium; Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA	University of London; University College London; University of London; University College London; Emory University	Hardcastle, AJ (corresponding author), UCL, Inst Ophthalmol, Dept Mol Genet, 11-43 Bath St, London EC1V 9EL, England.	ahardcas@hgmp.mrc.ac.uk	Van Maldergem, Lionel/O-3242-2019; Van Maldergem, Lionel/G-9849-2017	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Hardcastle, Alison/0000-0002-0038-6770				BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Hardcastle AJ, 1997, INVEST OPHTH VIS SCI, V38, P1893; Hardcastle AJ, 1997, INVEST OPHTH VIS SCI, V38, P2750; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2	15	86	89	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1210	1215		10.1086/302325	http://dx.doi.org/10.1086/302325			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090907	Bronze, Green Published			2022-12-18	WOS:000079632900033
J	Rudic, RD; Sessa, WC				Rudic, RD; Sessa, WC			Nitric oxide in endothelial dysfunction and vascular remodeling: Clinical correlates and experimental links	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; SYNTHASE GENE; HYPERTENSIVE PATIENTS; CAROTID-ARTERY; MICE LACKING; IN-VIVO; FLOW; INHIBITION; GROWTH; RATS		Yale Univ, Sch Med, Dept Pharmacol, Mol Cardiobiol Div,Boyer Ctr Mol Med, New Haven, CT 06536 USA	Yale University	Sessa, WC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, Mol Cardiobiol Div,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011; Rudic, Dan/B-3432-2016	Sessa, William C/0000-0001-5759-1938; Rudic, Dan/0000-0001-9122-3127	NHLBI NIH HHS [HL57665, HL 51948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL051948, R01HL057665] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birnbaum Y, 1997, J AM COLL CARDIOL, V30, P1149, DOI 10.1016/S0735-1097(97)00320-3; BONNARDEAUX A, 1995, CIRCULATION, V91, P96, DOI 10.1161/01.CIR.91.1.96; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Deng AY, 1997, HYPERTENSION, V29, P49, DOI 10.1161/01.HYP.29.1.49; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Ghiadoni L, 1998, HYPERTENSION, V32, P25, DOI 10.1161/01.HYP.32.1.25; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GIRERD X, 1994, AM J HYPERTENS, V7, P1076, DOI 10.1093/ajh/7.12.1076; Godecke A, 1998, CIRC RES, V82, P186; Gregg AR, 1998, AM J PHYSIOL-HEART C, V275, pH2319, DOI 10.1152/ajpheart.1998.275.6.H2319; Guzman RJ, 1997, SURGERY, V122, P273, DOI 10.1016/S0039-6060(97)90018-0; Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hunt SC, 1996, J HUM HYPERTENS, V10, P27; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Lacolley P, 1998, J HYPERTENS, V16, P31, DOI 10.1097/00004872-199816010-00006; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; Luvara G, 1998, ARTERIOSCL THROM VAS, V18, P1408, DOI 10.1161/01.ATV.18.9.1408; Mancini GBJ, 1996, CIRCULATION, V94, P258, DOI 10.1161/01.CIR.94.3.258; Miyamoto Y, 1998, HYPERTENSION, V32, P3, DOI 10.1161/01.HYP.32.1.3; Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293; NUMAGUCHI K, 1995, HYPERTENSION, V26, P957, DOI 10.1161/01.HYP.26.6.957; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Shimasaki Y, 1998, J AM COLL CARDIOL, V31, P1506, DOI 10.1016/S0735-1097(98)00167-3; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; Tronc F, 1996, ARTERIOSCL THROM VAS, V16, P1256, DOI 10.1161/01.ATV.16.10.1256; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wang XL, 1997, ARTERIOSCL THROM VAS, V17, P3147, DOI 10.1161/01.ATV.17.11.3147; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	34	86	90	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					673	677		10.1086/302304	http://dx.doi.org/10.1086/302304			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10052999	Green Published, Bronze			2022-12-18	WOS:000079204700001
J	Othman, MI; Sullivan, SA; Skuta, GL; Cockrell, DA; Stringham, HM; Downs, CA; Fornes, A; Mick, A; Boehnke, M; Vollrath, D; Richards, JE				Othman, MI; Sullivan, SA; Skuta, GL; Cockrell, DA; Stringham, HM; Downs, CA; Fornes, A; Mick, A; Boehnke, M; Vollrath, D; Richards, JE			Autosomal dominant nanophthalmos (NNO1) with high hyperopia and angle-closure glaucoma maps to chromosome 11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAX6 GENE DOSAGE; EYE DEVELOPMENT; HOMEOBOX GENE; MUTATION; ANIRIDIA; DIFFERENTIATION; LOCALIZATION; RETARDATION; EXPRESSION; JUVENILE	Nanophthalmos is an uncommon developmental ocular disorder characterized by a small eye, as indicated by short axial length, high hyperopia (severe farsightedness), high lens/eye volume ratio, and a high incidence of angle-closure glaucoma. We performed clinical and genetic evaluations of members of a large family in which nanophthalmos is transmitted in an autosomal dominant manner. Ocular examinations of 22 affected family members revealed high hyperopia (range +7.25-+13.00 diopters; mean +9.88 diopters) and short axial length (range 17.55-19.28 mm; mean 18.13 mm). Twelve affected family members had angle-closure glaucoma or occludable anterior-chamber angles. Linkage analysis of a genome scan demonstrated highly significant evidence that nanophthalmos in this family is the result of a defect in a previously unidentified locus (NNO1) on chromosome 11. The gene was localized to a 14.7-cM interval between D11S905 and D11S987, with a maximum LOD score of 5.92 at a recombination fraction of .00 for marker D11S903 and a multipoint maximum LOD score of 6.31 for marker D11S1313. NNO1 is the first human locus associated with nanophthalmos or with an angle-closure glaucoma phenotype, and the identification of the NNO1 locus is the first step toward the cloning of the gene. A cloned copy of the gene will enable examination of the relationship, if any, between nanophthalmos and less severe farms of hyperopia and between nanophthalmos and other conditions in which angle-closure glaucoma is a feature.	Univ Michigan, Dept Ophthalmol, Ann Arbor, MI USA; Univ Michigan, Dept Biostat, Ann Arbor, MI USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI USA; Univ Oklahoma, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK USA; Cockrell Eye Care Ctr Inc, Stillwater, OK USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Oklahoma System; University of Oklahoma Health Sciences Center; Stanford University	Richards, JE (corresponding author), WK Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48105 USA.				NATIONAL EYE INSTITUTE [R01EY011671, R01EY009580, R56EY011671] Funding Source: NIH RePORTER; NEI NIH HHS [EY09580, EY114405, EY11671] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Azuma N, 1996, NAT GENET, V13, P141, DOI 10.1038/ng0696-141; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; Bessant DAR, 1998, AM J HUM GENET, V62, P1113, DOI 10.1086/301843; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Brockhurst R J, 1974, Trans Am Ophthalmol Soc, V72, P371; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; David T, 1990, Bull Soc Ophtalmol Fr, V90, P263; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIEHL DLC, 1989, CAN J OPHTHALMOL, V24, P327; Duke-Elder S., 1964, SYSTEM OPHTHALMOLOGY, V3, P488; FRANCOIS J, 1977, OPHTHALMOLOGICA, V175, P321, DOI 10.1159/000308676; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gladwin A, 1997, HUM MOL GENET, V6, P123, DOI 10.1093/hmg/6.1.123; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GLASER T, 1994, GENOMICS, V19, P145, DOI 10.1006/geno.1994.1024; Graw J, 1996, DEV GENET, V18, P181, DOI 10.1002/(SICI)1520-6408(1996)18:3<181::AID-DVG1>3.0.CO;2-5; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KIMBROUGH RL, 1979, AM J OPHTHALMOL, V88, P572, DOI 10.1016/0002-9394(79)90517-8; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LENZ W, 1955, Z Kinderheilkd, V77, P384, DOI 10.1007/BF00437927; MACKAY CJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P366, DOI 10.1001/archopht.1987.01060030086032; MARTORINA M, 1988, J FR OPHTALMOL, V11, P357; MIRZAYANS F, 1995, AM J HUM GENET, V57, P539; MORISSETTE J, 1995, AM J HUM GENET, V56, P1431; MORTON NE, 1955, AM J HUM GENET, V7, P277; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OGUNYE OO, 1975, HUM HERED, V25, P493, DOI 10.1159/000152765; RAJIC DS, 1966, ANN RADIOL, V9, P224; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SHIONO T, 1992, GRAEF ARCH CLIN EXP, V230, P348, DOI 10.1007/BF00165943; SINGH OS, 1982, OPHTHALMOLOGY, V89, P1006; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; Tomarev SI, 1997, INT J DEV BIOL, V41, P835; Trifan OC, 1998, AM J OPHTHALMOL, V126, P17, DOI 10.1016/S0002-9394(98)00073-7; VINGOLO EM, 1994, J MED GENET, V31, P721, DOI 10.1136/jmg.31.9.721; WEISS AH, 1989, ARCH OPHTHALMOL-CHIC, V107, pS162; Wirtz MK, 1997, AM J HUM GENET, V60, P296; YUE BYJT, 1988, OPHTHALMOLOGY, V95, P56	45	86	94	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1411	1418		10.1086/302113	http://dx.doi.org/10.1086/302113			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792868	Green Published, Bronze			2022-12-18	WOS:000076985200017
J	Daniels, J; Holmans, P; Williams, N; Turic, D; McGuffin, P; Plomin, R; Owen, MJ				Daniels, J; Holmans, P; Williams, N; Turic, D; McGuffin, P; Plomin, R; Owen, MJ			A simple method for analyzing microsatellite allele image patterns generated from DNA pools and its application to allelic association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS; FREQUENCIES; LINKAGE; SAMPLES; MARKERS	Allelic association studies provide the most powerful method for locating genes of small effect contributing to complex diseases and traits. However, in outbred populations, allelic association is usually maintained only over distances of less than or equal to 1 cM. Therefore, systematic searches over large regions are costly. Here we present a method involving DNA pooling that can be used as a rapid preliminary screen for allelic association with the most common class of polymorphic markers, single-sequence repeats. Patient and control samples are pooled separately, and markers are typed in the two pools. By use of primers with fluorescent 5' ends, PCR products can be analyzed on an automated sequencing apparatus. Allele image patterns (AIPs) produced for the two groups are overlaid and differences in pattern area between pools computed. From this, a Delta AIP statistic is calculated from the difference in areas between the two AIPs expressed as a fraction of the total shared and nonshared area. AIPs of a range of different-sized pools were generated by computer simulation for markers with a range of allele sizes and frequencies, Delta AIPs from pools and chi(2) values for individual genotypings were compared, with both simulated and real data from microsatellite markers. The results demonstrated a high correlation between Delta ATP and chi(2) values. Delta AIP analysis of real microsatellite data indicated the feasibility of using this method in systematic searches for allelic association and generated a small number of false positives but few false negatives. We conclude that Delta AIP analysis of DNA pools can be used effectively and efficiently as a rapid screen for allelic association in case-control studies.	Univ Wales Coll Med, Neuropsychiat Genet Unit, Div Psychol Med, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Coll Med, Div Med Genet, Cardiff CF4 4XN, S Glam, Wales; Inst Psychiat, Ctr Social Genet & Dev Psychiat, London, England	Cardiff University; Cardiff University; University of London; King's College London	Owen, MJ (corresponding author), Univ Wales Coll Med, Neuropsychiat Genet Unit, Div Psychol Med, Tenovus Bldg,Heath Pk, Cardiff CF4 4XN, S Glam, Wales.		Holmans, Peter/F-4518-2015; Plomin, Robert/B-8911-2008; McGuffin, Peter/A-1565-2012	Holmans, Peter/0000-0003-0870-9412; McGuffin, Peter/0000-0002-9888-2907; Newton-Bishop, Julia/0000-0001-9147-6802; Plomin, Robert/0000-0002-0756-3629	NICHD NIH HHS [HD-27964] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; DANIELS JK, 1995, PSYCHIAT GENET S, V5, pS39; DARVASI A, 1994, GENETICS, V138, P1365; DEMERS DB, 1995, NUCLEIC ACIDS RES, V23, P3050, DOI 10.1093/nar/23.15.3050; KHATIB H, 1994, PCR METH APPL, V4, P13; LEDUC C, 1995, PCR METH APPL, V4, P331; OWEN MJ, 1993, J MED GENET, V30, P638, DOI 10.1136/jmg.30.8.638; Pacek P, 1993, PCR Methods Appl, V2, P313; PERLIN MW, 1995, AM J HUM GENET, V57, P1199; RAHACHOWDHURY R, 1995, HUM MOL GENET, V4, P1869, DOI 10.1093/hmg/4.10.1869; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x	14	86	89	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1189	1197		10.1086/301816	http://dx.doi.org/10.1086/301816			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545387	Green Published, Bronze			2022-12-18	WOS:000073487000024
J	Fukuda, S; Shimozawa, N; Suzuki, Y; Zhang, ZY; Tomatsu, S; Tsukamoto, T; Hashiguchi, N; Osumi, T; Masuno, M; Imaizumi, K; Kuroki, Y; Fujiki, Y; Orii, T; Kondo, N				Fukuda, S; Shimozawa, N; Suzuki, Y; Zhang, ZY; Tomatsu, S; Tsukamoto, T; Hashiguchi, N; Osumi, T; Masuno, M; Imaizumi, K; Kuroki, Y; Fujiki, Y; Orii, T; Kondo, N			Human peroxisome assembly factor-2 (PAF-2): A gene responsible for group C peroxisome biogenesis disorder in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAMMALIAN-CELL MUTANT; ZELLWEGER-SYNDROME; INSITU HYBRIDIZATION; DEFICIENT DISORDERS; COMPLEMENTATION; IDENTIFICATION; ASSIGNMENT; SEQUENCE; FIBROBLASTS; MUTATIONS	Peroxisome-biogenesis disorders (FED) are genetically heterogeneous and can be classified into at least ten complementation groups. We recently isolated the cDNA for rat peroxisome assembly factor-2 (PAF-2) by functional complementation using the peroxisome-deficient Chinese-hamster-ovary cell mutant, ZP92. To clarify the novel pathogenic gene of PBD, we cloned the full-length human PAF-2 cDNA that morphologically and biochemically restores peroxisomes of group C Zellweger fibroblasts (the same as group 4 in the Kennedy-Krieger Institute) and identified two pathogenic mutations in the PAF-2 gene in two patients with group C Zellweger syndrome. The 2,940-bp open reading Game of the human PAF-2 cDNA encodes a 980-amino-acid protein that shows 87.1% identity with rat PAE-2 and also restored the peroxisome assembly after gene transfer to fibroblasts of group C patients. Direct sequencing of the PAF-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 insT) in one patient with group C Zellweger syndrome (ZS), which introduces a premature termination codon in the PAF-2 gene, and, in the second patient, revealed a splice-site mutation in intron 3 (IVS3+1G-->A), which skipped exon 3, an event that leads to peroxisome deficiency. Chromosome mapping utilizing FISH indicates that PAF-2 is located on chromosome 6p21.1. These results confirm that human PAF-2 cDNA restores peroxisome of group C cells and that defects in the PAF-2 produce peroxisome deficiency of group C PBD.	HIMEJI INST TECHNOL,DEPT LIFE SCI,KAMIGORI,HYOGO,JAPAN; KANAGAWA CHILDRENS MED CTR,DIV MED GENET,YOKOHAMA,KANAGAWA,JAPAN; KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 812,JAPAN; CHUBU WOMENS COLL,SEKI,JAPAN	University of Hyogo; Kyushu University	Fukuda, S (corresponding author), GIFU UNIV,SCH MED,DEPT PEDIAT,TSUKASA MACHI 40,GIFU 500,JAPAN.			Shimozawa, Nobuyuki/0000-0003-3040-5458				CARSTENS RP, 1991, AM J HUM GENET, V48, P1105; CHIN DT, 1988, J BIOL CHEM, V263, P11718; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; HIDAKA Y, 1987, J CLIN INVEST, V80, P1409, DOI 10.1172/JCI113219; HORI T, 1990, HUM GENET, V85, P576; KUDO S, 1989, P NATL ACAD SCI USA, V86, P4619, DOI 10.1073/pnas.86.12.4619; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MASUNO M, 1992, CYTOGENET CELL GENET, V60, P121, DOI 10.1159/000133319; MASUNO M, 1994, GENOMICS, V20, P141, DOI 10.1006/geno.1994.1144; NARITOMI K, 1988, HUM GENET, V80, P201, DOI 10.1007/BF00702873; NUTTLEY WM, 1994, J BIOL CHEM, V64, P499; OKAMOTO H, 1992, EXP CELL RES, V201, P307, DOI 10.1016/0014-4827(92)90278-G; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; RABEN N, 1993, J BIOL CHEM, V268, P4963; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Sambrook J, 1989, MOL CLONING LAB MANU; SANTOS MJ, 1988, SCIENCE, V182, P62; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SPONG AP, 1993, J CELL BIOL, V123, P535, DOI 10.1083/jcb.123.3.535; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VIEGASPEQUIGNOT E, 1989, HUM GENET, V83, P33, DOI 10.1007/BF00274143; VOORNBROUWER T, 1993, BIOCHIM BIOPHYS ACTA, V1216, P325, DOI 10.1016/0167-4781(93)90166-B; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEIL D, 1988, J BIOL CHEM, V263, P8561; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334	30	86	87	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1210	1220						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940266				2022-12-18	WOS:A1996VV31500007
J	Whittemore, AS				Whittemore, AS			Genome scanning for linkage: An overview	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE-MEMBER METHOD; SIB-PAIR; TESTS; RESOLUTION; DESCENT; POWER; MAPS; LOCI	Several different methods for linkage analysis are shown to arise from a single likelihood function L for the observed allele-sharing data at multiple markers in a chromosomal region. These include classical parametric lod-score methods, nonparametric or ''model-free'' affected-pedigree-member (APM) methods, and the Gaussian process method. Setting the methods in the context of the likelihood function L clarifies their underlying assumptions. A test statistic derived from L, the efficient score statistic, is introduced. It is asymptotically equivalent to the lod score, but it can be easier to compute when the penetrances and frequencies of alleles of the trait gene are not known. APM test statistics and the Gaussian lod score are shown to be special cases of efficient score statistics. This unified framework facilitates exploration of a range of models for the effects of a putative trait-predisposing gene, and it facilitates sensitivity analyses to examine the consequences of model misspecification.			Whittemore, AS (corresponding author), STANFORD UNIV,DEPT HLTH RES & POLICY,SCH MED,REDWOOD BLDG,ROOM T204,STANFORD,CA 94305, USA.				NATIONAL CANCER INSTITUTE [R35CA047448] Funding Source: NIH RePORTER; NCI NIH HHS [CA-R29-47448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS D, 1995, AM J HUM GENET, V57, P703; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FIMMERS R, 1989, MULTIPOINT MAPPING L, V6, P123; GUO SW, 1995, AM J HUM GENET, V56, P1468; KARLIN S, 1972, 1 COURSE STOCHASTIC; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; MCCULLAGH P, 1991, MONOGRAPHS STAT PROB, V37; MOTRO U, 1985, GENETICS, V110, P525; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; SCHAID DJ, 1990, GENET EPIDEMIOL, V7, P359, DOI 10.1002/gepi.1370070506; SRIBNEY WM, 1992, AM J HUM GENET, V51, P773; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; SUAREZ BK, 1984, AM J MED GENET, V42, P315; Thompson EA, 1986, PEDIGREE ANAL HUMAN; TIERNEY C, 1993, HUM HERED, V43, P276, DOI 10.1159/000154145; Vieland VJ, 1996, AM J HUM GENET, V58, P1072; WARD PJ, 1993, AM J HUM GENET, V52, P1200; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	25	86	86	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					704	716						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751872				2022-12-18	WOS:A1996VN62500025
J	Feigenbaum, V; LombardPlatet, G; Guidoux, S; Sarde, CO; Mandel, JL; Aubourg, P				Feigenbaum, V; LombardPlatet, G; Guidoux, S; Sarde, CO; Mandel, JL; Aubourg, P			Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEROXISOMAL MEMBRANE-PROTEIN; GENE; INACTIVATION	X-linked adrenoleukodystrophy (ALD), a neurodegenerative disorder associated with impaired P-oxidation of very-long-chain fatty acids (VLCFA), is due to mutations in a gene encoding a peroxisomal ATP-binding cassette (ABC) transporter (ALD protein [ALDP]). We analyzed the open reading frame of the ALD gene in 44 French ALD kindred by using SSCP or denaturing gradient-gel electrophoresis and studied the effect of mutations on ALDP by immunocytofluorescence and western blotting of fibroblasts and/or white blood cells. Mutations were detected in 37 of 44 kindreds and were distributed over the whole protein-coding region, with the exception of the C terminus encoded in exon 10. Except for two mutations (delAG1801 and P560L) observed four times each, nearly every ALD family has a different mutation. Twenty-four of 37 mutations were missense mutations leading to amino acid changes located in or close to putative transmembrane segments (TMS 2, 3, 4, and 5), in the EAA-like motif and in the nucleotide fold of the ATP-binding domain of ALDP. Of 38 ALD patients tested, 27 (71%) lacked ALDP immunoreactivity in their fibroblasts and/or white blood cells. More than half of missense mutations studied (11 of 21) resulted in a complete lack of ALDP immunoreactivity, and six missense mutations resulted in decreased ALDP expression. The fibroblasts and/or white blood cells of 15 of 15 heterozygous carrier from ALD kindred with no ALDP showed a mixture of positive- and negative-ALDP immunoreactivity due to X-inactivation. Since 5%-15% of heterozygous women have normal VLCFA levels, the immunodetection of ALDP in white blood cells can be applicable in a majority of ALD kindred, to identify heterozygous women, particularly when the ALD gene mutation has not yet been identified.	HOP ST VINCENT DE PAUL,INSERM,U342,F-75014 PARIS,FRANCE; UNIV STRASBOURG 1,CNRS,INSERM,INST GENET & BIOL MOL & CELLULAIRE,ILLKIRCH GRAFFENS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								AUBOURG P, 1990, AM J HUM GENET, V46, P459; AUBOURG P, 1985, J LIPID RES, V26, P263; BARCELO A, 1994, HUM MOL GENET, V3, P1889, DOI 10.1093/hmg/3.10.1889; BERGER J, 1994, BIOCHEM BIOPH RES CO, V205, P1638, DOI 10.1006/bbrc.1994.2855; BOSSIER P, 1994, YEAST, V10, P681, DOI 10.1002/yea.320100512; BRAUN A, 1995, AM J HUM GENET, V56, P854; CARTIER N, 1995, P NATL ACAD SCI USA, V92, P1674, DOI 10.1073/pnas.92.5.1674; CARTIER N, 1993, HUM MOL GENET, V2, P1949, DOI 10.1093/hmg/2.11.1949; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; FANEN P, 1994, J CLIN INVEST, V94, P516, DOI 10.1172/JCI117363; FUCHS S, 1994, HUM MOL GENET, V3, P1903, DOI 10.1093/hmg/3.10.1903; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KEMP S, 1994, BIOCHEM BIOPH RES CO, V202, P647, DOI 10.1006/bbrc.1994.1979; KOK F, 1995, HUM MUTAT, V6, P104, DOI 10.1002/humu.1380060203; KOSTER W, 1992, MOL GEN GENET, V232, P399; LEIPER JM, 1995, TRENDS CELL BIOL, V5, P435, DOI 10.1016/S0962-8924(00)89103-5; LIGTENBERG MJL, 1995, AM J HUM GENET, V56, P44; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MAESTRI NE, 1992, AM J MED GENET, V44, P576, DOI 10.1002/ajmg.1320440509; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MOSER H, 1995, METABOLIC MOL BASES; MOSER HW, 1992, J INHERIT METAB DIS, V15, P645, DOI 10.1007/BF01799621; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; SARDE CO, 1994, GENOMICS, V22, P13, DOI 10.1006/geno.1994.1339; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; SOBUE G, 1994, ANN NEUROL, V36, P912, DOI 10.1002/ana.410360617; UCHIYAMA A, 1994, BIOCHEM BIOPH RES CO, V198, P632, DOI 10.1006/bbrc.1994.1092; VANGEEL BM, 1994, NEUROLOGY, V44, P2343, DOI 10.1212/WNL.44.12.2343; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WATKINS PA, 1995, AM J HUM GENET, V57, P292; WATKISS E, 1993, J MED GENET, V30, P651, DOI 10.1136/jmg.30.8.651; YASUTAKE T, 1995, J NEUROL SCI, V131, P58, DOI 10.1016/0022-510X(95)00047-6	35	86	90	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1135	1144						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651290				2022-12-18	WOS:A1996UM27100006
J	PERLIN, MW; LANCIA, G; NG, SK				PERLIN, MW; LANCIA, G; NG, SK			TOWARD FULLY AUTOMATED GENOTYPING - GENOTYPING MICROSATELLITE MARKERS BY DECONVOLUTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; BECKER MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; CYSTIC-FIBROSIS GENE; LINKAGE ANALYSIS; CARRIER DETECTION; HIGH-SPEED; DNA; IDENTIFICATION; DUCHENNE	Dense genetic linkage maps have been constructed for the human and mouse genomes, with average densities of 2.9 cM and 0.35 cM, respectively. These genetic maps are crucial for mapping both Mendelian and complex traits and are useful in clinical genetic diagnosis. Current maps are largely comprised of abundant, easily assayed, and highly polymorphic PCR-based microsatellite markers, primarily dinucleotide (CA), repeats. One key limitation of these length polymorphisms is the PCR stutter (or slippage) artifact that introduces additional stuffer bands. With two (or more) closely spaced alleles, the stutter bands overlap, and it is difficult to accurately determine the correct alleles; this stutter phenomenon has all but precluded full automation, since a human must visually inspect the allele data. We describe here novel deconvolution methods for accurate genotyping that mathematically remove PCR stutter artifact from microsatellite markers. These methods overcome the manual interpretation bottleneck and thereby enable full automation of genetic map construction and use. New functionalities, including the pooling of DNAs and the pooling of markers, are described that may greatly reduce the associated experimentation requirements.	CARNEGIE MELLON UNIV,GRAD SCH IND ADM,PITTSBURGH,PA 15213	Carnegie Mellon University	PERLIN, MW (corresponding author), CARNEGIE MELLON UNIV,DEPT COMP SCI,PITTSBURGH,PA 15213, USA.			Lancia, Giuseppe/0000-0001-5323-8483	NINDS NIH HHS [R01 NS32084] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032084] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CLEMENS PR, 1991, AM J HUM GENET, V49, P951; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEVLIN B, 1991, AM J HUM GENET, V48, P662; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAUGE XY, 1993, HUM MOL GENET, V2, P411, DOI 10.1093/hmg/2.4.411; JEFFREYS AJ, 1985, NATURE, V317, P818, DOI 10.1038/317818a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOBAYASHI H, 1995, HUM GENET, V95, P483; KOSTICHKA AJ, 1992, BIO-TECHNOL, V10, P78, DOI 10.1038/nbt0192-78; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1988, AM J HUM GENET, V42, P498; MANSFIELD DC, 1994, GENOMICS, V24, P225, DOI 10.1006/geno.1994.1610; MATHIES RA, 1992, NATURE, V359, P167, DOI 10.1038/359167a0; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Ott J., 1991, ANAL HUMAN GENETIC L; PAPADIMITRIOU CH, 1983, COMBINATORIAL OPTIMI; Papoulis A., 1977, SIGNAL ANAL; PERLIN MW, 1994, AM J HUM GENET, V55, P777; Press W. H., 1988, NUMERICAL RECIPES C; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Rich E., 1991, ARTIF INTELL; RIORDAN JR, 1989, SCIENCE, V245, P1066; SCHWARTZ LS, 1992, AM J HUM GENET, V51, P721; SCHWENGEL DA, 1994, GENOMICS, V22, P46, DOI 10.1006/geno.1994.1344; WEBER JL, 1989, AM J HUM GENET, V44, P388; WU KJ, 1993, RAPID COMMUN MASS SP, V7, P142, DOI 10.1002/rcm.1290070206; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	32	86	107	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1199	1210						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485172				2022-12-18	WOS:A1995TA44900028
J	GASPARINI, P; CALONGE, MJ; BISCEGLIA, L; PURROY, J; DIANZANI, I; NOTARANGELO, A; ROUSAUD, F; GALLUCCI, M; TESTAR, X; PONZONE, A; ESTIVILL, X; ZORZANO, A; PALACIN, M; NUNES, V; ZELANTE, L				GASPARINI, P; CALONGE, MJ; BISCEGLIA, L; PURROY, J; DIANZANI, I; NOTARANGELO, A; ROUSAUD, F; GALLUCCI, M; TESTAR, X; PONZONE, A; ESTIVILL, X; ZORZANO, A; PALACIN, M; NUNES, V; ZELANTE, L			MOLECULAR-GENETICS OF CYSTINURIA - IDENTIFICATION OF 4 NEW MUTATIONS AND 7 POLYMORPHISMS, AND EVIDENCE FOR GENETIC-HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID TRANSPORTER; EXPRESSION CLONING; RAT-KIDNEY; LOCALIZATION; CDNA	A cystinuria disease gene (rBAT) has been recently identified, and some mutations causing the disease have been described, The frequency of these mutations has been investigated in a large sample of 51 Italian and Spanish cystinuric patients. In addition, to identify new mutated alleles, genomic DNA has been analyzed by an accurate and sensitive method able to detect nucleotide changes. Because of the lack of information available on the genomic structure of rBAT gene, the study was carried out using the sequence data so far obtained by us. More than 70% of the entire coding sequence and 8 intronexon boundaries have been analyzed. Four new mutations and seven intragenic polymorphisms have been detected. All mutations so far identified in rBAT belong only to cystinuria type I alleles, accounting for similar to 44% of all type I cystinuric chromosomes. Mutation M467T is the most common mutated allele in the Italian and Spanish populations, After analysis of 70% of the rBAT coding region, we have detected normal sequences in cystinuria type II and type III chromosomes. The presence of rBAT mutated alleles only in type I chromosomes of homozygous (type I/I) and heterozygous (type I/III) patients provides evidence for genetic heterogeneity where rBAT would be responsible only for type I cystinuria and suggests a complementation mechanism to explain the intermediate type I/type III phenotype.	HOSP LLOBREGAT,INST RECERCA ONCOL,DEPT MOLEC GENET,BARCELONA,SPAIN; UNIV BARCELONA,FAC BIOL,DEPT BIOQUIM & FISIOL,BARCELONA,SPAIN; FDN PUIGVERT,IUNA,SERV NEFROL,BARCELONA,SPAIN; UNIV TURIN,IST CLIN PEDIAT,TURIN,ITALY; OSPED CRISTO RE,DIV UROL,ROME,ITALY	University of Barcelona; University of Barcelona; Fundacio Puigvert; University of Turin	GASPARINI, P (corresponding author), OSPED CASA SOLLIEVO SOFFERENZA,IRCCS,SERV GENET MED,I-71013 SAN GIOVANNI ROTO,ITALY.		Palacín, Manuel/G-9786-2015; Zorzano, Antonio/R-5479-2018; Bisceglia, Luigi/B-8720-2017; Nunes, Virginia/AAD-1014-2019; Nunes, Virginia/D-4356-2014; Gasparini, Paolo/B-6173-2014; Estivill, Xavier/A-3125-2013; Gallucci, Michele/K-9600-2016	Bisceglia, Luigi/0000-0001-5367-8518; Nunes, Virginia/0000-0002-5747-9310; Nunes, Virginia/0000-0002-5747-9310; Estivill, Xavier/0000-0002-0723-2256; Gallucci, Michele/0000-0002-3637-6531; Notarangelo, Angelantonio/0000-0002-1540-8530	Telethon [E.0083] Funding Source: Medline	Telethon(Fondazione Telethon)		BERTRAN J, 1993, J BIOL CHEM, V268, P14842; BISCEGLIA L, 1994, HUM MUTAT, V4, P136, DOI 10.1002/humu.1380040208; CALONGE MJ, IN PRESS P NATL ACAD; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; FURRIOLS M, 1993, J BIOL CHEM, V268, P27060; GASPARINI P, 1992, MOL CELL PROBE, V6, P1, DOI 10.1016/0890-8508(92)90064-5; GOODYER PR, 1993, J PEDIATR-US, V122, P568, DOI 10.1016/S0022-3476(05)83537-1; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; MCKUISCK V, 1992, MENDELIAN INHERITANC, P1322; MOSCKOVITZ R, 1994, FASEB J, V8, P1069, DOI 10.1096/fasebj.8.13.7926373; PALACIN M, 1994, J EXP BIOL, V196, P123; PICKEL VM, 1993, P NATL ACAD SCI USA, V90, P7779, DOI 10.1073/pnas.90.16.7779; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; Pras E., 1994, American Journal of Human Genetics, V55, pA236; Rosenberg L E, 1966, Trans Assoc Am Physicians, V79, P284; ROSENBERG LE, 1965, NEW ENGL J MED, V273, P1239, DOI 10.1056/NEJM196512022732303; ROSENBERG LE, 1966, J CLIN INVEST, V45, P365, DOI 10.1172/JCI105351; SALLY K, 1978, AM J MED GENET, V2, P175; SARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871, DOI 10.1093/nar/20.4.871; SEGAL S, 1989, METABOLIC BASIS INHE, P2479; SHAFER J, 1984, PFLUGERS ARCH, V401, P143; SILBERNAGL S, 1988, PHYSIOL REV, V68, P911, DOI 10.1152/physrev.1988.68.3.911; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; VOLKL H, 1982, PFLUG ARCH EUR J PHY, V395, P190, DOI 10.1007/BF00584808	25	86	87	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					781	788						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573036				2022-12-18	WOS:A1995RV79300006
J	HANNA, MG; NELSON, I; SWEENEY, MG; COOPER, JM; WATKINS, PJ; MORGANHUGHES, JA; HARDING, AE				HANNA, MG; NELSON, I; SWEENEY, MG; COOPER, JM; WATKINS, PJ; MORGANHUGHES, JA; HARDING, AE			CONGENITAL ENCEPHALOMYOPATHY AND ADULT-ONSET MYOPATHY AND DIABETES-MELLITUS - DIFFERENT PHENOTYPIC ASSOCIATIONS OF A NEW HETEROPLASMIC MTDNA TRANSFER-RNA GLUTAMIC-ACID MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUSCLE MITOCHONDRIAL-DNA; RED FIBERS MERRF; SKELETAL-MUSCLE; TRANSFER RNALEU(UUR); MYOCLONIC EPILEPSY; RNALYS MUTATION; DISEASE; DELETIONS; CARDIOMYOPATHY; DEAFNESS	We report the clinical, biochemical, and molecular genetic findings in a family with an unusual mitochondrial disease phenotype harboring a novel mtDNA tRNA glutamic acid mutation at position 14709. The proband and his sister presented with congenital myopathy and mental retardation and subsequently developed cerebellar ataxia. Other family members had either adult-onset diabetes mellitus with muscle weakness or adult-onset diabetes mellitus alone, Ragged-red and cytochrome c oxidase (COX)-negative fibers were present in muscle biopsies. Biochemical studies of muscle mitochondria showed reduced complex I and TV activities. The mtDNA mutation was heteroplasmic in blood and muscle in all matrilineal relatives analyzed. Primary myoblast, but not fibroblast, cultures containing high proportions of mutant mtDNA exhibited impaired mitochondrial translation. These observations indicate that mtDNA tRNA point mutations should be considered in the differential diagnosis of congenital myopathy. In addition they illustrate the diversity of phenotypes associated with this mutation in the same family and further highlight the association between mtDNA mutations and diabetes mellitus.	UNIV LONDON, INST NEUROL, DEPT CLIN NEUROL, LONDON WC1N 3BG, ENGLAND; ROYAL FREE HOSP, SCH MED, DEPT CLIN NEUROSCI, LONDON, ENGLAND; UNIV LONDON KINGS COLL HOSP, DEPT DIABET, LONDON SE5 9RS, ENGLAND	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London			Cooper, J Mark/D-5826-2013; Hanna, Michael G/B-1995-2009; Cooper, Jonathan/E-9000-2010	Cooper, J Mark/0000-0002-3007-3054; Cooper, Jonathan/0000-0002-2358-1050; Hanna, Michael/0000-0003-0825-4075; nelson, isabelle/0000-0001-6390-622X				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHCROFT FM, 1992, INSULIN MOL BIOL PAT, P97; Attardi G, 1979, Methods Enzymol, V56, P66; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BOULET L, 1992, AM J HUM GENET, V51, P1187; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; DIMAURO S, 1992, MOL GENETIC BASIS NE, P665; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; MANFREDI G, 1994, MUSCLE NERVE       S, V1, pS137; MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MERANTE F, 1994, AM J HUM GENET, V55, P437; Moraes C. T., 1994, American Journal of Human Genetics, V55, pA232; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284; MORGANHUGHES JA, 1977, BRAIN, V100, P617, DOI 10.1093/brain/100.4.617; MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; POULTON J, 1989, LANCET, V1, P236; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; SAHASHI K, 1994, MUSCLE NERVE       S, V1, pS139; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0; TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I; TANAKA M, 1992, BIOCHEM BIOPH RES CO, V188, P490, DOI 10.1016/0006-291X(92)91082-2; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YASIN R, 1977, J NEUROL SCI, V32, P347, DOI 10.1016/0022-510X(77)90018-1; YOON KL, 1993, PEDIATR RES, V33, P433, DOI 10.1203/00006450-199305000-00002; ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	43	86	87	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1026	1033						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726155				2022-12-18	WOS:A1995QU58600002
J	HEYER, E; TREMBLAY, M				HEYER, E; TREMBLAY, M			VARIABILITY OF THE GENETIC CONTRIBUTION OF QUEBEC POPULATION FOUNDERS ASSOCIATED TO SOME DELETERIOUS GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIES	Relatively high frequencies of some rare inherited disorders can be found in the Saguenay Region (Quebec). To understand this phenomenon, a research project on the 17th-century founder effect that led to the formation of French Canadians' gene pool is being carried out. The focus of this study is on founders who contributed to the Saguenay gene pool and who are related to contemporary probands suffering from any one of five hereditary diseases: cystic fibrosis, tyrosinemia, hemochromatosis, Charlevoix-Saguenay spastic ataxia, and sensorimotor polyneuropathia with or without agenesis of the corpus callosum. A control group has been added for comparison purposes. Altogether, 545 ascending genealogies have been reconstructed, using the Interuniversity Institute for Population Research's RETRO database, leading to >2,500 founders. The genetic contribution of each founder to each group has been measured. Results show that (1) nearly 80% of the individuals' gene pool come from founders who settled in Nouvelle-France in the 17th century, whatever the group; (2) 15% of the founders explain 90% of the total genetic contribution of the founders, but this pattern varies from one group to another; (3) there is no subgroup of founders more related to any given group of individuals.			HEYER, E (corresponding author), UNIV QUEBEC,INST POPULAT RES,555 BLVD UNIV,CHICOUTIMI,PQ G7H 2B1,CANADA.		Heyer, Evelyne/K-9184-2013	Heyer, Evelyne/0000-0002-0266-3196				BOTHWELLTH, 1989, METABOLIC BASIS INHE, P1433; BOUCHARD G, 1991, HIST GENOME, P281; Bouchard G, 1992, POURQUOI MALADIES HE; BOUCHARD G, 1991, HIST UN GENOME POPUL; BOUCHARD G, 1991, HIST POPULATIONS LIB, P319; BOUCHARD G, 1993, MOBILITE GEOGRAPHIQU; CHAPMAN AM, 1971, EDITIONS I NATIONAL, V60; CHARBONNEAU H, 1987, NAISSANCE UNE POPULA; DEBRAEKELEER M, 1991, HIST GENOME POPULATI, P427; DEMERS SI, 1994, AM J HUM GENET, V55, P327; FUJIWARA TM, 1989, AM J HUM GENET, V44, P327; GROMPE M, 1994, NEW ENGL J MED, V331, P353, DOI 10.1056/NEJM199408113310603; Henripin Jacques, POPULATION QUEBEC ET, P23; HEYER E, 1991, THESIS U C BERNARD L; HEYER E, 1993, ANN HUM BIOL, V206, P565; Jacquard A., 1974, GENETIC STRUCTURE PO; JOMPHE M, 1994, RETRO IIIC97 INT U I; Mayr E., 1963, ANIMAL SPECIES EVOLU; OBRIEN E, 1988, AM J PHYS ANTHROPOL, V77, P335, DOI 10.1002/ajpa.1330770306; POUYEZ C, 1983, SAGUENAYENS; ROBERTS DF, 1968, NATURE, V220, P1084, DOI 10.1038/2201084a0; ROZEN R, 1990, AM J HUM GENET, V47, P606; THOMPSON EA, 1989, ANN HUM GENET, V53, P357, DOI 10.1111/j.1469-1809.1989.tb01804.x; TTHOMPSON EA, 1986, PEDIGREE ANAL HUMAN; VIGNEAULT A, 1991, THESIS U QUEBEC CHIC	25	86	88	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					970	978						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717408				2022-12-18	WOS:A1995QP66300019
J	ELSAS, LJ; LANGLEY, S; STEELE, E; EVINGER, J; FRIDOVICHKEIL, JL; BROWN, A; SINGH, R; FERNHOFF, P; HJELM, LN; DEMBURE, PP				ELSAS, LJ; LANGLEY, S; STEELE, E; EVINGER, J; FRIDOVICHKEIL, JL; BROWN, A; SINGH, R; FERNHOFF, P; HJELM, LN; DEMBURE, PP			GALACTOSEMIA - A STRATEGY TO IDENTIFY NEW BIOCHEMICAL PHENOTYPES AND MOLECULAR GENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GALACTOSE-1-PHOSPHATE URIDYLTRANSFERASE; URIDYL TRANSFERASE; MUTATIONS; URIDYLYLTRANSFERASE; GENE; POLYMORPHISM; VARIANT	We describe a stratagem for identifying new mutations in the galactose-1-phosphate uridyl transferase (GALT) gene. GALT enzyme activity and isoforms were defined in erythrocytes from probands and their first-degree relatives. If the biochemical phenotypes segregated in an autosomal recessive pattern, we screened for common mutations by using multiplex PCR and restriction endonuclease digestions. If common mutant alleles were not present, the 11 exons of the GALT gene were amplified by PCR, and variations from the normal nucleotide sequences were identified by SSCP. The suspected region(s) was then analyzed by direct DNA sequencing. We identified 86 mutant GALT alleles that reduced erythrocyte GALT activity. Seventy-five of these GALT genomes had abnormal SSCP patterns, of which 41 were sequenced, yielding 12 new and 21 previously reported, rare mutations. Among the novel group of 12 new mutations, an unusual biochemical phenotype was found in a family whose newborn proband has classical galactosemia. He had inherited two mutations in cis (N314D-E203K) from his father, whose GALT activity was near normal, and an additional GALT mutation in the splice-acceptor site of intron C (IVSC) from his mother. The substitution of a positively charged E203K mutation created a unique isoform-banding pattern. An asymptomatic sister's GALT genes carries three mutations (E203K-N314D/N314D) with eight distinct isoform bands. Surprisingly, her erythrocytes have normal GALT activity. We conclude that the synergism of pedigree, biochemical, SSCP, and direct GALT gene analyses is an efficient protocol for identifying new mutations and speculate that E203K and N314D codon changes produce intraallelic complementation when in cis.	EMORY UNIV,SCH MED,DEPT MOLEC & MED GENET,ATLANTA,GA	Emory University	ELSAS, LJ (corresponding author), EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,2040 RIDGEWOOD DR NE,ATLANTA,GA 30322, USA.				NICHD NIH HHS [P0-1 HD29847-01] Funding Source: Medline; NIDDK NIH HHS [1R29DK46403-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD029847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046403] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN MW, 1984, HUM GENET, V65, P287, DOI 10.1007/BF00286519; ANDERSEN MW, 1983, ARCH BIOCHEM BIOPHYS, V222, P326, DOI 10.1016/0003-9861(83)90530-1; ASHINO J, 1993, AM J HUM GENET, V53, P887; BERGMEYER H, 1974, METHOD ENZYMAT AN, P1291; BEUTLER E, 1966, J LAB CLIN MED, V68, P646; BEUTLER E, 1973, ISRAEL J MED SCI, V9, P1323; BEUTLER E, 1965, J LAB CLIN MED, V64, P646; ELSAS LJ, 1994, AM J HUM GENET, V54, P1030; ELSAS LJ, IN PRESS EUR J PEDIA; Elsas LJ, 1993, INT PEDIATR, V8, P101; FLACH JE, 1990, MOL BIOL MED, V7, P365; FOX JG, 1987, CAN MED ASSOC J, V137, P883; FREY PA, 1982, METHOD ENZYMOL, V87, P20; FRIDOVICHKEIL JL, 1993, P NATL ACAD SCI USA, V90, P398, DOI 10.1073/pnas.90.2.398; Henry R.J., 1964, CLIN CHEM PRINCIPLES; KELLEY RI, 1983, HUM GENET, V63, P274; KELLEY RI, 1989, J LAB CLIN MED, V114, P152; KUHNL P, 1974, HUMANGENETIK, V24, P227; LEE JES, 1982, CLIN CHIM ACTA, V124, P351, DOI 10.1016/0009-8981(82)90429-6; LELOIR LF, 1957, ARCH BIOCHEM BIOPHYS, V33, P186; LEMAIRE HG, 1986, NUCLEIC ACIDS RES, V14, P7705, DOI 10.1093/nar/14.19.7705; LESLIE ND, 1992, GENOMICS, V14, P474, DOI 10.1016/S0888-7543(05)80244-7; LONGO N, 1992, J BIOL CHEM, V267, P12416; LONGO N, 1993, P NATL ACAD SCI USA, V90, P60, DOI 10.1073/pnas.90.1.60; MELLMAN WJ, 1965, J LAB CLIN MED, V66, P980; MELLMAN WJ, 1968, ANN HUM GENET, V32, P1, DOI 10.1111/j.1469-1809.1968.tb00043.x; NG WG, 1967, CLIN CHIM ACTA, V15, P489, DOI 10.1016/0009-8981(67)90014-9; NG WG, 1973, ANN HUM GENET, V37, P1, DOI 10.1111/j.1469-1809.1973.tb01808.x; REICHARDT JKV, 1992, BIOCHEMISTRY-US, V31, P5430, DOI 10.1021/bi00139a002; REICHARDT JKV, 1988, MOL BIOL MED, V5, P107; REICHARDT JKV, 1991, AM J HUM GENET, V49, P860; REICHARDT JKV, 1991, P NATL ACAD SCI USA, V88, P2633, DOI 10.1073/pnas.88.7.2633; REICHARDT JKV, 1993, HUM MOL GENET, V2, P325; REICHARDT JKV, 1992, GENOMICS, V12, P596, DOI 10.1016/0888-7543(92)90453-Y; REICHARDT JKV, 1993, INT PEDIAT, V8, P110; Segal S, 1989, METABOLIC BASIS INHE, P453; SHIN YS, 1987, CLIN CHIM ACTA, V166, P27, DOI 10.1016/0009-8981(87)90191-4; SPARKES MC, 1987, HUM GENET, V40, P93; Tajima M, 1985, Yeast, V1, P67, DOI 10.1002/yea.320010108; TEDESCO TA, 1972, J BIOL CHEM, V247, P6631	40	86	88	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					630	639						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887416				2022-12-18	WOS:A1995QK91800011
J	BOERWINKLE, E; BROWN, S; SHARRETT, AR; HEISS, G; PATSCH, W				BOERWINKLE, E; BROWN, S; SHARRETT, AR; HEISS, G; PATSCH, W			APOLIPOPROTEIN-E POLYMORPHISM INFLUENCES POSTPRANDIAL RETINYL PALMITATE BUT NOT TRIGLYCERIDE CONCENTRATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; LOW-DENSITY-LIPOPROTEIN; CHOLESTERYL-ESTER TRANSFER; RECEPTOR-BINDING ACTIVITY; LIPID TRANSFER PROTEINS; APOPROTEIN-E PHENOTYPE; CHYLOMICRON REMNANTS; PLASMA-CLEARANCE; RICH LIPOPROTEINS; HEPATIC LIPASE	To quantify the effect of the apolipoprotein (ape)E polymorphism on the magnitude of postprandial lipemia, we have defined its role in determining the response to a single high-fat meal in a large sample of (N = 474) individuals taking part in the biethnic Atherosclerosis Risk in Communities Study. The profile of postprandial response in plasma was monitored over 8 h by triglyceride, triglyceride-rich lipoprotein (TGRL)-triglyceride, apo B-48/apo B-100 ratio, and retinyl palmitate concentrations, and the apo E polymorphism was determined by DNA amplification and digestion. The frequency of the apo E alleles and their effects on fasting lipid levels in this sample were similar to those reported elsewhere. Postprandial plasma retinyl palmitate response to a high-fat meal with vitamin A was significantly different among ape E genotypes, with delayed clearance in individuals with an epsilon 2 allele, compared with epsilon 3/3 and epsilon 3/4 individuals. In the sample of 397 Caucasians, average retinyl palmitate response was 1,489 mu g/dl in epsilon 2/3 individuals, compared with 1,037 mu g/dl in epsilon 3/3 individuals and 1,108 mu g/dl in epsilon 3/4 individuals. The apo E polymorphism accounted for 7.1% of the interindividual variation in postprandial retinyl palmitate response, a contribution proportionally greater than its well-known effect on fasting LDL-cholesterol. However, despite this effect on postprandial retinyl palmitate, the profile of postprandial triglyceride response was not significantly different among apo E genotypes. The profile of postprandial response was consistent between the sample of Caucasians and a smaller sample of black subjects. While these data indicate that the removal of remnant particles from circulation is delayed in subjects with the epsilon 2/3 genotype, there is no reported evidence that the epsilon 2 allele predisposes to coronary artery disease (CAD). The results of this study provide not only a reliable estimate of the magnitude of the effect of the apo E polymorphism on various measurements commonly used to characterize postprandial lipemia, but also provide mechanistic insight into the effects of the apo E gene polymorphism on postprandial lipemia and CAD.	METHODIST HOSP, DEPT INTERNAL MED, HOUSTON, TX USA; BAYLOR COLL MED, HOUSTON, TX USA; NHLBI, EPIDEMIOL & BIOMETRY PROGRAM, BETHESDA, MD USA; UNIV N CAROLINA, DEPT EPIDEMIOL, CHAPEL HILL, NC USA	The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill	BOERWINKLE, E (corresponding author), UNIV TEXAS, HLTH SCI CTR, CTR GENET, POB 20334, HOUSTON, TX 77225 USA.				NHLBI NIH HHS [N01-HC55015, HL-40613, HL-27341] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL027341, P50HL027341, R29HL040613] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1984, ARTERIOSCLEROSIS, V4, P49, DOI 10.1161/01.ATV.4.1.49; AMEDEEMANESME O, 1984, AM J CLIN NUTR, V39, P315, DOI 10.1093/ajcn/39.2.315; [Anonymous], 1991, J Neuroimaging, V1, P68; [Anonymous], 1985, ANN INTERN MED, V103, P1073, DOI 10.7326/0003-4819-103-6-1073; AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2; BERR F, 1984, J LIPID RES, V25, P805; BERR F, 1992, J LIPID RES, V33, P915; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BRENNINKMEIJER BJ, 1987, J LIPID RES, V28, P361; BROWN AJ, 1991, ARTERIOSCLER THROMB, V11, P1737, DOI 10.1161/01.ATV.11.6.1737; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BROWN SA, 1988, CLIN CHEM, V34, P920; BROWN SA, 1992, AM J EPIDEMIOL, V136, P538, DOI 10.1093/oxfordjournals.aje.a116531; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; Cochran W.G, 1957, STAT METHODS, V6th ed; COHN JS, 1988, J LIPID RES, V29, P925; COHN JS, 1988, J LIPID RES, V29, P469; Conover WJ, 1980, PRACTICAL NONPARAMET; CRAIG WY, 1988, J BIOL CHEM, V263, P13880; CUMMING AM, 1984, CLIN GENET, V25, P310; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; Daniel Wayne W., 2000, APPL NONPARAMETRIC S; DAUGHERTY A, 1985, J LIPID RES, V26, P955; EHNHOLM C, 1984, P NATL ACAD SCI-BIOL, V81, P5566, DOI 10.1073/pnas.81.17.5566; EICHNER JE, 1989, GENET EPIDEMIOL, V6, P681, DOI 10.1002/gepi.1370060605; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; FAINARU M, 1982, J LIPID RES, V23, P702; FLOREN CH, 1981, BIOCHIM BIOPHYS ACTA, V663, P336, DOI 10.1016/0005-2760(81)90219-8; FUMERON F, 1988, CLIN GENET, V34, P258; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; GHISELLI G, 1982, J CLIN INVEST, V70, P474, DOI 10.1172/JCI110638; GIANTURCO SH, 1988, J CLIN INVEST, V82, P1633, DOI 10.1172/JCI113775; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; GROOT PHE, 1991, ARTERIOSCLER THROMB, V11, P653, DOI 10.1161/01.ATV.11.3.653; GUEGUEN R, 1989, AM J HUM GENET, V45, P793; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; HAZZARD WR, 1976, METABOLISM, V25, P777, DOI 10.1016/0026-0495(76)90149-9; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; HIXSON JE, 1990, J LIPID RES, V31, P545; HOEG JM, 1990, J LIPID RES, V31, P1761; HUFF MW, 1991, ARTERIOSCLER THROMB, V11, P221, DOI 10.1161/01.ATV.11.2.221; HUI DY, 1984, J BIOL CHEM, V259, P860; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; INNERARITY TL, 1978, J BIOL CHEM, V253, P6289; KESANIEMI YA, 1983, ARTERIOSCLEROSIS, V3, P170, DOI 10.1161/01.ATV.3.2.170; KESANIEMI YA, 1987, J CLIN INVEST, V80, P578, DOI 10.1172/JCI113107; KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENZEN HJ, 1986, CLIN CHEM, V32, P778; Lohman TG, 1988, ANTHROPOMETRIC STAND; Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195; MAHLEY RW, 1990, CURRENT OPINION LIPI, V1, P87; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MIESENBOCK G, 1990, ATHER REV, V21, P119; MIESENBOCK G, 1993, J CLIN INVEST, V91, P448, DOI 10.1172/JCI116222; MORRISON DF, 1976, MULTIVARIATE STATIST; NESTEL PJ, 1964, J CLIN INVEST, V43, P943, DOI 10.1172/JCI104980; NETER J, 1990, APPLIED LINEAR STATI; NIKKILA EA, 1987, AM HEART J, V113, P543, DOI 10.1016/0002-8703(87)90629-6; PATSCH JR, 1987, J CLIN INVEST, V80, P341, DOI 10.1172/JCI113078; PATSCH JR, 1984, J CLIN INVEST, V74, P2017, DOI 10.1172/JCI111624; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; PATSCH W, 1992, AM J EPIDEMIOL, V136, P546, DOI 10.1093/oxfordjournals.aje.a116532; PATSCH W, 1989, CLIN CHEM, V35, P265; RYU JE, 1992, STROKE, V23, P823, DOI 10.1161/01.STR.23.6.823; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; SCHONFELD G, 1974, J CLIN INVEST, V53, P1458, DOI 10.1172/JCI107694; SRINIVASAN SR, 1989, METABOLISM, V38, P1173, DOI 10.1016/0026-0495(89)90155-8; STENDER S, 1982, ARTERIOSCLEROSIS, V2, P493, DOI 10.1161/01.ATV.2.6.493; SUPERKO HR, 1991, ARTERY, V18, P315; TALL A, 1990, ATHEROSCLER REV, V21, P119; TALL AR, 1986, J LIPID RES, V27, P361; UTERMANN G, 1984, HUM GENET, V65, P232, DOI 10.1007/BF00286508; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WILSON DE, 1970, J LAB CLIN MED, V75, P264; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473; 1982, MANUAL OPERATIONS LI	82	86	88	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					341	360						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304350				2022-12-18	WOS:A1994MU31500018
J	DANPURE, CJ; PURDUE, PE; FRYER, P; GRIFFITHS, S; ALLSOP, J; LUMB, MJ; GUTTRIDGE, KM; JENNINGS, PR; SCHEINMAN, JI; MAUER, SM; DAVIDSON, NO				DANPURE, CJ; PURDUE, PE; FRYER, P; GRIFFITHS, S; ALLSOP, J; LUMB, MJ; GUTTRIDGE, KM; JENNINGS, PR; SCHEINMAN, JI; MAUER, SM; DAVIDSON, NO			ENZYMOLOGICAL AND MUTATIONAL ANALYSIS OF A COMPLEX PRIMARY HYPEROXALURIA TYPE-1 PHENOTYPE INVOLVING ALANINE - GLYOXYLATE AMINOTRANSFERASE PEROXISOME-TO-MITOCHONDRION MISTARGETING AND INTRAPEROXISOMAL AGGREGATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-LIVER; PYRUVATE AMINOTRANSFERASE; HEPATIC ALANINE; URATE OXIDASE; RAT-LIVER; IMMUNOCYTOCHEMICAL LOCALIZATION; SUBCELLULAR-DISTRIBUTION; CATALYTIC ACTIVITY; POINT MUTATION; SERINE	Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disease caused by a deficiency of the liver-specific peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT). Three unrelated PH1 patients, who possess a novel complex phenotype, are described. At the enzymological level, this phenotype is characterized by a complete, or nearly complete, absence of AGT catalytic activity and reduced AGT immunoreactivity. Unlike normal individuals in whom the AGT is confined to the peroxisomal matrix, the immunoreactive AGT in these three patients was distributed approximately equally between the peroxisomes and mitochondria. The peroxisomal AGT appeared to be aggregated into amorphous core-like structures in which no other peroxisomal enzymes could be identified. Mutational analysis of the AGT gene showed that two of the three patients were compound heterozygotes for two previously unrecognized point mutations which caused Gly41-->Arg and Phe152-->Iso amino acid substitutions. The third patient was shown to be a compound heterozygote for the Gly41-->Arg mutation and a previously recognized Gly170-->Arg mutation. All three patients were homozygous for the Pro11-->Leu polymorphism that had been found previously with a high allelic frequency in normal populations. It is suggested that the Phe152-->Iso and Gly170-->Arg substitutions, which are only eighteen residues apart and located in the same highly conserved internal region of 58 amino acids, might be involved in the inhibition of peroxisomal targeting and/or import of AGT and, in combination with the Pro11-->Leu polymorphism, be responsible for its aberrant mitochondrial compartmentalization. On the other hand, the Gly41-->Arg substitution, either in combination with the Pro11-->Leu polymorphism or by itself, is predicted to be responsible for the intraperoxisomal aggregation of the AGT protein.	MRC,CLIN RES CTR,ELECTRON MICROSCOPY SUPPORT GRP,HARROW HA1 3UJ,MIDDX,ENGLAND; DUKE UNIV,MED CTR,DURHAM,NC 27710; UNIV CHICAGO,SCH MED,CHICAGO,IL 60637; UNIV MINNESOTA,VARIETY CLUB CHILDRENS HOSP,MINNEAPOLIS,MN 55455	Medical Research Council Clinical Trials Unit; Duke University; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities	DANPURE, CJ (corresponding author), MRC,CLIN RES CTR,BIOCHEM GENET RES GRP,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR 00055] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AFZELIUS BA, 1965, J CELL BIOL, V26, P835, DOI 10.1083/jcb.26.3.835; ALLSOP J, 1987, CLIN CHIM ACTA, V170, P187, DOI 10.1016/0009-8981(87)90127-6; ANGERMULLER S, 1986, J HISTOCHEM CYTOCHEM, V34, P159, DOI 10.1177/34.2.3080517; BIEMPICA L, 1966, J CELL BIOL, V29, P383, DOI 10.1083/jcb.29.2.383; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COLLINS JC, 1989, GASTROENTEROLOGY, V97, P766, DOI 10.1016/0016-5085(89)90651-3; COOPER PJ, 1988, J HISTOCHEM CYTOCHEM, V36, P1285, DOI 10.1177/36.10.3418107; COOPER PJ, 1988, BIOCHEM SOC T, V16, P627, DOI 10.1042/bst0160627; DANPURE CJ, 1991, AM J KIDNEY DIS, V17, P366, DOI 10.1016/S0272-6386(12)80624-X; DANPURE CJ, 1988, CLIN SCI, V75, P315, DOI 10.1042/cs0750315; DANPURE CJ, 1990, J CELL SCI, V97, P669; DANPURE CJ, 1986, FEBS LETT, V201, P20, DOI 10.1016/0014-5793(86)80563-4; DANPURE CJ, 1989, J CELL BIOL, V108, P1345, DOI 10.1083/jcb.108.4.1345; DENETTO LA, 1991, ADV EXP MED BIOL, V309, P373; ECHAVARRIA AV, 1988, FASEB J, V2, P3092; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GRZYBEK H, 1986, EUR J CELL BIOL, V41, P16; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; JANSEN R, 1990, NUCLEIC ACIDS RES, V18, P5153, DOI 10.1093/nar/18.17.5153; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MINATOGAWA Y, 1992, HUM MOL GENET, V1, P643, DOI 10.1093/hmg/1.8.643; NISHIYAMA K, 1991, BIOCHEM BIOPH RES CO, V176, P1093, DOI 10.1016/0006-291X(91)90396-O; NOGUCHI T, 1978, J BIOL CHEM, V253, P7598; NOGUCHI T, 1979, ARCH BIOCHEM BIOPHYS, V196, P645, DOI 10.1016/0003-9861(79)90319-9; ODA T, 1987, EUR J BIOCHEM, V168, P537, DOI 10.1111/j.1432-1033.1987.tb13451.x; PURADUE PE, 1991, P NATL ACAD SCI USA, V88, P10900; PURDUE PE, 1991, HUM GENET, V87, P394; PURDUE PE, 1992, GENOMICS, V13, P215, DOI 10.1016/0888-7543(92)90225-H; PURDUE PE, 1991, GENOMICS, V10, P34, DOI 10.1016/0888-7543(91)90481-S; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; PURDUE PE, 1992, EUR J BIOCHEM, V207, P757, DOI 10.1111/j.1432-1033.1992.tb17106.x; ROTH J, 1982, TECHNIQUES IMMUNOCYT, P108; Sambrook J., 1989, MOL CLONING LAB MANU; STERNLIEB I, 1977, LAB INVEST, V36, P140; TAKADA Y, 1990, BIOCHEM J, V268, P517, DOI 10.1042/bj2680517; TAKADA Y, 1982, COMP BIOCHEM PHYS B, V72, P597, DOI 10.1016/0305-0491(82)90512-0; TENG BB, 1990, J BIOL CHEM, V265, P20616; THOMPSON JS, 1967, J BIOL CHEM, V242, P3614; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOLKL A, 1988, J HISTOCHEM CYTOCHEM, V36, P329, DOI 10.1177/36.4.3346536; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WATTS RWE, 1991, NEPHROL DIAL TRANSPL, V6, P502, DOI 10.1093/ndt/6.7.502; Williams HE, 1983, METABOLIC BASIS INHE, P204; WISE PJ, 1987, FEBS LETT, V222, P17, DOI 10.1016/0014-5793(87)80183-7; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; YELDANDI AV, 1990, BIOCHEM BIOPH RES CO, V171, P641, DOI 10.1016/0006-291X(90)91194-W; YOKOTA S, 1987, HISTOCHEMISTRY, V87, P601, DOI 10.1007/BF00492477	49	86	88	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					417	432						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8101040				2022-12-18	WOS:A1993LN82000014
J	DRYJA, TP; RAPAPORT, J; MCGEE, TL; NORK, TM; SCHWARTZ, TL				DRYJA, TP; RAPAPORT, J; MCGEE, TL; NORK, TM; SCHWARTZ, TL			MOLECULAR ETIOLOGY OF LOW-PENETRANCE RETINOBLASTOMA IN 2 PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY RETINOBLASTOMA; SUSCEPTIBILITY GENE; WILSON DISEASE; MUTATIONS; CHROMOSOME-13; POLYMORPHISMS; ASSIGNMENT; SEQUENCE	In one family with low-penetrance retinoblastoma, a germ-line deletion is shared by affected and unaffected, obligate carriers. The deletion encompasses exon 4 of the retinoblastoma gene and corresponds to a mutant protein without residues 127-166. In a second family, RFLP analysis shows that two distant relatives have independently derived mutations. These families, together with others reported elsewhere, indicate that attributes of alleles at the retinoblastoma locus specify penetrance.	W VIRGINIA UNIV,HLTH SCI CTR,UNIV EYE CTR,DEPT OPHTHALMOL,MORGANTOWN,WV 26506	West Virginia University	DRYJA, TP (corresponding author), HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,DEPT OPHTHALMOL,243 CHARLES ST,BOSTON,MA 02114, USA.				NEI NIH HHS [EY08724, EY05321] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008724, R01EY005321] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CONNOLLY MJ, 1983, HUM GENET, V65, P122, DOI 10.1007/BF00286647; DEVESA SS, 1975, AM J OPHTHALMOL, V80, P263, DOI 10.1016/0002-9394(75)90143-9; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GODBOUT R, 1983, NATURE, V304, P451, DOI 10.1038/304451a0; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; HAINES JL, 1988, GENET EPIDEMIOL, V5, P375, DOI 10.1002/gepi.1370050602; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HOGG A, 1992, ONCOGENE, V7, P1445; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; MACKLIN MT, 1960, AM J HUM GENET, V12, P1; MATSUNAGA E, 1980, HUM GENET, V56, P53; MATSUNAGA E, 1978, AM J HUM GENET, V30, P406; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; MUNIER F, 1992, HUM GENET, V89, P508, DOI 10.1007/BF00219175; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; ONADIM Z, 1991, BRIT J OPHTHALMOL, V75, P147, DOI 10.1136/bjo.75.3.147; ONADIM ZO, 1990, ARCH DIS CHILD-FETAL, V65, P651, DOI 10.1136/adc.65.7_Spec_No.651; Rosner B., 1986, FUNDAMENTALS BIOSTAT, V2nd, P442; SAKAI T, 1991, AM J HUM GENET, V48, P880; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; STRONG LC, 1981, SCIENCE, V213, P1501, DOI 10.1126/science.7280668; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YANDELL DW, 1989, AM J HUM GENET, V45, P547; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	36	86	88	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1122	1128						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8099255				2022-12-18	WOS:A1993LG13300013
J	ALTHERR, MR; BENGTSSON, U; ELDER, FFB; LEDBETTER, DH; WASMUTH, JJ; MCDONALD, ME; GUSELLA, JF; GREENBERG, F				ALTHERR, MR; BENGTSSON, U; ELDER, FFB; LEDBETTER, DH; WASMUTH, JJ; MCDONALD, ME; GUSELLA, JF; GREENBERG, F			MOLECULAR CONFIRMATION OF WOLF-HIRSCHHORN SYNDROME WITH A SUBTLE TRANSLOCATION OF CHROMOSOME-4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; DNA MARKERS; SHORT ARM; LOCUS; D4S10	Wolf-Hirschhorn syndrome is a clinically recognizable, multiple congenital anomaly syndrome usually associated with terminal deletion of the short arm of chromosome 4. A girl with clinical features of Wolf-Hirschhorn syndrome did not show an obvious deletion of chromosome 4, and a molecular defect was suspected. RFLPs of genomic DNA from the proband and her parents were studied using DNA probes from the distal region of chromosome 4p. Fluorescence in situ hybridization using a cosmid p847.351 containing the fragment 847 E-C was performed to investigate the possibility of a subtle translocation. Cytogenetic analyses done on the child and on both parents did not conclusively reveal abnormalities of chromosome 4. Molecular studies using two probes mapped to distal 4p showed the absence of the maternal haplotype in the child. These findings are thus consistent with a molecular deletion of 4p and confirm the diagnosis of Wolf-Hirschhorn syndrome. Cytogenetic experiments involving fluorescence in situ hybridization showed that the mother carried a subtle translocation between chromosomes 4 and 19, 46,XX,t(4,19)(p16.3; p13.3), which resulted in an unbalanced form in the child. Chorionic villus sampling for prenatal diagnosis in a subsequent pregnancy showed the fetus to be unaffected. This provides the first evidence, in chromosome 4p, of a molecular deletion due to a subtle, inherited translocation leading to the Wolf-Hirschhorn phenotype. Such subtle translocations may become an important mechanism for some recurrent genetic defects.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,ROOM S903,HOUSTON,TX 77030; UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Baylor College of Medicine; University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	GREENBERG, F (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,ROOM S903,HOUSTON,TX 77030, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025631] Funding Source: NIH RePORTER; NINDS NIH HHS [NS25631-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTHERR MR, 1989, GENOMICS, V5, P581, DOI 10.1016/0888-7543(89)90026-8; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BUCAN M, 1990, GENOMICS, V6, P1; BYRNE JLB, 1980, AM J HUM GENET S, pA64; DEGROUCHY J, 1985, CLIN ATLAS HUMAN CHR; DRISCOLL DA, 1989, PEDIATR RES, V25, pA140; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; HIRSCHHORN K, 1965, HUMANGENETIK, V1, P479; KUWANO A, 1991, AM J HUM GENET, V49, P707; LAMB J, 1989, LANCET, V2, P819; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LURIE IW, 1980, CLIN GENET, V17, P375; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; Maniatis T., 1982, MOL CLONING; MCKEOWN C, 1987, J MED GENET, V24, P410, DOI 10.1136/jmg.24.7.410; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; SCHINZEL A, 1988, J MED GENET, V25, P454, DOI 10.1136/jmg.25.7.454; SMITH B, 1988, AM J HUM GENET, V42, P335; TUCKER JD, 1988, CYTOGENET CELL GENET, V48, P103, DOI 10.1159/000132600; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WILSON MG, 1981, HUM GENET, V59, P297, DOI 10.1007/BF00295461; WOLF U, 1976, HUMANGENETIK, V1, P397; 1985, CYTOGENET CELL GENET, V31, P1	24	86	87	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1235	1242						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746553				2022-12-18	WOS:A1991GU67200010
J	HECHT, JT; WANG, Y; BLANTON, SH; MICHELS, VV; DAIGER, SP				HECHT, JT; WANG, Y; BLANTON, SH; MICHELS, VV; DAIGER, SP			CLEFT-LIP AND PALATE - NO EVIDENCE OF LINKAGE TO TRANSFORMING GROWTH FACTOR-ALPHA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICS	Recently, an association of a specific transforming growth factor alpha (TGFA) haplotype has been reported to occur in patients with nonsyndromic cleft lip and palate (CLP) who had a positive family history of the disorder. We tested linkage of CLP to TGFA in 12 multiplex families with clefting. TGFA haplotypes were constructed on the basis of three polymorphic restriction sites. No haplotype was associated with CLP, and discordant inheritance of TGFA haplotypes was observed in a single informative family. The log odds (LOD) score was -2.1 at theta = OS. These findings indicate that CLP and TGFA are not tightly linked in these families.	UNIV TEXAS, HLTH SCI CTR, GRAD SCH BIOMED SCI, HOUSTON, TX 77225 USA; MAYO CLIN & MAYO FDN, DEPT MED GENET, ROCHESTER, MN 55905 USA	University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic	HECHT, JT (corresponding author), UNIV TEXAS, SCH MED, DEPT PEDIAT, POB 20708, HOUSTON, TX 77030 USA.		Blanton, Susan Halloran/ABF-1323-2021		NEI NIH HHS [EY07142] Funding Source: Medline; NIDCR NIH HHS [1 RO3 DE09189-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE009189] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BONAITI C, 1982, J MED GENET, V19, P8, DOI 10.1136/jmg.19.1.8; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; CHUNG CS, 1989, GENET EPIDEMIOL, V6, P625, DOI 10.1002/gepi.1370060507; CHUNG CS, 1986, AM J HUM GENET, V39, P603; DEPAEPE A, 1989, J MED GENET, V26, P794, DOI 10.1136/jmg.26.12.794; FRASER FC, 1970, AM J HUM GENET, V22, P336; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; HAYWARD NK, 1987, NUCLEIC ACIDS RES, V15, P5503, DOI 10.1093/nar/15.13.5503; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1990, J MED GENET, V27, P597, DOI 10.1136/jmg.27.9.597; HECHT JT, 1988, FAMILIAL COMPONENT E; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P5117, DOI 10.1093/nar/14.12.5117; OTT J, 1976, AM J HUM GENET, V28, P528; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; Sambrook J., 1989, MOL CLONING LAB MANU; TEMPLE K, 1989, J MED GENET, V26, P386, DOI 10.1136/jmg.26.6.386	18	86	87	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					682	686						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1679292				2022-12-18	WOS:A1991GE36700023
J	GILBERT, DA; REID, YA; GAIL, MH; PEE, D; WHITE, C; HAY, RJ; OBRIEN, SJ				GILBERT, DA; REID, YA; GAIL, MH; PEE, D; WHITE, C; HAY, RJ; OBRIEN, SJ			APPLICATION OF DNA FINGERPRINTS FOR CELL-LINE INDIVIDUALIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701; JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218; NCI,AMER TYPE CULTURE COLLECT,ROCKVILLE,MD; NCI,BIOSTAT BRANCH,ROCKVILLE,MD; INFORMAT MANAGEMENT SERV INC,SILVER SPRING,MD	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.			OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BURKE T, 1987, NATURE, V327, P149, DOI 10.1038/327149a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS T, 1986, P NATL ACAD SCI USA, V83, P446, DOI 10.1073/pnas.83.2.446; FERRONE S, 1971, J IMMUNOL, V107, P613; GAIL MH, 1979, J APPL PROBAB, V16, P242, DOI 10.2307/3212893; Gartler S M, 1967, Natl Cancer Inst Monogr, V26, P167; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; GEY GO, 1954, HARVEY LECT, P154; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Gold M., 1986, CONSPIRACY CELLS; HARRIS NL, 1981, NATURE, V289, P354; HAY R, 1988, AM TYPE CULTURE COLL; HSU SH, 1976, SCIENCE, V191, P392, DOI 10.1126/science.1246620; JEFFREYS AJ, 1985, NATURE, V317, P818, DOI 10.1038/317818a0; JEFFREYS AJ, 1987, ANIM GENET, V18, P1, DOI 10.1111/j.1365-2052.1987.tb00739.x; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JONES HW, 1971, OBSTET GYNECOL, V38, P945; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LAVAPPA KS, 1976, NATURE, V259, P211, DOI 10.1038/259211a0; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; Maniatis T., 1982, MOL CLONING; MANN DL, 1983, NATURE, V305, P58, DOI 10.1038/305058a0; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NELSONRE.WA, 1974, SCIENCE, V184, P1093, DOI 10.1126/science.184.4141.1093; NELSONREES WA, 1976, SCIENCE, V191, P96, DOI 10.1126/science.1246601; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; NELSONREES WA, 1980, CYTOGENET CELL GENET, V27, P216, DOI 10.1159/000131490; OBRIEN SJ, 1980, IN VITRO CELL DEV B, V16, P119; OBRIEN SJ, 1977, SCIENCE, V195, P1345, DOI 10.1126/science.841332; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; STOKER NG, 1985, NUCLEIC ACIDS RES, V13, P4613, DOI 10.1093/nar/13.13.4613; THACKER J, 1988, SOMAT CELL MOLEC GEN, V14, P519, DOI 10.1007/BF01535307; VANHELDEN PD, 1988, CANCER RES, V48, P5660; WETTON JH, 1987, NATURE, V327, P147, DOI 10.1038/327147a0; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	42	86	86	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					499	514						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	1975479				2022-12-18	WOS:A1990DX22300015
J	OKANO, Y; WANG, T; EISENSMITH, RC; STEINMANN, B; GITZELMANN, R; WOO, SLC				OKANO, Y; WANG, T; EISENSMITH, RC; STEINMANN, B; GITZELMANN, R; WOO, SLC			MISSENSE MUTATIONS ASSOCIATED WITH RFLP HAPLOTYPE-1 AND HAPLOTYPE-4 OF THE HUMAN PHENYLALANINE-HYDROXYLASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR UNIV, HOWARD HUGHES MED INST, DEPT CELL BIOL, ONE BAYLOR PLAZA, HOUSTON, TX 77030 USA; BAYLOR UNIV, INST MOLEC GENET, HOUSTON, TX 77030 USA; KINDERSPITAL, DEPT PEDIAT, CH-8032 ZURICH, SWITZERLAND	Baylor University; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17711] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AULEHLASCHOLZ C, 1988, HUM GENET, V78, P353, DOI 10.1007/BF00291734; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DILELLA AG, 1987, METHOD ENZYMOL, V152, P447; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; GUTHRIE R, 1963, PEDIATRICS, V32, P338; GUTTLER F, 1987, J PEDIATR-US, V110, P68, DOI 10.1016/S0022-3476(87)80290-1; GUTTLER F, 1980, ACTA PAEDIATR SCAND, P1; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1988, J PEDIATR-US, V113, P463, DOI 10.1016/S0022-3476(88)80629-2; LEDLEY FD, 1985, SCIENCE, V228, P77, DOI 10.1126/science.3856322; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LICHTERKONECKI U, 1988, BIOCHEMISTRY-US, V27, P2881, DOI 10.1021/bi00408a032; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LYONNET S, 1989, AM J HUM GENET, V44, P511; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; MESSING J, 1983, METHOD ENZYMOL, V101, P20; REY F, 1988, AM J HUM GENET, V43, P914; RIESS O, 1988, HUM GENET, V78, P343, DOI 10.1007/BF00291732; ROBSON KJH, 1982, P NATL ACAD SCI-BIOL, V79, P4701, DOI 10.1073/pnas.79.15.4701; SCRIVER CR, 1988, ANNU REV GENET, V22, P301; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; SULLIVAN SE, 1989, AM J HUM GENET, V44, P652; WANG T, 1989, AM J HUM GENET, V45, P675; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623; WOO SLC, 1989, BIOCHEMISTRY-US, V28, P1, DOI 10.1021/bi00427a001; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468; [No title captured]	33	86	86	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					18	25						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	1967207				2022-12-18	WOS:A1990CJ04300004
J	KEREM, BS; BUCHANAN, JA; DURIE, P; COREY, ML; LEVISON, H; ROMMENS, JM; BUCHWALD, M; TSUI, LC				KEREM, BS; BUCHANAN, JA; DURIE, P; COREY, ML; LEVISON, H; ROMMENS, JM; BUCHWALD, M; TSUI, LC			DNA MARKER HAPLOTYPE ASSOCIATION WITH PANCREATIC SUFFICIENCY IN CYSTIC-FIBROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT PEDIAT,DIV GASTROENTEROL,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT PEDIAT,DIV RESP DIS,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto			Tsui, Lap-chee/A-1081-2010; Rommens, Johanna/AAT-7465-2021					BEAUDET A, 1986, AM J HUM GENET, V39, P681; BEAUDET AL, 1989, AM J HUM GENET, V44, P319; BERGER W, 1987, HUM GENET, V77, P197, DOI 10.1007/BF00272392; BUCHANAN J A, 1988, American Journal of Human Genetics, V43, pA79; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; COREY ML, IN PRESS J PEDIATR; CUTTING GR, 1989, AM J HUM GENET, V44, P307; DEVOTO M, 1988, American Journal of Human Genetics, V43, pA82; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; DURIE PR, 1986, PEDIATR RES, V20, P209, DOI 10.1203/00006450-198603000-00002; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FARRALL M, 1988, AM J HUM GENET, V43, P471; GASKIN K, 1982, J PEDIATR-US, V100, P857, DOI 10.1016/S0022-3476(82)80501-5; GASKIN KJ, 1984, GASTROENTEROLOGY, V86, P1; LATHROP GM, 1988, AM J HUM GENET, V42, P38; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; Poustka A, 1988, GENOMICS, V2, P337, DOI 10.1016/0888-7543(88)90023-7; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; ROMMENS JM, 1988, UNPUB LONG RANGE RES; SPENCE MA, 1987, CYTOGENET CELL GENET, V46, P170; STERN RC, 1976, J PEDIATR-US, V89, P412, DOI 10.1016/S0022-3476(76)80538-0; TALAMO RC, 1983, METABOLIC BASIS INHE, P1889; TSUI LC, 1986, COLD SPRING HARB SYM, V51, P325, DOI 10.1101/SQB.1986.051.01.038; TSUI LC, 1988, AM J HUM GENET, V42, P184; TSUI LC, 1986, AM J HUM GENET, V39, P720; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; VANDEKAMER JH, 1949, J BIOL CHEM, V177, P347; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	30	86	92	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					827	834						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2567116				2022-12-18	WOS:A1989U854900008
J	BOWCOCK, AM; FARRER, LA; HEBERT, JM; AGGER, M; STERNLIEB, I; SCHEINBERG, IH; BUYS, CHCM; SCHEFFER, H; FRYDMAN, M; CHAJEKSAUL, T; BONNETAMIR, B; CAVALLISFORZA, LL				BOWCOCK, AM; FARRER, LA; HEBERT, JM; AGGER, M; STERNLIEB, I; SCHEINBERG, IH; BUYS, CHCM; SCHEFFER, H; FRYDMAN, M; CHAJEKSAUL, T; BONNETAMIR, B; CAVALLISFORZA, LL			8 CLOSELY LINKED LOCI PLACE THE WILSON DISEASE LOCUS WITHIN 13Q14-Q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BOSTON UNIV SCH,DEPT NEUROL,BOSTON,MA; HARVARD UNIV,SCH MED,BOSTON,MA 02115; HADASSAH MED CTR,DEPT MED,JERUSALEM,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,TEL AVIV,ISRAEL; YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461; STATE UNIV GRONINGEN,DEPT HUMAN GENET,9700 AB GRONINGEN,NETHERLANDS; HASHARON HOSP,DEPT PEDIAT,PETAH TIKVA,ISRAEL	Boston University; Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Groningen; Rabin Medical Center	BOWCOCK, AM (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.		Farrer, Lindsay/AAS-1035-2020; Scheffer, Hans/E-4644-2012	Scheffer, Hans/0000-0002-2986-0915; Bowcock, Anne/0000-0001-8691-9090; Farrer, Lindsay/0000-0001-5533-4225	NIDDK NIH HHS [DK-34668] Funding Source: Medline; NIGMS NIH HHS [GM28428] Funding Source: Medline; NINDS NIH HHS [NS26454-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026454] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BONNETAMIR B, 1986, GENET EPIDEMIOL, V3, P201, DOI 10.1002/gepi.1370030307; BOWCOCK AM, 1987, CYTOGENET CELL GENET, V44, P236, DOI 10.1159/000132379; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1987, CYTOGENET CELL GENET, V46, P585; BOWCOCK AM, 1987, NUCLEIC ACIDS RES, V15, P382, DOI 10.1093/nar/15.1.382; BOWCOCK AM, 1988, NUCLEIC ACIDS RES, V16, P2745, DOI 10.1093/nar/16.6.2745; BOWCOCK AM, IN PRESS NUCLEIC ACI; CARTWRIGHT GE, 1978, NEW ENGL J MED, V298, P1347, DOI 10.1056/NEJM197806152982406; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COX DW, 1972, AM J HUM GENET, V24, P646; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRYJA TP, 1985, HUM GENET, V71, P192, DOI 10.1007/BF00284571; DUNCAN AMV, 1987, CYTOGENET CELL GENET, V44, P153, DOI 10.1159/000132361; FARRER LA, 1987, AM J HUM GENET, V40, P329; FARRER LA, 1988, HUM GENET, V79, P109, DOI 10.1007/BF00280547; FARRER LA, IN PRESS GENOMICS; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; KRAMER PL, 1986, GENET EPIDEMIOL S, V1, P153; LALANDE M, 1986, CANCER GENET CYTOGEN, V23, P151; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP M, 1987, CYTOGENET CELL GENET, V46, P643; LEE EYHP, 1986, P NATL ACAD SCI USA, V83, P6337, DOI 10.1073/pnas.83.17.6337; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEPPERT M, 1986, AM J HUM GENET, V39, P425; Mourant AE, 1976, DISTRIBUTION HUMAN B; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; PAKSTIS AJ, 1986, CYTOGENET CELL GENET, V41, P189, DOI 10.1159/000132226; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; SCHEFFER H, 1986, HUM GENET, V74, P249, DOI 10.1007/BF00282543; SCHEFFER H, 1987, CYTOGENET CELL GENET, V46, P688; SCHEFFER H, 1987, HUM GENET, V77, P335, DOI 10.1007/BF00291421; SCHEFFER H, 1986, NUCLEIC ACIDS RES, V14, P4374, DOI 10.1093/nar/14.10.4374; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; STERNLIEB I, 1968, NEW ENGL J MED, V278, P352, DOI 10.1056/NEJM196802152780702; WARD P, 1984, J MED GENET, V21, P92, DOI 10.1136/jmg.21.2.92; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YUNIS JJ, 1978, AM J DIS CHILD, V132, P161, DOI 10.1001/archpedi.1978.02120270059012; YUZBASIYANGURKAN V, 1988, AM J HUM GENET, V42, P825; [No title captured]; [No title captured]	48	86	87	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					664	674						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189332				2022-12-18	WOS:A1988Q933600012
J	EYRE, DR; UPTON, MP; SHAPIRO, FD; WILKINSON, RH; VAWTER, GF				EYRE, DR; UPTON, MP; SHAPIRO, FD; WILKINSON, RH; VAWTER, GF			NONEXPRESSION OF CARTILAGE TYPE-II COLLAGEN IN A CASE OF LANGER-SALDINO ACHONDROGENESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,SKELETAL DISORDERS LAB,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT RADIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School					NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM034075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM34078, AM34075] Funding Source: Medline; NIAMS NIH HHS [R37 AR037318, R01 AR036794] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BURGESON RE, 1979, BIOCHEM BIOPH RES CO, V87, P1124, DOI 10.1016/S0006-291X(79)80024-8; BYERS PH, 1986, BUTTERWORTHS INT MED, V5; EYRE DR, 1984, BIOCHEM BIOPH RES CO, V118, P724, DOI 10.1016/0006-291X(84)91454-2; EYRE DR, 1984, ANAL BIOCHEM, V137, P380, DOI 10.1016/0003-2697(84)90101-5; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; EYRE DR, 1975, BIOCHEM J, V151, P595, DOI 10.1042/bj1510595; FRACCARO M, 1952, FOLIA HERED PATHOL, V1, P190; GREBE H, 1952, FOLIA HERED PATHOL, V2, P23; HORTON WA, 1984, COLLAGEN REL RES, V4, P231; HORTON WA, 1985, PEDIATR RES, V19, P248; KIMATA K, 1981, J BIOL CHEM, V256, P6961; KUHN K, 1978, COLLAGEN PLATELET IN, P123; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER LO, 1969, RADIOLOGY, V92, P285, DOI 10.1148/92.2.285; MCKEOWN PJ, 1979, DEV BIOL, V71, P203, DOI 10.1016/0012-1606(79)90164-7; MCKUSICK VA, 1978, MENDELIAN INHERITANC, P399; MCKUSICK VA, 1972, HERITABLE DISORDERS, P740; MURPHY JD, 1981, J PEDIATR-US, V98, P962, DOI 10.1016/S0022-3476(81)80605-1; PARENTI GC, 1936, PATHOLOGICA, V28, P447; POTTER EL, 1975, PATHOLOGY FETUS INFA; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; QUELCESALGADO, 1964, ACTA GENET STAT MED, V14, P63; RIMOIN D L, 1974, Birth Defects Original Article Series, V10, P274; RIMOIN DL, 1975, ADV HUM GENET, V5, P1; SALDINO R M, 1973, Medical Radiography and Photography, V49, P61; SALDINO RM, 1971, AMER J ROENTGENOL RA, V112, P185, DOI 10.2214/ajr.112.1.185; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2815, DOI 10.1093/nar/13.8.2815; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2207, DOI 10.1093/nar/13.7.2207; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SHAPIRO F, 1983, ULTRASTRUCT PATHOL, V4, P151, DOI 10.3109/01913128309140786; SHEFFIELD VC, 1985, COLLAGEN REL RES, V5, P1; SOLOMON E, 1985, P NATL ACAD SCI USA, V82, P3330, DOI 10.1073/pnas.82.10.3330; STEGEMANN H, 1958, H-S Z PHYSIOL CHEM, V311, P41, DOI 10.1515/bchm2.1958.311.1.41; Stuart Houston C, 1972, J Can Assoc Radiol, V23, P45; VANDERREST M, 1985, J BIOL CHEM, V260, P220; XANTHAKOS UF, 1973, J PEDIATR-US, V82, P658, DOI 10.1016/S0022-3476(73)80592-X; YANG SS, 1974, J PEDIATR-US, V85, P796, DOI 10.1016/S0022-3476(74)80343-4	37	86	86	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					52	67						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3752081				2022-12-18	WOS:A1986D961500005
J	LAYDE, PM; ERICKSON, JD; FALEK, A; MCCARTHY, BJ				LAYDE, PM; ERICKSON, JD; FALEK, A; MCCARTHY, BJ			CONGENITAL-MALFORMATION IN TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									GEORGIA MENTAL HLTH INST,ATLANTA,GA 30306		LAYDE, PM (corresponding author), CTR DIS CONTROL,BUR EPIDEMIOL,ATLANTA,GA 30333, USA.							ANDERSON CE, 1978, AM J EPIDEMIOL, V107, P281, DOI 10.1093/oxfordjournals.aje.a112543; BULMER MG, 1970, BIOL TWINNING MAN, P68; FLYNT JW, 1973, PEDIATR ANN     1010; HAY S, 1970, American Journal of Human Genetics, V22, P662; HEATH CW, 1975, POSTGRAD MED J, V51, P69; Myrianthopoulos N C, 1975, Birth Defects Orig Artic Ser, V11, P1; MYRIANTHOPOULOS N C, 1974, Birth Defects Original Article Series, V10, P1; MYRIANTHOPOULOS NC, 1976, ACTA GENET MED GEMEL, V25, P331, DOI 10.1017/S0001566000014380; STEVENSON AC, 1966, CONGENITAL MALFORMAT, P79; WARKANY J, 1971, CONGENITAL MALFORMAT, P55	10	86	86	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					69	78						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	7189094				2022-12-18	WOS:A1980JH29600009
J	MOORE, EE; JONES, C; KAO, FT; OATES, DC				MOORE, EE; JONES, C; KAO, FT; OATES, DC			SYNTENY BETWEEN GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE AND SUPEROXIDE-DISMUTASE (SOLUBLE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,MED CTR,ELEANOR ROOSEVELT INST CANC RES,DENVER,CO 80262; UNIV COLORADO,MED CTR,DEPT BIOPHYS & GENET,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								HAM RG, 1965, P NATL ACAD SCI USA, V53, P288, DOI 10.1073/pnas.53.2.288; Hamerton J L, 1976, Birth Defects Orig Artic Ser, V12, P7; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; JONES C, 1975, SOMAT CELL GENET, V1, P345, DOI 10.1007/BF01538666; JONES C, 1972, J CELL PHYSIOL, V80, P291, DOI 10.1002/jcp.1040800217; Kao F T, 1974, Methods Cell Biol, V8, P23, DOI 10.1016/S0091-679X(08)60441-0; KAO FT, 1976, P NATL ACAD SCI USA, V73, P193, DOI 10.1073/pnas.73.1.193; KAO FT, 1970, NATURE, V228, P329, DOI 10.1038/228329a0; KAO FT, 1972, P NATL ACAD SCI USA, V69, P3273, DOI 10.1073/pnas.69.11.3273; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OATES DC, 1975, J CELL BIOL, V67, pA312; OATES DC, 1976, THESIS U COLORADO; PATTERSO.D, 1974, P NATL ACAD SCI USA, V71, P2057, DOI 10.1073/pnas.71.5.2057; Ruddle F H, 1976, Birth Defects Orig Artic Ser, V12, P31; SICHITIU S, 1974, HUMANGENETIK, V23, P65, DOI 10.1007/BF00295684; TAN YH, 1974, SCIENCE, V186, P61, DOI 10.1126/science.186.4158.61; TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317; THORSBY E, 1970, RAPID METHOD PREPARA, P655	18	86	86	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	4					389	396						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN459	889603				2022-12-18	WOS:A1977DN45900008
J	DEJONG, WW; KHAN, PM; BERNINI, LF				DEJONG, WW; KHAN, PM; BERNINI, LF			HEMOGLOBIN KOYA DORA - HIGH-FREQUENCY OF A CHAIN TERMINATION MUTANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV NIJMEGEN, DEPT BIOCHEM, NIJMEGEN, NETHERLANDS; STATE UNIV LEIDEN, DEPT HUMAN GENET, LEIDEN, NETHERLANDS	Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC								ABRAMSON RK, 1970, SCIENCE, V169, P194, DOI 10.1126/science.169.3941.194; BEAVEN GH, 1972, NATURE, V235, P46, DOI 10.1038/235046a0; BERNINI L F, 1970, Atti Associazione Genetica Italiana, V15, P191; CLEGG JB, 1966, J MOL BIOL, V19, P91, DOI 10.1016/S0022-2836(66)80052-9; CLEGG JB, 1971, NATURE, V234, P337, DOI 10.1038/234337a0; DEJONG WWW, 1971, BIOCHIM BIOPHYS ACTA, V236, P197, DOI 10.1016/0005-2795(71)90165-6; EFREMOV GD, 1971, J CLIN INVEST, V50, P1628, DOI 10.1172/JCI106651; ENG LIL, 1974, BLOOD, V43, P251, DOI 10.1182/blood.V43.2.251.251; FESSAS P, 1972, LANCET, V1, P1308; HOLLAN SR, 1972, NATURE, V235, P47, DOI 10.1038/235047a0; LEHMANN H, 1968, BRIT MED J, V4, P748, DOI 10.1136/bmj.4.5633.748; LIE-INJO L E, 1972, Human Heredity, V22, P118; LIEINJO LE, 1973, AM J HUM GENET, V25, P382; MILNER PF, 1971, LANCET, V1, P729; OSTERTAG W, 1972, NATURE-NEW BIOL, V237, P90, DOI 10.1038/newbio237090a0; SEIDAKHAVAN M, 1972, BLOOD-J HEMATOL, V40, P927; SHEENA AH, 1968, AM J CLIN PATHOL, V50, P142, DOI 10.1093/ajcp/50.1_ts.142; SMITHIES O, 1965, VOX SANG, V10, P359; WASI P, 1973, BRIT J HAEMATOL, V24, P267, DOI 10.1111/j.1365-2141.1973.tb01651.x	19	86	86	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					81	90						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V5202	1155453				2022-12-18	WOS:A1975V520200007
J	WILLIAMS, JD; SUMMITT, RL; MARTENS, PR; KIMBRELL, RA				WILLIAMS, JD; SUMMITT, RL; MARTENS, PR; KIMBRELL, RA			FAMILIAL DOWN SYNDROME DUE TO T(10-21) TRANSLOCATION - EVIDENCE THAT DOWN PHENOTYPE IS RELATED TO TRISOMY OF A SPECIFIC SEGMENT OF CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TENNESSEE,CTR HLTH SCI,DEPT ANAT,MEMPHIS,TN 38163; UNIV TENNESSEE,CTR HLTH SCI,CHILD DEV CTR,MEMPHIS,TN 38163; UNIV TENNESSEE,CTR HLTH SCI,DEPT PEDIAT,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center								AULA P, 1973, J CLIN GENET, V4, P241; BARTSCHSANDHOFF M, 1973, HUMANGENETIK, V18, P329, DOI 10.1007/BF00291130; COHEN MM, 1967, CYTOGENETICS, V6, P321, DOI 10.1159/000154936; Dekaban A S, 1968, J Ment Defic Res, V12, P216; DENT T, 1963, LANCET, V2, P484; GIORGI PL, 1968, HELV PAEDIATR ACTA, V23, P540; GUSTAVSON KH, 1964, DOWNS SYNDROME CLINI; HAMERTON JL, 1971, HUMAN CYTOGENETICS; HONGELL K, 1972, HUM HERED, V22, P80, DOI 10.1159/000152472; ILBERY PL, 1961, MED J AUSTRALIA, V2, P182, DOI 10.5694/j.1326-5377.1961.tb69389.x; Lejeune J, 1965, Ann Genet, V8, P60; MIGEON BR, 1962, B JOHNS HOPKINS HOSP, V111, P221; NEW RL, 1971, J MED GENET, V8, P528; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; REED TE, 1970, J PEDIATR-US, V77, P1024, DOI 10.1016/S0022-3476(70)80087-7; SACHDEVA S, 1971, J MENT DEFIC RES, V15, P181; SOUDEK D, 1966, LANCET, V2, P336; SUBRT I, 1970, Journal of Medical Genetics, V7, P407, DOI 10.1136/jmg.7.4.407; VOGEL W, 1972, HUMANGENETIK, V14, P255, DOI 10.1007/BF00278046; WARKANY J, 1963, J PEDIATR-US, V62, P890, DOI 10.1016/S0022-3476(63)80103-1; ZELLWEGER H, 1963, J PEDIATR-US, V62, P225, DOI 10.1016/S0022-3476(63)80396-0; 1972, BIRTH DEFECTS OAS, V8	22	86	86	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	4					478	485						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM544	125542				2022-12-18	WOS:A1975AM54400004
J	SMITH, C				SMITH, C			RECURRENCE RISKS FOR MULTIFACTORIAL INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CURNOW RN, IN PRESS; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; Falconer D.S., 1960, INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; MENDELL N, 1970, 7 INT BIOM C HAN; MORTON N E, 1970, Clinical Genetics, V1, P81; MORTON NE, IN PRESS; MORTON NE, 1969, COMPUTER APPLICATION, P129; SMITH C, 1970, ANN HUM GENET, V34, P85, DOI 10.1111/j.1469-1809.1970.tb00223.x; SMITH CC, IN PRESS	10	86	87	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	6					578	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2014	5132066				2022-12-18	WOS:A1971L201400004
J	STEINBERG, AG; BROWN, DC				STEINBERG, AG; BROWN, DC			ON THE INCIDENCE OF CYSTIC FIBROSIS OF THE PANCREAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSEN DH, 1946, AM J DIS CHILD, V72, P62, DOI 10.1001/archpedi.1946.02020300069004; BAUMANN T, 1958, HELVETICA PAEDIAT S8, V13; BODIAN M, 1953, FIBROCYSTIC DISEASE; CARTER CO, 1953, FIBROCYSTIC DISEASE; FANCONI G, 1944, SCHWEIZ MED WSCHR, V74, P85; GOODMAN HO, 1952, AM J HUM GENET, V4, P59; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; KOCH E, 1960, INTERNIST, V1, P35; LOWE CU, 1949, AM J DIS CHILD, V78, P349, DOI 10.1001/archpedi.1949.02030050362008; MARKS BL, 1960, LANCET, V1, P365; ROBERTS GBS, 1960, ANN HUM GENET, V24, P127; SCHWACHMAN H, 1955, ADV PEDIATRICS, V7; STEINBERG AG, 1956, AM J HUM GENET, V8, P162; STEINBERG AG, 1959, J MED EDUC, V34, P315	14	86	86	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	4					416	424						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF080	17948456				2022-12-18	WOS:A1960WF08000002
J	Civelek, M; Wu, Y; Pan, C; Raulerson, CK; Ko, A; He, AQ; Tilford, C; Saleem, NK; Stantcakova, A; Scott, LJ; Fuchsberger, C; Stringham, HM; Jackson, AU; Narisu, N; Chines, PS; Small, KS; Kuusisto, J; Parks, BW; Pajukanta, P; Kirchgessner, T; Collins, FS; Gargalovic, PS; Boehnke, M; Laakso, M; Mohlke, KL; Lusis, AJ				Civelek, Mete; Wu, Ying; Pan, Calvin; Raulerson, Chelsea K.; Ko, Arthur; He, Aiqing; Tilford, Charles; Saleem, Niyas K.; Stantcakova, Alena; Scott, Laura J.; Fuchsberger, Christian; Stringham, Heather M.; Jackson, Anne U.; Narisu, Narisu; Chines, Peter S.; Small, Kerrin S.; Kuusisto, Johanna; Parks, Brian W.; Pajukanta, Paivi; Kirchgessner, Todd; Collins, Francis S.; Gargalovic, Peter S.; Boehnke, Michael; Laakso, Markku; Mohlke, Karen L.; Lusis, Aldons J.			Genetic Regulation of Adipose Gene Expression and Cardio-Metabolic Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; CONGENITAL SIDEROBLASTIC ANEMIA; TYPE-2 DIABETES SUSCEPTIBILITY; INSULIN SENSITIVITY; COMMON VARIANTS; ADIPOCYTE DIFFERENTIATION; CARDIOVASCULAR-DISEASE; GLUCOSE-HOMEOSTASIS	Subcutaneous adipose tissue stores excess lipids and maintains energy balance. We performed expression quantitative trait locus (eQTL) analyses by using abdominal subcutaneous adipose tissue of 770 extensively phenotyped participants of the METSIM study. We identified cis-eQTLs for 12,400 genes at a 1% false-discovery rate. Among an approximately 680 known genome-wide association study (GWAS) loci for cardio-metabolic traits, we identified 140 coincident cis-eQTLs at 109 GWAS loci, including 93 eQTLs not previously described. At 49 of these 140 eQTLs, gene expression was nominally associated (p < 0.05) with levels of the GWAS trait. The size of our dataset enabled identification of five loci associated (p < 5 x 10(-8)) with at least five genes located >5 Mb away. These trans-eQTL signals confirmed and extended the previously reported KLF14-mediated network to 55 target genes, validated the CIITA regulation of class II MHC genes, and identified ZNF800 as a candidate master regulator. Finally, we observed similar expression-clinical trait correlations of genes associated with GWAS loci in both humans and a panel of genetically diverse mice. These results provide candidate genes for further investigation of their potential roles in adipose biology and in regulating cardio-metabolic traits.	[Civelek, Mete; Pan, Calvin; Parks, Brian W.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Civelek, Mete] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Civelek, Mete] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Wu, Ying; Raulerson, Chelsea K.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Ko, Arthur; Pajukanta, Paivi; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Ko, Arthur; Pajukanta, Paivi; Lusis, Aldons J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [He, Aiqing; Tilford, Charles; Kirchgessner, Todd; Gargalovic, Peter S.] Bristol Myers Squibb, Pennington, NJ 08534 USA; [Saleem, Niyas K.; Stantcakova, Alena; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70210, Finland; [Saleem, Niyas K.; Stantcakova, Alena; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Scott, Laura J.; Fuchsberger, Christian; Stringham, Heather M.; Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Scott, Laura J.; Fuchsberger, Christian; Stringham, Heather M.; Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Narisu, Narisu; Chines, Peter S.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Small, Kerrin S.] Kings Coll London, Sch Med, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Bristol-Myers Squibb; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of London; King's College London; University of California System; University of California Los Angeles	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.; Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.; Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.; Lusis, AJ (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.; Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	mohlke@med.unc.edu; jlusis@mednet.ucla.edu	Fuchsberger, Christian/ABD-7127-2021; Narisu, Narisu/T-6908-2019	Fuchsberger, Christian/0000-0002-5918-8947; Small, Kerrin/0000-0003-4566-0005; Yaluri, Alena/0000-0002-1375-0252; Raulerson, Chelsea/0000-0001-5888-5196	NIH [R00HL121172, P01HL28481, R01DK093757, U01DK105561, R01DK072193, U01DK062370, 1-ZIA-HG000024, R01HL095056, F31HL127921, R00HL123021, T32GM067553]; Academy of Finland [77299, 124243]; Finnish Heart Foundation; Finnish Diabetes Foundation; Finnish Funding Agency for Technology and Innovation (TEKES) [1510/31/06]; Commission of the European Community [HEALTH-F2-2007-201681]; MRC [MR/L01999X/1, MR/J010642/1] Funding Source: UKRI; Medical Research Council [MR/L01999X/1, MR/J010642/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL127921, R00HL123021, P01HL028481, R00HL121172, R01HL095056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093757, U01DK062370, U01DK105561, R01DK072193, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Finnish Heart Foundation; Finnish Diabetes Foundation; Finnish Funding Agency for Technology and Innovation (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Commission of the European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grants R00HL121172 (M.C.), P01HL28481 (A.J.L. and P.P.), R01DK093757 (K.L.M.), U01DK105561 (K.L.M.), R01DK072193 (K.L.M.), U01DK062370 (M.B.), 1-ZIA-HG000024 (F.S.C.), R01HL095056 (P.P.), F31HL127921 (A.K.), and R00HL123021 (B.W.P.); Academy of Finland grants 77299 and 124243 (M.L.); the Finnish Heart Foundation (M.L.); the Finnish Diabetes Foundation (M.L.); Finnish Funding Agency for Technology and Innovation (TEKES) contract 1510/31/06 (M.L.); and the Commission of the European Community HEALTH-F2-2007-201681 (M.L.). C.K.R. was supported by NIH T32GM067553. Bristol-Myers Squibb supported the generation of METSIM and HMDP microarray data.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; ARRIODUPONT M, 1985, BIOCHIM BIOPHYS ACTA, V829, P58, DOI 10.1016/0167-4838(85)90068-8; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Braenne I, 2015, ARTERIOSCL THROM VAS, V35, P2207, DOI 10.1161/ATVBAHA.115.306108; Braga M, 2014, J LIPID RES, V55, P375, DOI 10.1194/jlr.M039719; Brown ML, 2011, OBESITY, V19, P1940, DOI 10.1038/oby.2011.97; Castellani LW, 2008, J BIOL CHEM, V283, P11633, DOI 10.1074/jbc.M708995200; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181; Conde L, 2013, AM J HUM GENET, V92, P126, DOI 10.1016/j.ajhg.2012.11.009; Consortium CD, 2011, NAT GENET, V43, P339; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ijichi N, 2007, BIOCHEM BIOPH RES CO, V358, P813, DOI 10.1016/j.bbrc.2007.04.209; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kannengiesser C, 2011, HAEMATOL-HEMATOL J, V96, P808, DOI 10.3324/haematol.2010.039164; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kostem E, 2013, AM J HUM GENET, V92, P558, DOI 10.1016/j.ajhg.2013.03.010; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2012, J STAT SOFTW, V46, P1; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lusis AJ, 2016, J LIPID RES, V57, P925, DOI 10.1194/jlr.R066944; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mason RR, 2015, TRENDS ENDOCRIN MET, V26, P144, DOI 10.1016/j.tem.2015.01.005; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Parks BW, 2015, CELL METAB, V21, P334, DOI 10.1016/j.cmet.2015.01.002; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Talukdar HA, 2016, CELL SYST, V2, P196, DOI 10.1016/j.cels.2016.02.002; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tyler AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005805; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walford GA, 2016, DIABETES, V65, P3200, DOI 10.2337/db16-0199; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Wong D, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0494-z; Wong WS, 2015, J CLIN PATHOL, V68, P249, DOI 10.1136/jclinpath-2014-202211; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	91	85	85	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					428	443		10.1016/j.ajhg.2017.01.027	http://dx.doi.org/10.1016/j.ajhg.2017.01.027			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28257690	Green Published, Bronze			2022-12-18	WOS:000395851900010
J	Maxwell, KN; Hart, SN; Vijai, J; Schrader, KA; Slavin, TP; Thomas, T; Wubbenhorst, B; Ravichandran, V; Moore, RM; Hu, CL; Guidugli, L; Wenz, B; Domchek, SM; Robson, ME; Szabo, C; Neuhausen, SL; Weitzel, JN; Offit, K; Couch, FJ; Nathanson, KL				Maxwell, Kara N.; Hart, Steven N.; Vijai, Joseph; Schrader, Kasmintan A.; Slavin, Thomas P.; Thomas, Tinu; Wubbenhorst, Bradley; Ravichandran, Vignesh; Moore, Raymond M.; Hu, Chunling; Guidugli, Lucia; Wenz, Brandon; Domchek, Susan M.; Robson, Mark E.; Szabo, Csilla; Neuhausen, Susan L.; Weitzel, Jeffrey N.; Offit, Kenneth; Couch, Fergus J.; Nathanson, Katherine L.			Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INCIDENTAL FINDINGS; NEXT-GENERATION; SECONDARY FINDINGS; COLORECTAL-CANCER; SEQUENCE VARIANTS; RISK ASSESSMENT; CLINICAL EXOME; RARE MUTATIONS; OVARIAN-CANCER; GENOMICS	Sequencing tests assaying panels of genes or whole exomes are widely available for cancer risk evaluation. However, methods for classification of variants resulting from this testing are not well studied. We evaluated the ability of a variant-classification methodology based on American College of Medical Genetics and Genomics (ACMG) guidelines to define the rate of mutations and variants of uncertain significance (VUS) in 180 medically relevant genes, including all ACMG-designated reportable cancer and non-cancer-associated genes, in individuals who met guidelines for hereditary cancer risk evaluation. We performed whole-exome sequencing in 404 individuals in 253 families and classified 1,640 variants. Potentially clinically actionable (likely pathogenic [LP] or pathogenic [P]) versus non-actionable (VUS, likely benign, or benign) calls were 95% concordant with locus-specific databases and Clinvar. LP or P mutations were identified in 12 of 25 breast cancer susceptibility genes in 26 families without identified BRCA1/2 mutations (11%). Evaluation of 84 additional genes associated with autosomal-dominant cancer susceptibility identified LP or P mutations in only two additional families (0.8%). However, individuals from 10 of 253 families (3.9%) had incidental LP or P mutations in 32 non-cancer-associated genes, and 9% of individuals were monoallelic carriers of a rare LP or P mutation in 39 genes associated with autosomal-recessive cancer susceptibility. Furthermore, 95% of individuals had at least one VUS. In summary, these data support the clinical utility of ACMG variant-classification guidelines. Additionally, evaluation of extended panels of cancer-associated genes in breast/ovarian cancer families leads to only an incremental clinical benefit but substantially increases the complexity of the results.	[Maxwell, Kara N.] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hart, Steven N.; Moore, Raymond M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Vijai, Joseph; Thomas, Tinu; Ravichandran, Vignesh; Robson, Mark E.; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Res Lab, New York, NY 10065 USA; [Vijai, Joseph; Thomas, Tinu; Ravichandran, Vignesh; Robson, Mark E.; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, New York, NY 10065 USA; [Schrader, Kasmintan A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Slavin, Thomas P.; Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Div Clin Canc Genet, Dept Med Oncol, Duarte, CA 91010 USA; [Slavin, Thomas P.; Neuhausen, Susan L.; Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Wubbenhorst, Bradley; Wenz, Brandon; Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Dept Med, Div Translat Med & Genet, Philadelphia, PA 19104 USA; [Hu, Chunling; Guidugli, Lucia] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Domchek, Susan M.; Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Robson, Mark E.; Offit, Kenneth] Weill Cornell Med Coll, New York, NY 10065 USA; [Szabo, Csilla] NHGRI, NIH, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of British Columbia; City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Cornell University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Nathanson, KL (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Translat Med & Genet, Philadelphia, PA 19104 USA.; Nathanson, KL (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.	knathans@exchange.upenn.edu	Hart, Steven/AAI-4761-2021; Joseph, Vijai/J-9158-2013	Hart, Steven/0000-0001-7714-2734; Joseph, Vijai/0000-0002-7933-151X; Hu, Chunling/0000-0002-6814-4639; Ravichandran, Vignesh/0000-0002-1532-2593; Schrader, Kasmintan/0000-0002-7413-4314	National Institutes of Health [T32-GM008638, CA192393, CA176785, CA116167]; City of Hope Clinical Cancer Genomics Community Research Network [RC4 CA153828]; Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) [P50 CA116201]; Abramson Cancer Center [CA016520]; Memorial Sloan Kettering Cancer Center [CA008748]; U.S. Department of Defense [W81XWH-13-1-0338]; American Society of Clinical Oncology [10048914]; Avon Foundation [02-2013-044]; Breast Cancer Research Foundation; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; BC Cancer Foundation; Rooney Family Foundation; Komen Foundation for the Cure; Commonwealth of Pennsylvania; Sharon Levine Corzine Cancer Research Fund; Robert and Kate Niehaus Clinical Cancer Initiative; Filomen M. D'Agostino Foundation; Andrew Sabin Family Fund; American Cancer Society; Morris Family Endowed Professorship; Horowitz Family Endowed Professorship; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA116167, RC4CA153828, P30CA016520, P30CA008748, U01CA116167, R01CA176785, R01CA192393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of Hope Clinical Cancer Genomics Community Research Network; Mayo Clinic Breast Specialized Program of Research Excellence (SPORE); Abramson Cancer Center; Memorial Sloan Kettering Cancer Center; U.S. Department of Defense(United States Department of Defense); American Society of Clinical Oncology; Avon Foundation; Breast Cancer Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); BC Cancer Foundation; Rooney Family Foundation; Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Commonwealth of Pennsylvania; Sharon Levine Corzine Cancer Research Fund; Robert and Kate Niehaus Clinical Cancer Initiative; Filomen M. D'Agostino Foundation; Andrew Sabin Family Fund; American Cancer Society(American Cancer Society); Morris Family Endowed Professorship; Horowitz Family Endowed Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants (T32-GM008638 to K.N.M.; CA192393 to F.J.C. and K.L.N.; CA176785 to K.O., F.J.C., and K.L.N.; and CA116167 to F.J.C.); City of Hope Clinical Cancer Genomics Community Research Network grant RC4 CA153828 to J.N.W.; Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) grant P50 CA116201; Abramson Cancer Center Core grant CA016520; Memorial Sloan Kettering Cancer Center Core grant CA008748; the U.S. Department of Defense (W81XWH-13-1-0338 to K.N.M.), the American Society of Clinical Oncology (PD# 10048914 to K.N.M.); the Avon Foundation (02-2013-044 to J.N.W.); the Breast Cancer Research Foundation (K.N.M., S.M.D., M.E.R., J.N.W., K.O., F.J.C., and K.L.N.); the Canadian Institutes of Health Research (K.A.S.); the Michael Smith Foundation for Health Research (K.A.S.); the BC Cancer Foundation (K.A.S.); the Rooney Family Foundation (K.L.N. and S.M.D.); Komen Foundation for the Cure (S.M.D.); the Commonwealth of Pennsylvania (K.L.N.); the Sharon Levine Corzine Cancer Research Fund (K.O.); the Robert and Kate Niehaus Clinical Cancer Initiative (K.O.); Filomen M. D'Agostino Foundation (K.O.); the Andrew Sabin Family Fund (K.O.); the American Cancer Society (J.N.W.); and the Morris and Horowitz Families Endowed Professorship (S.L.N.). All work contained in this manuscript is original. K.O. is co-Chair of the ClinGen Hereditary Cancer Working Group, of which F.J.C. and K.L.N. are members; the views expressed in this article are those of the authors and not of this Working Group. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Views and opinions of and endorsements by the authors do not reflect those of the US Army or the Department of Defense. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions.	Alanee S, 2012, NEW ENGL J MED, V367, P480, DOI 10.1056/NEJMc1205138; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Atwal PS, 2014, GENET MED, V16, P717, DOI 10.1038/gim.2014.10; Biesecker LG, 2014, NEW ENGL J MED, V371, P1170, DOI 10.1056/NEJMc1408914; Castera L, 2014, EUR J HUM GENET, V22, P1305, DOI 10.1038/ejhg.2014.16; Chubb D, 2015, J CLIN ONCOL, V33, P426, DOI 10.1200/JCO.2014.56.5689; Couch FJ, 2015, J CLIN ONCOL, V33, P304, DOI 10.1200/JCO.2014.57.1414; Daly MB, 2014, J NATL COMPR CANC NE, V12, P1326, DOI 10.6004/jnccn.2014.0127; Ng D, 2013, CIRC-CARDIOVASC GENE, V6, P337, DOI 10.1161/CIRCGENETICS.113.000039; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Erlic Z, 2010, J CLIN ENDOCR METAB, V95, P308, DOI 10.1210/jc.2009-1728; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Gambin T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0171-1; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hilbers FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055734; Iglesias A, 2014, GENET MED, V16, P922, DOI 10.1038/gim.2014.58; Gracia-Aznarez FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055681; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Jurgens J, 2015, GENET MED, V17, P782, DOI 10.1038/gim.2014.196; Kiiski JI, 2014, P NATL ACAD SCI USA, V111, P15172, DOI 10.1073/pnas.1407909111; Kocher JPA, 2014, BIOINFORMATICS, V30, P1920, DOI 10.1093/bioinformatics/btu137; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; LaDuca H, 2014, GENET MED, V16, P830, DOI 10.1038/gim.2014.40; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Maxwell KN, 2015, GENET MED, V17, P630, DOI 10.1038/gim.2014.176; Maxwell KN, 2013, CURR BREAST CANCER R, V5, P170, DOI 10.1007/s12609-013-0117-9; Maxwell KN, 2012, NAT REV CLIN ONCOL, V9, P520, DOI 10.1038/nrclinonc.2012.123; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Munz M, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0195-6; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Park DJ, 2014, CANCER DISCOV, V4, P804, DOI 10.1158/2159-8290.CD-14-0212; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robson M, 2014, J CLIN ONCOL, V32, P1987, DOI 10.1200/JCO.2014.56.0474; Robson ME, 2015, J CLIN ONCOL, V33, P3660, DOI 10.1200/JCO.2015.63.0996; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654; Scheuner MT, 2015, GENET MED, V17, P27, DOI 10.1038/gim.2014.165; Shashi V, 2016, CLIN GENET, V89, P173, DOI 10.1111/cge.12569; Stadler ZK, 2014, J CLIN ONCOL, V32, P687, DOI 10.1200/JCO.2013.49.7271; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Toledo RA, 2015, ENDOCR-RELAT CANCER, V22, P65, DOI 10.1530/ERC-14-0491; Tung N, 2015, CANCER-AM CANCER SOC, V121, P25, DOI 10.1002/cncr.29010; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wienke S, 2014, J COMMUN GENET, V5, P191, DOI 10.1007/s12687-013-0169-6; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630	52	85	85	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					801	817		10.1016/j.ajhg.2016.02.024	http://dx.doi.org/10.1016/j.ajhg.2016.02.024			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27153395	Green Published, Bronze			2022-12-18	WOS:000375869300001
J	Chong, JX; McMillin, MJ; Shively, KM; Beck, AE; Marvin, CT; Armenteros, JR; Buckingham, KJ; Nkinsi, NT; Boyle, EA; Berry, MN; Bocian, M; Foulds, N; Uzielli, MLG; Haldeman-Englert, C; Hennekam, RCM; Kaplan, P; Kline, AD; Mercer, CL; Nowaczyk, MJM; Wassink-Ruiter, JSK; McPherson, EW; Moreno, RA; Scheuerle, AE; Shashi, V; Stevens, CA; Carey, JC; Monteil, A; Lory, P; Tabor, HK; Smith, JD; Shendure, J; Nickerson, DA; Bamshad, MJ				Chong, Jessica X.; McMillin, Margaret J.; Shively, Kathryn M.; Beck, Anita E.; Marvin, Colby T.; Armenteros, Jose R.; Buckingham, Kati J.; Nkinsi, Naomi T.; Boyle, Evan A.; Berry, Margaret N.; Bocian, Maureen; Foulds, Nicola; Uzielli, Maria Luisa Giovannucci; Haldeman-Englert, Chad; Hennekam, Raoul C. M.; Kaplan, Paige; Kline, Antonie D.; Mercer, Catherine L.; Nowaczyk, Malgorzata J. M.; Wassink-Ruiter, Jolien S. Klein; McPherson, Elizabeth W.; Moreno, Regina A.; Scheuerle, Angela E.; Shashi, Vandana; Stevens, Cathy A.; Carey, John C.; Monteil, Arnaud; Lory, Philippe; Tabor, Holly K.; Smith, Joshua D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.		Univ Washington	De Novo Mutations in NALCN Cause a Syndrome Characterized by Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR INVERSION PROBES; SODIUM LEAK CHANNELS; DISTAL ARTHROGRYPOSIS; CALCIUM-CHANNELS; WHISTLING FACE; DROSOPHILA-MELANOGASTER; MENTAL-RETARDATION; GENETIC-ANALYSIS; SHELDON-SYNDROME; CATION CHANNEL	Freeman-Sheldon syndrome, or distal arthrogryposis type 2A (DA2A), is an autosomal-dominant condition caused by mutations in MYH3 and characterized by multiple congenital contractures of the face and limbs and normal cognitive development. We identified a subset of five individuals who had been putatively diagnosed with "DA2A with severe neurological abnormalities'' and for whom congenital contractures of the limbs and face, hypotonia, and global developmental delay had resulted in early death in three cases; this is a unique condition that we now refer to as CLIFAHDD syndrome. Exome sequencing identified missense mutations in the sodium leak channel, non-selective (NALCN) in four families affected by CLIFAHDD syndrome. We used molecular-inversion probes to screen for NALCN in a cohort of 202 distal arthrogryposis (DA)-affected individuals as well as concurrent exome sequencing of six other DA-affected individuals, thus revealing NALCN mutations in ten additional families with "atypical'' forms of DA. All 14 mutations were missense variants predicted to alter amino acid residues in or near the S5 and S6 pore-forming segments of NALCN, highlighting the functional importance of these segments. In vitro functional studies demonstrated that NALCN alterations nearly abolished the expression of wild-type NALCN, suggesting that alterations that cause CLIFAHDD syndrome have a dominant-negative effect. In contrast, homozygosity for mutations in other regions of NALCN has been reported in three families affected by an autosomal-recessive condition characterized mainly by hypotonia and severe intellectual disability. Accordingly, mutations in NALCN can cause either a recessive or dominant condition characterized by varied though overlapping phenotypic features, perhaps based on the type of mutation and affected protein domain(s).	[Chong, Jessica X.; McMillin, Margaret J.; Shively, Kathryn M.; Beck, Anita E.; Marvin, Colby T.; Armenteros, Jose R.; Buckingham, Kati J.; Nkinsi, Naomi T.; Tabor, Holly K.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Boyle, Evan A.; Smith, Joshua D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Berry, Margaret N.; Haldeman-Englert, Chad] Wake Forest Sch Med, Dept Pediat, Med Genet Sect, Winston Salem, NC 27157 USA; [Bocian, Maureen] Univ Calif Irvine, Dept Pediat, Div Genet & Genom Med, Orange, CA 92868 USA; [Foulds, Nicola; Mercer, Catherine L.] Univ Hosp Southampton NHS Fdn Trust, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Foulds, Nicola; Mercer, Catherine L.] Univ Southampton, Fac Med, Southampton SO16 5YA, Hants, England; [Uzielli, Maria Luisa Giovannucci] Univ Florence, Dipartimento Sci, Genet & Mol Med, I-50139 Florence, Italy; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1100 DD Amsterdam, Netherlands; [Kaplan, Paige] Childrens Hosp Philadelphia, Div Med Genet, Dept Pediat, Philadelphia, PA 19104 USA; [Kline, Antonie D.] Greater Baltimore Med Ctr, Harvey Inst Human Genet, Dept Pediat, Baltimore, MD 21204 USA; [Nowaczyk, Malgorzata J. M.] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Nowaczyk, Malgorzata J. M.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Wassink-Ruiter, Jolien S. Klein] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [McPherson, Elizabeth W.] Marshfield Clin Fdn Med Res & Educ, Dept Med Genet, Marshfield, WI 54449 USA; [Moreno, Regina A.] Univ La Frontera, Fac Med, Dept Ciencias Basicas, Temuco 4811230, Chile; [Scheuerle, Angela E.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Genet & Metab, Dallas, TX 75390 USA; [Shashi, Vandana] Duke Univ, Med Ctr, Div Med Genet, Dept Pediat, Durham, NC 27710 USA; [Stevens, Cathy A.] Univ Tennessee, Coll Med, Dept Pediat, Chattanooga, TN 37403 USA; [Carey, John C.] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA; [Monteil, Arnaud; Lory, Philippe] CNRS, UMR 5203, Inst Genom Fonct, LabEx Ion Channel Sci & Therapeut, F-34094 Montpellier, France; [Monteil, Arnaud; Lory, Philippe] Univ Montpellier, Dept Physiol, F-34094 Montpellier, France; [Monteil, Arnaud; Lory, Philippe] INSERM, Paris, France; [Tabor, Holly K.] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; University of California System; University of California Irvine; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Florence; University of Amsterdam; Academic Medical Center Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Greater Baltimore Medical Center; McMaster University; McMaster University; University of Groningen; Marshfield Clinic; Universidad de La Frontera; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; University of Tennessee System; University of Tennessee Health Science Center; Utah System of Higher Education; University of Utah; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Seattle Children's Hospital	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	mbamshad@uw.edu	Browning, Brian L/A-1178-2010; Shendure, Jay/AAU-3684-2021; Monteil, Arnaud/G-3113-2012; Chong, Jessica/GZH-1625-2022; Beck, Anita E./AAS-8775-2021	Browning, Brian L/0000-0001-6454-6633; Monteil, Arnaud/0000-0003-1632-7318; Beck, Anita E./0000-0002-7965-0326; Blue, Elizabeth/0000-0002-0633-0305; Chong, Jessica/0000-0002-1616-2448; Boyle, Evan/0000-0003-4494-9771; LORY, philippe/0000-0002-1638-7604	NIH; National Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research Institute (NHGRI) [1U54HG006493, 1RC2HG005608, 5R000HG004316]; National Institute of Child Health and Human Development [1R01HD048895, 5K23HD057331]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057331, R01HD048895] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608, U54HG006493, R25HG007153, K99HG004316, UM1HG006493, R00HG004316] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Life Sciences Discovery Fund; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families for their participation and support; Christa Poel, Karynne Patterson, and Ian Glass for technical assistance; and J. David Spafford for helpful comments. Our work was supported in part by grants from the NIH, the National Heart, Lung, and Blood Institute (NHLBI), and the National Human Genome Research Institute (NHGRI) (1U54HG006493 to M.B., D.N., and J.S.; 1RC2HG005608 to M.B., D.N., and J.S.; 5R000HG004316 to H.K.T.), by the National Institute of Child Health and Human Development (1R01HD048895 to M.J.B. and 5K23HD057331 to A.E.B), by the Life Sciences Discovery Fund (2065508 and 0905001), and by the Washington Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI, NHLBI, or NIH.	Al-Sayed MD, 2013, AM J HUM GENET, V93, P721, DOI 10.1016/j.ajhg.2013.08.001; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Bandyopadhyay U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053575; Beck AE, 2014, AM J MED GENET A, V164, P2808, DOI 10.1002/ajmg.a.36762; Beck AE, 2013, AM J MED GENET A, V161A, P550, DOI 10.1002/ajmg.a.35809; Bonnett K, 2014, GENES BRAIN BEHAV, V13, P633, DOI 10.1111/gbb.12153; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Cochet-Bissuel M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00132; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Crisponi L, 2007, AM J HUM GENET, V80, P971, DOI 10.1086/516843; Dagoneau N, 2007, AM J HUM GENET, V80, P966, DOI 10.1086/513608; Dieterich K, 2013, HUM MOL GENET, V22, P1483, DOI 10.1093/hmg/dds514; DIROCCO M, 1992, AM J MED GENET, V44, P391; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; ILLUM N, 1988, NEUROPEDIATRICS, V19, P186, DOI 10.1055/s-2008-1052443; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kim BJ, 2012, CELL PHYSIOL BIOCHEM, V29, P501, DOI 10.1159/000338504; Koroglu C, 2013, J MED GENET, V50, P515, DOI 10.1136/jmedgenet-2013-101634; KRISHNAN KS, 1990, P NATL ACAD SCI USA, V87, P8632, DOI 10.1073/pnas.87.21.8632; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Liebeskind BJ, 2012, MOL BIOL EVOL, V29, P3613, DOI 10.1093/molbev/mss182; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018745; Maeda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106818; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; McMillin MJ, 2013, AM J HUM GENET, V92, P150, DOI 10.1016/j.ajhg.2012.11.014; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mezghrani A., J NEUROSCI, V28, P4501; Mir B, 1997, GENETICS, V147, P701; Monsieurs KG, 1998, J NEUROL SCI, V154, P62, DOI 10.1016/S0022-510X(97)00215-3; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nishikawa K, 1999, ANESTHESIOLOGY, V90, P1691, DOI 10.1097/00000542-199906000-00026; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; SCHRANDERSTUMPEL C, 1991, AM J MED GENET, V38, P557, DOI 10.1002/ajmg.1320380412; Senatore A, 2013, CHANNELS, V7, P60, DOI 10.4161/chan.23981; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Veugelers M, 2004, NEW ENGL J MED, V351, P460, DOI 10.1056/NEJMoa040584; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055; Zuberi SM, 2011, NEUROLOGY, V76, P594, DOI 10.1212/WNL.0b013e31820c309b	48	85	89	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					462	473		10.1016/j.ajhg.2015.01.003	http://dx.doi.org/10.1016/j.ajhg.2015.01.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25683120	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000350747800019
J	Peeters, K; Litvinenko, I; Asselbergh, B; Almeida-Souza, L; Chamova, T; Geuens, T; Ydens, E; Zimon, M; Irobi, J; De Vriendt, E; De Winter, V; Ooms, T; Timmerman, V; Tournev, I; Jordanova, A				Peeters, Kristien; Litvinenko, Ivan; Asselbergh, Bob; Almeida-Souza, Leonardo; Chamova, Teodora; Geuens, Thomas; Ydens, Elke; Zimon, Magdalena; Irobi, Joy; De Vriendt, Els; De Winter, Vicky; Ooms, Tinne; Timmerman, Vincent; Tournev, Ivailo; Jordanova, Albena			Molecular Defects in the Motor Adaptor BICD2 Cause Proximal Spinal Muscular Atrophy with Autosomal-Dominant Inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEREDITARY MOTOR; NEURON DISEASE; ONSET; GENE; FORM; MUTATIONS; DYNACTIN; TRAFFICKING; NEUROPATHY	The most common form of spinal muscular atrophy (SMA) is a recessive disorder caused by deleterious SMN1 mutations in 5q13, whereas the genetic etiologies of non-5q SMA are very heterogeneous and largely remain to be elucidated. In a Bulgarian family affected by autosomal-dominant proximal SMA, we performed genome-wide linkage analysis and whole-exome sequencing and found a heterozygous de novo c.320C>T (p.Ser107Leu) mutation in bicaudal D homolog 2 (Drosophila) (BICD2). Further analysis of BICD2 in a cohort of 119 individuals with non-5q SMA identified a second de novo BICD2 mutation, c.2321A>G (p.Glu774Gly), in a simplex case. Detailed clinical and electrophysiological investigations revealed that both families are affected by a very similar disease course, characterized by early childhood onset, predominant involvement of lower extremities, and very slow disease progression. The amino acid substitutions are located in two interaction domains of BICD2, an adaptor protein linking the dynein molecular motor with its cargo. Our immunoprecipitation and localization experiments in HeLa and SH-SY5Y cells and affected individuals' lymphoblasts demonstrated that p.Ser107Leu causes increased dynein binding and thus leads to accumulation of BICD2 at the microtubule-organizing complex and Golgi fragmentation. In addition, the altered protein had a reduced colocalization with RAB6A, a regulator of vesicle trafficking between the Golgi and the endoplasmic reticulum. The interaction between p.Glu744Gly altered BICD2 and RAB6A was impaired, which also led to their reduced colocalization. Our study identifies BICD2 mutations as a cause of non-5q linked SMA and highlights the importance of dynein-mediated motility in motor neuron function in humans.	[Peeters, Kristien; Zimon, Magdalena; De Vriendt, Els; Ooms, Tinne; Jordanova, Albena] Univ Antwerp VIB, Dept Mol Genet, Mol Neurogen Grp, B-2610 Antwerp, Belgium; [Peeters, Kristien; Asselbergh, Bob; Almeida-Souza, Leonardo; Geuens, Thomas; Ydens, Elke; Zimon, Magdalena; De Vriendt, Els; De Winter, Vicky; Ooms, Tinne; Timmerman, Vincent; Jordanova, Albena] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium; [Litvinenko, Ivan] Med Univ Sofia, Dept Pediat, Clin Child Neurol, Sofia 1000, Bulgaria; [Asselbergh, Bob; Irobi, Joy] Univ Antwerp VIB, Dept Mol Genet, Centralized Serv Facil, B-2610 Antwerp, Belgium; [Almeida-Souza, Leonardo; Geuens, Thomas; Ydens, Elke; De Winter, Vicky; Timmerman, Vincent] Univ Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, B-2610 Antwerp, Belgium; [Chamova, Teodora; Tournev, Ivailo] Med Univ Sofia, Dept Neurol, Sofia 1000, Bulgaria; [Tournev, Ivailo] New Bulgarian Univ, Dept Cognit Sci & Psychol, Sofia 1618, Bulgaria; [Jordanova, Albena] Med Univ Sofia, Mol Med Ctr, Dept Med Chem & Biochem, Sofia 1431, Bulgaria	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Medical University Sofia; Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; Medical University Sofia; New Bulgarian University; Medical University Sofia	Jordanova, A (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Mol Neurogen Grp, B-2610 Antwerp, Belgium.	albena.jordanova@molgen.vib-ua.be	Almeida-Souza, Leonardo/C-3437-2011; Chamova, Teodora/AAS-2081-2020; Timmerman, Vincent/O-7283-2019; Litvinenko, Ivan/GQZ-3185-2022	Almeida-Souza, Leonardo/0000-0002-7169-1238; Timmerman, Vincent/0000-0002-2162-0933; Asselbergh, Bob/0000-0003-2784-2470; Geuens, Thomas/0000-0002-1764-6233; Zimon, Magdalena/0000-0001-7255-6639	University of Antwerp [IWS BOF 2008 23064]; Fund for Scientific Research-Flanders; Medical Foundation Queen Elisabeth; Association Belge Contre les Maladies Neuromusculaires; Medical University-Sofia; FP7 EU Neuromics network; Institute for Science and Technology-Flanders	University of Antwerp; Fund for Scientific Research-Flanders(FWO); Medical Foundation Queen Elisabeth; Association Belge Contre les Maladies Neuromusculaires; Medical University-Sofia; FP7 EU Neuromics network; Institute for Science and Technology-Flanders	We are grateful to the study participants and their families for their cooperation. We thank the VIB Genetic Service Facility for sequencing and cell-maintenance support, the VIB Department of Molecular Genetics Centralized Service Facility for exome sequencing, P. De Rijk for bioinformatics support, S. Bichev for technical assistance, and C. Van Broeckhoven for helpful discussions. This work was supported in part by the University of Antwerp (IWS BOF 2008 23064 to A.J.), the Fund for Scientific Research-Flanders (to A.J. and V.T.), the Medical Foundation Queen Elisabeth (to V.T.), the Association Belge Contre les Maladies Neuromusculaires (to A.J. and V.T.), the Research Fund of Medical University-Sofia (to A.J.), and the FP7 EU Neuromics network (to V.T.). K.P., T.G., and M.Z. are supported by a PhD fellowship from the Fund for Scientific Research-Flanders. E.Y. receives a PhD fellowship from the Institute for Science and Technology-Flanders.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Christodoulou K, 2000, ANN NEUROL, V48, P877, DOI 10.1002/1531-8249(200012)48:6<877::AID-ANA8>3.3.CO;2-R; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Darras BT, 2011, NEUROLOGY, V77, P312, DOI 10.1212/WNL.0b013e3182267bd8; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dubowitz V, 2009, NEUROMUSCULAR DISORD, V19, P69, DOI 10.1016/j.nmd.2008.10.004; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; FRIJNS CJM, 1994, MUSCLE NERVE, V17, P192, DOI 10.1002/mus.880170210; Gopinath S, 2007, HUM GENET, V121, P559, DOI 10.1007/s00439-007-0348-9; Grohmann K, 2003, ANN NEUROL, V54, P719, DOI 10.1002/ana.10755; Harms MB, 2010, NEUROLOGY, V75, P539, DOI 10.1212/WNL.0b013e3181ec800c; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Maystadt I, 2007, AM J HUM GENET, V81, P67, DOI 10.1086/518900; McEntagart M, 2001, AM J HUM GENET, V68, P1270, DOI 10.1086/320122; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P125, DOI 10.1016/j.nmd.2003.09.005; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Penttila S, 2012, EUR J HUM GENET, V20, P1193, DOI 10.1038/ejhg.2012.76; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Reddel S, 2008, NEUROMUSCULAR DISORD, V18, P530, DOI 10.1016/j.nmd.2008.04.016; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Rudnik-Schoneborn S, 2007, NEUROGENETICS, V8, P137, DOI 10.1007/s10048-006-0070-0; SALMON P, 2006, CURR PROTOC NEUROSCI, V37; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x; Takashima H, 1999, NEUROMUSCULAR DISORD, V9, P368, DOI 10.1016/S0960-8966(99)00021-8; Teuling E, 2008, HUM MOL GENET, V17, P2849, DOI 10.1093/hmg/ddn182; Ting CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051826; Viollet L, 2002, ANN NEUROL, V51, P585, DOI 10.1002/ana.10182	36	85	89	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					955	964		10.1016/j.ajhg.2013.04.013	http://dx.doi.org/10.1016/j.ajhg.2013.04.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23664119	Bronze, Green Published			2022-12-18	WOS:000320415300012
J	Mendez, FL; Krahn, T; Schrack, B; Krahn, AM; Veeramah, KR; Woerner, AE; Fomine, FLM; Bradman, N; Thomas, MG; Karafet, TM; Hammer, MF				Mendez, Fernando L.; Krahn, Thomas; Schrack, Bonnie; Krahn, Astrid-Maria; Veeramah, Krishna R.; Woerner, August E.; Fomine, Forka Leypey Mathew; Bradman, Neil; Thomas, Mark G.; Karafet, Tatiana M.; Hammer, Michael F.			An African American Paternal Lineage Adds an Extremely Ancient Root to the Human Y Chromosome Phylogenetic Tree	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT COMMON ANCESTRY; GENETIC-EVIDENCE; POPULATION-STRUCTURE; ARCHAIC ADMIXTURE; MUTATION-RATE; DIVERGENCE; KHOISAN; ORIGIN; AGE	We report the discovery of an African American Y chromosome that carries the ancestral state of all SNPs that defined the basal portion of the Y chromosome phylogenetic tree. We sequenced similar to 240 kb of this chromosome to identify private, derived mutations on this lineage, which we named A00. We then estimated the time to the most recent common ancestor (TMRCA) for the Y tree as 338 thousand years ago (kya) (95% confidence interval = 237-581 kya). Remarkably, this exceeds current estimates of the mtDNA TMRCA, as well as those of the age of the oldest anatomically modern human fossils. The extremely ancient age combined with the rarity of the A00 lineage, which we also find at very low frequency in central Africa, point to the importance of considering more complex models for the origin of Y chromosome diversity. These models include ancient population structure and the possibility of archaic introgression of Y chromosomes into anatomically modern humans. The A00 lineage was discovered in a large database of consumer samples of African Americans and has not been identified in traditional hunter-gatherer populations from sub-Saharan Africa. This underscores how the stochastic nature of the genealogical process can affect inference from a single locus and warrants caution during the interpretation of the geographic location of divergent branches of the Y chromosome phylogenetic tree for the elucidation of human origins.	[Mendez, Fernando L.; Veeramah, Krishna R.; Woerner, August E.; Karafet, Tatiana M.; Hammer, Michael F.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA; [Krahn, Thomas; Schrack, Bonnie; Krahn, Astrid-Maria] Family Tree DNA, Genom Res Ctr, Houston, TX 77008 USA; [Fomine, Forka Leypey Mathew] Univ Yaounde I, Dept Hist, Yaounde, Cameroon; [Bradman, Neil] Henry Stewart Grp, London WC1A 2HN, England; [Thomas, Mark G.] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England	University of Arizona; University of Yaounde I; University of London; University College London	Hammer, MF (corresponding author), Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA.	mfh@email.arizona.edu	Thomas, Mark G/A-2219-2012	Thomas, Mark G/0000-0002-2452-981X; Mendez, Fernando/0000-0002-0879-3813				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batini C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-118; Batini C, 2011, MOL BIOL EVOL, V28, P2603, DOI 10.1093/molbev/msr089; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Eltis D, 2001, WILLIAM MARY QUART, V58, P17, DOI 10.2307/2674417; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Harvati K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024024; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Mendez FL, 2012, MOL BIOL EVOL, V29, P1513, DOI 10.1093/molbev/msr301; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilkins JF, 2006, CURR OPIN GENET DEV, V16, P611, DOI 10.1016/j.gde.2006.10.004; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	47	85	87	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					454	459		10.1016/j.ajhg.2013.02.002	http://dx.doi.org/10.1016/j.ajhg.2013.02.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23453668	Bronze, Green Published			2022-12-18	WOS:000316161700020
J	Reiner, AP; Beleza, S; Franceschini, N; Auer, PL; Robinson, JG; Kooperberg, C; Peters, U; Tang, H				Reiner, Alex P.; Beleza, Sandra; Franceschini, Nora; Auer, Paul L.; Robinson, Jennifer G.; Kooperberg, Charles; Peters, Ulrike; Tang, Hua			Genome-wide Association and Population Genetic Analysis of C-Reactive Protein in African American and Hispanic American Women	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUTRITION EXAMINATION SURVEY; GLOBAL CARDIOVASCULAR RISK; 3RD NATIONAL-HEALTH; HEART-DISEASE; ATHEROSCLEROSIS RISK; NATURAL-SELECTION; UNITED-STATES; INFLAMMATION; PREDICTION; GENDER	C-reactive protein (CRP) is a systemic inflammation marker that predicts future cardiovascular risk. CRP levels are higher in African Americans and Hispanic Americans than in European Americans, but the genetic determinants of CRP in these admixed United States minority populations are largely unknown. We performed genome-wide association studies (GWASs) of 8,280 African American (AA) and 3,548 Hispanic American (HA) postmenopausal women from the Women's Health Initiative SNP Health Association Resource. We discovered and validated a CRP-associated variant of triggering receptors expressed by myeloid cells 2 (TREM2) in chromosomal region 6p21 (p = 10(-10)). The TREM2 variant associated with higher CRP is common in Africa but rare in other ancestral populations. In AA women, the CRP region in 1q23 contained a strong admixture association signal (p = 10(-17)), which appears to be related to several independent CRP-associated alleles; the strongest of these is present only in African ancestral populations and is associated with higher CRP. Of the other genomic loci previously associated with CRP through GWASs of European populations, most loci (LEPR, IL1RN, IL6R, GCKR, NLRP3, HNF1A, HNF4A, and APOC1) showed consistent patterns of association with CRP in AA and HA women. In summary, we have identified a common TREM2 variant associated with CRP in United States minority populations. The genetic architecture underlying the CRP phenotype in AA women is complex and involves genetic variants shared across populations, as well as variants specific to populations of African descent.	[Reiner, Alex P.; Auer, Paul L.; Kooperberg, Charles; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Beleza, Sandra; Tang, Hua] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Beleza, Sandra; Tang, Hua] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Franceschini, Nora] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Robinson, Jennifer G.] Univ Iowa, Dept Epidemiol & Med, Iowa City, IA 52242 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa	Reiner, AP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	apreiner@u.washington.edu	, Jennifer/AAD-8336-2019; Auer, Paul/AAC-5060-2019	Beleza, Sandra/0000-0002-7004-3431	National Heart, Lung, and Blood Institute, National Institutes of Health; United States Department of Health and Human Services [HHSN268201100046C, HHSN2682011 00001C, HHSN268201100002C, HHSN268201100003C, HHSN2 68201100004C, HHSN271201100004C]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, and the United States Department of Health and Human Services through contracts HHSN268201100046C, HHSN2682011 00001C, HHSN268201100002C, HHSN268201100003C, HHSN2 68201100004C, and HHSN271201100004C. The authors thank the WHI investigators and staff for their dedication and the study participants for making the program possible. A listing of WHI investigators can be found at http://www.whiscience.org/publications/WHI_investigators_shortlist_2010-2015.pdf.	Albert MA, 2004, AM J CARDIOL, V93, P1238, DOI 10.1016/j.amjcard.2004.01.067; Albert MA, 2006, CIRCULATION, V114, pE67, DOI 10.1161/CIRCULATIONAHA.106.613570; Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Chambless LE, 2004, AM J EPIDEMIOL, V160, P259, DOI 10.1093/aje/kwh189; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Cushman M, 2009, CLIN CHEM, V55, P1627, DOI 10.1373/clinchem.2008.122093; DeBoer MD, 2011, DIABETES CARE, V34, P734, DOI 10.2337/dc10-1877; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Doumatey AP, 2012, HUM MOL GENET, V21, P3063, DOI 10.1093/hmg/dds133; Dupuis J, 2005, ATHEROSCLEROSIS, V182, P307, DOI 10.1016/j.atherosclerosis.2005.02.015; Ford ES, 2003, CLIN CHEM, V49, P1353, DOI 10.1373/49.8.1353; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Fox ER, 2008, AM J CARDIOL, V102, P835, DOI 10.1016/j.amjcard.2008.05.049; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Johnson N.A., 2011, THESIS STANFORD U ST; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Lakoski SG, 2006, AM HEART J, V152, P593, DOI 10.1016/j.ahj.2006.02.015; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Miller M, 2005, ARCH INTERN MED, V165, P2063, DOI 10.1001/archinte.165.18.2063; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Retterstol L, 2003, ATHEROSCLEROSIS, V169, P279, DOI 10.1016/S0021-9150(03)00192-8; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rodriguez F, 2012, AM J CARDIOL, V109, P665, DOI 10.1016/j.amjcard.2011.10.020; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shah T, 2010, CIRC-CARDIOVASC GENE, V3, P436, DOI 10.1161/CIRCGENETICS.110.957431; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Wee CC, 2008, OBESITY, V16, P875, DOI 10.1038/oby.2008.7; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	53	85	86	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					502	512		10.1016/j.ajhg.2012.07.023	http://dx.doi.org/10.1016/j.ajhg.2012.07.023			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22939635	Bronze, Green Published			2022-12-18	WOS:000308683100010
J	Hunter-Zinck, H; Musharoff, S; Salit, J; Al-Ali, KA; Chouchane, L; Gohar, A; Matthews, R; Butler, MW; Fuller, J; Hackett, NR; Crystal, RG; Clarks, AG				Hunter-Zinck, Haley; Musharoff, Shaila; Salit, Jacqueline; Al-Ali, Khalid A.; Chouchane, Lotfi; Gohar, Abeer; Matthews, Rebecca; Butler, Marcus W.; Fuller, Jennifer; Hackett, Neil R.; Crystal, Ronald G.; Clarks, Andrew G.			Population Genetic Structure of the People of Qatar	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; DIVERSITY; HISTORY; INFERENCE; DISEASE; LOCI	People of the Qatar peninsula represent a relatively recent founding by a small number of families from three tribes of the Arabian Peninsula, Persia, and Oman, with indications of African admixture. To assess the roles of both this founding effect and the customary first-cousin marriages among the ancestral Islamic populations in Qatar's population genetic structure, we obtained and genotyped with Affymetrix 500k SNP arrays DNA samples from 168 self-reported Qatari nationals sampled from Doha, Qatar. Principal components analysis was performed along with samples from the Human Genetic Diversity Project data set, revealing three clear clusters of genotypes whose proximity to other human population samples is consistent with Arabian origin, a more eastern or Persian origin, and individuals with African admixture. The extent of linkage disequilibrium (LD) is greater than that of African populations, and runs of homozygosity in some individuals reflect substantial consanguinity. However, the variance in runs of homozygosity is exceptionally high, and the degree of identity-by-descent sharing generally appears to be lower than expected for a population in which nearly half of marriages are between first cousins. Despite the fact that the SNPs of the Affymetrix 500k chip were ascertained with a bias toward SNPs common in Europeans, the data strongly support the notion that the Qatari population could provide a valuable resource for the mapping of genes associated with complex disorders and that tests of pairwise interactions are particularly empowered by populations with elevated LD like the Qatari.	[Clarks, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Hunter-Zinck, Haley; Musharoff, Shaila] Cornell Univ, Program Computat Biol & Med, Ithaca, NY 14850 USA; [Salit, Jacqueline; Butler, Marcus W.; Fuller, Jennifer; Hackett, Neil R.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10021 USA; [Al-Ali, Khalid A.] Qatar Univ, Dept Hlth Sci, Coll Arts & Sci, Doha, Qatar; [Chouchane, Lotfi; Gohar, Abeer; Matthews, Rebecca] Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar	Cornell University; Cornell University; Cornell University; Qatar University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Clarks, AG (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	ac347@cornell.edu	Chouchane, Lotfi/ABF-1360-2020	Butler, Marcus/0000-0003-2026-7709; Clark, Andrew/0000-0001-7159-8511	Qatar Foundation; Weill Cornell Medical College in Qatar; Cornell University; National Institutes of Health [HG003229, MH084685, HL084706]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084706] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Cornell University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the volunteers from Qatar who donated DNA. These studies were supported in part by the Qatar Foundation and Weill Cornell Medical College in Qatar. H.H.-Z. and S.M. were supported by the Tr-Institutional Training Program in Computational Biology and Medicine at Cornell University. This work was supported in part by National Institutes of Health research grants HG003229, MH084685, and HL084706.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Abu-Amero KK, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-59; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Badii R, 2008, ACTA DIABETOL, V45, P15, DOI 10.1007/s00592-007-0013-8; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Hartl D., 2007, PRINCIPLES POPULATIO; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nagy S, 2006, URBAN STUD, V43, P119, DOI 10.1080/00420980500409300; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Rice J. A., 1995, MATH STAT DATA ANAL; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sandridge AL, 2010, J BIOSOC SCI, V42, P59, DOI 10.1017/S002193200999023X; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	85	85	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					17	25		10.1016/j.ajhg.2010.05.018	http://dx.doi.org/10.1016/j.ajhg.2010.05.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20579625	Bronze, Green Published			2022-12-18	WOS:000280029200002
J	Meisinger, C; Prokisch, H; Gieger, C; Soranzo, N; Mehta, D; Rosskopf, D; Lichtner, P; Klopp, N; Stephens, J; Watkins, NA; Deloukas, P; Greinacher, A; Koenig, W; Nauck, M; Rimmbach, C; Volzke, H; Peters, A; Illig, T; Ouwehand, WH; Meitinger, T; Wichmann, HE; Doring, A				Meisinger, Christa; Prokisch, Holger; Gieger, Christian; Soranzo, Nicole; Mehta, Divya; Rosskopf, Dieter; Lichtner, Peter; Klopp, Norman; Stephens, Jonathan; Watkins, Nicholas A.; Deloukas, Panos; Greinacher, Andreas; Koenig, Wolfgang; Nauck, Matthias; Rimmbach, Christian; Voelzke, Henry; Peters, Annette; Illig, Thomas; Ouwehand, Willem H.; Meitinger, Thomas; Wichmann, H. -Erich; Doering, Angela			A Genome-wide Association Study Identifies Three Loci Associated with Mean Platelet Volume	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC INFLUENCES; DISEASE; KINASE	Mean platelet volume (MPV) is increased in myocardial and cerebral infarction and is an independent and strong predictor for postevent morbidity and mortality. We conducted a genome-wide association study (GWAS), the KORA (Kooperative Gesundheitsforschung in der Region Augsburg) F3 500K study, and found MPV to be strongly associated with three common single-nucleotide polymorphisms (SNPs): rs7961894 located within intron 3 of WDR66 on chromosome 12q24.31, rs12485738 upstream of the ARHGEF3 on chromosome 3p13-p21, and rs2138852 located upstream of TAOK1 on chromosome 17q11.2. We replicated all three SNPs in another GWAS from the UK and in two population-based samples from Germany. In a combined analysis including 10,048 subjects, the SNPs had p values of 7.24 x 10(-48) for rs7961894, 3.81 X 10(-27) for rs12485738, and 7.19 x 10(-28) for rs2138852. These three quantitative trait loci together accounted for 4%-5% of the variance in MPV. In-depth sequence analysis of WDR66 in 382 samples from the extremes revealed 20 new variants and a haplotype with three coding SNPs and one SNP at the transcription start site associated with MPV (p = 6.8 x 10(-5)). In addition, expression analysis indicated a direct correlation of WDR66 transcripts and MPV. These findings may not only enhance our understanding of platelet activation and function, but may also provide a focus for several novel research avenues.	[Meisinger, Christa; Gieger, Christian; Klopp, Norman; Peters, Annette; Illig, Thomas; Wichmann, H. -Erich; Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Prokisch, Holger; Mehta, Divya; Lichtner, Peter; Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Meisinger, Christa] MONICA KORA Myocardial Infarct Registry, Cent Hosp Augsburg, D-86156 Augsburg, Germany; [Prokisch, Holger; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81765 Munich, Germany; [Gieger, Christian; Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biopmetry & Epidemiol, D-81377 Munich, Germany; [Soranzo, Nicole; Deloukas, Panos; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Soranzo, Nicole] Kings Coll London, Twin Genet Epidemiol Unit, London SE1 7EH, England; [Rosskopf, Dieter; Rimmbach, Christian] Ernst Moritz Arndt Univ Greifswald, Dept Pharmacol, Ctr Pharmacol & Expt Therapeut, D-17487 Greifswald, Germany; [Greinacher, Andreas] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, D-17487 Greifswald, Germany; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem, D-17487 Greifswald, Germany; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Lab Med, D-17487 Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] NHSBT, Cambridge CB2 0PT, England; [Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med 2, D-89081 Ulm, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Wellcome Trust Sanger Institute; University of London; King's College London; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Cambridge; Ulm University	Doring, A (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany.	doering@helmholtz-muenchen.de	Prokisch, Holger/N-8964-2013; Meitinger, Thomas/O-1318-2015; Meisinger, Christine/B-5358-2014; Wichmann, Heinz Erich/AAA-5695-2022; Peters, Annette/A-6117-2011; Mehta, Divya/ABD-4551-2021; Deloukas, Panos/B-2922-2013	Peters, Annette/0000-0001-6645-0985; Deloukas, Panos/0000-0001-9251-070X; Mehta, Divya Deepak/0000-0002-7359-348X; Mehta, Divya/0000-0001-7971-7255; Meitinger, Thomas/0000-0002-8838-8403; Soranzo, Nicole/0000-0003-1095-3852; Koenig, Wolfgang/0000-0002-2064-9603; Meisinger, Christa/0000-0002-9026-6544; Prokisch, Holger/0000-0003-2379-6286; Gieger, Christian/0000-0001-6986-9554	Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFN); European Union [LSH-2005-037593]; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; Federal Ministry of Education and Research; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; state government of Mecklenburg-Vorpornmern [UG 07 034]; Wellcome Trust; National Institutes of Health Research	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFN); European Union(European Commission); Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; state government of Mecklenburg-Vorpornmern; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The MONICA/KORA Augsburg studies were financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany, and supported by grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was funded by the German National Genome Research Network (NGFN) and the European Union-sponsored project Cardiogenetics (LSH-2005-037593). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. SHIP is part of the Community Medicine Research net (CMR) of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research, the Ministry of Cultural Affairs, as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The SHIP genotyping was supported by the future fund of the state government of Mecklenburg-Vorpornmern (UG 07 034). The establishment and genotyping of the UKBS-CC1 collection was funded by the Wellcome Trust and by a National Institutes of Health Research Grant to NHSBT. We thank the staff of the DNA Collections and Genotyping Facilities at the Wellcome Trust Sanger Institute for sample preparation. We gratefully acknowledge the contribution of G. Eckstein, T. Strom and K. Heim, A. Loschner, R. Hellinger, and all other members of the Helmholtz Zentrurn Mfinchen genotyping staff in generating and analyzing the SNP and RNA data set and G. Fischer and B. KCihnel for data management and statistical analyses. We thank all members of field staffs who were involved in the planning and conduct of the MONICA/ KORA Augsburg, UKBS-CC1, and SHIP studies. Finally, we express our appreciation to all study participants. No conflict of interest relevant to this article was reported.	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang Y, 2007, J THROMB HAEMOST, V5, P318, DOI 10.1111/j.1538-7836.2007.02472.x; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Garner C, 2000, BLOOD, V95, P342; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Mahaney MC, 2005, BLOOD, V106, P1210, DOI 10.1182/blood-2004-12-4863; MARTIN JF, 1992, LANCET, V339, P1000, DOI 10.1016/0140-6736(92)91587-X; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Thiesen S, 2000, BIOCHEM BIOPH RES CO, V273, P364, DOI 10.1006/bbrc.2000.2925; Tsiara S, 2003, CLIN APPL THROMB-HEM, V9, P177, DOI 10.1177/107602960300900301; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zihni C, 2007, J BIOL CHEM, V282, P6484, DOI 10.1074/jbc.M608336200	18	85	87	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					66	71		10.1016/j.ajhg.2008.11.015	http://dx.doi.org/10.1016/j.ajhg.2008.11.015			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19110211	Bronze, Green Published			2022-12-18	WOS:000262679500008
J	Valdes, AM; Loughlin, J; Timms, KM; van Meurs, JJB; Southam, L; Wilson, SG; Doherty, S; Lories, RJ; Luyten, FP; Gutin, A; Abkevich, V; Ge, D; Hofman, A; Uitterlinden, AG; Hart, DJ; Zhang, F; Zhai, G; Egli, RJ; Doherty, M; Lanchbury, J; Spector, TD				Valdes, Ana M.; Loughlin, John; Timms, Kirsten M.; van Meurs, Joyce J. B.; Southam, Lorraine; Wilson, Scott G.; Doherty, Sally; Lories, Rik J.; Luyten, Frank P.; Gutin, Alexander; Abkevich, Victor; Ge, Dongliang; Hofman, Albert; Uitterlinden, Andre G.; Hart, Deborah J.; Zhang, Feng; Zhai, Guangju; Egli, Rainer J.; Doherty, Michael; Lanchbury, Jerry; Spector, Tim D.			Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; ARTICULAR CHONDROCYTES; HIP OSTEOARTHRITIS; SUSCEPTIBILITY; CARTILAGE; LRCH1; CALM1; CYCLOOXYGENASE-2; PATHOGENESIS; APOPTOSIS	Osteoarthritis (OA), the most prevalent form of arthritis in the elderly, is characterized by the degradation of articular cartilage and has a strong genetic component. Our aim was to identify genetic variants involved in risk of knee OA in women. A pooled genome-wide association scan with the Illumina550 Duo array was performed in 255 controls and 387 cases. Twenty-eight variants with p < 1 x 10(-5) were estimated to have probabilities of being false positives <= 0.5 and were genotyped individually in the original samples and in replication cohorts from the UK and the U.S. (599 and 272 cases, 1530 and 258 controls, respectively). The top seven associations were subsequently tested in samples from the Netherlands (306 cases and 584 controls). rs4140564 on chromosome 1 mapping 5' to both the PTGS2 and PLA2G4A genes was associated with risk of knee OA in all the cohorts studied (overall odds ratio ORMH = 1.55 95% C.I. 1.30-1.85, p < 6.9 x 10(-7)). Differential allelic expression analysis of PTGS2 with mRNA extracted from the cartilage of joint-replacement surgery OA patients revealed a significant difference in allelic expression (p < 1.0 x 10(-6)). These results suggest the existence of cis-acting regulatory polymorphisms that are in, or near to, PTGS2 and in modest linkage disequilibrium with rs4140564. Our results and previous studies on the role of the cyclooxygenase 2 enzyme encoded by PTGS2 underscore the importance of this signaling pathway in the pathogenesis of knee OA.	[Valdes, Ana M.; Hart, Deborah J.; Zhang, Feng; Zhai, Guangju; Spector, Tim D.] Kings Coll London, Sch Med, Twin Res Unit, London SE1 7EH, England; [Loughlin, John; Southam, Lorraine; Egli, Rainer J.] Univ Oxford, Inst Musculoskeletal Sci, Oxford OX3 7LD, England; [Loughlin, John] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Timms, Kirsten M.; Gutin, Alexander; Abkevich, Victor; Lanchbury, Jerry] Myriad Genet Inc, Salt Lake City, UT 84108 USA; [van Meurs, Joyce J. B.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Wilson, Scott G.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Wilson, Scott G.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Doherty, Sally; Doherty, Michael] Univ Nottingham, City Hosp Nottingham, Acad Rheumatol, Nottingham NG5 1PB, England; [Lories, Rik J.; Luyten, Frank P.] Katholieke Univ Leuven, Dept Musculoskeletal Sci, Div Rheumatol, Lab Skeletal Dev & Joint Disorders, B-3000 Louvain, Belgium; [Ge, Dongliang] Duke Univ, Ctr Populat Genom & Pharmacogenet, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; [Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol & Biostat, NL-3015 GE Rotterdam, Netherlands	University of London; King's College London; University of Oxford; Newcastle University - UK; Myriad Genetics, Inc; Erasmus University Rotterdam; Erasmus MC; University of Western Australia; University of Western Australia; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; KU Leuven; Duke University; Erasmus University Rotterdam; Erasmus MC	Valdes, AM (corresponding author), Kings Coll London, Sch Med, Twin Res Unit, St Thomas Hosp Campus, London SE1 7EH, England.	ana.valdes@kcl.ac.uk	Spector, Tim D/F-6533-2012; Lories, Rik/T-2196-2017; Luyten, Frank/GPS-7793-2022; Ge, Dongliang/A-2073-2010; Lories, Rik/Q-8328-2019	Lories, Rik/0000-0002-5986-3092; Lories, Rik/0000-0002-5986-3092; Loughlin, John/0000-0003-2018-3361; Valdes, Ana M./0000-0003-1141-4471; Wilson, Scott/0000-0002-0357-1373; Doherty, Michael/0000-0002-5763-8326; van Meurs, Joyce/0000-0001-6245-2123	Arthritis Research UK [17489] Funding Source: Medline; Versus Arthritis [17489] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botha-Scheepers S, 2008, ANN RHEUM DIS, V67, P1165, DOI 10.1136/ard.2007.084657; Burnett S, 1994, RADIOGRAPHIC ATLAS O; Carames B, 2008, OSTEOARTHR CARTILAGE, V16, P715, DOI 10.1016/j.joca.2007.10.006; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; DIBATTISTA JA, 1991, J RHEUMATOL, V18, P102; Docherty SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-214; Felson DT, 2004, RADIOL CLIN N AM, V42, P1, DOI 10.1016/S0033-8389(03)00161-1; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goldring MB, 2004, CLIN ORTHOP RELAT R, pS37, DOI 10.1097/01.blo.0000144484.69656.e4; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Gosset M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2024; Hardy MM, 2002, ARTHRITIS RHEUM, V46, P1789, DOI 10.1002/art.10356; HART DJ, 1993, J RHEUMATOL, V20, P331; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Jiang Q, 2008, J HUM GENET, V53, P42, DOI 10.1007/s10038-007-0216-4; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; KIRKWOOD BR, 1988, ESSENTIALS MED STAT, P27; Kobayashi T, 1999, ARTHRITIS RHEUM, V42, P519, DOI 10.1002/1529-0131(199904)42:3<519::AID-ANR17>3.0.CO;2-Q; Lane NE, 2006, ARTHRITIS RHEUM-US, V54, P1246, DOI 10.1002/art.21673; Loughlin J, 2006, OSTEOARTHR CARTILAGE, V14, P295, DOI 10.1016/j.joca.2005.11.001; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; Meulenbelt I, 2006, EUR J HUM GENET, V14, P1280, DOI 10.1038/sj.ejhg.5201704; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Relic B, 2002, LAB INVEST, V82, P1661, DOI 10.1097/01.LAB.0000041714.05322.C0; ROSENBAUM S, 1985, ANN HUM BIOL, V12, P115, DOI 10.1080/03014468500007621; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Snelling S, 2007, RHEUMATOLOGY, V46, P250, DOI 10.1093/rheumatology/kel265; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Spector TD, 2006, ARTHRITIS RHEUM-US, V54, P524, DOI 10.1002/art.21624; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Steer S, 2007, GENES IMMUN, V8, P57, DOI 10.1038/sj.gene.6364359; Valdes AM, 2008, ANN RHEUM DIS, V67, P124, DOI 10.1136/ard.2007.075838; Valdes AM, 2005, SPINE, V30, P2445, DOI 10.1097/01.brs.0000184369.79744.a5; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wilkins JM, 2007, HUM MOL GENET, V16, P537, DOI 10.1093/hmg/ddl488	45	85	89	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1231	1240		10.1016/j.ajhg.2008.04.006	http://dx.doi.org/10.1016/j.ajhg.2008.04.006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18471798	Green Published, Bronze			2022-12-18	WOS:000256647000001
J	Malo, N; Libiger, O; Schork, NJ				Malo, Nathalie; Libiger, Ondrej; Schork, Nicholas J.			Accommodating linkage disequilibrium in genetic-association analyses via ridge regression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LOCI; SUSCEPTIBILITY; EXPRESSION	Large-scale genetic-association studies that take advantage of an extremely dense set of genetic markers have begun to produce very compelling statistical associations between multiple makers exhibiting strong linkage disequilibrium (LD) in a single genomic region and a phenotype of interest. However, the ultimate biological or "functional" significance of these multiple associations has been difficult to discern. In fact, the LD relationships between not only the markers found to be associated with the phenotype but also potential functionally or causally relevant genetic variations that reside near those markers have been exploited in such studies. Unfortunately, LD, especially strong LD, between variations at neighboring loci can make it difficult to distinguish the functionally relevant variations from nonfunctional variations. Although there are (rare) situations in which it is impossible to determine the independent phenotypic effects of variations in LD, there are strategies for accommodating LD between variations at different loci, and they can be used to tease out their independent effects on a phenotype. These strategies make it possible to differentiate potentially causative from noncausative variations. We describe one such approach involving ridge regression. We showcase the method by using both simulated and real data. Our results suggest that ridge regression and related techniques have the potential to distinguish causative from noncausative variations in association studies.	[Malo, Nathalie; Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, La Jolla, CA 92037 USA; [Malo, Nathalie; Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Dept Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schork, NJ (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	nschork@scripps.edu		Schork, Nicholas/0000-0003-0920-5013	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL064777, R01HL070137, R01HL074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG023122] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL064777-06, R01 HL070137, HL074730-02, R01 HL074730, HL070137-01, U01 HL064777] Funding Source: Medline; NIA NIH HHS [U19 AG023122, U19 AG023122-01] Funding Source: Medline; PHS HHS [5 R01 HLMH065571-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Draper N. R., 2014, APPL REGRESSION ANAL; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Gruber MHJ., 1998, IMPROVING EFFICIENCY; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Halawa AM, 2000, J STAT COMPUT SIM, V65, P341, DOI 10.1080/00949650008812006; Hastie T, 2004, BIOSTATISTICS, V5, P329, DOI 10.1093/biostatistics/kxh010; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; HOERL AE, 1975, COMMUN STAT, V4, P105, DOI 10.1080/03610927508827232; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LECRESSIE S, 1992, APPL STAT, V41, P191; Li Y, 2007, AM J HUM GENET, V80, P705, DOI 10.1086/513205; Ott J., 1991, ANAL HUMAN GENETIC L; Salem Rany M., 2005, Human Genomics, V2, P39; Topol EJ, 2007, JAMA-J AM MED ASSOC, V298, P218, DOI 10.1001/jama.298.2.218; Valdes AM, 2005, HUM IMMUNOL, V66, P301, DOI 10.1016/j.humimm.2004.12.001; Walker SG, 2001, J APPL STAT, V28, P911, DOI 10.1080/02664760120074988; Wang HS, 2006, GENET EPIDEMIOL, V30, P356, DOI 10.1002/gepi.20150; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Zavattari P, 2001, HUM MOL GENET, V10, P881, DOI 10.1093/hmg/10.8.881; Zhang B, 2004, P ANN INT IEEE EMBS, V26, P2793	30	85	89	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					375	385		10.1016/j.ajhg.2007.10.012	http://dx.doi.org/10.1016/j.ajhg.2007.10.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252218	Bronze, Green Published			2022-12-18	WOS:000253223900010
J	Hart, CE; Race, V; Achouri, Y; Wiame, E; Sharrard, M; Olpin, SE; Watkinson, J; Bonham, JR; Jaeken, J; Matthijs, G; Van Schaftingen, E				Hart, Claire E.; Race, Valerie; Achouri, Younes; Wiame, Elsa; Sharrard, Mark; Olpin, Simon E.; Watkinson, Jennifer; Bonham, James R.; Jaeken, Jaak; Matthijs, Gert; Van Schaftingen, Emile			Phosphoserine aminotransferase deficiency: A novel disorder of the serine biosynthesis pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							3-PHOSPHOGLYCERATE DEHYDROGENASE-DEFICIENCY; PHOSPHORYLATED PATHWAY; PHOSPHATASE DEFICIENCY; EXPRESSION; SEIZURES; PATIENT	We present the first two identified cases of phosphoserine aminotransferase deficiency. This disorder of serine biosynthesis has been identified in two siblings who showed low concentrations of serine and glycine in plasma and cerebrospinal fluid. Clinically, the index patient presented with intractable seizures, acquired microcephaly, hypertonia, and psychomotor retardation and died at age 7 mo despite supplementation with serine ( 500 mg/kg/d) and glycine ( 200 mg/kg/d) from age 11 wk. The younger sibling received treatment from birth, which led to a normal outcome at age 3 years. Measurement of phosphoserine aminotransferase activity in cultured fibroblasts in the index patient was inconclusive, but mutational analysis revealed compound heterozygosity for two mutations in the PSAT1 gene - one frameshift mutation ( c. delG107) and one missense mutation ( c. 299ArC [ p. Asp100Ala]) - in both siblings. Expression studies of the p. Asp100Ala mutant protein revealed a V-max of only 15% of that of the wild-type protein.	Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; Sheffield Childrens Hosp, Dept Clin Chem, Sheffield, S Yorkshire, England; Sheffield Childrens Hosp, Dept Paediat, Sheffield, S Yorkshire, England; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Paediat, B-3000 Louvain, Belgium	Universite Catholique Louvain; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; KU Leuven; KU Leuven; University Hospital Leuven	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, Ave Hippocrate 75, B-1200 Brussels, Belgium.	vanschaftingen@bchm.ucl.ac.be	Van+Schaftingen, Emile/AAF-5532-2020	olpin, simon/0000-0001-9018-5173; ACHOURI, Younes/0000-0001-7409-1441; Van Schaftingen, Emile/0000-0002-6199-7647; Matthijs, Gert/0000-0001-6710-1912				Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Baek JY, 2003, BIOCHEM J, V373, P191, DOI 10.1042/BJ20030144; Danpure C. J., 2001, METABOLIC MOL BASES, V2, P3323; de Koning TJ, 1998, ANN NEUROL, V44, P261, DOI 10.1002/ana.410440219; de Koning TJ, 2004, LANCET, V364, P2221, DOI 10.1016/S0140-6736(04)17596-X; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; De Koning TJ, 2002, J INHERIT METAB DIS, V25, P119, DOI 10.1023/A:1015624726822; Fuchs SA, 2006, ANN NEUROL, V60, P476, DOI 10.1002/ana.20977; Hester G, 1999, J MOL BIOL, V286, P829, DOI 10.1006/jmbi.1998.2506; Jaeken J, 1996, ARCH DIS CHILD, V74, P542, DOI 10.1136/adc.74.6.542; Jaeken J, 1997, J MED GENET, V34, P594, DOI 10.1136/jmg.34.7.594; LUND K, 1985, ARCH BIOCHEM BIOPHYS, V237, P186, DOI 10.1016/0003-9861(85)90268-1; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; Pineda M, 2000, DEV MED CHILD NEUROL, V42, P629, DOI 10.1017/S0012162200001171; Ronzoni S, 1999, AM J OBSTET GYNECOL, V181, P477, DOI 10.1016/S0002-9378(99)70581-8; SCRIVER CR, 2001, METABOLIC MOL BASES, P1667; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V186, P355; VANSCHAFTINGEN E, 1989, FEBS LETT, V243, P127, DOI 10.1016/0014-5793(89)80113-9; Veiga-da-Cunha M, 2004, EUR J HUM GENET, V12, P163, DOI 10.1038/sj.ejhg.5201083; Yoshida K, 2004, J BIOL CHEM, V279, P3573, DOI 10.1074/jbc.C300507200	23	85	88	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					931	937		10.1086/517888	http://dx.doi.org/10.1086/517888			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436247	Bronze, Green Published			2022-12-18	WOS:000245973200011
J	Procaccio, V; Salazar, G; Ono, S; Styers, ML; Gearing, M; Davila, A; Jimenez, R; Juncos, J; Gutekunst, A; Meroni, G; Fontanella, B; Sontag, E; Sontag, JM; Faundez, V; Wainer, BH				Procaccio, Vincent; Salazar, Gloria; Ono, Shoichiro; Styers, Melanie L.; Gearing, Marla; Davila, Antonio; Jimenez, Richard; Juncos, Jorge; Gutekunst, Claire-Anne; Meroni, Germana; Fontanella, Bianca; Sontag, Estelle; Sontag, Jean Marie; Faundez, Victor; Wainer, Bruce H.			A mutation of beta-actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPITZ G/BBB SYNDROME; MUSCLE ALPHA-ACTIN; NEMALINE MYOPATHY; FILAMENT DYNAMICS; LATRUNCULIN-A; CELL MOTILITY; GBBB SYNDROME; GENE; CYTOSKELETON; XP22	Actin, one of the major filamentous cytoskeletal molecules, is involved in a variety of cellular functions. Whereas an association between muscle actin mutations and skeletal and cardiac myopathies has been well documented, reports of human disease arising from mutations of nonmuscle actin genes have been rare. We have identified a missense point mutation in the gene coding for beta-actin that results in an arginine-to-tryptophan substitution at position 183. The disease phenotype includes developmental midline malformations, sensory hearing loss, and a delayed-onset generalized dystonia syndrome in monozygotic twins. Cellular studies of a lymphoblastoid cell line obtained from an affected patient demonstrated morphological abnormalities of the actin cytoskeleton and altered actin depolymerization dynamics in response to latrunculin A, an actin monomer-sequestering drug. Resistance to latrunculin A was also observed in NIH 3T3 cells expressing the mutant actin. These findings suggest that mutations in nonmuscle actins may be associated with a broad spectrum of developmental malformations and/or neurological abnormalities such as dystonia.	Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA; Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30322 USA; Emory Univ, Dept Neurol, Sch Med, Atlanta, GA 30322 USA; Emory Univ, Dept Neurosurg, Sch Med, Atlanta, GA 30322 USA; Telethon Inst Genet & Med, Naples, Italy; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75230 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Emory University; Emory University; Emory University; Emory University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Procaccio, V (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Hewitt Hall,Room 2034, Irvine, CA 92697 USA.	vproca@uci.edu	Ono, Shoichiro/A-6475-2015; SONTAG, ESTELLE/AAE-9805-2020	Ono, Shoichiro/0000-0002-4763-0398; procaccio, Vincent/0000-0002-1537-4684; Faundez, Victor/0000-0002-2114-5271	NIAMS NIH HHS [R01 AR048615, T32 AR007587, 2T32AR007587-11] Funding Source: Medline; NIA NIH HHS [R01 AG018883, R01 AG18883, P30 AG012300, P30 AG10130, R01 AG024373, AG24373, P30 AG12300] Funding Source: Medline; NINDS NIH HHS [R01 NS021328, R01 NS21328, R01 NS42599, R01 NS042599, R01 NS041850, NS41850] Funding Source: Medline; Telethon [TGM06S01, TGM06Z03] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007587, R01AR048615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042599, R01NS041850, R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010130, R01AG018883, R01AG024373, P30AG012300] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguiar PMD, 2002, LANCET NEUROL, V1, P316, DOI 10.1016/S1474-4422(02)00137-0; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Belmont LD, 1999, J CELL SCI, V112, P1325; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Fechheimer M, 2002, TRENDS MOL MED, V8, P590, DOI 10.1016/S1471-4914(02)02439-5; Fujita M, 2003, ONCOGENE, V22, P627, DOI 10.1038/sj.onc.1206173; GARRELS JI, 1976, CELL, V9, P793, DOI 10.1016/0092-8674(76)90142-2; Gaudenz K, 1998, AM J HUM GENET, V63, P703, DOI 10.1086/302010; Gaudenz K, 1998, AM J HUM GENET, V63, P1571; Gearing M, 2002, ANN NEUROL, V52, P465, DOI 10.1002/ana.10319; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Graziano C, 2005, CLIN GENET, V68, P91, DOI 10.1111/j.1399-0004.2005.00442.x; Hidalgo-Bravo A, 2005, AM J MED GENET A, V136A, P190, DOI 10.1002/ajmg.a.30792; Hobbs CA, 2002, ARCH PEDIAT ADOL MED, V156, P315, DOI 10.1001/archpedi.156.4.315; Ilkovski B, 2004, HUM MOL GENET, V13, P1727, DOI 10.1093/hmg/ddh185; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Klein C, 2002, ANN NEUROL, V52, P675, DOI 10.1002/ana.10358; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; LEAVITT J, 1987, MOL CELL BIOL, V7, P2457, DOI 10.1128/MCB.7.7.2457; LLOYD C, 1992, J CELL BIOL, V117, P787, DOI 10.1083/jcb.117.4.787; Marston SB, 2001, J MUSCLE RES CELL M, V22, P1, DOI 10.1023/A:1010355716511; McDonaldMcGinn DM, 1996, AM J MED GENET, V64, P525, DOI 10.1002/ajmg.1320640304; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Nemeth AH, 2002, BRAIN, V125, P695, DOI 10.1093/brain/awf090; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nunbhakdi-Craig V, 2003, J VIROL, V77, P2807, DOI 10.1128/JVI.77.5.2807-2818.2003; Nunoi H, 1999, P NATL ACAD SCI USA, V96, P8693, DOI 10.1073/pnas.96.15.8693; Ozelius Laurie J, 2004, Adv Neurol, V94, P109; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Robin NH, 1996, AM J MED GENET, V62, P305, DOI 10.1002/(SICI)1096-8628(19960329)62:3<305::AID-AJMG20>3.0.CO;2-N; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; So J, 2005, AM J MED GENET A, V132A, P1, DOI 10.1002/ajmg.a.30407; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; WERTMAN KF, 1992, GENETICS, V132, P337; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	52	85	93	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					947	960		10.1086/504271	http://dx.doi.org/10.1086/504271			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685646	Green Published, Bronze			2022-12-18	WOS:000237553800005
J	Sung, YJ; Dawson, G; Munson, J; Estes, A; Schellenberg, GD; Wijsman, EM				Sung, YJ; Dawson, G; Munson, J; Estes, A; Schellenberg, GD; Wijsman, EM			Genetic investigation of quantitative traits related to autism: Use of multivariate polygenic models with ascertainment adjustment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECIPROCAL SOCIAL-BEHAVIOR; PERVASIVE DEVELOPMENTAL DISORDERS; FAMILY HISTORY; DIAGNOSTIC INTERVIEW; PEDIGREE ANALYSIS; INFANTILE-AUTISM; SAMPLING PROBLEM; SYMPTOM DOMAINS; GENOMIC SCREEN; TWIN	Autism is a severe developmental disorder of unknown etiology but with evidence for genetic influences. Here, we provide evidence for a genetic basis of several quantitative traits that are related to autism. These traits, from the Broader Phenotype Autism Symptom Scale (BPASS), were measured in nuclear families, each ascertained through two probands affected by autism spectrum disorder. The BPASS traits capture the continuum of severity of impairments and may be more informative for genetic studies than are the discrete diagnoses of autism that have been used by others. Using a sample of 201 nuclear families consisting of a total of 694 individuals, we implemented multivariate polygenic models with ascertainment adjustment to estimate heritabilities and genetic and environmental correlations between these traits. Our ascertainment adjustment uses conditioning on the phenotypes of probands, requires no modeling of the ascertainment process, and is applicable to multiplex ascertainment and multivariate traits. This appears to be the first such implementation for multivariate quantitative traits. The marked difference between heritability estimates of the trait for language onset with and without an ascertainment adjustment (0.08 and 0.22, respectively) shows that conclusions are sensitive to whether or not an ascertainment adjustment is used. Among the five BPASS traits that were analyzed, the traits for social motivation and range of interest/flexibility show the highest heritability (0.19 and 0.16, respectively) and also have the highest genetic correlation (0.92). This finding suggests a shared genetic basis of these two traits and that they may be most promising for future gene mapping and for extending pedigrees by phenotyping additional relatives.	Univ Washington, Div Med Genet, Autism Ctr, Seattle, WA 98195 USA; Univ Washington, Div Gerontol & Geriatr Med, Autism Ctr, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Psychol, Autism Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol & Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Wijsman, EM (corresponding author), Univ Washington, Div Med Genet, Autism Ctr, Box 357720, Seattle, WA 98195 USA.	wijsman@u.washington.edu		Wijsman, Ellen/0000-0002-2725-6669; Dawson, Geraldine/0000-0003-1410-2764; Munson, Jeffrey A/0000-0003-1798-8927	NICHD NIH HHS [U19 HD 35465, U19 HD035465] Funding Source: Medline; NIGMS NIH HHS [R01 GM046255, R01 GM 46255] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U19HD035465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046255] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; AUGUST GJ, 1981, BRIT J PSYCHIAT, V138, P416, DOI 10.1192/bjp.138.5.416; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; CANNINGS C, 1977, CLIN GENET, V12, P208; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AM ACAD CHILD PSY, V42, P458, DOI 10.1097/01.CHI.0000046811.95464.21; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN, 2000, AM J PSYCHIAT, V157, P2043, DOI 10.1176/appi.ajp.157.12.2043; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; DENNIS JR, 1983, NUMERICAL METHODS UN; Elston R C, 1979, Prog Clin Biol Res, V32, P391; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EWENS WJ, 1988, GENET EPIDEMIOL, V5, P433, DOI 10.1002/gepi.1370050607; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Goddard KAB, 1995, GENET EPIDEMIOL, V12, P759, DOI 10.1002/gepi.1370120638; Graham J, 1997, GENET EPIDEMIOL, V14, P999; Hokanson JE, 1999, AM J HUM GENET, V64, P608, DOI 10.1086/302234; Hollander M., 1999, NONPARAMETRIC STAT M; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JIANG CJ, 1995, GENETICS, V140, P1111; Kao CH, 1999, GENETICS, V152, P1203; Kolevzon A, 2004, AM J MED GENET B, V129B, P76, DOI 10.1002/ajmg.b.30011; LANDA R, 1992, PSYCHOL MED, V22, P245, DOI 10.1017/S0033291700032918; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; Lange K., 2002, MATH STAT METHODS GE; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MacLean JE, 1999, J AM ACAD CHILD PSY, V38, P746, DOI 10.1097/00004583-199906000-00023; MORTON NE, 1959, AM J HUM GENET, V11, P1; Mullen E. M., 1995, MULLEN SCALES EARLY; Murphy M, 2000, PSYCHOL MED, V30, P1411, DOI 10.1017/S0033291799002949; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Piven J, 1997, AM J PSYCHIAT, V154, P185; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; SARASON BR, 1985, J PERS SOC PSYCHOL, V49, P469; Sattler J., 1992, ASSESSMENT CHILDREN; SCHNABEL RB, 1985, ACM T MATH SOFTWARE, V11, P419, DOI 10.1145/6187.6192; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Silverman JM, 2002, AM J MED GENET, V114, P64, DOI 10.1002/ajmg.10048; SIMPSON JM, 1981, AM J HUM GENET, V33, P293; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; Spiker D, 2002, AM J MED GENET, V114, P129, DOI 10.1002/ajmg.10188; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Thompson E A, 1979, Prog Clin Biol Res, V32, P363; VIELAND VJ, 1995, AM J HUM GENET, V56, P33; WATSON D, 1969, J CONSULT CLIN PSYCH, V33, P448, DOI 10.1037/h0027806; Wechsler D., 1989, MANUAL WECHSLER PRES; Wechsler D., 1997, MANUAL WECHSLER ADUL, V3rd ed.; Wechsler D., 1991, MANUAL WECHSLER INTE; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WOLFF S, 1988, J CHILD PSYCHOL PSYC, V29, P143, DOI 10.1111/j.1469-7610.1988.tb00699.x	67	85	86	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					68	81		10.1086/426951	http://dx.doi.org/10.1086/426951			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15547804	Green Published, Bronze			2022-12-18	WOS:000225643600006
J	Mykytyn, K; Nishimura, DY; Searby, CC; Beck, G; Bugge, K; Haines, HL; Cornier, AS; Cox, GF; Fulton, AB; Carmi, R; Iannaccone, A; Jacobson, SG; Weleber, RG; Wright, AF; Riise, R; Hennekam, RCM; Luleci, G; Berker-Karauzum, S; Biesecker, LG; Stone, EM; Sheffield, VC				Mykytyn, K; Nishimura, DY; Searby, CC; Beck, G; Bugge, K; Haines, HL; Cornier, AS; Cox, GF; Fulton, AB; Carmi, R; Iannaccone, A; Jacobson, SG; Weleber, RG; Wright, AF; Riise, R; Hennekam, RCM; Luleci, G; Berker-Karauzum, S; Biesecker, LG; Stone, EM; Sheffield, VC			Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 16Q; OBESITY; DNA; IDENTIFICATION; MUTATIONS; LINKAGE; GENE	Bardet-Biedl syndrome (BBS) is a genetic disorder with the primary features of obesity, pigmentary retinopathy, polydactyly, renal malformations, mental retardation, and hypogenitalism. Patients with BBS are also at increased risk for diabetes mellitus, hypertension, and congenital heart disease. BBS is known to map to at least six loci: 11q13 (BBS1), 16q21 (BBS2), 3p13-p12 (BBS3), 15q22.3-q23 (BBS4), 2q31 (BBS5), and 20p12 (BBS6). Although these loci were all mapped on the basis of an autosomal recessive mode of inheritance, it has recently been suggested-on the basis of mutation analysis of the identified BBS2, BBS4, and BBS6 genes-that BBS displays a complex mode of inheritance in which, in some families, three mutations at two loci are necessary to manifest the disease phenotype. We recently identified BBS1, the gene most commonly involved in Bardet-Biedl syndrome. The identification of this gene allows for further evaluation of complex inheritance. In the present study we evaluate the involvement of the BBS1 gene in a cohort of 129 probands with BBS and report 10 novel BBS1 mutations. We demonstrate that a common BBS1 missense mutation accounts for 80% of all BBS1 mutations and is found on a similar genetic background across populations. We show that the BBS1 gene is highly conserved between mice and humans. Finally, we demonstrate that BBS1 is inherited in an autosomal recessive manner and is rarely, if ever, involved in complex inheritance.	Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Ponce Sch Med, Dept Biochem, Ponce, PR USA; Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Ben Gurion Univ Negev, Genet Inst, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; Oregon Hlth Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Cent Hosp Hedmark, Dept Ophthalmol, Hamar, Norway; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Arkdeniz Univ, Dept Med Biol Genet, Antalya, Turkey; NHGRI, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Ben Gurion University; Ben Gurion University; Soroka Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University; University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam; Akdeniz University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sheffield, VC (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA.		Mykytyn, Kirk/E-3723-2011; Biesecker, Leslie/AAG-2526-2021; Karauzum, Sibel/C-4848-2016	Mykytyn, Kirk/0000-0002-0158-4592; Searby, Charles/0000-0002-8108-8782; Jacobson, Samuel/0000-0003-2122-169X; Iannaccone, Alessandro/0000-0001-5737-8424; Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414	NCRR NIH HHS [2G12RR03050, G12 RR003050] Funding Source: Medline; NEI NIH HHS [R01-EY-11298, R01 EY011298] Funding Source: Medline; NHLBI NIH HHS [P50 HL055006] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000009] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Beales PL, 1999, J MED GENET, V36, P437; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; ELBEDOUR K, 1994, AM J MED GENET, V52, P164, DOI 10.1002/ajmg.1320520208; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; HARNETT JD, 1988, NEW ENGL J MED, V319, P615, DOI 10.1056/NEJM198809083191005; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Riise R, 2002, ARCH OPHTHALMOL-CHIC, V120, P1364, DOI 10.1001/archopht.120.10.1364; Riise R, 1997, BRIT J OPHTHALMOL, V81, P378, DOI 10.1136/bjo.81.5.378; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	20	85	90	3	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					429	437		10.1086/346172	http://dx.doi.org/10.1086/346172			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12524598	Green Published, Bronze			2022-12-18	WOS:000180680000022
J	Katsanis, N; Eichers, ER; Ansley, SJ; Lewis, RA; Kayserili, H; Hoskins, BE; Scambler, PJ; Beales, PL; Lupski, JR				Katsanis, N; Eichers, ER; Ansley, SJ; Lewis, RA; Kayserili, H; Hoskins, BE; Scambler, PJ; Beales, PL; Lupski, JR			BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 16Q; SYNDROME LOCUS; IDENTIFICATION; MUTATIONS; OBESITY; GENE; LINKAGE; PROTEIN; MAPS	Bardet-Biedl syndrome (BBS) is an uncommon multisystemic disorder characterized primarily by retinal dystrophy, obesity, polydactyly, and renal dysfunction. BBS has been modeled historically as an autosomal recessive trait, under which premise six independent BBS loci (BBS1-BBS6) have been mapped in the human genome. However, extended mutational analyses of BBS2 and BBS6, the first two BBS genes cloned, suggest that BBS exhibits a more complex pattern of inheritance, in which three mutations at two loci simultaneously are necessary and sufficient in some families to manifest the phenotype. We evaluated the spectrum of mutations in the recently identified BBS4 gene with a combination of haplotype analysis and mutation screening on a multiethnic cohort of 177 families. Consistent with predictions from previous genetic analyses, our data suggest that mutations in BBS4 contribute to BBS in <3% of affected families. Furthermore, integrated mutational data from all three currently cloned BBS genes raise the possibility that BBS4 may participate in triallelic inheritance with BBS2 and BBS1, but not the other known loci. Establishment of the loci pairing in triallelism is likely to be important for the elucidation of the functional relationships among the different BBS proteins.	Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; Baylor Coll Med, Texas Childrens Hosp, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Univ Istanbul, Inst Child Hlth, Div Med Genet, Istanbul, Turkey; UCL, Inst Child Hlth, Mol Med Unit, London, England	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Istanbul University; University of London; University College London	Katsanis, N (corresponding author), Johns Hopkins Univ, Inst Med Genet, 600 N Wolfe St, Baltimore, MD 21287 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Scambler, Peter J/C-4998-2008; Beales, Philip L/C-7367-2009; Scambler, Peter/AAZ-6026-2020; Kayserili, Hülya/AAA-5593-2021	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Kayserili, Hülya/0000-0003-0376-499X; Katsanis, Nicholas/0000-0002-2480-0171	NEI NIH HHS [EY12666] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012666] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Katsanis N, 1997, MAMM GENOME, V8, P526, DOI 10.1007/s003359900491; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	18	85	89	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					22	29		10.1086/341031	http://dx.doi.org/10.1086/341031			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12016587	Bronze, Green Published			2022-12-18	WOS:000176307700003
J	Wang, L; McDonnell, SK; Elkins, DA; Slager, SL; Christensen, E; Marks, AF; Cunningham, JM; Peterson, BJ; Jacobsen, SJ; Cerhan, JR; Blute, ML; Schaid, DJ; Thibodeau, SN				Wang, L; McDonnell, SK; Elkins, DA; Slager, SL; Christensen, E; Marks, AF; Cunningham, JM; Peterson, BJ; Jacobsen, SJ; Cerhan, JR; Blute, ML; Schaid, DJ; Thibodeau, SN			Analysis of the RNASEL gene in familial and sporadic prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSITIVE GEL-ELECTROPHORESIS; CHROMOSOME 1Q42.2-43; SUSCEPTIBILITY LOCUS; RISK; HPC2/ELAC2; HISTORY; INHERITANCE; INVOLVEMENT; POPULATION; INTERFERON	The RNASEL gene on chromosome 1q25 was recently identified as a candidate gene for hereditary prostate cancer (PC). To confirm these findings, we screened 326 patients from 163 families with familial PC for potential germline mutations, by use of conformation-sensitive gel electrophoresis, followed by direct sequence analysis. A total of six variants were identified, including one intronic and five exonic changes (three missense and two silent alterations). There were no unequivocal pathogenic changes. To further test for potential associations between genes and increased risk for disease, the three missense polymorphisms (Ile97Leu, Arg462Gln, and Glu541Asp) were genotyped in 438 patients with familial PC and in 510 population-based control subjects. Association testing revealed no significant differences between patients and control subjects for either the Leu97 variant (chi(2) trend test p = 1.42; P = .23) or the Asp541 variant (chi(2) = 1.52; P = .22). However, significant differences were detected for the Arg462Gln genotypes (chi(2) = 5.20; P = .02; odds ratio [OR] = 0.54; 95% confidence interval [CI] 0.32-0.91) when the genotype Gln/ Gln was compared with Arg/ Arg. In subset analyses, associations were also observed in the younger group (age at diagnosis less than or equal to64 years) (P = .0008; OR = 0.29; 95% CI = 0.13-0.66), in node-negative patients (P = .01; OR = 0.48; 95% CI 0.27-0.84), patients with stage T-1/T-2 disease (P = .008; OR = 0.39; 95%; CI 0.2-0.75), and patients with low-grade disease (P = .01; OR = 0.40; 95% CI 0.20-0.78). To evaluate whether this variant was also associated with sporadic PC, we genotyped an additional 499 patients with sporadic PC. Differences in frequency were not detected between patients with sporadic disease and control subjects. However, the same association was observed between patients with familial disease and patients with sporadic disease for the entire group (chi(2) = 4.82; P = .03), as well as in the subset analyses. These results suggest that polymorphic changes within the RNASEL gene may be associated with increased risk of familial but not sporadic PC.	Mayo Clin & Mayo Fdn, Genet Lab, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Thibodeau, SN (corresponding author), Mayo Clin & Mayo Fdn, Genet Lab, Dept Lab Med & Pathol, Hilton 970,200 1st St SW, Rochester, MN 55905 USA.		Slager, Susan L./B-6756-2009	Cerhan, James/0000-0002-7482-178X; McDonnell, Shannon/0000-0001-6201-369X; Jacobsen, Steven/0000-0002-8174-8533	NCI NIH HHS [CA 72818, R01 CA072818] Funding Source: Medline; NIAMS NIH HHS [R01 AR030582, AR30582] Funding Source: Medline; NIDDK NIH HHS [R01 DK058859, DK58859] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058859] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Cannon L., 1982, CANCER SURV, V1, P47; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GANGULY A, 1994, P NATL ACAD SCI USA, V91, P5217; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; HALLING KC, 1999, J NATL CANCER I, V91, P1267; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; LENGYEL P, 1993, P NATL ACAD SCI USA, V90, P5893, DOI 10.1073/pnas.90.13.5893; MEIKLE AW, 1982, J CLIN ENDOCR METAB, V54, P1104, DOI 10.1210/jcem-54-6-1104; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; PARK W, 2000, J MOL DIAGN, V2, P221; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Roberts RO, 2000, J UROLOGY, V163, P107, DOI 10.1016/S0022-5347(05)67984-0; Rokman A, 2001, CANCER RES, V61, P6038; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Suarez BK, 2001, CANCER RES, V61, P4982; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Thibodeau SN, 1998, CANCER RES, V58, P1713; Wang L, 2001, CANCER RES, V61, P6494; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2001, AM J HUM GENET, V68, P901, DOI 10.1086/319513; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	35	85	88	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					116	123		10.1086/341281	http://dx.doi.org/10.1086/341281			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12022038	Green Published, Bronze			2022-12-18	WOS:000176307700011
J	Giess, R; Holtmann, B; Braga, M; Grimm, T; Muller-Myhsok, B; Toyka, KV; Sendtner, M				Giess, R; Holtmann, B; Braga, M; Grimm, T; Muller-Myhsok, B; Toyka, KV; Sendtner, M			Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: Potential impact of CNTF as a candidate modifier gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; CILIARY NEUROTROPHIC FACTOR; MOTOR-NEURON DEGENERATION; MICE; EXPRESSION; SURVIVAL; DISEASE; INJURY; NERVE; ALS	Mutations in the copper/zinc superoxide dismutase 1 (SOD-1) gene are found in 20% of patients with familial amyotrophic lateral sclerosis (FALS), or amyotrophic lateral sclerosis 1. Here we describe a 25-year-old male patient who died from FALS after a rapid disease course of 11 mo. Sequencing of the SOD-1 gene revealed a heterozygous T-->G exchange at position 1513 within exon 5, coding for a V-->G substitution at position 148 of the mature protein. Genetic analysis of this family revealed the same mutation in both his healthy 35-year-old sister and his mother, who did not develop the disease before age 54 years. Screening for candidate modifier genes that might be responsible for the early onset and severe course of the disease in the 25-year-old patient revealed an additional homozygous mutation of the CNTF gene not found in his yet unaffected sister. hSOD-1G93A mice were crossbred with CNTF-/- mice and were investigated with respect to disease onset and duration, to test the hypothesis that CNTF acts as a candidate modifier gene in FALS with mutations in the SOD-1 gene. Such hSOD-1G93A/CNTF-deficient mice develop motoneuron disease at a significantly earlier stage than hSOD-1G93A/CNTF-wild-type mice. Linkage analysis revealed that the SOD-1 gene was solely responsible for the disease. However, disease onset as a quantitative trait was regulated by the allelic constitution at the CNTF locus. In addition, patients with sporadic amyotrophic lateral sclerosis who had a homozygous CNTF gene defect showed significantly earlier disease onset but did not show a significant difference in disease duration. Thus, we conclude that CNTF acts as a modifier gene that leads to early onset of disease in patients with FALS who have SOD-1 mutations, in patients with sporadic amyotrophic lateral sclerosis, and in the hSOD-1G93A mouse model.	Univ Wurzburg, Inst Clin Neurobiol, D-97080 Wurzburg, Germany; Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; Univ Wurzburg, Dept Human Genet, D-97080 Wurzburg, Germany; Bernhard Nocht Inst Trop Med, Lab Bioinformat, Hamburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Bernhard Nocht Institut fur Tropenmedizin	Sendtner, M (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.		Sendtner, Michael/M-8137-2014; Müller-Myhsok, Bertram/A-3289-2013; Sendtner, Michael/J-1542-2012	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; BRAGA, Massimiliano/0000-0001-8109-1001				Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Andersen PM, 1996, BRAIN, V119, P1153, DOI 10.1093/brain/119.4.1153; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BANNER LR, 1994, P NATL ACAD SCI USA, V91, P7109, DOI 10.1073/pnas.91.15.7109; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CLEVELAND DW, 1995, NATURE, V378, P342, DOI 10.1038/378342a0; Cookson MR, 1999, BRAIN PATHOL, V9, P165; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS R, 1994, NEURON, V12, P191, DOI 10.1016/0896-6273(94)90163-5; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Estevez AG, 1998, PROG BRAIN RES, V118, P269; Ferri A, 2000, J NEUROCHEM, V75, P606, DOI 10.1046/j.1471-4159.2000.0750606.x; Giess R, 1998, MUSCLE NERVE, V21, P236, DOI 10.1002/(SICI)1097-4598(199802)21:2<236::AID-MUS12>3.0.CO;2-#; Giess R, 2000, NEUROLOGY, V54, P1003, DOI 10.1212/WNL.54.4.1003; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Jackson M, 1997, ANN NEUROL, V42, P803, DOI 10.1002/ana.410420518; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; MAGAL E, 1991, DEV BRAIN RES, V63, P141, DOI 10.1016/0165-3806(91)90074-S; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUNSAT TL, 1988, NEUROLOGY, V38, P409, DOI 10.1212/WNL.38.3.409; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; ORRELL RW, 1995, J NEUROL NEUROSUR PS, V59, P266, DOI 10.1136/jnnp.59.3.266; Orrell RW, 2000, NEUROMUSCULAR DISORD, V10, P63, DOI 10.1016/S0960-8966(99)00071-1; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Radunovic A, 1996, J NEUROL NEUROSUR PS, V61, P565, DOI 10.1136/jnnp.61.6.565; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Siddique T, 1996, HUM MOL GENET, V5, P1465, DOI 10.1093/hmg/5.Supplement_1.1465; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515	44	85	93	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1277	1286		10.1086/340427	http://dx.doi.org/10.1086/340427			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11951178	Green Published, Bronze			2022-12-18	WOS:000175012400017
J	Soro, A; Pajukanta, P; Lilja, HE; Ylitalo, K; Hiekkalinna, T; Perola, M; Cantor, RM; Viikari, JSA; Taskinen, MR; Peltonen, L				Soro, A; Pajukanta, P; Lilja, HE; Ylitalo, K; Hiekkalinna, T; Perola, M; Cantor, RM; Viikari, JSA; Taskinen, MR; Peltonen, L			Genome scans provide evidence for Low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT-LOCUS; LINKAGE ANALYSIS; COMBINED HYPERLIPIDEMIA; LIPOPROTEIN DISORDERS; TANGIER-DISEASE; GENETICS; GENES; RISK; IDENTIFICATION; CHOLESTEROL	We performed a genomewide scan for genes that predispose to low serum HDL cholesterol (HDL-C) in 25 well-defined Finnish families that were ascertained for familial low HDL-C and premature coronary heart disease. The potential loci for low HDL-C that were identified initially were tested in an independent sample group of 29 Finnish families that were ascertained for familial combined hyperlipidemia (FCHL), expressing low HDL-C as one component trait. The data from the previous genome scan were also reanalyzed for this trait. We found evidence for linkage between the low-HDL-C trait and three loci, in a pooled data analysis of families with low HDL-C and FCHL. The strongest statistical evidence was obtained at a locus on chromosome 8q23, with a two-point LOD score of 4.7 under a recessive mode of inheritance and a multipoint LOD score of 3.3. Evidence for linkage also emerged for loci on chromosomes 16q24.1-24.2 and 20q13.11, the latter representing a recently characterized region for type 2 diabetes. Besides these three loci, loci on chromosomes 2p and 3p showed linkage in the families with low HDL-C and a locus on 2ptel in the families with FCHL.	Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pediat, Gonda Neurosci & Genet Res Ctr, Los Angeles, CA 90024 USA; Univ Helsinki, Dept Med, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Turku, Dept Med, Turku, Finland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Turku	Peltonen, L (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, 695 Charles E Young Dr S,Box 708822, Los Angeles, CA 90095 USA.		Taskinen, Marja-Riitta/AAN-5432-2020	Taskinen, Marja-Riitta/0000-0002-6229-3588; Hiekkalinna, Tero/0000-0002-3345-2981				Almasy L, 1999, AM J HUM GENET, V64, P1686, DOI 10.1086/302425; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aouizerat BE, 1999, AM J HUM GENET, V65, P397, DOI 10.1086/302490; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Clee SM, 2001, CIRCULATION, V103, P1198; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Davignon J, 1998, ENDOCRIN METAB CLIN, V27, P521, DOI 10.1016/S0889-8529(05)70024-4; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; LILJA HE, IN PRESS ATHEROSCLER; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ott J., 1991, ANAL HUMAN GENETIC L; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; PORKKA KVK, 1994, ACTA PAEDIATR, V83, P838, DOI 10.1111/j.1651-2227.1994.tb13155.x; ROSE G, 1982, CARDIOVASCULAR SURG; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sobel E, 1996, AM J HUM GENET, V58, P1323; Terwilliger JD, 2000, HUM BIOL, V72, P63; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495	28	85	85	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1333	1340		10.1086/339988	http://dx.doi.org/10.1086/339988			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11891617	Green Published, Bronze			2022-12-18	WOS:000175012400023
J	Francks, C; Fisher, SE; MacPhie, IL; Richardson, AJ; Marlow, AJ; Stein, JF; Monaco, AP				Francks, C; Fisher, SE; MacPhie, IL; Richardson, AJ; Marlow, AJ; Stein, JF; Monaco, AP			A genomewide linkage screen for relative hand skill in sibling pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT; IMMUNE DISORDERS; LEFT-HANDEDNESS; VARIANCE-COMPONENTS; FAMILY HANDEDNESS; PEDIGREES; DYSLEXIA; CHROMOSOME; LOCUS; SEX	Genomewide quantitative-trait locus (QTL) linkage analysis was performed using a continuous measure of relative hand skill (PegQ) in a sample of 195 reading-disabled sibling pairs from the United Kingdom. This was the first genomewide screen for any measure related to handedness. The mean PegQ in the sample was equivalent to that of normative data, and PegQ was not correlated with tests of reading ability (correlations between -0.13 and 0.05). Relative hand skill could therefore be considered normal within the sample. A QTL on chromosome 2p11.2-12 12 yielded strong evidence for linkage to PegQ (empirical P = .00007), and another suggestive QTL on 17p11-q23 was also identified (empirical P = .002). The 2p11.2-12 locus was further analyzed in an independent sample of 143 reading-disabled sibling pairs, and this analysis yielded an empirical P = .13. Relative hand skill therefore is probably a complex multifactorial phenotype with a heterogeneous background, but nevertheless is amenable to QTL-based gene-mapping approaches.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Oxford, Dept Physiol, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford, England.		Francks, Clyde/AGU-8875-2022; Francks, Clyde/E-1384-2012; Fisher, Simon E./E-9130-2012; Monaco, Anthony P/A-4495-2010	Francks, Clyde/0000-0002-9098-890X; Fisher, Simon E./0000-0002-3132-1996; Monaco, Anthony P/0000-0001-7480-3197; Richardson, Alex/0000-0001-5650-4409; Stein, John/0000-0001-5843-8986				Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; ANNETT M, 1994, BEHAV GENET, V24, P51, DOI 10.1007/BF01067928; ANNETT M, 1985, LIFT RIGHT HAND BRAI; CARTERSALTZMAN L, 1980, SCIENCE, V209, P1263, DOI 10.1126/science.7403887; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Fagerheim T, 1999, J MED GENET, V36, P664; Falconer D. S., 1989, Introduction to quantitative genetics.; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Geschwind DH, 2001, AM J MED GENET, V101, P370; GESCHWIND N, 1982, P NATL ACAD SCI-BIOL, V79, P5097, DOI 10.1073/pnas.79.16.5097; GILGER JW, 1992, NEUROPSYCHOLOGIA, V30, P209, DOI 10.1016/0028-3932(92)90001-3; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KILSHAW D, 1983, BRIT J PSYCHOL, V74, P253, DOI 10.1111/j.2044-8295.1983.tb01861.x; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Laval SH, 1998, AM J MED GENET, V81, P420, DOI 10.1002/(SICI)1096-8628(19980907)81:5<420::AID-AJMG11>3.0.CO;2-E; Marlow AJ, 2001, BEHAV GENET, V31, P219, DOI 10.1023/A:1010209629021; McKeever WF, 2000, BRIT J PSYCHOL, V91, P21, DOI 10.1348/000712600161655; McManus IC, 1992, HDB NEUROPSYCHOLOGY; PENNINGTON BF, 1987, ARCH NEUROL-CHICAGO, V44, P634, DOI 10.1001/archneur.1987.00520180054016; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Sicotte N L, 1999, Laterality, V4, P265, DOI 10.1080/135765099396980; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TONNESSEN FE, 1993, ARCH NEUROL-CHICAGO, V50, P411, DOI 10.1001/archneur.1993.00540040063016	29	85	88	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					800	805		10.1086/339249	http://dx.doi.org/10.1086/339249			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11774074	Green Published, Bronze			2022-12-18	WOS:000173880000025
J	Pfeifer, K				Pfeifer, K			Mechanisms of genomic imprinting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							BECKWITH-WIEDEMANN-SYNDROME; PRADER-WILLI-SYNDROME; MOUSE H19 GENE; SYNDROME CRITICAL REGION; METHYLATED CPG ISLAND; ANGELMAN-SYNDROME; DNA METHYLATION; SNRPN GENE; EPIGENETIC MODIFICATION; EXPRESSED TRANSCRIPT	Imprinted genes represent a curious defiance of normal Mendelian genetics. Mammals inherit two complete sets of chromosomes, one from the mother and one from the father, and most autosomal genes will be expressed from both the maternal and the paternal alleles. Imprinted genes, however, are expressed from only one chromosome, in a parent-of-origin-dependent manner. Because silent and active promoters are present in a single nucleus, the differences in activity cannot be explained by transcription-factor abundance. Thus, transcription of imprinted genes represents a clear situation in which epigenetic mechanisms restrict gene expression and, therefore, offers a model for understanding the role of DNA modifications and chromatin structure in maintaining appropriate patterns of expression. Furthermore, because of their parent-of-origin-restricted expression, phenotypes determined by imprinted genes are susceptible not only to genetic alterations in the genes but also to disruptions in the epigenetic programs controlling regulation. Imprinted genes are often associated with human diseases, including disorders affecting cell growth, development, and behavior.	NICHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pfeifer, K (corresponding author), NICHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA.	kpfeifer@helix.nih.gov		Pfeifer, Karl/0000-0002-0254-682X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001804] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001804] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ainscough JFX, 1998, GENET RES, V72, P237, DOI 10.1017/S0016672398003565; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Brown KW, 1996, HUM MOL GENET, V5, P2027, DOI 10.1093/hmg/5.12.2027; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burger J, 1997, AM J HUM GENET, V61, P88, DOI 10.1086/513900; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Catchpoole D, 1997, J MED GENET, V34, P353, DOI 10.1136/jmg.34.5.353; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; ELLIOTT M, 1994, J MED GENET, V31, P560, DOI 10.1136/jmg.31.7.560; Elson DA, 1997, MOL CELL BIOL, V17, P309, DOI 10.1128/MCB.17.1.309; Feinberg AP, 2000, CURR TOP MICROBIOL, V249, P87; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Glenn CC, 1996, AM J HUM GENET, V58, P335; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hark AT, 1998, HUM MOL GENET, V7, P1979, DOI 10.1093/hmg/7.12.1979; HATADA I, 1993, NUCLEIC ACIDS RES, V21, P5577, DOI 10.1093/nar/21.24.5577; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; JINNO Y, 1995, NAT GENET, V10, P318, DOI 10.1038/ng0795-318; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; Kaffer CR, 2000, GENE DEV, V14, P1908; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Khosla S, 1999, MOL CELL BIOL, V19, P2556; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Lee S, 2000, AM J HUM GENET, V66, P848, DOI 10.1086/302817; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Mannens M., 1994, European Journal of Human Genetics, V2, P3; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; Morison IM, 1998, HUM MOL GENET, V7, P1599, DOI 10.1093/hmg/7.10.1599; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Nicholls RD, 2000, J CLIN INVEST, V105, P413, DOI 10.1172/JCI9460; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Pfeifer K, 1996, P NATL ACAD SCI USA, V93, P13876, DOI 10.1073/pnas.93.24.13876; PING AJ, 1989, AM J HUM GENET, V44, P720; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; REIS A, 1994, AM J HUM GENET, V54, P741; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Srivastava M, 2000, GENE DEV, V14, P1186; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Sutcliffe JS, 1997, LANCET, V350, P1520, DOI 10.1016/S0140-6736(05)63943-8; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Svensson K, 1998, DEVELOPMENT, V125, P61; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 1998, MOL CELL BIOL, V18, P6767, DOI 10.1128/MCB.18.11.6767; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	98	85	91	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					777	787		10.1086/303101	http://dx.doi.org/10.1086/303101			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986038	Bronze, Green Published			2022-12-18	WOS:000089651100001
J	Wenstrup, RJ; Florer, JB; Willing, MC; Giunta, C; Steinmann, B; Young, F; Susic, M; Cole, WG				Wenstrup, RJ; Florer, JB; Willing, MC; Giunta, C; Steinmann, B; Young, F; Susic, M; Cole, WG			COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EHLERS-DANLOS-SYNDROME; IMPERFECTA TYPE-I; ALPHA-1(XI) COLLAGEN GENE; V COLLAGEN; MESSENGER-RNA; FIBRILLAR COLLAGEN; CONNECTIVE-TISSUE; PROTEIN-SYNTHESIS; NONSENSE CODONS; GRAVIS FORM	We have identified haploinsufficiency of the COL5A1 gene that encodes the pro alpha 1(V) chain of type V collagen in the classical form of the Ehlers-Danlos syndrome (EDS), a heritable connective-tissue disorder that severely alters the collagen-fibrillar structure of the dermis, joints, eyes, and blood vessels. Eight of 28 probands with classical EDS who were heterozygous for expressed polymorphisms in COL5A1 showed complete or nearly complete loss of expression of one COL5A1 allele. Reduced levels of pro alpha 1(V) mRNA relative to the levels of another type V collagen mRNA, pro alpha 2(V), were also observed in the cultured fibroblasts from EDS probands. Products of the two COL5A1 alleles were approximately equal after the addition of cycloheximide to the fibroblast cultures. After harvesting of mRNAs from cycloheximide-treated cultured fibroblasts, heteroduplex analysis of overlapping reverse transcriptase-PCR segments spanning the complete pro alpha 1(V) cDNA showed anomalies in four of the eight probands that led to identification of causative mutations, and, in the remaining four probands, targeting of CGA-->TGA mutations in genomic DNA revealed a premature stop at codon in one of them. We estimate that approximately one-third of individuals with classical EDS have mutations of COL5A1 that result in haploinsufficiency. These findings indicate that the normal formation of the heterotypic collagen fibrils that contain types I, III, and V collagen requires the expression of both COL5A1 alleles.	Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45229 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Zurich, Childrens Hosp, Dept Metab & Mol Dis, Zurich, Switzerland; Hosp Sick Children, Div Orthopaed, Toronto, ON M5G 1X8, Canada	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Iowa; University Children's Hospital Zurich; University of Zurich; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wenstrup, RJ (corresponding author), Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45229 USA.	wensr0@chmcc.org	Giunta, Cecilia/T-8222-2019	Giunta, Cecilia/0000-0002-9313-8257				ABEDIN MZ, 1981, BIOCHEM BIOPH RES CO, V102, P1237, DOI 10.1016/S0006-291X(81)80144-1; ANDRIKOPOULOS K, 1992, DEV DYNAM, V195, P113, DOI 10.1002/aja.1001950205; ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; ASHHURST DE, 1991, J RHEUMATOL, V18, P1669; BARABAS AP, 1967, BMJ-BRIT MED J, V2, P612, DOI 10.1136/bmj.2.5552.612; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BEIGHTON P, 1992, MCKUSICKS HERITABLE, P189; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BROWN RA, 1978, BIOCHEM BIOPH RES CO, V80, P866, DOI 10.1016/0006-291X(78)91324-4; BROWN RA, 1979, FEBS LETT, V106, P71, DOI 10.1016/0014-5793(79)80697-3; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Burch GH, 1997, AM J HUM GENET S, V59, pA16; Burrows NP, 1996, J INVEST DERMATOL, V106, P1273, DOI 10.1111/1523-1747.ep12348978; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; BYERS PH, 1995, METABOLIC MOL BASES, P4029; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Delacoux F, 1998, J BIOL CHEM, V273, P15069, DOI 10.1074/jbc.273.24.15069; DePaepe A, 1997, AM J HUM GENET, V60, P547; DEPAEPE A, 1998, AM J HUM GENET S, V63, pA265; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Giunta C, 2000, AM J MED GENET, V90, P72, DOI 10.1002/(SICI)1096-8628(20000103)90:1<72::AID-AJMG13>3.0.CO;2-C; GREENSPAN DS, 1994, HUM MOL GENET, V3, P385, DOI 10.1093/hmg/3.2.385-a; GREENSPAN DS, 1995, GENOMICS, V25, P737, DOI 10.1016/0888-7543(95)80021-D; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; HAUSSER I, 1994, HUM GENET, V93, P394; Imamura Y, 2000, J BIOL CHEM, V275, P8749, DOI 10.1074/jbc.275.12.8749; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; LUI VCH, 1995, BIOCHEM J, V311, P511, DOI 10.1042/bj3110511; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; MAYNE R, 1993, J BIOL CHEM, V268, P9381; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; Moursi AM, 1997, J CELL SCI, V110, P2187; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; OHH M, 1995, J CELL BIOCHEM, V59, P202, DOI 10.1002/jcb.240590210; PARRY DAD, 1988, COLLAGEN, V2, P1; POSCHL A, 1980, FEBS LETT, V115, P100; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; RAO PM, 1993, J CELL PHYSIOL, V156, P560, DOI 10.1002/jcp.1041560315; RHODES RK, 1981, COLLAGEN REL RES, V1, P337; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; SAGE H, 1981, BIOCHEMISTRY-US, V20, P3778, DOI 10.1021/bi00516a017; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; SOKOLOV BP, 1991, HUM GENET, V88, P125; Sponseller PD, 1997, J PEDIATR ORTHOP B, V6, P255, DOI 10.1097/01202412-199710000-00007; Steinmann Beat, 1993, P351; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; TAKAHARA K, 1991, J BIOL CHEM, V266, P13124; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VOGEL A, 1979, LAB INVEST, V40, P201; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WILLING MC, 1993, AM J MED GENET, V45, P223, DOI 10.1002/ajmg.1320450214; WILLING MC, 1994, AM J HUM GENET, V55, P638; WOODLEY DT, 1987, J INVEST DERMATOL, V88, P246, DOI 10.1111/1523-1747.ep12465467; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P173; Xie RL, 1996, J BIOL CHEM, V271, P8121, DOI 10.1074/jbc.271.14.8121; YOSHIOKA H, 1995, J BIOL CHEM, V270, P418, DOI 10.1074/jbc.270.1.418; YOSHIOKA H, 1995, DEV DYNAM, V204, P41, DOI 10.1002/aja.1002040106	65	85	89	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1766	1776		10.1086/302930	http://dx.doi.org/10.1086/302930			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10777716	Green Published, Bronze			2022-12-18	WOS:000088373800005
J	El-Shanti, H; Lidral, AC; Jarrah, N; Druhan, L; Ajlouni, K				El-Shanti, H; Lidral, AC; Jarrah, N; Druhan, L; Ajlouni, K			Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR AFFECTIVE-DISORDER; DIABETES-MELLITUS; OPTIC ATROPHY; DIDMOAD SYNDROME; MITOCHONDRIAL-DNA; LINKAGE ANALYSIS; TRANSMEMBRANE PROTEIN; MEXICAN-AMERICANS; GENOME SCAN; GENE	Wolfram syndrome, which is sometimes referred to as "DIDMOAD" (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness), is an autosomal recessive neurodegenerative disorder for which only insulin-dependent diabetes mellitus and optic atrophy are necessary to make the diagnosis. Researchers have mapped Wolfram syndrome to chromosome 4p16.1, and, recently, a gene encoding a putative transmembrane protein has been cloned and mutations have been identified in patients. To pursue the possibility of locus heterogeneity, 16 patients from four different families were recruited. These patients, who have the Wolfram syndrome phenotype, also have additional features that have not previously been reported. There is an absence of diabetes insipidus in all affected family members. In addition, several patients have profound upper gastrointestinal ulceration and bleeding. With the use of three microsatellite markers (D4S432, D4S3023, and D4S2366) reported to be linked to the chromosome 4p16.1 locus, we significantly excluded linkage in three of the fear families. The two affected individuals in one family showed homozygosity for all three markers from the region of linkage on chromosome 4p16.1. For the other three families, genetic heterogeneity for Wolfram syndrome was verified by demonstration of linkage to chromosome 4q22-24. In conclusion, we report the unique clinical findings and linkage-analysis results of 16 patients with Wolfram syndrome and provide further evidence for the genetic heterogeneity of this disorder. We also provide data on a new locus that plays a role in the etiology of insulin-dependent diabetes mellitus.	Ohio State Univ, Coll Dent, Sect Orthodont, Columbus, OH 43210 USA; Jordan Univ Sci & Technol, Sch Med, Dept Pediat, Irbid, Jordan; Jordan Univ Sci & Technol, Sch Med, Dept Med Technol, Irbid, Jordan; Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan	University System of Ohio; Ohio State University; Jordan University of Science & Technology; Jordan University of Science & Technology	Lidral, AC (corresponding author), Ohio State Univ, Coll Dent, Sect Orthodont, 4140 Postel Hall,305 W 12th Ave, Columbus, OH 43210 USA.	lidral.1@osu.edu	El-Shanti, Hatem/O-5990-2014; EL-SHANTI, HATEM/Q-4932-2016; Druhan, Lawrence/E-2994-2011	El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316; Ajlouni, Kamel/0000-0001-5569-6306	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE012533] Funding Source: NIH RePORTER; NIDCR NIH HHS [R03 DE012533-02, R03 DE12533-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANTONARAKIS SE, 1994, NAT GENET, V8, P211, DOI 10.1038/ng1194-211; Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838; Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226; Barrientos A, 1996, AM J HUM GENET, V58, P963; Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; BLASI C, 1986, DIABETES CARE, V9, P521, DOI 10.2337/diacare.9.5.521; BRETZ GW, 1970, AM J MED, V48, P398, DOI 10.1016/0002-9343(70)90071-9; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUELL G, 1992, FEBS LETT, V299, P90, DOI 10.1016/0014-5793(92)80107-R; Collier DA, 1996, AM J HUM GENET, V59, P855; CREMERS C W R J, 1977, Acta Paediatrica Scandinavica Supplement, P1; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ginns EI, 1998, P NATL ACAD SCI USA, V95, P15531, DOI 10.1073/pnas.95.26.15531; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Hofmann S, 1997, MOL CELL BIOCHEM, V174, P209, DOI 10.1023/A:1006856407698; Inglehearn CF, 1997, NAT GENET, V16, P15, DOI 10.1038/ng0597-15; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Kennedy JL, 1999, AM J MED GENET, V88, P224, DOI 10.1002/(SICI)1096-8628(19990618)88:3<224::AID-AJMG3>3.0.CO;2-J; KINSLEY BT, 1995, DIABETES CARE, V18, P1566, DOI 10.2337/diacare.18.12.1566; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Lidral AC, 1997, CLEFT PALATE-CRAN J, V34, P1, DOI 10.1597/1545-1569(1997)034<0001:SOTCGT>2.3.CO;2; MITCHELL BD, 1995, DIABETES, V44, P1046, DOI 10.2337/diabetes.44.9.1046; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Ohata T, 1998, HUM GENET, V103, P470, DOI 10.1007/s004390050852; PAGE MM, 1976, Q J MED, V45, P505; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; PROCHAZKA M, 1993, DIABETES, V42, P514, DOI 10.2337/diabetes.42.4.514; ROSE FC, 1966, Q J MED, V35, P385; ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267; SALIH MAM, 1991, ACTA PAEDIATR SCAND, V80, P567, DOI 10.1111/j.1651-2227.1991.tb11908.x; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Swift RG, 1998, MOL PSYCHIATR, V3, P86, DOI 10.1038/sj.mp.4000344; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; Yuan B, 1997, AM J HUM GENET, V60, P459	42	85	94	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1229	1236		10.1086/302858	http://dx.doi.org/10.1086/302858			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739754	Bronze, Green Published			2022-12-18	WOS:000088373400007
J	Finnila, S; Hassinen, IE; Ala-Kokko, L; Majamaa, K				Finnila, S; Hassinen, IE; Ala-Kokko, L; Majamaa, K			Phylogenetic network of the mtDNA haplogroup U in northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; RAPID DETECTION; SSCP ANALYSIS; PCR PRODUCTS; GENE POOL; MUTATIONS; DISEASE; EUROPE; POLYMORPHISMS	Mutations in mtDNA have accumulated sequentially, and maternal lineages have diverged to form population-specific genotypes. Classification of the genotypes has been made based on differences found in restriction fragment analysis of the coding region or in the sequence of the hypervariable segment I. Both methods have shortcomings, as the former may not detect all the important polymorphisms and the latter makes use of a segment containing hypervariable nucleotide positions. Here, we have used conformation-sensitive gel electrophoresis (CSGE) to detect polymorphisms within the coding region of mtDNA from 22 Finns belonging to haplogroup U. Sixty-three overlapping PCR fragments covering the entire coding region were analyzed by CSGE, and the fragments that differed in their migration pattern were sequenced. CSGE proved to be a sensitive and specific method for identifying mtDNA substitutions. The phylogenetic network of the 22 coding-region sequences constituted a perfect tree, free of homoplasy, and provided several previously unidentified common polymorphisms characterizing subgroups of U. After contrasting this data with that of hypervariable segment I, me concluded that position 16192 seems to be prone to recurrent mutations and that position 16270 has experienced a back mutation. Interestingly, all 22 samples were found to belong to subcluster U5, suggesting that this subcluster is more frequent in Finns than in other European populations. Complete sequence data of the mtDNA yield a more reliable phylogenetic network and a more accurate classification of the haplogroups than previous ones. In medical genetics, such networks may help to decide between a rare polymorphism and a pathogenic mutation; in population genetics, the networks may enable more detailed analyses of population history and mtDNA evolution.	Oulu Univ, Dept Neurol, FIN-90014 Oulu, Finland; Oulu Univ, Dept Med Biochem, FIN-90014 Oulu, Finland; Oulu Univ, Collagen Res Unit, FIN-90014 Oulu, Finland; Oulu Univ, Bioctr, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Majamaa, K (corresponding author), Oulu Univ, Dept Neurol, POB 5000, FIN-90014 Oulu, Finland.		sun, youming/F-7873-2011; Majamaa, Kari/A-1344-2012	Majamaa, Kari/0000-0002-9070-3791				Alonso A, 1996, ELECTROPHORESIS, V17, P1299, DOI 10.1002/elps.1150170804; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnason U, 1996, J MOL EVOL, V42, P145, DOI 10.1007/BF02198840; Ausenda C, 1996, Methods Enzymol, V264, P122, DOI 10.1016/S0076-6879(96)64013-0; BANDELT HJ, 1995, GENETICS, V141, P743; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Finnila S, 1999, MUTAT RES-GENOMICS, V406, P109, DOI 10.1016/S1383-5726(99)00007-2; GANGULY A, 1995, ELECTROPHORESIS, V16, P1830, DOI 10.1002/elps.11501601301; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GROSS AW, 1994, ANAL BIOCHEM, V222, P507, DOI 10.1006/abio.1994.1526; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Jordanova A, 1997, HUM MUTAT, V10, P65, DOI 10.1002/(SICI)1098-1004(1997)10:1<65::AID-HUMU9>3.3.CO;2-9; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Lahermo P, 1996, AM J HUM GENET, V58, P1309; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X; Ohlenbusch A, 1998, NEUROPEDIATRICS, V29, P175, DOI 10.1055/s-2007-973557; OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P1946, DOI 10.1073/pnas.91.5.1946; Pitkanen Kari, 1994, SUOMEN VAESTO, P19; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; THOMAS AW, 1994, HUM GENET, V94, P621; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006	33	85	87	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1017	1026		10.1086/302802	http://dx.doi.org/10.1086/302802			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712215	Green Published, Bronze			2022-12-18	WOS:000088373200023
J	Young, TL; Penney, L; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS				Young, TL; Penney, L; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS			A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FAMILIES; LINKAGE; DNA		Mem Univ Newfoundland, Dept Biochem, St Johns, NF A1B 3X9, Canada; Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3X9, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Young, TL (corresponding author), Mem Univ Newfoundland, Dept Biochem, St Johns, NF A1B 3X9, Canada.			Young, Terry-Lynn/0000-0003-4673-6470				Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; FARAG TI, 1989, CLIN GENET, V36, P463; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; KLEIN D, 1969, J NEUROL SCI, V9, P479, DOI 10.1016/0022-510X(69)90091-4; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; NELSON JK, 1994, MAYO CLIN DIET MANUA, P186; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Spur N K, 1996, Cytogenet Cell Genet, V73, P255, DOI 10.1159/000134352; Woods MO, 1999, GENOMICS, V55, P2, DOI 10.1006/geno.1998.5626	15	85	88	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					900	904		10.1086/302301	http://dx.doi.org/10.1086/302301			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053027	Green Published, Bronze			2022-12-18	WOS:000079204700030
J	Tomer, Y; Barbesino, G; Greenberg, DA; Concepcion, E; Davies, TF				Tomer, Y; Barbesino, G; Greenberg, DA; Concepcion, E; Davies, TF		Int Consortium Genetics Autoimmune Thyroid Dise	A new Graves disease-susceptibility locus maps to chromosome 20q11.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOIMMUNE THYROID-DISEASE; FRAGMENT-LENGTH-POLYMORPHISMS; LINKAGE ANALYSIS; CAUCASIAN POPULATION; THYROTROPIN RECEPTOR; GENE; HLA; FAMILIES; AUTOANTIBODIES; ASSOCIATION	The autoimmune thyroid diseases (AITDs) include two related disorders, Craves disease (CD) and Hashimoto thyroiditis, in which perturbations of immune regulation result in an immune attack on the thyroid gland. The AITDs are multifactorial and develop in genetically susceptible individuals. However, the genes responsible for this susceptibility remain unknown. Recently, we initiated a whole-genome linkage study of patients with AITD, in order to identify their susceptibility genes. We studied a data set of 53 multiplex, multigenerational AITD families (323 individuals), using highly polymorphic and densely spaced microsatellite markers (intermarker distance <10 cM). Linkage analysis was performed by use of two-point and multipoint parametric methods (classic LOD-score analysis). While studying chromosome 20, we found a locus on chromosome 20q11.2 that was strongly linked to GD. A maximum two-point LOD score of 3.2 was obtained at marker D20S195, assuming a recessive mode of inheritance and a penetrance of .3. The maximum nonparametric LOD score was 2.4 (P = .00043); this score also was obtained at marker D20S195. Multipoint linkage analysis yielded a maximum LOD score of 3.5 for a 6-cM interval between markers D20S195 and D20S107. There was no evidence for heterogeneity in our sample. In our view, these results indicate strong evidence for linkage and suggest the presence of a major CD-susceptibility gene on chromosome 20q11.2.	Mt Sinai Med Ctr, Div Endocrinol & Metab, New York, NY 10029 USA; Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; Mt Sinai Med Ctr, Sch Med, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Med Ctr, Sch Med, Dept Biomath, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tomer, Y (corresponding author), Mt Sinai Med Ctr, Div Endocrinol & Metab, Box 1055,1 Gustave L Levy Pl, New York, NY 10029 USA.	ytomer@smtplink.mssm.edu	Tomer, Yaron/GWU-8933-2022		NIDDK NIH HHS [DK45011, DK35764, DK52464] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035764, R01DK052464, R01DK045011] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHO K, 1983, ACTA ENDOCRINOL-COP, V102, P11; AHO K, 1998, J CLIN ENDOCR METAB, V83, P1580; Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P3290, DOI 10.1210/jc.83.9.3290; Barlow ABT, 1996, CLIN ENDOCRINOL, V44, P73, DOI 10.1046/j.1365-2265.1996.634454.x; Brix TH, 1998, CLIN ENDOCRINOL, V48, P397; BUREK CL, 1982, CLIN IMMUNOL IMMUNOP, V25, P395, DOI 10.1016/0090-1229(82)90204-5; Cuddihy RM, 1996, J CLIN ENDOCR METAB, V81, P4476, DOI 10.1210/jc.81.12.4476; Davies Terry F., 1996, P525; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P3483, DOI 10.1210/jc.81.10.3483; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FARID NR, 1980, CLIN ENDOCRINOL, V13, P535, DOI 10.1111/j.1365-2265.1980.tb03421.x; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; GREENBERG DA, 1994, AM J HUM GENET, V55, P834; HARVALD B, 1956, Dan Med Bull, V3, P150; Hodge SE, 1997, AM J HUM GENET, V60, P217; KENDALLTAYLOR P, 1988, CLIN ENDOCRINOL, V28, P601, DOI 10.1111/j.1365-2265.1988.tb00234.x; KITA M, 1997, 70 ANN M AM THYR ASS; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MANGKLABRUKS A, 1991, J CLIN ENDOCR METAB, V73, P236, DOI 10.1210/jcem-73-2-236; MATHER BA, 1980, CLIN ENDOCRINOL, V12, P155, DOI 10.1111/j.1365-2265.1980.tb02130.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAKAO Y, 1980, CLIN EXP IMMUNOL, V42, P20; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; OCONNOR G, 1993, AUTOIMMUNITY, V14, P237, DOI 10.3109/08916939309077371; OTT J, 1976, AM J HUM GENET, V28, P528; PAYAMI H, 1989, GENET EPIDEMIOL, V6, P137, DOI 10.1002/gepi.1370060126; PICKERILL AP, 1993, ACTA ENDOCRINOL-COP, V128, P499, DOI 10.1530/acta.0.1280499; Pirro MT, 1995, THYROID, V5, P461, DOI 10.1089/thy.1995.5.461; ROMAN SH, 1992, J CLIN ENDOCR METAB, V74, P496, DOI 10.1210/jc.74.3.496; SHIELDS DC, 1994, AM J HUM GENET, V55, P540; Shimojo N, 1996, P NATL ACAD SCI USA, V93, P11074, DOI 10.1073/pnas.93.20.11074; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; Tomer Y, 1997, TRENDS ENDOCRIN MET, V8, P63, DOI 10.1016/S1043-2760(96)00266-4; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 1997, J CLIN ENDOCR METAB, V82, P1645, DOI 10.1210/jc.82.5.1645; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; VOLPE R, 1985, AUTOIMMUNITY ENDOCRI, P109; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WEBER JL, 1990, GENOME ANAL, V1, P159; Yamaguchi KI, 1997, J CLIN ENDOCR METAB, V82, P4266, DOI 10.1210/jc.82.12.4266; YANAGAWA T, 1993, J CLIN ENDOCR METAB, V76, P1569, DOI 10.1210/jcem.76.6.8501164; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jcem.80.1.7829637	44	85	89	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1749	1756		10.1086/302146	http://dx.doi.org/10.1086/302146			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837828	Bronze, Green Published			2022-12-18	WOS:000077707700021
J	Amiel, J; Salomon, R; Attie, T; Pelet, A; Trang, H; Mokhtari, M; Gaultier, C; Munnich, A; Lyonnet, S				Amiel, J; Salomon, R; Attie, T; Pelet, A; Trang, H; Mokhtari, M; Gaultier, C; Munnich, A; Lyonnet, S			Mutations of the RET-GDNF signaling pathway in Ondine's curse	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CENTRAL HYPOVENTILATION SYNDROME; WAARDENBURG-HIRSCHSPRUNG-DISEASE; RECEPTOR TYROSINE KINASE; GERMLINE MUTATIONS; AUTOMATIC-CONTROL; GENE; VENTILATION; FAILURE		Hop Necker Enfants Malad, Dept Genet, F-75743 Paris 15, France; Hop Robert Debre, Serv Physiol Explorat Fonct, F-75019 Paris, France; Hop St Vincent de Paul, Unite Reanimat Pediat, F-75674 Paris, France; INSERM, U393, Unite Rech Handicaps Genet Enfant, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, Dept Genet, 149 Rue de Sevres, F-75743 Paris 15, France.	lyonnet@necker.fr	Mokhtari, Majid/AAD-6749-2020; ATTIE-BITACH, Tania/K-1453-2017; amiel, jeanne/H-3501-2017; amiel, jeanne/AGX-1124-2022; Lyonnet, Stanislas/H-5483-2017	ATTIE-BITACH, Tania/0000-0002-1155-3626; amiel, jeanne/0000-0001-5973-4728; Lyonnet, Stanislas/0000-0001-5426-9417; PELET, Anastella/0000-0002-8353-1725				Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; Bolk S, 1996, NAT GENET, V13, P395, DOI 10.1038/ng0896-395; Bolk S, 1996, AM J MED GENET, V63, P603, DOI 10.1002/(SICI)1096-8628(19960628)63:4<603::AID-AJMG14>3.0.CO;2-M; Burton MD, 1997, J AUTONOM NERV SYST, V63, P137, DOI 10.1016/S0165-1838(97)00002-7; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; HADDAD GG, 1978, MEDICINE, V57, P517, DOI 10.1097/00005792-197811000-00003; MCKUSICK VA, 1997, MENDELIAN INHERITANC; MELLINS RB, 1970, MEDICINE, V49, P487, DOI 10.1097/00005792-197011000-00003; NAKAHARA S, 1995, J PEDIATR SURG, V30, P1481, DOI 10.1016/0022-3468(95)90413-1; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; WEESEMAYER DE, 1993, AM J MED GENET, V47, P360, DOI 10.1002/ajmg.1320470313	17	85	92	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					715	717		10.1086/301759	http://dx.doi.org/10.1086/301759			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497256	Bronze, Green Published			2022-12-18	WOS:000072894400027
J	Excoffier, L; Slatkin, M				Excoffier, L; Slatkin, M			Incorporating genotypes of relatives into a test of linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; POPULATIONS; ALGORITHM; FREQUENCIES	Genetic data from autosomal loci in diploids generally consist of genotype data for which no phase information is available, making it difficult to implement a test of linkage disequilibrium. In this paper, we describe a test of linkage disequilibrium based on an empirical null distribution of the likelihood of a sample. Information on the genotypes of related individuals is explicitly used to help reconstruct the gametic phase of the independent individuals. Simulation studies show that the present approach improves on estimates of linkage disequilibrium gathered from samples of completely independent individuals but only if some offspring are sampled together with their parents. The failure to incorporate some parents sharply decreases the sensitivity and accuracy of the test. Simulations also show that for multiallelic data (more than two alleles) our testing procedure is not as powerful as an exact test based on known haplotype frequencies, owing to the interaction between departure from Hardy-Weinberg equilibrium and linkage disequilibrium.	Univ Geneva, Dept Anthropol & Ecol, Genet & Biometry Lab, Geneva, Switzerland; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Geneva; University of California System; University of California Berkeley	Excoffier, L (corresponding author), Univ Geneva, Dept Anthropol, Genet & Biometry Lab, CP 511, CH-1211 Geneva 24, Switzerland.		Excoffier, Laurent/D-3498-2013	Excoffier, Laurent/0000-0002-7507-6494	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOEHNKE M, 1991, AM J HUM GENET, V48, P22; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HILL WG, 1994, AM J HUM GENET, V54, P705; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILL WG, 1975, BIOMETRICS, V31, P881, DOI 10.2307/2529813; JORDE LB, 1995, AM J HUM GENET, V56, P11; LANGE K, 1983, HUM HERED, V33, P291, DOI 10.1159/000153393; LONG JC, 1995, AM J HUM GENET, V56, P799; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; SLATKIN M, 1994, GENETICS, V137, P331; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Weir B., 1996, GENETIC DATA ANAL	15	85	88	0	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					171	180		10.1086/301674	http://dx.doi.org/10.1086/301674			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443867	Bronze, Green Published			2022-12-18	WOS:000072127900022
J	McMahon, FJ; Hopkins, PJ; Xu, JF; McInnis, MG; Shaw, S; Cardon, L; Simpson, SG; MacKinnon, DF; Stine, OC; Sherrington, R; Meyers, DA; DePaulo, JR				McMahon, FJ; Hopkins, PJ; Xu, JF; McInnis, MG; Shaw, S; Cardon, L; Simpson, SG; MacKinnon, DF; Stine, OC; Sherrington, R; Meyers, DA; DePaulo, JR			Linkage of bipolar affective disorder to chromosome 18 markers in a new pedigree series	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; SUSCEPTIBILITY LOCUS; GENETIC DISSECTION; FAMILIAL BREAST; DNA MARKERS; ILLNESS; LINEALITY; CANCER; ONSET	Several groups have reported evidence suggesting linkage of bipolar affective disorder (BPAD) to chromosome 18. We have reported data from 28 pedigrees that showed linkage to marker loci on 18p and to loci 40 cM distant on 18q. Most of the linkage evidence derived from families with affected phenotypes in only the paternal lineage and from marker alleles transmitted on the paternal chromosome. We now report results from a series of 30 new pedigrees (259 individuals) genotyped for 13 polymorphic markers spanning chromosome 18. Subjects were interviewed by a psychiatrist and were diagnosed by highly reliable methods. Genotypes were generated with automated technology and were scored blind to phenotype. Affected sib pairs showed excess allele sharing at the 18q markers D18S541 and D18S38. A parent-of-origin effect was observed, but it was not consistently paternal. No robust evidence of linkage was detected for markers elsewhere on chromosome 18. Multipoint nonparametric linkage analysis in the new sample combined with the original sample of families supports linkage on chromosome 18q, but the susceptibility gene is not well localized.	Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Sequana Therapeut Inc, La Jolla, CA USA	Johns Hopkins University	McMahon, FJ (corresponding author), Meyer 3-181,600 N Wolfe St, Baltimore, MD 21287 USA.		McInnis, Melvin G/F-6963-2012; MacKinnon, Dean/AAG-6232-2020; McMahon, Francis J/A-7290-2009	McInnis, Melvin G/0000-0002-0375-6247; McMahon, Francis J/0000-0002-9469-305X; DePaulo, J Raymond/0000-0001-9221-9226				BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BLACKER D, 1993, PSYCHIATR GENET, V3, P5, DOI 10.1097/00041444-199321000-00002; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Coon H, 1996, BIOL PSYCHIAT, V39, P689, DOI 10.1016/0006-3223(95)00292-8; Debruyn A, 1996, BIOL PSYCHIAT, V39, P679, DOI 10.1016/0006-3223(95)00293-6; DeteraWadleigh SD, 1996, AM J HUM GENET, V58, P1279; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; EASTON DF, 1993, AM J HUM GENET, V52, P678; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; Hall JM, 1996, GENOME RES, V6, P781, DOI 10.1101/gr.6.9.781; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; KELSOE JR, 1995, PSYCHIAT GENET, V5, pS17; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Maier W, 1995, PSYCHIAT RES, V59, P7, DOI 10.1016/0165-1781(95)02799-8; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; MCMAHON FJ, 1994, AM J PSYCHIAT, V151, P210; NOTHEN MM, 1996, BIOL PSYCHIAT, V39, P615; PAULS DL, 1995, AM J HUM GENET, V57, P636; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1987, AM J HUM GENET, V40, P1; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; SIMPSON SG, 1992, AM J PSYCHIAT, V149, P1660; SMYTH C, 1995, PSYCHIAT GENET, V5, pS19; Spitzer R.L., 1975, RES DIAGNOSTIC CRITE, V2; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; YOUNG A, 1995, GAS 2 0 ANAL MODULES	35	85	91	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1397	1404		10.1086/301630	http://dx.doi.org/10.1086/301630			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399888	Green Published, hybrid			2022-12-18	WOS:000071555900024
J	Moreira, ES; Vainzof, M; Marie, SK; Sertie, AL; Zatz, M; PassosBueno, MR				Moreira, ES; Vainzof, M; Marie, SK; Sertie, AL; Zatz, M; PassosBueno, MR			The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RIMMED VACUOLE FORMATION; DISTAL MYOPATHY; BETA-SARCOGLYCAN; SKELETAL-MUSCLE; LARGE FAMILY; GENE; MUTATIONS; PROTEIN; LINKAGE; EXPRESSION	The group of autosomal recessive (AR) muscular dystrophies includes, among others, two main clinical entities, the limb-girdle muscular dystrophies (LGMDs) and the distal muscular dystrophies. The former are characterized mainly by muscle wasting of the upper and lower limbs, with a wide range of clinical severity. This clinical heterogeneity has been demonstrated at the molecular level, since the genes for six AR forms have been cloned and/or have been mapped to 15q15.1 (LGMD2A), 2p12-16 (LGMD2B), 13q12 (LGMD2C), 17q12-q21.33 (LGMD2D), 4q12 (LGMD2E), and 5q33-34 (LGMD2F). The AR distal muscular dystrophies originally included two subgroups, Miyoshi myopathy, characterized mainly by extremely elevated serum creatine kinase (CK) activity and by a dystrophic muscle pattern, and Nonaka myopathy, which is distinct from the others because of the normal to slightly elevated serum CK levels and a myopathic muscle pattern with rimmed vacuoles. With regard to our unclassified AR LGMD families, analysis of the affected sibs from one of them (family LG61) revealed some clinical and laboratory findings (early involvement of the distal muscles, mildly elevated serum CK levels, and rimmed vacuoles in muscle biopsies) that usually are not observed in the analysis of patients with LGMD2A-LGMD2F. In the present investigation, through a genomewide search in family LG61, we demonstrated linkage of the allele causing this form of muscular dystrophy to a 3-cM region on 17q11-12. We suggest that this form, which, interestingly, clinically resembles AR Kugelberg-Welander disease, should be classified as LGMD2G. In addition, our results indicate the existence of still another locus causing severe LGMD.	UNIV SAO PAULO, INST BIOCIENCIAS, DEPT BIOL, BR-05508900 SAO PAULO, BRAZIL	Universidade de Sao Paulo			Moreira, Eloisa/K-9155-2014; Passos-Bueno, Maria Rita/I-6796-2016; Vainzof, Mariz/J-7150-2012; Marie, Suely Kazue Nagahashi/D-1870-2012; Zatz, Mayana/M-5338-2015; Vainzof, Mariz/Q-4787-2019; Sertie, Andrea Laurato/H-8312-2014	Passos-Bueno, Maria Rita/0000-0002-9248-3008; Vainzof, Mariz/0000-0002-2797-0782; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Zatz, Mayana/0000-0003-3970-8025; Vainzof, Mariz/0000-0002-2797-0782; Sertie, Andrea Laurato/0000-0002-7453-0560				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Aubry H. L., 1995, American Journal of Human Genetics, V57, pA234; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Bonnemann CG, 1996, HUM MOL GENET, V5, P1953, DOI 10.1093/hmg/5.12.1953; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FUKUHARA N, 1980, ACTA NEUROPATHOL, V51, P229, DOI 10.1007/BF00687390; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; ISAACS H, 1988, J CLIN PATHOL, V41, P188, DOI 10.1136/jcp.41.2.188; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MARKESBERY WR, 1986, MYOLOGY, P1313; MCNALLY EM, 1994, P NATL ACAD SCI USA, V91, P9690, DOI 10.1073/pnas.91.21.9690; McNally EM, 1996, AM J HUM GENET, V59, P1040; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MitraniRosenbaum S, 1996, HUM MOL GENET, V5, P159, DOI 10.1093/hmg/5.1.159; MIYOSHI K, 1986, BRAIN, V109, P31, DOI 10.1093/brain/109.1.31; MURAKAMI N, 1995, ACTA NEUROPATHOL, V89, P29, DOI 10.1007/BF00294256; Nigro V, 1996, HUM MOL GENET, V5, P1179, DOI 10.1093/hmg/5.8.1179; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; OTHMANE KB, 1992, NAT GENET, V2, P316; OZAWA E, 1995, HUM MOL GENET, V4, P1711, DOI 10.1093/hmg/4.suppl_1.1711; PassosBueno MR, 1996, HUM MOL GENET, V5, P815, DOI 10.1093/hmg/5.6.815; PASSOSBUENO MR, 1995, GENOMICS, V27, P192, DOI 10.1006/geno.1995.1024; PassosBueno MR, 1996, J MED GENET, V33, P97, DOI 10.1136/jmg.33.2.97; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; SadouletPuccio HM, 1996, HUM MOL GENET, V5, P489, DOI 10.1093/hmg/5.4.489; SUNOHARA N, 1989, BRAIN, V112, P65, DOI 10.1093/brain/112.1.65; Terwilliger J., 1994, HDB HUMAN GENETIC LI; UDD B, 1991, MUSCLE NERVE, V14, P1050, DOI 10.1002/mus.880141103; UDD B, 1992, J MED GENET, V29, P383, DOI 10.1136/jmg.29.6.383; Vainzof M, 1996, HUM MOL GENET, V5, P1963, DOI 10.1093/hmg/5.12.1963; VAINZOF M, 1991, J NEUROL SCI, V94, P137; WALTON J, 1988, DISORDERS VOLUNTARY, P519; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; Weiler T, 1996, AM J HUM GENET, V59, P872; WORTON R, 1995, SCIENCE, V270, P755, DOI 10.1126/science.270.5237.755; YAMANOUCHI Y, 1994, J NEUROL SCI, V126, P70, DOI 10.1016/0022-510X(94)90096-5; YANG B, 1994, J BIOL CHEM, V269, P6040; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401	54	85	88	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					151	159		10.1086/513889	http://dx.doi.org/10.1086/513889			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245996	Green Published, Bronze			2022-12-18	WOS:A1997XM72800023
J	Bisceglia, L; Calonge, MJ; Totaro, A; Feliubadalo, L; Melchionda, S; Garcia, J; Testar, X; Gallucci, M; Ponzone, A; Zelante, L; Zorzano, A; Estivill, X; Gasparini, P; Nunes, V; Palacin, M				Bisceglia, L; Calonge, MJ; Totaro, A; Feliubadalo, L; Melchionda, S; Garcia, J; Testar, X; Gallucci, M; Ponzone, A; Zelante, L; Zorzano, A; Estivill, X; Gasparini, P; Nunes, V; Palacin, M			Localization, by linkage analysis, of the cystinuria type III gene to chromosome 19q13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID TRANSPORTER; MUTATIONS; KIDNEY; RBAT; HETEROGENEITY; EXPRESSION; ASSIGNMENT; CLONING; CDNA; MAP	Cystinuria is an autosomal recessive aminoaciduria in which three urinary phenotypes (I, II, and III) have been described. An amino acid transporter gene, SLC3A1 (formerly rBAT), was found to be responsible for this disorder. Mutational and linkage analysis demonstrated the presence of genetic heterogeneity in which the SLC3A1 gene is responsible for type I cystinuria but not for type II or type III. In this study, we report the identification of the cystinuria type III locus on the long arm of chromosome 19 (19q13.1), obtained after a genomewide search. Pairwise linkage analysis in a series of type III or type II families previously excluded from linkage to the cystinuria type I locus (SLC3A1 gene) revealed a significant maximum LOD score (Z(max)) of 13.11 at a maximum recombination fraction (theta(max)) of .00, with marker D19S225. Multipoint linkage analysis performed with the use of additional markers from the region placed the cystinuria type III locus between D19S414 and D19S220. Preliminary data on type II families also seem to place the disease locus for this rare type of cystinuria at 19q13.1 (significant Z(max) = 3.11 at theta(max) of .00, with marker D19S225).	INST REC ONCOL,DEPT MOL GENET,BARCELONA 08907,SPAIN; OSPED CSS SAN GIOVANNI ROTONDO,IRCCS,SERV GENET MED,SAN GIOVANNI ROTO,ITALY; UNIV BARCELONA,FAC BIOL,DEPT BIOQUIM & FISIOL,BARCELONA,SPAIN; OSPED CRISTO RE ROMA,DIV UROL,ROME,ITALY; UNIV TURIN,DIPARTIMENTO PEDIAT,TURIN,ITALY	IRCCS Casa Sollievo Della Sofferenza; University of Barcelona; University of Turin			Estivill, Xavier/A-3125-2013; Nunes, Virginia/D-4356-2014; Gasparini, Paolo/B-6173-2014; Nunes, Virginia/AAD-1014-2019; Bisceglia, Luigi/B-8720-2017; Feliubadalo, Lidia/G-4577-2016; Palacín, Manuel/G-9786-2015; Feliubadalo, Lidia/ABA-8696-2021; Estivill, Xavier/E-2957-2012; Zorzano, Antonio/R-5479-2018; Gallucci, Michele/K-9600-2016	Estivill, Xavier/0000-0002-0723-2256; Nunes, Virginia/0000-0002-5747-9310; Nunes, Virginia/0000-0002-5747-9310; Bisceglia, Luigi/0000-0001-5367-8518; Feliubadalo, Lidia/0000-0002-1736-0112; Feliubadalo, Lidia/0000-0002-1736-0112; Totaro, Antonio/0000-0002-9752-8471; Gallucci, Michele/0000-0002-3637-6531; Palacin, Manuel/0000-0002-8670-293X	Telethon [E.0218] Funding Source: Medline	Telethon(Fondazione Telethon)		BERTRAN J, 1993, J BIOL CHEM, V268, P14842; Bisceglia L, 1996, HUM GENET, V98, P447, DOI 10.1007/s004390050237; CALONGE MJ, 1995, HUM GENET, V95, P633; CALONGE MJ, 1995, P NATL ACAD SCI USA, V92, P9667, DOI 10.1073/pnas.92.21.9667; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FURRIOLS M, 1993, J BIOL CHEM, V268, P27060; GARCIA E, 1995, GENOMICS, V27, P52, DOI 10.1006/geno.1995.1007; GASPARINI P, 1995, AM J HUM GENET, V57, P781; GOODYER PR, 1993, J PEDIATR-US, V122, P568, DOI 10.1016/S0022-3476(05)83537-1; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Horsford J, 1996, KIDNEY INT, V49, P1401, DOI 10.1038/ki.1996.197; JONES EMC, 1994, GENOMICS, V23, P490, DOI 10.1006/geno.1994.1529; Kekuda R, 1996, J BIOL CHEM, V271, P18657, DOI 10.1074/jbc.271.31.18657; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; MAKITA N, 1994, GENOMICS, V23, P628, DOI 10.1006/geno.1994.1551; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P1128; MIYAMOTO K, 1995, BIOCHEM J, V310, P951, DOI 10.1042/bj3100951; Mora C, 1996, J BIOL CHEM, V271, P10569, DOI 10.1074/jbc.271.18.10569; OTT J, 1992, ANAL HUMAN LINKAGE; Palacin M, 1996, BIOCHEM SOC T, V24, P856, DOI 10.1042/bst0240856; PICKEL VM, 1993, P NATL ACAD SCI USA, V90, P7779, DOI 10.1073/pnas.90.16.7779; PRAS E, 1995, AM J HUM GENET, V56, P1297; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Rosenberg L E, 1966, Trans Assoc Am Physicians, V79, P284; ROSENBERG LE, 1965, NEW ENGL J MED, V273, P1239, DOI 10.1056/NEJM196512022732303; ROSENBERG LE, 1966, J CLIN INVEST, V45, P365, DOI 10.1172/JCI105351; SEGAL S, 1995, METABOLIC MOL BASES, P3581; WANG Y, 1995, FEBS LETT, V368, P389, DOI 10.1016/0014-5793(95)00685-3; YAN N, 1994, P NATL ACAD SCI USA, V91, P7548, DOI 10.1073/pnas.91.16.7548	33	85	85	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					611	616						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042921				2022-12-18	WOS:A1997WK40300018
J	Young, M; Inaba, H; Hoyer, LW; Higuchi, M; Kazazian, HH; Antonarakis, SE				Young, M; Inaba, H; Hoyer, LW; Higuchi, M; Kazazian, HH; Antonarakis, SE			Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE-III HOLOENZYME; INVITRO DNA-SYNTHESIS; ESCHERICHIA-COLI; MUTATIONAL SPECIFICITY; FRAMESHIFT MUTATION; BASE SUBSTITUTION; GAMMA-SUBUNIT; INVERSIONS; SITE; BETA	Although the molecular defect in patients in a Japanese family with mild to moderately severe hemophilia A was a deletion of a single nucleotide T within an A(8)TA(2) sequence of exon 14 of the factor VIII gene, the severity of the clinical phenotype did not correspond to that expected of a frameshift mutation, A small amount of functional factor VIII protein was detected in the patient's plasma. Analysis of DNA and RNA molecules from normal and affected individuals and in vitro transcription/translation suggested a partial correction of the molecular defect, because of the following: (i) DNA replication/RNA transcription errors resulting in restoration of the reading frame and/or (ii) ''ribosomal frameshifting'' resulting in the production of normal factor VIII polypeptide and, thus, in a milder than expected hemophilia A. All of these mechanisms probably were promoted by the longer run of adenines, A(10) instead of A(8)TA(2), after the delT. Errors in the complex steps of gene expression therefore may partially correct a severe frameshift defect and ameliorate an expected severe phenotype.	UNIV GENEVA,DEPT GENET & MICROBIOL,CH-1211 GENEVA,SWITZERLAND; CANTONAL HOSP,DIV MED GENET,GENEVA,SWITZERLAND; TOKYO MED COLL,DEPT CLIN PATHOL,TOKYO 160,JAPAN; AMER RED CROSS,HOLLAND LAB,ROCKVILLE,MD; JOHNS HOPKINS UNIV,BALTIMORE,MD; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104	University of Geneva; University of Geneva; Tokyo Medical University; American Red Cross; Johns Hopkins University; University of Pennsylvania			Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038165, R01HL036099] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38165, HL36099] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONARAKIS SE, 1995, HUM MUTAT, V5, P1, DOI 10.1002/humu.1380050102; ANTONARAKIS SE, 1995, BLOOD, V86, P2206, DOI 10.1182/blood.V86.6.2206.bloodjournal8662206; ARAI M, 1989, P NATL ACAD SCI USA, V86, P4277, DOI 10.1073/pnas.86.11.4277; ATKINS JF, 1972, P NATL ACAD SCI USA, V69, P1192, DOI 10.1073/pnas.69.5.1192; BLANK A, 1986, BIOCHEMISTRY-US, V25, P5920, DOI 10.1021/bi00368a013; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; CHAMORRO M, 1992, P NATL ACAD SCI USA, V89, P713, DOI 10.1073/pnas.89.2.713; CHANDLER M, 1993, MOL MICROBIOL, V7, P497, DOI 10.1111/j.1365-2958.1993.tb01140.x; CLARE JJ, 1988, P NATL ACAD SCI USA, V85, P6816, DOI 10.1073/pnas.85.18.6816; Cooper DN, 1995, METABOLIC MOL BASES, P259; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/pnas.88.19.8307; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P7405, DOI 10.1073/pnas.88.16.7405; HU PY, 1995, P NATL ACAD SCI USA, V92, P2136, DOI 10.1073/pnas.92.6.2136; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACQUES JP, 1991, GENE DEV, V5, P707, DOI 10.1101/gad.5.5.707; Kaufman Randall J., 1995, P1633; Kazazian HH, 1995, METABOLIC MOL BASES, P3241; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LAZARCHICK J, 1978, J CLIN INVEST, V62, P1048, DOI 10.1172/JCI109209; LINTON MF, 1992, P NATL ACAD SCI USA, V89, P11431, DOI 10.1073/pnas.89.23.11431; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MCGINNISS MJ, 1993, GENOMICS, V15, P392, DOI 10.1006/geno.1993.1073; PITTMAN DD, 1993, BLOOD, V81, P2925; ROEST PAM, 1993, HUM MOL GENET, V10, P1719; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; SEKINE Y, 1989, P NATL ACAD SCI USA, V86, P4609, DOI 10.1073/pnas.86.12.4609; TENDAM E, 1992, BIOCHEMISTRY-US, V31, P11665, DOI 10.1021/bi00162a001; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; TUDDENHAM EGD, 1994, NUCLEIC ACIDS RES, V22, P3511, DOI 10.1093/nar/22.17.3511; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529	36	85	86	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					565	573						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042915				2022-12-18	WOS:A1997WK40300012
J	Gayther, SA; Harrington, P; Russell, P; Kharkevich, G; Garkavtseva, RF; Ponder, BAJ; Bishop, DT; Carmichael, J; Collins, WP; Cox, D; Easton, D; Fraser, GR; Lowe, DG; Mackay, J; Shepherd, JH; Steel, CM				Gayther, SA; Harrington, P; Russell, P; Kharkevich, G; Garkavtseva, RF; Ponder, BAJ; Bishop, DT; Carmichael, J; Collins, WP; Cox, D; Easton, D; Fraser, GR; Lowe, DG; Mackay, J; Shepherd, JH; Steel, CM			Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Germ-line mutations of the BRCA1 gene are responsible for a substantial proportion of families with multiple cases of early-onset breast and/or ovarian cancer. Since the isolation of BRCA1 last year, >65 distinct mutations scattered throughout the coding region have been detected, making analysis of the gene time consuming and technically challenging. We have developed a multiplex heteroduplex analysis that is designed to analyze one-quarter of the coding sequence in a single-step screening procedure and that will detect similar to 50% of all BRCA1 mutations so far reported in breast/ovarian cancer families. We have used this technique to analyze BRCA1 in 162 families with a history of breast and/or ovarian cancer and identified 12 distinct mutations in 35 families.	RUSSIAN ACAD MED SCI,CANC RES CTR,MOSCOW 109801,RUSSIA	Russian Academy of Medical Sciences	Gayther, SA (corresponding author), ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,HILLS RD,BOX 238,CAMBRIDGE CB2 2QQ,ENGLAND.			Bishop, Tim/0000-0002-8752-8785				CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; DUNNING AM, 1992, AM J HUM GENET, V50, P208; EASTON DF, 1993, AM J HUM GENET, V52, P678; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FRIEND S, 1995, NAT GENET, V11, P238, DOI 10.1038/ng1195-238; GAYTHER SA, 1994, HUM MOL GENET, V3, P53, DOI 10.1093/hmg/3.1.53; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TAKAHASHI H, 1995, CANCER RES, V55, P2998; TONIN P, 1995, AM J HUM GENET, V57, P189; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119	20	85	93	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					451	456						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644703				2022-12-18	WOS:A1996TV56400002
J	PrimoParmo, SL; Bartels, CF; Wiersema, B; vanderSpek, AFL; Innis, JW; LaDu, BN				PrimoParmo, SL; Bartels, CF; Wiersema, B; vanderSpek, AFL; Innis, JW; LaDu, BN			Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SERUM-CHOLINESTERASE; AMINO-ACID-SEQUENCE; HUMAN ACETYLCHOLINESTERASE; PLASMA CHOLINESTERASE; QUANTITATIVE VARIANT; TORPEDO-CALIFORNICA; MOLECULAR-CLONING; IDENTIFICATION; MUTAGENESIS; MUTATION	The silent phenotype of human butyrylcholinesterase (BChE), present in most human populations in frequencies of similar to 1/100,000, is characterized by the complete absence of BChE activity or by activity <10% of the average levels of the usual phenotype. Heterogeneity in this phenotype has been well established at the phenotypic level, but only a few silent BCHE alleles have been characterized at the DNA level. Twelve silent alleles of the human butyrylcholinesterase gene (BCHE) have been identified in 17 apparently unrelated patients who were selected by their increased sensitivity to the muscle relaxant succinylcholine. All of these alleles are characterized by single nucleotide substitutions or deletions leading to distinct changes in the structure of the BChE enzyme molecule. Nine of the nucleotide substitutions result in the replacement of single amino acid residues. Three of these variants, BCHE*33C, BCHE*198G, and BCHE*-201T, produce normal amounts of immunoreactive but enzymatically inactive BChE protein in the plasma. The other six amino acid substitutions, encoded by BCHE*37S, BCHE*125F, BCHE*170E, BCHE*471R, and BCHE*518L, seem to cause reduced expression of BChE protein, and their role in determining the silent phenotype was confirmed by expression in cell culture. The other four silent alleles, BCHE*271STOP, BCHE*500STOP, BCHE*FS6, and BCHE*I2E3-8G, encode BChEs truncated at their C-terminus because of premature stop codons caused by nucleotide substitutions, a frame shift, or altered splicing. The large number of different silent BCHE alleles found within a relatively small number of patients shows that the heterogeneity of the silent BChE phenotype is high. The characterization of silent BChE variants will be useful in the study of the structure/function relationship for this and other closely related enzymes.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV NEBRASKA,MED CTR,EPPLEY INST,OMAHA,NE 68198	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Medical Center	PrimoParmo, SL (corresponding author), UNIV MICHIGAN,SCH MED,DEPT ANESTHESIOL,KRESGE II BLDG,ROOM R-4038,ANN ARBOR,MI 48109, USA.				NIGMS NIH HHS [GM44887] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044887] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNASON A, 1975, CLIN GENET, V7, P405; ARPAGAUS M, 1994, J BIOL CHEM, V269, P9957; ARPAGAUS M, 1991, J BIOL CHEM, V266, P6966; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; AUSUBEL FM, 1993, CURRENT PROTOCOLS MO, V2; BARTELS CF, 1992, AM J HUM GENET, V50, P1086; BARTELS CF, 1992, AM J HUM GENET, V50, P1104; CHAUTARDFREIREMAIA EA, 1991, HUM HERED, V41, P330, DOI 10.1159/000154021; DAS PK, 1973, HUM HERED, V23, P88, DOI 10.1159/000152559; DOCTOR BP, 1990, FEBS LETT, V266, P123, DOI 10.1016/0014-5793(90)81522-P; DUVAL N, 1992, FEBS LETT, V309, P421, DOI 10.1016/0014-5793(92)80821-W; EHRLICH G, 1994, GENOMICS, V22, P288, DOI 10.1006/geno.1994.1386; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GARRY PJ, 1976, J MED GENET, V13, P38, DOI 10.1136/jmg.13.1.38; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; GNATT A, 1994, J NEUROCHEM, V62, P749; GOEDDE H. W., 1965, BIOCHIM BIOPHYS ACTA, V107, P391, DOI 10.1016/0304-4165(65)90149-2; GOEDDE HW, 1968, ANN NY ACAD SCI, V151, P540, DOI 10.1111/j.1749-6632.1968.tb11913.x; GUTSCHE BB, 1967, NATURE, V215, P322, DOI 10.1038/215322b0; HADA T, 1992, INTERNAL MED, V31, P357, DOI 10.2169/internalmedicine.31.357; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; HAREL M, 1992, P NATL ACAD SCI USA, V89, P10827, DOI 10.1073/pnas.89.22.10827; HARRIS H, 1962, ANN HUM GENET, V26, P73, DOI 10.1111/j.1469-1809.1962.tb01311.x; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HARRIS H., 1960, ACTA GENET ET STATIST MED, V10, P1; HART SM, 1962, BRIT J ANAESTH, V34, P207, DOI 10.1093/bja/34.3.207; Hidaka K, 1992, Rinsho Byori, V40, P535; JBILO O, 1990, NUCLEIC ACIDS RES, V18, P3990, DOI 10.1093/nar/18.13.3990; JBILO O, 1994, J BIOL CHEM, V269, P20829; JBILO O, 1994, TOXICON, V32, P1445, DOI 10.1016/0041-0101(94)90416-2; JENSEN FS, 1992, PHARMACOGENETICS, V2, P234, DOI 10.1097/00008571-199210000-00006; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KRECJI E, 1991, P NATL ACAD SCI USA, V88, P6647; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; LEGAY C, 1993, FEBS LETT, V315, P1630; LIDDELL J, 1962, NATURE, V193, P561, DOI 10.1038/193561a0; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; Lockridge O., 1992, PHARMACOGENETICS DRU, P15; LUBIN AH, 1973, BIOCHEM MED METAB B, V8, P160, DOI 10.1016/0006-2944(73)90019-7; MAEKAWA M, 1995, CLIN CHIM ACTA, V235, P41, DOI 10.1016/0009-8981(95)06014-1; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; MCTIERNAN C, 1987, P NATL ACAD SCI USA, V84, P6682, DOI 10.1073/pnas.84.19.6682; MILLARD CB, 1992, BIOCHEM BIOPH RES CO, V189, P1280, DOI 10.1016/0006-291X(92)90212-4; Muellenbach R, 1989, TRENDS GENET, V5, P391; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; MUTERO A, 1994, MOL GEN GENET, V243, P699, DOI 10.1007/BF00279580; NEVILLE LF, 1992, EMBO J, V11, P1641, DOI 10.1002/j.1460-2075.1992.tb05210.x; NOGUEIRA CP, 1990, AM J HUM GENET, V46, P934; NOGUEIRA CP, 1992, AM J HUM GENET, V51, P821; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; PANTUCK EJ, 1993, ANESTH ANALG, V77, P380, DOI 10.1213/00000539-199377020-00027; PRIMOPARMO SL, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P61; PRODY CA, 1987, P NATL ACAD SCI USA, V84, P3555, DOI 10.1073/pnas.84.11.3555; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; RANDALL WR, 1994, BBA-GENE STRUCT EXPR, V1218, P453, DOI 10.1016/0167-4781(94)90204-6; RAO PR, 1979, HUM GENET, V52, P139; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; RUBINSTEIN H M, 1970, Journal of Clinical Investigation, V49, P479, DOI 10.1172/JCI106257; RUBINSTEIN HM, 1976, J MED GENET, V13, P43, DOI 10.1136/jmg.13.1.43; RUBINSTEIN HM, 1978, J MED GENET, V15, P27, DOI 10.1136/jmg.15.1.27; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SCOTT EM, 1970, BIOCHEM BIOPH RES CO, V38, P902, DOI 10.1016/0006-291X(70)90806-5; SCOTT EM, 1973, ANN HUM GENET, V37, P139, DOI 10.1111/j.1469-1809.1973.tb01821.x; SCOTT EM, 1976, AM J HUM GENET, V28, P253; SCOTT EM, 1970, AM J HUM GENET, V22, P363; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; STERN J, 1962, J MENT DEFIC RES, V6, P13; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; SZEINBERG A, 1972, CLIN GENET, V3, P123; WHITTAKER M, 1991, HUM HERED, V41, P77, DOI 10.1159/000153982; WHITTAKER M, 1987, HUM HERED, V37, P54, DOI 10.1159/000153677; Whittaker M., 1986, CHOLINESTERASE; WHITTAKER M, 1990, HUM HERED, V40, P152; Zakut H., 1993, HUMAN CHOLINESTERASE	83	85	90	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					52	64						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554068				2022-12-18	WOS:A1996TL69700009
J	DEANDRADE, M; THANDI, I; BROWN, S; GOTTO, A; PATSCH, W; BOERWINKLE, E				DEANDRADE, M; THANDI, I; BROWN, S; GOTTO, A; PATSCH, W; BOERWINKLE, E			RELATIONSHIP OF THE APOLIPOPROTEIN-E POLYMORPHISM WITH CAROTID-ARTERY ATHEROSCLEROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; III HYPERLIPOPROTEINEMIA; MYOCARDIAL-INFARCTION; RECEPTOR-BINDING; RISK-FACTORS; DISEASE; PLASMA; APOPROTEIN; BETA; POPULATIONS	From the cohort taking part in the Atherosclerosis Risk in Communities (ARIC) study, a multicenter investigation of atherosclerosis and its sequelae in women and men ages 45-64 years, a sample of 145 subjects with significant carotid artery atherosclerosis but without clinically recognized coronary heart disease was identified along with 224 group-matched control subjects. The aim of this paper is to measure the association of the apolipoprotein (ape) E polymorphism with the prevalence of significant carotid artery atherosclerotic disease (CAAD) after considering the contribution of established risk factor variables. The first model used a stepwise selection procedure to define a group of significant physical and lifestyle characteristics and a group of significant plasma lipid, lipoprotein, and apolipoprotein variables that were predictive of CAAD status in this sample. Those variables selected included age (years), body mass index (BMI; kg/m(2)), consumption of cigarettes (CigYears; number of cigarettes/d x the number of smoking years), hypertension status, high-density lipoprotein (HDL)-cholesterol (mg/dl), total cholesterol (mg/dl), and Lp[a] (mu g/ml). The second model was built by forcing into the equation an a priori set of demographic, anthropometric, and lipoprotein variables, which were age, BMI, CigYears, hypertensive status, LDL-cholesterol, and HDL-cholesterol. In both models, the apo E genotype epsilon 2/3 was related to CAAD status. For both models, the estimated odds ratio of being a CAAD case associated with the apo E genotype epsilon 2/3 was >2:1. The mechanism of the observed association between the epsilon 2/3 genotype and carotid atherosclerosis is unknown, but it is likely due to the known effects of the E2 isoform in causing delayed clearance of triglyceride-rich lipoproteins.	UNIV TEXAS,HLTH SCI CTR,CTR HUMAN GENET,HOUSTON,TX 77225; METHODIST HOSP,DEPT INTERNAL MED,HOUSTON,TX; BAYLOR COLL MED,HOUSTON,TX; DUKE UNIV,DIV ENDOCRINOL & METAB,DURHAM,NC	University of Texas System; University of Texas Health Science Center Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Duke University					DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL027341, R29HL040613, P60HL027341] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-40613, N01-HC55015, HL-27341] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1989, AM J EPIDEMIOL, V129, P687; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BOERWINKLE E, 1994, AM J HUM GENET, V54, P341; BOERWINKLE E, 1990, CURR OPIN LIPIDOL, V1, P151; BRENNINKMEIJER BJ, 1987, J LIPID RES, V28, P361; BROWN AJ, 1991, ARTERIOSCLER THROMB, V11, P1737, DOI 10.1161/01.ATV.11.6.1737; BROWN SA, 1988, CLIN CHEM, V34, P920; CUMMING AM, 1984, CLIN GENET, V25, P310; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EHNHOLM C, 1984, P NATL ACAD SCI-BIOL, V81, P5566, DOI 10.1073/pnas.81.17.5566; EICHNER JE, 1989, GENET EPIDEMIOL, V6, P681, DOI 10.1002/gepi.1370060605; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaubatz J W, 1986, Methods Enzymol, V129, P167; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; HIXSON JE, 1990, J LIPID RES, V31, P545; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; HUI DY, 1984, J BIOL CHEM, V259, P860; KAMEDA K, 1984, ATHEROSCLEROSIS, V51, P241, DOI 10.1016/0021-9150(84)90171-0; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; KUUSI T, 1989, ARTERIOSCLEROSIS, V9, P237, DOI 10.1161/01.ATV.9.2.237; LENZEN HJ, 1986, CLIN CHEM, V32, P778; Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195; MAHLEY RW, 1990, CURRENT OPINION LIPI, V1, P87; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; PATSCH JR, 1992, ARTERIOSCLER THROMB, V121, P1336; PATSCH W, 1989, CLIN CHEM, V265, P265; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHONFELD G, 1974, J CLIN INVEST, V53, P1458, DOI 10.1172/JCI107694; SHEA S, 1983, CARDIOVASC REV REP, V4, P1343; SING CF, 1985, AM J HUM GENET, V37, P268; SUPERKO HR, 1991, ARTERY, V18, P315; TENKATE LP, 1982, AM J CARDIOL, V50, P945, DOI 10.1016/0002-9149(82)90400-3; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1471; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WILSON PWF, 1994, CIRCULATION S, V1, P810; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473; 1990, CIRCULATION, V81, P1721	49	85	87	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1379	1390						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762561				2022-12-18	WOS:A1995RA79400017
J	GILBERT, JR; STAJICH, JM; WALL, S; CARTER, SC; QIU, H; VANCE, JM; STEWART, CS; SPEER, MC; PUFKY, J; YAMAOKA, LH; ROZEAR, M; SAMSON, F; FARDEAU, M; ROSES, AD; PERICAKVANCE, MA				GILBERT, JR; STAJICH, JM; WALL, S; CARTER, SC; QIU, H; VANCE, JM; STEWART, CS; SPEER, MC; PUFKY, J; YAMAOKA, LH; ROZEAR, M; SAMSON, F; FARDEAU, M; ROSES, AD; PERICAKVANCE, MA			EVIDENCE FOR HETEROGENEITY IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; DNA MARKER; DISEASE; GENE	Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive primary disease of muscle which is usually inherited as an autosomal dominant disorder. FSHD has been localized to the long arm of chromosome 4, specifically to the 4q3.5-qter region. Initially published linkage studies showed no evidence for heterogeneity in FSHD. In the present study we have examined individuals in seven FSHD families. Two-point lod scores show significant evidence for linkage for D4S163 (lod score 3.04 at recombination fraction .21) and D4S139 (lod score 3.84 at recombination fraction .20). D4S171 also gave a positive score (lod score 2.56 at recombination fraction .24). Significant evidence for heterogeneity was found for each of the three markers. Multipoint linkage analysis in this region resulted in a peak multipoint lod score of 6.47. The multipoint analysis supported the two-point studies with odds of 20:1 showing linkage and heterogeneity over linkage and homogeneity. Five of the seven families gave a posterior probability of >95% of being of the linked type, while two families appeared unlinked to this region of 4q (P < .01%). Individuals in the two unlinked families met the clinical criteria for the diagnosis of FSHD, including facial weakness, clavicular flattening, scapula winging, proximal muscle weakness, and myopathic changes on muscle biopsies without inflammatory or mitochondrial pathology. This study demonstrates genetic heterogeneity in FSHD and has important implications for both genetic counseling and the elucidation of the etiology of FSHD.	INSERM,U153,F-75005 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	GILBERT, JR (corresponding author), DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,BOX 2900,DURHAM,NC 27710, USA.			Vance, Jeffery/0000-0003-3815-8199	NCRR NIH HHS [MO1-RR30] Funding Source: Medline; DS NIH HHS [NINDSNS26330] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DS NIH HHS		DUBOWITZ V, 1985, MUSCLE BIOPSY MODERN; FISCHBECK KH, 1992, NAT GENET, V2, P3, DOI 10.1038/ng0992-3; GILBERT JR, 1992, AM J HUM GENET, V51, P424; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUNT PW, 1988, J NEUROL SCI, V88, P287, DOI 10.1016/0022-510X(88)90225-0; MORTON NE, 1960, AM J HUM GENET, V11, P360; MOSER H, 1966, SCHWEIZ MED WSCHR, V96, P169; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; UPADHYAYA M, 1991, J MED GENET, V28, P665, DOI 10.1136/jmg.28.10.665; WALTON JN, 1981, DISORDERS VOLUNTARY, P502; WEIFFENBACH B, IN PRESS NATURE GENE; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I	19	85	86	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					401	408						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328457				2022-12-18	WOS:A1993LN82000012
J	HAYASHI, A; WADA, Y; SUZUKI, T; SHIMIZU, A				HAYASHI, A; WADA, Y; SUZUKI, T; SHIMIZU, A			STUDIES ON FAMILIAL HYPOTRANSFERRINEMIA - UNIQUE CLINICAL COURSE AND MOLECULAR PATHOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ATRANSFERRINEMIA; TRANSFERRIN	Some unsolved problems-late onset of anemia and growth retardation (at age 7 years), healthy siblings showing very low transferrin (TF) level, and unexplained mode of inheritance-were found in family members of a congenital atransferrinemia already reported in 1972. The long-term clinical, laboratory, and developmental observations revealed that after 5 years of apo-TF supplementary therapy the patient's anemia gradually disappeared, and he started to grow again without further therapy. Immunoelectrophoretic study disclosed a severe deficiency of both TF and haptoglobin in the patient. The recovery from his anemia and the resumption of his physical development were dependent only on his TF level: that is, from a negligible level it increased to 10-20 mg/dl (normal, 205-370 mg/dl), a level similar to that of his TF-deficient siblings, who had been in good health since birth. The TF analysis of the patient and his family suggests that the minimum TF requisite in this family may be close to 10-20 mg/dl; subjects with more than 20 mg/dl are apparently healthy; with less than 10 mg/dl they may develop severe growth retardation and anemia, and extreme deficiency may be lethal. Also, coexisting haptoglobin deficiency might alleviate hemosiderosis. Further, the isoelectric focusing study disclosed that there was only a small amount of TF variant in these siblings including the patient. The study of the family confirmed that this variant was produced by an allelic gene derived from their father. So, the original diagnosis of congenital atransferrinemia should be revised as familial hypotransferrinemia transmitted with autosomal recessive mode, and the subjects with a recessive character may be compound heterozygotes of the ''variant'' allele and the ''null'' allele.	OSAKA MED COLL,DEPT CLIN PATHOL,TAKATSUKI,OSAKA 569,JAPAN; KYUSHU UNIV MED INST BIOREGULAT,DEPT CLIN GENET,OITA,JAPAN	Osaka Medical College; Kyushu University	HAYASHI, A (corresponding author), OSAKA MED CTR & RES INST MATERNAL & CHILD HLTH,840 MURODO CHO,IZUMI,OSAKA 59002,JAPAN.							BARNES D, 1980, CELL, V22, P649, DOI 10.1016/0092-8674(80)90540-1; BERNSTEIN SE, 1987, J LAB CLIN MED, V110, P690; Cap J, 1968, Cesk Pediatr, V23, P1020; EKBLOM P, 1983, P NATL ACAD SCI-BIOL, V80, P2651, DOI 10.1073/pnas.80.9.2651; FAIRBANKS VF, 1990, HEMATOLOGY, P506; GOYA N, 1972, BLOOD-J HEMATOL, V40, P239, DOI 10.1182/blood.V40.2.239.239; HAMILL RL, 1991, AM J CLIN PATHOL, V96, P215, DOI 10.1093/ajcp/96.2.215; HEILMEYER L, 1966, ACTA HAEMATOL-BASEL, V36, P40, DOI 10.1159/000209090; HEILMEYER L, 1961, DEUT MED WOCHENSCHR, V86, P1745, DOI 10.1055/s-0028-1113001; HUGGENVIK JI, 1987, ENDOCRINOLOGY, V120, P332, DOI 10.1210/endo-120-1-332; HUGGENVIK JI, 1989, BLOOD, V74, P482; Jendrassik L, 1938, BIOCHEM Z, V297, P81; Loperena L, 1974, Bol Med Hosp Infant Mex, V31, P519; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; PASCALI VL, 1982, HUM GENET, V61, P39, DOI 10.1007/BF00291329; REEVES WB, 1980, ANN CLIN LAB SCI, V10, P529; Ritchie R. F., 1975, PLASMA PROTEINS, V2, P375; Sakata T, 1969, SHONIKA SHINRYO, V32, P1523; SELIGMAN PA, 1987, MOL BASIS BLOOD DISE, P219; SMITH AL, 1983, PEDIATR CLIN N AM, V30, P209; SMITHIES O, 1957, NATURE, V180, P1482, DOI 10.1038/1801482a0; WALBAUM R, 1971, LILLE MED, V16, P1122; Williams CA, 1971, METHODS IMMUNOLOGY I, VIII, P234; 1987, HLTH INDEX, V34, P46	24	85	89	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					201	213						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317485				2022-12-18	WOS:A1993LJ38500024
J	KAPP, LN; PAINTER, RB; YU, LC; VANLOON, N; RICHARD, CW; JAMES, MR; COX, DR; MURNANE, JP				KAPP, LN; PAINTER, RB; YU, LC; VANLOON, N; RICHARD, CW; JAMES, MR; COX, DR; MURNANE, JP			CLONING OF A CANDIDATE GENE FOR ATAXIA-TELANGIECTASIA GROUP-D	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 11Q22-23; MOLECULAR-CLONING; HIGH-RESOLUTION; INTEGRATED DNA; HUMAN-CELLS; REPAIR; COMPLEMENTATION; LOCALIZATION; EXPRESSION; FAMILIES	Transfection, with a human cosmid clone library, of an ataxia-telangiectasia (AT) cell line (AT5BIVA) from complementation group D previously resulted in the isolation of a cell line (1B3) with partially restored resistance to ionizing radiation. We rescued the integrated cosmid sequences within 1B3 and obtained two cosmid clones that contained overlapping DNA from chromosomal region 11q23, previously shown to be the region containing the AT gene(s) from three complementation groups. Isolation of an apparently full-length 3.0-kb cDNA from a HeLa cell library demonstrated a previously unidentified gene (ATDC) within these cosmid clones. The transfected copy of the ATDC gene in 1B3 is truncated at the 3' end but is a complete transcription unit, because of the presence of SV40 termination sequences within the adjacent cosmid DNA. After further screening of cosmid clones from a chromosome 11 library, we identified contiguous DNA that contained the missing portion of the gene. Southern blot analysis indicated that the ATDC gene is present in a single copy in the human genome; however, RNA blot analysis revealed mRNA of several sizes (1.8, 2.6, 3.0, 4.7, and 5.7 kb) that varied among different cell lines. Because no large rearrangements were detected in AT5BIVA cells by Southern or RNA blot analysis, any alteration in the ATDC gene in this cell line would involve a point mutation or a small rearrangement. Transfection of the AT5BIVA cell line with one of the cosmids partially restored radioresistance. Analysis of 100 X-radiation hybrid cell lines containing various fragments from the chromosomal region 11q23 showed that the ATDC gene is closely linked to THY1. The ATDC gene therefore lies outside the linkage region predicted to contain the AT gene(s) for complementation groups A and C, indicating a separate locus for the AT complementation group D gene.	UNIV CALIF SAN FRANCISCO,RADIOBIOL & ENVIRONM HLTH LAB,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT RADIAT ONCOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT RADIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIMH NIH HHS [MH00802] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K11MH000802] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BODER E, 1985, ATAXIA TELANGIECTASI, P1; COLBEREGARAPIN F, 1986, GENE, V50, P279, DOI 10.1016/0378-1119(86)90332-X; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FOROUD T, 1991, AM J HUM GENET, V49, P1263; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1991, DEC AACR SPEC C CELL; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HOEIJMAKERS JHJ, 1987, EXP CELL RES, V169, P111, DOI 10.1016/0014-4827(87)90230-8; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; KAPP LN, 1989, INT J RADIAT BIOL, V56, P667, DOI 10.1080/09553008914551891; LAMBERT C, 1991, P NATL ACAD SCI USA, V88, P5907, DOI 10.1073/pnas.88.13.5907; LEFF SE, 1986, ANNU REV BIOCHEM, V55, P1091, DOI 10.1146/annurev.bi.55.070186.005303; MAYNE LV, 1988, GENE, V66, P65, DOI 10.1016/0378-1119(88)90225-9; MAYNE LV, 1989, GENE, V83, P395, DOI 10.1016/0378-1119(89)90128-5; MCCONVILLE CM, 1990, NUCLEIC ACIDS RES, V18, P4335, DOI 10.1093/nar/18.15.4335; MCCONVILLE CM, 1990, HUM GENET, V85, P215; MORRELL D, 1986, J NATL CANCER I, V77, P89; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; MURNANE JP, 1985, EXP CELL RES, V158, P119, DOI 10.1016/0014-4827(85)90437-9; MURNANE JP, 1986, MOL CELL BIOL, V6, P549, DOI 10.1128/MCB.6.2.549; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; RICHARD CW, 1991, AM J HUM GENET, V49, P1189; Sambrook J., 1989, MOL CLONING LAB MANU; SANAL O, 1990, AM J HUM GENET, V47, P860; TAYLOR AMR, 1982, ATAXIA TELANGIECTASI, P53; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; TRASK BJ, 1991, AM J HUM GENET, V48, P1; VANDUIN M, 1986, CELL, V44, P913, DOI 10.1016/0092-8674(86)90014-0; WEEDA G, 1990, MOL CELL BIOL, V10, P2570, DOI 10.1128/MCB.10.6.2570; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; ZIV Y, 1991, GENOMICS, V9, P373, DOI 10.1016/0888-7543(91)90268-J	34	85	92	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					45	54						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609804				2022-12-18	WOS:A1992JA46700006
J	PERUSSE, L; MOLL, PP; SING, CF				PERUSSE, L; MOLL, PP; SING, CF			EVIDENCE THAT A SINGLE GENE WITH GENDER-DEPENDENT AND AGE-DEPENDENT EFFECTS INFLUENCES SYSTOLIC BLOOD-PRESSURE DETERMINATION IN A POPULATION-BASED SAMPLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SODIUM-LITHIUM COUNTERTRANSPORT; FRENCH-CANADIAN POPULATION; SEGREGATION ANALYSIS; HYPERTENSION; PEDIGREES; MODEL; INHERITANCE; FAMILIES	A biometrical study was carried out to evaluate the role of genetic variation in determining interindividual differences in systolic blood pressure (SBP) in the population at large. SBP was measured in 1,266 Caucasian individuals in 278 pedigrees ascertained through children enrolled in the Rochester, MN, school system. The sample included 646 males and 620 females 550 years of age and not taking antihypertensive medication or oral contraceptives. Complex segregation analysis was first applied to these data by using a regression model for age, in which the intercept was gender and ousiotype specific but in which the slope was only gender specific. When the slope was independent of ousiotype, neither variation at a single gene combined with polygenic effects (mixed genetic model) nor variation in a single environmental factor combined with polygenetic effects (mixed environmental model) explained the distribution of SBP in this sample. However, when the regression model for age allowed both the intercept and slope to be gender and ousiotype specific, the mixed environmental model was rejected whereas the mixed genetic model was not. These results suggest that variability in SBP may be influenced by major effects of allelic variation at a single gene that are both gender and age dependent. This study (1) suggests that particular genotypes determined by a single gene are associated with a steeper increase of SBP with age among males and females 550 years of age in the general population and (2) illustrates the need to consider models that more realistically represent the relationship between genotypic variability and phenotypic variability, to understand the genetics of human quantitative traits.	UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, 4708 MED SCI BLDG 2, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT EPIDEMIOL, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Perusse, Louis/A-3444-2012	Perusse, Louis/0000-0001-6440-9698; Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHS [HL31907, HL24489, HL30428] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030428, R01HL024489] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANNEST JL, 1979, AM J EPIDEMIOL, V110, P492, DOI 10.1093/oxfordjournals.aje.a112830; BERRY TD, 1989, HYPERTENSION, V13, P3, DOI 10.1161/01.HYP.13.1.3; BOERWINKLE E, 1986, GENET EPIDEMIOL, V3, P365, DOI 10.1002/gepi.1370030509; CAMUSSI A, 1988, HYPERTENSION, V12, P620, DOI 10.1161/01.HYP.12.6.620; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CARTER CL, 1990, HUM HERED, V40, P235, DOI 10.1159/000153936; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GENEST O, 1983, HYPERTENSION PHYSIOP; HARLAN WR, 1973, HYPERTENSION MECHANI, P85; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1988, AM J MED GENET, V29, P193, DOI 10.1002/ajmg.1320290125; HASSTEDT SJ, 1988, AM J HUM GENET, V43, P14; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; KIRKENDALL WM, 1981, HYPERTENSION, V3, pA509; KRIEGER H, 1980, HUM GENET, V53, P415, DOI 10.1007/BF00287065; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; MARAZITA ML, 1987, AM J MED GENET, V26, P511, DOI 10.1002/ajmg.1320260302; MOLL P P, 1984, Genetic Epidemiology, V1, P301, DOI 10.1002/gepi.1370010403; MOLL PP, 1983, J CHRON DIS, V36, P317, DOI 10.1016/0021-9681(83)90117-0; MOLL PP, 1989, AM J HUM GENET, V44, P124; MORTON NE, 1980, HUM GENET, V53, P261; MOTULSKY AG, 1987, MOL APPROACHES HUMAN, P150; PERUSSE L, 1989, AM J HUM GENET, V45, P240; PICKERING GEORGE, 1967, P18; PLATT ROBERT, 1967, P9; RAPP JP, 1983, HYPERTENSION PHYSIOP, P582; REBBECK TR, 1991, AM J HUM GENET, V49; RICE T, 1990, AM J HUM GENET, V46, P37; SING CF, 1986, CLIN EXP HYPERTENS A, V8, P623, DOI 10.3109/10641968609046580; SING CF, 1989, INT J EPIDEMIOL, V18, pS183; SWALES JD, 1985, PLATT VERSUS PICKERI; TURNER ST, 1985, HYPERTENSION, V7, P955, DOI 10.1161/01.HYP.7.6.955; TURNER ST, 1989, HYPERTENSION, V13, P378, DOI 10.1161/01.HYP.13.4.378; TURNER ST, IN PRESS HYPERTENSIO; Ward R. H., 1979, GENETIC ANAL COMMON, P675; WILLIAMS RR, 1988, CLIN PHYSIOL BIOCH, V6, P136; WILLIAMS RR, 1988, J CARDIOVASC PHARM, V12, pS7	38	85	85	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					94	105						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063879				2022-12-18	WOS:A1991FW51100012
J	TANGUAY, RM; VALET, JP; LESCAULT, A; DUBAND, JL; LABERGE, C; LETTRE, F; PLANTE, M				TANGUAY, RM; VALET, JP; LESCAULT, A; DUBAND, JL; LABERGE, C; LETTRE, F; PLANTE, M			DIFFERENT MOLECULAR-BASIS FOR FUMARYLACETOACETATE HYDROLASE DEFICIENCY IN THE 2 CLINICAL FORMS OF HEREDITARY TYROSINEMIA (TYPE-I)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											TANGUAY, RM (corresponding author), CHU LAVAL,CTR RECH,2705 BLVD LAURIER,QUEBEC CITY G1V 4G2,QUEBEC,CANADA.			Duband, Jean-Loup/0000-0002-1831-6420				BERGER R, 1981, CLIN CHIM ACTA, V114, P37, DOI 10.1016/0009-8981(81)90225-4; BERGER R, 1988, Pediatric Research, V23, p328A; BERGER R, 1987, PEDIATR RES, V22, P394, DOI 10.1203/00006450-198710000-00005; BERGERON P, 1974, CLIN GENET, V5, P157; Edwards S. W., 1955, METHOD ENZYMOL, V2, P298; FALLSTROM SP, 1979, PEDIATR RES, V13, P78, DOI 10.1203/00006450-197901000-00056; FUKUHARA N, 1984, PEDIATR RES, V18, P463; GAGNE R, 1982, PRENATAL DIAG, V2, P185, DOI 10.1002/pd.1970020307; GOLDSMITH LA, 1989, METABOLIC BASIS INHE, P547; GRAY RGF, 1981, J INHERIT METAB DIS, V4, P37, DOI 10.1007/BF02263580; HAAGEN AAM, 1987, J INHERIT METAB DIS, V10, P323, DOI 10.1007/BF01811440; HOLME E, 1985, LANCET, V1, P527; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KVITTINGEN EA, 1986, SCAND J CLIN LAB INV, V46, P27; KVITTINGEN EA, 1981, CLIN CHIM ACTA, V115, P311, DOI 10.1016/0009-8981(81)90244-8; KVITTINGEN EA, 1985, PEDIATR RES, V19, P334, DOI 10.1203/00006450-198519040-00002; KVITTINGEN EA, 1983, PEDIATR RES, V14, P541; LABERGE C, 1969, AM J HUM GENET, V21, P36; LAROCHELLE J, 1967, CAN MED ASSOC J, V97, P1051; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; MAHURAN DJ, 1977, CAN J BIOCHEM CELL B, V55, P1; MELANCON SB, 1983, PEDIATRIC LIVER DISE, P223; NICOLE LM, 1986, BIOCHEM CELL BIOL, V64, P489, DOI 10.1139/o86-068; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; TANGUAY RM, 1984, ADV GENE TECHNOLOGY, P256; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEINBERG AG, 1976, J PEDIATR-US, V88, P434, DOI 10.1016/S0022-3476(76)80259-4	30	85	85	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					308	316						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378356				2022-12-18	WOS:A1990DT87100017
J	BARRANTES, R; SMOUSE, PE; MOHRENWEISER, HW; GERSHOWITZ, H; AZOFEIFA, J; ARIAS, TD; NEEL, JV				BARRANTES, R; SMOUSE, PE; MOHRENWEISER, HW; GERSHOWITZ, H; AZOFEIFA, J; ARIAS, TD; NEEL, JV			MICROEVOLUTION IN LOWER CENTRAL AMERICA - GENETIC-CHARACTERIZATION OF THE CHIBCHA-SPEAKING GROUPS OF COSTA-RICA AND PANAMA, AND A CONSENSUS TAXONOMY BASED ON GENETIC AND LINGUISTIC AFFINITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									RUTGERS STATE UNIV, COOK COLL, CTR THEORET & APPL GENET, POB 231, NEW BRUNSWICK, NJ 08903 USA; UNIV COSTA RICA, INST INVEST SALUD, SAN JOSE, COSTA RICA; UNIV PANAMA, INST ESPECIALIZADO ANAL, PANAMA CITY, PANAMA; UNIV CALIF LAWRENCE LIVERMORE NATL LAB, DIV BIOMED SCI, LIVERMORE, CA 94550 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA	Rutgers State University New Brunswick; Universidad Costa Rica; Universidad de Panama; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of Michigan System; University of Michigan								[Anonymous], 1959, SONS SHAKING EARTH P; ARIAS TD, 1988, CLIN PHARMACOL THER, V44, P343, DOI 10.1038/clpt.1988.160; ARIAS TD, 1988, CLIN PHARMACOL THER, V43, P456, DOI 10.1038/clpt.1988.58; BARRANTES R, 1982, AM J PHYS ANTHROPOL, V58, P201, DOI 10.1002/ajpa.1330580213; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CHAKRABORTY R, 1976, SOC BIOL, V23, P73, DOI 10.1080/19485565.1976.9988205; Conzemius E., 1932, SMITHSONIAN I BUREAU, V106; Cooke R.G., 1984, ARCHAEOLOGY LOWER CE, P263; de Wille Bozzoli, 1979, NACIMIENTO MUERTE EN; DEARAUZ RT, 1980, PANAMA INDIGENA; DYEN I, 1963, LANGUAGE, V39, P60, DOI 10.2307/410762; DYEN I, 1962, INT J AM LINGUIST, V28, P153, DOI 10.1086/464687; DYEN I, 1962, LANGUAGE, V38, P38, DOI 10.2307/411187; Eugenia Maria, 1986, INDIGENA COSTARRICEN; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FUENTES LUIS G., 1961, REV BIOL TROP, V9, P131; GABB WM, 1875, AM PHILOS SOC, V14, P483; Gagini Carlos, 1917, ABORIGENES COSTA RIC; GERSHOWITZ H, 1978, AM J PHYS ANTHROPOL, V49, P289, DOI 10.1002/ajpa.1330490302; Gordon BL, 1982, PANAMA FOREST SHORE; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HOWE J, 1976, FRONTIER ADAPTATIONS, P151; IBARRA E, 1984, THESIS U COSTA RICA; INABA T, 1988, BRIT J CLIN PHARMACO, V25, P75, DOI 10.1111/j.1365-2125.1988.tb03284.x; INABA T, 1987, CLIN PHARMACOL THER, V42, P493, DOI 10.1038/clpt.1987.186; IRVING WN, 1985, ANNU REV ANTHROPOL, V14, P529; Johnson F., 1948, HDB S AM INDIANS, V4, P43; Lange Frederick W., 1984, ARCHAEOLOGY LOWER CE; LEWIN R, 1987, SCIENCE, V238, P1230, DOI 10.1126/science.3685973; LINARES OF, 1979, ANNU REV ANTHROPOL, V8, P21, DOI 10.1146/annurev.an.08.100179.000321; LONG JC, 1987, GENETICS, V117, P273; LOTHROP SK, 1966, HDB MIDDLE AM INDIAN, V4, P180; Loukotka C., 1968, CLASSIFICATION S AM; Malecot G., 1969, MATH HEREDITY; MANTEL N, 1967, CANCER RES, V27, P209; MATSON GA, 1965, AM J PHYS ANTHROPOL, V23, P123; MATSON GA, 1965, AM J PHYS ANTHROPOL, V23, P107; MATSON GA, 1965, AM J PHYS ANTHROPOL, V23, P413; MAURER HR, 1972, Z KLIN CHEM KLIN BIO, V10, P220; MOHRENWEISER HW, 1987, ANN HUM GENET, V51, P303, DOI 10.1111/j.1469-1809.1987.tb01065.x; MOHRENWEISER HW, 1982, AM J HUM GENET, V34, P425; MOHRENWEISER HW, 1982, BIOCHIM BIOPHYS ACTA, V702, P90, DOI 10.1016/0167-4838(82)90030-9; MORTON NE, 1969, ANNU REV GENET, V3, P53, DOI 10.1146/annurev.ge.03.120169.000413; NEEL JV, 1988, MUTAT RES, V204, P365, DOI 10.1016/0165-1218(88)90035-3; NEEL JV, 1986, AM J HUM GENET, V38, P649; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; NEEL JV, 1978, ANNU REV GENET, V12, P365, DOI 10.1146/annurev.ge.12.120178.002053; NEEL JV, 1978, AM J HUM GENET, V30, P465; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; NEEL JV, 1977, HUM GENET, V37, P207, DOI 10.1007/BF00393584; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1972, THEOR POPUL BIOL, V3, P460, DOI 10.1016/0040-5809(72)90017-2; NEI M, 1976, P NATL ACAD SCI USA, V73, P4164, DOI 10.1073/pnas.73.11.4164; PIPERNO DR, 1985, AM ANTHROPOL, V87, P871, DOI 10.1525/aa.1985.87.4.02a00090; Romoli K., 1987, LENGUA CUEVA; SALZANO FM, 1986, AM J PHYS ANTHROPOL, V69, P3, DOI 10.1002/ajpa.1330690103; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SNARSKIS MJ, 1979, AM ANTIQUITY, V44, P125, DOI 10.2307/279194; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SOKAL RR, 1986, GENETICS, V114, P259; SPIELMAN RS, 1979, CURR ANTHROPOL, V20, P377, DOI 10.1086/202275; SPIELMAN RS, 1974, SCIENCE, V184, P637, DOI 10.1126/science.184.4137.637; STONE D, 1977, PRECOLUMBIAN MAN COS; Stone D., 1949, PAPERS PEABODY MUSEU, V26; STONE D, 1962, PAPERS PEABODY MUSEU, V43; Swadesh Morris, 1967, HDB MIDDLE AM INDIAN, V5, P79; TANIS RJ, 1977, AM J HUM GENET, V29, P419; TANIS RJ, 1973, AM J HUM GENET, V25, P655; Wright S, 1943, GENETICS, V28, P114; WURZINGER KH, 1982, ANN HUM GENET, V46, P191, DOI 10.1111/j.1469-1809.1982.tb00711.x; Young P.D., 1970, ETHNOHISTORY, V17, P11; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	115	85	88	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					63	84						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294755				2022-12-18	WOS:A1990CJ04300009
J	DEVLIN, RH; DEEB, S; BRUNZELL, J; HAYDEN, MR				DEVLIN, RH; DEEB, S; BRUNZELL, J; HAYDEN, MR			PARTIAL GENE DUPLICATION INVOLVING EXON-ALU INTERCHANGE RESULTS IN LIPOPROTEIN-LIPASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA, DEPT MED GENET, F168 UNIV HOSP, 2211 WESTBROOK MALL, VANCOUVER V6T 2B5, BC, CANADA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA	University of British Columbia; University of Washington; University of Washington Seattle			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30086] Funding Source: Medline; PHS HHS [OK-02456] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BORENSZTAJN J, 1987, LIPOPROTEIN LIPASE; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; CHANDLEY AC, 1988, CYTOGENET CELL GENET, V48, P152, DOI 10.1159/000132613; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DEEB SS, 1989, BIOCHEMISTRY-US, V28, P4132, DOI 10.1021/bi00436a001; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GATERMANN KB, 1988, BIOTECHNIQUES, V6, P951; GITSCHIER J, 1988, AM J HUM GENET, V43, P274; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HORSTHEMKE B, 1987, J MED GENET, V24, P144, DOI 10.1136/jmg.24.3.144; HU XY, 1988, J MED GENET, V25, P369, DOI 10.1136/jmg.25.6.369; HU XY, 1989, AM J HUM GENET, V44, P855; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LANGLOIS S, 1989, P NATL ACAD SCI USA, V86, P948, DOI 10.1073/pnas.86.3.948; LANGLOIS S, 1988, AM J HUM GENET, V43, P60; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; MANIATIS T, 1983, MOL CLONING; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAWADA I, 1985, J MOL EVOL, V22, P316, DOI 10.1007/BF02115687; SMITH HO, 1976, NUCLEIC ACIDS RES, V3, P2387, DOI 10.1093/nar/3.9.2387; THOMAS NST, 1986, J MED GENET, V23, P509, DOI 10.1136/jmg.23.6.509; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; YANG TP, 1984, NATURE, V310, P412, DOI 10.1038/310412a0	33	85	87	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					112	119						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294743				2022-12-18	WOS:A1990CJ04300014
J	FARRER, LA; CONNEALLY, PM				FARRER, LA; CONNEALLY, PM			A GENETIC MODEL FOR AGE AT ONSET IN HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											FARRER, LA (corresponding author), INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46223, USA.		Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225	NINDS NIH HHS [N01-NS-9-2320] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS092320] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BOEHNKE M, 1983, AM J HUM GENET, V35, P845; BRACKENRIDGE CJ, 1972, J MED GENET, V9, P23, DOI 10.1136/jmg.9.1.23; BURKE W, 1976, J MED GENET, V13, P462, DOI 10.1136/jmg.13.6.462; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FAUGHT E, 1983, SOUTHERN MED J, V76, P1266, DOI 10.1097/00007611-198310000-00018; Greenberg L J, 1978, Birth Defects Orig Artic Ser, V14, P249; HALL JG, 1983, AM J MED GENET, V16, P289, DOI 10.1002/ajmg.1320160218; HASLAM RHA, 1983, CAN J NEUROL SCI, V10, P200, DOI 10.1017/S0317167100044930; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; JONES M B, 1970, Journal of Medical Genetics, V7, P20, DOI 10.1136/jmg.7.1.20; Kohn R R, 1978, Birth Defects Orig Artic Ser, V14, P387; MEDVEDEV ZA, 1983, EXP GERONTOL, V18, P73, DOI 10.1016/0531-5565(83)90053-0; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1983, LANCET, V1, P208; MYERS RH, 1982, AM J HUM GENET, V34, P481; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; PERICAKVANCE MA, 1983, AM J MED GENET, V14, P49, DOI 10.1002/ajmg.1320140109; SMITH JR, 1980, MECH AGEING DEV, V13, P387, DOI 10.1016/0047-6374(80)90080-9; TICE RR, 1978, GENETICS AGING, P53; VEGTERVANDERVLIS M, 1976, ANN HUM GENET, V39, P329; VOGEL F, 1979, HUMAN GENETICS PROBL, P595; WENT LN, 1983, ANN HUM GENET, V47, P205, DOI 10.1111/j.1469-1809.1983.tb00989.x; WENT LN, 1984, LANCET, V1, P1100	24	85	86	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					350	357						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	3157315				2022-12-18	WOS:A1985AGY5900009
J	PAULS, DL; BUCHER, KD; CROWE, RR; NOYES, R				PAULS, DL; BUCHER, KD; CROWE, RR; NOYES, R			A GENETIC-STUDY OF PANIC DISORDER PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV IOWA,COLL MED,DEPT PSYCHIAT,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT PREVENT MED,DIV BIOSTAT,IOWA CITY,IA 52242	University of Iowa; University of Iowa					NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014620, T32MH014235] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-14620, MH-14235] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Brown F W, 1942, Proc R Soc Med, V35, P785; BUCHER KD, 1977, 1141 U N CAR I STAT; COHEN ME, 1961, AM J HUM GENET, V3, P126; CROWE RR, 1980, ARCH GEN PSYCHIAT, V37, P77; ELSTON RC, 1975, AM J HUM GENET, V27, P31; KAPLAN EB, UNPUBLISHED; MARKS I, 1973, J NERV MENT DIS, V156, P3, DOI 10.1097/00005053-197301000-00001; McInnes R G, 1937, Proc R Soc Med, V30, P895; MINER GD, 1973, ARCH GEN PSYCHIAT, V29, P111; NOYES R, 1978, ARCH GEN PSYCHIAT, V35, P1057; PAULS DL, 1979, J AFFECT DISORDERS, V1, P287, DOI 10.1016/0165-0327(79)90015-6; PAULS DL, 1979, J AFFECT DISORDERS, V1, P279, DOI 10.1016/0165-0327(79)90014-4; SLATER ELIOT, 1966, J MED GENET, V3, P159, DOI 10.1136/jmg.3.3.159; WEISS AN, 1975, CIRCULATION, V52, P1091, DOI 10.1161/01.CIR.52.6.1091; 1978, TASK FORCE NOMENCLAT	16	85	87	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					639	644						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KJ795	7424907				2022-12-18	WOS:A1980KJ79500001
J	KALLMANN, FJ				KALLMANN, FJ			TWIN AND SIBSHIP STUDY OF OVERT MALE HOMOSEXUALITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALEXANDER F, 1942, FUNDAMENTALS PSYCHOA; BENEDEK T, 1950, FUNCTIONS SEXUAL APP, pCH15; BERNSTEIN ME, 1951, SCIENCE, V114, P181, DOI 10.1126/science.114.2955.181-a; BOSS M, 1949, MEANING CONTENT SEXU; DARKE RA, 1948, J NERV MENT DIS, V107, P251, DOI 10.1097/00005053-194810730-00005; DARKE RA, 1948, J NERV MENT DIS, V108, P217, DOI 10.1097/00005053-194810830-00005; Fenichel O., 1945, PSYCHOANALYTIC THEOR; HENDERSON GD, 1946, TXB PSYCHIATRY STUDE; HENRY GW, 1948, SEX VARIANTS; HIRSCHFELD M, 1940, SEXUAL PATHOLOGY; Hoch P. H., 1949, PSYCHOSEXUAL DEV HLT; Jensch K, 1941, ARCH PSYCHIAT NERVEN, V112, P527, DOI 10.1007/BF01813997; Jensch K, 1941, ARCH PSYCHIAT NERVEN, V112, P679, DOI 10.1007/BF01814003; KALLMANN FJ, 1952, J NERV MENT DIS, V115, P283; KALLMANN FJ, 1951, T NEW YORK ACAD SCI, V13, P270, DOI 10.1111/j.2164-0947.1951.tb01026.x; KINSEY AC, 1948, SEXUAL BEHAVIOR HUMA; KOLLER S, 1942, Z MENSCHL VERERB, V26, P444; KRAFFTEBING R, 1922, PSYCHOPATHIA SEXUALI; Lang Theo, 1945, ARCH JULIUS KLAUS STIJTUNG, V20, P51; London L.S., 1950, SEXUAL DEVIATIONS; Mead Margaret., 2001, MALE AND FEMALE; PRICE B, 1950, AM J HUM GENET, V2, P293; SLATER E, 1950, GENETICAL ASPECTS PE, V6; Stern C., 1949, PRINCIPLES HUMAN GEN	24	85	87	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1952	4	2					136	146						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS397	14943713				2022-12-18	WOS:A1952XS39700006
J	Olsen, RKJ; Konarikova, E; Giancaspero, TA; Mosegaard, S; Boczonadi, V; Matakovic, L; Veauville-Merllie, A; Terrile, C; Schwarzmayr, T; Haack, TB; Auranen, M; Leone, P; Galluccio, M; Imbard, A; Gutierrez-Rios, P; Palmfeldt, J; Graf, E; Vianey-Saban, C; Oppenheim, M; Schiff, M; Pichard, S; Rigal, O; Pyle, A; Chinnery, PF; Konstantopoulou, V; Moslinger, D; Feichtinger, RG; Talim, B; Topaloglu, H; Coskun, T; Gucer, S; Botta, A; Pegoraro, E; Malena, A; Vergani, L; Mazza, D; Zollino, M; Ghezzi, D; Acquaviva, C; Tyni, T; Boneh, A; Meitinger, T; Strom, TM; Gregersen, N; Mayr, JA; Horvath, R; Barile, M; Prokisch, H				Olsen, Rikke K. J.; Konarikova, Eliska; Giancaspero, Teresa A.; Mosegaard, Signe; Boczonadi, Veronika; Matakovic, Lavinija; Veauville-Merllie, Alice; Terrile, Caterina; Schwarzmayr, Thomas; Haack, Tobias B.; Auranen, Mari; Leone, Piero; Galluccio, Michele; Imbard, Apolline; Gutierrez-Rios, Purificacion; Palmfeldt, Johan; Graf, Elisabeth; Vianey-Saban, Christine; Oppenheim, Marcus; Schiff, Manuel; Pichard, Samia; Rigal, Odile; Pyle, Angela; Chinnery, Patrick F.; Konstantopoulou, Vassiliki; Moslinger, Dorothea; Feichtinger, Rene G.; Talim, Beril; Topaloglu, Haluk; Coskun, Turgay; Gucer, Safak; Botta, Annalisa; Pegoraro, Elena; Malena, Adriana; Vergani, Lodovica; Mazza, Daniela; Zollino, Marcella; Ghezzi, Daniele; Acquaviva, Cecile; Tyni, Tiina; Boneh, Avihu; Meitinger, Thomas; Strom, Tim M.; Gregersen, Niels; Mayr, Johannes A.; Horvath, Rita; Barile, Maria; Prokisch, Holger			Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; VIALETTO-VAN LAERE; OVER-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; ESCHERICHIA-COLI; ISOFORM 2; MITOCHONDRIA; DISEASE; SYNTHETASE; COFACTORS	Multiple acyl-CoA dehydrogenase deficiencies (MADDs) are a heterogeneous group of metabolic disorders with combined respiratory-chain deficiency and a neuromuscular phenotype. Despite recent advances in understanding the genetic basis of MADD, a number of cases remain unexplained. Here, we report clinically relevant variants in FLAD1, which encodes FAD synthase (FADS), as the cause of MADD and respiratory-chain dysfunction in nine individuals recruited from metabolic centers in six countries. In most individuals, we identified biallelic frameshift variants in the molybdopterin binding (MPTb) domain, located upstream of the FADS domain. Inasmuch as FADS is essential for cellular supply of FAD cofactors, the finding of biallelic frameshift variants was unexpected. Using RNA sequencing analysis combined with protein mass spectrometry, we discovered FLAD1 isoforms, which only encode the FADS domain. The existence of these isoforms might explain why affected individuals with biallelic FLAD1 frameshift variants still harbor substantial FADS activity. Another group of individuals with a milder phenotype responsive to riboflavin were shown to have single amino acid changes in the FADS domain. When produced in E. coli, these mutant FADS proteins resulted in impaired but detectable FADS activity; for one of the variant proteins, the addition of FAD significantly improved protein stability, arguing for a chaperone-like action similar to what has been reported in other riboflavin-responsive inborn errors of metabolism. In conclusion, our studies identify FLAD1 variants as a cause of potentially treatable inborn errors of metabolism manifesting with MADD and shed light on the mechanisms by which FADS ensures cellular FAD homeostasis.	[Olsen, Rikke K. J.; Mosegaard, Signe; Palmfeldt, Johan] Aarhus Univ, Dept Clin Med, Res Unit Mol Med, DK-8200 Aarhus N, Denmark; [Olsen, Rikke K. J.; Mosegaard, Signe; Palmfeldt, Johan] Aarhus Univ Hosp, DK-8200 Aarhus N, Denmark; [Konarikova, Eliska; Schwarzmayr, Thomas; Haack, Tobias B.; Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Konarikova, Eliska; Terrile, Caterina; Schwarzmayr, Thomas; Haack, Tobias B.; Graf, Elisabeth; Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Munich, Germany; [Giancaspero, Teresa A.; Leone, Piero; Barile, Maria] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Boczonadi, Veronika; Pyle, Angela; Horvath, Rita] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Matakovic, Lavinija; Feichtinger, Rene G.] Paracelsus Med Univ, SALK Salzburg, Dept Paediat, A-5020 Salzburg, Austria; [Veauville-Merllie, Alice; Vianey-Saban, Christine; Acquaviva, Cecile] Ctr Hosp Univ Lyon, Serv Malad Hereditaires Metab & Depistage Neonata, Ctr Biol & Pathol Est, F-69500 Bron, France; [Auranen, Mari] Univ Helsinki, Neurol, Clin Neurosci, Helsinki 340, Finland; [Auranen, Mari] Helsinki Univ Hosp, Helsinki 340, Finland; [Galluccio, Michele] Univ Calabria, Dept DiBEST Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy; [Imbard, Apolline; Rigal, Odile] Robert Debre Hosp, Biochem Hormonol Lab, F-75019 Paris, France; [Imbard, Apolline] Univ Paris 11, Fac Pharm, F-92019 Chatenay Malabry, France; [Gutierrez-Rios, Purificacion] Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Oppenheim, Marcus] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WCIN 3BG, England; [Schiff, Manuel] Hop Robert Debre, INSERM, UMR 1141, F-75019 Paris, France; [Schiff, Manuel; Pichard, Samia] Hop Robert Debre, AP HP, Reference Ctr Inherited Metab Dis, F-75019 Paris, France; [Schiff, Manuel] Univ Paris 07, Fac Med Denis Diderot, F-75013 Paris, France; [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Konstantopoulou, Vassiliki; Moslinger, Dorothea] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria; [Talim, Beril; Gucer, Safak] Hacettepe Univ, Childrens Hosp, Dept Pediat, Pathol Unit, TR-06100 Ankara, Turkey; [Topaloglu, Haluk] Hacettepe Univ, Childrens Hosp, Dept Pediat, Neurol Unit, TR-06100 Ankara, Turkey; [Coskun, Turgay] Hacettepe Univ, Childrens Hosp, Dept Pediat, Metab Unit, TR-06100 Ankara, Turkey; [Botta, Annalisa] Univ Roma Tor Vergata, Med Genet Sect, Dept Biomed & Prevent, I-00133 Rome, Italy; [Pegoraro, Elena; Malena, Adriana; Vergani, Lodovica] Univ Padua, Dept Neurosci, Neuromuscular Ctr, I-35129 Padua, Italy; [Mazza, Daniela; Zollino, Marcella] Univ Cattolica Sacro Cuore, Italy Inst Med Genet, I-00168 Rome, Italy; [Ghezzi, Daniele] Fdn IRCCS Neurol Inst C Besta, Mol Neurogenet Unit, I-20126 Milan, Italy; [Tyni, Tiina] Univ Helsinki, Cent Hosp, Hosp Children & Adolescence, Dept Pediat Neurol, Helsinki 280, Finland; [Boneh, Avihu] Murdoch Childrens Res Inst, Melbourne, Vic 3010, Australia; [Boneh, Avihu] Univ Melbourne, Melbourne, Vic 3010, Australia	Aarhus University; Aarhus University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universita degli Studi di Bari Aldo Moro; Newcastle University - UK; Paracelsus Private Medical University; CHU Lyon; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Calabria; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; Medical University of Vienna; Hacettepe University; Hacettepe University; Hacettepe University; University of Rome Tor Vergata; University of Padua; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Helsinki; Helsinki University Central Hospital; Murdoch Children's Research Institute; University of Melbourne	Olsen, RKJ (corresponding author), Aarhus Univ, Dept Clin Med, Res Unit Mol Med, DK-8200 Aarhus N, Denmark.; Olsen, RKJ (corresponding author), Aarhus Univ Hosp, DK-8200 Aarhus N, Denmark.; Barile, M (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy.	rikke.olsen@clin.au.dk; maria.barile@uniba.it	Schiff, Manuel/G-3596-2017; Galluccio, Michele/AAA-3972-2020; TOPALOGLU, HALUK AYDIN/I-9318-2013; Mazzà, Daniela/AAK-3687-2021; Koňaříková, Eliška/AAG-4073-2021; Meitinger, Thomas/O-1318-2015; Galluccio, Michele/AAE-1478-2021; BOTTA, ANNALISA/AAD-1581-2022; Zollino, Marcella/AAC-3891-2022; botta, annalisa/AAB-8680-2019; Ghezzi, Daniele/J-7873-2016; Horvath, Rita/AAY-7042-2020; Barile, Maria/R-6171-2016	Schiff, Manuel/0000-0001-8272-232X; Galluccio, Michele/0000-0001-6268-9489; Mazzà, Daniela/0000-0003-4754-9394; Koňaříková, Eliška/0000-0001-7365-5006; BOTTA, ANNALISA/0000-0003-4031-5624; Zollino, Marcella/0000-0003-4871-9519; Ghezzi, Daniele/0000-0002-6564-3766; Horvath, Rita/0000-0002-9841-170X; Palmfeldt, Johan/0000-0001-5585-639X; Giancaspero, Teresa Anna/0000-0002-3293-7426; Olsen, Rikke/0000-0003-3470-5589; Barile, Maria/0000-0001-5025-551X; Meitinger, Thomas/0000-0002-8838-8403; Leone, Piero/0000-0001-5649-6031; Chinnery, Patrick/0000-0002-7065-6617; Mayr, Johannes/0000-0001-6970-336X; Mosegaard, Signe/0000-0002-4561-1978; Prokisch, Holger/0000-0003-2379-6286	Aarhus County Research Initiative; Danish Council of Independent Medical Research [4004-00548]; John and Birthe Meyer Foundation; European Commission [GA 317433]; Neuromuscular Research Association Angela Maria Nieddu; Telethon Genetic BioBank [GTB12001D]; EuroBioBank network; Telethon Foundation [GGP15041]; Italian Ministry of Health [GR2010-2316392]; Programma Operativo Nazionale "Ricerca e Competitivita" [01_00937]; European Research Council [309548]; UK Medical Research Council [G1000848]; German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET) [01GM1113C]; E-Rare project GENOMIT [01GM1207]; Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; Medical Research Council [G1000848] Funding Source: researchfish; MRC [G1000848] Funding Source: UKRI	Aarhus County Research Initiative; Danish Council of Independent Medical Research; John and Birthe Meyer Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Neuromuscular Research Association Angela Maria Nieddu; Telethon Genetic BioBank(Fondazione Telethon); EuroBioBank network; Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Programma Operativo Nazionale "Ricerca e Competitivita"(Ministry of Education, Universities and Research (MIUR)); European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET)(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; Juniorverbund in der Systemmedizin "mitOmics"; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all affected individuals and their families for their participation and for providing important samples for the present research study. We thank Dr. Francesco De Cillis for his participation in the early stages of this work, Dr. James Pitt for biochemical evaluation of individuals S1a and S1b, Dr. Norma Romero for muscle histology analysis of individual S7, and Dr. Maria Teresa Balsimelli, Dr. Carla Cozzolino, Prof. Vincenzo Nigro, and Dr. Filippo Maria Santorelli for their clinical care and biochemical evaluation of individual S6. The study was supported by the Aarhus County Research Initiative, the Danish Council of Independent Medical Research (4004-00548 to R.K.J.O.), the John and Birthe Meyer Foundation (N.G.), the European Commission FP7-PEOPLE-ITN Mitochondrial European Educational Training Project (GA 317433 to R.H., J.A.M., and H.P.), the Neuromuscular Research Association Angela Maria Nieddu (L.V.), the Telethon Genetic BioBank (GTB12001D to E.P.), the EuroBioBank network (E.P.), the Telethon Foundation (grant GGP15041 to D.G.), the Italian Ministry of Health (GR2010-2316392 to D.G.), the Programma Operativo Nazionale "Ricerca e Competitivita" 2007-2013 (01_00937 to M.B.), the European Research Council (309548 to R.H.), the UK Medical Research Council (G1000848 to R.H.), the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET; 01GM1113C to T.M. and H.P.), the E-Rare project GENOMIT (01GM1207 to T.M. and H.P.), and the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C to T.B.H.).	Ardissone A, 2015, MOLEC GENET METAB RE, V5, P51, DOI 10.1016/j.ymgmr.2015.10.006; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Barile M, 2013, CURR PHARM DESIGN, V19, P2649, DOI 10.2174/1381612811319140014; Bosch AM, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-83; Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; Carrozzo R, 2014, MITOCHONDRION, V18, P49, DOI 10.1016/j.mito.2014.09.006; Cornelius N, 2012, HUM MOL GENET, V21, P3435, DOI 10.1093/hmg/dds175; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P113, DOI 10.1016/j.cbi.2006.05.010; Fernandez-Guerra P, 2014, MOL GENET GENOM MED, V2, P383, DOI 10.1002/mgg3.88; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; Gianazza E, 2006, ELECTROPHORESIS, V27, P1182, DOI 10.1002/elps.200500687; Giancaspero TA, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00030; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; Giancaspero TA, 2015, BIOCHEM BIOPH RES CO, V465, P443, DOI 10.1016/j.bbrc.2015.08.035; Giancaspero TA, 2013, J BIOL CHEM, V288, P29069, DOI 10.1074/jbc.M113.500066; Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006; Grunert SC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0117-5; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Haack TB, 2012, J INHERIT METAB DIS, V35, P943, DOI 10.1007/s10545-012-9513-y; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Hansen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026634; Henriques BJ, 2010, BBA-MOL BASIS DIS, V1802, P1070, DOI 10.1016/j.bbadis.2010.07.015; Henriques BJ, 2009, J BIOL CHEM, V284, P4222, DOI 10.1074/jbc.M805719200; Higgins CL, 2005, PROTEIN PEPTIDE LETT, V12, P165, DOI 10.2174/0929866053005782; Ho G, 2011, HUM MUTAT, V32, pE1976, DOI 10.1002/humu.21399; Horvath R, 2012, J INHERIT METAB DIS, V35, P679, DOI 10.1007/s10545-011-9434-1; Johnson JO, 2012, BRAIN, V135, P2875, DOI 10.1093/brain/aws161; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kisslov I, 2014, MOL BIOL EVOL, V31, P2770, DOI 10.1093/molbev/msu221; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Lienhart WD, 2013, ARCH BIOCHEM BIOPHYS, V535, P150, DOI 10.1016/j.abb.2013.02.015; Liuzzi VC, 2012, BBA-GEN SUBJECTS, V1820, P521, DOI 10.1016/j.bbagen.2012.01.012; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; McCormick DB, 2000, J NUTR, V130, p323S, DOI 10.1093/jn/130.2.323S; Miccolis A, 2014, BBA-PROTEINS PROTEOM, V1844, P2086, DOI 10.1016/j.bbapap.2014.08.005; Miccolis A, 2012, INT J MOL SCI, V13, P16880, DOI 10.3390/ijms131216880; NAGAO M, 1992, J BIOL CHEM, V267, P17925; Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135; Olsen RKJ, 2014, HUM MUTAT, V35, P86, DOI 10.1002/humu.22455; Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226; Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROSS NS, 1992, BIOFACTORS, V3, P185; SAIJO T, 1995, J BIOL CHEM, V270, P1899, DOI 10.1074/jbc.270.4.1899; Schiff M, 2016, NEW ENGL J MED, V374, P795, DOI 10.1056/NEJMc1513610; Schiff M, 2015, HUM MOL GENET, V24, P3238, DOI 10.1093/hmg/ddv074; SPEEK AJ, 1982, J CHROMATOGR, V228, P311, DOI 10.1016/S0378-4347(00)80446-6; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Torchetti EM, 2011, FEBS J, V278, P4435, DOI 10.1111/j.1742-4658.2011.08368.x; Torchetti EM, 2010, MITOCHONDRION, V10, P263, DOI 10.1016/j.mito.2009.12.149; VEITCH K, 1989, BIOCHIM BIOPHYS ACTA, V1006, P335, DOI 10.1016/0005-2760(89)90021-0; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Wen B, 2010, J NEUROL NEUROSUR PS, V81, P231, DOI 10.1136/jnnp.2009.176404; Yonezawa A, 2013, MOL ASPECTS MED, V34, P693, DOI 10.1016/j.mam.2012.07.014	57	84	89	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1130	1145		10.1016/j.ajhg.2016.04.006	http://dx.doi.org/10.1016/j.ajhg.2016.04.006			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27259049	Green Published, hybrid			2022-12-18	WOS:000377286000008
J	Gerber, S; Alzayady, KJ; Burglen, L; Bremond-Gignac, D; Marchesin, V; Roche, O; Rio, M; Funalot, B; Calmon, R; Durr, A; Gil-Da-Silva-Lopes, VL; Bittar, MFR; Orssaud, C; Heron, B; Ayoub, E; Berquin, P; Bahi-Buisson, N; Bole, C; Masson, C; Munnich, A; Simons, M; Delous, M; Dollfus, H; Boddaert, N; Lyonnet, S; Kaplan, J; Calvas, P; Yule, DI; Rozet, JM; Taie, LF				Gerber, Sylvie; Alzayady, Kamil J.; Burglen, Lydie; Bremond-Gignac, Dominique; Marchesin, Valentina; Roche, Olivier; Rio, Marlene; Funalot, Benoit; Calmon, Raphael; Durr, Alexandra; Gil-da-Silva-Lopes, Vera Lucia; Ribeiro Bittar, Maria Fernanda; Orssaud, Christophe; Heron, Benedicte; Ayoub, Edward; Berquin, Patrick; Bahi-Buisson, Nadia; Bole, Christine; Masson, Cecile; Munnich, Arnold; Simons, Matias; Delous, Marion; Dollfus, Helene; Boddaert, Nathalie; Lyonnet, Stanislas; Kaplan, Josseline; Calvas, Patrick; Yule, David I.; Rozet, Jean-Michel; Taie, Lucas Fares			Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CA2+ RELEASE CHANNELS; MENTAL-RETARDATION; CEREBELLAR-ATAXIA; SPINOCEREBELLAR ATAXIA; PARTIAL ANIRIDIA; MISSENSE MUTATIONS; NONSENSE MUTATION; MOLECULAR-CLONING; PAX6 GENE	Gillespie syndrome (GS) is a rare variant form of aniridia characterized by non-progressive cerebellar ataxia, intellectual disability, and iris hypoplasia. Unlike the more common dominant and sporadic forms of aniridia, there has been no significant association with PAX6 mutations in individuals with GS and the mode of inheritance of the disease had long been regarded as uncertain. Using a combination of trio-based whole-exome sequencing and Sanger sequencing in five simplex GS-affected families, we found homozygous or compound heterozygous truncating mutations (c.4672C>T [p.Gln1558*], c.2182C>T [p.Arg728*], c.6366_3A>T [p.Gly2102Valfs5*], and c.6664_5G>T [p.Ala2221Valfs23*]) and de novo heterozygous mutations (c.7687_7689del [p.Lys2563del] and c.7659T>G [p.Phe2553Leu]) in the inositol 1,4,5-trisphosphate receptor type 1 gene (ITPR1). ITPR1 encodes one of the three members of the IP3-receptors family that form Ca2+ release channels localized predominantly in membranes of endoplasmic reticulum Ca2+ stores. The truncation mutants, which encompass the IP3-binding domain and varying lengths of the modulatory domain, did not form functional channels when produced in a heterologous cell system. Furthermore, ITPR1 p.Lys2563del mutant did not form IP3-induced Ca2+ channels but exerted a negative effect when co-produced with wild-type ITPR1 channel activity. In total, these results demonstrate biallelic and monoallelic ITPR1 mutations as the underlying genetic defects for Gillespie syndrome, further extending the spectrum of ITPR1-related diseases.	[Gerber, Sylvie; Kaplan, Josseline; Rozet, Jean-Michel; Taie, Lucas Fares] Paris Descartes Univ, Imagine Inst Genet Dis, INSERM, LGO,UMR1163, F-75015 Paris, France; [Alzayady, Kamil J.; Ayoub, Edward; Yule, David I.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14526 USA; [Burglen, Lydie] Trousseau Hosp, AP HP, Reference Ctr Cerebellar Malformat & Congenital D, Dept Genet, F-75012 Paris, France; [Burglen, Lydie] Robert Debre Hosp, INSERM, DHU PROTECT, U1141, F-75019 Paris, France; [Bremond-Gignac, Dominique; Roche, Olivier; Orssaud, Christophe] Paris Descartes Univ, IHU Necker Enfants Malades, Dept Ophthalmol, F-75015 Paris, France; [Marchesin, Valentina; Simons, Matias] Paris Descartes Univ, INSERM, Imagine Inst Genet Dis,UMR1163, Epithelial Biol & Dis Liliane Bettencourt Chair D, F-75015 Paris, France; [Rio, Marlene; Funalot, Benoit; Munnich, Arnold; Lyonnet, Stanislas] Univ Paris 05, IHU Necker Enfants Malades, Dept Genet, F-75015 Paris, France; [Funalot, Benoit] GHU Henri Mondor, Dept Genet, F-94010 Creteil, France; [Calmon, Raphael; Boddaert, Nathalie] Paris Descartes Univ, IHU Necker Enfants Malades, Dept Neuroradiol, F-75015 Paris, France; [Calmon, Raphael; Boddaert, Nathalie] Paris Descartes Univ, Imagine Inst Genet Dis, INSERM, Image Imagine,UMR1163, F-75015 Paris, France; [Durr, Alexandra] Hop La Pitie Salpetriere, CHU Paris GH La Pitie Salpetriere Charles Foix, Inst Cerveau & Moelle Epiniere, Malad Neurodegenerat, F-75013 Paris, France; [Gil-da-Silva-Lopes, Vera Lucia; Ribeiro Bittar, Maria Fernanda] Univ Estadual Campinas, Fac Med Sci, Dept Med Genet, BR-13083887 Sao Paulo, Brazil; [Heron, Benedicte] Hop Trousseau, Dept Neuropediat, F-75012 Paris, France; [Heron, Benedicte] Hop Jean Verdier, Dept Pediat, F-93143 Bondy, France; [Berquin, Patrick] CHU Amiens, Hop Nord, Ctr Act Neurol Pediat, Pole Pediat, F-80054 Amiens 1, France; [Bahi-Buisson, Nadia; Lyonnet, Stanislas] Paris Descartes Univ, Imagine Inst Genet Dis, INSERM, Embryol & Genet Human Malformat,UMR1163, F-75015 Paris, France; [Bole, Christine] Paris Descartes Univ, Imagine Inst Genet Dis, INSERM, Genom Platform,UMR1163, F-75015 Paris, France; [Masson, Cecile] Paris Descartes Univ, Imagine Inst Genet Dis, INSERM, Bioinformat Platform,UMR1163, F-75015 Paris, France; [Delous, Marion] Paris Descartes Univ, Imagine Inst Genet Dis, INSERM, Lab Hereditary Kidney Dis,UMR1163, F-75015 Paris, France; [Dollfus, Helene] Univ Strasbourg, INSERM, FMTS, Inst Genet Med Alsace,Lab Genet Med,U1112, F-67085 Strasbourg, France; [Calvas, Patrick] Hop Purpan, Serv Genet Clin, F-31300 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Rochester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidade Estadual de Campinas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse	Rozet, JM (corresponding author), Paris Descartes Univ, Imagine Inst Genet Dis, INSERM, LGO,UMR1163, F-75015 Paris, France.	jean-michel.rozet@inserm.fr	Gil-da-Silva-Lopes, Vera Lúcia L/G-2453-2012; Orssaud, Christophe/ACM-6549-2022; boddaert, nathalie/GWV-2865-2022; ROZET, Jean-Michel/E-5737-2016; Delous, Marion/H-3850-2017; Simons, Matias/I-2038-2017; Lyonnet, Stanislas/H-5483-2017; Delous, Marion/Q-1835-2019; Bahi-Buisson, Nadia/H-5207-2017; KAPLAN, Josseline/I-2622-2017; FARES TAIE, Lucas/H-2940-2017	Gil-da-Silva-Lopes, Vera Lúcia L/0000-0003-1288-0554; ROZET, Jean-Michel/0000-0001-7951-7886; Delous, Marion/0000-0003-2666-4457; Simons, Matias/0000-0003-3959-6350; Lyonnet, Stanislas/0000-0001-5426-9417; Delous, Marion/0000-0003-2666-4457; boddaert, nathalie/0000-0003-0991-7774; Dollfus, Helene/0000-0002-2249-895X; AYOUB, EDWARD/0000-0003-1321-0114; Rio, Marlene/0000-0003-2049-5058; Bahi-Buisson, Nadia/0000-0002-5352-0929; GERBER, Sylvie/0000-0002-6827-1769; BREMOND-GIGNAC, Dominique/0000-0002-3563-5482; Funalot, Benoit/0000-0001-6352-6518; KAPLAN, Josseline/0000-0002-1849-8658; FARES TAIE, Lucas/0000-0002-4613-0711	Federation des Aveugles de France (FAF); Retina France; Geniris; NIH [DE19245, DE14756]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019245, R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014756] Funding Source: NIH RePORTER	Federation des Aveugles de France (FAF); Retina France; Geniris; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to the families for their participation in the study. This work was supported by grants from the Federation des Aveugles de France (FAF) to L.F.T., Retina France to J.M.R., and Geniris to J.M.R. and P.C. K.J.A. and D.I.Y. were supported by NIH grants DE19245 and DE14756.	Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agarwal PK, 2009, J PEDIAT OPHTH STRAB, V46, P317, DOI 10.3928/01913913-20090903-12; Alzayady KJ, 2013, J BIOL CHEM, V288, P11122, DOI 10.1074/jbc.M113.453241; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bhatia S, 2013, AM J HUM GENET, V93, P1126, DOI 10.1016/j.ajhg.2013.10.028; Boughamoura L, 2006, ARCH PEDIATRIE, V13, P1323, DOI 10.1016/j.arcped.2006.06.028; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cassao BD, 2013, J NEUROGASTROENTEROL, V19, P538, DOI 10.5056/jnm.2013.19.4.538; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Dollfus H, 1998, AM J OPHTHALMOL, V125, P397, DOI 10.1016/S0002-9394(99)80157-3; Donald KA, 2006, J CHILD NEUROL, V21, P337, DOI 10.1177/08830738060210040201; Drivas TG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5370; Eden U, 2008, ACTA OPHTHALMOL, V86, P730, DOI 10.1111/j.1755-3768.2008.01310.x; Forman OP, 2015, MAMM GENOME, V26, P108, DOI 10.1007/s00335-014-9547-6; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FRANCOIS J, 1984, KLIN MONATSBL AUGENH, V184, P313, DOI 10.1055/s-2008-1054475; FUJINO I, 1995, CELL TISSUE RES, V280, P201, DOI 10.1007/BF00307790; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; GILLESPIE FD, 1965, ARCH OPHTHALMOL-CHIC, V73, P338; GLASER T, 1994, GENOMICS, V19, P145, DOI 10.1006/geno.1994.1024; Graziano C, 2007, AM J MED GENET A, V143A, P1802, DOI 10.1002/ajmg.a.31808; HASAN G, 1992, DEVELOPMENT, V116, P967; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Huang LJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-67; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P3646, DOI 10.1167/iovs.09-5074; Marelli C, 2011, ARCH NEUROL-CHICAGO, V68, P637, DOI 10.1001/archneurol.2011.81; Marien P, 2008, CORTEX, V44, P54, DOI 10.1016/j.cortex.2005.12.001; Matsumoto M, 1999, J MOL MED, V77, P406, DOI 10.1007/s001090050370; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; McEntagart M, 2016, AM J HUM GENET, V98, P981, DOI 10.1016/j.ajhg.2016.03.018; Mikoshiba Katsuhiko, 2015, Adv Biol Regul, V57, P217, DOI 10.1016/j.jbior.2014.10.001; Nelson J, 1997, AM J MED GENET, V71, P134, DOI 10.1002/(SICI)1096-8628(19970808)71:2<134::AID-AJMG3>3.3.CO;2-K; NEVIN NC, 1990, AM J MED GENET, V35, P468, DOI 10.1002/ajmg.1320350404; NUCIFORA FC, 1995, MOL BRAIN RES, V32, P291, DOI 10.1016/0169-328X(95)00089-B; QUARRELL O, 1993, BRIT J OPHTHALMOL, V77, P827, DOI 10.1136/bjo.77.12.827-c; RAGHU P, 1995, DEV BIOL, V171, P564, DOI 10.1006/dbio.1995.1305; Rozet JM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6504; Sasaki M, 2015, J NEUROL, V262, P1278, DOI 10.1007/s00415-015-7705-8; Schnekenberg RP, 2015, BRAIN, V138, P1817, DOI 10.1093/brain/awv117; Street VA, 1997, J NEUROSCI, V17, P635; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sugawara T, 2013, J NEUROSCI, V33, P12186, DOI 10.1523/JNEUROSCI.0545-13.2013; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Ticho BH, 2006, OPHTHALMIC GENET, V27, P145, DOI 10.1080/13816810600976897; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Luquetti DV, 2007, OPHTHALMIC GENET, V28, P89, DOI 10.1080/13816810701209495; Verhulst S, 1993, Bull Soc Belge Ophtalmol, V250, P37; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; WITTIG EO, 1988, AM J MED GENET, V30, P703, DOI 10.1002/ajmg.1320300302; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P16613; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	54	84	88	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					971	980		10.1016/j.ajhg.2016.03.004	http://dx.doi.org/10.1016/j.ajhg.2016.03.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27108797	Bronze, Green Published			2022-12-18	WOS:000375869300014
J	Smith, EM; Lajoie, BR; Jain, G; Dekker, J				Smith, Emily M.; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job			Invariant TAD Boundaries Constrain Cell-Type-Specific Looping Interactions between Promoters and Distal Elements around the CFTR Locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME CONFORMATION; GENE-EXPRESSION; CHROMATIN ARCHITECTURE; HYPERSENSITIVE SITES; TOPOLOGICAL DOMAINS; INSULATOR FUNCTION; HUMAN GENOME; ORGANIZATION; MECHANISMS; PRINCIPLES	Three-dimensional genome structure plays an important role in gene regulation. Globally, chromosomes are organized into active and inactive compartments while, at the gene level, looping interactions connect promoters to regulatory elements. Topologically associating domains (TADs), typically several hundred kilobases in size, form an intermediate level of organization. Major questions include how TADs are formed and how they are related to looping interactions between genes and regulatory elements. Here we performed a focused 5C analysis of a 2.8 Mb chromosome 7 region surrounding CFTR in a panel of cell types. We find that the same TAD boundaries are present in all cell types, indicating that TADs represent a universal chromosome architecture. Furthermore, we find that these TAD boundaries are present irrespective of the expression and looping of genes located between them. In contrast, looping interactions between promoters and regulatory elements are cell-type specific and occur mostly within TADs. This is exemplified by the CFTR promoter that in different cell types interacts with distinct sets of distal cell-type-specific regulatory elements that are all located within the same TAD. Finally, we find that long-range associations between loci located in different TADs are also detected, but these display much lower interaction frequencies than looping interactions within TADs. Interestingly, interactions between TADs are also highly cell-type-specific and often involve loci clustered around TAD boundaries. These data point to key roles of invariant TAD boundaries in constraining as well as mediating cell-type-specific long-range interactions and gene regulation.	[Smith, Emily M.; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Program Syst Biol, Worcester, MA 01605 USA; [Dekker, Job] Howard Hughes Med Inst, New York, NY 10032 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Program Syst Biol, 368 Plantat St, Worcester, MA 01605 USA.	job.dekker@umassmed.edu			National Human Genome Research Institute [HG003143, HG007010]; Human Frontier Science Project Organization; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, U54HG007010] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Human Frontier Science Project Organization(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Work in the Dekker lab is supported by the National Human Genome Research Institute (grants HG003143, HG007010) and the Human Frontier Science Project Organization. J.D. is an investigator of the Howard Hughes Medical Institute.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackledge NP, 2007, BIOCHEM J, V408, P267, DOI 10.1042/BJ20070429; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-25; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Doyle B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003867; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ferraiuolo MA, 2012, METHODS, V58, P255, DOI 10.1016/j.ymeth.2012.10.011; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Gheldof N, 2010, NUCLEIC ACIDS RES, V38, P4325, DOI 10.1093/nar/gkq175; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Gosalia N, 2014, NUCLEIC ACIDS RES, V42, P9612, DOI 10.1093/nar/gku648; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Iborra FJ, 1996, J CELL SCI, V109, P1427; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; McCarthy VA, 2005, PEDIATR PULM, V40, P1, DOI 10.1002/ppul.20199; Miele A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000478; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Naumova N, 2012, METHODS, V58, P192, DOI 10.1016/j.ymeth.2012.07.022; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nuthall HN, 1999, BIOCHEM J, V341, P601, DOI 10.1042/0264-6021:3410601; Ott CJ, 2009, P NATL ACAD SCI USA, V106, P19934, DOI 10.1073/pnas.0900946106; Ott CJ, 2009, BIOCHEM SOC T, V37, P843, DOI 10.1042/BST0370843; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhang ZL, 2015, AM J RESP CELL MOL, V52, P387, DOI 10.1165/rcmb.2014-0263OC; Zhang ZL, 2013, MOL CELL BIOL, V33, P2843, DOI 10.1128/MCB.00003-13; Zhang ZL, 2012, J CELL MOL MED, V16, P1321, DOI 10.1111/j.1582-4934.2011.01439.x; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	67	84	85	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					185	201		10.1016/j.ajhg.2015.12.002	http://dx.doi.org/10.1016/j.ajhg.2015.12.002			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26748519	Green Published, Bronze			2022-12-18	WOS:000368050800013
J	Ollila, HM; Ravel, JM; Han, F; Faraco, J; Lin, L; Zheng, XW; Plazzi, G; Dauvilliers, Y; Pizza, F; Hong, SC; Jennum, P; Knudsen, S; Kornum, BR; Dong, XS; Yan, H; Hong, H; Coquillard, C; Mahlios, J; Jolanki, O; Einen, M; Lavault, S; Hogl, B; Frauscher, B; Crowe, C; Partinen, M; Huang, YS; Bourgin, P; Vaarala, O; Desautels, A; Montplaisir, J; Mack, SJ; Mindrinos, M; Fernandez-Vina, M; Mignot, E				Ollila, Hanna M.; Ravel, Jean-Marie; Han, Fang; Faraco, Juliette; Lin, Ling; Zheng, Xiuwen; Plazzi, Giuseppe; Dauvilliers, Yves; Pizza, Fabio; Hong, Seung-Chul; Jennum, Poul; Knudsen, Stine; Kornum, Birgitte R.; Dong, Xiao Song; Yan, Han; Hong, Heeseung; Coquillard, Cristin; Mahlios, Joshua; Jolanki, Otto; Einen, Mali; Lavault, Sophie; Hoegl, Birgit; Frauscher, Birgit; Crowe, Catherine; Partinen, Markku; Huang, Yu Shu; Bourgin, Patrice; Vaarala, Outi; Desautels, Alex; Montplaisir, Jacques; Mack, Steven J.; Mindrinos, Michael; Fernandez-Vina, Marcelo; Mignot, Emmanuel			HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DIABETES GENETICS CONSORTIUM; MULTIPLE-SCLEROSIS; ETHNIC-GROUPS; HEPATITIS-B; SUSCEPTIBILITY; VACCINATION; ALLELES; ONSET; POPULATION	Type 1 narcolepsy, a disorder caused by a lack of hypocretin (orexin), is so strongly associated with human leukocyte antigen (HLA) class II HLA-DQA1*01:02-DQB1*06:02 (DQ0602) that very few non-DQ0602 cases have been reported. A known triggering factor for narcolepsy is pandemic 2009 influenza H1N1, suggesting autoimmunity triggered by upper-airway infections. Additional effects of other HLA-DQ alleles have been reported consistently across multiple ethnic groups. Using over 3,000 case and 10,000 control individuals of European and Chinese background, we examined the effects of other HLA loci. After careful matching of HLA-DR and HLA-DQ in case and control individuals, we found strong protective effects of HLA-DPA1*01:03-DPB1*04:02 (DP0402; odds ratio [OR] = 0.51 [0.38-0.67], p = 1.01 x 10(-6)) and HLA-DPA1*01:03-DPB1*04:01 (DP0401; OR = 0.61 [0.47-0.80], p = 2.07 x 10(-4)) and predisposing effects of HLA-DPB1*05:01 in Asians (OR = 1.76 [1.34-2.31], p = 4.71 x 10(-05)). Similar effects were found by conditional analysis controlling for HLA-DR and HLA-DQ with DP0402 (OR = 0.45 [0.38-0.55] p = 8.99 x 10(-17)) and DP0501 (OR = 1.38 [1.18-1.61], p = 7.11 x 10(-5)). HLA-class-II-independent associations with HLA-A*11:01 (OR = 1.32 [1.13-1.54], p = 4.92 x 10(-4)), HLA-B*35:03 (OR similar to 1.96 [1.41-2.70], p = 5.14 x 10(-5)), and HLA-B*51:01 (OR = 1.49 [1.25-1.78], p = 1.09 x 10(-5)) were also seen across ethnic groups in the HLA class I region. These effects might reflect modulation of autoimmunity or indirect effects of HLA class I and HLA-DP alleles on response to viral infections such as that of influenza.	[Ollila, Hanna M.; Ravel, Jean-Marie; Faraco, Juliette; Lin, Ling; Hong, Heeseung; Mahlios, Joshua; Jolanki, Otto; Einen, Mali; Mignot, Emmanuel] Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Han, Fang; Dong, Xiao Song; Yan, Han] Peking Univ, Peoples Hosp, Dept Pulm Med, Beijing 100044, Peoples R China; [Zheng, Xiuwen] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Plazzi, Giuseppe; Pizza, Fabio] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40123 Bologna, Italy; [Plazzi, Giuseppe; Pizza, Fabio] IRCCS Inst Neurol Sci, I-40139 Bologna, Italy; [Dauvilliers, Yves] Ctr Hosp Reg Univ Montpellier, Gui de Chauliac Hosp, Dept Neurol, INSERM U1061,Reference Ctr Narcolepsy,Sleep Wake, F-34090 Montpellier, France; [Hong, Seung-Chul] Catholic Univ Korea, St Vincents Hosp, Dept Psychiat, Suwon 442723, South Korea; [Jennum, Poul; Kornum, Birgitte R.] Univ Copenhagen, Glostrup Hosp, Dept Clin Neurophysiol, Danish Ctr Sleep Med, DK-2600 Glostrup, Denmark; [Knudsen, Stine] Oslo Univ Hosp, Norwegian Resource Ctr ADHD TS & Narcolepsy, N-0450 Ulleval, Norway; [Kornum, Birgitte R.] Glostrup Cty Hosp, Dept Diagnost, Mol Sleep Lab, DK-2600 Glostrup, Denmark; [Coquillard, Cristin; Fernandez-Vina, Marcelo] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94304 USA; [Lavault, Sophie] Ctr Natl Reference Narcolepsie & Hypersomnie, F-75019 Paris, France; [Hoegl, Birgit; Frauscher, Birgit] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Crowe, Catherine] Mater Private Hosp, Dublin 7, Ireland; [Partinen, Markku] Helsinki Sleep Clin, Vitalmed Res Ctr, Helsinki 00420, Finland; [Partinen, Markku] Univ Helsinki, Dept Clin Neurosci, SF-00100 Helsinki, Finland; [Huang, Yu Shu] Chang Gung Mem Hosp & Univ, Taipei 10591, Taiwan; [Bourgin, Patrice] Strasbourg Univ, Strasbourg Univ Hosp, Dept Sleep Med, F-67084 Strasbourg, France; [Vaarala, Outi] Univ Helsinki, Inst Clin Med, SF-00100 Helsinki, Finland; [Desautels, Alex; Montplaisir, Jacques] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H3T 1J4, Canada; [Desautels, Alex] Univ Montreal, Dept Neurosci, Montreal, PQ H3T 1J4, Canada; [Montplaisir, Jacques] Univ Montreal, Dept Psychiat, Montreal, PQ H3T 1J4, Canada; [Mack, Steven J.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Mindrinos, Michael] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Stanford University; Peking University; University of Washington; University of Washington Seattle; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Catholic University of Korea; University of Copenhagen; University of Oslo; University of Copenhagen; Stanford University; Medical University of Innsbruck; Mater Private Hospital; University of Helsinki; Chang Gung Memorial Hospital; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Helsinki; Universite de Montreal; Universite de Montreal; Universite de Montreal; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Stanford University	Mignot, E (corresponding author), Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Knudsen, Stine/O-2358-2017; Lavault, Sophie/GWC-0361-2022; Pizza, Fabio/AAC-1794-2020; Kornum, Birgitte Rahbek/K-9193-2015; Ollila, Hanna M/GQA-6308-2022; Plazzi, Giuseppe/AAB-9627-2020; Ollila, Hanna M/I-8552-2017; Zheng, Xiuwen/J-4047-2019	Knudsen, Stine/0000-0003-1946-1125; Kornum, Birgitte Rahbek/0000-0002-2515-9451; Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Zheng, Xiuwen/0000-0002-1390-0708; Hogl, Birgit/0000-0003-1894-7641; Dauvilliers, yves/0000-0003-0683-6506; PIZZA, FABIO/0000-0003-2294-9551; Fernandez-Vina, Marcelo A./0000-0002-5707-2588; Ravel, Jean-Marie/0000-0001-7038-7341; Lavault, Sophie/0000-0001-6344-6913; Plazzi, Giuseppe/0000-0002-1051-0472; Partinen, Markku/0000-0002-8182-9368	Wake Up Narcolepsy; NIH [NS23724]; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation; Orion-Farmos Research Foundation; 973 Program [2015CB856405]; Wellcome Trust; KORA ( Kooperative Gesundheitsforschung in der Region Augsburg, Germany); Helmholtz Zentrum Munchen-German Research Center for Environmental Health; German Federal Ministry of Education and Ressearch; State of Bavaria;  [NSFC81420108002]; Lundbeck Foundation [R105-2011-9362] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724, P01NS023724] Funding Source: NIH RePORTER	Wake Up Narcolepsy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation; Orion-Farmos Research Foundation; 973 Program(National Basic Research Program of China); Wellcome Trust(Wellcome TrustEuropean Commission); KORA ( Kooperative Gesundheitsforschung in der Region Augsburg, Germany); Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Ressearch; State of Bavaria; ; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the participating subjects, their families, and their physicians. We thank Jing Zhang for technical assistance. We thank collaborators M. Breban, W. M. Chen, P. Concannon, V. Damotte, P. Deloukas, M. Dobrovolna, L. Ehrmann, C. Erhardt, B. Fontaine, P. Geisler, C. Gieger, J. Hallmayer, P. E. Hesla, D. Kemlink, N. Klopp, L. Kolesar, P. Lichtner, S. Nevsimalova, G. T. Nepom, S. Onengut-Gumuscu, F. Poli, S. S. Rich, T. J. Rico, G. Rouleau, K. Sonka, S. D. Thompson, G. Trynka, C. Wijmenga, and J. Winkelmann for genotyping and providing samples for the study. The study was primarily funded by Wake Up Narcolepsy, NIH NS23724, and patient gifts to E. M. Funding to H.M.O. was provided by the Sigrid Juselius Foundation, the Paivikki and Sakari Sohlberg Foundation, and the Orion-Farmos Research Foundation. Funding for the Chinese portion of the study was supported by 973 Program 2015CB856405 and NSFC81420108002 to F. H. We thank the Wellcome Trust (British 1958 Birth Cohort Collection), and KORA (Kooperative Gesundheitsforschung in der Region Augsburg, Germany) for funding control genotypes. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Ressearch and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences, Ludwig-Maximilians-Universitat, as part of LMUinnovativ.	American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S; [Anonymous], 2010, R LANG ENV STAT COMP; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Begovich AB, 2001, TISSUE ANTIGENS, V57, P424, DOI 10.1034/j.1399-0039.2001.057005424.x; Dauvilliers Y, 2004, NEUROLOGY, V62, P2137, DOI 10.1212/WNL.62.11.2137; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; Eerligh P, 2011, GENES IMMUN, V12, P415, DOI 10.1038/gene.2011.24; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2012, TISSUE ANTIGENS, V80, P328, DOI 10.1111/j.1399-0039.2012.01948.x; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hohjoh H, 2001, TISSUE ANTIGENS, V57, P230, DOI 10.1034/j.1399-0039.2001.057003230.x; Hollenbach JA, 2012, IMMUNOGENETICS, V64, P559, DOI 10.1007/s00251-012-0615-3; Hollenbach Jill A, 2012, Methods Mol Biol, V882, P245, DOI 10.1007/978-1-61779-842-9_14; Hong SC, 2002, SLEEP, V25, P440; Hong SC, 2007, HUM IMMUNOL, V68, P59, DOI 10.1016/j.humimm.2006.10.006; HORIKI T, 1994, AUTOIMMUNITY, V19, P49, DOI 10.3109/08916939409008008; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; KWOK WW, 1993, J IMMUNOL, V150, P2263; Link J, 2010, J NEUROIMMUNOL, V226, P172, DOI 10.1016/j.jneuroim.2010.07.006; Luo H, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-21; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Mignot E., 2006, HLA 2004 IMMUNOBIOLO, P817; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Miyagawa T., 2014, HUM MOL GENET; Montplaisir J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108489; Moss AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071376; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nishida N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086449; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Flanagan D, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.17.20789; Ollila H.M., 2014, SLEEP; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pelin Z, 1998, TISSUE ANTIGENS, V51, P96, DOI 10.1111/j.1399-0039.1998.tb02952.x; Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rich SS, 2006, ANN NY ACAD SCI, V1079, P1, DOI 10.1196/annals.1375.001; Roh EY, 2006, HUM IMMUNOL, V67, P749, DOI 10.1016/j.humimm.2006.03.024; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shigetaka S, 2012, PEDIATR DIABETES, V13, P33, DOI 10.1111/j.1399-5448.2011.00833.x; Tafti M, 2014, SLEEP, V37, P19, DOI 10.5665/sleep.3300; Varney MD, 2010, DIABETES, V59, P2055, DOI 10.2337/db09-0680; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Wennerstrom A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079690; Wu HJ, 2014, SLEEP MED, V15, P607, DOI 10.1016/j.sleep.2013.12.012; Wu TW, 2014, GENES IMMUN, V15, P47, DOI 10.1038/gene.2013.62; Wu XM, 2009, MULT SCLER J, V15, P1422, DOI 10.1177/1352458509345905; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	60	84	88	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					136	146		10.1016/j.ajhg.2014.12.010	http://dx.doi.org/10.1016/j.ajhg.2014.12.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25574827	Bronze, Green Published			2022-12-18	WOS:000347707800010
J	Kubo, A; Shiohama, A; Sasaki, T; Nakabayashi, K; Kawasaki, H; Atsugi, T; Sato, S; Shimizu, A; Mikami, S; Tanizaki, H; Uchiyama, M; Maeda, T; Ito, T; Sakabe, J; Heike, T; Okuyama, T; Kosaki, R; Kosaki, K; Kudoh, J; Hata, K; Umezawa, A; Tokura, Y; Ishiko, A; Niizeki, H; Kabashima, K; Mitsuhashi, Y; Amagai, M				Kubo, Akiharu; Shiohama, Aiko; Sasaki, Takashi; Nakabayashi, Kazuhiko; Kawasaki, Hiroshi; Atsugi, Toru; Sato, Showbu; Shimizu, Atsushi; Mikami, Shuji; Tanizaki, Hideaki; Uchiyama, Masaki; Maeda, Tatsuo; Ito, Taisuke; Sakabe, Jun-ichi; Heike, Toshio; Okuyama, Torayuki; Kosaki, Rika; Kosaki, Kenjiro; Kudoh, Jun; Hata, Kenichiro; Umezawa, Akihiro; Tokura, Yoshiki; Ishiko, Akira; Niizeki, Hironori; Kabashima, Kenji; Mitsuhashi, Yoshihiko; Amagai, Masayuki			Mutations in SERPINB7, Encoding a Member of the Serine Protease Inhibitor Superfamily, Cause Nagashima-type Palmoplantar Keratosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PALMAR-PLANTAR KERATODERMA; NETHERTON-SYNDROME; CYSTIC-FIBROSIS; GENE; KERATIN-1; FAMILIES; VORNER; IDENTIFICATION; FILAGGRIN; KINDREDS	"Nagashima-type" palmoplantar keratosis (NPPK) is an autosomal recessive nonsyndromic diffuse palmoplantar keratosis characterized by well-demarcated diffuse hyperkeratosis with redness, expanding on to the dorsal surfaces of the palms and feet and the Achilles tendon area. Hyperkeratosis in NPPK is mild and nonprogressive, differentiating NPPK clinically from Mal de Meleda. We performed whole-exome and/or Sanger sequencing analyses of 13 unrelated NPPK individuals and identified biallelic putative loss-of-function mutations in SERPINB7, which encodes a cytoplasmic member of the serine protease inhibitor superfamily. We identified a major causative mutation of c.796C>T (p.Arg266*) as a founder mutation in Japanese and Chinese populations. SERPINB7 was specifically present in the cytoplasm of the stratum granulosum and the stratum corneum (SC) of the epidermis. All of the identified mutants are predicted to cause premature termination upstream of the reactive site, which inhibits the proteases, suggesting a complete loss of the protease inhibitory activity of SERPINB7 in NPPK skin. On exposure of NPPK lesional skin to water, we observed a whitish spongy change in the SC, suggesting enhanced water permeation into the SC due to overactivation of proteases and a resultant loss of integrity of the SC structure. These findings provide an important framework for developing pathogenesis-based therapies for NPPK.	[Kubo, Akiharu; Shiohama, Aiko; Sasaki, Takashi; Kawasaki, Hiroshi; Atsugi, Toru; Sato, Showbu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan; [Kubo, Akiharu; Sasaki, Takashi; Amagai, Masayuki] Keio Univ, Sch Med, Keio Maruho Lab Skin Barriol, Tokyo 1608582, Japan; [Kubo, Akiharu; Sasaki, Takashi] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan; [Shiohama, Aiko; Amagai, Masayuki] Keio Univ, Sch Med, MSD Endowed Program Allergy Res, Tokyo 1608582, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo 1578535, Japan; [Atsugi, Toru] KOSE Corp, Tokyo 1740051, Japan; [Shimizu, Atsushi] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Mikami, Shuji] Keio Univ Hosp, Div Diagnost Pathol, Tokyo 1608582, Japan; [Tanizaki, Hideaki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Uchiyama, Masaki; Maeda, Tatsuo; Mitsuhashi, Yoshihiko] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan; [Ito, Taisuke; Sakabe, Jun-ichi; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Okuyama, Torayuki] Natl Ctr Child Hlth & Dev, Dept Lab Med, Tokyo 1578535, Japan; [Kosaki, Rika] Natl Ctr Child Hlth & Dev, Dept Clin Genet, Tokyo 1578535, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo 1608582, Japan; [Kudoh, Jun] Keio Univ, Sch Med, Lab Gene Med, Tokyo 1608582, Japan; [Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan; [Ishiko, Akira] Toho Univ, Sch Med, Dept Dermatol, Tokyo 1438540, Japan; [Niizeki, Hironori] Natl Ctr Child Hlth & Dev, Dept Dermatol, Tokyo 1578535, Japan	Keio University; Keio University; Keio University; Keio University; National Center for Child Health & Development - Japan; Keio University; Keio University; Kyoto University; Tokyo Medical University; Hamamatsu University School of Medicine; Kyoto University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Keio University; Keio University; National Center for Child Health & Development - Japan; Toho University; National Center for Child Health & Development - Japan	Kubo, A (corresponding author), Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan.	akiharu@a5.keio.jp	Kubo, Akiharu/I-2711-2014; Sasaki, Takashi/AAD-1461-2019; Amagai, Masayuki/K-5325-2013; Kabashima, Kenji/G-2521-2014	Kubo, Akiharu/0000-0003-0902-3586; Amagai, Masayuki/0000-0003-3314-7052; Atsugi, Toru/0000-0001-6470-9949; Sasaki, Takashi/0000-0002-6275-046X; Uchiyama, Masaki/0000-0002-7162-7885; Sakabe, Jun-Ichi/0000-0002-8237-0472; Kabashima, Kenji/0000-0002-0773-0554	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan [24-5]; Maruho Co., Ltd.; MSD K.K.	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Maruho Co., Ltd.; MSD K.K.(Merck & Company)	We thank our clinical colleagues, and family members who contributed the samples used in this study. We also thank Nobuyo Nishimura, Hiromi Sakuragi, Asami Hirakiyama, Kazunari Shibata, and the Collaborative Research Resources of Keio University School of Medicine for technical support. This work was supported in parts by Health and Labour Sciences Research Grants for Research on Rare and Intractable Diseases, for Research on Allergic Disease and Immunology, and for Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan, The Grant of National Center for Child Health and Development (24-5), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This manuscript is dedicated to the memory of Professor Masaji Nagashima. Potential conflict of interest: M.A. has consultancy arrangements with Daiichi Sankyo Co. A.K., A.S., and T.S. have been supported by one or more grants from MSD K.K. and Maruho Co., Ltd. This work was supported in part by a grant from Maruho Co., Ltd.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Blaydon DC, 2013, AM J HUM GENET, V93, P330, DOI 10.1016/j.ajhg.2013.06.008; Blaydon DC, 2011, AM J HUM GENET, V89, P564, DOI 10.1016/j.ajhg.2011.09.001; Bouadjar B, 2000, ARCH DERMATOL, V136, P1247, DOI 10.1001/archderm.136.10.1247; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Cao X., 2013, J INVEST DE IN PRESS; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Covello SP, 1998, J INVEST DERMATOL, V111, P1207, DOI 10.1046/j.1523-1747.1998.00445.x; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Ehlers E., 1897, ARCH DERM SYPH-BERL, V40, P251; FAY WP, 1992, NEW ENGL J MED, V327, P1729, DOI 10.1056/NEJM199212103272406; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; Gach JE, 2005, J AM ACAD DERMATOL, V53, pS225, DOI 10.1016/j.jaad.2005.01.139; Garcon-Michel N, 2010, BRIT J DERMATOL, V163, P162, DOI 10.1111/j.1365-2133.2010.09764.x; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GREITHER A, 1952, Hautarzt, V3, P198; HAMM H, 1988, DERMATOLOGICA, V177, P138, DOI 10.1159/000248531; Hatsell SJ, 2001, J INVEST DERMATOL, V116, P606, DOI 10.1046/j.1523-1747.2001.13041234.x; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Isoda H, 2009, J EUR ACAD DERMATOL, V23, P737, DOI 10.1111/j.1468-3083.2009.03206.x; Kabashima K, 2008, ARCH DERMATOL, V144, P375, DOI 10.1001/archderm.144.3.375; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; KASTL I, 1990, ARCH DERMATOL RES, V282, P363, DOI 10.1007/BF00372085; KIMONIS V, 1994, J INVEST DERMATOL, V103, P764, DOI 10.1111/1523-1747.ep12412771; KUSTER W, 1992, ACTA DERM-VENEREOL, V72, P120; Kuster W, 2002, ARCH DERMATOL RES, V294, P268, DOI 10.1007/s00403-002-0328-9; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; LIND L, 1994, HUM MOL GENET, V3, P1789, DOI 10.1093/hmg/3.10.1789; LUCKER GPH, 1994, BRIT J DERMATOL, V131, P1, DOI 10.1111/j.1365-2133.1994.tb08450.x; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Matsui T, 2011, EMBO MOL MED, V3, P320, DOI 10.1002/emmm.201100140; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; MITSUHASHI Y, 1989, Dermatologica (Basel), V179, P231; Mitsuhashi Y., 1989, PRACTICAL DERMATOL, V11, P297; Miyata T, 1998, J CLIN INVEST, V102, P828, DOI 10.1172/JCI2450; NESBITT LT, 1975, ARCH DERMATOL, V111, P763, DOI 10.1001/archderm.111.6.763; NIELSEN PG, 1985, CLIN GENET, V28, P361; Ochiai K., 1977, HDB HUMAN GENETICS, V9, P23; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; Rickman L, 1999, HUM MOL GENET, V8, P971, DOI 10.1093/hmg/8.6.971; Sakabe JI, 2009, CLIN EXP DERMATOL, V34, pe282, DOI 10.1111/j.1365-2230.2008.03202.x; Sasaki T, 2012, J DERMATOL SCI, V68, P36, DOI 10.1016/j.jdermsci.2012.07.008; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; SYBERT VP, 1988, J AM ACAD DERMATOL, V18, P75, DOI 10.1016/S0190-9622(88)70012-2; Thost A, 1880, THESIS; UNNA PG, 1883, ARCH DERMATOL SYPHIL, V15, P231; Vorner H, 1901, ARCH DERMATOL SYPH-G, V56, P3; Wang YQ, 2012, GENESIS, V50, P899, DOI 10.1002/dvg.22046; Weibel L, 2012, NEW ENGL J MED, V366, pE32, DOI 10.1056/NEJMicm1103833	50	84	88	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					945	956		10.1016/j.ajhg.2013.09.015	http://dx.doi.org/10.1016/j.ajhg.2013.09.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24207119	Green Published, Bronze			2022-12-18	WOS:000326996600015
J	Mazor, M; Alkrinawi, S; Chalifa-Caspi, V; Manor, E; Sheffield, VC; Aviram, M; Parvari, R				Mazor, Masha; Alkrinawi, Soliman; Chalifa-Caspi, Vered; Manor, Esther; Sheffield, Val C.; Aviram, Micha; Parvari, Ruti			Primary Ciliary Dyskinesia Caused by Homozygous Mutation in DNAL1, Encoding Dynein Light Chain 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OUTER-ARM DYNEIN; GAMMA-HEAVY-CHAIN; MOTOR DOMAIN; CONFORMATIONAL SWITCH; MOTILE CILIA; IDENTIFICATION; DEFECTS; DISEASE; LRRC50; GENES	In primary ciliary dyskinesia (PCD), genetic defects affecting motility of cilia and flagella cause chronic destructive airway disease, randomization of left-right body asymmetry, and, frequently, male infertility. The most frequent defects involve outer and inner dynein arms (ODAs and IDAs) that are large multiprotein complexes responsible for cilia-beat generation and regulation, respectively. Although it has long been suspected that mutations in DNAL1 encoding the ODA light chain1 might cause PCD such mutations were not found. We demonstrate here that a homozygous point mutation in this gene is associated with PCD with absent or markedly shortened ODA. The mutation (NM_031427.3: c.449A>G; p.Asn150Ser) changes the Asn at position150, which is critical for the proper tight turn between the beta strand and the alpha helix of the leucine-rich repeat in the hydrophobic face that connects to the dynein heavy chain. The mutation reduces the stability of the axonernal dynein light chain 1 and damages its interactions with dynein heavy chain and with tubulin. This study adds another important component to understanding the types of mutations that cause PCD and provides clinical information regarding a specific mutation in a gene not yet known to be associated with PCD.	[Mazor, Masha; Manor, Esther; Parvari, Ruti] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Virol & Dev Genet, IL-84105 Beer Sheva, Israel; [Alkrinawi, Soliman; Aviram, Micha] Soroka Univ Med Ctr, Div Pediat, IL-84101 Beer Sheva, Israel; [Chalifa-Caspi, Vered] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Manor, Esther] Soroka Med Ctr, Inst Genet, IL-84101 Beer Sheva, Israel; [Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Howard Hughes Medical Institute; University of Iowa	Parvari, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Virol & Dev Genet, IL-84105 Beer Sheva, Israel.	ruthi@bgu.ac.il		Chalifa-Caspi, Vered/0000-0001-6030-5816; Sheffield, Val/0000-0002-6282-0835	Israel Science Foundation; NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to the patients and their families for their participation in this study. We are grateful to Noah Isakov, Ben Gurion University, for the generous gift of Myc antibodies. We thank Yona Lichtenfeld and Einat Nativ-Roth for the transmission electron microscope analyses. This work was supported by a grant from the Israel Science Foundation (to R.P.). V.C.S. is an investigator of the Howard Hughes Medical Institute.	Amir El-Ad David, 2010, Hum Genomics, V4, P394; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Benashski SE, 1999, BIOCHEMISTRY-US, V38, P7253, DOI 10.1021/bi990466y; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Failly M, 2008, RESPIRATION, V76, P198, DOI 10.1159/000128567; HASTIE AT, 1986, CELL MOTIL CYTOSKEL, V6, P25, DOI 10.1002/cm.970060105; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Horvath J, 2005, AM J RESP CELL MOL, V33, P41, DOI 10.1165/rcmb.2004-0335OC; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jeganathan D, 2004, J MED GENET, V41, P233, DOI 10.1136/jmg.2003.014084; Kosaki K, 2004, AM J MED GENET A, V129A, P308, DOI 10.1002/ajmg.a.30177; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu ZM, 2008, EUKARYOT CELL, V7, P1136, DOI 10.1128/EC.00102-08; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; MacCormick J, 2002, J OTOLARYNGOL, V31, P13, DOI 10.2310/7070.2002.19153; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Meeks M, 2000, PEDIATR PULM, V29, P307, DOI 10.1002/(SICI)1099-0496(200004)29:4<307::AID-PPUL11>3.0.CO;2-2; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Narayan RD, 2010, FUNGAL GENET BIOL, V47, P663, DOI 10.1016/j.fgb.2010.04.008; O'Callaghan C, 2004, PEDIATR PULM, P72, DOI 10.1002/ppul.70057; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Parvari R, 1998, AM J HUM GENET, V63, P163, DOI 10.1086/301915; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; ROTT HD, 1979, HUM GENET, V46, P249, DOI 10.1007/BF00273308; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; van's Gravesande KS, 2005, ANN MED, V37, P439, DOI 10.1080/07853890510011985; Wodehouse T, 2003, EUR RESPIR J, V21, P43, DOI 10.1183/09031936.03.00305503; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Wu HW, 2003, BIOCHEMISTRY-US, V42, P57, DOI 10.1021/bi026762j; Zariwala MA, 2006, AM J RESP CRIT CARE, V174, P858, DOI 10.1164/rccm.200603-370OC	40	84	91	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					599	607		10.1016/j.ajhg.2011.03.018	http://dx.doi.org/10.1016/j.ajhg.2011.03.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21496787	Green Published, Bronze			2022-12-18	WOS:000290832100007
J	Southgate, L; Machado, RD; Snape, KM; Primeau, M; Dafou, D; Ruddy, DM; Branney, PA; Fisher, M; Lee, GJ; Simpson, MA; He, Y; Bradshaw, TY; Blaumeiser, B; Winship, WS; Reardon, W; Maher, ER; FitzPatrick, DR; Wuyts, W; Zenker, M; Lamarche-Vane, N; Trembath, RC				Southgate, Laura; Machado, Rajiv D.; Snape, Katie M.; Primeau, Martin; Dafou, Dimitra; Ruddy, Deborah M.; Branney, Peter A.; Fisher, Malcolm; Lee, Grace J.; Simpson, Michael A.; He, Yi; Bradshaw, Teisha Y.; Blaumeiser, Bettina; Winship, William S.; Reardon, Willie; Maher, Eamonn R.; FitzPatrick, David R.; Wuyts, Wim; Zenker, Martin; Lamarche-Vane, Nathalie; Trembath, Richard C.			Gain-of-Function Mutations of ARHGAP31, a Cdc42/Rac1 GTPase Regulator, Cause Syndromic Cutis Aplasia and Limb Anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHO-GTPASES; BETA-CATENIN; ACTIVATING PROTEIN; CDGAP; RAC1; WNT; LOCALIZATION; FAMILY; GAP	Regulation of cell proliferation and motility is essential for normal development. The Rho family of GTPases plays a critical role in the control of cell polarity and migration by effecting the cytoskeleton, membrane trafficking, and cell adhesion-We investigated a recognized developmental disorder, Adams-Oliver syndrome (AOS), characterized by the combination of aplasia cutis congenita (ACC) and terminal transverse limb defects (TTLD). Through a genome-wide linkage analysis, we detected a locus for autosomal-dominant ACC-TTLD on 3q generating a maximum LOD score of 4.93 at marker rs1464311. Candidate-gene- and exome-based sequencing led to the identification of independent premature truncating mutations in the terminal exon of the Rho GTPase-activating protein 31 gene, ARHGAP31, which encodes a Cdc42/Rac1 regulatory protein. Mutant transcripts are stable and increase ARHGAP31 activity in vitro through a gain-of-function mechanism. Constitutively active ARHGAP31 mutations result in a loss of available active Cdc42 and consequently disrupt actin cytoskeletal structures. Arhgap37 expression in the mouse is substantially restricted to the terminal limb buds and craniofacial processes during early development; these locations closely mirror the sites of impaired organogenesis that characterize this syndrome. These data identify the requirement for regulated Cdc42 and/or Rac1 signaling processes during early human development.	[Southgate, Laura; Machado, Rajiv D.; Snape, Katie M.; Dafou, Dimitra; Lee, Grace J.; Simpson, Michael A.; Bradshaw, Teisha Y.; Trembath, Richard C.] Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England; [Primeau, Martin; He, Yi; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Ruddy, Deborah M.; Trembath, Richard C.] Guys Hosp, Dept Clin Genet, London SE1 9RT, England; [Branney, Peter A.; Fisher, Malcolm; FitzPatrick, David R.] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Blaumeiser, Bettina; Wuyts, Wim] Univ Edegem, Dept Med Genet, B-2650 Edegem, Belgium; [Blaumeiser, Bettina; Wuyts, Wim] Univ Antwerp Hosp, B-2650 Edegem, Belgium; [Winship, William S.] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Fac Hlth Sci, Nelson R Mandela Sch Med, ZA-4041 Durban, South Africa; [Reardon, Willie] Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin 12, Ireland; [Maher, Eamonn R.] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Zenker, Martin] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-91054 Erlangen, Germany; [Zenker, Martin] Univ Hosp Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; McGill University; Guy's & St Thomas' NHS Foundation Trust; University of Edinburgh; University of Antwerp; University of Kwazulu Natal; Our Ladys Children Hospital Crumlin; University of Birmingham; Birmingham Women's Hospital; University of Erlangen Nuremberg; University Hospital Magdeburg	Trembath, RC (corresponding author), Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England.	richard.trembath@kcl.ac.uk	MAHER, EAMONN R/A-9507-2008; Snape, Katie/AAA-8101-2022; Southgate, Laura/H-7924-2019; wuyts, wim/B-6262-2017; Machado, Rajiv D./AAD-7813-2019; Fisher, Malcolm Edgar/GQH-8954-2022; Simpson, Michael/F-4737-2011; wuyts, wim/B-1346-2012; Dafou, Dimitra/N-6094-2015; FitzPatrick, David R/C-7301-2013	MAHER, EAMONN R/0000-0002-6226-6918; Southgate, Laura/0000-0002-2090-1450; wuyts, wim/0000-0002-4349-9038; Machado, Rajiv D./0000-0001-9247-0744; Fisher, Malcolm Edgar/0000-0003-1074-8103; Simpson, Michael/0000-0002-8539-8753; wuyts, wim/0000-0002-4349-9038; Dafou, Dimitra/0000-0003-4170-0612; Reardon, Willie/0000-0001-7329-9179; Bradshaw, Teisha Yo-Stella/0000-0001-8760-2335; FitzPatrick, David R./0000-0003-4861-969X; Trembath, Richard/0000-0003-0550-3400	British Heart Foundation (BHF) [RG/08/006/25302]; Wellcome Trust [078751/Z/05/Z]; European Union [LSHM-CT-2005-018725]; Canadian Institute of Health Research [MOP-84449]; German Research Foundation [ZE 524/2-2]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; National Institute of Dental and Craniofacial Research (National Institutes of Health) Craniofacial Center [P50 DE-16215-05]; MRC [MC_U127561093] Funding Source: UKRI; British Heart Foundation [RG/08/006/25302] Funding Source: researchfish; Medical Research Council [MC_U127561093] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER	British Heart Foundation (BHF)(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; National Institute of Dental and Craniofacial Research (National Institutes of Health) Craniofacial Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank the participating families; the clinicians who recruited patients to the European AOS Consortium (L. Al-Gazali, D. Amor, F. Brancati, E. Craft, B. Dallapiccola, S. Davies, C. Deshpande, J. Dixon, S. Holden, J. Hurst, P. Itin, E. Jacquemin, D. Johnson, E. Kinning, Y. Lacassie, W. Lam, A. Lampe, P. Lapunzina, M. Maniscalco, V. McConnell, L. McGregor, V. Meiner, J. Nelson, K. Orstavik, J. Paprocka, M. Patel, S. Price, J. Prothero, E. Seemanova, M. Tekin, B. Tuysuz, A. Vandersteen, and M. Whiteford.); and A. Ridley, who critically read the manuscript. This work was supported by grants from the British Heart Foundation (BHF) to R.C.T. (RG/08/006/25302), Wellcome Trust to E.R.M. and R.C.T. (078751/Z/05/Z), European Union Framework 6 award for PULMOTENSION (LSHM-CT-2005-018725), Canadian Institute of Health Research to N.L-V. (MOP-84449), and German Research Foundation to M.Z. (ZE 524/2-2). The authors acknowledge use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. R.C.T. is a senior investigator at the NIHR. R.D.M. is a BHF Intermediate Research Fellow (FS/07/036). P.B. and M.F. are MRC career development fellows funded by the National Institute of Dental and Craniofacial Research (National Institutes of Health) Craniofacial Center Grant (P50 DE-16215-05). D.R.F. is a MRC senior clinician scientist. N.L-V. is a Fonds de la Recherche en Sante du Quebec chercheur-boursier senior.	Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418; BONAFEDE RP, 1979, AM J MED GENET, V3, P35, DOI 10.1002/ajmg.1320030109; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; Danek EI, 2007, J BIOL CHEM, V282, P3624, DOI 10.1074/jbc.M610073200; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Kelvin, 2010, BMC Res Notes, V3, P191, DOI 10.1186/1756-0500-3-191; Maatouk DM, 2009, DEV BIOL, V327, P516, DOI 10.1016/j.ydbio.2009.01.004; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Moskwa P, 2005, J BIOL CHEM, V280, P6716, DOI 10.1074/jbc.M412563200; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Snape KMG, 2009, AM J MED GENET A, V149A, P1860, DOI 10.1002/ajmg.a.32708; Stricker S, 2011, DEV DYNAM, V240, P990, DOI 10.1002/dvdy.22565; Suzuki D, 2009, DEV BIOL, V335, P396, DOI 10.1016/j.ydbio.2009.09.014; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tcherkezian J, 2006, BIOL CELL, V98, P445, DOI 10.1042/BC20050101; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Verdyck P, 2006, CLIN GENET, V69, P86, DOI 10.1111/j.1399-0004.2006.00552.x; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	36	84	90	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					574	585		10.1016/j.ajhg.2011.04.013	http://dx.doi.org/10.1016/j.ajhg.2011.04.013			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21565291	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000290832100005
J	Bhalla, K; Luo, Y; Buchan, T; Beachem, MA; Guzauskas, GF; Ladd, S; Bratcher, SJ; Schroer, RJ; Balsamo, J; DuPont, BR; Lillen, J; Srivastava, AK				Bhalla, Kavita; Luo, Yue; Buchan, Tim; Beachem, Michael A.; Guzauskas, Gregory F.; Ladd, Sydney; Bratcher, Shelly J.; Schroer, Richard J.; Balsamo, Janne; DuPont, Barbara R.; Lillen, Jack; Srivastava, Anand K.			Alterations in CDH15 and KIRREL3 in Patients with Mild to Severe Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSYNDROMIC MENTAL-RETARDATION; AUTISM SPECTRUM DISORDERS; MOLECULAR-CLONING; SYNAPTIC FUNCTION; PROTEIN CASK; MOUSE-BRAIN; XLMR GENES; M-CADHERIN; MUTATIONS; GENETICS	Cell-adhesion molecules play critical roles in brain development, as well as maintaining synaptic structure, function, and plasticity. Here we have found the disruption of two genes encoding putative cell-adhesion molecules, CDH15 (cadherin superfamily) and KIRREL3 (immunoglobulin superfamily), by a chromosomal translocation t(11;16) in a female patient with intellectual disability (ID). We screened coding regions of these two genes in a cohort of patients with ID and controls and identified four nonsynonymous CDH15 variants and three nonsynonymous KIRREL3 variants that appear rare and unique to ID. These variations altered highly conserved residues and were absent in more than 600 unrelated patients with ID and 800 control individuals. Furthermore, in vivo expression studies showed that three of the CDH15 variations adversely altered its ability to mediate cell-cell adhesion. We also show that in neuronal cells, human KIRREL3 colocalizes and interacts with the synaptic scaffolding protein, CASK, recently implicated in X-linked brain malformation and ID. Taken together, our data suggest that alterations in CDH15 and KIRREL3, either alone or in combination with other factors, could play a role in phenotypic expression of ID in some patients.	[Bhalla, Kavita; Luo, Yue; Beachem, Michael A.; Guzauskas, Gregory F.; Ladd, Sydney; Bratcher, Shelly J.; Schroer, Richard J.; DuPont, Barbara R.; Srivastava, Anand K.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Buchan, Tim; Balsamo, Janne; Lillen, Jack] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; [DuPont, Barbara R.; Srivastava, Anand K.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA	Greenwood Genetic Center; University of Iowa; Clemson University	Srivastava, AK (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, 113 Gregor Mendel Circle, Greenwood, SC 29646 USA.	anand@ggc.org			National Institutes of Child Health and Human Development [R01-HD39331]; National Eye Institute [R01-EY013363]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039331] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013363] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We wish to express our gratitude to the patients and their families for cooperation. We thank R.C. Rogers, S.A. Skinner, L.H. Seaver, and K.B. Clarkson for providing clinical details of patients; D. Bealer and C. Skinner for assistance in obtaining patients' samples; T. Moss for help with cell culture; D. Schultz for assistance in sequencing; L. Allen and J. John for technical assistance in mutation screening; J. Collins for assistance in statistical analysis and for discussion; K. Franek and J. Norris for assistance in preparation of expression constructs and confocal microscopy; and C.E. Schwartz and R.E. Stevenson for helpful discussion. This work was supported by a grant from the National Institutes of Child Health and Human Development (R01-HD39331 to A.K.S.) and from the National Eye Institute (R01-EY013363 to J.L. and J.B.). The authors report no conflict of interest.	American Association on Mental Retardation, 2002, MENT RET DEF CLASS S; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; BahjaouiBouhaddi M, 1997, J COMP NEUROL, V378, P180, DOI 10.1002/(SICI)1096-9861(19970210)378:2<180::AID-CNE3>3.0.CO;2-#; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bamji SX, 2005, NEURON, V47, P175, DOI 10.1016/j.neuron.2005.06.024; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Gerke P, 2006, J COMP NEUROL, V498, P466, DOI 10.1002/cne.21064; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Koch AW, 2004, CELL MOL LIFE SCI, V61, P1884, DOI 10.1007/s00018-004-4006-2; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; PILUSO G, 2007, 13 INT WORKSH FRAG X; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; ROSE O, 1995, P NATL ACAD SCI USA, V92, P6022, DOI 10.1073/pnas.92.13.6022; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shimoyama Y, 1998, J BIOL CHEM, V273, P10011, DOI 10.1074/jbc.273.16.10011; Sossey-Alaoui K, 1999, GENOMICS, V60, P330, DOI 10.1006/geno.1999.5924; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tamura S, 2005, NEUROSCIENCE, V133, P615, DOI 10.1016/j.neuroscience.2005.03.030; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	47	84	91	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					703	713		10.1016/j.ajhg.2008.10.020	http://dx.doi.org/10.1016/j.ajhg.2008.10.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19012874	Bronze, Green Published			2022-12-18	WOS:000261822100005
J	Michalk, A; Stricker, S; Becker, J; Rupps, R; Pantzar, T; Miertus, J; Botta, G; Naretto, VG; Janetzki, C; Yaqoob, N; Ott, CE; Seelow, D; Wieczorek, D; Fiebig, B; Wirth, B; Hoopmann, M; Walther, M; Koerber, F; Blankenburg, M; Mundlos, S; Heller, R; Hoffmann, K				Michalk, Anne; Stricker, Sigmar; Becker, Jutta; Rupps, Rosemarie; Pantzar, Tapio; Miertus, Jan; Botta, Giovanni; Naretto, Valeria G.; Janetzki, Catrin; Yaqoob, Nausheen; Ott, Claus-Eric; Seelow, Dominik; Wieczorek, Dagmar; Fiebig, Britta; Wirth, Brunhilde; Hoopmann, Markus; Walther, Marisa; Koerber, Friederike; Blankenburg, Markus; Mundlos, Stefan; Heller, Raoul; Hoffmann, Katrin			Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTHROGRYPOSIS MULTIPLEX CONGENITA; NEUROMUSCULAR-JUNCTION SYNAPTOPATHY; DELTA-SUBUNIT MUTATION; MYASTHENIC SYNDROME; PTERYGIUM SYNDROME; RAPSYN MUTATIONS; BINDING; LETHAL; UNDERLIE; ORIGIN	Impaired fetal movement causes malformations, summarized as fetal akinesia deformation sequence (FADS), and is triggered by environmental and genetic factors. Acetylcholine receptor (AChR) components are suspects because mutations in the fetally expressed gamma subunit (CHRNG) of AChR were found in two FADS disorders, lethal multiple pterygium syndrome (LMPS) and Escobar syndrome. Other AChR subunits alpha 1, beta 1, and delta (CHRNA1, CHRNB1, CHRND) as well as receptor-associated protein of the synapse (RAPSN) previously revealed missense or compound nonsense-missense mutations in viable congenital myasthenic syndrome; lethality of homozygous null mutations was predicted but never shown. We provide the first report to our knowledge of homozygous nonsense mutations in CHRNA1 and CHRND and show that they were lethal, whereas novel recessive missense mutations in RAPSN caused a severe but not necessarily lethal phenotype. To elucidate disease-associated malformations such as frequent abortions, fetal edema, cystic hygroma, or cardiac defects, we studied Chrna1, Chrnb1, Chrnd, Chrng, and Rapsn in mouse embryos and found expression in skeletal muscles but also in early somite development. This indicates that early developmental defects might be due to somite expression in addition to solely muscle-specific effects. We conclude that complete or severe functional disruption of fetal AChR causes lethal multiple pterygium syndrome whereas milder alterations result in fetal hypokinesia with inborn contractures or a myasthenic syndrome later in life.	[Michalk, Anne; Janetzki, Catrin; Ott, Claus-Eric; Seelow, Dominik; Mundlos, Stefan; Hoffmann, Katrin] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Stricker, Sigmar; Mundlos, Stefan; Hoffmann, Katrin] Max Planck Inst Mol Genet, FG Dev & Dis, D-14195 Berlin, Germany; [Becker, Jutta; Wirth, Brunhilde; Heller, Raoul] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Hoopmann, Markus] Univ Cologne, Dept Obstet & Gynaecol, D-50931 Cologne, Germany; [Rupps, Rosemarie; Pantzar, Tapio] British Columbia Childrens Hosp, Dept Med Genet, Vancouver, BC V6H 3V4, Canada; [Rupps, Rosemarie; Pantzar, Tapio] British Columbia Childrens Hosp, Dept Pathol, Vancouver, BC V6H 3V4, Canada; [Miertus, Jan] St Elizabeth Canc Inst, Dept Med Genet, Bratislava 81250, Slovakia; [Botta, Giovanni] OIRM S Anna Hosp, Dept Pathol, I-10126 Turin, Italy; [Naretto, Valeria G.] Azienda Ospedaliera San Giovanni Battista Torino, I-10126 Turin, Italy; [Yaqoob, Nausheen] King Abdul Aziz Specialist Hosp, At Taif, Saudi Arabia; [Wieczorek, Dagmar] Univ Duisburg Essen, Inst Human Genet, D-45122 Essen, Germany; [Fiebig, Britta] Univ Regensburg, Ctr Human Genet, D-93053 Regensburg, Germany; [Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Wirth, Brunhilde] Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; [Walther, Marisa] Med Ctr Rheumatol Berlin Buch, D-13125 Berlin, Germany; [Koerber, Friederike] Univ Cologne, Dept Pediat Radiol, D-50931 Cologne, Germany; [Michalk, Anne; Stricker, Sigmar] Univ Witten Herdecke, Vestische Kinder & Jugendklin, Dept Neuropaediat, D-45711 Datteln, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Cologne; University of Cologne; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Duisburg Essen; University of Regensburg; University of Cologne; University of Cologne; University of Cologne; Witten Herdecke University	Hoffmann, K (corresponding author), Charite, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	katrin.hoffmann.genetik@charite.de	Seelow, Dominik/HGB-3124-2022; Stricker, Sigmar/B-9169-2009; Wirth, Brunhilde/H-3192-2019; Mundlos, Stefan/ABH-9585-2020; Wieczorek, Dagmar/AAU-6008-2021; Ott, Claus E/G-1936-2011; Ott, Claus/U-8226-2019	Seelow, Dominik/0000-0002-9746-4412; Stricker, Sigmar/0000-0002-7174-5363; Wieczorek, Dagmar/0000-0003-2812-6492; Ott, Claus E/0000-0003-3627-3791; Ott, Claus/0000-0003-3627-3791; Wirth, Brunhilde/0000-0003-4051-5191; Mundlos, Stefan/0000-0002-9788-3166				Antolik C, 2007, NEUROSCIENCE, V145, P56, DOI 10.1016/j.neuroscience.2006.11.047; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; Banwell BL, 2004, NEUROMUSCULAR DISORD, V14, P202, DOI 10.1016/j.nmd.2003.11.004; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brownlow S, 2001, J CLIN INVEST, V108, P125, DOI 10.1172/JCI12935; Burke G, 2003, NEUROLOGY, V61, P826, DOI 10.1212/01.WNL.0000085865.55513.AE; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Dalton P, 2006, NEUROMUSCULAR DISORD, V16, P481, DOI 10.1016/j.nmd.2006.05.015; DRACHMAN DB, 1962, LANCET, V2, P523; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Gomez CM, 2002, ANN NEUROL, V51, P102, DOI 10.1002/ana.10077; HALL JG, 1984, AM J MED GENET, V17, P803, DOI 10.1002/ajmg.1320170410; HALL JG, 1986, AM J MED GENET, V25, P99, DOI 10.1002/ajmg.1320250112; Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002; Hammond E, 1995, Obstet Gynecol Surv, V50, P240, DOI 10.1097/00006254-199503000-00028; He LW, 2003, ANAT EMBRYOL, V207, P29, DOI 10.1007/s00429-003-0327-4; HESSELMANS LFGM, 1993, ANAT REC, V236, P553, DOI 10.1002/ar.1092360315; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; KUES WA, 1995, EUR J NEUROSCI, V7, P1376, DOI 10.1111/j.1460-9568.1995.tb01129.x; MOERMAN P, 1990, AM J MED GENET, V35, P415, DOI 10.1002/ajmg.1320350319; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Muller JS, 2006, NEUROLOGY, V67, P1159, DOI 10.1212/01.wnl.0000233837.79459.40; Muller JS, 2007, BRAIN, V130, P1497, DOI 10.1093/brain/awm068; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Ohno Kinji, 2002, Curr Neurol Neurosci Rep, V2, P78, DOI 10.1007/s11910-002-0057-7; Palace J, 2007, BRAIN, V130, P1507, DOI 10.1093/brain/awm072; Polizzi A, 2000, TERATOLOGY, V62, P332, DOI 10.1002/1096-9926(200011)62:5<332::AID-TERA7>3.3.CO;2-5; Romero NB, 2003, BRAIN, V126, P2341, DOI 10.1093/brain/awg244; Sanes JR, 1998, J PHYSIOLOGY-PARIS, V92, P167, DOI 10.1016/S0928-4257(98)80004-1; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schwabe GC, 2004, DEV DYNAM, V229, P400, DOI 10.1002/dvdy.10466; Shen XM, 2002, NEUROLOGY, V59, P1881, DOI 10.1212/01.WNL.0000042422.87384.2F; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Wilting J, 2006, DEV BIOL, V292, P165, DOI 10.1016/j.ydbio.2005.12.043; Wilting J, 2000, DEV DYNAM, V217, P271, DOI 10.1002/(SICI)1097-0177(200003)217:3<271::AID-DVDY5>3.3.CO;2-U; Wilting J, 2006, ANAT EMBRYOL, V211, pS57, DOI 10.1007/s00429-006-0120-2; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x	41	84	92	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					464	476		10.1016/j.ajhg.2007.11.006	http://dx.doi.org/10.1016/j.ajhg.2007.11.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252226	Green Published, Bronze			2022-12-18	WOS:000253223900018
J	Arita, K; South, AP; Hans, G; Sakuma, TH; Lai-Cheong, J; Clements, S; Odashiro, M; Dashiro, DN; Hans, G; Hans, NR; Holder, MV; Bhogal, BS; Hartshorne, ST; Akiyama, M; Shimizu, H; McGrath, JA				Arita, Ken; South, Andrew P.; Hans-Filho, Gtinter; Sakuma, Thais Harumi; Lai-Cheong, Joey; Clements, Suzanne; Odashiro, Macanori; Dashiro, Danilo Nakao; Hans-Neto, Guenter; Hans, Nelise Ritter; Holder, Maxine V.; Bhogal, Balbir S.; Hartshorne, Sian T.; Akiyama, Masashi; Shimizu, Hiroshi; McGrath, John A.			Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROXIMAL EXTRACELLULAR DOMAINS; MULTIPLE ENDOCRINE NEOPLASIA; LICHEN AMYLOIDOSIS; EPIDERMAL-KERATINOCYTES; SKIN INFLAMMATION; EPITHELIAL-CELLS; T-CELLS; INTERLEUKIN-31; ACTIVATION; EXPRESSION	Familial primary localized cutaneous amyloidosis (FPLCA) is an autosomal-dominant disorder associated with chronic skin itching and deposition of epidermal keratin filament-associated amyloid material in the dermis. FPLCA has been mapped to 5p13.1-q11.2, and by candidate gene analysis, we identified missense mutations in the OSMR gene, encoding oncostatin M-specific receptor beta (OSMR beta), in three families. OSMR beta is a component of the oncostatin M (OSM) type II receptor and the interleukin (IL)-31 receptor, and cultured FPLCA keratinocytes showed reduced activation of jak/STAT, MAPK, and PI3K/Akt pathways after OSM or IL-31 cytokine stimulation. The pathogenic amino acid substitutions are located within the extracellular fibronectin type III-like (FNIII) domains, regions critical for receptor dimerization and function. OSM and IL-31 signaling have been implicated in keratinocyte cell proliferation, differentiation, apoptosis, and inflammation, but our OSMR data in individuals with FPLCA represent the first human germline mutations in this cytokine receptor complex and provide new insight into mechanisms of skin itching.	[Arita, Ken; Lai-Cheong, Joey; Clements, Suzanne; McGrath, John A.] Guys Sch Med, Div Genet & Mol Med, St Johns Inst Dermatol, Genet Skin Dis Grp, London SE1 9RT, England; [Arita, Ken; Lai-Cheong, Joey; Clements, Suzanne; McGrath, John A.] Kings Coll London, Sch Med, Div Genet & Mol Med, St Johns Inst Dermatol,Genet Skin Dis Grp, London SE1 9RT, England; [Arita, Ken; Lai-Cheong, Joey; Clements, Suzanne; McGrath, John A.] St Thomas Sch Med, Div Genet & Mol Med, St Johns Inst Dermatol, Genet Skin Dis Grp, London SE1 9RT, England; [Arita, Ken; Akiyama, Masashi; Shimizu, Hiroshi] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [South, Andrew P.; Holder, Maxine V.] Barts & London Queen Marys Sch Med & Dent, Barts & London, Ctr Cutaneous Res, London E1 2AT, England; [Hans-Filho, Gtinter; Sakuma, Thais Harumi] Univ Fed Mato Grosso do Sul, Fac Med, Dept Dermatol, BR-79002510 Campo Grande, Brazil; [Odashiro, Macanori; Dashiro, Danilo Nakao] Univ Fed Mato Grosso do Sul, Fac Med, Dept Pathol, BR-79002510 Campo Grande, Brazil; [Hans-Neto, Guenter; Hans, Nelise Ritter] Univ Dev State & Pantanal Reg, BR-79002212 Campo Grande, Brazil; [Bhogal, Balbir S.] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Immunofluorescence Lab, London SE1 7EH, England; [Hartshorne, Sian T.] Univ Witwatersrand, Dept Med, Div Dermatol, ZA-2193 Parktown, South Africa	University of London; King's College London; University of London; King's College London; University of London; King's College London; Hokkaido University; University of London; Queen Mary University London; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Witwatersrand	McGrath, JA (corresponding author), Guys Sch Med, Div Genet & Mol Med, St Johns Inst Dermatol, Genet Skin Dis Grp, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	McGrath, John/N-3529-2019; Arita, Ken/A-5451-2012; HANS-FILHO, GUNTER/R-9779-2017; Shimizu, Hiroshi/A-5193-2012; Akiyama, Masashi/I-1122-2012; McGrath, John/D-6824-2012	HANS-FILHO, GUNTER/0000-0001-9324-3703; McGrath, John/0000-0002-3708-9964; Holder, Maxine/0000-0002-4613-2194				Bando T, 2006, NEUROSCIENCE, V142, P1263, DOI 10.1016/j.neuroscience.2006.07.009; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; BREATHNACH SM, 2004, ROOKS TXB DERMATOLOG, V3; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Finelt N, 2005, CYTOKINE, V31, P305, DOI 10.1016/j.cyto.2005.05.005; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hartshorne ST, 1999, CLIN EXP DERMATOL, V24, P438; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hofstra RMW, 1996, J INVEST DERMATOL, V107, P215, DOI 10.1111/1523-1747.ep12329651; KOBAYASHI H, 1983, J INVEST DERMATOL, V80, P66, DOI 10.1111/1523-1747.ep12531130; KUMAKIRI M, 1979, J INVEST DERMATOL, V73, P150, DOI 10.1111/1523-1747.ep12581609; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; Lee DD, 2006, BRIT J DERMATOL, V155, P1201, DOI 10.1111/j.1365-2133.2006.07524.x; Lee DD, 1996, J INVEST DERMATOL, V107, P30, DOI 10.1111/1523-1747.ep12297840; Lin MW, 2005, BRIT J DERMATOL, V152, P29, DOI 10.1111/J.1365-2133.2004.06254.X; Mirmohammadsadegh A, 2007, J INVEST DERMATOL, V127, P2207, DOI 10.1038/sj.jid.5700870; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; NEWTON JA, 1985, BRIT J DERMATOL, V112, P201, DOI 10.1111/j.1365-2133.1985.tb00084.x; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Rheinwald J G, 1989, Prog Clin Biol Res, V298, P113; Schepis C, 1999, ULTRASTRUCT PATHOL, V23, P279; Seri M, 1997, CLIN GENET, V51, P86; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Tamura S, 2003, EUR J NEUROSCI, V17, P2287, DOI 10.1046/j.1460-9568.2003.02681.x; Timmermann A, 2002, EUR J BIOCHEM, V269, P2716, DOI 10.1046/j.1432-1033.2002.02941.x; Verga U, 2003, CLIN ENDOCRINOL, V59, P156, DOI 10.1046/j.1365-2265.2003.01782.x	28	84	94	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					73	80		10.1016/j.ajhg.2007.09.002	http://dx.doi.org/10.1016/j.ajhg.2007.09.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179886	Bronze, Green Published			2022-12-18	WOS:000253223800008
J	Shiels, A; Bennett, TM; Knopf, HLS; Yamada, K; Yoshiura, KI; Niikawa, N; Shim, S; Hanson, PI				Shiels, Alan; Bennett, Thomas M.; Knopf, Harry L. S.; Yamada, Koki; Yoshiura, Koh-ichiro; Niikawa, Norio; Shim, Soomin; Hanson, Phyllis I.			CHMP4B, a novel gene for autosomal dominant cataracts linked to chromosome 20q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSTERIOR POLAR CATARACT; CONGENITAL CATARACT; MISSENSE MUTATION; RECESSIVE CATARACT; JUVENILE-ONSET; LOCUS; PROTEIN; MAPS; NONSENSE; LAMELLAR	Cataracts are a clinically diverse and genetically heterogeneous disorder of the crystalline lens and a leading cause of visual impairment. Here we report linkage of autosomal dominant "progressive childhood posterior subcapsular" cataracts segregating in a white family to short tandem repeat (STR) markers D20S847 (LOD score [Z] 5.50 at recombination fraction [theta] 0.0) and D20S195 (Z = 3.65 at theta = 0.0) on 20q, and identify a refined disease interval (rs2057262-(3.8 Mb)-rs1291139) by use of single-nucleotide polymorphism (SNP) markers. Mutation profiling of positional-candidate genes detected a heterozygous transversion (c.386A -> T) in exon 3 of the gene for chromatin modifying protein-4B (CHMP4B) that was predicted to result in the nonconservative substitution of a valine residue for a phylogenetically conserved aspartic acid residue at codon 129 (p.D129V). In addition, we have detected a heterozygous transition (c.481G -> A) in exon 3 of CHMP4B cosegregating with autosomal dominant posterior polar cataracts in a Japanese family that was predicted to result in the missense substitution of lysine for a conserved glutamic acid residue at codon 161 (p.E161K). Transfection studies of cultured cells revealed that a truncated form of recombinant D129V-CHMP4B had a different subcellular distribution than wild type and an increased capacity to inhibit release of virus-like particles from the cell surface, consistent with deleterious gain-of-function effects. These data provide the first evidence that CHMP4B, which encodes a key component of the endosome sorting complex required for the transport-III (ESCRT-III) system of mammalian cells, plays a vital role in the maintenance of lens transparency.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Nagasaki Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Nagasaki 852, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Nagasaki University; Nagasaki University	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Campus Box 8096,660 S Euclid Ave, St Louis, MO 63110 USA.	shiels@vision.wustl.edu	Hanson, Phyllis/E-9420-2012		NATIONAL EYE INSTITUTE [P30EY002687, R01EY012284] Funding Source: NIH RePORTER; NEI NIH HHS [EY012284, P30 EY002687, R01 EY012284, EY02687] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; Beebe D, 2004, INT J DEV BIOL, V48, P845, DOI 10.1387/ijdb.041869db; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Berry V, 1996, HUM MOL GENET, V5, P415, DOI 10.1093/hmg/5.3.415; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Conley YP, 2000, AM J HUM GENET, V66, P1426, DOI 10.1086/302871; EIBERG H, 1995, HUM GENET, V96, P33, DOI 10.1007/BF00214183; Gao LH, 2005, J HUM GENET, V50, P305, DOI 10.1007/s10038-005-0251-y; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Horii M, 2006, BIOCHEM J, V400, P23, DOI 10.1042/BJ20060897; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ionides ACW, 1997, HUM MOL GENET, V6, P47, DOI 10.1093/hmg/6.1.47; Kannabiran C, 1998, Mol Vis, V4, P21; Kato Noriko, 2004, BMC Pregnancy Childbirth, V4, P2; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Khaliq S, 2002, INVEST OPHTH VIS SCI, V43, P2083; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Li ND, 2006, MOL VIS, V12, P1506; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Mackay DS, 2002, AM J HUM GENET, V71, P1216, DOI 10.1086/344212; McKay JD, 2005, BRIT J OPHTHALMOL, V89, P831, DOI 10.1136/bjo.2004.058495; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; Rogaev EI, 1996, HUM MOL GENET, V5, P699, DOI 10.1093/hmg/5.5.699; Santhiya ST, 2002, J MED GENET, V39, P352, DOI 10.1136/jmg.39.5.352; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Talbot K, 2006, HUM MOL GENET, V15, pR182, DOI 10.1093/hmg/ddl202; Vanita, 2001, AM J HUM GENET, V68, P509; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WEST JD, 1986, MUTAT RES, V164, P127, DOI 10.1016/0165-1161(86)90051-8; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Yamada K, 2000, AM J OPHTHALMOL, V129, P159, DOI 10.1016/S0002-9394(99)00313-X; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zetterstrom C, 2005, J CATARACT REFR SURG, V31, P824, DOI 10.1016/j.jcrs.2005.01.012	51	84	92	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					596	606		10.1086/519980	http://dx.doi.org/10.1086/519980			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701905	Bronze, Green Published			2022-12-18	WOS:000249128200016
J	Heinzen, EL; Yoon, W; Tate, SK; Sen, A; Wood, NW; Sisodiya, SM; Goldstein, DB				Heinzen, Erin L.; Yoon, Woohyun; Tate, Sarah K.; Sen, Arjune; Wood, Nicholas W.; Sisodiya, Sanjay M.; Goldstein, David B.			Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; CHANNELS; WARFARIN; GENES; BRAIN	An intronic polymorphism in the SCN1A gene, which encodes a neuronal sodium-channel a subunit, has been previously associated with the dosing of two commonly used antiepileptic drugs that elicit their pharmacologic action primarily at this ion-channel subunit. This study sought to characterize the functional effects of this polymorphism on alternative splicing of SCN1A and to explore the potential for modulating the drug response in the pharmacologically unfavorable genotype by identification of a splice modifier acting on SCN1A. The effects of the genotype at the SCN1A IVS5N+ 5 G -> A polymorphism on SCN1A splice-variant proportions and the consequences of increased expression of splice modifiers were investigated both in human temporal neocortex tissue and in a cellular minigene expression system. Quantitative real-time polymerase chain reaction was used to quantify the amounts of SCN1A transcripts forms. We show that the polymorphism has a dramatic effect on the proportions of neonate and adult alternative transcripts of SCN1A in adult brain tissue and that the effect of the polymorphism also appears to be modified by Nova2 expression levels. A minigene expression system confirms both the effect of the polymorphism on transcript proportions and the role of Nova2 in the regulation of splicing, with higher Nova2 expression increasing the proportion of the neonate form. A larger Nova2-mediated effect was detected in the AA genotype that is associated with increased dose requirements. The effects of Nova2 on modulation of the alternative splicing of 17 other neuronally expressed genes were investigated, and no effect was observed. These findings emphasize the emerging role of genetic polymorphisms in modulation of drug effect and illustrate both alternative splicing as a potential therapeutic target and the importance of considering the activity of compounds at alternative splice forms of drug targets in screening programs.	Duke Univ, Med Ctr, Inst Genome Sci & Policy, Ctr Populat Genom & Pharmacogenet, Durham, NC 27710 USA; Inst Neurol, Dept Clin & Expt Epilespsy, London WC1N 3BG, England; Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England	Duke University; University of London; University College London; University of London; University College London	Goldstein, DB (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Ctr Populat Genom & Pharmacogenet, 103 Res Dr,GSRB 2,Room 4006, Durham, NC 27710 USA.	d.goldstein@duke.edu	Goldstein, David/AAY-8125-2020; Wood, Nicholas W/C-2505-2009	Wood, Nicholas W/0000-0002-9500-3348	MRC [G0400126] Funding Source: UKRI; Medical Research Council [G0400017, G0400126] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aronica E, 2001, EUR J NEUROSCI, V13, P1261, DOI 10.1046/j.0953-816x.2001.01502.x; Buchner DA, 2003, SCIENCE, V301, P967, DOI 10.1126/science.1086187; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Copley RR, 2004, TRENDS GENET, V20, P171, DOI 10.1016/j.tig.2004.02.001; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Du YZ, 2006, INSECT BIOCHEM MOLEC, V36, P161, DOI 10.1016/j.ibmb.2005.11.008; Gastaldi M, 1997, MOL BRAIN RES, V44, P179, DOI 10.1016/S0169-328X(96)00199-4; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Tan JG, 2002, J NEUROSCI, V22, P5300; Tate SK, 2006, PHARMACOGENET GENOM, V16, P721, DOI 10.1097/01.fpc.0000230114.41828.73; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	18	84	86	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					876	883		10.1086/516650	http://dx.doi.org/10.1086/516650			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436242	Green Published, Bronze			2022-12-18	WOS:000245973200006
J	Asai-Coakwell, M; French, CR; Berry, KM; Ye, M; Koss, R; Somerville, M; Mueller, R; van Heyningen, V; Waskiewicz, AJ; Lehmann, OJ				Asai-Coakwell, Mika; French, Curtis R.; Berry, Karyn M.; Ye, Ming; Koss, Ron; Somerville, Martin; Mueller, Rosemary; van Heyningen, Veronica; Waskiewicz, Andrew J.; Lehmann, Ordan J.			GDF6, a novel locus for a spectrum of ocular developmental anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TGF-BETA-SUPERFAMILY; PELIZAEUS-MERZBACHER-DISEASE; TRANSCRIPTION FACTOR; COLOBOMATOUS MICROPHTHALMIA; ZEBRAFISH RADAR; IRIS COLOBOMA; EYE ANOMALIES; GENE DOSAGE; PAX6 GENE; MUTATIONS	Colobomata represent visually impairing ocular closure defects that are associated with a diverse range of developmental anomalies. Characterization of a chromosome 8q21.2-q22.1 segmental deletion in a patient with chorioretinal coloboma revealed elements of nonallelic homologous recombination and nonhomologous end joining. This genomic architecture extends the range of chromosomal rearrangements associated with human disease and indicates that a broader spectrum of human chromosomal rearrangements may use coupled homologous and nonhomologous mechanisms. We also demonstrate that the segmental deletion encompasses GDF6, encoding a member of the bone-morphogenetic protein family, and that inhibition of gdf6a in a model organism accurately recapitulates the proband's phenotype. The spectrum of disorders generated by morpholino inhibition and the more severe defects (microphthalmia and anophthalmia) observed at higher doses illustrate the key role of GDF6 in ocular development. These results underscore the value of integrated clinical and molecular investigation of patients with chromosomal anomalies.	Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Alberta; University of Alberta; University of Alberta; University of Edinburgh	Lehmann, OJ (corresponding author), Univ Alberta, Dept Ophthalmol, 8-29 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	olehmann@ualberta.ca	Waskiewicz, Andrew/A-3769-2014; VAN HEYNINGEN, Veronica/GYE-0531-2022; van Heyningen, Veronica/B-8039-2008	van Heyningen, Veronica/0000-0003-0359-0141	Medical Research Council [MC_U127527199] Funding Source: Medline; MRC [MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; BARROSNUNEZ P, 1995, CLIN GENET, V48, P160; Brown DJ, 2002, AM J HUM GENET, V71, P618, DOI 10.1086/342067; Chang CB, 1999, DEVELOPMENT, V126, P3347; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Davidson AJ, 1999, GENOME RES, V9, P121; Eccles MR, 1999, CLIN GENET, V56, P1, DOI 10.1034/j.1399-0004.1999.560101.x; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Hall CJ, 2002, DEV BIOL, V251, P105, DOI 10.1006/dbio.2002.0794; Hanel ML, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-43; Huillard E, 2005, DEV BIOL, V283, P335, DOI 10.1016/j.ydbio.2005.04.027; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lehman DM, 2001, AM J MED GENET, V101, P114, DOI 10.1002/ajmg.1330; Lehmann OJ, 2002, INVEST OPHTH VIS SCI, V43, P1843; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; Morle L, 2000, AM J HUM GENET, V67, P1592, DOI 10.1086/316894; Morrison DA, 2002, BRIT J OPHTHALMOL, V86, P1316, DOI 10.1136/bjo.86.11.1316; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Nixon J, 1997, AM J MED GENET, V70, P324; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Pivnick EK, 1996, J MED GENET, V33, P772, DOI 10.1136/jmg.33.9.772; PORGES Y, 1992, AM J OPHTHALMOL, V114, P30, DOI 10.1016/S0002-9394(14)77409-4; Prince VE, 1998, DEVELOPMENT, V125, P393; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; RISSI M, 1995, MECH DEVELOP, V49, P223, DOI 10.1016/0925-4773(94)00320-M; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Schimmenti LA, 2003, AM J MED GENET A, V116A, P215, DOI 10.1002/ajmg.a.10884; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Sidi S, 2003, P NATL ACAD SCI USA, V100, P3315, DOI 10.1073/pnas.0530115100; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Stoll C, 1997, ANN GENET-PARIS, V40, P122; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Toker E, 2003, AM J MED GENET A, V121A, P25, DOI 10.1002/ajmg.a.20083; Varki A, 2006, NATURE, V440, P740, DOI 10.1038/440740b; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wadman M, 2006, NATURE, V439, P779, DOI 10.1038/439779a; Wang KS, 2005, MAMM GENOME, V16, P332, DOI 10.1007/s00335-004-2444-7; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Zhou E, 1997, MAMM GENOME, V8, P178, DOI 10.1007/s003359900385; Zollino M, 2003, AM J HUM GENET, V72, P590, DOI 10.1086/367925	53	84	93	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					306	315		10.1086/511280	http://dx.doi.org/10.1086/511280			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236135	Green Published, Bronze			2022-12-18	WOS:000243729500010
J	Baser, ME; Kuramoto, L; Joe, H; Friedman, JM; Wallace, AJ; Gillespie, JE; Ramsden, RT; Evans, DGR				Baser, ME; Kuramoto, L; Joe, H; Friedman, JM; Wallace, AJ; Gillespie, JE; Ramsden, RT; Evans, DGR			Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: A population-based study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERM-LINE MUTATIONS; VESTIBULAR SCHWANNOMA GROWTH; NF2 GENE; TYPE-2 NEUROFIBROMATOSIS; MISSENSE MUTATION; SPLICE-SITE; DISEASE; MOSAICISM; DELETION; SEVERITY	Neurofibromatosis 2 (NF2) is an autosomal dominant disease that is characterized by tumors on the vestibular branch of the VIII cranial nerve, but other types of nervous system tumors usually occur as well. Genotype-phenotype correlations are well documented for overall NF2 disease severity but have not been definitively evaluated for specific types of non - VIII nerve tumors. We evaluated genotype-phenotype correlations for various types of non - VIII nerve tumors in 406 patients from the population-based United Kingdom NF2 registry, using regression models with the additional covariates of current age and type of treatment center (specialty or nonspecialty). The models also permitted consideration of intrafamilial correlation. We found statistically significant genotype-phenotype correlations for intracranial meningiomas, spinal tumors, and peripheral nerve tumors. People with constitutional NF2 missense mutations, splice-site mutations, large deletions, or somatic mosaicism had significantly fewer tumors than did people with constitutional nonsense or frameshift NF2 mutations. In addition, there were significant intrafamilial correlations for intracranial meningiomas and spinal tumors, after adjustment for the type of constitutional NF2 mutation. The type of constitutional NF2 mutation is an important determinant of the number of NF2-associated intracranial meningiomas, spinal tumors, and peripheral nerve tumors.	Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1W5, Canada; Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Manchester Royal Infirm, Dept Radiol, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Dept Otolaryngol, Manchester M13 9WL, Lancs, England	University of British Columbia; University of British Columbia; University of Manchester; University of Manchester; University of Manchester	Baser, ME (corresponding author), 10622 Kinnard Ave,203, Los Angeles, CA 90024 USA.	michael.baser@verizon.net	Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; Friedman, Jan/0000-0002-7482-9570				Baser ME, 2003, J MED GENET, V40, P758, DOI 10.1136/jmg.40.10.758; Baser ME, 2002, J NEUROSURG, V96, P217, DOI 10.3171/jns.2002.96.2.0217; Baser ME, 2002, AM J HUM GENET, V71, P715, DOI 10.1086/342716; Bruder CEG, 2001, HUM MOL GENET, V10, P271, DOI 10.1093/hmg/10.3.271; Bruder CEG, 1999, GENE CHROMOSOME CANC, V25, P184, DOI 10.1002/(SICI)1098-2264(199906)25:2<184::AID-GCC15>3.0.CO;2-B; Evans DA, 1998, KLUW S INF, V2, P63; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Evans DGR, 1998, J MED GENET, V35, P450, DOI 10.1136/jmg.35.6.450; EVANS DGR, 1992, Q J MED, V84, P603; Evans DGR, 1999, ARCH DIS CHILD, V81, P496, DOI 10.1136/adc.81.6.496; Gardner WJ, 1930, ARCH NEURO PSYCHIATR, V23, P266, DOI 10.1001/archneurpsyc.1930.02220080050005; Gutmann DH, 1998, HUM MOL GENET, V7, P335, DOI 10.1093/hmg/7.3.335; Kluwe L, 1998, AM J MED GENET, V77, P228, DOI 10.1002/(SICI)1096-8628(19980518)77:3<228::AID-AJMG8>3.3.CO;2-1; Kluwe L, 2003, J MED GENET, V40, P109, DOI 10.1136/jmg.40.2.109; Kluwe L, 1996, HUM GENET, V98, P534, DOI 10.1007/s004390050255; Kluwe L, 1998, HUM MOL GENET, V7, P2051, DOI 10.1093/hmg/7.13.2051; Kluwe L, 1996, HUM GENET, V97, P224, DOI 10.1007/BF02265270; LEE DK, 1969, ARCH NEUROL-CHICAGO, V20, P154, DOI 10.1001/archneur.1969.00480080054006; Lopez-Correa C, 2000, J MED GENET, V37, P75, DOI 10.1136/jmg.37.1.75; MacCollin M, 1998, Semin Pediatr Neurol, V5, P243, DOI 10.1016/S1071-9091(98)80003-X; MAUTNER VF, 1993, NEUROSURGERY, V33, P92; MAUTNER VF, 1995, AM J ROENTGENOL, V165, P951, DOI 10.2214/ajr.165.4.7676998; Mautner VF, 2002, J NEUROSURG, V96, P223, DOI 10.3171/jns.2002.96.2.0223; Mautner VF, 1996, NEUROSURGERY, V38, P880, DOI 10.1097/00006123-199605000-00004; Mautner VF, 1996, HUM GENET, V98, P203, DOI 10.1007/s004390050191; Mautner VF, 1997, ARCH DERMATOL, V133, P1539, DOI 10.1001/archderm.133.12.1539; MAUTNER VF, 1995, AM J ROENTGENOL, V166, P1231; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; Moyhuddin A, 2003, J MED GENET, V40, P459, DOI 10.1136/jmg.40.6.459; Nunes F, 2003, J CHILD NEUROL, V18, P718, DOI 10.1177/08830738030180101301; Otsuka G, 2003, J NEUROSURG, V99, P480, DOI 10.3171/jns.2003.99.3.0480; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; Parry DM, 1996, AM J HUM GENET, V59, P529; Patronas NJ, 2001, RADIOLOGY, V218, P434, DOI 10.1148/radiology.218.2.r01fe40434; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Scoles DR, 2002, BIOCHEM BIOPH RES CO, V290, P366, DOI 10.1006/bbrc.2001.6178; Scoles DR, 1996, NEUROLOGY, V47, P544, DOI 10.1212/WNL.47.2.544; Trofatter J A, 1993, Cell, V75, P826; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Wallace AJ, 1999, GENET TEST, V3, P173, DOI 10.1089/gte.1999.3.173; Wishart J H, 1822, Edinb Med Surg J, V18, P393; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550; Zhao Y, 2002, GENET EPIDEMIOL, V23, P245, DOI 10.1002/gepi.10181; Zucman-Rossi J, 1998, HUM MOL GENET, V7, P2095, DOI 10.1093/hmg/7.13.2095	46	84	91	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					231	239		10.1086/422700	http://dx.doi.org/10.1086/422700			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15190457	Green Published, Bronze			2022-12-18	WOS:000222702000007
J	Wiggs, JL; Lynch, S; Ynagi, G; Maselli, M; Auguste, J; Del Bono, EA; Olson, LM; Haines, JL				Wiggs, JL; Lynch, S; Ynagi, G; Maselli, M; Auguste, J; Del Bono, EA; Olson, LM; Haines, JL			A genomewide scan identifies novel early-onset primary open-angle glaucoma loci on 9q22 and 20p12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRABECULAR MESHWORK CELLS; MYOCILIN GENE; GLN368STOP MUTATION; JUVENILE; FAMILIES; ADULT; RECOMBINATION; PREVALENCE; PHENOTYPE; PEDIGREES	Glaucoma is a leading cause of blindness worldwide. The disease is characterized by a degeneration of the optic nerve, which is usually associated with elevated intraocular pressure. The common form of adult-onset primary open-angle glaucoma is inherited as a complex trait, whereas the rarer early-onset juvenile open-angle glaucoma (JOAG) exhibits autosomal dominant inheritance. Of all cases of JOAG, similar to10%-20% are caused by mutations in the myocilin gene. We have identified 25 pedigrees that are affected with typical JOAG and that demonstrate autosomal dominant inheritance. We sequenced the myocilin gene in probands from each family and found mutations in 8% of this population. To identify novel genes responsible for JOAG, we used families that did not have myocilin mutations for a genomewide screen. Markers located on chromosomes 9q22 and 20p12 showed evidence for linkage, identifying two novel loci for early-onset open-angle glaucoma.	Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Vanderbilt University	Wiggs, JL (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.	janey_wiggs@meei.harvard.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NEI NIH HHS [R01 EY009847] Funding Source: Medline; PHS HHS [R01 09847] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Allingham RR, 1998, INVEST OPHTH VIS SCI, V39, P2288; Alward WLM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1189; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bruttini M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1034, DOI 10.1001/archopht.121.7.1034; Craig JE, 2001, OPHTHALMOLOGY, V108, P1607, DOI 10.1016/S0161-6420(01)00654-6; de Vasconcellos JPC, 2003, J GLAUCOMA, V12, P104, DOI 10.1097/00061198-200304000-00003; Dimitrov PN, 2003, INVEST OPHTH VIS SCI, V44, P5075, DOI 10.1167/iovs.02-0457; Farkas RH, 2001, INT OPHTHALMOL CLIN, V41, P111, DOI 10.1097/00004397-200101000-00011; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Graul TA, 2002, AM J OPHTHALMOL, V134, P884, DOI 10.1016/S0002-9394(02)01754-3; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lutjen-Drecoll E, 2001, J GLAUCOMA, V10, pS42; Mackey DA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1172, DOI 10.1001/archopht.121.8.1172; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Richards JE, 1998, OPHTHALMOLOGY, V105, P1698, DOI 10.1016/S0161-6420(98)99041-8; Rozsa F W, 1998, Mol Vis, V4, P20; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Wiggs JL, 1996, AM J HUM GENET, V58, P243; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wiggs JL, 1995, OPHTHALMOLOGY, V102, P1782, DOI 10.1016/S0161-6420(95)30793-2; Wiggs JL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1674; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109	29	84	91	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1314	1320		10.1086/421533	http://dx.doi.org/10.1086/421533			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15108121	Bronze, Green Published			2022-12-18	WOS:000221651900027
J	Baujat, G; Rio, M; Rossignol, S; Sanlaville, D; Lyonnet, S; Le Merrer, M; Munnich, A; Gicquel, C; Cormier-Daire, V; Colleaux, L				Baujat, G; Rio, M; Rossignol, S; Sanlaville, D; Lyonnet, S; Le Merrer, M; Munnich, A; Gicquel, C; Cormier-Daire, V; Colleaux, L			Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-HISTORY; FEATURES	Sotos syndrome is an overgrowth syndrome characterized by pre- and postnatal overgrowth, macrocephaly, advanced bone age, variable degrees of mental retardation, and typical facial features. Defects of the NSD1 gene account for greater than or equal to60% of cases of Sotos syndrome, whereas the disease-causing mechanism of other cases remains unknown. Beckwith-Wiedemann syndrome (BWS) is a distinct overgrowth condition characterized by macroglossia, abdominal-wall defects, visceromegaly, embryonic tumors, hemihyperplasia, ear anomalies, renal anomalies, and neonatal hypoglycemia. Deregulation of imprinted growth-regulatory genes within the 11p15 region is the major cause of BWS, whereas the molecular defect underlying a significant proportion of sporadic BWS cases remains unknown. Owing to clinical overlaps between the two syndromes, we investigated whether unexplained cases of Sotos syndrome could be related to 11p15 anomalies and, conversely, whether unexplained BWS cases could be related to NSD1 deletions or mutations. Two 11p15 anomalies were identified in a series of 20 patients with Sotos syndrome, and two NSD1 mutations were identified in a series of 52 patients with BWS. These results suggest that the two disorders may have more similarities than previously thought and that NSD1 could be involved in imprinting of the chromosome 11p15 region.	Hop Necker Enfants Malad, INSERM, U393, F-75743 Paris, France; Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France; Hop Armand Trousseau, Lab Explorat Fonct Endocriniennes, Paris, France; Hop Armand Trousseau, INSERM, U515, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Colleaux, L (corresponding author), Hop Necker Enfants Malad, INSERM, U393, Tour Lavoisier,149 Rue Sevres, F-75743 Paris, France.	colleaux@necker.fr	Rossignol, Sylvie/A-3439-2009; COLLEAUX, Laurence/H-6455-2017; ROSSIGNOL, Sylvie/A-8506-2012; COLLEAUX, LAURENCE/AAA-8144-2022; Lyonnet, Stanislas/H-5483-2017; Sanlaville, Damien/M-4716-2014; cormier-daire, valerie/H-6520-2017	COLLEAUX, LAURENCE/0000-0002-0987-7648; Lyonnet, Stanislas/0000-0001-5426-9417; Sanlaville, Damien/0000-0001-9939-2849; Rio, Marlene/0000-0003-2049-5058; ROSSIGNOL, Sylvie/0000-0003-1268-0632; cormier-daire, valerie/0000-0002-2839-9856				BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; COLE TRP, 1994, J MED GENET, V31, P20, DOI 10.1136/jmg.31.1.20; COLE TRP, 1990, J MED GENET, V27, P571, DOI 10.1136/jmg.27.9.571; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; ELLIOTT M, 1994, CLIN GENET, V46, P168; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Li M, 1998, AM J MED GENET, V79, P253; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Rio M, 2003, J MED GENET, V40, P436, DOI 10.1136/jmg.40.6.436; SOTOS JF, 1964, NEW ENGL J MED, V271, P109, DOI 10.1056/NEJM196407162710301	14	84	94	1	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					715	720		10.1086/383093	http://dx.doi.org/10.1086/383093			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	14997421	Bronze, Green Published			2022-12-18	WOS:000220280800010
J	Wall, JD; Frisse, LA; Hudson, RR; Di Rienzo, A				Wall, JD; Frisse, LA; Hudson, RR; Di Rienzo, A			Comparative linkage-disequilibrium analysis of the beta-globin hotspot in primates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION ANALYSIS; RECOMBINATION HOT-SPOTS; DNA-SEQUENCE VARIATION; MEIOTIC RECOMBINATION; GENE CONVERSION; STATISTICAL-METHOD; HELICAL STABILITY; CROSSOVER; REGION; HUMANS	Recombination rates vary both across the genome and between different species, but little information is available about the temporal and physical scales over which such rates change. To shed light on these questions, we performed a high-resolution analysis of a genomic region within the beta-globin gene cluster that is known to experience elevated recombination rates in humans. For this purpose, we developed new linkage disequilibrium-based methods that thoroughly search for subsets of the data with unusually high or unusually low estimated values of the population-recombination parameter (4Nr, where N is the effective population size and r is the crossover rate between adjacent base pairs). By resequencing a 15-kb segment in a human population sample, we were able to narrow the recombinational hotspot to a segment <2 kb in length that coincides with the &beta;-globin replication origin. In addition, we analyzed the orthologous region in samples of rhesus macaques and common chimpanzees. Whereas the analysis of the chimpanzee data is complicated by the sample structure, the macaque data imply that this region may not be a hotspot in that species. These results suggest a time scale for the evolution of hotspots in primates. Furthermore, they allow us to propose diverged sequence elements that may contribute to the differences in the recombinational landscape in the two species.	Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, Room 507F,920 E 58th St, Chicago, IL 60637 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772, R01HG002098] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 02098, F32 HG000219, R01 HG002772, HG 00219, HG 2772] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALADJEM MI, 1995, SCIENCE, V270, P815, DOI 10.1126/science.270.5237.815; Andolfatto P, 2000, GENETICS, V156, P257; ANDOLFATTO P, IN PRESS GENETICS; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; Ashburner M., 1989, DROSOPHILA LAB HDB; Badge RM, 2000, HUM MOL GENET, V9, P1239, DOI 10.1093/hmg/9.8.1239; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Deinard A, 1999, J HUM EVOL, V36, P687, DOI 10.1006/jhev.1999.0298; Deinard AS, 2002, J MED PRIMATOL, V31, P8, DOI 10.1034/j.1600-0684.2002.1o022.x; Dufour C, 2000, GENOMICS, V69, P14, DOI 10.1006/geno.2000.6313; Fearnhead P, 2001, GENETICS, V159, P1299; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; GROUDINE M, 1983, P NATL ACAD SCI-BIOL, V80, P7551, DOI 10.1073/pnas.80.24.7551; Huang YL, 2003, NUCLEIC ACIDS RES, V31, P3819, DOI 10.1093/nar/gkg562; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LI N, IN PRESS GENETICS; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; NATALE DA, 1992, P NATL ACAD SCI USA, V89, P2654, DOI 10.1073/pnas.89.7.2654; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; RATTRAY AJ, 1993, GENETICS, V134, P175; Rogers J, 2000, GENOMICS, V67, P237, DOI 10.1006/geno.2000.6245; Satta Y, 2001, GENES GENET SYST, V76, P159, DOI 10.1266/ggs.76.159; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; Smith RA, 1998, BLOOD, V92, P4415, DOI 10.1182/blood.V92.11.4415.423a07_4415_4421; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; True JR, 1996, GENETICS, V142, P507; Wall JD, 2000, MOL BIOL EVOL, V17, P156, DOI 10.1093/oxfordjournals.molbev.a026228; Wall JD, 2001, CURR OPIN GENET DEV, V11, P647, DOI 10.1016/S0959-437X(00)00248-3; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wiuf C, 2000, THEOR POPUL BIOL, V57, P357, DOI 10.1006/tpbi.2000.1462; Yip SP, 1999, HUM MOL GENET, V8, P1699, DOI 10.1093/hmg/8.9.1699; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	53	84	87	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1330	1340		10.1086/380311	http://dx.doi.org/10.1086/380311			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14628290	Green Published, Bronze			2022-12-18	WOS:000187491100010
J	Thye, T; Burchard, GD; Nilius, M; Muller-Myhsok, B; Horstmann, RD				Thye, T; Burchard, GD; Nilius, M; Muller-Myhsok, B; Horstmann, RD			Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAITS; IFN-GAMMA; IMMUNITY; RESPONSES; LOCUS; MAPS	Helicobacter pylori is considered the most prevalent infectious agent among humans, and it causes gastric inflammation, gastroduodenal ulcers, and a risk of gastric cancer. We performed a genomewide linkage analysis among Senegalese siblings phenotyped for H. pylori-reactive serum immunoglobulin G. A multipoint LOD score of 3.1 was obtained at IFNGR1, the gene that encodes chain 1 of the interferon-gamma (IFN-gamma) receptor. Sequencing of IFNGR1 revealed -56C-->T, H318P, and L450P variants, which were found to be associated with high antibody concentrations. The inclusion of these in the linkage analysis raised the LOD score to 4.2. The variants were more prevalent in Africans than in whites. Our findings indicate that IFN-gamma signaling plays an essential role in human H. pylori infection, and they contribute to an explanation of the observations of high prevalences and relatively low pathogenicity of H. pylori in Africa. Moreover, they provide further support for the value of genomewide linkage studies in the analysis of susceptibility to infection and other complex genetic traits.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Otto von Guericke University	Horstmann, RD (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.		Müller-Myhsok, Bertram/A-3289-2013					Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adams LJ, 1998, AM J HUM GENET, V62, P1084, DOI 10.1086/301826; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Blanchard TG, 1999, J INFECT DIS, V179, P725, DOI 10.1086/314617; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; DElios MM, 1997, J IMMUNOL, V158, P962; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; EVANS DJ, 1989, GASTROENTEROLOGY, V96, P1004, DOI 10.1016/0016-5085(89)91616-8; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; HOLCOMBE C, 1992, GUT, V33, P429, DOI 10.1136/gut.33.4.429; Kamradt AE, 2000, MICROBES INFECT, V2, P593, DOI 10.1016/S1286-4579(00)00367-1; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Marchildon P, 1999, AM J GASTROENTEROL, V94, P2105, DOI 10.1111/j.1572-0241.1999.01285.x; McKusick V.A., 1998, MENDELIAN INHERITANC; Merlin G, 1997, IMMUNOGENETICS, V45, P413, DOI 10.1007/s002510050223; Mitchell HN, 2002, SCAND J GASTROENTERO, V37, P517, DOI 10.1080/00365520252903044; MullerMyhsok B, 1997, AM J HUM GENET, V61, P452, DOI 10.1016/S0002-9297(07)64073-7; Nilius M, 2001, DIAGN MICR INFEC DIS, V41, P221, DOI 10.1016/S0732-8893(01)00306-6; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Schenkein HA, 2001, INFECT IMMUN, V69, P6612, DOI 10.1128/IAI.69.11.6612-6617.2001; Shtrichman R, 2001, CURR OPIN MICROBIOL, V4, P251, DOI 10.1016/S1369-5274(00)00199-5; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777	29	84	89	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					448	453		10.1086/367714	http://dx.doi.org/10.1086/367714			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12516030	Green Published, Bronze			2022-12-18	WOS:000180680000024
J	Qian, DJ; Beckmann, L				Qian, DJ; Beckmann, L			Minimum-recombinant haplotyping in pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; ALGORITHM; GENOME	This article presents a six-rule algorithm for the reconstruction of multiple minimum-recombinant haplotype configurations in pedigrees. The algorithm has three major features: First, it allows exhaustive search of all possible haplotype configurations under the criterion that there are minimum recombinants between markers. Second, its computational requirement is on the order of O(J(2)L(3)) in current implementation, where J is the family size and L is the number of marker loci under analysis. Third, it applies to various pedigree structures, with and without consanguinity relationship, and allows missing alleles to be imputed, during the haplotyping process, from their identical-by-descent copies. Haplotyping examples are provided using both published and simulated data sets.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ)	Qian, DJ (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St,CHP 218, Los Angeles, CA 90089 USA.				NATIONAL CANCER INSTITUTE [R01CA052862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058897] Funding Source: NIH RePORTER; NCI NIH HHS [CA 52862, R01 CA052862] Funding Source: Medline; NIGMS NIH HHS [GM 58897] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beckmann L, 2001, GENET EPIDEMIOL, V21, pS554, DOI 10.1002/gepi.2001.21.s1.s554; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANGE K, 1989, AM J HUM GENET, V45, P959; Lin SL, 1997, J COMPUT BIOL, V4, P535, DOI 10.1089/cmb.1997.4.535; LITT M, 1994, AM J HUM GENET, V55, P702; O'Connell JR, 2000, GENET EPIDEMIOL, V19, pS64, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI10>3.0.CO;2-G; Qian DJ, 2001, GENET EPIDEMIOL, V21, pS582, DOI 10.1002/gepi.2001.21.s1.s582; Sobel E, 1996, IMA VOLUMES MATH ITS, V81, P89; Tapadar P, 2000, HUM HERED, V50, P43, DOI 10.1159/000022890; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356	15	84	90	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1434	1445		10.1086/340610	http://dx.doi.org/10.1086/340610			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992251	Green Published, Bronze			2022-12-18	WOS:000175445700005
J	Mead, S; Mahal, SP; Beck, J; Campbell, T; Farrall, M; Fisher, E; Collinge, J				Mead, S; Mahal, SP; Beck, J; Campbell, T; Farrall, M; Fisher, E; Collinge, J			Sporadic - but not variant - Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP Exon 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRION PROTEIN GENE; CODON-129; GENOTYPE; CJD; LOCI; BSE	Human prion diseases have inherited, sporadic, and acquired etiologies. The appearance of the novel acquired prion disease, variant Creutzfeldt-Jakob disease (vCJD), and the demonstration that it is caused by the same prion strain as that causing bovine spongiform encephalopathy, has led to fears of a major human epidemic. The etiology of classical (sporadic) CJD, which has a worldwide incidence, remains obscure. A common human prion-protein-gene (PRNP) polymorphism (encoding either methionine or valine at codon 129) is a strong susceptibility factor for sporadic and acquired prion disease. However, a quantitative-trait-locus study of prion incubation periods in mice has demonstrated an important factor that is close to Prnp but is independent of its coding sequence or that of the nearby prion-like doppel gene (Prnd). We have analyzed the PRNP locus for such tightly linked susceptibility factors. Fifty-six polymorphic sites have been identified within 25 kb of the PRNP open reading frame, including sites within the PRNP promoter and the PRNP 3' untranslated region. These have been characterized in 61 Centre d'Etude du Polymorphisme Humain (CEPH) families, demonstrating extensive linkage disequilibrium around PRNP and the existence of 11 major European PRNP haplotypes. Haplotype frequencies estimated in healthy U.K. control individuals were very similar to those deduced in the CEPH families. A common haplotype was overrepresented in patients with sporadic CJD (sCJD). Through use of a log-linear modeling approach to simultaneously model Hardy-Weinberg and linkage disequilibria, a significant independent association was found between sCJD and a polymorphism upstream of PRNP exon 1 (P=.005), in addition to the strong susceptibility conferred by codon 129 (P=2 x 10(-8)). However, although our sample size was necessarily small, no association was found between these polymorphisms and vCJD or iatrogenic CJD, in keeping with their having distinct disease mechanisms. In addition, there was no evidence of a PRNP founder effect in the first reported geographical cluster of vCJD.	St Marys Hosp, Imperial Coll, MRC, Prion Unit, London W2 1PG, England; St Marys Hosp, Imperial Coll, Dept Neurogenet, London W2 1PG, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England	Imperial College London; Imperial College London; University of Oxford; Wellcome Centre for Human Genetics	Collinge, J (corresponding author), St Marys Hosp, Imperial Coll, MRC, Prion Unit, Praed St, London W2 1PG, England.		Mead, Simon/E-9414-2011; Fisher, Elizabeth/C-2168-2008	Mead, Simon/0000-0002-4326-1468; Fisher, Elizabeth/0000-0003-2850-9936				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; Berr C, 1998, NEUROLOGY, V51, P734, DOI 10.1212/WNL.51.3.734; BROWN P, 1987, NEUROLOGY, V37, P895, DOI 10.1212/WNL.37.6.895; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1992, BRAIN, V115, P687, DOI 10.1093/brain/115.3.687; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Cousens S, 2001, LANCET, V357, P1002, DOI 10.1016/S0140-6736(00)04236-7; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Mead S, 2000, NEUROSCI LETT, V290, P117, DOI 10.1016/S0304-3940(00)01319-7; OWEN F, 1990, AM J HUM GENET, V46, P1215; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Peoc'h K, 2000, NEUROSCI LETT, V286, P144, DOI 10.1016/S0304-3940(00)01100-9; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SALVATORE M, 1994, HUM GENET, V94, P375, DOI 10.1007/BF00201596; TIRET L, 1991, AM J HUM GENET, V48, P926; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1986, BIOMETRICS, V42, P665, DOI 10.2307/2531217; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; Zimmermann K, 1999, ACTA NEUROPATHOL, V97, P355, DOI 10.1007/s004010050998	28	84	84	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1225	1235		10.1086/324710	http://dx.doi.org/10.1086/324710			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704923	Green Published, Bronze			2022-12-18	WOS:000172086900007
J	Mejia, JE; Willmott, A; Levy, E; Earnshaw, WC; Larin, Z				Mejia, JE; Willmott, A; Levy, E; Earnshaw, WC; Larin, Z			Functional complementation of a genetic deficiency with human artificial chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAMMALIAN-CELLS; DNA-SEQUENCES; CENP-C; CENTROMERES; CONSTRUCTION; VECTORS; POLYETHYLENIMINE; GENERATION; SATELLITE; YEAST	We have shown functional complementation of a genetic deficiency in human cultured cells, using artificial chromosomes derived from cloned human genomic fragments. A 404-kb human-artificial-chromosome (HAC) vector, consisting of 220 kb of alphoid DNA from the centromere of chromosome 17, human telomeres, and the hypoxanthine guanine phosphoribosyltransferase (HPRT) genomic locus, was transferred to HPRT-deficient HT1080 fibrosarcoma cells. We generated several cell lines with low-copy-number, megabase-sized HACs containing a functional centromere and one or possibly several copies of the HPRT1 gene complementing the metabolic deficiency. The HACs consisted of alternating alphoid and nonalphoid DNA segments derived only from the input DNA (within the sensitivity limits of FISH detection), and the largest continuous alphoid segment was 158-250 kb. The study of both the structure and mitotic stability of these HACs offers insights into the mechanisms of centromere formation in synthetic chromosomes and will further the development of this human-gene-transfer technology.	Univ Oxford, Inst Mol Med, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh, Midlothian, Scotland	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh	Larin, Z (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.	zlarin@molbiol.ox.ac.uk	Earnshaw, William/AAY-7438-2020; Mejia, Jose Enrique/AAL-2278-2021; Mejia, Jose Enrique/K-1606-2014; Monaco, Zoia L/C-5762-2011	Mejia, Jose Enrique/0000-0002-2208-8870; Mejia, Jose Enrique/0000-0002-2208-8870; Earnshaw, William/0000-0002-7191-0621	Wellcome Trust [073915] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; CASKEY CT, 1979, CELL, V16, P1, DOI 10.1016/0092-8674(79)90182-X; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Ebersole TA, 2000, HUM MOL GENET, V9, P1623, DOI 10.1093/hmg/9.11.1623; FOLGER KR, 1982, MOL CELL BIOL, V2, P1372, DOI 10.1128/MCB.2.11.1372; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Henning KA, 1999, P NATL ACAD SCI USA, V96, P592, DOI 10.1073/pnas.96.2.592; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; LARIN Z, 1995, PULSED FIELD GEL ELE, P139; LUGO TG, 1983, SOMAT CELL GENET, V9, P175, DOI 10.1007/BF01543176; Marschall P, 1999, GENE THER, V6, P1634, DOI 10.1038/sj.gt.3300975; Mejia JE, 2000, GENOMICS, V70, P165, DOI 10.1006/geno.2000.6372; Mejia JE, 1997, GENOME RES, V7, P179, DOI 10.1101/gr.7.2.179; Mills W, 1999, HUM MOL GENET, V8, P751, DOI 10.1093/hmg/8.5.751; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Sena-Esteves M, 2000, MOL THER, V2, P9, DOI 10.1006/mthe.2000.0096; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Taylor SS, 1996, CHROMOSOMA, V105, P70, DOI 10.1007/BF02509516; TAYLOR SS, 1994, HUM MOL GENET, V3, P1383, DOI 10.1093/hmg/3.8.1383; Van Craenenbroeck K, 2000, EUR J BIOCHEM, V267, P5665, DOI 10.1046/j.1432-1327.2000.01645.x; Wade-Martins R, 2000, NAT BIOTECHNOL, V18, P1311, DOI 10.1038/82444; Watanabe Y, 2000, GENE, V252, P163, DOI 10.1016/S0378-1119(00)00208-0; Willard HF, 2000, SCIENCE, V290, P1308, DOI 10.1126/science.290.5495.1308; Willard HF, 1998, CURR OPIN GENET DEV, V8, P219, DOI 10.1016/S0959-437X(98)80144-5; Yang JW, 2000, HUM MOL GENET, V9, P1891, DOI 10.1093/hmg/9.12.1891; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	31	84	92	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					315	326		10.1086/321977	http://dx.doi.org/10.1086/321977			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11452360	Bronze, Green Published			2022-12-18	WOS:000170108200007
J	Thorstenson, YR; Shen, PD; Tusher, VG; Wayne, TL; Davis, RW; Chu, G; Oefner, PJ				Thorstenson, YR; Shen, PD; Tusher, VG; Wayne, TL; Davis, RW; Chu, G; Oefner, PJ			Global analysis of ATM polymorphism reveals significant functional constraint	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; ATAXIA-TELANGIECTASIA GENE; SINGLE-NUCLEOTIDE POLYMORPHISMS; BREAST-CANCER; Y-CHROMOSOME; LINKAGE DISEQUILIBRIUM; MUTATION DETECTION; SACCHAROMYCES-CEREVISIAE; STRANDED CONFORMATION; POPULATION EXPANSION	ATM, the gene that is mutated in ataxia-telangiectasia, is associated with cerebellar degeneration, abnormal proliferation of small blood vessels, and cancer. These clinically important manifestations have stimulated interest in defining the sequence variation in the ATM gene. Therefore, we undertook a comprehensive survey of sequence variation in ATM in diverse human populations. The protein-encoding exons of the gene (9,168 bp) and the adjacent intron and untranslated sequences (14,661 bp) were analyzed in 93 individuals from seven major human populations. In addition, the coding sequence was analyzed in one chimpanzee, one gorilla, one orangutan, and one Old World monkey. In human ATM, 88 variant sites were discovered by denaturing high-performance liquid chromatography, which is 96%-100% sensitive for detection of DNA sequence variation. ATM was compared to 14 other autosomal genes for nucleotide diversity. The noncoding regions of ATM had diversity values comparable to other genes, but the coding regions had very low diversity, especially in the last 29% of the protein sequence. A test of the neutral evolution hypothesis, through use of the Hudson/Kreitman/Aguade' statistic, revealed that this region of the human ATM gene was significantly constrained relative to that of the orangutan, the Old World monkey, and the mouse, but not relative to that of the chimpanzee or the gorilla. ATM displayed extensive linkage disequilibrium, consistent with suppression of meiotic recombination at this locus. Seven haplotypes were defined. Two haplotypes accounted for 82% of all chromosomes analyzed in all major populations; two others carrying the same D126E missense polymorphism accounted for 33% of chromosomes in Africa but were never observed outside of Africa. The high frequency of this polymorphism may be due either to a population expansion within Africa or to selective pressure.	Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Biochem, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Thorstenson, YR (corresponding author), Stanford Univ, Sch Med, Stanford Genome Technol Ctr, 855 Calif Ave, Palo Alto, CA 94304 USA.							Bay JO, 1999, HUM MUTAT, V14, P485, DOI 10.1002/(SICI)1098-1004(199912)14:6<485::AID-HUMU7>3.0.CO;2-T; Bay JO, 1998, INT J ONCOL, V12, P1385; Bebb DG, 1999, BRIT J CANCER, V80, P1979, DOI 10.1038/sj.bjc.6690630; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bonnen PE, 2000, AM J HUM GENET, V67, P1437, DOI 10.1086/316908; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Broeks A, 1998, HUM MUTAT, V12, P330, DOI 10.1002/(SICI)1098-1004(1998)12:5<330::AID-HUMU6>3.0.CO;2-H; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlo T, 1996, RNA, V2, P342; Castellvi-Bel S, 1999, HUM MUTAT, V14, P156, DOI 10.1002/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chen JD, 1998, CANCER RES, V58, P1376; Choy YS, 1999, ANN HUM GENET, V63, P383, DOI 10.1046/j.1469-1809.1999.6350383.x; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Dork T, 1997, MOL CELL PROBE, V11, P71, DOI 10.1006/mcpr.1996.0079; Ejima Y, 1998, HUM GENET, V102, P403, DOI 10.1007/s004390050712; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Gatti R., 2001, METABOLIC MOL BASIS, P705; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; GATTI RA, 1998, GENETIC BASIS HUMAN, P275; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Gordon D, 2000, GENOMICS, V66, P87, DOI 10.1006/geno.2000.6190; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Hacia JC, 1998, GENOME RES, V8, P1245, DOI 10.1101/gr.8.12.1245; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HUDSON RR, 1987, GENETICS, V116, P153; Huttley GA, 1999, GENETICS, V152, P1711; Janin N, 1999, BRIT J CANCER, V80, P1042, DOI 10.1038/sj.bjc.6690460; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Jones AC, 1999, CLIN CHEM, V45, P1133; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kimmel M, 1998, GENETICS, V148, P1921; LANGE E, 1995, AM J HUM GENET, V57, P112; Lavin MF, 1999, INT J BIOCHEM CELL B, V31, P735, DOI 10.1016/S1357-2725(99)00028-X; Li AR, 2000, AM J MED GENET, V92, P170, DOI 10.1002/(SICI)1096-8628(20000529)92:3<170::AID-AJMG3>3.0.CO;2-#; Li AR, 1999, AM J MED GENET, V86, P140, DOI 10.1002/(SICI)1096-8628(19990910)86:2<140::AID-AJMG10>3.3.CO;2-O; Maillet P, 1999, MOL CELL PROBE, V13, P67, DOI 10.1006/mcpr.1998.0219; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; MORRELL D, 1990, CANCER GENET CYTOGEN, V50, P119, DOI 10.1016/0165-4608(90)90245-6; MORRELL D, 1986, J NATL CANCER I, V77, P89; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Nachman MW, 1998, MOL BIOL EVOL, V15, P1744, DOI 10.1093/oxfordjournals.molbev.a025900; Nei M., 1987, MOL EVOLUTIONARY GEN; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266; OEFNER PJ, 1998, CURRENT PROTOCOLS HU; Olsen JH, 2001, JNCI-J NATL CANCER I, V93, P121, DOI 10.1093/jnci/93.2.121; Passarino G, 2001, GENOMICS, V71, P118, DOI 10.1006/geno.2000.6405; Platzer M, 1997, GENOME RES, V7, P592, DOI 10.1101/gr.7.6.592; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Sasaki T, 1998, HUM MUTAT, V12, P186, DOI 10.1002/(SICI)1098-1004(1998)12:3<186::AID-HUMU6>3.0.CO;2-F; Shayeghl M, 1998, BRIT J CANCER, V78, P922, DOI 10.1038/bjc.1998.602; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; SHERRY ST, 1994, HUM BIOL, V66, P761; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Telatar M, 1996, AM J HUM GENET, V59, P40; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Uziel T, 1996, GENOMICS, V33, P317, DOI 10.1006/geno.1996.0201; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Vorechovsky I, 1996, EUR J HUM GENET, V4, P352; Vorechovsky I, 1996, CANCER RES, V56, P2726; Wagner T, 1999, GENOMICS, V62, P369, DOI 10.1006/geno.1999.6026; Wagner TMU, 1999, HUM MOL GENET, V8, P413, DOI 10.1093/hmg/8.3.413; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354; Zietkiewicz E, 1997, GENE, V205, P161	79	84	92	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					396	412		10.1086/321296	http://dx.doi.org/10.1086/321296			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443540	Bronze, Green Published			2022-12-18	WOS:000170108200014
J	Longmate, JA				Longmate, JA			Complexity and power in case-control association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOMIC CONTROL	A general method is described for estimation of the power and sample size of studies relating a dichotomous phenotype to multiple interacting loci and environmental covariates. Either a simple case-control design or more complex stratified sampling may be used. The method can be used to design individual studies, to evaluate the power of alternative test statistics for complex traits, and to examine general questions of study design through explicit scenarios. The method is used here to study how the power of association tests is affected by problems of allelic heterogeneity and to investigate the potential role for collective testing of sets of related candidate genes in the presence of locus heterogeneity. The results indicate that allele-discovery efforts are crucial and that omnibus tests or collective testing of alleles can be substantially more powerful than separate testing of individual allelic variants. Joint testing of multiple candidate loci can also dramatically improve power, despite model misspecification and inclusion of irrelevant loci, but requires an a priori hypothesis defining the set of loci to investigate.	City Hope Natl Med Ctr, Dept Biostat, Duarte, CA 91010 USA; Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope	Longmate, JA (corresponding author), City Hope Natl Med Ctr, Dept Biostat, 1500 E Duarte Rd, Duarte, CA 91010 USA.			Longmate, Jeffrey/0000-0002-0869-7928	NCI NIH HHS [P30 CA033572, CA33572] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; BRESLOW NE, 1984, STAT METHODS CANC RE, V1; Brown BW, 1999, STAT MED, V18, P3137, DOI 10.1002/(SICI)1097-0258(19991130)18:22<3137::AID-SIM239>3.0.CO;2-O; Chambers J. M., 1998, PROGRAMMING DATA; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; GREENLAND S, 1985, STAT MED, V4, P117, DOI 10.1002/sim.4780040203; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Matthias C, 1998, PHARMACOGENETICS, V8, P91; O BRIEN R. G., 1986, P 11 ANN SAS US GROU, P778; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; SELF SG, 1992, BIOMETRICS, V48, P31, DOI 10.2307/2532736; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; SOBELL JL, 1992, GENOMICS, V12, P1, DOI 10.1016/0888-7543(92)90398-C; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	19	84	86	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1229	1237		10.1086/320106	http://dx.doi.org/10.1086/320106			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11294658	Green Published, Bronze			2022-12-18	WOS:000168171200016
J	Greer, WL; Dobson, MJ; Girouard, GS; Byers, DM; Riddell, DC; Neumann, PE				Greer, WL; Dobson, MJ; Girouard, GS; Byers, DM; Riddell, DC; Neumann, PE			Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NIEMANN-PICK-DISEASE; PROTEIN-KINASE-C; CHOLESTEROL HOMEOSTASIS; ZINC-FINGER; GENE; HEDGEHOG; SEQUENCE; PATHWAY; LINKAGE; REDUCTASE	Niemann-Pick type II disease is an autosomal recessive disorder characterized by a defect in intracellular trafficking of sterols. We have determined the intron/exon boundaries of eight exons from the conserved 3' portion of NPC1, the gene associated with most cases of the disease. SSCP analyses were designed for these exons and were used to identify the majority of mutations in 13 apparently unrelated families. Thirteen mutations were found, accounting for 13 of the 26 alleles. These mutations included eight different missense mutations (including one reported by Greer et al. [1998]), one 4-bp and two 2-bp deletions that generate premature stop codons, and two intronic mutations that are predicted to alter splicing. Two of the missense mutations were present in predicted transmembrane (TM) domains. Clustering of these and other reported NPC1 mutations in the carboxy-terminal third of the protein indicates that screening of these exons, by means of the SSCP analyses reported here, will detect most mutations. The carboxy-terminal half of the Npc1 protein shares amino acid similarity with the TM domains of the morphogen receptor Patched, with the largest stretch of unrelated sequence lying between two putative TM spans. Alignment of this portion of the human Npc1 protein sequence with Npc1-related sequences from mouse, yeast, nematode, and a plant, Arabinopsis, revealed conserved cysteine residues that may coordinate the structure of this domain. That 7 of a total of 13 NPC1 missense mutations are concentrated in this single Npc1-specific domain suggests that integrity of this region is particularly critical for normal functioning of the protein.	Dalhousie Univ, Dept Pathol, Div Mol Pathol & Mol Genet, Halifax, NS, Canada; Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Greer, WL (corresponding author), Queen Elizabeth 2 Hlth Sci Ctr, DNA Lab, Div Hematol, VG Site,Room 223B,Mackenzie Bldg,5788 Univ Ave, Halifax, NS B3H 1V8, Canada.	plmwlg@qe2-hsc.ns.ca		Neumann, Paul/0000-0002-8480-4799; Dobson, Melanie/0000-0001-9291-7200				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CARSTEA ED, 1993, P NATL ACAD SCI USA, V90, P2002, DOI 10.1073/pnas.90.5.2002; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Greer WL, 1997, AM J HUM GENET, V61, P139, DOI 10.1086/513899; Greer WL, 1998, AM J HUM GENET, V63, P52, DOI 10.1086/301931; Greer WL, 1999, CLIN GENET, V55, P248, DOI 10.1034/j.1399-0004.1999.550406.x; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hayashi K, 1991, PCR Methods Appl, V1, P34; HUBBARD SR, 1991, SCIENCE, V254, P1776; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Morris JA, 1999, BIOCHEM BIOPH RES CO, V261, P493, DOI 10.1006/bbrc.1999.1070; Morris JA, 1998, MOL MED TODAY, V4, P525, DOI 10.1016/S1357-4310(98)01374-4; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; OLENDER EH, 1992, J BIOL CHEM, V267, P4223; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; ROBINSON JS, 1991, MOL CELL BIOL, V11, P5813, DOI 10.1128/MCB.11.12.5813; SIDHU HS, 1993, BIOCHEM CELL BIOL, V71, P467, DOI 10.1139/o93-069; SPENCE MW, 1989, METABOLIC BASIS INHE, P1655; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vanier MT, 1996, AM J HUM GENET, V58, P118; Watari H, 1999, P NATL ACAD SCI USA, V96, P805, DOI 10.1073/pnas.96.3.805; WINSOR EJT, 1978, AM J HUM GENET, V30, P530	32	84	89	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1252	1260		10.1086/302620	http://dx.doi.org/10.1086/302620			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521290	Green Published, Bronze			2022-12-18	WOS:000083531000006
J	Feit, H; Silbergleit, A; Schneider, LB; Gutierrez, JA; Fitoussi, RP; Reyes, C; Rouleau, GA; Brais, B; Jackson, CE; Beckmann, JS; Seboun, E				Feit, H; Silbergleit, A; Schneider, LB; Gutierrez, JA; Fitoussi, RP; Reyes, C; Rouleau, GA; Brais, B; Jackson, CE; Beckmann, JS; Seboun, E			Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: Clinical description and gene localization to 5q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; LINKAGE ANALYSIS; MIYOSHI MYOPATHY; SYNDROME LOCUS; HUMAN GENOME; MAPS; IDENTIFICATION; LGMD2F	Distal myopathy refers to a heterogeneous group of disorders in which the initial manifestations are weakness and atrophy of the hands and feet. We report a family segregating an autosomal dominant distal myopathy, with multiple affected individuals in whom vocal cord and pharyngeal weakness may accompany the distal myopathy, without involvement of the ocular muscles. To our knowledge, this pedigree displays a distinct distal myopathy with the added features of pharyngeal and vocal cord dysfunction (VCPDM) that has not been previously reported. We mapped the MPD2 gene for VCPDM to chromosome 5q within a 12-cM linkage interval between markers D5S458 and D5S1972 in a large pedigree (a maximum LOD score of 12.94 at a recombination fraction of 0 for D5S393) and combined genome screening and DNA pooling successfully adapted to fluorescent markers. This technique provides for the possibility of fully automated genome scans.	Genethon, CNRS, URA 1922, F-91002 Evry, France; Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; Henry Ford Hosp, Dept Genet, Detroit, MI 48202 USA; McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada	Centre National de la Recherche Scientifique (CNRS); Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; McGill University	Seboun, E (corresponding author), Genethon, CNRS, URA 1922, 1 Rue Int, F-91002 Evry, France.		Beckmann, Jacques S/A-9772-2008; Brais, Bernard/Y-3910-2019	Beckmann, Jacques S/0000-0002-9741-1900; 				Askanas V., 1998, INCLUSION BODY MYOSI; ASKANAS V, 1998, INCLUSION BODY MYOSI, P3; Bartoloni L, 1997, AM J HUM GENET, V61, pA267; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; BROOKE MH, 1986, CLIN VIEW NEUROMUSCU, P174; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Damji KF, 1998, HUM GENET, V102, P207, DOI 10.1007/s004390050679; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FARDEAU M, 1998, INCLUSION BODY MYOSI, P252; Griggs RC, 1994, MYOLOGY, P1246; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; Ikeuchi T, 1997, ANN NEUROL, V41, P432, DOI 10.1002/ana.410410405; Illarioshkin SN, 1996, BRAIN, V119, P1895, DOI 10.1093/brain/119.6.1895; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAING NG, 1995, AM J HUM GENET, V56, P422; Nielsen MS, 1996, BBA-GENE STRUCT EXPR, V1306, P14, DOI 10.1016/0167-4781(95)00239-1; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PassosBueno MR, 1996, HUM MOL GENET, V5, P815, DOI 10.1093/hmg/5.6.815; PERLIN MW, 1995, AM J HUM GENET, V57, P1199; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Speer MC, 1998, J MED GENET, V35, P305, DOI 10.1136/jmg.35.4.305; Tome F, 1994, MYOLOGY, P1233; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Vignal Alain, 1993, V1, P211; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Weiler T, 1996, AM J HUM GENET, V59, P872; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YOUNG ID, 1980, J NEUROL NEUROSUR PS, V43, P413, DOI 10.1136/jnnp.43.5.413	33	84	85	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1732	1742		10.1086/302166	http://dx.doi.org/10.1086/302166			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837826	Green Published, Bronze			2022-12-18	WOS:000077707700019
J	Hejtmancik, JF				Hejtmancik, JF			The genetics of cataract: Our vision becomes clearer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HEAT-SHOCK PROTEIN; TRANSGENIC MICE; CRYSTALLIN GENE; CONGENITAL CATARACT; ALPHA-CRYSTALLIN; BETA-CRYSTALLIN; HEREDITARY CATARACT; ECTOPIC EXPRESSION; LENS; GAMMA		NEI, OGCSB, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hejtmancik, JF (corresponding author), NEI, OGCSB, NIH, Bldg 10,Room 10B10,10 Ctr Dr,MSC 1860, Bethesda, MD 20892 USA.	f3h@helix.nih.gov						ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; Berry V, 1996, HUM MOL GENET, V5, P415, DOI 10.1093/hmg/5.3.415; Bloemendal H, 1997, CELL MOL LIFE SCI, V53, P1, DOI 10.1007/PL00000571; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CARTER JM, 1995, EXP EYE RES, V60, P181, DOI 10.1016/S0014-4835(95)80009-3; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; Chepelinsky A. B., 1997, Investigative Ophthalmology and Visual Science, V38, pS934; CONNEALLY PM, 1978, CYTOGENET CELL GENET, V22, P295, DOI 10.1159/000130957; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; Dunia I, 1996, J CELL BIOL, V132, P701, DOI 10.1083/jcb.132.4.701; EGWUAGU CE, 1994, INVEST OPHTH VIS SCI, V35, P332; EHLING UH, 1991, ANNU REV GENET, V25, P255, DOI 10.1146/annurev.ge.25.120191.001351; EIBERG H, 1988, CLIN GENET, V34, P272; EIBERG H, 1995, HUM GENET, V96, P33, DOI 10.1007/BF00214183; EVA A, 1991, NEW BIOL, V3, P158; GEIGER K, 1994, INVEST OPHTH VIS SCI, V35, P2667; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Graw J, 1996, OPHTHALMIC RES, V28, P8, DOI 10.1159/000267936; GRIEP AE, 1993, J VIROL, V67, P1373, DOI 10.1128/JVI.67.3.1373-1384.1993; GRUIJTERS WTM, 1987, J CELL BIOL, V104, P565, DOI 10.1083/jcb.104.3.565; HEAD MW, 1995, EXP EYE RES, V61, P423, DOI 10.1016/S0014-4835(05)80137-X; Hejtmancik J. F., 1995, METABOLIC MOL BASES, P4325; HORWITZ J, 1993, INVEST OPHTH VIS SCI, V34, P10; KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112; Kantorow M., 1997, Investigative Ophthalmology and Visual Science, V38, pS205; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kramer P, 1996, GENOMICS, V35, P539, DOI 10.1006/geno.1996.0395; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; LIU J, 1994, INVEST OPHTH VIS SCI, V35, P388; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; Mackay D, 1997, AM J HUM GENET, V60, P1474, DOI 10.1086/515468; MAHON KA, 1987, SCIENCE, V235, P1622, DOI 10.1126/science.3029873; Mitton KP, 1996, J BIOL CHEM, V271, P31803, DOI 10.1074/jbc.271.50.31803; OGATA H, 1979, TRANSFUSION, V19, P166, DOI 10.1046/j.1537-2995.1979.19279160286.x; PADMA T, 1995, AM J HUM GENET, V57, P840; PEREZCASTRO AV, 1993, DEVELOPMENT, V119, P363; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; RENWICK J H, 1970, Journal of Medical Genetics, V7, P239, DOI 10.1136/jmg.7.3.239; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; RODRIGUEZ IR, 1992, BIOCHIM BIOPHYS ACTA, V1180, P44, DOI 10.1016/0925-4439(92)90025-I; Rosmini Francesco, 1994, Annals of Epidemiology, V4, P266; SANTHIYA ST, 1995, GRAEF ARCH CLIN EXP, V233, P795, DOI 10.1007/BF00184093; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; SHALINI VK, 1994, INDIAN J BIOCHEM BIO, V31, P261; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; SINGH DP, 1995, J IMMUNOL, V155, P993; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; STAMBOLIAN D, 1990, AM J HUM GENET, V47, P13; Steele E C Jr, 1997, Mol Vis, V3, P5	57	84	89	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					520	525		10.1086/301774	http://dx.doi.org/10.1086/301774			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497271	Green Published, Bronze			2022-12-18	WOS:000072894400004
J	Buraczynska, M; Wu, WP; Fujita, R; Buraczynska, K; Phelps, E; Andreasson, S; Bennett, J; Birch, DG; Fishman, GA; Hoffman, DR; Inana, G; Jacobson, SG; Musarella, MA; Sieving, PA; Swaroop, A				Buraczynska, M; Wu, WP; Fujita, R; Buraczynska, K; Phelps, E; Andreasson, S; Bennett, J; Birch, DG; Fishman, GA; Hoffman, DR; Inana, G; Jacobson, SG; Musarella, MA; Sieving, PA; Swaroop, A			Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; RCC1; HOMOLOGY	The RPGR (retinitis pigmentosa GTPase regulator) gene for RP3, the most frequent genetic subtype of X-linked retinitis pigmentosa (XLRP), has been shown to be mutated in 10%-15% of European XLRP patients. We have examined the RPGR gene for mutations in a cohort of 80 affected males from apparently unrelated XLRP families, by direct sequencing of the PCR-amplified products from the genomic DNA. Fifteen different putative disease-causing mutations were identified in 17 of the 80 families; these include four nonsense mutations, one missense mutation, six microdeletions, and four intronic-sequence substitutions resulting in splice defects. Most of the mutations were detected in the conserved N-terminal region of the RPGR protein, containing tandem repeats homologous to those present in the RCC-1 protein (a guanine nucleotide-exchange factor for Ran-GTPase). Our results indicate that mutations either in as yet uncharacterized sequences of the RPGR gene or in another gene located in its vicinity may be a more frequent cause of XLRP. The reported studies will be beneficial in establishing genotype-phenotype correlations and should lead to further investigations seeking to understand the mechanism of disease pathogenesis.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA; Univ Michigan, WK Kellogg Eye Ctr, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Lund, Dept Ophthalmol, Lund, Sweden; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; Univ Penn, Inst Human Gene Therapy, Philadelphia, PA 19104 USA; Retina Fdn SW, Dallas, TX USA; Univ Illinois, Eye & Ear Infirm, Chicago, IL 60612 USA; Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA; Univ Toronto, Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lund University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Retina Foundation of the Southwest; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Bascom Palmer Eye Institute; University of Miami; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Swaroop, A (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol, 1000 Wall St, Ann Arbor, MI 48105 USA.	swaroop@umich.edu		Birch, David/0000-0002-6594-2897; Fujita, Ricardo/0000-0002-9617-5109; Swaroop, Anand/0000-0002-1975-1141; Jacobson, Samuel/0000-0003-2122-169X	NATIONAL EYE INSTITUTE [R01EY007961, R01EY010820, R29EY007961, R01EY005627] Funding Source: NIH RePORTER; NEI NIH HHS [EY07961, EY10820, EY05627] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aldred MA, 1994, MOL GENETICS INHERIT, P259; Andreasson S, 1997, AM J OPHTHALMOL, V124, P95; Beaudet AL, 1996, HUM MUTAT, V8, P197; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Bruns G, 1997, INVEST OPHTH VIS SCI, V38, P3178; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; FISHMAN GA, IN PRESS ARCH OPHTHA; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Fujita R, 1996, Mol Vis, V2, P4; Jacobson SG, 1997, INVEST OPHTH VIS SCI, V38, P1983; Knebelmann B, 1996, AM J HUM GENET, V59, P1221; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; TEAGUE PW, 1994, AM J HUM GENET, V55, P105	19	84	89	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1287	1292		10.1086/301646	http://dx.doi.org/10.1086/301646			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399904	Green Published, hybrid			2022-12-18	WOS:000071555900011
J	Kaplan, NL; Martin, ER; Weir, BS				Kaplan, NL; Martin, ER; Weir, BS			Power studies for the transmission/disequilibrium tests with multiple alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MONTE-CARLO TESTS; LINKAGE DISEQUILIBRIUM; MARKER LOCI; ASSOCIATION; SIMULATION; DISEASE	Case-control studies compare marker-allele distributions in affected and unaffected individuals, and significant results suggest linkage but may simply reflect population structure. For markers with m alleles (m greater than or equal to 2), a McNemar-like statistic, I, estimates the level of population association between marker and disease loci. To test for linkage after significant case-control tests, within-family tests are performed. These operate on the contingency table, with i, jth element equal to the number of parents that transmit marker allele M(i) and do not transmit marker allele M(j) to an affected offspring. The dimension of the table is the number of alleles at the marker locus. Three test statistics have recently been proposed in the literature: T-c compares symmetric pairs of cells (i, j) and (j, i), T-m compares row and column totals for the same marker allele, and a likelihood ratio statistic T-l uses all the cells in the table. In addition, we consider a new statistic, T-mhet, that uses only the heterozygous parents and is approximately chi(2) With (m - 1) df. We use a Monte Carlo test to guarantee valid tests and to demonstrate the inferiority of T-c and the equality of T-m and T-l in terms of power. The power of the T-mhet test is close but not always equal to the power of the T-m test. We also show that under the alternative hypothesis of linkage, T-m is approximately noncentral chi(2) with (m - 1) df and noncentrality parameter 2N(T)(1 - 2 theta)I-2*, when data on single affecteds in N-T families are used. If the disease has a low population frequency, then I* is estimated using the case-control statistic I. This offers a basis for choosing sample size, or choosing a marker system.	N CAROLINA STATE UNIV,DEPT STAT,PROGRAM STAT GENET,RALEIGH,NC 27695	University of North Carolina; North Carolina State University	Kaplan, NL (corresponding author), NIEHS,BIOSTAT BRANCH,POB 12233,RES TRIANGLE PK,NC 27709, USA.				NIGMS NIH HHS [P01 GM45344, T32 GM08443] Funding Source: Medline; NINDS NIH HHS [R01 NS23360] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344, T32GM008443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023360] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnard G., 1963, J R STAT SOC B, V25, P294; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Bishop YM., 2007, DISCRETE MULTIVARIAT; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; HALL P, 1989, J ROY STAT SOC B MET, V51, P459; Hodge SE, 1995, GENET EPIDEMIOL, V12, P545, DOI 10.1002/gepi.1370120604; Holmans P, 1995, GENET EPIDEMIOL, V12, P613, DOI 10.1002/gepi.1370120615; JIN K, 1994, BIOMETRICS, V50, P1189, DOI 10.2307/2533457; KNAPP M, 1993, AM J HUM GENET, V52, P1085; LEHMANN EL, 1986, TESTING STATISTICAL; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; McGinnis RE, 1995, GENET EPIDEMIOL, V12, P637, DOI 10.1002/gepi.1370120619; ODEN NL, 1991, J AM STAT ASSOC, V86, P1074, DOI 10.2307/2290526; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1996, AM J HUM GENET, V59, P986; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THOMSON G, 1995, AM J HUM GENET, V57, P487; Weir B., 1996, GENETIC DATA ANAL	25	84	87	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					691	702						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042930				2022-12-18	WOS:A1997WK40300027
J	Chen, HM; Rossier, C; Lalioti, MD; Lynn, A; Chakravarti, A; Perrin, G; Antonarakis, SE				Chen, HM; Rossier, C; Lalioti, MD; Lynn, A; Chakravarti, A; Perrin, G; Antonarakis, SE			Cloning of the cDNA for a human homologue of the Drosophila white gene and mapping to chromosome 21q22.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEROXISOMAL MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; EXON AMPLIFICATION; DOWN-SYNDROME; CYSTIC-FIBROSIS; ABC TRANSPORTER; TRANSCRIPT MAP; HUMAN GENOME; LINKAGE MAP; MELANOGASTER	In an effort to contribute to the transcript map of human chromosome 21 and the understanding of the pathophysiology of trisomy 21, we have used exon trapping to identify fragments of chromosome 21 genes. Two trapped exons, from pools of chromosome 21-specific cosmids, showed homology to the Drosophila white (w) gene. We subsequently cloned the corresponding cDNA for a human homologue of the Drosophila w gene (hW) from human retina and fetal brain cDNA libraries. The gene belongs to the ATP-binding cassette transporter gene family and is homologous to Drosophila rrl (and to w genes from other species) and to a lesser extent to Drosophila brown (bw) and scarlet (st) genes that are all involved in the transport of eye pigment precursor molecules. A DNA polymorphism with 62% heterozygosity due to variation of a poly (T) region in the 3' UTR of the hW has been identified and used for the incorporation of this gene to the genetic map of chromosome 21. The hW is located at 21q22.3 between DNA markers D21S212 and D21S49 in a P1 clone that also contains marker BCEI. The gene is expressed at various levels in many human tissues. The contributions of this gene to the Down syndrome phenotypes, to human eye color, and to the resulting phenotypes of null or missense mutations are presently unknown.	UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,LAB HUMAN MOL GENET,CH-1211 GENEVA 4,SWITZERLAND; CANTONAL HOSP,DIV MED GENET,GENEVA,SWITZERLAND; CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106	University of Geneva; University of Geneva; Case Western Reserve University			Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTONARAKIS SE, 1993, TRENDS GENET, V9, P142, DOI 10.1016/0168-9525(93)90210-9; ANTONARAKIS SE, 1995, HUMAN GENE MAPPING 1, P732; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Besansky NJ, 1995, INSECT MOL BIOL, V4, P217, DOI 10.1111/j.1365-2583.1995.tb00027.x; BINGHAM PM, 1981, CELL, V25, P693, DOI 10.1016/0092-8674(81)90176-8; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHENG JF, 1994, GENOMICS, V23, P75, DOI 10.1006/geno.1994.1461; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CHURCH DM, 1993, HUM MOL GENET, V2, P1915, DOI 10.1093/hmg/2.11.1915; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; DREESEN TD, 1988, MOL CELL BIOL, V8, P5206, DOI 10.1128/MCB.8.12.5206; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; EWART GD, 1994, J BIOL CHEM, V269, P10370; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; *GIBC BRL, 1994, 18449017 GIBC BRL; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; ICHIKAWA H, 1993, NAT GENET, V4, P361, DOI 10.1038/ng0893-361; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; LUCENTE D, 1995, HUM MOL GENET, V4, P1305, DOI 10.1093/hmg/4.8.1305; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NIZETIC D, 1994, HUM MOL GENET, V3, P759, DOI 10.1093/hmg/3.5.759; OHARE K, 1984, J MOL BIOL, V180, P437, DOI 10.1016/0022-2836(84)90021-4; Patterson D, 1993, Prog Clin Biol Res, V384, P33; PEPLING M, 1990, NUCLEIC ACIDS RES, V18, P1633, DOI 10.1093/nar/18.6.1633; PETERSON A, 1994, HUM MOL GENET, V3, P1735, DOI 10.1093/hmg/3.10.1735; QIN SL, 1990, J BIOL CHEM, V265, P1903; RIORDAN JR, 1989, SCIENCE, V245, P1066; SERVOS J, 1993, MOL GEN GENET, V236, P214, DOI 10.1007/BF00277115; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SOEDA E, 1995, GENOMICS, V25, P73, DOI 10.1016/0888-7543(95)80111-X; TASSONE F, 1995, HUM MOL GENET, V4, P1509, DOI 10.1093/hmg/4.9.1509; TEARLE RG, 1989, GENETICS, V122, P595; VALLE D, 1993, NATURE, V361, P682, DOI 10.1038/361682a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; XU HX, 1995, GENOMICS, V27, P1, DOI 10.1006/geno.1995.1001; YASPO ML, 1995, HUM MOL GENET, V4, P1291, DOI 10.1093/hmg/4.8.1291; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525; ZWIEBEL LJ, 1995, SCIENCE, V270, P2005, DOI 10.1126/science.270.5244.2005	56	84	95	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					66	75						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659545				2022-12-18	WOS:A1996VL45500011
J	Takayama, K; Salazar, EP; Broughton, BC; Lehmann, AR; Sarasin, A; Thompson, LH; Weber, CA				Takayama, K; Salazar, EP; Broughton, BC; Lehmann, AR; Sarasin, A; Thompson, LH; Weber, CA			Defects in the DNA repair and transcription gene ERCC2(XPD) in trichothiodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							XERODERMA-PIGMENTOSUM; SACCHAROMYCES-CEREVISIAE; COMPLEMENTATION GROUP; ULTRAVIOLET-LIGHT; HELICASE; CLONING; HETEROGENEITY; DISORDER; RAD3	Trichothiodystrophy (TTD) is a rare autosomal recessive disorder characterized by brittle hair with reduced sulfur content, ichthyosis, peculiar face, and mental and growth retardation. Clinical photosensitivity is present in similar to 50% of TTD patients but is not associated with an elevated frequency of cancers. Previous complementation studies show that the photosensitivity in nearly all of the studied patients is due to a defect in the same genetic locus that underlies the cancer-prone genetic disorder xeroderma pigmentosum group D (XP-D). Nucleotide-sequence analysis of the ERCC2 cDNA from three TTD cell strains (TTD1VI, TTD3VI, and TTD1RO) revealed mutations within the region from amino acid 713-730 and within previously identified helicase functional domains. The various clinical presentations and DNA repair characteristics of the cell strains can be correlated with the particular mutations found in the ERCC2 locus. Mutations of Arg658 to either His or Cys correlate with TTD cell strains with intermediate UV-sensitivity, mutation of Arg722 to Trp correlates with highly UV-sensitive TTD cell strains, and mutation of Arg683 to Trp correlates with XP-D. Alleles with mutation of Arg616 to Pro or with the combined mutation of Leu461 to Val and deletion of 716-730 are found in both XP-D and TTD cell strains.	LAWRENCE LIVERMORE NATL LAB,BIOL & BIOTECHNOL RES PROGRAM,LIVERMORE,CA 94551; UNIV SUSSEX,MRC,CELL MUTAT UNIT,BRIGHTON BN1 9RR,E SUSSEX,ENGLAND; INST RECH SCI CANC,GENET MOLEC LAB,VILLEJUIF,FRANCE	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Sussex				Salazar, Edmund/0000-0003-0509-6008	NATIONAL CANCER INSTITUTE [R01CA052679] Funding Source: NIH RePORTER; NCI NIH HHS [CA52679] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILLY V, 1991, P NATL ACAD SCI USA, V88, P9712, DOI 10.1073/pnas.88.21.9712; BOOTSMA D, 1994, MUTAT RES, V307, P15, DOI 10.1016/0027-5107(94)90273-9; BROUGHTON BC, 1994, NAT GENET, V7, P189, DOI 10.1038/ng0694-189; BROUGHTON BC, 1995, AM J HUM GENET, V56, P167; BROUGHTON BC, 1990, MUTAT RES, V235, P33, DOI 10.1016/0921-8777(90)90020-6; BROUGHTON BC, IN PRESS MUTAT RES; Coletta Luis Della, 1995, Genomics, V26, P70; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; EVENO E, 1995, CANCER RES, V55, P4325; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FREDERICK GD, 1994, HUM MOL GENET, V3, P1783, DOI 10.1093/hmg/3.10.1783; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713; GUZDER SN, 1995, J BIOL CHEM, V270, P17660, DOI 10.1074/jbc.270.30.17660; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; JOHNSON RT, 1985, J CELL SCI, V76, P115; JOHNSON RT, 1992, MUTAT RES, V273, P97, DOI 10.1016/0921-8777(92)90072-B; KIRCHNER JM, 1994, GENOMICS, V23, P592, DOI 10.1006/geno.1994.1547; KLEIJER WJ, 1994, AM J MED GENET, V52, P227, DOI 10.1002/ajmg.1320520220; LEHMANN AR, 1988, CANCER RES, V48, P6090; LEHMANN AR, 1977, CANCER RES, V37, P904; LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6; MARIANI E, 1992, CLIN EXP IMMUNOL, V88, P376; MEZZINA M, 1994, CARCINOGENESIS, V15, P1493, DOI 10.1093/carcin/15.8.1493; MURRAY JM, 1992, NUCLEIC ACIDS RES, V20, P2673, DOI 10.1093/nar/20.11.2673; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; SARASIN A, 1992, BRIT J DERMATOL, V127, P485, DOI 10.1111/j.1365-2133.1992.tb14845.x; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; STEFANINI M, 1993, AM J HUM GENET, V53, P817; STORMO GD, 1987, NUCLEIC ACID PROTEIN, P231; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; TAKAYAMA K, 1995, CANCER RES, V55, P5656; VANNESTE D, 1989, TRENDS IN HUMAN HAIR GROWTH AND ALOPECIA RESEARCH, P195; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x	39	84	85	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					263	270						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571952				2022-12-18	WOS:A1996TR79100002
J	COHEN, MM; STRASS, E				COHEN, MM; STRASS, E			STATEMENT OF THE AMERICAN-SOCIETY-OF-HUMAN-GENETICS ON GENETIC TESTING FOR BREAST-CANCER AND OVARIAN-CANCER PREDISPOSITION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL BREAST; LINKAGE		AMER SOC HUMAN GENET,EXECUT OFF,BETHESDA,MD 20814									Andrews L. B., 1994, ASSESSING GENERIC RI; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; EASTON DF, 1993, AM J HUM GENET, V52, P678; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; LERMAN C, 1994, J CLIN ONCOL, V12, P843, DOI 10.1200/JCO.1994.12.4.843; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1994, JAMA-J AM MED ASSOC, V271, P785; 1992, AM J HUM GENET, V51, P1443; 1987, AM J HUM GENET, V40, P75	14	84	84	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					R1	R4						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682					2022-12-18	WOS:A1994QB68200001
J	BENJAMIN, CM; ADAM, S; WIGGINS, S; THEILMANN, JL; COPLEY, TT; BLOCH, M; SQUITIERI, F; MCKELLIN, W; COX, S; BROWN, SA; KREMER, HPH; BURGESS, M; MESHINO, W; SUMMERS, A; MACGREGOR, D; BUCHANAN, J; GREENBERG, C; CARSON, N; IVES, E; FRECKER, M; WELCH, JP; FULLER, A; ROSENBLATT, D; MILLER, S; DUFRASNE, S; ROY, M; ANDERMANN, E; PREVOST, C; KHALIFA, M; GIRARD, K; TAYLOR, S; HUNTER, A; GOLDSMITH, C; WHELAN, D; EISENBERG, D; SOLTAN, H; KANE, J; SHOKEIR, MHK; GIBSON, A; CARDWELL, S; BAMFORTH, S; GROVER, S; SUCHOWERSKY, O; KLIMEK, M; GARBER, T; GARDNER, HA; MACLEOD, P; HAYDEN, MR				BENJAMIN, CM; ADAM, S; WIGGINS, S; THEILMANN, JL; COPLEY, TT; BLOCH, M; SQUITIERI, F; MCKELLIN, W; COX, S; BROWN, SA; KREMER, HPH; BURGESS, M; MESHINO, W; SUMMERS, A; MACGREGOR, D; BUCHANAN, J; GREENBERG, C; CARSON, N; IVES, E; FRECKER, M; WELCH, JP; FULLER, A; ROSENBLATT, D; MILLER, S; DUFRASNE, S; ROY, M; ANDERMANN, E; PREVOST, C; KHALIFA, M; GIRARD, K; TAYLOR, S; HUNTER, A; GOLDSMITH, C; WHELAN, D; EISENBERG, D; SOLTAN, H; KANE, J; SHOKEIR, MHK; GIBSON, A; CARDWELL, S; BAMFORTH, S; GROVER, S; SUCHOWERSKY, O; KLIMEK, M; GARBER, T; GARDNER, HA; MACLEOD, P; HAYDEN, MR			PROCEED WITH CARE - DIRECT PREDICTIVE TESTING FOR HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELAYED-ONSET DISEASE; PRESYMPTOMATIC DIAGNOSIS; REPEAT LENGTH; ATTITUDES; EXPERIENCE; RISK; GENE; MUTATIONS; EXPANSION; PROTOCOL	The cloning of the Huntington disease (HD) gene allows highly accurate predictive testing using direct analysis of the CAG repeat. This new test provides results with almost complete certainty but poses unique counseling issues related to direct testing for an adult-onset disease. These include testing individuals who are at 25% risk, without the need for blood from a 50% at risk relative; the assessment of symptomatic individuals; the need for ongoing counseling despite simplification of laboratory procedures; and counseling of persons from families who represent a new mutation for HD. This paper describes protocols for direct predictive testing for adult and prenatal assessment, on the basis of the experience of the Canadian Collaborative Study on Predictive Testing (CCSPT). Over the past 8 years, we have provided >400 results by using linked markers and, more recently, 416 results by using direct assessment of CAG expansion in the HD gene. The vast majority (86%) of requests for direct predictive testing have been from persons who have not previously received results by using linked markers. Despite the ability to now directly assess for the mutation associated with HD, we still recommend assessment of DNA from an affected relative, as this may significantly enhance the accuracy of information to be provided to the at-risk individual. Distance from a genetics center has previously limited the availability of testing, and therefore we have developed approaches to providing predictive testing in the patient's own community.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V5K 2H5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT ANTHROPOL & SOCIOL,VANCOUVER V6T 2B2,BC,CANADA; UNIV CALGARY,DEPT BIOETH,CALGARY,AB,CANADA; ALBERTA CHILDRENS PROV GEN HOSP,CALGARY T2T 5C7,AB,CANADA; N YORK GEN HOSP,N YORK,ON,CANADA; CHILDRENS HOSP,WINNIPEG R3A 1S1,MB,CANADA; MEM UNIV NEWFOUNDLAND,ST JOHNS,NF,CANADA; DALHOUSIE UNIV,HALIFAX,NS,CANADA; MCGILL UNIV,MONTREAL,PQ,CANADA; CHICOUTIMI HOSP,DEPT GENET,CHICOUTIMI,PQ,CANADA; QUEENS UNIV,KINGSTON,ON,CANADA; CHILDRENS HOSP EASTERN ONTARIO,OTTAWA K1H 8L1,ON,CANADA; MCMASTER UNIV,MED CTR,HAMILTON,ON,CANADA; CHILDRENS HOSP WESTERN ONTARIO,LONDON,ON,CANADA; ROYAL UNIV HOSP,SASKATOON,SK,CANADA; UNIV ALBERTA HOSP,EDMONTON T6G 2B7,AB,CANADA; OSHAWA GEN HOSP,OSHAWA,ON,CANADA; ROYAL VICTORIA HOSP,VICTORIA,BC,CANADA	University of British Columbia; University of British Columbia; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; Memorial University Newfoundland; Dalhousie University; McGill University; Queens University - Canada; University of Ottawa; Children's Hospital of Eastern Ontario; McMaster University; Western University (University of Western Ontario); University of Saskatchewan; University of Alberta; McGill University			McKellin, William H/M-9325-2013; Hayden, Michael R/D-8581-2011; Squitieri, Ferdinando/N-1852-2019	McKellin, William H/0000-0002-1217-3035; Hayden, Michael R/0000-0001-5159-1419; Squitieri, Ferdinando/0000-0002-7397-1727; Benjamin, Caroline/0000-0002-0021-3650; Copley, Tobin/0000-0003-1791-2711; Adam, Shelin/0000-0002-4401-6157				ADAM S, 1993, J MED GENET, V30, P549, DOI 10.1136/jmg.30.7.549; ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ANDREW SE, 1994, AM J HUM GENET, V54, P852; BABUL R, 1993, JAMA-J AM MED ASSOC, V270, P2321, DOI 10.1001/jama.270.19.2321; Beck A. T., 1960, ARCH GEN PSYCHIAT, V4, P53, DOI DOI 10.1001/ARCHPSYC.1961.01710120031004; Bennett R L, 1993, J Genet Couns, V2, P123, DOI 10.1007/BF00962073; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BLOCH M, 1989, AM J MED GENET, V32, P217, DOI 10.1002/ajmg.1320320215; BLOCH M, 1993, AM J MED GENET, V47, P368, DOI 10.1002/ajmg.1320470314; BLOCH M, 1992, AM J MED GENET, V42, P499, DOI 10.1002/ajmg.1320420416; BLOCH M, 1990, AM J HUM GENET, V46, P1; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; CHAPMAN MA, 1990, AM J HUM GENET, V47, P1; COPLEY TT, 1993, AM J HUM GENET, V53, P53; CRAUFURD D, 1992, J MED GENET, V29, P915, DOI 10.1136/jmg.29.12.915; DEROGATIS LR, 1975, SCL 90R; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FOX S, 1989, AM J MED GENET, V32, P211, DOI 10.1002/ajmg.1320320214; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1993, J MED GENET, V30, P987, DOI 10.1136/jmg.30.12.987; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Harper PS, 1991, HUNTINGTONS DISEASE; HARPER PS, 1993, J MED GENET, V30, P1020; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HUGGINS M, 1992, AM J MED GENET, V42, P508, DOI 10.1002/ajmg.1320420417; HUGGINS M, 1990, AM J HUM GENET, V47, P4; KESSLER S, 1987, AM J ORTHOPSYCHIAT, V57, P212, DOI 10.1111/j.1939-0025.1987.tb03531.x; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; LAM R, 1990, J CLIN PSYCHOL, V49, P444; MACMILLAN JC, 1993, J MED GENET, V30, P1039, DOI 10.1136/jmg.30.12.1039; MASTROMAURO C, 1987, AM J MED GENET, V26, P271, DOI 10.1002/ajmg.1320260205; MEISSEN GJ, 1987, AM J MED GENET, V26, P283, DOI 10.1002/ajmg.1320260206; MENNIE ME, 1990, J MED GENET, V27, P224, DOI 10.1136/jmg.27.4.224; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Quaid K A, 1992, J Genet Couns, V1, P277, DOI 10.1007/BF00962825; QUAID KA, 1993, AM J MED GENET, V45, P41, DOI 10.1002/ajmg.1320450112; QUARRELL OWJ, 1989, JAMA-J AM MED ASSOC, V262, P2384; RUBENSZTEIN DC, 1993, HUM MOL GENET, V2, P1713; SIMPSON SA, 1993, J MED GENET, V30, P1036, DOI 10.1136/jmg.30.12.1036; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; TYLER A, 1992, BRIT MED J, V304, P1593, DOI 10.1136/bmj.304.6842.1593; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; 1990, J MED GENET, V27, P34; 1993, J MED GENET, V30, P1028; 1994, REPORT COMMITTEE ASS; 1993, CELL, V72, P971	48	84	85	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					606	617						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942838				2022-12-18	WOS:A1994PJ02700002
J	HAMOSH, A; KING, TM; ROSENSTEIN, BJ; COREY, M; LEVISON, H; DURIE, P; TSUI, LC; MCINTOSH, I; KESTON, M; BROCK, DJH; MACEK, M; ZEMKOVA, D; KRASNICANOVA, H; VAVROVA, V; MACEK, M; GOLDER, N; SCHWARZ, MJ; SUPER, M; WATSON, EK; WILLIAMS, C; BUSH, A; OMAHONEY, SM; HUMPHRIES, P; DEARCE, MA; REIS, A; BURGER, J; STUHRMANN, M; SCHMIDTKE, J; WULBRAND, U; DORK, T; TUMMLER, B; CUTTING, GR				HAMOSH, A; KING, TM; ROSENSTEIN, BJ; COREY, M; LEVISON, H; DURIE, P; TSUI, LC; MCINTOSH, I; KESTON, M; BROCK, DJH; MACEK, M; ZEMKOVA, D; KRASNICANOVA, H; VAVROVA, V; MACEK, M; GOLDER, N; SCHWARZ, MJ; SUPER, M; WATSON, EK; WILLIAMS, C; BUSH, A; OMAHONEY, SM; HUMPHRIES, P; DEARCE, MA; REIS, A; BURGER, J; STUHRMANN, M; SCHMIDTKE, J; WULBRAND, U; DORK, T; TUMMLER, B; CUTTING, GR			CYSTIC-FIBROSIS PATIENTS BEARING BOTH THE COMMON MISSENSE MUTATION GLY -] ASP AT CODON 551 AND THE DELTA-F508 MUTATION ARE CLINICALLY INDISTINGUISHABLE FROM DELTA-F508 HOMOZYGOTES, EXCEPT FOR DECREASED RISK OF MECONIUM ILEUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTIFICATION; GENE	The glycine-to-aspartic acid missense mutation at codon 551 (G551D), which is within the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator (CFTR), is the third most common cystic fibrosis (CF) mutation, with a worldwide frequency of 3.1% among CF chromosomes. Regions with a high frequency correspond to areas with large populations of Celtic descent. To determine whether G551D confers a different phenotype than does DELTA-F508, the most common CF mutation, we studied 79 compound heterozygotes for G551D/DELTA-F508, from nine centers in Europe and North America. Each subject was matched, by age and sex, with a DELTA-F508 homozygote from the same center. A retrospective cohort analysis was performed on the following outcome parameters: age at diagnosis, sweat chloride, meconium ileus at birth, height, weight, weight for height, FVC, FEV1, chest X-ray score, pseudomonas colonization, pancreatic sufficiency, and Shwachman clinical score. There was less meconium ileus among the G551D/DELTA-F508 compound heterozygotes (relative risk 0.33; 95% confidence interval .13-.86), as well as a trend toward later age at diagnosis of pancreatic insufficiency. No statistically significant difference was found between the groups for any other parameter. These results suggest that the CF genotype can be a predictor of pancreatic and intestinal phenotype. Prenatal counseling for the two genotype groups should differ only with respect to probability of meconium ileus. Clinical outcome (after survival of meconium ileus) for G551D/DELTA-F508 compound heterozygotes and DELTA-F508 homozygotes is indistinguishable; therefore, prognostic counseling should not differ.	JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT EPIDEMIOL, BALTIMORE, MD 21218 USA; HOSP SICK CHILDREN, DIV CYST FIBRUSIS RES, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, RES INST, DIV RESP DIS, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, DEPT GENET, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT MED GENET & MED BIOPHYS, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT PEDIAT, TORONTO M5S 1A1, ONTARIO, CANADA; WESTERN GEN HOSP, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; CHARLES UNIV, FAC MED 1, DEPT CLIN BIOCHEM, CS-11636 PRAGUE 1, CZECHOSLOVAKIA; CHARLES UNIV, FAC MED 2, CS-11636 PRAGUE 1, CZECHOSLOVAKIA; CHILDRENS FAC HOSP, CTR MED GENET, PRAGUE, CZECHOSLOVAKIA; ROYAL MANCHESTER CHILDRENS HOSP, PEDIAT GENET UNIT, MANCHESTER M27 1HA, LANCS, ENGLAND; ST MARYS HOSP, MED CTR, REG DNA LAB, MADISON, WI 53715 USA; ROYAL BROMPTON & NATL HEART HOSP, LONDON, ENGLAND; NATL UNIV IRELAND UNIV COLL DUBLIN, MED PROFESSORIAL UNINT, DUBLIN 4, IRELAND; ST VINCENTS HOSP, DUBLIN 4, IRELAND; UNIV DUBLIN TRINITY COLL, DEPT GENET, DUBLIN 2, IRELAND; FREE UNIV BERLIN, INST HUMAN GENET, W-1000 BERLIN 33, GERMANY; HANNOVER MED SCH, BIOPHYS CHEM ABT, W-3000 HANNOVER 61, GERMANY	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Edinburgh; Charles University Prague; Charles University Prague; Royal Manchester Children's Hospital; Imperial College London; University College Dublin; University College Dublin; Trinity College Dublin; Free University of Berlin; Hannover Medical School			Reis, André/D-2309-2009; Kitsoulis, Mary/GWU-7260-2022; Dörk, Thilo/J-8620-2012; Tsui, Lap-chee/A-1081-2010	Reis, André/0000-0002-6301-6363; Dörk, Thilo/0000-0002-9458-0282; 				Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BONDUELLE M, 1990, HUM GENET, V85, P436; BRASFIELD D, 1979, PEDIATRICS, V63, P24; CAMPBELL PW, 1991, J PEDIATR-US, V118, P239, DOI 10.1016/S0022-3476(05)80490-1; CHRISPIN AR, 1974, PEDIATR RADIOL, V2, P101, DOI 10.1007/BF01314939; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DISANTAGNESE PA, 1984, CYSTIC FIBROSIS, P212; JOHANSEN HK, 1991, LANCET, V337, P631, DOI 10.1016/0140-6736(91)92449-C; KAHN HA, 1989, STATISTICAL METHODS; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KEREM E, 1989, J PEDIATR-US, V114, P767, DOI 10.1016/S0022-3476(89)80134-9; MACEK M, 1991, AM J HUM GENET, V49, P474; OLSEN MM, 1987, J PEDIATR SURG, V22, P613, DOI 10.1016/S0022-3468(87)80111-2; SANTIS G, 1990, LANCET, V336, P1081, DOI 10.1016/0140-6736(90)92566-Z; SHWACHMAN H, 1958, AMA J DIS CHILD, V96, P6, DOI 10.1001/archpedi.1958.02060060008002; 1990, SYSTAT 5 0 MACINTOSH	19	84	84	4	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					245	250						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1379413				2022-12-18	WOS:A1992JF77600003
J	SMITH, LT; WERTELECKI, W; MILSTONE, LM; PETTY, EM; SEASHORE, MR; BRAVERMAN, IM; JENKINS, TG; BYERS, PH				SMITH, LT; WERTELECKI, W; MILSTONE, LM; PETTY, EM; SEASHORE, MR; BRAVERMAN, IM; JENKINS, TG; BYERS, PH			HUMAN DERMATOSPARAXIS - A FORM OF EHLERS-DANLOS SYNDROME THAT RESULTS FROM FAILURE TO REMOVE THE AMINO-TERMINAL PROPEPTIDE OF TYPE-I PROCOLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-VII; CHICK-EMBRYO TENDONS; COLLAGEN GENE; N-PROTEINASE; OSTEOGENESIS IMPERFECTA; PRO-ALPHA-2(I) CHAIN; PATIENT; MUTATION; FIBROBLASTS; DEFECT	Dermatosparaxis is a recessively inherited connective-tissue disorder that results from lack of the activity of type I procollagen N-proteinase, the enzyme that removes the amino-terminal propeptides from type I procollagen. Initially identified in cattle more than 20 years ago, the disorder was subsequently characterized in sheep, cats, and dogs. Affected animals have fragile skin, lax joints, and often die prematurely because of sepsis following avulsion of portions of skin. We recently identified two children with soft, lax, and fragile skin, which, when examined by transmission electron microscopy, contained the twisted, ribbon-like collagen fibrils characteristic of dermatosparaxis. Skin extracts from one child contained collagen precursors with amino-terminal extensions. Cultured fibroblasts from both children failed to cleave the amino-terminal propeptides from the pro-alpha-1(I) and pro-alpha-2(I) chains in type I procollagen molecules. Extracts of normal cells cleaved to collagen, the type I procollagen synthesized by cells from both children, demonstrating that the enzyme, not the substrate, was defective. These findings distinguish dermatosparaxis from Ehlers-Danlos syndrome type VII, which results from substrate mutations that prevent proteolytic processing of type I procollagen molecules.	UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; UNIV SO ALABAMA,DEPT MED GENET,MOBILE,AL 36688; YALE UNIV,DEPT DERMATOL,NEW HAVEN,CT 06520; YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06520; SACRED HEART HOSP,PENSACOLA,FL	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of South Alabama; Yale University; Yale University	SMITH, LT (corresponding author), UNIV WASHINGTON,DEPT BIOL STRUCT,SEATTLE,WA 98195, USA.			Byers, Peter H./0000-0001-7786-7030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 21557] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BATEMAN JF, 1990, BIOCHEM J, V267, P573, DOI 10.1042/bj2670573; BONADIO J, 1985, J BIOL CHEM, V260, P1734; COLE WG, 1986, J BIOL CHEM, V261, P5496; COUNTS DF, 1980, J INVEST DERMATOL, V74, P96, DOI 10.1111/1523-1747.ep12519991; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; EYRE DR, 1985, J BIOL CHEM, V260, P1322; FJOLSTAD M, 1974, J PATHOL, V112, P183, DOI 10.1002/path.1711120309; HANSET R, 1971, H-S Z PHYSIOL CHEM, V352, P13; HOJIMA Y, 1989, J BIOL CHEM, V264, P11336; HOLBROOK KA, 1982, J INVEST DERMATOL, V79, pS7, DOI 10.1111/1523-1747.ep12544609; HOLBROOK KA, 1980, J INVEST DERMATOL, V74, P100, DOI 10.1111/1523-1747.ep12520000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; LICHTENSTEIN JR, 1973, SCIENCE, V182, P298, DOI 10.1126/science.182.4109.298; MINOR RR, 1986, J BIOL CHEM, V261, P6; NUSGENS BV, IN PRESS NATURE GENE; PETTY EM, UNPUB CLIN PRESENTAT; PIERARD GE, 1976, J INVEST DERMATOL, V66, P2, DOI 10.1111/1523-1747.ep12477969; SIMAR LJ, 1971, H-S Z PHYSIOL CHEM, V352, P13; STEINMANN B, 1980, J BIOL CHEM, V255, P8887; TUDERMAN L, 1982, EUR J BIOCHEM, V125, P545, DOI 10.1111/j.1432-1033.1982.tb06716.x; VASAN NS, 1991, AM J HUM GENET, V48, P305; VOGEL BE, 1988, J BIOL CHEM, V263, P19249; WATSON RB, IN PRESS J BIOL CHEM; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1989, J BIOL CHEM, V264, P16804; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WEIL D, 1988, J BIOL CHEM, V263, P8561; WERTELECKI W, IN PRESS J PEDIATR; WIRTZ MK, 1990, J BIOL CHEM, V265, P6312; WIRTZ MK, 1987, J BIOL CHEM, V262, P16376	32	84	85	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					235	244						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642226				2022-12-18	WOS:A1992JF77600002
J	LAING, NG; MAJDA, BT; AKKARI, PA; LAYTON, MG; MULLEY, JC; PHILLIPS, H; HAAN, EA; WHITE, SJ; BEGGS, AH; KUNKEL, LM; GROTH, DM; BOUNDY, KL; KNEEBONE, CS; BLUMBERG, PC; WILTON, SD; SPEER, MC; KAKULAS, BA				LAING, NG; MAJDA, BT; AKKARI, PA; LAYTON, MG; MULLEY, JC; PHILLIPS, H; HAAN, EA; WHITE, SJ; BEGGS, AH; KUNKEL, LM; GROTH, DM; BOUNDY, KL; KNEEBONE, CS; BLUMBERG, PC; WILTON, SD; SPEER, MC; KAKULAS, BA			ASSIGNMENT OF A GENE (NEMI) FOR AUTOSOMAL DOMINANT NEMALINE MYOPATHY TO CHROMOSOME-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; POLYMORPHISMS; DYSTROPHY; LINKAGE; DISEASE; PROBE; LOCI; DNA	Nemaline myopathy (NEM) is a neuromuscular disorder characterized by the presence, in skeletal muscle, of nemaline rods composed at least in part of alpha-actinin. A candidate gene and linkage approach was used to localize the gene (NEM1) for an autosomal dominant form (MIM 161800) in one large kindred with 10 living affected family members. Markers on chromosome 19 that were linked to the central core disease gene, a marker at the complement 3 locus, and a marker on chromosome 1 at the alpha-actinin locus exclude these three candidate genes. The family was fully informative for APOA2, which is localized to 1q21-q23. NEM1 was assigned to chromosome 1 by close linkage for APOA2, which is localized to 1q21-q23. NEM1 was assigned to chromosome 1 by close linkage to APOA2, with a lod score of 3.8 at a recombination fraction of 0. Recombinants with NGFB (1p13) and AT3 (1q23-25.1) indicate that NEM1 lies between 1p13 and 1q25.1. In total, 47 loci were investigated on chromosomes 1, 2, 4, 5, 7-11, 14, 16, 17, and 19, with no indications of significant linkage other than to markers on chromosome 1.	CURTIN UNIV,SCH MED TECHNOL,BENTLEY,WA,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET,ADELAIDE,SA 5006,AUSTRALIA; ROYAL ADELAIDE UNIV,DEPT NEUROL,ADELAIDE,AUSTRALIA; INST MED & VET SCI,ADELAIDE,SA 5000,AUSTRALIA; CHILDRENS HOSP MED CTR,HOWARD HUGHES MED INST,DIV GENET,BOSTON,MA 02115; DUKE UNIV,MED CTR,DIV NEUROL,DURHAM,NC 27710	Curtin University; University of Adelaide; Institute Medical & Veterinary Science Australia; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Duke University	LAING, NG (corresponding author), AUSTRALIAN NEUROMUSCULAR RES INST,DEPT PATHOL,4TH FLOOR A BLOCK,QE2 MED CTR,NEDLANDS,WA 6009,AUSTRALIA.			Laing, Nigel/0000-0001-5111-3732; Wilton, Steve/0000-0002-9400-893X; Beggs, Alan/0000-0001-8818-0568				BIRD TD, 1980, AM J HUM GENET, V32, pA99; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; DAVIES KE, 1983, J MED GENET, V20, P259, DOI 10.1136/jmg.20.4.259; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; DUBOWITZ V, 1985, MUSCLE BIOPSY MODERN; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; GARDNERMEDWIN D, 1981, DISORDERS VOLUNTARY, P625; HAAN EA, 1990, HUM GENET, V86, P187; JENNEKENS FGI, 1983, MUSCLE NERVE, V6, P61, DOI 10.1002/mus.880060111; KAUSCH K, 1990, J NEUROL SCI, V98, P549; LAING NG, 1990, MED J AUSTRALIA, V152, P270, DOI 10.5694/j.1326-5377.1990.tb120926.x; McKusick VA, 1990, MENDELIAN INHERITANC; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OTT J, 1974, AM J HUM GENET, V26, P588; Sambrook J., 1989, MOL CLONING LAB MANU; SARFARAZI M, 1989, J MED GENET, V26, P481, DOI 10.1136/jmg.26.8.481; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; WALLIS J, 1990, HUM GENET, V85, P98; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4036, DOI 10.1093/nar/18.13.4036; WEBER JL, 1989, AM J HUM GENET, V44, P388; WU S, 1989, NUCLEIC ACIDS RES, V17, P6433, DOI 10.1093/nar/17.15.6433; 1990, CYTOGENET CELL GENET, V55, P1	26	84	85	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					576	583						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1347195				2022-12-18	WOS:A1992HH97400017
J	BOERWINKLE, E; BROWN, SA; ROHRBACH, K; GOTTO, AM; PATSCH, W				BOERWINKLE, E; BROWN, SA; ROHRBACH, K; GOTTO, AM; PATSCH, W			ROLE OF APOLIPOPROTEIN-E AND APOLIPOPROTEIN-B GENE VARIATION IN DETERMINING RESPONSE OF LIPID, LIPOPROTEIN, AND APOLIPOPROTEIN LEVELS TO INCREASED DIETARY-CHOLESTEROL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMPROVED LIPOLYTIC EFFICIENCY; CORONARY HEART-DISEASE; ENZYMATIC DETERMINATION; SERUM-CHOLESTEROL; E POLYMORPHISM; PLASMA; FAT; ATHEROSCLEROSIS; AMPLIFICATION; POLYMERASE	A large segment of the population is modifying its dietary cholesterol intake to achieve a healthier life-style. However, all individuals do not respond equally. We have investigated the effects that that two physiologically important polymorphisms in the apolipoprotein (apo) E and B genes have on the responses of plasma lipid, lipoprotein, and apolipoprotein levels to a high-cholesterol diet. Over a 6-wk period, individuals were prescribed two diets, one consisting of 300 mg dietary cholesterol/d for 3 wk and one consisting of 1,700 mg dietary cholesterol/d for 3 wk. Total cholesterol, low-density-lipoprotein cholesterol (LDL-C), and apo B levels were significantly increased on the high-cholesterol diet. Average total cholesterol (numbers in parentheses are SDs) went from 167.6 (23.4) mg/dl on the low-cholesterol diet to 190.8 (36.2) mg/dl on the high-cholesterol diet; LDL-C went from 99.9 (24.8) mg/dl to 119.2 (33.4) mg/dl, and apo B went from 74.9 (24.5) mg/dl to 86.8 (29.5) mg/dl. In 71 individuals, the frequencies of the apo epsilon-2, epsilon-3, and epsilon-4 alleles were .09, .84, and .07, respectively. The frequency of the longer, apo B signal peptide allele (5'beta-SP27) was .68. Apo epsilon-2/3 individuals had significantly lower LDL-C levels than did epsilon-3/3 homozygotes, on both the low-cholesterol diet (LDL-C lower by 21 mg/dl) and the high-cholesterol diet (LDL-C lower by 27 mg/dl). Average triglyceride levels were significantly different among apo B signal peptide genotypes, with the 5'beta-SP27/37 homozygotes having the lowest levels (70 mg/dl). When individuals were switched from the low-cholesterol diet to the high-cholesterol diet, in no case were the average responses in lipid levels significantly different among apo E or B genotypes. Therefore, these gene loci do not have a major effect on the response of lipid levels to increased dietary cholesterol.	BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; METHODIST HOSP,HOUSTON,TX 77030	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston	BOERWINKLE, E (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,POB 20334,HOUSTON,TX 77225, USA.				NHLBI NIH HHS [HL 40613, HL 27341, HL 41199] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041199, P50HL027341, P60HL027341, R29HL040613] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BOERWINKLE E, 1989, NUCLEIC ACIDS RES, V17, P4003, DOI 10.1093/nar/17.10.4003; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BOERWINKLE E, IN PRESS DIABETES; BROWN SA, 1990, CLIN CHEM, V36, P1662; BROWN SA, 1988, CLIN CHEM, V24, P920; CLARKSON TB, 1979, EXP MOL PATHOL, V30, P360, DOI 10.1016/0014-4800(79)90090-X; CLARKSON TB, 1980, CHILDHOOD PREVENTION, P127; CLIFTON PM, 1990, ARTERIOSCLEROSIS, V10, P394, DOI 10.1161/01.ATV.10.3.394; Conover WJ, 1980, PRACTICAL NONPARAMET; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EHNHOLM C, 1982, NEW ENGL J MED, V307, P850, DOI 10.1056/NEJM198209303071403; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; HIXSON JE, 1990, J LIPID RES, V31, P545; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KATAN MB, 1986, AM J EPIDEMIOL, V123, P221, DOI 10.1093/oxfordjournals.aje.a114231; KESANIEMI YA, 1987, J CLIN INVEST, V80, P578, DOI 10.1172/JCI113107; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; NETER J, 1974, APPLIED LINEAR STATI; PATSCH W, 1989, CLIN CHEM, V265, P265; RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712; Ross R., 1988, HEART DISEASE TXB CA, P1135; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIEDEL J, 1983, CLIN CHEM, V29, P1075; SNEDECOR GW, 1980, STATISTICALMETHODS; TIKKANEN MJ, 1990, ARTERIOSCLEROSIS, V10, P285, DOI 10.1161/01.ATV.10.2.285; UTERMANN G, 1977, NATURE, V341, P162; VOGEL F, 1986, HUMAN GENETICS; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; XU CF, 1990, GENET EPIDEMIOL, V7, P261, DOI 10.1002/gepi.1370070405; XU CF, 1990, J LIPID RES, V331, P1255; 1988, ARCH INTERN MED, V148, P36	34	84	84	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1145	1154						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746549				2022-12-18	WOS:A1991GU67200002
J	GODFREY, M; MENASHE, V; WELEBER, RG; KOLER, RD; BIGLEY, RH; LOVRIEN, E; ZONANA, J; HOLLISTER, DW				GODFREY, M; MENASHE, V; WELEBER, RG; KOLER, RD; BIGLEY, RH; LOVRIEN, E; ZONANA, J; HOLLISTER, DW			COSEGREGATION OF ELASTIN-ASSOCIATED MICROFIBRILLAR ABNORMALITIES WITH THE MARFAN PHENOTYPE IN FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SHRINERS HOSP CRIPPLED CHILDREN,PORTLAND UNIT,PORTLAND,OR; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT PEDIAT,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT OPHTHALMOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University								APPEL A, 1979, J BIOL CHEM, V254, P2199; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BOUCEK RJ, 1981, NEW ENGL J MED, V305, P988, DOI 10.1056/NEJM198110223051705; BURGIO RG, 1988, AM J MED GENET, V30, P905, DOI 10.1002/ajmg.1320300405; BYERS PH, 1981, P NATL ACAD SCI-BIOL, V78, P7745, DOI 10.1073/pnas.78.12.7745; Cleary E.G., 1987, CONNECTIVE TISSUE DI, V12, P55; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; COLOMBATTI A, 1988, J BIOL CHEM, V263, P17534; COTTAPEREIRA G, 1976, J INVEST DERMATOL, V66, P143, DOI 10.1111/1523-1747.ep12481882; DALGLEISH R, 1987, J MED GENET, V24, P148, DOI 10.1136/jmg.24.3.148; FRANCOMANO CA, 1988, AM J MED GENET, V29, P457, DOI 10.1002/ajmg.1320290233; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; GODFREY M, 1990, AM J HUM GENET, V46, P661; HOLLISTER DW, 1985, BIOL CHEM PATHOLOGY, P449; HOLLISTER DW, UNPUB MARFAN SYNDROM; HUTTUNEN K, 1989, AM J MED GENET, V32, P244; LAMBERG SI, 1973, J CLIN INVEST, V52, P2428, DOI 10.1172/JCI107433; LOW FN, 1962, ANAT REC, V142, P131, DOI 10.1002/ar.1091420205; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; McKusick V.A., 1972, CLIN GENET; MECHAM RP, 1988, BIOCHEM BIOPH RES CO, V151, P822, DOI 10.1016/S0006-291X(88)80355-3; OGILVIE DJ, 1987, AM J HUM GENET, V41, P1071; PEREJDA AJ, 1985, J LAB CLIN MED, V106, P376; PYERITZ RE, 1988, AM J HUM GENET, V43, P726; PYERITZ RE, 1986, AM FAM PHYSICIAN, V34, P83; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; PYERITZ RE, 1983, PRINCIPLES PRACTICE, P820; RAVIOLA G, 1971, INVEST OPHTH VISUAL, V10, P851; ROSENBLOOM J, 1984, LAB INVEST, V51, P605; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SARUK M, 1977, ARCH APTHOL LAB MED, V1, P74; SERAFINIFRACASSINI A, 1981, BIOCHEMISTRY-US, V20, P5424, DOI 10.1021/bi00522a011; STREETEN BW, 1983, INVEST OPHTH VIS SCI, V24, P119; STRETEN BW, 1987, BIOMEDICAL F OPHTTHA, V1, P1; TAKEBAYASHI S, 1988, ACTA PATHOL JAPON, V38, P1433; TSIPOURAS P, 1986, CLIN GENET, V30, P428; TSUJI T, 1986, J CUTAN PATHOL, V13, P144, DOI 10.1111/j.1600-0560.1986.tb01515.x	37	84	84	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					652	660						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2180284				2022-12-18	WOS:A1990CW54900004
J	VILKKI, J; SAVONTAUS, ML; NIKOSKELAINEN, EK				VILKKI, J; SAVONTAUS, ML; NIKOSKELAINEN, EK			GENETIC-HETEROGENEITY IN LEBER HEREDITARY OPTIC NEURORETINOPATHY REVEALED BY MITOCHONDRIAL-DNA POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TURKU,INST BIOMED,DEPT MED GENET,KIINAMYLLYNKATU 10,SF-20520 TURKU 52,FINLAND; UNIV TURKU,INST BIOMED,DEPT BIOL,SF-20520 TURKU 52,FINLAND; UNIV TURKU,CENT HOSP,DEPT OPHTHALMOL,SF-20520 TURKU 52,FINLAND	University of Turku; University of Turku; University of Turku								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; EGGER J, 1983, NEW ENGL J MED, V309, P142, DOI 10.1056/NEJM198307213090304; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1988, HUM GENET, V79, P53, DOI 10.1007/BF00291710; NIKOSKELAINEN E, 1984, LANCET, V2, P1474; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; POULTON J, 1988, J MED GENET, V25, P600, DOI 10.1136/jmg.25.9.600; ROSING HS, 1985, ANN NEUROL, V17, P227; SEEDORFF T, 1985, ACTA OPHTHALMOL, V63, P135; UEMURA A, 1987, BRIT J OPHTHALMOL, V71, P531, DOI 10.1136/bjo.71.7.531; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; VILKKI J, IN PRESS HUM GENET; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	19	84	84	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					206	211						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2757028				2022-12-18	WOS:A1989AK38000003
J	COMINGS, DE				COMINGS, DE			A CONTROLLED-STUDY OF TOURETTE SYNDROME .7. SUMMARY - A COMMON GENETIC DISORDER CAUSING DISINHIBITION OF THE LIMBIC SYSTEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR, DEPT MED GENET, 1500 E DUARTE RD, DUARTE, CA 91010 USA.							ALBRIGHT PS, 1980, EPILEPSIA, V21, P681, DOI 10.1111/j.1528-1157.1980.tb04321.x; Angrist B M, 1970, Biol Psychiatry, V2, P95; ANTELMAN SM, 1980, SCIENCE, V207, P329, DOI 10.1126/science.7188649; BANNON MJ, 1983, PHARMACOL REV, V35, P53; BANNON MJ, 1983, NATURE, V306, P791, DOI 10.1038/306791a0; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; BELLAK L, 1979, PSYCHIATRIC ASPECTS; BERNARDI G, 1982, BRAIN RES, V245, P267, DOI 10.1016/0006-8993(82)90809-5; BLANC G, 1980, NATURE, V284, P265, DOI 10.1038/284265a0; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; BUNNEY BS, 1976, LIFE SCI, V19, P1783, DOI 10.1016/0024-3205(76)90087-4; BUTLER IJ, 1979, ANN NEUROL, V6, P37, DOI 10.1002/ana.410060109; CARLI G, 1965, ARCH ITAL BIOL, V103, P751; CHASE TN, 1984, ANN NEUROL, V15, pS175; CHOUINARD G, 1978, LANCET, V2, P99; COHEN DJ, 1978, ARCH GEN PSYCHIAT, V35, P245; COHEN DJ, 1979, J AM ACAD CHILD PSY, V18, P320, DOI 10.1016/S0002-7138(09)61046-3; COMINGS D E, 1986, American Journal of Human Genetics, V39, pA151; COMINGS DE, 1987, AM J HUM GENET, V41, P782; COMINGS DE, 1987, AM J HUM GENET, V41, P701; COMINGS DE, 1984, J AM ACAD CHILD PSY, V23, P138, DOI 10.1097/00004583-198403000-00004; COMINGS DE, 1984, AM J HUM GENET, V36, P586; COMINGS DE, 1987, IN PRESS BR J PSYCHI, V148; COMINGS DE, 1986, SEP INT C HUM GEN BE; Connell PH, 1958, AMPHETAMINE PSYCHOSI; COSTA E, 1977, NONSTRIATAL DOPAMINE, P557; COSTALL B, 1977, BRAIN RES, V123, P89, DOI 10.1016/0006-8993(77)90645-X; COSTALL B, 1975, EUR J PHARMACOL, V32, P87, DOI 10.1016/0014-2999(75)90326-X; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; DABROWSKA J, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P345; De Wied D., 1979, TRENDS NEUROSCI, V2, P79; DEVINSKY O, 1983, ARCH NEUROL-CHICAGO, V40, P508, DOI 10.1001/archneur.1983.04210070048013; DONNAI D, 1987, LANCET, V1, P627; DONOVICK PJ, 1968, PHYSIOL BEHAV, V3, P285, DOI 10.1016/0031-9384(68)90100-5; DREWE E A, 1975, Cortex, V11, P8; EASTGATE SM, 1978, PSYCHOPHARMACOLOGY, V58, P157, DOI 10.1007/BF00426899; ERINOFF L, 1979, BRAIN RES, V164, P195, DOI 10.1016/0006-8993(79)90015-5; FADDA F, 1978, LIFE SCI, V23, P2219, DOI 10.1016/0024-3205(78)90207-2; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; FEINBERG M, 1979, ARCH GEN PSYCHIAT, V36, P979; FRIEDHOFF AJ, 1982, GILLES TOURETTE SYND, P133; FUXE K, 1980, EUR J PHARMACOL, V67, P329, DOI 10.1016/0014-2999(80)90521-X; GAGE FH, 1978, PHYSIOL PSYCHOL, V6, P314; GALEY D, 1976, NEUROSCI LETT, V3, P65, DOI 10.1016/0304-3940(76)90101-4; GALEY D, 1977, BRAIN RES, V124, P83, DOI 10.1016/0006-8993(77)90865-4; GALEY D, 1979, BEHAV NEURAL BIOL, V26, P81, DOI 10.1016/S0163-1047(79)92907-8; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; GLOWINSKI J, 1984, TRENDS NEUROSCI, V7, P414; GLOWINSKI J, 1981, PSYCHIATRY BIOL HUMA, P15; GOODWIN DW, 1979, ARCH GEN PSYCHIAT, V36, P57; Gray A., 1982, NEUROPSYCHOLOGY ANXI; GRIFFITH JD, 1972, ARCH GEN PSYCHIAT, V26, P97; HABER SN, 1986, J NEUROL SCI, V75, P225, DOI 10.1016/0022-510X(86)90097-3; HARACZ JL, 1982, SCHIZOPHRENIA BULL, V8, P438, DOI 10.1093/schbul/8.3.438; HARVEY JA, 1965, J COMP PHYSIOL PSYCH, V59, P49, DOI 10.1037/h0021600; HERVE D, 1979, NEUROSCI LETT, V15, P127, DOI 10.1016/0304-3940(79)96101-9; HILL DR, 1981, NATURE, V290, P149, DOI 10.1038/290149a0; HOKFELT T, 1980, NEUROSCIENCE, V5, P2093, DOI 10.1016/0306-4522(80)90127-X; HOKFELT T, 1974, SCIENCE, V184, P177, DOI 10.1126/science.184.4133.177; Isaacson R, 2013, THE LIMBIC SYSTEM; Iversen S D, 1977, Adv Biochem Psychopharmacol, V16, P209; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; JOUVET M, 1972, ERGEBN PHYSIOL, V64, P165; KALIVAS PW, 1983, NEUROSCIENCE, V8, P495, DOI 10.1016/0306-4522(83)90195-1; KELLEY AE, 1985, PSYCHOPHARMACOLOGY, V85, P37, DOI 10.1007/BF00427319; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; KELLY PH, 1976, EUR J PHARMACOL, V40, P45, DOI 10.1016/0014-2999(76)90352-6; KENDLER KS, 1982, ARCH GEN PSYCHIAT, V39, P639; KETY SS, 1983, AM J PSYCHIAT, V140, P720; KLAWANS HL, 1975, ARCH GEN PSYCHIAT, V32, P725; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; KONDO K, 1982, GILLES TOURETTE SYND, P271; LADURON P, 1977, N-S ARCH PHARMACOL, V296, P183, DOI 10.1007/BF00508472; LAVIELLE S, 1979, BRAIN RES, V168, P585, DOI 10.1016/0006-8993(79)90311-1; Le Moal M, 1977, Adv Biochem Psychopharmacol, V16, P237; LEBACQVERHEYDEN AM, 1987, SOMAT CELL MOLEC GEN, V13, P81, DOI 10.1007/BF02422302; LEMOAL M, 1969, PHYSIOL BEHAV, V4, P567, DOI 10.1016/0031-9384(69)90156-5; LEMOAL M, 1976, EXP NEUROL, V50, P521, DOI 10.1016/0014-4886(76)90024-8; LEMOAL M, 1975, BRAIN RES, V88, P190, DOI 10.1016/0006-8993(75)90972-5; LEMOAL M, 1977, BRAIN RES, V127, P383, DOI 10.1016/0006-8993(77)90586-8; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; LINDVALL O, 1978, BRAIN RES, V142, P1, DOI 10.1016/0006-8993(78)90173-7; LOWE TL, 1982, JAMA-J AM MED ASSOC, V247, P1729, DOI 10.1001/jama.247.12.1729; Luria A. R., 2012, HIGHER CORTICAL FUNC; MACLEAN PD, 1952, ELECTROEN CLIN NEURO, V4, P407, DOI 10.1016/0013-4694(52)90073-4; MACLEAN PD, 1949, PSYCHOSOM MED, V11, P338, DOI 10.1097/00006842-194911000-00003; MACLEAN PD, 1954, J NEUROSURG, V11, P29, DOI 10.3171/jns.1954.11.1.0029; MARKOWITSCH HJ, 1977, PSYCHOL BULL, V84, P817, DOI 10.1037/0033-2909.84.5.817; MATTHYSS.S, 1973, FED PROC, V32, P200; MCCLURE FD, 1984, J ABNORM CHILD PSYCH, V12, P561, DOI 10.1007/BF00916850; MCGUE M, 1986, BEHAV GENET, V16, P75, DOI 10.1007/BF01065480; MERALI Z, 1983, PEPTIDES, V4, P693, DOI 10.1016/0196-9781(83)90020-7; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; MESULAM MM, 1986, NEW ENGL J MED, V315, P398; MILLER FE, 1981, BRAIN RES, V229, P123, DOI 10.1016/0006-8993(81)90750-2; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; MOLDOFSKY H, 1974, J NERV MENT DIS, V159, P282, DOI 10.1097/00005053-197410000-00007; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; NAYLOR SL, 1987, SOMAT CELL MOLEC GEN, V13, P87, DOI 10.1007/BF02422303; NEMEROFF CB, 1980, TRENDS NEUROSCI, V3, P212, DOI 10.1016/0166-2236(80)90080-6; OWEN F, 1978, LANCET, V2, P223, DOI 10.1016/S0140-6736(78)91740-3; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PERT A, 1980, BRAIN RES, V193, P209, DOI 10.1016/0006-8993(80)90958-0; PIJENBURG AJJ, 1975, PSYCHOPHARMACOLOGIA, V41, P87; POST RM, 1975, AM J PSYCHIAT, V132, P225; POST RM, 1984, PSYCHOPHARMACOLOGY L, P134; Pribram K. H., 1971, LANGUAGES BRAIN EXPT; PRICE RA, 1986, NEUROLOGY, V36, P232, DOI 10.1212/WNL.36.2.232; PYCOCK CJ, 1980, NATURE, V286, P74, DOI 10.1038/286074a0; PYCOCK CJ, 1980, J NEUROCHEM, V34, P91, DOI 10.1111/j.1471-4159.1980.tb04625.x; Roberts E., 1977, NEUROREGULATORS PSYC, P347; ROSENTHAL D, 1980, HDB BIOL PSYCHIATR 3, P3; SANDYK R, 1985, NEUROLOGY, V35, P449, DOI 10.1212/WNL.35.3.449-b; SCHULZ DW, 1984, BRAIN RES, V304, P377, DOI 10.1016/0006-8993(84)90343-3; SCHWAB RS, 1951, AM J PSYCHIAT, V107, P901, DOI 10.1176/ajp.107.12.901; SESSIONS GR, 1980, PHARMACOL BIOCHEM BE, V12, P603; SHAYWITZ BA, 1976, NATURE, V261, P153, DOI 10.1038/261153a0; SHAYWITZ BA, 1978, ARCH NEUROL-CHICAGO, V35, P463, DOI 10.1001/archneur.1978.00500310065014; SHAYWITZ BA, 1976, SCIENCE, V191, P305, DOI 10.1126/science.942800; SHAYWITZ BA, 1975, PEDIATR RES, V9, pA385; SIMON H, 1980, NATURE, V286, P150, DOI 10.1038/286150a0; SIMON H, 1984, CATECHOLAMINES NEURO, P293; SINGER HS, 1985, ANN NEUROL, V18, P416; SKIRBOLL LR, 1981, NEUROSCIENCE, V6, P2111, DOI 10.1016/0306-4522(81)90002-6; STEVENS JR, 1973, ARCH GEN PSYCHIAT, V29, P177; STINUS L, 1977, BIOL PSYCHIAT, V12, P719; STINUS L, 1980, P NATL ACAD SCI-BIOL, V77, P2323, DOI 10.1073/pnas.77.4.2323; STINUS L, 1978, J COMP PHYSIOL PSYCH, V92, P289, DOI 10.1037/h0077467; STINUS L, 1978, NATURE, V276, P616, DOI 10.1038/276616a0; TAGHZOUTI K, 1985, BRAIN RES, V344, P9, DOI 10.1016/0006-8993(85)91184-9; TAGHZOUTI K, 1985, BEHAV BRAIN RES, V15, P1, DOI 10.1016/0166-4328(85)90012-9; TAGHZOUTI K, 1985, BEHAV NEURAL BIOL, V44, P354, DOI 10.1016/S0163-1047(85)90640-5; TASSIN JP, 1978, BRAIN RES, V141, P267, DOI 10.1016/0006-8993(78)90197-X; TERZIAN H, 1955, NEUROLOGY, V5, P373, DOI 10.1212/WNL.5.6.373; THIEME RE, 1980, PSYCHOPHARMACOLOGY, V67, P165, DOI 10.1007/BF00431972; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; TORREY EF, 1974, LANCET, V2, P942; TRIMBLE MR, 1981, BRIT J PSYCHIAT, V138, P56, DOI 10.1192/bjp.138.1.56; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VALZELLI L, 1973, PSYCHOPHARMACOLOGIA, V31, P305, DOI 10.1007/BF00421275; WEISS G, 1971, ARCH GEN PSYCHIAT, V24, P409; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P13; WOLF P, 1978, EXPERIENTIA, V34, P73, DOI 10.1007/BF01921910; WOOD CD, 1958, NEUROLOGY, V8, P215, DOI 10.1212/WNL.8.3.215; YIM CY, 1980, BRAIN RES, V181, P301; 1980, DIAGNOSTIC STATISTIC; 1987, DIAGNOSTIC STATISTIC; [No title captured]; [No title captured]; [No title captured]; [No title captured]	157	84	86	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					839	866						28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	3314491				2022-12-18	WOS:A1987K936100007
J	MULIVOR, RA; MENNUTI, M; ZACKAI, EH; HARRIS, H				MULIVOR, RA; MENNUTI, M; ZACKAI, EH; HARRIS, H			PRENATAL DIAGNOSIS OF HYPOPHOSPHATASIA - GENETIC, BIOCHEMICAL, AND CLINICAL STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104; CHILDRENS HOSP,CTR CLIN GENET,PHILADELPHIA,PA 19174	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	MULIVOR, RA (corresponding author), UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104, USA.							BARTTER FC, 1973, METABOLIC BASIS INHE, P1295; Benzie R, 1976, Birth Defects Orig Artic Ser, V12, P271; BERATIS NG, 1976, J MED GENET, V13, P307, DOI 10.1136/jmg.13.4.307; BROCK DJH, 1972, LANCET, V2, P197; CLARK PJ, 1976, LANCET, V1, P306; FRASER D, 1957, AM J MED, V22, P730, DOI 10.1016/0002-9343(57)90124-9; Harris, 1976, HDB ENZYME ELECTROPH; LANGMAN MJS, 1966, NATURE, V212, P41, DOI 10.1038/212041a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCANCE RA, 1956, Q J MED, V25, P523; MULIVOR R, UNPUBLISHED; PIMSTONE B, 1966, ANN INTERN MED, V65, P722, DOI 10.7326/0003-4819-65-4-722; RATHBUN JC, 1948, AM J DIS CHILD, V75, P822, DOI 10.1001/archpedi.1948.02030020840003; RUDD NL, 1976, NEW ENGL J MED, V295, P146, DOI 10.1056/NEJM197607152950306; SOBEL EH, 1953, PEDIATRICS, V11, P309; SUTCLIFFE RG, 1972, J OBSTET GYN BR COMM, V79, P902; TEREE TM, 1968, J PEDIATR-US, V72, P41, DOI 10.1016/S0022-3476(68)80399-3; VANNEUVILLE FJ, 1975, ARCH INT PHYSIOL BIO, V83, P1017	18	84	85	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	3					271	282						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FE044	677124				2022-12-18	WOS:A1978FE04400005
J	LEISTI, JT; KABACK, MM; RIMOIN, DL				LEISTI, JT; KABACK, MM; RIMOIN, DL			HUMAN X-AUTOSOME TRANSLOCATIONS - DIFFERENTIAL INACTIVATION OF X-CHROMOSOME IN A KINDRED WITH AN X-9 TRANSLOCATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF,HARBOR GEN HOSP,SCH MED,DIV MED GENET,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								ALLDERDICE PW, 1971, EXCERPTA MEDICA  233, P14; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; BUCKTON KE, 1971, ANN HUM GENET, V35, P171, DOI 10.1111/j.1469-1809.1956.tb01390.x; CHAPELLE ADL, 1973, CHROMOSOMES TODAY, V4, P261; COHEN MM, 1972, AM J HUM GENET, V24, P583; CRANDALL BF, 1973, AM J HUM GENET, V25, pA22; CRANDALL BF, 1974, AM J HUM GENET, V26, P385; ENGEL W, 1971, CYTOGENETICS, V10, P87, DOI 10.1159/000130131; FEINGOLD M, 1973, J MED GENET, V10, P184, DOI 10.1136/jmg.10.2.184; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; GERALD P, 1973, PEDIATR RES, V7, P344; GERMAN J, 1967, 3 P INT C HUM GEN, P123; GRUMBACH MM, 1974, TXB ENDOCRINOLOGY, P423; Hamerton JL, 1971, HUMAN CYTOGENETICS, V1; HUGHJONES K, 1965, ARCH DIS CHILD, V40, P274, DOI 10.1136/adc.40.211.274; KALLIO H, 1973, ACTA OBSTET GYNEC SC, V24, P1; LUCAS M, 1973, ANN HUM GENET, V37, P9, DOI 10.1111/j.1469-1809.1973.tb01809.x; LYON MARY F., 1966, ADVANCE TERATOLOGY, V1, P25; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; MANN J D, 1974, American Journal of Human Genetics, V26, P416; MANN JD, 1965, AM J HUM GENET, V17, P377; MIKKELSEN M, 1973, CYTOGENET CELL GENET, V12, P357, DOI 10.1159/000130474; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MUKERJEE D, 1966, NATURE, V212, P153, DOI 10.1038/212153a0; NEUHAUSER G, 1967, HUMANGENETIK, V3, P300; RETHORE MO, 1973, HUMANGENETIK, V18, P129, DOI 10.1007/BF00291480; ROHDE RA, 1964, LANCET, V2, P838; RUSSELL LB, 1970, GENETICS, V64, P281; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SARTO GE, 1973, AM J HUM GENET, V25, P262; SUJANSKY E, 1973, PEDIATR RES, V7, P343; SUMMITT RL, 1974, J PEDIATR-US, V84, P539, DOI 10.1016/S0022-3476(74)80674-8; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; THELEN TH, 1971, AM J HUM GENET, V23, P410; THORBURN M J, 1967, Journal of Medical Genetics, V4, P283, DOI 10.1136/jmg.4.4.283; THORBURN M J, 1970, Journal of Medical Genetics, V7, P402, DOI 10.1136/jmg.7.4.402; WIELIEGOUW, 1964, CYTOGENETICS, V3, P427	37	84	84	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	4					441	453						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM544	1155455				2022-12-18	WOS:A1975AM54400001
J	SHAW, RF; GLOVER, RA				SHAW, RF; GLOVER, RA			ABNORMAL SEGREGATION IN HEREDITARY RENAL DISEASE WITH DEAFNESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Eason J, 1924, LANCET, V2, P639; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; GOLDBLOOM RB, 1957, PEDIATRICS, V20, P241; GRAHAM JB, 1959, AM J HUM GENET, V11, P385; GRAHAM JB, 1959, AM J HUM GENET, V11, P333; HAMBURGER J, 1956, J Urol Medicale Chir, V62, P113; MATTHEY R, 1957, EXPERIENTIA, V13, P341, DOI 10.1007/BF02179156; Mitchell AG, 1930, AM J DIS CHILD, V40, P101, DOI 10.1001/archpedi.1930.01940010112011; Mitchell AG, 1930, AM J DIS CHILD, V40, P345, DOI 10.1001/archpedi.1930.01940020121012; MORTON NE, 1957, AM J HUM GENET, V9, P55; PEKBOFF GT, 1960, AM J HUM GENET, V12, P381; PERKOFF GT, 1958, ARCH INTERN MED, V102, P733, DOI 10.1001/archinte.1958.00260220049005; POLI M, 1955, Helv Med Acta, V22, P109; POLI M, 1953, NEFROPATIE MEDICHE B; REYERSBACH GC, 1954, NEW ENGL J MED, V251, P377, DOI 10.1056/NEJM195409022511003; SOHAR E, 1956, ARCH INTERN MED, V97, P627, DOI 10.1001/archinte.1956.00250230121013; STEPHENS FE, 1951, AM J HUM GENET, V3, P303; STURTZ GS, 1956, NEW ENGL J MED, V254, P1123, DOI 10.1056/NEJM195606142542404; STURTZ GS, 1958, P STAFF M MAYO CLIN, V33, P289	20	84	84	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	1					89	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2959A	17948465				2022-12-18	WOS:A19612959A00017
J	SUTTON, HE; MATSON, GA; ROBINSON, AR; KOUCKY, RW				SUTTON, HE; MATSON, GA; ROBINSON, AR; KOUCKY, RW			DISTRIBUTION OF HAPTOGLOBIN, TRANSFERRIN, AND HEMOGLOBIN TYPES AMONG INDIANS OF SOUTHERN MEXICO AND GUATEMALA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1958, NATURE, V181, P824, DOI 10.1038/181824a0; ALLISON AC, 1957, BRIT MED J, V2, P1137, DOI 10.1136/bmj.2.5054.1137; BAITSCH H, 1959, Blut, V5, P302, DOI 10.1007/BF01629797; BARNICOT NA, 1960, ANN HUM GENET, V24, P171; BARNICOT NA, 1959, NATURE, V184, P2042, DOI 10.1038/1842042a0; BECKMAN L, 1959, COMMUNICATION; BECMAN L, 1959, ACTA GENET STAT MED, V9, P306; BLUMBERG BS, 1959, ANN HUM GENET, V23, P349, DOI 10.1111/j.1469-1809.1959.tb01478.x; BLUMBERG BS, 1959, COMMUNICATION; BUDTZ-OLSEN O. E., 1958, MED JOUR AUSTRALIA II, V45, P689; BUTLER R, 1959, SCHWEIZ MED WSCHR, V89, P1041; CONNELL GE, 1959, BIOCHEM J, V72, P115, DOI 10.1042/bj0720115; DE RODRIGUEZ M. L. GALLANGO, 1959, NATURE, V183, P1465; DOUGLAS R, 1960, COMMUJICATION; DRABKIN DL, 1946, J BIOL CHEM, V164, P703; FLEISCHER E, 1959, 6TH P C EUR SOC HA 2, P907; GALATIUSJENSEN F, 1960, HAPTOGLOBINS GENETIC; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P248; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P232; GIBLETT ER, 1959, NATURE, V183, P1589, DOI 10.1038/1831589a0; GIBLETT ER, 1959, NATURE, V183, P192, DOI 10.1038/183192a0; GIBLETT ER, 1960, IN PRESS; GIBLETT ER, 1960, COMMUNICATION; HARRIS H, 1958, NATURE, V182, P452, DOI 10.1038/182452a0; HARRIS H, 1959, CIBA F S BIOCH HUMAN, P114; HORSFALL WR, 1958, SCIENCE, V128, P35, DOI 10.1126/science.128.3314.35; KIRK RI, 1909, COMMUNICATION; KIRK RL, 1960, NATURE, V185, P185, DOI 10.1038/185185a0; KIRK RL, 1960, MED J AUSTRALIA, P45; Kroeber A.L., 1939, CULTURAL NATURAL ARE; KUNKEL HG, 1955, SCIENCE, V122, P288, DOI 10.1126/science.122.3163.288; LAURELL CB, 1957, BLOOD, V12, P493, DOI 10.1182/blood.V12.6.493.493; MAKELA O, 1959, Acta Genet Stat Med, V9, P149; MATSON GA, 1959, AM J PHYS ANTHROPOL, V17, P49, DOI 10.1002/ajpa.1330170107; MATSUNAGA E, 1960, NATURE, V186, P320, DOI 10.1038/186320a0; Morley Sylvanus Griswold, 1946, ANCIENT MAYA; MOTULSKY AG, 1960, IN PRESS; MOULLEC J, 1959, NATURE, V184, P196, DOI 10.1038/184196a0; NYMAN M, 1958, CLIN CHIM ACTA, V3, P111, DOI 10.1016/0009-8981(58)90067-6; OWEN JA, 1958, NATURE, V182, P1373, DOI 10.1038/1821373a0; Polonovski M, 1938, CR SOC BIOL, V129, P457; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; SMITHIES O, 1959, BIOCHEM J, V72, P121, DOI 10.1042/bj0720121; SMITHIES O, 1957, NATURE, V180, P1482, DOI 10.1038/1801482a0; SMITHIES O, 1955, NATURE, V176, P1265, DOI 10.1038/1761265a0; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; SMITHIES O, 1955, NATURE, V175, P307, DOI 10.1038/175307a0; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, 1958, NATURE, V181, P1203, DOI 10.1038/1811203b0; SUTTON H E, 1959, Ann Hum Genet, V23, P175; SUTTON HE, 1956, NATURE, V178, P1287, DOI 10.1038/1781287a0; YAMAGUCHI M, 1959, COMMUNICATION	53	84	84	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1960	12	3					338	347						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF079	13835848				2022-12-18	WOS:A1960WF07900006
J	Dias, C; Estruch, SB; Graham, SA; McRae, J; Sawiak, SJ; Hurst, JA; Joss, SK; Holder, SE; Morton, JEV; Turner, C; Thevenon, J; Mellul, K; Sanchez-Andrade, G; Ibarra-Soria, X; Deriziotis, P; Santos, RF; Lee, SC; Faivre, L; Kleefstra, T; Liu, P; Hurles, ME; Fisher, SE; Logan, DW				Dias, Cristina; Estruch, Sara B.; Graham, Sarah A.; McRae, Jeremy; Sawiak, Stephen J.; Hurst, Jane A.; Joss, Shelagh K.; Holder, Susan E.; Morton, Jenny E. V.; Turner, Claire; Thevenon, Julien; Mellul, Kelly; Sanchez-Andrade, Gabriela; Ibarra-Soria, Ximena; Deriziotis, Pelagia; Santos, Rui F.; Lee, Song-Choon; Faivre, Laurence; Kleefstra, Tjitske; Liu, Pentao; Hurles, Mathew E.; Fisher, Simon E.; Logan, Darren W.		DDD Study	BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; PROJECTION NEURONS; AXON GUIDANCE; MICRODELETION; AUTISM; GENES; DELETION; PATIENT; 2P15P16.1; COMPLEXES	Intellectual disability (ID) is a common condition with considerable genetic heterogeneity. Next-generation sequencing of large cohorts has identified an increasing number of genes implicated in ID, but their roles in neurodevelopment remain largely unexplored. Here we report an ID syndrome caused by de novo heterozygous missense, nonsense, and frameshift mutations in BCL11A, encoding a transcription factor that is a putative member of the BAF swi/snf chromatin-remodeling complex. Using a comprehensive integrated approach to ID disease modeling, involving human cellular analyses coupled to mouse behavioral, neuroanatomical, and molecular phenotyping, we provide multiple lines of functional evidence for phenotypic effects. The etiological missense variants cluster in the amino-terminal region of human BCL11A, and we demonstrate that they all disrupt its localization, dimerization, and transcriptional regulatory activity, consistent with a loss of function. We show that Bcl11a haploinsufficiency in mice causes impaired cognition, abnormal social behavior, and microcephaly in accordance with the human phenotype. Furthermore, we identify shared aberrant transcriptional profiles in the cortex and hippocampus of these mouse models. Thus, our work implicates BCL11A haploinsufficiency in neurodevelopmental disorders and defines additional targets regulated by this gene, with broad relevance for our understanding of ID and related syndromes.	[Dias, Cristina; McRae, Jeremy; Sanchez-Andrade, Gabriela; Ibarra-Soria, Ximena; Lee, Song-Choon; Liu, Pentao; Hurles, Mathew E.; Logan, Darren W.; DDD Study] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Estruch, Sara B.; Graham, Sarah A.; Deriziotis, Pelagia; Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, POB 310, NL-6500 AH Nijmegen, Netherlands; [Sawiak, Stephen J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Sawiak, Stephen J.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 0QQ, England; [Hurst, Jane A.] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Joss, Shelagh K.] Queen Elizabeth Univ Hosp, West Scotland Reg Genet Serv, Level 2 Lab Med Bldg, Glasgow G51 4TF, Lanark, Scotland; [Holder, Susan E.] London North West Healthcare NHS Trust, North West Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Morton, Jenny E. V.] Birmingham Womens Hosp, Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Turner, Claire] Royal Devon & Exeter Hosp Heavitree, Royal Devon & Exeter NHS Fdn Trust, Dept Clin Genet, Peninsula Clin Genet Serv,Dept Clin Genet, Gladstone Rd, Exeter EX1 2ED, Devon, England; [Thevenon, Julien; Faivre, Laurence] Ctr Hosp Univ Dijon, Federat Hosp Univ Med Translat & Anomalies Dev TR, F-21079 Dijon, France; [Thevenon, Julien; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Genet, F-21079 Dijon, France; [Thevenon, Julien; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [Mellul, Kelly] Univ Sorbonne Paris Cite, Hop Necker Enfants Malad, Serv Genet, APHP,Inst Imagine,INSERM,UMR1163, F-75015 Paris, France; [Santos, Rui F.] Royal Manchester Childrens Hosp, Childrens Radiol Dept, Manchester M13 9WL, Lancs, England; [Lee, Song-Choon] Sci Ctr Singapore, 15 Sci Ctr Rd, Singapore 609081, Singapore; [Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Fisher, Simon E.] Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands	Wellcome Trust Sanger Institute; Max Planck Society; University of Cambridge; University of Cambridge; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Queen Elizabeth University Hospital (QEUH); Birmingham Women's Hospital; University of Exeter; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; Radboud University Nijmegen; Radboud University Nijmegen	Logan, DW (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England.; Fisher, SE (corresponding author), Max Planck Inst Psycholinguist, Language & Genet Dept, POB 310, NL-6500 AH Nijmegen, Netherlands.; Fisher, SE (corresponding author), Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands.	simon.fisher@mpi.nl; dl5@sanger.ac.uk	Graham, Sarah/G-7765-2014; Ibarra-Soria, Ximena/ABF-1624-2021; Fisher, Simon E./E-9130-2012; Kleefstra, Tjitske/G-2619-2012; Sawiak, Stephen/I-8944-2012	Graham, Sarah/0000-0003-2521-2416; Fisher, Simon E./0000-0002-3132-1996; Dias, Cristina/0000-0001-5411-4984; Derizioti, Pelagia/0000-0001-5004-6865; Logan, Darren/0000-0003-1545-5510; Sawiak, Stephen/0000-0003-4210-9816; Faivre, Laurence/0000-0001-9770-444X; , Rui Miguel/0000-0002-4642-5333	Max Planck Society; University of Cambridge Wellcome Trust; EMBO; Health Innovation Challenge Fund [HICF-1009-003]; Department of Health; Wellcome Trust Sanger Institute; National Institute for Health Research through the Comprehensive Clinical Research Network; Regional Council of Burgundy; Dijon University Hospital	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Cambridge Wellcome Trust; EMBO(European Molecular Biology Organization (EMBO)); Health Innovation Challenge Fund; Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Dijon University Hospital	This work was supported by the Wellcome Trust (grant number WT098051), the Max Planck Society (S.E.F.), The University of Cambridge Wellcome Trust PhD Programme for Clinicians (C.D.), and EMBO Young Investigator Programme (D.W.L.).; The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute. The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83 granted by the Cambridge South REC and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. For a complete list of DDD Study participants, please see Firth et al.<SUP>89</SUP>; The PARI2011 study was supported by the Regional Council of Burgundy and Dijon University Hospital.	Aghajanian H, 2014, J BIOL CHEM, V289, P17971, DOI 10.1074/jbc.M113.544833; Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Alajem A, 2015, CELL REP, V10, P2019, DOI 10.1016/j.celrep.2015.02.064; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Bagheri H, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85461; Balci TB, 2015, EUR J MED GENET, V58, P351, DOI 10.1016/j.ejmg.2015.04.006; Barber M, 2009, CEREB CORTEX, V19, pI22, DOI 10.1093/cercor/bhp041; Basak A, 2015, J CLIN INVEST, V125, P2363, DOI 10.1172/JCI81163; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Blockus H, 2014, CURR OPIN NEUROBIOL, V27, P82, DOI 10.1016/j.conb.2014.03.003; Bribian A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5265; Canovas J, 2015, J NEUROSCI, V35, P7552, DOI 10.1523/JNEUROSCI.0169-15.2015; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; De Leeuw N, 2008, J MED GENET, V45, P122, DOI 10.1136/jmg.2007.054049; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; deCarlos F., 2011, COMPUTED TOMOGRAPHY; Deriziotis P, 2014, JOVE-J VIS EXP, DOI 10.3791/51438; Deriziotis P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5954; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Felix TM, 2010, AM J MED GENET A, V152A, P2604, DOI 10.1002/ajmg.a.33612; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Florisson JMG, 2013, AM J MED GENET A, V161A, P244, DOI 10.1002/ajmg.a.35632; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Funnell APW, 2015, BLOOD, V126, P89, DOI 10.1182/blood-2015-04-638528; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Graham SA, 2015, ANNU REV GENET, V49, P131, DOI 10.1146/annurev-genet-120213-092236; Hancarova M, 2013, AM J MED GENET A, V161A, P865, DOI 10.1002/ajmg.a.35783; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hernandez-Miranda LR, 2011, J NEUROSCI, V31, P6174, DOI 10.1523/JNEUROSCI.5464-10.2011; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Hucthagowder V, 2012, EUR J MED GENET, V55, P485, DOI 10.1016/j.ejmg.2012.04.003; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; John A, 2012, DEVELOPMENT, V139, P1831, DOI 10.1242/dev.072850; Jorgez CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107028; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kochinke K, 2016, AM J HUM GENET, V98, P149, DOI 10.1016/j.ajhg.2015.11.024; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kuo TY, 2007, J NEUROSCI RES, V85, P1628, DOI 10.1002/jnr.21300; Kuo TY, 2009, MOL CELL NEUROSCI, V42, P195, DOI 10.1016/j.mcn.2009.07.006; Lee S. - C., 2009, COLD SPRING HARB PRO, V2009, pt5291; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mircsof D, 2015, NAT NEUROSCI, V18, P1731, DOI 10.1038/nn.4169; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Peter B, 2014, AM J MED GENET A, V164, P2091, DOI 10.1002/ajmg.a.36599; Piccione M, 2012, EUR J MED GENET, V55, P238, DOI 10.1016/j.ejmg.2012.01.014; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Sakurai A, 2012, CELL RES, V22, P23, DOI 10.1038/cr.2011.198; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Sawiak SJ, 2013, MAGN RESON IMAGING, V31, P1522, DOI 10.1016/j.mri.2013.06.001; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Wang F, 2015, BRAIN RES, V1616, P157, DOI 10.1016/j.brainres.2015.05.005; Wiegreffe C, 2015, NEURON, V87, P311, DOI 10.1016/j.neuron.2015.06.023; Wolman MA, 2007, J NEUROSCI, V27, P9653, DOI 10.1523/JNEUROSCI.1741-07.2007; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Yuan HM, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0214-3; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	89	83	85	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					253	274		10.1016/j.ajhg.2016.05.030	http://dx.doi.org/10.1016/j.ajhg.2016.05.030			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27453576	Green Published, hybrid			2022-12-18	WOS:000381617200001
J	McInerney-Leo, AM; Schmidts, M; Cortes, CR; Leo, PJ; Gener, B; Courtney, AD; Gardiner, B; Harris, JA; Lu, YP; Marshall, M; Scambler, PJ; Beales, PL; Brown, MA; Zankl, A; Mitchison, HM; Duncan, EL; Wicking, C				McInerney-Leo, Aideen M.; Schmidts, Miriam; Cortes, Claudio R.; Leo, Paul J.; Gener, Blanca; Courtney, Andrew D.; Gardiner, Brooke; Harris, Jessica A.; Lu, Yeping; Marshall, Mhairi; Scambler, Peter J.; Beales, Philip L.; Brown, Matthew A.; Zankl, Andreas; Mitchison, Hannah M.; Duncan, Emma L.; Wicking, Carol		UK10K Consortium	Short-Rib Polydactyly and Jeune Syndromes Are Caused by Mutations in WDR60	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPHYXIATING THORACIC DYSTROPHY; DNA-SEQUENCING DATA; INTRAFLAGELLAR TRANSPORT; CRANIOECTODERMAL DYSPLASIA; SENSENBRENNER SYNDROME; DYNC2H1 MUTATIONS; CILIOPATHIES; DISEASE; PROTEIN; GENE	Short-rib polydactyly syndromes (SRPS I-V) are a group of lethal congenital disorders characterized by shortening of the ribs and long bones, polydactyly, and a range of extraskeletal phenotypes. A number of other disorders in this grouping, including Jeune and Ellis-van Creveld syndromes, have an overlapping but generally milder phenotype. Collectively, these short-rib dysplasias (with or without polydactyly) share a common underlying defect in primary cilium function and form a subset of the ciliopathy disease spectrum. By using whole-exome capture and massive parallel sequencing of DNA from an affected Australian individual with SRPS type III, we detected two novel heterozygous mutations in WDR60, a relatively uncharacterized gene. These mutations segregated appropriately in the unaffected parents and another affected family member, confirming compound heterozygosity, and both were predicted to have a damaging effect on the protein. Analysis of an additional 54 skeletal ciliopathy exomes identified compound heterozygous mutations in WDR60 in a Spanish individual with Jeune syndrome of relatively mild presentation. Of note, these two families share one novel WDR60 missense mutation, although haplotype analysis suggested no shared ancestry. We further show that WDR60 localizes at the base of the primary cilium in wild-type human chondrocytes, and analysis of fibroblasts from affected individuals revealed a defect in ciliogenesis and aberrant accumulation of the GLI2 transcription factor at the centrosorne or basal body in the absence of an obvious axoneme. These findings show that WDR60 mutations can cause skeletal ciliopathies and suggest a role for WDR60 in ciliogenesis.	[McInerney-Leo, Aideen M.; Leo, Paul J.; Gardiner, Brooke; Harris, Jessica A.; Marshall, Mhairi; Brown, Matthew A.; Duncan, Emma L.] Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld 4102, Australia; [Schmidts, Miriam; Lu, Yeping; Scambler, Peter J.; Beales, Philip L.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Schmidts, Miriam; Lu, Yeping; Scambler, Peter J.; Beales, Philip L.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Birth Defects Res Ctr, London WC1N 1EH, England; [Cortes, Claudio R.; Courtney, Andrew D.; Wicking, Carol] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Gener, Blanca] Hosp Univ Cruces, BioCruces Hlth Res Inst, Serv Genet, Baracaldo, Bizkaia, Spain; [Zankl, Andreas] Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Dept Endocrinol, Herston, Qld 4029, Australia	University of Queensland; University of London; University College London; University of London; University College London; University of Queensland; Hospital Universitario Cruces; University of Queensland; Royal Brisbane & Women's Hospital	Zankl, A (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia.	a.zankl@uq.edu.au	Cortes, Claudio/AAM-3948-2020; McInerney-Leo, Aideen M/D-8302-2016; Scambler, Peter/AAZ-6026-2020; Leo, Paul J/B-3470-2011; Duncan, Emma L/L-1224-2013; Leo, Paul/R-4464-2019; Beales, Philip L/C-7367-2009; Schmidts, Miriam/A-3777-2012; Gardiner, Brooke B/C-7773-2011; McInerney-Leo, Aideen M/E-1788-2018; Brown, Matthew A/E-5749-2010; Wicking, Carol/J-1814-2014	Cortes, Claudio/0000-0003-2255-7806; McInerney-Leo, Aideen M/0000-0002-0059-5732; Scambler, Peter/0000-0002-1487-4628; Leo, Paul J/0000-0001-8325-4134; Duncan, Emma L/0000-0002-8143-4403; Schmidts, Miriam/0000-0002-1714-6749; Gardiner, Brooke B/0000-0003-3740-3244; Brown, Matthew A/0000-0003-0538-8211; Mitchison, Hannah/0000-0002-3163-6293; Kelly, Kirsten/0000-0003-4234-543X; Wicking, Carol/0000-0002-7225-3803	Australian Cancer Research Foundation; UQ International PhD Scholarship; NHMRC Senior Principal Research Fellowship; Rebecca Cooper Medical Research Foundation; EU FP-7 framework programme (SYSCILIA grant); Dutch Kidney Foundation [CP 11.18]; Wellcome Trust; British Heart Foundation; Action Medical Research UK; Newlife Foundation for Disabled Children UK; Henry Smith Charity UK; Action Medical Research UK Clinical Training Fellowship [RTF-1411]; Wellcome Trust UK [UK10K, WT091310]; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish; Action Medical Research [1794] Funding Source: researchfish	Australian Cancer Research Foundation; UQ International PhD Scholarship; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Research Foundation; EU FP-7 framework programme (SYSCILIA grant); Dutch Kidney Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Action Medical Research UK; Newlife Foundation for Disabled Children UK; Henry Smith Charity UK; Action Medical Research UK Clinical Training Fellowship; Wellcome Trust UK(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; Action Medical Research	The authors would like to thank the families for their cooperation and interest in the study. We also wish to thank Carlos Vazquez (Unidad de Fibrosis Quistica y Neumologia Pediatrica, Hospital Universitario Cruces, Baracaldo, Spain) for referring family JATD76, Linda Bradbury for collecting initial samples from family SKDP-42, Gael Phillips (Pathology Queensland) for the autopsy report on individual SKDP42.4, Thor Friis (QUT) for providing the C-28/I2 cell line, Sharon Song, Marina Doskoi, and Maria Rondon for technical support, and Kelly Smith for helpful discussion. All confocal microscopy was carried out at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, developed with the generous support of the Australian Cancer Research Foundation. C.R.C. is the recipient of a UQ International PhD Scholarship, and C.W. was an Australian National Health and Medical Research Council (NHMRC) Senior Research Fellow. M.A.B. was funded by an NHMRC Senior Principal Research Fellowship, and support was also received from the Rebecca Cooper Medical Research Foundation. P.L.B. is a Wellcome Trust Senior Research Fellow and received funding from the EU FP-7 framework programme (SYSCILIA grant). P.L.B. and M.S. acknowledge funding from the Dutch Kidney Foundation (CP 11.18). P.J.S. is supported by the Wellcome Trust and British Heart Foundation. H.M.M. received funds from Action Medical Research UK, Newlife Foundation for Disabled Children UK, and the Henry Smith Charity UK. M.S. is funded by an Action Medical Research UK Clinical Training Fellowship (RTF-1411). This publication used sequencing data generated by the UK10K project, which is funded by Wellcome Trust UK (award WT091310). A list of UK10K contributors can be found at http://www.uk10k.org.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Cavalcanti DP, 2011, J MED GENET, V48, P88, DOI 10.1136/jmg.2009.069468; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Hao LM, 2009, J CELL SCI, V122, P889, DOI 10.1242/jcs.023861; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hoffer JL, 2013, CLIN GENET, V83, P92, DOI 10.1111/j.1399-0004.2012.01880.x; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JE, 2011, GENOME MED, V3, DOI 10.1186/gm275; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Ruiz-Perez VL, 2003, AM J HUM GENET, V72, P728, DOI 10.1086/368063; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7	41	83	87	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					515	523		10.1016/j.ajhg.2013.06.022	http://dx.doi.org/10.1016/j.ajhg.2013.06.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23910462	Green Published, hybrid			2022-12-18	WOS:000330268900010
J	Tanackovic, G; Ransijn, A; Ayuso, C; Harper, S; Berson, EL; Rivolta, C				Tanackovic, Goranka; Ransijn, Adriana; Ayuso, Carmen; Harper, Shyana; Berson, Eliot L.; Rivolta, Carlo			A Missense Mutation in PRPF6 Causes Impairment of pre-mRNA Splicing and Autosomal-Dominant Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN HOMOLOG; U5 SNRNP; RP9 FORM; GENE; BRR2	Retinitis pigmentosa (RP) is an inherited form of retinal degeneration that leads to progressive visual-field constriction and blindness. Although the disease manifests only in the retina, mutations in ubiquitously expressed genes associated with the tri-snRNP complex of the spliceosome have been identified in patients with dominantly inherited RP. We screened for mutations in PRPF6 (NM_012469.3), a gene on chromosome 20q13.33 encoding an essential protein for tri-snRNP assembly and stability, in 188 unrelated patients with autosomal-dominant RP and identified a missense mutation, c.2185C>T (p.Arg729Trp). This change affected a residue that is conserved from humans to yeast and cosegregated with the disease in the family in which it was identified. Lymphoblasts derived from patients with this mutation showed abnormal localization of endogenous PRPF6 within the nucleus. Specifically, this protein accumulated in the Cajal bodies, indicating a possible impairment in the tri-snRNP assembly or recycling. Expression of GFP-tagged PRPF6 in HeLa cells showed that this phenomenon depended exclusively on the mutated form of the protein. Furthermore, analysis of endogenous transcripts in cells from patients revealed intron retention for pre-mRNA bearing specific splicing signals, according to the same pattern displayed by lymphoblasts with mutations in other PRPF genes. Our results identify PRPF6 as the sixth gene involved in pre-mRNA splicing and dominant RP, corroborating the hypothesis that deficiencies in the spliceosome play an important role in the molecular pathology of this disease.	[Tanackovic, Goranka; Ransijn, Adriana; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Harper, Shyana; Berson, Eliot L.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; [Ayuso, Carmen] IIS Fdn Jimenez Diaz, Dept Genet, ES-28040 Madrid, Spain; [Ayuso, Carmen] CIBERER, ES-28040 Madrid, Spain	University of Lausanne; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Rivolta, C (corresponding author), Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland.	carlo.rivolta@unil.ch		Rivolta, Carlo/0000-0002-0733-9950; Ayuso, Carmen/0000-0002-9242-7065	Swiss National Science Foundation [320000-121929]; Marie Heim-Vogtlin Programme [PMPDA-114446]; National Institutes of Health [EY00169, P30-EY014104]; Foundation Fighting Blindness USA; Research to Prevent Blindness (Harvard Medical School, Department of Ophthalmology); NATIONAL EYE INSTITUTE [R01EY000169, R37EY000169, P30EY014104] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Heim-Vogtlin Programme(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness USA; Research to Prevent Blindness (Harvard Medical School, Department of Ophthalmology)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Swiss National Science Foundation (grants PMPDA-114446 from the Marie Heim-Vogtlin Programme [to G.T.] and grant 320000-121929 [to C.R.]), the National Institutes of Health (grants EY00169 and P30-EY014104), The Foundation Fighting Blindness USA (to E.L.B.), by Research to Prevent Blindness (Harvard Medical School, Department of Ophthalmology, unrestricted grant). We would like to thank Zoltan Kutalik and Alexandra Title for discussion and for editing the manuscript, as well as Giulia Venturini and Marta Corton for providing reagents. We are indebted to Terri L. McGee for her help with DNA from patients.	Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; Cao HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015860; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Gonzalez-Santos JM, 2008, HUM MOL GENET, V17, P225, DOI 10.1093/hmg/ddm300; Hacker I, 2008, NAT STRUCT MOL BIOL, V15, P1206, DOI 10.1038/nsmb.1506; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Huranova M, 2009, HUM MOL GENET, V18, P2014, DOI 10.1093/hmg/ddp125; Ivings L, 2008, MOL VIS, V14, P2357; Keen TJ, 2002, EUR J HUM GENET, V10, P245, DOI 10.1038/sj.ejhg.5200797; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li ND, 2010, INVEST OPHTH VIS SCI, V51, P1036, DOI 10.1167/iovs.09-3725; Linder B, 2011, HUM MOL GENET, V20, P368, DOI 10.1093/hmg/ddq473; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Maita H, 2004, EXP CELL RES, V300, P283, DOI 10.1016/j.yexcr.2004.07.029; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Tanackovic G, 2011, HUM MOL GENET, V20, P2116, DOI 10.1093/hmg/ddr094; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wilkie SE, 2008, MOL VIS, V14, P683; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	31	83	87	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					643	649		10.1016/j.ajhg.2011.04.008	http://dx.doi.org/10.1016/j.ajhg.2011.04.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549338	Green Published, Bronze			2022-12-18	WOS:000290832100013
J	Okada, I; Hamanoue, H; Terada, K; Tohma, T; Megarbane, A; Chouery, E; Abou-Ghoch, J; Jalkh, N; Cogulu, O; Ozkinay, F; Horie, K; Takeda, J; Furuichi, T; Ikegawa, S; Nishiyama, K; Miyatake, S; Nishimura, A; Mizuguchi, T; Niikawa, N; Hirahara, F; Kaname, T; Yoshiura, K; Tsurusaki, Y; Doi, H; Miyake, N; Furukawa, T; Matsumoto, N; Saitsu, H				Okada, Ippei; Hamanoue, Haruka; Terada, Koji; Tohma, Takaya; Megarbane, Andre; Chouery, Eliane; Abou-Ghoch, Joelle; Jalkh, Nadine; Cogulu, Ozgur; Ozkinay, Ferda; Horie, Kyoji; Takeda, Junji; Furuichi, Tatsuya; Ikegawa, Shiro; Nishiyama, Kiyomi; Miyatake, Satoko; Nishimura, Akira; Mizuguchi, Takeshi; Niikawa, Norio; Hirahara, Fumiki; Kaname, Tadashi; Yoshiura, Koh-ichiro; Tsurusaki, Yoshinori; Doi, Hiroshi; Miyake, Noriko; Furukawa, Takahisa; Matsumoto, Naomichi; Saitsu, Hirotomo			SMOC1 Is Essential for Ocular and Limb Development in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPHTHALMO-ACROMELIC SYNDROME; BONE MORPHOGENETIC PROTEIN-7; SKELETAL ANOMALIES; MUTATIONS; WAARDENBURG; BINDING; EXPRESSION; BRAIN; LOCUS; GDF6	Microphthalmia with limb anomalies (MLA) is a rare autosomal-recessive disorder, presenting with anophthalmia or microphthalmia and hand and/or foot malformation. We mapped the MLA locus to 14q24 and successfully identified three homozygous (one nonsense and two splice site) mutations in the SPARC (secreted protein acidic and rich in cysteine)-related modular calcium binding 1 (SMOC1) in three families. Smoc1 is expressed in the developing optic stalk, ventral optic cup, and limbs of mouse embryos. Smoc1 null mice recapitulated MLA phenotypes, including aplasia or hypoplasia of optic nerves, hypoplastic fibula and bowed tibia, and syndactyly in limbs. A thinned and irregular ganglion cell layer and atrophy of the anteroventral part of the retina were also observed. Soft tissue syndactyly, resulting from inhibited apoptosis, was related to disturbed expression of genes involved in BMP signaling in the interdigital mesenchyme. Our findings indicate that SMOC1/Smoc1 is essential for ocular and limb development in both humans and mice.	[Okada, Ippei; Hamanoue, Haruka; Nishiyama, Kiyomi; Miyatake, Satoko; Nishimura, Akira; Mizuguchi, Takeshi; Tsurusaki, Yoshinori; Doi, Hiroshi; Miyake, Noriko; Matsumoto, Naomichi; Saitsu, Hirotomo] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Hamanoue, Haruka; Hirahara, Fumiki] Yokohama City Univ, Grad Sch Med, Dept Obstet & Gynecol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Terada, Koji; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka 5650874, Japan; [Tohma, Takaya] Okinawa Prefectural Nanbu Med Ctr, Div Pediat, Okinawa 9011193, Japan; [Tohma, Takaya] Childrens Med Ctr, Okinawa 9011193, Japan; [Megarbane, Andre; Chouery, Eliane; Abou-Ghoch, Joelle; Jalkh, Nadine] St Joseph Univ, Med Genet Unit, Beirut 11042020, Lebanon; [Cogulu, Ozgur; Ozkinay, Ferda] Ege Univ, Fac Med, Dept Pediat, TR-35100 Bornova, Turkey; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; [Takeda, Junji] Osaka Univ, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan; [Furuichi, Tatsuya; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; [Furuichi, Tatsuya] Jikei Univ, Sch Med, Res Ctr Med Sci, Lab Anim Facil,Minato Ku, Tokyo 1058461, Japan; [Niikawa, Norio] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Ishikari, Hokkaido 0610293, Japan; [Niikawa, Norio; Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 8528523, Japan; [Kaname, Tadashi] Univ Ryukyus, Fac Med, Dept Med Genet, Okinawa 9030215, Japan	Yokohama City University; Yokohama City University; Ege University; Osaka University; Osaka University; RIKEN; Jikei University; Health Sciences University of Hokkaido; Nagasaki University; University of the Ryukyus	Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp; hsaitsu@yokohama-cu.ac.jp	Megarbane, Andre/ABD-5574-2021; Chouery, Eliane/AAC-5957-2021; Terada, Koji/G-3049-2012; Saitsu, Hirotomo/AAM-7131-2021; Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147; Saitsu, Hirotomo/0000-0003-0723-0960; Horie, Kyoji/0000-0001-9036-8180; Tsurusaki, Yoshinori/0000-0002-7240-6355	Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Japan Society for the Promotion of Science	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We would like to thank the patients and their families for their participation in this study. We thank Yoshiko Takahashi (Nara Institute of Science and Technology) and Atsushi Yamada (Showa University) for providing the Bmp2 and Sox9 probes; Elizabeth J. Robertson (University of Oxford) and Makoto Ishibashi (Kyoto University) for the Bmp7 probe; Robert E. Maxson, Jr. (University of Southern California Keck School of Medicine) for the Msx2 probe; Tomonori Hirose, Kazunori Akimoto, and Kazunori Sasaki (Yokohama City University) for providing useful information about mouse breeding, taking photos on a stereo microscope, and mRNA quantification; and Kohei Shiota and Sumiko Kimura (Kyoto University) for helpful comments about NB staining and limb anomalies. This work was supported by research grants from the Ministry of Health, Labour and Welfare (T. Furuichi, N. Miyake, N. Matsumoto, and H.S.) and the Japan Science and Technology Agency (N. Matsumoto), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (T. Furuichi and N. Matsumoto), and a Grant-in-Aid for Young Scientist from the Japan Society for the Promotion of Science (K.N., H.D., N. Miyake, and H.S.). This work has been carried out at the Advanced Medical Research Center of Yokohama City University.	Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Cogulu O, 2000, AM J MED GENET, V90, P173, DOI 10.1002/(SICI)1096-8628(20000117)90:2<173::AID-AJMG17>3.3.CO;2-E; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Garavelli L, 2006, GENET COUNSEL, V17, P449; Gersdorff N, 2006, HISTOCHEM CELL BIOL, V126, P705, DOI 10.1007/s00418-006-0200-7; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Hamanoue H, 2009, AM J MED GENET A, V149A, P336, DOI 10.1002/ajmg.a.32656; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kimura S, 1996, J MORPHOL, V229, P337, DOI 10.1002/(SICI)1097-4687(199609)229:3<337::AID-JMOR8>3.0.CO;2-V; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Megarbane A, 1998, GENET COUNSEL, V9, P195; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; PARR BA, 1993, DEVELOPMENT, V119, P247; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Saitsu H, 2003, DEV DYNAM, V226, P112, DOI 10.1002/dvdy.10203; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Suzuki D, 2009, DEV BIOL, V335, P396, DOI 10.1016/j.ydbio.2009.09.014; Tamplin OJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-511; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Teiber ML, 2007, AM J MED GENET A, V143A, P2460, DOI 10.1002/ajmg.a.31930; Tekin M, 2000, AM J MED GENET, V90, P150, DOI 10.1002/(SICI)1096-8628(20000117)90:2<150::AID-AJMG12>3.0.CO;2-C; Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; WAARDENBURG PJ, 1961, GENET OPHTHALMOL, P773; Wyatt AW, 2010, HUM MUTAT, V31, P781, DOI 10.1002/humu.21280; Ye M, 2010, HUM MOL GENET, V19, P287, DOI 10.1093/hmg/ddp496; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou F, 2009, HUM MOL GENET, V18, P2472, DOI 10.1093/hmg/ddp185	37	83	87	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					30	41		10.1016/j.ajhg.2010.11.012	http://dx.doi.org/10.1016/j.ajhg.2010.11.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21194678	Green Published, Bronze			2022-12-18	WOS:000286501500003
J	Liu, XG; Tan, LJ; Lei, SF; Liu, YJ; Shen, H; Wang, L; Yan, H; Guo, YF; Xiong, DH; Chen, XD; Pan, F; Yang, TL; Zhang, YP; Guo, Y; Tang, NL; Zhu, XZ; Deng, HY; Levy, S; Recker, RR; Papasian, CJ; Deng, HW				Liu, Xiao-Gang; Tan, Li-Jun; Lei, Shu-Feng; Liu, Yong-Jun; Shen, Hui; Wang, Liang; Yan, Han; Guo, Yan-Fang; Xiong, Dong-Hai; Chen, Xiang-Ding; Pan, Feng; Yang, Tie-Lin; Zhang, Yin-Ping; Guo, Yan; Tang, Nelson L.; Zhu, Xue-Zhen; Deng, Hong-Yi; Levy, Shawn; Recker, Robert R.; Papasian, Christopher J.; Deng, Hong-Wen			Genome-wide Association and Replication Studies Identified TRHR as an Important Gene for Lean Body Mass	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-I; MUSCLE STRENGTH; SOLEUS MUSCLE; HORMONE; HYPOTHYROIDISM; LINKAGE; FAMILY; WOMEN; SCAN; RATS	Low lean body mass (LBM) is related to a series of health problems, such as osteoporotic fracture and sarcopenia. Here we report a genome-wide association (GWA) study on LBM variation, by using Affymetrix 500K single-nucleotide polymorphism (SNP) arrays. In the GWA scan, we tested 379,319 eligible SNPs in 1,000 unrelated US whites and found that two SNPs, rs16892496 (p = 7.55 X 10(-8)) and rs7832552 (p = 7.58 x 10(-8)), within the thyrotropin-releasing hormone receptor (TRHR) gene were significantly associated with LBM. Subjects carrying unfavorable genotypes at rs16892496 and rs7832552 had, on average, 2.70 and 2.55 kg lower LBM, respectively, compared to those with alternative genotypes. We replicated the significant associations in three independent samples: (1) 1488 unrelated US whites, (2) 2955 Chinese unrelated subjects, and (3) 593 nuclear families comprising 1972 US whites. Meta-analyses of the GWA scan and the replication studies yielded p values of 5.53 x 10(-9) for rs16892496 and 3.88 x 10(-10) for rs7832552. In addition, we found significant interactions between rs16892496 and polymorphisms of several other genes involved in the hypothalamic-pituitary-thyroid and the growth hormone-insulin-like growth factor-I axes. Results of this study, together with the functional relevance of TRHR in muscle metabolism, support the TRHR gene as an important gene for LBM variation.	[Liu, Xiao-Gang; Shen, Hui; Wang, Liang; Yan, Han; Guo, Yan-Fang; Pan, Feng; Yang, Tie-Lin; Zhang, Yin-Ping; Guo, Yan; Zhu, Xue-Zhen; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Liu, Xiao-Gang; Lei, Shu-Feng; Liu, Yong-Jun; Wang, Liang; Yan, Han; Xiong, Dong-Hai; Zhang, Yin-Ping; Deng, Hong-Yi; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Tan, Li-Jun; Lei, Shu-Feng; Chen, Xiang-Ding; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha 410081, Hunan, Peoples R China; [Tang, Nelson L.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L.] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Levy, Shawn] Vanderbilt Univ, Nashville, TN 37232 USA; [Recker, Robert R.] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA	Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; Hunan Normal University; Chinese University of Hong Kong; Chinese University of Hong Kong; Vanderbilt University; Creighton University	Deng, HW (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Shaanxi, Peoples R China.	dengh@umkc.edu	Yang, Tie-Lin/G-8365-2014; XIONG, DONGHAI/A-3691-2010; Liu, Yong/GWQ-6163-2022; Guo, Yan/G-8742-2014; Tang, Nelson L/P-5018-2017; Tan, Li-Jun/AAO-1130-2020	Yang, Tie-Lin/0000-0001-7062-3025; Guo, Yan/0000-0002-7364-2392; Tang, Nelson L/0000-0002-3607-5819; Levy, Shawn/0000-0002-1369-5740; Deng, Hong-Wen/0000-0002-0387-8818	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER; NIAAA NIH HHS [R21 AA015973] Funding Source: Medline; NIAMS NIH HHS [P50 AR055081, R01 AR050496-01, R01 AR050496] Funding Source: Medline; NIA NIH HHS [R01 AG026564, R21 AG027110] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chagnon YC, 2001, J APPL PHYSIOL, V90, P1777, DOI 10.1152/jappl.2001.90.5.1777; Chagnon YC, 2000, METABOLISM, V49, P203, DOI 10.1016/S0026-0495(00)91299-X; Collu R, 1997, J CLIN ENDOCR METAB, V82, P1561, DOI 10.1210/jc.82.5.1561; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Gibney J, 2007, ENDOCR REV, V28, P603, DOI 10.1210/er.2006-0052; Hansen RD, 1999, AM J CLIN NUTR, V70, P228; HOLLOSZY JO, 1995, J GERONTOL A-BIOL, V50, P1; Hsu FC, 2005, OBES RES, V13, P312, DOI 10.1038/oby.2005.42; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Lang CH, 2002, CURR OPIN CLIN NUTR, V5, P271, DOI 10.1097/00075197-200205000-00006; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; LARSSON L, 1994, J PHYSIOL-LONDON, V481, P149, DOI 10.1113/jphysiol.1994.sp020426; Liu XG, 2008, HUM GENET, V123, P189, DOI 10.1007/s00439-007-0463-7; Nguyen TV, 1998, AM J EPIDEMIOL, V147, P3; Norenberg KM, 1996, CAN J PHYSIOL PHARM, V74, P362, DOI 10.1139/cjpp-74-4-362; Platte P, 2003, AM J MED GENET C, V121C, P71, DOI 10.1002/ajmg.c.20005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Sipila S, 2006, J GERONTOL A-BIOL, V61, P92, DOI 10.1093/gerona/61.1.92; STIRLING WD, 1982, STATISTICIAN, V31, P211; Vadaszova A, 2006, PHYSIOL RES, V55, P221, DOI 10.33549/physiolres.930861; Van den Berghe G, 2002, CLIN ENDOCRINOL, V56, P655, DOI 10.1046/j.1365-2265.2002.01255.x	27	83	91	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					418	423		10.1016/j.ajhg.2009.02.004	http://dx.doi.org/10.1016/j.ajhg.2009.02.004			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19268274	Green Published, Bronze			2022-12-18	WOS:000264304200013
J	Casal, ML; Lewis, JR; Mauldin, EA; Tardivel, A; Ingold, K; Favre, M; Paradies, F; Demotz, S; Gaide, O; Schneider, P				Casal, Margret L.; Lewis, John R.; Mauldin, Elizabeth A.; Tardivel, Aubry; Ingold, Karine; Favre, Manuel; Paradies, Fabrice; Demotz, Stephane; Gaide, Olivier; Schneider, Pascal			Significant correction of disease after postnatal administration of recombinant ectodysplasin a in canine x-linked ectodermal dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION; FAMILY; MODEL	Patients with defective ectodysplasin A (EDA) are affected by X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition characterized by sparse hair, inability to sweat, decreased lacrimation, frequent pulmonary infections, and missing and malformed teeth. The canine model of XLHED was used to study the developmental impact of EDA on secondary dentition, since dogs have an entirely brachyodont, diphyodont dentition similar to that in humans, as opposed to mice, which have only permanent teeth (monophyodont dentition), some of which are very different (aradicular hypsodont) than brachyodont human teeth. Also, clinical signs in humans and dogs with XLHED are virtually identical, whereas several are missing in the murine equivalent. In our model, the genetically missing EDA was compensated for by postnatal intravenous administration of soluble recombinant EDA. Untreated XLHED dogs have an incomplete set of conically shaped teeth similar to those seen in human patients with XLHED. After treatment with EDA, significant normalization of adult teeth was achieved in four of five XLHED dogs. Moreover, treatment restored normal lacrimation and resistance to eye and airway infections and improved sweating ability. These results not only provide proof of concept for a potential treatment of this orphan disease but also demonstrate an essential role of EDA in the development of secondary dentition.	Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA; Univ Lausanne, Dept Biochem, Lausanne, Switzerland; Apoxis, Lausanne, Switzerland; Ctr Med Univ Geneva, Geneva, Switzerland	University of Pennsylvania; University of Lausanne; University of Geneva	Casal, ML (corresponding author), Univ Penn, Sch Vet Med, Med Genet Sect, 3850 Spruce St, Philadelphia, PA 19104 USA.	casalml@vet.upenn.edu		Schneider, Pascal/0000-0003-0677-9409	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR049817] Funding Source: NIH RePORTER; NCRR NIH HHS [RR02512, P40 RR002512] Funding Source: Medline; NIAMS NIH HHS [K01 AR049817, AR049817] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEAHRS JO, 1971, ANN INTERN MED, V74, P92, DOI 10.7326/0003-4819-74-1-92; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Brand R.D., 2003, ANATOMY OROFACIAL ST, P194; Casal ML, 2005, MAMM GENOME, V16, P524, DOI 10.1007/s00335-004-2463-4; Casal ML, 2005, VET IMMUNOL IMMUNOP, V107, P95, DOI 10.1016/j.vetimm.2005.04.005; Casal ML, 1997, J HERED, V88, P513, DOI 10.1093/oxfordjournals.jhered.a023146; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; EVANS HE, 1973, ANAT HISTOL EMBRYOL, V2, P11, DOI DOI 10.1111/J.1439-0264.1973.TB00253.X; FLETCHER MA, 1994, NEONATOLOGY PATHOPHY, P301; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; GILGENKRANTZ S, 1989, HUM GENET, V81, P120, DOI 10.1007/BF00293886; GRUNEBERG H, 1966, J EMBRYOL EXP MORPH, V15, P223; Johnson EL, 2002, AM J MED GENET, V112, P327, DOI 10.1002/ajmg.10654; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kristenova-Cermakova P, 2002, CONNECT TISSUE RES, V43, P283, DOI 10.1080/03008200290000727; LONG PH, 1999, PATHOLOGY MOUSE REFE, P13; Mulligan T, 1998, ATLAS CANINE FELINE; Sams W. M., 1990, PRINCIPLES PRACTICE, P3; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; SODERHOLM AL, 1985, CLIN GENET, V28, P136; Tape M W, 1995, Compend Contin Educ Dent, V16, P524; TOAL RL, 1996, HDB VET NUCL MED, P154; WIGGS RB, 1997, VET DENTISTRY PRINCI; WILLIAMS R C, 1978, Anatomia Histologia Embryologia, V7, P152, DOI 10.1111/j.1439-0264.1978.tb00665.x	25	83	85	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1050	1056		10.1086/521988	http://dx.doi.org/10.1086/521988			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924345	Green Published, Bronze			2022-12-18	WOS:000250480900015
J	Kim, HJ; Sohn, KM; Shy, ME; Krajewski, KM; Hwang, M; Park, JH; Jang, SY; Won, HH; Choi, BO; Hong, SH; Kim, BJ; Suh, YL; Ki, CS; Lee, SY; Kim, SH; Kim, JW				Kim, Hee-Jin; Sohn, Kwang-Min; Shy, Michael E.; Krajewski, Karen M.; Hwang, Miok; Park, June-Hee; Jang, Sue-Yon; Won, Hong-Hee; Choi, Byung-Ok; Hong, Sung Hwa; Kim, Byoung-Joon; Suh, Yeon-Lim; Ki, Chang-Seok; Lee, Soo-Youn; Kim, Sun-Hee; Kim, Jong-Won			Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (CMTX5)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEAFNESS	We have identified missense mutations at conserved amino acids in the PRPS1 gene on Xq22.3 in two families with a syndromic form of inherited peripheral neuropathy, one of Asian and one of European descent. The disease is inherited in an X-linked recessive manner, and the affected male patients invariably develop sensorineural hearing loss of prelingual type followed by gating disturbance and visual loss. The family of European descent was reported in 1967 as having Rosenberg-Chutorian syndrome, and recently a Korean family with the same symptom triad was identified with a novel disease locus CMTX5 on the chromosome band Xq21.32-q24. PRPS1 (phosphoribosyl pyrophosphate synthetase 1) is an isoform of the PRPS gene family and is ubiquitously expressed in human tissues, including cochlea. The enzyme mediates the biochemical step critical for purine metabolism and nucleotide biosynthesis. The mutations identified were E43D, in patients with Rosenberg-Chutorian syndrome, and M115T, in the Korean patients with CMTX5. We also showed decreased enzyme activity inpatients with M115T. PRPS1 is the first CMT gene that encodes a metabolic enzyme, shedding a new light on the understanding of peripheral nerve-specific metabolism and also suggesting the potential of PRPS1 as a target for drugs in prevention and treatment of peripheral neuropathy by antimetabolite therapy.	Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul 135710, South Korea; Ewha Womans Univ, Sch Med, Med Ctr, Dept Neurol, Seoul, South Korea; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Dept Neurol, Detroit, MI USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Ewha Womans University; Wayne State University	Kim, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, 50 Ilwon Dong, Seoul 135710, South Korea.	jwonk@smc.samsung.co.kr	Lee, Soo Youn/F-4614-2014; Kim, Hee Jin/F-4594-2014; Kim, Sun/GSN-4867-2022; Ki, Chang Seok/C-9599-2011; Ki, Chang-Seok/G-7559-2014; Won, Hong-Hee/D-2672-2011; Kim, Jong Won/C-9615-2011; ki, cs/O-5931-2014	Ki, Chang-Seok/0000-0001-7679-8731; Won, Hong-Hee/0000-0001-5719-0552; Shy, Michael/0000-0001-8460-6971; LEE, SOO-YOUN/0000-0001-7595-4042	NINDS NIH HHS [R01 NS43168-01A1, R01 NS043168] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043168] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; Becker MA, 1996, J BIOL CHEM, V271, P19894, DOI 10.1074/jbc.271.33.19894; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Brinkman RR, 2006, NAT REV GENET, V7, P249, DOI 10.1038/nrg1828; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Hausheer FH, 2006, SEMIN ONCOL, V33, P15, DOI 10.1053/j.seminoncol.2005.12.010; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kim HJ, 2005, NEUROLOGY, V64, P1964, DOI 10.1212/01.WNL.0000163768.58168.3A; Peltier AC, 2006, DRUG SAFETY, V29, P23, DOI 10.2165/00002018-200629010-00002; Resendes BL, 2002, JARO-J ASSOC RES OTO, V3, P45, DOI 10.1007/s101620020005; ROSENBER.RN, 1967, NEUROLOGY, V17, P827, DOI 10.1212/WNL.17.9.827; SIMMONDS HA, 1985, NEUROPEDIATRICS, V16, P106, DOI 10.1055/s-2008-1052552; SKRE H, 1974, CLIN GENET, V6, P98; Sul JK, 2006, SEMIN ONCOL, V33, P324, DOI 10.1053/j.seminoncol.2006.03.006; TAIRA M, 1989, BIOCHIM BIOPHYS ACTA, V1007, P203, DOI 10.1016/0167-4781(89)90040-7; Torres RJ, 1996, CLIN CHIM ACTA, V245, P105, DOI 10.1016/0009-8981(95)06178-9	16	83	92	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					552	558		10.1086/519529	http://dx.doi.org/10.1086/519529			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701900	Green Published, Bronze			2022-12-18	WOS:000249128200011
J	Bisceglia, L; Cerullo, G; Forabosco, P; Torres, DD; Scolari, F; Di Perna, M; Foramitti, M; Amoroso, A; Bertok, S; Floege, J; Mertens, PR; Zerres, K; Alexopoulos, E; Kirmizis, D; Ermelinda, M; Zelante, L; Schena, FP				Bisceglia, Luigi; Cerullo, Giuseppina; Forabosco, Paola; Torres, Diletta Domenica; Scolari, Francesco; Di Perna, Michele; Foramitti, Marina; Amoroso, Antonio; Bertok, Sara; Floege, Juergen; Mertens, Peter Rene; Zerres, Klaus; Alexopoulos, Efstathios; Kirmizis, Dimitrios; Ermelinda, Mazzucco; Zelante, Leopoldo; Schena, Francesco Paolo		European IgAN Consortium	Genetic heterogeneity in Italian families with IgA nephropathy: Suggestive linkage for two novel IgA nephropathy loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL-DISEASE; GLOMERULONEPHRITIS; SUSCEPTIBILITY; PREDOMINANCE; SIBLINGS; 6Q22-23	IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, but its etiologic mechanisms are still poorly understood. Different prevalences among ethnic groups and familial aggregation, together with an increased familial risk, suggest important genetic influences on its pathogenesis. A locus for familial IgAN, called "IGAN1," on chromosome 6q22-23 has been described, without the identification of any responsible gene. The partners of the European IgAN Consortium organized a second genomewide scan in 22 new informative Italian multiplex families. A total of 186 subjects (59 affected and 127 unaffected) were genotyped and were included in a two-stage genomewide linkage analysis. The regions 4q26-31 and 17q12-22 exhibited the strongest evidence of linkage by nonparametric analysis (best P = .0025 and .0045, respectively). These localizations were also supported by multipoint parametric analysis, in which peak LOD scores of 1.83 (alpha = 0.50) and 2.56 (alpha = 0.65) were obtained using the affected-only dominant model, and by allowance for the presence of genetic heterogeneity. Our results provide further evidence for genetic heterogeneity among families with IgAN. Evidence of linkage to multiple chromosomal regions is consistent with both an oligo/polygenic and a multiple-susceptibility-gene model for familial IgAN, with small or moderate effects in determining the pathological phenotype. Although we identified new candidate regions, replication studies are required to confirm the genetic contribution to familial IgAN.	Univ Bari, Dept Emergency & Organ Transplant, Renal Unit, I-70124 Bari, Italy; IRCCS Casa Sollievo Sofferenza, Med Genet Serv, Foggia, Italy; Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; Kings Coll London, Sch Med, Univ London Kings Coll Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; Kings Coll London, Sch Med, St Thomas Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; CNR, Ist Genet Popolaz, Alghero, Italy; Spedali Civil Brescia, Renal Unit, I-25125 Brescia, Italy; Univ Turin, Genet Unit, I-10124 Turin, Italy; Univ Trieste, Genet Unit, I-34127 Trieste, Italy; Univ Aachen, Rhein Westfal TH Aachen, Div Nephrol & Immunol, D-5100 Aachen, Germany; Univ Aachen, Rhein Westfal TH Aachen, Inst Human Genet, D-5100 Aachen, Germany; Aristotle Univ Thessaloniki, Renal Unit, GR-54006 Thessaloniki, Greece	Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Consiglio Nazionale delle Ricerche (CNR); Hospital Spedali Civili Brescia; University of Turin; University of Trieste; RWTH Aachen University; RWTH Aachen University; Aristotle University of Thessaloniki	Schena, FP (corresponding author), Univ Bari, Dept Emergency & Organ Transplant, Renal Unit, Piazza G Cesare 11, I-70124 Bari, Italy.	fp.schena@nephro.uniba.it	AMOROSO, ANTONIO/AAN-3884-2020; scolari, francesco/AAC-5957-2022; Bisceglia, Luigi/B-8720-2017; Forabosco, Paola/AAM-5540-2021; amoroso, antonio/AAL-1475-2020; Schena, Francesco P/K-6982-2016; Mertens, Peter/AAI-7310-2020	Bisceglia, Luigi/0000-0001-5367-8518; amoroso, antonio/0000-0002-9437-9407; Schena, Francesco P/0000-0001-7927-5207; Kirmizis, Dimitrios/0000-0002-5093-1570; Scolari, Francesco/0000-0003-0233-9705; FORABOSCO, PAOLA/0000-0002-2006-2693				Ebihara I, 2001, NEPHROL DIAL TRANSPL, V16, P1783, DOI 10.1093/ndt/16.9.1783; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; Kabasakal C, 1997, TURKISH J PEDIATR, V39, P395; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEVY M, 1993, CONTRIB NEPHROL, V104, P46; LI PKT, 1992, AM J KIDNEY DIS, V20, P458; Lim CS, 2001, NEPHROL DIAL TRANSPL, V16, P269, DOI 10.1093/ndt/16.2.269; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Preston GA, 2004, KIDNEY INT, V65, P420, DOI 10.1111/j.1523-1755.2004.00398.x; SABATIER JC, 1978, J UROL NEPHROL, V84, P672; Schena FP, 2006, EUR J HUM GENET, V14, P488, DOI 10.1038/sj.ejhg.5201591; Schena FP, 2002, J AM SOC NEPHROL, V13, P453, DOI 10.1681/ASN.V132453; Schena FP, 2005, OXFORD TXB CLIN NEPH, P469; Schena Francesco P, 2005, BMC Nephrol, V6, P14, DOI 10.1186/1471-2369-6-14; Scolari F, 1999, AM J KIDNEY DIS, V33, P857, DOI 10.1016/S0272-6386(99)70417-8; Sobel E, 1996, AM J HUM GENET, V58, P1323; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; TOLKOFFRUBIN NE, 1978, TRANSPLANTATION, V26, P430, DOI 10.1097/00007890-197812000-00014	21	83	98	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1130	1134		10.1086/510135	http://dx.doi.org/10.1086/510135			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186473	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000242131600016
J	Minichiello, MJ; Durbin, R				Minichiello, Mark J.; Durbin, Richard			Mapping trait loci by use of inferred ancestral recombination graphs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; DISEASE GENES; CLADISTIC-ANALYSIS; ASSOCIATION; COALESCENT; TREE; SUSCEPTIBILITY; ALGORITHMS; HAPLOTYPES; HISTORY	Large-scale association studies are being undertaken with the hope of uncovering the genetic determinants of complex disease. We describe a computationally efficient method for inferring genealogies from population genotype data and show how these genealogies can be used to fine map disease loci and interpret association signals. These genealogies take the form of the ancestral recombination graph (ARG). The ARG defines a genealogical tree for each locus, and, as one moves along the chromosome, the topologies of consecutive trees shift according to the impact of historical recombination events. There are two stages to our analysis. First, we infer plausible ARGs, using a heuristic algorithm, which can handle unphased and missing data and is fast enough to be applied to large-scale studies. Second, we test the genealogical tree at each locus for a clustering of the disease cases beneath a branch, suggesting that a causative mutation occurred on that branch. Since the true ARG is unknown, we average this analysis over an ensemble of inferred ARGs. We have characterized the performance of our method across a wide range of simulated disease models. Compared with simpler tests, our method gives increased accuracy in positioning untyped causative loci and can also be used to estimate the frequencies of untyped causative alleles. We have applied our method to Ueda et al.'s association study of CTLA4 and Graves disease, showing how it can be used to dissect the association signal, giving potentially interesting results of allelic heterogeneity and interaction. Similar approaches analyzing an ensemble of ARGs inferred using our method may be applicable to many other problems of inference from population genotype data.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Durbin, R (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	rd@sanger.ac.uk	Durbin, Richard/AAE-7178-2019	Durbin, Richard/0000-0002-9130-1006	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Balding David, 2005, Hum Genomics, V2, P79; Bardel C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-24; CHURCHILL GA, 1994, GENETICS, V138, P963; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Griffiths R., 1997, PROGR POPULATION GEN, P257; GRIFFITHS RC, 1995, MATH BIOSCI, V127, P77, DOI 10.1016/0025-5564(94)00044-Z; GUSFIELD D, 1991, NETWORKS, V21, P19, DOI 10.1002/net.3230210104; Gusfield Dan, 2004, J Bioinform Comput Biol, V2, P173, DOI 10.1142/S0219720004000521; HOGGART C, 2005, FREGENE SOFTWARE SIM; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Larribe F, 2002, THEOR POPUL BIOL, V62, P215, DOI 10.1006/tpbi.2002.1601; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; MacGregor S, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-34; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; McVean GAT, 2005, PHILOS T R SOC B, V360, P1387, DOI 10.1098/rstb.2005.1673; McVean GAT, 2002, GENETICS, V162, P987; Molitor J, 2003, AM J HUM GENET, V73, P1368, DOI 10.1086/380415; Morris AP, 2004, AM J HUM GENET, V74, P945, DOI 10.1086/420773; Morris AP, 2002, AM J HUM GENET, V70, P686, DOI 10.1086/339271; Myers SR, 2003, GENETICS, V163, P375; NORDBORD M, 2001, HDB STAT GENETICS; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Song YS, 2005, J COMPUT BIOL, V12, P147, DOI 10.1089/cmb.2005.12.147; Song YS, 2006, IEEE ACM T COMPUT BI, V3, P239, DOI 10.1109/TCBB.2006.31; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STPEHENS M, 2001, HDB STAT GENETICS; Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080; TEMPLETON AR, 1987, GENETICS, V117, P343; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Waldron ERB, 2006, GENET EPIDEMIOL, V30, P170, DOI 10.1002/gepi.20134; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	39	83	85	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					910	922		10.1086/508901	http://dx.doi.org/10.1086/508901			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033967	Green Published, Bronze			2022-12-18	WOS:000241667400012
J	Samani, NJ; Burton, P; Mangino, M; Ball, SG; Balmforth, AJ; Barrett, J; Bishop, T; Hall, A; Samani, NJ; Stribling, J; de Souza, P; Singh, R; Ogleby, J; Ridge, C; Logtens, E; Hopwood, L; Faulkes, J; Hall, AS; Morrell, C; Jackson, BM; Barthorpe, L; Burtonwood, N; Dorsch, M; Durham, N; Forest, C; Kelly, N; Hall, V; Lawrance, R; Oldham, J; Rennie, E; Smith, A; Thompson, S; Balmforth, AJ; Mangino, M; Adams, S; Braund, P; Clemitson, JR; Bodycote, C; Koekemoer, A; Raleigh, S; Maqbool, A; Yuldasheva, N; Ellis, S; Mason, S; Midgley, L; Pleasants, N; Cuthbert, R; Tooze, PF; Braund, P; Mangino, M; Platts, M; Fox, J; Dixon, R; Barrett, J; Burton, P; Mangino, M; Sheehan, N; Scurrah, K; Bishop, T; Pickett, S; Walters, K; Nsengimana, J; Hall, AS; Samani, NJ; Balmforth, AJ; Burton, P; Bishop, T; Ball, SG				Samani, NJ; Burton, P; Mangino, M; Ball, SG; Balmforth, AJ; Barrett, J; Bishop, T; Hall, A; Samani, NJ; Stribling, J; de Souza, P; Singh, R; Ogleby, J; Ridge, C; Logtens, E; Hopwood, L; Faulkes, J; Hall, AS; Morrell, C; Jackson, BM; Barthorpe, L; Burtonwood, N; Dorsch, M; Durham, N; Forest, C; Kelly, N; Hall, V; Lawrance, R; Oldham, J; Rennie, E; Smith, A; Thompson, S; Balmforth, AJ; Mangino, M; Adams, S; Braund, P; Clemitson, JR; Bodycote, C; Koekemoer, A; Raleigh, S; Maqbool, A; Yuldasheva, N; Ellis, S; Mason, S; Midgley, L; Pleasants, N; Cuthbert, R; Tooze, PF; Braund, P; Mangino, M; Platts, M; Fox, J; Dixon, R; Barrett, J; Burton, P; Mangino, M; Sheehan, N; Scurrah, K; Bishop, T; Pickett, S; Walters, K; Nsengimana, J; Hall, AS; Samani, NJ; Balmforth, AJ; Burton, P; Bishop, T; Ball, SG		BHF Family Heart Study Res Grp	A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British heart foundation (BHF) family heart study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCUS; COMPLEX TRAITS; CONFERS RISK; IN-VITRO; GENE; MAP; POLYMORPHISMS; CHROMOSOME-2; POPULATIONS	Coronary artery disease (CAD) and its most important complication, myocardial infarction (MI), are the leading cause of premature death in the Western world. CAD has a substantial genetic basis, especially when it occurs early. We investigated the genetic determinants of premature CAD by performing a genomewide linkage analysis of 4,175 affected subjects from 1,933 families recruited throughout the United Kingdom. Each family had at least two available siblings with CAD, with validated onset before age 66 years. Linkage analysis was performed using 416 microsatellite markers. We observed suggestive linkage, for both CAD and MI, to a region on chromosome 2. For CAD, a LOD score of 1.86 was observed at marker D2S2271, which, in an ordered subset analysis, increased to 2.70 in families (n = 1,698) with a minimum age at diagnosis of 56 years or younger. For MI, an overlapping peak with a LOD score of 1.15 was observed at marker D2S2216, which increased to 2.1 in families (n = 801) with a minimum age at diagnosis of 59 years or younger. Exclusion mapping showed that 100% of the autosomal genome could be excluded for locus-specific sibling relative risks of 1.5 and 1.6 for CAD and MI, respectively. The region identified on chromosome 2 overlaps linked regions observed in two other smaller genome scans for CAD. Together, these findings strongly suggest that there is a locus on chromosome 2 that influences coronary atherosclerosis risk. The exclusion of a common locus that increases risk of CAD to siblings by 150% has important implications for strategies for further defining the genetic basis of CAD.	Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Samani, NJ (corresponding author), Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Clin Sci Wing,Groby Rd, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Burton, Paul R/H-7527-2016; Nsengimana, Jeremie/AAP-3185-2020; de Souza, Paul/P-5069-2019; Hall, Alistair/K-1953-2019; Mangino, Massimo/F-5134-2011; Yuldasheva, Nadira Yusupovna/GXM-9013-2022; Scurrah, Katrina/K-2174-2015	Mangino, Massimo/0000-0002-2167-7470; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; raleigh, stuart/0000-0002-8882-0040; Scurrah, Katrina/0000-0001-5226-7370; Bishop, Tim/0000-0002-8752-8785				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Cordell HJ, 2004, AM J HUM GENET, V74, P1294, DOI 10.1086/421476; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fox CS, 2004, AM J HUM GENET, V74, P253, DOI 10.1086/381559; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iacoviello L, 2005, ARTERIOSCL THROM VAS, V25, P222, DOI 10.1161/01.ATV.0000150039.60906.02; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lange K, 2001, AM J HUM GENET, V69, P504; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Samani NJ, 1998, CLIN SCI, V95, P645, DOI 10.1042/CS19980321; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	36	83	86	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1011	1020						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380912				2022-12-18	WOS:000233241200010
J	Li, SL; Tiab, L; Jiao, XD; Munier, FL; Zografos, L; Frueh, BE; Sergeev, Y; Smith, J; Rubin, B; Meallet, MA; Forster, RK; Hejtmancik, JF; Schorderet, DF				Li, SL; Tiab, L; Jiao, XD; Munier, FL; Zografos, L; Frueh, BE; Sergeev, Y; Smith, J; Rubin, B; Meallet, MA; Forster, RK; Hejtmancik, JF; Schorderet, DF			Mutations in PIP5K3 are associated with Francois-Neetens Mouchetee fleck corneal dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE; PROTEIN-KINASE; PIKFYVE; OPTIMIZATION	Francois- Neetens fleck corneal dystrophy ( CFD) is a rare, autosomal dominant corneal dystrophy characterized by numerous small white flecks scattered in all layers of the stroma. Linkage analysis localized CFD to a 24- cM ( 18-Mb) interval of chromosome 2q35 flanked by D2S2289 and D2S126 and containing PIP5K3. PIP5K3 is a member of the phosphoinositide 3- kinase family and regulates the sorting and traffic of peripheral endosomes that contain lysosomally directed fluid phase cargo, by controlling the morphogenesis and function of multivesicular bodies. Sequencing analysis disclosed missense, frameshift, and/ or protein- truncating mutations in 8 of 10 families with CFD that were studied, including 2256delA, 2274delCT, 2709C -> T ( R851X), 3120C -> T ( Q988X), IVS19- 1G -> C, 3246G -> T ( E1030X), 3270C -> T ( R1038X), and 3466A -> G ( K1103R). The histological and clinical characteristics of patients with CFD are consistent with biochemical studies of PIP5K3 that indicate a role in endosomal sorting.	Inst Rech Ophtalmol, CH-1950 Sion, Switzerland; NEI, Ophthalm Genet & Clin Serv Branch, Bethesda, MD 20892 USA; NEI, Off Clin Director, Bethesda, MD 20892 USA; Jules Gonin Eye Hosp, Lausanne, Switzerland; Inselspital Bern, Dept Ophthalmol, CH-3010 Bern, Switzerland; LA Cty & USC Med Ctr, Doheny Eye Inst, Los Angeles, CA USA; Univ Miami, Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Bern; University Hospital of Bern; Doheny Eye Institute; Bascom Palmer Eye Institute; University of Miami	Schorderet, DF (corresponding author), Inst Rech Ophtalmol, Ave Grand Champ Sec 64, CH-1950 Sion, Switzerland.	daniel.schorderet@iro.vsnet.ch			NATIONAL EYE INSTITUTE [ZIAEY000367, Z01EY000367, Z01EY000272, ZIAEY000272] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akova Y A, 1994, Eur J Ophthalmol, V4, P123; BIRNDORF LA, 1972, AM J OPHTHALMOL, V73, P670, DOI 10.1016/0002-9394(72)90384-4; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; FRANCOIS J, 1957, Bull Soc Belge Ophtalmol, V114, P641; Frueh BE, 1999, CORNEA, V18, P658, DOI 10.1097/00003226-199911000-00005; GOLDBERG MF, 1977, ANN OPHTHALMOL, V9, P889; Ikonomov OC, 2003, J BIOL CHEM, V278, P50863, DOI 10.1074/jbc.M307260200; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jiao XD, 2003, HUM GENET, V112, P593, DOI 10.1007/s00439-002-0905-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NICHOLSON DH, 1977, AM J OPHTHALMOL, V83, P554, DOI 10.1016/0002-9394(77)90566-9; PATTEN J T, 1976, Annals of Ophthalmology, V8, P25; PURCELL JJ, 1977, ARCH OPHTHALMOL-CHIC, V95, P440; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; SMITH RJH, 1989, CYTOGENET CELL GENET, V50, P102, DOI 10.1159/000132733; STREETEN BW, 1961, AM J OPHTHALMOL, V51, P275, DOI 10.1016/0002-9394(61)91950-X; [No title captured]	26	83	86	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					54	63		10.1086/431346	http://dx.doi.org/10.1086/431346			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15902656	Green Published, Bronze			2022-12-18	WOS:000229794500005
J	Karmous-Benailly, H; Martinovic, J; Gubler, MC; Sirot, Y; Clech, L; Ozilou, C; Auge, J; Brahimi, N; Etchevers, H; Detrait, E; Esculpavit, C; Audollent, S; Goudefroye, G; Gonzales, M; Tantau, J; Loget, P; Joubert, M; Gaillard, D; Jeanne-Pasquier, C; Delezoide, AL; Peter, MO; Plessis, G; Simon-Bouy, B; Dollfus, H; Le Merrer, M; Munnich, A; Encha-Razavi, F; Vekemans, M; Attie-Bitach, T				Karmous-Benailly, H; Martinovic, J; Gubler, MC; Sirot, Y; Clech, L; Ozilou, C; Auge, J; Brahimi, N; Etchevers, H; Detrait, E; Esculpavit, C; Audollent, S; Goudefroye, G; Gonzales, M; Tantau, J; Loget, P; Joubert, M; Gaillard, D; Jeanne-Pasquier, C; Delezoide, AL; Peter, MO; Plessis, G; Simon-Bouy, B; Dollfus, H; Le Merrer, M; Munnich, A; Encha-Razavi, F; Vekemans, M; Attie-Bitach, T			Antenatal presentation of Bardet-Biedl syndrome may mimic Meckel syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DANDY-WALKER MALFORMATION; CYSTIC DYSPLASTIC KIDNEYS; HUMAN OBESITY SYNDROME; HEPATIC-FIBROSIS; GRUBER-SYNDROME; TRIALLELIC INHERITANCE; GOLDSTON-SYNDROME; GENE; BBS1; MUTATIONS	Bardet-Biedl syndrome (BBS) is a multisystemic disorder characterized by postaxial polydactyly, progressive retinal dystrophy, obesity, hypogonadism, renal dysfunction, and learning difficulty. Other manifestations include diabetes mellitus, heart disease, hepatic fibrosis, and neurological features. The condition is genetically heterogeneous, and eight genes (BBS1 - BBS8) have been identified to date. A mutation of the BBS1 gene on chromosome 11q13 is observed in 30% - 40% of BBS cases. In addition, a complex triallelic inheritance has been established in this disorder - that is, in some families, three mutations at two BBS loci are necessary for the disease to be expressed. The clinical features of BBS that can be observed at birth are polydactyly, kidney anomaly, hepatic fibrosis, and genital and heart malformations. Interestingly, polydactyly, cystic kidneys, and liver anomalies ( hepatic fibrosis with bile-duct proliferation) are also observed in Meckel syndrome, along with occipital encephalocele. Therefore, we decided to sequence the eight BBS genes in a series of 13 antenatal cases presenting with cystic kidneys and polydactyly and/or hepatic fibrosis but no encephalocele. These fetuses were mostly diagnosed as having Meckel or "Meckel-like" syndrome. In six cases, we identified a recessive mutation in a BBS gene ( three in BBS2, two in BBS4, and one in BBS6). We found a heterozygous BBS6 mutation in three additional cases. No BBS1, BBS3, BBS5, BBS7, or BBS8 mutations were identified in our series. These results suggest that the antenatal presentation of BBS may mimic Meckel syndrome.	Hop Necker Enfants Malad, Dept Genet, AP HP, Paris, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Hop Necker Enfants Malad, INSERM, U574, Paris, France; Hop Univ Strasbourg, Federat Genet Med, Strasbourg, France; Univ Versailles, Ctr Etud Biol Prenatale, Lab Cytogenet, F-78000 Versailles, France; Ctr Hosp Mulhouse, Serv Pediat, Mulhouse, France; CHU Caen, Serv Genet, F-14000 Caen, France; CHU Cote, Serv Anat Pathol, Nacre, France; Hop Maison Blanche, Lab Pol Bouin, Reims, France; CHU Nantes, F-44035 Nantes 01, France; Cabinet Anat & Cytol Pathol Richier, Rennes, France; Hop Robert Debre, AP HP, Serv Biol Dev, F-75019 Paris, France; Hop St Antoine, AP HP, Lab Embryol Pathol, F-75571 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Paris Saclay; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Reims; Universite de Reims Champagne-Ardenne; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Attie-Bitach, T (corresponding author), Hop Necker Enfants Malad, Dept Genet, AP HP, Paris, France.	tania.attie@necker.fr	Etchevers, Heather C./B-5813-2012; ATTIE-BITACH, Tania/K-1453-2017	Etchevers, Heather C./0000-0003-0201-3799; ATTIE-BITACH, Tania/0000-0002-1155-3626; Dollfus, Helene/0000-0002-2249-895X; Gubler, Marie-Claire/0000-0002-3526-5661				AlGazali LI, 1996, CLIN DYSMORPHOL, V5, P73, DOI 10.1097/00019605-199601000-00011; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Baskin E, 2002, J CHILD NEUROL, V17, P385, DOI 10.1177/088307380201700514; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; Blankenberg T A, 1987, Am J Med Genet Suppl, V3, P395; Cassart M, 2004, ULTRASOUND OBST GYN, V24, P51, DOI 10.1002/uog.1086; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Cincinnati P, 2000, CLIN DYSMORPHOL, V9, P35, DOI 10.1097/00019605-200009010-00007; DAGOSTINO AN, 1963, J NEUROPATH EXP NEUR, V22, P450, DOI 10.1097/00005072-196307000-00007; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; FRASER FC, 1981, AM J MED GENET, V9, P67, DOI 10.1002/ajmg.1320090112; GENUARDI M, 1993, AM J MED GENET, V47, P50, DOI 10.1002/ajmg.1320470111; GERSHONIBARUCH R, 1992, AM J MED GENET, V44, P269, DOI 10.1002/ajmg.1320440302; GLOEB D J, 1989, Pediatric Pathology, V9, P337; GOLDSTON AS, 1963, AM J DIS CHILD, V106, P484, DOI 10.1001/archpedi.1963.02080050486016; Gulcan H, 2001, GENET COUNSEL, V12, P263; HART MN, 1972, NEUROLOGY, V22, P771, DOI 10.1212/WNL.22.8.771; HUNTER AGW, 1991, AM J MED GENET, V41, P201, DOI 10.1002/ajmg.1320410214; Johnson CA, 2003, J MED GENET, V40, P311, DOI 10.1136/jmg.40.5.311; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KUDO M, 1985, AM J CLIN PATHOL, V84, P459, DOI 10.1093/ajcp/84.4.459; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; LURIE IW, 1991, CLIN GENET, V39, P104; MALPUECH G, 1979, J GENET HUM, V27, P167; MECKE S, 1971, ANN GENET-PARIS, V14, P97; MIRANDA D, 1972, ARCH PATHOL, V93, P483; Moerman P., 1993, Genetic Counseling, V4, P97; Morava E, 1996, CLIN GENET, V49, P211; Morgan NV, 2002, HUM GENET, V111, P456, DOI 10.1007/s00439-002-0817-0; Mykytyn K, 2003, AM J HUM GENET, V72, P429, DOI 10.1086/346172; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; PAAVOLA P, 1995, NAT GENET, V11, P213, DOI 10.1038/ng1095-213; PIANTANIDA M, 1993, AM J MED GENET, V47, P420, DOI 10.1002/ajmg.1320470325; PIERQUIN G, 1989, AM J MED GENET, V33, P483, DOI 10.1002/ajmg.1320330414; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; SALONEN R, 1984, AM J MED GENET, V18, P671, DOI 10.1002/ajmg.1320180414; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Slavotinek AM, 2002, HUM GENET, V110, P561, DOI 10.1007/s00439-002-0733-3; SUMMERS MC, 1995, AM J MED GENET, V55, P57, DOI 10.1002/ajmg.1320550116; TAL Y, 1980, DEV MED CHILD NEUROL, V22, P189; TEEBI AS, 1994, J MED GENET, V31, P224, DOI 10.1136/jmg.31.3.224; WALPOLE IR, 1991, AM J MED GENET, V39, P294, DOI 10.1002/ajmg.1320390310; Yapar EG, 1996, CLIN DYSMORPHOL, V5, P357; Zlotogora J, 1997, J MED GENET, V34, P765, DOI 10.1136/jmg.34.9.765	53	83	89	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					493	504		10.1086/428679	http://dx.doi.org/10.1086/428679			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15666242	Green Published, Bronze			2022-12-18	WOS:000226851900011
J	Zhang, JH; Rowe, WL; Clark, AG; Buetow, KH				Zhang, JH; Rowe, WL; Clark, AG; Buetow, KH			Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DROSOPHILA-MELANOGASTER; BLOCKS	Knowledge of human haplotype structure has important implications for strategies of disease-gene mapping and for understanding human evolutionary history. Many attributes of SNPs and haplotypes appear to exhibit highly nonrandom behavior, suggesting past operation of selection or other nonneutral forces. We report the exceptional abundance of a particular haplotype pattern in which two high-frequency haplotypes have different alleles at every SNP site (hence the name "yin yang haplotypes"). Analysis of common haplotypes in 62 random genomic loci and 85 gene coding regions in humans shows that the proportion of the genome spanned by yin yang haplotypes is 75%-85%. Population data of 28 genomic loci in Drosophila melanogaster reveal a similar pattern. The high recurrence (greater than or equal to85%) of these haplotype patterns in four distinct human populations suggests that the yin yang haplotypes are likely to predate the African diaspora. The pattern initially appeared to suggest deep population splitting or maintenance of ancient lineages by selection; however, coalescent simulation reveals that the yin yang phenomenon can be explained by strictly neutral evolution in a well-mixed population.	NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University	Zhang, JH (corresponding author), NCI, Lab Populat Genet, NIH, 8424 Helgerman Court,Room 101,MSC 8302, Bethesda, MD 20892 USA.			Clark, Andrew/0000-0001-7159-8511	NATIONAL CANCER INSTITUTE [ZIHBC010470, Z01BC010470] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balakirev ES, 1996, GENETICS, V144, P1511; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Hudson RR, 1997, P NATL ACAD SCI USA, V94, P7725, DOI 10.1073/pnas.94.15.7725; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Zhang JH, 2002, NUCLEIC ACIDS RES, V30, P5213, DOI 10.1093/nar/gkf654	12	83	85	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1073	1081		10.1086/379154	http://dx.doi.org/10.1086/379154			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14560401	Green Published, Bronze			2022-12-18	WOS:000186493400009
J	Fallin, MD; Lasseter, VK; Wolyniec, PS; McGrath, JA; Nestadt, G; Valle, D; Liang, KY; Pulver, AE				Fallin, MD; Lasseter, VK; Wolyniec, PS; McGrath, JA; Nestadt, G; Valle, D; Liang, KY; Pulver, AE			Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR AFFECTIVE-DISORDER; VULNERABILITY LOCUS; GENETIC-VARIATION; FOUNDER MUTATION; COMPLEX TRAITS; 6P22.3 GENE; WIDE SCAN; ASSOCIATION; POPULATIONS; ISRAELI	Previous linkage studies in schizophrenia have been discouraging due to inconsistent findings and weak signals. Genetic heterogeneity has been cited as one of the primary culprits for such inconsistencies. We have performed a 10-cM autosomal genomewide linkage scan for schizophrenia susceptibility regions, using 29 multiplex families of Ashkenazi Jewish descent. Although there is no evidence that the rate of schizophrenia among the Ashkenazim differs from that in other populations, we have focused on this population in hopes of reducing genetic heterogeneity among families and increasing the detectable effects of any particular locus. We pursued both allele-sharing and parametric linkage analyses as implemented in Genehunter, version 2.0. Our strongest signal was achieved at chromosome 10q22.3 (D10S1686), with a nonparametric linkage score (NPL) of 3.35 (genomewide empirical) and a dominant heterogeneity LOD score ( HLOD) of 3.14. Six other regions gave NPL scores >2.00 (on chromosomes 1p32.2, 4q34.3, 6p21.31, 7p15.2, 15q11.2, and 21q21.2). Upon follow- up with an additional 23 markers in the chromosome 10q region, our peak NPL score increased to 4.27 (D10S1774; empirical P = .00002), with a 95% confidence interval of 12.2 Mb for the location of the trait locus (D10S1677 to D10S1753). We find these results encouraging for the study of schizophrenia among Ashkenazi families and suggest further linkage and association studies in this chromosome 10q region.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Howard Hughes Med Inst, Dept Psychiat & Behav Sci, Baltimore, MD USA; Howard Hughes Med Inst, Dept Pediat, Baltimore, MD USA; Howard Hughes Med Inst, Dept Biol Mol, Baltimore, MD USA; Howard Hughes Med Inst, Dept Genet, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Pulver, AE (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 1820 Lancaster St,Suite 300, Baltimore, MD 21231 USA.	aepulver@jhmi.edu	Liang, Kung-Yee/F-8299-2011	McGrath, John A./0000-0002-9756-7892	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057314] Funding Source: NIH RePORTER; NIMH NIH HHS [5 R01 MH057314] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Cichon S, 2001, MOL PSYCHIATR, V6, P342, DOI 10.1038/sj.mp.4000864; Curtis D, 1999, AM J MED GENET, V88, P272, DOI 10.1002/(SICI)1096-8628(19990618)88:3<272::AID-AJMG12>3.0.CO;2-1; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; Devlin B, 2002, MOL PSYCHIATR, V7, P689, DOI 10.1038/sj.mp.4001056; Dror V, 1999, MOL PSYCHIATR, V4, P254, DOI 10.1038/sj.mp.4000508; EATON WW, 1985, EPIDEMIOL REV, V7, P105, DOI 10.1093/oxfordjournals.epirev.a036278; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; Ewald H, 2002, AM J MED GENET, V114, P196, DOI 10.1002/ajmg.10148; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; Gasperoni TL, 2003, AM J MED GENET B, V116B, P8, DOI 10.1002/ajmg.b.10757; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Kendler KS, 2000, AM J PSYCHIAT, V157, P402, DOI 10.1176/appi.ajp.157.3.402; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li W, 1999, AM J HUM GENET, V65, pA260; Liang KY, 2000, HUM HERED, V51, P64; MCGUE M, 1991, EUR ARCH PSY CLIN N, V240, P174, DOI 10.1007/BF02190760; MCKUSICK VA, 1973, ISRAEL J MED SCI, V9, P1276; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Mowry BJ, 2000, AM J MED GENET, V96, P864, DOI 10.1002/1096-8628(20001204)96:6<864::AID-AJMG35>3.3.CO;2-4; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Pato CN, 1997, AM J MED GENET, V74, P286, DOI 10.1002/(SICI)1096-8628(19970531)74:3<286::AID-AJMG9>3.0.CO;2-O; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; PULVER AE, 1994, AM J MED GENET, V54, P44, DOI 10.1002/ajmg.1320540109; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Schorge JO, 2001, GYNECOL ONCOL, V83, P383, DOI 10.1006/gyno.2001.6431; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; Schwartz DG, 2000, INTERNET RES, V10, P5; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; STANGL D, 1985, ARCH GEN PSYCHIAT, V42, P591; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Straub RE, 1996, MOL PSYCHIATR, V1, P89; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; TIKOCHINSKI Y, 1991, AM J HUM GENET, V48, P129; TSUANG MT, 1991, SCHIZOPHR RES, V4, P157, DOI 10.1016/0920-9964(91)90031-L; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41	66	83	86	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					601	611		10.1086/378158	http://dx.doi.org/10.1086/378158			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12929083	Bronze, Green Published			2022-12-18	WOS:000185134000012
J	Johanneson, B; Lima, G; von Salome, J; Alarcon-Segovia, D; Alarcon-Riquelme, ME				Johanneson, B; Lima, G; von Salome, J; Alarcon-Segovia, D; Alarcon-Riquelme, ME		Collaborative Grp Genetics SLE; BIOMED II Collaboration Genetics S	A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; POINT MUTATION; MULTIPLE-SCLEROSIS; GENETIC-LINKAGE; SOCIOECONOMIC-STATUS; PARP ALLELES; RISK-FACTORS; CD45 GENE; POLYMORPHISM; ASSOCIATION	A set of 87 multicase families with systemic lupus erythemathosus (SLE) from European (Iceland, Sweden, England, Norway, Italy, and Greece) and recently admixed (Mexico, Colombia, and the United States) populations were genotyped and analyzed for 62 microsatellite markers on chromosome 1. By parametric two-point linkage analysis, six regions (1p36, 1p21, 1q23, 1q25, 1q31, and 1q43) were identified that have LOD scores of Zgreater than or equal to1.50, with different contributions, depending on the population of origin of the families (European or admixed American). All of the regions have been described previously and have therefore been confirmed in this analysis. The locus at 1q31 showed a significant three-point LOD score of Z=3.79 and was contributed by families from all populations, with several markers and under the same parametric model. Analysis of a known mutation in the CD45 gene did not support the role that this mutation plays in disease. We conclude that the locus at 1q31 contains a major susceptibility gene, important to SLE in general populations.	Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Inst Genet & Pathol,Sect Med Genet, S-75185 Uppsala, Sweden; Inst Nacl ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico	Uppsala University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Alarcon-Riquelme, ME (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Inst Genet & Pathol,Sect Med Genet, Dag Hammarsjolds Vag 20, S-75185 Uppsala, Sweden.	marta.alarcon@genpat.uu.se	Alarcón-Riquelme, Marta E./ABF-8163-2020; lima, giuseppina GPPL/C-5995-2012	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; lima, giuseppina GPPL/0000-0002-1792-2605				ADEBAJO A, 1994, SEMIN ARTHRITIS RHEU, V24, P139, DOI 10.1016/S0049-0172(05)80007-1; Bae SC, 1998, ARTHRITIS RHEUM-US, V41, P2091, DOI 10.1002/1529-0131(199812)41:12<2091::AID-ART2>3.3.CO;2-4; Barcellos LF, 2001, NAT GENET, V29, P23, DOI 10.1038/ng722; BIAS WB, 1986, AM J HUM GENET, V39, P584; Bottto M, 1996, CLIN EXP IMMUNOL, V104, P264, DOI 10.1046/j.1365-2249.1996.33740.x; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Cerda-Flores RM, 2002, AM J HUM BIOL, V14, P257, DOI 10.1002/ajhb.10020; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Criswell LA, 2000, J CLIN INVEST, V105, P1501; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Delrieu O, 1999, ARTHRITIS RHEUM, V42, P2194, DOI 10.1002/1529-0131(199910)42:10<2194::AID-ANR22>3.0.CO;2-U; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Gorodezky C, 2001, HUM IMMUNOL, V62, P979, DOI 10.1016/S0198-8859(01)00296-8; Graham RR, 2001, ARTHRITIS RES, V3, P299, DOI 10.1186/ar319; Gray-McGuire C, 2000, AM J HUM GENET, V67, P1460, DOI 10.1086/316891; GREENWOO.BM, 1968, LANCET, V2, P380; GUDMUNDSSON S, 1990, J RHEUMATOL, V17, P1162; HOCHBERG MC, 1985, ARTHRITIS RHEUM-US, V28, P80, DOI 10.1002/art.1780280113; HOCHBERG MC, 1987, J RHEUMATOL, V14, P867; HOPKINSON ND, 1994, ANN RHEUM DIS, V53, P675, DOI 10.1136/ard.53.10.675; HOPKINSON ND, 1993, BRIT J RHEUMATOL, V32, P110; Hopkinson ND, 2000, ANN RHEUM DIS, V59, P116, DOI 10.1136/ard.59.2.116; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; JARVINEN P, 1994, SEMIN ARTHRITIS RHEU, V24, P19, DOI 10.1016/0049-0172(94)90096-5; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; JONSSON H, 1990, BRIT J RHEUMATOL, V29, P185; Karlson EW, 1997, ARTHRITIS RHEUM-US, V40, P47, DOI 10.1002/art.1780400108; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Komata T, 1999, TISSUE ANTIGENS, V53, P527, DOI 10.1034/j.1399-0039.1999.530602.x; Kung C, 2000, NAT MED, V6, P343; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LAWRENCE JS, 1987, J RHEUMATOL, V14, P913; Lindqvist AKB, 2000, J AUTOIMMUN, V14, P169, DOI 10.1006/jaut.1999.0357; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Malaviya AN, 1997, LUPUS, V6, P690, DOI 10.1177/096120339700600903; Manger K, 1998, ARTHRITIS RHEUM, V41, P1181, DOI 10.1002/1529-0131(199807)41:7<1181::AID-ART6>3.0.CO;2-C; MCCARTY DJ, 1995, ARTHRITIS RHEUM, V38, P1260, DOI 10.1002/art.1780380914; Molina JF, 1997, LUPUS, V6, P63, DOI 10.1177/096120339700600109; Molokhia M, 2001, LANCET, V357, P1414, DOI 10.1016/S0140-6736(00)04580-3; Morita C, 2001, ARTHRITIS RHEUM-US, V44, P2819, DOI 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Moser KL, 1999, ARTHRITIS RHEUM, V42, P1902, DOI 10.1002/1529-0131(199909)42:9<1902::AID-ANR16>3.0.CO;2-G; Ott J., 1991, ANAL HUMAN GENETIC L; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; SAMANTA A, 1992, BRIT J RHEUMATOL, V31, P679; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHWINZER R, 1990, J EXP MED, V171, P1803, DOI 10.1084/jem.171.5.1803; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Song YW, 1998, ARTHRITIS RHEUM, V41, P421, DOI 10.1002/1529-0131(199803)41:3<421::AID-ART7>3.3.CO;2-J; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; Takeuchi T, 1997, CLIN EXP IMMUNOL, V109, P20, DOI 10.1046/j.1365-2249.1997.4371334.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Tchilian EZ, 2002, IMMUNOGENETICS, V53, P980, DOI 10.1007/s00251-001-0410-z; Tchilian EZ, 2001, J IMMUNOL, V166, P6144, DOI 10.4049/jimmunol.166.10.6144; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THUDE H, 1995, EUR J IMMUNOL, V25, P2101, DOI 10.1002/eji.1830250745; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Tsao BP, 1999, J CLIN INVEST, V103, P1135, DOI 10.1172/JCI5967; Tsao BP, 2001, AM J HUM GENET, V69, P527; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wang F, 1997, LUPUS, V6, P248, DOI 10.1177/096120339700600306; Wood JP, 2002, EUR J IMMUNOGENET, V29, P73, DOI 10.1046/j.1365-2370.2002.00262.x; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616	73	83	83	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1060	1071		10.1086/344289	http://dx.doi.org/10.1086/344289			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12373647	Green Published, Bronze			2022-12-18	WOS:000178884300006
J	Schaid, DJ; McDonnell, SK; Wang, L; Cunningham, JM; Thibodeau, SN				Schaid, DJ; McDonnell, SK; Wang, L; Cunningham, JM; Thibodeau, SN			Caution on pedigree haplotype inference with software that assumes linkage equilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DISEQUILIBRIUM; FREQUENCIES; ALGORITHM		Mayo Clin & Mayo Fdn, Biostat Sect, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin & Mayo Fdn, Biostat Sect, Dept Hlth Sci Res, Harwick 775, Rochester, MN 55905 USA.			McDonnell, Shannon/0000-0001-6201-369X	NIGMS NIH HHS [R01 GM065450] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LONG JC, 1995, AM J HUM GENET, V56, P799; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rohde K, 2001, HUM MUTAT, V17, P289, DOI 10.1002/humu.26; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sobel E, 1996, AM J HUM GENET, V58, P1323; SOBEL E, 1996, IMA VOLUMES MATH ITS, P89; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281	13	83	89	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					992	995		10.1086/342666	http://dx.doi.org/10.1086/342666			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12387273	Bronze, Green Published			2022-12-18	WOS:000178613800029
J	Xu, JF; Zheng, SQL; Carpten, JD; Nupponen, NN; Robbins, CM; Mestre, J; Moses, TY; Faith, DA; Kelly, BD; Isaacs, SD; Wiley, KE; Ewing, DM; Bujnowszky, P; Chang, BI; Bailey-Wilson, J; Bleecker, ER; Walsh, PC; Trent, JM; Meyers, DA; Isaacs, WB				Xu, JF; Zheng, SQL; Carpten, JD; Nupponen, NN; Robbins, CM; Mestre, J; Moses, TY; Faith, DA; Kelly, BD; Isaacs, SD; Wiley, KE; Ewing, DM; Bujnowszky, P; Chang, BI; Bailey-Wilson, J; Bleecker, ER; Walsh, PC; Trent, JM; Meyers, DA; Isaacs, WB			Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; CHROMOSOME 1Q42.2-43; HIGH-RISK; DOMINANT INHERITANCE; HISTORY; TESTS; 1Q; 1Q24-25; SUPPORT; COHORT	To investigate the relationship between HPC2/ELAC2 and prostate cancer risk, we performed the following analyses: (1) a linkage study of six markers in and around the HPC2/ELAC2 gene at 17p11 in 159 pedigrees with hereditary prostate cancer (HPC); (2) a mutation-screening analysis of all coding exons of the gene in 93 probands with HPC; (3) family-based and population-based association study of common HPC2/ELAC2 missense variants in 159 probands with HPC, 249 patients with sporadic prostate cancer, and 222 unaffected male control subjects. No evidence for linkage was found in the total sample, nor in any subset of pedigrees based on characteristics that included age at onset, number of affected members, male-to-male disease transmission, or race. Furthermore, only the two previously reported missense changes (Ser217Leu and Ala541Thr) were identified by mutational analysis of all HPC2/ELAC exons in 93 probands with HPC. In association analyses, family-based tests did not reveal excess transmission of the Leu217 and/or Thr541 alleles to affected offspring, and population-based tests failed to reveal any statistically significant difference in the allele frequencies of the two polymorphisms between patients with prostate cancer and control subjects. The results of this study lead us to reject the three alternative hypotheses of (1) a highly penetrant, major prostate cancer-susceptibility gene at 17p11, (2) the allelic variants Leu217 or Thr541 of HPC2/ELAC2 as high-penetrance mutations, and (3) the variants Leu217 or Thr541 as low-penetrance, risk-modifying alleles. However, we did observe a trend of higher Leu217 homozygous carrier rates in patients than in control subjects. Considering the impact of genetic heterogeneity, phenocopies, and incomplete penetrance on the linkage and association studies of prostate cancer and on the power to detect linkage and association in our study sample, our results cannot rule out the possibility of a highly penetrant prostate cancer gene at this locus that only segregates in a small number of pedigrees. Nor can we rule out a prostate cancer-modifier gene that confers a lower-than-reported risk. Additional larger studies are needed to more fully evaluate the role of this gene in prostate cancer risk.	Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Wake Forest University; Wake Forest Baptist Medical Center; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Isaacs, WB (corresponding author), Johns Hopkins Univ Hosp, Marburg 115,600 N Wolfe St, Baltimore, MD 21287 USA.	wisaacs@jhmi.edu		Bailey-Wilson, Joan/0000-0002-9153-2920	NCI NIH HHS [P50 CA058236, CA58236] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000107] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cerhan JR, 1999, CANCER EPIDEM BIOMAR, V8, P53; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange EM, 1999, CLIN CANCER RES, V5, P4013; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Neuhausen SL, 1999, HUM MOL GENET, V8, P2437, DOI 10.1093/hmg/8.13.2437; Ott J, 1999, ANAL HUMAN GENETIC L; Peters MA, 2000, HUM HERED, V51, P107, DOI 10.1159/000022965; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Schuurman AG, 1999, EPIDEMIOLOGY, V10, P192, DOI 10.1097/00001648-199903000-00020; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Weir B., 1996, GENETIC DATA ANAL; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	38	83	88	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					901	911		10.1086/319513	http://dx.doi.org/10.1086/319513			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254448	Green Published, Bronze			2022-12-18	WOS:000167666000012
J	Kraft, P; Thomas, DC				Kraft, P; Thomas, DC			Bias and efficiency in family-based gene-characterization studies: Conditional, prospective, retrospective, and joint likelihoods	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENVIRONMENT INTERACTIONS; LINKAGE ANALYSIS; OVARIAN-CANCER; MUTATION; DISEASE; MODELS; BREAST; DESIGNS; TRAITS; SCORES	We revisit the usual conditional likelihood for stratum-matched case-control studies and consider three alternatives that may be more appropriate for family-based gene-characterization studies: First, the prospective likelihood, that is, Pr (D/G, A); second, the retrospective likelihood, Pr (G/D); and third, the ascertainment-corrected joint likelihood, Pr (D, G/A). These likelihoods provide unbiased estimators of genetic relative risk parameters, as well as population allele frequencies and baseline risks. The parameter estimates based on the retrospective likelihood remain unbiased even when the ascertainment scheme cannot be modeled, as long as ascertainment only depends on families' phenotypes. Despite the need to estimate additional parameters, the prospective, retrospective, and joint likelihoods can lead to considerable gains in efficiency, relative to the conditional likelihood, when estimating genetic relative risk. This is true if baseline risks and allele frequencies can be assumed to be homogeneous. In the presence of heterogeneity, however, the parameter estimates assuming homogeneity can be seriously biased. We discuss the extent of this problem and present a mixed models approach for providing consistent parameter estimates when baseline risks and allele frequencies are heterogeneous. The efficiency gains of the mixed-model prospective, retrospective, and joint likelihoods relative to the efficiency of conditional likelihood are small in the situations presented here.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90033 USA	University of Southern California	Kraft, P (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St,Suite 220, Los Angeles, CA 90033 USA.				NATIONAL CANCER INSTITUTE [U01CA078296, R01CA052862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA052862, CA52862, U01 CA078296, CA78296] Funding Source: Medline; NIEHS NIH HHS [ES07048, P30 ES007048] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; ELSTON RC, 1984, GENETIC EPIDEMIOLOGY, P349; GAIL MH, 1984, BIOMETRIKA, V71, P431; Gail MH, 1999, GENET EPIDEMIOL, V16, P15, DOI 10.1002/(SICI)1098-2272(1999)16:1<15::AID-GEPI3>3.0.CO;2-8; Gauderman WJ, 1997, AM J HUM GENET, V61, P1189, DOI 10.1086/301597; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; Greenland S, 1999, STAT MED, V18, P1, DOI 10.1002/(SICI)1097-0258(19990115)18:1<1::AID-SIM961>3.0.CO;2-L; HAUCK WW, 1991, J CLIN EPIDEMIOL, V44, P77, DOI 10.1016/0895-4356(91)90203-L; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; LAIRD N, 1978, J AM STAT ASSOC, V73, P805, DOI 10.2307/2286284; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEBIHAN C, 1995, GENET EPIDEMIOL, V12, P13, DOI 10.1002/gepi.1370120103; Liang KY, 1996, GENET EPIDEMIOL, V13, P575; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Siegmund KD, 1999, AM J HUM GENET, V65, pA398; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; WHITTEMORE AS, 1978, J ROY STAT SOC B MET, V40, P328; Witte JS, 1999, AM J EPIDEMIOL, V149, P693	23	83	83	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1119	1131		10.1086/302808	http://dx.doi.org/10.1086/302808			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712222	Green Published, Bronze			2022-12-18	WOS:000088373200030
J	Jamieson, CR; Govaerts, C; Abramowicz, MJ				Jamieson, CR; Govaerts, C; Abramowicz, MJ			Primary autosomal recessive microcephaly: Homozygosity mapping of MCPH4 to chromosome 15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TRAITS; DNA		Free Univ Brussels, Med Genet Lab, B-1070 Brussels, Belgium; Free Univ Brussels, IRIBHN, B-1070 Brussels, Belgium; Free Univ Brussels, Serv Genet Med, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Jamieson, CR (corresponding author), Free Univ Brussels, Med Genet Lab, 808 Route Lennik,Campus Erasme ULB,Bldg C, B-1070 Brussels, Belgium.	rjamieso@ulb.ac.bc	Abramowicz, Marc/AAX-6419-2020	Abramowicz, Marc/0000-0003-0623-8768				Arbour NC, 1997, HUM MOL GENET, V6, P689, DOI 10.1093/hmg/6.5.689; BARAITSER M, 1997, GENETICS NEUROLOGICA, P17; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; COWIE V, 1960, J MENT DEFIC RES, V4, P42; DACOUVOUTETAKIS C, 1974, J PEDIATR-US, V85, P498, DOI 10.1016/S0022-3476(74)80452-X; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Ross JJ, 1977, HDB CLIN NEUROLOGY, V30, P507; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; TOLMIE JL, 1987, AM J MED GENET, V27, P583, DOI 10.1002/ajmg.1320270311; VANDENBOSCH J, 1958, ANN HUM GENET, V23, P91; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7	13	83	84	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1465	1469		10.1086/302640	http://dx.doi.org/10.1086/302640			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521316	Green Published, Bronze			2022-12-18	WOS:000083531000032
J	Botta, E; Nardo, T; Broughton, BC; Marinoni, S; Lehmann, AR; Stefanini, M				Botta, E; Nardo, T; Broughton, BC; Marinoni, S; Lehmann, AR; Stefanini, M			Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: Site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGMENTOSUM GROUP-D; COMPLEMENTATION GROUP-D; PROTEIN SECONDARY STRUCTURE; ERCC2 DNA-REPAIR; XERODERMA-PIGMENTOSUM; EXCISION-REPAIR; TRANSCRIPTION GENE; MOLECULAR CHARACTERIZATION; REPAIR/TRANSCRIPTION GENE; HETEROGENEITY	Xeroderma pigmentosum (XP) complementation group D is a heterogeneous group, containing patients with XP alone, rare cases with both XP and Cockayne syndrome, and patients with trichothiodystrophy (TTD). TTD is a rare autosomal recessive multisystem disorder associated, in many patients, with a defect in nucleotide-excision repair; but in contrast to XP patients, TTD patients are not cancer prone. In most of the repair-deficient TTD patients, the defect has been assigned to the XPD gene. The XPD gene product is a subunit of transcription factor TFILH, which is involved in both DNA repair and transcription. We have determined the mutations and the pattern of inheritance of the XPD alleles in the 11 cases identified in Italy so far, in which the hair abnormalities diagnostic for TTD are associated with different disease severity but similar cellular photosensitivity. We have identified eight causative mutations, of which four have not been described before, either in T-TD or XP cases, supporting the hypothesis that the mutations responsible for TTD are different from those found in other pathological phenotypes. Arg112his was the most common alteration in the Italian patients, of whom five were homozygotes and two were heterozygotes, for this mutation. The presence of a specifically mutated XPD allele, irrespective of its homozygous, hemizygous, or heterozygous condition, was always associated with the same degree of cellular UV hypersensitivity. Surprisingly, however, the severity of the clinical symptoms did not correlate with the magnitude of the DNA-repair defect. The most severe clinical features were found in patients who appear to be functionally hemizygous for the mutated allele.	CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy; Univ Sussex, MRC, Cell Mutat Unit, Brighton, E Sussex, England; Ist Infanzia, Trieste, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Sussex	Stefanini, M (corresponding author), CNR, Ist Genet Biochim & Evoluzionist, Via Abbiategrasso 207, I-27100 Pavia, Italy.		BOTTA, ELENA/O-3892-2019; Botta, Elena/B-9065-2015	BOTTA, ELENA/0000-0003-2060-0110; 				Battistella PA, 1996, CHILD NERV SYST, V12, P110, DOI 10.1007/BF00819509; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; BOOTSMA D, 1998, METABOLIC BASIS INHE, P245; Broughton BC, 1996, MUTAT RES-DNA REPAIR, V362, P209, DOI 10.1016/0921-8777(95)00054-2; BROUGHTON BC, 1994, NAT GENET, V7, P189, DOI 10.1038/ng0694-189; BROUGHTON BC, 1995, AM J HUM GENET, V56, P167; de Boer J, 1998, CANCER RES, V58, P89; DELLACOLETTA L, 1995, GENOMICS, V26, P70, DOI 10.1016/0888-7543(95)80084-Y; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FREDERICK GD, 1994, HUM MOL GENET, V3, P1783, DOI 10.1093/hmg/3.10.1783; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; KIRCHNER JM, 1994, GENOMICS, V23, P592, DOI 10.1006/geno.1994.1547; Kobayashi T, 1997, HUM MUTAT, V9, P322, DOI 10.1002/(SICI)1098-1004(1997)9:4<322::AID-HUMU4>3.0.CO;2-7; LEHMANN AR, 1988, CANCER RES, V48, P6090; MARINONI S, 1991, DERMATOLOGY EUROPE, P632; MONDELLO C, 1994, MUTAT RES, V314, P159, DOI 10.1016/0921-8777(94)90079-5; Murray J.L., 1992, ALLOY PHASE DIAGRAMS, V3, P2; NUZZO F, 1990, J MED GENET, V27, P21, DOI 10.1136/jmg.27.1.21; PESERICO A, 1992, NEURORADIOLOGY, V34, P316, DOI 10.1007/BF00588190; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Satoh MS, 1997, BBA-GENE STRUCT EXPR, V1354, P241, DOI 10.1016/S0167-4781(97)00102-4; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; STEFANINI M, 1993, AM J HUM GENET, V53, P817; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Takayama K, 1997, HUM MUTAT, V9, P519; Takayama K, 1996, AM J HUM GENET, V58, P263; TAKAYAMA K, 1995, CANCER RES, V55, P5656; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Tolmie J L, 1994, Clin Dysmorphol, V3, P1; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; VERMEULEN W, 1994, AM J HUM GENET, V54, P191; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x	42	83	84	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1036	1048		10.1086/302063	http://dx.doi.org/10.1086/302063			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758621	Green Published, Bronze			2022-12-18	WOS:000076577800016
J	Veiga-da-Cunha, M; Gerin, I; Chen, YT; de Barsy, T; de Lonlay, P; Dionisi-Vici, C; Fenske, CD; Lee, PJ; Leonard, JV; Maire, I; McConkie-Rosell, A; Schweitzer, S; Vikkula, M; Van Schaftingen, E				Veiga-da-Cunha, M; Gerin, I; Chen, YT; de Barsy, T; de Lonlay, P; Dionisi-Vici, C; Fenske, CD; Lee, PJ; Leonard, JV; Maire, I; McConkie-Rosell, A; Schweitzer, S; Vikkula, M; Van Schaftingen, E			A gene on chromosome 11q23 coding for a putative glucose-6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLUCOSE-TRANSPORT PROTEIN; MICROSOMAL GLUCOSE-6-PHOSPHATASE; SYSTEM; IDENTIFICATION; MUTATIONS; DEFECT	Glycogen-storage diseases type I (GSD type I) are due to a deficiency in glucose-6-phosphatase, an enzymatic system present in the endoplasmic reticulum that plays a crucial role in blood glucose homeostasis. Unlike GSD type Ia, types Tb and Ic are not due to mutations in the phosphohydrolase gene and are clinically characterized by the presence of associated neutropenia and neutrophil dysfunction. Biochemical evidence indicates the presence of a defect in glucose-G-phosphate (GSD type Ib) or inorganic phosphate (Pi) (GSD type Ic) transport in the microsomes. We have recently cloned a cDNA encoding a putative glucose-G-phosphate translocase. We have now localized the corresponding gene on chromosome 11q23, the region where GSD types Ib and Ic have been mapped. Using SSCP analysis and sequencing, we have screened this gene, for mutations in genomic DNA, from patients from 22 different families who have GSD types Ib and Ic. Of 20 mutations found, 11 result in truncated proteins that are probably nonfunctional. Most other mutations result in substitutions of conserved or semiconserved residues. The two most common mutations (Gly339Cys and 1211-1212 delCT) together constitute similar to 40% of the disease alleles. The fact that the same mutations are found in GSD types Ib and Ic could indicate either that Pi and glucose-6-phosphate are transported in microsomes by the same transporter or that the biochemical assays used to differentiate Pi and glucose-6-phosphate transport defects are not reliable.	Catholic Univ Louvain, Brussels, Belgium; ICP, Physiol Chem Lab, Brussels, Belgium; ICP, Genet Mol Lab, Brussels, Belgium; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Hop Necker Enfants Malad, Dept Pediat, Med Genet Unit, Paris, France; Bambino Gesu Hosp, Dept Metab, Rome, Italy; St George Hosp, Sch Med, Dept Child Hlth, London, England; Inst Child Hlth, Biochem Endocrine & Metab Unit, London, England; Hop Debrousse, Enzymol Lab, Lyon, France; Childrens Hosp, Hannover Med Sch, Hannover, Germany	Universite Catholique Louvain; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Bambino Gesu; St Georges University London; University of London; University College London; CHU Lyon; Hannover Medical School	Van Schaftingen, E (corresponding author), 7539 Ave Hippocrate, B-1200 Brussels, Belgium.	vanschaftingen@bchm.ucl.ac.be	Vikkula, Miikka/Q-1038-2018; Dionisi-Vici, Carlo/K-2045-2018; Van+Schaftingen, Emile/AAF-5532-2020	Vikkula, Miikka/0000-0002-6236-338X; Dionisi-Vici, Carlo/0000-0002-0007-3379; Van Schaftingen, Emile/0000-0002-6199-7647	NCRR NIH HHS [MO1-RR30] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Annabi B, 1998, AM J HUM GENET, V62, P400, DOI 10.1086/301727; Arion WJ, 1998, J BIOL CHEM, V273, P6223, DOI 10.1074/jbc.273.11.6223; ARION WJ, 1980, J BIOL CHEM, V255, P396; ARION WJ, 1975, MOL CELL BIOCHEM, V6, P75, DOI 10.1007/BF01732001; Arion WJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P279, DOI 10.1006/abbi.1997.0563; BERTELOOT A, 1991, J BIOL CHEM, V266, P5497; BROWN BI, 1985, CONGENITAL METABOLIC, P227; Burchell A, 1998, BIOCHEM J, V331, P973, DOI 10.1042/bj3310973; BURCHELL A, 1990, CLIN CHEM, V36, P1633; Chen Y-T, 1995, METABOLIC MOL BASES, P935; Fenske CD, 1998, J MED GENET, V35, P269, DOI 10.1136/jmg.35.4.269; Gerin I, 1997, FEBS LETT, V419, P235, DOI 10.1016/S0014-5793(97)01463-4; GITZELMANN R, 1993, EUR J PEDIATR, V152, pS33; GOLDSMITH PK, 1979, BIOCHIM BIOPHYS ACTA, V583, P133, DOI 10.1016/0304-4165(79)90421-5; HAWKINS RA, 1995, J INHERIT METAB DIS, V18, P558, DOI 10.1007/BF02436000; HERS HG, 1951, B SOC CHIM BIOL, V33, P21; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; MALONEY PC, 1990, MICROBIOL REV, V54, P1; MALONEY PC, 1996, ESCHERICHIA COLI SAL, P1130; Marcolongo P, 1998, J CLIN ENDOCR METAB, V83, P224, DOI 10.1210/jc.83.1.224; NARISAWA K, 1978, BIOCHEM BIOPH RES CO, V83, P1360, DOI 10.1016/0006-291X(78)91371-2; NORDLIE RC, 1983, J BIOL CHEM, V258, P9739; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SCHULZE HU, 1986, J BIOL CHEM, V261, P6571; STDENIS JF, 1995, J BIOL CHEM, V270, P21092, DOI 10.1074/jbc.270.36.21092; TAKAHASHI T, 1978, BIOCHIM BIOPHYS ACTA, V524, P262, DOI 10.1016/0005-2744(78)90163-8; WADDELL ID, 1991, BIOCHEM J, V275, P363, DOI 10.1042/bj2750363; WADDELL ID, 1992, BIOCHEM J, V286, P173, DOI 10.1042/bj2860173	31	83	88	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					976	983		10.1086/302068	http://dx.doi.org/10.1086/302068			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758626	Green Published, Bronze			2022-12-18	WOS:000076577800009
J	VanHummelen, P; Manchester, D; Lowe, X; Wyrobek, AJ				VanHummelen, P; Manchester, D; Lowe, X; Wyrobek, AJ			Meiotic segregation, recombination, and gamete aneuploidy assessed in a t(1;10)(p22.1;q22.3) reciprocal translocation carrier by three- and four-probe multicolor FISH in sperm	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; FLUORESCENCE INSITU HYBRIDIZATION; HETEROZYGOTE; CHROMOSOMES; FERTILIZATION; FREQUENCY; HAMSTER; INVITRO; MEIOSIS; 2-COLOR	Meiotic segregation, recombination, and aneuploidy was assessed for sperm from a t(1;10)(p22.1;q22.3) reciprocal translocation carrier, by use of two multicolor FISH methods. The first method utilized three DNA probes (a telomeric and a centromeric probe on chromosome 1 plus a centromeric probe on chromosome 10) to analyze segregation patterns, in sperm, of the chromosomes involved in the translocation. The aggregate frequency of sperm products from alternate and adjacent I segregation was 90.5%, and the total frequency of normal and chromosomally balanced sperm was 48.1%. The frequencies of sperm products from adjacent II segregation and from 3:1 segregation were 4.3% and 3.9%, respectively. Reciprocal sperm products from adjacent I segregation deviated significantly from the expected 1:1 ratio (P < .0001). Our assay allowed us to evaluate recombination events in the interstitial segments at adjacent II segregation. The frequencies of sperm products resulting from interstitial recombination in chromosome 10 were significantly higher than those resulting from interstitial recombination in chromosome 1 (P < .006). No evidence of an interchromosomal effect on aneuploidy was found by use of a second FISH method that simultaneously utilized four chromosome-specific DNA probes to quantify the frequencies of aneuploid sperm for chromosomes X, Y, 18, and 21. However, a significant higher frequency of diploid sperm was detected in the translocation carrier than was detected in chromosomally normal and healthy controls. This study illustrates the advantages of multicolor FISH for assessment of the reproductive risk associated with translocation carriers and for investigation of the mechanisms of meiotic segregation of chromosomes.			VanHummelen, P (corresponding author), LAWRENCE LIVERMORE NATL LAB,BIOL & BIOTECHNOL RES PROGRAM,L-452,7000 EAST AVE,LIVERMORE,CA 94550, USA.			Wyrobek, Andrew/0000-0002-5921-5298				AURIAS A, 1978, HUM GENET, V45, P259, DOI 10.1007/BF00278725; BRANDRIFF B, 1986, AM J HUM GENET, V38, P197; Brandriff B.F., 1990, BIOL MAMMALIAN GERM, P183; BRANDRIFF BF, 1988, CYTOGENET CELL GENET, V47, P29, DOI 10.1159/000132500; BURNS JP, 1986, AM J HUM GENET, V38, P954; CARPENTER ATC, 1994, CELL, V77, P959, DOI 10.1016/0092-8674(94)90434-0; CHAYKO CA, 1992, HUM GENET, V90, P79, DOI 10.1007/BF00210748; ESTOP AM, 1992, HUM GENET, V89, P425; ESTOP AM, 1995, CYTOGENET CELL GENET, V70, P80, DOI 10.1159/000133997; GOLDMAN ASH, 1993, CYTOGENET CELL GENET, V63, P16, DOI 10.1159/000133493; GOLDMAN ASH, 1992, J MED GENET, V29, P98, DOI 10.1136/jmg.29.2.98; GOLDMAN ASH, 1993, CHROMOSOMA, V102, P102, DOI 10.1007/BF00356027; GRIER HJ, 1976, CELL TISSUE RES, V186, P419; HECHT F, 1987, PROGR TOPICS CYTOG A, V7, P9; HULTEN M, 1974, HEREDITAS, V76, P55; KIERSZENBAUM AL, 1978, FED PROC, V37, P2512; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; MARTIN RH, 1995, CLIN GENET, V47, P42; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; MOENS PB, 1975, J CELL SCI, V19, P487; NICKLAS RB, 1977, PHILOS T ROY SOC B, V277, P267, DOI 10.1098/rstb.1977.0017; Ning Y., 1996, American Journal of Human Genetics, V59, pA50; ROBBINS WA, 1993, AM J HUM GENET, V52, P799; Robbins WA, 1995, REPROD FERT DEVELOP, V7, P799, DOI 10.1071/RD9950799; ROUSSEAUX S, 1995, CYTOGENET CELL GENET, V71, P240, DOI 10.1159/000134118; Snedecor G.W., 1967, STAT METHODS; SONTA S, 1991, CYTOGENET CELL GENET, V57, P200, DOI 10.1159/000133146; Spence Janet T., 1983, ELEMENTARY STAT; SPRIGGS EL, 1994, MOL REPROD DEV, V38, P247, DOI 10.1002/mrd.1080380303; TEMPLADO C, 1988, HUM GENET, V79, P24, DOI 10.1007/BF00291704; THERMAN E, 1986, HUMAN CHROMOSOMES ST, P228; VanHummelen P, 1996, HUM GENET, V98, P608; WYROBEK AJ, 1994, AM J MED GENET, V53, P1, DOI 10.1002/ajmg.1320530102; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304	34	83	84	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					651	659						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326331				2022-12-18	WOS:A1997XY52300023
J	Wright, J; Teraoka, S; Onengut, S; Tolun, A; Gatti, RA; Ochs, HD; Concannon, P				Wright, J; Teraoka, S; Onengut, S; Tolun, A; Gatti, RA; Ochs, HD; Concannon, P			High frequency of distinct ATM gene mutations in ataxia-telangiectasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; LINKAGE ANALYSIS; DNA-SYNTHESIS; FAMILIES; RADIOSENSITIVITY; HETEROZYGOTES; SENSITIVITY; HOMOLOG; WOMEN; CHEST	The clinical features of the autosomal recessive disorder ataxia-telangiectasia (AT) include a progressive cerebellar ataxia, hypersensitivity to ionizing radiation, and an increased susceptibility to malignancies. Epidemiological studies have suggested that AT heterozygotes may also be at increased risk for malignancy, possibly as a consequence of radiation exposure. A gene mutated in AT patients (ATM) has recently been isolated, making mutation screening in both patients and the general population possible. Because of the relatively large size of the ATM gene, the design of screening programs will depend on the types and distribution of mutations in the general population. In this report, we describe 30 mutations identified in a panel of unrelated AT patients and controls. Twenty-five of the 30 were distinct, and most patients were compound heterozygotes. The most frequently detected mutation was found in three different families and had previously been reported in five others. This corresponds to a frequency of 8% of all reported ATM mutations. Twenty-two of the alterations observed would be predicted to lead to protein truncation at sites scattered throughout the molecule. Two fibroblast cell lines, which displayed normal responses to ionizing radiation, also proved to be heterozygous for truncation mutations of ATM. These observations suggest that the carrier frequency of ATM mutations may be sufficiently high to make population screening practical. However, such screening may need to be done prospectively, that is, by searching for new mutations rather than by screening for just those already identified in AT families.	VIRGINIA MASON MED CTR,DIV IMMUNOL,SEATTLE,WA 98101; UNIV WASHINGTON,SCH MED,DIV IMMUNOL,SEATTLE,WA; UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA; BOGAZICI UNIV,DEPT MOL BIOL & GENET,ISTANBUL,TURKEY; UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024	Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Bogazici University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA				Concannon, Patrick/0000-0002-5801-1859; tolun, aslihan/0000-0002-0328-6046	NCI NIH HHS [CA57569] Funding Source: Medline; NICHD NIH HHS [HD17427] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017427, R37HD017427] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA057569] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BOICE JD, 1978, RADIAT RES, V73, P373, DOI 10.2307/3574828; BOICE JD, 1977, J NATL CANCER I, V59, P823, DOI 10.1093/jnci/59.3.823; BOOTSMA D, 1995, PHILOS T ROY SOC B, V347, P75, DOI 10.1098/rstb.1995.0012; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; CORTESSIS V, 1993, CANCER RES, V53, P5083; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HAWKINS JD, 1991, GENE STRUCTURE EXPRE, P98; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; LANGE E, 1995, AM J HUM GENET, V57, P112; LEHMANN AR, 1986, INT J RADIAT BIOL, V49, P639; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PATERSON MC, 1979, CANCER RES, V39, P3725; PIPPARD EC, 1988, CANCER RES, V48, P2929; RASIO D, 1995, CANCER RES, V55, P6053; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Telatar M, 1996, AM J HUM GENET, V59, P40; TOKUNAGA M, 1987, RADIAT RES, V112, P243, DOI 10.2307/3577254; Uziel T, 1996, GENOMICS, V33, P317, DOI 10.1006/geno.1996.0201; WEEKS DE, 1991, RADIAT RES, V128, P90, DOI 10.2307/3578071; WOOSTER R, 1993, HUM GENET, V92, P91, DOI 10.1007/BF00216153; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040; ZIV Y, 1995, SOMAT CELL MOLEC GEN, V21, P99, DOI 10.1007/BF02255785	33	83	91	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					839	846						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808599				2022-12-18	WOS:A1996VL28300013
J	BonneTamir, B; DeStefano, AL; Briggs, CE; Adair, R; Franklyn, B; Weiss, S; Korostishevsky, M; Frydman, M; Baldwin, CT; Farrer, LA				BonneTamir, B; DeStefano, AL; Briggs, CE; Adair, R; Franklyn, B; Weiss, S; Korostishevsky, M; Frydman, M; Baldwin, CT; Farrer, LA			Linkage of congenital recessive deafness (gene DFNB10) to chromosome 21q22.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEARING IMPAIRMENT; POPULATION; CHILDHOOD; ETIOLOGY; MARKERS; MAP	Deafness is a heterogeneous trait affecting similar to 1/1,000 newborns. Genetic linkage studies have already implicated more than a dozen distinct loci causing deafness. We conducted a genome search for linkage in a large Palestinian family segregating an autosomal recessive form of nonsyndromic deafness. Our results indicate that in this family the defective gene, DFNB10, is located in a 12-cM region near the telomere of chromosome 21. This genetic distance corresponds to <2.4 Mbp. Five marker loci typed from this region gave maximum LOD scores greater than or equal to 3. Homozygosity of marker alleles was evident for only the most telomeric marker, D21S1259, suggesting that DFNB10 is closest to this locus. To our knowledge, this is the first evidence, at this location, for a gene that is involved in the development or maintenance of hearing, As candidate genes at these and other deafness loci are isolated and characterized, their roles in hearing will be revealed and may lead to development of mechanisms to prevent deafness.	BOSTON UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02118 USA; TEL AVIV UNIV, SACKLER SCH MED, DEPT HUMAN GENET, RAMAT AVIV, ISRAEL; BOSTON UNIV, SCH MED, DEPT BIOSTAT & EPIDEMIOL, BOSTON, MA 02118 USA; BOSTON UNIV, SCH MED, CTR HUMAN GENET, BOSTON, MA 02118 USA; INST HUMAN GENET, TEL HASHOMER, ISRAEL	Boston University; Tel Aviv University; Sackler Faculty of Medicine; Boston University; Boston University			Farrer, Lindsay/AAS-1035-2020	DeStefano, Anita/0000-0002-9335-2819; Baldwin, Clinton/0000-0002-3275-9463; Farrer, Lindsay/0000-0001-5533-4225	NIDCD NIH HHS [DC01848] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001848] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arnos K S, 1992, Clin Commun Disord, V2, P20; ARSLAN E, 1991, ANN NY ACAD SCI, V630, P315, DOI 10.1111/j.1749-6632.1991.tb19619.x; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BEIGHTON P, 1991, ANN NY ACAD SCI, V630, P290, DOI 10.1111/j.1749-6632.1991.tb19608.x; BODURTHA JN, 1988, OTOLOGIC MED SURGERY, V1, P831; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; BRUNNER HG, 1991, ANN NY ACAD SCI, V630, P176, DOI 10.1111/j.1749-6632.1991.tb19586.x; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CREMERS CWRJ, 1991, ANN NY ACAD SCI, V630, P191, DOI 10.1111/j.1749-6632.1991.tb19587.x; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; FUKUSHIMA K, 1995, HUM MOL GENET, V4, P1643, DOI 10.1093/hmg/4.9.1643; FUKUSHIMA K, IN PRESS GENOMIC RES; GOLD M, 1994, INT J PEDIATR OTORHI, V30, P91, DOI 10.1016/0165-5876(94)90191-0; Grundfast Kenneth M., 1992, Ear Nose and Throat Journal, V71, P479; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; JAIN PK, 1995, HUM MOL GENET, V4, P2391, DOI 10.1093/hmg/4.12.2391; Konigsmark B.W., 1976, GENETIC METABOLIC DE; LIU XZ, 1993, J LARYNGOL OTOL, V107, P990, DOI 10.1017/S0022215100125071; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Ott J., 1991, ANAL HUMAN GENETIC L; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SPILLMANN T, 1994, CURR OPIN NEUROL, V7, P81, DOI 10.1097/00019052-199402000-00015; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165; WANG D, 1994, GENOMICS, V20, P441, DOI 10.1006/geno.1994.1199	40	83	87	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1254	1259						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651303				2022-12-18	WOS:A1996UM27100019
J	Lahermo, P; Sajantila, A; Sistonen, P; Lukka, M; Aula, P; Peltonen, L; Savontaus, ML				Lahermo, P; Sajantila, A; Sistonen, P; Lukka, M; Aula, P; Peltonen, L; Savontaus, ML			The genetic relationship between the Finns and the Finnish Saami (Lapps): Analysis of nuclear DNA and mtDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; POLYMERASE CHAIN-REACTION; ENDONUCLEASE CLEAVAGE PATTERNS; FRAGMENT LENGTH POLYMORPHISM; ENZYMATIC AMPLIFICATION; TANDEM REPEATS; POPULATION; PCR; SEQUENCES; EVOLUTION	The genetic relationships between two Finno-Ugric-speaking populations, the Finns and the Finnish Saami (Lapps), were studied by using PCR for six nuclear-DNA marker loci, mitochondrial restriction-site polymorphism, and sequence variation of a 360-bp segment of the mitochondrial control region. The allele frequencies of each of the nuclear-DNA marker loci and the frequencies of mtDNA restriction haplotypes were significantly different between the populations. The Saami showed exceptionally low variation in their mtDNA restriction sites. The 9-bp deletion common in East Asian populations was not observed, nor did the haplotype data fit into the haplo-group categorization of Torroni et al. The average number of nucleotide substitutions from the mtDNA haplotype data indicated that the Finnish Saami may be closer to the Finns than to the other reference populations, whereas nuclear DNA suggested that the Finns are more closely related to the European reference populations than to the Finnish Saami. The similarity of the Finns to the other Europeans was even more pronounced according to the sequence data. We were unable to distinguish between the Finns and either the Swiss or Sardinian reference populations, whereas the Finnish Saami clearly stood apart. The Finnish Saami are distinct from other Circumarctic populations, although two of the lineages found among the Saami showed closer relationship to the Circumarctic than to the European lineages. The sequence data indicated an exceptionally high divergence for the Saami mtDNA control lineages. The distribution of the pairwise nucleotide differences in the Saami suggested that this population has not experienced an expansion similar to what was indicated for the Finns and the reference populations.	UNIV TURKU,DEPT GENET,FIN-20520 TURKU,FINLAND; UNIV MUNICH,INST ZOOL,W-8000 MUNICH,GERMANY; NATL PUBL HLTH INST,DEPT HUMAN MOL GENET,HELSINKI,FINLAND; NATL PUBL HLTH INST,DEPT IMMUNOBIOL,HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND	University of Turku; University of Munich; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Lahermo, P (corresponding author), UNIV TURKU,DEPT MED GENET,KIINAMYLYNKATU 10,FIN-20520 TURKU,FINLAND.		Sajantila, Antti/AAY-9084-2021	Sajantila, Antti/0000-0003-4117-5248				ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bishop YMM, 1989, DISCRETE MULTIVARIAT; BLANC H, 1983, AM J HUM GENET, V35, P167; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1984, GENETICS, V106, P479; CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; Chen Y.-S., 1994, American Journal of Human Genetics, V55, pA148; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DEKA R, 1991, GENOMICS, V11, P83, DOI 10.1016/0888-7543(91)90104-M; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; ERIKSSON AW, 1973, ISRAEL J MED SCI, V9, P1156; Eriksson AW, 1988, COLLEGIUM ANTROPOL, V2, P197; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GUGLIELMINO CR, 1990, AM J PHYS ANTHROPOL, V83, P57, DOI 10.1002/ajpa.1330830107; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HARIHARA S, 1986, JPN J HUM GENET, V31, P73, DOI 10.1007/BF01871401; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HAUSWIRTH WW, 1986, ACHIEVEMENTS PERSPEC, V2, P49; HORAI S, 1986, HUM GENET, V72, P105; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KADASI L, 1994, GENE GEOGR, V8, P121; KASAI K, 1990, J FORENSIC SCI, V35, P1196; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; Laakso J., 1991, URALILAISET KANSAT T, P123; LITT M, 1989, AM J HUM GENET, V44, P397; NEI M, 1978, JPN J HUM GENET, V23, P341, DOI 10.1007/BF01908190; NEI M, 1990, GENETICS, V125, P873; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P723, DOI 10.1073/pnas.91.2.723; PULT I, 1994, BIOL CHEM H-S, V375, P837; Ruhlen M., 1987, GUIDE WORLDS LANGUAG, V1; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SAJANTILA A, 1992, BIOTECHNIQUES, V12, P16; SAJANTILA A, 1992, AM J HUM GENET, V50, P816; SAJANTILA A, 1993, INT J LEGAL MED, V105, P355, DOI 10.1007/BF01222121; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santachiara Benerecetti A S, 1988, Ann Hum Genet, V52, P39; SARTORIS S, 1988, ANN HUM GENET, V52, P327, DOI 10.1111/j.1469-1809.1988.tb01112.x; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SISTONEN P, 1984, THESIS U HELSINKI FI; STONEKING M, 1991, AM J HUM GENET, V48, P370; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WEBER JL, 1989, AM J HUM GENET, V44, P388; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; WU S, 1990, NUCLEIC ACIDS RES, V18, P3102, DOI 10.1093/nar/18.10.3102-a	67	83	89	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1309	1322						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651309				2022-12-18	WOS:A1996UM27100025
J	CANCEL, G; ABBAS, N; STEVANIN, G; DURR, A; CHNEIWEISS, H; NERI, C; DUYCKAERTS, C; PENET, C; CANN, HM; AGID, Y; BRICE, A				CANCEL, G; ABBAS, N; STEVANIN, G; DURR, A; CHNEIWEISS, H; NERI, C; DUYCKAERTS, C; PENET, C; CANN, HM; AGID, Y; BRICE, A			MARKED PHENOTYPIC HETEROGENEITY ASSOCIATED WITH EXPANSION OF A CAG REPEAT SEQUENCE AT THE SPINOCEREBELLAR ATAXIA-3 MACHADO-JOSEPH DISEASE LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; TRINUCLEOTIDE REPEAT; HUNTINGTONS-DISEASE; INSTABILITY; GENE; STABILITY; MUTATIONS; LENGTH; CELLS	The spinocerebellar ataxia 3 locus (SCA3) for type I autosomal dominant cerebellar ataxia (ADCA type I), a clinically and genetically heterogeneous group of neurodegenerative disorders, has been mapped to chromosome 14q32.1, ADCA type I patients from families segregating SCA3 share clinical features in common with those with Machado-Joseph disease (MJD), the gene of which maps to the same region. We show here that the disease gene segregating in each of three French ADCA type I kindreds and in a French family with neuropathological findings suggesting the ataxochoreic form of dentatorubropallidoluysian atrophy carries an expanded CAG repeat sequence located at the same locus as that for MJD. Analysis of the mutation in these families shows a strong negative correlation between size of the expanded CAG repeat and age at onset of clinical disease. Instability of the expanded triplet repeat was not found to be affected by sex of the parent transmitting the mutation. Evidence was found for somatic and gonadal mosaicism for alleles carrying expanded trinucleotide repeats.	HOP LA PITIE SALPETRIERE,INSERM,U289,F-75651 PARIS 13,FRANCE; HOP LA PITIE SALPETRIERE,NEUROPATHOL LAB,F-75651 PARIS 13,FRANCE; COLL FRANCE,INSERM,U114,F-75651 PARIS 13,FRANCE; FDN JEAN DAUSSET,CEPH,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Foundation Jean Dausset-CEPH			herve, chneiweiss/Q-6818-2019; Neri, Christian/F-6729-2013; Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	herve, chneiweiss/0000-0001-7675-5061; Neri, Christian/0000-0002-3790-2978; Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Cancel-Tassin, Geraldine/0000-0002-9583-6382				BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; CANCEL G, 1994, NAT GENET, V6, P8, DOI 10.1038/ng0194-8; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DUBOURG O, 1995, ANN NEUROL, V37, P176, DOI 10.1002/ana.410370207; DURR A, 1993, BRAIN, V116, P1497, DOI 10.1093/brain/116.6.1497; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GARDNER K, 1994, NEUROLOGY S2, V44, pS921; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; HARDING AE, 1993, ADV NEUROL, V61, P1; IIZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288, DOI 10.1136/jnnp.47.12.1288; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; SEQUEIROS J, 1994, GENOMICS, V21, P645, DOI 10.1006/geno.1994.1327; STEVANIN G, 1994, AM J HUM GENET, V54, P11; Stevanin G, 1994, Neurobiol Dis, V1, P79, DOI 10.1006/nbdi.1994.0010; STEVANIN G, 1995, AM J HUM GENET, V56, P193; STEVANIN G, IN PRESS J MED GENET; STGEORGEHYSLOP P, 1994, AM J HUM GENET, V55, P120; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063; 1993, CELL, V72, P971	36	83	85	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					809	816						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573040				2022-12-18	WOS:A1995RV79300010
J	ZIELENSKI, J; PATRIZIO, P; COREY, M; HANDELIN, B; MARKIEWICZ, D; ASCH, R; TSUI, LC				ZIELENSKI, J; PATRIZIO, P; COREY, M; HANDELIN, B; MARKIEWICZ, D; ASCH, R; TSUI, LC			CFTR GENE VARIANT FOR PATIENTS WITH CONGENITAL ABSENCE OF VAS-DEFERENS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CYSTIC-FIBROSIS; BILATERAL ABSENCE; MUTATIONS; MEN		HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; HOSP SICK CHILDREN, DEPT PEDIAT, TORONTO, ON M5G 1X8, CANADA; UNIV TORONTO, DEPT PREVENT MED & BIOSTAT, TORONTO, ON, CANADA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON, CANADA; INTEGRATED GENET INC, FRAMINGHAM, MA 01701 USA; UNIV CALIF IRVINE, DEPT OBSTET & GYNECOL, IRVINE, CA 92717 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of California System; University of California Irvine			Tsui, Lap-chee/A-1081-2010; Patrizio, Pasquale/AGO-0674-2022					ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CULARD JF, 1994, HUM GENET, V93, P467; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DUMUR V, 1990, LANCET, V336, P512, DOI 10.1016/0140-6736(90)92066-Q; GERVAIS R, 1993, NEW ENGL J MED, V328, P446, DOI 10.1056/NEJM199302113280619; HOLSCLAW DS, 1971, J UROLOGY, V106, P568, DOI 10.1016/S0022-5347(17)61343-0; JEQUIER AM, 1985, J ANDROL, V6, P15; KAZAZIAN HH, 1994, HUM MUTAT, V4, P167; KEEN J, 1991, TRENDS GENET, V7, P5; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; Lipschultz L.I., 1980, CURRENT UROLOGIC THE, P399; OSBORNE L, 1994, PEDIATR PULM S, V10, P125; OSBORNE LR, 1993, HUM MOL GENET, V2, P1605, DOI 10.1093/hmg/2.10.1605; PATRIZIO P, 1993, HUM REPROD, V8, P215, DOI 10.1093/oxfordjournals.humrep.a138025; SCHELLEN TMCM, 1980, FERTIL STERIL, V34, P401; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, IN PRESS HUM MUTAT	20	83	85	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					958	960						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573058				2022-12-18	WOS:A1995RV79300028
J	DIDONATO, CJ; MORGAN, K; CARPTEN, JD; FUERST, P; INGRAHAM, SE; PRESCOTT, G; MCPHERSON, JD; WIRTH, B; ZERRES, K; HURKO, O; WASMUTH, JJ; MENDELL, JR; BURGHES, AHM; SIMARD, LR				DIDONATO, CJ; MORGAN, K; CARPTEN, JD; FUERST, P; INGRAHAM, SE; PRESCOTT, G; MCPHERSON, JD; WIRTH, B; ZERRES, K; HURKO, O; WASMUTH, JJ; MENDELL, JR; BURGHES, AHM; SIMARD, LR			ASSOCIATION BETWEEN AG1-CA ALLELES AND SEVERITY OF AUTOSOMAL RECESSIVE PROXIMAL SPINAL MUSCULAR-ATROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; REGION; LOCUS; GENE; POLYMORPHISMS; CHROMOSOME-5; 5Q13; SMA; INTERVAL; HUMANS	The gene for autosomal recessive proximal spinal muscular atrophy (SMA) has been mapped to an 850-kb interval on 5q11.2-q13.3, between the centromeric D5S823 and telomeric D5S557 markers. We report a new complex marker, Ag1-CA, that lies in this interval, whose primers produce one, Mo, or rarely three amplification-fragment-length variants (AFLVs) per allele. Class I chromosomes are those which amplify a single AFLV allele, and class II chromosomes are those which amplify an allele with two or three AFLVs. Ag1-CA shows highly significant allelic association with type,I SMA in both the French Canadian (Hopital Sainte-Justine [HSJ]) and American (Ohio State University [OSU]) populations (P<.0001). Significant association between the Ag1-CA genotype and disease severity was also observed. Type I patients were predominantly homozygous for class I chromosomes (P=.0003 OSU; P=.0012 HSJ), whereas the majority of type II patients were heterozygous for class I and II chromosomes (P=.0014 OSU; P=.001 HSJ). There was no significant difference in Ag1-CA genotype frequencies between type III patients (P=.5 OSU; P=.25 HSJ) and the paired normal chromosomes from both carrier parents. Our results indicate that Ag1-CA is the most closely linked marker to SMA and defines the critical candidate-gene region. Finally, we have proposed a model that should be taken into consideration when screening candidate SMA genes.	OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT MOLEC GENET,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT BIOCHEM MED,COLUMBUS,OH 43210; HOP ST JUSTINE,DEPT MED GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT EPIDEMIOL & BIOSTAT,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; UNIV CALIF IRVINE,DEPT BIOCHEM,IRVINE,CA 92717; INST HUMAN GENET,BONN,GERMANY; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universite de Montreal; McGill University; McGill University; McGill University; University of California System; University of California Irvine; University of Bonn; Johns Hopkins University			Wirth, Brunhilde/H-3192-2019; McPherson, John D/D-2633-2017; Ingraham, Susan/B-4565-2012; Fuerst, Paul A/I-3772-2012	McPherson, John D/0000-0001-8049-9347; Fuerst, Paul A/0000-0001-8905-0546; Wirth, Brunhilde/0000-0003-4051-5191; Burghes, Arthur/0000-0001-9031-1555; Simard, Louise/0000-0003-0391-8821	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Becker R.A., 1988, NEW S LANGUAGE PROGR; Bishop YM., 2007, DISCRETE MULTIVARIAT; BRAHE C, 1994, HUM GENET, V93, P494, DOI 10.1007/BF00202811; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; CARPTEN JD, IN PRESS GENOMICS; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; Fienberg S.E., 1980, ANAL CROSS CLASSIFIE, V2nd ed.; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEDBETTER SA, 1990, GENOMICS, V6, P475, DOI 10.1016/0888-7543(90)90477-C; LIEN LL, 1991, P NATL ACAD SCI USA, V88, P7873, DOI 10.1073/pnas.88.17.7873; MACKENZIE A, 1993, HUM GENET, V90, P501; MANKOO BS, 1991, NUCLEIC ACIDS RES, V19, P1963, DOI 10.1093/nar/19.8.1963-a; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MORRISON KE, 1992, AM J HUM GENET, V50, P520; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; PEARN J, 1980, LANCET, V1, P919; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Sambrook J., 1989, MOL CLONING LAB MANU; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; SIMARD LR, 1992, GENOMICS, V14, P188, DOI 10.1016/S0888-7543(05)80305-2; SMITH CAB, 1986, ANN HUM GENET, V50, P163, DOI 10.1111/j.1469-1809.1986.tb01035.x; SOARES VM, 1993, GENOMICS, V15, P365, DOI 10.1006/geno.1993.1069; THOMPSON TG, 1993, HUM MOL GENET, V2, P1169, DOI 10.1093/hmg/2.8.1169; WEATHERALL DJ, 1992, MOL BASIS BLOOD DISE, P157; WIRTH B, 1993, GENOMICS, V15, P113, DOI 10.1006/geno.1993.1018; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130; 1992, STATISTICAL SCI S PL	37	83	83	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1218	1229						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977383				2022-12-18	WOS:A1994QB68400020
J	LAMB, J; HARRIS, PC; WILKIE, AOM; WOOD, WG; DAUWERSE, JHG; HIGGS, DR				LAMB, J; HARRIS, PC; WILKIE, AOM; WOOD, WG; DAUWERSE, JHG; HIGGS, DR			DENOVO TRUNCATION OF CHROMOSOME-16P AND HEALING WITH (TTAGGG)N IN THE ALPHA-THALASSEMIA MENTAL-RETARDATION SYNDROME (ATR-16)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOBIN GENE-CLUSTER; TELOMERIC REPEAT; MILLER-DIEKER; DNA; DISEASE; MARKER; LOCUS	We have previously described a series of patients in whom the deletion of 1-2 megabases (Mb) of DNA from the tip of the short arm of chromosome 16 (band 16p13.3) is associated with alpha-thalassemia/mental retardation syndrome (ATR-16). We now show that one of these patients has a de novo truncation of the terminal 2 Mb of chromosome 16p and that telomeric sequence (TTAGGG)n has been added at the site of breakage. This suggests that the chromosomal break, which is paternal in origin and which probably arose at meiosis, has been stabilized in vivo by the direct addition of the telomeric sequence. Sequence comparisons of this breakpoint with that of a previously described chromosomal truncation (alphaalpha)TI do not reveal extensive sequence homology. However, both breakpoints show minimal complementarity (3-4 bp) to the proposed RNA template of human telomerase at the site at which telomere repeats have been added. Unlike previously characterized individuals with ATR-16, the clinical features of this patient appear to be solely due to monosomy for the terminal portion of 16p13.3. The identification of further patients with ''pure'' monosomy for the tip of chromosome 16p will be important for defining the loci contributing to the phenotype of this syndrome.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; UNIV HOSP WALES,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS	University of Oxford; Cardiff University; Leiden University; Leiden University - Excl LUMC			Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Lamb, Janette/0000-0002-8926-0516	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; BLONDEN LAJ, 1989, NUCLEIC ACIDS RES, V17, P5611, DOI 10.1093/nar/17.14.5611; BOROCHOVITZ D, 1970, CLIN PEDIATR, V9, P432, DOI 10.1177/000992287000900716; BOWCOCK AM, 1984, BRIT J HAEMATOL, V56, P69, DOI 10.1111/j.1365-2141.1984.tb01272.x; BREUNING MH, 1987, HUM GENET, V76, P287; BUCKLE VJ, 1988, J MED GENET, V25, P847, DOI 10.1136/jmg.25.12.847; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GERMINO GG, 1990, AM J HUM GENET, V46, P925; HARRINGTON LA, 1991, NATURE, V353, P451, DOI 10.1038/353451a0; HARRIS PC, 1990, GENOMICS, V7, P195, DOI 10.1016/0888-7543(90)90541-2; HIGGS DR, 1989, BLOOD, V73, P1081; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; JARMAN AP, 1988, AM J HUM GENET, V43, P249; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; LAMB J, 1989, LANCET, V2, P819; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LURIE IW, 1980, CLIN GENET, V17, P375; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; OLD JM, 1983, THALASSAEMIAS METHOD, P74; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VILLEGAS A, 1990, EUR J HAEMATOL, V44, P109; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; Zeitlin H C, 1983, Mol Biol Med, V1, P489	33	83	84	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					668	676						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460633				2022-12-18	WOS:A1993KY05900003
J	BROWN, MD; YANG, CC; TROUNCE, I; TORRONI, A; LOTT, MT; WALLACE, DC				BROWN, MD; YANG, CC; TROUNCE, I; TORRONI, A; LOTT, MT; WALLACE, DC			A MITOCHONDRIAL-DNA VARIANT, IDENTIFIED IN LEBER HEREDITARY OPTIC NEUROPATHY PATIENTS, WHICH EXTENDS THE AMINO-ACID-SEQUENCE OF CYTOCHROME-C-OXIDASE SUBUNIT-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE ORGANIZATION; POLYMORPHISM; GENOME; NEURORETINOPATHY	A G-to-A transition at nucleotide pair (np) 7444 in the mtDNA was found to correlate with Leber hereditary optic neuropathy (LHON). The mutation eliminates the termination codon of the cytochrome c oxidase subunit I (COI) gene, extending the COI polypeptide by three amino acids. The mutation was discovered as an XbaI restriction-endonuclease-site loss present in 2 (9.1%) of 22 LHON patients who lacked the np 11778 LHON mutation and in 6 (1.1%) of 545 unaffected controls. The mutant polypeptide has an altered mobility on SDS-PAGE, suggesting a structural alteration, and the cytochrome c oxidase enzyme activity of patient lymphocytes is reduced approximately 40% relative to that in controls. These data suggest that the np 7444 mutation results in partial respiratory deficiency and thus contributes to the onset of LHON.	EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,1462 CLIFTON RD,ROOM 403,DENT SCH BLDG,ATLANTA,GA 30322	Emory University			Torroni, Antonio/E-1557-2011; Trounce, Ian A/F-8338-2010	Torroni, Antonio/0000-0002-4163-4478; Trounce, Ian A/0000-0002-1070-8892; Lott, Marie/0000-0003-2035-479X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-00039] Funding Source: Medline; NINDS NIH HHS [NS 21328-07, NS09042] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BALLINGER SW, 1992, GENETICS, V130, P139; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1991, AM J HUM GENET S, V49, pA183; BUX S, 1991, P NATL ACAD SCI USA, V88, P8198; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HOWELL N, 1991, AM J HUM GENET, V48, P935; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; MOREADITH RW, 1984, ANAL BIOCHEM, V137, P360, DOI 10.1016/0003-2697(84)90098-8; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; ROE BA, 1985, J BIOL CHEM, V260, P9759; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Srere P.A., 1969, METHODS ENZYM, V13, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; SWOFFORD DL, 1990, PAUP PHYLOGENETIC AN; TORRONI A, 1992, GENETICS, V130, P153; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; VILKKI J, 1989, HUM GENET, V82, P208, DOI 10.1007/BF00291155; WALLACE DC, 1986, AM J HUM GENET, V38, P461; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	30	83	87	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					378	385						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1322638				2022-12-18	WOS:A1992JF77600018
J	GETMAN, DK; EUBANKS, JH; CAMP, S; EVANS, GA; TAYLOR, P				GETMAN, DK; EUBANKS, JH; CAMP, S; EVANS, GA; TAYLOR, P			THE HUMAN GENE ENCODING ACETYLCHOLINESTERASE IS LOCATED ON THE LONG ARM OF CHROMOSOME-7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS GENE; HUMAN GENOME; SINGLE GENE; HYBRIDIZATION; EXPRESSION; BUTYRYLCHOLINESTERASE; MEGAKARYOCYTOPOIESIS; IDENTIFICATION; DISORDERS; MEMBRANE	Acetylcholinesterase (AChE) is a secreted enzyme essential for regulating cholinergic neurotransmission at neuronal and neuromuscular synapses. In view of the altered expression of AChE in some central neurological and neuromuscular disorders with a probable genetic basis, we have identified the chromosomal location of the gene encoding AChE. Chromosomal in situ suppression hybridization analysis revealed a single gene to be at 7q22, a result which was confirmed by PCR analysis of genomic DNA from a human/hamster somatic cell hybrid containing a single human chromosome 7. The AChE gene thus maps to the same region in which frequent nonrandom chromosome 7 deletions occur in leukemias of myeloid cell precursors known to express the enzyme during normal differentiation.	SALK INST BIOL STUDIES,MOLEC GENET LAB,LA JOLLA,CA 92037	Salk Institute	GETMAN, DK (corresponding author), UNIV CALIF SAN DIEGO,DEPT PHARMACOL,LA JOLLA,CA 92093, USA.			Eubanks, James/0000-0001-8595-2024	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360, R37GM018360] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; BERGER R, 1985, CYTOGENET CELL GENET, V40, P490, DOI 10.1159/000132181; BERNSTEIN R, 1984, Cancer Genetics and Cytogenetics, V11, P300; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BURNSTEIN SA, 1985, J CELL PHYSL, V122, P159; BUTTARO DP, 1991, SCIENCE, V251, P802; CUNEO A, 1989, BLOOD, V74, P1781; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; ENGEL AG, 1990, SEMIN NEUROL, V10, P12, DOI 10.1055/s-2008-1041248; GAUGHAN G, 1991, GENOMICS, V11, P455, DOI 10.1016/0888-7543(91)90155-8; GETMAN D, 1991, FASEB J, V5, pA1172; GIBNEY G, 1990, J BIOL CHEM, V265, P12576; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; HAYNES AR, 1989, BIOL AMRKERS ALZHEIM, P138; HEIM S, 1989, CYTOGENET CELL GENET, V52, P136, DOI 10.1159/000132863; JOHNSON CD, 1988, NEURON, V1, P165, DOI 10.1016/0896-6273(88)90201-2; JUCKER M, 1990, HEMATOL ONCOL, V8, P191, DOI 10.1002/hon.2900080404; KERE J, 1987, NEW ENGL J MED, V316, P499, DOI 10.1056/NEJM198702263160902; KERE J, 1989, BLOOD, V73, P230; KERE J, 1991, NUCLEIC ACIDS RES, V19, P2755, DOI 10.1093/nar/19.10.2755; LAPIDOTLIFSON Y, 1989, P NATL ACAD SCI USA, V86, P4715, DOI 10.1073/pnas.86.12.4715; LI Y, 1991, J BIOL CHEM, V266, P23083; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MASSOULIE J, 1988, HDB EXP PHARM, V86, P167; MAULET Y, 1990, NEURON, V4, P289, DOI 10.1016/0896-6273(90)90103-M; MESULAM MM, 1987, ANN NEUROL, V22, P223, DOI 10.1002/ana.410220206; NAGOSHI RN, 1987, GENETICS, V117, P487; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; PATINKIN D, 1990, MOL CELL BIOL, V10, P6046, DOI 10.1128/MCB.10.11.6046; PERRY RH, 1980, AGE AGEING, V9, P9, DOI 10.1093/ageing/9.1.9; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; ROBERTS WL, 1987, P NATL ACAD SCI USA, V84, P7817, DOI 10.1073/pnas.84.22.7817; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROTUNDO RL, 1988, P NATL ACAD SCI USA, V85, P7805, DOI 10.1073/pnas.85.20.7805; SCHUMACHER M, 1988, J BIOL CHEM, V263, P18979; SELLERI L, 1991, P NATL ACAD SCI USA, V88, P887, DOI 10.1073/pnas.88.3.887; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; SILMAN I, 1987, EUR J BIOCHEM, V170, P11, DOI 10.1111/j.1432-1033.1987.tb13662.x; SOREQ H, 1987, HUM GENET, V77, P325, DOI 10.1007/BF00291419; STEPHENS JC, 1990, SCIENCE, V250, P237, DOI 10.1126/science.2218527; TAGO H, 1987, BRAIN RES, V406, P363, DOI 10.1016/0006-8993(87)90808-0; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; WAHL GM, 1987, P NATL ACAD SCI USA, V84, P2160, DOI 10.1073/pnas.84.8.2160; ZAKUT H, 1989, HUM REPROD, V4, P941, DOI 10.1093/oxfordjournals.humrep.a137017; ZELINSKI T, 1991, GENOMICS, V11, P165, DOI 10.1016/0888-7543(91)90113-S	45	83	87	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					170	177						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609795				2022-12-18	WOS:A1992JA46700018
J	PETERSEN, MB; SCHINZEL, AA; BINKERT, F; TRANEBJAERG, L; MIKKELSEN, M; COLLINS, FA; ECONOMOU, EP; ANTONARAKIS, SE				PETERSEN, MB; SCHINZEL, AA; BINKERT, F; TRANEBJAERG, L; MIKKELSEN, M; COLLINS, FA; ECONOMOU, EP; ANTONARAKIS, SE			USE OF SHORT SEQUENCE REPEAT DNA POLYMORPHISMS AFTER PCR AMPLIFICATION TO DETECT THE PARENTAL ORIGIN OF THE ADDITIONAL CHROMOSOME-21 IN DOWN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIOTIC RECOMBINATION; NON-DISJUNCTION; NONDISJUNCTION; TRISOMY-21; PROBES; GENE; MARKERS	The origin of nondisjunction in trisomy 21 has so far been studied using cytogenetic heteromorphisms and DNA polymorphisms using Southern blot analysis. Short sequence repeats have recently been described as an abundant class of DNA polymorphisms in the human genome, which can be typed using the polymerase chain reaction (PCR) amplification. We describe the usage of such markers on chromosome 21 in the study of parental origin of the additional chromosome 21 in 87 cases of Down syndrome. The polymorphisms studied were (a) two (GT)n repeats and a poly(A) tract of an Alu sequence within the HMG14 gene and (b) a (GT)n repeat of locus D21S156. The parental origin was determined in 68 cases by studying the segregation of polymorphic alleles in the nuclear families (either by scoring three different alleles in the proband or by dosage comparison of two different alleles in the proband). Our results demonstrate the usefulness of highly informative PCR markers for the study of nondisjunction in Down syndrome.	JOHNS HOPKINS UNIV HOSP, CTR MED GENET, CMSC 1003, 600 N WOLFE ST, BALTIMORE, MD 21205 USA; UNIV ZURICH, INST MED GENET, CH-8006 ZURICH, SWITZERLAND; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHN F KENNEDY INST, DEPT MED GENET, GLOSTRUP, DENMARK	Johns Hopkins University; Johns Hopkins Medicine; University of Zurich; Johns Hopkins University; Johns Hopkins University			Petersen, Michael Bjørn B/D-1483-2017; Antonarakis, Stylianos/N-8866-2014	Petersen, Michael Bjørn B/0000-0003-0316-8207; Antonarakis, Stylianos/0000-0001-8907-5823				ANTONARAKIS SE, 1985, P NATL ACAD SCI USA, V82, P3360, DOI 10.1073/pnas.82.10.3360; BLOUIN JL, 1990, AM J HUM GENET, V46, P518; CHAKRAVARTI A, 1989, AM J HUM GENET, V44, P639; DAGNABRICARELLI F, 1988, HUM GENET, V79, P124, DOI 10.1007/BF00280549; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; DELMAZO J, 1982, HUM GENET, V62, P316, DOI 10.1007/BF00304546; DRACOPOLI NC, 1990, GENOMICS, V7, P97, DOI 10.1016/0888-7543(90)90523-W; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; GALT J, 1989, HUM GENET, V81, P113, DOI 10.1007/BF00293885; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; LANDSMAN D, 1989, J BIOL CHEM, V264, P3421; LEWIS JG, 1990, GENOMICS, V8, P400, DOI 10.1016/0888-7543(90)90300-J; LITT M, 1989, AM J HUM GENET, V44, P397; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MEIJER H, 1989, HUM GENET, V83, P280, DOI 10.1007/BF00285173; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; PETERSEN MB, IN PRESS GENOMICS; RUDD NL, 1988, HUM GENET, V78, P175, DOI 10.1007/BF00278191; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART GD, 1988, AM J HUM GENET, V42, P227; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WEBER JL, 1989, AM J HUM GENET, V44, P388; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	31	83	84	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					65	71						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1824668				2022-12-18	WOS:A1991ET18800009
J	MACKENZIE, AE; KORNELUK, RG; ZORZATO, F; FUJII, J; PHILLIPS, M; ILES, D; WIERINGA, B; LEBLOND, S; BAILLY, J; WILLARD, HF; DUFF, C; WORTON, RG; MACLENNAN, DH				MACKENZIE, AE; KORNELUK, RG; ZORZATO, F; FUJII, J; PHILLIPS, M; ILES, D; WIERINGA, B; LEBLOND, S; BAILLY, J; WILLARD, HF; DUFF, C; WORTON, RG; MACLENNAN, DH			THE HUMAN RYANODINE RECEPTOR GENE - ITS MAPPING TO 19Q13.1, PLACEMENT IN A CHROMOSOME-19 LINKAGE GROUP, AND EXCLUSION AS THE GENE CAUSING MYOTONIC-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,401 SMYTH,OTTAWA K1H 8L1,ONTARIO,CANADA; CATHOLIC UNIV NIJMEGEN,DEPT CELL BIOL & HISTOL,NIJMEGEN,NETHERLANDS; CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; UNIV TORONTO,HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED RES,TORONTO M5S 1A1,ONTARIO,CANADA; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305	University of Ottawa; Children's Hospital of Eastern Ontario; Radboud University Nijmegen; Radboud University Nijmegen; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Stanford University			Wieringa, Berend/A-5346-2011	Wieringa, Berend/0000-0001-9192-8020				BRITT BA, 1979, FED PROC, V38, P44; BROOK JD, 1984, HUM GENET, V68, P282, DOI 10.1007/BF00292584; BRUNNER HG, 1989, GENOMICS, V5, P589, DOI 10.1016/0888-7543(89)90027-X; BRUNNER HG, 1989, HUM GENET, V81, P308, DOI 10.1007/BF00283680; BUFTON L, 1986, AM J HUM GENET, V38, P447; CAMPBELL KP, 1987, J BIOL CHEM, V262, P6490; CASSON H, 1977, 2ND P INT S MAL HYP, P3; COERWINKELDRIESSEN M, 1988, NUCLEIC ACIDS RES, V16, P8743, DOI 10.1093/nar/16.17.8743; DAVIES W, 1988, ANIM GENET, V19, P203, DOI 10.1111/j.1365-2052.1988.tb00809.x; EIBERG H, 1989, CYTOGENET CELL GENET, V51, P994; ENDO M, 1983, BIOMED RES, V72, P862; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRONERT GA, 1980, ANESTHESIOLOGY, V53, P395, DOI 10.1097/00000542-198011000-00007; HOJNY J, 1985, ANIM BLOOD GROUPS BI, V16, P307; INUI M, 1987, J BIOL CHEM, V262, P1740; JANDEL AS, 1985, CYTOGENET CELL GENET, V40, P660; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; JUNEJA RK, 1987, ANIM GENET, V18, P119; KIM DH, 1984, BIOCHIM BIOPHYS ACTA, V775, P320, DOI 10.1016/0005-2736(84)90187-1; KORNELUK RG, 1989, GENOMICS, V4, P146, DOI 10.1016/0888-7543(89)90293-0; KORNELUK RG, 1989, GENOMICS, V5, P596, DOI 10.1016/0888-7543(89)90028-1; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LUSIS AJ, 1986, P NATL ACAD SCI USA, V83, P3929, DOI 10.1073/pnas.83.11.3929; MACKENZIE AE, 1989, AM J HUM GENET, V44, P140; MACLENNAN DH, 1987, SOMAT CELL MOLEC GEN, V13, P341, DOI 10.1007/BF01534928; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MARTONOSI AN, 1984, PHYSIOL REV, V64, P1240, DOI 10.1152/physrev.1984.64.4.1240; MICKELSON JR, 1988, J BIOL CHEM, V263, P9310; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; Myotonic Dystrophy Foundation, 2017, VOIC PAT REP MYOT DY; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; OBRIEN PJ, 1986, CAN J VET RES, V50, P318; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; SCHEPENS J, 1987, NUCLEIC ACIDS RES, V15, P3192, DOI 10.1093/nar/15.7.3192; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SHARPE CR, 1984, NUCLEIC ACIDS RES, V12, P3917, DOI 10.1093/nar/12.9.3917; SHAW DJ, 1986, HUM GENET, V74, P262; SMEETS H, 1987, NUCLEIC ACIDS RES, V15, P8120, DOI 10.1093/nar/15.19.8120; Squire J, 1981, STRUCTURAL BASIS MUS; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; WAGENKNECHT T, 1989, NATURE, V338, P167, DOI 10.1038/338167a0; WALLIS SC, 1984, HUM GENET, V68, P286, DOI 10.1007/BF00292585; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	44	83	85	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1082	1089						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	1971150				2022-12-18	WOS:A1990DF20200008
J	COX, TC; BAWDEN, MJ; ABRAHAM, NG; BOTTOMLEY, SS; MAY, BK; BAKER, E; CHEN, LZ; SUTHERLAND, GR				COX, TC; BAWDEN, MJ; ABRAHAM, NG; BOTTOMLEY, SS; MAY, BK; BAKER, E; CHEN, LZ; SUTHERLAND, GR			ERYTHROID 5-AMINOLEVULINATE SYNTHASE IS LOCATED ON THE X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ADELAIDE, DEPT BIOCHEM, GPO BOX 498, ADELAIDE, SA 5001, AUSTRALIA; NEW YORK MED COLL, DEPT MED, VALHALLA, NY 10595 USA; VET ADM MED CTR, HEMATOL SECT, OKLAHOMA CITY, OK 73104 USA; ADELAIDE CHILDRENS HOSP INC, CYTOGENET UNIT, ADELAIDE, SA 5006, AUSTRALIA	University of Adelaide; New York Medical College; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Sutherland, Grant Robert/D-2606-2012					ABRAHAM NG, 1985, J LAB CLIN MED, V105, P593; ASTRIN KH, 1987, CYTOGENET CELL GENET, V46, P573; BAWDEN MJ, 1987, NUCLEIC ACIDS RES, V15, P8563, DOI 10.1093/nar/15.20.8563; BISHOP DF, 1981, ARCH BIOCHEM BIOPHYS, V206, P380, DOI 10.1016/0003-9861(81)90105-3; BOTTOMLEY SS, 1982, CLIN HAEMATOL, V11, P389; BOTTOMLEY SS, 1988, SEMIN HEMATOL, V25, P282; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; ELFERINK CJ, 1988, J BIOL CHEM, V263, P13012; ELLIOTT WH, 1989, BIOCHEM SOC SYMP, V55, P13; FITZSIMONS EJ, 1988, BRIT J HAEMATOL, V69, P281, DOI 10.1111/j.1365-2141.1988.tb07634.x; GRANDCHAMP B, 1983, HUM GENET, V64, P180, DOI 10.1007/BF00327121; MAY BK, 1986, CURR TOP CELL REGUL, V28, P233; POTLURI VR, 1987, HUM GENET, V76, P236; POVEY S, 1985, CYTOGENET CELL GENET, V40, P67, DOI 10.1159/000132170; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; SIMMERS RN, 1988, HUM GENET, V78, P144, DOI 10.1007/BF00278185; SRIVASTAVA G, 1988, J BIOL CHEM, V263, P5202; SUTHERLAND GR, 1988, AM J HUM GENET, V43, P331; SUTHERLAND GR, 1989, LEUKEMIA, V3, P9; WANG AL, 1981, P NATL ACAD SCI USA, V77, P6754; WATANABE N, 1983, BIOCHEM BIOPH RES CO, V113, P377, DOI 10.1016/0006-291X(83)91737-0; WHITE JM, 1971, BRIT J HAEMATOL, V20, P263, DOI 10.1111/j.1365-2141.1971.tb07037.x	23	83	85	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					107	111						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294742				2022-12-18	WOS:A1990CJ04300013
J	BIGBEE, WL; LANGLOIS, RG; SWIFT, M; JENSEN, RH				BIGBEE, WL; LANGLOIS, RG; SWIFT, M; JENSEN, RH			EVIDENCE FOR AN ELEVATED FREQUENCY OF INVIVO SOMATIC-CELL MUTATIONS IN ATAXIA TELANGIECTASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,BIOMED SCI RES CTR,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill	BIGBEE, WL (corresponding author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,POB 5507,L-452,LIVERMORE,CA 94550, USA.				NCI NIH HHS [CA 14235] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA014235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALSAADI A, 1980, HUM GENET, V55, P23; ARLETT CF, 1980, PROGR ENV MUTAGENESI, V7, P161; ARLETT CF, 1978, DNA REPAIR MECHANISM, P633; ARLETT CF, 1981, INDUCED MUTAGENESIS, P249; BIGBEE WL, 1987, ENVIRON MOL MUTAGEN, V9, P14; BODER E, 1985, ATAXIA TELANGIECTASI, P1; BORG DC, 1985, ASSESSMENT RISK LOW, P17; BRODEUR GM, 1986, PROG HEMATOL, V14, P229; CHEN P, 1984, MUTAT RES, V129, P165, DOI 10.1016/0027-5107(84)90149-0; COHEN MM, 1975, CYTOGENET CELL GENET, V15, P338, DOI 10.1159/000130530; FRIEND SH, 1988, NEW ENGL J MED, V318, P618; GROPP A, 1967, HUMANGENETIK, V5, P77, DOI 10.1007/BF00286217; HARNDEN DG, 1974, CHROMOSOMES CANCER, P619; INOUE T, 1981, BIOCHIM BIOPHYS ACTA, V655, P49, DOI 10.1016/0005-2787(81)90065-4; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; JENSEN RH, 1988, BANBURY REPORT, V28, P149; LANGLOIS RG, 1986, HUM GENET, V74, P353, DOI 10.1007/BF00280485; LANGLOIS RG, 1987, SCIENCE, V236, P445, DOI 10.1126/science.3563520; LANGLOIS RG, IN PRESS P NATL ACAD; LEVITT R, 1978, BLOOD, V52, P1003; MCKINNON PJ, 1987, HUM GENET, V75, P197, DOI 10.1007/BF00281059; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; OXFORD JM, 1975, J MED GENET, V12, P251, DOI 10.1136/jmg.12.3.251; PARSHAD R, 1985, CANCER GENET CYTOGEN, V14, P163, DOI 10.1016/0165-4608(85)90227-4; PATERSON MC, 1977, RES PHOTOBIOLOGY, P207; RARY JM, 1974, AM J HUM GENET, V26, pA70; ROSIN MP, 1986, HUM GENET, V74, P335, DOI 10.1007/BF00280482; SCHMID W, 1972, Archiv fuer Genetik, V45, P49; SIMONS JW, 1982, ATAXIA TELANGIECTASI, P155; Spector BD, 1982, ATAXIA TELANGIECTASI, P103; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; TATSUMI K, 1984, GANN, V75, P1040	33	83	85	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					402	408						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2916583				2022-12-18	WOS:A1989T353500014
J	HOFKER, MH; BERGEN, AAB; SKRAASTAD, MI; CARPENTER, NJ; VEENEMA, H; CONNOR, JM; BAKKER, E; VANOMMEN, GJB; PEARSON, PL				HOFKER, MH; BERGEN, AAB; SKRAASTAD, MI; CARPENTER, NJ; VEENEMA, H; CONNOR, JM; BAKKER, E; VANOMMEN, GJB; PEARSON, PL			EFFICIENT ISOLATION OF X-CHROMOSOME SPECIFIC SINGLE-COPY PROBES FROM A COSMID LIBRARY OF A HUMAN-X HAMSTER HYBRID-CELL LINE - MAPPING OF NEW PROBES CLOSE TO THE LOCUS FOR X-LINKED MENTAL-RETARDATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STATE UNIV LEIDEN,SYLVIUS LABS,DEPT HUMAN GENET,2333 AA LEIDEN,NETHERLANDS; UNIV GLASGOW,DUNCAN GUTHRIE INST MED GENET,GLASGOW G12 8QQ,SCOTLAND; CHILDRENS MED CTR,CHAPMAN INST MED GENET,TULSA,OK	Leiden University; Leiden University - Excl LUMC; University of Glasgow			Bakker, Egbert/D-3525-2009; Bergen, Arthur/J-3637-2013	Bakker, Egbert/0000-0002-2843-7357; Bergen, Arthur/0000-0002-6333-9576				BAKKER E, 1986, J MED GENET, V23, P573, DOI 10.1136/jmg.23.6.573; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BROWN WT, 1985, HUM GENET, V71, P11, DOI 10.1007/BF00295659; BUROKER NE, 1986, HUM GENET, V72, P86, DOI 10.1007/BF00278825; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; CHOO KH, 1982, NATURE, V299, P178, DOI 10.1038/299178a0; CONNOR JM, 1987, MED GENET, V24, P14; DAVIES KE, 1981, NATURE, V293, P252; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; FRANCKE U, 1985, AM J HUM GENET, V37, P250; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4; HOFKER MH, 1986, HUM GENET, V74, P275, DOI 10.1007/BF00282548; HOFKER MH, 1986, AM J HUM GENET, V39, P438; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; HOFKER MH, 1986, HUM GENET, V74, P270, DOI 10.1007/BF00282547; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; INGLE C, 1985, AM J HUM GENET, V37, P451; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LANGE K, 1982, AM J HUM GENET, V34, P842; MANIATIS T, 1982, MOL CLONING LABORATO; OBERLE I, 1986, P NATL ACAD SCI USA, V83, P1016, DOI 10.1073/pnas.83.4.1016; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; OLD JM, 1985, LANCET, V1, P73; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PATIL SR, 1985, CYTOGENET CELL GENET, V40, P720; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; VANOMMEN GJ, 1983, NUCLEIC ACIDS RES, V11, P2273; VEENEMA H, 1987, J MED GENET, V24, P23, DOI 10.1136/jmg.24.1.23; WIEACKER P, 1983, LANCET, V1, P1325; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WIERINGA B, 1985, CLIN GENET, V27, P522; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180	37	83	83	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1987	40	4					312	328						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H3196	2883888				2022-12-18	WOS:A1987H319600002
J	OTT, J				OTT, J			MAXIMUM LIKELIHOOD ESTIMATION BY COUNTING METHODS UNDER POLYGENIC AND MIXED MODELS IN HUMAN PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											OTT, J (corresponding author), UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195, USA.							BIRNBAUM A, 1972, GENETICS, V72, P739; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GERRARD JW, 1978, AM J HUM GENET, V30, P46; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; Isaacson E., 1966, ANAL NUMERICAL METHO; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; MARSAGLIA G, 1963, COMMUN ACM, V6, P37, DOI 10.1145/366193.366228; MITTMANN O., 1938, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V75, P191, DOI 10.1007/BF01847612; MORTON NE, 1974, AM J HUM GENET, V26, P489; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; OTT J, 1974, AM J HUM GENET, V26, pA64; PENROSE LS, 1969, ANN HUM GENET, V33, P15, DOI 10.1111/j.1469-1809.1969.tb01624.x; QUAAS RL, 1976, BIOMETRICS, V32, P949, DOI 10.2307/2529279; RAO CR, 1973, LINEAR STATISTICAL I; RAO DC, 1976, AM J HUM GENET, V28, P228; RAO DC, 1974, AM J HUM GENET, V26, P331; SLONIM MJ, 1967, SAMPLING; THOMPSON R, 1977, BIOMETRICS, V33, P485, DOI 10.2307/2529363; WEISS V, 1974, BIOL ZBL, V93, P311	24	83	83	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					161	175						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	453201				2022-12-18	WOS:A1979GZ38600008
J	OMENN, GS; CHEUNG, SCY				OMENN, GS; CHEUNG, SCY			PHOSPHOGLYCERATE MUTASE ISOENZYME MARKER FOR TISSUE DIFFERENTIATION IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle				Omenn, Gilbert S./0000-0002-8976-6074				CHEN SH, 1974, AM J HUM GENET, V26, P73; COHEN PTW, 1973, NATURE-NEW BIOL, V241, P229; DIEDERICH D, 1970, BIOCHIM BIOPHYS ACTA, V212, P441, DOI 10.1016/0005-2744(70)90250-0; EPPENBERGER HM, 1964, DEV BIOL, V10, P1, DOI 10.1016/0012-1606(64)90002-8; GRISOLIA J, 1970, BIOCHEM BIOPH RES CO, V41, P1238, DOI 10.1016/0006-291X(70)90219-6; JAMES E, 1971, CAN J BIOCHEM CELL B, V49, P1183, DOI 10.1139/o71-170; KUMANISHI T, 1970, ACTA NEUROPATHOL, V16, P220, DOI 10.1007/BF00687361; Liddle G W, 1969, Recent Prog Horm Res, V25, P283; OMENN GS, 1971, IN VITRO CELL DEV B, V7, P132, DOI 10.1007/BF02617956; OMENN GS, 1973, PATHOBIOL ANN, V3, P177; ROSE ZB, 1970, ARCH BIOCHEM BIOPHYS, V140, P508, DOI 10.1016/0003-9861(70)90095-0; SCHAPIRA F, 1970, BIOCHEM BIOPH RES CO, V40, P321, DOI 10.1016/0006-291X(70)91012-0; STOLBACH LL, 1969, NEW ENGL J MED, V281, P757, DOI 10.1056/NEJM196910022811403; TORRALBA A, 1966, J BIOL CHEM, V241, P1713	14	83	83	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					393	399						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0991	4827367				2022-12-18	WOS:A1974T099100009
J	ZUELZER, WW; BEATTIE, KM; REISMAN, LE				ZUELZER, WW; BEATTIE, KM; REISMAN, LE			GENERALIZED UNBALANCED MOSAICISM ATTRIBUTABLE TO DISPERMY + PROBABLE FERTILIZATION OF POLAR BODY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEATTIE KM, IN PRESS; GARTLER SM, 1962, P NATL ACAD SCI USA, V48, P332, DOI 10.1073/pnas.48.3.332; GIBLETT ER, 1963, AM J HUM GENET, V15, P62; MOORHEAD PS, 1960, EXP CELL RES, V20, P612; OHNO S., 1962, CYTOGENETICS, V1, P42, DOI 10.1159/000129712; WAXMAN SH, 1962, J PEDIAT, V60, P640	6	83	83	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	1					38	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2971A	14131873				2022-12-18	WOS:A19642971A00007
J	THOMPSON, MW				THOMPSON, MW			HEREDITY, MATERNAL AGE, AND BIRTH ORDER IN THE ETIOLOGY OF CELIAC DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSEN DH, 1947, J PEDIATR-US, V30, P564, DOI 10.1016/S0022-3476(47)80050-2; BRODY HP, 1946, LANCET, V251, P618; Brown A, 1925, AM J DIS CHILD, V30, P603; CHUTE AL, COMMUNICATION; COLLISHAW D, 1940, BRIT MED J, V2, P904; DALTON HW, 1946, LANCET, V251, P652; DAVIDSON LSP, 1950, BMJ-BRIT MED J, V1, P1157, DOI 10.1136/bmj.1.4663.1157; EBBS JH, COMMUNICATION; EBBS JH, UNPUB; FANCONI G, 1928, JB KINDERH K, P21; Gee S., 1888, ST BARTHOLOMEWS HOSP, V24, P17; Haas SV, 1932, J AMER MED ASSOC, V99, P448, DOI 10.1001/jama.1932.02740580016004; HABLUTZELWEBER E, 1923, INTESTINALEN INFANTI; Hanes FM, 1936, ARCH INTERN MED, V58, P1, DOI 10.1001/archinte.1936.00170110009001; JOSLIN EP, 1946, TREATMENT DIABETES M, pR1; KUNSTADTER R. H., 1942, Journal of Pediatrics, V21, P193, DOI 10.1016/S0022-3476(42)80217-6; LEHNDORFF H, 1927, ERG INN MED KINDERHK, V31, P456; May CD, 1941, J PEDIATR-US, V18, P200, DOI 10.1016/S0022-3476(41)80167-X; McCreary JF, 1942, J PEDIATR-US, V21, P289, DOI 10.1016/S0022-3476(42)80021-9; McKhann CF, 1943, J PEDIATR-US, V22, P362, DOI 10.1016/S0022-3476(43)80173-6; O'Donovan DK, 1942, LANCET, V2, P4; Parsons LG, 1932, AM J DIS CHILD, V43, P1293; Penrose L.S., 1934, INFLUENCE HEREDITY D; Penrose LS, 1934, ANN EUGENIC, V6, P108, DOI 10.1111/j.1469-1809.1934.tb02111.x; REWELL R. E., 1944, Guy's Hospital Reports, V93, P74; Riley ID, 1939, LANCET, V1, P262; Sauer LW, 1927, AM J DIS CHILD, V34, P934, DOI 10.1001/archpedi.1927.04130240013002; Stolte K, 1917, JB KINDERH, V36, P89; Thaysen TEH, 1935, Q J MED, V4, P359; THOMPSON MW, 1947, THESIS U TORONTO; WELLER GL, 1939, AM J DIG DIS, V5, P254; WILKERSON HLC, 1947, JAMA-J AM MED ASSOC, V135, P209, DOI 10.1001/jama.1947.02890040011003	32	83	83	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1951	3	2					159	166						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS393	14902759				2022-12-18	WOS:A1951XS39300004
J	Bamshad, MJ; Nickerson, DA; Chong, JX				Bamshad, Michael J.; Nickerson, Deborah A.; Chong, Jessica X.			Mendelian Gene Discovery: Fast and Furious with No End in Sight	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RARE; MUTATIONS; VARIANTS	Gene discovery for Mendelian conditions (MCs) offers a direct path to understanding genome function. Approaches based on next-generation sequencing applied at scale have dramatically accelerated gene discovery and transformed genetic medicine. Finding the genetic basis of similar to 6,000-13,000 MCs yet to be delineated will require both technical and computational innovation, but will rely to a larger extent on meaningful data sharing.	[Bamshad, Michael J.; Chong, Jessica X.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael J.; Nickerson, Deborah A.; Chong, Jessica X.] Brotman Baty Inst Precis Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Bamshad, MJ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Bamshad, MJ (corresponding author), Brotman Baty Inst Precis Med, Seattle, WA 98195 USA.	mbamshad@uw.edu	Chong, Jessica/GZH-1625-2022		National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI) [HG006493]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all of the families, clinicians, and investigators for their participation and support. We thank Kati Buckingham, John Carey, Katrina Dipple, Ada Hamosh, Colby Marvin, Jay Shendure, and Kathryn Shively for helpful discussion. This work was supported in part by grants from the National Human Genome Research Institute (NHGRI) and National Heart, Lung, and Blood Institute (NHLBI) grant HG006493 (to the University of Washington Center for Mendelian Genomics). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI and NHLBI or of the National Institutes of Health.	Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Brechtmann F, 2018, AM J HUM GENET, V103, P907, DOI 10.1016/j.ajhg.2018.10.025; Brewer MH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006177; Bult CJ, 2019, NUCLEIC ACIDS RES, V47, pD801, DOI 10.1093/nar/gky1056; Burstein MD, 2014, PEDIATRICS, V133, P690, DOI 10.1542/peds.2013-1592; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Coban-Akdemir Z, 2018, AM J HUM GENET, V103, P171, DOI 10.1016/j.ajhg.2018.06.009; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Hartley T, 2018, AM J MED GENET C, V178, P458, DOI 10.1002/ajmg.c.31662; Havrilla JM, 2019, NAT GENET, V51, P88, DOI 10.1038/s41588-018-0294-6; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Karolak JA, 2019, AM J HUM GENET, V104, P213, DOI 10.1016/j.ajhg.2018.12.010; Lacroix AJ, 2019, AM J HUM GENET, V104, P35, DOI 10.1016/j.ajhg.2018.11.005; Lambertson KF, 2015, HUM MUTAT, V36, P965, DOI 10.1002/humu.22852; Might M, 2014, GENET MED, V16, P736, DOI 10.1038/gim.2014.23; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ngcungcu T, 2017, AM J HUM GENET, V100, P737, DOI 10.1016/j.ajhg.2017.03.012; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Posey JE, 2019, GENET MED, V21, P798, DOI 10.1038/s41436-018-0408-7; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Short PJ, 2018, NATURE, V555, P611, DOI 10.1038/nature25983; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005; Spielmann M, 2012, AM J HUM GENET, V91, P629, DOI 10.1016/j.ajhg.2012.08.014; Starita LM, 2018, AM J HUM GENET, V103, P498, DOI 10.1016/j.ajhg.2018.07.016; Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014; Turner TN, 2019, TRENDS NEUROSCI, V42, P115, DOI 10.1016/j.tins.2018.11.002; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wieczorek D, 2014, AM J HUM GENET, V95, P698, DOI 10.1016/j.ajhg.2014.10.014; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829	35	82	83	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2019	105	3					448	455		10.1016/j.ajhg.2019.07.011	http://dx.doi.org/10.1016/j.ajhg.2019.07.011			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV7GX	31491408	Bronze, Green Published			2022-12-18	WOS:000484435700002
J	Lim, YH; Bacchiocchi, A; Qiu, JY; Straub, R; Bruckner, A; Bercovitch, L; Narayan, D; McNiff, J; Ko, C; Robinson-Bostom, L; Antaya, R; Halaban, R; Choate, KA				Lim, Young H.; Bacchiocchi, Antonella; Qiu, Jingyao; Straub, Robert; Bruckner, Anna; Bercovitch, Lionel; Narayan, Deepak; McNiff, Jennifer; Ko, Christine; Robinson-Bostom, Leslie; Antaya, Richard; Halaban, Ruth; Choate, Keith A.		Yale Ctr Mendelian Genomics	GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KASABACH-MERRITT PHENOMENON; GROWTH-FACTOR INDEPENDENCE; PROTEIN ALPHA-SUBUNITS; STURGE-WEBER SYNDROME; KAPOSIFORM HEMANGIOENDOTHELIOMA; INFANTILE HEMANGIOMA; TUFTED ANGIOMA; MELANOMA; PATHWAYS; IDENTIFICATION	Vascular tumors are among the most common neoplasms in infants and children; 5%-10% of newborns present with or develop lesions within the first 3 months of life. Most are benign infantile hemangiomas that typically regress by 5 years of age; other vascular tumors include congenital tufted angiomas (TAs), kaposiform hemangioendotheliomas (KHEs), and childhood lobular capillary hemangiomas (LCHs). Some of these lesions can become locally invasive and unresponsive to pharmacologic intervention, leading to significant complications. Recent investigation has revealed that activating mutations in HRAS, KRAS, NRAS, GNAQ, and GNA11 can cause certain types of rare childhood vascular tumors, and we have now identified causal recurrent somatic activating mutations in GNA14 by whole-exome and targeted sequencing. We found somatic activating GNA14 c.614A>T (p.Gln205Leu) mutations in one KHE, one TA, and one LCH and a GNA11 c.547C>T (p.Arg183Cys) mutation in two LCH lesions. We examined mutation pathobiology via expression of mutant GNA14 or GNA11 in primary human endothelial cells and melanocytes. GNA14 and GNA11 mutations induced changes in cellular morphology and rendered cells growth-factor independent by upregulating the MAPK pathway. Our findings identify GNA14 mutations as a cause of childhood vascular tumors, offer insight into mechanisms of oncogenic transformation by mutations affecting Gaq family members, and identify potential targets for therapeutic intervention.	[Lim, Young H.; Bacchiocchi, Antonella; Straub, Robert; McNiff, Jennifer; Ko, Christine; Antaya, Richard; Halaban, Ruth; Choate, Keith A.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Lim, Young H.; McNiff, Jennifer; Ko, Christine; Choate, Keith A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Lim, Young H.; Qiu, Jingyao; Choate, Keith A.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bruckner, Anna] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO 80045 USA; [Bruckner, Anna] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Bercovitch, Lionel; Robinson-Bostom, Leslie] Brown Univ, Dept Dermatol, Warren Alpert Med Sch, Providence, RI 02903 USA; [Narayan, Deepak] Yale Univ, Sch Med, Dept Surg, Sect Plast Surg, New Haven, CT 06510 USA; [Antaya, Richard] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Brown University; Yale University; Yale University	Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.; Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	keith.choate@yale.edu	Wang, Guilin/G-8794-2018	Ko, Christine/0000-0003-2270-2524	Doris Duke Charitable Foundation; Yale Center for Mendelian Genomics [NIH U54 HG006504]; Medical Scientist Training Program at Yale University [NIH/NIGMS T32 GM007205]; Yale SPORE in Skin Cancer - NIH National Cancer Institute [1P50CA121974]; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Yale Center for Mendelian Genomics; Medical Scientist Training Program at Yale University; Yale SPORE in Skin Cancer - NIH National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xinran Liu for assistance with electron-microscopy images, Elaine Zhou, Jing Zhou, Rong-Hua Hu, and Jonathan Levinsohn for technical assistance, Jordan Pober and William Chang for insightful correspondence on vascular biology, and members of the Yale Center Mendelian Genomics, including Richard P. Lifton, Shrikant M. Mane, and Kaya Bilguvar. This study was supported by a Doris Duke Charitable Foundation Clinical Scientist Development Award to K.A.C. and by the Yale Center for Mendelian Genomics (NIH U54 HG006504). Y.H.L. was supported by the Medical Scientist Training Program at Yale University (NIH/NIGMS T32 GM007205) and is a recipient of the Clinical Mentorship Award from the Doris Duke Charitable Foundation. R.H., A.B., and R.S. are supported by Yale SPORE in Skin Cancer, funded by the NIH National Cancer Institute under award number 1P50CA121974 (R.H.).	Ayturk UM, 2016, AM J HUM GENET, V98, P789, DOI 10.1016/j.ajhg.2016.03.009; BOSWELL HS, 1990, EXP HEMATOL, V18, P452; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Chiu YE, 2012, PEDIATR BLOOD CANCER, V59, P934, DOI 10.1002/pbc.24103; Chu CY, 2003, DERMATOLOGY, V206, P334, DOI 10.1159/000069947; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Couto JA, 2016, PLAST RECONSTR SURG, V137, p77E, DOI 10.1097/PRS.0000000000001868; DROCHMANS P, 1960, J BIOPHYS BIOCHEM CY, V8, P165, DOI 10.1083/jcb.8.1.165; Drolet BA, 2013, PEDIATRICS, V131, P128, DOI 10.1542/peds.2012-1691; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Funk T., 2016, J AM MED ASS DE 0720; Groesser L., 2015, J INVEST DERMATOL; Heydorn A, 2004, MOL PHARMACOL, V66, P250, DOI 10.1124/mol.66.2.250; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Jain Vishesh, 2012, Indian J Dermatol, V57, P126, DOI 10.4103/0019-5154.94281; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kohara K, 2008, HYPERTENS RES, V31, P203, DOI 10.1291/hypres.31.203; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kwan DHT, 2012, J CELL BIOCHEM, V113, P3486, DOI 10.1002/jcb.24225; Lei W, 2014, CELL BIOL INT, V38, P1041, DOI 10.1002/cbin.10292; Leonhardt RM, 2013, MOL BIOL CELL, V24, P964, DOI 10.1091/mbc.E12-10-0742; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim YH, 2015, J INVEST DERMATOL, V135, P1698, DOI 10.1038/jid.2015.55; Malhotra Y, 2014, PEDIATR DERMATOL, V31, P595, DOI 10.1111/pde.12090; Mulliken JB, 2004, J AM ACAD DERMATOL, V50, P875, DOI 10.1016/j.jaad.2003.10.670; Nakashima M, 2014, J HUM GENET, V59, P691, DOI 10.1038/jhg.2014.95; North PE, 2006, CARDIOVASC PATHOL, V15, P303, DOI 10.1016/j.carpath.2006.03.001; North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6; O'Rafferty C, 2015, BRIT J HAEMATOL, V171, P38, DOI 10.1111/bjh.13557; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RODECK U, 1993, CANCER METAST REV, V12, P219, DOI 10.1007/BF00665954; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Sivaraj KK, 2015, CARDIOVASC RES, V108, P171, DOI 10.1093/cvr/cvv216; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Thomas AC, 2016, J INVEST DERMATOL, V136, P770, DOI 10.1016/j.jid.2015.11.027; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang L, 2008, CANCER RES, V68, P4640, DOI 10.1158/0008-5472.CAN-07-5988; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zhao YJ, 2014, J HISTOCHEM CYTOCHEM, V62, P347, DOI 10.1369/0022155414521213	45	82	85	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					443	450		10.1016/j.ajhg.2016.06.010	http://dx.doi.org/10.1016/j.ajhg.2016.06.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27476652	Green Published, Bronze			2022-12-18	WOS:000381617200016
J	Herve, D; Philippi, A; Belbouab, R; Zerah, M; Chabrier, S; Collardeau-Frachon, S; Bergametti, F; Essongue, A; Berrou, E; Krivosic, V; Sainte-Rose, C; Houdart, E; Adam, F; Billiemaz, K; Lebret, M; Roman, S; Passemard, S; Boulday, G; Delaforge, A; Guey, S; Dray, X; Chabriat, H; Brouckaert, P; Bryckaert, M; Tournier-Lasserve, E				Herve, Dominique; Philippi, Anne; Belbouab, Reda; Zerah, Michel; Chabrier, Stephane; Collardeau-Frachon, Sophie; Bergametti, Francoise; Essongue, Aurore; Berrou, Eliane; Krivosic, Valerie; Sainte-Rose, Christian; Houdart, Emmanuel; Adam, Frederic; Billiemaz, Kareen; Lebret, Marilyne; Roman, Sabine; Passemard, Sandrine; Boulday, Gwenola; Delaforge, Audrey; Guey, Stephanie; Dray, Xavier; Chabriat, Hugues; Brouckaert, Peter; Bryckaert, Maryjke; Tournier-Lasserve, Elisabeth			Loss of alpha 1 beta 1 Soluble Guanylate Cyclase, the Major Nitric Oxide Receptor, Leads to Moyamoya and Achalasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHEAR-STRESS; DISEASE; DISCOVERY	Moyamoya is a cerebrovascular condition characterized by a progressive stenosis of the terminal part of the internal carotid arteries (ICAs) and the compensatory development of abnormal "moyamoya" vessels. The pathophysiological mechanisms of this condition, which leads to ischemic and hemorrhagic stroke, remain unknown. It can occur as an isolated cerebral angiopathy (so-called moyamoya disease) or in association with various conditions (moyamoya syndromes). Here, we describe an autosomal-recessive disease leading to severe moyamoya and early-onset achalasia in three unrelated families. This syndrome is associated in all three families with homozygous mutations in GUCY1A3, which encodes the alpha 1 subunit of soluble guanylate cyclase (sGC), the major receptor for nitric oxide (NO). Platelet analysis showed a complete loss of the soluble alpha 1 beta 1 guanylate cyclase and showed an unexpected stimulatory role of sGC within platelets. The NO-sGC-cGMP pathway is a major pathway controlling vascular smooth-muscle relaxation, vascular tone, and vascular remodeling. Our data suggest that alterations of this pathway might lead to an abnormal vascular-remodeling process in sensitive vascular areas such as ICA bifurcations. These data provide treatment options for affected individuals and strongly suggest that investigation of GUCY1A3 and other members of the NO-sGC-cGMP pathway is warranted in both isolated early-onset achalasia and non-syndromic moyamoya.	[Herve, Dominique; Philippi, Anne; Bergametti, Francoise; Essongue, Aurore; Boulday, Gwenola; Guey, Stephanie; Chabriat, Hugues; Tournier-Lasserve, Elisabeth] INSERM, U1161, F-75010 Paris, France; [Herve, Dominique; Philippi, Anne; Bergametti, Francoise; Essongue, Aurore; Boulday, Gwenola; Guey, Stephanie; Chabriat, Hugues; Tournier-Lasserve, Elisabeth] Univ Paris Diderot, Sorbonne Paris Cite, UMR S1161, F-75010 Paris, France; [Herve, Dominique; Chabriat, Hugues] AP HP, Grp Hosp Saint Louis Lariboisiere Fernand Widal, Ctr Reference Malad Vasc Rares Cerveau & Oeil, Serv Neurol, F-75010 Paris, France; [Belbouab, Reda] Etab Publ Hosp Hassen Badi el Harrach, Serv Pediat, Algiers 16200, Algeria; [Zerah, Michel; Sainte-Rose, Christian] AP HP, Grp Hosp Necker Enfants Malades, Serv Neurochirurgie, F-75015 Paris, France; [Chabrier, Stephane] Univ St Etienne Ctr Hosp, Serv Med Phys & Readaptat Pediat, Ctr Natl Reference AVC Enfant,Hop Bellevue, F-42100 St Etienne, France; [Collardeau-Frachon, Sophie] Hop Mere Enfant, Ctr Pathol Est, F-69500 Lyon, France; [Berrou, Eliane; Adam, Frederic; Lebret, Marilyne; Bryckaert, Maryjke] INSERM, F-75010 Paris, France; [Berrou, Eliane; Lebret, Marilyne; Bryckaert, Maryjke] Univ Paris Sud, F-94270 Le Kremlin Bicetre, France; [Krivosic, Valerie] AP HP, Grp Hosp Saint Louis Lariboisiere Fernand Widal, Ctr Reference Malad Vasc Rares Cerveau & Oeil, Serv Ophtalmol, F-75010 Paris, France; [Billiemaz, Kareen] Ctr Hospitalier Univ St Etienne, Serv Reanimat Pediat & Neonatal, F-42100 Saint Etienne, France; [Passemard, Sandrine] Univ Lyon 1, Hospices Civils Lyon, Serv Physiol Digest, Hop Edouard Herriot, F-69003 Lyon, France; [Passemard, Sandrine] AP HP, Grp Hosp Robert Debre, Serv Neurope diatrie, F-75019 Paris, France; [Delaforge, Audrey; Tournier-Lasserve, Elisabeth] AP HP, Grp Hosp Saint Louis Lariboisiere Fernand Widal, Ctr Reference Malad Vasc Rares Cerveau & Oeil, Serv Genet Mol Neurovasc, F-75010 Paris, France; [Dray, Xavier] AP HP, Grp Hosp Saint Louis Lariboisiere Fernand Widal, Ctr Reference Malad Vasc Rares Cerveau & Oeil, Serv Gastroenterol, F-75010 Paris, France; [Brouckaert, Peter] Univ Ghent, VIB Inflammat Res Ctr, B-9052 Ghent, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Flanders Institute for Biotechnology (VIB); Ghent University	Tournier-Lasserve, E (corresponding author), INSERM, U1161, F-75010 Paris, France.	tournier-lasserve@univ-paris-diderot.fr	Tournier-Lasserve, Elisabeth/N-7134-2017; Philippi, Anne/M-9853-2017; Boulday, Gwenola/AAV-3768-2020; Roman, Sabine/AAH-2564-2019; FRACHON, Sophie COLLARDEAU/H-2000-2014; Chabriat, Hugues/G-5699-2010	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Philippi, Anne/0000-0003-2184-6008; Boulday, Gwenola/0000-0002-5591-1659; Roman, Sabine/0000-0002-7798-7638; FRACHON, Sophie COLLARDEAU/0000-0001-8604-1089; Herve, Dominique/0000-0001-6197-6275; Chabrier, Stephane/0000-0002-6816-3266; Chabriat, Hugues/0000-0001-8436-6074; ADAM, Frederic/0000-0001-6603-2687	Institut National de la Sante et de la Recherche Medicale; Fondation Leducq Transatlantic Networks of Excellence Program [07 CVD 02]; Region Ile de France from the Domaine d'Interet Majeur Neurosciences et Maladies Neurodegeneratives	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation Leducq Transatlantic Networks of Excellence Program; Region Ile de France from the Domaine d'Interet Majeur Neurosciences et Maladies Neurodegeneratives(Region Ile-de-France)	We thank all family members for their participation in this research program, as well as the French Tanguy Moyamoya Association of affected individuals. We are also indebted to Pierre Francois Plouin, Jerome Viala, and Philippe Marteau for excellent clinical evaluation of some of the affected individuals and to Florence Marchelli for figure design. Research was supported by the Institut National de la Sante et de la Recherche Medicale, the Fondation Leducq Transatlantic Networks of Excellence Program (grant 07 CVD 02 Hemorrhagic Stroke to E.T.L.), and Region Ile de France (grant from the Domaine d'Interet Majeur Neurosciences et Maladies Neurodegeneratives to E.T.L.).	Achrol AS, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08302; Atochin DN, 2010, STROKE, V41, P1815, DOI 10.1161/STROKEAHA.109.577635; Bryan NS, 2009, FRONT BIOSCI-LANDMRK, V14, P1, DOI 10.2741/3228; Buys ES, 2008, CARDIOVASC RES, V79, P179, DOI 10.1093/cvr/cvn068; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Dangel O, 2010, J THROMB HAEMOST, V8, P1343, DOI 10.1111/j.1538-7836.2010.03806.x; De LaVega AJ, 2009, EXPERT OPIN INV DRUG, V18, P23, DOI [10.1517/13543780802525100, 10.1517/13543780802525100 ]; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Gockel HR, 2010, HUM GENET, V128, P353, DOI 10.1007/s00439-010-0874-8; Gockel I, 2006, J GASTROEN HEPATOL, V21, P727, DOI 10.1111/j.1440-1746.2006.04250.x; Goldblum JR, 1996, GASTROENTEROLOGY, V111, P648, DOI 10.1053/gast.1996.v111.pm8780569; Hyun SJ, 2010, ACTA NEUROCHIR, V152, P1181, DOI 10.1007/s00701-010-0638-1; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kauskot A, 2007, J BIOL CHEM, V282, P31990, DOI 10.1074/jbc.M701596200; Khelif K, 2003, AM J SURG PATHOL, V27, P667, DOI 10.1097/00000478-200305000-00010; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lin RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036386; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Roder C, 2010, J HUM GENET, V55, P711, DOI 10.1038/jhg.2010.103; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Seol HJ, 2010, J NEUROSURG-PEDIATR, V5, P297, DOI 10.3171/2009.10.PEDS09452; Sivarao DV, 2001, GASTROENTEROLOGY, V121, P34, DOI 10.1053/gast.2001.25541; Wentzel JJ, 2003, J BIOMECH, V36, P681, DOI 10.1016/S0021-9290(02)00446-3; YAMASHITA M, 1983, STROKE, V14, P50, DOI 10.1161/01.STR.14.1.50; Zhang GY, 2011, BLOOD, V118, P3670, DOI 10.1182/blood-2011-03-341107	28	82	91	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					385	394		10.1016/j.ajhg.2014.01.018	http://dx.doi.org/10.1016/j.ajhg.2014.01.018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24581742	Green Published, Bronze			2022-12-18	WOS:000332611400012
J	Zhou, D; Udpa, N; Ronen, R; Stobdan, T; Liang, J; Appenzeller, O; Zhao, HWW; Yin, Y; Du, YP; Guo, LX; Cao, R; Wang, Y; Jin, X; Huang, C; Jia, WL; Cao, DD; Guo, GW; Gamboa, JL; Villafuerte, F; Callacondo, D; Xue, J; Liu, SQ; Frazer, KA; Li, YR; Bafna, V; Haddad, GG				Zhou, Dan; Udpa, Nitin; Ronen, Roy; Stobdan, Tsering; Liang, Junbin; Appenzeller, Otto; Zhao, Huiwen W.; Yin, Yi; Du, Yuanping; Guo, Lixia; Cao, Rui; Wang, Yu; Jin, Xin; Huang, Chen; Jia, Wenlong; Cao, Dandan; Guo, Guangwu; Gamboa, Jorge L.; Villafuerte, Francisco; Callacondo, David; Xue, Jin; Liu, Siqi; Frazer, Kelly A.; Li, Yingrui; Bafna, Vineet; Haddad, Gabriel G.			Whole-Genome Sequencing Uncovers the Genetic Basis of Chronic Mountain Sickness in Andean Highlanders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-ALTITUDE ADAPTATION; DROSOPHILA-MELANOGASTER; GOLDEN BUG; HYPOXIA; SELECTION; TIBETAN; OXYGEN; MODEL; DESUMOYLATION; TOLERANCE	The hypoxic conditions at high altitudes present a challenge for survival, causing pressure for adaptation. Interestingly, many high-altitude denizens (particularly in the Andes) are maladapted, with a condition known as chronic mountain sickness (CMS) or Monge disease. To decode the genetic basis of this disease, we sequenced and compared the whole genomes of 20 Andean subjects (10 with CMS and 10 without). We discovered 11 regions genome-wide with significant differences in haplotype frequencies consistent with selective sweeps. In these regions, two genes (an erythropoiesis regulator, SENP1, and an oncogene, ANP32D) had a higher transcriptional response to hypoxia in individuals with CMS relative to those without. We further found that downregulating the orthologs of these genes in flies dramatically enhanced survival rates under hypoxia, demonstrating that suppression of SENP1 and ANP32D plays an essential role in hypoxia tolerance. Our study provides an unbiased framework to identify and validate the genetic basis of adaptation to high altitudes and identifies potentially targetable mechanisms for CMS treatment.	[Zhou, Dan; Stobdan, Tsering; Zhao, Huiwen W.; Xue, Jin; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Udpa, Nitin; Ronen, Roy] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Liang, Junbin; Yin, Yi; Du, Yuanping; Guo, Lixia; Cao, Rui; Wang, Yu; Jin, Xin; Huang, Chen; Jia, Wenlong; Cao, Dandan; Guo, Guangwu; Liu, Siqi; Li, Yingrui] BGI Amer, Cambridge, MA 02142 USA; [Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Dept Neurol, Albuquerque, NM 87122 USA; [Gamboa, Jorge L.] Vanderbilt Univ, Ctr Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37232 USA; [Villafuerte, Francisco] Univ Peruana Cayetano Heredia, Lab Fisiol Adaptac Altura LID, Lab Fisiol Comparada LID, Unidad Transporte Oxigeno IIA, Smp Lima 31, Peru; [Callacondo, David] Univ Peruana Cayetano Heredia, Smp Lima 31, Peru; [Frazer, Kelly A.] Univ Calif San Diego, Dept Pediat, Div Genome Informat Sci, La Jolla, CA 92093 USA; [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Vanderbilt University; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Haddad, GG (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu	Jin, Xin/ABF-1329-2020; Gamboa, Jorge/AFM-0631-2022; Li, Yingrui/K-1064-2015; Gamboa, Jorge/E-5879-2010; Zhou, Dan/T-7203-2017; Jia, Justin/AAV-4349-2021; Bafna, Vineet/AAY-8111-2020; Gamboa, Jorge/AAH-3052-2022	Jin, Xin/0000-0001-7554-4975; Gamboa, Jorge/0000-0002-4204-7670; Gamboa, Jorge/0000-0002-4204-7670; Jia, Justin/0000-0002-7136-9919; Bafna, Vineet/0000-0002-5810-6241; Gamboa, Jorge/0000-0002-4204-7670; Villafuerte, Francisco C./0000-0003-0731-8911; CAO, Dandan/0000-0003-2899-8813; Zhou, Dan/0000-0001-6401-9040; Frazer, Kelly/0000-0002-6060-8902	National Institutes of Health [1P01HL098053, 5P01HD32573];  [NSF-CCF-1115206];  [NSF-III-1318386];  [5RO1-HG004962];  [U54 HL108460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, U54HL108460] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK100533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mary Hsiao and Orit Poulsen for technical assistance and Abigail W. Bigham for providing Latin American highlander and lowlander genotype data. This study is supported by NSF-CCF-1115206, NSF-III-1318386, 5RO1-HG004962, and U54 HL108460 to V.B. and National Institutes of Health awards 1P01HL098053 and 5P01HD32573 to G.G.H.	Achaz G, 2009, GENETICS, V183, P249, DOI 10.1534/genetics.109.104042; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Azad P, 2012, G3-GENES GENOM GENET, V2, P1169, DOI 10.1534/g3.112.003681; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Beall CM, 2000, HUM BIOL, V72, P201; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham Abigail W., 2009, Human Genomics, V4, P79; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cavalli-Sforza L. L, 1969, P 12 INT C GEN, P405; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Diop SB, 2012, J CELL MOL MED, V16, P966, DOI 10.1111/j.1582-4934.2012.01522.x; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; ERGUETA J, 1971, RESPIRATION, V28, P485, DOI 10.1159/000192835; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frisancho AR, 1997, AM J HUM BIOL, V9, P191, DOI 10.1002/(SICI)1520-6300(1997)9:2<191::AID-AJHB5>3.0.CO;2-3; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Garcia M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000615; Gilbert LI, 2008, MOL CELL ENDOCRINOL, V293, P25, DOI 10.1016/j.mce.2008.02.009; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; HUDSON RR, 1992, GENETICS, V132, P583; Ji LD, 2012, MOL BIOL EVOL, V29, P3359, DOI 10.1093/molbev/mss144; Leon-Velarde F, 2003, ADV EXP MED BIOL, V543, P339; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Lorenzo VF, 2009, BLOOD CELL MOL DIS, V43, P221, DOI 10.1016/j.bcmd.2009.04.006; Lu BW, 2009, APOPTOSIS, V14, P1008, DOI 10.1007/s10495-009-0347-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Michno K, 2005, CURR TOP DEV BIOL, V71, P199, DOI 10.1016/S0070-2153(05)71006-1; MONGE C, 1992, INT J SPORTS MED, V13, pS79, DOI 10.1055/s-2007-1024603; MONGE CC, 1976, JOHNS HOPKINS MED J, V139, P87; Moore L. G., 2007, HYPOXIA EXERCISE, P101; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; NIERMEYER S, 1995, NEW ENGL J MED, V333, P1248, DOI 10.1056/NEJM199511093331903; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Polesello C, 2011, PROG MOL BIOL TRANSL, V100, P51, DOI 10.1016/B978-0-12-384878-9.00002-9; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rupert JL, 2001, J EXP BIOL, V204, P3151; Shriver Mark D, 2004, Hum Genomics, V1, P274; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Udpa Nitin, 2011, Frontiers in Genetics, V2, P83, DOI 10.3389/fgene.2011.00083; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; West JB, 2012, AM J RESP CRIT CARE, V186, P1229, DOI 10.1164/rccm.201207-1323CI; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu LY, 2010, J EXP MED, V207, P1183, DOI 10.1084/jem.20092215; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2009, PEDIATR RES, V66, P239, DOI 10.1203/PDR.0b013e3181b27275	63	82	88	3	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					452	462		10.1016/j.ajhg.2013.07.011	http://dx.doi.org/10.1016/j.ajhg.2013.07.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23954164	Green Published, Bronze			2022-12-18	WOS:000330268900004
J	Indrieri, A; van Randen, VA; Tiranti, V; Morleo, M; Iaconis, D; Tammaro, R; D'Amato, I; Conte, I; Maystadt, I; Demuth, S; Zvulunov, A; Kutsche, K; Zeviani, M; Franco, B				Indrieri, Alessia; van Randen, Vanessa Alexandra; Tiranti, Valeria; Morleo, Manuela; Iaconis, Daniela; Tammaro, Roberta; D'Amato, Ilaria; Conte, Ivan; Maystadt, Isabelle; Demuth, Stephanie; Zvulunov, Alex; Kutsche, Kerstin; Zeviani, Massimo; Franco, Brunella			Mutations in COX7B Cause Microphthalmia with Linear Skin Lesions, an Unconventional Mitochondrial Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; MALE-LETHAL DISORDERS; DEFECTS MLS SYNDROME; X-INACTIVATION; MOLECULAR CHARACTERIZATION; CELLS; VARIABILITY; DEFICIENCY; EXPRESSION; INSIGHTS	Microphthalmia with linear skin lesions (MLS) is an X-linked dominant male-lethal disorder associated with mutations in holocytochrome c-type synthase (HCCS), which encodes a crucial player of the mitochondrial respiratory chain (MRC). Unlike other mitochondrial diseases, MLS is characterized by a well-recognizable neurodevelopmental phenotype. Interestingly, not all clinically diagnosed MLS cases have mutations in HCCS, thus suggesting genetic heterogeneity for this disorder. Among the possible candidates, we analyzed the X-linked COX7B and found deleterious de novo mutations in two simplex cases and a nonsense mutation, which segregates with the disease, in a familial case. COX7B encodes a poorly characterized structural subunit of cytochrome c oxidase (COX), the MRC complex IV. We demonstrated that COX7B is indispensable for COX assembly, COX activity, and mitochondrial respiration. Downregulation of the COX7B ortholog (cox7B) in medaka (Oryzias latipes) resulted in microcephaly and microphthalmia that recapitulated the MLS phenotype and demonstrated an essential function of complex IV activity in vertebrate CNS development. Our results indicate an evolutionary conserved role of the MRC complexes III and IV for the proper development of the CNS in vertebrates and uncover a group of mitochondrial diseases hallmarked by a developmental phenotype.	[Indrieri, Alessia; Morleo, Manuela; Iaconis, Daniela; Tammaro, Roberta; Conte, Ivan; Franco, Brunella] Telethon Inst Genet & Med, I-80131 Naples, Italy; [van Randen, Vanessa Alexandra; Kutsche, Kerstin] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Tiranti, Valeria; D'Amato, Ilaria; Zeviani, Massimo] Fdn Carlo Besta Inst Neurol, Unit Mol Neurogenet, I-20126 Milan, Italy; [Maystadt, Isabelle] Ctr Genet Humaine, Inst Pathol & Genet, B-6041 Gosselies, Charleroi, Belgium; [Demuth, Stephanie] Gemeinschaftspraxis Humangenet, D-99084 Erfurt, Germany; [Zvulunov, Alex] Ben Gurion Univ Negev, Med Sch Int Hlth, Fac Hlth Sci, Schneider Childrens Med Ctr Israel, IL-84105 Beer Sheva, Israel; [Franco, Brunella] Univ Naples Federico II, Dept Pediat, Med Genet Serv, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Hamburg; University Medical Center Hamburg-Eppendorf; IRCCS Istituto Neurologico Besta; Ben Gurion University; University of Naples Federico II	Franco, B (corresponding author), Telethon Inst Genet & Med, I-80131 Naples, Italy.	franco@tigem.it	Indrieri, Alessia/I-7666-2019; Zeviani, Massimo/AAU-2632-2021; Iaconis, Daniela/AAD-9571-2019; Zeviani, Massimo/K-2891-2014; Tiranti, Valeria/AFN-5783-2022; Iaconis, Daniela/GZA-7677-2022; Tiranti, Valeria/J-8233-2016; Morleo, Manuela/AAK-5833-2020; Maystadt, Isabelle/AAH-1483-2021; D'Amato, Ilaria/AAI-1022-2021; FRANCO, Brunella/S-2882-2018	Indrieri, Alessia/0000-0002-2325-0913; Zeviani, Massimo/0000-0002-9067-5508; Iaconis, Daniela/0000-0002-1052-6634; Tiranti, Valeria/0000-0002-3584-7338; Iaconis, Daniela/0000-0002-1052-6634; Tiranti, Valeria/0000-0002-3584-7338; D'Amato, Ilaria/0000-0002-3031-329X; Conte, Ivan/0000-0002-8968-9021; Morleo, Manuela/0000-0002-7553-3245; FRANCO, Brunella/0000-0001-5588-4569	Pierfranco and Luisa Mariani Foundation Italy; Italian Telethon Foundation [GGP11011, GPP10005]; CARIPLO [2011/0526]; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); Deutsche Forschungsgemeinschaft [KU 1240/6-1]; Italian Telethon Foundation	Pierfranco and Luisa Mariani Foundation Italy; Italian Telethon Foundation(Fondazione Telethon); CARIPLO(Fondazione Cariplo); Italian Association of Mitochondrial Disease Patients and Families (Mitocon); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Telethon Foundation(Fondazione Telethon)	This work was supported by the Pierfranco and Luisa Mariani Foundation Italy, the Italian Telethon Foundation (GGP11011 and GPP10005), CARIPLO grant 2011/0526, and the Italian Association of Mitochondrial Disease Patients and Families (Mitocon) (to M.Z.) and the Deutsche Forschungsgemeinschaft (KU 1240/6-1 to K.K.). B.F. is also supported by the Italian Telethon Foundation. We thank Sandro Banfi, Nicola Brunetti-Pierri, and Graciana Diez-Roux for critical reading of the manuscript and helpful discussion. We also thank Francesco Salierno and Inka Jantke for excellent technical assistance.	Birch-Machin MA, 2000, CLIN EXP DERMATOL, V25, P141, DOI 10.1046/j.1365-2230.2000.00605.x; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Franco B, 2006, CURR OPIN GENET DEV, V16, P254, DOI 10.1016/j.gde.2006.04.012; Garcia-Rabasco A., 2012, PEDIAT DERMATOL; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Kono T, 1999, J HUM GENET, V44, P63, DOI 10.1007/s100380050110; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Morleo M, 2005, AM J MED GENET A, V137A, P190, DOI 10.1002/ajmg.a.30864; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Schaefer L, 1996, GENOMICS, V34, P166, DOI 10.1006/geno.1996.0261; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Schwarz QP, 2002, GENOMICS, V79, P51, DOI 10.1006/geno.2001.6677; Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163; Sharma VM, 2008, PEDIATR DERMATOL, V25, P548, DOI 10.1111/j.1525-1470.2008.00724.x; TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Van den Veyver IB, 2001, SEMIN REPROD MED, V19, P183, DOI 10.1055/s-2001-15398; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wimplinger I, 2006, AM J HUM GENET, V79, P878, DOI 10.1086/508474; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259; Zumwalt J, 2012, PEDIATR DERMATOL, V29, P217, DOI [10.1111/j.1525-1470.2011.01632.x, 10.1111/j.1525-1470.2011.01633.x]; Zvulunov A, 1998, BRIT J DERMATOL, V138, P1046	37	82	83	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					942	949		10.1016/j.ajhg.2012.09.016	http://dx.doi.org/10.1016/j.ajhg.2012.09.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23122588	Bronze, Green Published			2022-12-18	WOS:000311011400018
J	Spielmann, M; Brancati, F; Krawitz, PM; Robinson, PN; Ibrahim, DM; Franke, M; Hecht, J; Lohan, S; Dathe, K; Nardone, AM; Ferrari, P; Landi, A; Wittler, L; Timmermann, B; Chan, D; Mennen, U; Klopocki, E; Mundlos, S				Spielmann, Malte; Brancati, Francesco; Krawitz, Peter M.; Robinson, Peter N.; Ibrahim, Daniel M.; Franke, Martin; Hecht, Jochen; Lohan, Silke; Dathe, Katarina; Nardone, Anna Maria; Ferrari, Paola; Landi, Antonio; Wittler, Lars; Timmermann, Bernd; Chan, Danny; Mennen, Ulrich; Klopocki, Eva; Mundlos, Stefan			Homeotic Arm-to-Leg Transformation Associated with Genomic Rearrangements at the PITX1 Locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SCHINZEL-GIEDION SYNDROME; EMBRYONIC STEM-CELLS; ENHANCER; MICE; DROSOPHILA; MUTATIONS; HINDLIMB; IDENTITY; DELETION	The study of homeotic-transformation mutants in model organisms such as Drosophila revolutionized the field of developmental biology, but how these mutants relate to human developmental defects remains to be elucidated. Here, we show that Liebenberg syndrome, an autosomal-dominant upper-limb malformation, shows features of a homeotic limb transformation in which the arms have acquired morphological characteristics of a leg. Using high-resolution array comparative genomic hybridization and paired-end whole-genome sequencing, we identified two deletions and a translocation 5' of PITX1. The structural changes are likely to remove active PITX1 forelimb suppressor and/or insulator elements and thereby move active enhancer elements in the vicinity of the PITX1 regulatory landscape. We generated transgenic mice in which PITX1 was misexpressed under the control of a nearby enhancer and were able to recapitulate the Liebenberg phenotype.	[Spielmann, Malte; Krawitz, Peter M.; Robinson, Peter N.; Lohan, Silke; Dathe, Katarina; Klopocki, Eva; Mundlos, Stefan] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Spielmann, Malte; Ibrahim, Daniel M.; Franke, Martin; Hecht, Jochen; Lohan, Silke; Klopocki, Eva; Mundlos, Stefan] Max Planck Inst Mol Genet, Res Grp Dev & Dis, D-14195 Berlin, Germany; [Brancati, Francesco] Casa Sollievo Sofferenza Hosp, Mendel Inst, Ist Ricovero & Cura Carattere Sci, I-00198 Rome, Italy; [Brancati, Francesco; Nardone, Anna Maria] Policlin Tor Vergata Univ Hosp, I-00198 Rome, Italy; [Ibrahim, Daniel M.; Hecht, Jochen] Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Ferrari, Paola] Univ Modena & Reggio Emilia, Dept Pediat, I-41100 Modena, Italy; [Landi, Antonio] Policlin Modena, Hand Surg & Microsurg Unit, I-41100 Modena, Italy; [Wittler, Lars] Max Planck Inst Mol Genet, D-13353 Berlin, Germany; [Timmermann, Bernd] Max Planck Inst Mol Genet, Next Generat Sequencing Grp, D-14195 Berlin, Germany; [Chan, Danny] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Mennen, Ulrich] Jacaranda Hosp, ZA-0083 Pretoria, South Africa	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Rome Tor Vergata; Policlin Tor Vergata; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Max Planck Society; Max Planck Society; University of Hong Kong	Mundlos, S (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Brancati, Francesco/AAC-3778-2022; Mundlos, Stefan/ABH-9585-2020; Spielmann, Malte/H-2230-2018; Krawitz, Peter M/F-3142-2012; Lohan, Silke SL/N-8917-2013; Klopocki, Eva/B-6823-2017; Franke, Martin/AAX-6027-2021; Franke, Martin/O-8986-2017; Chan, Danny/C-4203-2009	Brancati, Francesco/0000-0003-3624-2354; Spielmann, Malte/0000-0002-0583-4683; Krawitz, Peter M/0000-0002-3194-8625; Klopocki, Eva/0000-0003-1438-2081; Franke, Martin/0000-0002-4626-3290; Franke, Martin/0000-0002-4626-3290; Mundlos, Stefan/0000-0002-9788-3166; Dathe, Katarina/0000-0002-8674-5817; Ibrahim, Daniel Murad/0000-0002-0019-3354; Robinson, Peter/0000-0002-0736-9199; Chan, Danny/0000-0003-3824-5778	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We would like to thank the families for their collaboration and contribution to this project. We acknowledge F. Trotier, R. Koll, and B. Teubner for technical assistance. We thank A. Proietti for her assistance with our patients. This project was supported by a grant from the Deutsche Forschungsgemeinschaft to S.M. and E.K.	Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; DeLaurier A, 2006, DEV BIOL, V299, P22, DOI 10.1016/j.ydbio.2006.06.055; Duboc V, 2011, DEV DYNAM, V240, P1017, DOI 10.1002/dvdy.22582; Emerald BS, 1997, NATURE, V389, P684, DOI 10.1038/39500; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; HORAN GSB, 1994, P NATL ACAD SCI USA, V91, P12644, DOI 10.1073/pnas.91.26.12644; LIEBENBERG F, 1973, S AFR MED J, V47, P745; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 2003, DEVELOPMENT, V130, P6401, DOI 10.1242/dev.00956; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; SHIMELL MJ, 1994, SCIENCE, V264, P968, DOI 10.1126/science.7909957; Suphapeetiporn K, 2011, CLIN GENET, V79, P391, DOI 10.1111/j.1399-0004.2010.01552.x; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672	20	82	84	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					629	635		10.1016/j.ajhg.2012.08.014	http://dx.doi.org/10.1016/j.ajhg.2012.08.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23022097	Green Published, Bronze			2022-12-18	WOS:000309568500005
J	Hassed, SJ; Wiley, GB; Wang, SF; Lee, JY; Li, SB; Xu, WH; Zhao, ZZJ; Mulvihill, JJ; Robertson, J; Warner, J; Gaffney, PM				Hassed, Susan J.; Wiley, Graham B.; Wang, Shaofeng; Lee, Ji-Yun; Li, Shibo; Xu, Weihong; Zhao, Zhizhuang J.; Mulvihill, John J.; Robertson, James; Warner, James; Gaffney, Patrick M.			RBPJ Mutations Identified in Two Families Affected by Adams-Oliver Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE INHERITANCE; APLASIA-CUTIS-CONGENITA; SEQUENCING DATA; DNA; HOMEOSTASIS; VARIANTS; KAPPA	Through exome resequencing, we identified two unique mutations in recombination signal binding protein for immunoglobulin kappa J (RBPJ) in two independent families affected by Adams-Oliver syndrome (AOS), a rare multiple-malformation disorder consisting primarily of aplasia cutis congenita of the vertex scalp and transverse terminal limb defects. These identified mutations link RBPJ, the primary transcriptional regulator for the Notch pathway, with AOS, a human genetic disorder. Functional assays confirmed impaired DNA binding of mutated RBPJ, placing it among other notch-pathway proteins altered in human genetic syndromes.	[Hassed, Susan J.; Li, Shibo; Xu, Weihong; Mulvihill, John J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA; [Wiley, Graham B.; Wang, Shaofeng; Robertson, James; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Li, Shibo; Zhao, Zhizhuang J.; Robertson, James] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Lee, Ji-Yun] Korea Univ, Coll Med, Dept Pathol, Seoul 136705, South Korea	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Korea University; Korea University Medicine (KU Medicine)	Hassed, SJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Univ Oklahoma Childrens Phys Bldg,1200 Childrens, Oklahoma City, OK 73104 USA.	susan-hassed@OUHSC.edu; gaffneyp@omrf.org		Gaffney, Patrick/0000-0002-1580-869X	Oklahoma Medical Research Foundation [9138-12]	Oklahoma Medical Research Foundation	We thank the individuals who participated in this research through contribution of personal health information and samples without the expectation of personal gain, as well as fellow medical professionals who referred them. We thank Hong Chen and Courtney Griffin for providing advice on the experimental design. We thank Xiao-Hong Sun for critically reading and providing advice on the content of the manuscript. This work was funded through an Oklahoma Medical Research Foundation Research Grant (9138-12 to P.M.G.).	ADAMS FH, 1945, J HERED, V36, P2; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BAMFORTH JS, 1994, AM J MED GENET, V49, P393, DOI 10.1002/ajmg.1320490408; BORK K, 1992, BRIT J DERMATOL, V127, P160, DOI 10.1111/j.1365-2133.1992.tb08049.x; CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938; Digilio MC, 2008, AM J MED GENET A, V146A, P2842, DOI 10.1002/ajmg.a.32526; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martinez-Frias M L, 1996, An Esp Pediatr, V45, P57; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mead TJ, 2012, ADV EXP MED BIOL, V727, P114, DOI 10.1007/978-1-4614-0899-4_9; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Tekin M, 1999, AM J MED GENET, V86, P90, DOI 10.1002/(SICI)1096-8628(19990903)86:1<90::AID-AJMG20>3.0.CO;2-9; Unay B, 2001, CLIN DYSMORPHOL, V10, P223; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WHITLEY CB, 1991, AM J MED GENET, V40, P319, DOI 10.1002/ajmg.1320400315	26	82	83	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					391	395		10.1016/j.ajhg.2012.07.005	http://dx.doi.org/10.1016/j.ajhg.2012.07.005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22883147	Green Published, Bronze			2022-12-18	WOS:000307608700020
J	Baasanjav, S; Al-Gazali, L; Hashiguchi, T; Mizumoto, S; Fischer, B; Horn, D; Seelow, D; Ali, BR; Aziz, SAA; Langer, R; Saleh, AAH; Becker, C; Nurnberg, G; Cantagrel, V; Gleeson, JG; Gomez, D; Michel, JB; Stricker, S; Lindner, TH; Nurnberg, P; Sugahara, K; Mundlos, S; Hoffmann, K				Baasanjav, Sevjidmaa; Al-Gazali, Lihadh; Hashiguchi, Taishi; Mizumoto, Shuji; Fischer, Bjoern; Horn, Denise; Seelow, Dominik; Ali, Bassam R.; Aziz, Samir A. A.; Langer, Ruth; Saleh, Ahmed A. H.; Becker, Christian; Nuernberg, Gudrun; Cantagrel, Vincent; Gleeson, Joseph G.; Gomez, Delphine; Michel, Jean-Baptiste; Stricker, Sigmar; Lindner, Tom H.; Nuernberg, Peter; Sugahara, Kazuyuki; Mundlos, Stefan; Hoffmann, Katrin			Faulty Initiation of Proteoglycan Synthesis Causes Cardiac and Joint Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; EHLERS-DANLOS-SYNDROME; PROTEIN LINKAGE REGION; HUMAN GLUCURONOSYLTRANSFERASE I; THUMB-CLUBFOOT SYNDROME; OF-FUNCTION MUTATIONS; GLYCOSAMINOGLYCAN BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; GENE; IDENTIFICATION	Proteoglycans are a major component of extracellular matrix and contribute to normal embryonic and postnatal development by ensuring tissue stability and signaling functions. We studied five patients with recessive joint dislocations and congenital heart defects, including bicuspid aortic valve (BAV) and aortic root dilatation. We identified linkage to chromosome 11 and detected a mutation (c.830G>A, p.Arg277Gln) in B3GAT3, the gene coding for glucuronosyltransferase-I (GIcAT-I). The enzyme catalyzes an initial step in the synthesis of glycosaminoglycan side chains of proteoglycans. Patients' cells as well as recombinant mutant protein showed reduced glucuronyltransferase activity. Patient fibroblasts demonstrated decreased levels of dermatan sulfate, chondroitin sulfate, and heparan sulfate proteoglycans, indicating that the defect in linker synthesis affected all three lines of O-glycanated proteoglycans. Further studies demonstrated that GlcAT-I resides in the cis and cis-medial Golgi apparatus and is expressed in the affected tissues, i.e., heart, aorta, and bone. The study shows that reduced GIcAT-I activity impairs skeletal as well as heart development and results in variable combinations of heart malformations, including mitral valve prolapse, ventricular septal defect, and bicuspid aortic valve. The described family constitutes a syndrome characterized by heart defects and joint dislocations resulting from altered initiation of proteoglycan synthesis (Larsen-like syndrome, B3GAT3 type).	[Baasanjav, Sevjidmaa; Fischer, Bjoern; Horn, Denise; Seelow, Dominik; Mundlos, Stefan; Hoffmann, Katrin] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Baasanjav, Sevjidmaa; Lindner, Tom H.] Univ Clin Leipzig, Dept Internal Med, Div Nephrol, D-04103 Leipzig, Germany; [Al-Gazali, Lihadh] United Arab Emirates Univ, Dept Pediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Hashiguchi, Taishi; Mizumoto, Shuji; Sugahara, Kazuyuki] Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Fac Adv Life Sci, Frontier Res Ctr Postgenom Sci & Technol,Grad Sch, Sapporo, Hokkaido 0010021, Japan; [Ali, Bassam R.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Aziz, Samir A. A.; Saleh, Ahmed A. H.] Saqr Hosp, Dept Pediat, Ras Al Khaymah, U Arab Emirates; [Langer, Ruth] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Radiol, Al Ain, U Arab Emirates; [Becker, Christian; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Cantagrel, Vincent; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA; [Gomez, Delphine; Michel, Jean-Baptiste] INSERM, U698, F-75018 Paris, France; [Stricker, Sigmar; Mundlos, Stefan; Hoffmann, Katrin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Hoffmann, Katrin] Charite, Res Grp Geriatr, Berlin Aging Study 2, D-13347 Berlin, Germany; [Hoffmann, Katrin] Univ Halle Wittenberg, Inst Human Genet, D-06112 Halle, Saale, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; United Arab Emirates University; Hokkaido University; United Arab Emirates University; United Arab Emirates University; University of Cologne; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg	Mundlos, S (corresponding author), Charite, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	stefan.mundlos@charite.de; katrin.hoffmann@medizin.uni-halle.de	Vincent, Cantagrel/H-8698-2017; Gomez, Delphine/J-6349-2019; Mundlos, Stefan/ABH-9585-2020; Ali, Bassam/J-7014-2012; Mizumoto, Shuji/F-8313-2018; Stricker, Sigmar/B-9169-2009; Michel, Jean-Baptiste/AAH-9336-2020; Fischer-Zirnsak, Björn/D-7487-2013; Seelow, Dominik/HGB-3124-2022	Vincent, Cantagrel/0000-0002-5180-4848; Gomez, Delphine/0000-0002-3880-6961; Mizumoto, Shuji/0000-0002-4641-1505; Stricker, Sigmar/0000-0002-7174-5363; Fischer-Zirnsak, Björn/0000-0002-1075-7571; Seelow, Dominik/0000-0002-9746-4412; Ali, Bassam R/0000-0003-1306-6618; Mundlos, Stefan/0000-0002-9788-3166	Mongolian government; Charite Medical faculty; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [20390019]; Northern Advancement Center for Science & Technology of Hokkaido; Japan Society for the Promotion of Science, Japan [23790066]; Deutsche Forschungsgemeinschaft (DFG) [SFB 577, A4]	Mongolian government; Charite Medical faculty; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Northern Advancement Center for Science & Technology of Hokkaido; Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the family for their interest and participation. Friedrich Luft critically read the manuscript. S.B. received a scholarship from the Mongolian government and from the Charite Medical faculty. K.S. was supported by Grants-in-aid for Scientific Research B (20390019) and the Matching Program for Innovations in Future Drug Discovery and Medical Care from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). S.M. was supported by Grants-in-Aid for regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido, and Grants-in-Aid for Young Scientists (B) 23790066 from Japan Society for the Promotion of Science, Japan. K.H. was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB 577, project A4) and is a recipient of a Rahel Hirsch Fellowship, provided by the Charite Medical Faculty. S.B. dedicates this work to her father, Baasanjav Tseveen. S.B. genotyped the family for fine mapping and resequenced candidate genes. She and B.F. performed immunostaining, western blot, and quantitative PCR. L.A., B.R.A., S.A.A.A., and R.L. examined the patients. L.A., R.L., K.H., S.M., and D.H. compared phenotypes and analyzed the X-rays. C.B. and RN. performed the Affymetrix SNP genotyping. Linkage analyses were run by K.H., T.H.L., and G.N. B.R.A. performed database searches identifying B3GAT3 as a candidate. Protein modeling was done by V.C., D.S., and J.G.G. T.H., S.M., and K.S. performed proteoglycan and GlcAT-I assays. K.H. supervised the project and wrote the manuscript. All authors edited and confirmed the manuscript.	Berninsone Patricia M, 2006, WormBook, P1; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Capurro MI, 2009, EMBO REP, V10, P901, DOI 10.1038/embor.2009.98; Chan CK, 2010, J CELL BIOCHEM, V111, P585, DOI 10.1002/jcb.22744; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; Dundar M, 2009, AM J HUM GENET, V85, P873, DOI 10.1016/j.ajhg.2009.11.010; Faiyaz-Ul-Haque M, 2004, AM J MED GENET A, V128A, P39, DOI 10.1002/ajmg.a.30005; Franks DM, 2006, DEV BIOL, V296, P409, DOI 10.1016/j.ydbio.2006.06.008; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; KRESSE H, 1987, AM J HUM GENET, V41, P436; Leong FT, 2009, HEART, V95, P442, DOI 10.1136/hrt.2006.105130; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; LZUMIKAWA T, 2010, J BIOL CHEM, V285, P12190; Malfait F, 2010, HUM MUTAT, V31, P1233, DOI 10.1002/humu.21355; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Ouzzine M, 2000, MOL PHARMACOL, V58, P1609, DOI 10.1124/mol.58.6.1609; Ouzzine M, 2002, J BIOL CHEM, V277, P25439, DOI 10.1074/jbc.M201912200; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Prydz K, 2000, J CELL SCI, V113, P193; Saigoh K, 2011, J HUM GENET, V56, P143, DOI 10.1038/jhg.2010.148; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Tone Y, 1999, FEBS LETT, V459, P415, DOI 10.1016/S0014-5793(99)01287-9; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Unger S, 2010, AM J MED GENET A, V152A, P2543, DOI 10.1002/ajmg.a.33641; van Roij MHH, 2008, AM J MED GENET A, V146A, P2376, DOI 10.1002/ajmg.a.32482; Wei G, 2004, J BIOL CHEM, V279, P5693, DOI 10.1074/jbc.M311621200; RCSC PROTEIN DATA BA	46	82	84	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					15	27		10.1016/j.ajhg.2011.05.021	http://dx.doi.org/10.1016/j.ajhg.2011.05.021			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21763480	Green Published, Bronze			2022-12-18	WOS:000293041700002
J	Volodko, NV; Starikovskaya, EB; Mazunin, IO; Eltsov, NP; Naidenko, PV; Wallace, DC; Sukernik, RI				Volodko, Natalia V.; Starikovskaya, Elena B.; Mazunin, Ilya O.; Eltsov, Nikolai P.; Naidenko, Polina V.; Wallace, Douglas C.; Sukernik, Rem I.			Mitochondrial genome diversity in arctic siberians, with particular reference to the evolutionary history of Beringia and Pleistocenic peopling of the Americas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RED-CELL ENZYMES; MTDNA VARIATION; NEW-WORLD; TAIMIR PENINSULA; GENETIC HISTORY; SERUM-PROTEINS; DNA DIVERSITY; BLOOD-GROUPS; POPULATIONS; ORIGINS	Through extended survey of mitochondrial DNA (mtDNA) diversity in the Nganasan, Yukaghir, Chuvantsi, Chukchi, Siberian Eskimos, and Commander Aleuts, we filled important gaps in previously unidentified internal sequence variation within haplogroups A, C, and D, three of five (A-D and X) canonical mtDNA lineages that defined Pleistocenic extension from the Old to the New World. Overall, 515 mtDNA samples were analyzed via high-resolution SNP analysis and then complete sequencing of the 84 mtDNAs. A comparison of the data thus obtained with published complete sequences has resulted in the most parsimonious phylogenetic structure of mtDNA evolution in Siberia-Beringia. Our data suggest that although the latest inhabitants of Beringia are well genetically reflected in the Chukchi-, Eskimo-Aleut-, and Na-Dene-speaking Indians, the direct ancestors of the Paleosiberian-speaking Yukaghir are primarily drawn from the southern belt of Siberia when environmental conditions changed, permitting recolonization the high arctic since early Postglacial. This study further confirms that (1) Alaska seems to be the ancestral homeland of haplogroup A2 originating in situ approximately 16.0 thousand years ago (kya), (2) an additional founding lineage for Native American D, termed here D10, arose approximately 17.0 kya in what is now the Russian Far East and eventually spread northward along the North Pacific Rim. The maintenance of two refugial sources, in the Altai-Sayan and mid-lower Amur, during the last glacial maximum appears to be at odds with the interpretation of limited founding mtDNA lineages populating the Americas as a single migration.	[Volodko, Natalia V.; Starikovskaya, Elena B.; Mazunin, Ilya O.; Eltsov, Nikolai P.; Naidenko, Polina V.; Sukernik, Rem I.] Russian Acad Sci, Siberian Div, Inst Cytol & Genet, Lab Human Mol Genet, Novosibirsk 630090, Russia; [Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of California System; University of California Irvine	Sukernik, RI (corresponding author), Russian Acad Sci, Siberian Div, Inst Cytol & Genet, Lab Human Mol Genet, Novosibirsk 630090, Russia.	sukernik@bionet.nsc.ru	Sukernik, Rem I/N-6990-2015; Starikovskaya, Elena/N-5636-2015	Dementyeva, Polina/0000-0002-6186-5863				Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BOGORAS W, 1919, PUBLICATIONS JESUP 1, V8; BOGORAS W, 1999, KOLYME ZHIZN, V6, P103; BONNATO S, 1997, AM J HUM GENET, V61, P1413; CHIKACHOV AG, 1990, RUSSKIE INDIGIRKE IS; Dalton R, 2003, NATURE, V422, P10, DOI 10.1038/422010a; Derbeneva O. A., 2002, Genetika, V38, P1554; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derevianko A. B., 1998, SELEMDZHA LATE PALEO; DEREVIANKO AP, 1998, PALEOLITHIC SIBERIA, P285; DOLGIKH BO, 1960, P I ETHN AC SCI USSR, V55, P3; DOLGIKH BO, 1952, ACAD SCI USSR, V18, P5; DYACHKOFF G, 1893, ANADYRSKI KRAI; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Forster P, 1996, AM J HUM GENET, V59, P935; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Goebel T., 2002, ARCHAEOLOGICAL PAPER, V12, P117, DOI 10.1525/ap3a.2002.12.1.117; GOLTZOVA TV, 1979, GENETIKA+, V15, P734; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; Hayes MG, 2001, AM J HUM GENET, V69, P179; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2007, HUM MOL GENET, V16, P2281, DOI 10.1093/hmg/ddm180; JOCHELSON W, 1919, PUBLICATIONS JESUP 1, V9; KARAPHET TM, 1981, AM J PHYS ANTHROPOL, V56, P139, DOI 10.1002/ajpa.1330560205; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; KHLOBYSTIN LP, 1998, ANCIENT HIST TAIMYR; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Krauss ME, 1988, CROSSROADS CONTINENT, P145; KREINOVITCH E, 1978, SOVETSKOE FINNO UGRO, V4, P241; Kuntz M. L., 1994, SCIENCE, V263, P660; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; MENOVSHSHIKOV GA, 1980, LANGUAGE BEING STRAI; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; NEEL JV, 1992, SOC ST HUM, V33, P17; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; Okladnikov Alexey P., 1955, YAKUTIYA PRISOEDINEN; OKLADNIKOV AP, 1975, YUKAGHIRY; OSIPOVA LP, 1983, J IMMUNOGENET, V10, P11; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; ROGERS R A, 1986, Canadian Journal of Anthropology, V5, P11; ROGERS RA, 1991, J BIOGEOGR, V18, P623, DOI 10.2307/2845543; Rubicz R, 2003, HUM BIOL, V75, P809, DOI 10.1353/hub.2004.0009; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Simchenko YU.B., 1976, KULTURA OKHOTNIKOV O; SPIRIDONOV NI, 1935, ODULY YUKAGHIRY KOLY; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; SUKERNIK RI, 1981, AM J PHYS ANTHROPOL, V55, P121, DOI 10.1002/ajpa.1330550116; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Tugolukov VA, 1979, WHO ARE YOU YUKAGHIR; Vasil'ev SA, 2002, RADIOCARBON, V44, P503, DOI 10.1017/S0033822200031878; VOLODKO N, 2003, GENETIKA, V12, P1710; VOLODKO N, 2006, 56 ANN M ASHG NEW OR; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; West F.H., 1996, AM BEGINNINGS PREHIS; WRANGEL E, 1841, PUTESHESTVIE SEVERNI; [No title captured]	73	82	90	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1084	1100		10.1016/j.ajhg.2008.03.019	http://dx.doi.org/10.1016/j.ajhg.2008.03.019			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18452887	Green Published, Bronze			2022-12-18	WOS:000255923600008
J	Tarpey, PS; Stevens, C; Teague, J; Edkins, S; O'Meara, S; Avis, T; Barthorpe, S; Buck, G; Butler, A; Cole, J; Dicks, E; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jones, D; Menzies, A; Mironenko, T; Perry, J; Raine, K; Richardson, D; Shepherd, R; Small, A; Tofts, C; Varian, J; West, S; Widaa, S; Yates, A; Catford, R; Butler, J; Mallya, U; Moon, J; Luo, Y; Dorkins, H; Thompson, D; Easton, DF; Wooster, R; Bobrow, M; Carpenter, N; Simensen, RJ; Schwartz, CE; Stevenson, RE; Turner, G; Partington, M; Gecz, J; Stratton, MR; Futreal, PA; Raymond, FL				Tarpey, Patrick S.; Stevens, Claire; Teague, Jon; Edkins, Sarah; O'Meara, Sarah; Avis, Tim; Barthorpe, Syd; Buck, Gemma; Butler, Adam; Cole, Jennifer; Dicks, Ed; Gray, Kristian; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jonathon; Jones, David; Menzies, Andrew; Mironenko, Tatiana; Perry, Janet; Raine, Keiran; Richardson, David; Shepherd, Rebecca; Small, Alexandra; Tofts, Calli; Varian, Jennifer; West, Sofie; Widaa, Sara; Yates, Andy; Catford, Rachael; Butler, Julia; Mallya, Uma; Moon, Jenny; Luo, Ying; Dorkins, Huw; Thompson, Deborah; Easton, Douglas F.; Wooster, Richard; Bobrow, Martin; Carpenter, Nancy; Simensen, Richard J.; Schwartz, Charles E.; Stevenson, Roger E.; Turner, Gillian; Partington, Michael; Gecz, Jozef; Stratton, Michael R.; Futreal, P. Andrew; Raymond, F. Lucy			Mutations in the gene encoding the sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLATHRIN; IDENTIFICATION; ENDOCYTOSIS; AP-1; PITS; LIFE; ARH	In a systematic sequencing screen of the coding exons of the X chromosome in 250 families with X-linked mental retardation (XLMR), we identified two nonsense mutations and one consensus splice-site mutation in the AP1S2 gene on Xp22 in three families. Affected individuals in these families showed mild-to-profound mental retardation. Other features included hypotonia early in life and delay in walking. AP1S2 encodes an adaptin protein that constitutes part of the adaptor protein complex found at the cytoplasmic face of coated vesicles located at the Golgi complex. The complex mediates the recruitment of clathrin to the vesicle membrane. Aberrant endocytic processing through disruption of adaptor protein complexes is likely to result from the AP1S2 mutations identified in the three XLMR-affected families, and such defects may plausibly cause abnormal synaptic development and function. AP1S2 is the first reported XLMR gene that encodes a protein directly involved in the assembly of endocytic vesicles.	Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Mol Biosci, Adelaide, SA, Australia; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; Cambridge Inst Med Res, Cambridge, England; Canc Res UK Genet Epidemiol Unit, Cambridge, England; Northwick Pk Hosp & Clin Res Ctr, NW Reg Genet Ctr, Harrow HA1 3UJ, Middx, England; Hunter Genet, GOLD Serv, Waratah, Australia; Ctr Genet Testing, Tulsa, OK USA	University of Cambridge; Wellcome Trust Sanger Institute; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; Greenwood Genetic Center; University of Cambridge; Cancer Research UK; University of Cambridge; Imperial College London	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861; Raine, Keiran/0000-0002-5634-1539; Buck, Gemma/0000-0001-5289-1050; Gray, Kristian/0000-0002-7035-7107; Avis, Tim/0000-0001-6120-5729; Richardson, David/0000-0003-0247-9118; Yates, Andrew/0000-0002-8886-4772; Dorkins, Huw/0000-0001-8421-9939	NICHD NIH HHS [R01 HD026202, HD26202] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Carpenter NJ, 1999, AM J MED GENET, V85, P266, DOI 10.1002/(SICI)1096-8628(19990730)85:3<266::AID-AJMG16>3.0.CO;2-P; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Garuti R, 2005, J BIOL CHEM, V280, P40996, DOI 10.1074/jbc.M509394200; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Jung J, 2006, BLOOD, V108, P362, DOI 10.1182/blood-2005-11-4377; Kim MH, 2004, J BIOL CHEM, V279, P12580, DOI 10.1074/jbc.M310681200; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sirinian MI, 2005, J BIOL CHEM, V280, P38416, DOI 10.1074/jbc.M504343200; Turner G, 2003, AM J MED GENET A, V117A, P245, DOI 10.1002/ajmg.a.10005; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Zhao XH, 2001, J CELL SCI, V114, P353	17	82	83	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1119	1124		10.1086/510137	http://dx.doi.org/10.1086/510137			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186471	Green Published, Bronze			2022-12-18	WOS:000242131600014
J	Winther, JF; Boice, JD; Mulvihill, JJ; Stovall, M; Frederiksen, K; Tawn, EJ; Olsen, JH				Winther, JF; Boice, JD; Mulvihill, JJ; Stovall, M; Frederiksen, K; Tawn, EJ; Olsen, JH			Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: A population-based study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK	Ionizing radiation and many cancer drugs have the potential to produce germ-cell mutations that might lead to genetic disease in the next generation. In a population-based study, we identified, from records in the Danish Cancer Registry, 4,676 children treated for cancer. Their 6,441 siblings provided a comparison cohort. The results of a search of the Central Population Register identified 2,630 live-born offspring of the survivors and 5,504 live-born offspring of their siblings. The occurrence of abnormal karyotypes diagnosed in these offspring and also in any pregnancies terminated following prenatal diagnosis of a chromosome abnormality was determined from the Danish Cytogenetic Registry. After exclusion of hereditary cases and inclusion of the prenatal cases, after correction for expected viability, the adjusted proportion of live-born children in survivor families with abnormal karyotypes (5.5/2,631.5 [0.21%]) was the same as that among the comparison sibling families (11.8/5,505.8 [0.21%]). There were no significant differences in the occurrence of Down syndrome (relative risk; 95% CI 0.16-5.47) or [ RR] p 1.07 Turner syndrome (RR = 1.32; 95% CI 0.17-7.96) among the children of cancer survivors, compared with the children of their siblings. These reassuring results are of importance to the survivors, to their families, and to genetic counselors.	Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; Int Epidemiol Inst, Rockville, MD USA; Vanderbilt Univ, Dept Med, Vanderbilt Med Ctr, Nashville, TN USA; Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN USA; Univ Oklahoma, Dept Pediat, Oklahoma City, OK USA; Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; Westlakes Res Inst, Moor Row, Cumbria, England	Danish Cancer Society; Vanderbilt University; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; UTMD Anderson Cancer Center; University of Central Lancashire	Winther, JF (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strand Blvd 49, DK-2100 Copenhagen, Denmark.	jeanette@cancer.dk	Winther, Jeanette Falck/AAS-2754-2020	Winther, Jeanette Falck/0000-0002-3440-5108; Olsen, Jorgen Helge/0000-0001-9633-5662				Boice JD, 2003, HEALTH PHYS, V85, P65, DOI 10.1097/00004032-200307000-00013; Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; HOOK EB, 1989, AM J HUM GENET, V45, P855; JENSEN PKA, 1998, KROMOSOMAFVIGELSER H; STOVALL M, IN PRESS INT J RAD O; *UNSCEAR, 2001, E01IX2 UNSCEAR	7	82	84	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1282	1285		10.1086/421473	http://dx.doi.org/10.1086/421473			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15106125	Bronze, Green Published			2022-12-18	WOS:000221651900022
J	Behar, DM; Thomas, MG; Skorecki, K; Hammer, MF; Bulygina, E; Rosengarten, D; Jones, AL; Held, K; Moses, V; Goldstein, D; Bradman, N; Weale, ME				Behar, DM; Thomas, MG; Skorecki, K; Hammer, MF; Bulygina, E; Rosengarten, D; Jones, AL; Held, K; Moses, V; Goldstein, D; Bradman, N; Weale, ME			Multiple origins of Ashkenazi Levites: Y chromosome evidence for both Near Eastern and European ancestries	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROSATELLITE LOCI; HUMAN-POPULATIONS; MUTATION-RATES; HAPLOTYPES; FREQUENCIES; RESOLUTION; DIVERSITY; DISTANCE; PRIESTS; JEWISH	Previous Y chromosome studies have shown that the Cohanim, a paternally inherited Jewish priestly caste, predominantly share a recent common ancestry irrespective of the geographically defined post-Diaspora community to which they belong, a finding consistent with common Jewish origins in the Near East. In contrast, the Levites, another paternally inherited Jewish caste, display evidence for multiple recent origins, with Ashkenazi Levites having a high frequency of a distinctive, non-Near Eastern haplogroup. Here, we show that the Ashkenazi Levite microsatellite haplotypes within this haplogroup are extremely tightly clustered, with an inferred common ancestor within the past 2,000 years. Comparisons with other Jewish and non-Jewish groups suggest that a founding event, probably involving one or very few European men occurring at a time close to the initial formation and settlement of the Ashkenazi community, is the most likely explanation for the presence of this distinctive haplogroup found today in >50% of Ashkenazi Levites.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Nephrol & Mol Med, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; Rambam Med Ctr, IL-31096 Haifa, Israel; UCL, Dept Biol, Ctr Genet Anthropol, London, England; UCL, Dept Biol, Ctr Populat Genet & Human Hlth, London, England; Univ Arizona, Div Biotechnol, Tucson, AZ USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; University of London; University College London; University of London; University College London; University of Arizona	Skorecki, K (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Nephrol & Mol Med, POB 9602, IL-31096 Haifa, Israel.	skorecki@techunix.technion.ac.il	Thomas, Mark G/A-2219-2012; Weale, Michael E/F-2587-2010	Thomas, Mark G/0000-0002-2452-981X; Weale, Michael E/0000-0003-4593-1186				[Anonymous], 1972, ENCY JUDAICA; BARON SW, 1957, SOCIAL RELIG HIST JE, V3, P173; BENSASSON HH, 1976, HIST JEWISH PEOPLE, P593; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bonne-Tamir B, 2003, ANN HUM GENET, V67, P153, DOI 10.1046/j.1469-1809.2003.00024.x; BRADMAN N, 1999, POPULATION SPECIFIC, P31; Caglia A, 1997, EUR J HUM GENET, V5, P288, DOI 10.1159/000484779; Calabrese PP, 2001, GENETICS, V159, P839; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Carvalho-Silva DR, 1999, J MOL EVOL, V49, P204, DOI 10.1007/PL00006543; DellaPergola S., 2001, PAPERS JEWISH DEMOGR, V11, P11; Dunlop D. M., 1967, HIST JEWISH KHAZARS; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; Gagnon A, 2001, AM J HUM BIOL, V13, P645, DOI 10.1002/ajhb.1103; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Holtkemper U, 2001, HUM MOL GENET, V10, P629, DOI 10.1093/hmg/10.6.629; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; KEYS D, 1999, CATASTROPHE INVESTIG; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Nei M., 1987, MOL EVOLUTIONARY GEN; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Redd AJ, 2002, FORENSIC SCI INT, V130, P97, DOI 10.1016/S0379-0738(02)00347-X; Reif S.C., 1993, JUDAISM HEBREW PRAYE; REYNOLDS J, 1983, GENETICS, V105, P767; Rolf B, 1998, EUR J HUM GENET, V6, P583, DOI 10.1038/sj.ejhg.5200223; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Skorecki K, 1997, NATURE, V385, P32, DOI 10.1038/385032a0; SLATKIN M, 1995, GENETICS, V139, P457; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; Weale ME, 2001, HUM GENET, V109, P659, DOI 10.1007/s00439-001-0627-9; WEXLER P, 1993, ASHKENAZI JEWS SLAVO; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P2141, DOI 10.1093/oxfordjournals.molbev.a003759	43	82	84	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					768	779		10.1086/378506	http://dx.doi.org/10.1086/378506			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	13680527	Green Published, Bronze			2022-12-18	WOS:000185676100005
J	Gillanders, E; Juo, SHH; Holland, EA; Jones, M; Nancarrow, D; Freas-Lutz, D; Sood, R; Park, N; Faruque, M; Markey, C; Kefford, RF; Palmer, J; Bergman, W; Bishop, DT; Tucker, MA; Bressac-de Paillerets, B; Hansson, J; Stark, M; Gruis, N; Bishop, JN; Goldstein, AM; Bailey-Wilson, JE; Mann, GJ; Hayward, N; Trent, J				Gillanders, E; Juo, SHH; Holland, EA; Jones, M; Nancarrow, D; Freas-Lutz, D; Sood, R; Park, N; Faruque, M; Markey, C; Kefford, RF; Palmer, J; Bergman, W; Bishop, DT; Tucker, MA; Bressac-de Paillerets, B; Hansson, J; Stark, M; Gruis, N; Bishop, JN; Goldstein, AM; Bailey-Wilson, JE; Mann, GJ; Hayward, N; Trent, J		Lund Melanoma Study Grp; Melanoma Genetics Consortium	Localization of a novel melanoma susceptibility locus to 1p22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSPLASTIC NEVUS SYNDROME; FAMILIAL MELANOMA; LINKAGE ANALYSIS; GERMLINE MUTATIONS; CUTANEOUS MELANOMA; PANCREATIC-CANCER; CDKN2A MUTATIONS; DUTCH FAMILIES; PRONE FAMILIES; RISK	Over the past 20 years, the incidence of cutaneous malignant melanoma (CMM) has increased dramatically worldwide. A positive family history of the disease is among the most established risk factors for CMM; it is estimated that 10% of CMM cases result from an inherited predisposition. Although mutations in two genes, CDKN2A and CDK4, have been shown to confer an increased risk of CMM, they account for only 20%-25% of families with multiple cases of CMM. Therefore, to localize additional loci involved in melanoma susceptibility, we have performed a genomewide scan for linkage in 49 Australian pedigrees containing at least three CMM cases, in which CDKN2A and CDK4 involvement has been excluded. The highest two-point parametric LOD score (1.82; recombination fraction [theta] 0.2) was obtained at D1S2726, which maps to the short arm of chromosome 1 (1p22). A parametric LOD score of 4.65 (theta = 0) and a nonparametric LOD score of 4.19 were found at D1S2779 in nine families selected for early age at onset. Additional typing yielded seven adjacent markers with LOD scores 13 in this subset, with the highest parametric LOD score, 4.95 (theta = 0) ( nonparametric LOD score 5.37), at D1S2776. Analysis of 33 additional multiplex families with CMM from several continents provided further evidence for linkage to the 1p22 region, again strongest in families with the earliest mean age at diagnosis. A nonparametric ordered sequential analysis was used, based on the average age at diagnosis in each family. The highest LOD score, 6.43, was obtained at D1S2779 and occurred when the 15 families with the earliest ages at onset were included. These data provide significant evidence of a novel susceptibility gene for CMM located within chromosome band 1p22.	Translat Genom Res Inst, Phoenix, AZ 85004 USA; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; Columbia Univ, Dept Epidemiol, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia; Queensland Canc Fund Res Unit, Brisbane, Qld, Australia; Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; Canc Res UK Clin Ctr, Genet Epidemiol Div, Leeds, W Yorkshire, England; Inst Gustave Roussy, Villejuif, France; Karolinska Hosp, Dept Oncol Pathol, S-10401 Stockholm, Sweden; Univ Hosp, Lund Canc Ctr, Dept Oncol, Lund, Sweden; NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA	Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University; Columbia University; University of Sydney; Westmead Institute for Medical Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Cancer Research UK; University of Leeds; UNICANCER; Gustave Roussy; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA)	Trent, J (corresponding author), Translat Genom Res Inst, 400 N 5th St,Suite 1600, Phoenix, AZ 85004 USA.		Stark, Mitchell/K-3874-2019; Paillerets, Brigitte Bressac-de/D-8954-2018; hayward, nick/AAV-8802-2020; Juo, Suh-Hang/A-1765-2010; Tucker, Margaret A/B-4297-2015; hayward, nicholas k/C-1367-2015; Stark, Mitchell/K-6794-2019; Stark, Mitchell S/E-3542-2010; Mann, Graham J/G-4758-2014; Juo, Suh-Hang/C-9545-2009	Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell/0000-0002-4510-2161; Stark, Mitchell S/0000-0002-4510-2161; Mann, Graham J/0000-0003-1301-405X; Bailey-Wilson, Joan/0000-0002-9153-2920; Kefford, Richard/0000-0001-9251-9229; Bishop, Tim/0000-0002-8752-8785; Newton-Bishop, Julia/0000-0001-9147-6802; Gruis, Nelleke/0000-0002-5210-9150	NCI NIH HHS [CA88363, R01 CA088363] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088363] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000112] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; BERGMAN W, 1992, CYTOGENET CELL GENET, V59, P161, DOI 10.1159/000133232; Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894; Bishop JAN, 2000, J INVEST DERMATOL, V114, P28, DOI 10.1046/j.1523-1747.2000.00823.x; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Goldstein AM, 2000, J NATL CANCER I, V92, P1006, DOI 10.1093/jnci/92.12.1006; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Harland M, 2000, GENE CHROMOSOME CANC, V28, P45, DOI 10.1002/(SICI)1098-2264(200005)28:1<45::AID-GCC6>3.3.CO;2-6; Harland M, 2001, HUM MOL GENET, V10, P2679, DOI 10.1093/hmg/10.23.2679; Hashemi J, 1999, MELANOMA RES, V9, P21, DOI 10.1097/00008390-199902000-00004; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Kefford RF, 1999, J CLIN ONCOL, V17, P3245, DOI 10.1200/JCO.1999.17.10.3245; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; MORTON NE, 1956, AM J HUM GENET, V8, P80; NANCARROW DJ, 1992, GENOMICS, V12, P18, DOI 10.1016/0888-7543(92)90401-D; NANCARROW DJ, 1992, GENOMICS, V14, P939, DOI 10.1016/S0888-7543(05)80115-6; Newton-Bishop JA, 1999, BRIT J CANCER, V80, P295, DOI 10.1038/sj.bjc.6690354; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Platz A, 1997, J NATL CANCER I, V89, P697, DOI 10.1093/jnci/89.10.697; Ries LAG, 2003, SEER CANC STAT REV 1; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; van der Velden PA, 2001, AM J HUM GENET, V69, P774, DOI 10.1086/323411; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.3.CO;2-L; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	42	82	84	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					301	313		10.1086/377140	http://dx.doi.org/10.1086/377140			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12844286	Bronze, Green Published			2022-12-18	WOS:000184223900007
J	Badge, RM; Alisch, RS; Moran, JV				Badge, RM; Alisch, RS; Moran, JV			ATLAS: A system to selectively identify human-specific L1 insertions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-FREQUENCY RETROTRANSPOSITION; HUMAN TRANSPOSABLE ELEMENT; CLOSELY-RELATED GENOMES; LINE-1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; INTERSPERSED REPEATS; SEQUENCE ALIGNMENT; CELLS; RNA; MECHANISM	Retrotransposition of L1 LINEs (long interspersed elements) continues to sculpt the human genome. However, because recent insertions are dimorphic, they are not fully represented in sequence databases. Here, we have developed a system, termed "ATLAS" (amplification typing of L1 active subfamilies), that enables the selective amplification and display of DNA fragments containing the termini of human-specific L1s and their respective flanking sequences. We demonstrate that ATLAS is robust and that the resultant display patterns are highly reproducible, segregate in Centre d'Etude du Polymorphisme Humain pedigrees, and provide an individual-specific fingerprint. ATLAS also allows the identification of L1s that are absent from current genome databases, and we show that some of these L1s can retrotranspose at high frequencies in cultured human cells. Finally, we demonstrate that ATLAS also can identify single-nucleotide polymorphisms within a subset of older, primate-specific L1s. Thus, ATLAS provides a simple, high-throughput means to assess genetic variation associated with L1 retrotransposons.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	University of Leicester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Badge, RM (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	rmb19@leicester.ac.uk; moranj@umich.edu		Badge, Richard/0000-0003-3201-336X	NIGMS NIH HHS [R01 GM060518, GM60518] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; BROUHA B, IN PRESS P NATL ACAD; Buzdin A, 2002, GENOMICS, V79, P413, DOI 10.1006/geno.2002.6705; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; EDWARDS MC, 1992, GENOMICS, V14, P590, DOI 10.1016/S0888-7543(05)80156-9; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GUO SW, 1992, AM J HUM GENET, V51, P1111; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; KASS DH, 1995, MOL CELL BIOL, V15, P19, DOI 10.1128/MCB.15.1.19; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavrentieva I, 1999, FEBS LETT, V443, P341, DOI 10.1016/S0014-5793(99)00004-6; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; Mamedov I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf071; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Moran JV, 1999, GENETICA, V107, P39, DOI 10.1023/A:1004035023356; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Naas TP, 2001, EMBO J, V20, P2608; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Roessli D, 2000, ARLEQUIN VERSION 2 0; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saxton JA, 1998, J MOL BIOL, V280, P611, DOI 10.1006/jmbi.1998.1899; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Takai D, 2000, JPN J CLIN ONCOL, V30, P306, DOI 10.1093/jjco/hyd079; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	46	82	83	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					823	838		10.1086/373939	http://dx.doi.org/10.1086/373939			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12632328	Bronze, Green Published			2022-12-18	WOS:000181972600005
J	Hahn, KA; Salomons, GS; Tackels-Horne, D; Wood, TC; Taylor, HA; Schroer, RJ; Lubs, HA; Jakobs, C; Olson, RL; Holden, KR; Stevenson, RE; Schwartz, CE				Hahn, KA; Salomons, GS; Tackels-Horne, D; Wood, TC; Taylor, HA; Schroer, RJ; Lubs, HA; Jakobs, C; Olson, RL; Holden, KR; Stevenson, RE; Schwartz, CE			X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETT-SYNDROME; MASA SYNDROME; XLMR GENES; MECP2; HYDROCEPHALUS; LOCALIZATION; CHILDREN; KINASE; BORN	A family with X-linked mental retardation characterized by severe mental retardation, speech and behavioral abnormalities, and seizures in affected male patients has been found to have a G1141C transversion in the creatine-transporter gene SLC6A8. This mutation results in a glycine being replaced by an arginine (G381R) and alternative splicing, since the G C transversion occurs at the 5 1 position of the 5 splice junction of intron 7. Two female relatives who are heterozygous for the SLC6A8 mutation also exhibit mild mental retardation with behavior and learning problems. Male patients with the mutation have highly elevated creatine in their urine and have decreased creatine uptake in fibroblasts, which reflects the deficiency in creatine transport. The ability to measure elevated creatine in urine makes it possible to diagnose SLC6A8 deficiency in male patients with mental retardation of unknown etiology.	Greenwood Genet Ctr, JC Self Res Inst, Ctr Mol Studies, Greenwood, SC 29646 USA; VU Univ, Med Ctr, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands; Univ Miami, Sch Med, Dept Pediat, Div Genet, Miami, FL USA	Greenwood Genetic Center; Vrije Universiteit Amsterdam; University of Miami	Schwartz, CE (corresponding author), Greenwood Genet Ctr, JC Self Res Inst, Ctr Mol Studies, 1 Gregor Mendel Circle, Greenwood, SC 29646 USA.				NICHD NIH HHS [R01 HD026202, HD26202] Funding Source: Medline; NIMH NIH HHS [R24 MH057840, MH57840] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH057840] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson G, 1996, P GREENWOOD GENET CT, V15, P32; Armfield K, 1999, AM J MED GENET, V85, P236, DOI 10.1002/(SICI)1096-8628(19990730)85:3<236::AID-AJMG10>3.0.CO;2-9; Cecil KM, 2001, ANN NEUROL, V49, P401, DOI 10.1002/ana.79; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chelly J, 2000, AM J MED GENET, V94, P364, DOI 10.1002/1096-8628(20001023)94:5<364::AID-AJMG3>3.0.CO;2-O; Chiurazzi P, 2001, EUR J HUM GENET, V9, P71, DOI 10.1038/sj.ejhg.5200603; Clark EA, 2001, J PHARMACEUT BIOMED, V25, P795, DOI 10.1016/S0731-7085(01)00340-5; COOPER D, 1995, HUMAN GENE MUTATION, P224; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; GUSTAVSON KH, 1977, NEUROPADIATRIE, V8, P293, DOI 10.1055/s-0028-1091525; HUNTER AGW, 1980, DEV MED CHILD NEUROL, V22, P145; Item CB, 2001, AM J HUM GENET, V69, P1127, DOI 10.1086/323765; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; KAVEGGIA EG, 1975, P 3 C INT ASS SCI ST, P82; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LAXOVA R, 1977, AM J MED GENET, V1, P75, DOI 10.1002/ajmg.1320010109; LEBEL RR, IN PRESS CLIN GENET; LEHRKE R G, 1974, Birth Defects Original Article Series, V10, P1; Lubs H, 1999, AM J MED GENET, V83, P237, DOI 10.1002/(SICI)1096-8628(19990402)83:4<237::AID-AJMG2>3.3.CO;2-#; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; MOSER H W, 1971, Birth Defects Original Article Series, V7, P117; NASH SR, 1994, RECEPTOR CHANNEL, V2, P165; NERI G, 1991, AM J MED GENET, V38, P186, DOI 10.1002/ajmg.1320380204; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Penrose L.S., 1938, CLIN GENETIC STUDY 1; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; SCHWARTZ CE, 1993, AM J HUM GENET, V52, P1025; STEVENSON R.E., 2000, X LINKED MENTAL RETA; STEVENSON RE, 1990, AM J HUM GENET, V47, P446; Stevenson RE, 1998, AM J HUM GENET, V62, P1092, DOI 10.1086/301835; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; TURNER G, 1974, J MED GENET, V11, P109, DOI 10.1136/jmg.11.2.109; VITS L, 1994, NAT GENET, V7, P408, DOI 10.1038/ng0794-408; VONFIGURA K, 2000, METABOLIC MOL BASIS, P1897; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; Wang YME, 1998, J NEUROSCI, V18, P987	40	82	85	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1349	1356		10.1086/340092	http://dx.doi.org/10.1086/340092			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11898126	Bronze, Green Published			2022-12-18	WOS:000175012400025
J	Villard, L; Nguyen, K; Cardoso, C; Martin, CL; Weiss, AM; Sifry-Platt, M; Grix, AW; Graham, JM; Winter, RM; Leventer, RJ; Dobyns, WB				Villard, L; Nguyen, K; Cardoso, C; Martin, CL; Weiss, AM; Sifry-Platt, M; Grix, AW; Graham, JM; Winter, RM; Leventer, RJ; Dobyns, WB			A locus for bilateral perisylvian polymicrogyria maps to Xq28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; BRAIN	Polymicrogyria (PMG) is one of a large group of human cortical malformations that collectively account for a significant percentage of patients with epilepsy, congenital neurological deficits, and intellectual disability. PMG is characterized by an excess of small gyri and abnormal cortical lamination. The most common distribution is bilateral, symmetrical, and maximal, in the region surrounding the sylvian fissures, and is known as "bilateral perisylvian polymicrogyria" (BPP). Most cases are sporadic, although several families have been observed with multiple affected members, usually following an X-linked inheritance pattern. Here we report the first genetic locus for BPP mapped by linkage analysis in five families. Linkage places the critical region for BPP at Xq28 (LOD score 3.08 in Xq28, distal to DXS8103 by multipoint analysis). We suggest that this region contains a gene that is necessary for correct neuronal organization and that the identification of this gene will both enhance our understanding of normal cortical development and accelerate the identification of other genes responsible for PMG.	Fac Med La Timone, INSERM, U491, F-13385 Marseille 5, France; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Kaiser Permanente Point W Med Off, Dept Med Genet, Sacramento, CA USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Inst Child Hlth, Dept Clin & Mol Genet, London, England; Royal Childrens Hosp, Childrens Neurosci Ctr, Melbourne, Vic, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Chicago; University of Chicago; University of Chicago; Kaiser Permanente; Cedars Sinai Medical Center; University of London; University College London; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Villard, L (corresponding author), Fac Med La Timone, INSERM, U491, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.		Nguyen, Karine/J-9219-2016; Cardoso, Carlos/H-4520-2016; Cardoso, Carlos/M-2767-2019; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020; Graham, John M./J-1429-2019; Villard, Laurent/E-3941-2016	Nguyen, Karine/0000-0002-6889-3891; Cardoso, Carlos/0000-0003-1914-9553; Cardoso, Carlos/0000-0003-1914-9553; Dobyns, William/0000-0002-7681-2844; Villard, Laurent/0000-0001-6657-5008				Baker EM, 1996, NEUROPEDIATRICS, V27, P54, DOI 10.1055/s-2007-973749; Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1814; BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703; Borgatti R, 1999, NEUROLOGY, V52, P1910, DOI 10.1212/WNL.52.9.1910; CROME L, 1952, J PATHOL BACTERIOL, V64, P479, DOI 10.1002/path.1700640308; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FERRER I, 1984, ACTA NEUROPATHOL, V65, P69, DOI 10.1007/BF00689830; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Guerreiro MM, 2000, ANN NEUROL, V48, P39, DOI 10.1002/1531-8249(200007)48:1<39::AID-ANA7>3.0.CO;2-X; Guerrini R, 1997, ANN NEUROL, V41, P65, DOI 10.1002/ana.410410112; Guerrini R, 2000, NEUROLOGY, V54, P909, DOI 10.1212/WNL.54.4.909; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUZNIECKY R, 1993, LANCET, V341, P608, DOI 10.1016/0140-6736(93)90363-L; Kuzniecky R., 1995, MAGNETIC RESONANCE E; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Villard L, 2001, J MED GENET, V38, P435, DOI 10.1136/jmg.38.7.435; VINTERS HV, 1992, CHILD NERV SYST, V8, P8, DOI 10.1007/BF00316556	17	82	84	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1003	1008		10.1086/339433	http://dx.doi.org/10.1086/339433			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11822025	Green Published, Bronze			2022-12-18	WOS:000174252100017
J	Ardlie, K; Liu-Cordero, SN; Eberle, MA; Daly, M; Barrett, J; Winchester, E; Lander, ES; Kruglyak, L				Ardlie, K; Liu-Cordero, SN; Eberle, MA; Daly, M; Barrett, J; Winchester, E; Lander, ES; Kruglyak, L			Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN LIPOPROTEIN-LIPASE; HUMAN GENOME; SEQUENCE VARIATION; DISEASE GENES; HUMAN ORIGINS; POPULATIONS; RECOMBINATION; REGIONS; LOCUS	Understanding the pattern of linkage disequilibrium (LD) in the human genome is important both for successful implementation of disease-gene mapping approaches and for inferences about human demographic histories. Previous studies have examined LD between loci within single genes or confined genomic regions, which may not be representative of the genome; between loci separated by large distances, where little LD is seen; or in population groups that differ from one study to the next. We measured LD in a large set of locus pairs distributed throughout the genome, with loci within each pair separated by short distances (average 124 bp). Given current models of the history of the human population, nearly all pairs of loci at such short distances would be expected to show complete LD as a consequence of lack of recombination in the short interval. Contrary to this expectation, a significant fraction of pairs showed incomplete LD. A standard model of recombination applied to these data leads to an estimate of effective human population size of 110,000. This estimate is an order of magnitude higher than most estimates based on nucleotide diversity. The most likely explanation of this discrepancy is that gene conversion increases the apparent rate of recombination between nearby loci.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; MIT, Dept Biol, Cambridge, MA USA; MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Kruglyak, L (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave N,D4-100, Seattle, WA 98109 USA.	leonid@fhcrc.org		Eberle, Michael/0000-0001-8965-1253				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Andolfatto P, 1998, GENETICS, V148, P1397; ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Drake JW, 1998, GENETICS, V148, P1667; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eaves IA, 2000, NAT GENET, V25, P320; FOSS E, 1993, GENETICS, V133, P681; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Huttley GA, 1999, GENETICS, V152, P1711; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; KIMURA M, 1969, P NATL ACAD SCI USA, V63, P1181, DOI 10.1073/pnas.63.4.1181; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Nachman MW, 1998, GENETICS, V150, P1133; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Richter B, 1997, GENETICS, V145, P311; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wiuf C, 2000, GENETICS, V155, P451; Wiuf C, 2000, THEOR POPUL BIOL, V57, P357, DOI 10.1006/tpbi.2000.1462; ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407	40	82	83	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					582	589		10.1086/323251	http://dx.doi.org/10.1086/323251			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11473344	Green Published, Bronze			2022-12-18	WOS:000170271400010
J	Li, DX; Ahmad, F; Gardner, MJ; Weilbaecher, D; Hill, R; Karibe, A; Gonzalez, O; Tapscott, T; Sharratt, GP; Bachinski, LL; Roberts, R				Li, DX; Ahmad, F; Gardner, MJ; Weilbaecher, D; Hill, R; Karibe, A; Gonzalez, O; Tapscott, T; Sharratt, GP; Bachinski, LL; Roberts, R			The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DILATED CARDIOMYOPATHY; LONG ARM; APOPTOSIS; DEATH; FORM	Arrhythmogenic right-ventricular dysplasia (ARVD), a cardiomyopathy inherited as an autosomal-dominant disease, is characterized by fibro-fatty infiltration of the right-ventricular myocardium. Four loci for ARVD have been mapped in the Italian population, and recently the first locus was mapped in inhabitants of North America. None of the genes have been identified. We have now identified another North American family with early onset of ARVD and high penetrance. All of the children with the disease haplotype had pathological or clinical evidence of the disease at age <10 years. The family spans five generations, having 10 living and 2 dead affected individuals, with ARVD segregating as an autosomal-dominant disorder. Genetic linkage analysis excluded known loci, and a novel locus was identified on chromosome 10p12-p14. A peak two-point LOD score of 3.92 was obtained with marker D10S1664, at a recombination fraction of 0. Additional genotyping and haplotype analysis identified a shared region of 10.6 cM between marker D10S547 and D10S1653. Thus, a novel gene responsible for ARVD resides on the short arm of chromosome 10. This disease is intriguing, since it initiates exclusively in the right ventricle and exhibits pathological features of apoptosis, Chromosomal localization of the ARVD gene is the first step in identification of the genetic defect and the unraveling of the molecular basis responsible for the pathogenesis of the disease.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, DeBakey Heart Ctr, Grad Program Cardiovasc Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; Izaak Walton Killam Hosp Children, Queen Elizabeth Hlth Sci Ctr, Halifax, NS B3J 3G9, Canada	Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Baylor College of Medicine; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Roberts, R (corresponding author), Baylor Coll Med, Dept Med, Cardiol Sect, 6550 Fannin,MS SM677, Houston, TX 77030 USA.			Ahmad, Ferhaan/0000-0003-2877-4641	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054313, T32HL007706] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50-HL54313-01-01, T32-HL07706, P50 HL054313, T32 HL007706] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983; BHARATI S, 1978, CIRCULATION, V57, P636, DOI 10.1161/01.CIR.57.3.636; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; DUNGAN WT, 1981, AM HEART J, V102, P745, DOI 10.1016/0002-8703(81)90101-0; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Fontaine G, 1998, CIRCULATION, V97, P1532, DOI 10.1161/01.CIR.97.16.1532; Frances R, 1997, AM J MED GENET, V73, P125, DOI 10.1002/(SICI)1096-8628(19971212)73:2<125::AID-AJMG4>3.0.CO;2-T; FRANKE WW, 1987, CELL, V49, P131, DOI 10.1016/0092-8674(87)90763-X; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Mallat Z, 1996, NEW ENGL J MED, V335, P1190, DOI 10.1056/NEJM199610173351604; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; MARCUS FI, 1997, CARDIOL REV, V5, P25, DOI DOI 10.1097/00045415-199701000-00009; MARIAN AJ, 1995, CIRCULATION, V92, P1336, DOI 10.1161/01.CIR.92.5.1336; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; NAVA A, 1987, AM J CARDIOL, V59, P1405, DOI 10.1016/0002-9149(87)90929-5; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Ott J., 1991, ANAL HUMAN GENETIC L; PAWAL B, 1994, PEDIATR PATHOL, V14, P987; RAMPAZZO A, 1995, HUM MOL GENET, V4, P2151, DOI 10.1093/hmg/4.11.2151; Rampazzo A, 1997, GENOMICS, V45, P259, DOI 10.1006/geno.1997.4927; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Severini GM, 1996, GENOMICS, V31, P193, DOI 10.1006/geno.1996.0031; SHEN WK, 1995, AM J CARDIOL, V76, P148, DOI 10.1016/S0002-9149(99)80047-2; SHEN WK, 1994, J AM COLL CARDIOL, V23, P34; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Thiene G, 1997, TRENDS CARDIOVAS MED, V7, P84, DOI 10.1016/S1050-1738(97)00011-X; Valente M, 1998, AM J PATHOL, V152, P479; VECHT RJ, 1979, BRIT HEART J, V41, P676	32	82	88	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					148	156		10.1086/302713	http://dx.doi.org/10.1086/302713			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631146	Bronze, Green Published			2022-12-18	WOS:000085033600017
J	Rickards, O; Martinez-Labarga, C; Lum, JK; De Stefano, GF; Cann, RL				Rickards, O; Martinez-Labarga, C; Lum, JK; De Stefano, GF; Cann, RL			mtDNA history of the Cayapa Amerinds of Ecuador: Detection of additional founding lineages for the native American populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; NEW-WORLD; GENETIC-CHARACTERIZATION; SUBSTITUTION RATE; UNIQUE MARKER; COSTA-RICA; DIVERSITY; SEQUENCES; POLYMORPHISM; DELETION	mtDNA variation in the Cayapa, an Ecuadorian Amerindian tribe belonging to the Chibcha-Paezan linguistic branch, was analyzed by use of hypervariable control regions I and II along with two linked regions undergoing insertion/deletion mutations. Three major maternal lineage clusters fit into the A, B, and C founding groups first described by Schurr and colleagues in 1990, whereas a fourth lineage, apparently unique to the Cayapa, has ambiguous affinity to known clusters. The time of divergence from a common maternal ancestor of the four lineage groups is of sufficient age that it indicates an origin in Asia and supports the hypothesis that the degree of variability carried by the Asian ancestral populations into the New World was rather high. Spatial autocorrelation analysis points out (a) statistically significant nonrandom distributions of the founding lineages in the Americas, because of north-south population movements that have occurred since the first Asian migrants spread through Beringia into the Americas, and (b) an unusual pattern associated with the D lineage cluster. The values of haplotype and nucleotide diversity that are displayed by the Cayapa appear to differ from those observed in other Chibchan populations but match those calculated for South American groups belonging to various linguistic stocks. These data, together with the results of phylogenetic analysis performed with the Amerinds of Central and South America, highlight the difficulty in the identification of clear coevolutionary patterns between linguistic and genetic relationships in particular human populations.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Inst Stat Math, Minato Ku, Tokyo 106, Japan; Univ Hawaii Manoa, Dept Genet & Mol Biol, Manoa, HI USA	University of Rome Tor Vergata; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Hawaii System; University of Hawaii Manoa	Rickards, O (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci 1, I-00133 Rome, Italy.	rickards@uniroma2.it	MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Rickards, Olga/L-7878-2015	MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Rickards, Olga/0000-0003-2880-7466				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BARRIGALOPEZ F, 1987, CAYAPAS CHACHIS, V4; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Cavalli-Sforza LL, 1998, TRENDS GENET, V14, P60, DOI 10.1016/S0168-9525(97)01327-9; DONNELLY P, 1986, ADV APPL PROBAB, V18, P1, DOI 10.2307/1427237; Easton RD, 1996, AM J HUM GENET, V59, P213; EFRON B, 1979, JACKKNIFE BOOTSTRAP; ERLICH AH, 1989, PCR TECHNOLOGY PRINC; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Forster P, 1996, AM J HUM GENET, V59, P935; GINTHER C, 1993, EXS, V67, P211; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Hanski IA, 1997, METAPOPULATION BIOL; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HAUSWIRTH WW, 1994, EXPERIENTIA, V50, P585, DOI 10.1007/BF01921729; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOCHER TD, 1991, EVOLUTION OF LIFE, P391; KOLMAN CJ, 1995, GENETICS, V140, P275; Lum JK, 1998, AM J PHYS ANTHROPOL, V105, P109, DOI 10.1002/(SICI)1096-8644(199802)105:2<109::AID-AJPA1>3.0.CO;2-Q; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1995, AM J HUM GENET, V56, P812; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEI M, 1981, GENETICS, V97, P145; NEI M, 1974, GENETICS, V76, P379; NELSON DE, 1986, SCIENCE, V232, P749, DOI 10.1126/science.232.4751.749; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PEPE G, 1994, HUM BIOL, V66, P979; RICKARDS O, 1994, HUM BIOL, V66, P299; Rickards O., 1995, HUM EVOL, V10, P5, DOI [10.1007/BF02437510, DOI 10.1007/BF02437510]; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS M, 1994, HUM BIOL, V66, P963; SANTOS M, 1994, AM J HUM GENET, V55, P413; SANTOS M, 1995, AM J HUM GENET, V57, P195; SANTOS M, 1994, HUM GENET, V93, P435; SCACCHI R, 1994, ANN HUM BIOL, V21, P67, DOI 10.1080/03014469400003082; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SLATKIN M, 1991, GENETICS, V129, P555; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Stone Anne C, 1996, ANCIENT BIOMOLECULES, V1, P83; Swofford D., 1998, PAUP PHYLOGENETIC AN; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; TAYLOR RE, 1985, AM ANTIQUITY, V50, P136, DOI 10.2307/280638; TITUSTRACHTENBERG EA, 1994, AM J HUM GENET, V55, P160; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Turner CG, 1998, AM J PHYS ANTHROPOL, V106, P408, DOI 10.1002/(SICI)1096-8644(199807)106:3<408::AID-AJPA15>3.0.CO;2-4; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; Wakeley J, 1997, GENETICS, V145, P847; WAKELEY J, 1993, J MOL EVOL, V37, P613; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WATENBERG D, 1989, SAAP SPATIAL AUTOCOR; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEST FH, 1996, AM BEGINNINGS; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	82	83	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					519	530		10.1086/302513	http://dx.doi.org/10.1086/302513			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417294	Bronze, Green Published			2022-12-18	WOS:000081836900027
J	Riordan, JR				Riordan, JR			Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHLORIDE CHANNEL ACTIVITY; ENDOPLASMIC-RETICULUM; DELTA-F508 CFTR; CONFORMATIONAL MATURATION; INTRACELLULAR-TRANSPORT; CYTOPLASMIC LOOP; PROTEIN; MUTATION; DEGRADATION; COMPARTMENT		Mayo Clin Scottsdale, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA; Mayo Fdn, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; SC Johnson & Son; Mayo Clinic	Riordan, JR (corresponding author), Mayo Clin Scottsdale, SC Johnson Med Res Ctr, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.							AGULARBRYAN L, 1996, DIABETES REV, V4, P336; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Casals T, 1997, HUM MUTAT, V10, P387, DOI 10.1002/(SICI)1098-1004(1997)10:5<387::AID-HUMU9>3.3.CO;2-V; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jiang CW, 1998, AM J PHYSIOL-CELL PH, V275, pC171, DOI 10.1152/ajpcell.1998.275.1.C171; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Nichols WC, 1999, AM J HUM GENET, V64, P1493, DOI 10.1086/302433; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; PIND S, 1994, J BIOL CHEM, V269, P12784; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Seibert FS, 1997, J BIOENERG BIOMEMBR, V29, P429, DOI 10.1023/A:1022478822214; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; THOMAS PJ, 1992, J BIOL CHEM, V267, P5727; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	39	82	83	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1499	1504		10.1086/302429	http://dx.doi.org/10.1086/302429			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330337	Bronze, Green Published			2022-12-18	WOS:000080696200002
J	Durner, M; Vieland, VJ; Greenberg, DA				Durner, M; Vieland, VJ; Greenberg, DA			Further evidence for the increased power of LOD scores compared with nonparametric methods	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-LOCUS APPROXIMATIONS; LINKAGE ANALYSIS; 2-LOCUS MODELS; SEGREGATION ANALYSIS; OLIGOGENIC TRAITS; HETEROGENEITY; CONCLUSIONS; INHERITANCE; LIKELIHOOD; PENETRANCE	In genetic analysis of diseases in which the underlying model is unknown, "model free" methods-such as affected sib pair (ASP) tests-are often preferred over LOD-score methods, although LOD-score methods under the correct or even approximately correct model are more powerful than ASP tests. However, there might be circumstances in which nonparametric methods wi:ll outperform LOD-score methods. Recently, Dizier et al. reported that, in some complex two-locus (2L) models, LOD-score methods with segregation analysis-derived parameters had less power to detect linkage than ASP tests. We investigated whether these particular models, in fact, represent a situation that ASP rests are more powerful than LOD scores. We simulated data according to the parameters specified by Dizier et al. and analyzed the data by using a (a) single locus (SL) LOD-score analysis performed twice, under a simple dominant and a recessive mode of inheritance (MOI), (b) ASP methods, and (c) nonparametric linkage (NPL) analysis. We show that SL analysis performed twice and corrected for the type I-error increase due to multiple testing yields almost as much linkage information as does an analysis under the correct 2L model and is more powerful than either the ASP method or the NPL method. We demonstrate that, even for complex genetic models, the most important condition for linkage analysis is that the assumed MOI at the disease locus being tested is approximately correct, not that the inheritance of the disease per se is correctly specified. In the analysis by Dizier et al., segregation analysis led to estimates of dominance parameters that were grossly misspecified for the locus tested in those models in which ASP tests appeared to be more powerful than LOD-score analyses.	CUNY, Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Med Ctr, Dept Biomath, New York, NY 10029 USA; Univ Iowa, Coll Med, Dept Prevent Med & Environm Hlth, Div Biostat, Iowa City, IA USA; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Iowa; University of Iowa	Durner, M (corresponding author), CUNY, Mt Sinai Med Ctr, Dept Psychiat, Box 1229,1 Gustave Levy Pl, New York, NY 10029 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31775] Funding Source: Medline; NIMH NIH HHS [MH48858] Funding Source: Medline; NINDS NIH HHS [NS2741] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P310; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; Dizier MH, 1996, AM J HUM GENET, V58, P1338; DIZIER MH, 1993, AM J HUM GENET, V53, P1338; DURNER M, 1992, AM J HUM GENET, V51, P859; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; Goldin L. R., 1994, GENETIC APPROACHES M, P77; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; Greenberg DA, 1996, AM J HUM GENET, V58, P892; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1986, AM J HUM GENET, V39, P329; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hodge SE, 1998, AM J MED GENET, V81, P66, DOI 10.1002/(SICI)1096-8628(19980207)81:1<66::AID-AJMG13>3.3.CO;2-V; Kidd KK, 1997, AM J MED GENET, V74, P104, DOI 10.1002/(SICI)1096-8628(19970221)74:1<104::AID-AJMG21>3.0.CO;2-U; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LALOUEL JM, 1980, POINTER COMPUTER PRO; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; OTT J, 1974, AM J HUM GENET, V26, P588; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155	26	82	82	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					281	289		10.1086/302181	http://dx.doi.org/10.1086/302181			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915967	Green Published, Bronze			2022-12-18	WOS:000078477400033
J	van Grunsven, EG; van Berkel, E; Mooijer, PAW; Watkins, PA; Moser, HW; Suzuki, Y; Jiang, LL; Hashimoto, T; Hoefler, G; Adamski, J; Wanders, RJA				van Grunsven, EG; van Berkel, E; Mooijer, PAW; Watkins, PA; Moser, HW; Suzuki, Y; Jiang, LL; Hashimoto, T; Hoefler, G; Adamski, J; Wanders, RJA			Peroxisomal bifunctional protein deficiency revisited: Resolution of its true enzymatic and molecular basis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACYL-COA OXIDASE; RAT-LIVER PEROXISOMES; ACID BETA-OXIDATION; COMPLEMENTATION ANALYSIS; D-3-HYDROXYACYL-COA DEHYDRATASE; PRISTANIC ACID; FATTY-ACIDS; 17-BETA-HYDROXYSTEROID DEHYDROGENASE; 17-BETA-ESTRADIOL DEHYDROGENASE; 3-OXOACYL-COA THIOLASE	In the past few years, many patients have been described who have a defect of unknown origin in the peroxisomal beta-oxidation pathway. Complementation analysis has been done by various groups to establish the extent of the genetic heterogeneity among the patients. These studies were based on the use of two established cell lines, one with a deficiency of acyl-CoA oxidase and one with a deficiency of L-bifunctional protein (L-BP), and they showed that most patients belong to the L-BP-deficient group. However, molecular analysis of the cDNA encoding L-BP in patients failed to show any mutations. The recent identification of a new D-specific bifunctional protein (D-BP) prompted us to reinvestigate the original patient with presumed L-BP deficiency. In a collaborative effort, we have now found that the hue defect in this patient is at the level of the D-BP and not at the Level of the L-BP. Our results suggest that most, if not all, patients whose condition has been diagnosed as L-BP are, in fact, D-BP deficient. We tested this hypothesis in nine patients whose condition was diagnosed as L-BP deficiency on the basis of complementation analysis and found clear-cut mutations in the D-BP cDNA from all patients.	Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan; Shinshu Univ, Sch Med, Dept Biochem, Nagano, Japan; Graz Univ, Inst Pathol, Graz, Austria; GSF Forschungszentrum Umwelt & Gesundheit GMBH, Inst Saugetiergenet, Neuherberg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Johns Hopkins University; Kennedy Krieger Institute; Gifu University; Shinshu University; University of Graz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wanders, RJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Room FO-226,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Hoefler, Gerald/B-7006-2008; Hoefler, Gerald/H-1796-2016	Watkins, Paul A./0000-0002-3246-1405; Adamski, Jerzy/0000-0001-9259-0199; Hoefler, Gerald/0000-0002-9056-3063				ADAMSKI J, 1995, BIOCHEM J, V311, P437, DOI 10.1042/bj3110437; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; Bun-ya M, 1998, J BIOCHEM-TOKYO, V123, P347; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DieuaideNoubhani M, 1996, EUR J BIOCHEM, V240, P660, DOI 10.1111/j.1432-1033.1996.0660h.x; DieuaideNoubhani M, 1997, BIOCHEM J, V325, P367, DOI 10.1042/bj3250367; Erdmann R, 1997, TRENDS CELL BIOL, V7, P400, DOI 10.1016/S0962-8924(97)01126-4; Fukuda S, 1998, J INHERIT METAB DIS, V21, P23, DOI 10.1023/A:1005355112975; FURUTA S, 1980, J BIOCHEM, V88, P1059, DOI 10.1093/oxfordjournals.jbchem.a133057; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; HEIKOOP JC, 1991, BIOCHIM BIOPHYS ACTA, V1097, P62, DOI 10.1016/0925-4439(91)90025-5; HOEFLER G, 1994, GENOMICS, V19, P60, DOI 10.1006/geno.1994.1013; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P364; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; Jiang LL, 1996, J BIOCHEM-TOKYO, V120, P624; KROZOWSKI Z, 1992, MOL CELL ENDOCRINOL, V84, pC25, DOI 10.1016/0303-7207(92)90064-D; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEENDERS F, 1994, MOL CELL ENDOCRINOL, V104, P127, DOI 10.1016/0303-7207(94)90114-7; LEENDERS F, 1994, EUR J BIOCHEM, V222, P221, DOI 10.1111/j.1432-1033.1994.tb18860.x; LEENDERS F, IN PRESS MAMM GENOME; Lin SX, 1996, J ENDOCRINOL, V150, pS13; MCGUINNESS MC, 1993, BIOCHEM MED METAB B, V49, P228, DOI 10.1006/bmmb.1993.1025; MCKIE JH, 1991, FEBS LETT, V279, P5, DOI 10.1016/0014-5793(91)80236-V; MIYAZAWA S, 1981, J BIOCHEM, V90, P511, DOI 10.1093/oxfordjournals.jbchem.a133499; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Paton BC, 1996, J CLIN INVEST, V97, P681, DOI 10.1172/JCI118465; Qin YM, 1997, BIOCHEM J, V321, P21, DOI 10.1042/bj3210021; Qin YM, 1997, BIOCHEM J, V328, P377, DOI 10.1042/bj3280377; Subramani S, 1996, J BIOL CHEM, V271, P32483, DOI 10.1074/jbc.271.51.32483; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; SUZUKI Y, 1994, AM J HUM GENET, V54, P36; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; vanGrunsven EG, 1997, J INHERIT METAB DIS, V20, P437, DOI 10.1023/A:1005323221660; vanGrunsven EG, 1997, BIOCHEM BIOPH RES CO, V235, P176, DOI 10.1006/bbrc.1997.6755; VANHOVE GF, 1993, J BIOL CHEM, V268, P10335; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P385, DOI 10.1007/BF02435983; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; Wanders RJA, 1997, BIOCHEM BIOPH RES CO, V236, P565, DOI 10.1006/bbrc.1997.7007; Wanders RJA, 1996, ANN NY ACAD SCI, V804, P450, DOI 10.1111/j.1749-6632.1996.tb18636.x; WATKINS PA, 1995, ANN NEUROL, V38, P472, DOI 10.1002/ana.410380322; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956; Xu RF, 1996, BIOCHEM BIOPH RES CO, V221, P271, DOI 10.1006/bbrc.1996.0585	43	82	82	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					99	107		10.1086/302180	http://dx.doi.org/10.1086/302180			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915948	Bronze, Green Published			2022-12-18	WOS:000078477400014
J	Woodward, K; Kendall, E; Vetrie, D; Malcolm, S				Woodward, K; Kendall, E; Vetrie, D; Malcolm, S			Pelizaeus-Merzbacher disease: Identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED SPASTIC PARAPLEGIA; TOOTH NEUROPATHY TYPE-1A; HUMAN X-CHROMOSOME; GENE DOSAGE; PLP GENE; ANGELMAN-SYNDROME; CMT1A-REP REPEAT; POINT MUTATION; MESSENGER-RNA; DNA MARKERS	Pelizaeus-Merzbacher disease (PMD) is an X-linked, dysmyelinating disorder of the CNS. Duplications of the proteolipid protein (PLP) gene have been found in a proportion of patients, suggesting that, in addition to coding-region or splice-site mutations, overdosage of the gene can cause PMD. We show that the duplication can be detected by interphase FISH, using a PLP probe in five patients and their four asymptomatic carrier mothers. The extent of the duplication was analyzed in each family by interphase FISH, with probes from a 1.7-Mb region surrounding the PLP gene between markers DXS83 and DXS94. A large duplication greater than or equal to 500 kb was detected, with breakpoints that differed, between families, at the proximal end. Distinct separation of the duplicated PLP signals could be seen only on metaphase chromosomes in one family, providing further evidence that different duplication events are involved. Quantitative fluorescent multiplex PCR was used to confirm the duplication in patients, by the detection of increased copy number of the PLP gene, Multiallelic markers from the duplicated region were analyzed, since the identification of two alleles in an affected boy would indicate a duplication. The majority of boys were homozygous for all four markers, compared with their mothers, who were heterozygous for one to three of the markers. These results suggest that intrachromosomal rearrangements may be a common mechanism by which duplications arise in PMD. One boy was heterozygous for the PLP marker, indicating a duplication and suggesting that interchromosomal rearrangements of maternal origin also can be involved. Since duplications are a major cause of PMD, we propose that interphase FISH is a reliable method for diagnosis and identification of female carriers.	Inst Child Hlth, Mol Genet Unit, London WC1N 1EH, England; Guys Hosp, Paediat Res Unit, London SE1 9RT, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Woodward, K (corresponding author), Inst Child Hlth, Mol Genet Unit, 30 Guilford St, London WC1N 1EH, England.	kwoodwar@hgmp.mrc.ac.uk		Vetrie, David/0000-0003-2075-4662	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BOESPFLUGTANGUY O, 1994, AM J HUM GENET, V55, P461; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; CARANGO P, 1995, ANN NEUROL, V38, P610, DOI 10.1002/ana.410380409; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; FITZGIBBON J, 1993, ANN HUM GENET, V57, P203, DOI 10.1111/j.1469-1809.1993.tb01596.x; GRIFFITHS IR, 1995, NEUROPATH APPL NEURO, V21, P85, DOI 10.1111/j.1365-2990.1995.tb01034.x; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; Huang B, 1997, HUM GENET, V99, P11; Inoue K, 1996, AM J HUM GENET, V59, P32; Inoue Y, 1996, NEUROSCI RES, V25, P161; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; IONASESCU VV, 1993, HUM MOL GENET, V2, P405; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; Kendall E, 1997, GENOMICS, V43, P171, DOI 10.1006/geno.1997.4795; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; Kiyosawa H, 1996, HUM MOL GENET, V5, P745, DOI 10.1093/hmg/5.6.745; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; Lazzarini A, 1997, NEUROLOGY, V49, P824, DOI 10.1212/WNL.49.3.824; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MATTEI MG, 1986, HUM GENET, V72, P352, DOI 10.1007/BF00290964; MIMAULT C, 1995, HUM GENET, V96, P236, DOI 10.1007/BF00207388; NADON NL, 1990, DEVELOPMENT, V110, P529; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NAVE KA, 1986, P NATL ACAD SCI USA, V83, P9264, DOI 10.1073/pnas.83.23.9264; Nelis E, 1996, EUR J HUM GENET, V4, P25; OSAKA H, 1995, BIOCHEM BIOPH RES CO, V215, P835, DOI 10.1006/bbrc.1995.2539; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SISTERMANS EA, IN PRESS NEUROLOGY; Thomas PK, 1997, BRAIN, V120, P465, DOI 10.1093/brain/120.3.465; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TRASK BJ, 1991, AM J HUM GENET, V48, P1; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; VALENTIJN LJ, 1993, HUM MOL GENET, V2, P2143, DOI 10.1093/hmg/2.12.2143; VETRIE D, 1994, GENOMICS, V19, P42, DOI 10.1006/geno.1994.1010; Wang PJ, 1997, PEDIATR NEUROL, V17, P125, DOI 10.1016/S0887-8994(97)00088-X; WHEATER RF, 1987, J MED GENET, V24, P113, DOI 10.1136/jmg.24.2.113; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606	50	82	83	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					207	217		10.1086/301933	http://dx.doi.org/10.1086/301933			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634530	Bronze, Green Published			2022-12-18	WOS:000074761000029
J	Adams, LJ; Mitchell, PB; Fielder, SL; Rosso, A; Donald, JA; Schofield, PR				Adams, LJ; Mitchell, PB; Fielder, SL; Rosso, A; Donald, JA; Schofield, PR			A susceptibility locus for bipolar affective disorder on chromosome 4q35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; OLD-ORDER AMISH; LINKAGE ANALYSIS; DNA MARKERS; PEDIGREES; SUPPORT; SEARCH; GENE	Bipolar affective disorder (BAD) affects similar to 1% of the population and shows strong heritability. To identify potential BAD susceptibility loci, we undertook a 15-cM genome screen, using 214 microsatellite markers on the 35 most informative individuals of a large, statistically powerful pedigree. Data were analyzed by parametric two-point linkage methods under several diagnostic models. LOD scores >1.00 were obtained for 21 markers, with four of these >2.00 for at least one model. The remaining 52 individuals in the family were genotyped with these four markers, and LOD scores remained positive for three markers. A more intensive screen was undertaken in these regions, with the most positive results being obtained for chromosome 4q35. Using a dominant model of inheritance with 90% maximum age-specific penetrance and including bipolar I, II, schizoaffective/mania, and unipolar individuals as affected, we obtained a maximum two-point LOD score of 2.20 (theta = .15) at D4S1652 and a maximum three-point LOD score of 3.19 between D4S408 and D4S2924. Nonparametric analyses further supported the presence of a locus on chromosome 4q35. A maximum score of 2.62 (P = .01) was obtained between D4S1652 and D4S171 by use of the GENEHUNTER program, and a maximum score of 3.57 (P = .0002) was obtained at D4S2924 using the affected pedigree member method. Analysis of a further IO pedigrees suggests the presence of this locus in at least one additional family, indicating a possible predisposing locus and not a pedigree-specific mutation. Our results suggest the presence of a novel BAD susceptibility locus on chromosome 4q35.	Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia; Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; Prince Henry Hosp, Mood Disorders Unit, Sydney, NSW, Australia; Prince Henry Hosp, Garvan Inst Med Res, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney; Garvan Institute of Medical Research	Schofield, PR (corresponding author), Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia.		Schofield, Peter/C-9669-2011	Schofield, Peter/0000-0003-2967-9662; Donald, Jennifer/0000-0002-2732-1379; Mitchell, Philip/0000-0002-7954-5235				Adams LJ, 1997, AM J MED GENET, V74, P304, DOI 10.1002/(SICI)1096-8628(19970531)74:3<304::AID-AJMG12>3.0.CO;2-S; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; Baron M, 1997, MOL PSYCHIATR, V2, P200, DOI 10.1038/sj.mp.4000211; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; BYERLEY W, 1995, AM J MED GENET, V60, P231, DOI 10.1002/ajmg.1320600312; Claes S, 1997, J AFFECT DISORDERS, V43, P195, DOI 10.1016/S0165-0327(97)01429-8; Coon H, 1996, BIOL PSYCHIAT, V39, P689, DOI 10.1016/0006-3223(95)00292-8; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; CURTIS D, 1995, AM J HUM GENET, V57, P703; Debruyn A, 1996, BIOL PSYCHIAT, V39, P679, DOI 10.1016/0006-3223(95)00293-6; DeteraWadleigh SD, 1996, AM J HUM GENET, V58, P1279; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; GURLING H, 1995, NAT GENET, V1, P8; Kelsoe JR, 1997, PSYCHIAT ANN, V27, P285, DOI 10.3928/0048-5713-19970401-12; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MacKinnon DF, 1997, ANNU REV NEUROSCI, V20, P355, DOI 10.1146/annurev.neuro.20.1.355; Maier W, 1995, PSYCHIAT RES, V59, P7, DOI 10.1016/0165-1781(95)02799-8; MITCHELL P, 1991, J AFFECT DISORDERS, V21, P23, DOI 10.1016/0165-0327(91)90015-K; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PAULS DL, 1995, AM J HUM GENET, V57, P636; PEKKARINEN P, 1995, GENOME RES, V5, P105, DOI 10.1101/gr.5.2.105; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; Smyth C, 1997, GENOMICS, V39, P271, DOI 10.1006/geno.1996.4486; SPENCE MA, 1995, AM J MED GENET, V60, P370, DOI 10.1002/ajmg.1320600505; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	34	82	85	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1084	1091		10.1086/301826	http://dx.doi.org/10.1086/301826			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545396	Green Published, Bronze			2022-12-18	WOS:000073487000012
J	Mazoyer, S; Puget, N; Perrin-Vidoz, L; Lynch, HT; Serova-Sinilnikova, OM; Lenoir, GM				Mazoyer, S; Puget, N; Perrin-Vidoz, L; Lynch, HT; Serova-Sinilnikova, OM; Lenoir, GM			A BRCA1 nonsense mutation causes exon skipping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; DEFECTS		Int Agcy Res Canc, F-69372 Lyon 08, France; CNRS, UMR 5641, Genet Lab, Lyon, France; Hop Edouard Herriot, Lyon, France; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA	World Health Organization; International Agency for Research on Cancer (IARC); Centre National de la Recherche Scientifique (CNRS); CHU Lyon; Creighton University	Lenoir, GM (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.		Mazoyer, Sylvie/N-7559-2017; PUGET, Nadine/AAB-9689-2020	PUGET, Nadine/0000-0003-4046-737X; Mazoyer, Sylvie/0000-0002-2135-0160				Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; HULL J, 1994, GENOMICS, V19, P362, DOI 10.1006/geno.1994.1070; Maquat LE, 1996, AM J HUM GENET, V59, P279; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; Pie J, 1997, BIOCHEM J, V323, P329, DOI 10.1042/bj3230329; Puget N, 1997, CANCER RES, V57, P828; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; Swensen J, 1997, HUM MOL GENET, V6, P1513, DOI 10.1093/hmg/6.9.1513; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	17	82	85	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					713	715		10.1086/301768	http://dx.doi.org/10.1086/301768			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497265	Bronze, Green Published			2022-12-18	WOS:000072894400026
J	Berman, DB; WagnerCostalas, J; Schultz, DC; Lynch, HT; Daly, M; Godwin, AK				Berman, DB; WagnerCostalas, J; Schultz, DC; Lynch, HT; Daly, M; Godwin, AK			Two distinct origins of a common BRCA 1 mutation in breast-ovarian cancer families: A genetic study of 15 185delAG-mutation kindreds	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE	We screened 163 women from breast-ovarian cancer-prone families, as well as 178 individuals affected with breast and/or ovarian cancer but unselected for family history, for germ-line mutations in exon 2 of BRCA1, by SSCP analysis and direct sequencing. A total of 25 mutations were detected. Thirteen of 64 Jewish Ashkenazi women and 2 non-Jewish individuals were found to possess the 185delAG mutation. Haplotype data for all 15 individuals, with markers intragenic to BRCA1, suggest that the Jewish Ashkenazi individuals share a common ancestry that is distinct from the lineage shared by the other two women. These data provide the first evidence of two distinct lines of transmission for the 185delAG mutation, only one of which has its origins in the Jewish Ashkenazi population. Our screening also uncovered 10 affected individuals with an 11-bp deletion at nucleotide 188 of BRCA1 (188del11), 4 of whom are Ashkenazi Jews. This is only the third reported mutation detected within the Jewish Ashkenazi population and may represent the second most common alteration in BRCA1 found in Ashkenazi Jews in the United States. The observed overrepresentation of specific mutations within a subgroup of the general population may eventually contribute to the development of inexpensive and routine tests for BRCA1 mutations, as well as to the elucidation of other contributory factors (e.g., diet, environment, and chemical exposures) that may play a key role in cancer initiation and development. The implications of the mutational data, as well as the role that founder effect, demographic history, and penetrance play in the resulting observed phenomena, are discussed.	FOX CHASE CANC CTR,DEPT MED ONCOL,PHILADELPHIA,PA 19111; FOX CHASE CANC CTR,DEPT POPULAT SCI,PHILADELPHIA,PA 19111; CREIGHTON UNIV,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE 68178	Fox Chase Cancer Center; Fox Chase Cancer Center; Creighton University					NATIONAL CANCER INSTITUTE [R01CA060643] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA60643] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; DELLAPERGOLA S, 1992, GENETIC DIVERSITY AMONG JEWS, P3; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; GODWIN AK, 1994, AM J HUM GENET, V55, P666; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; INOUE R, 1995, CANCER RES, V55, P3521; KRONN D, 1995, AM J HUM GENET, V57, P2150; LYNCH HT, 1993, ARCH INTERN MED, V153, P1979; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; NAROD SA, 1995, AM J HUM GENET, V56, P254; NAROD SA, 1991, LANCET, V338, P82; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; PATAI R, 1989, MYTH JEWISH RACE 1 4; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SCHULTZ DC, 1995, CANCER RES, V55, P2150; Serova O, 1996, AM J HUM GENET, V58, P42; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TONIN P, 1995, AM J HUM GENET, V57, P189; TRIGGSRAINE B, 1995, AM J HUM GENET, V56, P870	32	82	85	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1166	1176						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651293				2022-12-18	WOS:A1996UM27100009
J	ADAMSON, D; ALBERTSEN, H; BALLARD, L; BRADLEY, P; CARLSON, M; CARTWRIGHT, P; COUNCIL, C; ELSNER, T; FUHRMAN, D; GERKEN, S; HARRIS, L; HOLIK, PR; KIMBALL, A; KNELL, J; LAWRENCE, E; LU, J; MARKS, A; MATSUNAMI, N; MELIS, R; MILNER, B; MOORE, M; NELSON, L; ODELBERG, S; PETERS, G; PLAETKE, R; RILEY, R; ROBERTSON, M; SARGENT, R; STAKER, G; TINGEY, A; WARD, K; ZHAO, XY; WHITE, R				ADAMSON, D; ALBERTSEN, H; BALLARD, L; BRADLEY, P; CARLSON, M; CARTWRIGHT, P; COUNCIL, C; ELSNER, T; FUHRMAN, D; GERKEN, S; HARRIS, L; HOLIK, PR; KIMBALL, A; KNELL, J; LAWRENCE, E; LU, J; MARKS, A; MATSUNAMI, N; MELIS, R; MILNER, B; MOORE, M; NELSON, L; ODELBERG, S; PETERS, G; PLAETKE, R; RILEY, R; ROBERTSON, M; SARGENT, R; STAKER, G; TINGEY, A; WARD, K; ZHAO, XY; WHITE, R			A COLLECTION OF ORDERED TETRANUCLEOTIDE-REPEAT MARKERS FROM THE HUMAN GENOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; POLYMORPHISMS; MAP; AMPLIFICATION; SEQUENCES	A collection of 1,069 human PCR-based genetic markers has been developed, and their distribution over the 22 autosomes and the X chromosome has been determined. Each marker was developed around a short-tandem-repeat DNA sequence. The majority (85%) of the markers described here were selected to contain tetranucleotide repeats, because these repeats show better stability during PCR than do dinucleotide repeats. Linkage maps constructed from genotypes collected with these markers in four CEPH pedigrees (1331, 1332, 1362, and 884) covered 3,417 cM of the human genome. More than 600 of the loci revealed heterozygosities >.70. Overall, 444 loci were ordered, with odds >100:1 against inversion of adjacent loci. The average distance between markers was 7.4 cM on the autosomes and 24.8 cM on the X chromosome. Likely locations (100:1 odds intervals) were assigned for the remaining 621 short-tandem-repeat polymorphisms, as well as for 160 other markers that are present on the framework maps published by the Cooperative Human Linkage Center. Four markers specific to the Y chromosome are also reported here. From our maps, 347 markers were chosen to define ''index'' maps for each of the 22 autosomes, The index markers detect loci with an average heterozygosity of .85 and cover 3,169 cM of the autosomes, with an average distance between markers of 9.2 cM. These polymorphic short tandem repeats will be highly useful as reagents for the ongoing genetic and physical mapping of the human genome and for characterization of genetic changes in cancer.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah								ALBERTSEN H, 1994, AM J HUM GENET, V54, P516; ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; EDWARDS A, 1991, AM J HUM GENET, V49, P746; EISNER TI, 1995, AM J HUM GENET, V56, P500; GERKEN SC, 1995, AM J HUM GENET, V56, P484; Gerken S, 1994, CHROMOSOME RES, V2, P423, DOI 10.1007/BF01552864; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1989, AM J HUM GENET, V44, P397; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MELIS R, 1993, GENOMICS, V16, P56, DOI 10.1006/geno.1993.1140; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; ODELBERG SJ, 1993, PCR METH APPL, V3, P7; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITE RL, 1990, GENOMICS, V6, P393, DOI 10.1016/0888-7543(90)90469-B; ZULIANI G, 1990, AM J HUM GENET, V46, P963; 1991, PROGRAM MANUAL GCG P	27	82	83	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					619	628						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605					2022-12-18	WOS:A1995RR60500011
J	CULLEN, M; ERLICH, H; KLITZ, W; CARRINGTON, M				CULLEN, M; ERLICH, H; KLITZ, W; CARRINGTON, M			MOLECULAR MAPPING OF A RECOMBINATION HOTSPOT LOCATED IN THE 2ND INTRON OF THE HUMAN TAP2 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II REGION; E-BETA GENE; MEIOTIC RECOMBINATION; LINKAGE DISEQUILIBRIUM; CROSSING-OVER; HUMAN INSULIN; HOT SPOT; MOUSE; DNA	Recombination across the HLA class II region is not randomly distributed, as indicated by both strong linkage disequilibrium within the 100 kb encompassing the DRB1-DQA1-DQB1 loci and complete equilibrium between TAP1 and TAP2, the closest variant sites of which are <15 kb. In an attempt to explain these observations, 39 novel polymorphic markers in a region encompassing the TAP, LMP, and DOB genes were used to delineate the site of crossover in 11 class II recombinant chromosomes. SSCP demonstrated that two recombination events occurred within an 850-bp interval in the second intron of TAP2, which separates the variant sites of TAP1 and TAP2. These data indicate the presence of a recombination hotspot, the first to be identified from the analysis of familial transmission in the human major histocompatibility complex. The region of crossover was cloned and sequenced from one of the recombinants, further defining the crossover site to a 138-bp segment nested within the 850-bp region. This represents the most precisely defined region of recombination in the human genome.	NCI,FREDERICK CANC RES & DEV CTR,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702; ROCHE MOLEC SYST,DEPT HUMAN GENET,ALAMEDA,CA; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Roche Holding; University of California System; University of California Berkeley					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35326] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECK S, 1992, J MOL BIOL, V228, P433, DOI 10.1016/0022-2836(92)90832-5; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BOWCOCK AM, 1988, P NATL ACAD SCI USA, V85, P2701, DOI 10.1073/pnas.85.8.2701; BRYDA EC, 1992, MAMM GENOME, V2, P123, DOI 10.1007/BF00353860; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; CARRINGTON M, 1994, HUM MOL GENET, V3, P218, DOI 10.1093/hmg/3.1.218; CARRINGTON M, 1993, IMMUNOGENETICS, V38, P446; CARRINGTON M, 1993, IMMUNOGENETICS, V37, P266; CARRINGTON M, 1994, HUM IMMUNOL, V41, P234, DOI 10.1016/0198-8859(94)90041-8; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHARMLEY P, 1990, P NATL ACAD SCI USA, V87, P4823, DOI 10.1073/pnas.87.12.4823; GHOSH D, 1993, NUCLEIC ACIDS RES, V21, P3117, DOI 10.1093/nar/21.13.3117; GREGERSEN PK, 1988, J IMMUNOL, V141, P1365; GRIMM T, 1989, AM J HUM GENET, V45, P368; HAAS JP, 1994, HUM IMMUNOL, V39, P31, DOI 10.1016/0198-8859(94)90098-1; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KOBORI JA, 1986, SCIENCE, V234, P173, DOI 10.1126/science.3018929; KOBORI JA, 1984, J MOL CELL IMMUNOL, V1, P125; LAFUSE WP, 1986, J EXP MED, V163, P1518, DOI 10.1084/jem.163.6.1518; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; LING XB, 1993, IMMUNOGENETICS, V37, P331, DOI 10.1007/BF00216797; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; PASSMORE HC, 1987, BIOCHEM GENET, V25, P513, DOI 10.1007/BF00554353; POWIS SH, 1993, IMMUNOGENETICS, V37, P373, DOI 10.1007/BF00216802; SAHA BK, 1986, J IMMUNOL, V137, P4004; SAHA BK, 1986, J IMMUNOL, V136, P1112; SATYANARAYANA K, 1992, IMMUNOGENETICS, V35, P235, DOI 10.1007/BF00166828; SHIROISHI T, 1990, IMMUNOGENETICS, V31, P79, DOI 10.1007/BF00661217; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; SMITH GR, 1981, CELL, V24, P429, DOI 10.1016/0092-8674(81)90333-0; Sokal R.R., 1981, BIOMETRY PRINCIPLES; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; THOMSEN M, 1989, TISSUE ANTIGENS, V33, P38, DOI 10.1111/j.1399-0039.1989.tb01675.x; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; UEMATSU Y, 1988, IMMUNOGENETICS, V27, P96, DOI 10.1007/BF00351082; UEMATSU Y, 1986, EMBO J, V5, P2123, DOI 10.1002/j.1460-2075.1986.tb04475.x; VANENDERT PM, 1992, P NATL ACAD SCI USA, V89, P11594, DOI 10.1073/pnas.89.23.11594; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; YOSHINO M, 1994, IMMUNOGENETICS, V39, P381, DOI 10.1007/BF00176154; ZIMMERER EJ, 1991, IMMUNOGENETICS, V33, P132, DOI 10.1007/BF00210827; 1994, WISCONSIN PACKAGE VE	44	82	85	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1350	1358						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762558				2022-12-18	WOS:A1995RA79400013
J	HOGLUND, P; HOLMBERG, C; DELACHAPELLE, A; KERE, J				HOGLUND, P; HOLMBERG, C; DELACHAPELLE, A; KERE, J			PATERNAL ISODISOMY FOR CHROMOSOME-7 IS COMPATIBLE WITH NORMAL GROWTH AND DEVELOPMENT IN A PATIENT WITH CONGENITAL CHLORIDE DIARRHEA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROMES; UNIPARENTAL DISOMY; CYSTIC-FIBROSIS; LINKAGE MAP; HUMANS; ANGELMAN; CHILDREN; RECEPTOR; WEIGHT; ORIGIN	Uniparental disomy for maternal chromosome 7 has been described in three patients with recessive disorders. Short stature in each of these patients has been explained by the effect of imprinting of growth-related genes on maternal chromosome 7. Alternatively, although less likely, all these patients may be homozygous for a rare recessive mutation. Here we report both paternal isodisomy for chromosome 7 and normal growth in a patient with a recessive disorder, congenital chloride diarrhea. She had inherited only paternal alleles at 10 loci and was homozygous for another 10 chromosome 7 loci studied. Her physical status and laboratory tests were normal except for a mild high-frequency sensorineural hearing loss. As the patient has normal stature, it is likely that the paternal chromosome 7 lacks the suggested maternal imprinting effect on growth. Paternal isodisomy for human chromosome 7 may have no phenotypic effect on growth.	UNIV HELSINKI,CHILDRENS HOSP,HELSINKI,FINLAND	University of Helsinki	HOGLUND, P (corresponding author), UNIV HELSINKI,DEPT MED GENET,HAARTMANINKATU 3,POB 21,SF-00014 HELSINKI,FINLAND.		Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271				BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1990, DEV S; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; DURANT RH, 1981, J AM DIET ASSOC, V78, P35; EHRENBORG E, 1992, HUM GENET, V89, P234; ENGEL E, 1993, AM J MED GENET, V46, P670, DOI 10.1002/ajmg.1320460613; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FREZAL J, 1991, CYTOGENET CELL GENET, V58, P986, DOI 10.1159/000133716; FRYBURG JS, 1993, PRENATAL DIAG, V13, P481, DOI 10.1002/pd.1970130610; GRZESCHIK KH, 1994, CYTOGENET CELL GENET, V65, P52; HAAPANIEMI J, 1992, ANN U TURKUENSIS D, V104; HAIG D, 1991, CELL, V64, P1045; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOLMBERG C, 1977, ARCH DIS CHILD, V52, P255, DOI 10.1136/adc.52.4.255; HOLMBERG C, 1986, CLIN GASTROENTEROL, V3, P583; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KERE J, 1993, P NATL ACAD SCI USA, V90, P10686, DOI 10.1073/pnas.90.22.10686; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCFADDEN DE, 1991, AM J MED GENET, V38, P535, DOI 10.1002/ajmg.1320380407; McKusick V. A. E., 1991, MENDELIAN INHERITANC; NICHOLLS RD, 1993, AM J MED GENET, V46, P16, DOI 10.1002/ajmg.1320460106; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NORIO R, 1971, Clinical Genetics, V2, P182; PELLESTOR F, 1991, HUM GENET, V86, P283; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; Sambrook J., 1989, MOL CLONING LAB MANU; SCHINZEL AA, 1994, AM J HUM GENET, V54, P21; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P498, DOI 10.1111/j.1651-2227.1990.tb11503.x; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; SURANI MA, 1990, DEV S; VOSS R, 1989, AM J HUM GENET, V45, P373; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143	38	82	82	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					747	752						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942853				2022-12-18	WOS:A1994PJ02700018
J	VANDERSTEENSTRATEN, IM; TIBBEN, A; ROOS, RAC; VANDEKAMP, JJP; NIERMEIJER, MF				VANDERSTEENSTRATEN, IM; TIBBEN, A; ROOS, RAC; VANDEKAMP, JJP; NIERMEIJER, MF			PREDICTIVE TESTING FOR HUNTINGTON DISEASE - NONPARTICIPANTS COMPARED WITH PARTICIPANTS IN THE DUTCH PROGRAM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATTITUDES; RISK; EXPERIENCE; PARTNERS; DECISION; ONSET	Attitudes toward predictive testing programs, in individuals who choose not to undertake the test (i.e., nonparticipants), may be influenced by fears of an unfavorable result. The reasons not to participate in predictive testing programs for Huntington disease (HD) were studied in members of the Dutch Huntington Association who were at 50% risk. They had completed the same baseline psychological questionnaires as had the participants in the Dutch DNA-testing program. The group of 34 nonparticipants was similar to the tested participants in the Dutch predictive testing program, with respect to average age (31.1 years), male:female ratio (1:2), the frequency of a stable relationship (70%), and a level of education (67% had high school education or higher). Testing did not seem to be a realistic option for nonparticipants for improving their quality of life. In comparison with participants, nonparticipants had a significantly more pessimistic outlook on themselves and their futures. When asked to consider the possibility of an unfavorable result, nonparticipants expected more difficulties in their families; more problems for their children, their partners, and themselves; a lowered quality of life; and, more often, a depressive reaction. In their opinion, a favorable result would reduce the problems for their children but not for themselves, a result that was found more often in the nonparticipant than in the participant group. Nonparticipants learned about their being at risk for HD during adolescence (mean age 15.6 years), whereas participants did so in adulthood (mean age 22.7 years). The nonparticipants' attitude toward the test might be explained by the influence of HD in the adolescent's separation-individuation process and personality development. This finding could be relevant for future research and for the discussion about testing minors for delayed-onset disorders.	UNIV HOSP DIJKZIGT,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT MED PSYCHOL & PSYCHOTHERAPY,ROTTERDAM,NETHERLANDS; LEIDEN UNIV HOSP,DEPT NEUROL,2333 AA LEIDEN,NETHERLANDS; LEIDEN UNIV HOSP,CTR CLIN GENET,LEIDEN,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus University Rotterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)			Tibben, Aad/A-9540-2008	Tibben, Aad/0000-0002-4560-1710				BECK AT, 1990, AM J PSYCHIAT, V147, P190; BLOCH M, 1989, AM J MED GENET, V32, P217, DOI 10.1002/ajmg.1320320215; BLOCH M, 1992, AM J MED GENET, V42, P499, DOI 10.1002/ajmg.1320420416; BLOCH M, 1990, AM J HUM GENET, V46, P1; Blos P, 1967, Psychoanal Study Child, V22, P162; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; CRAUFURD D, 1989, LANCET, V2, P603; EVERSKIEBOOMS G, 1987, J MED GENET, V24, P275, DOI 10.1136/jmg.24.5.275; EVERSKIEBOOMS G, 1989, CLIN GENET, V35, P29; Goldberg DP., 1972, DETECTION PSYCHIATRI; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Harper PS, 1991, HUNTINGTONS DISEASE; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; KESSLER S, 1987, AM J MED GENET, V26, P259, DOI 10.1002/ajmg.1320260204; KOETER MWJ, 1992, GENERAL HLTH QUESTIO; MARKEL DS, 1987, AM J MED GENET, V26, P295, DOI 10.1002/ajmg.1320260207; MASTROMAURO C, 1987, AM J MED GENET, V26, P271, DOI 10.1002/ajmg.1320260205; MEISSEN GJ, 1987, AM J MED GENET, V26, P283, DOI 10.1002/ajmg.1320260206; MEISSEN GJ, 1991, AM J MED GENET, V39, P404, DOI 10.1002/ajmg.1320390408; QUAID KA, 1993, AM J MED GENET, V45, P41, DOI 10.1002/ajmg.1320450112; QUAID KA, 1989, CLIN GENET, V36, P431; ROOS RAC, 1991, J MED GENET, V28, P515, DOI 10.1136/jmg.28.8.515; SKRAASTAD MI, 1991, AM J MED GENET, V38, P217; TIBBEN A, 1993, AM J MED GENET, V48, P10, DOI 10.1002/ajmg.1320480105; TIBBEN A, 1993, AM J MED GENET, V48, P103, DOI 10.1002/ajmg.1320480209; TIBBEN A, 1992, LANCET, V340, P1416, DOI 10.1016/0140-6736(92)92610-R; Tibben A., 1993, THESIS ERASMUS U ROT; TYLER A, 1992, BRIT MED J, V304, P1593, DOI 10.1136/bmj.304.6842.1593; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; 1993, CELL, V72, P971	30	82	83	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					618	625						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942839				2022-12-18	WOS:A1994PJ02700003
J	BOILEAU, C; JONDEAU, G; BABRON, MC; COULON, M; ALEXANDRE, JA; SAKAI, L; MELKI, J; DELORME, G; DUBOURG, O; BONAITIPELLIE, C; BOURDARIAS, JP; JUNIEN, C				BOILEAU, C; JONDEAU, G; BABRON, MC; COULON, M; ALEXANDRE, JA; SAKAI, L; MELKI, J; DELORME, G; DUBOURG, O; BONAITIPELLIE, C; BOURDARIAS, JP; JUNIEN, C			AUTOSOMAL-DOMINANT MARFAN-LIKE CONNECTIVE-TISSUE DISORDER WITH AORTIC DILATION AND SKELETAL ANOMALIES NOT LINKED TO THE FIBRILLIN GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITRAL-VALVE PROLAPSE; ECHOCARDIOGRAPHIC MEASUREMENTS; LINKAGE ANALYSIS; CHROMOSOME-15; ABNORMALITIES; ASSOCIATION; DIAGNOSIS; LOCUS; MAP	We describe a large family with a connective-tissue disorder that exhibits some of the skeletal and cardiovascular features seen in Marfan syndrome. However, none of the 19 affected individuals displayed ocular abnormalities and therefore did not comply with recognized criteria for this disease. These patients could alternatively be diagnosed as MASS (mitral valve, aorta, skeleton, and skin) phenotype patients or represent a distinct clinical entity, i.e., a new autosomal dominant connective-tissue disorder. The fibrillin genes located on chromosomes 15 and 5 are clearly involved in the classic form of Marfan syndrome and a clinically related disorder (congenital contractural arachnodactyly), respectively. To test whether one of these genes was also implicated in this French family, we performed genetic analyses. Blood samples were obtained for 56 family members, and four polymorphic fibrillin gene markers, located on chromosomes 15 (Fib15) and 5 (Fib5), respectively, were tested. Linkage between the disease allele and the markers of these two genes was excluded with lod scores of -11.39 (for Fib15) and -13.34 (for Fib5), at theta = .001, indicating that the mutation is at a different locus. This phenotype thus represents a new connective-tissue disorder, overlapping but different from classic Marfan syndrome.	INSERM,U73,CHATEAU DE LONGCHAMP,BOIS DE BOULOGNE,F-75016 PARIS,FRANCE; INSERM,U155,F-75016 PARIS,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U12,F-75730 PARIS 15,FRANCE; CHU AMBROISE PARE,CENT BIOCHIM & GENET MOLEC LAB,BOULOGNE,FRANCE; CHU AMBROISE PARE,SERV CARDIOL,BOULOGNE,FRANCE; SHRINERS HOSP CRIPPLED CHILDREN,PORTLAND,OR	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP			boileau, catherine/M-4482-2017	boileau, catherine/0000-0002-0371-7539; Babron, Marie-Claude/0000-0002-4100-0299				BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BLANTON SH, 1990, J MED GENET, V27, P73, DOI 10.1136/jmg.27.2.73; BOILEAU C, 1990, J MED GENET, V27, P78, DOI 10.1136/jmg.27.2.78; BOILEAU C, 1990, AM J HUM GENET, V47, pA682; CLARK BA, 1991, NUCLEIC ACIDS RES, V19, P4309, DOI 10.1093/nar/19.15.4309; DEVEREUX RB, 1987, AM HEART J, V113, P1265, DOI 10.1016/0002-8703(87)90955-0; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ELHABBAL M, 1989, AM J CARDIOL, V63, P322; EMMANUAL R, 1977, BRIT HEART J, V39, P190; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GLESBY MJ, 1989, JAMA-J AM MED ASSOC, V262, P523, DOI 10.1001/jama.262.4.523; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HENRY I, 1984, AM J HUM GENET, V36, P760; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KAINULAINEN K, 1990, NEW ENGL J MED, V323, P935, DOI 10.1056/NEJM199010043231402; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; McKusick V.A., 1972, HERITABLE DISORDERS, P61; McKusick VA, 1990, MENDELIAN INHERITANC; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; PYERITZ RE, 1990, PRINCIPLES PRACTICE, P1047; READ RC, 1965, CIRCULATION, V32, P897, DOI 10.1161/01.CIR.32.6.897; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SARFARAZI M, 1992, J MED GENET, V29, P75, DOI 10.1136/jmg.29.2.75; Sempe M., 1979, AUXOLOGIE METHODES S; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401	33	82	83	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					46	54						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317497				2022-12-18	WOS:A1993LJ38500007
J	WOLFF, RK; FRAZER, KA; JACKLER, RK; LANSER, MJ; PITTS, LH; COX, DR				WOLFF, RK; FRAZER, KA; JACKLER, RK; LANSER, MJ; PITTS, LH; COX, DR			ANALYSIS OF CHROMOSOME-22 DELETIONS IN NEUROFIBROMATOSIS TYPE-2-RELATED TUMORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILATERAL ACOUSTIC NEUROFIBROMATOSIS; GENETIC-LINKAGE; LONG ARM; DNA; MENINGIOMA; MARKERS; RETINOBLASTOMA; MECHANISMS; ALLELES; MAP	The neurofibromatosis type 2 (NF2) gene has been hypothesized to be a recessive tumor suppressor, with mutations at the same locus on chromosome 22 that lead to NF2 also leading to sporadic tumors of the types seen in NF2. Flanking markers for this gene have previously been defined as D22S1 centromeric and D22S28 telomeric. Identification of subregions of this interval that are consistently rearranged in the NF2-related tumors would aid in better defining the disease locus. To this end, we have compared tumor and constitutional DNAs, isolated from 39 unrelated patients with sporadic and NF2-associated acoustic neuromas, meningiomas, schwannomas, and ependymomas, at eight polymorphic loci on chromosome 22. Two of the tumors studied revealed loss-of-heterozygosity patterns, which is consistent with the presence of chromosome 22 terminal deletions. By using additional polymorphic markers, the terminal deletion breakpoint found in one of the tumors, an acoustic neuroma from an NF2 patient, was mapped within the previously defined NF2 region. The breakpoint occurred between the haplotyped markers D22S41/D22S46 and D22S56. This finding redefines the proximal flanking marker and localizes the NF2 gene between markers D22S41/D22S46 and D22S28. In addition, we identified a sporadic acoustic neuroma that reveals a loss-of-heterozygosity pattern consistent with mitotic recombination or deletion and reduplication, which are mechanisms not previously seen in studies of these tumors. This finding, while inconsistent with models of tumorigenesis that invoke single deletions and their gene-dosage effects, lends further support to the recessive tumor-suppressor model.	UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OTOLARYNGOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT NEUROSURG, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	WOLFF, RK (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PSYCHIAT, 3RD & PARNASSUS AVE, HSE 1556, BOX 0554, SAN FRANCISCO, CA 94143 USA.			Frazer, Kelly/0000-0002-6060-8902; jackler, robert/0000-0003-2525-8377	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024610] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; ARMOUR JAL, 1990, GENOMICS, V8, P501, DOI 10.1016/0888-7543(90)90037-U; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BUDARF ML, 1991, GENOMICS, V10, P996, DOI 10.1016/0888-7543(91)90190-P; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DAO DD, 1987, AM J HUM GENET, V41, P202; DELATTRE O, 1991, GENOMICS, V9, P721, DOI 10.1016/0888-7543(91)90366-M; DUMANSKI JP, 1990, CANCER RES, V50, P5863; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; DUMANSKI JP, 1991, GENOMICS, V11, P709, DOI 10.1016/0888-7543(91)90079-T; Eldridge R, 1981, Adv Neurol, V29, P57; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONTAINE B, 1991, ANN NEUROL, V29, P183, DOI 10.1002/ana.410290211; FRAZER KA, IN PRESS GENOMICS; KNUDSON AG, 1975, P NATL ACAD SCI USA, V72, P5116, DOI 10.1073/pnas.72.12.5116; KRAPCHO K, 1988, NUCLEIC ACIDS RES, V16, P5221, DOI 10.1093/nar/16.11.5221; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MEESE E, 1987, HUM GENET, V77, P349, DOI 10.1007/BF00291425; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OKAZAKI M, 1988, MOL BIOL MED, V5, P15; ROSCHMANN E, 1987, NUCLEIC ACIDS RES, V15, P1883, DOI 10.1093/nar/15.4.1883; ROULEAU GA, 1990, AM J HUM GENET, V46, P323; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; WELLER P, 1984, EMBO J, V3, P439, DOI 10.1002/j.1460-2075.1984.tb01825.x; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; YOUNG D F, 1971, Birth Defects Original Article Series, V7, P73	33	82	87	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					478	485						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496981				2022-12-18	WOS:A1992JJ82800004
J	FARRER, LA; MYERS, RH; CONNOR, L; CUPPLES, LA; GROWDON, JH				FARRER, LA; MYERS, RH; CONNOR, L; CUPPLES, LA; GROWDON, JH			SEGREGATION ANALYSIS REVEALS EVIDENCE OF A MAJOR GENE FOR ALZHEIMER-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNITED-STATES POPULATION; CLINICAL-FEATURES; COMPLEX SEGREGATION; SEVERE DEMENTIA; HETEROGENEITY; RISK; FAMILY; RELATIVES; LINKAGE; CHROMOSOME-21	In an attempt to resolve the relative influences of major genes, multifactorial heritability, and cohort effects on the susceptibility to Alzheimer disease (AD), complex segregation analysis was performed on 232 nuclear families. All families were consecutively ascertained through a single proband who was referred for diagnostic evaluation of a memory disorder. The results suggest that susceptibility to AD is determined, in part, by a major autosomal dominant allele with an additional multifactorial component. Single-locus, polygenic, sporadic, and no-transmission models, as well as recessive inheritance of the major effect, were significantly rejected. Excess transmission from the heterozygote was marginally significant and probably reflects the presence of phenocopies or perhaps the existence of two or more major loci for AD. The frequency of the AD susceptibility allele was estimated to be .038, but the major locus accounts for only 24% of the transmission variance, indicating a substantial role for other genetic and nongenetic mechanisms in the causation of AD.	BOSTON UNIV,SCH MED,SCH PUBL HLTH,BOSTON,MA 02118; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115	Boston University; Harvard University; Harvard Medical School	FARRER, LA (corresponding author), BOSTON UNIV,SCH MED,DEPT NEUROL,80 E CONCORD ST,BOSTON,MA 02118, USA.		Farrer, Lindsay/AAS-1035-2020	Cupples, L. Adrienne/0000-0003-0273-7965; Myers, Richard/0000-0002-8365-2674; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG006865] Funding Source: NIH RePORTER; NIA NIH HHS [AG06865, P50AG05134] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; BIRD TD, 1989, NEUROBIOL AGING, V10, P432, DOI 10.1016/0197-4580(89)90085-7; BREITNER JCS, 1988, NEUROLOGY, V38, P207; BREITNER JCS, 1984, PSYCHOL MED, V14, P63, DOI 10.1017/S0033291700003081; CHUI HC, 1985, NEUROLOGY, V35, P1544, DOI 10.1212/WNL.35.11.1544; CONSTANTINIDIS J, 1962, Encephale, V51, P301; CUPPLES LA, 1991, IN PRESS AM J HUM GE, V49; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FARRER LA, 1990, NEUROLOGY, V40, P395, DOI 10.1212/WNL.40.3_Part_1.395; FARRER LA, 1989, ANN NEUROL, V25, P485, DOI 10.1002/ana.410250511; FARRER LA, IN PRESS ARCH NEUROL; FOLSTEIN MF, 1989, NEUROBIOL AGING, V10, P434, DOI 10.1016/0197-4580(89)90086-9; FRIEDLAND RP, 1988, ANN INTERN MED, V109, P298, DOI 10.7326/0003-4819-109-4-298; GOATE AM, 1989, LANCET, V1, P352; HESTON LL, 1981, ARCH GEN PSYCHIAT, V38, P1085; HESTON LL, 1977, ARCH GEN PSYCHIAT, V34, P976; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; HUFF FJ, 1988, NEUROLOGY, V38, P786, DOI 10.1212/WNL.38.5.786; JARVIK LF, 1980, ARCH GEN PSYCHIAT, V37, P280; JOACHIM CL, 1988, ANN NEUROL, V24, P50, DOI 10.1002/ana.410240110; KALLMAN FJ, 1956, MENTAL DISORDERS LAT, P26; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LARSSON R, 1963, ACTA PSYCHIATR SCA S, V39, P167; MARTIN JJ, 1991, NEUROLOGY, V41, P62, DOI 10.1212/WNL.41.1.62; MARTIN RL, 1988, ARCH GEN PSYCHIAT, V45, P894; MAYEUX R, 1985, NEUROLOGY, V35, P453, DOI 10.1212/WNL.35.4.453; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEE LE, 1987, NEUROLOGY, V37, P359, DOI 10.1212/WNL.37.3.359; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; ROSES A D, 1990, Neurology, V40, P275; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1990, AM J HUM GENET S, V47, pA198; SCHOENBERG BS, 1985, ARCH NEUROL-CHICAGO, V42, P740, DOI 10.1001/archneur.1985.04210090004002; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; SJOGREN T, 1952, ACTA PSYCHIATR NEU S, V829, P1; STGEORGEHYSLOP PH, 1989, NEUROBIOL AGING, V10, P417, DOI 10.1016/0197-4580(89)90082-1; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; SULKAVA R, 1985, NEUROLOGY, V35, P1025, DOI 10.1212/WNL.35.7.1025; VANBROECKHOVEN C, 1988, AM J HUM GENET S, V43, pA205; VANDUIJN CM, IN PRESS ALZHEIMER D; WHALLEY LJ, 1982, BRIT J PSYCHIAT, V140, P249, DOI 10.1192/bjp.140.3.249; ZUBENKO GS, 1988, ARCH GEN PSYCHIAT, V45, P889; [No title captured]; 1982, PC801B23 US DEP COMM, V1, P23	50	82	84	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1026	1033						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035523				2022-12-18	WOS:A1991FP09200002
J	SAI, T; SEINO, S; CHANG, C; TRIFIRO, M; PINSKY, L; MHATRE, A; KAUFMAN, M; LAMBERT, B; TRAPMAN, J; BRINKMANN, AO; ROSENFIELD, RL; LIAO, SS				SAI, T; SEINO, S; CHANG, C; TRIFIRO, M; PINSKY, L; MHATRE, A; KAUFMAN, M; LAMBERT, B; TRAPMAN, J; BRINKMANN, AO; ROSENFIELD, RL; LIAO, SS			AN EXONIC POINT MUTATION OF THE ANDROGEN RECEPTOR GENE IN A FAMILY WITH COMPLETE ANDROGEN INSENSITIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHICAGO, BEN MAY INST, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT BIOCHEM & MOLEC BIOL, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT PEDIAT, CHICAGO, IL 60637 USA; MCGILL UNIV, DEPT BIOL, LADY DAVIS INST, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, DEPT PEDIAT, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, DEPT MED, MONTREAL H3A 2T5, QUEBEC, CANADA; HOP HOTEL DIEU, MONTREAL H2W 1T8, QUEBEC, CANADA; ERASMUS UNIV, DEPT BIOCHEM 2, 3000 DR ROTTERDAM, NETHERLANDS; ERASMUS UNIV, DEPT PATHOL, 3000 DR ROTTERDAM, NETHERLANDS	University of Chicago; University of Chicago; University of Chicago; Lady Davis Institute; McGill University; McGill University; McGill University; Universite de Montreal; Erasmus University Rotterdam; Erasmus University Rotterdam					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD006308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037694] Funding Source: NIH RePORTER; NICHD NIH HHS [HD06308] Funding Source: Medline; NIDDK NIH HHS [DK37694] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROWN CJ, 1989, AM J HUM GENET, V44, P264; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; BROWN TR, 1982, J CLIN ENDOCR METAB, V55, P61, DOI 10.1210/jcem-55-1-61; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; ELAWADY MK, 1983, AM J HUM GENET, V35, P376; FABER PW, 1989, MOL CELL ENDOCRINOL, V61, P257, DOI 10.1016/0303-7207(89)90137-8; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GREENBERG CR, 1987, AM J HUM GENET, V41, P128; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; KAUFMAN M, 1976, J CLIN INVEST, V58, P345, DOI 10.1172/JCI108478; KUIPER GGJM, 1989, J MOL ENDOCRINOL, V2, pR1, DOI 10.1677/jme.0.002R001; LUBAHN DB, 1989, P NATL ACAD SCI USA, V86, P9534, DOI 10.1073/pnas.86.23.9534; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; MARCELLI M, 1989, JUN ANN M END SOC SE; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P6339, DOI 10.1073/pnas.78.10.6339; ODELL WD, 1989, ENDOCRINOLOGY, P1860; PINSKY L, 1989, American Journal of Human Genetics, V45, pA212; PINSKY L, 1977, CAN MED ASSOC J, V116, P1274; PINSKY L, 1987, ADV HUM GENET, V16, P299; RISSTALPERS C, 1989, UROL RES, V17, P341; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; TRAPMAN J, 1988, BIOCHEM BIOPH RES CO, V153, P241, DOI 10.1016/S0006-291X(88)81214-2; TRIFIRO M, 1989, American Journal of Human Genetics, V45, pA225; WIEACKER P, 1987, HUM GENET, V76, P248	27	82	85	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1095	1100						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339702				2022-12-18	WOS:A1990DF20200010
J	COHEN, JE				COHEN, JE			DNA FINGERPRINTING FOR FORENSIC IDENTIFICATION - POTENTIAL EFFECTS ON DATA INTERPRETATION OF SUBPOPULATION HETEROGENEITY AND BAND NUMBER VARIABILITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	Rockefeller University								Bishop YM., 2007, DISCRETE MULTIVARIAT; BLACK B, 1988, SCIENCE, V239, P1508, DOI 10.1126/science.3281252; CHEN T, 1976, BIOMETRICS, V32, P133, DOI 10.2307/2529344; Cochran W.G, 1957, STAT METHODS, V6th ed; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEGROOT M, 1986, STATISTICS LAW; Fienberg S.E., 1980, ANAL CROSS CLASSIFIE, V2nd ed.; FIENBERG SE, 1986, BOSTON U LAW REV, V66, P771; GILL P, 1987, ELECTROPHORESIS, V8, P38, DOI 10.1002/elps.1150080109; GOOD IJ, 1987, ANN STAT, V15, P694, DOI 10.1214/aos/1176350369; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HABER M, 1986, BIOMETRICS, V42, P429, DOI 10.2307/2531063; Haberman S. J., 1974, ANAL FREQUENCY DATA, VIV; JEFFREYS AJ, 1986, AM J HUM GENET, V39, P11; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1987, ANIM GENET, V18, P1, DOI 10.1111/j.1365-2052.1987.tb00739.x; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KOEHLER KJ, 1986, J AM STAT ASSOC, V81, P483, DOI 10.2307/2289239; KRUSKAL W, 1988, J AM STAT ASSOC, V83, P929, DOI 10.2307/2290117; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LEWIN R, 1989, SCIENCE, V244, P1033, DOI 10.1126/science.2727690; MARX JL, 1988, SCIENCE, V240, P1616, DOI 10.1126/science.2898170; SENSABAUGH G, 1989, 32 COLD SPRING HARB; TRIBE LH, 1971, HARVARD LAW REV, V84, P1329, DOI 10.2307/1339610; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; Yule GU, 1902, BIOMETRIKA, V2, P121; 1989, IDENTIFICATION PAREN	28	82	82	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					358	368						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301401				2022-12-18	WOS:A1990CM93800017
J	MURRAY, JC; BUETOW, KH; DONOVAN, M; HORNUNG, S; MOTULSKY, AG; DISTECHE, C; DYER, K; SWISSHELM, K; ANDERSON, J; GIBLETT, E; SADLER, E; EDDY, R; SHOWS, TB				MURRAY, JC; BUETOW, KH; DONOVAN, M; HORNUNG, S; MOTULSKY, AG; DISTECHE, C; DYER, K; SWISSHELM, K; ANDERSON, J; GIBLETT, E; SADLER, E; EDDY, R; SHOWS, TB			LINKAGE DISEQUILIBRIUM OF PLASMINOGEN POLYMORPHISMS AND ASSIGNMENT OF THE GENE TO HUMAN CHROMOSOME-6Q26-6Q27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PUGET SOUND BLOOD CTR, SEATTLE, WA 98104 USA; NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, BUFFALO, NY 14263 USA; FOX CHASE CANC CTR, PHILADELPHIA, PA 19111 USA; UNIV WASHINGTON, DEPT BIOCHEM, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA	Puget Sound Blood Center; Roswell Park Cancer Institute; Fox Chase Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	MURRAY, JC (corresponding author), UNIV IOWA, GEN HOSP, DEPT PEDIAT, T-306, IOWA CITY, IA 52242 USA.							AOKI N, 1978, J CLIN INVEST, V61, P1186, DOI 10.1172/JCI109034; BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BISSBORT S, 1983, HUM GENET, V63, P126, DOI 10.1007/BF00291531; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P177; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; DEEB SS, 1986, P NATL ACAD SCI USA, V83, P419, DOI 10.1073/pnas.83.2.419; EIBERG H, 1984, CLIN GENET, V26, P23; EIBERG H, 1981, CLIN GENET, V19, P500; EIBERG H, 1982, CYTOGENET CELL GENET, V32, P270; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Lewontin R. C., 1974, COLUMBIA BIOL SERIES, V25; LI CC, 1976, 1ST COURSE POPULATIO; MALINOWSKI DP, 1984, BIOCHEMISTRY-US, V23, P4243, DOI 10.1021/bi00313a035; Mourant AE, 1976, DISTRIBUTION HUMAN B; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; MURRAY JC, 1983, P NATL ACAD SCI-BIOL, V80, P5951, DOI 10.1073/pnas.80.19.5951; OHLSSON M, 1985, P NATL ACAD SCI USA, V82, P4473, DOI 10.1073/pnas.82.13.4473; RAUM D, 1980, AM J HUM GENET, V32, P681; SHOWS T, 1984, SOMAT CELL MOLEC GEN, V10, P315, DOI 10.1007/BF01535253; SHOWS TB, 1983, ISOZYMES-CURR T BIOL, V10, P323; SHOWS TB, 1978, CYTOGENET CELL GENET, V21, P99, DOI 10.1159/000130882; SHOWS TB, 1982, ADV HUM GENET, V12, P341; WABER P G, 1985, American Journal of Human Genetics, V37, pA180	28	82	82	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1987	40	4					338	350						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H3196	2883890				2022-12-18	WOS:A1987H319600004
J	CHAKRABO.R; SHAW, M; SCHULL, W				CHAKRABO.R; SHAW, M; SCHULL, W			EXCLUSION OF PATERNITY - CURRENT STATE OF ART	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULATION GENET,HOUSTON,TX 77025; MAHATMA GANDHI MEM MED COLL,DEPT PAEDIAT,INDORE,INDIA; UNIV TEXAS,HLTH SCI CTR,MED GENET CTR,HOUSTON,TX 77025	University of Texas System; University of Texas Health Science Center Houston; MGM Medical College Indore; University of Texas System; University of Texas Health Science Center Houston								ALPER CA, 1968, J CLIN INVEST, V47, P2181, DOI 10.1172/JCI105904; ANDRESEN PH, 1952, HUMAN BLOOD GROUPS U; AZEN EA, 1972, SCIENCE, V176, P673, DOI 10.1126/science.176.4035.673; AZEN EA, 1969, BIOCHEM GENET, V3, P215, DOI 10.1007/BF00521138; BERG K, 1966, J EXP MED, V123, P379, DOI 10.1084/jem.123.2.379; BLUMBERG BS, 1964, NATURE, V202, P561, DOI 10.1038/202561a0; BOWMAN JE, 1967, NATURE, V214, P1156, DOI 10.1038/2141156a0; BOYD WC, 1954, AM J HUM GENET, V6, P426; CHEN SH, 1971, SCIENCE, V173, P148, DOI 10.1126/science.173.3992.148; CHEN SH, 1971, AM J HUM GENET, V23, P419; CLEGHORN TE, 1962, NATURE, V195, P297, DOI 10.1038/195297b0; COATES PM, 1972, SCIENCE, V175, P1466, DOI 10.1126/science.175.4029.1466; Cohen P T, 1972, Biochem Genet, V7, P303, DOI 10.1007/BF00484830; COOPER AJ, 1963, AM J HUM GENET, V15, P420; DAVIDSON RG, 1967, ANN HUM GENET, V30, P355, DOI 10.1111/j.1469-1809.1967.tb00037.x; ELLIS FR, 1963, HUM BIOL, V35, P26; FISHER RA, 1951, HEREDITY, V5, P95, DOI 10.1038/hdy.1951.5; FURUHATA T, 1961, P JPN ACAD, V37, P319, DOI 10.2183/pjab1945.37.319; FURUHATA T., 1957, PROC JAPANESE ACAD, V33, P228; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GIBLETT E. R., 1962, PROGR MED GENET, V2, P34; GIBLETT ER, 1965, AM J HUM GENET, V17, P425; GIBLETT ER, 1959, BRIT J HAEMATOL, V5, P319, DOI 10.1111/j.1365-2141.1959.tb04040.x; GILES CM, 1967, VOX SANG, V13, P171, DOI 10.1111/j.1423-0410.1967.tb03946.x; HARADA S, 1969, JPN J HUM GENET, V14, P248; HOPKINSON DA, 1966, ANN HUM GENET, V30, P167, DOI 10.1111/j.1469-1809.1966.tb00016.x; HOPKINSON DA, 1969, ANN HUM GENET, V32, P361, DOI 10.1111/j.1469-1809.1969.tb00087.x; HURSH RD, 1954, 46 AM LAW REP, P1000; ISHIMOTO G, 1969, JPN J HUM GENET, V14, P183; JACQUARD A, 1971, POPULATION, V26, P677, DOI 10.2307/1529856; JOHNSON AM, 1969, J CLIN INVEST, V48, P2293, DOI 10.1172/JCI106195; KELLERMA.G, 1970, HUMANGENETIK, V10, P145, DOI 10.1007/BF00295513; Landsteiner K, 1934, J IMMUNOL, V27, P469; LAYRISSE M, 1958, AM J PHYS ANTHROPOL, V16, P173, DOI 10.1002/ajpa.1330160203; LEWIS M, 1957, AM J HUM GENET, V9, P274; LEWIS WHP, 1969, ANN HUM GENET, V32, P317, DOI 10.1111/j.1469-1809.1969.tb00081.x; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; LEWIS WHP, 1971, EXCERPTA MEDICA  233, P111; LISKER R, 1967, AM J HUM GENET, V19, P174; LUBIN AH, 1971, SCIENCE, V173, P161, DOI 10.1126/science.173.3992.161; MACVIE SI, 1967, VOX SANG, V13, P493; MATSUNAGA E, 1964, ANNU REP NAT I GENET, V15, P150; MERRITT AD, 1971, EXCERPTA MEDICA  233, P120; Miller EB, 1954, AM J PHYS ANTHROP-NE, V12, P427, DOI 10.1002/ajpa.1330120316; NAKAJIMA H, 1971, J ANTHROPOL SOC NIP, V79, P178; NAKAJIMA H, 1962, P JPN ACAD, V38, P690, DOI 10.2183/pjab1945.38.690; NAKAJIMA HACHIRO, 1967, JAP J HUM GENET, V12, P29; NEEL JV, 1964, AM J HUM GENET, V16, P52; Neel JV, 1954, HUMAN HEREDITY; NEI M, 1966, HEREDITY, V21, P9, DOI 10.1038/hdy.1966.2; OMOTO K, 1969, JPN J HUM GENET, V14, P241; OSBORNE RH, 1958, AM J PHYS ANTHROPOL, V16, P187, DOI 10.1002/ajpa.1330160204; POLLITZER WS, 1956, AM J PHYS ANTHROPOL, V14, P445, DOI 10.1002/ajpa.1330140319; POVEY S, 1972, ANN HUM GENET, V35, P455, DOI 10.1111/j.1469-1809.1957.tb01870.x; Race R. R, 1968, BLOOD GROUPS MAN; REED TE, 1969, AM J HUM GENET, V21, P71; SALMON D, 1971, MED LEG DOMMAGE CORPOR, V4, P348; SAMLOFF IM, 1973, AM J HUM GENET, V25, P178; SAMLOFF IM, 1970, SCIENCE, V168, P144, DOI 10.1126/science.168.3927.144; SHAW MC, TO BE PUBLISHED; SHINODA T, 1969, Japanese Journal of Human Genetics, V13, P249; SHINODA T, 1969, ANN REP NATL I GENET, V20, P101; Shreffler D C, 1967, Biochem Genet, V1, P101, DOI 10.1007/BF00486512; SMITH M, 1972, ANN HUM GENET, V35, P243, DOI 10.1111/j.1469-1809.1957.tb01398.x; SMITH M, 1971, ANN HUM GENET, V34, P251, DOI 10.1111/j.1469-1809.1971.tb00238.x; STEINBERG A. G., 1964, HUM BIOL, V36, P77; SUYAMA H, 1969, HUM HERED, V19, P74, DOI 10.1159/000152202; TEISBERG P, 1972, VOX SANG, V22, P213, DOI 10.1111/j.1423-0410.1972.tb05194.x; WALTER H, 1970, HUMANGENETIK, V10, P298, DOI 10.1007/BF00278766; WIENER AS, 1954, SCIENCE, V119, P734, DOI 10.1126/science.119.3099.734; YAMAMOTO M, 1969, Japanese Journal of Human Genetics, V13, P256; YANASE T, 1968, Japanese Journal of Human Genetics, V13, P40	72	82	88	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	4					477	488						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	T5051	4841637				2022-12-18	WOS:A1974T505100006
J	HUIJING, F; FERNANDES, J				HUIJING, F; FERNANDES, J			X-CHROMOSOMAL INHERITANCE OF LIVER GLYCOGENOSIS WITH PHOSPHORYLASE KINASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CHAYOTH R, 1967, ISRAEL J MED SCI, V3, P422; FERNANDES J, IN PRESS; FIELD JB, 1965, J CLIN INVEST, V44, P1240, DOI 10.1172/JCI105230; HUIJING F, 1967, BIOCHIM BIOPHYS ACTA, V148, P601, DOI 10.1016/0304-4165(67)90171-7; HUIJING F, 1964, THESIS U AMSTERDAM; HUIJING F, 1968, CONTROL GLYCOGEN MET, P115; HULSMANN WC, 1961, LANCET, V2, P581; KREBS EG, 1964, BIOCHEMISTRY-US, V3, P1022, DOI 10.1021/bi00896a003; LYON JB, 1967, SCIENCE, V155, P1550, DOI 10.1126/science.155.3769.1550; LYON MF, 1962, AM J HUM GENET, V14, P135; VANHOOF F, 1967, EUR J BIOCHEM, V2, P265; WALLIS PG, 1966, AM J DIS CHILD, V111, P278, DOI 10.1001/archpedi.1966.02090060088008; WHELAN WJ, 1968, CONTROL GLYCOGEN  ED, P115; WILLIAMS HE, 1963, METABOLISM, V12, P235; WILLIAMS HE, 1961, J CLIN INVEST, V40, P1841, DOI 10.1172/JCI104408	15	82	83	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	3					275	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D4606	5306139				2022-12-18	WOS:A1969D460600005
J	GALL, JC; STERN, AM; COHEN, MM; ADAMS, MS; DAVIDSON, RT				GALL, JC; STERN, AM; COHEN, MM; ADAMS, MS; DAVIDSON, RT			HOLT-ORAM SYNDROME - CLINICAL AND GENETIC STUDY OF A LARGE FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COHEN MM, 1961, AM J HUM GENET, V13, P379; Cummins H, 1926, AM J ANAT, V38, P89, DOI 10.1002/aja.1000380105; Cummins H, 1943, FINGERPRINTS PALMS S, V1st; GRAHAM JB, 1959, AM J HUM GENET, V11, P333; HOLMES LB, 1965, NEW ENGL J MED, V272, P437, DOI 10.1056/NEJM196503042720901; HOLT M, 1960, BRIT HEART J, V22, P236; KUHN E, 1963, JPN HEART J, V4, P205; LEWIS KB, 1964, CIRCULATION, V30, P113; MCKUSICK VA, 1961, MEDICAL GENETICS 195, P426; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PENROSE LS, 1965, NATURE, V205, P544, DOI 10.1038/205544a0; PRUZANSKI W., 1964, CARDIOLOGIA, V45, P21, DOI 10.1159/000168096; SHAW RF, 1961, AM J HUM GENET, V13, P89; ZETTERQVIST P, 1963, ACTA PAEDIATR, V52, P115, DOI 10.1111/j.1651-2227.1963.tb04085.x	14	82	83	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	2					187	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	74253	5904863				2022-12-18	WOS:A19667425300006
J	Wright, CF; West, B; Tuke, M; Jones, SE; Patel, K; Laver, TW; Beaumont, RN; Tyrrell, J; Wood, AR; Frayling, TM; Hattersley, AT; Weedon, MN				Wright, Caroline F.; West, Ben; Tuke, Marcus; Jones, Samuel E.; Patel, Kashyap; Laver, Thomas W.; Beaumont, Robin N.; Tyrrell, Jessica; Wood, Andrew R.; Frayling, Timothy M.; Hattersley, Andrew T.; Weedon, Michael N.			Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASCERTAINMENT BIAS; COMPLEX TRAITS; MUTATIONS; ASSOCIATION; PHENOTYPE; GENE; HETEROGENEITY; INDIVIDUALS; GENERATION; PLEIOTROPY	More than 100,000 genetic variants are classified as disease causing in public databases. However, the true penetrance of many of these rare alleles is uncertain and might be over-estimated by clinical ascertainment. Here, we use data from 379,768 UK Biobank (UKB) participants of European ancestry to assess the pathogenicity and penetrance of putatively clinically important rare variants. Although rare variants are harder to genotype accurately than common variants, we were able to classify as high quality 1,244 of 4,585 (27%) putatively clinically relevant rare (MAF < 1%) variants genotyped on the UKB microarray. We defined as "clinically relevant'' variants that were classified as either pathogenic or likely pathogenic in ClinVar or are in genes known to cause two specific monogenic diseases: maturity-onset diabetes of the young (MODY) and severe developmental disorders (DDs). We assessed the penetrance and pathogenicity of these high-quality variants by testing their association with 401 clinically relevant traits. 27 of the variants were associated with a UKB trait, and we were able to refine the penetrance estimate for some of the variants. For example, the HNF4A c.340C>T (p.Arg114Trp) (GenBank: NM_175914.4) variant associated with diabetes is <10% penetrant by the time an individual is 40 years old. We also observed associations with relevant traits for heterozygous carriers of some rare recessive conditions, e.g., heterozygous carriers of the ERCC4 c.2395C>T (p.Arg799Trp) variant that causes Xeroderma pigmentosum were more susceptible to sunburn. Finally, we refute the previous disease association of RNF135 in developmental disorders. In conclusion, this study shows that very large population-based studies will help refine our understanding of the pathogenicity of rare genetic variants.	[Wright, Caroline F.; West, Ben; Tuke, Marcus; Jones, Samuel E.; Patel, Kashyap; Laver, Thomas W.; Beaumont, Robin N.; Tyrrell, Jessica; Wood, Andrew R.; Frayling, Timothy M.; Hattersley, Andrew T.; Weedon, Michael N.] Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Royal Devon & Exeter Hosp, Res Innovat Learning & Dev Bldg,Barrack Rd, Exeter EX2 5DW, Devon, England	University of Exeter	Wright, CF; Weedon, MN (corresponding author), Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Royal Devon & Exeter Hosp, Res Innovat Learning & Dev Bldg,Barrack Rd, Exeter EX2 5DW, Devon, England.	caroline.wright@exeter.ac.uk; m.n.weedon@exeter.ac.uk	Wood, Andrew R/AAB-3807-2019; Patel, Kashyap/AAR-1475-2021	Wood, Andrew R/0000-0003-1726-948X; Patel, Kashyap/0000-0002-9240-8104; Frayling, Timothy/0000-0001-8362-2603; Jones, Samuel Edward/0000-0003-0153-922X; Hattersley, Andrew/0000-0001-5620-473X; Wright, Caroline/0000-0003-2958-5076; Beaumont, Robin/0000-0003-0750-8248; Laver, Thomas/0000-0001-6399-0089	UK Biobank [871]; Medical Research Council [MR/M005070/1]; European Research Council [SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC, 323195]; Wellcome Trust [110082/Z/15/Z]; Royal Society [104150/Z/14/Z, 105636/Z/14/Z]; Diabetes Research and Wellness Foundation fellowship; MRC [MR/M005070/1] Funding Source: UKRI	UK Biobank; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Diabetes Research and Wellness Foundation fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank Resource. This work was carried out under UK Biobank project number 871. M.N.W. and S.E.J. are funded by the Medical Research Council (grant: MR/M005070/1). A.R.W. and T.M.F. are supported by the European Research Council (grants: SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC and 323195). R.B. is funded by the Wellcome Trust and Royal Society (grant: 104150/Z/14/Z). J.T. is funded by a Diabetes Research and Wellness Foundation fellowship. K.A.P. has a postdoctoral fellowship funded by the Wellcome Trust (110082/Z/15/Z). T.W.L. is funded by the Wellcome Trust and the Royal Society (105636/Z/14/Z). A.T.H. is a Wellcome Trust Senior Investigator (WT098395/Z/12/Z), and A.T.H. is a National Institute for Health Research (NIHR) Senior Investigator.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Bastarache L, 2018, SCIENCE, V359, P1233, DOI 10.1126/science.aal4043; Bevan CL, 1996, HUM MOL GENET, V5, P265, DOI 10.1093/hmg/5.2.265; Boycott KM, 2017, NEW ENGL J MED, V376, P83, DOI 10.1056/NEJMe1614384; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Chakera AJ, 2015, DIABETES CARE, V38, P1383, DOI 10.2337/dc14-2769; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; DeBoever C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03910-9; Douglas J, 2007, NAT GENET, V39, P963, DOI 10.1038/ng2083; Ellard S, 2013, DIABETOLOGIA, V56, P1958, DOI 10.1007/s00125-013-2962-5; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Ganguli M, 1998, J GERONTOL A-BIOL, V53, pM39, DOI 10.1093/gerona/53A.1.M39; Gillentine MA, 2018, J HUM GENET, V63, P795, DOI 10.1038/s10038-018-0451-x; Goldwurm S, 2011, MOVEMENT DISORD, V26, P2144, DOI 10.1002/mds.23807; Gratten J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0332-x; Harrison SM, 2016, CURR PROTOC HUM GENE, V89, P8; Hattersley AT, 2017, DIABETOLOGIA, V60, P769, DOI 10.1007/s00125-017-4226-2; Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197; Hormozdiari F, 2017, AM J HUM GENET, V100, P789, DOI 10.1016/j.ajhg.2017.04.005; Horner-Johnson W, 2013, J POLICY PRACT INTEL, V10, P260, DOI 10.1111/jppi.12048; Jefferson JA, 1997, NEPHROL DIAL TRANSPL, V12, P1595, DOI 10.1093/ndt/12.8.1595; Jones S. E., 2018, BIORXIV, DOI [10.1101/303941, DOI 10.1101/303941]; Jordan N, 2003, J CLIN ENDOCR METAB, V88, P1002, DOI 10.1210/jc.2002-021301; Karlsson R, 2014, EUR UROL, V65, P169, DOI 10.1016/j.eururo.2012.07.027; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Kelly MA, 2018, GENET MED, V20, P351, DOI 10.1038/gim.2017.218; King RA, 2003, AM J HUM GENET, V73, P638, DOI 10.1086/377569; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Laver TW, 2016, DIABETES, V65, P3212, DOI 10.2337/db16-0628; Lee AJ, 2017, MOVEMENT DISORD, V32, P1432, DOI 10.1002/mds.27059; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lunetta KL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8756; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Minikel EV, 2014, AM J HUM GENET, V95, P371, DOI 10.1016/j.ajhg.2014.09.003; Origa R, 1993, GENEREVIEWS; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Park S, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0198-6; Preising MN, 2007, MOL VIS, V13, P1851; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie MD, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.05; Shah N, 2018, AM J HUM GENET, V102, P609, DOI 10.1016/j.ajhg.2018.02.019; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tatton-Brown K, 2017, AM J HUM GENET, V100, P725, DOI 10.1016/j.ajhg.2017.03.010; Theunissen TEJ, 2017, J PEDIATR-US, V182, P371, DOI 10.1016/j.jpeds.2016.12.032; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Tuke M. A., 2017, BIORXIV, DOI [10.1101/177659, DOI 10.1101/177659]; Turan S, 2015, CURR OSTEOPOROS REP, V13, P146, DOI 10.1007/s11914-015-0268-x; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Visscher PM, 2016, NAT GENET, V48, P707, DOI 10.1038/ng.3604; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wright CF, 2018, NAT REV GENET, V19, P253, DOI 10.1038/nrg.2017.116; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Wright CF, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6845; Wu X, 2012, PARKINSONISM RELAT D, V18, P722, DOI 10.1016/j.parkreldis.2012.04.013; Zhang LY, 2016, P NATL ACAD SCI USA, V113, pE1536, DOI 10.1073/pnas.1600039113; Zhu J, 2018, BIOCHEM BIOPH RES CO, V496, P575, DOI 10.1016/j.bbrc.2018.01.099	69	81	81	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2019	104	2					275	286		10.1016/j.ajhg.2018.12.015	http://dx.doi.org/10.1016/j.ajhg.2018.12.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL2SW	30665703	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000458557800008
J	Poli, MC; Ebstein, F; Nicholas, SK; de Guzman, MM; Forbes, LR; Chinn, IK; Mace, EM; Vogel, TP; Carisey, AF; Benavides, F; Coban-Akdemir, ZH; Gibbs, RA; Jhangiani, SN; Muzny, DM; Carvalho, CMB; Schady, DA; Jain, M; Rosenfeld, JA; Emrick, L; Lewis, RA; Lee, B; Zieba, BA; Kury, S; Kruger, E; Lupski, JR; Bostwick, BL; Orange, JS				Poli, M. Cecilia; Ebstein, Frederic; Nicholas, Sarah K.; de Guzman, Marietta M.; Forbes, Lisa R.; Chinn, Ivan K.; Mace, Emily M.; Vogel, Tiphanie P.; Carisey, Alexandre F.; Benavides, Felipe; Coban-Akdemir, Zeynep H.; Gibbs, Richard A.; Jhangiani, Shalini N.; Muzny, Donna M.; Carvalho, Claudia M. B.; Schady, Deborah A.; Jain, Mahim; Rosenfeld, Jill A.; Emrick, Lisa; Lewis, Richard A.; Lee, Brendan; Zieba, Barbara A.; Kury, Sebastien; Krueger, Elke; Lupski, James R.; Bostwick, Bret L.; Orange, Jordan S.		Undiagnosed Dis Network	Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MONOGENIC AUTOINFLAMMATORY DISEASES; MESSENGER-RNA DECAY; LOSS-OF-FUNCTION; MUTATIONS CAUSE; PROTEASOME SYSTEM; DOMINANT; IMMUNOPROTEASOMES; HOMEOSTASIS; PRECURSORS; CHAPERONE	The proteasome processes proteins to facilitate immune recognition and host defense. When inherently defective, it can lead to aberrant immunity resulting in a dysregulated response that can cause autoimmunity and/or autoinflammation. Biallelic or digenic loss-of-function variants in some of the proteasome subunits have been described as causing a primary immunodeficiency disease that manifests as a severe dysregulatory syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE). Proteasome maturation protein (POMP) is a chaperone for proteasome assembly and is critical for the incorporation of catalytic subunits into the proteasome. Here, we characterize and describe POMP-related autoinflammation and immune dysregulation disease (PRAID) discovered in two unrelated individuals with a unique constellation of early-onset combined immunodeficiency, inflammatory neutrophilic dermatosis, and autoimmunity. We also begin to delineate a complex genetic mechanism whereby de novo heterozygous frameshift variants in the penultimate exon of POMP escape nonsense-mediated mRNA decay (NMD) and result in a truncated protein that perturbs proteasome assembly by a dominant-negative mechanism. To our knowledge, this mechanism has not been reported in any primary immunodeficiencies, autoinflammatory syndromes, or autoimmune diseases. Here, we define a unique hypo- and hyper-immune phenotype and report an immune dysregulation syndrome caused by frameshift mutations that escape NMD.	[Poli, M. Cecilia; Nicholas, Sarah K.; de Guzman, Marietta M.; Chinn, Ivan K.; Mace, Emily M.; Vogel, Tiphanie P.; Carisey, Alexandre F.; Emrick, Lisa; Lewis, Richard A.; Lupski, James R.; Bostwick, Bret L.; Orange, Jordan S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Poli, M. Cecilia; Nicholas, Sarah K.; de Guzman, Marietta M.; Forbes, Lisa R.; Chinn, Ivan K.; Mace, Emily M.; Vogel, Tiphanie P.; Carisey, Alexandre F.; Orange, Jordan S.] Texas Childrens Hosp, Div Pediat Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Poli, M. Cecilia; Benavides, Felipe; Lee, Brendan] Univ Desarrollo, Clin Alemana Santiago, Inst Ciencias & Innovac Med, Rm 7590943, Chile; [Ebstein, Frederic; Zieba, Barbara A.; Krueger, Elke] Univ Med Greifswald, Inst Med Biochem & Mol Biol, D-17475 Greifswald, Germany; [Coban-Akdemir, Zeynep H.; Gibbs, Richard A.; Carvalho, Claudia M. B.; Jain, Mahim; Rosenfeld, Jill A.; Lewis, Richard A.; Lupski, James R.; Bostwick, Bret L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gibbs, Richard A.; Jhangiani, Shalini N.; Muzny, Donna M.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Schady, Deborah A.] Texas Childrens Hosp, Dept Pathol & Immunol, Houston, TX 77030 USA; [Emrick, Lisa] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Kury, Sebastien] Ctr Hosp Univ Nantes Hotel Dieu, Inst Biol, Serv Genet Med, Lab Genet Mol, F-44093 Nantes 1, France; [Lupski, James R.; Bostwick, Bret L.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Clinica Alemana; Universidad del Desarrollo; Greifswald Medical School; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Nantes Universite; CHU de Nantes; Baylor College of Medicine	Orange, JS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Orange, JS (corresponding author), Texas Childrens Hosp, Div Pediat Immunol Allergy & Rheumatol, Houston, TX 77030 USA.	orange@bcm.edu	Krueger, Elke/B-1462-2012; Carisey, Alexandre F/A-5026-2015; Poli, Cecilia/AAU-1373-2020; KÜRY, Sébastien/G-5971-2015	Krueger, Elke/0000-0002-2551-242X; Carisey, Alexandre F/0000-0003-1326-2205; Poli, Cecilia/0000-0001-6817-0573; KÜRY, Sébastien/0000-0001-5497-0465; Brown, Donna/0000-0002-8805-7225; Chinn, Ivan/0000-0001-5684-5457; Benavides, Felipe/0000-0002-8251-1394; orange, jordan/0000-0001-7117-7725	NIH National Institute of Allergy and Infectious Diseases [R01AI120989]; Jeffrey Modell Foundation; NIH National Institute of Neurological Disorders and Stroke [R35NS105078]; National Human Genome Research Institute [U01 HG006542]; National Heart, Lung, and Blood Institute [U01 HG006542]; Fritz-Thyssen-Foundation [10.16.2.022 MN]; German Research Foundation [SFBTRR 167 A04]; NIH Common Fund through the Office of Strategic Coordination; NIH Common Fund through the Office of the NIH Director [U01 HG007709]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, UM1HG006542, U01HG007709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS105078, R01NS058529] Funding Source: NIH RePORTER	NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jeffrey Modell Foundation; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fritz-Thyssen-Foundation; German Research Foundation(German Research Foundation (DFG)); NIH Common Fund through the Office of Strategic Coordination; NIH Common Fund through the Office of the NIH Director; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge members of the Undiagnosed Diseases Network (listed in the Consortia section) for their participation in this study. We are also grateful to Lisa Bouchier-Hayes for her scientific advice and to the following clinical consult physicians who participated in patient care: Ryan Himes, gastroenterology; Timothy Vece, pulmonology; Carl Allen and Caridad Martinez, hematology; Reagan Hunt, dermatology; and Alisa Acosta, nephrology. Finally, we thank both individuals described in this manuscript and their families for facilitating this work. Research reported in this manuscript was supported in part by the NIH National Institute of Allergy and Infectious Diseases (R01AI120989 to J.S.O.), the Jeffrey Modell Foundation (to J.S.O.), the NIH National Institute of Neurological Disorders and Stroke (R35NS105078 to J.R.L.), the National Human Genome Research Institute and National Heart, Lung, and Blood Institute (U01 HG006542 to the Baylor Hopkins Center for Mendelian Genomics), the Fritz-Thyssen-Foundation (AZ: 10.16.2.022 MN to E.K.), the German Research Foundation (SFBTRR 167 A04 to E.K.), and the NIH Common Fund through the Office of Strategic Coordination and Office of the NIH Director (U01 HG007709). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bayram Y, 2017, AM J HUM GENET, V101, P149, DOI 10.1016/j.ajhg.2017.06.006; Ben-Shachar S, 2009, CLIN GENET, V75, P394, DOI 10.1111/j.1399-0004.2008.01114.x; Boisson B, 2015, CURR OPIN IMMUNOL, V32, P90, DOI 10.1016/j.coi.2015.01.005; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Bousfiha A, 2015, J CLIN IMMUNOL, V35, P727, DOI 10.1007/s10875-015-0198-5; Brehm A, 2015, J CLIN INVEST, V125, P4196, DOI 10.1172/JCI81260; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; Burrage LC, 2015, AM J HUM GENET, V97, P904, DOI 10.1016/j.ajhg.2015.11.006; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7128, DOI 10.1073/pnas.1521651112; Dahlmann B, 2016, ARCH BIOCHEM BIOPHYS, V591, P132, DOI 10.1016/j.abb.2015.12.012; Dahlqvist J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029471; Dahlqvist J, 2010, AM J HUM GENET, V86, P596, DOI 10.1016/j.ajhg.2010.02.018; de Graaf N, 2011, EUR J IMMUNOL, V41, P926, DOI 10.1002/eji.201041040; Feist E, 2016, CLIN IMMUNOL, V172, P83, DOI 10.1016/j.clim.2016.07.018; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Gatz SA, 2016, HUM MUTAT, V37, P257, DOI 10.1002/humu.22939; Gerbracht JV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10847-4; Groot N, 2017, ANN RHEUM DIS, V76, P1637, DOI 10.1136/annrheumdis-2016-211001; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; Hoefer MM, 2006, INT J BIOL MACROMOL, V38, P259, DOI 10.1016/j.ijbiomac.2006.03.015; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jansen S, 2017, AM J HUM GENET, V100, P650, DOI 10.1016/j.ajhg.2017.02.005; Kock M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7123; Koerner J, 2017, ONCOTARGET, V8, P50873, DOI 10.18632/oncotarget.15141; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Megarbane A, 2002, J RHEUMATOL, V29, P1084; Miller JN, 2014, MUTAT RES-REV MUTAT, V762, P52, DOI 10.1016/j.mrrev.2014.05.001; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Oda H, 2017, RHEUM DIS CLIN N AM, V43, P327, DOI 10.1016/j.rdc.2017.04.011; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pathak S, 2017, J CLIN PATHOL, V70, P1, DOI 10.1136/jclinpath-2016-203810; Sasaki K, 2010, MOL CELL BIOL, V30, P3864, DOI 10.1128/MCB.00216-10; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seifert U, 2008, BIOCHEM SOC T, V36, P879, DOI 10.1042/BST0360879; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Sotzny F, 2016, ANTIOXID REDOX SIGN, V25, P870, DOI 10.1089/ars.2015.6539; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tosato G, 2007, CURR PROTOC IMMUNOL, P22; Veitia RA, 2007, PLANT CELL, V19, P3843, DOI 10.1105/tpc.107.055053; Veitia RA, 2009, J PATHOL, V218, P409, DOI 10.1002/path.2583; White JJ, 2016, AM J HUM GENET, V98, P553, DOI 10.1016/j.ajhg.2016.01.005; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Xia F, 2014, AM J HUM GENET, V94, P784, DOI 10.1016/j.ajhg.2014.04.006; Zhang X, 2015, MOL CELL, V59, P243, DOI 10.1016/j.molcel.2015.05.036	50	81	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1126	1142		10.1016/j.ajhg.2018.04.010	http://dx.doi.org/10.1016/j.ajhg.2018.04.010			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29805043	Bronze, Green Published			2022-12-18	WOS:000434946200010
J	Aref-Eshghi, E; Rodenhiser, DI; Schenkel, LC; Lin, HX; Skinner, C; Ainsworth, P; Pare, G; Hood, RL; Bulman, DE; Kernohan, KD; Boycott, KM; Campeau, PM; Schwartz, C; Sadikovic, B				Aref-Eshghi, Erfan; Rodenhiser, David I.; Schenkel, Laila C.; Lin, Hanxin; Skinner, Cindy; Ainsworth, Peter; Pare, Guillaume; Hood, Rebecca L.; Bulman, Dennis E.; Kernohan, Kristin D.; Boycott, Kym M.; Campeau, Philippe M.; Schwartz, Charles; Sadikovic, Bekim		Care4Rare Canada Consortium	Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLOATING-HARBOR SYNDROME; KABUKI SYNDROME; EPIGENETIC MACHINERY; MENDELIAN DISORDERS; MUTATIONS; CHARGE; VALIDATION; PATTERNS; OVERLAP; LINKING	Pediatric developmental syndromes present with systemic, complex, and often overlapping clinical features that are not infrequently a consequence of Mendelian inheritance of mutations in genes involved in DNA methylation, establishment of histone modifications, and chromatin remodeling (the "epigenetic machinery''). The mechanistic cross-talk between histone modification and DNA methylation suggests that these syndromes might be expected to display specific DNA methylation signatures that are a reflection of those primary errors associated with chromatin dysregulation. Given the interrelated functions of these chromatin regulatory proteins, we sought to identify DNA methylation epi-signatures that could provide syndrome-specific biomarkers to complement standard clinical diagnostics. In the present study, we examined peripheral blood samples from a large cohort of individuals encompassing 14 Mendelian disorders displaying mutations in the genes encoding proteins of the epigenetic machinery. We demonstrated that specific but partially overlapping DNA methylation signatures are associated with many of these conditions. The degree of overlap among these epi-signatures is minimal, further suggesting that, consistent with the initial event, the downstream changes are unique to every syndrome. In addition, by combining these epi-signatures, we have demonstrated that a machine learning tool can be built to concurrently screen for multiple syndromes with high sensitivity and specificity, and we highlight the utility of this tool in solving ambiguous case subjects presenting with variants of unknown significance, along with its ability to generate accurate predictions for subjects presenting with the overlapping clinical and molecular features associated with the disruption of the epigenetic machinery.	[Aref-Eshghi, Erfan; Schenkel, Laila C.; Lin, Hanxin; Ainsworth, Peter; Sadikovic, Bekim] Western Univ, Dept Pathol & Lab Med, London, ON N6A 5C1, Canada; [Aref-Eshghi, Erfan; Lin, Hanxin; Ainsworth, Peter; Sadikovic, Bekim] London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON N6A5W9, Canada; [Rodenhiser, David I.] Western Univ, Dept Pediat, London, ON N6A 5C1, Canada; [Rodenhiser, David I.] Western Univ, Dept Biochem & Oncol, London, ON N6A 5C1, Canada; [Rodenhiser, David I.] Childrens Hlth Res Inst, London, ON N6A 5C1, Canada; [Skinner, Cindy; Schwartz, Charles] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Hood, Rebecca L.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Bulman, Dennis E.; Kernohan, Kristin D.; Boycott, Kym M.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H5B2, Canada; [Campeau, Philippe M.] Univ Montreal, Dept Pediat, Montreal, PQ H3T1J4, Canada	Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Greenwood Genetic Center; McMaster University; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Universite de Montreal	Sadikovic, B (corresponding author), Western Univ, Dept Pathol & Lab Med, London, ON N6A 5C1, Canada.; Sadikovic, B (corresponding author), London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON N6A5W9, Canada.	bekim.sadikovic@lhsc.on.ca	Campeau, Philippe/J-8614-2015; Pare, Guillaume/T-9631-2018	Campeau, Philippe/0000-0001-9713-7107; Pare, Guillaume/0000-0002-6795-4760	Children's Health Research Institute Epigenetics Trainee Award - Children's Health Foundation, London, Ontario, Canada	Children's Health Research Institute Epigenetics Trainee Award - Children's Health Foundation, London, Ontario, Canada	We thank the families, the molecular genetics diagnostic laboratory at the Greenwood Genetic Center for identifying the mutations in the subjects, and the clinical geneticists at the Greenwood Genetic Center for making the clinical diagnosis. We also thank the Care4Rare Canada Consortium for the identification and molecular analyses of subjects with a subset of the neurodevelopmental conditions that were part of this study. E.A.-E. was supported by Children's Health Research Institute Epigenetics Trainee Award, funded by the Children's Health Foundation, London, Ontario, Canada. Dedicated to the memory of Ethan Francis Schwartz, 1996-1998.	Aref-Eshghi E, 2017, EPIGENETICS-US, V12, P923, DOI 10.1080/15592294.2017.1381807; Aref-Eshghi E, 2017, J MOL DIAGN, V19, P848, DOI 10.1016/j.jmoldx.2017.07.002; Barault L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055896; Baujat G, 2005, AM J MED GENET C, V137C, P4, DOI 10.1002/ajmg.c.30060; Berdasco M, 2013, HUM GENET, V132, P359, DOI 10.1007/s00439-013-1271-x; Bjornsson HT, 2015, GENOME RES, V25, P1473, DOI 10.1101/gr.190629.115; Bogershausen N, 2016, HUM MUTAT, V37, P847, DOI 10.1002/humu.23026; Butcher DT, 2017, AM J HUM GENET, V100, P773, DOI 10.1016/j.ajhg.2017.04.004; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Ehrhart F, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0545-5; Fahrner JA, 2014, ANNU REV GENOM HUM G, V15, P269, DOI 10.1146/annurev-genom-090613-094245; Gossai N, 2015, AM J MED GENET A, V167, P3186, DOI 10.1002/ajmg.a.37356; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Harmeyer KM, 2017, TRENDS CANCER, V3, P713, DOI 10.1016/j.trecan.2017.08.004; Hood RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38803; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Karagianni P, 2016, AM J MED GENET A, V170, P1333, DOI 10.1002/ajmg.a.37584; Kernohan KD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0254-x; Kim JH, 2014, CANCER RES, V74, P1705, DOI 10.1158/0008-5472.CAN-13-1896; Kulkarni K, 2013, J PEDIAT HEMATOL ONC, V35, P238, DOI 10.1097/MPH.0b013e318279b232; Lonardo F, 2017, CLIN GENET; Ma BS, 2014, NUCLEIC ACIDS RES, V42, P3515, DOI 10.1093/nar/gkt1380; Montano CM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r94; Patel N, 2015, AM J MED GENET A, V167, P259, DOI 10.1002/ajmg.a.36804; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schenkel LC, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0118-4; Schenkel LC, 2016, J MOL DIAGN, V18, P834, DOI 10.1016/j.jmoldx.2016.06.005; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Stagi S, 2016, IMMUNOL RES, V64, P345, DOI 10.1007/s12026-015-8707-4; Watson RE, 2004, MOL CARCINOGEN, V41, P54, DOI 10.1002/mc.20043; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323	36	81	81	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					156	174		10.1016/j.ajhg.2017.12.008	http://dx.doi.org/10.1016/j.ajhg.2017.12.008			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29304373	Green Published, Bronze			2022-12-18	WOS:000419305500012
J	Darin, N; Reid, E; Prunetti, L; Samuelsson, L; Husain, RA; Wilson, M; El Yacoubi, B; Footitt, E; Chong, WK; Wilson, LC; Prunty, H; Pope, S; Heales, S; Lascelles, K; Champion, M; Wassmer, E; Veggiotti, P; de Crecy-Lagard, V; Mills, PB; Clayton, PT				Darin, Niklas; Reid, Emma; Prunetti, Laurence; Samuelsson, Lena; Husain, Ralf A.; Wilson, Matthew; El Yacoubi, Basma; Footitt, Emma; Chong, W. K.; Wilson, Louise C.; Prunty, Helen; Pope, Simon; Heales, Simon; Lascelles, Karine; Champion, Mike; Wassmer, Evangeline; Veggiotti, Pierangelo; de Crecy-Lagard, Valerie; Mills, Philippa B.; Clayton, Peter T.			Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT EPILEPSY; 5'-PHOSPHATE; DEFICIENCY; PROTEINS; ACID; PYRIDOXAL-5'-PHOSPHATE; HYPOPHOSPHATASIA; MECHANISM; SEIZURES; BINDING	Pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, functions as a cofactor in humans for more than 140 enzymes, many of which are involved in neurotransmitter synthesis and degradation. A deficiency of PLP can present, therefore, as seizures and other symptoms that are treatable with PLP and/or pyridoxine. Deficiency of PLP in the brain can be caused by inborn errors affecting B6 vitamer metabolism or by inactivation of PLP, which can occur when compounds accumulate as a result of inborn errors of other pathways or when small molecules are ingested. Whole-exome sequencing of two children from a consanguineous family with pyridoxine-dependent epilepsy revealed a homozygous nonsense mutation in proline synthetase co-transcribed homolog (bacterial), PROSC, which encodes a PLP-binding protein of hitherto unknown function. Subsequent sequencing of 29 unrelated indivduals with pyridoxine-responsive epilepsy identified four additional children with biallelic PROSC mutations. Pre-treatment cerebrospinal fluid samples showed low PLP concentrations and evidence of reduced activity of PLP-dependent enzymes. However, cultured fibroblasts showed excessive PLP accumulation. An E. coli mutant lacking the PROSC homolog (Delta YggS) is pyridoxine sensitive; complementation with human PROSC restored growth whereas hPROSC encoding p.Leu175Pro, p.Arg241Gln, and p.Ser78Ter did not. PLP, a highly reactive aldehyde, poses a problem for cells, which is how to supply enough PLP for apoenzymes while maintaining free PLP concentrations low enough to avoid unwanted reactions with other important cellular nucleophiles. Although the mechanism involved is not fully understood, our studies suggest that PROSC is involved in intracellular homeostatic regulation of PLP, supplying this cofactor to apoenzymes while minimizing any toxic side reactions.	[Darin, Niklas] Univ Gothenburg, Dept Pediat, S-41685 Gothenburg, Sweden; [Darin, Niklas] Sahlgrens Univ Hosp, S-41685 Gothenburg, Sweden; [Reid, Emma; Wilson, Matthew; Heales, Simon; Mills, Philippa B.; Clayton, Peter T.] UCL, Inst Child Hlth, Genet & Genom Med, London WC1N 1EH, England; [Prunetti, Laurence; El Yacoubi, Basma; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Inst Food & Agr Sci, Gainesville, FL 32611 USA; [Prunetti, Laurence; El Yacoubi, Basma; de Crecy-Lagard, Valerie] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Samuelsson, Lena] Sahlgrens Univ Hosp, Dept Clin Genet, S-41345 Gothenburg, Sweden; [Husain, Ralf A.] Jena Univ Hosp, Dept Neuroped, Ctr Inborn Metab Disorders, D-07740 Jena, Germany; [Footitt, Emma] Great Ormond St Hosp NHS Fdn Trust, Dept Metab Med, London WC1N 3JH, England; [Chong, W. K.] Great Ormond St Hosp NHS Fdn Trust, Dept Radiol, London WC1N 3JH, England; [Wilson, Louise C.] Great Ormond St Hosp NHS Fdn Trust, Dept Clin Genet, London WC1N 3JH, England; [Prunty, Helen; Heales, Simon] Great Ormond St Hosp NHS Fdn Trust, Dept Chem Pathol, London WC1N 3JH, England; [Pope, Simon; Heales, Simon] Natl Hosp, Neurometab Unit, Queen Sq, London WC1N 3BG, England; [Lascelles, Karine] St Thomas Hosp, Evelina London Childrens Hosp, Dept Neurosci, Westminster Bridge Rd, London SE1 7EH, England; [Champion, Mike] St Thomas Hosp, Evelina London Childrens Hosp, Dept Inherited Metab Dis, Westminster Bridge Rd, London SE1 7EH, England; [Wassmer, Evangeline] Birmingham Childrens Hosp, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England; [Veggiotti, Pierangelo] C Mondino Natl Neurol Inst, Dept Child Neurol & Psychiat, Mondino 2, I-27100 Pavia, Italy; [Veggiotti, Pierangelo] Univ Pavia, Brain & Behav Dept, Str Nuova 65, Pavia, Italy; [El Yacoubi, Basma] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sahlgrenska University Hospital; Friedrich Schiller University of Jena; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of Birmingham; IRCCS Fondazione Casimiro Mondino; University of Pavia; State University System of Florida; University of Florida	Mills, PB; Clayton, PT (corresponding author), UCL, Inst Child Hlth, Genet & Genom Med, London WC1N 1EH, England.	p.mills@ucl.ac.uk; peter.clayton@ucl.ac.uk	Wassmer, Evangeline/K-5467-2019; Darin, Niklas/AAL-6345-2020; Wilson, Matthew/ABA-8602-2021; Husain, Ralf A./AAO-7658-2020; de Crecy-Lagard, Valerie/AAN-8995-2020	Wilson, Matthew/0000-0003-2252-8730; Husain, Ralf A./0000-0003-0798-6346; Chong, Kling/0000-0002-4335-3864; Pope, Simon Alexander Samuel/0000-0002-2991-3722; Mills, Philippa/0000-0002-9704-1268; Clayton, Peter/0000-0001-7592-4302	National Institute for Health Research Biomedical Research Centre at GOSH for Children NHS Foundation Trust; University College London; US National Science Foundationgrant [MCB1611711]; GOSH Children's Charity; GOSH Children's Charity [V4115]; Great Ormond Street Hospital (GOSH) Children's Charity Leadership awards [V2516, V1254]; Direct For Biological Sciences [1153413] Funding Source: National Science Foundation; Great Ormond Street Hospital Childrens Charity [V1273, V4115] Funding Source: researchfish	National Institute for Health Research Biomedical Research Centre at GOSH for Children NHS Foundation Trust; University College London(General Electric); US National Science Foundationgrant(National Science Foundation (NSF)); GOSH Children's Charity; GOSH Children's Charity; Great Ormond Street Hospital (GOSH) Children's Charity Leadership awards; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Great Ormond Street Hospital Childrens Charity	P.B.M. and P.T.C. received Great Ormond Street Hospital (GOSH) Children's Charity Leadership awards (V2516 and V1254), and P.B.M., P.T.C. and S.H. are supported by the National Institute for Health Research Biomedical Research Centre at GOSH for Children NHS Foundation Trust and University College London. V.d.C.-L. is funded by a US National Science Foundationgrant (MCB1611711). E.R. was funded by an award from University College London and GOSH Children's Charity, and M.W. is also funded by GOSH Children's Charity (V4115). We thank Georg F. Hoffmann (Division of Neuropediatrics and Pediatric Metabolic Medicine, University Children's Hospital Heidelberg) and Gajja S. Salomons (Metabolic Laboratory, VU University Medical Centre, Amsterdam) for laboratory studies (regarding subject 5), Andrew Hanson, with whom early discussions helped formulate a possible link between PROSC and PLP homeostasis, and Dr. Stephan Coburn (Department of Chemistry, Indiana University) for the kind gift of the D2-PLP.	Albersen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120972; Albersen M, 2012, PEDIATRICS, V130, pE191, DOI 10.1542/peds.2011-3751; Belachew D, 2013, JIMD REP, V11, P17, DOI 10.1007/8904_2013_217; BOHNEY JP, 1992, FEBS LETT, V298, P266, DOI 10.1016/0014-5793(92)80073-P; di Salvo ML, 2015, BBA-PROTEINS PROTEOM, V1854, P1160, DOI 10.1016/j.bbapap.2015.01.013; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; Eswaramoorthy S, 2003, ACTA CRYSTALLOGR D, V59, P127, DOI 10.1107/S0907444902018012; Farrant RD, 2001, J BIOL CHEM, V276, P15107, DOI 10.1074/jbc.M010860200; Footitt EJ, 2012, J INHERIT METAB DIS, V35, pS18, DOI 10.1007/s10545-012-9493-y; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Hatch J, 2016, JIMD REP, V26, P91, DOI 10.1007/8904_2015_482; Hoffmann GF, 2007, J INHERIT METAB DIS, V30, P96, DOI 10.1007/s10545-006-0508-4; Ikegawa S, 1999, J HUM GENET, V44, P337, DOI 10.1007/s100380050172; INK SL, 1984, J BIOL CHEM, V259, P5833; Ito T, 2013, J BACTERIOL, V195, P5439, DOI 10.1128/JB.00593-13; Kajita R, 2013, CHEM RES TOXICOL, V26, P1926, DOI 10.1021/tx400354d; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Mills PB, 2014, BRAIN, V137, P1350, DOI 10.1093/brain/awu051; Mills PB, 2010, BRAIN, V133, P2148, DOI 10.1093/brain/awq143; Ng BG, 2015, J INHERIT METAB DIS, V38, P171, DOI 10.1007/s10545-014-9752-1; Phillips RS, 2015, BBA-PROTEINS PROTEOM, V1854, P1167, DOI 10.1016/j.bbapap.2014.12.028; Pons R, 2004, NEUROLOGY, V62, P1058, DOI 10.1212/WNL.62.7.1058; Prunetti L, 2016, MICROBIOL-SGM, V162, P694, DOI 10.1099/mic.0.000255; Safo MK, 2005, ACTA CRYSTALLOGR D, V61, P599, DOI 10.1107/S0907444905005512; SCHONBECK ND, 1975, J BIOL CHEM, V250, P5343; STEPURO II, 1988, UKR BIOKHIM ZH+, V60, P34; Terzuoli L, 1998, LIFE SCI, V63, P1251, DOI 10.1016/S0024-3205(98)00387-7; van Karnebeek CDM, 2016, PEDIATR NEUROL, V59, P6, DOI 10.1016/j.pediatrneurol.2015.12.013; Vistoli G, 2013, EUR J MED CHEM, V66, P153, DOI 10.1016/j.ejmech.2013.05.009; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wassenberg T, 2010, MOL GENET METAB, V101, P349, DOI 10.1016/j.ymgme.2010.08.003; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; Whittaker JW, 2016, ARCH BIOCHEM BIOPHYS, V592, P20, DOI 10.1016/j.abb.2015.11.031; WHYTE MP, 1988, J CLIN INVEST, V81, P1234, DOI 10.1172/JCI113440	37	81	87	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1325	1337		10.1016/j.ajhg.2016.10.011	http://dx.doi.org/10.1016/j.ajhg.2016.10.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27912044	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000389148600008
J	Arboleda, VA; Lee, H; Dorrani, N; Zadeh, N; Willis, M; Macmurdo, CF; Manning, MA; Kwan, A; Hudgins, L; Barthelemy, F; Miceli, MC; Quintero-Rivera, F; Kantarci, S; Strom, SP; Deignan, JL; Grody, WW; Vilain, E; Nelson, SF				Arboleda, Valerie A.; Lee, Hane; Dorrani, Naghmeh; Zadeh, Neda; Willis, Mary; Macmurdo, Colleen Forsyth; Manning, Melanie A.; Kwan, Andrea; Hudgins, Louanne; Barthelemy, Florian; Miceli, M. Carrie; Quintero-Rivera, Fabiola; Kantarci, Sibel; Strom, Samuel P.; Deignan, Joshua L.; Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.		UCLA Clinical Genomics Ctr	De Novo Nonsense Mutations in KAT6A, a Lysine Acetyl-Transferase Gene, Cause a Syndrome Including Microcephaly and Global Developmental Delay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUKEMIA ZINC-FINGER; CAUSE GENITOPATELLAR SYNDROME; DUCHENNE MUSCULAR-DYSTROPHY; HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; MONOCYTIC LEUKEMIA; HISTONE ACETYLTRANSFERASE; MENDELIAN DISORDERS; NITRIC-OXIDE; MOZ	Chromatin remodeling through histone acetyltransferase (HAT) and histone deactylase (HDAC) enzymes affects fundamental cellular processes including the cell-cycle, cell differentiation, metabolism, and apoptosis. Nonsense mutations in genes that are involved in histone acetylation and deacetylation result in multiple congenital anomalies with most individuals displaying significant developmental delay, microcephaly and dysmorphism. Here, we report a syndrome caused by de novo heterozygous nonsense mutations in KAT6A (a.k.a., MOZ, MYST3) identified by clinical exome sequencing (CES) in four independent families. The same de novo nonsense mutation (c.3385C>T [p.Arg1129*]) was observed in three individuals, and the fourth individual had a nearby de novo nonsense mutation (c.3070C>T [p.Arg1024*]). Neither of these variants was present in 1,815 in-house exomes or in public databases. Common features among all four probands include primary microcephaly, global developmental delay including profound speech delay, and craniofacial dysmorphism, as well as more varied features such as feeding difficulties, cardiac defects, and ocular anomalies. We further demonstrate that KAT6A mutations result in dysregulation of H3K9 and H3K18 acetylation and altered P53 signaling. Through histone and non-histone acetylation, KAT6A affects multiple cellular processes and illustrates the complex role of acetylation in regulating development and disease.	[Arboleda, Valerie A.; Lee, Hane; Quintero-Rivera, Fabiola; Kantarci, Sibel; Strom, Samuel P.; Deignan, Joshua L.; Grody, Wayne W.; Nelson, Stanley F.; UCLA Clinical Genomics Ctr] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Dorrani, Naghmeh; Grody, Wayne W.; Vilain, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Med Genet, Los Angeles, CA 90095 USA; [Zadeh, Neda] CHOC, Div Med Genet, Orange, CA 92868 USA; [Zadeh, Neda] Genet Ctr, Orange, CA 92868 USA; [Willis, Mary] Naval Med Ctr, Dept Pediat, San Diego, CA 92134 USA; [Macmurdo, Colleen Forsyth; Manning, Melanie A.; Kwan, Andrea; Hudgins, Louanne] Stanford Univ, Sch Med, Div Med Genet, Dept Pediat, Stanford, CA 94305 USA; [Manning, Melanie A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Kwan, Andrea] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Barthelemy, Florian; Miceli, M. Carrie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Defense; United States Navy; Naval Medical Center San Diego; Stanford University; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nelson, SF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	snelson@ucla.edu	Barthelemy, Florian/AGR-7080-2022; Barthelemy, Florian/AAA-1008-2019; Nelson, Stanley F/D-4771-2009; Arboleda, Valerie A/C-9608-2011	Barthelemy, Florian/0000-0002-9896-9551; Barthelemy, Florian/0000-0002-9896-9551; Nelson, Stanley F/0000-0002-2082-3114; Arboleda, Valerie A/0000-0002-9687-9122; Douine, Emilie/0000-0002-6048-2887; Willis, Mary/0000-0002-8046-7887	UCLA Translational Pathology Research Fund; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER	UCLA Translational Pathology Research Fund; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the all the families for participating in the study. Individuals who are interested in connecting with other families with KAT6A can find more information at http://www.chloekat6a.org/. Expansion of the cell lines was supported by NIH/National Institute of Arthritis Musculoskeletal and Skin (NIAMS) NIH-P30-5P30AR057230. NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI UL1TR000124 provided support for cores. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. The views expressed in this article are the authors' and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government. Partial support for this project was provided by UCLA Translational Pathology Research Fund grant to V.A.A., S.F.N., and H.L.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Ali M, 2012, J MOL BIOL, V424, P328, DOI 10.1016/j.jmb.2012.10.004; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Campeau PM, 2012, HUM MUTAT, V33, P1520, DOI 10.1002/humu.22141; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; Chaffanet M, 2000, GENE CHROMOSOME CANC, V28, P138, DOI 10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2; Champagne N, 2001, ONCOGENE, V20, P404, DOI 10.1038/sj.onc.1204114; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Colussi C, 2009, FASEB J, V23, P2131, DOI 10.1096/fj.08-115618; Consalvi S, 2013, MOL MED, V19, P79, DOI 10.2119/molmed.2013.00011; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doenecke D, 2014, CELL TISSUE RES, V356, P467, DOI 10.1007/s00441-014-1873-1; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fang YW, 2013, J CELL SCI, V126, P2551, DOI 10.1242/jcs.120220; Good-Jacobson KL, 2014, P NATL ACAD SCI USA, V111, P9585, DOI 10.1073/pnas.1402485111; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kong YW, 2014, CHEM BIOL, V21, P488, DOI 10.1016/j.chembiol.2014.02.013; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Leung KSS, 2014, CURR STEM CELL RES T, V9, P388, DOI 10.2174/1574888X09666140507154005; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mahgoub M, 2014, LEARN MEMORY, V21, P564, DOI 10.1101/lm.036012.114; McGann J, 2014, ELIFE, V3, DOI 10.7554/eLife.04235; MURRAY K, 1966, J MOL BIOL, V15, P409, DOI 10.1016/S0022-2836(66)80116-X; Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606; Perez-Campo FM, 2009, BLOOD, V113, P4866, DOI 10.1182/blood-2008-04-152017; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rokudai S, 2013, P NATL ACAD SCI USA, V110, P3895, DOI 10.1073/pnas.1300490110; Rokudai S, 2009, J BIOL CHEM, V284, P237, DOI 10.1074/jbc.M805101200; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; Sapountzi V, 2011, CELL MOL LIFE SCI, V68, P1147, DOI 10.1007/s00018-010-0599-9; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Voss AK, 2012, DEV CELL, V23, P652, DOI 10.1016/j.devcel.2012.07.010; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang YYV, 2011, GENE DEV, V25, P1426, DOI 10.1101/gad.2024411; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	46	81	82	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					498	506		10.1016/j.ajhg.2015.01.017	http://dx.doi.org/10.1016/j.ajhg.2015.01.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25728775	Green Published, Bronze			2022-12-18	WOS:000350747800023
J	Homan, CC; Kumar, R; Nguyen, LS; Haan, E; Raymond, FL; Abidi, F; Raynaud, M; Schwartz, CE; Wood, SA; Gecz, J; Jolly, LA				Homan, Claire C.; Kumar, Raman; Nguyen, Lam Son; Haan, Eric; Raymond, F. Lucy; Abidi, Fatima; Raynaud, Martine; Schwartz, Charles E.; Wood, Stephen A.; Gecz, Jozef; Jolly, Lachlan A.			Mutations in USP9X Are Associated with X-Linked Intellectual Disability and Disrupt Neuronal Cell Migration and Growth	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOUBLECORTIN-LIKE-KINASE; FAT FACETS; DEUBIQUITYLATING ENZYME; EXPRESSION ANALYSIS; GENE; PROTEIN; FAM/USP9X; INTERACTS	With a wealth of disease-associated DNA variants being recently reported, the challenges of providing their functional characterization are mounting. Previously, as part of a large systematic resequencing of the X chromosome in 208 unrelated families with nonsyndromic X-linked intellectual disability, we identified three unique variants (two missense and one protein truncating) in USP9X. To assess the functional significance of these variants, we took advantage of the Usp9x knockout mouse we generated. Loss of Usp9x causes reduction in both axonal growth and neuronal cell migration. Although overexpression of wild-type human USP9X rescued these defects, all three USP9X variants failed to rescue axonal growth, caused reduced USP9X protein localization in axonal growth cones, and (in 2/3 variants) failed to rescue neuronal cell migration. Interestingly, in one of these families, the proband was subsequently identified to have a microdeletion encompassing ARID1B, a known ID gene. Given our findings it is plausible that loss of function of both genes contributes to the individual's phenotype. This case highlights the complexity of the interpretations of genetic findings from genome-wide investigations. We also performed proteomics analysis of neurons from both the wild-type and Usp9x knockout embryos and identified disruption of the cytoskeleton as the main underlying consequence of the loss of Usp9x. Detailed clinical assessment of all three families with USP9X variants identified hypotonia and behavioral and morphological defects as common features in addition to ID. Together our data support involvement of all three USP9X variants in ID in these families and provide likely cellular and molecular mechanisms involved.	[Homan, Claire C.; Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Kumar, Raman; Gecz, Jozef] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Kumar, Raman] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [Kumar, Raman; Nguyen, Lam Son; Haan, Eric; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Haan, Eric] SA Pathol Womens & Childrens Hosp, South Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Abidi, Fatima; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA; [Raymond, F. Lucy] CHRU Tours, Serv Genet, F-37000 Tours, France; [Raynaud, Martine] Inserm U930, UMR Imagerie & Cerveau, F-37000 Tours, France; [Wood, Stephen A.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia; [Gecz, Jozef; Jolly, Lachlan A.] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia	University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; SA Pathology; University of Cambridge; Greenwood Genetic Center; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Griffith University; Robinson Research Institute; University of Adelaide	Gecz, J (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	jozef.gecz@adelaide.edu.au; lachlan.jolly@adelaide.edu.au	Jolly, Lachlan/B-5892-2015; Homan, Claire C/P-9469-2018; Wood, Stephen A/E-8357-2011; Kumar, Raman/AHE-0538-2022; Gecz, Jozef/X-3469-2019; Raynaud, Martine/R-9811-2019	Jolly, Lachlan/0000-0003-4538-2658; Wood, Stephen A/0000-0002-2576-7457; Kumar, Raman/0000-0001-7976-8386; Gecz, Jozef/0000-0002-7884-6861; Raynaud, Martine/0000-0002-6888-6480; Homan, Claire/0000-0003-2847-8586; Nguyen, Lam Son/0000-0002-0114-1222	Women's and Children's Hospital Foundation; National Health and Medical Research Council of Australia [APP628952, APP1041920, APP1008077, APP1009248]; National Institutes of Health [2R01HD026202, 1R01NS73854]; Australian Postgraduate Award Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073854] Funding Source: NIH RePORTER	Women's and Children's Hospital Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Postgraduate Award Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for the cooperation of the families involved in this study. We thank Vishva M. Dixit, Gentech, Genentech, Inc. (San Francisco, CA, USA) for the provision of the pRK5-USP9X plasmid; Orly Reiner, Weizmann Institute of Science (Rehovot, Israel) for providing the Flag-Dcx plasmid; and Steven Reed, The Scripps Research Institute (San Diego, CA, USA) for the 6xHA-Ubiquitin plasmid. This work was supported by the Women's and Children's Hospital Foundation Grant to L.A.J.; the National Health and Medical Research Council of Australia grants APP628952, APP1041920, and APP1008077 to J.G. and APP1009248 to S. A. W.; National Institutes of Health 2R01HD026202 (NICHD) and 1R01NS73854 (NINDS) to C.S.; and an Australian Postgraduate Award Scholarship to C.C.H.	Angata K, 2010, METHOD ENZYMOL, V479, P25, DOI 10.1016/S0076-6879(10)79002-9; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Durbec Pascale, 2008, V438, P213, DOI 10.1007/978-1-59745-133-8_18; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Fischer JA, 2002, BIOESSAYS, V24, P13, DOI 10.1002/bies.10030; Friocourt G, 2005, MOL CELL NEUROSCI, V28, P153, DOI 10.1016/j.mcn.2004.09.005; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Jean DC, 2012, HUM MOL GENET, V21, P5511, DOI 10.1093/hmg/dds395; Jolly LA, 2013, HUM MOL GENET, V22, P4673, DOI 10.1093/hmg/ddt315; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Khut PY, 2007, ZEBRAFISH, V4, P95, DOI 10.1089/zeb.2006.0502; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Ocbina PJ, 2006, MOL CELL NEUROSCI, V33, P126, DOI 10.1016/j.mcn.2006.06.014; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Stegeman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068287; Stinchfield MJ, 2012, DEVELOPMENT, V139, P2721, DOI 10.1242/dev.077206; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066	36	81	85	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					470	478		10.1016/j.ajhg.2014.02.004	http://dx.doi.org/10.1016/j.ajhg.2014.02.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24607389	Green Published, Bronze			2022-12-18	WOS:000332611400020
J	Krawitz, PM; Murakami, Y; Riess, A; Hietala, M; Kruger, U; Zhu, N; Kinoshita, T; Mundlos, S; Hecht, J; Robinson, PN; Horn, D				Krawitz, Peter M.; Murakami, Yoshiko; Riess, Angelika; Hietala, Marja; Krueger, Ulrike; Zhu, Na; Kinoshita, Taroh; Mundlos, Stefan; Hecht, Jochen; Robinson, Peter N.; Horn, Denise			PGAP2 Mutations, Affecting the GPI-Anchor-Synthesis Pathway, Cause Hyperphosphatasia with Mental Retardation Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROLOGIC DEFICIT; PIGV MUTATIONS; SEIZURES; EXPRESSION; EFFICIENT; PROTEINS; PROMOTER	Recently, mutations in genes involved in the biosynthesis of the glycosylphosphatidylinositol (GPI) anchor have been identified in a new subclass of congenital disorders of glycosylation (CDGs) with a distinct spectrum of clinical features. To date, mutations have been identified in six genes (PIGA, PIGL, PIGM, PIGN, PIGO, and PIGV) encoding proteins in the GPI-anchor-synthesis pathway in individuals with severe neurological features, including seizures, muscular hypotonia, and intellectual disability. We developed a diagnostic gene panel for targeting all known genes encoding proteins in the GPI-anchor-synthesis pathway to screen individuals matching these features, and we detected three missense mutations in PGAP2, c.46C>T, c.380T>C, and c.479C>T, in two unrelated individuals with hyperphosphatasia with mental retardation syndrome (HPMRS). The mutations cosegregated in the investigated families. PGAP2 is involved in fatty-acid GPI-anchor remodeling, which occurs in the Golgi apparatus and is required for stable association between GPI-anchored proteins and the cell-surface membrane rafts. Transfection of the altered protein constructs, p.Arg16Trp (NP_001243169.1), p.Leu127Ser, and p.Thr160Ile, into PGAP2-null cells showed only partial restoration of GPI-anchored marker proteins, CD55 and CD59, on the cell surface. In this work, we show that an impairment of GPI-anchor remodeling also causes HPMRS and conclude that targeted sequencing of the genes encoding proteins in the GPI-anchor-synthesis pathway is an effective diagnostic approach for this subclass of CDGs.	[Krawitz, Peter M.; Krueger, Ulrike; Zhu, Na; Mundlos, Stefan; Robinson, Peter N.; Horn, Denise] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Krawitz, Peter M.; Mundlos, Stefan; Hecht, Jochen; Robinson, Peter N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Krawitz, Peter M.; Mundlos, Stefan; Hecht, Jochen; Robinson, Peter N.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Osaka 565, Japan; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka 565, Japan; [Riess, Angelika] Univ Tubingen, Inst Human Genet, D-72076 Tubingen, Germany; [Hietala, Marja] Univ Turku, FIN-20520 Turku, Finland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Osaka University; Osaka University; Eberhard Karls University of Tubingen; University of Turku	Robinson, PN (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	peter.robinson@charite.de; denise.horn@charite.de	Kinoshita, Taroh/C-7353-2009; Zhu, Na/L-3444-2019; Krawitz, Peter M/F-3142-2012; Mundlos, Stefan/ABH-9585-2020	Krawitz, Peter M/0000-0002-3194-8625; Mundlos, Stefan/0000-0002-9788-3166; Zhu, Na/0000-0001-6460-3087; Robinson, Peter/0000-0002-0736-9199	Bundesministerium fur Forschung und Technologie [0313911]; Deutsche Forschungsgemeinschaft [DFG KR 3985/1-1, SFB 665]; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan	Bundesministerium fur Forschung und Technologie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Bundesministerium fur Forschung und Technologie (0313911), by a Deutsche Forschungsgemeinschaft grant to P.M.K. (DFG KR 3985/1-1) and to S.M. (SFB 665), and by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labour, and Welfare of Japan. We wish to thank all individuals involved in this study for their generous help.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3; Kamphans T, 2012, BIOINFORMATICS, V28, P2515, DOI 10.1093/bioinformatics/bts462; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; MABRY CC, 1970, J PEDIATR-US, V77, P74, DOI 10.1016/S0022-3476(70)80047-6; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Thompson MD, 2012, AM J MED GENET A, V158A, P553, DOI 10.1002/ajmg.a.35202; Thompson MD, 2010, AM J MED GENET A, V152A, P1661, DOI 10.1002/ajmg.a.33438; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	22	81	85	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					584	589		10.1016/j.ajhg.2013.03.011	http://dx.doi.org/10.1016/j.ajhg.2013.03.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23561847	Green Published, Bronze			2022-12-18	WOS:000317449700010
J	Shaheen, R; Aglan, M; Keppler-Noreuil, K; Faqeih, E; Ansari, S; Horton, K; Ashour, A; Zaki, MS; Al-Zahrani, F; Cueto-Gonzalez, AM; Abdel-Salam, G; Temtamy, S; Alkuraya, FS				Shaheen, Ranad; Aglan, Mona; Keppler-Noreuil, Kim; Faqeih, Eissa; Ansari, Shinu; Horton, Kim; Ashour, Adel; Zaki, Maha S.; Al-Zahrani, Fatema; Cueto-Gonzalez, Anna M.; Abdel-Salam, Ghada; Temtamy, Samia; Alkuraya, Fowzan S.			Mutations in EOGT Confirm the Genetic Heterogeneity of Autosomal-Recessive Adams-Oliver Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED-N-ACETYLGLUCOSAMINE; O-GLCNAC; NOTCH RECEPTORS; PHOSPHORYLATION; GLCNACYLATION; PROTEINS; APLASIA; DOMAIN; TAU	Adams-Oliver syndrome (AOS) is a rare, autosomal-dominant or -recessive disorder characterized primarily by aplasia cutis congenita and terminal transverse limb defects. Recently, we demonstrated that homozygous mutations in DOCK6 cause an autosomal-recessive form of AOS. In this study, we sought to determine the contribution of DOCK6 mutations to the etiology of AOS in several consanguineous families. In two of the five families studied, we identified two homozygous truncating mutations (a splice-site mutation and a frameshift duplication). DOCK6 sequencing revealed no mutation in the remaining three families, consistent with their autozygosity mapping and linkage-analysis results, which revealed a single candidate locus in 3p14.1 on three different haplotype backgrounds in the three families. Indeed, exome sequencing in one family revealed one missense mutation in EOGT (C3orf64), and subsequent targeted sequencing of this gene revealed a homozygous missense mutation and a homozygous frameshift deletion mutation in the other two families. EOGT encodes EGF-domain-specific O-linked N-acetylglucosamine (O-GlcNAc) transferase, which is involved in the O-GlcNAcylation (attachment of O-GlcNAc to serine and threonine residues) of a subset of extracellular EGF-domain-containing proteins. It has a documented role in epithelial-cell-matrix interactions in Drosophila, in which deficiency of its ortholog causes wing blistering. Our findings highlight a developmental role of O-GlcNAcylation in humans and expand the genetic heterogeneity of autosomal-recessive AOS.	[Shaheen, Ranad; Ansari, Shinu; Al-Zahrani, Fatema; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Aglan, Mona; Ashour, Adel; Zaki, Maha S.; Abdel-Salam, Ghada; Temtamy, Samia] Natl Res Ctr, Dept Clin Genet, Cairo 12311, Egypt; [Keppler-Noreuil, Kim] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Faqeih, Eissa] King Fahad Med City, Med Genet Sect, Dept Pediat, Riyadh 11525, Saudi Arabia; [Horton, Kim] Univ Iowa, Reg Genet Consultat Serv, Iowa City, IA 52242 USA; [Cueto-Gonzalez, Anna M.] Hosp Univ Vall dHebron, Clin Genet Serv, Barcelona 08035, Spain; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); King Fahad Medical City; University of Iowa; Hospital Universitari Vall d'Hebron; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, POB 3354, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Abdel-Salam, Ghada/W-1718-2017; Ashour, Adel/AAW-4983-2021; Zaki, Maha S/B-9361-2013	Abdel-Salam, Ghada/0000-0003-2893-8802; temtamy, samia/0000-0002-6452-823X; ASHOUR, ADEL/0000-0003-1847-7125; aglan, mona/0000-0002-0908-0639; SHAHEEN, RANAD/0000-0002-2590-1759; Zaki, Maha/0000-0001-7840-0002	King Abdulaziz City for Science and Technology [09-MED941-20]; Dubai Harvard Foundation for Medical Research Collaborative Research Center grant	King Abdulaziz City for Science and Technology; Dubai Harvard Foundation for Medical Research Collaborative Research Center grant	We thank the affected individuals and their families for their enthusiastic participation. We are grateful to Mais Hashem and Niema Ibrahim for their help as clinical research coordinators. We also thank the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center for their technical help. This work was supported by King Abdulaziz City for Science and Technology grant 09-MED941-20 (to F.S.A.) and a Dubai Harvard Foundation for Medical Research Collaborative Research Center grant (to F.S.A.).	Adams Forrest H., 1945, JOUR HEREDITY, V36, P3; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; KEARSE KP, 1991, ARCH BIOCHEM BIOPHYS, V290, P543, DOI 10.1016/0003-9861(91)90579-8; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Prout M, 1997, GENETICS, V146, P275; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sewell W, 2009, DEV BIOL, V329, P400, DOI 10.1016/j.ydbio.2009.02.023; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Snape KMG, 2009, AM J MED GENET A, V149A, P1860, DOI 10.1002/ajmg.a.32708; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Temtamy SA, 1978, GENETICS HAND MALFOR; Temtamy SA, 2007, CLIN DYSMORPHOL, V16, P141, DOI 10.1097/MCD.0b013e3280f9df22; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; WHITLEY CB, 1991, AM J MED GENET, V40, P319, DOI 10.1002/ajmg.1320400315; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]	27	81	84	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					598	604		10.1016/j.ajhg.2013.02.012	http://dx.doi.org/10.1016/j.ajhg.2013.02.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23522784	Bronze, Green Published			2022-12-18	WOS:000317449700012
J	Li, MX; Kwan, JSH; Sham, PC				Li, Miao-Xin; Kwan, Johnny S. H.; Sham, Pak C.			HYST: A Hybrid Set-Based Test for Genome-wide Association Studies, with Application to Protein-Protein Interaction-Based Association Analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING HERITABILITY; SUSCEPTIBILITY LOCI; METAANALYSIS; DISEASE; GENES; APPROXIMATION; NETWORK; PATHWAY; TOOL	The extended Simes' test (known as GATES) and scaled chi-square test were proposed to combine a set of dependent genome-wide association signals at multiple single-nucleotide polymorphisms (SNPs) for assessing the overall significance of association at the gene or pathway levels. The two tests use different strategies to combine association p values and can outperform each other when the number of and linkage disequilibrium between SNPs vary. In this paper, we introduce a hybrid set-based test (HYST) combining the two tests for genome-wide association studies (GWASs). We describe how HYST can be used to evaluate statistical significance for association at the protein-protein interaction (PPI) level in order to increase power for detecting disease-susceptibility genes of moderate effect size. Computer simulations demonstrated that HYST had a reasonable type 1 error rate and was generally more powerful than its parents and other alternative tests to detect a PPI pair where both genes are associated with the disease of interest. We applied the method to three complex disease GWAS data sets in the public domain; the method detected a number of highly connected significant PPI pairs involving multiple confirmed disease-susceptibility genes not found in the SNP- and gene-based association analyses. These results indicate that HYST can be effectively used to examine a collection of predefined SNP sets based on prior biological knowledge for revealing additional disease-predisposing genes of modest effects in GWASs.	[Li, Miao-Xin; Kwan, Johnny S. H.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.] Univ Hong Kong, Ctr Genom Sci, Pokfulam, Hong Kong, Peoples R China; [Kwan, Johnny S. H.] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Sham, Pak C.] Univ Hong Kong, State Key Lab Cognit & Brain Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Sham, PC (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China.	pcsham@hku.hk	Li, Miaoxin/B-7079-2013		Hong Kong Research Grants Council [HKU 774707M, 777511M]; Theme-Based Research Scheme [T12-705/11]; European Community Seventh Framework Programme Grant on European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI); University of Hong Kong [HKU 201109176063]; Strategic Research Theme on Genomics	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Theme-Based Research Scheme; European Community Seventh Framework Programme Grant on European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI); University of Hong Kong(University of Hong Kong); Strategic Research Theme on Genomics	We are grateful to Barrett et al.,<SUP>32</SUP> Stahl et al.,<SUP>33</SUP> and Zeggini et al.<SUP>34</SUP> for the GWAS results of Crohn Disease, rheumatoid arthritis and type 2 diabetes. This work was funded by Hong Kong Research Grants Council General Research Fund (HKU 774707M and 777511M), Theme-Based Research Scheme (T12-705/11), European Community Seventh Framework Programme Grant on European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI), and the University of Hong Kong Small Project Fund (HKU 201109176063) and Strategic Research Theme on Genomics. We also thank two anonymous reviewers for their useful comments, which improved this paper substantially.	Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Casals F, 2012, J NEUROIMMUNOL, V248, P10, DOI 10.1016/j.jneuroim.2011.12.017; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Curtis David, 2008, Adv Appl Bioinform Chem, V1, P115; Deleuran M, 1996, J DERMATOL SCI, V13, P228, DOI 10.1016/S0923-1811(96)00539-7; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P108, DOI 10.1016/j.mrfmmm.2010.01.017; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Heng HHQ, 2008, BIOESSAYS, V30, P196, DOI 10.1002/bies.20711; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hou CD, 2005, STAT PROBABIL LETT, V73, P179, DOI 10.1016/j.spl.2004.11.028; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Maharshak N, 2010, INFLAMM BOWEL DIS, V16, P1496, DOI 10.1002/ibd.21254; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Moskvina V, 2011, GENET EPIDEMIOL, V35, P861, DOI 10.1002/gepi.20636; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wilkins AS, 2007, BIOESSAYS, V29, P1179, DOI 10.1002/bies.20685; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zintzaras E, 2008, J HUM GENET, V53, P1, DOI 10.1007/s10038-007-0223-5	47	81	81	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					478	488		10.1016/j.ajhg.2012.08.004	http://dx.doi.org/10.1016/j.ajhg.2012.08.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22958900	Green Published, Bronze			2022-12-18	WOS:000308683100008
J	Staropoli, JF; Karaa, A; Lim, ET; Kirby, A; Elbalalesy, N; Romansky, SG; Leydiker, KB; Coppel, SH; Barone, R; Xin, WN; MacDonald, ME; Abdenur, JE; Daly, MJ; Sims, KB; Cotman, SL				Staropoli, John F.; Karaa, Amel; Lim, Elaine T.; Kirby, Andrew; Elbalalesy, Naser; Romansky, Stephen G.; Leydiker, Karen B.; Coppel, Scott H.; Barone, Rosemary; Xin, Winnie; MacDonald, Marcy E.; Abdenur, Jose E.; Daly, Mark J.; Sims, Katherine B.; Cotman, Susan L.			A Homozygous Mutation in KCTD7 Links Neuronal Ceroid Lipofuscinosis to the Ubiquitin-Proteasome System	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE MYOCLONIC EPILEPSY; CHANNEL-RELATED GENE; KUFS-DISEASE; AUTOPHAGY; LIGASES; MATURATION; SUBUNITS; SPECTRUM; ADAPTER; FAMILY	Neuronal ceroid lipofuscinosis (NCL) is a genetically heterogeneous group of lysosomal diseases that collectively compose the most common Mendelian form of childhood-onset neurodegeneration. It is estimated that similar to 8% of individuals diagnosed with NCL by conservative clinical and histopathologic criteria have been ruled out for mutations in the nine known NCL-associated genes, suggesting that additional genes remain unidentified. To further understand the genetic underpinnings of the NCLs, we performed whole-exome sequencing on DNA samples from a Mexican family affected by a molecularly undefined form of NCL characterized by infantile-onset progressive myoclonic epilepsy (PME), vision loss, cognitive and motor regression, premature death, and prominent NCL-type storage material. Using a recessive model to filter the identified variants, we found a single homozygous variant, c.550C>T in KCTD7, that causes a p.Arg184Cys missense change in potassium channel tetramerization domain-containing protein 7 (KCTD7) in the affected individuals. The mutation was predicted to be deleterious and was absent in over 6,000 controls. The identified variant altered the localization pattern of KCTD7 and abrogated interaction with cullin-3, a ubiquitin-ligase component and known KCTD7 interactor. Intriguingly, murine cerebellar cells derived from a juvenile NCL model (CLN3) showed enrichment of endogenous KCTD7. Whereas KCTD7 mutations have previously been linked to PME without lysosomal storage, this study clearly demonstrates that KCTD7 mutations also cause a rare, infantile-onset NCL subtype designated as CLN14.	[Staropoli, John F.; Karaa, Amel; Lim, Elaine T.; Kirby, Andrew; Coppel, Scott H.; Barone, Rosemary; Xin, Winnie; MacDonald, Marcy E.; Daly, Mark J.; Sims, Katherine B.; Cotman, Susan L.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Staropoli, John F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lim, Elaine T.; Kirby, Andrew; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kirby, Andrew; Daly, Mark J.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Elbalalesy, Naser] Childrens Hosp Orange Cty, Div Neurol, Orange, CA 92868 USA; [Romansky, Stephen G.] Miller Childrens Hosp, Long Beach, CA 90806 USA; [Leydiker, Karen B.; Abdenur, Jose E.] Childrens Hosp Orange Cty, Div Metab Disorders, Orange, CA 92868 USA; [Xin, Winnie; MacDonald, Marcy E.; Sims, Katherine B.; Cotman, Susan L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Childrens Hospital of Orange County; Childrens Hospital of Orange County; Harvard University; Massachusetts General Hospital	Cotman, SL (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	cotman@helix.mgh.harvard.edu	Lim, Elaine/H-9032-2016; Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Leydiker, MA, MS, LCGC, Karen/0000-0002-5988-8716; Karaa, Amel/0000-0001-5781-9824; Lim, Teng Ting/0000-0003-3651-0654	National Institutes of Health National Institute of Neurological Disorders and Stroke [R01NS073813, R01NS33648]; Batten Disease Support and Research Association; Massachusetts General Hospital Executive Committee on Research Tosteson Award; Kirschstein National Research Service Award Training Program [GM007748-32]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, RC2HL103010, RC2HL102923, UC2HL102925, UC2HL102924, UC2HL102926, RC2HL102924, UC2HL102923, RC2HL102926, RC2HL102925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073813, R01NS033648] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Batten Disease Support and Research Association; Massachusetts General Hospital Executive Committee on Research Tosteson Award; Kirschstein National Research Service Award Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke (R01NS073813 to S.L.C and R01NS33648 to M.E.M.) and the Batten Disease Support and Research Association (J.F.S.). J.F.S. is supported by a Massachusetts General Hospital Executive Committee on Research Tosteson Award. A.K. receives training support from the Kirschstein National Research Service Award Training Program T32 (grant GM007748-32). We would like to thank the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and the following ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). Plasmids encoding Myc-Cullin-1 and Myc-Cullin-3 were gifts from Yue Xiong (plasmids 19896 and 19893, respectively; Addgene, Cambridge, MA). We thank Xin Feng and Yi Cao for expert technical support. S.L.C. and K.B.S. are members of the Batten Disease Support and Research Association scientific and medical advisory boards, respectively.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Azizieh R, 2011, MOL NEUROBIOL, V44, P111, DOI 10.1007/s12035-011-8194-0; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Benatar M, 2000, QJM-MON J ASSOC PHYS, V93, P787, DOI 10.1093/qjmed/93.12.787; Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Cooper JD, 2010, BIOCHEM SOC T, V38, P1448, DOI 10.1042/BST0381448; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Huotari J, 2012, P NATL ACAD SCI USA, V109, P823, DOI 10.1073/pnas.1118744109; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Krabichler B, 2012, ANN HUM GENET, V76, P326, DOI 10.1111/j.1469-1809.2012.00710.x; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Oresic K, 2009, BIOSCIENCE REP, V29, P173, DOI 10.1042/BSR20080143; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Sadzot B, 2000, J NEUROL, V247, P447, DOI 10.1007/s004150070174; Santos R. X., 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P158; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Van Bogaert P, 2007, ANN NEUROL, V61, P579, DOI 10.1002/ana.21121; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wisniewski KE, 2001, NEUROLOGY, V57, P576, DOI 10.1212/WNL.57.4.576	35	81	91	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					202	208		10.1016/j.ajhg.2012.05.023	http://dx.doi.org/10.1016/j.ajhg.2012.05.023			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22748208	Green Published, Bronze			2022-12-18	WOS:000306445000019
J	Hanson, D; Murray, PG; O'Sullivan, J; Urquhart, J; Daly, S; Bhaskar, SS; Biesecker, LG; Skae, M; Smith, C; Cole, T; Kirk, J; Chandler, K; Kingston, H; Donnai, D; Clayton, PE; Black, GCM				Hanson, Dan; Murray, Philip G.; O'Sullivan, James; Urquhart, Jill; Daly, Sarah; Bhaskar, Sanjeev S.; Biesecker, Leslie G.; Skae, Mars; Smith, Claire; Cole, Trevor; Kirk, Jeremy; Chandler, Kate; Kingston, Helen; Donnai, Dian; Clayton, Peter E.; Black, Graeme C. M.			Exome Sequencing Identifies CCDC8 Mutations in 3-M Syndrome, Suggesting that CCDC8 Contributes in a Pathway with CUL7 and OBSL1 to Control Human Growth	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSCURIN-LIKE-1; DOMAIN; P53	3-M syndrome, a primordial growth disorder, is associated with mutations in CUL7 and OBSL1. Exome sequencing now identifies mutations in CCDC8 as a cause of 3-M syndrome. CCDC8 is a widely expressed gene that is transcriptionally associated to CUL7 and OBSL1 and coimmunoprecipitation indicates a physical interaction between CCDC8 and OBSL1 but not CUL7. We propose that CUL7, OBSL1, and CCDC8 are members of a pathway controlling mammalian growth.	[Hanson, Dan; Murray, Philip G.; O'Sullivan, James; Urquhart, Jill; Daly, Sarah; Bhaskar, Sanjeev S.; Chandler, Kate; Kingston, Helen; Donnai, Dian; Black, Graeme C. M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Genet Med Res Grp, Manchester M13 9WL, Lancs, England; [Hanson, Dan; Murray, Philip G.; O'Sullivan, James; Urquhart, Jill; Daly, Sarah; Bhaskar, Sanjeev S.; Chandler, Kate; Kingston, Helen; Donnai, Dian; Black, Graeme C. M.] Cent Manchester Fdn Trust, St Marys Hosp, Manchester M13 9WL, Lancs, England; [Hanson, Dan; Murray, Philip G.; Clayton, Peter E.] Univ Manchester, Sch Biomed, Dept Endocrinol, MAHSC, Manchester M13 9WL, Lancs, England; [Murray, Philip G.; O'Sullivan, James; Urquhart, Jill; Daly, Sarah; Bhaskar, Sanjeev S.; Skae, Mars; Chandler, Kate; Kingston, Helen; Donnai, Dian; Clayton, Peter E.; Black, Graeme C. M.] Cent Manchester Univ Hosp Fdn Trust, Manchester M13 9WL, Lancs, England; [Biesecker, Leslie G.] NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Biesecker, Leslie G.] NHGRI, NIH, Bethesda, MD 20814 USA; [Smith, Claire] E Lancashire Hosp NHS Trust, Royal Blackburn Hosp, Blackburn BB2 3HH, Lancs, England; [Cole, Trevor] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Kirk, Jeremy] Birmingham Childrens Hosp, Dept Paediat Endocrinol, Birmingham B4 6NH, W Midlands, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Birmingham Women's Hospital; University of Birmingham	Black, GCM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Genet Med Res Grp, Manchester M13 9WL, Lancs, England.	graeme.black@manchester.ac.uk	Biesecker, Leslie/AAG-2526-2021; Urquhart, Jill/G-2282-2015; Skae, Mars/AAD-2033-2021; Skae, Mars/AAY-6448-2020; Black, Graeme/K-7374-2015	Urquhart, Jill/0000-0002-5788-5511; Black, Graeme/0000-0001-8727-6592; Murray, Philip/0000-0002-1480-1576; Clayton, Peter/0000-0003-1225-4537	National Institute of Health Research Manchester Biomedical Research Centre; National Human Genome Research Institute of the NIH; MRC [G0700541] Funding Source: UKRI; Medical Research Council [G0700541] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200359] Funding Source: NIH RePORTER	National Institute of Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); National Human Genome Research Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all healthcare professionals contributing to the care of families described here. Support from the National Institute of Health Research Manchester Biomedical Research Centre is acknowledged. P.G.M. is a Medical Research Council (UK) Clinical Research Fellow. The NISC Comparative Sequencing Program and the ClinSeq study are funded by the National Human Genome Research Institute of the NIH.	[Anonymous], DBSNP; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Geisler SB, 2007, GENOMICS, V89, P521, DOI 10.1016/j.ygeno.2006.12.004; Hanson D, 2009, AM J HUM GENET, V84, P801, DOI 10.1016/j.ajhg.2009.04.021; Huber C, 2005, NAT GENET, V37, P1119, DOI 10.1038/ng1628; Huber C, 2010, HUM MUTAT, V31, P20, DOI 10.1002/humu.21150; Huber C, 2009, EUR J HUM GENET, V17, P395, DOI 10.1038/ejhg.2008.200; Jung P, 2007, P NATL ACAD SCI USA, V104, P11388, DOI 10.1073/pnas.0609467104; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; Maksimova N, 2007, J MED GENET, V44, P772, DOI 10.1136/jmg.2007.051979; Miller J D, 1975, Birth Defects Orig Artic Ser, V11, P39; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Temtamy SA, 2006, CLIN DYSMORPHOL, V15, P55, DOI 10.1097/01.mcd.0000198926.01706.33; van der Wall G, 2001, CLIN DYSMORPHOL, V10, P241, DOI 10.1097/00019605-200110000-00002; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; AUTOSNPA	21	81	89	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					148	153		10.1016/j.ajhg.2011.05.028	http://dx.doi.org/10.1016/j.ajhg.2011.05.028			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21737058	Green Published, Bronze			2022-12-18	WOS:000293041700013
J	Wright, EMMB; Spencer, HL; Daly, SB; Manson, FDC; Zeef, LAH; Urquhart, J; Zoppi, N; Bonshek, R; Tosounidis, I; Mohan, M; Madden, C; Dodds, A; Chandler, KE; Banka, S; Au, L; Clayton-Smith, J; Khan, N; Biesecker, LG; Wilson, M; Rohrbach, M; Colombi, M; Giunta, C; Black, GCM				Wright, Emma M. M. Burkitt; Spencer, Helen L.; Daly, Sarah B.; Manson, Forbes D. C.; Zeef, Leo A. H.; Urquhart, Jill; Zoppi, Nicoletta; Bonshek, Richard; Tosounidis, Ioannis; Mohan, Meyyammai; Madden, Colm; Dodds, Annabel; Chandler, Kate E.; Banka, Siddharth; Au, Leon; Clayton-Smith, Jill; Khan, Naz; Biesecker, Leslie G.; Wilson, Meredith; Rohrbach, Marianne; Colombi, Marina; Giunta, Cecilia; Black, Graeme C. M.			Mutations in PRDM5 in Brittle Cornea Syndrome Identify a Pathway Regulating Extracellular Matrix Development and Maintenance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KYPHOSCOLIOTIC TYPE; CROSS-LINKS; FAMILY; ABNORMALITIES; INTEGRIN; COL5A1; GENES	Extreme corneal fragility and thinning, which have a high risk of catastrophic spontaneous rupture, are the cardinal features of brittle cornea syndrome (BCS), an autosomal-recessive generalized connective tissue disorder. Enucleation is frequently the only management option for this condition, resulting in blindness and psychosocial distress. Even when the cornea remains grossly intact, visual function could also be impaired by a high degree of myopia and keratoconus. Deafness is another common feature and results in combined sensory deprivation. Using autozygosity mapping, we identified mutations in PRDM5 in families with BCS. We demonstrate that regulation of expression of extracellular matrix components, particularly fibrillar collagens, by PRDM5 is a key molecular mechanism that underlies corneal fragility in BCS and controls normal corneal development and maintenance. ZNF469, encoding a zinc finger protein of hitherto undefined function, has been identified as a quantitative trait locus for central corneal thickness, and mutations in this gene have been demonstrated in Tunisian Jewish and Palestinian kindreds with BCS. We show that ZNF469 and PRDM5, two genes that when mutated cause BCS, participate in the same regulatory pathway.	[Wright, Emma M. M. Burkitt; Spencer, Helen L.; Daly, Sarah B.; Manson, Forbes D. C.; Urquhart, Jill; Chandler, Kate E.; Banka, Siddharth; Clayton-Smith, Jill; Khan, Naz; Black, Graeme C. M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Genet Med Res Grp, Manchester M13 9WL, Lancs, England; [Wright, Emma M. M. Burkitt; Spencer, Helen L.; Daly, Sarah B.; Manson, Forbes D. C.; Urquhart, Jill; Chandler, Kate E.; Banka, Siddharth; Clayton-Smith, Jill; Khan, Naz; Black, Graeme C. M.] St Marys Hosp, Cent Manchester Fdn Trust, Manchester M13 9WL, Lancs, England; [Zeef, Leo A. H.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Zoppi, Nicoletta; Colombi, Marina] Univ Brescia, Fac Med, Div Biol & Genet, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; [Bonshek, Richard; Au, Leon] Manchester Royal Eye Hosp, Cent Manchester Fdn Trust, Manchester M13 9WL, Lancs, England; [Bonshek, Richard; Tosounidis, Ioannis] Manchester Royal Infirm, Cent Manchester Fdn Trust, Natl Specialist Ophthalm Pathol Lab, Manchester M13 9WL, Lancs, England; [Mohan, Meyyammai] Royal Blackburn Hosp, Dept Ophthalmol, Blackburn BB2 3HH, Lancs, England; [Madden, Colm] Moss Side Hlth Ctr, Dept Paediat Audiol, Manchester M14 4GP, Lancs, England; [Dodds, Annabel] St Peters Ctr, Dept Audiol, Burnley BB11 2DL, Lancs, England; [Biesecker, Leslie G.] NHGRI, NIH, Bethesda, MD 20814 USA; [Biesecker, Leslie G.] Natl Inst Hlth Intramural Sequencing Ctr NISC, NIH, Rockville, MD 20892 USA; [Wilson, Meredith] Childrens Hosp, Dept Clin Genet, Westmead Sydney, NSW 2145, Australia; [Rohrbach, Marianne; Giunta, Cecilia] Univ Childrens Hosp, Div Metab, Connect Tissue Unit, CH-8032 Zurich, Switzerland; [Rohrbach, Marianne; Giunta, Cecilia] Childrens Res Ctr, CH-8032 Zurich, Switzerland	University of Manchester; University of Manchester; University of Manchester; University of Brescia; Manchester Royal Eye Hospital; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; University Children's Hospital Zurich	Black, GCM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Genet Med Res Grp, Manchester M13 9WL, Lancs, England.	graeme.black@manchester.ac.uk	Manson, Forbes/G-2222-2015; Giunta, Cecilia/T-8222-2019; Biesecker, Leslie/AAG-2526-2021; Urquhart, Jill/G-2282-2015; Black, Graeme/K-7374-2015	Manson, Forbes/0000-0002-8342-660X; Giunta, Cecilia/0000-0002-9313-8257; Urquhart, Jill/0000-0002-5788-5511; Colombi, Marina/0000-0002-3105-5990; Banka, Siddharth/0000-0002-8527-2210; Black, Graeme/0000-0001-8727-6592; Rohrbach, Marianne/0000-0002-4013-6012; ZOPPI, Nicoletta/0000-0003-0197-8927	UK National Institute for Health Research; Wellcome Trust; Fight for Sight; National Human Genome Research Institute of the National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200359] Funding Source: NIH RePORTER	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Fight for Sight; National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all healthcare professionals contributing to the care of the families described here, particularly R.W. Paton (Royal Black-burn Hospital), and J. Teer of the National Human Genome Research Institute, for sequence coverage analysis in the ClinSeq cohort. We thank B. Steinmann for useful discussion and support, H. Al-Hussein for referral of some BCS families, and A. Schwarze and C. Burer for expert technical assistance. The support of the Manchester Biomedical Research Centre, funded by the UK National Institute for Health Research, is gratefully acknowledged. E.B.W. is funded by a Clinical Research Training Fellowship from the Wellcome Trust, and F.D.C.M. by Fight for Sight. The NISC comparative sequencing program and the ClinSeq study are funded by the National Human Genome Research Institute of the National Institutes of Health.	Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; Al-Hussain H, 2004, AM J MED GENET A, V124A, P28, DOI 10.1002/ajmg.a.20326; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CAMERON JA, 1993, CORNEA, V12, P54, DOI 10.1097/00003226-199301000-00009; Christensen AE, 2010, INVEST OPHTH VIS SCI, V51, P47, DOI 10.1167/iovs.09-4251; Daly SB, 2010, AM J HUM GENET, V87, P309, DOI 10.1016/j.ajhg.2010.07.010; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Giunta C, 2005, AM J MED GENET A, V133A, P158, DOI 10.1002/ajmg.a.30529; Hosseini HRJ, 2010, CORNEA, V29, P1091, DOI 10.1097/ICO.0b013e3181cf98e5; Izquierdo L, 1999, CORNEA, V18, P621, DOI 10.1097/00003226-199909000-00019; Khan AO, 2010, ARCH OPHTHALMOL-CHIC, V128, P1376, DOI 10.1001/archophthalmol.2010.238; Kraenzlin ME, 2008, CLIN CHEM, V54, P1546, DOI 10.1373/clinchem.2008.105262; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; Meani N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004273; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Segev F, 2006, INVEST OPHTH VIS SCI, V47, P565, DOI 10.1167/iovs.05-0771; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200; Zoppi N, 2008, BBA-MOL CELL RES, V1783, P1177, DOI 10.1016/j.bbamcr.2008.03.003	26	81	82	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					767	777		10.1016/j.ajhg.2011.05.007	http://dx.doi.org/10.1016/j.ajhg.2011.05.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21664999	Bronze, Green Published			2022-12-18	WOS:000291768500008
J	Corbett, MA; Schwake, M; Bahlo, M; Dibbens, LM; Lin, M; Gandolfo, LC; Vears, DF; O'Sullivan, JD; Robertson, T; Bayly, MA; Gardner, AE; Vlaar, AM; Korenke, GC; Bloem, BR; de Coo, IF; Verhagen, JMA; Lehesjoki, AE; Gecz, J; Berkovic, SF				Corbett, Mark A.; Schwake, Michael; Bahlo, Melanie; Dibbens, Leanne M.; Lin, Meng; Gandolfo, Luke C.; Vears, Danya F.; O'Sullivan, John D.; Robertson, Thomas; Bayly, Marta A.; Gardner, Alison E.; Vlaar, Annemarie M.; Korenke, G. Christoph; Bloem, Bastiaan R.; de Coo, Irenaeus F.; Verhagen, Judith M. A.; Lehesjoki, Anna-Elina; Gecz, Jozef; Berkovic, Samuel F.			A Mutation in the Golgi Qb-SNARE Gene GOSR2 Causes Progressive Myoclonus Epilepsy with Early Ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEINS; ALIGNMENT; DELETION; COMPLEX; SYSTEM; GENOME; ER	The progressive myoclonus epilepsies (PMEs) are a group of predominantly recessive disorders that present with action myoclonus, tonic-clonic seizures, and progressive neurological decline. Many PMEs have similar clinical presentations yet are genetically heterogeneous, making accurate diagnosis difficult. A locus for PME was mapped in a consanguineous family with a single affected individual to chromosome 17q21. An identical-by-descent, homozygous mutation in GOSR2 (c.430G>T, p.Gly144Trp), a Golgi vesicle transport gene, was identified in this patient and in four apparently unrelated individuals. A comparison of the phenotypes in these patients defined a clinically distinct PME syndrome characterized by early-onset ataxia, action myoclonus by age 6, scoliosis, and mildly elevated serum creatine kinase. This p.Gly144Trp mutation is equivalent to a loss of function and results in failure of GOSR2 protein to localize to the cis-Golgi.	[Corbett, Mark A.; Dibbens, Leanne M.; Bayly, Marta A.; Gecz, Jozef] SA Pathol, Genet & Mol Pathol, Adelaide, SA 5000, Australia; [Schwake, Michael; Lin, Meng] Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; [Bahlo, Melanie; Gandolfo, Luke C.] Walter & Eliza Hall Res Inst Med Res, Parkville, Vic 3052, Australia; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia; [Dibbens, Leanne M.; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5000, Australia; [Vears, Danya F.; Berkovic, Samuel F.] Univ Melbourne, Epilepsy Res Ctr, Melbourne, Vic 3084, Australia; [O'Sullivan, John D.] Univ Queensland, Sch Med, Royal Brisbane Clin Sch, Herston, Qld 4006, Australia; [Robertson, Thomas] Royal Brisbane & Womens, Pathol Queensland, Anat Pathol, Herston, Qld 4029, Australia; [Gardner, Alison E.; Gecz, Jozef] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Vlaar, Annemarie M.] St Lucas Andreas Ziekenhuis, Dept Neurol, NL-1061 AE Amsterdam, Netherlands; [Korenke, G. Christoph] Klinikum Oldenburg, Dept Neuropediat, D-26131 Oldenburg, Germany; [Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [de Coo, Irenaeus F.] Erasmus MC, Dept Neurol, NL-3015 CE Rotterdam, Netherlands; [Verhagen, Judith M. A.] Erasmus MC, Dept Clin Genet, NL-3015 CE Rotterdam, Netherlands; [Lehesjoki, Anna-Elina] Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia	SA Pathology; University of Kiel; University of Melbourne; University of Adelaide; University of Melbourne; University of Queensland; Royal Brisbane & Women's Hospital; Womens & Childrens Hospital Australia; Sint Lucas Andreas Hospital; Klinikum Oldenburg; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Helsinki; University of Helsinki; University of Adelaide	Gecz, J (corresponding author), SA Pathol, Genet & Mol Pathol, Adelaide, SA 5000, Australia.	jozef.gecz@adelaide.edu.au; samuelfb@unimelb.edu.au	Bloem, Bastiaan R/E-3812-2010; O'Sullivan, John/C-6119-2013; Gecz, Jozef/X-3469-2019; Corbett, Mark/A-8063-2010; Schwake, Michael/F-5381-2010; Bayly, Marta A/F-3977-2013; Bloem, Bastiaan/H-8013-2014; jiang, yu/HGU-0029-2022	Gecz, Jozef/0000-0002-7884-6861; Corbett, Mark/0000-0001-9298-3072; Bloem, Bastiaan/0000-0002-6371-3337; O'Sullivan, John/0000-0003-0422-8590; Bahlo, Melanie/0000-0001-5132-0774; Berkovic, Samuel/0000-0003-4580-841X; de Coo, Irenaeus/0000-0003-0533-7422; Bayly, Marta/0000-0002-6011-4478; Verhagen, Judith/0000-0002-0340-3433; Schwake, Michael/0000-0002-4173-2166; Dibbens, Leanne/0000-0002-5824-3342	National Health and Medical Research Council (NHMRC); Principal Research Fellowship; Deutsche Forschungsgemeinschaft (DFG) [400121, GRK1459]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Principal Research Fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We are grateful for the cooperation of the families involved in this study. Thank you to Maike Langer, Thomas Hoefken, Lisa van Winsen, Maria Digenis, Bev Johns, and Rob King for excellent technical assistance; Paul Saftig for valuable advice; and Johannes Aerts for kindly providing us with the anti-human beta-GC antibody 8E4. M.B. and J.G. were supported by the National Health and Medical Research Council (NH&MRC) with a Career Development Award and a Principal Research Fellowship, respectively. This project was supported by NH&MRC program grant 400121 and by the Research Training Group (GRK1459), funded by the Deutsche Forschungsgemeinschaft (DFG) to P.S. and M.S. The study was approved by the Austin Health Human Research Ethics Committee and informed consent was obtained from all participants.	Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Dibbens LM, 2009, ANN NEUROL, V66, P532, DOI 10.1002/ana.21765; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Lehesjoki AE, 2003, EMBO J, V22, P3473, DOI 10.1093/emboj/cdg338; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Morsomme P, 2003, J CELL BIOL, V162, P403, DOI 10.1083/jcb.200212101; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ramachandran N, 2009, EPILEPSIA, V50, P29, DOI 10.1111/j.1528-1167.2009.02117.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	27	81	85	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					657	663		10.1016/j.ajhg.2011.04.011	http://dx.doi.org/10.1016/j.ajhg.2011.04.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549339	Green Published, Bronze			2022-12-18	WOS:000290832100015
J	Endicott, P; Ho, SYW				Endicott, Phillip; Ho, Simon Y. W.			A Bayesian evaluation of human mitochondrial substitution rates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TIME DEPENDENCY; GENOME VARIATION; NEANDERTHAL DNA; MTDNA VARIATION; EVOLUTION; SELECTION; SEQUENCE; ORIGIN; DIVERGENCE; MUTATIONS	Accurate estimates of mitochondrial substitution rates are central to molecular studies of human evolution, but meaningful of published studies are problematic because Of the wide range of methodologies and data sets employed. comparisons These differences are nowhere more pronounced than among rates estimated from phylogenies, genealogies, and pedigrees. By using a data set comprising mitochondrial genomes from 177 humans, we estimate substitution rates for various data partitions by using Bayesian phylogenetic analysis with a relaxed molecular clock. We compare the effect of multiple internal calibrations with the customary human-chimpanzee split. The analyses reveal wide variation among estimated substitution rates and divergence times made with different partitions and calibrations, with evidence of substitutional saturation, natural selection, and significant rate heterogeneity among lineages and among sites. Collectively, the results support dates for migration out of Africa and the common mitochondrial ancestor of humans that are considerably more recent than most previous estimates. Our results also demonstrate that human mitochondrial genomes exhibit a number of molecular evolutionary complexities that necessitate the use of sophisticated analytical models for genetic analyses.	[Endicott, Phillip; Ho, Simon Y. W.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Ho, SYW (corresponding author), Australian Natl Univ, Sch Bot & Zool, Ctr Macroevolut & Macroecol, GPO Box 4, Canberra, ACT 0200, Australia.	simon.ho@anu.edu.au	Ho, Simon YW/A-8417-2008	Ho, Simon YW/0000-0002-0361-2307; Endicott, Phillip/0000-0003-2452-8507				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Brook BW, 2002, P NATL ACAD SCI USA, V99, P14624, DOI 10.1073/pnas.232126899; Charlesworth B, 2005, GENET RES, V86, P149, DOI 10.1017/S0016672305007743; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Forster P, 1996, AM J HUM GENET, V59, P935; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; HASEGAWA M, 1991, J MOL EVOL, V32, P37, DOI 10.1007/BF02099927; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2007, HUM MOL GENET, V16, P2281, DOI 10.1093/hmg/ddm180; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Meyer S, 1999, GENETICS, V152, P1103; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nielsen R, 1999, GENETICS, V153, P497; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tang H, 2002, GENETICS, V161, P447; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199; Woodhams M, 2006, MOL BIOL EVOL, V23, P2271, DOI 10.1093/molbev/msl107	61	81	82	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					895	902		10.1016/j.ajhg.2008.01.019	http://dx.doi.org/10.1016/j.ajhg.2008.01.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18371929	Green Published, Bronze			2022-12-18	WOS:000255103900008
J	Quinzi, CM; Vu, TH; Min, KC; Tanji, K; Barral, S; Grewal, RP; Kattah, A; Camano, P; Otaegui, D; Kunimatsu, T; Blake, DM; Wilhelmsen, KC; Rowland, LP; Hays, AP; Bonilla, E; Hirano, M				Quinzi, Catarina M.; Vu, Tuan H.; Min, K. Christopher; Tanji, Kurenai; Barral, Sandra; Grewal, Raji P.; Kattah, Andrea; Camano, Pilir; Otaegui, David; Kunimatsu, Teruhito; Blake, David M.; Wilhelmsen, Kirk C.; Rowland, Lewis P.; Hays, Arthur P.; Bonilla, Eduardo; Hirano, Michio			X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-Half-LIM protein 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUSCLE LIM PROTEIN-1; DOMAIN; CYTOSKELETON; ASSOCIATION; ISOFORM; ROLES	Scapuloperoneal (SP) syndrome encompasses heterogeneous neuromuscular disorders characterized by weakness in the shoulder-girdle and peroneal muscles. In a large Italian-American pedigree with dominant SP myopathy (SPM) previously linked to chromosome 12q, we have mapped the disease to Xq26, and, in all of the affected individuals, we identified a missense change (c.36SG -> C) in the FHL1 gene encoding four-and-a-half-LIM protein 1 (THL1). The mutation substitutes a serine for a conserved trypophan at amino acid 122 in the second LIM domain of the protein. Western blot analyses of muscle extracts revealed FHL1 loss that paralleled disease severity. FHL1 and an isoform, FHL1C, are highly expressed in skeletal muscle and may contribute to stability of sarcomeres and sarcolemma, myofibrillary assembly, and transcriptional regulation. This is the first report, to our knowledge, of X-linked dominant SP myopathy and the first human mutation in FHL1.	[Quinzi, Catarina M.; Vu, Tuan H.; Min, K. Christopher; Barral, Sandra; Kattah, Andrea; Camano, Pilir; Otaegui, David; Kunimatsu, Teruhito; Blake, David M.; Wilhelmsen, Kirk C.; Rowland, Lewis P.; Bonilla, Eduardo; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Vu, Tuan H.; Hays, Arthur P.] Wellspan Neurol, York, PA 17402 USA; [Tanji, Kurenai; Bonilla, Eduardo] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Grewal, Raji P.] New Jersey Neurosci Inst, Edison, NJ 08818 USA; [Camano, Pilir; Otaegui, David] Hosp Donostia, Unidad Expt, San Sebastian 20014, Spain; [Wilhelmsen, Kirk C.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	Columbia University; Columbia University; University Hospital Donostia; University of North Carolina; University of North Carolina Chapel Hill	Hirano, M (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.	mh29@columbia.edu	Vu, Tuan H/I-6812-2012; Camaño, Pilar/B-7733-2018; Otaegui, David/H-4390-2013	Camaño, Pilar/0000-0002-4116-5579; Otaegui, David/0000-0002-6625-5976	NIAMS NIH HHS [R01 AR047989] Funding Source: Medline; NINDS NIH HHS [P01 NS011766, NS11766] Funding Source: Medline; Telethon [GFP03009] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROUSSARD J, 1886, THESIS STEINHEIL; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Davidenkow S, 1939, ARCH NEURO PSYCHIATR, V41, P694, DOI 10.1001/archneurpsyc.1939.02270160050004; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Greene WK, 1999, GENE, V232, P203, DOI 10.1016/S0378-1119(99)00125-0; HAUSMANOWAPETRU.I, 1962, Z NERVENHEILKD, V183, P377; Isozumi K, 1996, HUM MOL GENET, V5, P1377, DOI 10.1093/hmg/5.9.1377; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; KAESER HE, 1965, BRAIN, V88, P407, DOI 10.1093/brain/88.2.407; Lee SMY, 1999, GENE, V237, P253, DOI 10.1016/S0378-1119(99)00251-6; Lee SMY, 1998, GENE, V216, P163, DOI 10.1016/S0378-1119(98)00302-3; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; McGrath MJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1513, DOI 10.1152/ajpcell.00207.2003; Morgan MJ, 1999, BIOCHEM BIOPH RES CO, V255, P245, DOI 10.1006/bbrc.1999.0179; Morgan MJ, 1996, BIOCHEM BIOPH RES CO, V225, P632, DOI 10.1006/bbrc.1996.1222; Ng EKO, 2001, J CELL BIOCHEM, V82, P1, DOI 10.1002/jcb.1110; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OKA C, 1995, DEVELOPMENT, V121, P3291; Pegoraro E, 2007, NEUROMUSCULAR DISORD, V17, P321, DOI 10.1016/j.nmd.2007.01.010; Robinson PA, 2003, AM J PHYSIOL-CELL PH, V284, pC681, DOI 10.1152/ajpcell.00370.2002; Steidl L, 1973, Cesk Neurol, V36, P147; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; Walter MC, 2007, BRAIN, V130, P1485, DOI 10.1093/brain/awm039; Wilhelmsen KC, 1996, ANN NEUROL, V39, P507, DOI 10.1002/ana.410390413	26	81	91	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					208	213		10.1016/j.ajhg.2007.09.013	http://dx.doi.org/10.1016/j.ajhg.2007.09.013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179901	Green Published, Bronze			2022-12-18	WOS:000253223800023
J	Patin, E; Barreiro, LB; Sabeti, PC; Austerlitz, F; Luca, F; Sajantila, A; Behar, DM; Semino, O; Sakuntabhai, A; Guiso, N; Gicquel, B; McElreavey, K; Harding, RM; Heyer, E; Quintana-Murci, L				Patin, E; Barreiro, LB; Sabeti, PC; Austerlitz, F; Luca, F; Sajantila, A; Behar, DM; Semino, O; Sakuntabhai, A; Guiso, N; Gicquel, B; McElreavey, K; Harding, RM; Heyer, E; Quintana-Murci, L			Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; HUMAN GENOME; ACETYLATION PHENOTYPE; SEQUENCE VARIATION; NATURAL-SELECTION; INTRAALLELIC VARIABILITY; POLYMORPHIC ACETYLATION; MOLECULAR EVOLUTION; HAPLOTYPE STRUCTURE; POPULATION HISTORY	The human N-acetyltransferase genes NAT1 and NAT2 encode two phase-II enzymes that metabolize various drugs and carcinogens. Functional variability at these genes has been associated with adverse drug reactions and cancer susceptibility. Mutations in NAT2 leading to the so-called slow-acetylation phenotype reach high frequencies worldwide, which questions the significance of altered acetylation in human adaptation. To investigate the role of population history and natural selection in shaping NATs variation, we characterized genetic diversity through the resequencing and genotyping of NAT1, NAT2, and the pseudogene NATP in a collection of 13 different populations with distinct ethnic backgrounds and demographic pasts. This combined study design allowed us to define a detailed map of linkage disequilibrium of the NATs region as well as to perform a number of sequence-based neutrality tests and the long-range haplotype (LRH) test. Our data revealed distinctive patterns of variability for the two genes: the reduced diversity observed at NAT1 is consistent with the action of purifying selection, whereas NAT2 functional variation contributes to high levels of diversity. In addition, the LRH test identified a particular NAT2 haplotype (NAT2*5B) under recent positive selection in western/central Eurasians. This haplotype harbors the mutation 341T -> C and encodes the "slowest-acetylator" NAT2 enzyme, suggesting a general selective advantage for the slow-acetylator phenotype. Interestingly, the NAT2*5B haplotype, which seems to have conferred a selective advantage during the past similar to 6,500 years, exhibits today the strongest association with susceptibility to bladder cancer and adverse drug reactions. On the whole, the patterns observed for NAT2 well illustrate how geographically and temporally fluctuating xenobiotic environments may have influenced not only our genome variability but also our present-day susceptibility to disease.	Inst Pasteur, CNRS, FRE 2849, Unit Mol Prevent & Therapy Human Dis, F-75724 Paris 15, France; Inst Pasteur, Unite Maladies Infect & Autoimmunes, F-75724 Paris 15, France; Inst Pasteur, Unite Genet Mycobacterienne, F-75724 Paris 15, France; Inst Pasteur, Unit Reprod Fertil & Populat, F-75724 Paris 15, France; CNRS, UMR 5145, Musee Homme, Paris, France; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Univ Paris Sud, Orsay, France; Univ Calabria, I-87036 Arcavacata Di Rende, Italy; Univ Helsinki, Helsinki, Finland; Tech & Rambam Med Ctr, Bruce Rappaport Fac Med, Haifa, Israel; Tech & Rambam Med Ctr, Res Inst, Haifa, Israel; Univ Pavia, I-27100 Pavia, Italy; Univ Oxford, Oxford, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Massachusetts Institute of Technology (MIT); Whitehead Institute; UDICE-French Research Universities; Universite Paris Saclay; University of Calabria; University of Helsinki; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Pavia; University of Oxford	Quintana-Murci, L (corresponding author), Inst Pasteur, CNRS, FRE 2849, Unit Mol Prevent & Therapy Human Dis, 25 Rue Dr Roux, F-75724 Paris 15, France.	quintana@pasteur.fr	Barreiro, Luis/I-7772-2015; Sajantila, Antti/AAY-9084-2021; Heyer, Evelyne/K-9184-2013; Luca, Francesca/B-4850-2019; Quintana-Murci, Lluis/AAB-7468-2022; Patin, Etienne/G-6768-2012; Sabeti, Pardis/GQH-8610-2022	Luca, Francesca/0000-0001-8252-9052; Quintana-Murci, Lluis/0000-0003-2429-6320; Barreiro, Luis/0000-0001-9456-367X; Heyer, Evelyne/0000-0002-0266-3196; Sajantila, Antti/0000-0003-4117-5248; SEMINO, Ornella/0000-0002-9675-9403; Austerlitz, Frederic/0000-0001-8031-455X; Patin, Etienne/0000-0002-9911-4459				Asprodini EK, 1998, EUR J DRUG METAB PH, V23, P501, DOI 10.1007/BF03190002; Austerlitz F, 2003, GENETICS, V165, P1579; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; BOZKURT A, 1990, EUR J CLIN PHARMACOL, V38, P53, DOI 10.1007/BF00314803; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CARTWRIGHT RA, 1982, LANCET, V2, P842; CASCORBI I, 1995, AM J HUM GENET, V57, P581; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cornuet JM, 1996, GENETICS, V144, P2001; de Leon JH, 2000, MOL PHARMACOL, V58, P288, DOI 10.1124/mol.58.2.288; EIDUS L, 1974, REV CAN BIOL EXPTL, V33, P117; ELYAZIGI A, 1992, J CLIN PHARMACOL, V32, P905, DOI 10.1002/j.1552-4604.1992.tb04636.x; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; Fay JC, 2000, GENETICS, V155, P1405; Ferguson LR, 2002, TOXICOLOGY, V181, P79, DOI 10.1016/S0300-483X(02)00258-5; FU YX, 1993, GENETICS, V133, P693; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Garrigan D, 2005, MOL BIOL EVOL, V22, P189, DOI 10.1093/molbev/msi013; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Harris D. R, 1996, ORIGINS SPREAD AGR P; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HASHIGUCHI M, 1992, CLIN PHARMACOL THER, V52, P274, DOI 10.1038/clpt.1992.141; HAYAKAWA T, 2005, GENETICS; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29; HILL WG, 1968, GENETICS, V60, P615; HODGKIN MM, 1979, CAN J PHYSIOL PHARM, V57, P760, DOI 10.1139/y79-117; HOMBHANJE F, 1990, PAPUA NEW GUINEA MED, V33, P107; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hughes NC, 1998, PHARMACOGENETICS, V8, P55, DOI 10.1097/00008571-199802000-00008; ILETT KF, 1993, PHARMACOGENETICS, V3, P264, DOI 10.1097/00008571-199310000-00006; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; IRSHAID Y, 1992, EUR J CLIN PHARMACOL, V43, P621, DOI 10.1007/BF02284960; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; JEYAKUMAR LH, 1981, XENOBIOTICA, V11, P319; Jorge-Neberta LF, 2002, PHARMACOGENETICS, V12, P39, DOI 10.1097/00008571-200201000-00006; KARIM AKMB, 1981, J MED GENET, V18, P325, DOI 10.1136/jmg.18.5.325; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KUKONGVIRIYAPAN V, 1984, HUM HERED, V34, P246, DOI 10.1159/000153471; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Lee SY, 2002, CLIN CHEM, V48, P775; LEWIN R, 1987, SCIENCE, V237, P1292, DOI 10.1126/science.3114877; LEWONTIN RC, 1964, GENETICS, V50, P757; LILYIN ET, 1984, GENETIKA+, V20, P1557; Marth G, 2003, P NATL ACAD SCI USA, V100, P376, DOI 10.1073/pnas.222673099; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nei M., 1987, MOL EVOLUTIONARY GEN; NHACHI CFB, 1988, J MED GENET, V25, P29, DOI 10.1136/jmg.25.1.29; ONG ML, 1990, BRIT J RHEUMATOL, V29, P462; Paabo S, 2003, NATURE, V421, P409, DOI 10.1038/nature01400; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Roessli D, 2000, ARLEQUIN VERSION 2 0; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saleem M, 1989, J Pak Med Assoc, V39, P285; SARDAS S, 1993, PHARMACOGENETICS, V3, P131; Saunders MA, 2005, GENETICS, V171, P1219, DOI 10.1534/genetics.105.048140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Sim E, 2000, HUM MOL GENET, V9, P2435, DOI 10.1093/hmg/9.16.2435; Slatkin M, 1997, AM J HUM GENET, V60, P447; Slatkin M, 2001, GENETICS, V158, P865; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; Takahata N, 2001, MOL BIOL EVOL, V18, P172, DOI 10.1093/oxfordjournals.molbev.a003791; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Tang K, 2004, HUM MOL GENET, V13, P783, DOI 10.1093/hmg/ddh099; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Toomajian C, 2003, GENETICS, V165, P287; Toomajian C, 2002, GENETICS, V161, P1609; Upton A, 2001, TRENDS PHARMACOL SCI, V22, P140, DOI 10.1016/S0165-6147(00)01639-4; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEBER WW, 1987, ACETYLATOR GENES DRU; Webster MT, 2003, HUM GENET, V113, P123, DOI 10.1007/s00439-003-0954-0; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Wooding SP, 2002, AM J HUM GENET, V71, P528, DOI 10.1086/342260; Woolhouse NM, 1997, PHARMACOGENETICS, V7, P73, DOI 10.1097/00008571-199702000-00010; WRIGHT S, 1969, EVOLUTION GENETICS P, P33; Zaid RB, 2004, BIOPHARM DRUG DISPOS, V25, P237, DOI 10.1002/bdd.403; Zang Y, 2004, PHARMACOGENETICS, V14, P717, DOI 10.1097/00008571-200411000-00002; Zhao B, 2000, EUR J CLIN PHARMACOL, V56, P689, DOI 10.1007/s002280000203	94	81	88	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					423	436		10.1086/500614	http://dx.doi.org/10.1086/500614			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16416399	Green Published, Bronze			2022-12-18	WOS:000236747500010
J	van der Voet, M; Olson, JM; Kuivaniemi, H; Dudek, DM; Skunca, M; Ronkainen, A; Niemela, M; Jaaskelainen, J; Hernesniemi, J; Helin, K; Leinonen, E; Biswas, M; Tromp, G				van der Voet, M; Olson, JM; Kuivaniemi, H; Dudek, DM; Skunca, M; Ronkainen, A; Niemela, M; Jaaskelainen, J; Hernesniemi, J; Helin, K; Leinonen, E; Biswas, M; Tromp, G			Intracranial aneurysms in Finnish families: Confirmation of linkage and refinement of the interval to chromosome 19q13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBARACHNOID HEMORRHAGE; SACCULAR ANEURYSMS; COMPLEX TRAITS; SIBLING PAIRS; DISEASE; PROTEIN; RUPTURE; MARKERS; MODELS; MUSCLE	We recently reported a two-stage genomewide screen of 48 sib pairs affected with intracranial aneurysms (IAs) that revealed suggestive linkage to chromosome 19q13, with a LOD score of 2.58. The region supporting linkage spanned similar to 22 cM. Here, we report a follow-up study of the locus at 19q13, with a sample size expanded to 139 affected sib pairs, along with 83 other affected relative pairs ( 222 affected relative pairs in total). Suggestive linkage was observed in both independent sample sets, and linkage was significant in the combined set at 70 cM ( LOD score 3.50; P = .00006) and at 80 cM (LOD score 3.93; P = .00002). Linkage was highly significant at 70 cM ( LOD score 5.70; P = .000001) and at 80 cM (LOD score 3.99; P = .00005) when a covariate measuring the number of affected individuals in the nuclear family was included. To evaluate further the contribution to the linkage signal from families with more than two affected relatives, we performed model-based linkage analysis with a recessive model and a range of penetrances, and we obtained maximum linkage at 70 cM (LOD score 3.16; P = .00007) with a penetrance of 0.3. We then estimated location by using GENEFINDER. The most likely location for a gene predisposing to IAs in the Finnish population is in a region with a 95% confidence interval of 11.6 cM (P = .00007) centered 2.0 cM proximal to D19S246.	Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Univ Kuopio, Dept Neurosurg, FIN-70211 Kuopio, Finland; Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland	Wayne State University; Wayne State University; Case Western Reserve University; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital	Tromp, G (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 3116 Gordon H Scott Hall Basic Med Sci,540 E Canf, Detroit, MI 48201 USA.	tromp@sanger.med.wayne.edu	Niemelä, Mika R/F-2539-2015; Tromp, Gerard/B-2677-2017; van der Voet, Monique/F-5772-2012; Kuivaniemi, Helena/Q-8178-2019	Niemelä, Mika R/0000-0003-1526-0684; Tromp, Gerard/0000-0002-7761-0806; van der Voet, Monique/0000-0002-8829-1767; Kuivaniemi, Helena/0000-0001-5753-8766	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001577, R29HG001577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034395] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHGRI NIH HHS [R29 HG001577, HG01577, R01 HG001577] Funding Source: Medline; NINDS NIH HHS [NS034395, R01 NS034395] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chiu YF, 2002, MOL PSYCHIATR, V7, P658, DOI 10.1038/sj.mp.4001045; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Glidden DV, 2003, GENET EPIDEMIOL, V24, P107, DOI 10.1002/gepi.10215; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; Guo MQ, 2001, ADV GENET, V42, P459; Kissela BM, 2002, STROKE, V33, P1321, DOI 10.1161/01.STR.0000014773.57733.3E; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuivaniemi H, 2002, CLIN CHEM, V48, P1601; Liang KY, 2000, HUM HERED, V51, P64; Nonaka H, 2001, CIRCULATION, V104, P1746, DOI 10.1161/hc4001.098048; Norio R, 2003, HUM GENET, V112, P457, DOI 10.1007/s00439-002-0876-2; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Olson Jane M, 2002, BMC Med Genet, V3, P7, DOI 10.1186/1471-2350-3-7; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Olson JM, 2002, GENET EPIDEMIOL, V23, P444, DOI 10.1002/gepi.10186; Olson JM, 2002, AM J HUM GENET, V71, P154, DOI 10.1086/341034; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; OLSON JM, 2002, GENES IMMUN S, V3, P5; Onda H, 2001, AM J HUM GENET, V69, P804, DOI 10.1086/323614; OSTERGAARD JR, 1989, ACTA NEUROL SCAND, V80, P81, DOI 10.1111/j.1600-0404.1989.tb03847.x; PATHAK RK, 1992, J MUSCLE RES CELL M, V13, P366, DOI 10.1007/BF01766464; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; RISCH N, 1990, AM J HUM GENET, V46, P229; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8; RONKAINEN A, 1993, NEUROSURGERY, V33, P787; *SAGE, 2003, STAT AN GEN EP; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; SEKHAR LN, 1981, NEUROSURGERY, V8, P248, DOI 10.1227/00006123-198102000-00020; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005; Wellman GC, 2002, STROKE, V33, P802, DOI 10.1161/hs0302.104089; Whittemore AS, 1998, AM J HUM GENET, V62, P1228, DOI 10.1086/301820; Wills S, 2003, STROKE, V34, P1370, DOI 10.1161/01.STR.0000072822.35605.8B; Yamada S, 2003, STROKE, V34, P892, DOI 10.1161/01.STR.0000062887.71400.B4; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	37	81	83	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					564	571		10.1086/382285	http://dx.doi.org/10.1086/382285			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14872410	Green Published, Bronze			2022-12-18	WOS:000220118500023
J	Veltman, JA; Jonkers, Y; Nuijten, I; Janssen, I; van der Vliet, W; Huys, E; Vermeesch, J; Van Buggenhout, G; Fryns, JP; Admiraal, R; Terhal, P; Lacombe, D; van Kessel, AG; Smeets, D; Schoenmakers, EFPM; van Ravenswaaij-Arts, CM				Veltman, JA; Jonkers, Y; Nuijten, I; Janssen, I; van der Vliet, W; Huys, E; Vermeesch, J; Van Buggenhout, G; Fryns, JP; Admiraal, R; Terhal, P; Lacombe, D; van Kessel, AG; Smeets, D; Schoenmakers, EFPM; van Ravenswaaij-Arts, CM			Definition of a critical region on chromosome 18 for congenital aural atresia by arrayCGH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LONG ARM; DELETION; FAMILY; DNA	Deletions of the long arm of chromosome 18 occur in similar to1 in 10,000 live births. Congenital aural atresia (CAA), or narrow external auditory canals, occurs in similar to66% of all patients who have a terminal deletion 18q. The present report describes a series of 20 patients with CAA, of whom 18 had microscopically visible 18q deletions. The extent and nature of the chromosome-18 deletions were studied in detail by array-based comparative genomic hybridization (arrayCGH). High-resolution chromosome-18 profiles were obtained for all patients, and a critical region of 5 Mb that was deleted in all patients with CAA could be defined on 18q22.3-18q23. Therefore, this region can be considered as a candidate region for aural atresia. The array-based high-resolution copy-number screening enabled a refined cytogenetic diagnosis in 12 patients. Our approach appeared to be applicable to the detection of genetic mosaicisms and, in particular, to a detailed delineation of ring chromosomes. This study clearly demonstrates the power of the arrayCGH technology in high-resolution molecular karyotyping. Deletion and amplification mapping can now be performed at the submicroscopic level and will allow high-throughput definition of genomic regions harboring disease genes.	Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Dept Otorhinolaryngol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; Univ Hosp Leuven, Ctr Human Genet, Louvain, Belgium; Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands; Pellegrin Childrens Hosp, Dept Med Genet, Bordeaux, France	Radboud University Nijmegen; Radboud University Nijmegen; KU Leuven; University Hospital Leuven; Utrecht University; Utrecht University Medical Center; CHU Bordeaux	Veltman, JA (corresponding author), Univ Nijmegen, Dept Human Genet, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.veltman@antrg.umcn.nl	Admiraal, R.J.C./L-4171-2015; Smeets, D.F.C.M./L-4653-2015; Veltman, Joris A/F-5128-2010; Versleijen-Jonkers, Yvonne M.H./L-4717-2015; Janssen, Irene M/V-3667-2018; van Kessel, Ad Geurts/A-2810-2010	Veltman, Joris A/0000-0002-3218-8250; Versleijen-Jonkers, Yvonne/0000-0001-7623-0505; Lacombe, Didier/0000-0002-8956-2207; Vermeesch, Joris/0000-0002-3071-1191				Cody JD, 1999, AM J MED GENET, V85, P455, DOI 10.1002/(SICI)1096-8628(19990827)85:5<455::AID-AJMG5>3.0.CO;2-Z; Cremers C W, 1988, Adv Otorhinolaryngol, V40, P9; DE GROUCHY J, 1964, Pathol Biol, V12, P579; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Holmes DIR, 1999, GENOMICS, V60, P105, DOI 10.1006/geno.1999.5897; Julia S, 2002, AM J MED GENET, V110, P179, DOI 10.1002/ajmg.10433; Keppler-Noreuil KM, 1998, AM J MED GENET, V76, P372, DOI 10.1002/(SICI)1096-8628(19980413)76:5<372::AID-AJMG2>3.0.CO;2-P; KLINE AD, 1993, AM J HUM GENET, V52, P895; Kohlhase J, 1999, GENOMICS, V62, P216, DOI 10.1006/geno.1999.6005; LISMAA TP, 1998, ANN NY ACAD SCI, V863, P56; MELNICK M, 1979, BIRTH DEFECTS, V15, P1; NUIJTEN I, IN PRESS OTOL NEUROT; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 2002, NAT GENET, V32, P515, DOI 10.1038/ng1035; SCHINZEL A, 1991, J MED GENET, V28, P352, DOI 10.1136/jmg.28.5.352; Schinzel A., 2001, CATALOGUE UNBALANCED, P717; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Strathdee G, 1997, AM J HUM GENET, V60, P860; STRATHDEE G, 1995, AM J MED GENET, V59, P476, DOI 10.1002/ajmg.1320590414; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; WEISS BJ, 1991, ANN NEUROL, V30, P419, DOI 10.1002/ana.410300316; Wilhelm M, 2002, CANCER RES, V62, P957; WILSON MG, 1979, AM J MED GENET, V3, P155, DOI 10.1002/ajmg.1320030207	24	81	85	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1578	1584		10.1086/375695	http://dx.doi.org/10.1086/375695			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12740760	Bronze, Green Published			2022-12-18	WOS:000183275500022
J	Bulik, CM; Devlin, B; Bacanu, SA; Thornton, L; Klump, KL; Fichter, MM; Halmi, KA; Kaplan, AS; Strober, M; Woodside, DB; Bergen, AW; Ganjei, JK; Crow, S; Mitchell, J; Rotondo, A; Mauri, M; Cassano, G; Keel, P; Berrettini, WH; Kaye, WH				Bulik, CM; Devlin, B; Bacanu, SA; Thornton, L; Klump, KL; Fichter, MM; Halmi, KA; Kaplan, AS; Strober, M; Woodside, DB; Bergen, AW; Ganjei, JK; Crow, S; Mitchell, J; Rotondo, A; Mauri, M; Cassano, G; Keel, P; Berrettini, WH; Kaye, WH			Significant linkage on chromosome 10p in families with bulimia nervosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIABETES SUSCEPTIBILITY GENES; TRANSMISSION RATIO DISTORTION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; 10-YEAR FOLLOW-UP; BODY-MASS INDEX; ANOREXIA-NERVOSA; GENOME SCAN; EATING DISORDERS; 72 FAMILIES; SCHIZOPHRENIA	Bulimia nervosa (BN) is strongly familial, and additive genetic effects appear to contribute substantially to the observed familiality. In turn, behavioral components of BN, such as self-induced vomiting, are reliably measured and heritable. To identify regions of the genome harboring genetic variants conferring susceptibility to BN, we conducted a linkage analysis of multiplex families with eating disorders that were identified through a proband with BN. Linkage analysis of the entire sample of 308 families yielded a double peak, with the highest nonparametric multipoint maximum LOD score (MLS), of 2.92, on chromosome 10. Given the high heritability of self-induced vomiting and the reliability with which it can be measured, we performed linkage analysis in a subset (n = 133) of families in which at least two affected relatives reported a symptom pattern that included self-induced vomiting. The highest MLS (3.39) observed was on chromosome 10, between markers D10S1430 and D10S1423. These results provide evidence of the presence of a susceptibility locus for BN on chromosome 10p. Using simulations, we demonstrate that both of these scores, 2.92 and 3.39, meet the widely accepted criterion for genomewide significance. Another region on 14q meets the criterion for genomewide suggestive linkage, with MLSs of 1.97 (full sample) and 1.75 (subset) at 62 centimorgans from p-ter.	Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA; Univ Pittsburgh, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; Univ Munich, Roseneck Hosp Behav Med, Prien Am Chiemsee, Germany; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, White Plains, NY USA; Toronto Gen Hosp, Univ Hlth Network, Program Eating Disorders, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; NCI, Core Genotyping Facil, Ctr Adv Technol, Gaithersburg, MD USA; Biognosis US, Gaithersburg, MD USA; Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; Neuropsychiat Res Unit, Fargo, ND USA; Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, Pisa, Italy; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Penn, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Michigan State University; University of Munich; Cornell University; NewYork-Presbyterian Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; Neuropsychiatric Research Institute; University of Pisa; Harvard University; University of Pennsylvania; Pennsylvania Medicine	Bulik, CM (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA.			Keel, Pamela/0000-0001-6542-5147; Bacanu, Silviu-Alin/0000-0002-4364-1583; Bergen, Andrew/0000-0002-1237-7644	NIMH NIH HHS [R01 MH057881, MH57881, R37 MH057881, K01-MH01553] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001553, R01MH057881, R37MH057881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000016, Z01AA000302] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Bulik CM, 2000, INT J EAT DISORDER, V27, P1; Bulik CM, 1998, BIOL PSYCHIAT, V44, P1210, DOI 10.1016/S0006-3223(98)00280-7; BULIK CM, IN PRESS INT J EAT D; Camp NJ, 2001, ANN HUM GENET, V65, P577, DOI [10.1046/j.1469-1809.2001.6560577.x, 10.1017/S0003480001008922]; COCKERHAM C, 1972, GENETICS, V74, P679; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Devlin B, 2002, HUM MOL GENET, V11, P689, DOI 10.1093/hmg/11.6.689; ECKERT ED, 1995, PSYCHOL MED, V25, P143, DOI 10.1017/S0033291700028166; Fairburn CG, 1997, ARCH GEN PSYCHIAT, V54, P509; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Faraone SV, 1999, AM J MED GENET, V88, P607, DOI 10.1002/(SICI)1096-8628(19991215)88:6<607::AID-AJMG6>3.0.CO;2-Q; Fichter MM, 1998, INT J EAT DISORDER, V24, P227, DOI 10.1002/(SICI)1098-108X(199811)24:3<227::AID-EAT1>3.3.CO;2-O; GARFINKEL PE, 1980, ARCH GEN PSYCHIAT, V37, P1036, DOI 10.1001/archpsyc.1980.01780220074008; Gelernter J, 2001, AM J MED GENET, V105, P548, DOI 10.1002/ajmg.1496; GILLBERG IC, 1994, J AM ACAD CHILD PSY, V33, P729, DOI 10.1097/00004583-199406000-00014; GRACE PS, 1985, J CLIN PSYCHOL, V41, P173, DOI 10.1002/1097-4679(198503)41:2<173::AID-JCLP2270410208>3.0.CO;2-N; Gray-McGuire C, 2000, AM J HUM GENET, V67, P1460, DOI 10.1086/316891; Grice DE, 2002, AM J HUM GENET, V70, P787, DOI 10.1086/339250; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hebebrand J, 1996, INT J EAT DISORDER, V19, P359, DOI 10.1002/(SICI)1098-108X(199605)19:4&lt;359::AID-EAT4&gt;3.0.CO;2-K; Hinney A, 2000, J CLIN ENDOCR METAB, V85, P2962, DOI 10.1210/jc.85.8.2962; JOHNSONSABINE E, 1988, PSYCHOL MED, V18, P615, DOI 10.1017/S0033291700008291; Kaye WH, 2000, BIOL PSYCHIAT, V47, P794, DOI 10.1016/S0006-3223(99)00240-1; Kaye WH, 2001, AM J PSYCHIAT, V158, P1152, DOI 10.1176/appi.ajp.158.7.1152; Kaye WH, 1998, ARCH GEN PSYCHIAT, V55, P927, DOI 10.1001/archpsyc.55.10.927; KENDLER KS, 1991, AM J PSYCHIAT, V148, P1627; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kortegaard LS, 2001, PSYCHOL MED, V31, P361, DOI 10.1017/S0033291701003087; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levitan RD, 2001, BIOL PSYCHIAT, V50, P640, DOI 10.1016/S0006-3223(01)01201-X; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lockwood JR, 2001, GENET EPIDEMIOL, V20, P17, DOI 10.1002/1098-2272(200101)20:1<17::AID-GEPI3>3.0.CO;2-Q; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Paterson AD, 1999, AM J MED GENET, V88, P657, DOI 10.1002/(SICI)1096-8628(19991215)88:6<657::AID-AJMG15>3.3.CO;2-R; Rao SQ, 2001, ARTHRITIS RHEUM, V44, P2807, DOI 10.1002/1529-0131(200112)44:12<2807::AID-ART468>3.0.CO;2-C; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; SCHORK EJ, 1994, COMPR PSYCHIAT, V35, P113, DOI 10.1016/0010-440X(94)90055-M; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; Schwab SG, 1999, AM J MED GENET, V88, P750; Sekine M, 2001, HUM MOL GENET, V10, P1421, DOI 10.1093/hmg/10.13.1421; SMITH C, 1993, J AM ACAD CHILD PSY, V32, P1237, DOI 10.1097/00004583-199311000-00018; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; Strober M, 2000, AM J PSYCHIAT, V157, P393, DOI 10.1176/appi.ajp.157.3.393; Sullivan PF, 1998, BRIT J PSYCHIAT, V173, P75, DOI 10.1192/bjp.173.1.75; Teng J, 1998, BIOMETRICS, V54, P1247, DOI 10.2307/2533654; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; VANDERHAM T, 1994, ACTA PSYCHIAT SCAND, V90, P229; VIESSELMAN JO, 1985, J CLIN PSYCHIAT, V46, P118; Wade T, 1999, BEHAV GENET, V29, P1, DOI 10.1023/A:1021429604095; Wade TD, 2000, BRIT J PSYCHIAT, V177, P72, DOI 10.1192/bjp.177.1.72	59	81	83	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					200	207		10.1086/345801	http://dx.doi.org/10.1086/345801			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12476400	Bronze, Green Published			2022-12-18	WOS:000180186800021
J	Brunetti-Pierri, N; Corso, G; Rossi, M; Ferrari, P; Balli, F; Rivasi, F; Annunziata, I; Ballabio, A; Dello Russo, A; Andria, G; Parenti, G				Brunetti-Pierri, N; Corso, G; Rossi, M; Ferrari, P; Balli, F; Rivasi, F; Annunziata, I; Ballabio, A; Dello Russo, A; Andria, G; Parenti, G			Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3 beta-hydroxysteroid-Delta(5)-desaturase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEMLI-OPITZ-SYNDROME; CULTURED SKIN FIBROBLASTS; C-5 STEROL DESATURASE; CHOLESTEROL-BIOSYNTHESIS; MOLECULAR-CLONING; REDUCTASE GENE; YEAST MUTANT; MUTATIONS; 7-DEHYDROCHOLESTEROL; EXPRESSION	We report the clinical, biochemical, and molecular characterization of a patient with a novel defect of cholesterol biosynthesis. This patient presented with a complex phenotype, including multiple congenital anomalies, mental retardation, and liver disease. In the patient's plasma and cells, we found increased levels of lathosterol. The biosynthesis of cholesterol in the patient's fibroblasts was defective, showing a block in the conversion of lathosterol into 7-dehydrocholesterol. The activity of 3beta-hydroxysteroid-Delta(5)-desaturase (SC5D), the enzyme involved in this reaction, was deficient in the patient's fibroblasts. Sequence analysis of the SC5D gene in the patient's DNA, showing the presence of two missense mutations (R29Q and G211D), confirmed that the patient is affected by a novel defect of cholesterol biosynthesis.	Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy; Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; Univ Naples 2, Telethon Inst Genet & Med, Naples, Italy; Univ Modena, Dept Pediat, I-41100 Modena, Italy; Univ Modena, Dept Pathol, I-41100 Modena, Italy	University of Naples Federico II; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Parenti, G (corresponding author), Univ Naples Federico II, Dept Pediat, Via S Pansini 5, I-80131 Naples, Italy.		andria, generoso/V-7172-2019; Corso, Gaetano/H-9450-2013; Rossi, Massimiliano/AAO-5615-2020; Dello Russo, Antonio/AAB-5030-2022; Melis, Daniela/AAD-3623-2019; Brunetti-Pierri, Nicola/K-8465-2016	Corso, Gaetano/0000-0003-4720-1320; Rossi, Massimiliano/0000-0002-5797-8152; Dello Russo, Antonio/0000-0001-7737-421X; Melis, Daniela/0000-0002-9458-3926; parenti, giancarlo/0000-0002-6287-5748; BALLABIO, Andrea/0000-0003-1381-4604; Brunetti-Pierri, Nicola/0000-0002-6895-8819	Telethon [TGM00S01, TGM06S01, E.0790] Funding Source: Medline	Telethon(Fondazione Telethon)		ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Braverman N, 1999, NAT GENET, V22, P291, DOI 10.1038/10357; Corso G, 2002, J CHROMATOGR B, V766, P365, DOI 10.1016/S0378-4347(01)00520-5; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Gachotte D, 1996, PLANT J, V9, P391, DOI 10.1046/j.1365-313X.1996.09030391.x; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; HONDA A, 1995, J LIPID RES, V36, P1595; IRONS M, 1993, LANCET, V341, P1414, DOI 10.1016/0140-6736(93)90983-N; Kelley R I, 2000, Adv Pediatr, V47, P1; Kelley RI, 2000, J MED GENET, V37, P321, DOI 10.1136/jmg.37.5.321; Kelley RI, 2002, AM J MED GENET, V110, P95, DOI 10.1002/ajmg.10510; Kelley RI, 1998, AM J HUM GENET, V63, P322, DOI 10.1086/301987; Kelley RI, 1999, AM J MED GENET, V83, P213, DOI 10.1002/(SICI)1096-8628(19990319)83:3<213::AID-AJMG15>3.0.CO;2-C; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Konig A, 2000, AM J MED GENET, V90, P339; Krakowiak PA, 2001, AM J HUM GENET, V69, P190; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Matsushima M, 1996, CYTOGENET CELL GENET, V74, P252, DOI 10.1159/000134427; Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2; Nishi S, 2000, BBA-GENE STRUCT EXPR, V1490, P106, DOI 10.1016/S0167-4781(99)00248-1; Opitz John M., 1999, Current Opinion in Pediatrics, V11, P353, DOI 10.1097/00008480-199908000-00015; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sugawara T, 2001, BBA-MOL CELL BIOL L, V1533, P277, DOI 10.1016/S1388-1981(01)00160-3; Taton M, 2000, BIOCHEMISTRY-US, V39, P701, DOI 10.1021/bi991467t; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982	28	81	83	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					952	958		10.1086/342668	http://dx.doi.org/10.1086/342668			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12189593	Green Published, Bronze			2022-12-18	WOS:000178613800022
J	Williams, CJ; Zhang, Y; Timms, A; Bonavita, G; Caeiro, F; Broxholme, J; Cuthbertson, J; Jones, Y; Marchegiani, R; Reginato, A; Russell, RGG; Wordsworth, BP; Carr, AJ; Brown, MA				Williams, CJ; Zhang, Y; Timms, A; Bonavita, G; Caeiro, F; Broxholme, J; Cuthbertson, J; Jones, Y; Marchegiani, R; Reginato, A; Russell, RGG; Wordsworth, BP; Carr, AJ; Brown, MA			Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRANIOMETAPHYSEAL DYSPLASIA; CHONDROCALCINOSIS; OSTEOARTHRITIS; ASSOCIATION; ARTHRITIS; LINKAGE; GENE	Familial autosomal dominant calcium pyrophosphate dihydrate (CPPD) chondrocalcinosis has previously been mapped to chromosome 5p15. We have identified a mutation in the ANKH gene that segregates with the disease in a family with this condition. ANKH encodes a putative transmembrane inorganic pyrophosphate (PPi) transport channel. We postulate that loss of function of ANKH causes elevated extracellular PPi levels, predisposing to CPPD crystal deposition.	Wellcome Trust Ctr Human Genet, Spondyloarthrit & Bone Dis Res Grp, Headington OX3 7BN, England; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Univ Oxford, Dept Biochem, Oxford OX1 2JD, England; Univ Oxford, Inst Musculoskeletal Sci, Headington, England; Univ Oxford, Nuffield Dept Orthopaed Surg, Nuffield Orthopaed Ctr, Oxford, England; Hosp Privado, Cordoba, Argentina; Univ Med & Dent New Jersey, Div Rheumatol, Camden, NJ USA	University of Oxford; Wellcome Centre for Human Genetics; Jefferson University; University of Oxford; University of Oxford; Nuffield Orthopaedic Centre; University of Oxford; Hospital Privado - Universitario de Cordoba; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brown, MA (corresponding author), Wellcome Trust Ctr Human Genet, Spondyloarthrit & Bone Dis Res Grp, Roosevelt Dr, Headington OX3 7BN, England.		Brown, Matthew A/E-5749-2010; Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019	Brown, Matthew A/0000-0003-0538-8211; Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893				Andrew LJ, 1999, AM J HUM GENET, V64, P136, DOI 10.1086/302186; BALDWIN CT, 1995, AM J HUM GENET, V56, P692; Doherty M, 1996, ANN RHEUM DIS, V55, P432, DOI 10.1136/ard.55.7.432; DOHERTY M, 1991, BRIT J RHEUMATOL, V30, P10; FELSON DT, 1989, J RHEUMATOL, V16, P1241; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Johnson M, 2001, ARTHRITIS RHEUM, V44, pS161; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/88236; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Pendleton A, 2001, ARTHRITIS RHEUM, V44, pS101; Reichenberger E, 2001, AM J HUM GENET, V68, P1321, DOI 10.1086/320612; RUSSELL RGG, 1970, LANCET, V2, P899, DOI 10.1016/S0140-6736(70)92070-2; Timms AE, 2002, RHEUMATOLOGY, V41, P725, DOI 10.1093/rheumatology/41.7.725	13	81	85	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					985	991		10.1086/343053	http://dx.doi.org/10.1086/343053			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12297989	Bronze, Green Published			2022-12-18	WOS:000178613800028
J	Hakonarson, H; Bjornsdottir, US; Halapi, E; Palsson, S; Adalsteinsdottir, E; Gislason, D; Finnbogason, G; Gislason, T; Kristjansson, K; Arnason, T; Birkisson, I; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K				Hakonarson, H; Bjornsdottir, US; Halapi, E; Palsson, S; Adalsteinsdottir, E; Gislason, D; Finnbogason, G; Gislason, T; Kristjansson, K; Arnason, T; Birkisson, I; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K			A major susceptibility gene for asthma maps to chromosome 14q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE ANALYSIS; CANDIDATE GENES; LOCI; COMPLEX; RESPONSIVENESS; ENVIRONMENT; PHENOTYPES; MARKERS	Asthma is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. Numerous loci and candidate genes have been reported to show linkage and association to asthma and atopy. Although some studies reporting these observations are compelling, no gene has been mapped that confers a sufficiently high risk of asthma to meet the stringent criteria for genomewide significance. Using 175 extended Icelandic families that included 596 patients with asthma, we performed a genomewide scan with 976 microsatellite markers. The families were identified by cross-matching a list of patients with asthma from the Department of Allergy/Pulmonary Medicine of the National University Hospital of Iceland with a genealogy database of the entire Icelandic nation. We detected linkage of asthma to chromosome 14q24, with an allele-sharing LOD score of 2.66. After we increased the marker density within the locus to an average of one microsatellite every 0.2 cM, the LOD score rose to 4.00. We designate this locus "asthma locus one" (AS1). Taken together, these results provide evidence of a novel susceptibility gene for asthma on chromosome 14q24.	DeCode Genet, IS-101 Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Dept Allergy Pulm Med, Reykjavik, Iceland	Landspitali National University Hospital	Hakonarson, H (corresponding author), DeCode Genet, Sturlugata 1, IS-101 Reykjavik, Iceland.	hak-onh@decode.is; kstefans@decode.is	Halapi, Eva/AAL-7666-2020; Palsson, Snaebjorn/J-9113-2012; Stefansson, Kari/AAE-7187-2019	Halapi, Eva/0000-0003-2025-7148; Palsson, Snaebjorn/0000-0002-4297-3500				[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bleecker ER, 1997, AM J RESP CRIT CARE, V156, pS113, DOI 10.1164/ajrccm.156.4.12tac7; Burney P, 1997, AM J RESP CRIT CARE, V156, P1773; Cho SH, 2001, CLIN EXP ALLERGY, V31, P103, DOI 10.1046/j.1365-2222.2001.00952.x; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; COLLINGS A, 2000, AM J HUM GENET, V66, pA1366; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; FJALLDAL JB, 2001, P INT JOINT C NEUR N, pA1; Green SL, 1998, AM J RESP CRIT CARE, V158, P1487, DOI 10.1164/ajrccm.158.5.9707099; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Gulcher JR, 2001, CURR OPIN GENET DEV, V11, P264, DOI 10.1016/S0959-437X(00)00188-X; Hakonarson H, 2001, AM J RESP CRIT CARE, V164, P2036, DOI 10.1164/ajrccm.164.11.2101086; Hakonarson H, 2001, CURR OPIN PEDIATR, V13, P267, DOI 10.1097/00008480-200106000-00010; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Hizawa N, 1998, J ALLERGY CLIN IMMUN, V102, P436, DOI 10.1016/S0091-6749(98)70132-0; Holloway JW, 1999, CLIN EXP ALLERGY, V29, P1023; Kauffmann F, 2002, CHEST, V121, p27S, DOI 10.1378/chest.121.3_suppl.27S; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Koppelman GH, 1999, EUR RESPIR J, V13, P2, DOI 10.1183/09031936.99.13100299; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/88319; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Lonjou C, 1999, CLIN EXP ALLERGY, V29, P57; Mansur AH, 1999, AM J RESP CRIT CARE, V159, P1796, DOI 10.1164/ajrccm.159.6.9804036; Marsh DG, 1997, NAT GENET, V15, P389; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; NICOLAE DL, 1999, THESIS U CHICAGO CHI; *NIH, 1997, NIH PUBL; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Palmer LJ, 2001, GENET EPIDEMIOL, V21, pS9, DOI 10.1002/gepi.2001.21.s1.s9; PALMQUIST M, 1988, HYGIEA, V97, P108; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; Unoki M, 2000, HUM GENET, V106, P440, DOI 10.1007/s004390000267; Weiss ST, 2001, ANN ALLERG ASTHMA IM, V87, P5, DOI 10.1016/S1081-1206(10)62188-6; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Wjst M, 1998, BIOINFORMATICS, V14, P827, DOI 10.1093/bioinformatics/14.9.827; Xu JF, 2001, AM J HUM GENET, V68, P1437, DOI 10.1086/320589; Xu X, 2001, AM J HUM GENET, V69, P1271, DOI 10.1086/324650; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201	48	81	86	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					483	491		10.1086/342205	http://dx.doi.org/10.1086/342205			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12119603	Bronze, Green Published			2022-12-18	WOS:000177489600003
J	Amiel, J; Espinosa-Parrilla, Y; Steffann, J; Gosset, P; Pelet, A; Prieur, M; Boute, O; Choiset, A; Lacombe, D; Philip, N; Le Merrer, M; Tanaka, H; Till, M; Touraine, R; Toutain, A; Vekemans, M; Munnich, A; Lyonnet, S				Amiel, J; Espinosa-Parrilla, Y; Steffann, J; Gosset, P; Pelet, A; Prieur, M; Boute, O; Choiset, A; Lacombe, D; Philip, N; Le Merrer, M; Tanaka, H; Till, M; Touraine, R; Toutain, A; Vekemans, M; Munnich, A; Lyonnet, S			Large-scale deletions and SMADIP1 truncating mutations in syndromic hirschsprung disease with involvement of midline structures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GOLDBERG-SHPRINTZEN-SYNDROME; MENTAL-RETARDATION; IRIS COLOBOMA; PROTEINS; SIP1	Hirschsprung disease (HSCR) is a common malformation of neural-crest-derived enteric neurons that is frequently associated with other congenital abnormalities. The SMADIP1 gene recently has been recognized as disease causing in some patients with 2q22 chromosomal rearrangement, resulting in syndromic HSCR with mental retardation, with microcephaly, and with facial dysmorphism. We screened 19 patients with HSCR and mental retardation and eventually identified large-scale SMADIP1 deletions or truncating mutations in 8 of 19 patients. These results allow further delineation of the spectrum of malformations ascribed to SMADIP1 haploinsufficiency, which includes frequent features such as hypospadias and agenesis of the corpus callosum. Thus, SMADIP1, which encodes a transcriptional corepressor of Smad target genes, may play a role not only in the patterning of neural-crest-derived cells and of CNS but also in the development of midline structures in humans.	Hop Necker Enfants Malad, Dept Genet, F-75743 Paris 15, France; Hop Necker Enfants Malad, INSERM, U393, F-75743 Paris 15, France; Hop St Vincent de Paul, Cytogenet Serv, F-75674 Paris, France; Ctr Hosp Reg & Univ Lille, Hop Huriez, Serv Pediat, F-59037 Lille, France; Hop Pellegrin, Serv Genet, F-33076 Bordeaux, France; Hop Enfants La Timone, Dept Genet, Marseille, France; Asahikawa Habilitat Ctr Disabled Children, Dept Pediat, Asahikawa, Hokkaido, Japan; Hop Debrousse, Serv Pediat, Lyon, France; Hop Nord St Etienne, Serv Genet, St Etienne, France; Hop Bretonneau, Serv Genet, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; CHU Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Lyon; CHU de St Etienne; CHU Tours	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, Dept Genet, 149 Rue Sevres, F-75743 Paris 15, France.	lyonnet@necker.fr	Lyonnet, Stanislas/H-5483-2017; Espinosa-Parrilla, Yolanda/E-6368-2013; Philip, Nicole/I-2881-2016; amiel, jeanne/H-3501-2017; Espinosa-Parrilla, Yolanda/GSN-8107-2022; amiel, jeanne/AGX-1124-2022; Touraine, Renaud/AAV-1605-2020; Steffann, Julie/I-2820-2017	Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; Espinosa-Parrilla, Yolanda/0000-0002-5441-3113; Steffann, Julie/0000-0001-9493-3239; Lacombe, Didier/0000-0002-8956-2207; PELET, Anastella/0000-0002-8353-1725; Toutain, Annick/0000-0002-5999-5300				Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; HURST JA, 1988, J MED GENET, V25, P494, DOI 10.1136/jmg.25.7.494; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Lurie I. W., 1994, Genetic Counseling, V5, P11; LYONNET S, 2001, METABOLIC MOL BASES, P6231; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Ohnuma K, 1997, AM J MED GENET, V73, P230; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; TANAKA H, 1993, PEDIATR NEUROL, V9, P479, DOI 10.1016/0887-8994(93)90029-C; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860	12	81	86	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1370	1377		10.1086/324342	http://dx.doi.org/10.1086/324342			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11595972	Green Published, Bronze			2022-12-18	WOS:000172086900020
J	Vincent, JB; Herbrick, JA; Gurling, HMD; Bolton, PF; Roberts, W; Scherer, SW				Vincent, JB; Herbrick, JA; Gurling, HMD; Bolton, PF; Roberts, W; Scherer, SW			Identification of a novel gene on chromosome 7q31 that is interrupted by a translocation breakpoint in an autistic individual	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISORDER	The results of genetic linkage studies for autism have suggested that a susceptibility locus for the disease is located on the long arm of chromosome 7 (7q). An autistic individual carrying a translocation, t(7;13)(q31.3;q21), with the chromosome 7 breakpoint located in the region of 7q implicated by genetic studies was identified. A novel gene known as "RAY1" (or "FAM4A1") was found to be directly interrupted by the translocation breakpoint. The gene, which was found to be encoded by 16 exons with evidence of alternative splicing, spanned greater than or equal to 220 kb of DNA at 7q31.3. Mutation screening of the entire coding region in a set of 27 unrelated autistic individuals failed to identify phenotype-specific variants, suggesting that coding region mutations are unlikely to be involved in the etiology of autism. Apparent homologues of RAY1 have also been identified in mouse, rat, pig, chicken, fruit fly, and nematode. The human and mouse genes share similar splicing patterns, and their predicted protein products are 98% identical.	Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Child Dev Ctr, Toronto, ON M5G 1X8, Canada; UCL, Sch Med, Dept Psychiat & Behav Sci, Windeyer Inst Med Sci,Mol Psychiat Lab, London W1N 8AA, England; Univ Cambridge, Dept Psychiat, Cambridge, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; University College London; UCL Medical School; University of Cambridge	Scherer, SW (corresponding author), Univ Toronto, Hosp Sick Children, Dept Genet, Room 9107,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	steve@genet.sickkids.on.ca	Scherer, Stephen W./B-3785-2013; Gurling, Hugh M/A-5029-2010	Scherer, Stephen W./0000-0002-8326-1999; 				Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; Barrett S, 1999, AM J MED GENET, V88, P609; BOLTON P, 1992, PSYCHIATR GENET, V2, P277, DOI 10.1097/00041444-199210000-00005; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; LORD C, 1989, J AUTISM DEV DISORD, V19, P505; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805	10	81	88	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					510	514		10.1086/303005	http://dx.doi.org/10.1086/303005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10889047	Bronze, Green Published			2022-12-18	WOS:000089357800027
J	Cordell, HJ; Wedig, GC; Jacobs, KB; Elston, RC				Cordell, HJ; Wedig, GC; Jacobs, KB; Elston, RC			Multilocus linkage tests based on affected relative pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; DIABETES SUSCEPTIBILITY GENES; AFFECTED SIB PAIRS; MODELS; STRATEGIES; LOCUS; FAMILIES; DISEASE; SEARCH; POWER	For complex diseases, recent interest has focused on methods that take into account joint effects at interacting loci. Conditioning on effects of disease loci at known locations can lead to increased power to detect effects at other loci. Moreover, use of joint models allows investigation of the etiologic mechanisms that may be involved in the disease. Here we present a method for simultaneous analysis of the joint genetic effects at several loci that uses affected relative pairs. The method is a generalization of the two-locus LOD-score analysis for affected sib pairs proposed by Cordell et al. We derive expressions for the relative risk, lambda(R), to a relative of an affected individual, in terms of the additive and epistatic components of variance at an arbitrary number of disease loci, and we show how these can be used to fit a likelihood model to the identity-by-descent sharing among pairs of affected relatives in extended pedigrees. We implement the method by use of a stepwise strategy in which, given evidence of linkage to disease at m - 1 locations on the genome, we calculate the conditional likelihood curve across the genome for an mth disease locus, using multipoint methods similar to those proposed by Kruglyak et al. We evaluate the properties of our method by use of simulated data and present an application to real data from families with insulin-dependent diabetes mellitus.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University	Cordell, HJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust Ctr, Study Mol Mechanisms Dis, Hills Rd, Cambridge CB2 2XY, England.	heather.cordell@cimr.cam.ac.uk	Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Cordell, Heather/0000-0002-1879-5572; Jacobs, Kevin/0000-0002-4657-6473	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, 1 P41 RR03655] Funding Source: Medline; NIGMS NIH HHS [GM28356, R01 GM028356, R37 GM028356] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BORECKI IB, 1990, AM J HUM GENET, V47, P542; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cordell HJ, 1999, GENET EPIDEMIOL, V17, pS521; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; COX NJ, 1998, AM J HUM GENET S, V63, pA286; Cucca F, 1998, DIABETES, V47, P1525, DOI 10.2337/diabetes.47.9.1525; Cucca F, 1998, NAT GENET, V19, P301, DOI 10.1038/995; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delepine M, 1997, AM J HUM GENET, V60, P174; DIZIER MH, 1986, GENET EPIDEMIOL, V3, P343, DOI 10.1002/gepi.1370030507; DIZIER MH, 1994, AM J HUM GENET, V55, P1042; DUPUIS J, 1995, GENETICS, V140, P843; ELSTON RC, 1995, CLIN EXP ALLERGY, V25, P103, DOI 10.1111/j.1365-2222.1995.tb00434.x; Elston RC, 1998, AM J HUM GENET, V63, P931, DOI 10.1086/302073; Farrall M, 1997, GENET EPIDEMIOL, V14, P103, DOI 10.1002/(SICI)1098-2272(1997)14:2<103::AID-GEPI1>3.0.CO;2-8; Greenwood CMT, 1999, AM J HUM GENET, V64, P1248, DOI 10.1086/302315; HAMMERSLEY JM, MONTE CARLO METHODS; HOLMANS P, 1993, AM J HUM GENET, V52, P362; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; Juo SH, 1998, GENET EPIDEMIOL, V15, P73, DOI 10.1002/(SICI)1098-2272(1998)15:1<73::AID-GEPI6>3.0.CO;2-5; Kempthorne O, 1957, INTRO GENETIC STAT; KNAPP M, 1994, AM J HUM GENET, V55, P1030; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; KONG A, 1992, AM J HUM GENET, V51, P1413; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LUO DF, 1995, AM J HUM GENET, V57, P911; Lynch M, 1998, GENETICS ANAL QUANTI; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Meunier F, 1997, GENET EPIDEMIOL, V14, P1107, DOI 10.1002/(SICI)1098-2272(1997)14:6<1107::AID-GEPI91>3.0.CO;2-K; Olson JM, 1997, HUM HERED, V47, P110, DOI 10.1159/000154398; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; *SAGE, 1998, STAT AN GEN EP BET 4; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; STRAUCH K, 1998, GENET EPIDEMIOL, V15, P523; Tiwari HK, 1997, ANN HUM GENET, V61, P253, DOI 10.1017/S0003480097006167; TRUSTRUM GB, 1961, P CAMB PHILOS SOC, V57, P315; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Zhao HY, 1999, AM J HUM GENET, V65, P1449, DOI 10.1086/302607; Zinn-Justin A, 1998, GENET EPIDEMIOL, V15, P491	44	81	84	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1273	1286		10.1086/302847	http://dx.doi.org/10.1086/302847			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10729111	Bronze, Green Published			2022-12-18	WOS:000088373400011
J	Moller, LB; Tumer, Z; Lund, C; Petersen, C; Cole, T; Hanusch, R; Seidel, J; Jensen, LR; Horn, N				Moller, LB; Tumer, Z; Lund, C; Petersen, C; Cole, T; Hanusch, R; Seidel, J; Jensen, LR; Horn, N			Similar splice-site mutations of the ATP7A gene lead to different phenotypes: Classical Menkes disease or occipital horn syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EARLY COPPER THERAPY; GOLGI LOCALIZATION; QUANTITATIVE PCR; PROTEIN; TRANSPORT; DELETION; DEFECTS; PATIENT	More than 150 point mutations have now been identified in the ATP7A gene. Most of these mutations lead to the classic form of Menkes disease (MD), and a few lead to the milder occipital horn syndrome (OHS). To get a better understanding of molecular changes leading to classic MD and OHS, we took advantage of the unique finding of three patients with similar mutations but different phenotypes. Although all three patients had mutations located in the splice-donor site of intron 6, only two of the patients had the MD phenotype; the third had the OHS phenotype. Fibroblast cultures from the three patients were analyzed by reverse transcriptase (RT)-PCR to try to find an explanation of the different phenotypes. In all three patients, exon 6 was deleted in the majority of the ATP7A transcripts. However, by RT-PCR amplification with an exon 6-specific primer, we were able to amplify exon 6-containing mRNA products from all three patients, even though they were in law abundance. Sequencing of these products indicated that only the patient with OHS had correctly spliced exon 6-containing transcripts. We used two different methods of quantitative RT-PCR analysis and found that the level of correctly spliced mRNA in this patient was 2%-5% of the level found in unaffected individuals. These findings indicate that the presence of barely detectable amounts of correctly spliced ATP7A transcript is sufficient to permit the development of the milder OHS phenotype, as opposed to classic MD.	John F Kennedy Inst, DK-2600 Glostrup, Denmark; Univ Copenhagen, Panum Inst, Dept Med Genet, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Dept Biol Chem, DK-2200 Copenhagen, Denmark; Birmingham Womans Hosp, Dept Clin Genet, Birmingham, W Midlands, England; Klinikum Plauen, Childrens Clin, Plauen, Germany; Fredrich Schiller Univ Jena, Dept Clin Genet, Jena, Germany	University of Copenhagen; University of Copenhagen; Birmingham Women's Hospital; Friedrich Schiller University of Jena	Moller, LB (corresponding author), John F Kennedy Inst, Gl Landevej 7, DK-2600 Glostrup, Denmark.	lbm@kennedy.dk	Tümer, Zeynep/C-4235-2014; Tumer, Zeynep/AAF-8501-2019	Tumer, Zeynep/0000-0002-4777-5802; Moller, Lisbeth/0000-0002-9524-4301				BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; DiDonato M, 1997, BBA-MOL BASIS DIS, V1360, P3, DOI 10.1016/S0925-4439(96)00064-6; DIERICK HA, 1995, GENOMICS, V28, P462, DOI 10.1006/geno.1995.1175; Dierick HA, 1997, HUM MOL GENET, V6, P409, DOI 10.1093/hmg/6.3.409; Francis MJ, 1998, HUM MOL GENET, V7, P1245, DOI 10.1093/hmg/7.8.1245; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HENCO K, 1990, NUCLEIC ACIDS RES, V18, P6733, DOI 10.1093/nar/18.22.6733; Horton R. M., 1993, PCR PROTOCOLS, P251; Kaler SG, 1995, ANN NEUROL, V38, P921, DOI 10.1002/ana.410380613; Kaler SG, 1996, BIOCHEM MOL MED, V57, P37, DOI 10.1006/bmme.1996.0007; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kemppainen R, 1996, ARCH BIOCHEM BIOPHYS, V328, P101, DOI 10.1006/abbi.1996.0148; Ketterling RP, 1999, HUM MUTAT, V13, P221, DOI 10.1002/(SICI)1098-1004(1999)13:3<221::AID-HUMU6>3.3.CO;2-L; Kodama H, 1999, PEDIATR INT, V41, P423, DOI 10.1046/j.1442-200x.1999.01095.x; Kodama K, 1999, PEDIATR INT, V41, P430, DOI 10.1046/j.1442-200x.1999.01091.x; Levinson B, 1996, HUM MOL GENET, V5, P1737, DOI 10.1093/hmg/5.11.1737; Mentzel HJ, 1999, PEDIATR RADIOL, V29, P19, DOI 10.1007/s002470050526; NEDELMAN J, 1992, COMPUT APPL BIOSCI, V8, P65; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Proud VK, 1996, AM J MED GENET, V65, P44, DOI 10.1002/(SICI)1096-8628(19961002)65:1<44::AID-AJMG7>3.0.CO;2-Y; Qi M, 1998, HUM MOL GENET, V7, P465, DOI 10.1093/hmg/7.3.465; Ronce N, 1997, AM J HUM GENET, V61, P233; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; TUMER Z, 1995, GENOMICS, V26, P437, DOI 10.1016/0888-7543(95)80160-N; Tumer Z, 1997, AM J HUM GENET, V60, P63; Tumer Z, 1999, ADV EXP MED BIOL, V448, P83; Tumer Z, 1996, NAT GENET, V12, P11, DOI 10.1038/ng0196-11; TUMER Z, 1994, J INHERIT METAB DIS, V17, P267, DOI 10.1007/BF00711804; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030	34	81	83	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1211	1220		10.1086/302857	http://dx.doi.org/10.1086/302857			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739752	Bronze, Green Published			2022-12-18	WOS:000088373400005
J	Williams, RC; Long, JC; Hanson, RL; Sievers, ML; Knowler, WC				Williams, RC; Long, JC; Hanson, RL; Sievers, ML; Knowler, WC			Individual estimates of European genetic admixture associated with lower body-mass index, plasma glucose, and prevalence of type 2 diabetes in Pima Indians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEXICAN-AMERICANS; GALLBLADDER-DISEASE; HYBRID POPULATIONS; MELLITUS; COMMUNITY; ARIZONA; PROPORTIONS; TOLERANCE; FREQUENCY; OBESITY	Individual genetic admixture estimates (IA) from European Americans (EAs) were computed in 7,996 members of the Gila River Indian Community (Arizona). Parental populations for the analysis were European Americans and full-heritage Pima Indians. A logistic regression was performed on 7,796 persons, to assess association of IA with type 2 diabetes. The odds ratio, comparing diabetes risk in full-heritage EAs with full-heritage Pima Indians, was 0.329 (95% confidence interval [CI] 0.225-0.482). proportional-hazards analysis was performed on 5,482 persons who were nondiabetic at their first examination and 1,215 subjects who developed diabetes during the study. The hazard risk ratio for IA was 0.455 (95% CI 0.301-0.688). Nondiabetic persons had significantly more European IA. In nondiabetic Pimans, multivariate linear regressions of quantitative predictors of type 2 diabetes mellitus, including fasting plasma glucose, 2-h post-load plasma glucose, and body-mass index, showed significant inverse relations with IA when controlled for sex and age. These results illustrate the ongoing evolution of populations by the mechanism of gene flow and its effect on disease risk in the groups with admixture. When the two parental populations differ in disease prevalence, higher or lower risk is associated with admixture, depending on the origin of the admired alleles and the relative magnitude of the disease prevalence in the parental populations. These data also illustrate the strong genetic components in type 2 diabetes and are consistent with one susceptibility locus common to obesity and diabetes.	Arizona State Univ, Dept Anthropol, Tempe, AZ 85287 USA; Blood Syst Inc, Histocompatibil Lab, Scottsdale, AZ USA; NIAAA, Populat Genet & Linkage Sect, Bethesda, MD USA; NIDDKD, Diabet & Arthrit Epidemiol Sect, Phoenix, AZ 85016 USA	Arizona State University; Arizona State University-Tempe; Vitalant; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Williams, RC (corresponding author), Arizona State Univ, Dept Anthropol, Box 872402, Tempe, AZ 85287 USA.		Hanson, Robert L/O-3238-2015	Hanson, Robert L/0000-0002-4252-7068	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069028, ZIADK069028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000017] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Allison P, 2010, SURVIVAL ANAL USING; BAUR MP, 1984, HISTOCOMPATIBILITY T; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; HANSON RL, 1995, AM J HUM GENET, V57, P160; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157; KLEINGAUM DG, 1994, LOGISTIC REGRESSION; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; KNOWLER WC, 1981, AM J EPIDEMIOL, V113, P144, DOI 10.1093/oxfordjournals.aje.a113079; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; LONG JC, 1991, AM J PHYS ANTHROPOL, V84, P141, DOI 10.1002/ajpa.1330840204; MACLEAN CJ, 1973, ANN HUM GENET, V36, P459, DOI 10.1111/j.1469-1809.1973.tb00607.x; MACLEAN CJ, 1974, AM J HUM GENET, V26, P614; MACLEAN CJ, 1973, ANN HUM GENET, V36, P341, DOI 10.1111/j.1469-1809.1973.tb00596.x; MILLER M, 1968, PAHO SCI  PUB, V165, P89; PRICE RA, 1994, HUM BIOL, V66, P251; REED TE, 1973, NATURE, V244, P575, DOI 10.1038/244575a0; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; RUSHFORT.NB, 1971, DIABETES, V20, P756, DOI 10.2337/diab.20.11.756; RUSHFORTH NB, 1979, DIABETOLOGIA, V16, P373, DOI 10.1007/BF01223157; SILVER H, 1982, PROBABILITY INCLUSIO; Sokal R.R., 1981, BIOMETRY, V2nd ed.; TILLS D, 1983, DISTRIBUTION HUMAN S, V1; Tseng M, 1998, AM J PHYS ANTHROPOL, V106, P361, DOI 10.1002/(SICI)1096-8644(199807)106:3<361::AID-AJPA8>3.3.CO;2-J; Weiss K. M., 1993, GENETIC VARIATION HU; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WILLIAMS RC, 1992, HUM IMMUNOL, V33, P29, DOI 10.1016/0198-8859(92)90049-S; WILLIAMS RC, 1992, HUM IMMUNOL, V33, P39, DOI 10.1016/0198-8859(92)90050-W; WILLIAMS RC, 1981, DIABETOLOGIA, V21, P460; WILLIAMS RC, 1992, AM J HUM GENET, V51, P101	35	81	88	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					527	538		10.1086/302773	http://dx.doi.org/10.1086/302773			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	337QL	10677313	Bronze, Green Published			2022-12-18	WOS:000088373100020
J	Thomas, R; McConnell, R; Whittacker, J; Kirkpatrick, P; Bradley, J; Sandford, R				Thomas, R; McConnell, R; Whittacker, J; Kirkpatrick, P; Bradley, J; Sandford, R			Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC-KIDNEY-DISEASE-1 PKD1; PROTEIN; SEQUENCE; DNA; SPECTRUM; ENCODES; DOMAINS; PROGRAM; REVEALS; REGION	We have used long-range PCR to identify mutations in the duplicated part of the PKD1 gene. By means of a PKD1-specific primer in intron 1, an similar to 13.6-kb PCR product that includes exons 2-15 of the PKD1 gene has been used to search for mutations, by direct sequence analysis. This region contains the majority of the predicted extracellular domains of the PKD1-gene product, polycystin, including the 16 novel PKD domains that have similarity to immunoglobulin-like domains found in many cell-adhesion molecules and cell-surface receptors. Direct sequence analysis of exons encoding all the 16 PKD domains was performed on PCR products from a group of 24 unrelated patients with autosomal dominant polycystic kidney disease (ADPKD [MIM 173900]). Seven novel mutations were found in a screening of 42% of the PKD1-coding region in each patient, representing a 29% detection rate; these mutations included two deletions (one of 3 kb and the other of 28 bp), one single-base insertion, and four nucleotide substitutions (one splice site, one nonsense, and two missense). Five of these mutations would be predicted to cause a prematurely truncated protein. Two coding and 18 silent polymorphisms were also found. When, for the PKD1 gene, this method is coupled with existing mutation-detection methods, virtually the whole of this large, complex gene can now be screened for mutations.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2XY, England; Addenbrookes Hosp, Dept Med, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Sandford, R (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 2XY, England.			Bradley, John/0000-0002-7774-8805	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BREUNING MH, 1990, J MED GENET, V27, P614, DOI 10.1136/jmg.27.10.614; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Daniells C, 1998, HUM GENET, V102, P216, DOI 10.1007/s004390050681; HARRIS PC, 1995, HUM MOL GENET, V4, P1745, DOI 10.1093/hmg/4.suppl_1.1745; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin P, 1998, J AM SOC NEPHROL, V9, P2291; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Paterson AD, 1998, KIDNEY INT, V54, P1759, DOI 10.1046/j.1523-1755.1998.00166.x; Pei Y, 1998, J AM SOC NEPHROL, V9, P1853; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1996, AM J HUM GENET, V58, P86; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Roelfsema JH, 1996, NEPHROL DIAL TRANSPL, V11, P5; Roelfsema JH, 1997, AM J HUM GENET, V61, P1044, DOI 10.1086/301600; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Veldhuisen B, 1997, AM J HUM GENET, V61, P547, DOI 10.1086/515497; WARD CJ, 1994, CELL, V77, P881; Watnick TJ, 1997, HUM MOL GENET, V6, P1473, DOI 10.1093/hmg/6.9.1473; Watnick TJ, 1998, HUM MOL GENET, V7, P1239, DOI 10.1093/hmg/7.8.1239; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Watson ML, 1996, OXFORD CLIN NEPHROLO	30	81	90	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					39	49		10.1086/302460	http://dx.doi.org/10.1086/302460			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364515	Green Published, Bronze			2022-12-18	WOS:000081224300007
J	Gryfe, R; Di Nicola, N; Lal, G; Gallinger, S; Redston, M				Gryfe, R; Di Nicola, N; Lal, G; Gallinger, S; Redston, M			Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENOMATOUS POLYPS; MUTATIONS; BRCA2; GENE; JEWS	Germ-line and somatic truncating mutations of the APC gene are thought to initiate colorectal tumor formation in familial adenomatous polyposis syndrome and sporadic colorectal carcinogenesis, respectively, Recently, an isoleucine-->lysine polymorphism at codon 1307 (I1307K) of the APC gene has been identified in 6%-7% of the Ashkenazi Jewish population. To assess the risk of this common APC allelic variant in colorectal carcinogenesis, we have analyzed a large cohort of unselected Ashkenazi Jewish subjects with adenomatous polyps and or colorectal cancer, for the APC I1307K polymorphism. The APC I1307K allele was identified in 48 (10.1%) of 476 patients. Compared with the frequency in two separate population control groups, the APC I1307K allele is associated with an estimated relative risk of 1.5-1.7 for colorectal neoplasia (both P = .01). Furthermore, compared with noncarriers, APC I1307K carriers had increased numbers of adenomas and colorectal cancers per patient (P = .03), as well as a younger age at diagnosis. We conclude that the APC I1307K variant leads to increased adenoma formation and directly contributes to 3%-4% of all Ashkenazi Jewish colorectal cancer. The estimated relative risk for carriers may justify specific clinical screening for the 360,000 Americans expected to harbor this allele, and genetic testing in the setting of long-term-outcome studies may impact significantly on colorectal cancer prevention in this population.	Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Surg, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Redston, M (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Canc Genet, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	mredston@mtsinai.on.ca	Gallinger, Steven/E-4575-2013; Gryfe, Robert/AAF-1870-2021					Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Abrahamson J, 1998, CANCER RES, V58, P2919; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P107; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; FERNANDES MJG, 1992, GENET EPIDEMIOL, V9, P169, DOI 10.1002/gepi.1370090303; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Gryfe R, 1998, CANCER RES, V58, P4040; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lake RIE, 1997, GENET EPIDEMIOL, V14, P17, DOI 10.1002/(SICI)1098-2272(1997)14:1<17::AID-GEPI2>3.0.CO;2-2; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Landis SH, 1998, CA-CANCER J CLIN, V48, P192; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Ozcelik H, 1997, NAT GENET, V16, P17, DOI 10.1038/ng0597-17; Petersen GM, 1998, AM J HUM GENET, V62, P1516, DOI 10.1086/301871; Petrukhin L, 1997, CANCER RES, V57, P5480; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; vanderLuijt RB, 1996, HUM GENET, V98, P727, DOI 10.1007/s004390050293; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204; Woodage T, 1998, NAT GENET, V20, P62, DOI 10.1038/1722	26	81	83	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					378	384		10.1086/302262	http://dx.doi.org/10.1086/302262			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973276	Green Published, Bronze			2022-12-18	WOS:000078740600008
J	Rauch, A; Pfeiffer, RA; Leipold, G; Singer, H; Tigges, M; Hofbeck, M				Rauch, A; Pfeiffer, RA; Leipold, G; Singer, H; Tigges, M; Hofbeck, M			A novel 22q11.2 microdeletion in DiGeorge syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CARDIO-FACIAL-SYNDROME; CHROMOSOME 22Q11; CRITICAL REGION; MOLECULAR DEFINITION; MONOZYGOTIC TWINS; DELETION; PHENOTYPE; SPECTRUM		Univ Erlangen Nurnberg, Inst Humangenet, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Pediat Cardiol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Div Phoniatr & Pediat Audiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Humangenet, Schwabachanlage 10, D-91054 Erlangen, Germany.	arauch@humgenet.uni-erlangen.de	Rauch, Anita/C-5568-2014; Hofbeck, Michael/ABB-3259-2020	Rauch, Anita/0000-0003-2930-3163; Hofbeck, Michael/0000-0001-7034-1132				BURN J, 1993, J MED GENET, V30, P822, DOI 10.1136/jmg.30.10.822; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Carlson C, 1997, AM J HUM GENET, V60, P851; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Collins JE, 1997, GENOME RES, V7, P522, DOI 10.1101/gr.7.5.522; Collins JE, 1997, GENOME RES, V7, P942; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; Dallapiccola B, 1996, AM J HUM GENET, V59, P7; DESILVA D, 1995, CLIN DYSMORPHOL, V4, P294, DOI 10.1097/00019605-199510000-00004; Devriendt K, 1997, CLIN GENET, V51, P246; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DRISCOLL DA, 1990, AM J HUM GENET, V47, pA215; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; FIDLEROVA H, 1994, CYTOGENET CELL GENET, V65, P203, DOI 10.1159/000133632; FIREMAN P, 1965, J PEDIATR-US, V67, P907; GIANNOTTI A, 1994, AM J MED GENET, V53, P303, DOI 10.1002/ajmg.1320530320; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALL JG, 1993, J MED GENET, V30, P801, DOI 10.1136/jmg.30.10.801; Hatchwell E, 1996, J MED GENET, V33, P261, DOI 10.1136/jmg.33.3.261; Kurahashi H, 1997, AM J MED GENET, V72, P180, DOI 10.1002/(SICI)1096-8628(19971017)72:2<180::AID-AJMG10>3.0.CO;2-J; KURAHASHI H, 1994, HUM GENET, V93, P248, DOI 10.1007/BF00212017; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; LeanaCox J, 1996, AM J MED GENET, V65, P309, DOI 10.1002/(SICI)1096-8628(19961111)65:4<309::AID-AJMG12>3.0.CO;2-Y; MARINEAU C, 1992, NUCLEIC ACIDS RES, V20, P1430, DOI 10.1093/nar/20.6.1430; MCDONALDMCGINN DM, 1995, AM J MED GENET, V59, P103, DOI 10.1002/ajmg.1320590122; Mitelman F., 1995, ISCN INT SYSTEM HUMA; MORROW B, 1995, AM J HUM GENET, V56, P1391; Morrow BE, 1997, AM J HUM GENET, V61, pA7; NICKEL RE, 1994, AM J MED GENET, V52, P445, DOI 10.1002/ajmg.1320520410; ODonnell H, 1997, AM J HUM GENET, V60, P1544; PORTER JC, 1993, GENOMICS, V15, P57, DOI 10.1006/geno.1993.1009; Rauch A, 1996, AM J MED GENET, V63, P243, DOI 10.1002/(SICI)1096-8628(19960503)63:1<243::AID-AJMG42>3.0.CO;2-L; Rauch A, 1998, AM J MED GENET, V78, P322, DOI 10.1002/(SICI)1096-8628(19980724)78:4<322::AID-AJMG4>3.3.CO;2-L; Rauch A, 1998, AM J MED GENET, V75, P113, DOI 10.1002/(SICI)1096-8628(19980106)75:1<113::AID-AJMG23>3.0.CO;2-O; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SHPRINTZEN RJ, 1981, PEDIATRICS, V67, P167; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; WILSON DI, 1993, ARCH DIS CHILD, V68, P187, DOI 10.1136/adc.68.2.187; WILSON DI, 1994, AM J HUM GENET, V22, P55	42	81	83	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					659	667		10.1086/302235	http://dx.doi.org/10.1086/302235			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973528	Bronze, Green Published			2022-12-18	WOS:000078740600039
J	Tregouet, DA; Ducimetiere, P; Tiret, L				Tregouet, DA; Ducimetiere, P; Tiret, L			Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENERALIZED ESTIMATING EQUATIONS; SEGREGATION ANALYSIS; BINARY DATA; FAMILIAL CORRELATIONS; LINEAR-MODELS; ODDS-RATIO; REGRESSION; PARAMETERS; LINKAGE; PAIRS	Association studies are one of the major strategies for identifying genetic factors underlying complex traits. In samples of related individuals, conventional statistical procedures are not valid for testing association, and maximum likelihood (ML) methods have to be used, but they are computationally demanding and are not necessarily robust to violations of their assumptions. Estimating equations (EE) offer an alternative to ML methods, for estimating association parameters in correlated data. We studied through simulations the behavior of EE in a large range of practical situations, including samples of nuclear families of varying sizes and mixtures of related and unrelated individuals. For a quantitative phenotype, the power of the EE test was comparable to that of a conventional ML test and close to the power expected in a sample of unrelated individuals. For a binary phenotype, the power of the EE test decreased with the degree of clustering, as did the power of the ML test. This result might be partly explained by a modeling of the correlations between responses that is less efficient than that in the quantitative case. In small samples (<50 families), the variance of the EE association parameter tended to be underestimated, leading to an inflation of the type I error. The heterogeneity of cluster size induced a slight loss of efficiency of the FE estimator, by comparison with balanced samples. The major advantages of the EE technique are its computational simplicity and its great flexibility, easily allowing investigation of gene-gene and gene-environment interactions. It constitutes a powerful tool for testing genotype-phenotype association in related individuals.	HOP BROUSSAIS, INSERM, U258, F-75674 PARIS 14, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019	Trégouët, David-Alexandre/0000-0001-9084-7800				ABEL L, 1993, AM J HUM GENET, V53, P894; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; BONNEY GE, 1992, HUM HERED, V42, P28, DOI 10.1159/000154044; Bull SB, 1995, GENET EPIDEMIOL, V12, P729, DOI 10.1002/gepi.1370120633; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.1093/biomet/80.3.517; DEMENAIS F, 1994, GENET EPIDEMIOL, V11, P291; DEMENAIS FM, 1991, AM J HUM GENET, V49, P773; DONNER A, 1991, J CLIN EPIDEMIOL, V44, P449, DOI 10.1016/0895-4356(91)90084-M; Emrich LJ, 1992, J STAT COMPUT SIM, V41, P19, DOI DOI 10.1080/00949659208811388; Georges JL, 1996, GENET EPIDEMIOL, V13, P179; GODAMBE VP, 1960, ANN MATH STAT, V31, P1208, DOI 10.1214/aoms/1177705693; GODAMBE VP, 1991, ESTIMATING FUNCTION; GROVE JS, 1993, GENET EPIDEMIOL, V10, P539, DOI 10.1002/gepi.1370100635; Hendricks SA, 1996, STAT MED, V15, P1951, DOI 10.1002/(SICI)1097-0258(19960930)15:18<1951::AID-SIM407>3.0.CO;2-P; Hsu L, 1996, AM J HUM GENET, V58, P1057; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEE H, 1993, GENET EPIDEMIOL, V10, P61, DOI 10.1002/gepi.1370100107; Lee H, 1996, AM J HUM GENET, V58, P213; Liang KY, 1996, GENET EPIDEMIOL, V13, P253, DOI 10.1002/(SICI)1098-2272(1996)13:3<253::AID-GEPI3>3.0.CO;2-7; LIANG KY, 1991, GENET EPIDEMIOL, V8, P361, DOI 10.1002/gepi.1370080602; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lindpaintner K, 1996, NEW ENGL J MED, V334, P1023, DOI 10.1056/NEJM199604183341604; LIPSITZ SR, 1991, BIOMETRIKA, V78, P153; Lipsitz SR, 1996, BIOMETRICS, V52, P903, DOI 10.2307/2533051; LUE PZ, 1992, AM J HUM GENET, V51, P178; Mancl LA, 1996, BIOMETRICS, V52, P500, DOI 10.2307/2532890; OLSON JM, 1993, GENET EPIDEMIOL, V10, P87, DOI 10.1002/gepi.1370100202; OLSON JM, 1994, GENET EPIDEMIOL, V11, P41, DOI 10.1002/gepi.1370110105; OLSON JM, 1994, BIOMETRICS, V50, P665, DOI 10.2307/2532781; PARK T, 1993, STAT MED, V12, P1723, DOI 10.1002/sim.4780121807; PRENTICE RL, 1988, BIOMETRICS, V44, P1033, DOI 10.2307/2531733; RICE T, 1994, AM J HUM GENET, V55, P1019; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROTNITZKY A, 1990, BIOMETRIKA, V77, P485, DOI 10.1093/biomet/77.3.485; STRM DO, 1993, GENET EPIDEMIOL, V10, P575, DOI 10.1002/gepi.1370100641; TIRET L, 1992, AM J HUM GENET, V51, P197; WHITTEMORE AS, 1994, BIOMETRICS, V50, P1073, DOI 10.2307/2533445; ZHAO LP, 1994, BIOMETRIKA, V81, P197; ZHAO LP, 1992, J ROY STAT SOC B MET, V54, P805; ZHAO LP, 1995, HUM HERED, V45, P286, DOI 10.1159/000154315	43	81	81	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					189	199		10.1086/513895	http://dx.doi.org/10.1086/513895			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9246000	Green Published, Bronze			2022-12-18	WOS:A1997XM72800027
J	Lin, T; Orrison, BM; Leahey, AM; Suchy, SF; Bernard, DJ; Lewis, RA; Nussbaum, RL				Lin, T; Orrison, BM; Leahey, AM; Suchy, SF; Bernard, DJ; Lewis, RA; Nussbaum, RL			Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INOSITOL POLYPHOSPHATE-5-PHOSPHATASE; 5-PHOSPHATASE; TRANSLOCATION	The oculocerebrorenal syndrome of Lowe (OCRL) is a multisystem disorder characterized by congenital cataracts, mental retardation, and renal Fanconi syndrome. The OCRL1 gene, which, when mutated, is responsible for OCRL, encodes a 105-kD Golgi protein with phosphatidylinositol (4,5)bisphosphate (PtdIn[4,5]P-2) 5-phosphatase activity. We have examined the OCRL1 gene in 12 independent patients with OCRL and have found 11 different mutations. Six were nonsense mutations, and one a deletion of one or two nucleotides that leads to frameshift and premature termination. In one, a 1.2-kb genomic deletion of exon 14 was identified. In four others, missense mutations or the deletion of a single codon were found to involve amino acid residues known to be highly conserved among proteins with PtdIns(4,5)P-2 5-phosphatase activity. All patients had markedly reduced PtdIns(4,5)P-2 5-phosphatase activity in their fibroblasts, whereas the ocrl1 protein was detectable by immunoblotting in some patients with either missense mutations or a codon deletion but was not detectable in those with premature termination mutations. These results confirm and extend our previous observation that the OCRL phenotype results from loss of function of the ocrl1 protein and that mutations are generally heterogeneous. Missense mutations that abolish enzyme activity but not expression of the protein will be useful for studying structure-function. relationships in PtdIns(4,5)P-2 5-phosphatases.	NIH,LAB GENET DIS RES,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; CHILDRENS HOSP PHILADELPHIA,DEPT PEDIAT,PHILADELPHIA,PA 19104; BAYLOR COLL MED,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; Baylor College of Medicine					NCI NIH HHS [T32-CA09615] Funding Source: Medline; NICHD NIH HHS [R01-HD23245] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023245] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; ERNEUX C, 1995, M S-MED SCI, V11, P240, DOI 10.4267/10608/2191; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; HODGSON SV, 1986, AM J MED GENET, V23, P837, DOI 10.1002/ajmg.1320230311; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; LEAHEY AM, 1993, HUM MOL GENET, V4, P461; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; MATZARIS M, 1994, J BIOL CHEM, V269, P3397; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MUELLER OT, 1991, AM J HUM GENET, V49, P804; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; ROSS TS, 1991, J BIOL CHEM, V266, P20283; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	19	81	89	2	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1384	1388		10.1086/515471	http://dx.doi.org/10.1086/515471			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199559	Bronze, Green Published			2022-12-18	WOS:A1997XE29400016
J	Rebbeck, TR; Couch, FJ; Kant, J; Calzone, K; DeShano, M; Peng, Y; Chen, K; Garber, JE; Weber, BL				Rebbeck, TR; Couch, FJ; Kant, J; Calzone, K; DeShano, M; Peng, Y; Chen, K; Garber, JE; Weber, BL			Genetic heterogeneity in hereditary breast cancer: Role of BRCA1 and BRCA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; LINKAGE ANALYSIS; FAMILIES; MUTATIONS	The common hereditary forms of breast cancer have been largely attributed to the inheritance of mutations in the BRCA1 or BRCA2 genes. However, it is not yet clear what proportion of hereditary breast cancer is explained by BRCA1 and BRCA2 or by some other unidentified susceptibility gene(s). We describe the proportion of hereditary breast cancer explained by BRCA2 or BRCA2 in a sample of North American hereditary breast cancers and assess the evidence for additional susceptibility genes that may confer hereditary breast or ovarian cancer risk Twenty-three families were identified through two high-risk breast cancer research programs. Genetic analysis was undertaken to establish linkage between the breast or ovarian cancer cases and markers on chromosomes 17q (BRCA1) and 13q (BRCA2). Mutation analysis in the BRCA1 and BRCA2 genes was also undertaken in all families. The pattern of hereditary cancer in 14 (61%) of the 23 families studied was attributed to BRCA1 by a combination of linkage and mutation analyses. No families were attributed to BRCA2. Five families (22%) provided evidence against linkage to both BRCA1 and BRCA2. No BRCA1 or BRCA2 mutations were detected in these five families. The BRCA1 or BRCA2 status of four families (17%) could not be determined. BRCA1 and BRCA2 probably explain the majority of hereditary breast cancer that exists in the North American population. However, one or more additional genes may yet be found that explain some proportion of hereditary breast cancer.	UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT LAB MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,CTR CANC,PHILADELPHIA,PA 19104; DANA FARBER CANC INST,BOSTON,MA 02115	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute	Rebbeck, TR (corresponding author), UNIV PENN,SCH MED,DEPT BIOSTAT & EPIDEMIOL,ROOM 904,BLOCKLEY HALL,PHILADELPHIA,PA 19104, USA.		Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900; Calzone, Kathleen/0000-0002-2354-6810	NATIONAL CANCER INSTITUTE [K07CA060798, F32CA067403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008031] Funding Source: NIH RePORTER; NCI NIH HHS [CA67403, CA60798] Funding Source: Medline; NIEHS NIH HHS [ES08031] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BULLER RE, 1993, GYNECOL ONCOL, V51, P160, DOI 10.1006/gyno.1993.1265; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; EASTON DF, 1993, AM J HUM GENET, V52, P678; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; *GEN DAT BAS, 1995, HUM GEN DAT BAS PROJ; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; JOLLY KW, 1994, ONCOGENE, V9, P97; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; NAROD SA, 1995, AM J HUM GENET, V56, P254; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SOBOL H, 1994, LANCET, V344, P1151, DOI 10.1016/S0140-6736(94)90655-6; SPURR NK, 1995, AM J HUM GENET S, V57, pA5; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	19	81	82	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					547	553						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751855				2022-12-18	WOS:A1996VN62500008
J	Thomas, GH				Thomas, GH			High male:female ratio of germ-line mutations: An alternative explanation for postulated gestational lethality in males in X-linked dominant disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROBABLE SEX DIFFERENCE; SEVERE HEMOPHILIA-A; RETT SYNDROME; RATES; GENE; DNA; INVERSIONS; FAMILIES; DISEASE	In this paper I suggest that a vastly higher rate of de novo mutations in males than in females would explain some, if not most, X-linked dominant disorders associated with a low incidence of affected males. It is the inclusion of the impact of a high ratio of male:female de novo germ-line mutations that makes this model new and unique. Specifically, it is concluded that, if an X-linked disorder results in a dominant phenotype with a significant reproductive disadvantage (genetic lethality), affected females will, in virtually all cases, arise from de novo germ-line mutations inherited from their fathers rather than from their mothers. Under this hypothesis, the absence of affected males is explained by the simple fact that sons do not inherit their X chromosome (normal or abnormal) from their fathers. Because females who are heterozygous for a dominant disorder will be clinically affected and will, in most cases, either be infertile or lack reproductive opportunities, the mutant gene will not be transmitted by them to the next generation (i.e., it will be a genetic lethal). This, not gestational lethality in males, may explain the absence of affected males in most, if not all, of the 13 known X-linked dominant diseases characterized by high ratios of affected female to male individuals. Evidence suggesting that this mechanism could explain the findings in the Rett syndrome is reviewed in detail.	JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Thomas, GH (corresponding author), KENNEDY KRIEGER INST,ROOM 503,707 N BROADWAY,BALTIMORE,MD 21205, USA.				NICHD NIH HHS [HD2448] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKESSON HO, 1992, AM J MED GENET, V42, P104, DOI 10.1002/ajmg.1320420121; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BONAITIPELLIE C, 1990, HUM GENET, V84, P163; BROCKERVRIENDS AHJT, 1991, J MED GENET, V28, P672, DOI 10.1136/jmg.28.10.672; COMINGS DE, 1986, AM J MED GENET, V24, P383; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; DROST JB, 1995, ENV MOL MUTAGEN S, V26, P48; FRANCKE U, 1977, AM J HUM GENET, V29, P307; FRANCKE U, 1976, AM J HUM GENET, V28, P123; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; KLING S, 1992, EUR J HAEMATOL, V48, P142; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Mckusick V.A., 1994, MENDELIAN INHERITANC; MIGEON BR, 1995, AM J HUM GENET, V56, P647; Miyata T., 1990, POPULATION BIOL GENE, P341; MURPHY M, 1986, AM J MED GENET, V24, P73; NAIDU S, 1988, J CHILD NEUROL, V3, pS78, DOI 10.1177/0883073888003001S16; NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; TREVATHAN E, 1988, J CHILD NEUROL, V3, pS6, DOI 10.1177/0883073888003001S03; TUCHMAN M, 1995, AM J MED GENET, V55, P67, DOI 10.1002/ajmg.1320550118; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1977, AM J HUM GENET, V29, P312; VOGEL F, 1986, HUM GENET, P334; Wahlstrom, 1993, RETT SYNDROME CLIN B; WETTKESCHAFER R, 1983, HUM GENET, V64, P1, DOI 10.1007/BF00289472; WITTENGERSTROM I, 1992, DEV MED CHILD NEUROL, V34, P1022; ZOGHBI H, 1988, J CHILD NEUROL, V3, pS76, DOI 10.1177/0883073888003001S15	35	81	88	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1364	1368						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651313				2022-12-18	WOS:A1996UM27100029
J	KRUYER, H; MILA, M; GLOVER, G; CARBONELL, P; BALLESTA, F; ESTIVILL, X				KRUYER, H; MILA, M; GLOVER, G; CARBONELL, P; BALLESTA, F; ESTIVILL, X			FRAGILE X SYNDROME AND THE (CGG)(N) MUTATION - 2 FAMILIES WITH DISCORDANT MZ TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABNORMAL METHYLATION; DNA; INSTABILITY; REGION; SEGREGATION; SEQUENCES; REPEAT	The fragile X phenotype has been found, in the majority of cases, to be due to the expansion of a CGG repeat in the 5' UTR region of the FMR-1 gene, accompanied by methylation of the adjacent CpG island and inactivation of the FMR-1 gene. Although several important aspects of the genetics of fragile X have been resolved, it remains to be elucidated at which stage in development the transition from the premutation to the full mutation occurs. We present two families in which discordance between two sets of MZ twins illustrates two important genetic points. In one family, two affected MZ brothers differed in the number of CGG repeats, demonstrating in vivo mitotic instability of this CGG repeat and suggesting that the transition to the full mutation occurred postzygotically. In the second family, two MZ sisters had the same number of repeats, but only one was mentally retarded. When the methylation status of the FMR-1 CpG island was studied, we found that the majority of normal chromosomes had been inactivated in the affected twin, thus leading to the expression of the fragile X phenotype.	HOSP CLIN BARCELONA,GENET SERV,BARCELONA,SPAIN; HOSP CLIN BARCELONA,CLIN RES FDN,BARCELONA,SPAIN; CONJUNTO RESIDENCIAL ESPINARDO,CTR BIOCHEM & CLIN GENET,MURCIA,SPAIN; HOSP DURAN & REYNALS,IRO,CANC RES INST,DEPT MOLEC GENET,E-08907 LHOSPITALET LLOBR,SPAIN	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals			Carbonell, Pablo/I-4111-2015; Estivill, Xavier/A-3125-2013	Carbonell, Pablo/0000-0002-3861-9883; Estivill, Xavier/0000-0002-0723-2256; Mila, Montserrat/0000-0002-7906-0916				BELL MV, 1989, CYTOGENET CELL GENET, V51, P902; BOCKLAGE CE, 1981, TWIN BIOL MULTIPLE P, P155; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; BROOK JD, 1993, NAT GENET, V3, P279; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; DIETRICH A, 1991, NUCLEIC ACIDS RES, V19, P2567, DOI 10.1093/nar/19.10.2567; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; FUENTES JJ, 1993, INT J LEGAL MED, V105, P271, DOI 10.1007/BF01370384; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HUPKES PE, 1989, CYTOGENET CELL GENET, V51, P918; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; MALMGREN H, 1992, AM J MED GENET, V43, P268, DOI 10.1002/ajmg.1320430142; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PATTERSON M, 1988, AM J HUM GENET, V43, P684; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sambrook J., 1989, MOL CLONING LAB MANU; Sherman S., 1991, FRAGILE X SYNDROME D, P69; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SUTHERLAND GR, 1985, TRENDS GENET, V1, P108, DOI 10.1016/0168-9525(85)90042-3; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERS GK, 1989, CYTOGENET CELL GENET, V51, P940; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WILLEMS PJ, 1992, HUM MOL GENET, V1, P511, DOI 10.1093/hmg/1.7.511; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; ZNEIMER SM, 1993, AM J MED GENET, V45, P601, DOI 10.1002/ajmg.1320450517; 1993, CELL, V72, P971	29	81	81	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					437	442						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116613				2022-12-18	WOS:A1994MZ15800005
J	MERANTE, F; PETROVABENEDICT, R; MACKAY, N; MITCHELL, G; LAMBERT, M; MORIN, C; DEBRAEKELEER, M; LAFRAMBOISE, R; GAGNE, R; ROBINSON, BH				MERANTE, F; PETROVABENEDICT, R; MACKAY, N; MITCHELL, G; LAMBERT, M; MORIN, C; DEBRAEKELEER, M; LAFRAMBOISE, R; GAGNE, R; ROBINSON, BH			A BIOCHEMICALLY DISTINCT FORM OF CYTOCHROME-OXIDASE (COX) DEFICIENCY IN THE SAGUENAY-LAC-SAINT-JEAN REGION OF QUEBEC	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESPIRATORY-CHAIN DEFECTS; C-OXIDASE; LEIGH DISEASE; SUBUNIT-VIIA; MUSCLE; DENITRIFICANS; FIBROBLASTS; SEQUENCE; PRODUCT; INFANT	We report the results of biochemical and molecular investigations on a group of patients from the Saguenay-Lac-Saint-Jean region of Quebec who have an unusual form of cytochrome oxidase deficiency and Leigh disease. This group can be distinguished from the classical presentation of cytochrome oxidase deficiency with Leigh disease, by the severity of the biochemical defect in different tissues. The activity in skin fibroblasts, amniocytes, and skeletal muscle of cytochrome oxidase is 50% of normal, while in kidney and heart it is close to normal values. Brain and liver, on the other hand, have very low activities. The defect in activity appears to result from a failure of assembly of the cytochrome oxidase complex in liver, but levels of mRNA for both mitochondrially encoded and nuclear-encoded subunits in liver and skin fibroblasts were found to be the same as those in controls. The cDNA sequence of the liver-specific cytochrome oxidase subunits VIa and VIIa were determined in samples from patient liver and skin fibroblasts and showed normal coding sequence.	HOSP SICK CHILDREN, RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT PEDIAT, TORONTO M5S 1A1, ONTARIO, CANADA; HOP CHICOUTIMI, UNITE RECH CLIN, CHICOUTIMI, PQ, CANADA; HOP ST JUSTINE, DEPT GENET MED, MONTREAL H3T 1C5, QUEBEC, CANADA; CHU LAVAL, DEPT GENET HUMAINE, QUEBEC CITY G1V 4G2, QUEBEC, CANADA; UNIV QUEBEC, DEPT SCI HUMAINES, GENET EPIDEMIOL LAB, CHICOUTIMI G7H 2P9, QUEBEC, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Universite de Montreal; Laval University; University of Quebec; University of Quebec Chicoutimi								CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209; DIMAURO S, 1985, BIOCHEM SOC T, V13, P651, DOI 10.1042/bst0130651; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; FABRIZI GM, 1989, NUCLEIC ACIDS RES, V17, P7107, DOI 10.1093/nar/17.17.7107; FABRIZI GM, 1989, NUCLEIC ACIDS RES, V17, P6409, DOI 10.1093/nar/17.15.6409; Fourney R.M., 1988, FOCUS, V10, P5; GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X; GLERUM DM, 1989, MOL BASIS MEMBRANE A, P228; GLERUM M, 1987, AM J HUM GENET, V41, P584; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; LOMBES A, 1991, NEUROLOGY, V41, P491, DOI 10.1212/WNL.41.4.491; MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484; MORIN C, 1993, AM J HUM GENET, V53, P488; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Robinson B.H., 1989, METABOLIC BASIS INHE, P869; ROBINSON BH, 1986, J CLIN INVEST, V77, P1422, DOI 10.1172/JCI112453; ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027; ROBINSON BH, 1992, EUR J PEDIATR, V151, P347, DOI 10.1007/BF02113256; ROBINSON BH, 1987, J PEDIATR-US, V110, P216, DOI 10.1016/S0022-3476(87)80157-9; SENGERS RCA, 1984, EUR J PEDIATR, V141, P178, DOI 10.1007/BF00443221; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; VANBEEUMEN JJ, 1990, FEBS LETT, V263, P213, DOI 10.1016/0014-5793(90)81376-Y; VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005; VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S; WILLEMS JL, 1977, PEDIATRICS, V60, P850	28	81	82	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					481	487						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8392290				2022-12-18	WOS:A1993LN82000020
J	EISENSMITH, RC; OKANO, Y; DASOVICH, M; WANG, T; GUTTLER, F; LOU, H; GULDBERG, P; LICHTERKONECKI, U; KONECKI, DS; SVENSSON, E; HAGENFELDT, L; REY, F; MUNNICH, A; LYONNET, S; COCKBURN, F; CONNOR, JM; PEMBREY, ME; SMITH, I; GITZELMANN, R; STEINMANN, B; APOLD, J; EIKEN, HG; GIOVANNINI, M; RIVA, E; LONGHI, R; ROMANO, C; CERONE, R; NAUGHTEN, ER; MULLINS, C; CAHALANE, S; OZALP, I; FEKETE, G; SCHULER, D; BERENCSI, GY; NASZ, I; BRDICKA, R; KAMARYT, J; PIJACKOVA, A; CABALSKA, B; BOSZKOWA, K; SCHWARTZ, E; KALININ, VN; JIN, L; CHAKRABORTY, R; WOO, SLC				EISENSMITH, RC; OKANO, Y; DASOVICH, M; WANG, T; GUTTLER, F; LOU, H; GULDBERG, P; LICHTERKONECKI, U; KONECKI, DS; SVENSSON, E; HAGENFELDT, L; REY, F; MUNNICH, A; LYONNET, S; COCKBURN, F; CONNOR, JM; PEMBREY, ME; SMITH, I; GITZELMANN, R; STEINMANN, B; APOLD, J; EIKEN, HG; GIOVANNINI, M; RIVA, E; LONGHI, R; ROMANO, C; CERONE, R; NAUGHTEN, ER; MULLINS, C; CAHALANE, S; OZALP, I; FEKETE, G; SCHULER, D; BERENCSI, GY; NASZ, I; BRDICKA, R; KAMARYT, J; PIJACKOVA, A; CABALSKA, B; BOSZKOWA, K; SCHWARTZ, E; KALININ, VN; JIN, L; CHAKRABORTY, R; WOO, SLC			MULTIPLE ORIGINS FOR PHENYLKETONURIA IN EUROPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENYLALANINE-HYDROXYLASE LOCUS; POLYMORPHIC DNA HAPLOTYPES; BETA-GLOBIN GENE; LINKAGE DISEQUILIBRIUM; PKU MUTATION; PAH LOCUS; MOLECULAR CHARACTERIZATION; CLASSICAL PHENYLKETONURIA; TERMINATION MUTATION; PRENATAL-DIAGNOSIS	Phenylketonuria (PKU), a disorder of amino acid metabolism prevalent among Caucasians and other ethnic groups, is caused primarily by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH). PKU is a highly heterogeneous disorder, with more than 60 molecular lesions identified in the PAH gene. The haplotype associations, relative frequencies, and distributions of five prevalent PAH mutations (R158Q, R261Q, IVS10nt546, R408W, and IVS12nt1) were established in a comprehensive European sample population and subsequently were examined to determine the potential roles of several genetic mechanisms in explaining the present distribution of the major PKU alleles. Each of these five mutations was strongly associated with only one of the more than 70 chromosomal haplotypes defined by eight RFLPs in or near the PAH gene. These findings suggest that each of these mutations arose through a single founding event that occurred within time periods ranging from several hundred to several thousand years ago. From the significant differences observed in the relative frequencies and distributions of these five alleles throughout Europe, four of these putative founding events could be localized to specific ethnic subgroups. Together, these data suggest that there were multiple, geographically and ethnically distinct origins for PKU within the European population.	BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; UNIV TEXAS, GRAD SCH BIOMED SCI, CTR GENET, HOUSTON, TX 77025 USA; JOHN F KENNEDY INST, GLOSTRUP, DENMARK; UNIV HEIDELBERG KINDERKLIN, HEIDELBERG, GERMANY; HUDDINGE UNIV HOSP, DEPT CLIN CHEM, S-14186 HUDDINGE, SWEDEN; HOP ENFANTS MALAD, UNITE RECH HANDICAPS GENET ENFANT, PARIS, FRANCE; UNIV GLASGOW, DUNCAN GUTHRIE INST MED GENET, DEPT MED GENET, GLASGOW G12 8QQ, SCOTLAND; RES INST PEDIAT, BRNO, CZECHOSLOVAKIA; INST NATL MERE ENFAT, INST MATKI DZIECKA, WARSAW, POLAND; ST PETERSBURG INST NUCL PHYS, CTR MOLEC DIAGNOST, GATCHINA, RUSSIA; ST PETERSBURG INST NUCL PHYS, HUMAN MOLEC GENET LAB, GATCHINA, RUSSIA; UNIV LONDON, INST CHILD HLTH, LONDON, ENGLAND; UNIV ZURICH, KINDERKLIN, CH-8006 ZURICH, SWITZERLAND; UNIV BERGEN, AVDELING MED GENET, N-5014 BERGEN, NORWAY; UNIV MILAN, PEDIAT CLIN 5, I-20122 MILAN, ITALY; UNIV GENOA, CTR REG RIFERIMENTAO MALATT ENDOCRINE METABOL PEDI, PEDIAT CLIN, I-16126 GENOA, ITALY; CHILDRENS HOSP, METAB UNIT, DUBLIN, IRELAND; HACETTEPE UNIV, INST CHILD HLTH, DEPT METAB, ANKARA, TURKEY; SEMMELWEIS UNIV MED, SCH MED, DEPT PAEDIAT 2, H-1085 BUDAPEST 8, HUNGARY; HACETTEPE UNIV, SCH MED, DEPT MICROBIOL, ANKARA, TURKEY; INST HEMATOL & BLOOD TRANSFUS, CS-12820 PRAGUE 2, CZECHOSLOVAKIA; NATL RES CTR MED GENET, MOLEC GENET LAB, MOSCOW, RUSSIA	Baylor College of Medicine; University of Texas System; Ruprecht Karls University Heidelberg; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; University of Glasgow; Mother & Child Institute; Polish Mother's Memorial Hospital - Research Institute; University of London; University College London; University of Zurich; University of Bergen; University of Milan; University of Genoa; Trinity College Dublin; Hacettepe University; Semmelweis University; Hacettepe University; Institute of Hematology Prague; Research Centre for Medical Genetics	EISENSMITH, RC (corresponding author), BAYLOR COLL MED, HOWARD HUGHES MED INST, DEPT CELL BIOL, HOUSTON, TX 77030 USA.		Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Lyonnet, Stanislas/H-5483-2017	Jin, Li/0000-0002-4546-2415; Lyonnet, Stanislas/0000-0001-5426-9417	NICHD NIH HHS [HD-17711] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017711, R37HD017711] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; Aoki K, 1988, Acta Paediatr Jpn, V30, P429; APOLD J, 1990, AM J HUM GENET, V47, P1002; AULEHLASCHOLZ C, 1988, HUM GENET, V78, P353, DOI 10.1007/BF00291734; AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; BICKEL H, 1981, EUR J PEDIATR, V137, P133; BONDUELLE M, 1990, HUM GENET, V85, P436; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P323, DOI 10.1002/gepi.1370030505; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DASOVICH M, 1991, SOMAT CELL MOLEC GEN, V17, P303, DOI 10.1007/BF01232824; DIANZANI I, 1990, HUM GENET, V86, P69; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DWORNICZAK B, 1991, GENOMICS, V11, P242, DOI 10.1016/0888-7543(91)90129-3; DWORNICZAK B, 1989, HUM GENET, V84, P95, DOI 10.1007/BF00210683; DWORNICZAK B, 1991, HUM GENET, V87, P731; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; EISENSMITH RC, 1991, MOL BIOL MED, V8, P3; EISENSMITH RC, 1992, IN PRESS AM J HUM GE; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI DOI 10.1515/BCHM2.1934.227.1-4.169; GOLTSOV AA, 1992, AM J HUM GENET, V51, P627; HERRMANN FH, 1988, CLIN GENET, V34, P176; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HOFMAN KJ, 1989, MOL BIOL MED, V6, P245; JOHN SWM, 1990, AM J HUM GENET, V46, P970; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KALAYDJIEVA L, 1990, J MED GENET, V27, P742, DOI 10.1136/jmg.27.12.742; KALAYDJIEVA L, 1991, LANCET, V337, P865, DOI 10.1016/0140-6736(91)92584-O; KONECKI DS, 1991, HUM GENET, V87, P377; LEWONTIN RC, 1964, GENETICS, V49, P49; LICHTERKONECKI U, 1989, HUM GENET, V81, P373, DOI 10.1007/BF00283695; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LIU SR, 1986, CHINESE MED J-PEKING, V99, P113; LYONNET S, 1992, AM J HUM GENET, V51, P191; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; OKANO Y, 1990, AM J HUM GENET, V46, P18; ORKIN SH, 1984, ANNU REV GENET, V18, P131; OZALP I, 1986, J INHERIT METAB DIS, V9, P237, DOI 10.1007/BF01799716; PEREZ B, 1992, HUM GENET, V89, P341; REY F, 1988, AM J HUM GENET, V43, P914; RIESS O, 1988, HUM GENET, V78, P343, DOI 10.1007/BF00291732; ROMANO V, IN PRESS BRAIN DYS; SCRIVER CR, IN PRESS BRAIN DYS; SHIRAHASE W, 1991, BRAIN DEV-JPN, V13, P283, DOI 10.1016/S0387-7604(12)80064-7; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; STUHRMANN M, 1989, CLIN GENET, V36, P117; SULLIVAN SE, 1989, AM J HUM GENET, V44, P652; SVENSSON E, 1991, HUM GENET, V87, P11, DOI 10.1007/BF01213084; TSAI TF, 1990, HUM GENET, V84, P409; WANG T, 1991, AM J HUM GENET, V48, P628; WANG T, 1991, P NATL ACAD SCI USA, V88, P2146, DOI 10.1073/pnas.88.6.2146; WANG T, 1989, AM J HUM GENET, V45, P675; WANG T, 1992, GENOMICS, V13, P230, DOI 10.1016/0888-7543(92)90229-L; WANG T, 1991, GENOMICS, V10, P449, DOI 10.1016/0888-7543(91)90331-8; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; ZYGULSKA M, 1991, HUM GENET, V86, P292; [No title captured]	63	81	87	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1355	1365						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1361100				2022-12-18	WOS:A1992KC99500018
J	WILSON, DI; CROSS, IE; GOODSHIP, JA; BROWN, J; SCAMBLER, PJ; BAIN, HH; TAYLOR, JFN; WALSH, K; BANKIER, A; BURN, J; WOLSTENHOLME, J				WILSON, DI; CROSS, IE; GOODSHIP, JA; BROWN, J; SCAMBLER, PJ; BAIN, HH; TAYLOR, JFN; WALSH, K; BANKIER, A; BURN, J; WOLSTENHOLME, J			A PROSPECTIVE CYTOGENETIC STUDY OF 36 CASES OF DIGEORGE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARTIAL MONOSOMY; CHROMOSOME 22; 10P DELETION; CHILD; TRANSLOCATION; PATIENT; INFANT; DEFECT	Cytogenetic analysis was carried out in a prospective series of 36 children with DiGeorge syndrome. High-resolution banding (>850 bands/haploid set) was achieved in 30 cases. Monosomy 22q11.21-->q11.23 was found in 9 of these 30 cases. In each of these cases monosomy 22q11.21-->q11.23 resulted from an interstitial deletion and not from a translocation. No other chromosome abnormalities were seen.	ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON,ENGLAND; HOSP SICK CHILDREN,DEPT PAEDIAT CARDIOL,LONDON WC1N 3JH,ENGLAND; ROYAL LIVERPOOL CHILDRENS HOSP,DEPT PAEDIAT CARDIOL,LIVERPOOL L7 7DG,MERSEYSIDE,ENGLAND; MURDOCH INST,MELBOURNE,AUSTRALIA; FREEMAN RD HOSP,DEPT PAEDIAT CARDIOL,NEWCASTLE TYNE NE7 7DN,TYNE & WEAR,ENGLAND	Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Murdoch Children's Research Institute; Newcastle Freeman Hospital	WILSON, DI (corresponding author), UNIV NEWCASTLE UPON TYNE,DIV HUMAN GENET,19 CLAREMONT PL,NEWCASTLE TYNE NE2 4AA,ENGLAND.		Wilson, David/A-6264-2010; Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020	Wilson, David/0000-0001-8779-2060; Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Burn, John/0000-0002-9823-2322				ANNEREN G, 1989, UPSALA J MED SCI, V94, P47, DOI 10.3109/03009738909179246; [Anonymous], 1985, INT SYSTEM HUMAN CYT; BOWEN P, 1986, CLIN GENET, V29, P174; BRIDGMAN G, 1980, ARCH DIS CHILD, V55, P474, DOI 10.1136/adc.55.6.474; CAREY AH, 1992, AM J HUM GENET, V51, P964; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; DALLAPICCOLA B, 1989, ANN GENET-PARIS, V32, P92; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; ELFOULY MH, 1991, AM J MED GENET, V38, P569, DOI 10.1002/ajmg.1320380415; FAED MJW, 1987, J MED GENET, V24, P225, DOI 10.1136/jmg.24.4.225; GREENBERG F, 1986, J PEDIATR-US, V109, P489, DOI 10.1016/S0022-3476(86)80124-X; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GREENBERG F, 1984, HUM GENET, V65, P317, DOI 10.1007/BF00291554; GREENBERG F, 1988, AM J MED GENET, V31, P1, DOI 10.1002/ajmg.1320310102; HERVE J, 1984, ANN PEDIATR-PARIS, V31, P77; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; MASCARELLO JT, 1989, AM J MED GENET, V32, P112, DOI 10.1002/ajmg.1320320124; MOERMAN P, 1987, BRIT HEART J, V58, P274; MONACO G, 1991, AM J MED GENET, V39, P215, DOI 10.1002/ajmg.1320390220; SCHWANITZ G, 1987, ANN GENET-PARIS, V30, P80; TAYLOR MJ, 1981, AM J MED GENET, V9, P5, DOI 10.1002/ajmg.1320090103; TOWNES PL, 1978, AM J DIS CHILD, V132, P498, DOI 10.1001/archpedi.1978.02120300058012; VANDENBE.H, 1973, HUMANGENETIK, V18, P225; WILSON DI, 1991, BRIT HEART J, V66, P308	24	81	81	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					957	963						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415264				2022-12-18	WOS:A1992JU84000004
J	LEDBETTER, DH				LEDBETTER, DH			CRYPTIC TRANSLOCATIONS AND TELOMERE INTEGRITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							SHORT ARM; YEAST; CLONING; DNA; POLYMORPHISM; DELETIONS; DISEASE				LEDBETTER, DH (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030, USA.				NHGRI NIH HHS [HG00024] Funding Source: Medline; NICHD NIH HHS [HD20619] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTHERR MR, 1991, AM J HUM GENET, V49, P1235; BATES GP, 1990, AM J HUM GENET, V46, P762; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; KUWANO A, 1991, AM J HUM GENET, V49, P707; LAMB J, 1989, LANCET, V2, P819; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; SPEED RM, 1988, HUM GENET, V78, P260, DOI 10.1007/BF00291673; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112	14	81	84	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					451	456						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496980				2022-12-18	WOS:A1992JJ82800001
J	PAKSTIS, AJ; HEUTINK, P; PAULS, DL; KURLAN, R; VANDEWETERING, BJM; LECKMAN, JF; SANDKUYL, LA; KIDD, JR; BREEDVELD, GJ; CASTIGLIONE, CM; WEBER, J; SPARKES, RS; COHEN, DJ; KIDD, KK; OOSTRA, BA				PAKSTIS, AJ; HEUTINK, P; PAULS, DL; KURLAN, R; VANDEWETERING, BJM; LECKMAN, JF; SANDKUYL, LA; KIDD, JR; BREEDVELD, GJ; CASTIGLIONE, CM; WEBER, J; SPARKES, RS; COHEN, DJ; KIDD, KK; OOSTRA, BA			PROGRESS IN THE SEARCH FOR GENETIC-LINKAGE WITH TOURETTE SYNDROME - AN EXCLUSION MAP COVERING MORE THAN 50-PERCENT OF THE AUTOSOMAL GENOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GILLES-DELATOURETTE SYNDROME; DNA POLYMORPHISMS; FAMILIAL PATTERN; MULTIPLE TICS; MARKERS; TRANSMISSION; COMMITTEE; SET	Gilles de la Tourette syndrome is a neuropsychiatric disorder with an autosomal dominant mode of inheritance and reduced penetrance at a single genetic locus. Several research groups have genetic linkage studies underway to detect the chromosomal location of the gene that predisposess for this disorder. Strong and clear evidence of linkage has not yet been produced for Tourette syndrome. This paper presents an overview of the methods and progress of the groups centered at Yale University and Erasmus University in excluding linkage from a large portion of the genome. Our labs have screened 228 genetic marker loci for linkage with a gene for this disorder in a series of affected families in the United States, Canada. The Netherlands, and Norway. More than 50% (and perhaps as much as 66%) of the autosomal genome has now been excluded on the assumption that genetic heterogeneity is not an important factor in the Tourette syndrome pedigrees pooled for this summary.	YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,CTR CHILD STUDY,NEW HAVEN,CT 06510; UNIV ROCHESTER,SCH MED,DEPT NEUROL,ROCHESTER,NY 14627; ERASMUS UNIV,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT PSYCHIAT,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,HOSP DIJKZIGT,ROTTERDAM,NETHERLANDS; MARSHFIELD CLIN FDN MED RES & EDUC,MARSHFIELD,WI 54449; UNIV CALIF LOS ANGELES,SCH MED,DIV MED GENET,LOS ANGELES,CA 90024; ERASMUS UNIV,DEPT CELL BIOL,3000 DR ROTTERDAM,NETHERLANDS	Yale University; Yale University; University of Rochester; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Marshfield Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Erasmus University Rotterdam			Leckman, James/O-2426-2015	Heutink, Peter/0000-0001-5218-1737	NCRR NIH HHS [1S10RR03456-01] Funding Source: Medline; NIMH NIH HHS [MH00508, MH39239] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039239, R01MH039239] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		COMINGS DE, 1989, CYTOGENET CELL GENET, V51, P979; COMINGS DE, 1986, 7TH INT C HUM GEN W; DEVOR EJ, 1990, HUM HERED, V40, P105, DOI 10.1159/000153914; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GELERNTER J, 1990, ARCH GEN PSYCHIAT, V47, P1073; HEUTINK P, 1990, J MED GENET, V27, P433, DOI 10.1136/jmg.27.7.433; KIDD KK, 1986, HUM HERED, V36, P243, DOI 10.1159/000153634; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; KURLAN R, 1986, NEUROLOGY, V36, P772, DOI 10.1212/WNL.36.6.772; KURLAN R, 1987, ARCH NEUROL-CHICAGO, V44, P268, DOI 10.1001/archneur.1987.00520150024013; KURLAN R, 1989, NEUROLOGY, V39, P1625, DOI 10.1212/WNL.39.12.1625; LATHROP GM, 1989, GENOMICS, V5, P866, DOI 10.1016/0888-7543(89)90128-6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, GENOMICS, V3, P361; Maniatis T., 1982, MOL CLONING; MCALPINE PJ, 1989, CYTOGENET CELL GENET, V51, P13, DOI 10.1159/000132780; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1214; NAKAMURA Y, 1988, GENOMICS, V3, P342, DOI 10.1016/0888-7543(88)90125-5; NAKAMURA Y, 1988, Genomics, V3, P67, DOI 10.1016/0888-7543(88)90161-9; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OCONNELL P, 1988, GENOMICS, V3, P367, DOI 10.1016/0888-7543(88)90129-2; OTT J, 1974, AM J HUM GENET, V26, P588; PAULS DL, 1984, J AM ACAD CHILD PSY, V23, P134, DOI 10.1097/00004583-198403000-00003; PAULS DL, 1981, ARCH GEN PSYCHIAT, V38, P1091; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1990, J AM ACAD CHILD PSY, V29, P195, DOI 10.1097/00004583-199003000-00007; PAULS DL, 1980, UNPUB SCHEDULE TOURN; PRICE RA, 1987, PSYCHIAT RES, V24, P251; SPENCE MA, 1977, AM J HUM GENET, V29, P397; WEBER JL, 1989, AM J HUM GENET, V44, P388; 1989, CYTOGENET CELL GENET, V51, P1	32	81	82	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					281	294						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	EV744	1990837				2022-12-18	WOS:A1991EV74400013
J	SCHWARTZ, CE; ULMER, J; BROWN, A; PANCOAST, I; GOODMAN, HO; STEVENSON, RE				SCHWARTZ, CE; ULMER, J; BROWN, A; PANCOAST, I; GOODMAN, HO; STEVENSON, RE			ALLAN-HERNDON SYNDROME .2. LINKAGE TO DNA MARKERS IN XQ21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SELF MEM HOSP,DEPT MED GENET,GREENWOOD,SC; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,MED GENET SECT,WINSTON SALEM,NC 27103	Wake Forest University; Wake Forest Baptist Medical Center	SCHWARTZ, CE (corresponding author), GREENWOOD GENET CTR,1 GREGOR MENDEL CIRCLE,GREENWOOD,SC 29646, USA.							Allan W, 1944, AM J MENT DEF, V48, P325; ARVEILER B, 1987, Genomics, V1, P60, DOI 10.1016/0888-7543(87)90105-4; DAVIS JG, 1981, AM J HUM GENET, V33, pA75; FEIL RP, 1989, NUCLEIC ACIDS RES, V17, P1279, DOI 10.1093/nar/17.3.1279; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; MILES J, 1979, AM J HUM GENET, V31, pA120; MILES JH, IN PRESS AM J MED GE; RICHARDS BW, 1981, J MENT DEFIC RES, V25, P253; SCHWARTZ CE, 1986, CYTOGENET CELL GENET, V43, P117, DOI 10.1159/000132307; STEVENSON RE, 1990, AM J HUM GENET, V47, P446; WIEACKER P, 1987, AM J MED GENET, V28, P245, DOI 10.1002/ajmg.1320280137; WIEACKER P, 1985, AM J MED GENET, V20, P597, DOI 10.1002/ajmg.1320200405; WILLEMS P J, 1989, American Journal of Human Genetics, V45, pA167; WINTER RM, 1989, HUM GENET, V82, P367	20	81	81	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					454	458						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393020				2022-12-18	WOS:A1990DX22300010
J	RUSSO, P; OREGAN, S				RUSSO, P; OREGAN, S			VISCERAL PATHOLOGY OF HEREDITARY TYROSINEMIA TYPE-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP ST JUSTINE,DEPT NEPHROL,MONTREAL H3T 1C5,QUEBEC,CANADA; UNIV MONTREAL,MONTREAL H3C 3J7,QUEBEC,CANADA	Universite de Montreal; Universite de Montreal	RUSSO, P (corresponding author), HOP ST JUSTINE,DEPT PATHOL,3175 COTE ST CATHERINE,MONTREAL H3T 1C5,QUEBEC,CANADA.							BENDON R W, 1986, Pediatric Pathology, V6, P411; CALLARD P, 1975, AM J PATHOL, V80, P329; CARSON NAJ, 1976, ARCH DIS CHILD, V51, P106, DOI 10.1136/adc.51.2.106; CHRISTENSEN EI, 1980, KIDNEY INT, V17, P771, DOI 10.1038/ki.1980.90; DEHNER LP, 1989, HUM PATHOL, V20, P149, DOI 10.1016/0046-8177(89)90179-2; DEHNER LP, 1987, PEDIATRIC SURGICAL P, P434; EDWARDS MA, 1987, LANCET, V1, P1438; FALLSTROM SP, 1981, ACTA PAEDIATR SCAND, V70, P315, DOI 10.1111/j.1651-2227.1981.tb16558.x; FOX JG, 1987, CAN MED ASSOC J, V137, P883; GAGNE R, 1983, NEW ENGL J MED, V309, P1063; GENTZ J, 1965, J PEDIATR-US, V66, P670, DOI 10.1016/S0022-3476(65)80002-6; GORDON RD, 1986, SURG CLIN N AM, V66, P541; GRENIER A, 1974, CLIN CHIM ACTA, V57, P71, DOI 10.1016/0009-8981(74)90179-X; HALVORSEN S, 1966, ARCH DIS CHILD, V42, P238; Hardwick D F, 1976, Perspect Pediatr Pathol, V3, P103; HOSTETTER MK, 1983, NEW ENGL J MED, V308, P1265, DOI 10.1056/NEJM198305263082105; Jaffe R, 1982, Perspect Pediatr Pathol, V7, P137; JEVTIC MM, 1974, AM J CLIN PATHOL, V61, P423; KAPLAN C, 1975, AM J PATHOL, V80, P227; KOGUT MD, 1967, AM J DIS CHILD, V13, P47; KVITTINGEN EA, 1986, SCAND J CLIN LAB INV, V46, P27; KVITTINGEN EA, 1986, J INHERIT METAB DIS, V9, P216, DOI 10.1007/BF01799465; Laberge C., 1986, Essential nutrients in carcinogenesis, P209; Larochelle J, 1973, Pediatrie, V28, P5; LINDBERG T, 1979, ACTA PAEDIATR SCAND, V68, P619, DOI 10.1111/j.1651-2227.1979.tb05068.x; LINDBLAD B, 1987, J INHERIT METAB DIS, V10, P319, DOI 10.1007/BF01811439; MCDIARMID SV, 1989, TRANSPLANTATION, V47, P314, DOI 10.1097/00007890-198902000-00025; MOWAT AP, 1987, TRANSPLANT P, V19, P3236; Parington MW, 1967, CAN MED ASSOC J, V97, P1059; PERRY TL, 1967, CAN MED ASSOC J, V97, P1067; Phillips MJ., 1987, LIVER ATLAS TEXT ULT; PRIVE L, 1967, CAN MED ASSOC J, V97, P1054; SMITH SM, 1989, ARCH PATHOL LAB MED, V113, P1253; STARZL TE, 1985, J PEDIATR-US, V106, P604, DOI 10.1016/S0022-3476(85)80081-0; SUZUKI Y, 1987, INT J PED NEPHROL, V8, P171; TREMBLAY M, 1977, UNION MED CAN, V106, P1014; TUCHMAN M, 1987, J PEDIATR-US, V110, P399, DOI 10.1016/S0022-3476(87)80501-2; VANTHIEL DH, 1986, J HEPATOL, V3, P42, DOI 10.1016/S0168-8278(86)80144-1; WATANABE S, 1983, CANCER, V51, P2197, DOI 10.1002/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5; WEINBERG AG, 1976, J PEDIATR-US, V88, P434, DOI 10.1016/S0022-3476(76)80259-4; WOOLF LI, 1986, P ROY SOC MED, V59, P814; WORTHEN HG, 1963, LAB INVEST, V12, P791; YU JS, 1971, ARCH DIS CHILD, V46, P306, DOI 10.1136/adc.46.247.306	43	81	85	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					317	324						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378357				2022-12-18	WOS:A1990DT87100018
J	KLITZ, W; THOMSON, G; BAUR, MP				KLITZ, W; THOMSON, G; BAUR, MP			CONTRASTING EVOLUTIONARY HISTORIES AMONG TIGHTLY LINKED HLA LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DIABET RES INST,DEPT BIOMETR,D-4000 DUSSELDORF,FED REP GER		KLITZ, W (corresponding author), UNIV CALIF BERKELEY,DEPT GENET,BERKELEY,CA 94720, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NICHD NIH HHS [HD12731] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON R, 1979, THESIS MONASH U CLAY; [Anonymous], 1984, HISTOCOMPATIBILITY T; BAUR MP, 1984, HISTOCOMPATIBILITY T, P333; BAUR MP, 1980, HISTOCOMPATIBILITY T, P994; BERTRAMS J, 1984, IMMUNOBIOLOGY, V166, P335, DOI 10.1016/S0171-2985(84)80012-1; Bodmer WF, 1972, HISTOCOMPATIBILITY T; BOHME J, 1985, JUN MHC GEN CLON WOR; BUSI BR, 1979, HUM GENET, V49, P105; CARROLL MC, 1985, EMBO J, V4, P2547, DOI 10.1002/j.1460-2075.1985.tb03969.x; CARROLL MC, 1984, NATURE, V307, P237, DOI 10.1038/307237a0; CHAPPELL MA, 1984, P NATL ACAD SCI-BIOL, V81, P5484, DOI 10.1073/pnas.81.17.5484; EWENS WJ, 1974, THEOR POPUL BIOL, V6, P35, DOI 10.1016/0040-5809(74)90030-6; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; GOODFELLOW PN, 1978, TISSUE ANTIGENS, V11, P350, DOI 10.1111/j.1399-0039.1978.tb01267.x; HEDRICK PW, 1983, GENETICS, V104, P449; JARAQUEMADA D, 1984, TISSUE ANTIGENS, V23, P23; KEITH TP, 1983, GENETICS, V105, P153; NEI M, 1980, BIOMATHEMATICS, V53, P214; OLAISEN B, 1984, 9TH HIST WORKSH C MU; Porter R R, 1983, Mol Biol Med, V1, P161; PREVOST P, 1984, TISSUE ANTIGENS, V23, P301; RAUM D, 1984, AM J HUM GENET, V36, P72; RITTNER C, 1981, HUM GENET, V56, P235, DOI 10.1007/BF00274674; RITTNER C, 1984, TISSUE ANTIGENS, V23, P130; ROBSON EB, 1984, CYTOGENET CELL GENET, V37, P47, DOI 10.1159/000132004; SCHENDEL DJ, 1984, IMMUNOGENETICS, V20, P23, DOI 10.1007/BF00373444; Sokal R.R., 1981, BIOMETRY, V2nd ed.; SPIELMAN RS, 1981, HLA ENDOCRINE METABO, P33; URINGLAMBERT B, 1984, HISTOCOMPATIBILITY T; VANENDEN W, 1982, HUMAN GENETICS B, P37; WATTERSON GA, 1978, GENETICS, V88, P405; WEISS EH, 1984, NATURE, V310, P650, DOI 10.1038/310650a0	32	81	82	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					340	349						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3766540				2022-12-18	WOS:A1986E364400006
J	CARRITT, B; WELCH, HM; PARRYJONES, NJ				CARRITT, B; WELCH, HM; PARRYJONES, NJ			SEQUENCES HOMOLOGOUS TO THE HUMAN D1S1 LOCUS PRESENT ON HUMAN CHROMOSOME-3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CARRITT, B (corresponding author), UNIV LONDON UNIV COLL, MRC, HUMAN BIOCHEM GENET UNIT, 4 STEPHENSON WAY, LONDON NW1 2HE, ENGLAND.							BISHOP JO, 1972, NATURE, V240, P149, DOI 10.1038/240149a0; CARRITT B, 1977, EXP CELL RES, V106, P71, DOI 10.1016/0014-4827(77)90242-7; CARRITT B, 1982, P NATL ACAD SCI-BIOL, V79, P7400, DOI 10.1073/pnas.79.23.7400; CARRITT B, 1982, ANN HUM GENET, V46, P329, DOI 10.1111/j.1469-1809.1982.tb01583.x; DONLON TA, 1984, CYTOGENET CELL GENET, V37, P454; GOODE M E, 1983, Genetics, V104, pS30; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; Harris, 1976, HDB ENZYME ELECTROPH; HUMPHRIES P, 1983, MOL GEN GENET, V190, P143, DOI 10.1007/BF00330337; LEDER P, 1977, SCIENCE, V196, P175, DOI 10.1126/science.322278; LEDERMAN L, 1981, ANAL BIOCHEM, V117, P158, DOI 10.1016/0003-2697(81)90705-3; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MUNKE M, 1984, SOMAT CELL MOLEC GEN, V10, P589, DOI 10.1007/BF01535224; SKOLNICK MH, 1982, CYTOGENET CELL GENET, V32, P194, DOI 10.1159/000131699; TASHIMA M, 1981, P NATL ACAD SCI-BIOL, V78, P1508, DOI 10.1073/pnas.78.3.1508; VANSOMEREN H, 1974, HUMANGENETIK, V25, P189; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7	18	81	81	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					428	436						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3010709				2022-12-18	WOS:A1986C489300003
J	MYERS, RH; MADDEN, JJ; TEAGUE, JL; FALEK, A				MYERS, RH; MADDEN, JJ; TEAGUE, JL; FALEK, A			FACTORS RELATED TO ONSET AGE OF HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									GEORGIA MENTAL HLTH INST,HUMAN & BEHAV GENET RES LAB,ATLANTA,GA 30306; EMORY UNIV,SCH MED,DEPT PSYCHIAT,ATLANTA,GA 30322	Emory University				Myers, Richard/0000-0002-8365-2674				BELL J, 1942, ANN EUGEN, V11, P272; BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BITTENBENDER JB, 1962, ARCH NEUROL-CHICAGO, V7, P275, DOI 10.1001/archneur.1962.04210040027003; BRACKENRIDGE C J, 1971, Clinical Genetics, V2, P287; BRACKENRIDGE CJ, 1975, J MED GENET, V12, P64, DOI 10.1136/jmg.12.1.64; BRACKENRIDGE CJ, 1972, J MED GENET, V9, P23, DOI 10.1136/jmg.9.1.23; BRACKENRIDGE CJ, 1978, J MED GENET, V15, P23, DOI 10.1136/jmg.15.1.23; BRACKENRIDGE CJ, 1973, J MED GENET, V10, P333, DOI 10.1136/jmg.10.4.333; BRACKENRIDGE CJ, 1971, CLIN GENET, V7, P267; BRUYN GW, 1969, PROGR NEUROGENETICS, P666; BURKE W, 1976, J MED GENET, V13, P462, DOI 10.1136/jmg.13.6.462; CHASE TN, 1979, ADV NEUROLOGY, V23; HAYDEN MR, 1982, AM J MED GENET; JONES M B, 1970, Journal of Medical Genetics, V7, P20, DOI 10.1136/jmg.7.1.20; JONES MB, 1973, ADV NEUROL, V1, P171; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; OEPEN H, 1967, HOMO S, V5, P296; REED TE, 1958, AM J HUM GENET, V10, P201; STRICKBERGER MW, 1976, GENETICS, P186; VEGTERVANDERVLIS M, 1976, ANN HUM GENET, V39, P329; WALLACE DC, 1979, ADV NEUROL, V23, P73	21	81	82	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					481	488						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	6211092				2022-12-18	WOS:A1982NR13300013
J	MATSUNAGA, E				MATSUNAGA, E			HEREDITARY RETINOBLASTOMA - DELAYED MUTATION OR HOST-RESISTANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MATSUNAGA, E (corresponding author), NATL INST GENET,DEPT HUMAN GENET,MISHIMA,SHIZUOKA 411,JAPAN.							AUERBACH C, 1956, ANN HUM GENET, V20, P266; BERTRAMS J, 1973, TISSUE ANTIGENS, V3, P78; BOHRINGER H. R., 1956, ARCH JULIUS KLAUS STIFT, V31, P1; Boniuk M, 1969, Trans Am Acad Ophthalmol Otolaryngol, V73, P194; BRIARDGUILLEMOT ML, 1974, HUMANGENETIK, V24, P271, DOI 10.1007/BF00297591; CHAR DH, 1974, AM J OPHTHALMOL, V78, P5, DOI 10.1016/0002-9394(74)90003-8; CZEIZEL A, 1974, HUMANGENETIK, V22, P153; Ellsworth R M, 1969, Trans Am Ophthalmol Soc, V67, P462; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FALCONER DS, 1960, INTRO QUANTITATIVE G, P191; FALLS HF, 1951, AMA ARCH OPHTHALMOL, V46, P367; FRANCOIS J, 1975, OPHTHALMOLOGICA, V170, P405, DOI 10.1159/000307248; GORDON H, 1974, Birth Defects Original Article Series, V10, P185; HALDANE JBS, 1949, ANN EUGENIC, V14, P339; Herrmann J, 1976, Birth Defects Orig Artic Ser, V12, P79; HERRMANN J, 1977, GENETICS HUMAN CANCE, P417; KAELIN A., 1955, ARCH JULIUS KLAUS STIFT, V30, P263; KANTER YC, 1964, ARCH OPHTHALMOL-CHIC, V72, P783; KNUDSON AG, 1975, P NATL ACAD SCI USA, V72, P5116, DOI 10.1073/pnas.72.12.5116; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; MACKLIN MT, 1960, AM J HUM GENET, V12, P1; MATSUNAGA E, 1976, HUM GENET, V33, P1, DOI 10.1007/BF00447281; MATSUNAGA E, 1976, JPN J OPHTHALMOL, V20, P266; MATSUNAGA E, 1959, JPN J HUM GENET, V4, P156; MINODA K, 1976, ACTA SOC OPHTHALMOL, V80, P1648; MORRIS W E, 1974, Annals of Ophthalmology, V6, P1192; NEEL JV, 1962, METHODOLOGY HUMAN GE, P203; NEWCOMBE HB, 1964, 2 INT C CONG MALF, P345; NIELSEN M, 1968, ACTA OPHTHALMOL, V46, P736; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; SCHAPPER.J, 1966, OPHTHALMOLOGICA, V151, P197, DOI 10.1159/000304891; SORSBY A, 1972, BRIT MED J, V2, P580, DOI 10.1136/bmj.2.5813.580; TUCKER DP, 1957, ARCH OPHTHALMOL-CHIC, V57, P532; VOGEL F, 1957, Z MENSCH VERERB KONS, V34, P205; VOGEL F, 1967, MODERN TRENDS OPHTHA, P34; WARBURG M, 1974, GENETIC METABOLIC EY, P447	36	81	81	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	4					406	424						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP353	717402				2022-12-18	WOS:A1978FP35300009
J	CAWLEY, RH; MCKEOWN, T; RECORD, RG				CAWLEY, RH; MCKEOWN, T; RECORD, RG			PARENTAL STATURE AND BIRTH WEIGHT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CASTLE WE, 1922, CARNEG I PUBL, V320; Cawley RH, 1954, BRIT J PREV SOC MED, V8, P66; Green CV, 1931, J EXP ZOOL, V58, P247, DOI 10.1002/jez.1400580112; HAGEDOORN A, 1928, NEDERL TIJDSCHR GENE, V1, P1792; Kopec S, 1924, J GENET, V14, P241, DOI 10.1007/BF02983098; KOPEC S, 1922, ANAT REC, V27, P95; LENNER A, 1943, ACTA OBSTET GYNEC S1, V24; Livesay EA, 1930, GENETICS, V15, P17; MCKEOWN T, 1954, AM J HUM GENET, V6, P457; MCKEOWN T, 1953, J ENDOCRINOL, V10, P73, DOI 10.1677/joe.0.0100073; MCKEOWN T, 1953, J ENDOCRINOL, V9, P418, DOI 10.1677/joe.0.0090418; PATON DN, 1926, SPEC REP SER MED RES, V101; PEARSE MS, 1928, J GENET, V20, P261; Pearson K., 1903, BIOMETRIKA, V2, P357; Punnett RC, 1918, J GENET, V8, P1, DOI 10.1007/BF02983477; RIFE QC, 1943, J ANIM SCI, V2, P50; Robb RC, 1929, BR J EXP BIOL, V6, P293; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029	18	81	81	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	4					448	456						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB735	14349950				2022-12-18	WOS:A1954YB73500008
J	Reijnders, MRF; Ansor, NM; Kousi, M; Yue, WW; Tan, PL; Clarkson, K; Clayton-Smith, J; Corning, K; Jones, JR; Lam, WWK; Mancini, GMS; Marcelis, C; Mohammed, S; Pfundt, R; Roifman, M; Cohn, R; Chitayat, D; Millard, TH; Katsanis, N; Brunner, HG; Banka, S				Reijnders, Margot R. F.; Ansor, Nurhuda M.; Kousi, Maria; Yue, Wyatt W.; Tan, Perciliz L.; Clarkson, Katie; Clayton-Smith, Jill; Corning, Ken; Jones, Julie R.; Lam, Wayne W. K.; Mancini, Grazia M. S.; Marcelis, Carlo; Mohammed, Shehla; Pfundt, Rolph; Roifman, Maian; Cohn, Ronald; Chitayat, David; Millard, Tom H.; Katsanis, Nicholas; Brunner, Han G.; Banka, Siddharth		Deciphering Dev Disorders Study	RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHO GTPASES; INTELLECTUAL DISABILITY; EXPRESSION; VARIANTS; SURVIVAL; SPECTRUM; SYSTEM; FAMILY; GROWTH; CDC42	RAC1 is a widely studied Rho GTPase, a class of molecules that modulate numerous cellular functions essential for normal development. RAC1 is highly conserved across species and is under strict mutational constraint. We report seven individuals with distinct de novo missense RAC1 mutations and varying degrees of developmental delay, brain malformations, and additional phenotypes. Four individuals, each harboring one of c.53G>A (p.Cys18Tyr), c.116A>G (p.Asn39Ser), c.218C>T (p.Pro73Leu), and c.470G>A (p.Cys157Tyr) variants, were microcephalic, with head circumferences between -2.5 to -5 SD. In contrast, two individuals with c.151G>A (p.Val51Met) and c.151G>C (p.Val51Leu) alleles were macrocephalic with head circumferences of +4.16 and +4.5 SD. One individual harboring a c.190T>G (p.Tyr64Asp) allele had head circumference in the normal range. Collectively, we observed an extraordinary spread of similar to 10 SD of head circumferences orchestrated by distinct mutations in the same gene. In silico modeling, mouse fibroblasts spreading assays, and in vivo overexpression assays using zebrafish as a surrogate model demonstrated that the p.Cys18Tyr and p.Asn39Ser RAC1 variants function as dominant-negative alleles and result in microcephaly, reduced neuronal proliferation, and cerebellar abnormalities in vivo. Conversely, the p.Tyr64Asp substitution is constitutively active. The remaining mutations are probably weakly dominant negative or their effects are context dependent. These findings highlight the importance of RAC1 in neuronal development. Along with TRIO and HACE1, a sub-category of rare developmental disorders is emerging with RAC1 as the central player. We show that ultra-rare disorders caused by private, non-recurrent missense mutations that result in varying phenotypes are challenging to dissect, but can be delineated through focused international collaboration.	[Reijnders, Margot R. F.; Marcelis, Carlo; Pfundt, Rolph; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Ansor, Nurhuda M.; Millard, Tom H.] Univ Manchester, Fac Biol Med & Hlth, Div Dev Biol & Med, Manchester M13 9PL, Lancs, England; [Ansor, Nurhuda M.] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas 13200, Penang, Malaysia; [Kousi, Maria; Tan, Perciliz L.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Yue, Wyatt W.] Univ Oxford, Nuffield Dept Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Clarkson, Katie; Corning, Ken; Jones, Julie R.; Lam, Wayne W. K.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Clayton-Smith, Jill; Banka, Siddharth] Manchester Acad Hlth Sci Ctr, Cent Manchester NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Clayton-Smith, Jill; Banka, Siddharth] Univ Manchester, Fac Biol Med & Hlth, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Lam, Wayne W. K.] Western Gen Hosp, South East Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Mohammed, Shehla] Guys & St Thomas Hosp, Dept Clin Genet, London SE1 7EH, England; [Roifman, Maian; Chitayat, David] Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Roifman, Maian; Cohn, Ronald; Chitayat, David] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, NL-6202 AZ Maastricht, Netherlands	Radboud University Nijmegen; University of Manchester; Universiti Sains Malaysia; Duke University; University of Oxford; Greenwood Genetic Center; University of Manchester; University of Manchester; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; Guy's & St Thomas' NHS Foundation Trust; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Maastricht University; Maastricht University	Brunner, HG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.; Banka, S (corresponding author), Manchester Acad Hlth Sci Ctr, Cent Manchester NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England.; Banka, S (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England.; Brunner, HG (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands.; Brunner, HG (corresponding author), Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, NL-6202 AZ Maastricht, Netherlands.	han.brunner@radboudumc.nl; siddharth.banka@manchester.ac.uk	Cohn, Ronald/AAC-5835-2021; Marcelis, C.L.M./L-4504-2015; Pfundt, Rolph/L-4576-2015; Ansor, Nurhuda Mohamad/T-4022-2019	Marcelis, C.L.M./0000-0001-7095-4641; Banka, Siddharth/0000-0002-8527-2210; Mohamad Ansor, Nurhuda/0000-0003-2351-6838	Rare Disease Foundation; BC Children's Hospital Foundation [17-48]; Structural Genomics Consortium [1097737]; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research through the Comprehensive Clinical Research Network	Rare Disease Foundation; BC Children's Hospital Foundation; Structural Genomics Consortium(University of Toronto); Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	We would like to thank all the families for agreeing to participate in this study. We acknowledge the Rare Disease Foundation and the BC Children's Hospital Foundation for their support for this work (S.B., grant number 17-48). N.K. is a Distinguished George W. Brumley Professor. W.W.Y. is a researcher at the Structural Genomics Consortium, a registered charity (number 1097737; funding details online). We thank Prof. Viki Allan (University of Manchester) for providing mammalian expression plasmids encoding GFP-Rac1, GFP-Rac1-T17N, and GFP-Rac1-Q61L. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83 granted by the Cambridge South REC and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network.	Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Ba W, 2016, HUM MOL GENET, V25, P892, DOI 10.1093/hmg/ddv618; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Duquette Philippe M, 2014, Small GTPases, V5, P8, DOI 10.4161/sgtp.29716; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hetmanski Joseph H R, 2018, Small GTPases, V9, P224, DOI 10.1080/21541248.2016.1218406; Hobbs GA, 2015, FREE RADICAL BIO MED, V79, P237, DOI 10.1016/j.freeradbiomed.2014.09.027; Hollstein R, 2015, J MED GENET, V52, P797, DOI 10.1136/jmedgenet-2015-103344; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Leone DP, 2010, DEV NEUROBIOL, V70, P659, DOI 10.1002/dneu.20804; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Matos P, 2000, BIOCHEM BIOPH RES CO, V277, P741, DOI 10.1006/bbrc.2000.3743; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Mulherkar S, 2014, DEV BIOL, V394, P39, DOI 10.1016/j.ydbio.2014.08.004; Nevado J, 2015, EUR J HUM GENET, V23, P1615, DOI 10.1038/ejhg.2015.51; Pengelly R. J., 2016, J MED GENET; Perles Z, 2015, J MED GENET, V52, P840, DOI 10.1136/jmedgenet-2015-103336; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Van Dijck A, 2015, EUR J MED GENET, V58, P503, DOI 10.1016/j.ejmg.2015.08.004; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wojnacki Jose, 2014, Small GTPases, V5, pe28430	45	80	82	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					466	477		10.1016/j.ajhg.2017.08.007	http://dx.doi.org/10.1016/j.ajhg.2017.08.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28886345	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000409530900013
J	Jiang, Q; Arnold, S; Heanue, T; Kilambi, KP; Doan, B; Kapoor, A; Ling, AY; Sosa, MX; Guy, M; Jiang, QG; Burzynski, G; West, K; Bessling, S; Griseri, P; Amiel, J; Fernandez, RM; Verheij, JBGM; Hofstra, RMW; Borrego, S; Lyonnet, S; Ceccherini, I; Gray, JJ; Pachnis, V; McCallion, AS; Chakravarti, A				Jiang, Qian; Arnold, Stacey; Heanue, Tiffany; Kilambi, Krishna Praneeth; Doan, Betty; Kapoor, Ashish; Ling, Albee Yun; Sosa, Maria X.; Guy, Moltu; Jiang, Qingguang; Burzynski, Grzegorz; West, Kristen; Bessling, Seneca; Griseri, Paola; Amiel, Jeanne; Fernandez, Raquel M.; Verheij, Joke B. G. M.; Hofstra, Robert M. W.; Borrego, Salud; Lyonnet, Stanislas; Ceccherini, Isabella; Gray, Jeffrey J.; Pachnis, Vassilis; McCallion, Andrew S.; Chakravarti, Aravinda			Functional Loss of Semaphorin 3C and/or Semaphorin 3D and Their Epistatic Interaction with Ret Are Critical to Hirschsprung Disease Liability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENTERIC NERVOUS-SYSTEM; GENOME-WIDE ASSOCIATION; TYROSINE KINASE; COMMON; EXPRESSION; RECEPTOR; ENHANCER; MARKER; CELLS; MIGRATION	Innervation of the gut is segmentally lost in Hirschsprung disease (HSCR), a consequence of cell-autonomous and non-autonomous defects in enteric neuronal cell differentiation, proliferation, migration, or survival. Rare, high-penetrance coding variants and common, low-penetrance non-coding variants in 13 genes are known to underlie HSCR risk, with the most frequent variants in the ret proto-oncogene (RET). We used a genome-wide association (220 trios) and replication (429 trios) study to reveal a second non-coding variant distal to RET and a non-coding allele on chromosome 7 within the class 3 Semaphorin gene cluster. Analysis in Ret wild-type and Ret-null mice demonstrates specific expression of Sema3a, Sema3c, and Sema3d in the enteric nervous system (ENS). In zebrafish embryos, sema3 knockdowns show reduction of migratory ENS precursors with complete ablation under conjoint ret loss of function. Seven candidate receptors of Sema3 proteins are also expressed within the mouse ENS and their expression is also lost in the ENS of Ret-null embryos. Sequencing of SEMA3A, SEMA3C, and SEMA3D in 254 HSCR-affected subjects followed by in silico protein structure modeling and functional analyses identified five disease-associated alleles with loss-of-function defects in semaphorin dimerization and binding to their cognate neuropilin and plexin receptors. Thus, semaphorin 3C/3D signaling is an evolutionarily conserved regulator of ENS development whose dys-regulation is a cause of enteric aganglionosis.	[Jiang, Qian; Arnold, Stacey; Doan, Betty; Kapoor, Ashish; Ling, Albee Yun; Sosa, Maria X.; Guy, Moltu; Burzynski, Grzegorz; West, Kristen; Bessling, Seneca; McCallion, Andrew S.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Jiang, Qian] Capital Inst Pediat, Dept Med Genet, Beijing 100020, Peoples R China; [Heanue, Tiffany; Pachnis, Vassilis] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Kilambi, Krishna Praneeth; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Jiang, Qingguang] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Griseri, Paola; Ceccherini, Isabella] Ist Giannina Gaslini, UOC Genet Med, I-16147 Genoa, Italy; [Amiel, Jeanne; Lyonnet, Stanislas] INSERM, Lab Embryol & Genet Congenital Malformat, UMR 1163, F-75015 Paris, France; [Amiel, Jeanne; Lyonnet, Stanislas] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, F-75015 Paris, France; [Fernandez, Raquel M.; Borrego, Salud] Univ Seville, Univ Hosp Virgen del Rocio, Dept Genet Reprod & Fetal Med, Inst Biomed Seville IBIS,CSIC, Seville 41013, Spain; [Fernandez, Raquel M.; Borrego, Salud] Ctr Biomed Network Res Rare Dis CIBERER, Seville 41013, Spain; [Verheij, Joke B. G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Genet, D-9700 Groningen, Germany; [Hofstra, Robert M. W.] Univ Rotterdam, Erasmus Med Ctr, Dept Clin Genet, NL-3015 CE Rotterdam, Netherlands; [Hofstra, Robert M. W.] UCL Inst Child Hlth, Neural Dev Unit, London WC1 NEH, England; [Hofstra, Robert M. W.] UCL Inst Child Hlth, Gastroenterol Unit, London WC1 NEH, England	Johns Hopkins University; Capital Institute of Pediatrics (CIP); MRC National Institute for Medical Research; Johns Hopkins University; Johns Hopkins University; University of Genoa; IRCCS Istituto Giannina Gaslini; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of London; University College London	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu	IBIS, GENETICA/P-3384-2015; Ceccherini, Isabella/P-8195-2014; amiel, jeanne/H-3501-2017; Gray, Jeffrey J./B-5682-2008; Jiang, Qian/ABG-8183-2020; griseri, paola/AAJ-4823-2020; Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; Borrego, Salud/M-6314-2015	Ceccherini, Isabella/0000-0001-8732-1955; amiel, jeanne/0000-0001-5973-4728; Gray, Jeffrey J./0000-0001-6380-2324; Jiang, Qian/0000-0001-6023-2290; Lyonnet, Stanislas/0000-0001-5426-9417; Kilambi, Krishna Praneeth/0000-0003-4848-2611; Heanue, Tiffany/0000-0002-6678-8246; Pachnis, Vassilis/0000-0001-9733-7686; Kapoor, Ashish/0000-0003-3977-6140; Hofstra, Robert/0000-0001-7498-3829	MERIT NIH Award [HD28088]; NIH [GM71648]; National Natural Science Foundation of China [81300266]; Beijing Natural Science Foundation [7142029]; Beijing Excellent Scientist Fund [2013D003034000007]; MRC; Italian Ministry of Health ("Cinque per mille," Ricerca Corrente); Italian Ministry of Health (Ricerca Finalizzata) [RF-2010-2314356]; Fondo de Investigacion Sanitaria, Spain [PI070080]; European E-Rare program [PI071315]; Consejeria de Educacion Ciencia Y Empresa de la Junta de Andalucia [CTS2590]; NWO Bernoulle Foundation [901-04-225]; Ubbo Emmius Foundation;  [ANR-10-IAHU-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028088] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078221, R01GM071648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER; Medical Research Council [MC_U117537087] Funding Source: researchfish; The Francis Crick Institute [10128] Funding Source: researchfish; MRC [MC_U117537087] Funding Source: UKRI	MERIT NIH Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Excellent Scientist Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Italian Ministry of Health ("Cinque per mille," Ricerca Corrente); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); Fondo de Investigacion Sanitaria, Spain(Instituto de Salud Carlos III); European E-Rare program; Consejeria de Educacion Ciencia Y Empresa de la Junta de Andalucia(Junta de Andalucia); NWO Bernoulle Foundation; Ubbo Emmius Foundation; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank our subjects, their families, referring physicians, and genetic counselors for participating in these studies, and we are grateful to Courtney Berrios, Julie Albertus, Maura Kenton, and Jennifer (Scott) Bubb for family ascertainment and genetic counseling; Priyanka Nandakumar, Alexis Rhea, Ankit Rakha, and Carl Kashuk for technical assistance; Drs. David Ginty (Johns Hopkins University, Baltimore; Sema3a/c/d/e), Kevin Mitchell (University of Dublin, Ireland; PlexinA2/A4), and Jeffrey Macklis (Harvard University, Cambridge; PlexinD1) for reagents; and Dr. Ian Shephard (Emory University, Atlanta) for protocols and technical advice on zebrafish analysis. We are also thankful to Drs. David Ginty and Alex Kolodkin for discussions and comments on this paper. The studies here were supported by the following grants: MERIT NIH Award HD28088 to A.C.; NIH GM71648 to A.S.M.; National Natural Science Foundation of China (No. 81300266), Beijing Natural Science Foundation (No. 7142029), and Beijing Excellent Scientist Fund (No. 2013D003034000007) to Qian Jiang; MRC grants to T.H. and V.P.; Italian Ministry of Health ("Cinque per mille," Ricerca Corrente to the Gaslini Institute and Ricerca Finalizzata # RF-2010-2314356) to I. C.; ANR-10-IAHU-01 grant to J.A. and S.L.; Fondo de Investigacion Sanitaria, Spain (PI070080), European E-Rare program (PI071315), and Consejeria de Educacion Ciencia Y Empresa de la Junta de Andalucia (CTS2590) to S. Borrego; and NWO (no. 901-04-225) Bernoulle Foundation and Ubbo Emmius Foundation to R.M. W.H. The arrays were a gift from Affymetrix. A. C. was a member of the Advisory Board of Affymetrix (2000-2013), a potential conflict of interest managed by the policies of the Johns Hopkins School of Medicine.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alves MM, 2013, DEV BIOL, V382, P320, DOI 10.1016/j.ydbio.2013.05.019; Anderson RB, 2007, DEV BIOL, V305, P287, DOI 10.1016/j.ydbio.2007.02.020; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brown CB, 2001, DEVELOPMENT, V128, P3071; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Cann HM, 2002, SCIENCE, V296, P261; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Carrillo RA, 2010, NEURON, V68, P32, DOI 10.1016/j.neuron.2010.09.005; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Degenhardt K, 2013, NAT MED, V19, P760, DOI 10.1038/nm.3185; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Durbec PL, 1996, DEVELOPMENT, V122, P349; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Feiner L, 2001, DEVELOPMENT, V128, P3061; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Gershon MD, 1998, THE 2 BRAIN; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Heanue TA, 2008, MECH DEVELOP, V125, P687, DOI 10.1016/j.mod.2008.04.006; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Jiang Q, 2012, HUM MUTAT, V33, P281, DOI 10.1002/humu.21602; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lin S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r63; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Osborne NJ, 2005, DEV DYNAM, V232, P939, DOI 10.1002/dvdy.20258; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Scholl AM, 2009, WIRES SYST BIOL MED, V1, P220, DOI 10.1002/wsbm.8; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shepherd IT, 1999, DEV BIOL, V212, P42, DOI 10.1006/dbio.1999.9294; Tanaka H, 2011, DEV DYNAM, V240, P9, DOI 10.1002/dvdy.22499; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Yu HH, 2005, DEV BIOL, V280, P373, DOI 10.1016/j.ydbio.2005.01.029	56	80	84	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					581	596		10.1016/j.ajhg.2015.02.014	http://dx.doi.org/10.1016/j.ajhg.2015.02.014			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25839327	Green Published, Bronze			2022-12-18	WOS:000352212600006
J	Liegel, RP; Handley, MT; Ronchetti, A; Brown, S; Langemeyer, L; Linford, A; Chang, B; Morris-Rosendahl, DJ; Carpanini, S; Posmyk, R; Harthill, V; Sheridan, E; Abdel-Salam, GMH; Terhal, PA; Faravelli, F; Accorsi, P; Giordano, L; Pinelli, L; Hartmann, B; Ebert, AD; Barr, FA; Aligianis, IA; Sidjanin, DJ				Liegel, Ryan P.; Handley, Mark T.; Ronchetti, Adam; Brown, Stephen; Langemeyer, Lars; Linford, Andrea; Chang, Bo; Morris-Rosendahl, Deborah J.; Carpanini, Sarah; Posmyk, Renata; Harthill, Verity; Sheridan, Eamonn; Abdel-Salam, Ghada M. H.; Terhal, Paulien A.; Faravelli, Francesca; Accorsi, Patrizia; Giordano, Lucio; Pinelli, Lorenzo; Hartmann, Britta; Ebert, Allison D.; Barr, Francis A.; Aligianis, Irene A.; Sidjanin, Duska J.			Loss-of-Function Mutations in TBC1 D20 Cause Cataracts and Male Infertility in blind sterile Mice and Warburg Micro Syndrome in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GTPASE-ACTIVATING PROTEINS; LIPID DROPLETS; CONGENITAL CATARACT; ENDOPLASMIC-RETICULUM; OPTIC ATROPHY; 2ND FAMILY; RAB18; LOCALIZATION; RAB3GAP1; STAGE	blind sterile (bs) is a spontaneous autosomal-recessive mouse mutation discovered more than 30 years ago. Phenotypically, bs mice exhibit nuclear cataracts and male infertility; genetic analyses assigned the bs locus to mouse chromosome Z. In this study, we first positionally cloned the bs locus and identified a putative causative mutation in the Tbc1d20 gene. Functional analysis established the mouse TBC1D20 protein as a GTPase-activating protein (GAP) for RAB1 and RAB2, and bs as a TBC1D20 loss-of-function mutation. Evaluation of bs mouse embryonic fibroblasts (mEFs) identified enlarged Golgi morphology and aberrant lipid droplet (LD) formation. Based on the function of TBC1D20 as a RABGAP and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and RAB18. Sequence analysis of a cohort of 77 families affected by WARBM identified five distinct TBC1D20 loss-of-function mutations, thereby establishing these mutations as causative of WARBM. Evaluation of human fibroblasts deficient in TBC1D20 function identified aberrant LDs similar to those identified in the bs mEFs. Additionally, our results show that human fibroblasts deficient in RAB18 and RAB3GAP1 function also exhibit aberrant LD formation. These findings collectively indicate that a defect in LD formation/metabolism may be a common cellular abnormality associated with WARBM, although it remains unclear whether abnormalities in LD metabolism are contributing to WARBM disease pathology.	[Liegel, Ryan P.; Ronchetti, Adam; Ebert, Allison D.; Sidjanin, Duska J.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Sidjanin, Duska J.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Handley, Mark T.; Brown, Stephen; Carpanini, Sarah; Aligianis, Irene A.] Univ Edinburgh, MRC IGMM, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Langemeyer, Lars; Linford, Andrea; Barr, Francis A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA; [Morris-Rosendahl, Deborah J.; Hartmann, Britta] Univ Med Ctr Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Posmyk, Renata] Childrens Univ Hosp, Dept Clin Genet, PL-15274 Bialystok, Poland; [Harthill, Verity; Sheridan, Eamonn] Chapel Allerton Hosp, Dept Clin Genet, Leeds LS7 4SA, W Yorkshire, England; [Sheridan, Eamonn] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Abdel-Salam, Ghada M. H.] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo 12622, Egypt; [Terhal, Paulien A.] Univ Med Ctr Utrecht, Dept Biomed Genet, NL-3584 CX Utrecht, Netherlands; [Faravelli, Francesca] Galliera Hosp, Div Med Genet, I-16128 Genoa, Italy; [Accorsi, Patrizia; Giordano, Lucio; Pinelli, Lorenzo] Spedali Civil Brescia, Dept Child Neurol & Psychiat, I-25125 Brescia, Italy	Medical College of Wisconsin; Medical College of Wisconsin; University of Edinburgh; University of Oxford; Jackson Laboratory; University of Freiburg; Chapel Allerton Hospital; Saint James's University Hospital; University of Leeds; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Utrecht University; Utrecht University Medical Center; Ente Ospedaliero Ospedali Galliera; Hospital Spedali Civili Brescia	Aligianis, IA (corresponding author), Univ Edinburgh, MRC IGMM, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	irene.aligianis@igmm.ed.ac.uk; dsidjani@mcw.edu	Abdel-Salam, Ghada/W-1718-2017; Pinelli, Lorenzo/AAA-7079-2019; accorsi, patrizia/AAB-7808-2019	Abdel-Salam, Ghada/0000-0003-2893-8802; Pinelli, Lorenzo/0000-0003-0177-7682; accorsi, patrizia/0000-0002-8801-5498; Morris-Rosendahl, Deborah/0000-0002-7780-4707; Handley, Mark/0000-0001-7200-747X; Chang, Bo/0000-0001-8259-7290; Barr, Francis/0000-0001-7518-253X; Langemeyer, Lars/0000-0002-4309-0910; Carpanini, Sarah/0000-0002-7609-7529	UK Newlife Charity; Program Leader Development Track Fellowship from the Medical Research Council; Healthier Wisconsin Grant from the Medical College of Wisconsin; National Eye Institute at the National Institutes of Health [EY019943, EY018872]; NATIONAL EYE INSTITUTE [R01EY018872, P30EY001931, R01EY019943] Funding Source: NIH RePORTER	UK Newlife Charity; Program Leader Development Track Fellowship from the Medical Research Council; Healthier Wisconsin Grant from the Medical College of Wisconsin; National Eye Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank the WARBM subjects, their families, and many health care professionals for referring affected families and the West Midlands Regional Genetics laboratory. We are grateful to A. Gallacher, S. McKay, and M.A. Maier for technical assistance. The study was supported by research grants from the UK Newlife Charity (I.A.A.), Program Leader Development Track Fellowship from the Medical Research Council (I.A.A.), Healthier Wisconsin Grant from the Medical College of Wisconsin (A.D.E.), and the National Eye Institute at the National Institutes of Health (EY019943 to B.C. and EY018872 to D.J.S.).	Abdel-Salam GMH, 2007, GENET COUNSEL, V18, P423; Ainsworth JR, 2001, OPHTHALMOLOGY, V108, P491, DOI 10.1016/S0161-6420(00)00540-6; Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bem D, 2011, AM J HUM GENET, V88, P499, DOI 10.1016/j.ajhg.2011.03.012; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Borck G, 2011, HUM GENET, V129, P45, DOI 10.1007/s00439-010-0896-2; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Criado GR, 1999, CLIN DYSMORPHOL, V8, P241; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Derbent M, 2004, AM J MED GENET A, V128A, P232, DOI 10.1002/ajmg.a.30109; Dursun F, 2012, J PEDIATR ENDOCR MET, V25, P379, DOI 10.1515/jpem-2011-0459; FOUQUET JP, 1992, TISSUE CELL, V24, P655, DOI 10.1016/0040-8166(92)90036-7; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Handley MT, 2013, HUM MUTAT, V34, P686, DOI 10.1002/humu.22296; Handley MT, 2012, BIOCHEM SOC T, V40, P1394, DOI 10.1042/BST20120169; Hassemer EL, 2010, GENETICS, V185, P245, DOI 10.1534/genetics.109.113167; Jadeja S, 2013, INVEST OPHTH VIS SCI, V54, P3569, DOI 10.1167/iovs.12-11125; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Liegel R, 2011, MOL GENET METAB, V103, P51, DOI 10.1016/j.ymgme.2011.02.002; Listenberger L. L., 2007, CURR PROTOC CELL BIO, V24, P2; LUTCKE A, 1994, J CELL SCI, V107, P3437; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; MALI P, 1989, REPROD FERT DEVELOP, V1, P369, DOI 10.1071/RD9890369; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Megarbane A, 1999, J MED GENET, V36, P637; Mitra S, 2011, SEMIN CELL DEV BIOL, V22, P57, DOI 10.1016/j.semcdb.2010.12.005; Moreno RD, 2000, BIOL REPROD, V63, P89, DOI 10.1095/biolreprod63.1.89; Morris-Rosendahl DJ, 2010, EUR J HUM GENET, V18, P1100, DOI 10.1038/ejhg.2010.79; Muller M, 2011, NEURON, V69, P749, DOI 10.1016/j.neuron.2011.01.025; Nevo-Yassaf I, 2012, J VIROL, V86, P6491, DOI 10.1128/JVI.00496-12; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Pereira LAVD, 1998, INT J ANDROL, V21, P34; Pulido MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022931; Reue K, 2011, J LIPID RES, V52, P1865, DOI 10.1194/jlr.E020602; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; SOTOMAYOR RE, 1986, BIOL REPROD, V34, P171, DOI 10.1095/biolreprod34.1.171; SPENCE SE, 1992, GENOMICS, V12, P403, DOI 10.1016/0888-7543(92)90392-6; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Talamas E, 2006, GENOMICS, V88, P44, DOI 10.1016/j.ygeno.2006.02.012; VARNUM DS, 1983, J HERED, V74, P206, DOI 10.1093/oxfordjournals.jhered.a109768; Vazquez-Martinez R, 2008, J CLIN ENDOCR METAB, V93, P2269, DOI 10.1210/jc.2007-1893; Vazquez-Martinez R, 2007, TRAFFIC, V8, P867, DOI 10.1111/j.1600-0854.2007.00570.x; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032086; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; Yanagimachi R, 2004, P NATL ACAD SCI USA, V101, P1691, DOI 10.1073/pnas.0307832100; Yildirim MS, 2012, GENET COUNSEL, V23, P169; Yuksel A, 2007, CLIN DYSMORPHOL, V16, P89, DOI 10.1097/MCD.0b013e328054c404; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	64	80	88	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1001	1014		10.1016/j.ajhg.2013.10.011	http://dx.doi.org/10.1016/j.ajhg.2013.10.011			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24239381	Green Published, Bronze			2022-12-18	WOS:000328521300001
J	Ozgul, RK; Siemiatkowska, AM; Yucel, D; Myers, CA; Collin, RWJ; Zonneveld, MN; Beryozkin, A; Banin, E; Hoyng, CB; van den Born, LI; Bose, R; Shen, W; Sharon, D; Cremers, FPM; Klevering, BJ; den Hollander, AI; Corbo, JC				Ozgul, Riza Koksal; Siemiatkowska, Anna M.; Yucel, Didem; Myers, Connie A.; Collin, Rob W. J.; Zonneveld, Marijke N.; Beryozkin, Avigail; Banin, Eyal; Hoyng, Carel B.; van den Born, L. Ingeborgh; Bose, Ron; Shen, Wei; Sharon, Dror; Cremers, Frans P. M.; Klevering, B. Jeroen; den Hollander, Anneke I.; Corbo, Joseph C.		European Retinal Dis Consortium	Exome Sequencing and cis-Regulatory Mapping Identify Mutations in MAK, a Gene Encoding a Regulator of Ciliary Length, as a Cause of Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME BROWSER DATABASE; CHIP-SEQ REVEALS; TRANSCRIPTIONAL NETWORK; FLAGELLAR LENGTH; RETINAL DISEASE; RHODOPSIN GENE; KINASE; MOUSE; FAMILY; CRX	A fundamental challenge in analyzing exome-sequence data is distinguishing pathogenic mutations from background polymorphisms. To address this problem in the context of a genetically heterogeneous disease, retinitis pigmentosa (RP), we devised a candidate-gene prioritization strategy called cis-regulatory mapping that utilizes ChIP-seq data for the photoreceptor transcription factor CRX to rank candidate genes. Exome sequencing combined with this approach identified a homozygous nonsense mutation in male germ cell-associated kinase (MA K) in the single affected member of a consanguineous Turkish family with RP. MAK encodes a cilium-associated mitogen-activated protein kinase whose function is conserved from the ciliated alga, Chlamydomonas reinhardtii, to humans. Mutations in MAK orthologs in mice and other model organisms result in abnormally long cilia and, in mice, rapid photoreceptor degeneration. Subsequent sequence analyses of additional individuals with RP identified five probands with missense mutations in MAK. Two of these mutations alter amino acids that are conserved in all known kinases, and an in vitro kinase assay indicates that these mutations result in a loss of kinase activity. Thus, kinase activity appears to be critical for MAK function in humans. This study highlights a previously underappreciated role for CRX as a direct transcriptional regulator of ciliary genes in photoreceptors. In addition, it demonstrates the effectiveness of CRX-based cis-regulatory mapping in prioritizing candidate genes from exome data and suggests that this strategy should be generally applicable to a range of retinal diseases.	[Siemiatkowska, Anna M.; Collin, Rob W. J.; Zonneveld, Marijke N.; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HC Nijmegen, Netherlands; [Ozgul, Riza Koksal; Yucel, Didem] Hacettepe Univ, Inst Child Hlth, TR-06100 Ankara, Turkey; [Ozgul, Riza Koksal; Yucel, Didem] Hacettepe Univ, Metab Unit, Dept Pediat, TR-06100 Ankara, Turkey; [Siemiatkowska, Anna M.; Collin, Rob W. J.; Zonneveld, Marijke N.; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HC Nijmegen, Netherlands; [Myers, Connie A.; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Collin, Rob W. J.; Hoyng, Carel B.; Klevering, B. Jeroen; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HC Nijmegen, Netherlands; [Beryozkin, Avigail; Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, NL-3011 BH Rotterdam, Netherlands; [Bose, Ron; Shen, Wei] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA	Radboud University Nijmegen; Hacettepe University; Hacettepe University; Radboud University Nijmegen; Washington University (WUSTL); Radboud University Nijmegen; Hebrew University of Jerusalem; Rotterdam Eye Hospital; Washington University (WUSTL)	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HC Nijmegen, Netherlands.	a.denhollander@antrg.umcn.nl; jcorbo@pathology.wustl.edu	Tracewska, Anna M/N-7087-2015; Klevering, B.J./L-4434-2015; Cremers, Frans/A-5625-2014; Hollander, Anneke den/N-4911-2014; De Baere, Elfride/E-7405-2017; OZGUL, RIZA KOKSAL/J-1569-2013; Sharon, Dror/P-4539-2015; Hoyng, C.B./H-8050-2014; Collin, Rob/N-3575-2014	Tracewska, Anna M/0000-0001-9690-4458; Cremers, Frans/0000-0002-4954-5592; De Baere, Elfride/0000-0002-5609-6895; Sharon, Dror/0000-0002-1789-5811; Toomes, Carmel/0000-0001-8373-9545; Ozgul, Riza Koksal/0000-0002-0283-635X; Corbo, Joseph/0000-0002-9323-7140	National Eye Institute [EY018826]; Hope Center for Neurologic Diseases; American Health Assistance Foundation; Netherlands Organisation for Scientific Research [40-00812-98-09047]; Foundation Fighting Blindness USA [BR-GE-0510-04890RAD]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienden, Retina Nederland; Stichting Oogfonds Nederland; Rotterdamse Vereniging Blindenbelangen; Hacettepe University [801601003]; Foundation Fighting Blindness [BR-GE-0510-0490-HUJ]; NATIONAL EYE INSTITUTE [R01EY018826] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hope Center for Neurologic Diseases; American Health Assistance Foundation; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness USA; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienden, Retina Nederland; Stichting Oogfonds Nederland; Rotterdamse Vereniging Blindenbelangen; Hacettepe University(Hacettepe University); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We sincerely thank all of the families that participated in this study. We also would like to thank Bill Harbour, Mohammed Hussaini, Serkan Kaygin, Lutfiye Mesci, and Atilla Goknur. The European Retinal Disease Consortium consists of Carmen Ayuso, Sandro Banfi, Tamar Ben-Yosef, Elfride de Baere, Christian Hamel, Chris Inglehearn, Robert K. Koenekoop, Susanne Kohl, Bart P. Leroy, Carmel Toomes, and Bernd Wissinger. This work was supported by the National Eye Institute (EY018826), the Hope Center for Neurologic Diseases, and the American Health Assistance Foundation to J.C.C.; the Netherlands Organisation for Scientific Research (TOP-grant 40-00812-98-09047) to F.P.M.C. and A.I.d.H.; the Foundation Fighting Blindness USA (grant BR-GE-0510-04890RAD) to A.I.d.H.; the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Gelderse Blinden Stichting, the Landelijke Stichting voor Blinden en Slechtzienden, Retina Nederland, the Stichting Oogfonds Nederland, and the Rotterdamse Vereniging Blindenbelangen to F.P.M.C.; and Hacettepe University Research Fund (801601003) to R.K.O. and a grant from the Foundation Fighting Blindness (BR-GE-0510-0490-HUJ) to D.S.	Azam M, 2010, MOL VIS, V16, P774; Bengs F, 2005, MOL MICROBIOL, V55, P1606, DOI 10.1111/j.1365-2958.2005.04498.x; Berman SA, 2003, CURR BIOL, V13, P1145, DOI 10.1016/S0960-9822(03)00415-9; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Collin RWJ, 2011, INVEST OPHTH VIS SCI, V52, P2227, DOI 10.1167/iovs.10-6185; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Daiger Stephen P, 2004, Novartis Found Symp, V255, P17; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002; TAYLOR SS, 1993, PHILOS T ROY SOC B, V340, P315, DOI 10.1098/rstb.1993.0073; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cellbio.8.1.429; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035	38	80	83	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					253	264		10.1016/j.ajhg.2011.07.005	http://dx.doi.org/10.1016/j.ajhg.2011.07.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21835304	Green Published, Bronze			2022-12-18	WOS:000294148800005
J	Pemberton, TJ; Wang, CL; Li, JZ; Rosenberg, NA				Pemberton, Trevor J.; Wang, Chaolong; Li, Jun Z.; Rosenberg, Noah A.			Inference of Unexpected Genetic Relatedness among Individuals in HapMap Phase III	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; HUMAN-POPULATIONS; HAPLOTYPE MAP; PATTERNS; LINKAGE; PAIRS	The International Haplotype Map Project (HapMap) has provided an essential database for studies of human population genetics and genome-wide association. Phases I and II of the HapMap project generated genotype data across similar to 3 million SNP loci in 270 individuals representing four populations Phase III provides dense genotype data on similar to 1 5 million SNPs, generated by Illumina and Affymetnx platforms in a larger set of individuals Release 3 of phase III of the HapMap contains 1397 individuals from 11 populations, including 250 of the original 270 phase 1 and phase II individuals and 1147 additional individuals Although some known relationships among the phase III individuals have been described in the data release, the genotype data that are currently available provide an opportunity to empirically ascertain previously unknown relationships We performed a systematic analysis of genetic relatedness and were able not only to confirm the reported relationships, but also to detect numerous additional, previously unidentified pairs of close relatives in the HapMap sample The inferred relative pairs make It possible to propose standardized subsets of unrelated individuals for use in future studies in which relatedness needs to be clearly defined	[Pemberton, Trevor J.; Li, Jun Z.; Rosenberg, Noah A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Wang, Chaolong; Rosenberg, Noah A.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Rosenberg, Noah A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pemberton, TJ (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.		Pemberton, Trevor/F-9206-2018	Li, Jun/0000-0001-6727-0812; Pemberton, Trevor/0000-0003-1224-1146; Rosenberg, Noah/0000-0002-1829-8664; Wang, Chaolong/0000-0003-3945-1012	NIH [GM081441]; Burroughs Wellcome Fund; Alfred P Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081441] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alfred P Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank William Duren and Michael Boehnke for their assistance with RELPAIR and Zachary Szpiech for providing the C program used to calculate allele-sharing distance This investigation was supported by NIH grant GM081441 (N A.R), and by grants from the Burroughs Wellcome Fund (N A R) and the Alfred P Sloan Foundation (N A.R)	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Coast E, 2006, J COMP FAM STUD, V37, P399, DOI 10.3138/jcfs.37.3.399; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; R Development Core Team, 2009, R LANG ENV STAT COMP; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Talle A, 2007, AFRICA, V77, P351, DOI 10.1353/afr.2007.0062; Waller R. D., 1993, BEING MAASAI ETHNICI, P226; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Weir B., 1996, GENETIC DATA ANAL	16	80	84	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					457	464		10.1016/j.ajhg.2010.08.014	http://dx.doi.org/10.1016/j.ajhg.2010.08.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20869033	Green Published, Bronze			2022-12-18	WOS:000283037600002
J	Ghezzi, D; Saada, A; D'Adamo, P; Fernandez-Vizarra, E; Gasparini, P; Tiranti, V; Elpeleg, O; Zeviani, M				Ghezzi, Daniele; Saada, Ann; D'Adamo, Pio; Fernandez-Vizarra, Erika; Gasparini, Paolo; Tiranti, Valeria; Elpeleg, Orly; Zeviani, Massimo			FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN IMPORT; DISORDERS; IDENTIFICATION; COMMUNICATION; GENES	In two siblings we found a mitochondrial encephalomyopathy, characterized by developmental delay, hemiplegia, convulsions, asymmetrical brain atrophy, and low cytochrome c oxidase (COX) activity in skeletal muscle. The disease locus was identified on chromosome 2 by homozygosity mapping; candidate genes were prioritized for their known or predicted mitochondrial localization and then sequenced in probands and controls. A homozygous nonsense mutation in the KIAA0971 gene segregated with the disease in the proband family. The corresponding protein is known as fas activated serine-threonine kinase domain 2, FASTKD2. Confocal immunofluorescence colocalized a tagged recombinant FASTKD2 protein with mitochondrial markers, and membrane-potential-dependent in vitro mitochondrial import was demonstrated in isolated mitochondria. In staurosporine-induced-apoptosis experiments, decreased nuclear fragmentation was detected in treated mutant versus control fibroblasts. In conclusion, we found a loss-of-function mutation in a gene segregating with a peculiar mitochondrial encephalomyopathy associated with COX deficiency in skeletal muscle. The corresponding protein is localized in the mitochondrial inner compartment. Preliminary data indicate that FASTKD2 plays a role in mitochondrial apoptosis.	[Ghezzi, Daniele; Fernandez-Vizarra, Erika; Tiranti, Valeria; Zeviani, Massimo] Neurol Inst C Besta, Fdn IRCCS, Div Mol Neurogenet, I-20126 Milan, Italy; [Saada, Ann; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [D'Adamo, Pio; Gasparini, Paolo] IRCCS Burlo Garofolo Univ Trieste, Div Med Genet, I-34137 Trieste, Italy	IRCCS Istituto Neurologico Besta; Hebrew University of Jerusalem; Hadassah University Medical Center; IRCCS Burlo Garofolo; University of Trieste	Zeviani, M (corresponding author), Neurol Inst C Besta, Fdn IRCCS, Div Mol Neurogenet, I-20126 Milan, Italy.	zeviani@istituto-besta.it	Zeviani, Massimo/AAU-2632-2021; Fernandez-Vizarra, Erika/AAE-5600-2020; Saada, Ann/J-6864-2017; Ghezzi, Daniele/J-7873-2016; Tiranti, Valeria/AFN-5783-2022; Zeviani, Massimo/K-2891-2014; d'Adamo, Adamo Pio/G-4064-2011; Tiranti, Valeria/J-8233-2016; Gasparini, Paolo/B-6173-2014	Zeviani, Massimo/0000-0002-9067-5508; Saada, Ann/0000-0003-2951-0656; Ghezzi, Daniele/0000-0002-6564-3766; Tiranti, Valeria/0000-0002-3584-7338; d'Adamo, Adamo Pio/0000-0001-9367-4909; Tiranti, Valeria/0000-0002-3584-7338; Fernandez-Vizarra, Erika/0000-0002-2469-142X; Gasparini, Paolo/0000-0002-0859-0856	Pierfranco; Luisa Mariani Foundation; Fondazione Telethon-Italy [GGP07019]; Italian Ministry of University and Research [RBLA038RMA]; the Italian Ministry of Health [RF2006 ex 56/05/21]; Marie Curie intra-European fellowship [040140-MAD]; MITOCIRCLE; EUMITOCOMBAT [LSHM-CT-2004-503116]	Pierfranco; Luisa Mariani Foundation; Fondazione Telethon-Italy(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); the Italian Ministry of Health(Ministry of Health, Italy); Marie Curie intra-European fellowship(European Commission); MITOCIRCLE; EUMITOCOMBAT	This work was supported by the Pierfranco and Luisa Mariani Foundation, Fondazione Telethon-Italy grant number GGP07019, the Italian Ministry of University and Research (FIRB 2003 - project RBLA038RMA), the Italian Ministry of Health RF2006 ex 56/05/21, Marie Curie intra-European fellowship (FP6-2005-Mobility-5) number 040140-MAD, and MITOCIRCLE and EUMITOCOMBAT (LSHM-CT-2004-503116) network grants from the European Union framework program 6.	Bien CG, 2005, BRAIN, V128, P454, DOI 10.1093/brain/awh415; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Li W, 2004, MOL CELL BIOL, V24, P10718, DOI 10.1128/MCB.24.24.10718-10732.2004; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Rotig A, 2004, BBA-BIOENERGETICS, V1659, P129, DOI 10.1016/j.bbabio.2004.07.007; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; YANG J, 1997, SCIENCE, V275, P1132; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259; Zeviani M, 2001, SEMIN CELL DEV BIOL, V12, P407, DOI 10.1006/scdb.2001.0278; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; Zhivotosky B., 2001, CURR PROTOC CELL BIO	22	80	82	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					415	423		10.1016/j.ajhg.2008.08.009	http://dx.doi.org/10.1016/j.ajhg.2008.08.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18771761	Bronze, Green Published			2022-12-18	WOS:000259307200012
J	Barel, O; Shorer, Z; Flusser, H; Ofir, R; Narkis, G; Finer, G; Shalev, H; Nasasra, A; Saada, A; Birk, OS				Barel, Ortal; Shorer, Zamir; Flusser, Hagit; Ofir, Rivka; Narkis, Ginat; Finer, Gal; Shalev, Hanah; Nasasra, Ahmad; Saada, Ann; Birk, Ohad S.			Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-B MUTATION; GENE-MUTATIONS; BCS1L GENE; DNA; ENCEPHALOPATHY; DELETION	A consanguineous Israeli Bedouin kindred presented with an autosomal-recessive nonlethal phenotype of severe psychomotor retardation and extrapyramidal signs, dystonia, athetosis and ataxia, mild axial hypotonia, and marked global dementia with defects in verbal and expressive communication skills. Metabolic workup was normal except for mildly elevated blood lactate levels. Brain magnetic resonance imaging (MRI) showed increased density in the putamen, with decreased density and size of the caudate and lentiform nuclei. Reduced activity specifically of mitochondrial complex III and variable decrease in complex I activity were evident in muscle biopsies. Homozygosity of affected individuals to UQCRB and to BCSIL, previously associated with isolated complex III deficiency, was ruled out. Genome-wide linkage analysis identified a homozygosity locus of approximately 9 cM on chromosome 5q31 that was further narrowed down to 2.14 cM, harboring 30 genes (logarithm of the odds [LOD] score 8.82 at theta = 0). All 30 genes were sequenced, revealing a single missense (p.Ser45Phe) mutation in UQCRQ (encoding ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5 kDa), one of the ten nuclear genes encoding proteins of mitochondrial complex III.	[Barel, Ortal; Ofir, Rivka; Narkis, Ginat; Finer, Gal; Birk, Ohad S.] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Barel, Ortal; Ofir, Rivka; Narkis, Ginat; Finer, Gal; Birk, Ohad S.] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Shorer, Zamir; Flusser, Hagit; Shalev, Hanah; Nasasra, Ahmad] Soroka Med Ctr, Dept Pediat, IL-84101 Beer Sheva, Israel; [Saada, Ann] Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [Birk, Ohad S.] Soroka Med Ctr, Inst Genet, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	obirk@bgu.ac.il	Finer, Gal/C-7858-2015; Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656; Birk, Ohad/0000-0003-1430-1296				Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; BROWN MD, 1991, AM J HUM GENET S, V49, P973; De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.3.CO;2-Q; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171; Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Harel T, 2004, EUR J HUM GENET, V12, P38, DOI 10.1038/sj.ejhg.5201087; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044; Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151; USUI S, 1990, BIOCHEMISTRY-US, V29, P4618, DOI 10.1021/bi00471a017; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773	21	80	88	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1211	1216		10.1016/j.ajhg.2008.03.020	http://dx.doi.org/10.1016/j.ajhg.2008.03.020			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439546	Bronze, Green Published			2022-12-18	WOS:000255923600022
J	Mutsuddi, M; Morris, DW; Waggoner, SG; Daly, MJ; Scolnick, EM; Sklar, P				Mutsuddi, Mousumi; Morris, Derek W.; Waggoner, Skye G.; Daly, Mark J.; Scolnick, Edward M.; Sklar, Pamela			Analysis of high-resolution HapMap of DTNBP1 (dysbindin) suggests no consistency between reported common variant associations and schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY-BASED ASSOCIATION; RISK HAPLOTYPE; GENE DTNBP1; 6P22.3 GENE; EXPRESSION; IDENTIFICATION; LOCUS; GENOME; BRAIN; IRISH	DTNBP1 was first identified as a putative schizophrenia-susceptibility gene in Irish pedigrees, with a report of association to common genetic variation. Several replication studies have reported confirmation of an association to DTNBP1 in independent European samples; however, reported risk alleles and haplotypes appear to differ between studies, and comparison among studies has been confounded because different marker sets were employed by each group. To facilitate evaluation of existing evidence of association and further work, we supplemented the extensive genotype data, available through the International HapMap Project (HapMap), about DTNBP1 by specifically typing all associated single-nucleotide polymorphisms reported in each of the studies of the Centre d'Etude du Polymorphisme Humain (CEPH)-derived HapMap sample (CEU). Using this high-density reference map, we compared the putative disease-associated haplotype from each study and found that the association studies are inconsistent with regard to the identity of the disease-associated haplotype at DTNBP1. Specifically, all five "replication" studies define a positively associated haplotype that is different from the association originally reported. We further demonstrate that, in all six studies, the European-derived populations studied have haplotype patterns and frequencies that are consistent with HapMap CEU samples (and each other). Thus, it is unlikely that population differences are creating the inconsistency of the association studies. Evidence of association is, at present, equivocal and unsatisfactory. The new dense map of the region may be valuable in more-comprehensive follow-up studies.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Cambridge, MA 02138 USA; MIT, Psychiat Dis Initiat, Cambridge, MA 02139 USA; MIT, Med & Populat Genet Program, Broad Inst, Cambridge, MA 02139 USA; St James Hosp, Trinity Coll, Inst Mol Med, Neuropsychiat Genet Grp, Dublin 8, Ireland; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Trinity College Dublin; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sklar, P (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,Room 6242, Boston, MA 02114 USA.	sklar@chgr.mgh.harvard.edu	Morris, Derek/AAW-8343-2021; Daly, Mark J/B-2453-2017	Morris, Derek/0000-0002-3413-570X; Daly, Mark J/0000-0002-0949-8752				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Li T, 2004, MOL PSYCHIATR, V9, P698, DOI 10.1038/sj.mp.4001485; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336	26	80	83	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					903	909		10.1086/508942	http://dx.doi.org/10.1086/508942			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033966	Bronze, Green Published			2022-12-18	WOS:000241667400011
J	Seaman, SR; Muller-Myhsok, B				Seaman, SR; Muller-Myhsok, B			Rapid simulation of P values for product methods and multiple-testing adjustment in association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENOMEWIDE ASSOCIATION; TRUNCATED PRODUCT; DISEASE; TRAITS; POLYMORPHISMS; HAPLOTYPES; POWER; GENE	A major aim of association studies is the identification of polymorphisms ( usually SNPs) associated with a trait. Tests of association may be based on individual SNPs or on sets of neighboring SNPs, by use of ( for example) a product P value method or Hotelling's T test. Linkage disequilibrium, the nonindependence of SNPs in physical proximity, causes problems for all these tests. First, multiple-testing correction for individual-SNP tests or for multilocus tests either leads to conservative P values ( if Bonferroni correction is used) or is computationally expensive ( if permutation is used). Second, calculation of product P values usually requires permutation. Here, we present the direct simulation approach (DSA), a method that accurately approximates P values obtained by permutation but is much faster. It may be used whenever tests are based on score statistics - for example, with Armitage's trend test or its multivariate analogue. The DSA can be used with binary, continuous, or count traits and allows adjustment for covariates. We demonstrate the accuracy of the DSA on real and simulated data and illustrate how it might be used in the analysis of a whole-genome association study.	Max Planck Inst Psychiat, Munich, Germany	Max Planck Society	Seaman, SR (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, Munich, Germany.	shaun@mpipsykl.mpg.de	Müller-Myhsok, Bertram/A-3289-2013	Seaman, Shaun/0000-0003-3726-5937				[Anonymous], 1932, STAT METHODS RES WOR; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Czika W, 2004, BIOMETRICS, V60, P69, DOI 10.1111/j.0006-341X.2004.00166.x; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Fan RZ, 2003, AM J HUM GENET, V72, P850, DOI 10.1086/373966; GE YC, 2003, TEST, V12, P1, DOI DOI 10.1007/BF02595811; Greenspan G, 2004, BIOINFORMATICS, V20, P137, DOI 10.1093/bioinformatics/bth907; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; LIN DY, IN PRESS BIOINFORMAT; Long AD, 1999, GENOME RES, V9, P720; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Neuhauser M, 2003, BIOMETRICAL J, V45, P974, DOI 10.1002/bimj.200390064; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; WESTFALL PH, 2001, MULTIPLE TESTS GENET; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	24	80	82	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					399	408		10.1086/428140	http://dx.doi.org/10.1086/428140			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15645388	Green Published, Bronze			2022-12-18	WOS:000226851900003
J	Hinds, DA; Stokowski, RP; Patil, N; Konvicka, K; Kershenobich, D; Cox, DR; Ballinger, DG				Hinds, DA; Stokowski, RP; Patil, N; Konvicka, K; Kershenobich, D; Cox, DR; Ballinger, DG			Matching strategies for genetic association studies in structured populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXED POPULATIONS; LINKAGE; ADMIXTURE; TOOL	Association studies in populations that are genetically heterogeneous can yield large numbers of spurious associations if population subgroups are unequally represented among cases and controls. This problem is particularly acute for studies involving pooled genotyping of very large numbers of single-nucleotide-polymorphism (SNP) markers, because most methods for analysis of association in structured populations require individual genotyping data. In this study, we present several strategies for matching case and control pools to have similar genetic compositions, based on ancestry information inferred from genotype data for similar to300 SNPs tiled on an oligonucleotide-based genotyping array. We also discuss methods for measuring the impact of population stratification on an association study. Results for an admixed population and a phenotype strongly confounded with ancestry show that these simple matching strategies can effectively mitigate the impact of population stratification.	Perlegen Sci, Mountain View, CA 94043 USA; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Hinds, DA (corresponding author), Perlegen Sci, 2021 Stierlin Court, Mountain View, CA 94043 USA.	David_Hinds@perlegen.com	Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Hinds, David/0000-0002-4911-803X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Weir B., 1996, GENETIC DATA ANAL	26	80	89	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					317	325		10.1086/381716	http://dx.doi.org/10.1086/381716			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14740319	Green Published, Bronze			2022-12-18	WOS:000188860000012
J	Miller, BJ; Wang, D; Krahe, R; Wright, FA				Miller, BJ; Wang, D; Krahe, R; Wright, FA			Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							SOMATIC GENETIC CHANGES; COMMON FRAGILE SITES; CHROMOSOME ARM 16Q; ALLELIC-LOSS DATA; PROSTATE-CANCER; CADHERIN GENE; CELL-LINES; DELETED REGION; OVARIAN-CANCER; FREQUENT LOSS	Somatic loss of heterozygosity (LOH) has been widely reported in breast cancer as a means of identifying putative tumor-suppressor genes. However, individual studies have rarely spanned more than a single chromosome, and the varying criteria used to declare LOH complicate efforts to formally differentiate regions of consistent versus sporadic (random) loss. We report here the compilation of an extensive database from 151 published LOH studies of breast cancer, with summary data from 115,000 tumors and primary allelotypes from 14,300 tumors. Allelic loss was evaluated at 1,168 marker loci, with large variation in the density of informative observations across the genome. Using studies in which primary allelotype information was available, we employed a likelihood-based approach with a formal chromosomal instability and selection model. The approach seeks direct evidence for preferential loss at each locus compared with nearby loci, accounts for heterogeneity across studies, and enables the direct comparison of candidate regions across the genome. Striking preferential loss was observed (in descending order of significance) in specific regions of chromosomes 7q, 16q, 13q, 17p, 8p, 21q, 3p, 18q, 2q, and 19p, as well as other regions, in many cases coinciding with previously identified candidate genes or known fragile sites. Many of these observations were not possible from any single LOH study, and our results suggest that many previously reported LOH results are not systematic or reproducible. Our approach provides a comparative framework for further investigation of regions exhibiting LOH and identifies broad genomic regions for which there exist few data.	Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; Ohio State Univ, Coll Med & Publ Hlth, Columbus, OH 43210 USA; Ohio State Univ, Program Human Canc Genet, Columbus, OH 43210 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center	Wright, FA (corresponding author), Univ N Carolina, Dept Biostat, 3107B McGavran Greenberg Hall,CB 7420, Chapel Hill, NC 27599 USA.	fwright@bios.unc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058934] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelaide J, 1998, GENE CHROMOSOME CANC, V22, P186, DOI 10.1002/(SICI)1098-2264(199807)22:3<186::AID-GCC4>3.0.CO;2-S; *AM CANC SOC, 2002, ACS BREAST CANC FACT; Arlt MF, 2002, GENE CHROMOSOME CANC, V33, P82, DOI 10.1002/gcc.10000; Becker KF, 2002, J PATHOL, V197, P567, DOI 10.1002/path.1149; Bednarek AK, 2001, CANCER RES, V61, P8068; Bell DW, 2002, CANCER RES, V62, P2741; Benachenhou N, 1999, BRIT J CANCER, V79, P1012, DOI 10.1038/sj.bjc.6690162; Bieche I, 1999, GENE CHROMOSOME CANC, V24, P255, DOI 10.1002/(SICI)1098-2264(199903)24:3<255::AID-GCC11>3.0.CO;2-2; Bieche I, 1998, ONCOL REP, V5, P267; Bogliolo M, 2002, MUTAGENESIS, V17, P529, DOI 10.1093/mutage/17.6.529; Brown VL, 2002, BRIT J CANCER, V87, P208, DOI 10.1038/sj.bjc.6600418; Bruening W, 1999, CANCER RES, V59, P4973; Buchholz TA, 1999, RADIAT ONCOL INVESTI, V7, P55, DOI 10.1002/(SICI)1520-6823(1999)7:2<55::AID-ROI1>3.0.CO;2-#; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P4169, DOI 10.1038/sj.onc.1204539; Callahan R, 1998, BIOCHEM SOC SYMP, P211; CALLAHAN R, 1993, J CELL BIOCHEM, P167; Callen DF, 2002, CANCER GENET CYTOGEN, V133, P76, DOI 10.1016/S0165-4608(01)00565-9; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Castells A, 2000, CANCER RES, V60, P2836; Chalmers IJ, 2001, CANCER GENET CYTOGEN, V126, P39, DOI 10.1016/S0165-4608(00)00376-9; Chen TP, 1996, CANCER RES, V56, P5605; Chen WY, 1998, ONCOGENE, V17, P1717, DOI 10.1038/sj.onc.1202098; Chen ZH, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-18; CLETONJANSEN AM, 1994, GENE CHROMOSOME CANC, V9, P101, DOI 10.1002/gcc.2870090205; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COUCH FJ, 1997, GENETIC HUMAN CANC, P537; Cox DR., 1974, THEORETICAL STAT; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Devilee P, 2001, TRENDS GENET, V17, P569, DOI 10.1016/S0168-9525(01)02416-7; DEVILEE P, 1994, BBA-REV CANCER, V1198, P113, DOI 10.1016/0304-419X(94)90009-4; DEVILEE P, 1991, ONCOGENE, V6, P311; Dong SM, 2002, CLIN CANCER RES, V8, P2939; Driouch K, 1997, GENE CHROMOSOME CANC, V19, P185, DOI 10.1002/(SICI)1098-2264(199707)19:3<185::AID-GCC8>3.0.CO;2-U; Ellisen LW, 1998, ANNU REV MED, V49, P425; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Forsti A, 2001, CARCINOGENESIS, V22, P27, DOI 10.1093/carcin/22.1.27; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Gaki V, 2000, EUR J SURG ONCOL, V26, P455, DOI 10.1053/ejso.1999.0921; Geck P, 1999, J STEROID BIOCHEM, V68, P41, DOI 10.1016/S0960-0760(98)00165-4; Geck P, 2001, AM J HUM GENET, V69, P461, DOI 10.1086/321968; Gentile M, 2001, INT J CANCER, V92, P208, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1169>3.0.CO;2-4; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Ho KYK, 1999, HISTOPATHOLOGY, V35, P249; Hsu YY, 2002, J BIOL CHEM, V277, P17315, DOI 10.1074/jbc.M200901200; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Huiping C, 2000, EUR J CANCER, V36, P1552, DOI 10.1016/S0959-8049(00)00143-X; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KERANGUEVEN F, 1995, GENE CHROMOSOME CANC, V13, P291, DOI 10.1002/gcc.2870130410; Kerangueven F, 1997, ONCOGENE, V14, P339, DOI 10.1038/sj.onc.1200818; Kiss H, 2002, EUR J HUM GENET, V10, P52, DOI 10.1038/sj.ejhg.5200758; Kochetkova M, 2002, CANCER RES, V62, P4599; Kollias J, 2000, BREAST CANCER RES TR, V64, P241, DOI 10.1023/A:1026575619155; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Komiya A, 1997, JPN J CANCER RES, V88, P389, DOI 10.1111/j.1349-7006.1997.tb00394.x; Kremmidiotis G, 1998, GENOMICS, V49, P467, DOI 10.1006/geno.1998.5281; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; LANGE K, 1995, GENOME RES, V5, P136, DOI 10.1101/gr.5.2.136; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; Le Beau MM, 1998, GENE CHROMOSOME CANC, V21, P281, DOI 10.1002/(SICI)1098-2264(199804)21:4<281::AID-GCC1>3.0.CO;2-V; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; Lucke CD, 2001, CANCER RES, V61, P482; MacGrogan D, 1996, GENOMICS, V35, P55, DOI 10.1006/geno.1996.0322; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maitra A, 2001, AM J PATHOL, V159, P119, DOI 10.1016/S0002-9440(10)61679-3; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Matsumoto S, 1997, GENE CHROMOSOME CANC, V20, P268; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Murphy KM, 2002, CANCER RES, V62, P3789; Murphy LC, 1996, J CLIN ENDOCR METAB, V81, P1420, DOI 10.1210/jc.81.4.1420; NAGAI H, 1995, CANCER RES, V55, P1752; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; NEWSHAM IF, 1997, GENETIC BASIS HUMAN, P363; Newton MA, 2000, BIOMETRICS, V56, P1088, DOI 10.1111/j.0006-341X.2000.01088.x; Newton MA, 1998, STAT MED, V17, P1425, DOI 10.1002/(SICI)1097-0258(19980715)17:13<1425::AID-SIM861>3.0.CO;2-V; Noviello C, 1996, CLIN CANCER RES, V2, P1601; Oesterreich S, 2001, BRIT J CANCER, V84, P493, DOI 10.1054/bjoc.2000.1606; OLOPADE OI, 1992, GENOMICS, V14, P437, DOI 10.1016/S0888-7543(05)80238-1; Osborne RJ, 2000, CANCER RES, V60, P3706; Ott J, 1999, ANAL HUMAN GENETIC L; Ott L, 2000, INTRO STAT METHODS D; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Phillips NJ, 1996, CANCER RES, V56, P606; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Powell JA, 2002, GENOMICS, V80, P303, DOI 10.1006/geno.2002.6828; Rassool FV, 1996, GENOMICS, V35, P109, DOI 10.1006/geno.1996.0329; Richard F, 2000, INT J CANCER, V89, P305; Salicioni AM, 2000, GENOMICS, V69, P54, DOI 10.1006/geno.2000.6315; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Seitz S, 1997, ONCOGENE, V14, P741, DOI 10.1038/sj.onc.1200881; Seitz S, 2001, J PATHOL, V194, P318, DOI 10.1002/1096-9896(200107)194:3<318::AID-PATH881>3.0.CO;2-4; Sham P, 2001, PHARMACOGENOMICS, V2, P195, DOI 10.1517/14622416.2.3.195; Shen CY, 2000, CANCER RES, V60, P3884; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Smith DI, 1998, INT J ONCOL, V12, P187; Stiewe T, 2002, CELL DEATH DIFFER, V9, P237, DOI 10.1038/sj.cdd.4400995; Strachan T, 1999, HUMAN MOL GENETICS; Thompson D, 2002, P NATL ACAD SCI USA, V99, P827, DOI 10.1073/pnas.012584499; THOMPSON SG, 1998, ENCY BIOSTATISTICS, P2570; Tomlinson IPM, 2002, GENE CHROMOSOME CANC, V34, P349, DOI 10.1002/gcc.10085; Toyooka KO, 2001, CANCER RES, V61, P4556; Tranter D, 1999, DRUG DISCOV TODAY, V4, P1, DOI 10.1016/S1359-6446(98)01289-6; Utada Y, 2000, JPN J CANCER RES, V91, P293, DOI 10.1111/j.1349-7006.2000.tb00944.x; White GRM, 1996, BRIT J CANCER, V74, P863, DOI 10.1038/bjc.1996.449; Wilentz RE, 2001, AM J PATHOL, V158, P1561, DOI 10.1016/S0002-9440(10)64109-0; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	111	80	82	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					748	767		10.1086/378522	http://dx.doi.org/10.1086/378522			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	13680524	Green Published, Bronze			2022-12-18	WOS:000185676100004
J	Keeler, LC; Marsh, SE; Leeflang, EP; Woods, CG; Sztriha, L; Al-Gazali, L; Gururaj, A; Gleeson, JG				Keeler, LC; Marsh, SE; Leeflang, EP; Woods, CG; Sztriha, L; Al-Gazali, L; Gururaj, A; Gleeson, JG			Linkage analysis in families with Joubert syndrome plus oculo-renal involvement identifies the CORS2 locus on chromosome 11p12-q13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETARDATION; VERMIS	Joubert syndrome (JS) is an autosomal recessive developmental brain condition characterized by hypoplasia/dysplasia of the cerebellar vermis and by ataxia, hypotonia, oculomotor apraxia, and neonatal breathing dysregulation. A form of JS that includes retinal dysplasia and cystic dysplastic kidneys has been differentiated from other forms of JS, called either "JS type B" or "cerebello-oculo-renal syndrome" (CORS), but the genetic basis of this condition is unknown. Here, we describe three consanguineous families that display CORS. Linkage analysis defines a novel locus on chromosome 11p12-q13.3, with a maximum two-point LOD score of Z = 5.2 at the marker D11S1915. Therefore, the cerebello-oculo-renal form of JS is a distinct genetic entity from the Joubert syndrome 1 (JBTS1) locus described elsewhere, in which there is minimal involvement of retina or kidney. We suggest the term "CORS2" for this new locus.	Univ Calif San Diego, Dept Neurosci, Div Pediat Neurol, Neurogenet Lab, San Diego, CA 92103 USA; St Jamess Univ Hosp, Mol Med Unit, Leeds, W Yorkshire, England; St Jamess Univ Hosp, Yorkshire Clin Genet Serv, Leeds, W Yorkshire, England; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates	University of California System; University of California San Diego; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; United Arab Emirates University	Gleeson, JG (corresponding author), 9500 Gilman Dr,MTF312, La Jolla, CA 92093 USA.		woods, christopher g/A-1361-2010; Marsh, Sarah/E-9164-2010	Marsh, Sarah/0000-0003-4194-043X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS052455] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andermann F, 1999, J CHILD NEUROL, V14, P565, DOI 10.1177/088307389901400903; Dahlstrom JE, 2000, PATHOLOGY, V32, P283; Gentile M, 1996, AM J MED GENET, V64, P514, DOI 10.1002/(SICI)1096-8628(19960823)64:3<514::AID-AJMG13>3.0.CO;2-O; GLEESON JG, IN PRESS AM J MED GE; Hildebrandt F, 1998, PEDIATR NEPHROL, V12, P16, DOI 10.1007/s004670050394; HILDEBRANDT F, 1992, CLIN INVESTIGATOR, V70, P802; JOUBERT M, 1968, NEUROLOGY, V18, P302; KEELER LC, 2001, AM SOC HUM GEN ABSTR, P2021; Kher Archana S., 1994, Indian Journal of Pediatrics, V61, P729, DOI 10.1007/BF02751991; KING MD, 1984, ARCH DIS CHILD, V59, P709, DOI 10.1136/adc.59.8.709; KING MD, 1984, ARCH NEUROL-CHICAGO, V41, P1235, DOI 10.1001/archneur.1984.04050230013004; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Maria BL, 1999, J CHILD NEUROL, V14, P368, DOI 10.1177/088307389901400605; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Satran D, 1999, AM J MED GENET, V86, P459; Sztriha L, 1999, PEDIATR NEUROL, V20, P274, DOI 10.1016/S0887-8994(98)00154-4; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241	19	80	81	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					656	662		10.1086/378206	http://dx.doi.org/10.1086/378206			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12917796	Bronze, Green Published			2022-12-18	WOS:000185134000019
J	Tayebi, N; Stubblefield, BK; Park, JK; Orvisky, E; Walker, JM; LaMarca, ME; Sidransky, E				Tayebi, N; Stubblefield, BK; Park, JK; Orvisky, E; Walker, JM; LaMarca, ME; Sidransky, E			Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: Implications for complexity in Gaucher disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; FUSION GENE; PHENOTYPIC VARIATION; HUNTER-SYNDROME; MUTANT ALLELES; HUMAN GENOME; CYP21 GENE; HOT-SPOTS; IDS GENE; MUTATION	Gaucher disease results from an autosomal recessive deficiency of the lysosomal enzyme glucocerebrosidase. The glucocerebrosidase gene is located in a gene-rich region of 1q21 that contains six genes and two pseudogenes within 75 kb. The presence of contiguous, highly homologous pseudogenes for both glucocerebrosidase and metaxin at the locus increases the likelihood of DNA rearrangements in this region. These recombinations can complicate genotyping in patients with Gaucher disease and contribute to the difficulty in interpreting genotype-phenotype correlations in this disorder. In the present study, DNA samples from 240 patients with Gaucher disease were examined using several complementary approaches to identify and characterize recombinant alleles, including direct sequencing, long-template polymerase chain reaction, polymorphic microsatellite repeats, and Southern blots. Among the 480 alleles studied, 59 recombinant alleles were identified, including 34 gene conversions, 18 fusions, and 7 downstream duplications. Twenty-two percent of the patients evaluated had at least one recombinant allele. Twenty-six recombinant alleles were found among 310 alleles from patients with type 1 disease, 18 among 74 alleles from patients with type 2 disease, and 15 among 96 alleles from patients with type 3 disease. Several patients carried two recombinations or mutations on the same allele. Generally, alleles resulting from nonreciprocal recombination (gene conversion) could be distinguished from those arising by reciprocal recombination (crossover and exchange), and the length of the converted sequence was determined. Homozygosity for a recombinant allele was associated with early lethality. Ten different sites of crossover and a shared pentamer motif sequence (CACCA) that could be a hotspot for recombination were identified. These findings contribute to a better understanding of genotype-phenotype relationships in Gaucher disease and may provide insights into the mechanisms of DNA rearrangement in other disorders.	NIMH, Clin Neurosci Branch, Sect Mol Neurogenet, NIH, Bethesda, MD 20892 USA; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sidransky, E (corresponding author), NIMH, Clin Neurosci Branch, Sect Mol Neurogenet, NIH, 49 Convent Dr MSC4405,49-B1EE16, Bethesda, MD 20892 USA.			Park, Joseph/0000-0003-1699-3951	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002667] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aarskog NK, 2001, ACTA NEUROL SCAND, V104, P97, DOI 10.1034/j.1600-0404.2001.104002097.x; Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bell SJ, 1998, GENE, V216, P285, DOI 10.1016/S0378-1119(98)00333-3; BEUTLER E, 1995, BLOOD CELL MOL DIS, V21, P20, DOI 10.1006/bcmd.1995.0004; Beutler E, 1998, BLOOD CELL MOL DIS, V24, P2, DOI 10.1006/bcmd.1998.0165; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Birot AM, 1996, HUM MUTAT, V8, P44, DOI 10.1002/(SICI)1098-1004(1996)8:1<44::AID-HUMU6>3.0.CO;2-P; Blanco-Gelaz MA, 2001, HUM IMMUNOL, V62, P1042, DOI 10.1016/S0198-8859(01)00299-3; Bogdanova N, 2001, GENOMICS, V74, P333, DOI 10.1006/geno.2001.6568; Brooks EM, 2001, MUTAT RES-FUND MOL M, V476, P43, DOI 10.1016/S0027-5107(01)00065-3; Bunge S, 1998, EUR J HUM GENET, V6, P492, DOI 10.1038/sj.ejhg.5200213; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cormand B, 2000, BLOOD CELL MOL DIS, V26, P409, DOI 10.1006/bcmd.2000.0317; Dracopoulou-Vabouli M, 2001, J CLIN ENDOCR METAB, V86, P2845, DOI 10.1210/jc.86.6.2845; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; EYAL N, 1990, GENE, V96, P277, DOI 10.1016/0378-1119(90)90264-R; Filocamo M, 2000, BLOOD CELL MOL DIS, V26, P307, DOI 10.1006/bcmd.2000.0308; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; Hatton CE, 1997, ARCH DIS CHILD, V77, P17, DOI 10.1136/adc.77.1.17; Hattori Y, 1999, Rinsho Byori, V47, P244; Hodanova K, 1999, BLOOD CELL MOL DIS, V25, P287, DOI 10.1006/bcmd.1999.0256; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Jagla WM, 2002, HUM MOL GENET, V11, P23, DOI 10.1093/hmg/11.1.23; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Karsten SL, 1997, GENOMICS, V43, P123, DOI 10.1006/geno.1997.4811; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Kutsche K, 2002, HUM MUTAT, V19, P526, DOI 10.1002/humu.10072; LATHAM T, 1990, AM J HUM GENET, V47, P79; Lau EK, 1999, HUM GENET, V104, P293, DOI 10.1007/s004390050957; LISKAY RM, 1987, GENETICS, V115, P161; Lobato MN, 1998, HUM HERED, V48, P216, DOI 10.1159/000022804; Long GL, 1996, GENOMICS, V33, P177, DOI 10.1006/geno.1996.0181; Lopes J, 1999, HUM MOL GENET, V8, P2285, DOI 10.1093/hmg/8.12.2285; Lucas RE, 2001, EUR J HUM GENET, V9, P892, DOI 10.1038/sj.ejhg.5200734; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lutskiy MI, 2002, HUM GENET, V110, P515, DOI 10.1007/s00439-002-0716-4; Martinez J, 2001, J MOL BIOL, V308, P587, DOI 10.1006/jmbi.2001.4755; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; METZENBERG AB, 1991, GENETICS, V128, P143; MISTRY PK, 1992, LANCET, V339, P889, DOI 10.1016/0140-6736(92)90928-V; Orvisky E, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9024; Papadakis MN, 1999, HUM GENET, V104, P117, DOI 10.1007/s004390050923; Park JK, 2002, CLIN GENET, V61, P32, DOI 10.1034/j.1399-0004.2002.610106.x; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Purandare SM, 1997, GENOME RES, V7, P773, DOI 10.1101/gr.7.8.773; Reissner K, 1998, MOL GENET METAB, V63, P281, DOI 10.1006/mgme.1998.2675; SAMBROOK J, 1989, MOL CLONING, V9, P14; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stone DL, 2000, HUM MUTAT, V15, P181, DOI 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S; STRACHAN T, 1999, HUMAN MOL GENETICS, V2; STRASBERG PM, 1994, BIOCHEM MED METAB B, V53, P16, DOI 10.1006/bmmb.1994.1052; Tayebi N, 2000, HUM GENET, V107, P400, DOI 10.1007/s004390000380; Tayebi N, 1997, AM J MED GENET, V73, P41, DOI 10.1002/(SICI)1096-8628(19971128)73:1<41::AID-AJMG9>3.0.CO;2-S; Tayebi N, 1998, PEDIATR RES, V43, P571, DOI 10.1203/00006450-199805000-00003; Tayebi N, 1996, AM J HUM GENET, V59, P740; Tayebi N, 1996, AM J MED GENET, V66, P316, DOI 10.1002/(SICI)1096-8628(19961218)66:3<316::AID-AJMG15>3.0.CO;2-P; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Timms KM, 1997, HUM MOL GENET, V6, P479, DOI 10.1093/hmg/6.3.479; TUSIELUNA MT, 1995, P NATL ACAD SCI USA, V92, P10796, DOI 10.1073/pnas.92.23.10796; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; Wahls WP, 1998, CURR TOP DEV BIOL, V37, P37; WALLEY AJ, 1993, HUM MOL GENET, V2, P1737, DOI 10.1093/hmg/2.10.1737; Watnick TJ, 1998, HUM MOL GENET, V7, P1239, DOI 10.1093/hmg/7.8.1239; Waye JS, 2001, HEMOGLOBIN, V25, P391, DOI 10.1081/HEM-100107876; WEAVER RF, 1989, GENETICS, P184; Wedell A, 1998, ACTA PAEDIATR, V87, P159, DOI 10.1080/08035259850157598; Winfield SL, 1997, GENOME RES, V7, P1020, DOI 10.1101/gr.7.10.1020; Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415; ZIMRAN A, 1994, AM J MED GENET, V50, P74, DOI 10.1002/ajmg.1320500116	78	80	83	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					519	534		10.1086/367850	http://dx.doi.org/10.1086/367850			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12587096	Green Published, Bronze			2022-12-18	WOS:000181152600002
J	Fackenthal, JD; Cartegni, L; Krainer, AR; Olopade, OI				Fackenthal, JD; Cartegni, L; Krainer, AR; Olopade, OI			BRCA2 T2722R is a deleterious allele that causes exon skipping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER FAMILIES; NONSENSE-MEDIATED DECAY; MESSENGER-RNA; SR PROTEINS; MUTATIONS; SEQUENCE; RISK; GENE; IDENTIFICATION; OVARIAN	Patients with a strong family history of breast cancer are often counseled to receive genetic screening for BRCA1 and BRCA2 mutations, the strongest known predictors of breast cancer. A major limitation of genetic testing is the number of inconclusive results due to unclassified BRCA1 and BRCA2 sequence variants. Many known deleterious BRCA1 and BRCA2 mutations affect splicing, and these typically lie near intron/exon boundaries. However, there are also potential internal exonic mutations that disrupt functional exonic splicing enhancer (ESE) sequences, resulting in exon skipping. Using previously established sequence matrices for the scoring of putative ESE motifs, we have systematically examined several BRCA2 mutations for potential ESE disruption mutations. These predictions revealed that BRCA2 T2722R (8393C-->G), which segregates with affected individuals in a family with breast cancer, disrupts three potential ESE sites. Reverse-transcriptase polymerase chain reaction analysis confirms that this mutation causes exon skipping, leading to an out-of-frame fusion of BRCA2 exons 17 and 19. This represents the first BRCA2 missense mutation shown to be a predicted deleterious protein-truncating mutation and suggests a potentially useful method for determining the clinical significance of a subset of the many unclassified variants in BRCA1 and BRCA2.	Univ Chicago, Med Ctr, Dept Med, Ctr Clin Canc Genet, Chicago, IL 60637 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Chicago; University of Chicago Medical Center; Cold Spring Harbor Laboratory	Olopade, OI (corresponding author), Univ Chicago, Med Ctr, Dept Med MC2115, 5841 S Maryland Ave, Chicago, IL 60637 USA.			Krainer, Adrian/0000-0001-9024-9501	NCI NIH HHS [CA13106, P01 CA013106] Funding Source: Medline; NCRR NIH HHS [M01 RR00055, M01 RR000055] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Ganguly A, 1997, GENET TEST, V1, P85, DOI 10.1089/gte.1997.1.85; Hanamura A, 1998, RNA, V4, P430; Krainer M, 1997, NEW ENGL J MED, V336, P1416, DOI 10.1056/NEJM199705153362003; Lancaster JM, 1998, BRIT J CANCER, V78, P1417, DOI 10.1038/bjc.1998.701; Levine DA, 2001, GYNECOL ONCOL, V80, P395, DOI 10.1006/gyno.2000.6082; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; MAQUAT LE, 1995, RNA, V1, P453; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Montagna M, 1999, ONCOGENE, V18, P4160, DOI 10.1038/sj.onc.1202754; Moseley CT, 2002, J CLIN ENDOCR METAB, V87, P847, DOI 10.1210/jc.87.2.847; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; PetrijBosch A, 1997, NAT GENET, V17, P503, DOI 10.1038/ng1297-503a; Puget N, 1997, CANCER RES, V57, P828; Puget N, 1999, CANCER RES, V59, P455; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Shih HA, 2002, J CLIN ONCOL, V20, P994, DOI 10.1200/JCO.20.4.994; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Swensen J, 1997, HUM MOL GENET, V6, P1513, DOI 10.1093/hmg/6.9.1513; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Wagner TMU, 1999, HUM MOL GENET, V8, P413, DOI 10.1093/hmg/8.3.413; Wagner TMU, 1999, HUM MOL GENET, V8, P717; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	43	80	82	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					625	631		10.1086/342192	http://dx.doi.org/10.1086/342192			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145750	Bronze, Green Published			2022-12-18	WOS:000177489600016
J	Liu, JJ; Juo, SH; Holopainen, P; Terwilliger, J; Tong, XM; Grunn, A; Brito, M; Green, P; Mustalahti, K; Maki, M; Gilliam, TC; Partanen, J				Liu, JJ; Juo, SH; Holopainen, P; Terwilliger, J; Tong, XM; Grunn, A; Brito, M; Green, P; Mustalahti, K; Maki, M; Gilliam, TC; Partanen, J			Genomewide linkage analysis of celiac disease in Finnish families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC CONTRIBUTION; HUMAN-POPULATIONS; HLA-DR; REGION; SUSCEPTIBILITY; DISEQUILIBRIUM; FINLAND; ERRORS; ASSOCIATION; ALLELES	Celiac disease (CD), or gluten-sensitive enteropathy, is a common multifactorial disorder resulting from intolerance to cereal prolamins. The only established genetic susceptibility factor is HLA-DQ, which appears to explain only part of the overall genetic risk. We performed a genomewide scan of CD in 60 Finnish families. In addition to strong evidence for linkage to the HLA region at 6p21.3 (Z(max)>5), suggestive evidence for linkage was found for six other chromosomal regions-1p36, 4p15, 5q31, 7q21, 9p21-23, and 16q12. We further analyzed the three most convincing regions-4p15, 5q31, and 7q21- by evaluation of dense marker arrays across each region and by analysis of an additional 38 families. Although multipoint analysis with dense markers provided supportive evidence (multipoint LOD scores 3.25 at 4p15, 1.49 at 5q31, and 1.04 at 7q21) for the initial findings, the additional 38 families did not strengthen evidence for linkage. The role that HLA-DQ plays was studied in more detail by analysis of DQB1 alleles in all 98 families. All but one patient carried one or two HLA-DQ risk alleles, and 65% of HLA-DQ2 carriers were affected. Our study indicates that the HLA region harbors a predominant CD-susceptibility locus in these Finnish families.	Finnish Red Cross Blood Transfus Serv, Dept Tissue Typing, Helsinki 00310, Finland; Columbia Univ, Columbia Genome Ctr, New York, NY USA; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Dept Med, New York, NY USA; Columbia Univ, Dept Genet & Dev, New York, NY USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland	Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Tampere University; Tampere University; Tampere University Hospital	Partanen, J (corresponding author), Finnish Red Cross Blood Transfus Serv, Dept Tissue Typing, Kivihaantie 7, Helsinki 00310, Finland.		Juo, Suh-Hang/A-1765-2010; Saavalainen, Päivi M/E-8621-2011; Liu, Jianjun/AAK-4989-2020; Partanen, Jukka/B-7207-2014; Juo, Suh-Hang/C-9545-2009	Liu, Jianjun/0000-0002-3255-3019; Partanen, Jukka/0000-0001-6681-4734; 				ADAMS P, 1994, GENET EPIDEMIOL, V11, P87, DOI 10.1002/gepi.1370110109; Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; Bevan S, 1999, J MED GENET, V36, P687; Brett PM, 1998, ANN HUM GENET, V62, P25, DOI 10.1046/j.1469-1809.1998.6210025.x; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Chiaravalloti G, 1995, Minerva Pediatr, V47, P43; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Eaves IA, 2000, NAT GENET, V25, P320; Ellis A., 1981, GENETICS COELIAC DIS, p197 ~200; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; Greco L, 2001, ANN HUM GENET, V65, P35, DOI 10.1046/j.1469-1809.2001.6510035.x; GRECO L, IN PRESS GUT; Grillo R, 2000, HUM HERED, V50, P180, DOI 10.1159/000022911; Hervonen K, 2000, J INVEST DERMATOL, V115, P990, DOI 10.1046/j.1523-1747.2000.00172.x; Holopainen P, 1999, TISSUE ANTIGENS, V53, P470, DOI 10.1034/j.1399-0039.1999.530503.x; Holopainen P, 2001, GUT, V48, P696, DOI 10.1136/gut.48.5.696; Houlston RS, 1997, HUM MOL GENET, V6, P1335, DOI 10.1093/hmg/6.8.1335; KARELL K, IN PRESS SCAND J GAS; King AL, 2000, ANN HUM GENET, V64, P479, DOI 10.1046/j.1469-1809.2000.6460479.x; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lie BA, 1999, TISSUE ANTIGENS, V54, P162, DOI 10.1034/j.1399-0039.1999.540207.x; Liu JJ, 2001, AM J MED GENET, V105, P189, DOI 10.1002/ajmg.1195; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; MAKI M, 1991, LANCET, V338, P1350, DOI 10.1016/0140-6736(91)92234-S; Maki M, 1997, LANCET, V349, P1755, DOI 10.1016/S0140-6736(96)70237-4; MEARIN ML, 1983, GUT, V24, P532, DOI 10.1136/gut.24.6.532; Naluai AT, 2000, TISSUE ANTIGENS, V56, P350; Not T, 1998, SCAND J GASTROENTERO, V33, P494; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PANKAU R, 1993, MONATSSCHR KINDERH, V141, P577; PAPADATOU B, 1996, 7 INT S COEL DIS TAM; PARTANEN J, 1997, HLA 1997, P214; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Petronzelli F, 1997, ANN HUM GENET, V61, P307; PITTSCHIELER K, 1993, ACTA PAEDIATR, V82, pR4; POLANCO I, 1981, GENETICS COELIAC DIS, P211; Polvi A, 1998, HUM IMMUNOL, V59, P169, DOI 10.1016/S0198-8859(98)00008-1; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RISCH N, 1987, AM J HUM GENET, V40, P1; ROTTER JI, 1984, CLIN GENET, V26, P529; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; SPURKLAND A, 1990, HUM IMMUNOL, V29, P157, DOI 10.1016/0198-8859(90)90111-2; SPURKLAND A, 1992, HUM IMMUNOL, V35, P188, DOI 10.1016/0198-8859(92)90104-U; Zhong F, 1996, NAT GENET, V14, P329, DOI 10.1038/ng1196-329	48	80	83	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					51	59		10.1086/338453	http://dx.doi.org/10.1086/338453			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11715113	Green Published, Bronze			2022-12-18	WOS:000172571900006
J	Yamada, K; Yamada, Y; Nomura, N; Miura, K; Wakako, R; Hayakawa, C; Matsumoto, A; Kumagai, T; Yoshimura, I; Miyazaki, S; Kato, K; Sonta, S; Ono, H; Yamanaka, T; Nagaya, M; Wakamatsu, N				Yamada, K; Yamada, Y; Nomura, N; Miura, K; Wakako, R; Hayakawa, C; Matsumoto, A; Kumagai, T; Yoshimura, I; Miyazaki, S; Kato, K; Sonta, S; Ono, H; Yamanaka, T; Nagaya, M; Wakamatsu, N			Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GOLDBERG-SHPRINTZEN-SYNDROME; WAARDENBURG-HIRSCHSPRUNG-DISEASE; MENTAL-RETARDATION; GERMLINE MUTATIONS; RET PROTOONCOGENE; ENDOTHELIN-3 GENE; UNUSUAL FACE; FAMILY; MEMBERS; GDNF	Mutations in ZFHX1B, encoding Smad-interacting protein 1 (SIP1), have been recently reported to cause a form of Hirschsprung disease (HSCR). Patients with ZFHX1B deficiency typically show mental retardation, delayed motor development, epilepsy, microcephaly, distinct facial features, and/or congenital heart disease, in addition to the cardinal form of HSCR. To investigate the breadth of clinical variation, we studied DNA samples from six patients with clinical profiles quite similar to those described elsewhere for ZFHX1B deficiency, except that they did not have HSCR. The results showed the previously reported R695X mutation to be present in three cases, with three novel mutations-a 2-bp insertion (760insCA resulting in 254fs262X), a single-base deletion (270delG resulting in 91fs107X), and a 2-bp deletion (2178delTT resulting in 727fs754X)-newly identified in the other three. All mutations occurred in one allele and were de novo events. These results demonstrate that ZFHX1B deficiency is an autosomal dominant complex developmental disorder and that individuals with functional null mutations present with mental retardation, delayed motor development, epilepsy, and a wide spectrum of clinically heterogeneous features suggestive of neurocristopathies at the cephalic, cardiac, and vagal levels.	Aichi Human Serv Ctr, Inst Dev Res, Dept Genet, Aichi 4800392, Japan; Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Aichi 4800392, Japan; Aichi Human Serv Ctr, Cent Hosp, Dept Pediat Neurol, Aichi 4800392, Japan; Aichi Human Serv Ctr, Cent Hosp, Dept Psychiat, Aichi 4800392, Japan; Aichi Human Serv Ctr, Cent Hosp, Dept Pediat, Aichi 4800392, Japan; Aichi Human Serv Ctr, Cent Hosp, Dept Pediat Surg, Aichi 4800392, Japan; Aichi Human Serv Ctr, Residential Facil Children Mental & Phys Disabil, Aichi 4800392, Japan		Wakamatsu, N (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Genet, 713-8 Kamiya, Aichi 4800392, Japan.			Yamada, Kenichiro/0000-0003-0486-284X; Nobuaki, Wakamatsu/0000-0003-1956-8977				Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Brooks AS, 1999, J MED GENET, V36, P485; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Fryer AE, 1998, CLIN DYSMORPHOL, V7, P97, DOI 10.1097/00019605-199804000-00003; GOLDBERG RB, 1981, J CRAN GENET DEV BIO, V1, P185; HALAL F, 1990, AM J MED GENET, V37, P106, DOI 10.1002/ajmg.1320370125; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HURST JA, 1988, J MED GENET, V25, P494, DOI 10.1136/jmg.25.7.494; KUMASAKA K, 1988, AM J MED GENET, V31, P465, DOI 10.1002/ajmg.1320310227; Lurie I. W., 1994, Genetic Counseling, V5, P11; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Postigo AA, 2000, P NATL ACAD SCI USA, V97, P6391, DOI 10.1073/pnas.97.12.6391; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; TANAKA H, 1993, PEDIATR NEUROL, V9, P479, DOI 10.1016/0887-8994(93)90029-C; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; YAMADA Y, 1992, HUM GENET, V90, P379; YOMO A, 1991, AM J MED GENET, V41, P188, DOI 10.1002/ajmg.1320410211	27	80	85	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1178	1185		10.1086/324343	http://dx.doi.org/10.1086/324343			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11592033	Green Published, Bronze			2022-12-18	WOS:000172086900002
J	Gibbs, M; Stanford, JL; Jarvik, GP; Janer, M; Badzioch, M; Peters, MA; Goode, EL; Kolb, S; Chakrabarti, L; Shook, M; Basom, R; Ostrander, EA; Hood, L				Gibbs, M; Stanford, JL; Jarvik, GP; Janer, M; Badzioch, M; Peters, MA; Goode, EL; Kolb, S; Chakrabarti, L; Shook, M; Basom, R; Ostrander, EA; Hood, L			A genomic scan of families with prostate cancer identifies multiple regions of interest	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; CHROMOSOME 1Q42.2-43; DOMINANT INHERITANCE; HIGH-RISK; HISTORY; 1Q; 1Q24-25; SUPPORT; SWEDEN	A 10-cM genomewide scan of 94 families with hereditary prostate cancer, including 432 affected men, was used to identify regions of putative prostate cancer-susceptibility loci. There was an average of 3.6 affected, genotyped men per family, and an overall mean age at diagnosis of 65.4 years. A total of 50 families were classified as early onset (mean age at diagnosis <66 pears), and 44 families were classified as later onset (mean age at diagnosis greater than or equal to 66 years). When the entire data set is considered, regions of interest (LOD score greater than or equal to 1.5) were identified on chromosomes 10, 12, and 14, with a dominant model of inheritance. Under a recessive model LOD scores greater than or equal to 1.5 were found on chromosomes 1, 8, 10, and 16. Stratification by age at diagnosis highlighted a putative susceptibility locus on chromosome 11, among the later-onset families, with a LOD score of 3.02 (recombination fraction 0) at marker ATA34E08. Overall, this genomic scan suggests that there are multiple prostate cancer loci responsible for the hereditary form of this common and complex disease and that stratification by a variety of factors will be required for identification of all relevant genes.	Fred Hutchinson Canc Res Ctr, Div Human Biol & Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Med, Div Med Genet, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ostrander, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol & Clin Res, D4-100,100 Fairview Ave N,POB 10924, Seattle, WA 98109 USA.	eostrand@fhcrc.org	Chakrabarti, Lisa/G-4236-2011; Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708; Kolb, Suzanne/0000-0002-6443-644X; Chakrabarti, Lisa/0000-0001-7213-6837; Ostrander, Elaine/0000-0001-6075-9738	NATIONAL CANCER INSTITUTE [R01CA080122, R01CA078836, T32CA080416] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA078836, 1T32CA 30416, 5T32CA 80416, R01 CA080122, T32 CA080416, R01CA 78836] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; EASTON DF, 1995, AM J HUM GENET, V56, P265; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; Goode EL, 2000, GENET EPIDEMIOL, V18, P251, DOI 10.1002/(SICI)1098-2272(200003)18:3<251::AID-GEPI5>3.0.CO;2-X; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Gronberg H, 1997, CANCER RES, V57, P4707; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Gronberg H, 1999, AM J HUM GENET, V65, P134, DOI 10.1086/302447; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; GRONBERG H, 1997, JAMA-J AM MED ASSOC, V278, P1284; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Jarvik Gail P., 1999, Journal of the National Cancer Institute Monographs, P81; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lange EM, 1999, CLIN CANCER RES, V5, P4013; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Page WF, 1997, PROSTATE, V33, P240; PETERS MA, IN PRESS HUM HERED; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1999, NIH PUB, V99-4543; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807	41	80	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					100	109		10.1086/302969	http://dx.doi.org/10.1086/302969			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10820127	Green Published, Bronze			2022-12-18	WOS:000088926900013
J	Bassi, MT; Ramesar, RS; Caciotti, B; Winship, IM; De Grandi, A; Riboni, M; Townes, PL; Beighton, P; Ballabio, A; Borsani, G				Bassi, MT; Ramesar, RS; Caciotti, B; Winship, IM; De Grandi, A; Riboni, M; Townes, PL; Beighton, P; Ballabio, A; Borsani, G			X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCULAR ALBINISM TYPE-1; HEARING IMPAIRMENT; SHARES HOMOLOGY; PROTEIN; CHROMOSOME; REGION; CLONING; INACTIVATION; RESOLUTION; ALIGNMENT	We have, identified a novel gene, transducin (beta)-like 1 (TBL1), in the Xp22.3 genomic region, that shows high homology with members of the WD-40-repeat protein family. The gene Contains 18 exons: spanning similar to 150 kb of the genomic region adjacent to the ocular albinism gene (OA1) on the telomeric side. However, unlike OA1, TBL1 is' transcribed from telomere. to centromere. Northern analysis indicates that TBL1 is ubiquitously expressed, with two transcripts of similar to 2.1 kb and 6.0 kb. The open reading frame encodes a 526-amino acid protein, which shows the presence of six beta-transducin repeats (WD-40 motif) in the C-terminal domain. The homology with known beta-subunits of G proteins and other WD-40-repeat containing proteins-is restricted to the WD-40 motif. Genomic analysis revealed that the gene is either partly or entirely deleted in patients carrying Xp22.3 terminal deletions, The complexity of the contiguous gene-syndrome phenotype shared by these patients depends on the number of known disease genes involved in the deletions; Interestingly, one patient carrying a microinterstitial deletion involving the 3' portion of both TBL1 and OA1 shows the OA1 phenotype associated with X-linked late-onset sensorineural deafness. We postulate an involvement of TBL1 in the pathogenesis of the ocular albinism with late-onset sensorineural deafness phenotype.	Telethon Inst Genet & Med, I-20132 Milan, Italy; Univ Vita & Salute San Raffaele, Milan, Italy; Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; Univ Cape Town, Sch Med, Dept Human Genet, MRC,Unit Med Genet, ZA-7925 Cape Town, South Africa; Univ Massachusetts, Med Ctr, Dept Pediat, Worcester, MA USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Vita-Salute San Raffaele University; University of Siena; University of Cape Town; University of Massachusetts System; University of Massachusetts Worcester	Borsani, G (corresponding author), Telethon Inst Genet & Med, Via Olgettina 58, I-20132 Milan, Italy.		Ramesar, Raj S/I-6941-2015; BALLABIO, Andrea/AAL-2672-2020; Bassi, Maria Teresa T/A-3517-2014; Borsani, Giuseppe/B-1709-2010; Winship, Ingrid M/D-7204-2016	Ramesar, Raj S/0000-0001-5688-1634; BALLABIO, Andrea/0000-0003-1381-4604; Bassi, Maria Teresa T/0000-0002-8236-1197; Borsani, Giuseppe/0000-0003-0110-1148; Winship, Ingrid/0000-0001-8535-6003	Telethon [TGM97000, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASSI MT, 1995, NAT GENET, V10, P13, DOI 10.1038/ng0595-13; BASSI MT, 1994, HUM MOL GENET, V3, P647, DOI 10.1093/hmg/3.4.647; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; delCastillo I, 1996, HUM MOL GENET, V5, P1383, DOI 10.1093/hmg/5.9.1383; Disteche CM, 1998, MAMM GENOME, V9, P1062, DOI 10.1007/s003359900926; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FRANCA JRD, 1995, J ATMOS CHEM, V22, P81; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; LALWANI AK, 1994, AM J HUM GENET, V55, P685; LOVETT M, 1994, TRENDS GENET, V10, P352, DOI 10.1016/0168-9525(94)90131-7; MANNHAUPT G, 1994, YEAST, V10, P1363, DOI 10.1002/yea.320101014; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Rubin GM, 1996, GENOME RES, V6, P71, DOI 10.1101/gr.6.2.71; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Sambrook J, 1989, MOL CLONING LAB MANU; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P373, DOI 10.1093/hmg/4.3.373; Schnur RE, 1998, AM J HUM GENET, V62, P800, DOI 10.1086/301776; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; SPEVAK W, 1993, MOL CELL BIOL, V13, P4953, DOI 10.1128/MCB.13.8.4953; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; WAPENAAR MC, 1993, HUM MOL GENET, V2, P947, DOI 10.1093/hmg/2.7.947; WINSHIP I, 1984, AM J MED GENET, V19, P797, DOI 10.1002/ajmg.1320190421; WINSHIP IM, 1993, GENOMICS, V18, P444, DOI 10.1006/geno.1993.1495	34	80	85	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1604	1616		10.1086/302408	http://dx.doi.org/10.1086/302408			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330347	Green Published, Bronze			2022-12-18	WOS:000080696200012
J	Segal, Y; Peissel, B; Renieri, A; de Marchi, M; Ballabio, A; Pei, Y; Zhou, J				Segal, Y; Peissel, B; Renieri, A; de Marchi, M; Ballabio, A; Pei, Y; Zhou, J			LINE-1 elements at the sites of molecular rearrangements in Alport syndrome - Diffuse leiomyomatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-6(IV) COLLAGEN GENES; SMOOTH-MUSCLE TUMORS; IV COLLAGEN; BASEMENT-MEMBRANES; DELETION; CHAINS; ALPHA-5(IV); GOODPASTURE; NEPHRITIS; DNA	Deletions encompassing the 5' termini of the paired type IV collagen genes COL4A5 and COL4A6 on chromosome Xq22 give rise to Alport syndrome (AS) and associated diffuse leiomyomatosis (DL), a syndrome of disseminated smooth-muscle tumors involving the esophagus, large airways, and female reproductive tract. In this study, we report isolation and characterization of two deletion junctions. The first, in a patient described elsewhere, arose by a nonhomologous recombination event fusing a LINE-1 (L1) repetitive element in intron 1 of COL4A5 to intron 2 of COL4A6, resulting in a 13.4-kb deletion. The second, in a previously undescribed family, arose by unequal homologous recombination between the same L1 and a colinear L1 element in intron 2 of COL4A6, resulting in a >40-kb deletion. L1 elements have contributed to the emergence of this locus as a site of frequent recombinations by diverse mechanisms. These give rise to AS-DL by disruption of type IV collagen and perhaps other as yet unidentified genes, evidenced by deletions as small as 13.4 kb.	Brigham & Womens Hosp, Div Renal, HIM 522, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Siena, I-53100 Siena, Italy; Telethon Inst Genet & Med, Milan, Italy; Univ Toronto, Dept Med, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Siena; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Toronto	Zhou, J (corresponding author), Brigham & Womens Hosp, Div Renal, HIM 522, Dept Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	zhou@rics.bwh.harvard.edu	Renieri, Alessandra/K-5950-2016; De Marchi, Mario E./G-7558-2011; BALLABIO, Andrea/AAL-2672-2020; Peissel, Bernard/E-8187-2017; Segal, Yoav/E-2326-2019	Renieri, Alessandra/0000-0002-0846-9220; De Marchi, Mario E./0000-0002-6425-3205; BALLABIO, Andrea/0000-0003-1381-4604; Peissel, Bernard/0000-0001-9233-3571; 	Telethon [TGM97000, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; COCHAT P, 1988, J PEDIATR-US, V113, P339, DOI 10.1016/S0022-3476(88)80280-4; DRACOPOLI NC, 1997, CURRENT PROTOCOLS HU; Drechsler M, 1996, HUM GENET, V98, P297, DOI 10.1007/s004390050210; GARCIATORRES R, 1993, AM J KIDNEY DIS, V22, P641, DOI 10.1016/S0272-6386(12)80425-2; GREGORY MC, 1993, DIS KIDNEY, V1, P571; HASSTEDT SJ, 1986, AM J HUM GENET, V38, P940; Heidet L, 1998, AM J PATHOL, V152, P673; Heidet L, 1997, CYTOGENET CELL GENET, V78, P240, DOI 10.1159/000134666; Heidet L, 1997, LAB INVEST, V76, P233; HEIDET L, 1995, HUM MOL GENET, V4, P99, DOI 10.1093/hmg/4.1.99; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KLEPPEL MM, 1989, LAB INVEST, V61, P278; NAKANISHI K, 1994, KIDNEY INT, V46, P1413, DOI 10.1038/ki.1994.413; PEISSEL B, 1995, J CLIN INVEST, V96, P1948, DOI 10.1172/JCI118241; RENIERI A, 1994, HUM MUTAT, V4, P195, DOI 10.1002/humu.1380040304; ROTH DB, 1989, MOL CELL BIOL, V9, P3049, DOI 10.1128/MCB.9.7.3049; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Tryggvason K, 1996, Contrib Nephrol, V117, P154; Ueki Y, 1998, AM J HUM GENET, V62, P253, DOI 10.1086/301703; ZHOU J, 1994, J BIOL CHEM, V269, P13193; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	28	80	81	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					62	69		10.1086/302213	http://dx.doi.org/10.1086/302213			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915944	Bronze, Green Published			2022-12-18	WOS:000078477400010
J	Field, LL; Kaplan, BJ				Field, LL; Kaplan, BJ			Absence of linkage of phonological coding dyslexia to chromosome 6p23-p21.3 in a large family data set	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; PEDIGREE-MEMBER METHOD; READING-DISABILITY; DEVELOPMENTAL DYSLEXIA; LOCUS; DNA; DISEASE; GENE; MICROSATELLITES; SUSCEPTIBILITY	Previous studies have suggested that a locus predisposing to specific readings disability (dyslexia) resides an, chromosome 6p23-p21.3. We investigated 79 families having at least two siblings affected with phonological coding dyslexia, the most common form of reading disability (617 people genotyped, 294 affected), and we tested for linkage with the genetic markers reported to be linked to dyslexia in those studies, No evidence for linkage was found by LOD score analysis or affected-sib-pair methods. However, using the affected-pedigree-member (APM) method, we detected significant evidence for linkage and/or association with some markers when we used published allele frequencies with weighting of rarer alleles. APM results were not significant when we used marker allele frequencies estimated from parents. Furthermore, results were not significant with the more robust SIMIBD method using either published or parental marker frequencies. Finally, family-based association analysis using the AFBAC program showed no evidence for association with any marker. We conclude that the APM method should be used only with extreme caution, because it appears to have generated false-positive results. In summary, using a large data set with high power to detect linkage, we were unable to find evidence for linkage or association between phonological coding dyslexia and chromosome 6p markers.	Univ Calgary, Fac Med, Dept Med Genet, Hlth Sci Ctr, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; Univ Calgary, Dept Pediat, Fac Med, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Alberta Childrens Hospital; University of Calgary; University of Calgary	Field, LL (corresponding author), Univ Calgary, Fac Med, Dept Med Genet, Hlth Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	field@ucalgary.ca			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [1-P41-RR03655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 1998, WOODCOCK READING MAS; BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; BAKWIN H, 1973, DEV MED CHILD NEUROL, V15, P184; BISGAARD ML, 1987, CLIN GENET, V32, P118; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CHASE CH, 1996, DEV DYSLEXIA NEURAL; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRAWFORD SG, 1992, CORTEX, V28, P483, DOI 10.1016/S0010-9452(13)80156-6; Davis S, 1996, AM J HUM GENET, V58, P867; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUARA R, 1991, ARCH NEUROL-CHICAGO, V48, P410, DOI 10.1001/archneur.1991.00530160078018; ELSTON RC, 1992, STAT ANAL GENETIC EP; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; FINUCCI JM, 1976, ANN HUM GENET, V40, P1, DOI 10.1111/j.1469-1809.1976.tb00161.x; GILGER JW, 1991, READ WRIT, V3, P205, DOI 10.1007/BF00354958; GILGER JW, 1992, NEUROPSYCHOLOGIA, V30, P209, DOI 10.1016/0028-3932(92)90001-3; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jastak S, 1984, WIDE RANGE ACHIEVEME; KAPLAN BJ, 1994, BRAIN COGNITION, V26, P291, DOI 10.1006/brcg.1994.1064; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEONARD CM, 1993, ARCH NEUROL-CHICAGO, V50, P461, DOI 10.1001/archneur.1993.00540050013008; LERNER JW, 1989, J AM ACAD CHILD PSY, V28, P326, DOI 10.1097/00004583-198905000-00004; LEWITTER FI, 1980, BEHAV GENET, V10, P9, DOI 10.1007/BF01067316; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; PENNINGTON BF, 1987, ANN DYSLEXIA, V37, P62, DOI 10.1007/BF02648060; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4306, DOI 10.1093/nar/19.15.4306-a; ROSNER J, 1971, J LEARN DISABIL, V4, P384, DOI 10.1177/002221947100400706; SMITH SD, 1991, READ WRIT, V3, P285, DOI 10.1007/BF00354963; SMITH SD, 1990, J AM ACAD CHILD PSY, V29, P204, DOI 10.1097/00004583-199003000-00008; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Spreen O., 1988, LEARNING DISABLED CH; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; STOFFEL M, 1993, DIABETES, V42, P1215, DOI 10.2337/diabetes.42.8.1215; THOMSON G, 1995, AM J HUM GENET, V57, P487; Van Orden G. C., 1996, DEV DYSLEXIA NEURAL, P185; VANEERDEWEGH P, 1993, GENET EPIDEMIOL, V10, P395, DOI 10.1002/gepi.1370100611; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Woodcock R.W., 1989, WOODCOCK JOHNSON PSY; ZAHALKOVA M, 1972, J MED GENET, V9, P48, DOI 10.1136/jmg.9.1.48	53	80	81	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1448	1456		10.1086/302107	http://dx.doi.org/10.1086/302107			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	138QZ	9792873	Green Published, Bronze			2022-12-18	WOS:000076985200022
J	Goodman, F; Giovannucci-Uzielli, ML; Hall, C; Reardon, W; Winter, R; Scambler, P				Goodman, F; Giovannucci-Uzielli, ML; Hall, C; Reardon, W; Winter, R; Scambler, P			Deletions in HOXD13 segregate with an identical, novel foot malformation in two unrelated families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC INTERACTIONS; LIMB DEVELOPMENT; NONSENSE CODONS; EXPRESSION; CELLS; MICE; DISRUPTION; PHENOTYPES; MUTATIONS; HOXD-13	Synpolydactyly (SPD) is a dominantly inherited congenital limb malformation consisting of 3/4 syndactyly in the hands and 4/5 syndactyly in the feet, with digit duplication in the syndactylous web. The condition recently has been found to result from different-sized expansions of an amino-terminal polyalanine tract in HOXD13. We report a novel type of mutation in HOXD13, associated in some cases with features of classic SPD and in all cases with a novel foot phenotype. In two unrelated families, each with a different intragenic deletion in HOXD13, all mutation carriers have a rudimentary extra digit between the first and second metatarsals and often between the fourth and fifth metatarsals as well. This phenotype has not been reported in any mice with genetic modifications of the HoxD gene cluster. The two different deletions affect the first exon and the homeobox, respectively, in each case producing frameshifts followed by a long stretch of novel sequence and a premature stop codon. Although the affected genes may encode proteins that exert a dominant negative or novel effect, they are most likely to act as null alleles. Either possibility has interesting implications for the role of HOXD13 in human autopod development.	Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Inst Child Hlth, Clin Genet Unit, London WC1N 1EH, England; Univ Florence, Human Genet Serv, Florence, Italy; Great Ormond St Hosp Children NHS Trust, Dept Radiol, London WC1N 3JH, England	University of London; University College London; University of London; University College London; University of Florence; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Goodman, F (corresponding author), Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.		Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Reardon, Willie/0000-0001-7329-9179				Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; CHARIOT A, 1995, BIOCHEM BIOPH RES CO, V215, P713, DOI 10.1006/bbrc.1995.2522; Copeland JWR, 1996, NATURE, V379, P162, DOI 10.1038/379162a0; CROSS HE, 1968, AM J HUM GENET, V20, P368; Davis AP, 1996, DEVELOPMENT, V122, P1175; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Edery P, 1997, BIOESSAYS, V19, P389, DOI 10.1002/bies.950190506; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Fujimoto S, 1998, GENE, V209, P77, DOI 10.1016/S0378-1119(98)00014-6; Goff DJ, 1997, DEVELOPMENT, V124, P627; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; HANSON IM, 1993, HUM MOL GENET, V2, P915; HONG YS, 1995, GENE, V159, P209, DOI 10.1016/0378-1119(95)92712-G; Hyduk D, 1996, GENETICS, V142, P481; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kalderon D, 1996, CURR BIOL, V6, P662, DOI 10.1016/S0960-9822(09)00443-6; MAQUAT LE, 1995, RNA, V1, P453; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; RIJLI FM, 1994, DEV DYNAM, V201, P366, DOI 10.1002/aja.1002010408; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; SAYLI BS, 1995, J MED GENET, V32, P421, DOI 10.1136/jmg.32.6.421; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; TEMTAMY SA, 1978, GENETICS HAND MALFOR, V14, P301; THOMSEN OLUF, 1927, ACTA MED SCAND, V65, P609; Willing MC, 1996, AM J HUM GENET, V59, P799; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0	33	80	87	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					992	1000		10.1086/302070	http://dx.doi.org/10.1086/302070			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758628	Green Published, Bronze			2022-12-18	WOS:000076577800011
J	Guo, SW				Guo, SW			Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; PROSTATE-CANCER RISK; FAMILY HISTORY; LINKAGE STRATEGIES; AGGREGATION; DISEASE; FUTURE	One widely used measure of familial aggregation is the sibling recurrence-risk ratio, which is defined as the ratio of risk of disease manifestation, given that one's sibling is affected, as compared with the disease prevalence in the general population. Known as lambda(S), it has been used extensively in the mapping of complex diseases. In this paper, I show that, for a fictitious disease that is strictly nongenetic and nonenvironmental, lambda(S), can be dramatically inflated because of misunderstanding of the original definition of lambda(S),, ascertainment bias, and overreporting. Therefore, for a disease of entirely environmental origin, the lambda(S) inflation due to ascertainment bias and/or overreporting is expected to be more prominent if the risk factor also is familially aggregated. This suggests that, like segregation analysis, the estimation of lambda(S) also is prone to ascertainment bias and should be performed with great care. This is particularly important if one uses lambda(S) for exclusion mapping, for discrimination between different genetic models, and for association studies, since these practices hinge tightly on an accurate estimation of lambda(S).	Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55454 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Guo, SW (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056515, R29GM052205] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM56515, R29-GM52205] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY JM, 1993, AM J PSYCHIAT, V150, P272; BAILEY NTJ, 1951, ANN EUGENIC, V16, P215, DOI 10.1111/j.1469-1809.1951.tb02473.x; ENTERLINE PE, 1959, AM J PUBLIC HEALTH N, V49, P205, DOI 10.2105/AJPH.49.2.205; EWENS WJ, 1991, HDB STAT, V8, P29; FARRALL M, 1992, AM J HUM GENET, V50, P270; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; Floderus B, 1990, Epidemiology, V1, P318, DOI 10.1097/00001648-199007000-00011; Galton F, 1904, NATURE, V70, P626, DOI 10.1038/070626c0; Galton F, 1904, NATURE, V70, P529, DOI 10.1038/070529a0; HAENSZEL W, 1959, J NATL CANCER I, V23, P487; HASTRUP JL, 1985, HEALTH PSYCHOL, V4, P291, DOI 10.1037/0278-6133.4.4.291; HERRMANN N, 1985, AM J EPIDEMIOL, V121, P937, DOI 10.1093/oxfordjournals.aje.a114064; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; Khoury M, 1993, FUNDAMENTALS GENETIC; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; MACMAHON B, 1978, GENETIC EPIDEMIOLOGY, P3; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; PENROSE L S, 1953, Acta Genet Stat Med, V4, P257; PILLARD RC, 1986, ARCH GEN PSYCHIAT, V43, P808; RAPHAEL K, 1987, INT J EPIDEMIOL, V16, P167, DOI 10.1093/ije/16.2.167; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SADOVNICK AD, 1994, ANN NEUROL, V36, pS194, DOI 10.1002/ana.410360806; SCHULL WJ, 1969, J CHRON DIS, V22, P217, DOI 10.1016/0021-9681(69)90015-0; Weinberg W, 1912, ARCH RASSEN GES BIOL, V9, P694; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495	32	80	82	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					252	258		10.1086/301928	http://dx.doi.org/10.1086/301928			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634526	Green Published, Bronze			2022-12-18	WOS:000074761000033
J	Schanen, C; Francke, U				Schanen, C; Francke, U			A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CHROMOSOME		Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA; Howard Hughes Med Inst, Stanford, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute	Schanen, C (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pediat, 10833 Le Conte Ave,MDCC 22-398, Los Angeles, CA 90095 USA.	schanen@ucla.edu			NICHD NIH HHS [HD01103] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARCHIDIACONO N, 1991, HUM GENET, V86, P604; BROWN D, 1997, WASHINGTON POST 1018; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELLISON KA, 1992, AM J HUM GENET, V50, P278; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; HOLM VA, 1985, J DEV BEHAV PEDIATR, V6, P32; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; Schanen NC, 1998, J CHILD NEUROL, V13, P229, DOI 10.1177/088307389801300507; Schanen NC, 1997, AM J HUM GENET, V61, P634, DOI 10.1086/515525	9	80	84	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					267	269		10.1086/301932	http://dx.doi.org/10.1086/301932			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9637791	Green Published, Bronze			2022-12-18	WOS:000074761000035
J	Au, KS; Rodriguez, JA; Finch, JL; Volcik, KA; Roach, ES; Delgado, MR; Rodriguez, E; Northrup, H				Au, KS; Rodriguez, JA; Finch, JL; Volcik, KA; Roach, ES; Delgado, MR; Rodriguez, E; Northrup, H			Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; TUMOR-SUPPRESSOR GENE; P53 GENE; DIAGNOSTIC-CRITERIA; TANDEM DUPLICATION; HETEROGENEITY; IDENTIFICATION; CHROMOSOME-9; FAMILY; DELETION	Ninety patients with tuberous-sclerosis complex (TSC) were tested for subtle mutations in the TSC2 gene, by means of single-strand conformational analysis (SSCA) of genomic DNA. Patients included 56 sporadic cases and 34 familial probands. For all patients, SSCA was performed for each of the 41 exons of the TSC2 gene. We identified 32 SSCA changes, 22 disease-causing mutations, and 10 polymorphic variants. Interestingly, we detected mutations at a much higher frequency in the sporadic cases (32%) than in the multiplex families (9%). Among the eight families for which linkage to the TSC2 region had been determined, only one mutation was found. Mutations were distributed equally across the gene; they included 5 deletions, 3 insertions, 10 missense mutations, 2 nonsense mutations, and 2 tandem duplications. We did not detect an increase in mutations either in the GTPase-activating protein (GAP)-related domains of TSC2 or in the activating domains that have been identified in rat tuberin. We did not detect any mutations in the exons (25 and 31) that are spliced out in the isoforms. There was no evidence for correspondence between variability of phenotype and type of mutation (missense versus early termination), Diagnostic testing will be difficult because of the genetic heterogeneity of TSC (which has at least two causative genes: TSC1 and TSC2), the large size of the TSC2 gene, and the variety of mutations. More than half of the mutations that we identified (missense, small in-frame deletion, and tandem duplication) are not amenable to the mutation-detection methods, such as protein-truncation testing, that are commonly employed for genes that encode proteins with tumor-suppressor function.	Univ Texas, Sch Med, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; Univ Texas, SW Med Sch, Div Pediat Neurol, Dallas, TX 75230 USA; Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA	University of Texas System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children	Northrup, H (corresponding author), Univ Texas, Sch Med, Dept Pediat, Div Med Genet, 6431 Fannin St, Houston, TX 77030 USA.	hnorthru@pedl.med.uth.tmc.edu	Roach, Ewell/E-3958-2011	Au, Kit Sing/0000-0002-2694-5833	NINDS NIH HHS [NS32300-02] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Au KS, 1997, HUM MUTAT, V9, P23, DOI 10.1002/(SICI)1098-1004(1997)9:1<23::AID-HUMU4>3.0.CO;2-Q; BAKER SJ, 1990, CANCER RES, V50, P7717; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; BROW MAD, IN PRESS CURR OPIN B; CALVERT RJ, 1995, BIOTECHNIQUES, V18, P782; CHIBA I, 1990, ONCOGENE, V5, P1603; CURATOLO P, 1991, ANN NY ACAD SCI, V615, P8; FRYER AE, 1987, LANCET, V1, P659; Gomez MR, 1988, TUBEROUS SCLEROSIS; GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HAINES JL, 1991, AM J HUM GENET, V49, P764; Henske EP, 1996, AM J HUM GENET, V59, P400; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; HUNT A, 1987, DEV MED CHILD NEUROL, V29, P190; JANSSEN LAJ, 1990, GENOMICS, V8, P237, DOI 10.1016/0888-7543(90)90277-2; Jin F, 1996, P NATL ACAD SCI USA, V93, P9154, DOI 10.1073/pnas.93.17.9154; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; KEEN J, 1991, TRENDS GENET, V7, P5; KUMAR A, 1995, HUM MOL GENET, V4, P2295, DOI 10.1093/hmg/4.12.2295; KUMAR A, 1995, HUM MOL GENET, V4, P1471, DOI 10.1093/hmg/4.8.1471; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Liu Q, 1994, PCR Methods Appl, V4, P97; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; NELLIST M, 1993, CELL, V75, P1305; NORTHRUP H, 1992, AM J HUM GENET, V51, P709; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Ott J., 1991, ANAL HUMAN GENETIC L; ROACH ES, 1995, DERMATOL CLIN, V13, P151, DOI 10.1016/S0733-8635(18)30118-9; ROACH ES, 1992, J CHILD NEUROL, V7, P221, DOI 10.1177/088307389200700219; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SAUNDERS WB, 1994, DORLANDS ILLUSTRATED; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; TOGUCHIDA J, 1992, CANCER RES, V52, P6194; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Tsuchiya H, 1996, CANCER RES, V56, P429; vanBakel I, 1997, HUM MOL GENET, V6, P1409, DOI 10.1093/hmg/6.9.1409; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Vrtel R, 1996, J MED GENET, V33, P47, DOI 10.1136/jmg.33.1.47; WARD CJ, 1994, CELL, V77, P881; Webb DW, 1996, BRIT J DERMATOL, V135, P1; WIEDERHOLT WC, 1985, NEUROLOGY, V35, P600, DOI 10.1212/WNL.35.4.600; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Wilson PJ, 1996, HUM MOL GENET, V5, P249, DOI 10.1093/hmg/5.2.249; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; XU L, 1995, GENOMICS, V27, P475, DOI 10.1006/geno.1995.1079	53	80	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					286	294		10.1086/301705	http://dx.doi.org/10.1086/301705			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463313	Green Published, Bronze			2022-12-18	WOS:000072416000011
J	Snieder, H; vanDoornen, LJP; Boomsma, DI				Snieder, H; vanDoornen, LJP; Boomsma, DI			The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-HEART-DISEASE; RISK FACTOR VARIABLES; CARDIOVASCULAR-DISEASE; CHOLESTEROL LEVELS; A-I; TWINS; HERITABILITY; ATHEROSCLEROSIS; PHENOTYPES; POPULATION	The aim of this study was to investigate and disentangle the genetic and nongenetic causes of stability and change in lipids and (apo)lipoproteins that occur during the lifespan. Total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides, apolipoprotein Al (ApoA1), apolipoprotein B (ApoB), and lipoprotein(a) (Lp[a]) were measured in a group of 160 middle-aged parents and their twin offspring (first project) and in a group of 203 middle-aged twin pairs (second project). Combining the data of both projects enabled the estimation of the extent to which measured lipid parameters are influenced by different genes in adolescence and adulthood. To that end, an extended quantitative genetic model was specified, which allowed the estimation of heritabilities for each sex and generation separately. Heritabilities were similar for both sexes and both generations. Larger variances in the parental generation could be ascribed to proportional increases in both unique environmental and additive genetic variance from childhood to adulthood, which led to similar heritability estimates in adolescent and middle-aged twins. Although the magnitudes of heritabilities were similar across generations, results showed that, for total cholesterol, triglycerides, HDL, and LDL, partly different genes are expressed in adolescence compared to adulthood. For triglycerides, only 46% of the genetic variance was common to both age groups; for total cholesterol this was 80%. Intermediate values were found for HDL (66%) and LDL (76%). For ApoA1, ApoB, and Lp(a), the same genes seem to act in both generations.	VRIJE UNIV AMSTERDAM,DEPT PSYCHOPHYSIOL,AMSTERDAM,NETHERLANDS	Vrije Universiteit Amsterdam			Boomsma, Dorret I/AAX-4470-2020					[Anonymous], 1993, NETH J CARDIOL; AUSTIN MA, 1992, AM J HUM GENET, V51, P829; AVOGARO P, 1979, LANCET, V1, P901; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; BERENSON GS, 1979, AM J DIS CHILD, V133, P1049, DOI 10.1001/archpedi.1979.02130100073015; BERENSON GS, 1978, CIRCULATION, V57, P603, DOI 10.1161/01.CIR.57.3.603; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; BODURTHA JN, 1991, ARTERIOSCLER THROMB, V11, P844, DOI 10.1161/01.ATV.11.4.844; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; BOOMSMA DI, 1993, ATHEROSCLEROSIS, V99, P23, DOI 10.1016/0021-9150(93)90047-X; BOOMSMA DI, 1989, BEHAV GENET, V19, P123, DOI 10.1007/BF01065888; Boomsma DI, 1996, GENET EPIDEMIOL, V13, P49, DOI 10.1002/(SICI)1098-2272(1996)13:1<49::AID-GEPI5>3.0.CO;2-1; BRENN T, 1994, ANN HUM GENET, V58, P369, DOI 10.1111/j.1469-1809.1994.tb00733.x; DEMEESTER CA, 1995, AM J HUM GENET, V56, P287; DURRINGTON PN, 1988, LANCET, V1, P1070; FINKEL D, 1995, BEHAV GENET, V25, P421, DOI 10.1007/BF02253371; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; HELLER DA, 1993, NEW ENGL J MED, V328, P1160; HOPKINS PN, 1989, ANNU REV NUTR, V9, P303; ISELIUS L, 1979, CLIN GENET, V15, P300; ISELIUS L, 1988, 2ND P INT C QUANT GE, P341; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KOSTNER GM, 1989, CIRCULATION, V80, P1313, DOI 10.1161/01.CIR.80.5.1313; KRAUSS RM, 1991, AM J MED, V90, pS36, DOI 10.1016/0002-9343(91)90035-V; KROMHOUT D, 1990, AM J EPIDEMIOL, V131, P855, DOI 10.1093/oxfordjournals.aje.a115576; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; LAMONFAVA S, 1991, ATHEROSCLEROSIS, V91, P97, DOI 10.1016/0021-9150(91)90191-5; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LOBO RA, 1990, OBSTET GYNECOL, V75, pS18; MACIEJKO JJ, 1987, CLIN CHEM, V33, P2065; MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1989, BEHAV GENET, V19, P63, DOI 10.1007/BF01065884; NEALE MC, 1994, MX STAT MODELING; NEWSCHAFFER CJ, 1992, AM J EPIDEMIOL, V136, P23, DOI 10.1093/oxfordjournals.aje.a116417; OCONNELL DL, 1988, GENET EPIDEMIOL, V5, P323, DOI 10.1002/gepi.1370050504; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; RADER DJ, 1994, GENETIC FACTORS CORO, P83; RAO DC, 1994, GENETIC FACTORS CORO, P71; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REILLY SL, 1990, J CLIN EPIDEMIOL, V43, P921, DOI 10.1016/0895-4356(90)90076-2; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; SCHULTE PA, 1993, MOL EPIDEMIOLOGY PRI, P341; SEED M, 1991, ATHEROSCLEROSIS, V90, P1, DOI 10.1016/0021-9150(91)90238-X; SING CF, 1990, ANNU REV GENET, V24, P171; SING CF, 1989, INT J EPIDEMIOL, V18, pS183; SNIEDER H, 1996, THESIS VRIJE U AMSTE; SNIEDER H, 1995, BEHAV GENETIC APPROA, P105; STALLINGS MC, 1989, BEHAV GENET, V19, P777; SUNDELL IB, 1989, ATHEROSCLEROSIS, V80, P9; TWISK JWR, 1995, INT J EPIDEMIOL, V24, P69, DOI 10.1093/ije/24.1.69; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; WANG XL, 1992, PEDIATRICS, V89, P401; Weiss K. M., 1993, GENETIC VARIATION HU; WILLIAMS CJ, 1993, GENET EPIDEMIOL, V10, P551, DOI 10.1002/gepi.1370100637	56	80	83	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					638	650						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042925				2022-12-18	WOS:A1997WK40300022
J	Tumer, Z; Lund, C; Tolshave, J; Vural, B; Tonnesen, T; Horn, N				Tumer, Z; Lund, C; Tolshave, J; Vural, B; Tonnesen, T; Horn, N			Identification of point mutations in 41 unrelated patients affected with Menkes disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPPER-TRANSPORTING ATPASE; X-LINKED DISEASE; OCCIPITAL HORN SYNDROME; WILSON-DISEASE; CANDIDATE GENE; PRENATAL-DIAGNOSIS; DNA; TRANSLOCATION; HYBRIDIZATION; AMPLIFICATION	Genomic DNA of 41 unrelated patients affected with the classical severe form of Menkes disease was investigated for point mutations in the A TP7A gene (previously designated as the ''MNK'' gene). Using SSCP analysis and direct sequencing of the exons amplified by PCR, we identified 41 different mutations, including 19 insertions/deletions, 10 nonsense mutations, 4 missense mutations, and 8 splice-site alterations. Approximately 90% of the mutations were predicted to result in the truncation of the protein (ATP7A). In 20 patients the mutations were within exons 7-10, and half of these mutations affected exon 8. Furthermore, five alterations were observed within the 6-bp sequence at the splice-donor site of intron 8, which would be predicted to affect the efficiency of splicing of exon 8. Although a specific function has not been attributed to the protein region encoded by this exon, this region may be important in serving as a ''stalk'' joining the metal-binding domains and the ATPase core. The present findings not only help us in understanding the underlying genetic defect but are invaluable data especially for carrier detection and prenatal diagnosis of this lethal disorder.	ISTANBUL UNIV,DEPT GENET,INST EXPT MED RES,ISTANBUL,TURKEY	Istanbul University	Tumer, Z (corresponding author), JOHN F KENNEDY INST,GL LANDEVEJ 7,DK-2600 GLOSTRUP,COPENHAGEN,DENMARK.		Tumer, Zeynep/AAF-8501-2019; Tümer, Zeynep/C-4235-2014; vural, burçak/AAC-6553-2020	Tumer, Zeynep/0000-0002-4777-5802; 				BECK J, 1994, CLIN GENET, V46, P295; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chuang LM, 1996, J MED GENET, V33, P521, DOI 10.1136/jmg.33.6.521; Danks D. M, 1995, METABOLIC BASIS INHE, VI, P2211; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; DIERICK HA, 1995, GENOMICS, V28, P462, DOI 10.1006/geno.1995.1175; FIGUS A, 1995, AM J HUM GENET, V57, P1318; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HORN N, 1980, J MED GENET, V17, P262, DOI 10.1136/jmg.17.4.262; HORN N, 1981, PRENATAL DIAG, V1, P107, DOI 10.1002/pd.1970010205; HORN N, 1995, GENETIC RESPONSE TO METALS, P285; HORN N, 1980, J MED GENET, V17, P257, DOI 10.1136/jmg.17.4.257; HORN N, 1983, J INHERIT METAB DIS, V6, P59, DOI 10.1007/BF01811325; HORN N, 1992, BRAIN PATHOL, V2, P351, DOI 10.1111/j.1750-3639.1992.tb00711.x; HORN N, 1985, 1ST TRIMESTER FETAL, P251; HOUWEN RHJ, 1995, J MED GENET, V32, P180; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; MENKES JH, 1962, PEDIATRICS, V29, P764; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; PELTONEN L, 1983, BIOCHEMISTRY-US, V22, P6156, DOI 10.1021/bi00295a018; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; ROSSITER BJF, 1990, J BIOL CHEM, V265, P12753; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; THOMAS GR, 1995, AM J HUM GENET, V56, P1315; THOMAS GR, 1995, AM J HUM GENET, V56, P1140; TONNESEN T, 1989, J INHERIT METAB DIS, V1, P207; TUMER Z, 1995, GENOMICS, V26, P437, DOI 10.1016/0888-7543(95)80160-N; TUMER Z, 1994, J MED GENET, V31, P615, DOI 10.1136/jmg.31.8.615; TUMER Z, 1992, HUM MOL GENET, V1, P483, DOI 10.1093/hmg/1.7.483; TUMER Z, 1992, HUM GENET, V88, P668, DOI 10.1007/BF02265295; Tumer Z, 1996, NAT GENET, V12, P11, DOI 10.1038/ng0196-11; TUMER Z, 1994, J INHERIT METAB DIS, V17, P267, DOI 10.1007/BF00711804; Tumer Z, 1996, ANN MED, V28, P121; VERGA V, 1991, AM J HUM GENET, V48, P1133; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471	44	80	80	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					63	71						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981948				2022-12-18	WOS:A1997WA81800011
J	Pallotti, F; Chen, X; Bonilla, E; Schon, EA				Pallotti, F; Chen, X; Bonilla, E; Schon, EA			Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; POLYMERASE CHAIN-REACTION; NUCLEOTIDE-SEQUENCE PRESERVATION; CYTOCHROME-C-OXIDASE; OXIDATIVE DAMAGE; RINR-38 CELLS; HUMAN-TISSUES; HUMAN BRAIN; DELETION; REPAIR	It is unclear at present whether specific mtDNA point mutations accumulate during normal human aging. In order to address this question, we used quantitative PCR of total DNA isolated from skeletal muscle from normal individuals of various ages to search for the presence and amount of spontaneous mtDNA point mutations in two small regions of the human mitochondrial genome. We observed low levels of somatic mutations above background in both regions, but there was no correlation between the amount of mutation detected and the age of the subject. These results contrasted with our finding of an age-related increase in the amount of the mtDNA ''common deletion'' in these very samples. Thus, it appears that both somatic mtDNA point mutations and mtDNA deletions can arise at low frequency in normal individuals but that, unlike deletions, there is no preferential amplification or accumulation of specific point mutations in skeletal muscle over the course of the normal human life span.	COLUMBIA UNIV,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032	Columbia University; Columbia University				Pallotti, Francesco/0000-0001-9946-8516	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, P01NS011766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012131] Funding Source: NIH RePORTER; NIA NIH HHS [AG12131] Funding Source: Medline; NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS11766] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; BODENTEICH A, 1991, GENE, V108, P305, DOI 10.1016/0378-1119(91)90451-G; CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234; CHEN X, 1995, AM J HUM GENET, V57, P239; CHEN X, 1993, B MOL BIOL MED, V18, P57; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; CLEAVER JE, 1992, RADIAT RES, V131, P338, DOI 10.2307/3578425; COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; CROIZAT B, 1975, J CELL SCI, V19, P69; DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319; DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042; Eckert K A, 1991, PCR Methods Appl, V1, P17; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELLEYBOSCO E, 1991, NUCLEIC ACIDS RES, V19, P2913, DOI 10.1093/nar/19.11.2913; GERSCHENSON M, 1994, J MOL CELL CARDIOL, V26, P31, DOI 10.1006/jmcc.1994.1005; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMBLET NS, 1995, BIOCHEM BIOPH RES CO, V207, P839, DOI 10.1006/bbrc.1995.1262; HARE JF, 1980, BIOCHEMISTRY-US, V19, P2023, DOI 10.1021/bi00551a003; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; HAYASHI JI, 1994, J BIOL CHEM, V269, P6878; HEGLER J, 1993, CARCINOGENESIS, V14, P2309, DOI 10.1093/carcin/14.11.2309; HOLT IJ, 1990, AM J HUM GENET, V46, P428; KAHN SM, 1991, ONCOGENE, V6, P1079; KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KUMAR R, 1988, ONCOGENE, V3, P647; LANSMAN RA, 1975, J MOL BIOL, V99, P761, DOI 10.1016/S0022-2836(75)80183-5; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732; Ling L L, 1991, PCR Methods Appl, V1, P63; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122; MITA S, 1988, CANCER RES, V48, P4578; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MONNAT RJ, 1985, CANCER RES, V45, P1809; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913; Moraes CT, 1995, PROG CELL R, V5, P209; MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099; MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H; MURATA T, 1990, BIOCHEM INT, V20, P949; PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113; PIRSEL M, 1993, CARCINOGENESIS, V14, P2105, DOI 10.1093/carcin/14.10.2105; POULTON J, 1994, AM J HUM GENET, V54, P385; POURZAND C, 1993, MUTAT RES, V288, P113, DOI 10.1016/0027-5107(93)90213-Y; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100; SCHON EA, 1995, CELLULAR AGING CELL, P19; SEIBEL P, 1990, BIOCHEM BIOPH RES CO, V173, P561, DOI 10.1016/S0006-291X(05)80071-3; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V; SOONG NW, 1992, NAT GENET, V2, P318; SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7; ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158	64	80	84	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					591	602						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751860				2022-12-18	WOS:A1996VN62500013
J	HIETALA, M; HAKONEN, A; ARO, AR; NIEMELA, P; PELTONEN, L; AULA, P				HIETALA, M; HAKONEN, A; ARO, AR; NIEMELA, P; PELTONEN, L; AULA, P			ATTITUDES TOWARD GENETIC TESTING AMONG THE GENERAL-POPULATION AND RELATIVES OF PATIENTS WITH A SEVERE GENETIC-DISEASE - A SURVEY FROM FINLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS; FOLLOW-UP; PARTICIPANTS; KNOWLEDGE	In the present study we explore the attitudes of the Finnish population toward genetic testing by conducting a questionnaire study of a stratified sample of the population as well as of family members of patients with a severe hereditary disease, aspartylglucosaminuria (AGU). The questionnaire evaluated attitudes toward gene tests in general and also respondents' preparedness to undergo gene tests for predictive testing, carrier detection, prenatal diagnosis, and selective abortion, in theoretical situations. The results of the study indicate that both the Finnish population in general and family members of AGU patients have a favorable attitude toward genetic testing. However, a commonly expressed reason against testing was that test results might lead to discrimination in employment or insurance policies. Based on the responses, we predict that future genetic testing programs will most probably be met with a high acceptance rate by the Finnish population.	NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00300 HELSINKI,FINLAND; NATL PUBL HLTH INST,DEPT MENTAL HLTH,SF-00300 HELSINKI,FINLAND; UNIV TURKU,DEPT MED GENET,TURKU,FINLAND; UNIV TURKU,DEPT PSYCHOL,TURKU,FINLAND	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Turku; University of Turku				Aro, Arja R/0000-0002-5499-2848				ANGASTINIOTIS M, 1986, World Health Forum, V7, P291; AULA P, 1982, GENETIC ERRORS GLYCO, P122; BEKKER H, 1994, J MED GENET, V31, P364, DOI 10.1136/jmg.31.5.364; CLOW CL, 1977, PEDIATRICS, V59, P86; CONWAY SP, 1994, CLIN GENET, V45, P308; DECRUYENAERE M, 1992, CLIN GENET, V41, P189; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GREEN JM, 1992, J MED GENET, V29, P313, DOI 10.1136/jmg.29.5.313; Hietala Marja, 1993, European Journal of Human Genetics, V1, P296; KAPLAN F, 1991, AM J HUM GENET, V49, P240; MENNIE M, 1993, CLIN GENET, V44, P102; MITCHELL J, 1993, J MED GENET, V30, P538, DOI 10.1136/jmg.30.7.538; ROWLEY PT, 1984, AM J HUM GENET, V36, P677; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; WATSON EK, 1991, BRIT J GEN PRACT, V41, P237; WATSON EK, 1992, LANCET, V340, P217, DOI 10.1016/0140-6736(92)90477-K; WILLIAMSON R, 1989, PRENATAL DIAG, V9, P727, DOI 10.1002/pd.1970091008; WITT D, 1993, AM J HUM GENET, V53, P49; ZEESMAN S, 1984, AM J MED GENET, V18, P769, DOI 10.1002/ajmg.1320180424	20	80	80	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1493	1500						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762573				2022-12-18	WOS:A1995RA79400029
J	RUSSELL, LJ; DIGIOVANNA, JJ; HASHEM, N; COMPTON, JG; BALE, SJ				RUSSELL, LJ; DIGIOVANNA, JJ; HASHEM, N; COMPTON, JG; BALE, SJ			LINKAGE OF AUTOSOMAL RECESSIVE LAMELLAR ICHTHYOSIS TO CHROMOSOME 14Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOMIC ORGANIZATION; CELL-ENVELOPE; GENE; FILAMENTS; PROTEINS; CLUSTER; DNA	We have mapped the locus for lamellar ichthyosis (LI), an autosomal recessive skin disease characterized by abnormal cornification of the epidermis. Analysis using both inbred and outbred families manifesting severe LI showed complete linkage to several markers within a 9.3-cM region on chromosome 14qll. Affected individuals in inbred families were also found to have striking homozygosity for markers in this region. Linkage-based genetic counseling and prenatal diagnosis is now available for informative at-risk families. Several transcribed genes have been mapped to the chromosome 14 region containing the LI gene. The transglutaminase 1 gene (TGM1), which encodes one of the enzymes responsible for crosslinking epidermal proteins during formation of the stratum corneum, maps to this interval. The TGM1 locus was completely linked to LI((Z) over cap=9.11), suggesting that TGM1 is a good candidate for further investigation of this disorder. The genes for four serine proteases also map to this region but are expressed only in hematopoietic or mast cells, making them less likely candidates.	NIAMSD,GENET STUDIES SECT,SKIN BIOL LAB,BETHESDA,MD 20892; AIN SHAMS UNIV,CTR MED GENET,CAIRO,EGYPT; NCI,DERMATOL BRANCH,BETHESDA,MD	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Egyptian Knowledge Bank (EKB); Ain Shams University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				DiGiovanna, John J./0000-0002-2750-2313				BERGERS M, 1990, J INVEST DERMATOL, V94, P407, DOI 10.1111/1523-1747.ep12874475; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CAPRA R, 1993, J NEUROL, V240, P336, DOI 10.1007/BF00839963; CAUGHEY GH, 1993, GENOMICS, V15, P614, DOI 10.1006/geno.1993.1115; DALE BA, 1978, NATURE, V276, P729, DOI 10.1038/276729a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAFEZ M, 1983, J MED GENET, V20, P58, DOI 10.1136/jmg.20.1.58; HANSON RD, 1990, P NATL ACAD SCI USA, V87, P960, DOI 10.1073/pnas.87.3.960; HOHL D, 1993, ARCH DERMATOL, V129, P618, DOI 10.1001/archderm.129.5.618; HOHL D, 1991, J BIOL CHEM, V266, P6626; HOHN PA, 1989, J BIOL CHEM, V264, P13412; KIM IG, 1992, J BIOL CHEM, V267, P7710; KLEIN JL, 1989, GENOMICS, V5, P110, DOI 10.1016/0888-7543(89)90093-1; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; NIEMI KM, 1991, ARCH DERMATOL RES, V283, P211, DOI 10.1007/BF01106104; OTT J, 1985, ANAL HUMAN GENETIC L; Reichert Uwe, 1993, P107; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P4097, DOI 10.1073/pnas.78.7.4097; TRAUPE H, 1989, ICHTHYOSES, P111; VANHOOIJDONK CAEM, 1991, ACTA DERM-VENEREOL, V71, P173; WILLIAMS ML, 1993, ARCH DERMATOL, V129, P626, DOI 10.1001/archderm.129.5.626; WILLIAMS ML, 1985, ARCH DERMATOL, V121, P477, DOI 10.1001/archderm.121.4.477; WILLIAMS ML, 1987, DERMATOL CLIN, P155; 1987, ICHTHYOSIS OVERVIEW, P3	25	80	83	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1146	1152						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977373				2022-12-18	WOS:A1994QB68400010
J	KLITZ, W; ALDRICH, CL; FILDES, N; HORNING, SJ; BEGOVICH, AB				KLITZ, W; ALDRICH, CL; FILDES, N; HORNING, SJ; BEGOVICH, AB			LOCALIZATION OF PREDISPOSITION TO HODGKIN DISEASE IN THE HLA CLASS-II REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; EBV; MHC; ANTIGEN; SUSCEPTIBILITY; EXPRESSION; LYMPHOMA; AMPLIFICATION; RESTRICTION	Molecular typing of HLA class II loci has been performed on a sample of 196 patients with Hodgkin lymphoma. Division of patients into two histological categories-nodular sclerosing Hodgkin disease versus all other types-shows significant overall association of the nodular sclerosing group with the HLA class II region. Haplotypes and alleles defined for the four loci typed-DRB1, DQA1, DQB1, and DPB1-were present in both excess and deficit in the nodular sclerosing sample. Some of the effects are attributable to particular DRB1 and DQB1 alleles, while other effects are best explained by haplotypes marking the entire class II region. The latter effects might be due to variation in additional, as-yet-unexamined loci in the class II region or to particular combinations of alleles from two or more loci. These data also explain why earlier studies showed HLA linkage but not association, and they substantiate the specific involvement of the immune system in certain neoplastic diseases.	ROCHE MOLEC SYST,DEPT HUMAN GENET,ALAMEDA,CA; STANFORD UNIV,SCH MED,DEPT MED ONCOL,PALO ALTO,CA 94304	Roche Holding; Stanford University	KLITZ, W (corresponding author), UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,345 MULFORD HALL,BERKELEY,CA 94720, USA.				NIAID NIH HHS [AI29042] Funding Source: Medline; NICHD NIH HHS [HD12731] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029042] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGNARSSON BA, 1989, CANCER, V63, P2083, DOI 10.1002/1097-0142(19890601)63:11<2083::AID-CNCR2820631102>3.0.CO;2-U; AISENBERG AC, 1991, MALIGNANT LYMPHOMA B; Amiel J.L, 1967, HISTOCOMPAT TEST, V1967, P79; ANAGNOSTOPOULOS I, 1989, BLOOD, V74, P810; Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BERBERICH FR, 1983, HUM IMMUNOL, V6, P207, DOI 10.1016/0198-8859(83)90094-0; BODMER JG, 1989, LANCET, V1, P1455; BODMER JG, 1992, HLA 1991, P701; CESBRON A, 1993, HUM IMMUNOL, V36, pA51; DEACON EM, 1993, J EXP MED, V177, P339, DOI 10.1084/jem.177.2.339; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; HERBST H, 1991, P NATL ACAD SCI USA, V88, P4766, DOI 10.1073/pnas.88.11.4766; HERBST H, 1989, LEUKEMIA RES, V13, P103, DOI 10.1016/0145-2126(89)90134-3; HORS J, 1983, IMMUNOL REV, V70, P167, DOI 10.1111/j.1600-065X.1983.tb00714.x; JOHANSSO.B, 1970, INT J CANCER, V6, P450, DOI 10.1002/ijc.2910060316; KALIDI I, 1989, NOUV REV FR HEMATOL, V31, P149; KHANNA R, 1992, J EXP MED, V176, P169, DOI 10.1084/jem.176.1.169; LARNTZ K, 1978, J AM STAT ASSOC, V73, P253, DOI 10.2307/2286650; LOSS GE, 1993, J EXP MED, V178, P73, DOI 10.1084/jem.178.1.73; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; MISKO IS, 1984, INT J CANCER, V33, P239, DOI 10.1002/ijc.2910330212; MOONSAMY PV, 1992, TISSUE ANTIGENS, V40, P153, DOI 10.1111/j.1399-0039.1992.tb02039.x; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; MUNOZ N, 1978, INT J CANCER, V22, P10, DOI 10.1002/ijc.2910220104; MURRAY RJ, 1992, J EXP MED, V176, P157, DOI 10.1084/jem.176.1.157; NUCHTERN JG, 1990, NATURE, V343, P74, DOI 10.1038/343074a0; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x; Sokal R.R., 1981, BIOMETRY, V2nd ed.; SPURKLAND A, 1992, TRANSPL P, V24, P298; TROWSDALE J, 1991, IMMUNOL TODAY, V12, P443, DOI 10.1016/0167-5699(91)90017-N; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WEISS LM, 1987, AM J PATHOL, V129, P86; WEISS LM, 1989, NEW ENGL J MED, V320, P502, DOI 10.1056/NEJM198902233200806; WEISS S, 1991, CELL, V64, P767, DOI 10.1016/0092-8674(91)90506-T; WU TC, 1990, INT J CANCER, V46, P801, DOI 10.1002/ijc.2910460509	38	80	82	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					497	505						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116619				2022-12-18	WOS:A1994MZ15800013
J	THEIN, SL; SAMPIETRO, M; ROHDE, K; ROCHETTE, J; WEATHERALL, DJ; LATHROP, GM; DEMENAIS, F				THEIN, SL; SAMPIETRO, M; ROHDE, K; ROCHETTE, J; WEATHERALL, DJ; LATHROP, GM; DEMENAIS, F			DETECTION OF A MAJOR GENE FOR HETEROCELLULAR HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN AFTER ACCOUNTING FOR GENETIC MODIFIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REGRESSIVE MODELS; F-CELLS; SEGREGATION ANALYSIS; NORMAL INDIVIDUALS; GLOBIN CLUSTER; HUMAN ADULTS; LINKAGE; DNA; ASSOCIATION; TRAITS	''Heterocellular hereditary persistence of fetal hemoglobin'' (HPFH) is the term used to describe the genetically determined persistence of fetal hemoglobin (Hb F) production into adult life, in the absence of any related hematological disorder. Whereas some forms are caused by mutations in the beta-globin gene cluster on chromosome 11, others segregate independently. While the latter are of particular interest with respect to the regulation of globin gene switching, it has not been possible to determine their chromosomal location, mainly because their mode of inheritance is not clear, but also because several other factors are known to modify Hb F production. We have examined a large Asian Indian pedigree which includes individuals with heterocellular HPFH associated with beta-thalassemia and/or alpha-thalassemia. Segregation analysis was conducted on the HPFH trait FC, defined to be the percentage of Hb F-containing cells (F-cells), using the class D regressive model. Our results provide evidence for the presence of a major gene, dominant or codominant, which controls the FC values with residual familial correlations. The major gene was detected when the effects of genetic modifiers, notably beta-thalassemia and the XmnI-(G) gamma polymorphism, are accounted for in the analysis. Linkage with the beta-globin gene cluster is excluded. The transmission of the FC values in this pedigree is informative enough to allow detection of linkage with an appropriate marker(s). The analytical approach outlined in this study, using simple regression to allow for genetic modifiers and thus allowing the mode of inheritance of a trait to be dissected out, may be useful as a model for segregation and linkage analyses of other complex phenotypes.	OSPED POLICLIN, IST MED INTERNA & FISIOPATOL MED, MILAN, ITALY; INSERM, U358, UNITE RECH GENET MALAD HUMAINES, PARIS, FRANCE; HOP COCHIN, PARIS, FRANCE; MAX DELBRUCK CTR, BERLIN, GERMANY	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Max Delbruck Center for Molecular Medicine	THEIN, SL (corresponding author), JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND.		Demenais, Florence/G-3298-2013	Demenais, Florence/0000-0001-8361-0936	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTAY C, 1977, HEMOGLOBIN, V1, P125; [Anonymous], 1992, Science, V258, P67; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; CRAIG JE, 1993, BRIT J HAEMATOL, V84, P106, DOI 10.1111/j.1365-2141.1993.tb03032.x; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; DEMENAIS FM, 1990, GENET EPIDEMIOL, V7, P319, DOI 10.1002/gepi.1370070503; DEMENAIS FM, IN PRESS GENET EPIDE; DOVER GJ, 1992, BLOOD, V80, P816; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GIAMPAOLO A, 1984, HUM GENET, V66, P151, DOI 10.1007/BF00286590; GIANNI AM, 1983, EMBO J, V2, P921, DOI 10.1002/j.1460-2075.1983.tb01522.x; GILMAN JG, 1985, BLOOD, V66, P783; GROSVELD F, 1993, BAILLIERE CLIN HAEM, V6, P31, DOI 10.1016/S0950-3536(05)80065-4; JEFFREYS AJ, 1986, AM J HUM GENET, V39, P11; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARTI HR, 1961, ACTA HAEMATOL-BASEL, V26, P65, DOI 10.1159/000206642; MARTINEZ G, 1989, HUM GENET, V82, P335, DOI 10.1007/BF00273993; MIYOSHI K, 1988, BLOOD, V72, P1854; OLD JM, 1990, SCIENCE, V63, P665; RUTLAND PC, 1983, BRIT J HAEMATOL, V53, P673, DOI 10.1111/j.1365-2141.1983.tb07319.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMPIETRO M, 1992, BLOOD, V79, P832; STAMATOYANNOPOU.G, 1987, MOL BASIS BLOOD DISE, P67; STAMATOYANNOPOULOS G, 1975, BLOOD, V46, P683; Thein SI., 1986, HUMAN GENETIC DIS PR, P33; THEIN SL, 1991, BRIT J HAEMATOL, V79, P113, DOI 10.1111/j.1365-2141.1991.tb08016.x; Thein SL, 1989, HEMOGLOBIN SWITCHI B, P97; THORPE SJ, 1981, THESIS U LONDON LOND; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOOD WG, 1975, BLOOD, V46, P671; ZAGO MA, 1979, BLOOD, V53, P977	38	80	82	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					214	228						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	7508182				2022-12-18	WOS:A1994MU31500006
J	BACH, G; MOSKOWITZ, SM; TIEU, PT; MATYNIA, A; NEUFELD, EF				BACH, G; MOSKOWITZ, SM; TIEU, PT; MATYNIA, A; NEUFELD, EF			MOLECULAR ANALYSIS OF HURLER-SYNDROME IN DRUZE AND MUSLIM ARAB PATIENTS IN ISRAEL - MULTIPLE ALLELIC MUTATIONS OF THE IDUA GENE IN A SMALL GEOGRAPHIC AREA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-L-IDURONIDASE; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; MUCOPOLYSACCHARIDOSIS-I; NONSENSE MUTATIONS; EXPRESSION; FREQUENCY; PHENOTYPE; SEQUENCE; CLONING	The mutations underlying Hurler syndrome (mucopolysaccharidosis IH) in Druze and Muslim Israeli Arab patients have been characterized. Four alleles were identified, using a combination of (a) PCR amplification of reverse-transcribed RNA or genomic DNA segments, (b) cycle sequencing of PCR products, and (c) restriction-enzyme analysis. One allele has two amino acid substitutions, Gly409-->Arg in exon 9 and Ter-->Cys in exon 14. The other three alleles have mutations in exon 2 (Tyr64-->Ter), exon 7 (Gln310-->Ter), or exon 8 (Thr366-->Pro). Transfection of mutagenized cDNAs into Cos-1 cells showed that two missense mutations, Thr366-->Pro and Ter-->Cys, permitted the expression of only trace amounts Of alpha-L-iduronidase activity, whereas Gly409-->Arg permitted the expression of 60% as much enzyme as did the normal cDNA. The nonsense mutations were associated with abnormalities of RNA processing: (1) both a very low level of mRNA and skipping of exon 2 for Tyr64-->Ter and (2) utilization of a cryptic splice site for Gln310-->Ter. In all instances, the probands were found homozygous, and the parents heterozygous, for the mutant alleles, as anticipated from the consanguinity in each family. The two-mutation allele was identified in a family from Gaza; the other three alleles were found in seven families, five of them Druze, residing in a very small area of northern Israel. Since such clustering suggests a classic founder effect, the presence of three mutant alleles of the IDUA gene was unexpected.	UNIV CALIF LOS ANGELES,DEPT BIOL CHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,BRAIN RES INST,LOS ANGELES,CA 90024; HADASSAH MED CTR,DEPT HUMAN GENET,JERUSALEM,ISRAEL	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Hebrew University of Jerusalem; Hadassah University Medical Center					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038857] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38857] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; KADOWAKI T, 1990, P NATL ACAD SCI USA, V87, P658, DOI 10.1073/pnas.87.2.658; Kohn G, 1978, Monogr Hum Genet, V10, P7; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOWRY RB, 1971, NEW ENGL J MED, V284, P221; MENON KP, 1992, GENOMICS, V14, P763, DOI 10.1016/S0888-7543(05)80182-X; Moskowitz S. M., 1992, American Journal of Human Genetics, V51, pA173; MOSKOWITZ SM, 1993, HUM MUTAT, V2, P71, DOI 10.1002/humu.1380020113; MOSKOWITZ SM, 1992, FASEB J, V6, pA77; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1991, AM J HUM GENET, V48, P1139; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAAP T, 1980, HUM GENET, V56, P221, DOI 10.1007/BF00295699; Scott Hamish S., 1992, Human Mutation, V1, P333, DOI 10.1002/humu.1380010412; Scott Hamish S., 1992, Human Mutation, V1, P103, DOI 10.1002/humu.1380010204; SCOTT HS, 1991, P NATL ACAD SCI USA, V88, P9695, DOI 10.1073/pnas.88.21.9695; SCOTT HS, 1992, GENOMICS, V13, P1311, DOI 10.1016/0888-7543(92)90053-U; SMITH DP, 1990, BIOTECHNIQUES, V9, P48; STOLTZFUS LJ, 1992, J BIOL CHEM, V267, P6570; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868	28	80	82	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					330	338						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328452				2022-12-18	WOS:A1993LN82000005
J	HODGE, SE				HODGE, SE			LINKAGE ANALYSIS VERSUS ASSOCIATION ANALYSIS - DISTINGUISHING BETWEEN 2 MODELS THAT EXPLAIN DISEASE-MARKER ASSOCIATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOPAMINE RECEPTOR GENE; DEPENDENT DIABETES-MELLITUS; RELATIVE RISKS; INSULIN GENE; ALCOHOLISM; HLA; SUSCEPTIBILITY; LOCUS; IDDM; HETEROGENEITY	Human genetics researchers have been intrigued for many years by weak-to-moderate associations between markers and diseases. However, in most cases of association, the cause of this phenomenon is still not known. Recently, interest has grown in pursuing association studies for complex diseases, either instead of or in addition to linkage studies. Hence, it is timely to reconsider what a disease-marker association, particularly in the weak-to-moderate range (relative risk <10), can tell us about disease etiology. To this end, this study accomplishes three aims: (1) It formulates two different models explaining weak-to-moderate associations and derives the relationship between them. One is a linkage disequilibrium model, and the other is a ''susceptibility,'' or pure association, model. The importance of drawing the distinction between these two models and the implications for our understanding of the genetics of human disease will also be discussed. It will be argued that the linkage disequilibrium model represents true linkage but that the susceptibility model does not. (2) It examines two family-based association tests proposed recently by Parsian et al. and Spielman et al. and derives formulas for their behavior under the two models described above. It demonstrates that these tests yield almost identical results under these two models. It shows that, whereas these tests can confirm an association, they cannot determine whether the association is caused by the linkage disequilibrium model or the susceptibility model. The study also characterizes the probabilities yielded by the family association tests in the presence of weak-to-moderate associations, which will aid researchers using these tests. (3) It proposes two approaches, both based on linkage analysis, which can distinguish between the two models described above. One approach involves a straightforward linkage analysis of the data; the other involves a partitioned association-linkage (PAL) test, as suggested by Greenberg. Formulas are derived for testing identity by descent in affected sib pairs by using both approaches. (4) Finally, the formulas and arguments are illustrated with two examples from the literature and one computer-simulated data set.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PSYCHIAT, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT BIOSTAT, NEW YORK, NY 10032 USA	Columbia University; Columbia University	HODGE, SE (corresponding author), NEW YORK STATE PSYCHIAT INST & HOSP, DIV CLIN GENET EPIDEMIOL, UNIT 14, 722 W 168TH, NEW YORK, NY 10032 USA.				NIDDK NIH HHS [DK-31813, DK-31775] Funding Source: Medline; NIMH NIH HHS [MH-48858] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031813, R55DK031813, R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARINAMI T, 1993, BIOL PSYCHIAT, V33, P108, DOI 10.1016/0006-3223(93)90309-2; BILLIARD M, 1985, LANCET, V1, P226; BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156; CAMPBELL MA, 1971, ANN HUM GENET, V35, P225, DOI 10.1111/j.1469-1809.1956.tb01395.x; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CLERGETDARPOUX F, 1980, ANN HUM GENET, V44, P195, DOI 10.1111/j.1469-1809.1980.tb00958.x; CLERGETDARPOUX F, 1989, GENET EPIDEMIOL, V6, pR6, DOI 10.1002/gepi.1370060102; CLONINGER CR, 1991, JAMA-J AM MED ASSOC, V266, P1833; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FARID NR, 1979, J CLIN INVEST, V63, P108, DOI 10.1172/JCI109263; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1986, GENET EPIDEMIOL, P323; FIELD LL, 1989, GENET EPIDEMIOL, V6, P101, DOI 10.1002/gepi.1370060119; GELERNTER J, 1991, JAMA-J AM MED ASSOC, V266, P1801, DOI 10.1001/jama.266.13.1801; Greenberg D. A., 1992, American Journal of Human Genetics, V51, pA150; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; HAILE RW, 1983, INT J EPIDEMIOL, V12, P8, DOI 10.1093/ije/12.1.8; HODGE SE, 1981, AM J HUM GENET, V33, P396; HODGE SE, 1981, AM J HUM GENET, V33, P381; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KIDD KK, 1977, HLA DISEASE, P72; MACKINTOSH P, 1978, BRIT MED BULL, V34, P291, DOI 10.1093/oxfordjournals.bmb.a071514; MORTON NE, 1955, AM J HUM GENET, V7, P277; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; NOTHEN MM, IN PRESS J MED GENET; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Ott J., 1991, ANAL HUMAN GENETIC L; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; ROTTER JI, 1978, DIABETES, V27, P599, DOI 10.2337/diabetes.27.5.599; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1978, TISSUE ANTIGENS, V12, P87, DOI 10.1111/j.1399-0039.1978.tb01303.x; SVEJGAARD A, 1989, GENET EPIDEMIOL, V6, P1, DOI 10.1002/gepi.1370060104; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1977, HLA DISEASE, P46; TURNER E, 1992, BIOL PSYCHIAT, V31, P285, DOI 10.1016/0006-3223(92)90052-2	39	80	83	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					367	384						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328455				2022-12-18	WOS:A1993LN82000009
J	THARAPEL, AT; ANDERSON, KP; SIMPSON, JL; MARTENS, PR; WILROY, RS; LLERENA, JC; SCHWARTZ, CE				THARAPEL, AT; ANDERSON, KP; SIMPSON, JL; MARTENS, PR; WILROY, RS; LLERENA, JC; SCHWARTZ, CE			DELETION (X)(Q26.1-]Q28) IN A PROBAND AND HER MOTHER - MOLECULAR CHARACTERIZATION AND PHENOTYPIC-KARYOTYPIC DEDUCTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN X-CHROMOSOME; FRAGMENT LENGTH POLYMORPHISMS; MENTAL-RETARDATION; LONG ARM; PREMATURE MENOPAUSE; ALPHA-THALASSEMIA; LOCUS; DNA; FAMILIES; MARKERS	During a routine prenatal diagnosis we detected a female fetus with an apparent terminal deletion of an X chromosome with a karyotype 46,X,del(X)(q25); the mother, who later underwent premature ovarian failure, had the same Xq deletion. To further delineate this familial X deletion and to determine whether the deletion was truly terminal or, rather, interstitial (retaining a portion of the terminal Xq28), we used a combination of fluorescence in situ hybridization (FISH) and Southern analyses. RFLP analyses and dosage estimation by densitometry were performed with a panel of nine probes (DXS3, DXS17, DXS11, DXS42, DXS86, DXS144E, DXS105, DXS304, and DXS52) that span the region Xq21 to subtelomeric Xq28. We detected a deletion involving the five probes spanning Xq26-Xq28. FISH with a cosmid probe (CLH 128) that defined Xq28 provided further evidence of a deletion in that region. Analysis with the X chromosome-specific cocktail probes spanning Xpter-qter showed hybridization signal all along the abnormal X, excluding the possibility of a cryptic translocation. However, sequential FISH with the X alpha-satellite probe DXZ1 and a probe for total human telomeres showed the presence of telomeres on both the normal and deleted X chromosomes. From the molecular and FISH analyses we interpret the deletion in this family as 46,X,del(X)(pter-->q26=qter). In light of previous phenotypic-karyotypic correlations, it can be deduced that this region contains a locus responsible for ovarian maintenance.	UNIV TENNESSEE CTR HLTH SCI,DEPT OBSTET & GYNECOL,MEMPHIS,TN 38163; GREENWOOD GENET CTR,DEPT MOLEC GENET,GREENWOOD,SC 29646	University of Tennessee System; University of Tennessee Health Science Center; Greenwood Genetic Center	THARAPEL, AT (corresponding author), UNIV TENNESSEE CTR HLTH SCI,DEPT PEDIAT,CLIN & MOLEC CYTOGENET LAB,711 JEFFERSON AVE,SUITE 523,MEMPHIS,TN 38163, USA.			Llerena Jr, Juan/0000-0002-4308-3841	PHS HHS [MCJ-131002] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BRUNS G, 1984, CYTOGENET CELL GENET, V37, P428; CAVENEE W, 1984, AM J HUM GENET, V36, P10; DAHL N, 1989, NUCLEIC ACIDS RES, V17, P2884, DOI 10.1093/nar/17.7.2884; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DEGROUCHY J, 1981, ANN GENET-PARIS, V24, P229; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FITCH N, 1982, AM J OBSTET GYNECOL, V142, P968, DOI 10.1016/0002-9378(82)90776-1; FRYNS JP, 1982, CLIN GENET, V22, P76; GILLIAM TC, 1984, HUM GENET, V68, P154, DOI 10.1007/BF00279306; GOONEWARDENA P, 1986, CLIN GENET, V30, P249; GREIDER CW, 1991, CELL, V67, P645, DOI 10.1016/0092-8674(91)90058-7; HANAUER A, 1985, CYTOGENET CELL GENET, V40, P647; HOFKER MH, 1987, AM J HUM GENET, V40, P312; Hu Xiuyuan, 1992, Human Mutation, V1, P3, DOI 10.1002/humu.1380010103; KRAUSS CM, 1987, NEW ENGL J MED, V317, P125, DOI 10.1056/NEJM198707163170301; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; NAGUIB KK, 1988, FERTIL STERIL, V49, P917; OBERLE I, 1987, HUM GENET, V77, P60; REKILA AM, 1988, HUM GENET, V80, P193, DOI 10.1007/BF00702869; SCAMBLER PJ, 1985, NUCLEIC ACIDS RES, V13, P3016, DOI 10.1093/nar/13.8.3016; SCHWARTZ C, 1987, HUM GENET, V76, P54; SCHWARTZ CE, 1986, CYTOGENET CELL GENET, V43, P117, DOI 10.1159/000132307; SIMPSON JL, 1987, 7 P INT C HUM GEN, P224; TAYSI K, 1983, AM J MED GENET, V14, P367, DOI 10.1002/ajmg.1320140217; TRUNCA C, 1984, HUM GENET, V68, P87, DOI 10.1007/BF00293879; VENEMAN TF, 1991, FERTIL STERIL, V55, P631; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	32	80	83	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					463	471						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8095365				2022-12-18	WOS:A1993KR72000003
J	HECHT, JT; YANG, P; MICHELS, VV; BUETOW, KH				HECHT, JT; YANG, P; MICHELS, VV; BUETOW, KH			COMPLEX SEGREGATION ANALYSIS OF NONSYNDROMIC CLEFT-LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-ANALYSIS; CONTINUOUS TRAITS; MODELS; DANISH	This study was undertaken to examine the inheritance pattern of nonsyndromic cleft lip with or without cleft palate (CL/P). Complex segregation analysis using the unified model as in POINTER and the regressive model as in REGD programs were applied to analyze a midwestern U.S. Caucasian population of 79 families ascertained through a proband with CL/F. In REGD, the dominant or codominant Mendelian major locus models of inheritance were the most parsimonious fit. In POINTER, besides the Mendelian major locus model, the multifactorial threshold (MF/T) model and the mixed model were also consistent with the observed data. However, the high heritability parameter of .93 (SD .063) in the MF/T model suggests that any random exongenous factors are unlikely to be the underlying mechanisms, and the mixed model indicates that this high heritability is accounted for by a major dominant locus component. These findings indicate that the best explanation for the etiology of CL/P in this study population is a putative major locus associated with markedly decreased penetrance. Molecular studies may provide further insight into the genetic mechanism underlying CL/P.	FOX CHASE CANC INST, PHILADELPHIA, PA 19111 USA; MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA	Fox Chase Cancer Center; Mayo Clinic	HECHT, JT (corresponding author), UNIV TEXAS, SCH MED, DEPT PEDIAT, POB 20708, HOUSTON, TX 77225 USA.				NIDCR NIH HHS [DE 08559, R03 DE 09189-01] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, R03DE009189] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; CHUNG CS, 1989, GENET EPIDEMIOL, V6, P625, DOI 10.1002/gepi.1370060507; CHUNG CS, 1986, AM J HUM GENET, V39, P603; DEMENAIS F, 1982, AM J MED GENET, V11, P287, DOI 10.1002/ajmg.1320110305; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; DEMENIAS FM, 1990, AM J HUM GENET, V47, pA132; DEPAEPE A, 1989, J MED GENET, V26, P794, DOI 10.1136/jmg.26.12.794; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FRASER FC, 1970, AM J HUM GENET, V22, P336; HECHT JT, 1989, AM J MED GENET, V33, P244, DOI 10.1002/ajmg.1320330221; HECHT JT, 1990, J MED GENET, V27, P597, DOI 10.1136/jmg.27.9.597; KIDD KK, 1976, J MED GENET, V13, P290, DOI 10.1136/jmg.13.4.290; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; MORTON NE, 1974, AM J HUM GENET, V26, P489; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; TEMPLE K, 1989, J MED GENET, V26, P386, DOI 10.1136/jmg.26.6.386; WANG JH, 1988, AM J HUM GENET, V42, P772	24	80	80	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					674	681						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1882845				2022-12-18	WOS:A1991GE36700022
J	FEDDE, KN; WHYTE, MP				FEDDE, KN; WHYTE, MP			ALKALINE-PHOSPHATASE (TISSUE-NONSPECIFIC ISOENZYME) IS A PHOSPHOETHANOLAMINE AND PYRIDOXAL-5'-PHOSPHATE ECTOPHOSPHATASE - NORMAL AND HYPOPHOSPHATASIA FIBROBLAST STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DIV ORTHOPED SURG,ST LOUIS,MO 63110	Washington University (WUSTL)	FEDDE, KN (corresponding author), WASHINGTON UNIV,JEWISH HOSP ST LOUIS,MED CTR,SCH MED,DIV BONE & MINERAL DIS,216 S KINGSHIGHWAY,ST LOUIS,MO 63110, USA.				PHS HHS [5 PO1 AC32087-05] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CHODIRKER B N, 1987, Genomics, V1, P280, DOI 10.1016/0888-7543(87)90056-5; FEDDE KN, 1988, ARCH BIOCHEM BIOPHYS, V264, P400, DOI 10.1016/0003-9861(88)90305-0; FERNLEY HN, 1965, BIOCHEM J, V97, P95, DOI 10.1042/bj0970095; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; HARRIS H, 1980, PRINCIPLES HUMAN BIO; HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234; HENTHORN PS, 1988, J BIOL CHEM, V263, P12011; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5597, DOI 10.1073/pnas.83.15.5597; HOFMANN MC, 1989, CANCER RES, V49, P4696; KOLATA G, 1985, SCIENCE, V229, P850, DOI 10.1126/science.229.4716.850; KOMINAMI T, 1985, BIOCHEM J, V227, P183, DOI 10.1042/bj2270183; LOW MG, 1977, BIOCHEM J, V167, P281, DOI 10.1042/bj1670281; LOW MG, 1980, BIOCHEMISTRY-US, V19, P3913, DOI 10.1021/bi00558a004; MALIK AS, 1986, BIOCHEM J, V240, P519, DOI 10.1042/bj2400519; McComb R.B., 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MILLAN JL, 1988, P NATL ACAD SCI USA, V85, P3024, DOI 10.1073/pnas.85.9.3024; MOSS DW, 1984, HUMAN ALKALINE PHOSP, P79; MULIVOR RA, 1985, J LAB CLIN MED, V105, P342; POLLARD HB, 1978, ANAL BIOCHEM, V86, P761, DOI 10.1016/0003-2697(78)90805-9; SCHALI C, 1984, BIOCHIM BIOPHYS ACTA, V769, P277, DOI 10.1016/0005-2736(84)90307-9; TAMURA Z., 1970, Methods in Enzymology, V18A, P471, DOI 10.1016/0076-6879(71)18346-2; WEISS MJ, 1989, AM J HUM GENET, V44, P686; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; WHYTE MP, 1988, J CLIN INVEST, V81, P1234, DOI 10.1172/JCI113440; WHYTE MP, 1983, J CLIN ENDOCR METAB, V57, P831, DOI 10.1210/jcem-57-4-831; WHYTE MP, 1986, J PEDIATR-US, V108, P82, DOI 10.1016/S0022-3476(86)80773-9; WHYTE MP, 1985, J CLIN INVEST, V76, P752, DOI 10.1172/JCI112031; WHYTE MP, 1989, BONE MINERAL RES, V6, P175; WHYTE MP, 1989, METABOLIC BASIS INHE, P2843	31	80	81	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					767	775						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220817				2022-12-18	WOS:A1990EE94000001
J	GRANDY, DK; ZHOU, QY; ALLEN, L; LITT, R; MAGENIS, RE; CIVELLI, O; LITT, M				GRANDY, DK; ZHOU, QY; ALLEN, L; LITT, R; MAGENIS, RE; CIVELLI, O; LITT, M			A HUMAN-D1 DOPAMINE RECEPTOR GENE IS LOCATED ON CHROMOSOME-5 AT Q35.1 AND IDENTIFIES AN ECORI RFLP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,DEPT BIOCHEM,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,DEPT MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,DEPT CELL BIOL & ANAT,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,DIV CRIPPLED CHILDREN,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University			Civelli, Olivier/A-8392-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025370] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37231] Funding Source: Medline; NIMH NIH HHS [MH45614] Funding Source: Medline; NINDS NIH HHS [R01NS25370] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN L J, 1989, American Journal of Human Genetics, V45, pA14; BARNES DM, 1988, SCIENCE, V241, P415, DOI 10.1126/science.3393909; BASSETT AS, 1988, LANCET, V1, P799; BEAULIEU M, 1987, CAN J NEUROL SCI, V14, P402, DOI 10.1017/S031716710003780X; BOYD CD, 1988, AM J HUM GENET, V42, P309; CASH R, 1987, J NEUROCHEM, V49, P1075, DOI 10.1111/j.1471-4159.1987.tb09996.x; CLARK D, 1987, SYNAPSE, V1, P347, DOI 10.1002/syn.890010408; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CREESE I, 1986, RECEPTORS, V4, P171; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Harnden DG, 1985, INT SYSTEM HUMAN CYT; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HESS EJ, 1987, DOPAMINE RECEPTORS R, V8, P1; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; LANKFORD KL, 1988, P NATL ACAD SCI USA, V85, P4567, DOI 10.1073/pnas.85.12.4567-a; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEE T, 1978, NATURE, V273, P59, DOI 10.1038/273059a0; MOHANDAS T, 1986, SOMAT CELL MOLEC GEN, V12, P89, DOI 10.1007/BF01560731; PEROUTKA SJ, 1980, AM J PSYCHIAT, V137, P1518; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; SEEMAN P, 1984, SCIENCE, V225, P728, DOI 10.1126/science.6147018; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Waddington J L, 1989, J Psychopharmacol, V3, P54, DOI 10.1177/026988118900300202; WALTERS JR, 1987, SCIENCE, V236, P719; WASMUTH JJ, 1989, CYTOGENET CELL GENET, V51, P137, DOI 10.1159/000132789; WASSERMANN GD, 1986, J THEOR BIOL, V120, P277, DOI 10.1016/S0022-5193(86)80200-4; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516; ZHOU QY, IN PRESS NATURE	32	80	85	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					828	834						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	1977312				2022-12-18	WOS:A1990EE94000010
J	CAVALLISFORZA, LL; KING, MC				CAVALLISFORZA, LL; KING, MC			DETECTING LINKAGE FOR GENETICALLY HETEROGENEOUS DISEASES AND DETECTING HETEROGENEITY WITH LINKAGE DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF BERKELEY,BERKELEY,CA 94720	University of California System; University of California Berkeley	CAVALLISFORZA, LL (corresponding author), STANFORD UNIV,STANFORD,CA 94305, USA.			King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [CA-27632] Funding Source: Medline; NIADDK NIH HHS [AM-34942] Funding Source: Medline; NIGMS NIH HHS [GM-28428] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM034942] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		HODGE SE, 1983, AM J HUM GENET, V35, P1139; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; OTT J, 1985, ANAL HUMAN GENETIC L; RISCH N, 1982, ANN HUM GENET, V46, P153, DOI 10.1111/j.1469-1809.1982.tb00706.x; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x	7	80	80	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					599	616						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3459352				2022-12-18	WOS:A1986C973000001
J	DEMARTINVILLE, B; WYMAN, AR; WHITE, R; FRANCKE, U				DEMARTINVILLE, B; WYMAN, AR; WHITE, R; FRANCKE, U			ASSIGNMENT OF THE 1ST RANDOM RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP) LOCUS (D14S1) TO A REGION OF HUMAN CHROMOSOME-14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MIT,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV UTAH,DEPT CELLULAR VIRAL & MOLEC BIOL,SALT LAKE CITY,UT	Massachusetts Institute of Technology (MIT); Utah System of Higher Education; University of Utah	DEMARTINVILLE, B (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510, USA.				NIGMS NIH HHS [GM-29789, GM-26105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029789, R01GM026105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; EDWARDS YH, 1971, ANN HUM GENET, V34, P395, DOI 10.1111/j.1469-1809.1971.tb00252.x; FRANCKE U, 1981, SOMAT CELL GENET, V7, P171; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P5776; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P1147, DOI 10.1073/pnas.74.3.1147; FRANCKE U, 1975, CYTOGENET CELL GENET, V14, P308, DOI 10.1159/000130370; FRANCKE U, 1976, SOMAT CELL GENET, V2, P27, DOI 10.1007/BF01539240; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FRANCKE U, 1977, SOMAT CELL GENET, V3, P381, DOI 10.1007/BF01542967; GIBLETT ER, 1975, LANCET, V1, P1010, DOI 10.1016/S0140-6736(75)91950-9; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; JONES C, 1981, SOMAT CELL GENET, V7, P399, DOI 10.1007/BF01542985; KAO FT, 1980, J CELL BIOL, V87, pA291; KHAN PM, 1971, ARCH BIOCHEM BIOPHYS, V145, P470, DOI 10.1016/S0003-9861(71)80007-3; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; OLIVER N, 1978, CYTOGENET CELL GENET, V22, P506, DOI 10.1159/000131009; PEARSON S, 1981, CYTOGENET CELL GENET; SANDERSHAIGH L, 1980, NATURE, V283, P683, DOI 10.1038/283683a0; VANSOMEREN H, 1974, HUMANGENETIK, V25, P189; WEIL D, 1980, ANN GENET-PARIS, V23, P150; WEITKAMP LR, 1978, CYTOGENET CELL GENET, V22, P647, DOI 10.1159/000131044; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; 1981, CYTOGENET CELL GENET; 1979, CYTOGENET CELL GENET, V25, P1	25	80	81	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					216	226						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6280496				2022-12-18	WOS:A1982NH73200005
J	ROTTER, JI				ROTTER, JI			THE MODES OF INHERITANCE OF INSULIN-DEPENDENT DIABETES-MELLITUS OR THE GENETICS OF IDDM, NO LONGER A NIGHTMARE BUT STILL A HEADACHE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES, HARBOR MED CTR, SCH MED, DEPT PEDIAT, TORRANCE, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	ROTTER, JI (corresponding author), UNIV CALIF LOS ANGELES, HARBOR MED CTR, SCH MED, DEPT MED, DIV MED GENET, TORRANCE, CA 90509 USA.				NIADDK NIH HHS [AM-00523, AM-25834] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON C, 1980, AM J HUM GENET, V32, pA97; BARBOSA J, 1980, LANCET, V2, P330; BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BARBOSA J, 1978, J CLIN INVEST, V62, P492, DOI 10.1172/JCI109151; BARTA L, 1977, NEW ENGL J MED, V296, P397; BERTRAMS J, 1979, LANCET, V2, P98; BERTRAMS J, 1976, TISSUE ANTIGENS, V8, P13; BOTTAZZO GF, 1976, LANCET, V2, P800; BOTTAZZO GF, 1978, BRIT MED J, V2, P165, DOI 10.1136/bmj.2.6131.165; BOTTAZZO GF, 1978, BRIT MED J, V2, P1253, DOI 10.1136/bmj.2.6147.1253; CAHILL GF, 1979, GENETIC ANAL COMMON, P113; CATHELINEAU G, 1976, NOUV PRESSE MED, V5, P586; Christy M, 1979, Diabetes Care, V2, P209, DOI 10.2337/diacare.2.2.209; CLERGETDARPOUX F, 1980, ANN HUM GENET, V44, P195, DOI 10.1111/j.1469-1809.1980.tb00958.x; CONTU L, UNPUB; CUDWORTH AG, 1978, BRIT MED BULL, V34, P285, DOI 10.1093/oxfordjournals.bmb.a071513; CUDWORTH AG, 1978, DIABETOLOGIA, V14, P281, DOI 10.1007/BF01223018; CUDWORTH AG, 1976, BRIT MED J, V2, P846, DOI 10.1136/bmj.2.6040.846; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DEGNBOL B, 1978, ANN HUM GENET, V42, P25, DOI 10.1111/j.1469-1809.1978.tb00929.x; DESCHAMPS I, 1980, DIABETOLOGIA, V19, P189, DOI 10.1007/BF00275267; DORNAN J, 1980, DIABETES, V29, P423, DOI 10.2337/diabetes.29.6.423; FALK CT, 1980, ANN HUM GENET, V43, P295; FARID NR, 1978, TISSUE ANTIGENS, V12, P215, DOI 10.1111/j.1399-0039.1978.tb01326.x; FARID NR, 1979, DIABETES, V28, P552, DOI 10.2337/diabetes.28.6.552; FARID NR, 1978, TISSUE ANTIGENS, V12, P205, DOI 10.1111/j.1399-0039.1978.tb01324.x; FIALKOW PJ, 1975, ANN INTERN MED, V83, P170, DOI 10.7326/0003-4819-83-2-170; FINKELSTEIN S, 1972, TISSUE ANTIGENS, V2, P74; GORWITZ K, 1976, DIABETES, V25, P122, DOI 10.2337/diabetes.25.2.122; GOTTLIEB MS, 1968, DIABETES, V17, P693, DOI 10.2337/diab.17.11.693; GREENBERG DA, 1981, AM J MED GENET, V8, P205, DOI 10.1002/ajmg.1320080211; HODGE SE, 1981, AM J HUM GENET, V33, P396; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; ILONEN J, 1978, TISSUE ANTIGENS, V11, P144, DOI 10.1111/j.1399-0039.1978.tb01239.x; IRVINE WJ, 1978, J CLIN LAB IMMUNOL, V1, P111; IRVINE WJ, 1978, J CLIN LAB IMMUNOL, V1, P107; IRVINE WJ, 1977, DIABETES, V26, P138, DOI 10.2337/diabetes.26.2.138; IRVINE WJ, 1977, LANCET, V1, P638; IRVINE WJ, 1979, J CLIN LAB IMMUNOL, V2, P23; KIDD CJ, 1978, DIABETES, V27, P57; KIRK RL, 1979, LANCET, V2, P537; LENDRUM R, 1976, BRIT MED J, V1, P1565, DOI 10.1136/bmj.1.6025.1565; LUDVIGSSON J, 1977, DIABETOLOGIA, V13, P13, DOI 10.1007/BF00996321; LUDWIG H, 1976, NEW ENGL J MED, V294, P1066; LUDWIG H, 1979, METABOLISM, V28, P797, DOI 10.1016/0026-0495(79)90204-X; LUDWIG H, 1977, DEUT MED WOCHENSCHR, V102, P1221, DOI 10.1055/s-0028-1105483; MACDONALD MJ, 1980, DIABETES, V29, P110, DOI 10.2337/diab.29.2.110; McMichael A, 1977, Prog Med Genet, V2, P39; MORRIS PJ, 1976, LANCET, V2, P652; NAKAO Y, 1981, NEW ENGL J MED, V304, P407, DOI 10.1056/NEJM198102123040706; NAKAO Y, 1980, CLIN EXP IMMUNOL, V42, P20; NERUP J, 1978, DIABETES, V27, P247, DOI 10.2337/diab.27.1.S247; NERUP J, 1977, HLA DISEASE, P149; NERUP J, 1976, GENETICS DIABETES ME, P106; NEUFELD M, 1980, DIABETES, V29, P589, DOI 10.2337/diabetes.29.8.589; NEUFELD MR, 1980, NEW ENGL J MED, V303, P111; NISSLEY SP, 1973, DIABETES, V22, P63, DOI 10.2337/diab.22.1.63; PENA AS, 1978, GASTROENTEROLOGY, V75, P230; PYKE DA, 1979, DIABETOLOGIA, V17, P333, DOI 10.1007/BF01236266; PYKE DA, 1978, TWIN RES C, P1; PYKE DA, 1976, GENETICS DIABETES ME, P194; RAUM D, 1979, LANCET, V1, P1208; RICHENS ER, 1979, CLIN EXP IMMUNOL, V36, P198; RILEY WJ, 1980, J PEDIATR-US, V97, P191, DOI 10.1016/S0022-3476(80)80472-0; RIMOIN DL, 1967, DIABETES, V16, P346, DOI 10.2337/diab.16.5.346; RIMOIN DL, 1976, GENETICS DIABETES ME, P43; RIMOIN DL, 1971, GENETIC DISORDERS EN, P150; Rotter J I, 1979, Diabetes Care, V2, P215, DOI 10.2337/diacare.2.2.215; ROTTER JI, 1978, DIABETES, V27, P599, DOI 10.2337/diabetes.27.5.599; ROTTER JI, 1980, DIABETES, V29, P115, DOI 10.2337/diabetes.29.2.115; ROTTER JI, 1978, GENETIC EPIDEMIOLOGY, P381; ROTTER JI, 1981, ETIOLOGY PATHOGENESI, P37; ROTTER JI, 1981, HDB DIABETES MELLITU, P3; RUBINSTEIN P, 1981, AM J HUM GENET, V33, P865; RUBINSTEIN P, 1977, NEW ENGL J MED, V297, P1036, DOI 10.1056/NEJM197711102971905; SCHERNTHANER G, 1979, J CLIN ENDOCR METAB, V48, P403, DOI 10.1210/jcem-48-3-403; SCHERNTHANER G, 1976, NEW ENGL J MED, V295, P622; SCHERNTHANER G, 1981, BASIC CLIN ASPECTS I; SMITH WI, 1978, DIABETES, V27, P1092, DOI 10.2337/diabetes.27.11.1092; SOLOW H, 1979, DIABETES, V28, P1, DOI 10.2337/diabetes.28.1.1; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; SPIELMAN RS, 1979, GENETIC ANAL COMMON, P567; STROBER W, 1980, GENETICS HETEROGENEI, P243; SUAREZ B, 1979, DIABETES, V28, P527, DOI 10.2337/diabetes.28.6.527; SUAREZ BK, 1979, CLIN GENET, V15, P126; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; SVEJGAARRD A, 1975, TRANSPLANT REV, V22, P1; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Thomson G, 1977, HLA DISEASE, P84; WOODROW JC, 1979, GENETIC VARIATION HO, V2, P63	91	80	81	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					835	851						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199	7034532				2022-12-18	WOS:A1981MV19900001
J	KURCZYNSKI, TW; STEINBERG, AG				KURCZYNSKI, TW; STEINBERG, AG			A GENERAL PROGRAM FOR MAXIMUM LIKELIHOOD ESTIMATION OF GENE FREQUENCIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter																		STEINBERG AG, 1966, AM J HUM GENET, V18, P459	1	80	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	2					178	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	91653	4164485				2022-12-18	WOS:A19679165300010
J	TASHIAN, RE; SHAW, MW				TASHIAN, RE; SHAW, MW			INHERITANCE OF AN ERYTHROCYTE ACETYLESTERASE VARIANT IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALDRIDGE WN, 1953, BIOCHEM J, V53, P110, DOI 10.1042/bj0530110; ALLEN SL, 1961, ANN NY ACAD SCI, V94, P753, DOI 10.1111/j.1749-6632.1961.tb35571.x; AUGUSTINSSON K, 1961, ANN NY ACAD SCI, V94, P844, DOI 10.1111/j.1749-6632.1961.tb35578.x; BACH MARILYN L., 1961, FED PROC, V20, P255; DAVIS BJ, 1959, P SOC EXP BIOL MED, V101, P90; MARKERT CL, 1959, J HISTOCHEM CYTOCHEM, V7, P42, DOI 10.1177/7.1.42; SHAW CR, 1962, SCIENCE; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; TASHIAN RE, 1961, P SOC EXP BIOL MED, V108, P364; WACHSTEIN M, 1958, J HISTOCHEM CYTOCHEM, V6, P457, DOI 10.1177/6.6.457	10	80	80	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	3					295	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2964A	13919743				2022-12-18	WOS:A19622964A00008
J	Aref-Eshghi, E; Kerkhof, J; Pedro, VP; DI France, G; Barat-Houari, M; Ruiz-Pallares, N; Andrau, JC; Lacombe, D; Van-Gils, J; Fergelot, P; Dubourg, C; Cormier-Daire, V; Rondeau, S; Lecoquierre, F; Saugier-Veber, P; Nicolas, G; Lesca, G; Chatron, N; Sanlaville, D; Vitobello, A; Faivre, L; Thauvin-Robinet, C; Laumonnier, F; Raynaud, M; Alders, M; Mannens, M; Henneman, P; Hennekam, RC; Velasco, G; Francastel, C; Ulveling, D; Ciolfi, A; Pizzi, S; Tartaglia, M; Heide, S; Heron, D; Mignot, C; Keren, B; Whalen, S; Afenjar, A; Bienvenu, T; Campeau, PM; Rousseau, J; Levy, MA; Brick, L; Kozenko, M; Balci, TB; Siu, VM; Stuart, A; Kadour, M; Masters, J; Takano, K; Kleefstra, T; de Leeuw, N; Field, M; Shaw, M; Gecz, J; Ainsworth, PJ; Lin, HX; Rodenhiser, DI; Friez, MJ; Tedder, M; Lee, JA; DuPont, BR; Stevenson, RE; Skinner, SA; Schwartz, CE; Genevieve, D; Sadikovic, B				Aref-Eshghi, Erfan; Kerkhof, Jennifer; Pedro, Victor P.; DI France, Groupe; Barat-Houari, Mouna; Ruiz-Pallares, Nathalie; Andrau, Jean-Christophe; Lacombe, Didier; Van-Gils, Julien; Fergelot, Patricia; Dubourg, Christele; Cormier-Daire, Valerie; Rondeau, Sophie; Lecoquierre, Francois; Saugier-Veber, Pascale; Nicolas, Gael; Lesca, Gaetan; Chatron, Nicolas; Sanlaville, Damien; Vitobello, Antonio; Faivre, Laurence; Thauvin-Robinet, Christel; Laumonnier, Frederic; Raynaud, Martine; Alders, Marielle; Mannens, Marcel; Henneman, Peter; Hennekam, Raoul C.; Velasco, Guillaume; Francastel, Claire; Ulveling, Damien; Ciolfi, Andrea; Pizzi, Simone; Tartaglia, Marco; Heide, Solveig; Heron, Delphine; Mignot, Cyril; Keren, Boris; Whalen, Sandra; Afenjar, Alexandra; Bienvenu, Thierry; Campeau, Philippe M.; Rousseau, Justine; Levy, Michael A.; Brick, Lauren; Kozenko, Mariya; Balci, Tugce B.; Siu, Victoria Mok; Stuart, Alan; Kadour, Mike; Masters, Jennifer; Takano, Kyoko; Kleefstra, Tjitske; de Leeuw, Nicole; Field, Michael; Shaw, Marie; Gecz, Jozef; Ainsworth, Peter J.; Lin, Hanxin; Rodenhiser, David, I; Friez, Michael J.; Tedder, Matt; Lee, Jennifer A.; DuPont, Barbara R.; Stevenson, Roger E.; Skinner, Steven A.; Schwartz, Charles E.; Genevieve, David; Sadikovic, Bekim			Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANTS	Genetic syndromes frequently present with overlapping clinical features and inconclusive or ambiguous genetic findings which can confound accurate diagnosis and clinical management. An expanding number of genetic syndromes have been shown to have unique genomic DNA methylation patterns (called "episignatures"). Peripheral blood episignatures can be used for diagnostic testing as well as for the interpretation of ambiguous genetic test results. We present here an approach to episignature mapping in 42 genetic syndromes, which has allowed the identification of 34 robust disease-specific episignatures. We examine emerging patterns of overlap, as well as similarities and hierarchical relationships across these episignatures, to highlight their key features as they are related to genetic heterogeneity, dosage effect, unaffected carrier status, and incomplete penetrance. We demonstrate the necessity of multiclass modeling for accurate genetic variant classification and show how disease classification using a single episignature at a time can sometimes lead to classification errors in closely related episignatures. We demonstrate the utility of this tool in resolving ambiguous clinical cases and identification of previously undiagnosed cases through mass screening of a large cohort of subjects with developmental delays and congenital anomalies. This study more than doubles the number of published syndromes with DNA methylation episignatures and, most significantly, opens new avenues for accurate diagnosis and clinical assessment in individuals affected by these disorders.	[Aref-Eshghi, Erfan; Kerkhof, Jennifer; Levy, Michael A.; Stuart, Alan; Ainsworth, Peter J.; Lin, Hanxin; Sadikovic, Bekim] London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON N6A 5W9, Canada; [Pedro, Victor P.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [DI France, Groupe] French Rare Dis Network Filiere AnDDI Rare France, Grp DI, Montpellier, France; [Barat-Houari, Mouna; Ruiz-Pallares, Nathalie] CHU Montpellier, Med Genet Dept Rare Dis & Personalized Med, Autoinflammatory & Rare Dis Unit, F-34090 Montpellier, France; [Andrau, Jean-Christophe] Univ Montpellier, IGMM, CNRS, UMR5535, F-34090 Montpellier, France; [Lacombe, Didier; Van-Gils, Julien; Fergelot, Patricia] Bordeaux Univ, CHU Bordeaux, Reference Ctr AD SOOR, Inserm U1211,Med Genet Dept,AnDDI Rare, F-33076 Bordeaux, France; [Dubourg, Christele] CHU Rennes, Serv Genet Mol & Genom, F-35000 Rennes, France; [Cormier-Daire, Valerie; Rondeau, Sophie] Paris Descartes Univ, Necker Enfants Malad Hosp, Imagine Inst, Dept Med Genet,INSERM,UMR 1163, F-75015 Paris, France; [Lecoquierre, Francois; Saugier-Veber, Pascale; Nicolas, Gael] Univ Bourgogne Franche Comte, FHU TRANSLAD, Genet Dev Disorders, INSERM,UMR 1231,GAD, Dijon, France; [Lesca, Gaetan; Chatron, Nicolas; Sanlaville, Damien] Univ Hosp Lyon, Dept Med Genet, F-69007 Lyon, France; [Vitobello, Antonio; Faivre, Laurence; Thauvin-Robinet, Christel] Univ Bourgogne Franche Comte, INSERM, Equipe GAD, UMR1231, Batiment B3, F-21000 Dijon, France; [Laumonnier, Frederic; Raynaud, Martine] Univ Tours, INSERM, iBrain, UMR 1253, F-37200 Tours, France; [Laumonnier, Frederic; Raynaud, Martine] CHU Tours, Serv Genet, F-37000 Tours, France; [Alders, Marielle; Mannens, Marcel; Henneman, Peter] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Reprod & Dev Res Inst, Dept Clin Genet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1012 WX Amsterdam, Netherlands; [Velasco, Guillaume; Francastel, Claire; Ulveling, Damien] Univ Paris, CNRS, Epigenet & Destin Cellulaire, F-75013 Paris, France; [Ciolfi, Andrea; Pizzi, Simone; Tartaglia, Marco] IRCCS, Genet & Rare Dis Res Div, Osped Pediatr Bambino Gesu, I-00146 Rome, Italy; [Heide, Solveig; Heron, Delphine; Mignot, Cyril; Keren, Boris] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Genet,Referral Ctr Intellectual Disabil, F-75013 Paris, France; [Whalen, Sandra; Afenjar, Alexandra] Sorbonne Univ, Trousseau Hosp, AP HP, Unit Genet, F-75012 Paris, France; [Bienvenu, Thierry] Cochin Hosp, Dept Mol Genet, F-75014 Paris, France; [Campeau, Philippe M.; Rousseau, Justine] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1J4, Canada; [Levy, Michael A.; Ainsworth, Peter J.; Lin, Hanxin; Sadikovic, Bekim] Western Univ, Dept Pathol & Lab Med, London, ON N6A 3K7, Canada; [Brick, Lauren; Kozenko, Mariya] McMaster Univ, Dept Pediat, Genet Div, Hamilton, ON L8S 4K1, Canada; [Balci, Tugce B.; Siu, Victoria Mok] Western Univ, Dept Pediat, Div Med Genet, London, ON N6A 3K7, Canada; [Balci, Tugce B.; Siu, Victoria Mok] London Hlth Sci Ctr, Med Genet Program Southwestern Ontario, London, ON N6A 5W9, Canada; [Kadour, Mike; Masters, Jennifer] London Hlth Sci Ctr, Dept Pathol & Lab Med, London, ON N6A 5W9, Canada; [Kadour, Mike; Masters, Jennifer] St Josephs Hlth Care London, London, ON N6A 5W9, Canada; [Takano, Kyoko] Shinshu Univ Hosp, Ctr Med Genet, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Kleefstra, Tjitske; de Leeuw, Nicole] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Kleefstra, Tjitske; de Leeuw, Nicole] Donders Ctr Med Neurosci, NL-6525 GA Nijmegen, Netherlands; [Field, Michael] Hunter Genet, Genet Learning Disabil Serv, Waratah, NSW 2298, Australia; [Shaw, Marie; Gecz, Jozef] Univ Adelaide, Sch Med, Robinson Res Inst, Adelaide, SA 5005, Australia; [Gecz, Jozef] South Australian Hlth & Med Res Inst, Adelaide, SA 5005, Australia; [Rodenhiser, David, I] Childrens Hlth Res Inst, London, ON N6A 3K7, Canada; [Rodenhiser, David, I] Western Univ, Dept Biochem, London, ON N6A 3K7, Canada; [Friez, Michael J.; Tedder, Matt; Lee, Jennifer A.; DuPont, Barbara R.; Stevenson, Roger E.; Skinner, Steven A.; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Genevieve, David] Montpellier Univ, CHU Montpellier, Reference Ctr AD SOOR,Med Genet Dept Rare Dis & P, AnDDI RARE,Grp DI,Inserm U1183,Inst Regenerat Med, F-34090 Montpellier, France; [Vitobello, Antonio] Dijon Univ Hosp, Unite Fonct Innovat Diagnost Genom Malad Rares, FHU TRANSLAD, F-21000 Dijon, France; [Faivre, Laurence; Thauvin-Robinet, Christel] CHU Dijon, Ctr Reference Deficiences Intellectuelles Causes, F-21000 Dijon, France	London Health Sciences Centre; Western University (University of Western Ontario); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Lyon; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; IRCCS Bambino Gesu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Western University (University of Western Ontario); McMaster University; Western University (University of Western Ontario); London Health Sciences Centre; London Health Sciences Centre; Western University (University of Western Ontario); Shinshu University; Radboud University Nijmegen; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Western University (University of Western Ontario); Greenwood Genetic Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne	Sadikovic, B (corresponding author), London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON N6A 5W9, Canada.; Sadikovic, B (corresponding author), Western Univ, Dept Pathol & Lab Med, London, ON N6A 3K7, Canada.	Bekim.Sadikovic@lhsc.on.ca	Gecz, Jozef/X-3469-2019; Vitobello, Antonio/ABC-2970-2021; Balci, Tugce/AAA-8617-2021; Francastel, Claire/AAI-4798-2021; Velasco, Guillaume/AAM-2447-2020; Lesca, Gaetan/C-6111-2019; Campeau, Philippe/J-8614-2015; Laumonnier, Frederic/N-1165-2016; Ciolfi, Andrea/J-4954-2018; Tartaglia, Marco/K-2955-2018	Gecz, Jozef/0000-0002-7884-6861; Vitobello, Antonio/0000-0003-3717-8374; Campeau, Philippe/0000-0001-9713-7107; Laumonnier, Frederic/0000-0003-2567-0708; Ciolfi, Andrea/0000-0002-6191-0978; Tartaglia, Marco/0000-0001-7736-9672; Lesca, Gaetan/0000-0001-7691-9492; Saugier-Veber, Pascale/0000-0002-8045-6432; Francastel, Claire/0000-0002-6353-4320; Rousseau, Justine/0000-0002-3554-2673; Andrau, Jean-Christophe/0000-0003-0203-8507; Stuart, Alan/0000-0001-6370-8581; Lecoquierre, Francois/0000-0002-9110-1856; Nicolas, Gael/0000-0001-9391-7800; Faivre, Laurence/0000-0001-9770-444X	Amsterdam Reproduction and Development Institute	Amsterdam Reproduction and Development Institute	We thank the staff, molecular geneticists, and clinical geneticists in centers across France, USA, Italy, Australia, the Netherlands, Japan, and Canada for the identification, evaluation, and diagnosis of the individuals with neurodevelopmental conditions presented in this study. Special thanks to Andrea Venema, Ab Chudley, Cindy Curry, Alasdair Hunter, Yanagi K., and Kaname T. for involvement in the collection and processing of samples for some of the cohorts in this study. We also thank the families of the affected subjects for providing consent and information. The study was partially financially supported by the Amsterdam Reproduction and Development Institute. Dedicated to the memory of Ethan Francis Schwartz, 1996-1998.	Aref-Eshghi E, 2019, HUM MUTAT, V40, P1684, DOI 10.1002/humu.23833; Aref-Eshghi E, 2018, TRANSL EPIGENET SER, V6, P837, DOI 10.1016/B978-0-12-812215-0.00027-3; Aref-Eshghi E, 2019, AM J HUM GENET, V104, P685, DOI 10.1016/j.ajhg.2019.03.008; Aref-Eshghi E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07193-y; Aref-Eshghi E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00100; Aref-Eshghi E, 2018, AM J HUM GENET, V102, P156, DOI 10.1016/j.ajhg.2017.12.008; Aref-Eshghi E, 2017, EPIGENETICS-US, V12, P923, DOI 10.1080/15592294.2017.1381807; Aref-Eshghi E, 2017, J MOL DIAGN, V19, P848, DOI 10.1016/j.jmoldx.2017.07.002; Aref-Eshghi E, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0745-5; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Aygun D, 2020, DEV MED CHILD NEUROL, V62, P192, DOI 10.1111/dmcn.14398; Barbosa M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04540-x; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Bend EG, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0658-5; Bjornsson HT, 2015, GENOME RES, V25, P1473, DOI 10.1101/gr.190629.115; Ciolfi A, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-019-0804-0; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Godler DE, 2019, ESSAYS BIOCHEM, V63, P785, DOI 10.1042/EBC20190056; Guerra JVS, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.103737; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Johansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Krzyzewska IM, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0749-3; Kular L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04732-5; Martin-Herranz DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1753-9; Nascimento RMP, 2006, AM J HUM GENET, V79, P549, DOI 10.1086/507047; Platt JC, 2000, ADV NEUR IN, P61; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sadikovic B, 2019, EPIGENOMICS-UK, V11, P563, DOI 10.2217/epi-2018-0192; Schenkel LC, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0453-8; Schulze KV, 2019, GENET MED, V21, P2453, DOI 10.1038/s41436-019-0516-z; Su D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166486; Tan WH, 2014, AM J MED GENET A, V164, P975, DOI 10.1002/ajmg.a.36416; Van Baak TE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1374-0; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Velasco G, 2019, CLIN GENET, V95, P210, DOI 10.1111/cge.13480; Velasco G, 2018, HUM MOL GENET, V27, P2409, DOI 10.1093/hmg/ddy130; Ventham NT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13507; Yousefi P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2034-y	43	79	79	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2020	106	3					356	370		10.1016/j.ajhg.2020.01.019	http://dx.doi.org/10.1016/j.ajhg.2020.01.019			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT6CT	32109418	Green Published, Bronze			2022-12-18	WOS:000519101800013
J	Gasperini, M; Findlay, GM; McKenna, A; Milbank, JH; Lee, C; Zhang, MD; Cusanovich, DA; Shendure, J				Gasperini, Molly; Findlay, Gregory M.; McKenna, Aaron; Milbank, Jennifer H.; Lee, Choli; Zhang, Melissa D.; Cusanovich, Darren A.; Shendure, Jay			CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG NONCODING RNAS; HUMAN-CELLS; MAMMALIAN-CELLS; GENETIC SCREENS; STEM-CELLS; CRISPR-CAS9; DNA; CHROMATIN; PROMOTER; VARIANTS	The extent to which non-coding mutations contribute to Mendelian disease is a major unknown in human genetics. Relatedly, the vast majority of candidate regulatory elements have yet to be functionally validated. Here, we describe a CRISPR-based system that uses pairs of guide RNAs (gRNAs) to program thousands of kilobase-scale deletions that deeply scan across a targeted region in a tiling fashion ("ScanDel''). We applied ScanDel to HPRT1, the housekeeping gene underlying Lesch-Nyhan syndrome, an X-linked recessive disorder. Altogether, we programmed 4,342 overlapping 1 and 2 kb deletions that tiled 206 kb centered on HPRT1 (including 87 kb upstream and 79 kb downstream) with median 27-fold redundancy per base. We functionally assayed programmed deletions in parallel by selecting for loss of HPRT function with 6-thioguanine. As expected, sequencing gRNA pairs before and after selection confirmed that all HPRT1 exons are needed. However, HPRT1 function was robust to deletion of any intergenic or deeply intronic non-coding region, indicating that proximal regulatory sequences are sufficient for HPRT1 expression. Although our screen did identify the disruption of exon-proximal non-coding sequences (e.g., the promoter) as functionally consequential, long-read sequencing revealed that this signal was driven by rare, imprecise deletions that extended into exons. Our results suggest that no singular distal regulatory element is required for HPRT1 expression and that distal mutations are unlikely to contribute substantially to Lesch-Nyhan syndrome burden. Further application of ScanDel could shed light on the role of regulatory mutations in disease at other loci while also facilitating a deeper understanding of endogenous gene regulation.	[Gasperini, Molly; Findlay, Gregory M.; McKenna, Aaron; Milbank, Jennifer H.; Lee, Choli; Zhang, Melissa D.; Cusanovich, Darren A.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Gasperini, M; Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	gasperim@uw.edu; shendure@uw.edu	Findlay, Gregory/AAX-9029-2020; Shendure, Jay/AAU-3684-2021	Findlay, Gregory/0000-0002-7767-8608; Cusanovich, Darren/0000-0001-6889-0095; Milbank, Jennifer/0000-0001-5091-8053	NIH [DP1HG007811]; National Human Genome Research Institute [1R01HG006768]; National Cancer Institute [1R01CA197139, F30CA213728]; NIH; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007312]; NHLBI [T32HL007828]; NATIONAL CANCER INSTITUTE [F30CA213728, R01CA197139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828, T32HL007312] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811, R01HG006768, T32HG000035, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For discussion and advice, the authors thank all members of the Shendure Lab, particularly Lea Starita, Andrew Hill, Ron Hause, Seungsoo Kim, Martin Kircher, and Beth Martin. We thank the University of Washington PacBio Sequencing Services core for their assistance. This work was supported by an NIH Director's Pioneer Award (DP1HG007811 to J.S.), the National Human Genome Research Institute (1R01HG006768 to J.S.), and the National Cancer Institute (1R01CA197139 to J.S. and F30CA213728 to G.M.F.). M.G. is a National Science Foundation Graduate Research Fellow. A.M. was supported by the NIH and National Heart, Lung, and Blood Institute (NHLBI; T32HL007312). D.A.C. was supported in part by the NHLBI (T32HL007828). J.S. is an investigator of the Howard Hughes Medical Institute.	Aguet F., 2016, LOCAL GENETIC EF FEC; Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/NMETH.4264, 10.1038/nmeth.4264]; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Fu R, 2014, BRAIN, V137, P1282, DOI 10.1093/brain/awt202; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Horlbeck M. A., 2016, ELIFE, V5, P1; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jacobs L., 1984, HDB MUTAGENICITY TES, P321; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kumasaka N, 2016, NAT GENET, V48, P206, DOI 10.1038/ng.3467; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Li MLJ, 2013, NUCLEIC ACIDS RES, V41, pW150, DOI 10.1093/nar/gkt456; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A., 2016, WHOLE ORGANISM LINEA, P353; Monnat R. J., 2009, PROTOCOL HPRT MUTAGE; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RINCONLIMAS DE, 1991, MOL CELL BIOL, V11, P4157, DOI 10.1128/MCB.11.8.4157; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wakabayashi A, 2016, P NATL ACAD SCI USA, V113, P4434, DOI 10.1073/pnas.1521754113; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	57	79	82	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					192	205		10.1016/j.ajhg.2017.06.010	http://dx.doi.org/10.1016/j.ajhg.2017.06.010			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28712454	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000406854800004
J	Anikster, Y; Haack, TB; Vilboux, T; Pode-Shakked, B; Thony, B; Shen, N; Guarani, V; Meissner, T; Mayatepek, E; Trefz, FK; Marek-Yagel, D; Martinez, A; Huttlin, EL; Paulo, JA; Berutti, R; Benoist, JF; Imbard, A; Dorboz, I; Heimer, G; Landau, Y; Ziv-Strasser, L; Malicdan, MCV; Gemperle-Britschgi, C; Cremer, K; Engels, H; Meili, D; Keller, I; Bruggmann, R; Strom, TM; Meitinger, T; Mullikin, JC; Schwartz, G; Ben-Zeev, B; Gahl, WA; Harper, JW; Blau, N; Hoffmann, GF; Prokisch, H; Opladen, T; Schiff, M				Anikster, Yair; Haack, Tobias B.; Vilboux, Thierry; Pode-Shakked, Ben; Thony, Beat; Shen, Nan; Guarani, Virginia; Meissner, Thomas; Mayatepek, Ertan; Trefz, Friedrich K.; Marek-Yagel, Dina; Martinez, Aurora; Huttlin, Edward L.; Paulo, Joao A.; Berutti, Riccardo; Benoist, Jean-Francois; Imbard, Apolline; Dorboz, Imen; Heimer, Gali; Landau, Yuval; Ziv-Strasser, Limor; Malicdan, May Christine V.; Gemperle-Britschgi, Corinne; Cremer, Kirsten; Engels, Hartmut; Meili, David; Keller, Irene; Bruggmann, Remy; Strom, Tim M.; Meitinger, Thomas; Mullikin, James C.; Schwartz, Gerard; Ben-Zeev, Bruria; Gahl, William A.; Harper, J. Wade; Blau, Nenad; Hoffmann, Georg F.; Prokisch, Holger; Opladen, Thomas; Schiff, Manuel			Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAPERONE DNAJB6; PHENYLKETONURIA; GENETICS; DEFICIENCY; VARIANTS	Phenylketonuria (PKU, phenylalanine hydroxylase deficiency), an inborn error of metabolism, can be detected through newborn screening for hyperphenylalaninemia (HPA). Most individuals with HPA harbor mutations in the gene encoding phenylalanine hydroxylase (PAH), and a small proportion (2%) exhibit tetrahydrobiopterin (BH4) deficiency with additional neurotransmitter (dopamine and serotonin) deficiency. Here we report six individuals from four unrelated families with HPA who exhibited progressive neurodevelopmental delay, dystonia, and a unique profile of neurotransmitter deficiencies without mutations in PAH or BH4 metabolism disorder-related genes. In these six affected individuals, whole-exome sequencing (WE'S) identified biallelic mutations in DNAIC12, which encodes a heat shock co-chaperone family member that interacts with phenylalanine, tyrosine, and tryptophan hydroxylases catalyzing the BH4-activated conversion of phenylalanine into tyrosine, tyrosine into L-dopa (the precursor of dopamine), and tryptophan into 5-hydroxytryptophan (the precursor of serotonin), respectively. DNAJC12 was un-detectable in fibroblasts from the individuals with null mutations. PAH enzyme activity was reduced in the presence of DNAIC12 mutations. Early treatment with BH4 and/or neurotransmitter precursors had dramatic beneficial effects and resulted in the prevention of neurodevelopmental delay in the one individual treated before symptom onset. Thus, DNAJC12 deficiency is a preventable and treatable cause of intellectual disability that should be considered in the early differential diagnosis when screening results are positive for HPA. Sequencing of DNAIC12 may resolve any uncertainty and should be considered in all children with unresolved HPA.	[Anikster, Yair; Pode-Shakked, Ben; Marek-Yagel, Dina; Landau, Yuval; Schwartz, Gerard] Edmond & Lily Safra Childrens Hosp, Metab Dis Unit, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Anikster, Yair; Pode-Shakked, Ben; Marek-Yagel, Dina; Heimer, Gali; Landau, Yuval; Schwartz, Gerard; Ben-Zeev, Bruria] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Anikster, Yair; Marek-Yagel, Dina] Sheba Med Ctr, Wohl Inst Translat Med, IL-52621 Tel Hashomer, Israel; [Haack, Tobias B.; Berutti, Riccardo; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Trogerstr 32, D-81675 Munich, Germany; [Haack, Tobias B.; Berutti, Riccardo; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Vilboux, Thierry; Malicdan, May Christine V.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Vilboux, Thierry; Malicdan, May Christine V.] Inova Translat Med Inst, Div Med Genom, Falls Church, VA 22042 USA; [Pode-Shakked, Ben; Heimer, Gali] Sheba Med Ctr, Dr Pinchas Borenstein Talpiot Med Leadership Prog, IL-52621 Tel Hashomer, Israel; [Thony, Beat; Gemperle-Britschgi, Corinne; Meili, David] Univ Zurich, Div Metab Clin Chem & Biochem, Div Metab, Dept Pediat, CH-8032 Zurich, Switzerland; [Shen, Nan; Trefz, Friedrich K.; Blau, Nenad; Hoffmann, Georg F.; Opladen, Thomas] Univ Childrens Hosp, Div Neuropediat & Metab Med, D-69120 Heidelberg, Germany; [Guarani, Virginia; Huttlin, Edward L.; Paulo, Joao A.; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Meissner, Thomas; Mayatepek, Ertan] Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Martinez, Aurora] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Martinez, Aurora] Univ Bergen, KG Jebsen Ctr Neuropsychiat Disorders, N-5009 Bergen, Norway; [Benoist, Jean-Francois; Imbard, Apolline] Robert Debre Univ Hosp, APHP, Dept Biochem, F-75019 Paris, France; [Dorboz, Imen; Schiff, Manuel] Univ Paris Diderot, Sorbonne Paris Cite, UMR1141, PROTECT,INSERM, F-75019 Paris, France; [Heimer, Gali; Ben-Zeev, Bruria] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Pediat Neurol Unit, IL-52621 Tel Hashomer, Israel; [Ziv-Strasser, Limor] Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Malicdan, May Christine V.; Gahl, William A.] NIH, Undiagnosed Dis Program, Common Fund, Off Director, Bldg 10, Bethesda, MD 20892 USA; [Cremer, Kirsten; Engels, Hartmut] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Keller, Irene; Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, CH-3012 Bern, Switzerland; [Keller, Irene; Bruggmann, Remy] Univ Bern, Swiss Inst Bioinformat, CH-3012 Bern, Switzerland; [Keller, Irene] Univ Bern, Dept Clin Res, CH-3012 Bern, Switzerland; [Mullikin, James C.] NHGRI, NISC, NIH, Bethesda, MD 20892 USA; [Schiff, Manuel] Robert Debre Univ Hosp, APHP, Reference Ctr Inborn Errors Metab, F-75019 Paris, France	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Chaim Sheba Medical Center; University of Zurich; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bergen; University of Bergen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Chaim Sheba Medical Center; Chaim Sheba Medical Center; National Institutes of Health (NIH) - USA; University of Bonn; University of Bern; Swiss Institute of Bioinformatics; University of Bern; University of Bern; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Anikster, Y (corresponding author), Edmond & Lily Safra Childrens Hosp, Metab Dis Unit, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel.; Anikster, Y (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel.; Anikster, Y (corresponding author), Sheba Med Ctr, Wohl Inst Translat Med, IL-52621 Tel Hashomer, Israel.; Schiff, M (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, UMR1141, PROTECT,INSERM, F-75019 Paris, France.; Schiff, M (corresponding author), Robert Debre Univ Hosp, APHP, Reference Ctr Inborn Errors Metab, F-75019 Paris, France.	yair.anikster@sheba.health.gov.il; manuel.schiff@aphp.fr	Schiff, Manuel/G-3596-2017; Martinez, Aurora/M-3088-2019; Malicdan, May Christine/AAK-7422-2021; Paulo, Joao/AAO-3981-2020; Meitinger, Thomas/O-1318-2015	Schiff, Manuel/0000-0001-8272-232X; Martinez, Aurora/0000-0003-1643-6506; Paulo, Joao/0000-0002-4291-413X; Prokisch, Holger/0000-0003-2379-6286; Bruggmann, Remy/0000-0001-5629-6363; Blau, Nenad/0000-0003-4347-3230; Huttlin, Edward/0000-0002-1822-1173; Meitinger, Thomas/0000-0002-8838-8403; Harper, Jeffrey/0000-0002-6944-7236; Thony, Beat/0000-0002-8420-4769	NIH National Human Genome Research Intramural Research Program; NIH [U41 HG006673]; Dietmar Hopp Foundation; St. Leon-Rot, the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders [01GM1113C]; Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; E-Rare project GENOMIT [01GM1207]; EU Horizon Collaborative Research Project SOUND [633974]; Illig-Stiftung for HPA individuals; EU [305444, FP7-HEALTH-2012-INNOVATION-1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006673, ZIAHG000215, ZIBHG000196] Funding Source: NIH RePORTER	NIH National Human Genome Research Intramural Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dietmar Hopp Foundation; St. Leon-Rot, the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders(Federal Ministry of Education & Research (BMBF)); Juniorverbund in der Systemmedizin "mitOmics"; E-Rare project GENOMIT; EU Horizon Collaborative Research Project SOUND; Illig-Stiftung for HPA individuals; EU(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors wish to thank the participants in this study and their families for their cooperation and support. We would also like to acknowledge the professional manuscript services of American Journal Experts (AJE). This study was supported in part by the NIH National Human Genome Research Intramural Research Program; the NIH (U41 HG006673); the Dietmar Hopp Foundation; St. Leon-Rot, the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET, 01GM1113C) and the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C); the E-Rare project GENOMIT (01GM1207); the EU Horizon 2020 Collaborative Research Project SOUND (633974); and the Illig-Stiftung for HPA individuals and the FP7-HEALTH-2012-INNOVATION-1 EU Grant No. 305444 (RD-CONNECT).	Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Bjorgo E, 1998, EUR J BIOCHEM, V257, P1, DOI 10.1046/j.1432-1327.1998.2570001.x; Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; Blau N, 2016, HUM MUTAT, V37, P508, DOI 10.1002/humu.22980; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Dekker SL, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00035; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Heintz C, 2012, MOL GENET METAB, V105, P559, DOI 10.1016/j.ymgme.2011.12.025; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Leuzzi V, 2010, CLIN GENET, V77, P249, DOI 10.1111/j.1399-0004.2009.01306.x; Luke MM, 2009, STROKE, V40, P363, DOI 10.1161/STROKEAHA.108.521328; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Ng J, 2015, NAT REV NEUROL, V11, P567, DOI 10.1038/nrneurol.2015.172; Opladen T, 2012, J INHERIT METAB DIS, V35, P963, DOI 10.1007/s10545-012-9506-x; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Stephen J, 2016, EUR J HUM GENET, V24, P1268, DOI 10.1038/ejhg.2016.5; van Kerkhof LWM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135652	25	79	83	4	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					257	266		10.1016/j.ajhg.2017.01.002	http://dx.doi.org/10.1016/j.ajhg.2017.01.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28132689	Green Published, Bronze			2022-12-18	WOS:000393352000007
J	Arno, G; Agrawal, SA; Eblimit, A; Bellingham, J; Xu, MC; Wang, F; Chakarova, C; Parfitt, DA; Lane, A; Burgoyne, T; Hull, S; Carss, KJ; Fiorentino, A; Hayes, MJ; Munro, PM; Nicols, R; Pontikos, N; Holder, GE; Asomugha, C; Raymond, FL; Moore, AT; Plagnol, V; Michaelides, M; Hardcastle, AJ; Li, YM; Cukras, C; Webster, AR; Cheetham, ME; Chen, R				Arno, Gavin; Agrawal, Smriti A.; Eblimit, Aiden; Bellingham, James; Xu, Mingchu; Wang, Feng; Chakarova, Christina; Parfitt, David A.; Lane, Amelia; Burgoyne, Thomas; Hull, Sarah; Carss, Keren J.; Fiorentino, Alessia; Hayes, Matthew J.; Munro, Peter M.; Nicols, Ralph; Pontikos, Nikolas; Holder, Graham E.; Asomugha, Chinwe; Raymond, F. Lucy; Moore, Anthony T.; Plagnol, Vincent; Michaelides, Michel; Hardcastle, Alison J.; Li, Yumei; Cukras, Catherine; Webster, Andrew R.; Cheetham, Michael E.; Chen, Rui		UKIRDC	Mutations in REEP6 Cause Autosomal-Recessive Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; OPTIC CUPS; DISEASE; IDENTIFICATION; MECHANISMS; GENES; EXPRESSION; GENOMICS	Retinitis pigmentosa (RP) is the most frequent form of inherited retinal dystrophy. RP is genetically heterogeneous and the genes identified to date encode proteins involved in a wide range of functional pathways, including photoreceptor development, phototransduction, the retinoid cycle, cilia, and outer segment development. Here we report the identification of biallelic mutations in Receptor Expression Enhancer Protein 6 (REEP6) in seven individuals with autosomal-recessive RP from five unrelated families. REEP6 is a member of the REEP/Yop1 family of proteins that influence the structure of the endoplasmic reticulum but is relatively unstudied. The six variants identified include three frameshift variants, two missense variants, and a genomic rearrangement that disrupts exon 1. Human 3D organoid optic cups were used to investigate REEP6 expression and confirmed the expression of a retina-specific isoform REEP6.1, which is specifically affected by one of the frameshift mutations. Expression of the two missense variants (c.383C>T [p.Pro128Leu] and c.404T>C [p.Leu135Pro]) and the REEP6.1 frameshift mutant in cultured cells suggest that these changes destabilize the protein. Furthermore, CRISPR-Cas9-mediated gene editing was used to produce Reep6 knock-in mice with the p.Leu135Pro RP-associated variant identified in one RP-affected individual. The homozygous knock-in mice mimic the clinical phenotypes of RP, including progressive photoreceptor degeneration and dysfunction of the rod photoreceptors. Therefore, our study implicates REEP6 in retinal homeostasis and highlights a pathway previously uncharacterized in retinal dystrophy.	[Arno, Gavin; Bellingham, James; Chakarova, Christina; Parfitt, David A.; Lane, Amelia; Burgoyne, Thomas; Hull, Sarah; Fiorentino, Alessia; Hayes, Matthew J.; Munro, Peter M.; Pontikos, Nikolas; Holder, Graham E.; Moore, Anthony T.; Michaelides, Michel; Hardcastle, Alison J.; Webster, Andrew R.; Cheetham, Michael E.] UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England; [Arno, Gavin; Hull, Sarah; Holder, Graham E.; Moore, Anthony T.; Michaelides, Michel; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Agrawal, Smriti A.; Eblimit, Aiden; Xu, Mingchu; Wang, Feng; Li, Yumei; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Agrawal, Smriti A.; Eblimit, Aiden; Xu, Mingchu; Wang, Feng; Li, Yumei; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Carss, Keren J.; Raymond, F. Lucy] Cambridge Univ Hosp NHS Fdn Trust, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Carss, Keren J.] Univ Cambridge, Dept Haematol, NHS Blood & Transplant Ctr, Cambridge CB2 0PT, England; [Nicols, Ralph] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Asomugha, Chinwe] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Moore, Anthony T.] UCSF, Sch Med, Dept Ophthalmol, Koret Vis Ctr, San Francisco, CA 94133 USA; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Cukras, Catherine] NEI, NIH, Bethesda, MD 20892 USA	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Baylor College of Medicine; Baylor College of Medicine; University of Cambridge; University of Cambridge; Baylor College of Medicine; Baylor College of Medicine; University of Cambridge; University of California System; University of California San Francisco; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Cheetham, ME (corresponding author), UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.; Chen, R (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Chen, R (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	michael.cheetham@ucl.ac.uk; ruichen@bcm.edu	Xu, Mingchu/J-9369-2019; Pontikos, Nikolas/U-3642-2018; Fiorentino, Alessia/ABC-3638-2020; Burgoyne, Thomas/HCI-9054-2022; Bellingham, James/GVS-8955-2022; Black, Graeme/K-7374-2015; Poulter, James/A-8190-2013	Pontikos, Nikolas/0000-0003-1782-4711; Burgoyne, Thomas/0000-0002-8428-720X; Bellingham, James/0000-0003-3368-5221; Toomes, Carmel/0000-0001-8373-9545; Hardcastle, Alison/0000-0002-0038-6770; Lord, Emma/0000-0001-9216-7382; Lise, Stefano/0000-0003-4472-6893; Parfitt, David/0000-0001-5095-0766; Black, Graeme/0000-0001-8727-6592; Fiorentino, Alessia/0000-0002-1403-4581; Taylor, Rachel/0000-0002-1235-4303; Cheetham, Michael/0000-0001-6429-654X; van Heyningen, Veronica/0000-0003-0359-0141; Carss, Keren/0000-0003-4939-156X; Poulter, James/0000-0003-2048-5693	Foundation Fighting Blindness [BR-GE-0613-0618-BCM]; National Eye Institute [R01EY022356, R01EY020540]; NEI vision core grant [P30EY002520]; RP Fighting Blindness and Fight for Sight; Wellcome Trust [092621]; National Institute for Health Research (UK); Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Fight for Sight UK; Moorfields Eye Hospital Special Trustees; Foundation Fighting Blindness - USA; Medical Research Council [1125070] Funding Source: researchfish; National Institute for Health Research [ACF-2013-06-009] Funding Source: researchfish; Fight for Sight [1511/12] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY022356, P30EY002520, R01EY020540] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI vision core grant; RP Fighting Blindness and Fight for Sight; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Fight for Sight UK; Moorfields Eye Hospital Special Trustees; Foundation Fighting Blindness - USA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank all the individuals and their family members for participating in this study. We also thank the Integrated Microscopy Core at Baylor College of Medicine for OCT experiments. Additionally, we thank Dr. Anand Swaroop for providing the Reep6 antibody and Dr. Peter MacLeish for providing the 7G6 antibody. We would also like to thank the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE) and Amy Turiff, the NEI coordinator, the UK Inherited Retinal Disease Consortium (UKIRDC), and the NIHR BioResource - RareDiseases project (BRIDGE-SPEED). This project was funded by the Foundation Fighting Blindness (BR-GE-0613-0618-BCM) and National Eye Institute (R01EY022356, R01EY020540) to R.C. Sequencing effort is also supported by the NEI vision core grant (P30EY002520). The UKIRDC is funded by RP Fighting Blindness and Fight for Sight. This project was also supported by The Wellcome Trust (092621 to M.E.C.), The National Institute for Health Research (UK), Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, Fight for Sight UK, Moorfields Eye Hospital Special Trustees, and Foundation Fighting Blindness - USA.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Beetz C, 2013, J CLIN INVEST, V123, P4273, DOI 10.1172/JCI65665; Beetz C, 2012, AM J HUM GENET, V91, P139, DOI 10.1016/j.ajhg.2012.05.007; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bjork S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076366; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Ellingford JM, 2016, J MED GENET, V53, P761, DOI 10.1136/jmedgenet-2016-103837; Esteves T, 2014, AM J HUM GENET, V94, P268, DOI 10.1016/j.ajhg.2013.12.005; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Hao H, 2014, HUM MOL GENET, V23, P4260, DOI 10.1093/hmg/ddu143; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim YS, 2015, ANN NEUROL, V78, P679, DOI 10.1002/ana.24488; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nash BM, 2015, TRANSL PEDIATR, V4, P139, DOI 10.3978/j.issn.2224-4336.2015.04.03; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang F, 2014, HUM GENET, V133, P331, DOI 10.1007/s00439-013-1381-5; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	34	79	80	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1305	1315		10.1016/j.ajhg.2016.10.008	http://dx.doi.org/10.1016/j.ajhg.2016.10.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27889058	Green Published, hybrid			2022-12-18	WOS:000389148600006
J	Ogura, Y; Kou, I; Miura, S; Takahashi, A; Xu, LL; Takeda, K; Takahashi, Y; Kono, K; Kawakami, N; Uno, K; Ito, M; Minami, S; Yonezawa, I; Yanagida, H; Taneichi, H; Zhu, ZZ; Tsuji, T; Suzuki, T; Sudo, H; Kotani, T; Watanabe, K; Hosogane, N; Okada, E; Iida, A; Nakajima, M; Sudo, A; Chiba, K; Hiraki, Y; Toyama, Y; Qiu, Y; Shukunami, C; Kamatani, Y; Kubo, M; Matsumoto, M; Ikegawal, S				Ogura, Yoji; Kou, Ikuyo; Miura, Shigenori; Takahashi, Atsushi; Xu, Leilei; Takeda, Kazuki; Takahashi, Yohei; Kono, Katsuki; Kawakami, Noriaki; Uno, Koki; Ito, Manabu; Minami, Shohei; Yonezawa, Ikuho; Yanagida, Haruhisa; Taneichi, Hiroshi; Zhu, Zezhang; Tsuji, Taichi; Suzuki, Teppei; Sudo, Hideki; Kotani, Toshiaki; Watanabe, Kota; Hosogane, Naobumi; Okada, Eijiro; Iida, Aritoshi; Nakajima, Masahiro; Sudo, Akihiro; Chiba, Kazuhiro; Hiraki, Yuji; Toyama, Yoshiaki; Qiu, Yong; Shukunami, Chisa; Kamatani, Yoichiro; Kubo, Michiaki; Matsumoto, Mono; Ikegawal, Shiro			A Functional SNP in BNC2 Is Associated with Adolescent Idiopathic Scoliosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; LBX1; CHINESE; IDENTIFICATION; POPULATION; RS11190870; BASONUCLIN; ZEBRAFISH; VARIANTS	Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity. We previously conducted a genome-wide association study (GWAS) and detected two loci associated with AIS. To identify additional loci, we extended our GWAS by increasing the number of cohorts (2,109 affected subjects and 11,140 control subjects in total) and conducting a whole-genome imputation. Through the extended GWAS and replication studies using independent Japanese and Chinese populations, we identified a susceptibility locus on chromosome 9p22.2 (p = 2.46 x 10(-13); odds ratio = 1.21). The most significantly associated SNPs were in intron 3 of BNC2, which encodes a zinc finger transcription factor, basonuclin-2. Expression quantitative trait loci data suggested that the associated SNPs have the potential to regulate the BNC2 transcriptional activity and that the susceptibility alleles increase BNC2 expression. We identified a functional SNP, rs10738445 in BNC2, whose susceptibility allele showed both higher binding to a transcription factor, YY1 (yin and yang 1), and higher BNC2 enhancer activity than the non-susceptibility allele. BNC2 overexpression produced body curvature in developing zebrafish in a gene-dosage-dependent manner. Our results suggest that increased BNC2 expression is implicated in the etiology of AIS.	[Ogura, Yoji; Kou, Ikuyo; Takeda, Kazuki; Takahashi, Yohei; Iida, Aritoshi; Nakajima, Masahiro; Ikegawal, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Integrat Sci, Tokyo 1088639, Japan; [Ogura, Yoji; Takeda, Kazuki; Takahashi, Yohei; Watanabe, Kota; Hosogane, Naobumi; Toyama, Yoshiaki; Matsumoto, Mono] Keio Univ, Dept Orthopaed Surg, Sch Med, Tokyo 1608582, Japan; [Miura, Shigenori] Kyoto Univ, Dept Cellular Differentiat, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Takahashi, Atsushi; Kamatani, Yoichiro] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Xu, Leilei; Zhu, Zezhang; Qiu, Yong] Nanjing Univ, Sch Med, Dept Spine Surg, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Kono, Katsuki] Eiju Gen Hosp, Dept Orthopaed Surg, Tokyo 1108645, Japan; [Kawakami, Noriaki; Tsuji, Taichi] Meijo Hosp, Dept Orthopaed Surg, Nagoya, Aichi 4600001, Japan; [Uno, Koki; Suzuki, Teppei] Natl Hosp Org, Dept Orthopaed Surg, Kobe Med Ctr, Kobe, Hyogo 6540155, Japan; [Ito, Manabu; Sudo, Hideki] Hokkaido Univ, Dept Adv Med Spine & Spinal Cord Disorders, Grad Sch Med, Sapporo, Hokkaido 0608648, Japan; [Minami, Shohei; Kotani, Toshiaki] Seirei Sakura Citizen Hosp, Dept Orthopaed Surg, Sakura 2858765, Japan; [Yonezawa, Ikuho] Juntendo Univ, Dept Orthopaed Surg, Sch Med, Tokyo 1138431, Japan; [Yanagida, Haruhisa] Fukuoka Childrens Hosp, Dept Orthopaed Surg, Fukuoka 8100063, Japan; [Taneichi, Hiroshi] Dokkyo Med Univ, Dept Orthopaed Surg, Sch Med, Tochigi 3210293, Japan; [Okada, Eijiro] Saiseikai Cent Hosp, Dept Orthopaed Surg, Tokyo 1080073, Japan; [Sudo, Akihiro] Mie Univ, Dept Orthopaed Surg, Sch Med, Tsu, Mie 5148507, Japan; [Chiba, Kazuhiro] Kitasato Univ, Kitasato Inst Hosp, Dept Orthopaed Surg, Tokyo 1088642, Japan; [Shukunami, Chisa] Hiroshima Univ, Dept Mol Biol & Biochem, Div Basic Life Sci, Inst Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan	RIKEN; Keio University; Kyoto University; RIKEN; Nanjing University; Kobe City Medical Center General Hospital; Hokkaido University; Juntendo University; Dokkyo Medical University; Tokyo Saiseikai Central Hospital; Mie University; Kitasato University; Hiroshima University; RIKEN	Ikegawal, S (corresponding author), RIKEN, Lab Bone & Joint Dis, Ctr Integrat Sci, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ogura, Yoji/V-2740-2019; Kubo, Michiaki/N-7947-2015; 重徳, 三浦/GRJ-5008-2022; Ikegawa, Shiro/N-6895-2015; Shukunami, Chisa/G-2887-2019; Iida, Aritoshi/CAA-1373-2022; Sudo, Hideki/G-2748-2012; Kamatani, Yoichiro/N-5513-2015	重徳, 三浦/0000-0001-9206-2986; Ikegawa, Shiro/0000-0003-0316-2147; Shukunami, Chisa/0000-0001-5616-6761; Iida, Aritoshi/0000-0001-7538-1651; 				Buchan JG, 2014, DEV DYNAM, V243, P1646, DOI 10.1002/dvdy.24208; Fan YH, 2012, J HUM GENET, V57, P244, DOI 10.1038/jhg.2012.11; Jiang H, 2013, EUR SPINE J, V22, P282, DOI 10.1007/s00586-012-2532-4; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lang MR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000744; Londono D, 2014, J MED GENET, V51, P401, DOI 10.1136/jmedgenet-2013-102067; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Romano RA, 2004, GENOMICS, V83, P821, DOI 10.1016/j.ygeno.2003.11.009; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7452; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Takahashi Y, 2011, J ORTHOP RES, V29, P1055, DOI 10.1002/jor.21347; Tang NLS, 2012, J ORTHOP RES, V30, P1464, DOI 10.1002/jor.22090; Ueno M, 2011, J ORTHOP SCI, V16, P1, DOI 10.1007/s00776-010-0009-z; Vanhoutteghem A, 2004, P NATL ACAD SCI USA, V101, P3468, DOI 10.1073/pnas.0400268101; Vanhoutteghem A, 2011, BIOCHIMIE, V93, P127, DOI 10.1016/j.biochi.2010.09.010; Vanhoutteghem A, 2009, P NATL ACAD SCI USA, V106, P14432, DOI 10.1073/pnas.0905840106; Ward K, 2010, AM J MED GENET A, V152A, P1178, DOI 10.1002/ajmg.a.33145; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; WYNNEDAVIES R, 1973, DEV MED CHILD NEUROL, V15, P809; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	26	79	82	2	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					337	342		10.1016/j.ajhg.2015.06.012	http://dx.doi.org/10.1016/j.ajhg.2015.06.012			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26211971	Green Published, Bronze			2022-12-18	WOS:000359328800014
J	Buchert, R; Tawamie, H; Smith, C; Uebe, S; Innes, AM; Al Hallak, B; Ekici, AB; Sticht, H; Schwarze, B; Lamont, RE; Parboosingh, JS; Bernier, FP; Abou Jamra, R				Buchert, Rebecca; Tawamie, Hasan; Smith, Christopher; Uebe, Steffen; Innes, A. Micheil; Al Hallak, Bassam; Ekici, Arif B.; Sticht, Heinrich; Schwarze, Bernd; Lamont, Ryan E.; Parboosingh, Jillian S.; Bernier, Francois P.; Abou Jamra, Rami			A Peroxisomal Disorder of Severe Intellectual Disability, Epilepsy, and Cataracts Due to Fatty Acyl-CoA Reductase 1 Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; ZELLWEGER-SYNDROME; PTS2 RECEPTOR; PLASMALOGEN DEFICIENCY; HUMAN PEX7; BIOSYNTHESIS; DISEASE; HEALTH; ACID; HETEROGENEITY	Rhizomelic chondrodysplasia punctata (RCDP) is a group of disorders with overlapping clinical features including rhizomelia, chondrodysplasia punctata, coronal clefts, cervical dysplasia, congenital cataracts, profound postnatal growth retardation, severe intellectual disability, and seizures. Mutations in PEX7, GNPAT, and AGPS, all involved in the plasmalogen-biosynthesis pathway, have been described in individuals with RCDP. Here, we report the identification of mutations in another gene in plasmalogen biosynthesis, fatty acyl-CoA reductase 1 (FAR1) in two families affected 1 by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity. Exome analyses revealed a homozygous in-frame indel mutation (c.495_507delinsT [p.Glu165_Pro169delinsAsp]) in two siblings from a consanguineous family and compound-heterozygous mutations (c.[787C>T]; [1094A>G], p.[Arg263*];[Asp365Gly]) in a third unrelated individual. FAR1 reduces fatty acids to their respective fatty alcohols for the plasmalogen-biosynthesis pathway. To assess the pathogenicity of the identified mutations, we transfected human embryonic kidney 293 cells with plasmids encoding FAR1 with either wild-type or mutated constructs and extracted the lipids from the Cells. We screened the lipids with gas chromatography and mass spectrometry and found that all three mutations abolished the reductase activity of FAR1, given that no fatty alcohols could be detected. We also observed reduced plasmalogens in red blood cells in one individual to a range similar to that seen in individuals with RCDP, further supporting abolished FAR1 activity. We thus expand the spectrum of clinical features associated with defects in plasmalogen biosynthesis to include FAR1 deficiency as a cause of syndromic severe intellectual disability with cataracts, epilepsy, and growth retardation but without rhizomelia.	[Buchert, Rebecca; Tawamie, Hasan; Uebe, Steffen; Ekici, Arif B.; Abou Jamra, Rami] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Smith, Christopher; Innes, A. Micheil; Lamont, Ryan E.; Parboosingh, Jillian S.; Bernier, Francois P.] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Innes, A. Micheil; Lamont, Ryan E.; Parboosingh, Jillian S.; Bernier, Francois P.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 4N1, Canada; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Schwarze, Bernd] Univ Erlangen Nurnberg, Dept Forens Med, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Abou Jamra, R (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	rami.aboujamra@uk-erlangen.de	innes, allan micheil/A-9955-2017; Buchert, Rebecca/R-6386-2019; Bernier, Francois/AAP-2174-2020; Ekici, Arif B/C-3971-2013; Bernier, Francois/V-7150-2018; Abou Jamra, Rami/AAC-8192-2019; Jamra, Rami Abou/I-2350-2012; Jamra, Rami Abou/I-4805-2015	Buchert, Rebecca/0000-0001-7576-3326; Ekici, Arif B/0000-0001-6099-7066; Abou Jamra, Rami/0000-0002-1542-1399; Jamra, Rami Abou/0000-0002-1542-1399; Jamra, Rami Abou/0000-0002-1542-1399; Bernier, Francois/0000-0001-7063-4269; Sticht, Heinrich/0000-0001-5644-045X; Innes, Micheil/0000-0001-9881-5467	Deutsche Forschungsgemeinschaft [AB393/2-1, AB393/2-2]; Deutscher Akademischer Austauschdienst; Alberta Children's Hospital Research Institute Genomics and Bioinformatics Facility; Alberta Children's Hospital Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Alberta Children's Hospital Research Institute Genomics and Bioinformatics Facility; Alberta Children's Hospital Foundation	We are grateful to the families who participated in this study. We thank David Russell (Dallas) for providing us with the pCMV6-XL6-hFAR1 vector. We thank Andre Reis (Erlangen) for continued support. We thank Petra Rothe, Angelika Diem, and Farah Radwan from Erlangen for assistance with SNP array genotyping, Sanger sequencing, and next-generation sequencing. This study was supported by Deutsche Forschungsgemeinschaft through grants AB393/2-1 and AB393/2-2 to R.A.J. and by Deutscher Akademischer Austauschdienst through a scholarship to H.T. We also thank the Alberta Children's Hospital Research Institute Genomics and Bioinformatics Facility, Paul Gordon and Richard Pon for their expertise, the Alberta Children's Hospital Foundation for their generous funding support to A.M.I., J.S.P., and F.P.B., and Brenda McInnes for clinical support. We acknowledge the expert reviews of the skeletal survey by Sarah Nikkel (University of Ottawa) and of the neuroimaging by Luis Bello-Espinos (University of Calgary).	Abou Jamra R, 2011, EUR J HUM GENET, V19, P1161, DOI 10.1038/ejhg.2011.98; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Beams-Mengerink AM, 2006, NEUROLOGY, V66, P798, DOI 10.1212/01.wnl.0000205594.34647.d0; BJORKHEM I, 1986, J LIPID RES, V27, P786; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Brites P, 2009, BRAIN, V132, P482, DOI 10.1093/brain/awn295; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; GLASER PE, 1994, BIOCHEMISTRY-US, V33, P5805, DOI 10.1021/bi00185a019; Grimm MOW, 2011, J NEUROCHEM, V116, P916, DOI 10.1111/j.1471-4159.2010.07070.x; Hashimoto F, 2001, BIOL PHARM BULL, V24, P600, DOI 10.1248/bpb.24.600; HEIKOOP JC, 1992, HUM GENET, V89, P439; HEYMANS HSA, 1985, NEW ENGL J MED, V313, P187; HEYMANS HSA, 1983, NATURE, V306, P69, DOI 10.1038/306069a0; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; Honsho M, 2013, J BIOL CHEM, V288, P34588, DOI 10.1074/jbc.M113.498345; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; James PF, 1997, J BIOL CHEM, V272, P23540, DOI 10.1074/jbc.272.38.23540; Khan M, 2008, J NEUROCHEM, V106, P1766, DOI 10.1111/j.1471-4159.2008.05513.x; Moser AB, 1999, NEUROCHEM RES, V24, P187, DOI 10.1023/A:1022549618333; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Motley AM, 2002, AM J HUM GENET, V70, P612, DOI 10.1086/338998; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; RIZZO WB, 1993, BIOCHEM MED METAB B, V50, P93, DOI 10.1006/bmmb.1993.1050; Sanchez R, 2000, METH MOL B, V143, P97; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHRAKAMP G, 1985, BIOCHIM BIOPHYS ACTA, V833, P170, DOI 10.1016/0005-2760(85)90266-8; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pW152, DOI 10.1093/nar/gkm381	42	79	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					602	610		10.1016/j.ajhg.2014.10.003	http://dx.doi.org/10.1016/j.ajhg.2014.10.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439727	Green Published, Bronze			2022-12-18	WOS:000344845000011
J	Bui, C; Huber, C; Tuysuz, B; Alanay, Y; Bole-Feysot, C; Leroy, JG; Mortier, G; Nitschke, P; Munnich, A; Cormier-Daire, V				Bui, Catherine; Huber, Celine; Tuysuz, Beyhan; Alanay, Yasemin; Bole-Feysot, Christine; Leroy, Jules G.; Mortier, Geert; Nitschke, Patrick; Munnich, Arnold; Cormier-Daire, Valerie			XYLT1 Mutations in Desbuquois Dysplasia Type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EHLERS-DANLOS-SYNDROME; PROTEOGLYCAN SYNTHESIS; LARSEN-SYNDROME; XT-II; XYLOSYLTRANSFERASE; DEFICIENCY; SULFATE; SKELETAL; DEFECTS; VARIANT	Desbuquois dysplasia (DBQD) is a severe condition characterized by short stature, joint laxity, and advanced carpal ossification. Based on the presence of additional hand anomalies, we have previously distinguished DBQD type 1 and identified CANT1 (calcium activated nucleotidase 1) mutations as responsible for DBQD type 1. We report here the identification of five distinct homozygous xylosyltransferase 1 (XYLT1) mutations in seven DBQD type 2 subjects from six consanguineous families. Among the five mutations, four were expected to result in loss of function and a drastic reduction of XYLT1 cDNA level was demonstrated in two cultured individual fibroblasts. Because xylosyltransferase 1 (XT-I) catalyzes the very first step in proteoglycan (PG) biosynthesis, we further demonstrated in the two individual fibroblasts a significant reduction of cellular PG content. Our findings of XYLT1 mutations in DBQD type 2 further support a common physiological basis involving PG synthesis in the multiple dislocation group of disorders. This observation sheds light on the key role of the XT-I during the ossification process.	[Bui, Catherine; Huber, Celine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malades AP HP,INSERM U781, Inst Imagine,Dept Genet, F-75015 Paris, France; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Med Fac, Dept Pediat Genet, TR-34098 Istanbul, Turkey; [Alanay, Yasemin] Acibadem Univ, Sch Med, Dept Pediat, Pediat Genet Unit, TR-34457 Istanbul, Turkey; [Bole-Feysot, Christine] Fondat IMAGINE, Plateforme Genom, F-75015 Paris, France; [Leroy, Jules G.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Mortier, Geert] Univ Antwerp Hosp, Dept Med Genet, B-2650 Edegem, Belgium; [Mortier, Geert] Univ Antwerp, B-2650 Edegem, Belgium; [Nitschke, Patrick] Univ Paris 05, Plateforme Bioinformat, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Istanbul University; Istanbul University - Cerrahpasa; Acibadem University; UDICE-French Research Universities; Universite Paris Cite; Greenwood Genetic Center; University of Antwerp; University of Antwerp; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malades AP HP,INSERM U781, Inst Imagine,Dept Genet, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Alanay, Yasemin/A-1516-2016; Tüysüz, Beyhan/AAN-4858-2020; Mortier, Geert/D-2542-2012; cormier-daire, valerie/H-6520-2017	Alanay, Yasemin/0000-0003-0683-9731; Mortier, Geert/0000-0001-9871-4578; Tuysuz, Beyhan/0000-0002-9620-5021; huber, celine/0000-0002-8601-9655; cormier-daire, valerie/0000-0002-2839-9856	FRM (Fondation pour la Recherche Medicale) [DEQ20120323703]	FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale)	This work has been supported by FRM (Fondation pour la Recherche Medicale) funding (DEQ20120323703).	Baasanjav S, 2011, AM J HUM GENET, V89, P15, DOI 10.1016/j.ajhg.2011.05.021; Blanquaert F, 1995, BONE, V17, P499, DOI 10.1016/8756-3282(95)00402-5; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Faivre L, 2004, AM J MED GENET A, V124A, P48, DOI 10.1002/ajmg.a.20440; Faivre L, 2003, J MED GENET, V40, P282, DOI 10.1136/jmg.40.4.282; Furuichi T, 2011, J MED GENET, V48, P32, DOI 10.1136/jmg.2010.080226; Gotting C, 2007, CELL MOL LIFE SCI, V64, P1498, DOI 10.1007/s00018-007-7069-z; Gotting C, 2004, J BIOL CHEM, V279, P42566, DOI 10.1074/jbc.M401340200; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Guo MH, 2013, AM J MED GENET A, V161, P2519, DOI 10.1002/ajmg.a.36128; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Helledie T, 2012, STEM CELLS DEV, V21, P1897, DOI 10.1089/scd.2011.0367; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Huber C, 2009, AM J HUM GENET, V85, P706, DOI 10.1016/j.ajhg.2009.10.001; Kim OH, 2010, AM J MED GENET A, V152A, P875, DOI 10.1002/ajmg.a.33347; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Malfait F, 2013, AM J HUM GENET, V92, P935, DOI 10.1016/j.ajhg.2013.04.016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mis EK, 2014, DEV BIOL, V385, P67, DOI 10.1016/j.ydbio.2013.10.014; Nakajima M, 2013, AM J HUM GENET, V92, P927, DOI 10.1016/j.ajhg.2013.04.003; Nizon M, 2012, AM J MED GENET A, V158A, P2183, DOI 10.1002/ajmg.a.35504; Nizon M, 2012, HUM MUTAT, V33, P1261, DOI 10.1002/humu.22104; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; Prydz K, 2000, J CELL SCI, V113, P193; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; Roch C, 2010, BIOCHEM BIOPH RES CO, V391, P685, DOI 10.1016/j.bbrc.2009.11.121; Schreml J, 2014, HUM GENET, V133, P29, DOI 10.1007/s00439-013-1351-y; Schwartz NB, 2004, GLYCOCONJUGATE J, V21, P329, DOI 10.1023/B:GLYC.0000046278.34016.36; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Unger S, 2010, AM J MED GENET A, V152A, P2543, DOI 10.1002/ajmg.a.33641; Venkatesan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034020; Vissers LELM, 2011, AM J HUM GENET, V88, P608, DOI 10.1016/j.ajhg.2011.04.002; Voglmeir J, 2007, J BIOL CHEM, V282, P5984, DOI 10.1074/jbc.M608087200; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Zhang D, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038695	40	79	81	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					405	414		10.1016/j.ajhg.2014.01.020	http://dx.doi.org/10.1016/j.ajhg.2014.01.020			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24581741	Green Published, Bronze			2022-12-18	WOS:000332611400014
J	Yariz, KO; Duman, D; Seco, CZ; Dallman, J; Huang, MQ; Peters, TA; Sirmaci, A; Lu, N; Schraders, M; Skromne, I; Oostrik, J; Diaz-Horta, O; Young, JI; Tokgoz-Yilmaz, S; Konukseven, O; Shahin, H; Hetterschijt, L; Kanaan, M; Oonk, AMM; Edwards, YJK; Li, HW; Atalay, S; Blanton, S; DeSmidt, AA; Liu, XZ; Pennings, RJE; Lu, ZM; Chen, ZY; Kremer, H; Tekin, M				Yariz, Kemal O.; Duman, Duygu; Seco, Celia Zazo; Dallman, Julia; Huang, Mingqian; Peters, Theo A.; Sirmaci, Asli; Lu, Na; Schraders, Margit; Skromne, Isaac; Oostrik, Jaap; Diaz-Horta, Oscar; Young, Juan I.; Tokgoz-Yilmaz, Suna; Konukseven, Ozlem; Shahin, Hashem; Hetterschijt, Lisette; Kanaan, Moien; Oonk, Anne M. M.; Edwards, Yvonne J. K.; Li, Huawei; Atalay, Semra; Blanton, Susan; DeSmidt, Alexandra A.; Liu, Xue-Zhong; Pennings, Ronald J. E.; Lu, Zhongmin; Chen, Zheng-Yi; Kremer, Hannie; Tekin, Mustafa			Mutations in OTOGL, Encoding the Inner Ear Protein Otogelin-like, Cause Moderate Sensorineural Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; GENE; ZEBRAFISH	Hereditary hearing loss is characterized by a high degree of genetic heterogeneity. Here we present OTOGL mutations, a homozygous one base pair deletion (c.1430 delT) causing a frameshift (p.Val477Glufs*25) in a large consanguineous family and two compound heterozygous mutations, c.547C>T (p.Arg183*) and c.5238+5G>A, in a nonconsanguineous family with moderate nonsyndromic sensorineural hearing loss. OTOGL maps to the DFNB84 locus at 12q21.31 and encodes otogelin-like, which has structural similarities to the epithelial-secreted mucin protein family. We demonstrate that Otogl is expressed in the inner ear of vertebrates with a transcription level that is high in embryonic, lower in neonatal, and much lower in adult stages. Otogelin-like is localized to the acellular membranes of the cochlea and the vestibular system and to a variety of inner ear cells located underneath these membranes. Knocking down of otogl with morpholinos in zebrafish leads to sensorineural hearing loss and anatomical changes in the inner ear, supporting that otogelin-like is essential for normal inner ear function. We propose that OTOGL mutations affect the production and/or function of acellular structures of the inner ear, which ultimately leads to sensorineural hearing loss.	[Yariz, Kemal O.; Sirmaci, Asli; Diaz-Horta, Oscar; Young, Juan I.; Edwards, Yvonne J. K.; Blanton, Susan; Liu, Xue-Zhong; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Yariz, Kemal O.; Sirmaci, Asli; Diaz-Horta, Oscar; Young, Juan I.; Edwards, Yvonne J. K.; Blanton, Susan; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Liu, Xue-Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Duman, Duygu; Tokgoz-Yilmaz, Suna; Atalay, Semra; Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Genet, TR-06100 Ankara, Turkey; [Seco, Celia Zazo; Peters, Theo A.; Schraders, Margit; Oostrik, Jaap; Oonk, Anne M. M.; Pennings, Ronald J. E.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Seco, Celia Zazo; Peters, Theo A.; Schraders, Margit; Oostrik, Jaap; Oonk, Anne M. M.; Pennings, Ronald J. E.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Seco, Celia Zazo; Peters, Theo A.; Schraders, Margit; Oostrik, Jaap; Hetterschijt, Lisette; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Hetterschijt, Lisette; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Dallman, Julia; Skromne, Isaac; DeSmidt, Alexandra A.; Lu, Zhongmin] Univ Miami, Dept Biol, Miami, FL 33146 USA; [Huang, Mingqian; Lu, Na; Chen, Zheng-Yi] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otol & Laryngol,Eaton Peabody Lab, Boston, MA 02114 USA; [Lu, Na; Li, Huawei] Fudan Univ, Affiliated Eye & ENT Hosp, Dept Otol & Skull Base Surg, Shanghai 200031, Peoples R China; [Konukseven, Ozlem] Ataturk Training & Res Hosp, Hearing & Balance Disorders Diag & Rehabil Ctr, TR-06800 Ankara, Turkey; [Shahin, Hashem; Kanaan, Moien] Bethlehem Univ, Dept Life Sci, Bethlehem, Palestine; [Liu, Xue-Zhong] Cent S Univ, Xiangya Hosp 2, Dept Otolaryngol Head & Neck Surg, Changsha 410011, Hunan, Peoples R China	University of Miami; University of Miami; University of Miami; Ankara University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Miami; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Fudan University; Ankara Ataturk Training & Research Hospital; Central South University	Tekin, M (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	mtekin@med.miami.edu	Tokgoz-Yilmaz, Suna/AAA-1420-2020; Peters, T.A./L-4571-2015; Kremer, Hannie/F-5126-2010; Dallman, Julia/I-1414-2019; Seco, Celia Zazo/AAB-7636-2020; Tokgoz-Yilmaz, Suna/AAT-3892-2020; Blanton, Susan Halloran/ABF-1323-2021; duman, duygu/AAF-8093-2020; Oonk, Anne/G-3935-2016; Tekin, Mustafa/ABG-7627-2020; Dallman, Julia/AGG-3507-2022; Oostrik, Jaap/A-1703-2016; Duman, Duygu/AAG-7765-2019; Pennings, Ronald JE/J-6651-2012; Schraders, Margit/A-1607-2016	Tokgoz-Yilmaz, Suna/0000-0002-4656-099X; Peters, T.A./0000-0001-8443-5500; Kremer, Hannie/0000-0002-0841-8693; Seco, Celia Zazo/0000-0003-3506-7611; Tokgoz-Yilmaz, Suna/0000-0002-4656-099X; duman, duygu/0000-0001-7583-0349; Dallman, Julia/0000-0002-5839-807X; Pennings, Ronald JE/0000-0001-5517-9683; Kanaan, Moien/0000-0002-3227-4685; Tekin, Mustafa/0000-0002-3525-7960; Edwards, Yvonne/0000-0001-8505-3168; Skromne, Isaac/0000-0003-2369-7210	National Institutes of Health [R01DC009645, R01 DC006908, R21 DC009879, RO1DC05575]; Fredrick and Ines Yeatts Inner Ear Hair Cell Regeneration Fellowship; Heinsius Houbolt Foundation; Oticon Foundation [09-3742]; ZonMW [40-00812-98-09047, 90700388]; RNID [GR36]; China Scholarship Council, P.R. China; Hurong Scholar Award in Hunan, China; University of Miami Provost Research Award and College of Arts; Sciences Gabelli Fellowship; National Science Foundation [IOS-0920449]; University of Miami Provost Research Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009645, R01DC005575, R01DC006908, R21DC009879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fredrick and Ines Yeatts Inner Ear Hair Cell Regeneration Fellowship; Heinsius Houbolt Foundation; Oticon Foundation; ZonMW(Netherlands Organization for Health Research and Development); RNID; China Scholarship Council, P.R. China(China Scholarship Council); Hurong Scholar Award in Hunan, China; University of Miami Provost Research Award and College of Arts; Sciences Gabelli Fellowship; National Science Foundation(National Science Foundation (NSF)); University of Miami Provost Research Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We want to acknowledge the families for their participation in the study. This work was supported by National Institutes of Health grants R01DC009645 to M.T., R01 DC006908 to Z.-Y.C, R21 DC009879 to Z. L., RO1DC05575 to X.-Z.L., the Fredrick and Ines Yeatts Inner Ear Hair Cell Regeneration Fellowship to M.H. and N.L., the Heinsius Houbolt Foundation to H.K., the Oticon Foundation (09-3742) to H.K., ZonMW to H.K. (40-00812-98-09047) and R.J.E.P. (90700388), and the RNID (GR36) to H.K. N.L. was supported by a grant from the China Scholarship Council, P.R. China. X.Z.L. was supported by Hurong Scholar Award in Hunan, China. Z.L. and J.D. were supported by the University of Miami Provost Research Award and College of Arts. Z.L. was supported by Sciences Gabelli Fellowship. I.S. was supported by National Science Foundation grant IOS-0920449 and by the University of Miami Provost Research Award. We are grateful to Atlas Antibodies for providing the OTOGL immunogenic peptide.	BOHR H, 1988, FEBS LETT, V241, P223, DOI 10.1016/0014-5793(88)81066-4; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; de Heer AMR, 2011, AUDIOL NEURO-OTOL, V16, P93, DOI 10.1159/000313282; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; El-Amraoui A, 2001, HEARING RES, V158, P151, DOI 10.1016/S0378-5955(01)00312-4; Francey LJ, 2012, AM J MED GENET A, V158A, P298, DOI 10.1002/ajmg.a.34391; Go W, 2010, CELL CALCIUM, V48, P302, DOI 10.1016/j.ceca.2010.09.012; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Huang MQ, 2008, DEV DYNAM, V237, P3305, DOI 10.1002/dvdy.21735; Gamundi MJ, 2008, HUM MUTAT, V29, P869, DOI 10.1002/humu.20747; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lenz DR, 2011, HEARING RES, V281, P3, DOI 10.1016/j.heares.2011.05.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luijendijk MWJ, 2003, GENOMICS, V82, P480, DOI 10.1016/S0888-7543(03)00150-2; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Marlin S, 2005, ARCH OTOLARYNGOL, V131, P481, DOI 10.1001/archotol.131.6.481; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moorman SJ, 2002, DEV DYNAM, V223, P285, DOI 10.1002/dvdy.10052; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schraders M, 2010, AM J HUM GENET, V86, P604, DOI 10.1016/j.ajhg.2010.02.015; Shahin H, 2010, J MED GENET, V47, P643, DOI 10.1136/jmg.2009.075697; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Sirmaci A, 2010, AM J HUM GENET, V86, P797, DOI 10.1016/j.ajhg.2010.04.004; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Starr CJ, 2004, P NATL ACAD SCI USA, V101, P2572, DOI 10.1073/pnas.0308474100; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE	31	79	90	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					872	882		10.1016/j.ajhg.2012.09.011	http://dx.doi.org/10.1016/j.ajhg.2012.09.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23122586	Green Published, Bronze			2022-12-18	WOS:000311011400009
J	Dumas, LJ; O'Bleness, MS; Davis, JM; Dickens, CM; Anderson, N; Keeney, JG; Jackson, J; Sikela, M; Raznahan, A; Giedd, J; Rapoport, J; Nagamani, SSC; Erez, A; Brunetti-Pierri, N; Sugalski, R; Lupski, JR; Fingerlin, T; Cheung, SW; Sikela, JM				Dumas, Laura J.; O'Bleness, Majesta S.; Davis, Jonathan M.; Dickens, C. Michael; Anderson, Nathan; Keeney, J. G.; Jackson, Jay; Sikela, Megan; Raznahan, Armin; Giedd, Jay; Rapoport, Judith; Nagamani, Sandesh S. C.; Erez, Ayelet; Brunetti-Pierri, Nicola; Sugalski, Rachel; Lupski, James R.; Fingerlin, Tasha; Cheung, Sau Wai; Sikela, James M.			DUF1220-Domain Copy Number Implicated in Human Brain-Size Pathology and Evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMATE EVOLUTION; GENE; REARRANGEMENTS; DUPLICATIONS; 1Q21.1; EVI5	DUF1220 domains show the largest human-lineage-specific increase in copy number of any protein-coding region in the human genome and map primarily to 1q21, where deletions and reciprocal duplications have been associated with microcephaly and macrocephaly, respectively. Given these findings and the high correlation between DUF1220 copy number and brain size across primate lineages (R-2 = 0.98; p = 1.8 x 10(-6)), DUF1220 sequences represent plausible candidates for underlying 1q21-associated brain-size pathologies. To investigate this possibility, we used specialized bioinformatics tools developed for scoring highly duplicated DUF1220 sequences to implement targeted 1q21 array comparative genomic hybridization on individuals (n = 42) with 1q21-associated microcephaly and macrocephaly. We show that of all the 1q21 genes examined (n = 53), DUF1220 copy number shows the strongest association with brain size among individuals with 1q21-associated microcephaly, particularly with respect to the three evolutionarily conserved DUF1220 clades CON1(p = 0.0079), CON2 (p = 0.0134), and CON3 (p = 0.0116). Interestingly, all 1q21 DUF1220-encoding genes belonging to the NBPF family show significant correlations with frontal-occipital-circumference Z scores in the deletion group. In a similar survey of a nondisease population, we show that DUF1220 copy number exhibits the strongest correlation with brain gray-matter volume (CON1, p = 0.0246; and CON2, p = 0.0334). Notably, only DUF1220 sequences are consistently significant in both disease and nondisease populations. Taken together, these data strongly implicate the loss of DUF1220 copy number in the etiology of 1q21-associated microcephaly and support the view that DUF1220 domains function as general effectors of evolutionary, pathological, and normal variation in brain size.	[Dumas, Laura J.; O'Bleness, Majesta S.; Davis, Jonathan M.; Dickens, C. Michael; Anderson, Nathan; Keeney, J. G.; Jackson, Jay; Sikela, Megan; Sikela, James M.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Dumas, Laura J.; O'Bleness, Majesta S.; Davis, Jonathan M.; Dickens, C. Michael; Anderson, Nathan; Keeney, J. G.; Jackson, Jay; Sikela, Megan; Sikela, James M.] Univ Colorado, Sch Med, Human Med Genet Program, Aurora, CO 80045 USA; [Dumas, Laura J.; O'Bleness, Majesta S.; Davis, Jonathan M.; Dickens, C. Michael; Anderson, Nathan; Keeney, J. G.; Jackson, Jay; Sikela, Megan; Sikela, James M.] Univ Colorado, Sch Med, Neurosci Program, Aurora, CO 80045 USA; [Davis, Jonathan M.; Fingerlin, Tasha] Univ Colorado, Sch Publ Hlth, Dept Epidemiol, Aurora, CO 80045 USA; [Raznahan, Armin; Giedd, Jay; Rapoport, Judith] NIMH, NIH, Bethesda, MD 20892 USA; [Nagamani, Sandesh S. C.; Erez, Ayelet; Lupski, James R.; Cheung, Sau Wai] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Brunetti-Pierri, Nicola] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Brunetti-Pierri, Nicola] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy; [Sugalski, Rachel] Brooke Army Med Ctr, San Antonio, TX 78234 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Baylor College of Medicine; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; San Antonio Military Medical Center; United States Department of Defense; United States Army	Sikela, JM (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	james.sikela@ucdenver.edu	Raznahan, Armin/F-4534-2012; Brunetti-Pierri, Nicola/K-8465-2016; Giedd, Jay N/B-7302-2012; Giedd, Jay/J-9644-2015	Raznahan, Armin/0000-0002-5622-1190; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Giedd, Jay N/0000-0003-0827-3460; Giedd, Jay/0000-0003-2002-8978; Nagamani, Sandesh/0000-0001-6818-7367	National Institutes of Health (NIH) [R01 MH081203-1, R01 AA11853-11]; Butcher Foundation; JFK Partners, University of Colorado; Maternal Child Health Bureau; Leadership Education in Neurodevelopmental Disabilities grant [T73MC11044]; National Institute on Alcohol Abuse and Alcoholism/National Institute on Drug Abuse [5T32AA007464-32]; American Recovery and Reinvestment Act grant [R01 AA011853-12S1]; NIH Computational Bioscience Program Training Grant [5T15 LM009451-05]; National Institute of Mental Health [R01 MH0811203-02S1]; Coleman Institute for Cognitive Disabilities; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002794, R01MH081203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011853, T32AA007464] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM009451] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Butcher Foundation; JFK Partners, University of Colorado; Maternal Child Health Bureau(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Leadership Education in Neurodevelopmental Disabilities grant; National Institute on Alcohol Abuse and Alcoholism/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Recovery and Reinvestment Act grant; NIH Computational Bioscience Program Training Grant; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Coleman Institute for Cognitive Disabilities; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Fondazione Telethon(Fondazione Telethon)	We thank Pawel Stankiewicz, Martin Kennedy, John Hokanson, and Mark Johnston for helpful comments; Scott Vacha and Amir Ben-Dor for help with aCGH analyses; Andrew Fortna for programming expertise; Gunter Scherer and Elaine Spector for blood draws and DNA isolations; and Jake Saunders for graphics help. We also thank Oxford Gene Technology for high-quality aCGH services. This work was supported by National Institutes of Health (NIH) grants R01 MH081203-1 and R01 AA11853-11 to J.M.S. and a Butcher Foundation grant to J.M.S. and T.F. J.D. was supported in part by JFK Partners, University of Colorado funding from the Maternal Child Health Bureau, and Leadership Education in Neurodevelopmental Disabilities grant T73MC11044. M.O. was supported by a postdoctoral fellowship from the National Institute on Alcohol Abuse and Alcoholism/National Institute on Drug Abuse (5T32AA007464-32). C.M.D. was supported by American Recovery and Reinvestment Act grant R01 AA011853-12S1 and by an NIH Computational Bioscience Program Training Grant (5T15 LM009451-05). N.A. was supported by National Institute of Mental Health Supplementary Grant R01 MH0811203-02S1; J.K. was supported in part through a Graduate Assistantship from the Coleman Institute for Cognitive Disabilities. J.M.S. is a founder and shareholder of GATC Science. J.R.L. is a consultant for Athena Diagnostics, holds stock ownership of 23andMe and Ion Torrent Systems, and is a coinventor on multiple United States and European patents for DNA diagnostics. The Baylor College of Medicine and Department of Molecular and Human Genetics derive revenue from molecular genetics testing clinical services provided by the Medical Genetics Laboratories (https://www.bcm.edu/geneticlabs).	Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; de Leon MSP, 2008, P NATL ACAD SCI USA, V105, P13764, DOI 10.1073/pnas.0803917105; Dumas L, 2009, COLD SH Q B, V74, P375, DOI 10.1101/sqb.2009.74.025; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Faitar SL, 2005, GENOMICS, V86, P594, DOI 10.1016/j.ygeno.2005.06.002; Falk D., 1986, P477; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Hallast P, 2007, MOL CELL ENDOCRINOL, V260, P2, DOI 10.1016/j.mce.2005.11.049; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; O'Bleness M., 2012, GENETICS, V2; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Vandepoele K, 2009, MOL BIOL EVOL, V26, P1321, DOI 10.1093/molbev/msp047	17	79	82	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					444	454		10.1016/j.ajhg.2012.07.016	http://dx.doi.org/10.1016/j.ajhg.2012.07.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22901949	Green Published, Bronze			2022-12-18	WOS:000308683100005
J	Ishiura, H; Sako, W; Yoshida, M; Kawarai, T; Tanabe, O; Goto, J; Takahashi, Y; Date, H; Mitsui, J; Ahsan, B; Ichikawa, Y; Iwata, A; Yoshino, H; Izumi, Y; Fujita, K; Maeda, K; Goto, S; Koizumi, H; Morigaki, R; Ikemura, M; Yamauchi, N; Murayama, S; Nicholson, GA; Ito, H; Sobue, G; Nakagawa, M; Kaji, R; Tsujii, S				Ishiura, Hiroyuki; Sako, Wataru; Yoshida, Mari; Kawarai, Toshitaka; Tanabe, Osamu; Goto, Jun; Takahashi, Yuji; Date, Hidetoshi; Mitsui, Jun; Ahsan, Budrul; Ichikawa, Yaeko; Iwata, Atsushi; Yoshino, Hiide; Izumi, Yuishin; Fujita, Koji; Maeda, Kouji; Goto, Satoshi; Koizumi, Hidetaka; Morigaki, Ryoma; Ikemura, Masako; Yamauchi, Naoko; Murayama, Shigeo; Nicholson, Garth A.; Ito, Hidefumi; Sobue, Gen; Nakagawa, Masanori; Kaji, Ryuji; Tsujii, Shoji			The TRK-Fused Gene Is Mutated in Hereditary Motor and Sensory Neuropathy with Proximal Dominant Involvement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HEXANUCLEOTIDE REPEAT; HMSN-P; TDP-43; ALS; INCLUSIONS; PARTNER; C9ORF72; TFG	Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) is an autosomal-dominant neurodegenerative disorder characterized by widespread fasciculations, proximal-predominant muscle weakness, and atrophy followed by distal sensory involvement. To date, large families affected by HMSN-P have been reported from two different regions in Japan. Linkage and haplotype analyses of two previously reported families and two new families with the use of high-density SNP arrays further defined the minimum candidate region of 3.3 Mb in chromosomal region 3q12. Exome sequencing showed an identical c.854C>T (p.Pro285-Leu) mutation in the TRK-fused gene (TFG) in the four families. Detailed haplotype analysis suggested two independent origins of the mutation. Pathological studies of an autopsied patient revealed TFG- and ubiquitin-immunopositive cytoplasmic inclusions in the spinal and cortical motor neurons. Fragmentation of the Golgi apparatus, a frequent finding in amyotrophic lateral sclerosis, was also observed in the motor neurons with inclusion bodies. Moreover, TAR DNA-binding protein 43 kDa (TDP-43)-positive cytoplasmic inclusions were also demonstrated. In cultured cells expressing mutant TFG, cytoplasmic aggregation of TDP-43 was demonstrated. These findings indicate that formation of TFG-containing cytoplasmic inclusions and concomitant mislocalization of TDP-43 underlie motor neuron degeneration in HMSN-P. Pathological overlap of proteinopathies involving TFG and TDP-43 highlights a new pathway leading to motor neuron degeneration.	[Ishiura, Hiroyuki; Goto, Jun; Takahashi, Yuji; Date, Hidetoshi; Mitsui, Jun; Ahsan, Budrul; Ichikawa, Yaeko; Iwata, Atsushi; Tsujii, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; [Tsujii, Shoji] Tokyo Univ Hosp, Med Genome Ctr, Bunkyo Ku, Tokyo 1138655, Japan; [Sako, Wataru; Kawarai, Toshitaka; Tanabe, Osamu; Izumi, Yuishin; Fujita, Koji; Maeda, Kouji; Goto, Satoshi; Koizumi, Hidetaka; Morigaki, Ryoma; Kaji, Ryuji] Univ Tokushima, Dept Clin Neurosci, Grad Sch Med, Tokushima 7708503, Japan; [Yoshida, Mari] Aichi Med Univ, Dept Neuropathol, Inst Med Sci Aging, Nagakute, Aichi 4801195, Japan; [Tanabe, Osamu] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Yoshino, Hiide] Yoshino Neurol Clin, Ichikawa, Chiba 2720827, Japan; [Ikemura, Masako; Yamauchi, Naoko] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Itabashi Ku, Tokyo 1730015, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Brain Bank Aging Res, Itabashi Ku, Tokyo 1730015, Japan; [Nicholson, Garth A.] Univ Sydney, Mol Med Lab, Sydney, NSW 2139, Australia; [Ito, Hidefumi] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; [Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4660065, Japan; [Nakagawa, Masanori] Kyoto Prefectural Univ, Dept Neurol & Gerontol, Grad Sch Med, Kamigyo Ku, Kyoto 6020841, Japan; [Tsujii, Shoji] Natl Inst Genet, Div Appl Genet, Mishima, Shizuoka 118540, Japan	University of Tokyo; University of Tokyo; Tokushima University; Aichi Medical University; University of Michigan System; University of Michigan; University of Tokyo; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; University of Sydney; Kyoto University; Nagoya University; Kyoto Prefectural University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Tsujii, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	rkaji@clin.med.tokushima-u.ac.jp; tsuji@m.u-tokyo.ac.jp	Iwata, Atsushi/AAH-8924-2019; Sako, Wataru/AAH-9933-2020; Fujita, Koji/AAB-1215-2019; Kawarai, Toshitaka/C-2822-2013; Mitsui, Jun/B-5455-2012; Iwata, Atsushi/A-9598-2013	Iwata, Atsushi/0000-0001-7308-5314; Fujita, Koji/0000-0003-4789-1579; Kawarai, Toshitaka/0000-0003-4547-8131; Mitsui, Jun/0000-0001-7425-4765; Iwata, Atsushi/0000-0001-7308-5314; Nicholson, Garth/0000-0001-9694-066X	Global Centers of Excellence Program; Integrated Database Project; Ministry of Education, Culture, Sports, Science, and Technology of Japan [B21406026, 23659458]; Ministry of Health, Labour, and Welfare, Japan; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour, and Welfare of Japan; Charcot-Marie-Tooth Association; National Medical Research Council of Australia; Japan Society for the Promotion of Science for Young Scientists;  [22129002]; Grants-in-Aid for Scientific Research [23500428, 23659458, 22129001, 24790348] Funding Source: KAKEN	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Integrated Database Project; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Charcot-Marie-Tooth Association; National Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the families for participating in the study. We also thank the doctors who obtained clinical information of the patients. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (22129002); the Global Centers of Excellence Program; the Integrated Database Project; Scientific Research (A) (B21406026) and Challenging Exploratory Research (23659458) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a Grant-in-Aid for Research on Intractable Diseases and Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour, and Welfare, Japan; Grants-in-Aid from the Research Committee of CNS Degenerative Diseases; the Ministry of Health, Labour, and Welfare of Japan; the Charcot-Marie-Tooth Association; and the National Medical Research Council of Australia. H.I. was supported by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists. We also thank S. Ogawa (Cancer Genomics Project, The University of Tokyo) for his kind help in the analyses employing GAIIx and SOLiD4.	Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Fujita K, 2011, J NEUROL NEUROSUR PS, V82, P1402, DOI 10.1136/jnnp-2011-300783; Fukuda Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-121; GRECO A, 1995, MOL CELL BIOL, V15, P6118; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hernandez L, 1999, BLOOD, V94, P3265; Hisaoka M, 2004, GENE CHROMOSOME CANC, V40, P325, DOI 10.1002/gcc.20044; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Kuroda Y, 2012, HUM MOL GENET, V21, P991, DOI 10.1093/hmg/ddr530; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maeda K, 2007, CLIN NEUROL NEUROSUR, V109, P830, DOI 10.1016/j.clineuro.2007.07.015; Maeda K, 2007, J HUM GENET, V52, P907, DOI 10.1007/s10038-007-0193-7; Nakagawa Masanori, 2009, Rinsho Shinkeigaku, V49, P950; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Patroclo CB, 2009, ARQ NEURO-PSIQUIAT, V67, P892, DOI 10.1590/S0004-282X2009000500021; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stieber A, 1998, ACTA NEUROPATHOL, V95, P245, DOI 10.1007/s004010050794; TAKAHASHI H, 1994, ACTA NEUROPATHOL, V88, P185; Takashima H, 1997, ANN NEUROL, V41, P771, DOI 10.1002/ana.410410613; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225	29	79	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					320	329		10.1016/j.ajhg.2012.07.014	http://dx.doi.org/10.1016/j.ajhg.2012.07.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22883144	Bronze, Green Published			2022-12-18	WOS:000307608700010
J	Doherty, D; Chudley, AE; Coghlan, G; Ishak, GE; Innes, AM; Lemire, EG; Rogers, RC; Mhanni, AA; Phelps, IG; Jones, SJM; Zhan, SH; Fejes, AP; Shahin, H; Kanaan, M; Akay, H; Tekin, M; Triggs-Raine, B; Zelinski, T				Doherty, Dan; Chudley, Albert E.; Coghlan, Gail; Ishak, Gisele E.; Innes, A. Micheil; Lemire, Edmond G.; Rogers, R. Curtis; Mhanni, Aizeddin A.; Phelps, Ian G.; Jones, Steven J. M.; Zhan, Shing H.; Fejes, Anthony P.; Shahin, Hashem; Kanaan, Moien; Akay, Hatice; Tekin, Mustafa; Triggs-Raine, Barbara; Zelinski, Teresa		FORGE Canada Consortium	GPSM2 Mutations Cause the Brain Malformations and Hearing Loss in Chudley-McCullough Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILATERAL SENSORINEURAL DEAFNESS; PLANAR DIVISIONS; CORPUS-CALLOSUM; HYDROCEPHALUS; PROGENITORS; AGENESIS	Autosomal-recessive inheritance, severe to profound sensorineural hearing loss, and partial agenesis of the corpus callosum are hallmarks of the clinically well-established Chudley-McCullough syndrome (CMS). Although not always reported in the literature, frontal polymicrogyria and gray matter heterotopia are uniformly present, whereas cerebellar dysplasia, ventriculomegaly, and arachnoid cysts are nearly invariant. Despite these striking brain malformations, individuals with CMS generally do not present with significant neuro-developmental abnormalities, except for hearing loss. Homozygosity mapping and whole-exome sequencing of DNA from affected individuals in eight families (including the family in the first report of CMS) revealed four molecular variations (two single-base deletions, a nonsense mutation, and a canonical splice-site mutation) in the G protein-signaling modulator 2 gene, GPSM2, that underlie CMS. Mutations in GPSM2 have been previously identified in people with profound congenital nonsyndromic hearing loss (NSHL). Subsequent brain imaging of these individuals revealed frontal polymicrogyria, abnormal corpus callosum, and gray matter heterotopia, consistent with a CMS diagnosis, but no ventriculomegaly. The gene product, GPSM2, is required for orienting the mitotic spindle during cell division in multiple tissues, suggesting that the sensorineural hearing loss and characteristic brain malformations of CMS are due to defects in asymmetric cell divisions during development.	[Doherty, Dan; Phelps, Ian G.] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98105 USA; [Chudley, Albert E.; Mhanni, Aizeddin A.; Triggs-Raine, Barbara; Zelinski, Teresa] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Chudley, Albert E.; Mhanni, Aizeddin A.; Triggs-Raine, Barbara; Zelinski, Teresa] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada; [Coghlan, Gail; Zelinski, Teresa] Univ Manitoba, Rh Lab, Dept Pediat & Child Hlth, Winnipeg, MB R3E 0L8, Canada; [Ishak, Gisele E.] Univ Washington, Dept Radiol, Seattle Childrens Hosp, Seattle, WA 98105 USA; [Innes, A. Micheil] Univ Calgary, Dept Pediat, Calgary, AB T3B 6A8, Canada; [Lemire, Edmond G.] Univ Saskatchewan, Dept Pediat, Saskatoon, SK S7N 0W8, Canada; [Rogers, R. Curtis] Greenwood Genet Ctr, Greenville, SC 29605 USA; [Jones, Steven J. M.; Zhan, Shing H.; Fejes, Anthony P.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Shahin, Hashem; Kanaan, Moien] Bethlehem Univ, Dept Life Sci, Bethlehem, Palestine; [Akay, Hatice] Mem Hosp, TR-21070 Diyarbakir, Turkey; [Tekin, Mustafa] Univ Miami, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Genet, TR-06100 Ankara, Turkey	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Manitoba; University of Manitoba; University of Manitoba; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Calgary; University of Saskatchewan; Greenwood Genetic Center; British Columbia Cancer Agency; University of Miami; University of Miami; Ankara University	Doherty, D (corresponding author), Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98105 USA.	ddoher@u.washington.edu; zelinski@cc.umanitoba.ca	Scherer, Stephen W./B-3785-2013; innes, allan micheil/A-9955-2017; Akay, Hatice/AAD-8547-2021; Tekin, Mustafa/ABG-7627-2020; Jones, Steven J/C-3621-2009; Triggs-Raine, Barbara/AAF-6209-2021	Scherer, Stephen W./0000-0002-8326-1999; Akay, Hatice/0000-0002-0854-0904; Jones, Steven J/0000-0003-3394-2208; Triggs-Raine, Barbara/0000-0003-4719-6779; Zhan, Shing/0000-0002-6351-8873; Innes, Micheil/0000-0001-9881-5467; Tekin, Mustafa/0000-0002-3525-7960; Kanaan, Moien/0000-0002-3227-4685	National Institutes of Health [KL2-RR025015, R01DC009645, R01DC011835]; Manitoba Institute of Child Health; Winnipeg Rh Institute Foundation; government of Canada through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011835, R01DC009645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manitoba Institute of Child Health; Winnipeg Rh Institute Foundation; government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to the family members who participated in this study, to Sunita Khatkar for conducting candidate gene analysis, to Kirk McManus for preparing Figure 2, and to Tom Walsh and Mary-Claire King for critically reading the manuscript. The research was supported by grants from the National Institutes of Health, KL2-RR025015 (to D.D.), R01DC009645 (to M.T.), and R01DC011835 (to M.K.); the Manitoba Institute of Child Health (to A.E.C. and B.T.R.); and the Winnipeg Rh Institute Foundation (to T.Z.). FORGE (Finding of Rare Disease Genes) Canada funding was provided by the government of Canada through Genome Canada, the Canadian Institutes of Health Research, and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia.	Alrashdi I, 2011, CLIN DYSMORPHOL, V20, P107, DOI 10.1097/MCD.0b013e328341d007; Chudley AE, 1997, AM J MED GENET, V68, P350, DOI 10.1002/(SICI)1096-8628(19970131)68:3<350::AID-AJMG19>3.0.CO;2-S; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Guo XZ, 2009, CELL RES, V19, P838, DOI 10.1038/cr.2009.54; Hendriks YMC, 1999, AM J MED GENET, V86, P183; Kau T, 2012, NEUROPEDIATRICS, V43, P44, DOI 10.1055/s-0032-1307451; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lemire EG, 2000, AM J MED GENET, V90, P127, DOI 10.1002/(SICI)1096-8628(20000117)90:2<127::AID-AJMG8>3.0.CO;2-E; Matteucci F, 2006, AM J MED GENET A, V140A, P1183, DOI 10.1002/ajmg.a.31178; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Ostergaard E, 2004, AM J MED GENET A, V124A, P74, DOI 10.1002/ajmg.a.20380; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Shioi G, 2009, CEREB CORTEX, V19, pI55, DOI 10.1093/cercor/bhp042; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Welch KO, 2003, AM J MED GENET A, V119A, P71, DOI 10.1002/ajmg.a.10180; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Yariz KO, 2012, CLIN GENET, V81, P289, DOI 10.1111/j.1399-0004.2011.01654.x; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	19	79	83	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1088	1093		10.1016/j.ajhg.2012.04.008	http://dx.doi.org/10.1016/j.ajhg.2012.04.008			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22578326	Green Published, Bronze			2022-12-18	WOS:000305262600013
J	Cruciani, F; Trombetta, B; Massaia, A; Destro-Bisol, G; Sellitto, D; Scozzari, R				Cruciani, Fulvio; Trombetta, Beniamino; Massaia, Andrea; Destro-Bisol, Giovanni; Sellitto, Daniele; Scozzari, Rosaria			A Revised Root for the Human Y Chromosomal Phylogenetic Tree: The Origin of Patrilineal Diversity in Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE CONVERSION; MTDNA VARIATION; POPULATION; NUCLEOTIDE; RESOLUTION; PATTERNS	To shed light on the structure of the basal backbone of the human Y chromosome phylogeny, we sequenced about 200 kb of the male-specific region of the human Y chromosome (MSY) from each of seven Y chromosomes belonging to clades A1, A2, A3, and BT. We detected 146 biallelic variant sites through this analysis. We used these variants to construct a patrilineal tree, without taking into account any previously reported information regarding the phylogenetic relationships among the seven Y chromosomes here analyzed. There are several key changes at the basal nodes as compared with the most recent reference Y chromosome tree. A different position of the root was determined, with important implications for the origin of human Y chromosome diversity. An estimate of 142 KY was obtained for the coalescence time of the revised MSY tree, which is earlier than that obtained in previous studies and easier to reconcile with plausible scenarios of modern human origin. The number of deep branchings leading to African-specific clades has doubled, further strengthening the MSY-based evidence for a modern human origin in the African continent. An analysis of 2204 African DNA samples showed that the deepest clades of the revised MSY phylogeny are currently found in central and northwest Africa, opening new perspectives on early human presence in the continent.	[Cruciani, Fulvio; Trombetta, Beniamino; Massaia, Andrea; Scozzari, Rosaria] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Destro-Bisol, Giovanni] Univ Roma La Sapienza, Dipartimento Biol Ambientale, I-00185 Rome, Italy; [Destro-Bisol, Giovanni] Ist Italiano Antropol, I-00185 Rome, Italy; [Sellitto, Daniele] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Cruciani, F (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy.	fulvio.cruciani@uniroma1.it; rosaria.scozzari@uniroma1.it	Cruciani, Fulvio/G-6105-2012	Trombetta, Beniamino/0000-0001-8245-9437; Destro Bisol, Giovanni/0000-0002-4232-9715; Cruciani, Fulvio/0000-0002-6900-024X	Italian Ministry of Education, University and Research; Sapienza Universita di Roma (Ricerche Universitarie); Ateneo Federato della Scienza e della Tecnologia	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza Universita di Roma (Ricerche Universitarie); Ateneo Federato della Scienza e della Tecnologia	We thank Gabriella Spedini for collecting the Bakola Pygmy samples from Cameroon and A. Achilli for helpful advice on maximum likelihood analysis. This research received support from the Italian Ministry of Education, University and Research (grant "Progetti di Ricerca di Interesse Nazionale"), the Sapienza Universita di Roma (Ricerche Universitarie) (both to R.S.), and the Ateneo Federato della Scienza e della Tecnologia (grant "Progetti AST") (to F.C.).	Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cruciani F, 2010, EUR J HUM GENET, V18, P1186, DOI 10.1038/ejhg.2010.89; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Cruciani F, 2010, AM J HUM GENET, V86, P495, DOI 10.1016/j.ajhg.2010.01.033; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 1996, AM J HUM GENET, V59, P935; Goncalves R, 2003, HUM GENET, V113, P467, DOI 10.1007/s00439-003-1007-4; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; King TE, 2007, EUR J HUM GENET, V15, P288, DOI 10.1038/sj.ejhg.5201771; Nachman MW, 2000, GENETICS, V156, P297; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2004, AM J HUM GENET, V75, P514, DOI 10.1086/423394; Rosa A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-124; Rosser ZH, 2009, AM J HUM GENET, V85, P130, DOI 10.1016/j.ajhg.2009.06.009; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Tang H, 2002, GENETICS, V161, P447; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	40	79	79	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					814	818		10.1016/j.ajhg.2011.05.002	http://dx.doi.org/10.1016/j.ajhg.2011.05.002			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21601174	Green Published, Bronze			2022-12-18	WOS:000291768500013
J	Miskinyte, S; Butler, MG; Herve, D; Sarret, C; Nicolino, M; Petralia, JD; Bergametti, F; Arnould, M; Pham, VN; Gore, AV; Spengos, K; Gaza, S; Woimant, F; Steinberg, GK; Weinstein, BM; Tournier-Lasserve, E				Miskinyte, Snaigune; Butler, Matthew G.; Herve, Dominique; Sarret, Catherine; Nicolino, Marc; Petralia, Jacob D.; Bergametti, Francoise; Arnould, Minh; Pham, Van N.; Gore, Aniket V.; Spengos, Konstantinos; Gaza, Steven; Woimant, France; Steinberg, Gary K.; Weinstein, Brant M.; Tournier-Lasserve, Elisabeth			Loss of BRCC3 Deubiquitinating Enzyme Leads to Abnormal Angiogenesis and Is Associated with Syndromic Moyamoya	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE; GENE; EXPRESSION; COMPLEX; MTCP-1; LOCUS	Moyamoya is a cerebrovascular angiopathy characterized by a progressive stenosis of the terminal part of the intracranial carotid arteries and the compensatory development of abnormal and fragile collateral vessels, also called moyamoya vessels, leading to ischemic and hemorrhagic stroke. Moyamoya angiopathy can either be the sole manifestation of the disease (moyamoya disease) or be associated with various conditions, including neurofibromatosis, Down syndrome, TAAD (autosomal-dominant thoracic aortic aneurysm), and radiotherapy of head tumors (moyamoya syndromes). Its prevalence is ten times higher in Japan than in Europe, and an estimated 6%-12% of moyamoya disease is familial in Japan. The pathophysiological mechanisms of this condition remain obscure. Here, we report on three unrelated families affected with an X-linked moyamoya syndrome characterized by the association of a moyamoya angiopathy, short stature, and a stereotyped facial dysmorphism. Other symptoms include an hypergonadotropic hypogonadism, hypertension, dilated cardiomyopathy, premature coronary heart disease, premature hair graying, and early bilateral acquired cataract. We show that this syndromic moyamoya is caused by Xq28 deletions removing MTCP1/MTCP1NB and BRCC3. We also show that brcc3 morphant zebrafish display angiogenesis defects that are rescued by endothelium-specific expression of brcc3. Altogether, these data strongly suggest that BRCC3, a deubiquitinating enzyme that is part of the cellular BRCA1 and BRISC complexes, is an important player in angiogenesis and that BRCC3 loss-of-function mutations are associated with moyamoya angiopathy.	[Miskinyte, Snaigune; Bergametti, Francoise; Arnould, Minh; Tournier-Lasserve, Elisabeth] Univ Paris 07, INSERM, UMR S 740, F-75010 Paris, France; [Butler, Matthew G.; Pham, Van N.; Gore, Aniket V.; Weinstein, Brant M.] NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Herve, Dominique; Woimant, France] Grp Hosp Lariboisiere St Louis, AP HP, Serv Neurol, Ctr Reference Malad Vasculaires Rares Cerveau & O, F-75010 Paris, France; [Sarret, Catherine] Hosp Civils Lyon, Hop Femme Mere Enfant, Serv Neurol Pediat, Grp Hosp Est, F-69677 Bron, France; [Nicolino, Marc] Univ Lyon 1, Lyon Univ Pediat Hosp, Ctr Invest Clin 201, Div Pediat Endocrinol,Hosp Civiels Lyon,INSERM U, Lyon, France; [Petralia, Jacob D.; Steinberg, Gary K.] Stanford Univ, Sch Med, Stanford Stroke Ctr, Dept Neurosurg, Stanford, CA 94305 USA; [Petralia, Jacob D.; Steinberg, Gary K.] Stanford Univ, Sch Med, Stanford Inst Neuroinnovat & Translat Neuro Sci, Stanford, CA 94305 USA; [Spengos, Konstantinos] Univ Athens, Sch Med, Eginit Hosp, Dept Neurol 1, Athens 11528, Greece; [Gaza, Steven] Hosp Univ Nord, Hop Bichat, AP HP, Plateforme Genom Constitut Grp, F-75010 Paris, France; [Tournier-Lasserve, Elisabeth] Hosp Lariboisiere St Louis, AP HP, Ctr Reference Malad Vasc Rares Cerveau & Oeil, Lab Genet, F-75010 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Stanford University; Stanford University; Athens Medical School; National & Kapodistrian University of Athens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Tournier-Lasserve, E (corresponding author), Univ Paris 07, INSERM, UMR S 740, 7 Denis Diderot,10 Ave Verdun, F-75010 Paris, France.	tournier-lasserve@univ-paris-diderot.fr	Tournier-Lasserve, Elisabeth/N-7134-2017; Gazal, Steven/AAK-3764-2020	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Gazal, Steven/0000-0003-4510-5730; Steinberg, Gary/0000-0001-6374-1058; Herve, Dominique/0000-0001-6197-6275; Gore, Aniket/0000-0003-4088-5264	INSERM; Leducq Foundation; Foundation Leducq Transatlantic Network of Excellence; Eunice Kenndy Shriver National Institute of Child Health and Human Development (NICHD); Huber Family Moyamoya Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008915] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Leducq Foundation(Leducq Foundation); Foundation Leducq Transatlantic Network of Excellence; Eunice Kenndy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Huber Family Moyamoya Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research was supported by the INSERM and the Leducq Foundation (grant to E.T.L. and B.M.W.), Foundation Leducq Transatlantic Network of Excellence (07 CVD 02 Hemorrhagic Stroke), the intramural program of the Eunice Kenndy Shriver National Institute of Child Health and Human Development (NICHD; to B.M.W.), and the Huber Family Moyamoya Fund (G.K.S.).	Achrol AS, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08302; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bober MB, 2010, AM J MED GENET A, V152A, P960, DOI 10.1002/ajmg.a.33252; Brancati F, 2005, AM J MED GENET A, V139A, P212, DOI 10.1002/ajmg.a.31009; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Cilenti L, 2011, J MOL CELL CARDIOL, V50, P652, DOI 10.1016/j.yjmcc.2010.12.015; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Desai SS, 2006, INT J RADIAT ONCOL, V65, P1222, DOI 10.1016/j.ijrobp.2006.01.038; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Giri N, 2007, J CLIN ENDOCR METAB, V92, P2624, DOI 10.1210/jc.2007-0135; Grabher C, 2004, METHOD CELL BIOL, V77, P381; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Herve D, 2010, NEUROLOGY, V75, P259, DOI 10.1212/WNL.0b013e3181e8ee3f; Hu X, 2011, J BIOL CHEM, V286, P11734, DOI 10.1074/jbc.M110.200857; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Madani A, 1996, BLOOD, V87, P1923; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; Poon HK, 2004, CELL TISSUE RES, V316, P305, DOI 10.1007/s00441-004-0871-0; Roder C, 2011, EUR J PAEDIATR NEURO, V15, P117, DOI 10.1016/j.ejpn.2010.09.002; Roder C, 2010, J HUM GENET, V55, P711, DOI 10.1038/jhg.2010.103; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; SOULIER J, 1994, ONCOGENE, V9, P3565; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STERN MH, 1993, ONCOGENE, V8, P2475; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; YAMASHITA M, 1983, STROKE, V14, P50, DOI 10.1161/01.STR.14.1.50	37	79	82	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					718	728		10.1016/j.ajhg.2011.04.017	http://dx.doi.org/10.1016/j.ajhg.2011.04.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21596366	Bronze, Green Published			2022-12-18	WOS:000291768500004
J	Decker, E; Stellzig-Eisenhauer, A; Fiebig, BS; Rau, C; Kress, W; Saar, K; Rueschendorf, F; Hubner, N; Grimm, T; Weber, BHF				Decker, Eva; Stellzig-Eisenhauer, Angelika; Fiebig, Britta S.; Rau, Christiane; Kress, Wolfram; Saar, Kathrin; Rueschendorf, Franz; Hubner, Norbert; Grimm, Tiemo; Weber, Bernhard H. F.			PTHR1 Loss-of-Function Mutations in Familial, Nonsyndromic Primary Failure of Tooth Eruption	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; BLOMSTRAND-CHONDRODYSPLASIA; INACTIVATING MUTATION; PTH/PTHRP RECEPTOR; LINKAGE ANALYSIS; GENE; PROTEIN; BONE; OSTEOCHONDRODYSPLASIA	Tooth eruption is a complex developmental process requiring coordinated navigation through alveolar bone and oral epithelium. Primary failure of tooth eruption (PFE) is associated with several syndromes primarily affecting skeletal development, but it is also known as a nonsyndromic autosomal-dominant condition. Teeth in the posterior quadrants of the upper and lower jaw are preferentially affected and usually result in an open bite extending from anterior to posterior. In this study, we show that familial, nonsyndromic PFE is caused by heterozygous Mutations in the gene encoding the G protein-coupled receptor for parathyroid hormone and parathyroid hormone-like hormone (PTHR1). Three distinct mutations, namely c.1050-3C > G, c.543+1G > A, and c.463G > T, were identified in 15 affected individuals from four multiplex pedigrees. All mutations truncate the mature protein and therefore should lead to a functionless receptor, strongly Suggesting that haplo-insufficiency of PTHR1 is the underlying cause of nonsyndromic PFE. Although complete inactivation of PTHR1 is known to underlie the autosomal-recessive Blomstrand osteochondrodysplasia (BOCD), a lethal form of short-limbed dwarfism, our data now imply that dominantly acting PTHR1 mutations that lead to haplo-insufficiency of the receptor result in a nonsyndromic phenotype affecting tooth development with high penetrance and variable expressivity.	[Decker, Eva; Fiebig, Britta S.; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Decker, Eva] Univ Heidelberg, Inst Human Genet, D-69120 Heidelberg, Germany; [Stellzig-Eisenhauer, Angelika; Rau, Christiane] Univ Wurzburg, Dept Orthodont, D-97070 Wurzburg, Germany; [Kress, Wolfram; Grimm, Tiemo] Univ Wurzburg, Inst Human Genet, D-97074 Wurzburg, Germany; [Saar, Kathrin; Rueschendorf, Franz; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	University of Regensburg; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Wurzburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Weber, BHF (corresponding author), Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany.	bweb@klinik.uni-regensburg.de		Saar, Kathrin/0000-0002-4483-1557; Weber, Bernhard H.F./0000-0002-8808-7723	German Orthodontic Society (DGKFO); German Ministry of Science and Education (NGFN2)	German Orthodontic Society (DGKFO); German Ministry of Science and Education (NGFN2)	We are grateful to the patients and their families for their participation in this study and to Yana Walczak (Institute of Human Genetics, University of Regensburg, Germany) for helping with RNA extraction. This work was Supported in part by a grant from the German Orthodontic Society (DGKFO) and the German Ministry of Science and Education (NGFN2).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Calvi LM, 2004, MECH DEVELOP, V121, P397, DOI 10.1016/j.mod.2004.02.004; Couvineau A, 2008, HUM MOL GENET, V17, P2766, DOI 10.1093/hmg/ddn176; Duchatelet S, 2005, HUM MOL GENET, V14, P1, DOI 10.1093/hmg/ddi001; Hoogendam J, 2007, J CLIN ENDOCR METAB, V92, P1088, DOI 10.1210/jc.2006-0300; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; Karperien M, 1999, J CLIN ENDOCR METAB, V84, P3713, DOI 10.1210/jc.84.10.3713; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; MARKS SC, 1983, AM J ANAT, V168, P277, DOI 10.1002/aja.1001680303; MARTIN TJ, 1989, METABOLIC BONE DIS, P833; Mundy G.R., 1987, BONE MINERAL RES ANN, P209; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; PROFFIT WR, 1981, AM J ORTHOD DENTOFAC, V80, P173, DOI 10.1016/0002-9416(81)90217-7; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; RAGHOEBAR GM, 1991, J ORAL PATHOL MED, V20, P159, DOI 10.1111/j.1600-0714.1991.tb00913.x; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Schipani Ernestina, 2003, Birth Defects Research, V69, P352, DOI 10.1002/bdrc.10028; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788; Zhang P, 1998, J CLIN ENDOCR METAB, V83, P3365, DOI 10.1210/jc.83.9.3373	27	79	86	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					781	786		10.1016/j.ajhg.2008.11.006	http://dx.doi.org/10.1016/j.ajhg.2008.11.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19061984	Green Published, Bronze			2022-12-18	WOS:000261822100013
J	Lin, PF; Li, JW; Liu, QJ; Mao, F; Li, JS; Qiu, RF; Hu, HL; Song, Y; Yang, Y; Gao, GM; Yan, CZ; Yang, WL; Shao, CS; Gong, YQ				Lin, Pengfei; Li, Jianwei; Liu, Qiji; Mao, Fei; Li, Jisheng; Qiu, Rongfang; Hu, Huili; Song, Yang; Yang, Yang; Gao, Guimin; Yan, Chuanzhu; Yang, Wanling; Shao, Changshun; Gong, Yaoqin			A Missense Mutation in SLC33A1, which Encodes the Acetyl-CoA Transporter, Causes Autosomal-Dominant Spastic Paraplegia (SPG42)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY; PROTEIN; GENE; TYPE-31	Hereditary spastic paraplegias (HSPs), characterized by progressive and bilateral spasticity of the legs, are usually caused by developmental failure or degeneration of motor axons in the corticospinal tract. There are considerable interfamilial and intrafamilial variations in age at onset and severity of spasticity. Genetic studies also showed that there are dozens of genetic loci, on multiple chromosomes, that are responsible for HSPs. Through linkage study of a pedigree of HSP with autosomal-dominant inheritance, we mapped the causative gene to 3q24-q26. Screening of candidate genes revealed that the HSP is caused by a missense mutation in the gene for acetyl-CoA transporter (SLC33A1). It is predicted that the missense mutation, causing the change of the highly conserved serine to arginine at the codon 113 (p. S113R), disrupts the second transmembrane domain in the transporter and reverses the orientation of all of the descending domains. Knockdown of Slc33a1 in zebrafish caused a curve-shaped tail and defective axon outgrowth from the spinal cord. Although the wild-type human SLC33A1 was able to rescue the phenotype caused by Slc33a1 knockdown in zebrafish, the mutant SLC33A1 (p.S113R) was not, suggesting that S113R mutation renders SLC33A1 nonfunctional and one that wild-type allele is not sufficient for sustaining the outgrowth and maintenance of long motor axons in human heterozygotes. Thus, our study illustrated a critical role of acetyl-CoA transporter in motor-neuron development and function.	[Lin, Pengfei; Li, Jianwei; Liu, Qiji; Mao, Fei; Li, Jisheng; Qiu, Rongfang; Hu, Huili; Song, Yang; Yang, Yang; Gao, Guimin; Yang, Wanling; Shao, Changshun; Gong, Yaoqin] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Lin, Pengfei; Li, Jianwei; Liu, Qiji; Mao, Fei; Li, Jisheng; Qiu, Rongfang; Hu, Huili; Song, Yang; Yang, Yang; Gao, Guimin; Yang, Wanling; Shao, Changshun; Gong, Yaoqin] Shandong Univ, Sch Med, Inst Med Genet, Jinan 250012, Shandong, Peoples R China; [Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Shandong, Peoples R China; [Yang, Wanling] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Shao, Changshun] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Shandong University; Shandong University; Shandong University; University of Hong Kong; Rutgers State University New Brunswick	Gong, YQ (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.	yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342; Li, Jianwei/0000-0002-0262-3901	National Basic Research Program of China [2007CB512001]; National Science Foundation Research Gramt [30771201]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation Research Gramt(National Science Foundation (NSF))	We thank the patients and their families for their participation, and we thank Hongwei Zhang and Ming Shao (Shandong University School of Life Science), for expert technical assistance. This work was supported by the National Basic Research Program of China (grant no. 2007CB512001) and the National Science Foundation Research Grant (grant no. 30771201).	Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Fink JK, 2003, EXP NEUROL, V184, pS106, DOI 10.1016/j.expneurol.2003.08.005; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; HARDING AE, 1983, LANCET, V1, P1151; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hirabayashi Y, 2004, PFLUG ARCH EUR J PHY, V447, P760, DOI 10.1007/s00424-003-1071-6; Kanamori A, 1997, P NATL ACAD SCI USA, V94, P2897, DOI 10.1073/pnas.94.7.2897; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Sauter S M, 2004, Hum Mutat, V23, P98, DOI 10.1002/humu.9205; Valdmanis PN, 2007, AM J HUM GENET, V80, P152, DOI 10.1086/510782; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	17	79	90	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					752	759		10.1016/j.ajhg.2008.11.003	http://dx.doi.org/10.1016/j.ajhg.2008.11.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19061983	Bronze, Green Published			2022-12-18	WOS:000261822100010
J	Hirose, Y; Chiba, K; Karasugi, T; Nakajima, M; Kawaguchi, Y; Mikami, Y; Furuichi, T; Mio, F; Miyake, A; Miyamoto, T; Ozaki, K; Takahashi, A; Mizuta, H; Kubo, T; Kimura, T; Tanaka, T; Toyama, Y; Ikegawa, S				Hirose, Yuichiro; Chiba, Kazuhiro; Karasugi, Tatsuki; Nakajima, Masahiro; Kawaguchi, Yoshiharu; Mikami, Yasuo; Furuichi, Tatsuya; Mio, Futoshi; Miyake, Atsushi; Miyamoto, Takeshi; Ozaki, Kouichi; Takahashi, Atsushi; Mizuta, Hiroshi; Kubo, Toshikazu; Kimura, Tomoatsu; Tanaka, Toshihiro; Toyama, Yoshiaki; Ikegawa, Shiro			A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; CHONDROSARCOMA CELL-LINE; GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-BETA; MATRIX METALLOPROTEINASE-2; POPULATION STRATIFICATION; MATRICELLULAR PROTEINS; INTERVERTEBRAL DISC; ADHESIVE DEFECT; IV COLLAGENASE	Lumbar-disc herniation (LDH), one of the most common musculoskeletal diseases, has strong genetic determinants. Recently, several genes that encode extracellular matrix (ECM) proteins in the intervertebral disc have been reported to associate with LDH. Thrombospondins (THBSs) I and 2 are good candidates for the LDH susceptibility gene: They are intervertebral disc ECM proteins that regulate the effective levels of matrix metalloproteinases (MMPs) 2 and 9, which are key effectors of ECM remodeling. Here, we report that THBS2 is associated with LDH in Japanese populations. An intronic SNP in THBS2 (IVS10-8C -> T; rs9406328) showed significant association (p = 0.0000028) with LDH in two independent Japanese populations. This SNP, located in a polypyrimidine tract upstream of the 3' splice site of intron 10, exerts allelic differences on exon 11 skipping rates in vivo, with the susceptibility allele showing increased skipping. Skipping of exon 11 results in decreased THBS2 interaction with MMP2 and MMP9. Further, a missense SNP in MMP9 (Q279R; rs17576) is also strongly associated with LDH in the Japanese population (p = 0.00049) and shows a combinatorial effect with THBS2 (odds ratio 3.03, 95% confidence interval 1.58-5.77). Thus, a splicing-affecting SNP in THBS2 and a missense SNP in MMP9 are associated with susceptibility to LDH. Our data indicate that regulation of intervertebral disc ECM metabolism by the THBS2-MMP system plays an essential role in the etiology and pathogenesis of LDH.	[Hirose, Yuichiro; Karasugi, Tatsuki; Nakajima, Masahiro; Furuichi, Tatsuya; Mio, Futoshi; Miyake, Atsushi; Ikegawa, Shiro] RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; [Hirose, Yuichiro; Chiba, Kazuhiro; Mio, Futoshi; Miyake, Atsushi; Miyamoto, Takeshi; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Karasugi, Tatsuki; Mizuta, Hiroshi] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Orthopaed & Neuro Musculoskeletal Surg, Kumamoto 8608556, Japan; Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 9300194, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, SNP Res Ctr, Lab Cardiovasc Dis, Minato Ku, Tokyo 1088639, Japan; [Takahashi, Atsushi] RIKEN, SNP Res Ctr, Stat Lab, Minato Ku, Tokyo 1088639, Japan	RIKEN; Keio University; Kumamoto University; University of Toyama; Kyoto Prefectural University of Medicine; RIKEN; RIKEN	Ikegawa, S (corresponding author), RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; Tanaka, Toshihiro/J-9310-2014; Toyama, Yoshiaki/K-5743-2013	Ikegawa, Shiro/0000-0003-0316-2147; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570				Adams JC, 2000, DEV DYNAM, V218, P280; Agah A, 2005, AM J PATHOL, V167, P81, DOI 10.1016/S0002-9440(10)62955-0; ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; BATTIE MC, 1995, J BONE JOINT SURG AM, V77A, P1662, DOI 10.2106/00004623-199511000-00004; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; BORNSTEIN P, 1994, METHOD ENZYMOL, V245, P62; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Chano T, 1998, VIRCHOWS ARCH, V432, P529, DOI 10.1007/s004280050201; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Gruber HE, 2006, SPINE, V31, P2556, DOI 10.1097/01.brs.0000241117.31510.e3; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hu ZB, 2005, CLIN CANCER RES, V11, P5433, DOI 10.1158/1078-0432.CCR-05-0311; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Matsui H, 1998, SPINE, V23, P1029, DOI 10.1097/00007632-199805010-00013; Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40; O'Farrell TJ, 2000, J BIOL CHEM, V275, P27964; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; SAAL JA, 1989, SPINE, V14, P431, DOI 10.1097/00007632-198904000-00018; Sambrook PN, 1999, ARTHRITIS RHEUM-US, V42, P366, DOI 10.1002/1529-0131(199902)42:2<366::AID-ANR20>3.0.CO;2-6; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Seki S, 2005, NAT GENET, V37, P607, DOI 10.1038/ng1557; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353	36	79	95	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1122	1129		10.1016/j.ajhg.2008.03.013	http://dx.doi.org/10.1016/j.ajhg.2008.03.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18455130	Green Published, Bronze			2022-12-18	WOS:000255923600011
J	Higgins, AW; Alkuraya, FS; Bosco, AE; Brown, KK; Bruns, GAP; Donovan, DJ; Eisenman, R; Fan, Y; Farra, CG; Ferguson, HL; Gusella, JF; Harris, DJ; Herrick, SR; Kelly, C; Kim, HG; Kishikawa, S; Korf, BR; Kulkarni, S; Lally, E; Leach, NT; Lemyre, E; Lewis, J; Ligon, AH; Lu, WN; Maas, RL; MacDonald, ME; Moore, SDP; Peters, RE; Quade, BJ; Quintero-Rivera, F; Saadi, I; Shen, Y; Shendure, J; Williamson, RE; Morton, CC				Higgins, Anne W.; Alkuraya, Fowzan S.; Bosco, Amy E.; Brown, Kerry K.; Bruns, Gail A. P.; Donovan, Diana J.; Eisenman, Robert; Fan, Yanli; Farra, Chantal G.; Ferguson, Heather L.; Gusella, James F.; Harris, David J.; Herrick, Steven R.; Kelly, Chantal; Kim, Hyung-Goo; Kishikawa, Shotaro; Korf, Bruce R.; Kulkarni, Shashikant; Lally, Eric; Leach, Natalia T.; Lemyre, Emma; Lewis, Janine; Ligon, Azra H.; Lu, Weining; Maas, Richard L.; MacDonald, Marcy E.; Moore, Steven D. P.; Peters, Roxanna E.; Quade, Bradley J.; Quintero-Rivera, Fabiola; Saadi, Irfan; Shen, Yiping; Shendure, Jay; Williamson, Robin E.; Morton, Cynthia C.			Characterization of apparently balanced chromosomal rearrangements from the developmental genome anatomy project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE CONGENITAL-ANOMALIES; MENTAL-RETARDATION; CLEFT-LIP; TRANSLOCATION; DISRUPTION; GENE; HAPLOINSUFFICIENCY; IDENTIFICATION; MECHANISMS; BREAKPOINT	Apparently balanced chromosomal rearrangements in individuals with major congenital anomalies represent natural experiments of gene disruption and dysregulation. These individuals can be studied to identify novel genes critical in human development and to annotate further the function of known genes, Identification and characterization of these genes is the goal of the Developmental Genome Anatomy Project (DGAP). DGAP is a multidisciplinary effort that leverages the recent advances resulting from the Human Genome Project to increase our understanding of birth defects and the process of human development. Clinically significant phenotypes of individuals enrolled in DGAP are varied and, in most cases, involve multiple organ systems. Study of these individuals' chromosomal rearrangements has resulted in the mapping of 77 breakpoints from 40 chromosomal rearrangements by FISH with BACs and fosmids, array CGH, Southern-blot hybridization, MLPA, RT-PCR, and suppression PCR. Eighteen chromosomal breakpoints have been cloned and sequenced. Unsuspected genomic imbalances and cryptic rearrangements were detected, but less frequently than has been reported previously. Chromosomal rearrangements, both balanced and unbalanced, in individuals with multiple congenital anomalies continue to be a valuable resource for gene discovery and annotation.	[Higgins, Anne W.; Donovan, Diana J.; Farra, Chantal G.; Lally, Eric; Ligon, Azra H.; Peters, Roxanna E.; Quade, Bradley J.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Brown, Kerry K.; Gusella, James F.; Herrick, Steven R.; Shendure, Jay; Williamson, Robin E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Alkuraya, Fowzan S.; Fan, Yanli; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bosco, Amy E.; Ferguson, Heather L.; Kelly, Chantal; Leach, Natalia T.; Moore, Steven D. P.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Bruns, Gail A. P.; Eisenman, Robert] Childrens Hosp Boston, Dept Pediat, Div Genet, Boston, MA 02115 USA; [Gusella, James F.; Kim, Hyung-Goo; Kishikawa, Shotaro; Lewis, Janine; MacDonald, Marcy E.; Quintero-Rivera, Fabiola; Shen, Yiping] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Gusella, James F.; Kim, Hyung-Goo; Kishikawa, Shotaro; Lewis, Janine; MacDonald, Marcy E.; Quintero-Rivera, Fabiola; Shen, Yiping] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Korf, Bruce R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Kulkarni, Shashikant] Washington Univ, Sch Med, Dept Pathol, Div Lab & Genom Med, St Louis, MO 63110 USA; [Lemyre, Emma] Univ Montreal, Hop St Justine, Div Med Genet, Montreal, PQ H3T 1C5, Canada; [Lu, Weining] Boston Univ, Med Ctr, Dept Med, Renal Sect, Boston, MA 02118 USA; [MacDonald, Marcy E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Universite de Montreal; Boston University; Harvard University; Harvard Medical School	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	cmorton@partners.org	Shendure, Jay/AAU-3684-2021; Saadi, Irfan/I-5989-2019; Donovan, Diana J./A-1256-2010; Alkuraya, Fowzan S./A-1542-2009; Korf, Bruce R/H-4882-2012	Saadi, Irfan/0000-0002-6250-6651; Alkuraya, Fowzan S./0000-0003-4158-341X; Shendure, Jay/0000-0002-1516-1865; Moore, Steven/0000-0002-3209-6102; Lu, Weining/0000-0002-6570-3044	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD043627] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748, P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005712, F31DC007540] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006516, P30CA06516] Funding Source: Medline; NICHD NIH HHS [F32 HD043627] Funding Source: Medline; NIDCD NIH HHS [F31 DC007540, F31 DC005712] Funding Source: Medline; NIGMS NIH HHS [P01 GM061354, T32 GM007748] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Abo-Dalo B, 2007, AM J MED GENET A, V143A, P2668, DOI 10.1002/ajmg.a.32034; Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Astbury C, 2004, GENET MED, V6, P81, DOI 10.1097/01.GIM.0000117850.04443.C9; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Etienne A, 2007, CANCER GENET CYTOGEN, V176, P80, DOI 10.1016/j.cancergencyto.2007.03.009; Gajecka M, 2006, HUM GENET, V120, P519, DOI 10.1007/s00439-006-0222-1; Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141; ISHIKIRIYAMA S, 1989, AM J MED GENET, V33, P505, DOI 10.1002/ajmg.1320330419; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Johnson D, 2006, J MED GENET, V43, P280, DOI 10.1136/jmg.2005.032946; Kim HG, 2005, J MED GENET, V42, P666, DOI 10.1136/jmg.2004.026989; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim HG, 2007, AM J MED GENET A, V143A, P107, DOI 10.1002/ajmg.a.31544; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; Lu WN, 2007, PLOS GENET, V3, P830, DOI 10.1371/journal.pgen.0030080; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Mao XY, 2007, GENE CHROMOSOME CANC, V46, P675, DOI 10.1002/gcc.20452; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Nothwang HG, 2001, HUM MOL GENET, V10, P797, DOI 10.1093/hmg/10.8.797; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Quintero-Rivera F, 2007, AM J MED GENET A, V143A, P558, DOI 10.1002/ajmg.a.31618; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Shanske AL, 2004, AM J MED GENET A, V131A, P29, DOI 10.1002/ajmg.a.30311; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SPINNER NB, 1994, AM J HUM GENET, V55, P238; TOMMERUP N, 1992, AM J MED GENET, V44, P237, DOI 10.1002/ajmg.1320440223; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Watson SK, 2007, HUM GENET, V120, P795, DOI 10.1007/s00439-006-0251-9; Williamson RE, 2007, AM J MED GENET A, V143A, P1630, DOI 10.1002/ajmg.a.31724	36	79	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					712	722		10.1016/j.ajhg.2008.01.011	http://dx.doi.org/10.1016/j.ajhg.2008.01.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319076	Bronze, Green Published			2022-12-18	WOS:000254067800015
J	Laumonnier, F; Cuthbert, PC; Grant, SGN				Laumonnier, Frederic; Cuthbert, Peter C.; Grant, Seth G. N.			The role of neuronal complexes in human X-linked brain diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							PROTEOLIPID PROTEIN GENE; MENTAL-RETARDATION; POSTSYNAPTIC DENSITY; PROTEOMIC ANALYSIS; SYNAPSE FORMATION; GLUTAMATE RECEPTORS; IN-VIVO; MOLECULAR CHARACTERIZATION; MULTIPROTEIN COMPLEXES; NMDA RECEPTORS	Beyond finding individual genes that are involved in medical disorders, an important challenge is the integration of sets of disease genes with the complexities of basic biological processes. We examine this issue by focusing on neuronal multiprotein complexes and their components encoded on the human X chromosome. Multiprotein signaling complexes in the postsynaptic terminal of central nervous system synapses are essential for the induction of neuronal plasticity and cognitive processes in animals. The prototype complex is the N-methyl-D-aspartate receptor complex/membrane-associated guanylate kinase-associated signaling complex (NRC/MASC) comprising 185 proteins and embedded within the postsynaptic density (PSD), which is a set of complexes totaling similar to 1,100 proteins. It is striking that 86% (6 of 7) of X-linked NRC/MASC genes and 49% (19 of 39) of X-chromosomal PSD genes are already known to be involved in human psychiatric disorders. Moreover, of the 69 known proteins mutated in X-linked mental retardation, 19 (28%) encode postsynaptic proteins. The high incidence of involvement in cognitive disorders is also found in mouse mutants and indicates that the complexes are functioning as integrated entities or molecular machines and that disruption of different components impairs their overall role in cognitive processes. We also noticed that NRC/MASC genes appear to be more strongly associated with mental retardation and autism spectrum disorders. We propose that systematic studies of PSD and NRC/MASC genes in mice and humans will give a high yield of novel genes important for human disease and new mechanistic insights into higher cognitive functions.	Wellcome Trust Sanger Inst, Genes Cognit Programme, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Genes Cognit Programme, Genome Campus, Cambridge CB10 1SA, England.	sg3@sanger.ac.uk	Laumonnier, Frederic/N-1165-2016	Laumonnier, Frederic/0000-0003-2567-0708; Grant, Seth/0000-0001-8732-8735	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; BAIRD PA, 1985, AM J MENT DEF, V89, P323; BANKER G, 1974, J CELL BIOL, V63, P456, DOI 10.1083/jcb.63.2.456; Barnes AP, 2002, INT J DEV NEUROSCI, V20, P397, DOI 10.1016/S0736-5748(02)00016-3; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; CUTHBERT PC, IN PRESS J NEUROSCI; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Delaunoy JP, 2001, HUM MUTAT, V17, P103, DOI 10.1002/1098-1004(200102)17:2<103::AID-HUMU2>3.0.CO;2-N; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; DRILLIEN CM, 1967, PEDIATRICS, V39, P238; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Farr CD, 2004, J NEUROCHEM, V91, P438, DOI 10.1111/j.1471-4159.2004.02735.x; Gecz J, 1999, GENOMICS, V62, P356, DOI 10.1006/geno.1999.6032; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grant SGN, 2006, BIOCHEM SOC T, V34, P59, DOI 10.1042/BST0340059; Grant SGN, 2005, HUM MOL GENET, V14, pR225, DOI 10.1093/hmg/ddi330; GRANT SGN, 2004, EXCITATORY INHIBITOR, P13; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Harsha HC, 2005, NAT GENET, V37, P331, DOI 10.1038/ng0405-331; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; KIM TW, 1995, ANN NEUROL, V38, P446, DOI 10.1002/ana.410380315; KIM TW, 1992, P NATL ACAD SCI USA, V89, P11642, DOI 10.1073/pnas.89.23.11642; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Kleefstra T, 2005, CLIN GENET, V67, P451, DOI 10.1111/j.1399-0004.2005.00434.x; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; MCLAREN J, 1987, AM J MENT RETARD, V92, P243; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pocklington A. J., 2006, Briefings in Functional Genomics & Proteomics, V5, P66, DOI 10.1093/bfgp/ell013; POCKLINGTON AJ, 2006, MOL SYST BIOL   0117; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; Renieri A, 2005, J CELL PHYSIOL, V204, P8, DOI 10.1002/jcp.20296; Robbins TW, 2006, TRENDS PHARMACOL SCI, V27, P141, DOI 10.1016/j.tips.2006.01.009; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stevenson RE, 2002, CYTOGENET GENOME RES, V99, P265, DOI 10.1159/000071603; STOLLER A, 1965, P 4 INT C MENT DEF M, P18; Swanton E, 2005, P NATL ACAD SCI USA, V102, P4342, DOI 10.1073/pnas.0407287102; Sweigard JA, 2001, CURR OPIN MICROBIOL, V4, P387, DOI 10.1016/S1369-5274(00)00222-8; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Vallender EJ, 2005, NAT GENET, V37, P343, DOI 10.1038/ng0405-343; van der Plas MC, 2006, J NEUROSCI, V26, P333, DOI 10.1523/JNEUROSCI.4069-05.2006; van Galen EJM, 2005, PROG BRAIN RES, V147, P295, DOI 10.1016/S0079-6123(04)47022-8; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vickers CA, 2006, BRAIN RES, V1090, P89, DOI 10.1016/j.brainres.2006.03.075; Vidan S, 2001, CURR OPIN BIOTECH, V12, P28, DOI 10.1016/S0958-1669(00)00171-3; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Whittard JD, 2006, MOL BIOL CELL, V17, P2696, DOI 10.1091/mbc.E06-01-0090; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; WU Y, 2005, 12 INT WORKSH FRAG X; Yool DA, 2000, HUM MOL GENET, V9, P987, DOI 10.1093/hmg/9.6.987; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	106	79	80	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					205	220		10.1086/511441	http://dx.doi.org/10.1086/511441			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236127	Green Published, Bronze			2022-12-18	WOS:000243729500001
J	Tekin, M; Hismi, BO; Fitoz, S; Ozdag, H; Cengiz, FB; Sirmaci, A; Aslan, I; Inceoglu, B; Yuksel-Konuk, EB; Yilmaz, ST; Yasun, O; Akar, N				Tekin, Mustafa; Hismi, Burcu Ozturk; Fitoz, Suat; Ozdag, Hilal; Cengiz, Filiz Basak; Sirmaci, Asli; Aslan, Idil; Inceoglu, Bora; Yuksel-Konuk, E. Berrin; Yilmaz, Seda Tasir; Yasun, Oztan; Akar, Nejat			Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTO-ONCOGENE INT-2; INDUCTION; PROTOONCOGENE; EXPRESSION; FGF10	We identified nine individuals from three unrelated Turkish families with a unique autosomal recessive syndrome characterized by type I microtia, microdontia, and profound congenital deafness associated with a complete absence of inner ear structures (Michel aplasia). We later demonstrated three different homozygous mutations (p.S156P, p.R104X, and p.V206SfsX117) in the fibroblast growth factor 3 (FGF3) gene in affected members of these families, cosegregating with the autosomal recessive transmission as a completely penetrant phenotype. These findings demonstrate the involvement of FGF3 mutations in a human malformation syndrome for the first time and contribute to our understanding of the role this gene plays in embryonic development. Of particular interest is that the development of the inner ear is completely disturbed at a very early stage-or the otic vesicle is not induced at all-in all of the affected individuals who carried two mutant FGF3 alleles.	Ankara Univ, Sch Med, Dept Pediat, Div Clin Mol Pathol & Genet, TR-06100 Ankara, Turkey; Ankara Univ, Sch Med, Dept Radiodiagnost, TR-06100 Ankara, Turkey; Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey; Ankara Numune Hosp, Dept Dent, Ankara, Turkey	Ankara University; Ankara University; Ankara University; Ankara Numune Training & Research Hospital	Tekin, M (corresponding author), Birlik Mah 65 Sok 20-7, TR-06610 Ankara, Turkey.	mtekin@medicine.ankara.edu.tr	Fitoz, Suat/AAI-8009-2020; Tekin, Mustafa/ABG-7627-2020; Akar, Nejat/H-2949-2019; Taşır Yılmaz, Seda/G-6235-2019; Ozturk-Hismi, Burcu/AAH-6558-2019; yuksel, berrin/AAB-5080-2019; Özdag, Hilal/C-9929-2009; Inceoglu, Bora/G-2892-2015	Fitoz, Suat/0000-0002-0180-0013; Taşır Yılmaz, Seda/0000-0001-8879-0016; Ozturk-Hismi, Burcu/0000-0001-7146-0248; yuksel, berrin/0000-0001-7107-1939; Özdag, Hilal/0000-0001-7940-2499; Tekin, Mustafa/0000-0002-3525-7960; Inceoglu, Bora/0000-0002-8473-6036				ALLANSON J, 2004, HEREDITARY HEARING L, P101; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Bamiou DE, 2000, ARCH DIS CHILD, V82, P257, DOI 10.1136/adc.82.3.257; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; HERSH J H, 1991, Ear Nose and Throat Journal, V70, P155; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Mafong DD, 2002, LARYNGOSCOPE, V112, P1, DOI 10.1097/00005537-200201000-00001; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; Michel E.M., 1863, GAZ MED STRASBOURG, V4, P55; Milunsky JM, 2006, CLIN GENET, V69, P349, DOI 10.1111/j.1399-0004.2006.00597.x; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; REPRESA J, 1991, NATURE, V353, P561, DOI 10.1038/353561a0; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Vendrell V, 2000, DEVELOPMENT, V127, P2011; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555	19	79	85	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					338	344		10.1086/510920	http://dx.doi.org/10.1086/510920			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236138	Bronze, Green Published			2022-12-18	WOS:000243729500013
J	Lindsay, SJ; Khajavi, M; Lupski, JR; Hurles, ME				Lindsay, Sarah J.; Khajavi, Mehrdad; Lupski, James R.; Hurles, Matthew E.			A chromosomal rearrangement hotspot can be identified from population genetic variation and is coincident with a hotspot for allelic recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; HUMAN-GENOME; SEGMENTAL DUPLICATIONS; HOMOLOGOUS RECOMBINATION; SEQUENCE VARIATION; STRAND EXCHANGE; COMMON DELETION; SOTOS-SYNDROME; HUMANS; CHIMPANZEES	Insights into the origins of structural variation and the mutational mechanisms underlying genomic disorders would be greatly improved by a genomewide map of hotspots of nonallelic homologous recombination (NAHR). Moreover, our understanding of sequence variation within the duplicated sequences that are substrates for NAHR lags far behind that of sequence variation within the single-copy portion of the genome. Perhaps the best-characterized NAHR hotspot lies within the 24-kb-long Charcot-Marie-Tooth disease type 1A (CMT1A)-repeats (REPs) that sponsor deletions and duplications that cause peripheral neuropathies. We investigated structural and sequence diversity within the CMT1A-REPs, both within and between species. We discovered a high frequency of retroelement insertions, accelerated sequence evolution after duplication, extensive paralogous gene conversion, and a greater than twofold enrichment of SNPs in humans relative to the genome average. We identified an allelic recombination hotspot underlying the known NAHR hotspot, which suggests that the two processes are intimately related. Finally, we used our data to develop a novel method for inferring the location of an NAHR hotspot from sequence variation within segmental duplications and applied it to identify a putative NAHR hotspot within the LCR22 repeats that sponsor velocardiofacial syndrome deletions. We propose that a large-scale project to map sequence variation within segmental duplications would reveal a wealth of novel chromosomal-rearrangement hotspots.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Wellcome Trust Sanger Institute; Baylor College of Medicine; Baylor College of Medicine	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk	Lindsay, Sarah/CAF-4613-2022	Lindsay, Sarah/0000-0002-0965-3070	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Cann HM, 2002, SCIENCE, V296, P261; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Hallast P, 2005, GENOME RES, V15, P1535, DOI 10.1101/gr.4270505; Hurles M, 2002, SCIENCE, V298; Hurles ME, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r55; HURLES ME, 2006, GENOMIC DISORDERS GE; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jackson MS, 2005, AM J HUM GENET, V77, P824, DOI 10.1086/497704; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kiyosawa H, 1996, HUM MOL GENET, V5, P745, DOI 10.1093/hmg/5.6.745; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; Li N, 2003, GENETICS, V165, P2213; Lindsay SJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni152; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lupski J.R., 2006, GENOMIC DISORDERS TH; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-242; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pavlicek A, 2005, GENOME RES, V15, P1487, DOI 10.1101/gr.4281205; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Reitemeier A, 1997, Z HIST FORSCH, V24, P1; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	56	79	82	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					890	902		10.1086/508709	http://dx.doi.org/10.1086/508709			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033965	Bronze, Green Published			2022-12-18	WOS:000241667400010
J	Pichler, I; Marroni, F; Volpato, CB; Gusella, JF; Klein, C; Casari, G; De Grandi, A; Pramstaller, PP				Pichler, Irene; Marroni, Fabio; Volpato, Claudia Beu; Gusella, James F.; Klein, Christine; Casari, Giorgio; De Grandi, Alessandro; Pramstaller, Peter P.			Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-HETEROGENEITY; SUSCEPTIBILITY LOCUS; RECONSTRUCTION; EPIDEMIOLOGY; CONFIRMATION; DEFINITION; HLODS; 14Q	Restless legs syndrome (RLS) is a common neurological condition with three loci (12q, 14q, and 9p) described so far, although none of these genes has yet been identified. We report a genomewide linkage scan of patients with RLS (n = 37) assessed in a population isolate (n = 530) of South Tyrol ( Italy). Using both nonparametric and parametric analyses, we initially obtained suggestive evidence of a novel locus on chromosome 2q, with nominal evidence of linkage on chromosomes 5p and 17p. Follow-up genotyping yielded significant evidence of linkage (nonparametric LOD score 5.5, P <= .0000033; heterogeneity LOD score 5.1; alpha = 1.0) on chromosome 2q. Three families (S01, S05, and S016) were shown to descend from a common founder couple. A disease haplotype shared between family S01 and family S05 defines a candidate region of 8.2 cM; in addition, the single affected individual in family S016 shares three linked alleles at neighboring markers, which suggests a reduced candidate interval of only 1.6 cM. Two-point linkage analysis in this 10-generation pedigree provided significant evidence of a novel RLS locus in this region ( LOD score 4.1). These findings reemphasize the genetic heterogeneity of the disorder and strongly support the identification of a novel locus for RLS on chromosome 2q.	European Acad, Inst Med Genet, I-39100 Bolzano, Italy; Gen Reg Hosp, Dept Neurol, Bolzano, Italy; Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; Med Univ Lubeck, Dept Human Genet, D-23538 Lubeck, Germany; Univ Vita Salute San Raffaele, Milan, Italy; Ist Sci San Raffaele, I-20132 Milan, Italy	European Academy of Bozen-Bolzano; Harvard University; Massachusetts General Hospital; University of Lubeck; University of Lubeck; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pramstaller, PP (corresponding author), European Acad, Inst Med Genet, Viale Druso 1, I-39100 Bolzano, Italy.	peter.pramstaller@eurac.edu	Marroni, Fabio/R-1819-2017; Pramstaller, Peter P/C-2357-2008; Klein, Christine/AGK-8003-2022; Casari, Giorgio/J-3070-2018	Marroni, Fabio/0000-0002-1556-5907; Casari, Giorgio/0000-0002-0115-8980; Klein, Christine/0000-0003-2102-3431; Pichler, Irene/0000-0001-8251-0757				Allen RP, 2001, SLEEP MED, V2, P239, DOI 10.1016/S1389-9457(00)00080-0; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Bonati MT, 2003, BRAIN, V126, P1485, DOI 10.1093/brain/awg137; Chen SH, 2004, AM J HUM GENET, V74, P876, DOI 10.1086/420772; Desautels A, 2005, ARCH NEUROL-CHICAGO, V62, P591, DOI 10.1001/archneur.62.4.591; Desautels A, 2001, AM J HUM GENET, V69, P1266, DOI 10.1086/324649; Ferini-Strambi L, 2004, SLEEP MED, V5, P301, DOI 10.1016/j.sleep.2004.01.005; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; Kock N, 2002, AM J HUM GENET, V71, pA205, DOI 10.1086/341097; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lazzarini A, 1999, MOVEMENT DISORD, V14, P111, DOI 10.1002/1531-8257(199901)14:1<111::AID-MDS1018>3.3.CO;2-0; Levchenko A, 2004, ANN NEUROL, V55, P887, DOI 10.1002/ana.20140; Marroni F, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S77; MARRONI F, 2006, IN PRESS ANN HUM GEN; Ondo WG, 2000, NEUROLOGY, V55, P1404, DOI 10.1212/WNL.55.9.1404; Picchietti DL, 1999, MOVEMENT DISORD, V14, P1000, DOI 10.1002/1531-8257(199911)14:6<1000::AID-MDS1014>3.0.CO;2-P; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tison F, 2005, NEUROLOGY, V65, P239, DOI 10.1212/01.wnl.0000168910.48309.4a; Trenkwalder C, 2005, LANCET NEUROL, V4, P465, DOI 10.1016/S1474-4422(05)70139-3; Vieland VJ, 2002, HUM HERED, V53, P23, DOI 10.1159/000048601; VOGL FD, 2006, MOV DISORD; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; WALTERS AS, 1990, ARCH NEUROL-CHICAGO, V47, P1219, DOI 10.1001/archneur.1990.00530110079020; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Whittemore AS, 2001, AM J HUM GENET, V68, P457, DOI 10.1086/318186; Winkelmann J, 2006, MOVEMENT DISORD, V21, P28, DOI 10.1002/mds.20627; Winkelmann J, 2002, SLEEP MED, V3, pS9, DOI 10.1016/S1389-9457(02)00141-7; Winkelmann J, 2002, ANN NEUROL, V52, P297, DOI 10.1002/ana.10282; Winkelmann J, 2006, SLEEP MED REV, V10, P179, DOI 10.1016/j.smrv.2006.01.003	34	79	82	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					716	723		10.1086/507875	http://dx.doi.org/10.1086/507875			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960808	Bronze, Green Published			2022-12-18	WOS:000240855900013
J	Woodward, KJ; Cundall, M; Sperle, K; Sistermans, EA; Ross, M; Howell, G; Gribble, SM; Burford, DC; Carter, NP; Hobson, DL; Garbern, JY; Kamholz, J; Heng, H; Hodes, ME; Malcolm, S; Hobson, GM				Woodward, KJ; Cundall, M; Sperle, K; Sistermans, EA; Ross, M; Howell, G; Gribble, SM; Burford, DC; Carter, NP; Hobson, DL; Garbern, JY; Kamholz, J; Heng, H; Hodes, ME; Malcolm, S; Hobson, GM			Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOLIPID PROTEIN GENE; STRAND BREAK REPAIR; LINKED MENTAL-RETARDATION; HUMAN INHERITED DISEASE; MAMMALIAN-CELLS; TOPOISOMERASE-II; DELETION BREAKPOINTS; GENOMIC DISORDERS; CHROMOSOMAL TRANSLOCATIONS; SEGMENTAL DUPLICATIONS	We describe genomic structures of 59 X-chromosome segmental duplications that include the proteolipid protein 1 gene (PLP1) in patients with Pelizaeus-Merzbacher disease. We provide the first report of 13 junction sequences, which gives insight into underlying mechanisms. Although proximal breakpoints were highly variable, distal breakpoints tended to cluster around low-copy repeats (LCRs) (50% of distal breakpoints), and each duplication event appeared to be unique (100 kb to 4.6 Mb in size). Sequence analysis of the junctions revealed no large homologous regions between proximal and distal breakpoints. Most junctions had microhomology of 1-6 bases, and one had a 2-base insertion. Boundaries between single-copy and duplicated DNA were identical to the reference genomic sequence in all patients investigated. Taken together, these data suggest that the tandem duplications are formed by a coupled homologous and nonhomologous recombination mechanism. We suggest repair of a double-stranded break (DSB) by one-sided homologous strand invasion of a sister chromatid, followed by DNA synthesis and nonhomologous end joining with the other end of the break. This is in contrast to other genomic disorders that have recurrent rearrangements formed by nonallelic homologous recombination between LCRs. Interspersed repetitive elements (Alu elements, long interspersed nuclear elements, and long terminal repeats) were found at 18 of the 26 breakpoint sequences studied. No specific motif that may predispose to DSBs was revealed, but single or alternating tracts of purines and pyrimidines that may cause secondary structures were common. Analysis of the 2-Mb region susceptible to duplications identified proximal-specific repeats and distal LCRs in addition to the previously reported ones, suggesting that the unique genomic architecture may have a role in nonrecurrent rearrangements by promoting instability.	Alfred I duPont Hosp Children, Nemours Childrens Clin, Wilmington, DE 19899 USA; Inst Child Hlth, London, England; Western Diagnost Pathol, Perth, WA, Australia; Univ Nijmegen St Radboud Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Wellcone Trust Sanger Inst, Hinxton, England; Wayne State Univ, Dept Neurol, Detroit, MI USA; Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; University of London; University College London; Radboud University Nijmegen; Wellcome Trust Sanger Institute; Wayne State University; Wayne State University; Indiana University System; Indiana University-Purdue University Indianapolis; Jefferson University	Hobson, GM (corresponding author), Alfred I duPont Hosp Children, Nemours Childrens Clin, Wilmington, DE 19899 USA.	ghobson@nemours.org	Sistermans, Erik/B-1109-2009	Sistermans, Erik/0000-0001-7187-4563	NCRR NIH HHS [P20 RR020173, P20 RR-020173-01] Funding Source: Medline; NINDS NIH HHS [NS043783, R01 NS043783] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043783] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BEEN MD, 1984, NUCLEIC ACIDS RES, V12, P3097, DOI 10.1093/nar/12.7.3097; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; Brooks EM, 2001, MUTAT RES-FUND MOL M, V476, P43, DOI 10.1016/S0027-5107(01)00065-3; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Chuzhanova N, 2003, HUM MUTAT, V22, P245, DOI 10.1002/humu.10253; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DOMER PH, 1995, LEUKEMIA, V9, P1305; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; Ferrante MI, 2001, GENE, V275, P217, DOI 10.1016/S0378-1119(01)00659-X; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; Graw SL, 2000, AM J HUM GENET, V66, P1138, DOI 10.1086/302821; HARDING B, 1995, NEUROPATH APPL NEURO, V21, P111, DOI 10.1111/j.1365-2990.1995.tb01036.x; Heath KE, 2000, J MED GENET, V37, P272, DOI 10.1136/jmg.37.4.272; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Hodes ME, 2000, AM J HUM GENET, V67, P14, DOI 10.1086/302965; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kurahashi H, 2003, AM J HUM GENET, V72, P733, DOI 10.1086/368062; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lovett BD, 2001, P NATL ACAD SCI USA, V98, P9802, DOI 10.1073/pnas.171309898; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lutskiy MI, 2002, HUM GENET, V110, P515, DOI 10.1007/s00439-002-0716-4; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Megonigal MD, 1998, P NATL ACAD SCI USA, V95, P6413, DOI 10.1073/pnas.95.11.6413; Mimault C, 1999, AM J HUM GENET, V65, P360, DOI 10.1086/302483; Nobile C, 2002, HUM GENET, V110, P418, DOI 10.1007/s00439-002-0721-7; Raffini LJ, 2002, P NATL ACAD SCI USA, V99, P4568, DOI 10.1073/pnas.062066799; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Rodriguez-Gabin AG, 2004, J NEUROSCI RES, V76, P758, DOI 10.1002/jnr.20121; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Sironi M, 2003, HUM GENET, V112, P272, DOI 10.1007/s00439-002-0881-5; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; SPERRY AO, 1989, P NATL ACAD SCI USA, V86, P5497, DOI 10.1073/pnas.86.14.5497; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Tsukamoto Y, 1998, GENES CELLS, V3, P135, DOI 10.1046/j.1365-2443.1998.00180.x; Ussery D, 2002, COMPUT CHEM, V26, P531, DOI 10.1016/S0097-8485(02)00013-X; WATANABE I, 1973, J NEUROPATH EXP NEUR, V32, P313, DOI 10.1097/00005072-197304000-00010; WILKUS RJ, 1976, NEUROLOGY, V26, P1042, DOI 10.1212/WNL.26.11.1042; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409; Woodward K, 2000, EUR J HUM GENET, V8, P449, DOI 10.1038/sj.ejhg.5200480; Woodward K, 1999, TRENDS GENET, V15, P125, DOI 10.1016/S0168-9525(99)01716-3; Woodward K, 2003, AM J MED GENET A, V118A, P15, DOI 10.1002/ajmg.a.10103; Woodward K, 1998, AM J HUM GENET, V63, P207, DOI 10.1086/301933; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	75	79	82	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					966	987		10.1086/498048	http://dx.doi.org/10.1086/498048			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380909	Green Published, Bronze			2022-12-18	WOS:000233241200007
J	Wijsman, EM; Daw, EW; Yu, CE; Payami, H; Steinbart, EJ; Nochlin, D; Conlon, EM; Bird, TD; Schellenberg, GD				Wijsman, EM; Daw, EW; Yu, CE; Payami, H; Steinbart, EJ; Nochlin, D; Conlon, EM; Bird, TD; Schellenberg, GD			Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2-LOCUS LINKAGE ANALYSIS; RECEPTOR-RELATED PROTEIN; RNA-BINDING PROTEINS; AGE-OF-ONSET; APOLIPOPROTEIN-E; GENETIC-LINKAGE; MISSENSE MUTATIONS; EXTENDED PEDIGREES; MARKOV-CHAINS; TYPE-4 ALLELE	Late-onset familial Alzheimer disease (LOFAD) is a genetically heterogeneous and complex disease for which only one locus, APOE, has been definitively identified. Difficulties in identifying additional loci are likely to stem from inadequate linkage analysis methods. Nonparametric methods suffer from low power because of limited use of the data, and traditional parametric methods suffer from limitations in the complexity of the genetic model that can be feasibly used in analysis. Alternative methods that have recently been developed include Bayesian Markov chain Monte Carlo methods. These methods allow multipoint linkage analysis under oligogenic trait models in pedigrees of arbitrary size; at the same time, they allow for inclusion of covariates in the analysis. We applied this approach to an analysis of LOFAD on five chromosomes with previous reports of linkage. We identified strong evidence of a second LOFAD gene on chromosome 19p13.2, which is distinct from APOE on 19q. We also obtained weak evidence of linkage to chromosome 10 at the same location as a previous report of linkage but found no evidence for linkage of LOFAD age-at-onset loci to chromosomes 9, 12, or 21.	Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA USA; Univ Washington, Harborview Med Ctr, Neuropathol Lab, Seattle, WA 98104 USA; Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Harborview Medical Center; University of Washington; University of Washington Seattle; Oregon Health & Science University	Wijsman, EM (corresponding author), Univ Washington, Div Med Genet, Box 357720, Seattle, WA 98195 USA.	wijsman@u.washington.edu	Payami, Haydeh/ABE-1944-2020	Wijsman, Ellen/0000-0002-2725-6669	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046255, R01GM046255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021544, R01AG011762, P30AG008017, R37AG011762, P50AG005136, U24AG021886] Funding Source: NIH RePORTER; NIA NIH HHS [U24 AG021886, AG 05136, AG 11762, R01 AG011762, P50 AG005136, R37 AG011762, P30 AG008017, R01 AG021544, AG 21544, AG 08017] Funding Source: Medline; NIGMS NIH HHS [R37 GM046255, GM 46255, R01 GM046255] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; AMOS CI, 1994, AM J HUM GENET, V54, P535; Bacanu SA, 2002, NEUROLOGY, V59, P118, DOI 10.1212/WNL.59.1.118; BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blacker D, 1998, ARCH NEUROL-CHICAGO, V55, P294, DOI 10.1001/archneur.55.3.294; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Breitner JCS, 1998, ALZ DIS ASSOC DIS, V12, P40, DOI 10.1097/00002093-199803000-00006; CHAPMAN N, IN PRESS AM J MED GE; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Curtis D, 2001, ANN HUM GENET, V65, P473, DOI 10.1017/S0003480001008776; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; Daw EW, 1999, AM J HUM GENET, V64, P839, DOI 10.1086/302276; Daw EW, 2003, GENET EPIDEMIOL, V24, P181, DOI 10.1002/gepi.10230; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Falconer DS., 1995, INTRO QUANTITATIVE G; Forrest WF, 2000, AM J HUM GENET, V66, P1642, DOI 10.1086/302897; Gagnon F, 2003, HUM GENET, V113, P522, DOI 10.1007/s00439-003-1006-5; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GODDARD KAB, 1999, THESIS U WASHINGTON; Goldstein AM, 1996, AM J HUM GENET, V58, P1050; Goring HHH, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S72; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Heath SC, 1997, GENET EPIDEMIOL, V14, P1011, DOI 10.1002/(SICI)1098-2272(1997)14:6<1011::AID-GEPI75>3.3.CO;2-E; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; HIXSON JE, 1990, J LIPID RES, V31, P545; HODGE SE, 1983, AM J HUM GENET, V35, P1139; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Loria PM, 2003, CURR BIOL, V13, P1317, DOI 10.1016/S0960-9822(03)00532-3; Lu PJ, 1999, NATURE, V399, P784; Mayeux R, 2002, AM J HUM GENET, V70, P237, DOI 10.1086/324773; McCarthy MI, 1998, GENET EPIDEMIOL, V15, P317, DOI 10.1002/(SICI)1098-2272(1998)15:4<317::AID-GEPI1>3.0.CO;2-#; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Meyer JM, 1998, AM J MED GENET, V81, P92, DOI 10.1002/(SICI)1096-8628(19980207)81:1<92::AID-AJMG16>3.0.CO;2-R; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Olson JM, 2001, AM J HUM GENET, V69, P895, DOI 10.1086/323472; OTT J, 1992, AM J HUM GENET, V51, P283; Pedersen NL, 2001, AM J MED GENET, V105, P724, DOI 10.1002/ajmg.1608; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; Scott WK, 1999, JAMA-J AM MED ASSOC, V281, P513, DOI 10.1001/jama.281.6.513; Scott WK, 2003, AM J HUM GENET, V73, P1041, DOI 10.1086/379083; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shmulewitz D, 2001, GENET EPIDEMIOL, V21, pS686, DOI 10.1002/gepi.2001.21.s1.s686; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TIENARI PJ, 1994, GENOMICS, V19, P320, DOI 10.1006/geno.1994.1064; TIERNEY L, 1994, ANN STAT, V22, P1701, DOI 10.1214/aos/1176325750; Tunstall N, 2000, BRIT J PSYCHIAT, V176, P156, DOI 10.1192/bjp.176.2.156; WavrantDeVrieze F, 1997, NEUROSCI LETT, V227, P68, DOI 10.1016/S0304-3940(97)00304-2; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Wijsman EM, 2003, GENET EPIDEMIOL, V25, pS64, DOI 10.1002/gepi.10286; Wijsman EM, 2002, METH MOL B, V195, P139; WIJSMAN EM, IN PRESS MOL BIOTECH; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101	75	79	82	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					398	409		10.1086/423393	http://dx.doi.org/10.1086/423393			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15248153	Bronze, Green Published			2022-12-18	WOS:000223272200005
J	Arya, R; Duggirala, R; Jenkinson, CP; Almasy, L; Blangero, J; O'Connell, P; Stern, MP				Arya, R; Duggirala, R; Jenkinson, CP; Almasy, L; Blangero, J; O'Connell, P; Stern, MP			Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; MAJOR SUSCEPTIBILITY LOCUS; GENOME-WIDE SCAN; II DIABETES-MELLITUS; NON-HISPANIC WHITES; A RECEPTOR GENE; LINKAGE ANALYSIS; FOOD-INTAKE; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS	Although several genomewide scans have identified quantitative-trait loci influencing several obesity-related traits in humans, genes influencing normal variation in obesity phenotypes have not yet been identified. We therefore performed a genome scan of body mass index (BMI) on Mexican Americans, a population prone to obesity and diabetes, using a variance-components linkage analysis to identify loci that influence BMI. We used phenotypic data from 430 individuals (26% diabetics, 59% females, mean age+/-SD=43+/-17 years, mean BMI+/-SD=30.0+/-6.7, mean leptin (ng/ml)+/-SD=22.1+/-17.1) distributed across 27 low-income Mexican American pedigrees who participated in the San Antonio Family Diabetes Study (SAFDS) for whom a 10-15-cM map is available. In this genomewide search, after accounting for the covariate effects of age, sex, diabetes, and leptin, we identified a genetic region exhibiting the most highly significant evidence for linkage (LOD 4.5) with BMI on chromosome 4p (4p15.1) at 42 cM, near marker D4S2912. This linkage result has been confirmed in an independent linkage study of severe obesity in Utah pedigrees. Two strong positional candidates, the human peroxisome proliferator-activated receptor gamma coactivator 1 (PPARGC1) and cholecystokinin A receptor (CCKAR) with major roles in the development of obesity, are located in this region. In conclusion, we identified a major genetic locus influencing BMI on chromosome 4p in Mexican Americans.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Med, Div Diabet, San Antonio, TX 78229 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Virginia Commonwealth Univ, Dept Genet, Richmond, VA 23284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; Virginia Commonwealth University	Arya, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	arya@uthscsa.edu	Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021		NIDDK NIH HHS [R01 DK079195, DK47482, R01 DK047482, DK42273, DK53889, R01 DK053889] Funding Source: Medline; NIMH NIH HHS [MH59490, R37 MH059490, R01 MH059490] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047482, R01DK053889, R01DK079195, R01DK042273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adeyemo A, 2003, OBES RES, V11, P266, DOI 10.1038/oby.2003.40; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Arya R, 2002, NAT GENET, V30, P102, DOI 10.1038/ng810; Arya R, 2001, GENET EPIDEMIOL, V21, pS774, DOI 10.1002/gepi.2001.21.s1.s774; Arya R, 2001, OBES RES, V9, p70S; Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Beglinger C, 2001, AM J PHYSIOL-REG I, V280, pR1149, DOI 10.1152/ajpregu.2001.280.4.R1149; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Blangero J, 1999, GENET EPIDEMIOL, V17, pS67; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; Bouchard C, 1997, J NUTR, V127, pS1887, DOI 10.1093/jn/127.9.1887S; Chagnon YC, 2003, OBES RES, V11, P313, DOI 10.1038/oby.2003.47; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Comuzzie AG, 2001, J MOL MED, V79, P57, DOI 10.1007/s001090100202; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DEWEERTH A, 1993, BIOCHEM BIOPH RES CO, V194, P811, DOI 10.1006/bbrc.1993.1894; Diehl A K, 1989, Adv Intern Med, V34, P73; Donahue RP, 1999, DIABETES CARE, V22, P1092, DOI 10.2337/diacare.22.7.1092; DREWE J, 1992, GASTROENTEROLOGY, V102, P1654, DOI 10.1016/0016-5085(92)91726-K; Duggirala R, 2000, AM J HUM GENET, V66, P1237, DOI 10.1086/302849; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Duggirala R, 2003, AM J HUM GENET, V73, P195; Duggirala R, 1996, AM J HUM GENET, V59, P694; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Esterbauer H, 2002, DIABETES, V51, P1281, DOI 10.2337/diabetes.51.4.1281; Funakoshi A, 2000, FEBS LETT, V466, P264, DOI 10.1016/S0014-5793(00)01080-2; Geary N, 1996, PHYSIOL BEHAV, V59, P613, DOI 10.1016/0031-9384(95)02121-3; Green P., 1990, DOCUMENTATION CRIMAP; Gutzwiller JP, 2000, AM J PHYSIOL-REG I, V279, pR189, DOI 10.1152/ajpregu.2000.279.1.R189; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; HAFFNER SM, 1991, DIABETES CARE, V14, P102, DOI 10.2337/diacare.14.2.102; HAFFNER SM, 1986, INT J OBESITY, V10, P493; Haffner SM, 1996, DIABETES, V45, P822, DOI 10.2337/diabetes.45.6.822; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hinney A, 2000, EUR J PHARMACOL, V410, P147, DOI 10.1016/S0014-2999(00)00812-8; HUPPI K, 1995, GENOMICS, V25, P727, DOI 10.1016/0888-7543(95)80018-H; Inoue H, 1997, GENOMICS, V42, P331, DOI 10.1006/geno.1997.4749; JOOS SK, 1984, ANN HUM BIOL, V11, P167, DOI 10.1080/03014468400007031; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kaplan L.M., 2000, CURR OPIN ENDOCRINOL, V7, P218; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Larrouy D, 1999, INT J OBESITY, V23, P1327, DOI 10.1038/sj.ijo.0801106; LIEVERSE RJ, 1994, GASTROENTEROLOGY, V106, P1451, DOI 10.1016/0016-5085(94)90397-2; Lowell BB, 1998, CURR BIOL, V8, pR517, DOI 10.1016/S0960-9822(07)00336-3; Ma ZM, 1996, CLIN CHEM, V42, P942; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MAHANEY MC, 1995, CIRCULATION, V92, P3240, DOI 10.1161/01.CIR.92.11.3240; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; MITCHELL BD, 1990, AM J EPIDEMIOL, V131, P423, DOI 10.1093/oxfordjournals.aje.a115517; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nadler ST, 2001, J NUTR, V131, P2078, DOI 10.1093/jn/131.8.2078; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perusse L, 2001, DIABETES, V50, P614, DOI 10.2337/diabetes.50.3.614; Platte P, 2003, AM J MED GENET C, V121C, P71, DOI 10.1002/ajmg.c.20005; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rice T, 1997, OBES RES, V5, P417, DOI 10.1002/j.1550-8528.1997.tb00664.x; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; STERN MP, 1990, INT J OBESITY, V14, P623; STERN MP, 1989, JAMA-J AM MED ASSOC, V262, P360, DOI 10.1001/jama.262.3.360; STERN MP, 1993, DIABETES, V42, P706, DOI 10.2337/diabetes.42.5.706; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Tritos NA, 1997, DIABETOLOGIA, V40, P1371, DOI 10.1007/s001250050838; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wu XD, 2002, AM J HUM GENET, V70, P1247, DOI 10.1086/340362; Wu ZD, 1999, CURR OPIN CELL BIOL, V11, P689, DOI 10.1016/S0955-0674(99)00037-X; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	80	79	82	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					272	282		10.1086/381717	http://dx.doi.org/10.1086/381717			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14740316	Green Published, Bronze			2022-12-18	WOS:000188860000008
J	Whitfield, JB				Whitfield, JB			Alcohol dehydrogenase and alcohol dependence: Variation in genotype-associated risk between populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENETIC-POLYMORPHISM; JAPANESE ALCOHOLICS; LIVER-DISEASE; ADH2; EUROPEANS; ALLELE; ALDH2		Royal Prince Alfred Hosp, Dept Clin Biochem, Camperdown, NSW 2050, Australia	University of Sydney	Whitfield, JB (corresponding author), Royal Prince Alfred Hosp, Dept Clin Biochem, Camperdown, NSW 2050, Australia.			Whitfield, John/0000-0002-1103-0876				Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Espinos C, 1997, HEREDITAS, V126, P247, DOI 10.1111/j.1601-5223.1997.00247.x; Frenzer A, 2002, J GASTROEN HEPATOL, V17, P177, DOI 10.1046/j.1440-1746.2002.02670.x; GILDER FJ, 1993, ADDICTION, V88, P383, DOI 10.1111/j.1360-0443.1993.tb00825.x; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; Lee HC, 2001, J KOREAN MED SCI, V16, P745, DOI 10.3346/jkms.2001.16.6.745; MAEZAWA Y, 1995, ALCOHOL CLIN EXP RES, V19, P951, DOI 10.1111/j.1530-0277.1995.tb00972.x; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Ogurtsov PP, 2001, ADDICT BIOL, V6, P377, DOI 10.1080/13556210020077109; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Tanaka F, 1996, HEPATOLOGY, V23, P234, DOI 10.1002/hep.510230206; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; Whitfield JB, 1997, ALCOHOL ALCOHOLISM, V32, P613; Yao Chung-Tay, 1997, Proceedings of the National Science Council Republic of China Part B Life Sciences, V21, P106; Yin SJ, 2001, ALCOHOL IN HEALTH AND DISEASE, P1	22	79	82	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1247	1250		10.1086/344287	http://dx.doi.org/10.1086/344287			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12452180	Green Published, Bronze			2022-12-18	WOS:000178884300031
J	Malhi, RS; Eshleman, JA; Greenberg, JA; Weiss, DA; Shook, BAS; Kaestle, FA; Lorenz, JG; Kemp, BM; Johnson, JR; Smith, DG				Malhi, RS; Eshleman, JA; Greenberg, JA; Weiss, DA; Shook, BAS; Kaestle, FA; Lorenz, JG; Kemp, BM; Johnson, JR; Smith, DG			The structure of diversity within new world mitochondrial DNA haplogroups: Implications for the prehistory of North America	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA CONTROL REGION; CHROMOSOME-SPECIFIC POLYMORPHISMS; SUBSTITUTION RATE VARIATION; MATERNAL LINEAGES; SITES; POPULATIONS; SINGLE; ORIGIN; FREQUENCIES; AFFINITIES	The mitochondrial DNA haplogroups and hypervariable segment I (HVSI) sequences of 1,612 and 395 Native North Americans, respectively, were analyzed to identify major prehistoric population events in North America. Gene maps and spatial autocorrelation analyses suggest that populations with high frequencies of haplogroups A, B, and X experienced prehistoric population expansions in the North, Southwest, and Great Lakes region, respectively. Haplotype networks showing high levels of reticulation and high frequencies of nodal haplotypes support these results. The haplotype networks suggest the existence of additional founding lineages within haplogroups B and C; however, because of the hypervariability exhibited by the HVSI data set, similar haplotypes exhibited in Asia and America could be due to convergence rather than common ancestry. The hypervariability and reticulation preclude the use of estimates of genetic diversity within haplogroups to argue for the number of migrations to the Americas.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Davis, CA 95616 USA; Univ Calif Davis, Calif Reg Primate Res Ctr, Davis, CA 95616 USA; Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; Coriell Inst Med Res, Camden, NJ USA; Santa Barbara Museum Nat Hist, Santa Barbara, CA USA	University of Michigan System; University of Michigan; University of California System; University of California Davis; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; Coriell Institute for Medical Research	Malhi, RS (corresponding author), Univ Michigan, Dept Human Genet, 3726 Med Sci II,1301 E Catherine St, Ann Arbor, MI 48109 USA.	malhi@umich.edu		Malhi, Ripan/0000-0002-1484-0292; Greenberg, Jonathan/0000-0001-8435-9077	NCRR NIH HHS [RR 05090, P51 RR000169, R24 RR005090, RR 00169] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR005090, P51RR000169] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BETTINGER RL, 1982, AM ANTIQUITY, V47, P485, DOI 10.2307/280231; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Carlyle SW, 2000, AM J PHYS ANTHROPOL, V113, P85, DOI 10.1002/1096-8644(200009)113:1<85::AID-AJPA8>3.0.CO;2-1; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DENNY P, 1991, 22 ALG C, P86; Derenko MV, 2001, AM J HUM GENET, V69, P237, DOI 10.1086/321266; DOSSANTOS AKR, 1996, AM J PHYS ANTHROPOL, V101, P29; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; FAGAN BM, 2000, ANCIENT N AM ARCHAEO; Fiedel SJ, 1999, AM ANTIQUITY, V64, P95, DOI 10.2307/2694348; Finnila S, 2001, J HUM GENET, V46, P64, DOI 10.1007/s100380170110; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Forster P, 1996, AM J HUM GENET, V59, P935; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Gurven M, 2000, HUM BIOL, V72, P455; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; KAESTLE FA, 1998, THESIS U CALIFORNIA; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; KELLY RL, 1988, AM ANTIQUITY, V53, P231, DOI 10.2307/281017; Kolman CJ, 1997, GENETICS, V147, P1289; Kolman CJ, 1996, GENETICS, V142, P1321; Lalueza Fox C., 1996, ANCIENT BIOMOLECULES, V1, P43; Lorenz JG, 1996, AM J PHYS ANTHROPOL, V101, P307, DOI 10.1002/(SICI)1096-8644(199611)101:3<307::AID-AJPA1>3.0.CO;2-W; Lorenz JG, 1997, HUM BIOL, V69, P749; Malhi RS, 2001, HUM BIOL, V73, P17, DOI 10.1353/hub.2001.0008; MALHI RS, 2001, THESIS U CALIFORNIA; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Meyer S, 1999, GENETICS, V152, P1103; Nei M., 1987, MOL EVOLUTIONARY GEN; O'Rourke DH, 2000, HUM BIOL, V72, P15; Parr RL, 1996, AM J PHYS ANTHROPOL, V99, P507; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schneider S, 1997, ARLEQUIN SOFTWARE PO; SCHULTZ BA, 2001, P 32 ALG C, P470; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Scozzari R, 1997, AM J HUM GENET, V60, P241; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Smith DG, 2000, AM J PHYS ANTHROPOL, V111, P557; Sokal RR, 1999, HUM BIOL, V71, P447; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; TEMPLETON AR, IN PRESS NATURE; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; WAKELEY J, 1993, J MOL EVOL, V37, P613; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weiss DA, 2001, AM J PHYS ANTHROPOL, P163; Yao YG, 2000, HUM GENET, V107, P504, DOI 10.1007/s004390000403	67	79	82	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					905	919		10.1086/339690	http://dx.doi.org/10.1086/339690			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11845406	Bronze, Green Published			2022-12-18	WOS:000174252100008
J	Xin, ZH; Allis, CD; Wagstaff, J				Xin, ZH; Allis, CD; Wagstaff, J			Parent-specific complementary patterns of histone H3 lysine 9 and H3 lysine 4 methylation at the Prader-Willi syndrome imprinting center	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; GENE; EXPRESSION; PROTEIN; MUTATIONS; EVOLUTION; UBE3A; SITE	The Prader-Willi syndrome (PWS)/Angelman syndrome (AS) region, on human chromosome 15q11-q13, exemplifies coordinate control of imprinted gene expression over a large chromosomal domain. Establishment of the paternal state of the region requires the PWS imprinting center (PWS-IC); establishment of the maternal state requires the AS-IC. Cytosine methylation of the PWS-IC, which occurs during oogenesis in mice, occurs only after fertilization in humans, so this modification cannot be the gametic imprint for the PWS/AS region in humans. Here, we demonstrate that the PWS-IC shows parent-specific complementary patterns of H3 lysine 9 (Lys9) and H3 lysine 4 (Lys4) methylation. H3 Lys9 is methylated on the maternal copy of the PWS-IC, and H3 Lys4 is methylated on the paternal copy. We suggest that H3 Lys9 methylation is a candidate maternal gametic imprint for this region, and we show how changes in chromatin packaging during the life cycle of mammals provide a means of erasing such an imprint in the male germline.	Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA USA; Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA	University of Virginia; University of Virginia	Wagstaff, J (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Pediat, Jordan Hall,Box 800733, Charlottesville, VA 22908 USA.	wagstaff@virginia.edu						Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Chung WY, 1996, HUM MOL GENET, V5, P1101, DOI 10.1093/hmg/5.8.1101; DITTRICH B, 1992, HUM GENET, V90, P313; El Kharroubi A, 2001, J BIOL CHEM, V276, P8674, DOI 10.1074/jbc.M009392200; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Fulmer-Smentek SB, 2001, HUM MOL GENET, V10, P645, DOI 10.1093/hmg/10.6.645; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; Glenn CC, 1996, AM J HUM GENET, V58, P335; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6	30	79	83	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1389	1394		10.1086/324469	http://dx.doi.org/10.1086/324469			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11592036	Green Published, Bronze			2022-12-18	WOS:000172086900023
J	Mazoyer, S; Leary, J; Kirk, J; Fleischmann, E; Wagner, T; Claes, K; Messiaen, L; Foulkes, W; Desrochers, M; Simard, J; Phelan, CM; Kwan, E; Narod, SA; Vahteristo, P; Nevanlinna, H; Durando, X; Bignon, YJ; Peyrat, JP; Bonnardel, C; Sinilnikova, OM; Puget, N; Lenoir, GM; Mazoyer, S; Audoynaud, C; Goldgar, D; Maugard, C; Caux, V; Gad, S; Stoppa-Lyonnet, D; Nogues, C; Lidereau, R; Machavoine, C; Bressac-de Paillerets, B; Kuschel, B; Betz, B; Niederacher, D; Beckmann, MW; Hamann, U; Gayther, SA; Ponder, BAP; Robinson, M; Taylor, GR; Bishop, T; Catteau, A; Solomon, E; Cohen, B; Steel, M; Collins, N; Stratton, M; van der Looij, M; Olah, E; Miller, NJ; Barton, DE; Sverdlov, RS; Friedman, E; Radice, P; Montagna, M; Sensi, E; Caligo, M; van Eijk, R; Devilee, P; van der Luijt, R; Heimdal, K; Moller, P; Borg, A; Diez, O; Cortes, J; Domenech, M; Baiget, M; Osorio, A; Benitez, J; Borg, A; Maillet, P; Sappino, AP; Ozdag, H; Ozcelik, T; Ozturk, M; Rohlfs, EM; Boyd, J; McDermott, D; Offit, K; Unger, M; Nathanson, K; Weber, BL; Sellers, TA; Hampton, E; Couch, FJ; Neuhausen, S				Mazoyer, S; Leary, J; Kirk, J; Fleischmann, E; Wagner, T; Claes, K; Messiaen, L; Foulkes, W; Desrochers, M; Simard, J; Phelan, CM; Kwan, E; Narod, SA; Vahteristo, P; Nevanlinna, H; Durando, X; Bignon, YJ; Peyrat, JP; Bonnardel, C; Sinilnikova, OM; Puget, N; Lenoir, GM; Mazoyer, S; Audoynaud, C; Goldgar, D; Maugard, C; Caux, V; Gad, S; Stoppa-Lyonnet, D; Nogues, C; Lidereau, R; Machavoine, C; Bressac-de Paillerets, B; Kuschel, B; Betz, B; Niederacher, D; Beckmann, MW; Hamann, U; Gayther, SA; Ponder, BAP; Robinson, M; Taylor, GR; Bishop, T; Catteau, A; Solomon, E; Cohen, B; Steel, M; Collins, N; Stratton, M; van der Looij, M; Olah, E; Miller, NJ; Barton, DE; Sverdlov, RS; Friedman, E; Radice, P; Montagna, M; Sensi, E; Caligo, M; van Eijk, R; Devilee, P; van der Luijt, R; Heimdal, K; Moller, P; Borg, A; Diez, O; Cortes, J; Domenech, M; Baiget, M; Osorio, A; Benitez, J; Borg, A; Maillet, P; Sappino, AP; Ozdag, H; Ozcelik, T; Ozturk, M; Rohlfs, EM; Boyd, J; McDermott, D; Offit, K; Unger, M; Nathanson, K; Weber, BL; Sellers, TA; Hampton, E; Couch, FJ; Neuhausen, S		BRCA1 Exon 13 Duplicat Screening Grp	The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER FAMILIES; IDENTIFICATION; DELETIONS	Recently a 6-kb duplication of exon 13, which creates a frameshift in the coding sequence of the BRCA1 gene, has been described in three unrelated U.S. families of European ancestry and in one Portuguese family. Here, our goal was to estimate the frequency and geographic diversity of carriers of this duplication. To do this, a collaborative screening study was set up that involved 39 institutions from 19 countries and included 3,580 unrelated individuals with a family history of the disease and 934 early-onset breast and/or ovarian cancer cases. A total of 11 additional families carrying this mutation were identified in Australia (1), Belgium (1), Canada (1), Great Britain (6), and the United States (2). Haplotyping showed that they are likely to derive from a common ancestor, possibly of northern British origin. Our results demonstrate that it is strongly advisable, for laboratories carrying out screening either in English-speaking countries or in countries with historical links with Britain, to include within their BRCA1 screening protocols the polymerase chain reaction-based assay described in this report.	Fac Med, UMR CNRS UCBL 5641, F-69373 Lyon 08, France		Mazoyer, S (corresponding author), Fac Med, UMR CNRS UCBL 5641, 8 Ave Rockefeller, F-69373 Lyon 08, France.	smazoyer@rockefeller.univ-lyon1.fr	DEVILEE, PETER/ABR-2140-2022; Barton, David E/B-9460-2008; Shiri-Sverdlov, Ronit/E-5571-2017; , bignon/Y-3243-2019; Özdag, Hilal/C-9929-2009; Foulkes, William D./AAR-9586-2021; Radice, Paolo/O-3119-2013; Mazoyer, Sylvie/N-7559-2017; PUGET, Nadine/AAB-9689-2020; Caligo, Adelaide Maria/K-4289-2018; Narod, Steven A/AAA-6112-2022; OZTURK, MEHMET/AAS-7241-2021; Barton, David E/I-1795-2019; ozturk, mehmet/G-3330-2014; Claes, Kathleen/AFR-6830-2022; montagna, marco/E-2225-2012; Shiri-Sverdlov, Ronit/X-2642-2019; Paillerets, Brigitte Bressac-de/D-8954-2018; Osorio, Ana/I-4324-2014	Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Özdag, Hilal/0000-0001-7940-2499; Foulkes, William D./0000-0001-7427-4651; Radice, Paolo/0000-0001-6298-4111; Caligo, Adelaide Maria/0000-0003-0589-1829; OZTURK, MEHMET/0000-0002-6092-9706; Barton, David E/0000-0002-2031-9719; Claes, Kathleen/0000-0003-0841-7372; montagna, marco/0000-0002-4929-2150; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Osorio, Ana/0000-0001-8124-3984; Durocher, Francine/0000-0001-8012-4641; PUGET, Nadine/0000-0003-4046-737X; Bishop, Tim/0000-0002-8752-8785				Montagna M, 1999, ONCOGENE, V18, P4160, DOI 10.1038/sj.onc.1202754; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; Puget N, 1997, CANCER RES, V57, P828; Puget N, 1999, CANCER RES, V59, P455; Rohlfs EM, 2000, GENE CHROMOSOME CANC, V28, P300, DOI 10.1002/1098-2264(200007)28:3<300::AID-GCC8>3.0.CO;2-1; Swensen J, 1997, HUM MOL GENET, V6, P1513, DOI 10.1093/hmg/6.9.1513; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179	8	79	80	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					207	212		10.1086/302974	http://dx.doi.org/10.1086/302974			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY		Bronze, Green Published			2022-12-18	WOS:000088926900023
J	Bykhovskaya, Y; Estivill, X; Taylor, K; Hang, T; Hamon, M; Casano, RAMS; Yang, HY; Rotter, JI; Shohat, M; Fischel-Ghodsian, N				Bykhovskaya, Y; Estivill, X; Taylor, K; Hang, T; Hamon, M; Casano, RAMS; Yang, HY; Rotter, JI; Shohat, M; Fischel-Ghodsian, N			Candidate locus for a nuclear modifier gene for maternally inherited deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RIBOSOMAL-RNA MUTATION; NON-SYNDROMIC DEAFNESS; SENSORINEURAL DEAFNESS; A1555G MUTATION; HEARING-LOSS; MITOCHONDRIAL; PEDIGREE; FAMILIES; TRAITS; MTDNA	Maternally inherited deafness associated with the A1555G mutation in the mitochondrial 12S ribosomal RNA (rRNA) gene appears to require additional environmental or genetic changes for phenotypic expression. Aminoglycosides have been identified as one such environmental factor. In one large Arab-Israeli pedigree with congenital hearing loss in some of the family members with the A1555G mutation and with no exposure to aminoglycosides, biochemical evidence has suggested the role of nuclear modifier gene(s), but a genomewide search has indicated the absence of a single major locus having such an effect. Thus it has been concluded that the penetrance of the mitochondrial mutation appears to depend on additive effects of several nuclear genes. We have now investigated 10 multiplex Spanish and Italian families with 35 members with the A1555G mutation and sensorineural deafness. Parametric analysis of a genomewide screen again failed to identify significant evidence for linkage to a single autosomal locus, However, nonparametric analysis supported the role of the chromosomal region around marker D8S277, The combined maximized allele-sharing LOD score of 3.1 in Arab-Israeli/Spanish/Italian families represents a highly suggestive linkage result, We suggest that this region should be considered a candidate for containing the first human nuclear modifier gene for a mitochondrial DNA disorder, The locus operates in Arab-Israeli, Spanish, and Italian families, resulting in the deafness phenotype on a background of the mitochondrial A1555G mutation. No obvious candidate genes are located in this region.	Cedars Sinai Med Ctr, Ahmanson Dept Pediat, Steven Spielberg Pediat Res Ctr, Ctr Med Genet Birth Defects, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Hosp Duran & Reynals, Inst Recerca Oncol, Med & Mol Genet Ctr, Deafness Genet Res Grp, Barcelona, Spain; Azienda Osped Careggi, Cytogenet & Genet Unit, Florence, Italy; Tel Aviv Univ, Rabin Med Ctr, Dept Pediat & Med Genet, IL-49100 Petah Tiqwa, Israel; Tel Aviv Univ, Basil & Gerald Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Florence; Azienda Ospedaliero Universitaria Careggi; Rabin Medical Center; Tel Aviv University; Tel Aviv University	Fischel-Ghodsian, N (corresponding author), Cedars Sinai Med Ctr, Ahmanson Dept Pediat, Steven Spielberg Pediat Res Ctr, Ctr Med Genet Birth Defects, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.		Estivill, Xavier/A-3125-2013; Estivill, Xavier/E-2957-2012; Hamon, Melanie/B-3501-2013	Estivill, Xavier/0000-0002-0723-2256; Hamon, Melanie/0000-0001-5078-4083	NIDCD NIH HHS [R01DC01402, R01DC04092] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001402, R01DC004092] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BU XD, 1993, GENET EPIDEMIOL, V10, P3, DOI 10.1002/gepi.1370100102; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Casano RAMS, 1998, AM J MED GENET, V79, P388, DOI 10.1002/(SICI)1096-8628(19981012)79:5<388::AID-AJMG11>3.0.CO;2-N; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Ott J., 1991, ANAL HUMAN GENETIC L; Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Torroni A, 1999, AM J HUM GENET, V65, P1349, DOI 10.1086/302642	17	79	91	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1905	1910		10.1086/302914	http://dx.doi.org/10.1086/302914			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10788333	Bronze, Green Published			2022-12-18	WOS:000088373800018
J	Condit, CM; Ofulue, N; Sheedy, KM				Condit, CM; Ofulue, N; Sheedy, KM			Determinism and mass-media portrayals of genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Scholars have expressed concern that the introduction of substantial coverage of "medical genetics" in the mass media during the past 2 decades represents an increase in biological determinism in public discourse. To test this contention, we analyzed the contents of a randomly selected, structured sample of American public newspapers (n = 250) and magazines (n = 722) published during 1919-95. Three coders, using three measures, all with interceder reliability >85%, were employed. Results indicate that the introduction of the discourse of medical genetics is correlated with both a statistically significant decrease in the degree to which articles attribute human characteristics to genetic causes (P < .001) and a statistically significant increase in the differentiation of attributions to genetic and other causes among various conditions or outcomes (P < .016). There has been no statistically significant change in the relative proportions of physical phenomena attributed to genetic causes, but there has been a statistically significant decrease in the number of articles assigning genetic causes to mental (P < .002) and behavioral (P < .000) characteristics. These results suggest that the current discourse of medical genetics is not accurately described as more biologically deterministic than its antecedents.	Univ Georgia, Dept Speech Commun, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Condit, CM (corresponding author), Univ Georgia, Dept Speech Commun, Athens, GA 30602 USA.				NHGRI NIH HHS [5 R01 HG01362-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001362] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ASHKENAS J, 1997, AM J HUM GENET, V60, P248; Condit CM, 1997, HEALTH COMMUN, V9, P219, DOI 10.1207/s15327027hc0903_2; CONDIT CM, 1997, ANN C AM ASS ADV SCI; Cranor C. F., 1994, ARE GENES US SOCIAL, P125; Hubbard R., 1993, EXPLODING GENE MYTH; *HW WILS CO, READ GUID PER LIT 19; Kaye Howard, 1986, SOCIAL MEANING MODER; LIPPMAN A, 1992, SOC SCI MED, V35, P1469, DOI 10.1016/0277-9536(92)90049-V; Nelkin D., 1995, DNA MYSTIQUE GENE CU; PETERS T, 1997, PLAYING GOD GENETIC; SMITH KC, 1992, BIOL PHILOS, V7, P331, DOI 10.1007/BF00129974	11	79	81	0	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					979	984		10.1086/301784	http://dx.doi.org/10.1086/301784			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ZM197	9529342	Bronze, Green Published			2022-12-18	WOS:000073514400030
J	Parker, WD; Swerdlow, RH				Parker, WD; Swerdlow, RH			Mitochondrial dysfunction in idiopathic Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ELECTRON-TRANSPORT CHAIN; COMPLEX-I; ALZHEIMERS-DISEASE; CYTOCHROME-OXIDASE; SUBSTANTIA NIGRA; METABOLITE; DEFICIENCY; TOXICITY; INCREASE; DEFECT	Disordered mitochondrial metabolism may play an important role in a number of idiopathic neurodegenerative disorders. The question of mitochondrial dysfunction is particularly attractive in the case of idiopathic Parkinson disease (PD), since Vyas et al. recognized in the 1980s that the parkinsonism-inducing compound N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a mitochondrial toxin. The unique genetic properties of mitochondria also make them worthy of consideration for a pathogenic role in PD, as well as in other late-onset, sporadic neurodegenerative disorders. Although affected persons occasionally do provide family histories that suggest Mendelian inheritance, the vast majority of the time these diseases appear sporadically. Because of unique features such as heteroplasmy, replicative segregation, and threshold effects, mitochondrial inheritance can allow for the apparent sporadic nature of these diseases.	Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22901 USA; Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22901 USA	University of Virginia; University of Virginia	Parker, WD (corresponding author), Univ Virginia, Sch Med, Dept Neurol, Davis Wing,Room B437, Charlottesville, VA 22901 USA.	dp8m@galen.med.virginia.edu						BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451; BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254; GAI WP, 1997, MOV DISORD S1, V12, P5; GU M, 1997, MOV DISORD S1, V12, P2; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; KALRA J, 1992, MOL CELL BIOCHEM, V110, P165, DOI 10.1007/BF02454194; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Kosel S, 1996, J NEUROSCI RES, V44, P174; KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; LAZZARINI AM, 1994, NEUROLOGY, V44, P499, DOI 10.1212/WNL.44.3_Part_1.499; MARSDEN CD, 1987, J NEUROL NEUROSUR PS, V50, P105, DOI 10.1136/jnnp.50.1.105; MARTTILA RJ, 1988, NEUROLOGY, V38, P1217, DOI 10.1212/WNL.38.8.1217; MARTTILA RJ, 1988, J NEUROL SCI, V86, P321, DOI 10.1016/0022-510X(88)90108-6; Miller SW, 1996, J NEUROCHEM, V67, P1897; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Morrison PJ, 1996, J MED GENET, V33, P504, DOI 10.1136/jmg.33.6.504; MYTILINEOU C, 1994, J NEURAL TRANSM-PARK, V8, P223, DOI 10.1007/BF02260943; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Sheehan JP, 1997, J NEUROSCI, V17, P4612; Sheehan JP, 1997, J NEUROCHEM, V68, P1221; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Swerdlow R. H., 1997, Society for Neuroscience Abstracts, V23, P1907; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x; WARD CD, 1983, NEUROLOGY, V33, P815, DOI 10.1212/WNL.33.7.815; Wooten George F., 1997, Neurology, V48, pA333; Wooten GF, 1997, ANN NEUROL, V41, P265, DOI 10.1002/ana.410410218; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619; YOUNG WI, 1977, CLIN GENET, V11, P189; [No title captured]	44	79	81	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					758	762		10.1086/301812	http://dx.doi.org/10.1086/301812			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529370	Bronze, Green Published			2022-12-18	WOS:000073514400003
J	Veldhuisen, B; Saris, JJ; deHaij, S; Hayashi, T; Reynolds, DM; Mochizuki, T; Elles, R; Fossdal, R; Bogdanova, N; vanDijk, MA; Coto, E; Ravine, D; Norby, S; VerellenDumoulin, C; Breuning, MH; Somlo, S; Peters, DJM				Veldhuisen, B; Saris, JJ; deHaij, S; Hayashi, T; Reynolds, DM; Mochizuki, T; Elles, R; Fossdal, R; Bogdanova, N; vanDijk, MA; Coto, E; Ravine, D; Norby, S; VerellenDumoulin, C; Breuning, MH; Somlo, S; Peters, DJM			A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC-KIDNEY-DISEASE-1 PKD1; NONSENSE MUTATION; INTRACRANIAL ANEURYSMS; SPLICING MUTATIONS; RENAL-DISEASE; 2ND GENE; HETEROGENEITY; FAMILY; LOCALIZATION; RECOGNITION	Recently the second gene for autosomal dominant poly-cystic kidney disease (ADPKD), located on chromosome 4q21-q22, has been cloned and characterized. The gene encodes an integral membrane protein, polycystin-2, that shows amino acid similarity to the PKD1 gene product and to the family of voltage-activated calcium (and sodium) channels. We have systematically screened the gene for mutations by single-strand conformation-poly-morphism analysis in 35 families with the second type of ADPKD and have identified 20 mutations. So far, most mutations found seem to be unique and occur throughout the gene, without any evidence of clustering. In addition to small deletions, insertions, and substitutions leading to premature translation stops, one amino acid substitution and five possible splice-site mutations have been found. These findings suggest that the first step toward cyst formation in PKD2 patients is the loss of one functional copy of polycystin-2.	LEIDEN UNIV, DEPT HUMAN GENET, SYLVIUS LAB, NL-2300 RA LEIDEN, NETHERLANDS; UNIV LEIDEN HOSP, DEPT NEPHROL, NL-2300 RC LEIDEN, NETHERLANDS; ALBERT EINSTEIN COLL MED, DIV NEPHROL, NEW YORK, NY USA; ST MARYS HOSP, DEPT MED GENET, MANCHESTER M13 0JH, LANCS, ENGLAND; UNIV ICELAND, FAC MED, REYKJAVIK, ICELAND; UNIV MUNSTER, INST HUMAN GENET, D-4400 MUNSTER, GERMANY; HOSP CENT ASTURIAS, SERV IMMUNOL, OVIEDO, SPAIN; UNIV WALES HOSP, INST MED GENET, CARDIFF CF4 4XN, S GLAM, WALES; INST FORENS MED, COPENHAGEN, DENMARK; UNIV CATHOLIQUE LOUVAIN, UNITE GENET MED, BRUSSELS, BELGIUM	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Yeshiva University; University of Manchester; University of Iceland; University of Munster; Central University Hospital Asturias; Cardiff University; Universite Catholique Louvain			Ravine, David/A-6797-2008; Peters, Dorien/AFH-8507-2022; Breuning, Martijn H/E-3429-2010	Peters, Dorien/0000-0001-6974-7143; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048383] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48383] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; BEAR JC, 1992, AM J MED GENET, V43, P548, DOI 10.1002/ajmg.1320430309; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BOGDANOVA N, 1995, HUM GENET, V95, P645; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CHAPMAN AB, 1992, NEW ENGL J MED, V327, P916, DOI 10.1056/NEJM199209243271303; COTO E, 1995, J MED GENET, V32, P442, DOI 10.1136/jmg.32.6.442; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DEALMEIDA S, 1995, HUM GENET, V96, P83, DOI 10.1007/BF00214191; FLORIJN KW, 1992, CONTRIB NEPHROL, V97, P71; FOSSDAL R, 1993, HUM GENET, V91, P609; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; HAYASHI T, IN PRESS GENOMICS; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; KRAWCZAK M, 1992, HUM GENET, V90, P41; Maquat LE, 1996, AM J HUM GENET, V59, P279; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Neophytou P, 1996, HUM GENET, V98, P437, DOI 10.1007/s004390050235; NORBY S, 1990, LANCET, V336, P323; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1996, AM J HUM GENET, V58, P86; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Roelfsema J H, 1996, Adv Nephrol Necker Hosp, V25, P131; Rossetti S, 1996, AM J MED GENET, V65, P155, DOI 10.1002/(SICI)1096-8628(19961016)65:2<155::AID-AJMG15>3.0.CO;2-P; TURCO AE, 1995, HUM MOL GENET, V4, P1331, DOI 10.1093/hmg/4.8.1331; vanDijk MA, 1995, J AM SOC NEPHROL, V6, P1670; Veldhuisen B, 1996, NEPHROL DIAL TRANSPL, V11, P13; WARD CJ, 1994, CELL, V77, P881; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	46	79	86	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					547	555		10.1086/515497	http://dx.doi.org/10.1086/515497			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326320	Green Published, Bronze			2022-12-18	WOS:A1997XY52300012
J	Biery, BJ; Stein, DE; Morton, DH; Goodman, SI				Biery, BJ; Stein, DE; Morton, DH; Goodman, SI			Gene structure and mutations of glutaryl-coenzyme a dehydrogenase: Impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACIDURIA TYPE-I; COA DEHYDROGENASE; A DEHYDROGENASE; ENCEPHALOPATHY; CLONING; LIVER	The structure of the human glutaryl coenzyme A dehydrogenase (GCD) gene was determined to contain 11 exons and to span similar to 7 kb. Fibroblast DNA from 64 unrelated glutaric acidemia type I (GA1) patients was screened for mutations by PCR amplification and analysis of SSCP. Fragments with altered electrophoretic mobility were subcloned and sequenced to detect mutations that caused GA1. This report describes the structure of the GCD gene, as well as point mutations and polymorphisms found in 7 of its 11 exons. Several mutations were found in more than one patient, but no one prevalent mutation was detected in the general population. As expected from pedigree analysis, a single mutant allele causes GA1 in the Old Order Amish of Lancaster County, Pennsylvania. Several mutations have been expressed in Escherichia coli, and all produce diminished enzyme activity. Reduced activity in GCD encoded by the A421V mutation in the Amish may be due to impaired association of enzyme subunits.	UNIV COLORADO,SCH MED,DEPT PEDIAT,DENVER,CO 80262; UNIV COLORADO,SCH MED,DEPT CELLULAR & STRUCT BIOL,DENVER,CO; CLIN SPECIAL CHILDREN,STRASBURG,PA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NICHD NIH HHS [HD-04024, HD-08315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD004024] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		GOODMAN SI, 1995, HUM MOL GENET, V4, P1493; GOODMAN SI, 1995, METABOLIC MOL BASES, P1451; GREENBERG CR, 1994, GENOMICS, V21, P289, DOI 10.1006/geno.1994.1264; GREENBERG CR, 1995, HUM MOL GENET, V4, P493, DOI 10.1093/hmg/4.3.493; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOFFMANN GF, 1991, PEDIATRICS, V88, P1194; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; KOELLER DM, 1995, GENOMICS, V28, P508, DOI 10.1006/geno.1995.1182; KYLLERMAN M, 1994, MOVEMENT DISORD, V9, P22, DOI 10.1002/mds.870090105; LENICH AC, 1986, J BIOL CHEM, V261, P4090; MORTON DH, 1991, AM J MED GENET, V41, P89, DOI 10.1002/ajmg.1320410122; Sambrook J, 1989, MOL CLONING LAB MANU; YOKOTA I, 1992, Pediatric Research, V31, p136A	13	79	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1006	1011						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900227				2022-12-18	WOS:A1996VN90000006
J	EZOE, K; HOLMES, SA; HO, LL; BENNETT, CP; BOLOGNIA, JL; BRUETON, L; BURN, J; FALABELLA, R; GATTO, EM; ISHII, N; MOSS, C; PITTELKOW, MR; THOMPSON, E; WARD, KA; SPRITZ, RA				EZOE, K; HOLMES, SA; HO, LL; BENNETT, CP; BOLOGNIA, JL; BRUETON, L; BURN, J; FALABELLA, R; GATTO, EM; ISHII, N; MOSS, C; PITTELKOW, MR; THOMPSON, E; WARD, KA; SPRITZ, RA			NOVEL MUTATIONS AND DELETIONS OF THE KIT (STEEL FACTOR-RECEPTOR) GENE IN HUMAN PIEBALDISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONCOGENE C-KIT; TYROSINE KINASE; PROTO-ONCOGENE; MUTANT ALLELE; W-LOCUS; PROTOONCOGENE; DNA; POLYMORPHISM; POLYMERASE; PDGFRA	Piebaldism is an autosomal dominant genetic disorder of pigmentation characterized by white patches of skin and hair. Melanocytes are lacking in these hypopigmented regions, the result of mutations of the KIT gene, which encodes the cell surface receptor for steel factor (SLF). We describe the analysis of 26 unrelated patients with piebaldism-like hypopigmentation-17 typical patients, 5 with atypical clinical features or family histories, and 4 with other disorders that involve white spotting. We identified novel pathologic mutations or deletions of the KIT gene in 10 (59%) of the typical patients, and in 2 (40%) of the atypical patients. Overall, we have identified pathologic KIT gene mutations in 21 (75%) of 28 unrelated patients with typical piebaldism we have studied. Of the patients without apparent KIT mutations, none have apparent abnormalities of the gene encoding SLF itself (MGF), and genetic linkage analyses in two of these families are suggestive of linkage of the piebald phenotype to KIT. Thus, most patients with typical piebaldism appear to have abnormalities of the KIT gene.	UNIV WISCONSIN,DEPT MED GENET,GENET LAB 317,MADISON,WI 53706; ST JAMESS UNIV HOSP,DEPT CLIN GENET,LEEDS,W YORKSHIRE,ENGLAND; YALE UNIV,SCH MED,DEPT DERMATOL,NEW HAVEN,CT 06510; NORTHWICK PK HOSP & CLIN RES CTR,KENNEDY GALTON CTR,HARROW,MIDDX,ENGLAND; UNIV NEWCASTLE UPON TYNE,DIV HUMAN GENET,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND; UNIV VALLE,SCH MED,DERMATOL SECT,CALI,COLOMBIA; UNIV BUENOS AIRES,DEPT NEUROL,BUENOS AIRES,DF,ARGENTINA; YOKOHAMA CITY UNIV,SCH MED,DEPT DERMATOL,YOKOHAMA,KANAGAWA 232,JAPAN; GEN HOSP,DEPT DERMATOL,BIRMINGHAM B4 6NH,W MIDLANDS,ENGLAND; MAYO CLIN & MAYO FDN,DEPT DERMATOL,ROCHESTER,MN 55905; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI	University of Wisconsin System; University of Wisconsin Madison; Saint James's University Hospital; University of Leeds; Yale University; Imperial College London; Newcastle University - UK; Universidad del Valle; University of Buenos Aires; Yokohama City University; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 39892] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AUFDERHEIDE A C, 1972, Birth Defects Original Article Series, V8, P63; BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; FLEISCHMAN RA, 1992, J CLIN INVEST, V89, P1713, DOI 10.1172/JCI115772; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10855; Gatto M, 1985, Med Cutan Ibero Lat Am, V13, P545; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; GIEBEL LB, 1992, ONCOGENE, V7, P2207; ISHII N, 1985, RINSHO HIFUKA, V39, P469; KAPLAN P, 1988, AM J MED GENET, V31, P679, DOI 10.1002/ajmg.1320310324; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; OTT J, 1974, AM J HUM GENET, V26, P588; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH EA, 1991, P NATL ACAD SCI USA, V88, P4811, DOI 10.1073/pnas.88.11.4811; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRITZ RA, 1992, AM J HUM GENET, V51, P1058; SPRITZ RA, 1993, J INVEST DERMATOL, V101, P22, DOI 10.1111/1523-1747.ep12358440; SPRITZ RA, 1992, AM J HUM GENET, V50, P261; SPRITZ RA, 1992, AM J MED GENET, V44, P492, DOI 10.1002/ajmg.1320440422; SPRITZ RA, 1993, HUM MOL GENET, V2, P1499, DOI 10.1093/hmg/2.9.1499; SPRITZ RA, 1994, GENOMICS, V22, P431, DOI 10.1006/geno.1994.1405; SPRITZ RA, 1993, HUM GENET, V92, P208; SPRITZ RA, 1994, J INVEST DERMATOL, V105, P148; STEPHENSON DA, 1991, P NATL ACAD SCI USA, V88, P6, DOI 10.1073/pnas.88.1.6; STEPHENSON DA, IN PRESS MAMM GENOME; TSUJIMURA T, 1991, BLOOD, V78, P1942; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x	32	79	85	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					58	66						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7529964				2022-12-18	WOS:A1995QC10100008
J	KOBAYASHI, K; SHAHEEN, N; KUMASHIRO, R; TANIKAWA, K; OBRIEN, WE; BEAUDET, AL; SAHEKI, T				KOBAYASHI, K; SHAHEEN, N; KUMASHIRO, R; TANIKAWA, K; OBRIEN, WE; BEAUDET, AL; SAHEKI, T			A SEARCH FOR THE PRIMARY ABNORMALITY IN ADULT-ONSET TYPE-II CITRULLINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARGININOSUCCINATE SYNTHETASE LOCUS; UREA CYCLE; GALACTOSIALIDOSIS; HETEROGENEITY; FIBROBLASTS; DEFICIENCY; MUTATIONS; PROTEIN; LIVER	Deficiency of argininosuccinate synthetase (ASS) causes citrullinemia in human beings. Type II citrullinemia is found in most patients with adult-onset citrullinemia in Japan, and ASS deficiency is found specifically in the liver. Previous studies have shown that the decrease of hepatic ASS activity is caused by a decrease in enzyme protein with normal kinetic properties and that there were no apparent abnormalities in the amount, translational activity, and gross structure of hepatic ASS mRNA. In the present work, we show by sequencing analysis that there was no mutation in the ASS mRNA from two patients with type II citrullinemia. We also report RFLP analysis of a consanguineous family with type II citrullinemia, by using three DNA polymorphisms located within the ASS gene locus. In spite of having consanguineous parents, the patient was not a homozygous haplotype for the ASS gene. The RFLP analysis of 16 affected patients from consanguineous parents showed that 5 of 16 patients had the heterozygous pattern for one of the three DNA probes and that the frequency of the heterozygous haplotype was not different from the control frequency. These results suggest that the primary defect of type II citrullinemia is not within the ASS gene locus.	KURUME UNIV,DEPT MED,KURUME,FUKUOKA 830,JAPAN; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Kurume University; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	KOBAYASHI, K (corresponding author), KAGOSHIMA UNIV,FAC MED,DEPT BIOCHEM,SAKURAGAOKA 8-35-1,KAGOSHIMA 890,JAPAN.		Shaheen, Nicholas J/A-1898-2013					AKABOSHI I, 1983, J INHERIT METAB DIS, V6, P36, DOI 10.1007/BF02391191; BEAUDET AL, 1986, ADV HUM GENET, P161; Brusilow S.W., 1989, METABOLIC BASIS INHE, P629; Dahlberg G, 1929, GENETICS, V14, P421; DAHLBERG G, 1948, ADV GENET, P67; HOOGEVEEN AT, 1983, J BIOL CHEM, V258, P2143; IMAIZUMI Y, 1975, JPN J HUM GENET, V20, P91; IMAMURA Y, 1987, CLIN CHIM ACTA, V164, P201, DOI 10.1016/0009-8981(87)90071-4; JACKSON MJ, 1989, MOL BIOL MED, V6, P179; KOBAYASHI K, 1986, AM J HUM GENET, V38, P667; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; KOBAYASHI K, 1991, MOL BIOL MED, V8, P95; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; NANBA E, 1987, BIOCHEM BIOPH RES CO, V144, P138, DOI 10.1016/S0006-291X(87)80486-2; NORTHRUP H, 1989, GENOMICS, V5, P442, DOI 10.1016/0888-7543(89)90007-4; PALMERI S, 1986, AM J HUM GENET, V38, P137; SAHEKI T, 1982, CLIN CHIM ACTA, V118, P93; SAHEKI T, 1987, ENZYME, V38, P227, DOI 10.1159/000469209; SAHEKI T, 1987, CLIN CHIM ACTA, V170, P297, DOI 10.1016/0009-8981(87)90140-9; SAHEKI T, 1987, REV PHYSIOL BIOCH P, V108, P21, DOI 10.1007/BFb0034071; SAHEKI T, 1981, CLIN CHIM ACTA, V109, P325, DOI 10.1016/0009-8981(81)90318-1; Saheki T, 1983, ADV EXP MED BIOL, V153, P63; SAHEKI T, 1985, GUANIDINES, P149; Sameshima Y., 1986, J CLIN BIOCHEM NUTR, V1, P129; SASE M, 1985, HUM GENET, V69, P130, DOI 10.1007/BF00293282; SU TS, 1990, J BIOL CHEM, V265, P19716; SU TS, 1982, J CLIN INVEST, V70, P1334, DOI 10.1172/JCI110736; TODO S, 1992, HEPATOLOGY, V15, P419, DOI 10.1002/hep.1840150311; YAGI Y, 1988, AM J CLIN PATHOL, V89, P735, DOI 10.1093/ajcp/89.6.735	29	79	81	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1024	1030						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8105687				2022-12-18	WOS:A1993MC33300006
J	SWEENEY, MG; DAVIS, MB; LASHWOOD, A; BROCKINGTON, M; TOSCANO, A; HARDING, AE				SWEENEY, MG; DAVIS, MB; LASHWOOD, A; BROCKINGTON, M; TOSCANO, A; HARDING, AE			EVIDENCE AGAINST AN X-LINKED LOCUS CLOSE TO DXS7 DETERMINING VISUAL-LOSS SUSCEPTIBILITY IN BRITISH AND ITALIAN FAMILIES WITH LEBER HEREDITARY OPTIC NEUROPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; MUTATION; LINKAGE	Leber hereditary optic neuropathy (LHON) is associated with mutations of mtDNA, but two features of LHON pedigrees are not explicable solely on the basis of mitochondrial inheritance. There is a large excess of affected males, and not all males at risk develop the disease. These observations could be explained by the existence of an X-linked visual loss susceptibility gene. This hypothesis was supported by linkage studies in Finland, placing the susceptibility locus at DXS7, with a maximum lod score of 2.48 at a recombination fraction of 0. Linkage studies in 1 Italian and 12 British families with LHON, analyzed either together or separately depending on the associated mtDNA mutation, have excluded the presence of such a locus from an interval of about 30 cM around DXS7 in these kindreds, with a total lod score of -26.51 at a recombination fraction of 0.	UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND	University of London; University College London					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; HOLT IJ, 1988, HUM GENET, V79, P53, DOI 10.1007/BF00291710; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; IKONEN E, 1990, AM J HUM GENET, V46, P5; JOHNS DR, 1990, NEW ENGL J MED, V323, P1488; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; KEATS B, 1989, CYTOGENET CELL GENET, V51, P583; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; OTT J, 1985, ANAL HUMAN LINKAGE; PALLINI AF, 1988, J NEUROL S, V235, pS7; POULTON J, 1991, J MED GENET, V28, P765, DOI 10.1136/jmg.28.11.765; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	17	79	81	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					741	748						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415219				2022-12-18	WOS:A1992JQ66700007
J	KNEBELMANN, B; DESCHENES, G; GROS, F; HORS, MC; GRUNFELD, JP; TRYGGVASON, K; GUBLER, MC; ANTIGNAC, C				KNEBELMANN, B; DESCHENES, G; GROS, F; HORS, MC; GRUNFELD, JP; TRYGGVASON, K; GUBLER, MC; ANTIGNAC, C			SUBSTITUTION OF ARGININE FOR GLYCINE-325 IN THE COLLAGEN ALPHA-5 (IV) CHAIN ASSOCIATED WITH X-LINKED ALPORT SYNDROME - CHARACTERIZATION OF THE MUTATION BY DIRECT SEQUENCING OF PCR-AMPLIFIED LYMPHOBLAST CDNA FRAGMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; HEREDITARY NEPHRITIS; FAMILIAL NEPHRITIS; GENE; DNA; IDENTIFICATION; LOCALIZATION; CHROMOSOME; ANTIGEN; REGION	A large kindred with adult-type X-linked Alport syndrome was studied with regard to a defect in the recently described COL4A5 collagen gene. Southern blot analysis with COL4A5 cDNA probes showed loss of a MspI restriction site. Direct sequencing of cDNA amplified from lymphoblast mRNA demonstrated a single-base substitution converting a glycine codon to arginine at position 325 in the alpha-5 chain of type IV collagen. The triple-helical collagenous domain of alpha-5(IV), characterized by a Gly-X-Y repeat sequence, is interrupted 22 times by noncollagenous sequences. The mutation creates an additional interruption in the Gly-X-Y repeat motif, between interruptions 4 and 5. It is interesting that such glycine substitutions inside the COL1A1 or COL1A2 genes have been associated with many cases of osteogenesis imperfecta. This gly325-to-arg substitution presumably alters the triple-helix formation, and, in turn, modifies the ultrastructural and functional characteristics of the type IV collagen network inside the glomerular basement membrane.	HOP NECKER ENFANTS MALAD,INSERM,U192,TOUR TECH 6,149 RUE SEVRES,F-75730 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U12,F-75730 PARIS 15,FRANCE; HOP CLOCHEVILLE,SERV NEPHROL PEDIAT,TOURS,FRANCE; UNIV OULU,BIOCTR,SF-90100 OULU 10,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90100 OULU 10,FINLAND	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu			ANTIGNAC, Corinne/H-8945-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Gubler, Marie-Claire/0000-0002-3526-5661; deschenes, georges/0000-0002-5158-2915				ALPORT AC, 1927, BRIT MED J, V1, P504; ATKIN CL, 1988, AM J HUM GENET, V42, P249; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BRUNNER H, 1988, KIDNEY INT, V34, P507, DOI 10.1038/ki.1988.210; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVATELIS G, 1987, NUCLEIC ACIDS RES, V15, P4694, DOI 10.1093/nar/15.11.4694; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; FLINTER FA, 1989, GENOMICS, V4, P335, DOI 10.1016/0888-7543(89)90339-X; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; GRUNFELD JP, 1985, KIDNEY INT, V27, P83, DOI 10.1038/ki.1985.14; GUBLER MC, 1988, PROGR BASEMENT MEMBR, P177; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; KASHTAN C, 1986, J CLIN INVEST, V78, P1035, DOI 10.1172/JCI112658; KLEPPEL MM, 1989, LAB INVEST, V61, P278; KNEBELMANN B, 1991, P NATL ACAD SCI USA, V88, P3767, DOI 10.1073/pnas.88.9.3767; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; MACDERMOT KD, 1987, HUM GENET, V77, P263, DOI 10.1007/BF00284482; MORRISON KE, 1991, AM J HUM GENET, V49, P545; OSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P13758; POCHET JM, 1989, NEPHROL DIAL TRANSPL, V4, P1016; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAVAGE COS, 1989, LAB INVEST, V60, P613; SOININEN R, 1988, J BIOL CHEM, V263, P17217; Spear G S, 1973, Clin Nephrol, V1, P336; SZPIROTAPIA S, 1988, HUM GENET, V81, P85, DOI 10.1007/BF00283736; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z; ZHOU J, 1991, GENOMICS, V9, P1, DOI 10.1016/0888-7543(91)90214-Y; [No title captured]	32	79	80	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					135	142						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1376965				2022-12-18	WOS:A1992JA46700014
J	CHENEVIXTRENCH, G; JONES, K; GREEN, A; MARTIN, N				CHENEVIXTRENCH, G; JONES, K; GREEN, A; MARTIN, N			FURTHER EVIDENCE FOR AN ASSOCIATION BETWEEN GENETIC-VARIATION IN TRANSFORMING GROWTH-FACTOR ALPHA AND CLEFT-LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TGFA		UNIV QUEENSLAND,DEPT PATHOL,ST LUCIA,QLD 4067,AUSTRALIA	University of Queensland	CHENEVIXTRENCH, G (corresponding author), QUEENSLAND INST MED RES,JOINT ONCOL PROGRAMME,BRAMSTON TERRACE,HERSTON,QLD 4006,AUSTRALIA.		Chenevix-Trench, Georgia/AAV-2014-2020	Chenevix-Trench, Georgia/0000-0002-1878-2587				ARDINGER HH, 1989, AM J HUM GENET, V45, P348; HAYWARD N, 1988, INT J CANCER, V42, P558, DOI 10.1002/ijc.2910420415; HAYWARD NK, 1987, NUCLEIC ACIDS RES, V15, P5503, DOI 10.1093/nar/15.13.5503; HECH JT, 1990, AM J HUM GENET S, V47, pA220; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P7136, DOI 10.1093/nar/14.17.7136	5	79	80	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					1012	1013						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673285				2022-12-18	WOS:A1991FK89700024
J	TIRET, L; AMOUYEL, P; RAKOTOVAO, R; CAMBIEN, F; DUCIMETIERE, P				TIRET, L; AMOUYEL, P; RAKOTOVAO, R; CAMBIEN, F; DUCIMETIERE, P			TESTING FOR ASSOCIATION BETWEEN DISEASE AND LINKED MARKER LOCI - A LOG-LINEAR-MODEL ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENOTYPE; GENE	One approach frequently used for identifying genetic factors involved in the process of a complex disease is the comparison of patients and controls for a number of genetic markers near a candidate gene. The analysis of such association studies raises some specific problems because of the fact that genotypic and not gametic data are generally available. We present a log-linear-model analysis providing a valid method for analyzing such studies. When studying the association of disease with one marker locus, the log-linear model allows one to test for the difference between allelic frequencies among affected and unaffected individuals, Hardy-Weinberg (H-W) equilibrium in both groups, and interaction between the association of alleles at the marker locus and disease. This interaction provides information about the dominance of the disease susceptibility locus, with dominance defined using the epidemiological notion of odds ratio. The degree of dominance measured at the marker locus depends on the strength of linkage disequilibrium between the marker locus and the disease locus. When studying the association of disease with several linked markers, the model becomes rapidly complex and uninterpretable unless it is assumed that affected and unaffected populations are in H-W equilibrium at each locus. This hypothesis must be tested before going ahead in the analysis. If it is not rejected, the log-linear model offers a stepwise method of identification of the parameters causing the difference between populations. This model can be extended to any number of loci, alleles, or populations.	INST PASTEUR,SERV SANTE PUBL,LILLE,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	TIRET, L (corresponding author), HOP BROUSSAIS,INSERM,U258,96 RUE DIDOT,F-75674 PARIS 14,FRANCE.		Cambien, Francois/AAP-9751-2020	Amouyel, Philippe/0000-0001-9088-234X				EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; GENEST JJ, 1990, ATHEROSCLEROSIS, V82, P7, DOI 10.1016/0021-9150(90)90138-9; HILL WG, 1975, BIOMETRICS, V31, P881, DOI 10.2307/2529813; Jacquard A., 1974, GENETIC STRUCTURE PO; KHAMIS HJ, 1984, BIOMETRICS, V40, P177, DOI 10.2307/2530756; LALOUEL JM, 1981, 14 U UT DEP MED BIOP; Mourant AE, 1976, DISTRIBUTION HUMAN B; NORWOOD PK, 1978, BIOMETRICS, V34, P593, DOI 10.2307/2530378; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1986, BIOMETRICS, V42, P665, DOI 10.2307/2531217; Weir BS, 1990, GENETIC DATA ANAL	12	79	79	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					926	934						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018040				2022-12-18	WOS:A1991FK89700011
J	CASKEY, CT; KABACK, MM; BEAUDET, AL				CASKEY, CT; KABACK, MM; BEAUDET, AL			THE AMERICAN-SOCIETY-OF-HUMAN-GENETICS STATEMENT ON CYSTIC-FIBROSIS SCREENING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																			0	79	79	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					393	393						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301404				2022-12-18	WOS:A1990CM93800021
J	COMINGS, BG; COMINGS, DE				COMINGS, BG; COMINGS, DE			A CONTROLLED-STUDY OF TOURETTE SYNDROME .5. DEPRESSION AND MANIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR,DEPT MED GENET,1500 E DUARTE RD,DUARTE,CA 91010; CAMBRIDGE GRAD SCH PSYCHOL,LOS ANGELES,CA	City of Hope								BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; Beck A. T., 1960, ARCH GEN PSYCHIAT, V4, P53, DOI DOI 10.1001/ARCHPSYC.1961.01710120031004; COMINGS BG, 1987, THESIS CAMBRIDGE GRA; COMINGS D E, 1986, American Journal of Human Genetics, V39, pA151; COMINGS DE, 1985, AM J HUM GENET, V37, P435; COMINGS DE, 1987, AM J HUM GENET, V41, P701; COMINGS DE, 1986, P NATL ACAD SCI USA, V83, P2551, DOI 10.1073/pnas.83.8.2551; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; PENNA MW, 1975, DIS NERV SYST, V36, P41; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381	12	79	81	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					804	821						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	K9361	3479016				2022-12-18	WOS:A1987K936100005
J	CANNIZZARO, LA; CROCE, CM; GRIFFIN, CA; SIMEONE, A; BONCINELLI, E; HUEBNER, K				CANNIZZARO, LA; CROCE, CM; GRIFFIN, CA; SIMEONE, A; BONCINELLI, E; HUEBNER, K			HUMAN HOMEO BOX-CONTAINING GENES LOCATED AT CHROMOSOME REGIONS 2Q31-]2Q37 AND 12Q12-]12Q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WISTAR INST ANAT & BIOL,36TH ST SPRUCE,PHILADELPHIA,PA 19104; PENN STATE UNIV,MILTON S HERSHEY MED CTR,HERSHEY,PA 17033; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104; INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY	The Wistar Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)			Young, Richard A/F-6495-2012; Simeone, Antonio/ABG-5269-2020	Young, Richard A/0000-0001-8855-8647; Simeone, Antonio/0000-0003-2693-9836				ANDREWS PW, 1984, LAB INVEST, V50, P147; ANDREWS PW, 1985, DIFFERENTIATION, V29, P127, DOI 10.1111/j.1432-0436.1985.tb00305.x; ATKIN NB, 1982, LANCET, V2, P1349; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; BONCINELLI E, 1985, COLD SPRING HARB SYM, V50, P301, DOI 10.1101/SQB.1985.050.01.038; BUCAN M, 1986, EMBO J, V5, P2899, DOI 10.1002/j.1460-2075.1986.tb04585.x; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4; COLBERGPOLEY AM, 1985, NATURE, V314, P713, DOI 10.1038/314713a0; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DAYTON AI, 1984, P NATL ACAD SCI-BIOL, V81, P4495, DOI 10.1073/pnas.81.14.4495; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; FJOSE A, 1985, NATURE, V313, P284, DOI 10.1038/313284a0; GARCIABELLIDO A, 1977, AM ZOOL, V17, P613; GEHRING WJ, 1985, CELL, V40, P3, DOI 10.1016/0092-8674(85)90300-9; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HART CP, 1985, CELL, V43, P9, DOI 10.1016/0092-8674(85)90007-8; HAUSER CA, 1985, CELL, V43, P19, DOI 10.1016/0092-8674(85)90008-X; HUEBNER K, 1985, SCIENCE, V230, P1282, DOI 10.1126/science.2999978; HUEBNER K, 1985, P NATL ACAD SCI USA, V82, P3790, DOI 10.1073/pnas.82.11.3790; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P3934, DOI 10.1073/pnas.83.11.3934; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P1403, DOI 10.1073/pnas.83.5.1403; HUEBNER K, 1986, AM J HUM GENET, V38, P819; ISOBE M, 1985, P NATL ACAD SCI USA, V82, P5836, DOI 10.1073/pnas.82.17.5836; ISOBE M, 1986, P NATL ACAD SCI USA, V83, P4399, DOI 10.1073/pnas.83.12.4399; JOYNER AL, 1985, NATURE, V314, P173, DOI 10.1038/314173a0; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; KAUFMAN TC, 1980, GENETICS, V94, P115; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LAUGHON A, 1985, COLD SPRING HARB SYM, V50, P253, DOI 10.1101/SQB.1985.050.01.032; LEVINE M, 1984, CELL, V38, P667, DOI 10.1016/0092-8674(84)90261-7; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANLEY JL, 1985, CELL, V43, P1, DOI 10.1016/0092-8674(85)90002-9; MARTIN GR, 1987, NATURE, V325, P21, DOI 10.1038/325021b0; MAVILIO F, 1986, NATURE, V324, P664, DOI 10.1038/324664a0; MCALPINE PJ, 1985, CYTOGENET CELL GENET, V40, P9; MCBRIDE OW, 1983, NUCLEIC ACIDS RES, V11, P8221, DOI 10.1093/nar/11.23.8221; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCGINNIS W, 1984, CELL, V38, P675, DOI 10.1016/0092-8674(84)90262-9; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; MUELLER MM, 1984, CELL, V39, P157; MUNKE M, 1985, CYTOGENET CELL GENET, V40, P706; NAGARAJAN L, 1986, P NATL ACAD SCI USA, V83, P2556, DOI 10.1073/pnas.83.8.2556; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; POPESCU NC, 1985, SOMAT CELL MOLEC GEN, V11, P149, DOI 10.1007/BF01534703; RABIN M, 1985, NATURE, V314, P175, DOI 10.1038/314175a0; RABIN M, 1986, P NATL ACAD SCI USA, V83, P9104, DOI 10.1073/pnas.83.23.9104; RETIEF AE, 1985, CYTOGENET CELL GENET, V40, P730; RUDDLE FH, 1985, COLD SPRING HARB SYM, V50, P277, DOI 10.1101/SQB.1985.050.01.035; RYAN J, 1983, P NATL ACAD SCI-BIOL, V80, P4460, DOI 10.1073/pnas.80.14.4460; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SIMEONE A, 1986, NATURE, V320, P763, DOI 10.1038/320763a0; SIMEONE A, 1987, UNPUB HUMAN HOMEO BO; SOLOMON E, 1985, P NATL ACAD SCI USA, V82, P3330, DOI 10.1073/pnas.82.10.3330; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUKHATME VP, 1985, J EXP MED, V161, P429, DOI 10.1084/jem.161.2.429; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2	58	79	79	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1987	41	1					1	15						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J0581	2886047				2022-12-18	WOS:A1987J058100001
J	HOFKER, MH; SKRAASTAD, MI; BERGEN, AAB; WAPENAAR, MC; BAKKER, E; MILLINGTONWARD, A; VANOMMEN, GJB; PEARSON, PL				HOFKER, MH; SKRAASTAD, MI; BERGEN, AAB; WAPENAAR, MC; BAKKER, E; MILLINGTONWARD, A; VANOMMEN, GJB; PEARSON, PL			THE X-CHROMOSOME SHOWS LESS GENETIC-VARIATION AT RESTRICTION SITES THAN THE AUTOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HOFKER, MH (corresponding author), STATE UNIV LEIDEN, DEPT HUMAN GENET, SYLVIUS LABS, 2333 AL LEIDEN, NETHERLANDS.		Bergen, Arthur/J-3637-2013; Bakker, Egbert/D-3525-2009	Bakker, Egbert/0000-0002-2843-7357; Bergen, Arthur/0000-0002-6333-9576				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BAKKER E, 1983, CLIN GENET, V23, P225; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COLLARD JG, 1984, CYTOMETRY, V5, P9, DOI 10.1002/cyto.990050104; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; COWAN EP, 1985, J IMMUNOL, V135, P2835; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; EWENS WJ, 1981, P NATL ACAD SCI-BIOL, V78, P3748, DOI 10.1073/pnas.78.6.3748; FRANCKE U, 1976, AM J HUM GENET, V28, P123; GITSCHIER J, 1985, NATURE, V314, P738, DOI 10.1038/314738a0; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; MATTESON KJ, 1985, HUM GENET, V69, P263, DOI 10.1007/BF00293037; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; Nei M., 1975, MOL POPULATION GENET; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; SCHUMM J, 1985, CYTOGENET CELL GENET, V40, P739; SKOLNICK MH, 1982, CYTOGENET CELL GENET, V32, P58, DOI 10.1159/000131687; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WIJSMAN EM, 1984, NUCLEIC ACIDS RES, V12, P9209, DOI 10.1093/nar/12.23.9209; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180	27	79	80	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1986	39	4					438	451						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7063	2876629				2022-12-18	WOS:A1986E706300002
J	ALLDERDICE, PW; BROWNE, N; MURPHY, DP				ALLDERDICE, PW; BROWNE, N; MURPHY, DP			CHROMOSOME-3 DUPLICATION Q21-]QTER DELETION P25-]PTER SYNDROME IN CHILDREN OF CARRIERS OF A PERICENTRIC INVERSION INV(3) (P25Q21)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MEMORIAL UNIV,FAC MED,ST JOHNS,NEWFOUNDLAND,CANADA; DR CHARLES A JANEWAY CHILD HLTH CTR,ST JOHNS,NEWFOUNDLAND,CANADA	Memorial University Newfoundland								ALLDERDICE PW, 1973, J CELL SCI, V12, P263; ALLDERDICE PW, 1969, AM J HUM GENET, V21, P449; ALLDERDICE PW, 1975, LANCET, V2, P39; Boon W H, 1967, J Singapore Paediatr Soc, V9, P88; Boue J, 1974, ANN PEDIATR, V21, P567; BREG WR, 1970, J PEDIATR-US, V77, P782, DOI 10.1016/S0022-3476(70)80236-0; COMBS JT, 1966, NEW ENGL J MED, V275, P236, DOI 10.1056/NEJM196608042750502; FRANCKE U, 1972, AM J HUM GENET, V24, P189; Gray SW., 1972, EMBRYOLOGY SURGEONS, VSecond; GROUCHY JD, 1969, BIRTH DEFECTS OAS, V5, P74; HAMERTON J L, 1974, Birth Defects Original Article Series, V10, P13; LEE CSN, 1964, NEW ENGL J MED, V271, P12, DOI 10.1056/NEJM196407022710102; LURIE IW, 1974, GENETIKA, V10, P136; MCKEOWN T, 1953, AM J HUM GENET, V5, P168; MILLER OJ, 1970, J PEDIATR-US, V77, P792, DOI 10.1016/S0022-3476(70)80237-2; POTTER EL, 1961, PATHOLOGY FETUS INFA; SEABRIGH.M, 1971, LANCET, V2, P971; SUMMITT RL, 1966, AM J HUM GENET, V18, P172; TAYLOR A I, 1968, Journal of Medical Genetics, V5, P227, DOI 10.1136/jmg.5.3.227; TEDESCO TA, 1974, P NATL ACAD SCI USA, V71, P3483, DOI 10.1073/pnas.71.9.3483; WARBURTON D, 1959, CLIN OBSTET GYNECOL, V2, P22, DOI 10.1097/00003081-195903000-00003; WARKANY J, 1966, AM J DIS CHILD, V112, P502, DOI 10.1001/archpedi.1966.02090150046002	22	79	79	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	6					699	718						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX924	1200027				2022-12-18	WOS:A1975AX92400001
J	MORTON, NE; KRIEGER, H				MORTON, NE; KRIEGER, H			NATURAL SELECTION ON POLYMORPHISMS IN NORTHEASTERN BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		[Anonymous], 1964, ECOLOGICAL GENETICS; AZEVEDO E, 1965, AM J HUM GENET, V17, P87; AZEVEDO E, 1964, AM J HUM GENET, V16, P451; BEIGUELMAN B, 1964, B SOC BRAS GENET, V6, P47; BENNETT JH, 1958, ANN HUM GENET LOND, V20, P299; CARSON HL, 1961, EVOLUTION, V15, P496, DOI 10.2307/2406318; CEPPELLINI R, 1959, BIOCHEMISTRY HUMAN G, P242; CHUNG CH, IN PRESS, P34501; CHUNG CS, 1961, AM J HUM GENET, V13, P9; CHUNG CS, 1960, JPN J HUM GENET, V5, P124; CHUNG CS, 1961, JPN J HUM GENET, V6, P1; DACUNHA AB, 1963, GENETICS TODAY, V1, P158; Ford E. B., 1940, NEW SYSTEMATICS, P493; GERSHOWITZ H, 1963, ANNUAL M AMERICAN SO, P26; HARRIS H, 1959, BIOCHEMISTRY HUMAN G, P151; HIRAIZUM.Y, 1964, COLD SPRING HARB SYM, V29, P51, DOI 10.1101/SQB.1964.029.01.010; HUXLEY J, 1940, NEW SYSTEMATICS   ED, P493; KOCHWA S, 1961, J CLIN INVEST, V40, P874, DOI 10.1172/JCI104322; KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x; LEVENE HOWARD, 1961, PROGR MED GENET, V1, P120; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MI MP, IN PRESS; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; MORTON NE, 1959, AM J HUM GENET, V11, P237; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1965, AM J HUM GENET, V17, P94; MORTON NE, IN PRESS; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; NANCE WE, 1965, HUM BIOL, V37, P238; NEWCOMBE HB, 1963, AM J HUM GENET, V15, P449; PERITZ E, 1964, THESIS U CALIFORNIA; RACE RR, 1962, BLOOD GROUPS MAN; REED TE, 1964, AM J HUM GENET, V16, P161; ROSENFIELD RE, 1964, VOX SANG, V9, P168, DOI 10.1111/j.1423-0410.1964.tb03676.x; SALDANHA PH, 1956, LANCET, V271, P74; SALZANO FM, 1963, ACTA GENET STAT MED, V13, P1; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; VOGEL F., 1960, ACTA GENET ET STATIST MED, V10, P267; WIENER A S, 1953, Acta Genet Med Gemellol (Roma), V2, P391; WOLSTENHOLME GEW, 1959, BIOCHEMISTRY HUMA ED, P242; WOLSTENHOLME GEW, 1959, BIOCHEMISTRY HUMA ED, P151; WORKMAN PL, 1963, AM J HUM GENET, V15, P429; Wright S, 1931, GENETICS, V16, P0097; YASUDA N, 1965, THESIS U HAWAII; ZUELZER WW, 1954, AMA AM J DIS CHILD, V88, P319, DOI 10.1001/archpedi.1954.02050100321005	45	79	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	2					153	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	74253	5948309				2022-12-18	WOS:A19667425300004
J	Hira, A; Yoshida, K; Sato, K; Okuno, Y; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Shimamoto, A; Tahara, H; Ito, E; Kojima, S; Kurumizaka, H; Ogawa, S; Takata, M; Yabe, H; Yabe, M				Hira, Asuka; Yoshida, Kenichi; Sato, Koichi; Okuno, Yusuke; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Shimamoto, Akira; Tahara, Hidetoshi; Ito, Etsuro; Kojima, Seiji; Kurumizaka, Hitoshi; Ogawa, Seishi; Takata, Minoru; Yabe, Hiromasa; Yabe, Miharu			Mutations in the Gene Encoding the E2 Conjugating Enzyme UBE2T Cause Fanconi Anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FANCD2 MONOUBIQUITINATION; DNA; COMPLEX; REPAIR; ALDEHYDES; PATHWAY	Fanconi anemia (FA) is a rare genetic disorder characterized by genome instability, increased cancer susceptibility, progressive bone marrow failure (BMF), and various developmental abnormalities resulting from the defective FA pathway. FA is caused by mutations in genes that mediate repair processes of interstrand crosslinks and/or DNA adducts generated by endogenous aldehydes. The UBE2T E2 ubiquitin conjugating enzyme acts in FANCD2/FANCI monoubiquitination, a critical event in the pathway. Here we identified two unrelated FA-affected individuals, each harboring biallelic mutations in UBE2T. They both produced a defective UBE2T protein with the same missense alteration (p.Gln2Glu) that abolished FANCD2 monoubiquitination and interaction with FANCL. We suggest this FA complementation group be named FA-T.	[Hira, Asuka; Takata, Minoru] Kyoto Univ, Dept Late Effects Studies, Ctr Radiat Biol, Lab DNA Damage Signaling, Kyoto 6068501, Japan; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Sato, Koichi; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo 1628480, Japan; [Okuno, Yusuke; Kojima, Seiji] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo 1088639, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo 1088639, Japan; [Shimamoto, Akira; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cellular & Mol Biol, Minami Ku, Hiroshima 7348551, Japan; [Ito, Etsuro] Hirosaki Univ, Dept Pediat, Grad Sch Med, Hirosaki, Aomori 0368562, Japan; [Yabe, Hiromasa; Yabe, Miharu] Tokai Univ, Dept Cell Transplantat & Regenerat Med, Sch Med, Isehara, Kanagawa 2591193, Japan	Kyoto University; Kyoto University; Waseda University; Nagoya University; University of Tokyo; University of Tokyo; Hiroshima University; Hirosaki University; Tokai University	Takata, M (corresponding author), Kyoto Univ, Dept Late Effects Studies, Ctr Radiat Biol, Lab DNA Damage Signaling, Kyoto 6068501, Japan.	mtakata@house.rbc.kyoto-u.ac.jp	Okuno, Yusuke/C-9082-2009; Tahara, Hidetoshi/G-7697-2019; Takata, Minoru/K-3772-2019; Ogawa, Seishi/AAE-7088-2019	Okuno, Yusuke/0000-0003-3139-9272; Sato, Koichi/0000-0002-0574-774X; Miyano, Satoru/0000-0002-1753-6616; Ito, Etsuro/0000-0002-0168-2475; Takata, Minoru/0000-0002-4926-3675; Kurumizaka, Hitoshi/0000-0001-7412-3722; Yoshida, Kenichi/0000-0003-4612-2778	Ministry of Health, Labor and Welfare of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The use of FANCT as an alias for UBE2T was approved by the HUGO Gene Nomenclature Committee. We would like to thank the individuals PNGS-252 and -255 and their family members for making this work possible. We also thank Dr. Masao S. Sasaki (Professor Emeritus, Kyoto University) for his long-standing effort to collect Japanese FA samples, including AP65P fibroblasts; Dr. James Hejna (Graduate School of Biostudies, Kyoto University) for critical reading of the manuscript and English editing; Dr. Takayuki Yamashita (Gunma University) for GM6914 cells; Dr. Hiroyuki Miyoshi (RIKEN, currently at Keio University) and RIKEN Bio-resource Center (Tsukuba, Ibaragi, Japan) for a lentivirus construct (CSII-CMV-MCS-IRES-Bsd) and the packaging system; Dr. Settara C. Chandrasekharappa (NIH) for advice on the CGH array; Dr. Yoko Katsuki for advice on immunofluorescence; Ms. Tomoko Hirayama (JCRB) for a protocol for karyotyping in fibroblasts; Ms. Fumiko Tsuchida, Chinatsu Ohki, Akiko Watanabe, and Mao Hisano for expert technical help; and Drs. Toshiyasu Taniguchi and Agata Smogorzewska for advice on anti-FANCD2/FANCI immunoblotting. The AP65P cell line (KURB1562) was kindly provided by JCRB Cell Bank, National Institute of Biomedical Innovation (Saito, Ibaraki, Osaka). This work was supported in part by grants from the Ministry of Health, Labor and Welfare of Japan.	Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alter Blanche P, 2007, Hematology Am Soc Hematol Educ Program, P29, DOI 10.1182/asheducation-2007.1.29; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Hira A, 2013, BLOOD, V122, P3206, DOI 10.1182/blood-2013-06-507962; Hodson C, 2014, STRUCTURE, V22, P337, DOI 10.1016/j.str.2013.12.004; Kelsall IR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036970; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Nascimento RMP, 2006, AM J HUM GENET, V79, P549, DOI 10.1086/507047; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Yamada T, 2000, J HUM GENET, V45, P159, DOI 10.1007/s100380050203; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	25	78	80	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					1001	1007		10.1016/j.ajhg.2015.04.022	http://dx.doi.org/10.1016/j.ajhg.2015.04.022			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26046368	Green Published, Bronze			2022-12-18	WOS:000355931200015
J	Hansen, L; Tawamie, H; Murakami, Y; Mang, Y; Rehman, SU; Buchert, R; Schaffer, S; Muhammad, S; Bak, M; Nothen, MM; Bennett, EP; Maeda, Y; Aigner, M; Reis, A; Kinoshita, T; Tommerup, N; Baig, SM; Abou Jamra, R				Hansen, Lars; Tawamie, Hasan; Murakami, Yoshiko; Mang, Yuan; Rehman, Shoaib Ur; Buchert, Rebecca; Schaffer, Stefanie; Muhammad, Safia; Bak, Mads; Noethen, Markus M.; Bennett, Eric P.; Maeda, Yusuke; Aigner, Michael; Reis, Andre; Kinoshita, Taroh; Tommerup, Niels; Baig, Shahid Mahmood; Abou Jamra, Rami			Hypomorphic Mutations in PGAP2, Encoding a GPI-Anchor-Remodeling Protein, Cause Autosomal-Recessive Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGV MUTATIONS; HYPERPHOSPHATASIA; TRAFFICKING; FAMILIES	PGAP2 encodes a protein involved in remodeling the glycosylphosphatidylinositol (GPI) anchor in the Golgi apparatus. After synthesis in the endoplasmic reticulum (ER), GPI anchors are transferred to the proteins and are remodeled while transported through the Golgi to the cell membrane. Germ line mutations in six genes (PIGA, PIGL, PIGM, PIGV, PIGN, and PIGO) in the ER-located part of the GPI-anchor-biosynthesis pathway have been reported, and all are associated with phenotypes extending from malformation and lethality to severe intellectual disability, epilepsy, minor dysmorphisms, and elevated alkaline phosphatase (ALP). We performed autozygosity mapping and ultra-deep sequencing followed by stringent filtering and identified two homozygous PGAP2 alterations, p.Tyr99Cys and p.Arg177Pro, in seven offspring with nonspecific autosomal-recessive intellectual disability from two consanguineous families. Rescue experiments with the altered proteins in PGAP2-deficient Chinese hamster ovary cell lines showed less expression of cell-surface GPI-anchored proteins DAF and CD59 than of the wild-type protein, substantiating the pathogenicity of the identified alterations. Furthermore, we observed a full rescue when we used strong promoters before the mutant cDNAs, suggesting a hypomorphic effect of the mutations. We report on alterations in the Golgi-located part of the GPI-anchor-biosynthesis pathway and extend the phenotypic spectrum of the GPI-anchor deficiencies to isolated intellectual disability with elevated ALP. GPI-anchor deficiencies can be interpreted within the concept of a disease family, and we propose that the severity of the phenotype is dependent on the location of the altered protein in the biosynthesis chain.	[Hansen, Lars; Mang, Yuan; Rehman, Shoaib Ur; Bak, Mads; Tommerup, Niels] Univ Copenhagen, Panum Inst, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark; [Hansen, Lars; Mang, Yuan; Bak, Mads; Tommerup, Niels] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Tawamie, Hasan; Buchert, Rebecca; Reis, Andre; Abou Jamra, Rami] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Rehman, Shoaib Ur; Baig, Shahid Mahmood] Pakistan Inst Engn & Appl Sci, Natl Inst Biotechnol & Genet Engn, Hlth Biotechnol Div, Human Mol Genet Lab, Faisalabad 38000, Pakistan; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, D-53127 Bonn, Germany; [Noethen, Markus M.] Univ Bonn, German Ctr Neurodegenerat Disorders, D-53127 Bonn, Germany; [Hansen, Lars; Bennett, Eric P.] Univ Copenhagen, Panum Inst, Copenhagen Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Bennett, Eric P.] Univ Copenhagen, Dept Odontol, DK-2200 Copenhagen N, Denmark; [Schaffer, Stefanie; Aigner, Michael] Univ Erlangen Nurnberg, Med Clin 5, D-91054 Erlangen, Germany	University of Copenhagen; University of Copenhagen; University of Erlangen Nuremberg; Osaka University; Osaka University; Pakistan Institute of Engineering & Applied Science; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Copenhagen; University of Copenhagen; University of Erlangen Nuremberg	Hansen, L (corresponding author), Univ Copenhagen, Panum Inst, Wilhelm Johannsen Ctr Funct Genome Res, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	lah@sund.ku.dk; rami.aboujamra@uk-erlangen.de	BAig, Shahid Mahmood/AAS-8365-2020; Abou Jamra, Rami/AAC-8192-2019; Jamra, Rami Abou/I-2350-2012; Buchert, Rebecca/R-6386-2019; Bennett, Eric/AAG-6120-2020; Tommerup, Niels/T-8776-2017; Reis, André/D-2309-2009; Baig, Shahid Mahmood/I-7309-2015; Kinoshita, Taroh/C-7353-2009; Jamra, Rami Abou/I-4805-2015	Abou Jamra, Rami/0000-0002-1542-1399; Jamra, Rami Abou/0000-0002-1542-1399; Buchert, Rebecca/0000-0001-7576-3326; Bennett, Eric/0000-0002-4976-0647; Tommerup, Niels/0000-0003-2304-0112; Reis, André/0000-0002-6301-6363; Jamra, Rami Abou/0000-0002-1542-1399; Bak, Mads/0000-0003-2762-1002; Nothen, Markus/0000-0002-8770-2464	German Intellectual Disability Network through German Ministry of Research and Education [01GS08160, 01GR0804-4]; Deutsche Forschungsgemeinschaft [AB393/2-1]; Detusches Austauschdienst DAAD; Lundbeck Foundation; Danish National Research Foundation; Higher Education Commission in Pakistan; European Molecular Biology Organization; Lundbeck Foundation [R67-2010-6206, R151-2013-14290, R13-2007-1172] Funding Source: researchfish	German Intellectual Disability Network through German Ministry of Research and Education; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Detusches Austauschdienst DAAD; Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Higher Education Commission in Pakistan(Higher Education Commission of Pakistan); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Lundbeck Foundation(Lundbeckfonden)	We are grateful to the families involved in this study for their participation. We thank Karen Friis Henriksen and Linda Boje Dalsgaard for their help in library generation, sequencing, and molecular biology analyses. We thank Kana Miyanagi for the excellent assistance in Chinese hamster cell transfection and fluorescence-activated cell sorting. We thank Barbel Lippke and Margrieta Alblas from Bonn and Farah Radwan, Angelika Diem, Petra Rothe, Steffen Uebe, and Arif Ekici from Erlangen for assistance with lymphoblast cells lines, SNP array genotyping, and next-generation sequencing. This study was supported by the German Intellectual Disability Network through grants from the German Ministry of Research and Education to A.R. (01GS08160 and 01GR0804-4), by the Deutsche Forschungsgemeinschaft through a grant to R.A.J. (AB393/2-1), by the Detusches Austauschdienst DAAD through a grant to H.T., by the Lundbeck Foundation and the Danish National Research Foundation through grants to N.T., and by the Higher Education Commission in Pakistan and a research fellowship from European Molecular Biology Organization to S.u.R.	Abou Jamra R, 2011, EUR J HUM GENET, V19, P1161, DOI 10.1038/ejhg.2011.98; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nozaki M, 1999, LAB INVEST, V79, P293; Rehman SU, 2011, NEUROGENETICS, V12, P247, DOI 10.1007/s10048-011-0286-5; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Slosson R. L., 1985, SLOSSON INTELLIGENCE; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	22	78	80	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					575	583		10.1016/j.ajhg.2013.03.008	http://dx.doi.org/10.1016/j.ajhg.2013.03.008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23561846	Green Published, Bronze			2022-12-18	WOS:000317449700009
J	Heinzen, EL; Depondt, C; Cavalleri, GL; Ruzzo, EK; Walley, NM; Need, AC; Ge, DL; He, M; Cirulli, ET; Zhao, Q; Cronin, KD; Gumbs, CE; Campbell, CR; Hong, LK; Maia, JM; Shianna, KV; McCormack, M; Radtke, RA; O'Conner, GD; Mikati, MA; Gallentine, WB; Husain, AM; Sinha, SR; Chinthapalli, K; Puranam, RS; McNamara, JO; Ottman, R; Sisodiya, SM; Delanty, N; Goldstein, DB				Heinzen, Erin L.; Depondt, Chantal; Cavalleri, Gianpiero L.; Ruzzo, Elizabeth K.; Walley, Nicole M.; Need, Anna C.; Ge, Dongliang; He, Min; Cirulli, Elizabeth T.; Zhao, Qian; Cronin, Kenneth D.; Gumbs, Curtis E.; Campbell, C. Ryan; Hong, Linda K.; Maia, Jessica M.; Shianna, Kevin V.; McCormack, Mark; Radtke, Rodney A.; O'Conner, Gerard D.; Mikati, Mohamad A.; Gallentine, William B.; Husain, Aatif M.; Sinha, Saurabh R.; Chinthapalli, Krishna; Puranam, Ram S.; McNamara, James O.; Ottman, Ruth; Sisodiya, Sanjay M.; Delanty, Norman; Goldstein, David B.			Exome Sequencing Followed by Large-Scale Genotyping Fails to Identify Single Rare Variants of Large Effect in Idiopathic Generalized Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECURRENT MICRODELETIONS; 16P13.11 PREDISPOSE; ASSOCIATION; SPECTRUM; RISK	Idiopathic generalized epilepsy (ICE) is a complex disease with high heritability, but little is known about its genetic architecture. Rare copy-number variants have been found to explain nearly 3% of individuals with IGE; however, it remains unclear whether variants with moderate effect size and frequencies below what are reliably detected with genome-wide association studies contribute significantly to disease risk. In this study, we compare the exome sequences of 118 individuals with IGE and 242 controls of European ancestry by using next-generation sequencing. The exome-sequenced epilepsy cases include study subjects with two forms of IGE, including juvenile myoclonic epilepsy (n = 93) and absence epilepsy (n = 25). However, our discovery strategy did not assume common genetic control between the subtypes of IGE considered. In the sequence data, as expected, no variants were significantly associated with the IGE phenotype or more specific IGE diagnoses. We then selected 3,897 candidate epilepsy-susceptibility variants from the sequence data and genotyped them in a larger set of 878 individuals with IGE and 1,830 controls. Again, no variant achieved statistical significance. However, 1,935 variants were observed exclusively in cases either as heterozygous or homozygous genotypes. It is likely that this set of variants includes real risk factors. The lack of significant association evidence of single variants with disease in this two-stage approach emphasizes the high genetic heterogeneity of epilepsy disorders, suggests that the impact of any individual single-nucleotide variant in this disease is small, and indicates that gene-based approaches might be more successful for future sequencing studies of epilepsy predisposition.	[Heinzen, Erin L.; Ruzzo, Elizabeth K.; Walley, Nicole M.; Need, Anna C.; Ge, Dongliang; He, Min; Cirulli, Elizabeth T.; Zhao, Qian; Cronin, Kenneth D.; Gumbs, Curtis E.; Campbell, C. Ryan; Hong, Linda K.; Maia, Jessica M.; Shianna, Kevin V.; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Heinzen, Erin L.; Need, Anna C.; Ge, Dongliang; Shianna, Kevin V.] Duke Univ, Sch Med, Dept Med, Med Genet Sect, Durham, NC 27708 USA; [Depondt, Chantal] Univ Libre Bruxelles, Hop Erasme, Dept Neurol, B-1070 Brussels, Belgium; [Cavalleri, Gianpiero L.; McCormack, Mark; Delanty, Norman] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Radtke, Rodney A.; Husain, Aatif M.; Sinha, Saurabh R.] Duke Univ, Sch Med, Div Neurol, Dept Med, Durham, NC 27710 USA; [O'Conner, Gerard D.; Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland; [Mikati, Mohamad A.; Gallentine, William B.] Duke Univ, Sch Med, Dept Pediat, Div Pediat Neurol, Durham, NC 27710 USA; [Chinthapalli, Krishna; Sisodiya, Sanjay M.] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; [Puranam, Ram S.; McNamara, James O.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Ottman, Ruth] Columbia Univ, Sergievsky Ctr, New York, NY 10032 USA; [Ottman, Ruth] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Ottman, Ruth] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; [Ottman, Ruth] New York State Psychiat Inst & Hosp, Div Epidemiol, New York, NY 10032 USA; [Goldstein, David B.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA	Duke University; Duke University; Universite Libre de Bruxelles; Royal College of Surgeons - Ireland; Duke University; Duke University; University of London; University College London; Duke University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Duke University	Heinzen, EL (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA.	e.heinzen@duke.edu; d.goldstein@duke.edu	Goldstein, David/AAY-8125-2020; McCormack, Mark/A-5482-2010; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Husain, Aatif/AAN-7058-2021; Ottman, Ruth/O-2371-2013; Chinthapalli, Krishna/P-8428-2019; Cavalleri, Gianpiero/A-6632-2010	McCormack, Mark/0000-0002-8213-6141; Ottman, Ruth/0000-0001-7074-242X; Chinthapalli, Krishna/0000-0003-4136-4882; PURANAM, RAM/0000-0003-4383-3849; Cirulli Rogers, Liz/0000-0001-7808-2809; Delaney, Norman/0000-0002-3953-9842; Need, Anna/0000-0003-3955-8207; Mikati, Mohamad/0000-0003-0363-8715; Cavalleri, Gianpiero/0000-0002-9802-0506	National Institute of Neurological Disorders and Stroke [RC2NS070344]; National Institute of Mental Health [RC2MH089915]; National Institute of Allergy and Infectious Diseases [UO1AIO67854, 1RC2NS070342]; Ellison Medical Foundation; National Institute on Aging [P30 AG028377]; Wellcome Trust [084730]; National Institute for Health Research [08-08-SCC]; Fonds National de la Recherche Scientifique; Fondation Erasme; Universite Libre de Bruxelles; Fondation Erasme, Universite Libre de Bruxelles, Brainwave-The Irish Epilepsy Association/the Medical Research Charities Group of Ireland/Health Research Board [2009/001]; Programme for Human Genomics; Programme for Research in Third Level Institutions (PRTLI3); Irish Higher Education Authority; Health Research Board of Ireland's Translational Research Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070342, RC2NS070344] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fondation Erasme; Universite Libre de Bruxelles; Fondation Erasme, Universite Libre de Bruxelles, Brainwave-The Irish Epilepsy Association/the Medical Research Charities Group of Ireland/Health Research Board; Programme for Human Genomics; Programme for Research in Third Level Institutions (PRTLI3); Irish Higher Education Authority; Health Research Board of Ireland's Translational Research Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the individuals who kindly participated, as well as the physicians who recruited them. We also acknowledge all of the collaborators and groups who contributed controls for ascertaining the frequency of candidate variants in the population; these collaborators include the Murdock Study Community Registry and Biorepository (R. Murdock), D. Daskalakis, D. Attix, V. Dixon, O. Chiba-Falek, J. McEvoy, V. Shashi, R. Brown, A. Holden, E. Behr, W. Lowe, P. Lugar, J. Milner, K. Welsh-Bohmer, C. Hulette, J. Burke, D. Valle, J. Hoover-Fong, N. Sobriera, D. Marchuk, S. Palmer, E. Pras, D. Lancet, and Z. Farfel. This project was funded by the National Institute of Neurological Disorders and Stroke (RC2NS070344), the National Institute of Mental Health (RC2MH089915), the National Institute of Allergy and Infectious Diseases (UO1AIO67854, 1RC2NS070342), the Ellison Medical Foundation (O. Chiba-Falek), the National Institute on Aging (P30 AG028377), the Wellcome Trust (084730), the National Institute for Health Research (grant 08-08-SCC), the Fonds National de la Recherche Scientifique, the Fondation Erasme, Universite Libre de Bruxelles, Brainwave-The Irish Epilepsy Association/the Medical Research Charities Group of Ireland/Health Research Board award 2009/001, and the Programme for Human Genomics and the Programme for Research in Third Level Institutions (PRTLI3) funded by the Irish Higher Education Authority. M.M.C. was supported by a Health Research Board of Ireland's Translational Research Scholars award.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldinger KA, 2009, CLIN GENET, V75, P425, DOI 10.1111/j.1399-0004.2009.01186_2.x; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hemminki K, 2006, NEUROEPIDEMIOLOGY, V27, P67, DOI 10.1159/000094976; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mefford HC, 2010, GENOME MED, V2, DOI 10.1186/gm192; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mishto M, 2011, BIOCHEM BIOPH RES CO, V408, P65, DOI 10.1016/j.bbrc.2011.03.117; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Need A. G., 2012, AM J HUM GENET; Need Anna C, 2010, Dialogues Clin Neurosci, V12, P37; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; The Epi4K Consortium, 2012, EPILEPSIA, DOI doi.org/10.1111/j.1528-1167.2012.03511.x; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	32	78	82	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					293	302		10.1016/j.ajhg.2012.06.016	http://dx.doi.org/10.1016/j.ajhg.2012.06.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22863189	hybrid, Green Published			2022-12-18	WOS:000307608700007
J	Mayr, JA; Zimmermann, FA; Fauth, C; Bergheim, C; Meierhofer, D; Radmayr, D; Zschocke, J; Koch, J; Sperl, W				Mayr, Johannes A.; Zimmermann, Franz A.; Fauth, Christine; Bergheim, Christa; Meierhofer, David; Radmayr, Doris; Zschocke, Johannes; Koch, Johannes; Sperl, Wolfgang			Lipoic Acid Synthetase Deficiency Causes Neonatal-Onset Epilepsy, Defective Mitochondrial Energy Metabolism, and Glycine Elevation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESCHERICHIA-COLI; RESPIRATORY-CHAIN; DEHYDROGENASE; MUTATIONS; GENE; BIOSYNTHESIS; COMPLEX; PROTEIN; CLONING	Lipoic acid is an essential prosthetic group of four mitochondrial enzymes involved in the oxidative decarboxylation of pyruvate, alpha-ketoglutarate, and branched chain amino acids and in the glycine cleavage. Lipoic acid is synthesized stepwise within mitochondria through a process that includes lipoic acid synthetase. We identified the homozygous mutation c.746G>A (p.Arg249His) in LIAS in an individual with neonatal-onset epilepsy, muscular hypotonia, lactic acidosis, and elevated glycine concentration in plasma and urine. Investigation of the mitochondrial energy metabolism showed reduced oxidation of pyruvate and decreased pyruvate dehydrogenase complex activity. A pronounced reduction of the prosthetic group lipoamide was found in lipoylated proteins.	[Mayr, Johannes A.; Zimmermann, Franz A.; Radmayr, Doris; Koch, Johannes; Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Fauth, Christine; Zschocke, Johannes] Med Univ Innsbruck, Dept Human Genet, A-6020 Innsbruck, Austria; [Bergheim, Christa] Marienhausklin, Dept Pediat Kohlhof, D-66539 Neunkirchen, Germany; [Meierhofer, David] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Paracelsus Private Medical University; Medical University of Innsbruck; Max Planck Society	Mayr, JA (corresponding author), Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.	h.mayr@salk.at	Meierhofer, David/V-4711-2019; Zschocke, Johannes/C-5885-2013	Meierhofer, David/0000-0002-0170-868X; Zschocke, Johannes/0000-0002-0046-8274; Mayr, Johannes/0000-0001-6970-336X	Austrian Pediatric Society (OGKJ); Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg	Austrian Pediatric Society (OGKJ); Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg	We thank Christine Fischer for performing linkage analysis. This work was supported by the "Wissenschaftspreis 2008" of the Austrian Pediatric Society (OGKJ) to J.A.M. and the Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg.	Al-Shareef I, 2011, J CHILD NEUROL, V26, P970, DOI 10.1177/0883073811399150; ANGELIDES KJ, 1978, P NATL ACAD SCI USA, V75, P4877, DOI 10.1073/pnas.75.10.4877; Bodner-Leidecker A, 2000, J INHERIT METAB DIS, V23, P805, DOI 10.1023/A:1026708618507; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; De Meirleir L, 2002, J CHILD NEUROL, V17, pS26; Duin EC, 1997, BIOCHEMISTRY-US, V36, P11811, DOI 10.1021/bi9706430; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; HAMOSH A, 2009, GENEREVIEWS; HAYDEN MA, 1993, BIOCHEMISTRY-US, V32, P3778, DOI 10.1021/bi00065a033; HERBERT AA, 1968, J GEN MICROBIOL, V53, P363, DOI 10.1099/00221287-53-3-363; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; JILKA JM, 1986, J BIOL CHEM, V261, P1858; Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Odievre MH, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9319; Okajima K, 2008, MOL GENET METAB, V93, P371, DOI 10.1016/j.ymgme.2007.10.135; Puckett RL, 2010, MOL GENET METAB, V100, P136, DOI 10.1016/j.ymgme.2009.11.010; Rock CO, 2009, J BACTERIOL, V191, P6782, DOI 10.1128/JB.01151-09; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Strassburg HM, 2006, NEUROPEDIATRICS, V37, P137, DOI 10.1055/s-2006-924555; SULO P, 1993, J BIOL CHEM, V268, P17634; Yasuno R, 1998, PLANT PHYSIOL, V118, P935, DOI 10.1104/pp.118.3.935; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; YOSHIDA T, 1973, J BIOCHEM-TOKYO, V73, P1013, DOI 10.1093/oxfordjournals.jbchem.a130155; Zimmermann FA, 2009, BRIT J CANCER, V100, P1434, DOI 10.1038/sj.bjc.6605028	27	78	83	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					792	797		10.1016/j.ajhg.2011.11.011	http://dx.doi.org/10.1016/j.ajhg.2011.11.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152680	Green Published, Bronze			2022-12-18	WOS:000298208700011
J	Liu, PF; Lacaria, M; Zhang, F; Withers, M; Hastings, PJ; Lupski, JR				Liu, Pengfei; Lacaria, Melanie; Zhang, Feng; Withers, Marjorie; Hastings, P. J.; Lupski, James R.			Frequency of Nonallelic Homologous Recombination Is Correlated with Length of Homology: Evidence that Ectopic Synapsis Precedes Ectopic Crossing-Over	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; GENOMIC DISORDERS; SACCHAROMYCES-CEREVISIAE; MALE-INFERTILITY; GENE CONVERSION; REARRANGEMENTS; DELETION; MECHANISM; SEQUENCES	Genomic disorders constitute a class of diseases that are associated with DNA rearrangements resulting from region-specific genome instability, that is, genome architecture incites genome instability. Nonallelic homologous recombination (NAHR) or crossing-over in meiosis between sequences that are not in allelic positions (i.e., paralogous sequences) can result in recurrent deletions or duplications causing genomic disorders. Previous studies of NAHR have focused on description of the phenomenon, but it remains unclear how NAHR occurs during meiosis and what factors determine its frequency. Here we assembled two patient cohorts with reciprocal genomic disorders; deletion associated Smith-Magenis syndrome and duplication associated Potocki-Lupski syndrome. By assessing the full spectrum of rearrangement types from the two cohorts, we find that complex rearrangements (those with more than one breakpoint) are more prevalent in copy-number gains (17.7%) than in copy-number losses (2.3%); an observation that supports a role for replicative mechanisms in complex rearrangement formation. Interestingly, for NAHR-mediated recurrent rearrangements, we show that crossover frequency is positively associated with the flanking low-copy repeat (LCR) length and inversely influenced by the inter-LCR distance. To explain this, we propose that the probability of ectopic chromosome synapsis increases with increased LCR length, and that ectopic synapsis is a necessary precursor to ectopic crossing-over.	[Liu, Pengfei; Lacaria, Melanie; Zhang, Feng; Withers, Marjorie; Hastings, P. J.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu	Zhang, Feng/C-7735-2009; Liu, Pengfei/U-9743-2019	Zhang, Feng/0000-0003-4556-8276; Liu, Pengfei/0000-0002-4177-709X	SMS Research Foundation; National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS058529]; National Institutes of General Medical Science [R01GM064022]; Texas Children's Hospital General Clinical Research Center [M01RR00188]; Intellectual and Developmental Disabilities Research Centers [P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	SMS Research Foundation; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of General Medical Science; Texas Children's Hospital General Clinical Research Center; Intellectual and Developmental Disabilities Research Centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the participating subjects and families for their time, efforts, and collaboration; the referring physicians and genetic counselors for sample acquisition; and Weimin Bi, Wenli Gu, and Pawel Stankiewicz for comments. This work was supported in part by the SMS Research Foundation and the National Institutes of Health, National Institute of Neurological Disorders and Stroke grant R01NS058529 to J.R.L., the National Institutes of General Medical Science grant R01GM064022 to P.J.H., Texas Children's Hospital General Clinical Research Center grant M01RR00188, and the Intellectual and Developmental Disabilities Research Centers grant P30HD024064. J.R.L. is a consultant for Athena Diagnostics and Ion Torrent Systems, holds stock ownership of 23andMe, and is a coinventor on multiple US and European patents for DNA diagnostics. The Baylor College of Medicine and Department of Molecular and Human Genetics derive revenue from diagnostic testing provided by the Medical Genetics Laboratories.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Boone PM, 2011, GENET MED, V13, P582, DOI 10.1097/GIM.0b013e3182106775; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Carvalho CMB, 2011, SYST BIOL REPROD MED, V57, P3, DOI 10.3109/19396368.2010.527427; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Goldman ASH, 1996, GENETICS, V144, P43; HABER JE, 1991, P NATL ACAD SCI USA, V88, P1120, DOI 10.1073/pnas.88.4.1120; Hastings PJ, 2010, GENES-BASEL, V1, P427, DOI 10.3390/genes1030427; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; LICHTEN M, 1987, GENETICS, V115, P233; LISKAY RM, 1987, GENETICS, V115, P161; Lu CC, 2009, HUM MOL GENET, V18, P1122, DOI 10.1093/hmg/ddn427; Lupski JR, 2009, GENOME MED, V1, DOI 10.1186/gm42; Lupski JR, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-242; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Morrow DM, 1997, GENETICS, V147, P371; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Myers SR, 2006, NAT GENET, V38, P1363, DOI 10.1038/ng1206-1363; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park JP, 1998, AM J MED GENET, V77, P23, DOI 10.1002/(SICI)1096-8628(19980428)77:1<23::AID-AJMG6>3.0.CO;2-M; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Shaw CJ, 2004, J MED GENET, V41, P113, DOI 10.1136/jmg.2003.012831; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Zhang F, 2007, J MED GENET, V44, P437, DOI 10.1136/jmg.2007.049056; Zhang F, 2010, AM J HUM GENET, V86, P462, DOI 10.1016/j.ajhg.2010.02.001; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	48	78	81	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					580	588		10.1016/j.ajhg.2011.09.009	http://dx.doi.org/10.1016/j.ajhg.2011.09.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21981782	Green Published, Bronze			2022-12-18	WOS:000295951300012
J	Bakalkin, G; Watanabe, H; Jezierska, J; Depoorter, C; Verschuuren-Bemelmans, C; Bazov, I; Artemenko, KA; Yakovleva, T; Dooijes, D; Van de Warrenburg, BPC; Zubarev, RA; Kremer, B; Knapp, PE; Hauser, KF; Wijmenga, C; Nyberg, F; Sinke, RJ; Verbeek, DS				Bakalkin, Georgy; Watanabe, Hiroyuki; Jezierska, Justyna; Depoorter, Cloe; Verschuuren-Bemelmans, Corien; Bazov, Igor; Artemenko, Konstantin A.; Yakovleva, Tatjana; Dooijes, Dennis; Van de Warrenburg, Bart P. C.; Zubarev, Roman A.; Kremer, Berry; Knapp, Pamela E.; Hauser, Kurt F.; Wijmenga, Cisca; Nyberg, Fred; Sinke, Richard J.; Verbeek, Dineke S.			Prodynorphin Mutations Cause the Neurodegenerative Disorder Spinocerebellar Ataxia Type 23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; MESSENGER-RNA EXPRESSION; ADULT HUMAN BRAIN; STRIATAL NEURONS; DIFFERENTIAL INVOLVEMENT; DYNORPHIN NEUROPEPTIDES; OPIOID-RECEPTOR; SPINAL-CORD; DEGRADATION; MECHANISM	Spinocerebellar ataxias (SCAs) are dominantly inherited neurodegenerative disorders characterized by progressive cerebellar ataxia and dysarthria We have identified missense mutations in prodynorphin (PDYN) that cause SCA23 in four Dutch families displaying progressive gait and limb ataxia PDYN is the precursor protein for the opioid neuropeptides alpha neoendorphin, and dynorphins A and B (Dyn A and B) Dynorphins regulate pain processing and modulate the rewarding effects of addictive substances Three mutations were located in Dyn A a peptide with both opioid activities and nonoproid neurodegenerative actions Two of these mutations resulted in excessive generation of Dyn A in a cellular model system In addition two of the mutant Dyn A peptides induced toxicity above that of wild type Dyn A in cultured striatal neurons The fourth mutation was located in the nonoproid PDYN domain and was associated with altered expression of components of the oproid and glutamate system, as evident from analysis of SCA23 autopsy tissue Thus, alterations in Dyn A activities and/or impairment of secretory pathways by mutant PDYN may lead to glutamate neurotoxicity, which underlies Purkinje cell degeneration and ataxia PDYN mutations are identified in a small subset of ataxia families, indicating that SCA23 is an infrequent SCA type (similar to 0 5%) in the Netherlands and suggesting further genetic SCA heterogeneity	[Jezierska, Justyna; Depoorter, Cloe; Verschuuren-Bemelmans, Corien; Wijmenga, Cisca; Sinke, Richard J.; Verbeek, Dineke S.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Bakalkin, Georgy; Watanabe, Hiroyuki; Bazov, Igor; Yakovleva, Tatjana; Nyberg, Fred] Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; [Artemenko, Konstantin A.] Uppsala Univ, Dept Physiol & Analyt Chem, SE-75123 Uppsala, Sweden; [Dooijes, Dennis; Sinke, Richard J.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Van de Warrenburg, Bart P. C.] Univ Med Ctr Nijmegen, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Zubarev, Roman A.] Karolinska Inst, Div Mol Biometry, Dept Med Biochem, SE-17177 Stockholm, Sweden; [Zubarev, Roman A.] Karolinska Inst, Dept Biophys, SE-17177 Stockholm, Sweden; [Kremer, Berry] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands; [Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA 23298 USA	University of Groningen; Uppsala University; Uppsala University; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; University of Groningen; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Verbeek, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands.		Hauser, Kurt/AAX-8361-2020; Zmorzynska, Justyna/AAN-1287-2020; Zubarev, Roman A/W-7891-2018; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; van de Warrenburg, Bart PC/D-1935-2010	Zmorzynska, Justyna/0000-0001-8489-8732; Zubarev, Roman A/0000-0001-9839-2089; Wijmenga, Cisca/0000-0002-5635-1614; van de Warrenburg, Bart PC/0000-0003-4412-1616; Hauser, Kurt/0000-0001-7886-0332; Bakalkin, Georgy/0000-0002-8074-9833; Bazov, Igor/0000-0003-4388-1656	University of Groningen; National Institute on Drug Abuse [DA027374]; Swedish Science Council; Swedish Institute; AFA Forsakring; Swedish Council for Working Life and Social Research; Uppsala University; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA027374] Funding Source: NIH RePORTER	University of Groningen; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Swedish Science Council; Swedish Institute; AFA Forsakring; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Uppsala University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the participating family members for their cooperation and all the members of the SpinoCerebellaire Ataxie Nederland working group for their input and help regarding this study We acknowledge Henk Moorlag for preparing the cerebellar slides, Alexander Zubarev for protein quantification software Henrik Druid Kanar Alkass and Pieter Wesseling for human brain samples, and Jackie Senior for improving the manuscript I his work was supported in part by a Rosalind Franklin Fellowship from the University of Groningen (D S V) and a National Institute on Drug Abuse Independent Scientist Award (DA027374, K F H), as well as by the Swedish Science Council, Swedish Institute, AFA Forsakring and Swedish Council for Working Life and Social Research (G B), and an Uppsala University Fellowship (H W)	AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Carlson KM, 2009, CURR OPIN GENET DEV, V19, P247, DOI 10.1016/j.gde.2009.02.009; Caudle RM, 2000, PAIN, V87, P235, DOI 10.1016/S0304-3959(00)00360-2; Day R, 1998, J BIOL CHEM, V273, P829, DOI 10.1074/jbc.273.2.829; Duenas AM, 2010, CEREBELLUM, V9, P148; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Goody RJ, 2003, NEUROSCIENCE, V116, P807, DOI 10.1016/S0306-4522(02)00563-8; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; HERMAN BH, 1980, LIFE SCI, V27, P883, DOI 10.1016/0024-3205(80)90084-3; Hugonin L, 2008, BBA-BIOMEMBRANES, V1778, P1267, DOI 10.1016/j.bbamem.2008.02.003; Hugonin L, 2006, FEBS LETT, V580, P3201, DOI 10.1016/j.febslet.2006.04.078; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lai J, 2001, Mol Interv, V1, P160; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Marinova Z, 2005, J BIOL CHEM, V280, P26360, DOI 10.1074/jbc.M412494200; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; NAKAZAWA T, 1989, NEUROPEPTIDES, V13, P277, DOI 10.1016/0143-4179(89)90082-6; Nguyen XV, 2005, BEHAV BRAIN RES, V161, P254, DOI 10.1016/j.bbr.2005.02.010; Nikoshkov A, 2005, FASEB J, V19, P1543, DOI 10.1096/fj.05-3743fje; NYLANDER IC, 1985, REGUL PEPTIDES, V11, P65; Okvist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000930; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schadrack J, 1999, NEUROREPORT, V10, P619, DOI 10.1097/00001756-199902250-00032; Schols L, 1997, ANN NEUROL, V42, P924, DOI 10.1002/ana.410420615; Schorge S, 2010, TRENDS NEUROSCI, V33, P211, DOI 10.1016/j.tins.2010.02.005; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; SILBERRING J, 1992, J BIOL CHEM, V267, P21324; Singh IN, 2005, NEUROSCIENCE, V135, P781, DOI 10.1016/j.neuroscience.2005.05.028; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Tan-No K, 2001, EXP CELL RES, V269, P54, DOI 10.1006/excr.2001.5309; Tan-No K, 2005, PAIN, V113, P301, DOI 10.1016/j.pain.2004.11.004; Verbeek DS, 2009, CEREBELLUM, V8, P104, DOI 10.1007/s12311-008-0085-1; Verbeek DS, 2004, BRAIN, V127, P2551, DOI 10.1093/brain/awh276; Waldvogel HJ, 2006, NAT PROTOC, V1, P2719, DOI 10.1038/nprot.2006.354; WALKER JM, 1982, SCIENCE, V218, P1136, DOI 10.1126/science.6128791; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yakovleva T, 2007, NEUROBIOL AGING, V28, P1700, DOI 10.1016/j.neurobiolaging.2006.07.002; Yakovleva T, 2006, FASEB J, V20, P2124, DOI 10.1096/fj.06-6174fje	45	78	83	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					593	603		10.1016/j.ajhg.2010.10.001	http://dx.doi.org/10.1016/j.ajhg.2010.10.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21035104	Green Published, Bronze			2022-12-18	WOS:000284668400005
J	Brancati, F; Fortugno, P; Bottillo, I; Lopez, M; Josselin, E; Boudghene-Stambouli, O; Agolini, E; Bernardini, L; Bellacchio, E; Iannicelli, M; Rossi, A; Dib-Lachachi, A; Stuppia, L; Palka, G; Mundlos, S; Stricker, S; Kornak, U; Zambruno, G; Dallapiccola, B				Brancati, Francesco; Fortugno, Paola; Bottillo, Irene; Lopez, Marc; Josselin, Emmanuelle; Boudghene-Stambouli, Omar; Agolini, Emanuele; Bernardini, Laura; Bellacchio, Emanuele; Iannicelli, Miriam; Rossi, Alfredo; Dib-Lachachi, Amina; Stuppia, Liborio; Palka, Giandomenico; Mundlos, Stefan; Stricker, Sigmar; Kornak, Uwe; Zambruno, Giovanna; Dallapiccola, Bruno			Mutations in PVRL4, Encoding Cell Adhesion Molecule Nectin-4, Cause Ectodermal Dysplasia-Syndactyly Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEFT LIP/PALATE; ADHERENS JUNCTIONS; MACULAR DYSTROPHY; P-CADHERIN; AFADIN; PROTEIN; EXPRESSION; DEATH; LIMB; SKIN	Ectodermal dysplasias form a large disease family with more than 200 members. The combination of hair and tooth abnormalities, alopecia, and cutaneous syndactyly is characteristic of ectodermal dysplasia-syndactyly syndrome (EDSS). We used a homozygosity mapping approach to map the EDSS locus to 1q23 in a consanguineous Algerian family. By candidate gene analysis, we identified a homozygous mutation in the PVRL4 gene that not only evoked an amino acid change but also led to exon skipping. In an Italian family with two siblings affected by EDSS, we further detected a missense and a frameshift mutation. PVRL4 encodes for nectin-4, a cell adhesion molecule mainly implicated in the formation of cadherin-based adherens junctions. We demonstrated high nectin-4 expression in hair follicle structures, as well as in the separating digits of murine embryos, the tissues mainly affected by the EDSS phenotype. In patient keratinocytes, mutated nectin-4 lost its capability to bind nectin-1. Additionally, in discrete structures of the hair follicle, we found alterations of the membrane localization of nectin-afadin and cadherin-catenin complexes, which are essential for adherens junction formation, and we found reorganization of actin cytoskeleton. Together with cleft lip and/or palate ectodermal dysplasia (CLPED1, or Zlotogora-Ogur syndrome) due to an impaired function of nectin-1, EDSS is the second known "nectinopathy" caused by mutations in a nectin adhesion molecule.	[Brancati, Francesco; Stuppia, Liborio; Palka, Giandomenico] Gabriele dAnnunzio Univ, Aging Res Ctr, Dept Biomed Sci, I-66100 Chieti, Italy; [Brancati, Francesco; Bottillo, Irene; Agolini, Emanuele; Bernardini, Laura; Bellacchio, Emanuele; Iannicelli, Miriam] Casa Sollievo Sofferenza Hosp, IRCCS, Mendel Lab, I-71013 San Giovanni Rotondo, Italy; [Fortugno, Paola; Zambruno, Giovanna] IDI IRCCS, Lab Mol & Cell Biol, I-00167 Rome, Italy; [Lopez, Marc; Josselin, Emmanuelle] Univ Aix Marseille 2, Inst J Paoli I Calmettes, INSERM, Ctr Rech Cancerol Marseille,UMR 891, F-13009 Marseille, France; [Boudghene-Stambouli, Omar; Dib-Lachachi, Amina] Aboubakr Belkaid Univ Hosp, Dermatol Unit, Tilimsen 13000, Algeria; [Rossi, Alfredo] Univ Roma La Sapienza, Dept Dermatol, I-00161 Rome, Italy; [Mundlos, Stefan; Stricker, Sigmar; Kornak, Uwe] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Mundlos, Stefan; Stricker, Sigmar; Kornak, Uwe] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Dallapiccola, Bruno] Bambino Gesu Children Hosp, IRCCS, I-00165 Rome, Italy	G d'Annunzio University of Chieti-Pescara; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Universite Abou Bekr Belkaid; Sapienza University Rome; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; IRCCS Bambino Gesu	Brancati, F (corresponding author), Gabriele dAnnunzio Univ, Aging Res Ctr, Dept Biomed Sci, I-66100 Chieti, Italy.	f.brancati@css-mendel.it	Paola, Fortugno/AAB-4197-2021; Brancati, Francesco/AAC-3778-2022; Zambruno, Giavanna/K-2933-2018; Mundlos, Stefan/ABH-9585-2020; Fortugno, Paola/AAG-9787-2020; Bottillo, Irene/K-5361-2012; Bellacchio, Emanuele/AAH-9255-2019; Agolini, Emanuele/AAC-1378-2019; Stricker, Sigmar/B-9169-2009; Bernardini, Laura/H-5360-2016; Bottillo, Irene/AFM-2547-2022; Agolini, Emanuele/A-2106-2015; Rossi, Alfredo/K-1725-2018; Dallapiccola, Bruno/K-8692-2016	Paola, Fortugno/0000-0002-0151-6477; Brancati, Francesco/0000-0003-3624-2354; Fortugno, Paola/0000-0002-8445-4004; Bottillo, Irene/0000-0003-0396-7981; Agolini, Emanuele/0000-0001-6543-6225; Stricker, Sigmar/0000-0002-7174-5363; Bernardini, Laura/0000-0002-3554-2817; Bottillo, Irene/0000-0003-0396-7981; Agolini, Emanuele/0000-0002-8947-7344; Bellacchio, Emanuele/0000-0002-2757-849X; Zambruno, Giovanna/0000-0002-1295-056X; Mundlos, Stefan/0000-0002-9788-3166; Rossi, Alfredo/0000-0002-7442-3423; Dallapiccola, Bruno/0000-0002-5031-1013; Stuppia, Liborio/0000-0002-6232-0996	Italian Ministry of Health, Ricerca Corrente	Italian Ministry of Health, Ricerca Corrente(Ministry of Health, Italy)	We are very grateful to the family members for their generous participation in this study. We thank Sheila Pierce for critically revising the manuscript, Enza Maria Valente for LOD score calculations, Sara Loddo, Naomi De Luca, and Massimo Teson for technical support, and Bjorn Fischer for quantitative PCR in mouse. This study was supported in part by funding from the Italian Ministry of Health, Ricerca Corrente 2009-2010 (F.B., G.Z., and B.D.).	Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BOUDGHENESTAMBOULI O, 1991, ANN DERMATOL VENER, V118, P107; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Freire-Maia N, 2001, AM J MED GENET, V104, P84, DOI 10.1002/ajmg.1586; FREIREMAIA N, 1971, HUM HERED, V21, P309, DOI 10.1159/000152419; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Irie K, 2004, SEMIN CELL DEV BIOL, V15, P643, DOI 10.1016/j.semcdb.2004.09.002; Irvine AD, 2009, AM J MED GENET A, V149A, P1970, DOI 10.1002/ajmg.a.32852; Itin Peter H, 2009, Am J Med Genet A, V149A, P1973, DOI 10.1002/ajmg.a.32739; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kjaer KW, 2005, J MED GENET, V42, P292, DOI 10.1136/jmg.2004.027821; Matsushima H, 2003, BRIT J DERMATOL, V148, P755, DOI 10.1046/j.1365-2133.2003.05225.x; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; Montero JA, 2010, APOPTOSIS, V15, P365, DOI 10.1007/s10495-009-0444-5; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Okabe N, 2004, DEV DYNAM, V230, P174, DOI 10.1002/dvdy.20033; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007; Salinas Carlos F, 2009, Am J Med Genet A, V149A, P1958, DOI 10.1002/ajmg.a.32882; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Sprecher E, 2001, NAT GENET, V29, P134, DOI 10.1038/ng716; Stricker S, 2006, DEV DYNAM, V235, P3456, DOI 10.1002/dvdy.20993; Suzuki D, 2009, DEV BIOL, V335, P396, DOI 10.1016/j.ydbio.2009.09.014; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Visinoni AF, 2009, AM J MED GENET A, V149A, P1980, DOI 10.1002/ajmg.a.32864; ZAKERI Z, 1994, DEV BIOL, V165, P294, DOI 10.1006/dbio.1994.1255; ZLOTOGORA J, 1994, J MED GENET, V31, P957, DOI 10.1136/jmg.31.12.957; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	42	78	84	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					265	273		10.1016/j.ajhg.2010.07.003	http://dx.doi.org/10.1016/j.ajhg.2010.07.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20691405	Bronze, Green Published			2022-12-18	WOS:000281107000011
J	Philippe, O; Rio, M; Carioux, A; Plaza, JM; Guigue, P; Molinari, F; Boddaert, N; Bole-Feysot, C; Nitschke, P; Smahi, A; Munnich, A; Colleaux, L				Philippe, Orianne; Rio, Marlene; Carioux, Astrid; Plaza, Jean-Marc; Guigue, Philippe; Molinari, Florence; Boddaert, Nathalie; Bole-Feysot, Christine; Nitschke, Patrick; Smahi, Asma; Munnich, Arnold; Colleaux, Laurence			Combination of Linkage Mapping and Microarray-Expression Analysis Identifies NF-kappa B Signaling Defect as a Cause of Autosomal-Recessive Mental Retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; ACTIVATION; GENE; NEURONS; DISEASE; MUTATION; PROTEIN; MEMORY; ALPHA	Autosomal-recessive inheritance accounts for nearly 25% of nonsyndromic mental retardation (MR), but the extreme heterogeneity of such conditions markedly hampers gene identification. Combining autozygosity mapping and RNA expression profiling in a consanguineous Tunisian family of three MR children with mild microcephaly and white-matter abnormalities identified the TRAPPG9 gene, which encodes a NF-kappa B-inducing kinase (NIK) and I kappa B kinase complex beta (IKK-beta) binding protein, as a likely candidate. Sequencing analysis revealed a nonsense variant (c.1708C>T [p.RS70X]) within exon 9 of this gene that is responsible for an undetectable level of TRAPPC9 protein in patient skin fibroblasts. Moreover, TNF-alpha stimulation assays showed a defect in IkB alpha degradation, suggesting impaired NF-kappa B signaling in patient cells. This study provides evidence of an NF-kappa B signaling defect in isolated MR.	[Philippe, Orianne; Rio, Marlene; Guigue, Philippe; Molinari, Florence; Boddaert, Nathalie; Smahi, Asma; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, INSERM, U781, Hop Necker Enfants Malad,Dept Genet, F-75015 Paris, France; [Philippe, Orianne; Rio, Marlene; Guigue, Philippe; Molinari, Florence; Boddaert, Nathalie; Smahi, Asma; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Dept Pediat Radiol, Hop Necker Enfants Malad, F-75015 Paris, France; [Carioux, Astrid; Bole-Feysot, Christine] Plateforme Genom Fdn Imagine, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Colleaux, L (corresponding author), Univ Paris 05, INSERM, U781, Hop Necker Enfants Malad,Dept Genet, F-75015 Paris, France.	laurence.colleaux@inserm.fr	COLLEAUX, Laurence/H-6455-2017; Smahi, Asma/J-4184-2017; Molinari, Florence/M-7683-2016; COLLEAUX, LAURENCE/AAA-8144-2022; boddaert, nathalie/GWV-2865-2022	Smahi, Asma/0000-0002-6002-0981; Molinari, Florence/0000-0001-5111-7215; COLLEAUX, LAURENCE/0000-0002-0987-7648; Rio, Marlene/0000-0003-2049-5058; boddaert, nathalie/0000-0003-0991-7774	Centre National dela Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR); Fondation Lejeune; Ministere de la Recherche et de I'Enseigneinent Superieur	Centre National dela Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation Lejeune; Ministere de la Recherche et de I'Enseigneinent Superieur	We are grateful to the patients for their participation in the study. We sincerely acknowledge Elodie Bal, Celine Cluzeau, Mohammed Zarhrate, and Sarah Boissel for technical assistance. This study was supported by the Centre National dela Recherche Scientifique (CNRS), the Agence Nationale de la Recherche (ANR), the Fondation Lejeune, and the Ministere de la Recherche et de I'Enseigneinent Superieur.	Albensi BC, 2000, SYNAPSE, V35, P151; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Romano A, 2006, EUR J NEUROSCI, V24, P1507, DOI 10.1111/j.1460-9568.2006.05022.x; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Uyguner O, 2007, CLIN GENET, V71, P212, DOI 10.1111/j.1399-0004.2007.00762.x; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200	30	78	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					903	908		10.1016/j.ajhg.2009.11.007	http://dx.doi.org/10.1016/j.ajhg.2009.11.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004764	Green Published, Bronze			2022-12-18	WOS:000272797100014
J	Armistead, J; Khatkar, S; Meyer, B; Mark, BL; Patel, N; Coghlan, G; Lamont, RE; Liu, SB; Wiechert, J; Cattini, PA; Koetter, P; Wrogemann, K; Greenberg, CR; Entian, KD; Zelinski, T; Triggs-Raine, B				Armistead, Joy; Khatkar, Sunita; Meyer, Britta; Mark, Brian L.; Patel, Nehal; Coghlan, Gail; Lamont, Ryan E.; Liu, Shuangbo; Wiechert, Jill; Cattini, Peter A.; Koetter, Peter; Wrogemann, Klaus; Greenberg, Cheryl R.; Entian, Karl-Dieter; Zelinski, Teresa; Triggs-Raine, Barbara			Mutation of a Gene Essential for Ribosome Biogenesis, EMG1, Causes Bowen-Conradi Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL-SUBUNIT PROCESSOME; DIAMOND-BLACKFAN ANEMIA; SWISS-MODEL; CELL-CYCLE; YEAST; METHYLTRANSFERASES; SUPERFAMILY; ENVIRONMENT; EUKARYOTES; ALIGNMENT	Bowen-Conradi syndrome (BCS) is an autosomal-recessive disorder characterized by severely impaired prenatal and postnatal growth, profound psychomotor retardation, and death in early childhood. Nearly all reported BCS cases have been among Hutterites, with an estimated birth prevalence of 1/355. We previously localized the BCS gene to a 1.9 Mbp interval on human chromosome 12p13.3. The 59 genes in this interval were ranked as candidates for BCS, and 35 of these, including all of the best candidates, were sequenced. We identified variant NM-006331.6:c.400A -> G, p.D86G in the 18S ribosome assembly protein EMG1 as the probable cause of BCS. This mutation segregated with disease, was not found in 414 non-Hutterite alleles, and altered a highly conserved aspartic acid (D) residue. A structural model of human EMG1 suggested that the D86 residue formed a salt bridge with arginine 84 that would be disrupted by the glycine (G) substitution. EMG1 mRNA was detected in all human adult and fetal tissues tested. In BCS patient fibroblasts, EMG1 mRNA levels did not differ from those of normal cells, but EMG1 protein was dramatically reduced in comparison to that of normal controls. In mammalian cells, overexpression of EMG1 harboring the D86G mutation decreased the level of soluble EMG1 protein, and in yeast two-hybrid analysis, the D86G substitution increased interaction between EMG1 subunits. These findings suggested that the D-to-G mutation caused aggregation of EMG1, thereby reducing the level of the protein and causing BCS.	[Armistead, Joy; Khatkar, Sunita; Patel, Nehal; Lamont, Ryan E.; Liu, Shuangbo; Wiechert, Jill; Wrogemann, Klaus; Greenberg, Cheryl R.; Zelinski, Teresa; Triggs-Raine, Barbara] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3R 0J9, Canada; [Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3R 0J9, Canada; [Coghlan, Gail; Wrogemann, Klaus; Greenberg, Cheryl R.; Zelinski, Teresa; Triggs-Raine, Barbara] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3R 0J9, Canada; [Cattini, Peter A.] Univ Manitoba, Dept Physiol, Winnipeg, MB R3R 0J9, Canada; [Armistead, Joy; Khatkar, Sunita; Patel, Nehal; Coghlan, Gail; Lamont, Ryan E.; Wiechert, Jill; Cattini, Peter A.; Wrogemann, Klaus; Greenberg, Cheryl R.; Zelinski, Teresa; Triggs-Raine, Barbara] Manitoba Inst Child Hlth, Ctr Invest Genet Dis, Winnipeg, MB R3E 3P4, Canada; [Meyer, Britta; Koetter, Peter; Entian, Karl-Dieter] Univ Frankfurt, Excellence Ctr Macromol Complexes, Inst Mol Biosci, D-60439 Frankfurt, Germany	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Goethe University Frankfurt	Triggs-Raine, B (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, 745 Bannatyne Ave, Winnipeg, MB R3R 0J9, Canada.	traine@ms.umanitoba.ca	Entian, Karl-Dieter/D-3080-2011; Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779; Armistead, Joy/0000-0003-2759-0090; Mark, Brian/0000-0002-7344-1355	Manitoba Institute for Child Health to The Centre for the Investigation of Genetic Disease; Canadian Institutes of Health Research [MOP-62786]; Winnipeg Rh Institute Foundation; Manitoba Institute of Child Health; Manitoba Health Research Council; Canadian Institutes of Health Research	Manitoba Institute for Child Health to The Centre for the Investigation of Genetic Disease; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Winnipeg Rh Institute Foundation; Manitoba Institute of Child Health; Manitoba Health Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are especially grateful to the families for their participation in this research study. We also thank Roberta Butturini, Cynthia Curry, Michael Innes, Shubha Phadke, Sergio Pena, and Emma Wakeling, who were involved in identifying and screening non-Hutterite patients for possible BCS. This work was supported by a grant from the Manitoba Institute for Child Health to The Centre for the Investigation of Genetic Disease and grant, MOP-62786 from the Canadian Institutes of Health Research (to C.R.G., B.T.R., K.W., and T.Z.). Financial support from the Winnipeg Rh Institute Foundation (to T.Z.) is greatly appreciated. Research was conducted with the use of facilities of the Manitoba Institute of Child Health in the John Bubler Research Centre. R.L. was supported by a studentship from the Manitoba Institute of Child Health. J.A. was supported by graduate studentships from the Manitoba Health Research Council and the Canadian Institutes of Health Research.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aynaci F. Mujgan, 1994, Genetic Counseling, V5, P369; Beemer F A, 1982, Tijdschr Kindergeneeskd, V50, P54; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Bernstein KA, 2004, MOL BIOL CELL, V15, P5038, DOI 10.1091/mbc.E04-06-0515; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; BOWEN R, 1976, BIRTH DEFECTS ORIG A, V12, P101; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Buchhaupt M, 2006, MOL GENET GENOMICS, V276, P273, DOI 10.1007/s00438-006-0132-x; Campagnoli MF, 2008, HUM MUTAT, V29, P911, DOI 10.1002/humu.20752; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Dixon J, 2007, ORTHOD CRANIOFAC RES, V10, P88, DOI 10.1111/j.1601-6343.2007.00388.x; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Eschrich D, 2002, CURR GENET, V40, P326, DOI 10.1007/s00294-001-0269-4; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta A, 2001, CLIN DYSMORPHOL, V10, P155, DOI 10.1097/00019605-200104000-00016; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hostetler J., 1996, HUTTERITES N AM; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; James P, 1996, GENETICS, V144, P1425; KATO R, 2001, RYOIKIBETSU SHOKOGUN, V33, P825; Kevil CG, 1997, BIOCHEM BIOPH RES CO, V238, P277, DOI 10.1006/bbrc.1997.7284; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Lamont RE, 2005, AM J MED GENET A, V132A, P136, DOI 10.1002/ajmg.a.30420; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Lowry RB, 2003, AM J MED GENET A, V120A, P423, DOI 10.1002/ajmg.a.20059; MANGE AP, 1964, HUM BIOL, V36, P104; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981; Taylor AB, 2008, NUCLEIC ACIDS RES, V36, P1542, DOI 10.1093/nar/gkm1172; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Towbin H, 1992, Biotechnology, V24, P145; WU DY, 1991, DNA CELL BIOL, V10, P233, DOI 10.1089/dna.1991.10.233	40	78	80	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					728	739		10.1016/j.ajhg.2009.04.017	http://dx.doi.org/10.1016/j.ajhg.2009.04.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19463982	Bronze, Green Published			2022-12-18	WOS:000267042800004
J	Friedman, JS; Ray, JW; Waseem, N; Johnson, K; Brooks, MJ; Hugosson, T; Breuer, D; Branham, KE; Krauth, DS; Bowne, SJ; Sullivan, LS; Ponjavic, V; Granse, L; Khanna, R; Trager, EH; Gieser, LM; Hughbanks-Wheaton, D; Cojocaru, RI; Ghiasvand, NM; Chakarova, CF; Abrahamson, M; Goring, HHH; Webster, AR; Birch, DG; Abecasis, GR; Fann, Y; Bhattacharya, SS; Daiger, SP; Heckenlively, JR; Andreasson, S; Swaroop, A				Friedman, James S.; Ray, Joseph W.; Waseem, Naushin; Johnson, Kory; Brooks, Matthew J.; Hugosson, Therese; Breuer, Debra; Branham, Kari E.; Krauth, Daniel S.; Bowne, Sara J.; Sullivan, Lori S.; Ponjavic, Vesna; Granse, Lotta; Khanna, Ritu; Trager, Edward H.; Gieser, Linn M.; Hughbanks-Wheaton, Dianna; Cojocaru, Radu I.; Ghiasvand, Noor M.; Chakarova, Christina F.; Abrahamson, Magnus; Goering, Harald H. H.; Webster, Andrew R.; Birch, David G.; Abecasis, Goncalo R.; Fann, Yang; Bhattacharya, Shomi S.; Daiger, Stephen P.; Heckenlively, John R.; Andreasson, Sten; Swaroop, Anand			Mutations in a BTB-Kelch Protein, KLHL7, Cause Autosomal-Dominant Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SWISS-MODEL; RHODOPSIN GENE; HOMOLOGY; UBIQUITIN; FAMILIES; LOCALIZATION; DEGRADATION; ENVIRONMENT; DYSTROPHY; LINKAGE	Retinitis pigmentosa (RP) refers to a genetically heterogeneous group of progressive neurodegenerative diseases that result in dysfunction and/or death of rod and cone photoreceptors in the retina. So far, 18 genes have been identified for autosomal-dominant (ad) RP. Here, we describe an adRP locus (RP42) at chromosome 7p15 through linkage analysis in a six-generation Scandinavian family and identify a disease-causing mutation, c.449G -> A (p.S150N), in exon 6 of the KLHL7 gene. Mutation screening of KLHL7 in 502 retinopathy probands has revealed three different missense mutations in six independent families. KLHL7 is widely expressed, including expression in rod photoreceptors, and encodes a 75 kDa protein of the BTB-Kelch Subfamily within the BTB superfamily. BTB-Kelch proteins have been implicated in ubiquitination through Cullin E3 ligases. Notably, all three putative disease-causing KLHL7 mutations are within a conserved BACK domain; homology modeling suggests that mutant amino acid side chains can potentially fill the cleft between two helices, thereby affecting the ubiquitination complexes. Mutations in an identical region of another BTB-Kelch protein, gigaxonin, have previously been associated with giant axonal neuropathy. Our studies suggest an additional role of the ubiquitin-proteasome protein-degradation pathway in maintaining neuronal health and in disease.	[Friedman, James S.; Brooks, Matthew J.; Krauth, Daniel S.; Gieser, Linn M.; Cojocaru, Radu I.; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Ray, Joseph W.; Bowne, Sara J.; Sullivan, Lori S.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; [Waseem, Naushin; Chakarova, Christina F.; Webster, Andrew R.; Bhattacharya, Shomi S.] Inst Ophthalmol, Dept Mol Genet, London EC1 9EL, England; [Johnson, Kory; Fann, Yang] Natl Inst Neurol Disorders & Stroke, Bioinformat Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Hugosson, Therese; Ponjavic, Vesna; Granse, Lotta; Andreasson, Sten] Univ Lund Hosp, Dept Ophthalmol, S-22185 Lund, Sweden; [Breuer, Debra; Branham, Kari E.; Khanna, Ritu; Trager, Edward H.; Ghiasvand, Noor M.; Heckenlively, John R.; Swaroop, Anand] Univ Michigan, Dept Ophthalmol, Ann Arbor, MI 48105 USA; [Hughbanks-Wheaton, Dianna; Birch, David G.] Retina Fdn SW, Dallas, TX 75231 USA; [Abrahamson, Magnus] Lund Univ, Dept Lab Med, S-22185 Lund, Sweden; [Goering, Harald H. H.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48105 USA; [Swaroop, Anand] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Texas System; University of Texas Health Science Center Houston; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Lund University; Skane University Hospital; University of Michigan System; University of Michigan; Retina Foundation of the Southwest; Lund University; Texas Biomedical Research Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Swaroop, A (corresponding author), NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA.	swaroopa@mail.nih.gov	Abecasis, Goncalo R/B-7840-2010; Abrahamson, Magnus/CAG-9507-2022; Waseem, Naushin/C-9573-2013; Bhattacharya, Shom/N-2926-2016; Branham, Kari/AAA-8336-2022; Chakarova, Christina/C-9479-2013	Bhattacharya, Shom/0000-0002-1601-6344; Birch, David/0000-0002-6594-2897; Branham, Kari/0000-0002-2492-254X; Abecasis, Goncalo/0000-0003-1509-1825; Swaroop, Anand/0000-0002-1975-1141	NEI; NIH; Foundation Fighting Blindness; Harold F. Falls and Paul R. Lichter Professorships; Research to Prevent Blindness; Elmer and Sylvia Sramek Foundation; European Union (GENORET); British Retinitis Pigmentosa Society (UK); NIHR Biomedical Research Centre for Ophthalmology (UK); Swedish Medical Research Council; NATIONAL EYE INSTITUTE [ZIAEY000473, R01EY007142] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Harold F. Falls and Paul R. Lichter Professorships; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Elmer and Sylvia Sramek Foundation; European Union (GENORET)(European Commission); British Retinitis Pigmentosa Society (UK); NIHR Biomedical Research Centre for Ophthalmology (UK); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We sincerely acknowledge Abby Woodroffe for discussions; Rivka Rachel and Tiziana Cogliati for comments on the manuscript; and Mohammad Othman, Jessica Chang, Bob Fariss, Manessa Shaw, Ashley Garibaldi, Hema Karamchandani, and George Thomas for technical assistance. We thank Lucia Lawrence and Sharyn Ferrara for administrative support. This work was supported by NEI intramural funds and grants from the NIH, The Foundation Fighting Blindness, Harold F. Falls and Paul R. Lichter Professorships, Research to Prevent Blindness, the Elmer and Sylvia Sramek Foundation, the European Union (GENORET), The British Retinitis Pigmentosa Society (UK), The NIHR Biomedical Research Centre for Ophthalmology (UK), and the Swedish Medical Research Council.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; ANDREASSON S, 1991, ACTA OPHTHALMOL, V69, P162; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bredholt G, 2006, SCAND J IMMUNOL, V64, P325, DOI 10.1111/j.1365-3083.2006.01821.x; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FARRAR GJ, 1991, GENOMICS, V11, P1170; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; INGLEHEARN CF, 1994, AM J HUM GENET, V54, P675; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; KREMER H, 1994, HUM MOL GENET, V3, P299, DOI 10.1093/hmg/3.2.299; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Uchida K, 2005, IMMUNOLOGY, V116, P53, DOI 10.1111/j.1365-2567.2005.02197.x; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Yang Y, 2007, CELL MOL LIFE SCI, V64, P601, DOI 10.1007/s00018-007-6396-4	45	78	79	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					792	800		10.1016/j.ajhg.2009.05.007	http://dx.doi.org/10.1016/j.ajhg.2009.05.007			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19520207	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000267042800009
J	Salo, AM; Cox, H; Farndon, P; Moss, C; Grindulis, H; Risteli, M; Robins, SP; Myllyla, R				Salo, Antti M.; Cox, Helen; Farndon, Peter; Moss, Celia; Grindulis, Helen; Risteli, Maija; Robins, Simon P.; Myllyla, Raili			A Connective Tissue Disorder Caused by Mutations of the Lysyl Hydroxylase 3 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN CROSS-LINKING; LYSYL-HYDROXYLASE-3; EXPRESSION; IDENTIFICATION; GLYCOSYLATION; LOCALIZATION; PROGRESSION; TELOPEPTIDE	Lysyl hydroxylase 3 (LH3, encoded by PLOD3) is a multifunctional enzyme capable of catalyzing hydroxylation of lysyl residues and O-glycosylation of hydroxylysyl residues producing either monosaccharide (Gal) or disaccharide (Glc-Gal) derivatives, reactions that form part of the many posttranslational modifications required during collagen biosynthesis. Animal studies have confirmed the importance of LH3, particularly in biosynthesis of the highly glycosylated type IV and VI collagens, but to date, the functional significance in vivo of this enzyme in man is predominantly unknown. We report here a human disorder of LH3 presenting as a compound heterozygote with recessive inheritance. One mutation dramatically reduced the sugar-transfer activity of LH3, whereas another abrogated lysyl hydroxylase activity; these changes were accompanied by reduced LH3 protein levels in cells. The disorder has a unique phenotype causing severe morbidity as a result of features that overlap with a number of known collagen disorders.	[Salo, Antti M.; Risteli, Maija; Myllyla, Raili] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Cox, Helen; Farndon, Peter] Birmingham Womes Hosp, W Midlands Reg Genet Unit, Birmingham B15 2TG, W Midlands, England; [Moss, Celia] Prince Wales Childrens Hosp, Birmingham B4 6NH, W Midlands, England; [Grindulis, Helen] Sandwell & Dist Gen Hosp, Lyndon B71 4HJ, W Bromwich, England; [Robins, Simon P.] Rowett Res Inst, Mat Biochem Grp, Aberdeen AB21 9SB, Scotland	Finland National Institute for Health & Welfare; University of Oulu; Birmingham Women's Hospital; University of Aberdeen	Myllyla, R (corresponding author), Univ Oulu, Dept Biochem, POB 3000, FI-90014 Oulu, Finland.	raili.myllyla@oulu.fi			Academy of Finland [109784]; Biocenter Oulu; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Biocenter Oulu; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	We thank the family participating in this study, clinicians for sample collection, Piia Makela for technical help, and Robert Winqvist for providing control lymphoblastoid cells. The work was supported by research grants to R.M., research grants by the Academy of Finland (grant 109784), by Biocenter Oulu, and by Sigrid Juselius Foundation, a graduate school position to A.S. by Biocenter Oulu, and a graduate school position to M.R. by Glycoscience Graduate School. Orion-Farmos Research Foundation is acknowledged for a grant to A.S. S.R. is indebted to the Scottish Government Rural and Environment Research and Analysis Directorate for support. R.M. designed this study, supervised A.S., and obtained the funding; S.R. made initial observations of urinary abnormalities; A.S. designed and performed all other laboratory work with the help of the technician funded by R.M.; M.R. designed the oligos for DNA sequencing, H.C., RE, C.M., and H.G. performed phenotype assessment, H.C., RE, and C.M. provided clinical photographs, and H.C., A.S., S.R., and R.M. contributed to the writing of this paper.	Ausubel F.M., 1989, SHORT PROTOCOLS MOL; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Casetta B, 2000, RAPID COMMUN MASS SP, V14, P2238, DOI 10.1002/1097-0231(20001215)14:23<2238::AID-RCM157>3.0.CO;2-A; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P21, DOI 10.1002/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; KIELTY CM, 2002, CONNECTIVE TISSUE IT, P103; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; PRATT DA, 1992, ANAL BIOCHEM, V207, P168, DOI 10.1016/0003-2697(92)90519-D; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; ROBINS SP, 1990, OSTEOPOROSIS 1990, P465; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 1999, MATRIX BIOL, V18, P325, DOI 10.1016/S0945-053X(99)00016-5; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Snead MP, 1999, J MED GENET, V36, P353; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Uitto J, 2005, CLIN DERMATOL, V23, P33, DOI 10.1016/j.clindermatol.2004.09.015; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Wang D, 2008, HEALTH TECHNOL ASSES, V12, P1; Young-Min S, 2007, ARTHRITIS RHEUM-US, V56, P3236, DOI 10.1002/art.22923; Zuurmond AM, 2005, MATRIX BIOL, V24, P261, DOI 10.1016/j.matbio.2005.04.002	29	78	81	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					495	503		10.1016/j.ajhg.2008.09.004	http://dx.doi.org/10.1016/j.ajhg.2008.09.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18834968	Green Published, Bronze			2022-12-18	WOS:000260239200007
J	Wimplinger, I; Morleo, M; Rosenberger, G; Iaconis, D; Orth, U; Meinecke, P; Lerer, I; Ballabio, A; Gal, A; Franco, B; Kutsche, K				Wimplinger, Isabella; Morleo, Manuela; Rosenberger, Georg; Iaconis, Daniela; Orth, Ulrike; Meinecke, Peter; Lerer, Israela; Ballabio, Andrea; Gal, Andreas; Franco, Brunella; Kutsche, Kerstin			Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRAMMED CELL-DEATH; MIDAS SYNDROME MICROPHTHALMIA; GTPASE-ACTIVATING PROTEIN; MALE-LETHAL DISORDERS; CYTOCHROME-C; MLS SYNDROME; SACCHAROMYCES-CEREVISIAE; HEME LYASE; MOLECULAR CHARACTERIZATION; INDUCED APOPTOSIS	The microphthalmia with linear skin defects syndrome (MLS, or MIDAS) is an X-linked dominant male-lethal disorder almost invariably associated with segmental monosomy of the Xp22 region. In two female patients, from two families, with MLS and a normal karyotype, we identified heterozygous de novo point mutations-a missense mutation (p.R217C) and a nonsense mutation (p.R197X)-in the HCCS gene. HCCS encodes the mitochondrial holocytochrome c-type synthase that functions as heme lyase by covalently adding the prosthetic heme group to both apocytochrome c and c(1). We investigated a third family, displaying phenotypic variability, in which the mother and two of her daughters carry an 8.6-kb submicroscopic deletion encompassing part of the HCCS gene. Functional analysis demonstrates that both mutant proteins (R217C and Delta 197-268) were unable to complement a Saccharomyces cerevisiae mutant deficient for the HCCS orthologue Cyc3p, in contrast to wild-type HCCS. Moreover, ectopically expressed HCCS wild-type and the R217C mutant protein are targeted to mitochondria in CHO-K1 cells, whereas the C-terminal-truncated Delta 197-268 mutant failed to be sorted to mitochondria. Cytochrome c, the final product of holocytochrome c-type synthase activity, is implicated in both oxidative phosphorylation (OXPHOS) and apoptosis. We hypothesize that the inability of HCCS-deficient cells to undergo cytochrome c-mediated apoptosis may push cell death toward necrosis that gives rise to severe deterioration of the affected tissues. In summary, we suggest that disturbance of both OXPHOS and the balance between apoptosis and necrosis, as well as the X-inactivation pattern, may contribute to the variable phenotype observed in patients with MLS.	Univ Klinikum Hamburg Eppendorf, Inst Human Genet, D-22529 Hamburg, Germany; Altonaer Kinderkrankenhaus, Abt Med Genet, Hamburg, Germany; Univ Naples Federico II, Telethon Inst Genet & Med, Naples, Italy; Univ Naples Federico II, Dept Pediat, Naples, Italy; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II; Hebrew University of Jerusalem; Hadassah University Medical Center	Kutsche, K (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Human Genet, Butenfeld 42, D-22529 Hamburg, Germany.	kkutsche@uke.uni-hamburg.de	Iaconis, Daniela/GZA-7677-2022; Morleo, Manuela/AAK-5833-2020; Iaconis, Daniela/AAD-9571-2019; BALLABIO, Andrea/AAL-2672-2020; FRANCO, Brunella/S-2882-2018	Iaconis, Daniela/0000-0002-1052-6634; Iaconis, Daniela/0000-0002-1052-6634; BALLABIO, Andrea/0000-0003-1381-4604; Morleo, Manuela/0000-0002-7553-3245; FRANCO, Brunella/0000-0001-5588-4569	Fondazione Telethon Funding Source: Custom; Telethon [TGM06S01] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		ALLANSON J, 1991, J MED GENET, V28, P143, DOI 10.1136/jmg.28.2.143-a; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; BIRD LM, 1994, AM J MED GENET, V53, P141, DOI 10.1002/ajmg.1320530205; Boya Patricia, 2005, Birth Defects Research, V75, P281, DOI 10.1002/bdrc.20054; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; Cape CJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1070, DOI 10.1001/archopht.122.7.1070; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Diekert K, 1999, P NATL ACAD SCI USA, V96, P11752, DOI 10.1073/pnas.96.21.11752; DUMONT ME, 1991, MOL CELL BIOL, V11, P5487, DOI 10.1128/MCB.11.11.5487; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; DUMONT ME, 1993, MOL CELL BIOL, V13, P6442, DOI 10.1128/MCB.13.10.6442; Franco B, 2006, CURR OPIN GENET DEV, V16, P254, DOI 10.1016/j.gde.2006.04.012; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; HAPPLE R, 1993, AM J MED GENET, V47, P710, DOI 10.1002/ajmg.1320470525; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kherbaoui-Redouani L, 2003, ARCH PEDIATRIE, V10, P224, DOI 10.1016/S0929-693X(03)00014-9; Kobayashi M, 1998, J PEDIAT OPHTH STRAB, V35, P122; Kono T, 1999, J HUM GENET, V44, P63, DOI 10.1007/s100380050110; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kutsche K, 2002, CYTOGENET GENOME RES, V99, P297, DOI 10.1159/000071607; Laemle LK, 1999, DEV BRAIN RES, V112, P129, DOI 10.1016/S0165-3806(98)00153-9; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; MAJNO G, 1995, AM J PATHOL, V146, P3; Martin AG, 2002, J BIOL CHEM, V277, P50834, DOI 10.1074/jbc.M209369200; Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002; Morleo M, 2005, AM J MED GENET A, V137A, P190, DOI 10.1002/ajmg.a.30864; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; Nicotera P, 2002, TOXICOL LETT, V127, P189, DOI 10.1016/S0378-4274(01)00500-8; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Prakash SK, 2002, HUM MOL GENET, V11, P3237, DOI 10.1093/hmg/11.25.3237; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Schaefer L, 1996, GENOMICS, V34, P166, DOI 10.1006/geno.1996.0261; Schaefer L, 1997, GENOMICS, V46, P268, DOI 10.1006/geno.1997.5040; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Schwarz QP, 2002, GENOMICS, V79, P51, DOI 10.1006/geno.2001.6677; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Tong JC, 1998, J BIOL CHEM, V273, P25695, DOI 10.1074/jbc.273.40.25695; Van den Veyver IB, 2002, CYTOGENET GENOME RES, V99, P289, DOI 10.1159/000071606; Van den Veyver IB, 2001, SEMIN REPROD MED, V19, P183, DOI 10.1055/s-2001-15398; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155; Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259; Zvulunov A, 1998, BRIT J DERMATOL, V138, P1046	54	78	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					878	889		10.1086/508474	http://dx.doi.org/10.1086/508474			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033964	Bronze, Green Published			2022-12-18	WOS:000241667400009
J	Lacombe, A; Lee, H; Zahed, L; Choucair, M; Muller, JM; Nelson, SF; Salameh, W; Vilain, E				Lacombe, Arnaud; Lee, Hane; Zahed, Laila; Choucair, Mahmoud; Muller, Jean-Marc; Nelson, Stanley F.; Salameh, Wael; Vilain, Eric			Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-DEATH; CYTOKINESIS; GENES; BREAKPOINTS; APOPTOSIS; XQ21; AGE; MAP; DNA	Premature ovarian failure ( POF) is characterized by elevated gonadotropins and amenorrhea in women aged < 40 years. In a Lebanese family with five sisters who received the diagnosis of POF, we established linkage to the long arm of the X chromosome ( between Xq21.1 and Xq21.3.3), using whole-genome SNP typing and homozygosity-by-descent-mapping. By sequencing one candidate gene within that region, POF1B, we identified a point mutation localized in exon 10. This substitution of a nucleotide ( G -> A), at position 1123, results in an arginine -> glutamine mutation of the protein sequence at position 329 ( mutation R329Q). All the affected family members were homozygous for the mutation, whereas the unaffected members were heterozygous. Because POF1B shares high homology with the tail portion of the human myosin, we assessed the ability of both wild-type and mutant POF1B proteins to bind nonmuscle actin filaments in vitro. We found that the capacity of the mutant protein to bind nonmuscle actin filaments was diminished fourfold compared with the wild type, suggesting a function of POF1B in germ-cell division. Our study suggests that a homozygous point mutation in POF1B influences the pathogenesis of POF by altering POF1B binding to nonmuscle actin filaments.	Univ Calif Los Angeles, David Geffen Sch Med, Gonda Ctr, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Endocrinol, Beirut, Lebanon; Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon; CNRS, Inst Physiol & Biol Cellulaire, UMR 6187, Pole Biol Sante, Poitiers, France; Harbor UCLA Med Ctr, Dept Med, Div Endocrinol, Torrance, CA 90509 USA; Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; American University of Beirut; American University of Beirut; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Vilain, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Gonda Ctr, Dept Human Genet, Room 5506,695 Charles Young Dr S, Los Angeles, CA 90095 USA.	evilain@ucla.edu	Salameh, Wael/I-4484-2019; Nelson, Stanley F/D-4771-2009	Salameh, Wael/0000-0001-5553-5895; Nelson, Stanley F/0000-0002-2082-3114				BAKER TG, 1972, ACTA ENDOCRINOL-COP, V71, P18; Bione S, 2004, HUM REPROD, V19, P2759, DOI 10.1093/humrep/deh502; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Bione S, 2000, SEMIN REPROD MED, V18, P51, DOI 10.1055/s-2000-13475; Christin-Maitre S, 1998, MOL CELL ENDOCRINOL, V145, P75, DOI 10.1016/S0303-7207(98)00172-5; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; De Felici M, 2005, REPROD BIOMED ONLINE, V10, P182, DOI 10.1016/S1472-6483(10)60939-X; DEMORAESRUEHSEN M, 1967, FERTIL STERIL, V18, P440; Gersak K, 2003, HUM REPROD, V18, P1637, DOI 10.1093/humrep/deg327; Glotzer M, 1997, CURR BIOL, V7, pR274, DOI 10.1016/S0960-9822(06)00135-7; Glotzer M, 1997, CURR OPIN CELL BIOL, V9, P815, DOI 10.1016/S0955-0674(97)80082-8; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MABUCHI I, 1986, INT REV CYTOL, V101, P175, DOI 10.1016/S0074-7696(08)60249-1; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; MCKINLAY S, 1972, J BIOSOC SCI, V4, P161, DOI 10.1017/S0021932000008464; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Prueitt RL, 2000, CYTOGENET CELL GENET, V89, P44, DOI 10.1159/000015560; Prueitt RL, 2002, CYTOGENET GENOME RES, V97, P32, DOI 10.1159/000064052; Riva P, 1996, CLIN GENET, V50, P267; Robinson DN, 2000, J CELL BIOL, V150, P823, DOI 10.1083/jcb.150.4.823; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Sala C, 1997, GENOMICS, V40, P123, DOI 10.1006/geno.1996.4542; Santoro N, 2001, J SOC GYNECOL INVEST, V8, pS10, DOI 10.1016/S1071-5576(00)00097-6; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; THERMAN E, 1990, HUM GENET, V85, P455; Vegetti W, 2000, MOL CELL ENDOCRINOL, V161, P53, DOI 10.1016/S0303-7207(99)00224-5; Vegetti W, 1998, HUM REPROD, V13, P1796, DOI 10.1093/humrep/13.7.1796; Wheatcroft N, 1997, AUTOIMMUNITY, V25, P157, DOI 10.3109/08916939709008022; WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707	34	78	87	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					113	119		10.1086/505406	http://dx.doi.org/10.1086/505406			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773570	Green Published, Bronze			2022-12-18	WOS:000238341200011
J	O'Brien, EK; Zhang, XY; Nishimura, C; Tomblin, JB; Murray, JC				O'Brien, EK; Zhang, XY; Nishimura, C; Tomblin, JB; Murray, JC			Association of specific language impairment (SLI) to the region of 7q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR SUSCEPTIBILITY LOCUS; TRANSLOCATION BREAKPOINT; AUTISTIC DISORDER; FAMILY-HISTORY; SEVERE SPEECH; GENE; LINKAGE; FOXP2; IDENTIFICATION; CHILDREN	FOXP2 (forkhead box P2) was the first gene characterized in which a mutation affects human speech and language abilities. A common developmental language disorder, specific language impairment (SLI), affects 6%-7% of children with normal nonverbal intelligence and has evidence of a genetic basis in familial and twin studies. FOXP2 is located on chromosome 7q31, and studies of other disorders with speech and language impairment, including autism, have found linkage to this region. In the present study, samples from children with SLI and their family members were used to study linkage and association of SLI to markers within and around FOXP2, and samples from 96 probands with SLI were directly sequenced for the mutation in exon 14 of FOXP2. No mutations were found in exon 14 of FOXP2, but strong association was found to a marker within the CFTR gene and another marker on 7q31, D7S3052, both adjacent to FOXP2, suggesting that genetic factors for regulation of common language impairment reside in the vicinity of FOXP2.	Univ Iowa, Dept Otolaryngol, Iowa City, IA USA; Univ Iowa, Dept Speech Pathol & Audiol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Murray, JC (corresponding author), Med Labs 2182, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu		O'Brien, Erin/0000-0002-4891-9548	NCRR NIH HHS [P41 RR003655, 1 P41 RR03655] Funding Source: Medline; NIDCD NIH HHS [P0-DC-02748, T32 DC00040, T32 DC000040] Funding Source: Medline; NIDCR NIH HHS [R37 DE008559, R01 DE008559, DE08559] Funding Source: Medline; NIEHS NIH HHS [ES-10876, R01 ES010876] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000040] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Bailey A, 1998, HUM MOL GENET, V7, P571; Barrett S, 1999, AM J MED GENET, V88, P609; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; BoghosianSell L, 1996, AM J HUM GENET, V59, P999; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Bruce HA, 2002, HUM GENET, V111, P136, DOI 10.1007/s00439-002-0768-5; Dale PS, 1998, NAT NEUROSCI, V1, P324, DOI 10.1038/1142; Dunn L. M., 2007, PEABODY PICTURE VOCA, DOI DOI 10.1037/T15144-000; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; GASPARINI P, 1991, HUM GENET, V86, P625; Hannula K, 2001, GENOMICS, V73, P1, DOI 10.1006/geno.2001.6502; Hunt K., 1970, SYNTACTIC MATURITY S; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; LAHEY M, 1995, J SPEECH HEAR RES, V38, P643, DOI 10.1044/jshr.3803.643; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Law J, 2000, INT J LANG COMM DIS, V35, P165, DOI 10.1080/136828200247133; LEWIS BA, 1992, J SPEECH HEAR RES, V35, P1086, DOI 10.1044/jshr.3505.1086; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Meaburn E, 2002, NEUROREPORT, V13, P1075, DOI 10.1097/00001756-200206120-00020; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nakabayashi K, 2002, HUM MOL GENET, V11, P1743, DOI 10.1093/hmg/11.15.1743; NEILS J, 1986, PERCEPT MOTOR SKILL, V63, P655, DOI 10.2466/pms.1986.63.2.655; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Newbury DF, 2002, AM J HUM GENET, V70, P384; NEWCOMER P, 1988, TEST LANGUAGE DEV, V2; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHICK JH, 2002, JOINT C 9 INT C STUD; Semel EM., 1995, CELF3 CLIN EVALUATIO; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Tentler D, 2001, AM J MED GENET, V105, P729, DOI 10.1002/ajmg.1607; THOMSON G, 1995, AM J HUM GENET, V57, P474; THOMSON G, 1995, AM J HUM GENET, V57, P487; TOMBLIN JB, 1989, J SPEECH HEAR DISORD, V54, P287, DOI 10.1044/jshd.5402.287; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tomblin JB, 1996, J SPEECH HEAR RES, V39, P1284, DOI 10.1044/jshr.3906.1284; VanderLely HKJ, 1996, BRAIN LANG, V52, P484, DOI 10.1006/brln.1996.0026; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; Wallace G., 1994, COMPREHENSIVE RECEPT; Warburton P, 2000, AM J MED GENET, V96, P228, DOI 10.1002/(SICI)1096-8628(20000403)96:2<228::AID-AJMG20>3.0.CO;2-G; Wassink TH, 2002, AM J MED GENET, V114, P566, DOI 10.1002/ajmg.10415; Wassink TH, 2001, AM J MED GENET, V105, P406, DOI 10.1002/ajmg.1401; Wechsler D., 1997, WECHSLER INTELLIGENC	56	78	84	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1536	1543		10.1086/375403	http://dx.doi.org/10.1086/375403			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	685QV	12721956	Green Published, Bronze			2022-12-18	WOS:000183275500016
J	Zabetian, CP; Buxbaum, SG; Elston, RC; Kohnke, MD; Anderson, GM; Gelernter, J; Cubells, JF				Zabetian, CP; Buxbaum, SG; Elston, RC; Kohnke, MD; Anderson, GM; Gelernter, J; Cubells, JF			The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEGATIVE REGULATORY ELEMENTS; COMMON DISEASE GENES; HUMAN GENOME; GAMETIC DISEQUILIBRIUM; SILENCER REGION; POLYMORPHISM; COMPLEX; EXPRESSION; BLOCKS; REPEAT	There is currently a great deal of interest in using linkage disequilibrium (LD) mapping to locate both disease and quantitative-trait loci on a genomewide scale. Recent findings suggest that much of the human genome is organized in discrete "blocks" of low haplotype diversity, but the utility of such blocks in identifying genes influencing complex traits is not yet known and must ultimately be tested empirically through use of real data. We recently identified a putative functional polymorphism (-1021 C-->T) in the 5' upstream region of the DBH gene that accounted for 35%-52% of the total phenotypic variance in plasma dopamine beta-hydroxylase (DBH) activity in samples from three distinct populations. In the present study, we genotyped 11 diallelic markers at the DBH locus surrounding -1021C-->T in 386 unrelated individuals of European origin. We identified a single 10-kb block containing -1021C-->T, in which four haplotypes comprised 93% of the observed chromosomes. Only markers within the block were highly associated with phenotype (P less than or equal to 2.2 x 10(-10)), with one exception. In general, association with phenotype was strongly correlated with the degree of LD between each marker and -1021C-->T. Of four LD measures assessed, d(2) was the best predictor of this relationship. Had one attempted to map quantitative-trait loci for plasma DBH activity on a genomewide basis without prior knowledge of candidate regions and not included (by chance) markers within this haplotype block, the DBH locus might have been missed entirely. These results provide a direct example of the potential value of constructing a haplotype map of the human genome prior to embarking on large-scale association studies.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; VA Connecticut Healthcare Syst, Dept Psychiat, West Haven, CT USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Univ Tubingen Hosp, Univ Hosp Psychiat & Psychotherapy, Tubingen, Germany	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Case Western Reserve University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Cubells, JF (corresponding author), Univ Washington, Sch Med, Dept Neurol, West Haven, CT 06516 USA.	joseph.cubells@yale.edu	Buxbaum, Sarah G./E-1970-2013; Cubells, Joe F./V-2543-2018	Buxbaum, Sarah G./0000-0002-4886-3564; Zabetian, Cyrus/0000-0002-7739-4306; Gelernter, Joel/0000-0002-4067-1859	NCRR NIH HHS [RR 03655, P41 RR003655] Funding Source: Medline; NHLBI NIH HHS [T32-HL07567, T32 HL007567] Funding Source: Medline; NIAAA NIH HHS [R01 AA011330, R01-AA11330] Funding Source: Medline; NIDA NIH HHS [R01 DA012422, K12 DA000167, 5T32-DA-07238, K-12-DA-00167, T32 DA007238, R01-DA12422] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, GM 28356, R37 GM028356] Funding Source: Medline; NIMH NIH HHS [MH 30929, T32-MH2005, K02-MH01387] Funding Source: Medline; NINDS NIH HHS [K08 NS044138, K08-NS44138, K08 NS044138-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001387, P30MH030929, P50MH030929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS044138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K12DA000167, T32DA007238, R01DA012422] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P; Cubells JF, 1998, HUM GENET, V102, P533, DOI 10.1007/s004390050736; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EDWARDS AWF, 1963, J R STAT SOC SER A-G, V126, P109, DOI 10.2307/2982448; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GOLDIN LR, 1982, AM J HUM GENET, V34, P250; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HILL WG, 1994, AM J HUM GENET, V54, P705; HOYLE GW, 1994, J NEUROSCI, V14, P2455; ISHIGURO H, 1993, J BIOL CHEM, V268, P17987; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; JORDE LB, 1994, AM J HUM GENET, V54, P884; Kim HS, 1998, J NEUROCHEM, V71, P41; Kohnke MD, 2002, BIOL PSYCHIAT, V52, P1151; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1964, GENETICS, V49, P49; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Nahmias Joseph, 1992, Human Molecular Genetics, V1, P286, DOI 10.1093/hmg/1.4.286; NEI M, 1980, GENET RES, V35, P65, DOI 10.1017/S001667230001394X; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Schneider S., 2000, ARLEQUIN VERSION 200; Schork NJ, 2000, AM J HUM GENET, V67, P1208, DOI 10.1086/321201; Schork NJ, 2002, AM J HUM GENET, V70, P1480, DOI 10.1086/340788; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tiret L, 2002, HUM MOL GENET, V11, P419, DOI 10.1093/hmg/11.4.419; Wei J, 1997, HUM GENET, V99, P52; WEINSHILBOUM R, 1971, CIRC RES, V28, P307, DOI 10.1161/01.RES.28.3.307; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; WILSON AF, 1988, AM J HUM GENET, V42, P160; Zabetian CP, 2001, AM J HUM GENET, V68, P515, DOI 10.1086/318198; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	41	78	85	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1389	1400		10.1086/375499	http://dx.doi.org/10.1086/375499			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12730829	Bronze, Green Published			2022-12-18	WOS:000183275500003
J	Johnson, D; Kan, SH; Oldridge, M; Trembath, RC; Roche, P; Esnouf, RM; Giele, H; Wilkie, AOM				Johnson, D; Kan, SH; Oldridge, M; Trembath, RC; Roche, P; Esnouf, RM; Giele, H; Wilkie, AOM			Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-BINDING; PROTEINS; GENES; MALFORMATION; EXPANSION; PROGRAM; LINKAGE; HOXA13; FAMILY; GROWTH	HOXD13, the most 5' gene of the HOXD cluster, encodes a homeodomain transcription factor with important functions in limb patterning and growth. Heterozygous mutations of human HOXD13, encoding polyalanine expansions or frameshifts, are believed to act by dominant negative or haploinsufficiency mechanisms and are predominantly associated with synpolydactyly phenotypes. Here, we describe two mutations of HOXD13 (923C-->G encoding Ser308Cys and 940A-->C encoding Ile314Leu) that cause missense substitutions within the homeodomain. Both are associated with distinctive limb phenotypes in which brachydactyly of specific metacarpals, metatarsals, and phalangeal bones is the most constant feature, exhibiting overlap with brachydactyly types D and E. We investigated the binding of synthetic mutant proteins to double-stranded DNA targets in vitro. No consistent differences were found for the Ser308Cys mutation compared with the wild type, but the Ile314Leu mutation ( which resides at the 47th position of the homeodomain) exhibited increased affinity for a target containing the core recognition sequence 5'-TTAC-3' but decreased affinity for a 5'-TTAT-3' target. Molecular modeling of the Ile314Leu mutation indicates that this mixed gain and loss of affinity may be accounted for by the relative positions of methyl groups in the amino acid side chain and target base.	John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Radcliffe Infirm, Dept Plast & Reconstruct Surg, Oxford OX2 6HE, England; Div Struct Biol, Oxford, England; Dept Genet & Med, Div Med Genet, Leicester, Leics, England	University of Oxford; Radcliffe Infirmary; University of Oxford	Wilkie, AOM (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	awilkie@molbiol.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020; ROCHE, Philippe/E-5661-2010; Kan, Shih-hsin/GLT-3129-2022	Wilkie, Andrew/0000-0002-2972-5481; ROCHE, Philippe/0000-0002-5580-0588; Kan, Shih-hsin/0000-0003-0209-4963; Giele, Henk/0000-0003-2017-5193; Trembath, Richard/0000-0003-0550-3400	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Albrecht AN, 2002, MECH DEVELOP, V112, P53, DOI 10.1016/S0925-4773(01)00639-6; Armour CM, 2000, J MED GENET, V37, P292, DOI 10.1136/jmg.37.4.292; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P291, DOI 10.1093/nar/29.1.291; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; Billeter M, 1996, PROG BIOPHYS MOL BIO, V66, P211, DOI 10.1016/S0079-6107(97)00006-0; BRAILSFORD JF, 1945, BRIT J RADIOL, V18, P167, DOI 10.1259/0007-1285-18-210-167; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bruneau S, 2001, DEV BIOL, V237, P345, DOI 10.1006/dbio.2001.0382; Burglin T.R, 1994, EVOLUTION HOMEOBOX G, P27; CALABRESE O, 2000, EUR J HUM GENET, V8, pS1; Caronia G, 2003, DEVELOPMENT, V130, P1701, DOI 10.1242/dev.00396; D'Elia AV, 2001, HUM MUTAT, V18, P361, DOI 10.1002/humu.1207; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Davey RA, 1997, J VIROL, V71, P8096, DOI 10.1128/JVI.71.11.8096-8102.1997; Debeer P, 2002, J MED GENET, V39, P852, DOI 10.1136/jmg.39.11.852; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; GARN SM, 1972, RADIOLOGY, V105, P375, DOI 10.1148/105.2.375; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Goodman F, 1998, AM J HUM GENET, V63, P992, DOI 10.1086/302070; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Innis Jeffrey W, 2002, Hum Mutat, V19, P573; KAN SH, IN PRESS AM J MED GE; Kosaki K, 2002, TERATOLOGY, V65, P50, DOI 10.1002/tera.10009; KRONSTAD JW, 1990, GENE DEV, V4, P1384, DOI 10.1101/gad.4.8.1384; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Luttikhuis MEMO, 1996, J MED GENET, V33, P873, DOI 10.1136/jmg.33.10.873; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; POZNANSK.AK, 1972, RADIOLOGY, V104, P1; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; SARFARAZI M, 1995, HUM MOL GENET, V4, P1453, DOI 10.1093/hmg/4.8.1453; SAYLI BS, 1995, J MED GENET, V32, P421, DOI 10.1136/jmg.32.6.421; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zhu WD, 2000, J BIOL CHEM, V275, P35291, DOI 10.1074/jbc.M000525200	53	78	92	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					984	997		10.1086/374721	http://dx.doi.org/10.1086/374721			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12649808	Green Published, Bronze			2022-12-18	WOS:000181972600018
J	Martin, AM; Hammond, E; Nolan, D; Pace, C; Den Boer, M; Taylor, L; Moore, H; Martinez, OP; Christiansen, FT; Mallal, S				Martin, AM; Hammond, E; Nolan, D; Pace, C; Den Boer, M; Taylor, L; Moore, H; Martinez, OP; Christiansen, FT; Mallal, S			Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOXICITY; POLYMERASE	Nucleoside reverse-transcriptase inhibitor (NRTI) therapy for human immunodeficiency virus (HIV) infection has been associated with mitochondrial DNA (mtDNA) polymerase-gamma inhibition and subsequent mtDNA depletion. Effects on mtDNA mutation, although suggested by critical involvement of polymerase-gamma in DNA-repair reactions, are unknown. In the present study, we assessed the nature and frequency of mitochondrial genome sequence differences in peripheral-blood samples taken prior to NRTI therapy and after 6-77 mo of treatment in 16 NRTI-treated patients. Samples from 10 HIV-infected, treatment-naive control individuals were taken at similar time intervals. Single-stranded conformation polymorphism (SSCP) and DNA-sequencing analysis techniques were used to detect mitochondrial genome sequence variants between paired longitudinal samples, and heteroplasmic populations were quantified after cloning and repeat SSCP/sequencing. Of 16 individuals treated with NRTIs, 5 exhibited altered SSCP profiles associated with the development of novel heteroplasmic DNA sequence changes, whereas no SSCP pattern change within these regions was observed in the control individuals. Heteroplasmic sequence changes were distributed across four regions of the genome: the noncoding region to 12S ribosomal RNA, reduced-nicotinamide-adenine-dinucleotide dehydrogenase 1, and cytochrome oxidase subunits I and III. Of the total of 26 patients who were examined in the present study, 4 of 5 patients with detectable mtDNA sequence changes since commencement of therapy developed evidence of peripheral fat wasting (lipoatrophy) between sample intervals (P = .031). One patient, without detectable sequence changes on NRTI therapy, also developed lipoatrophy. Levels of mtDNA copies/cell in blood samples were determined by quantitative PCR for 11 of the 16 NRTI-exposed patients; 7 of these 11 patients showed reduced levels of mtDNA in blood after therapy, including all 3 patients tested with evidence of mtDNA sequence changes on therapy. These data indicate that NRTI therapy provides conditions permissive for the development of peripheral-blood mtDNA mutations in vivo.	Murdoch Univ, Ctr Clin Immunol & Biomed Stat, Perth, WA 6150, Australia; Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA, Australia; TNO Protect & Hlth, Leiden, Netherlands; Univ Western Australia, Dept Pathol, Nedlands, WA 6009, Australia	Murdoch University; Royal Perth Hospital; University of Western Australia; Netherlands Organization Applied Science Research; University of Western Australia	Mallal, S (corresponding author), Murdoch Univ, Ctr Clin Immunol & Biomed Stat, Perth, WA 6150, Australia.		Mallal, Simon Alexander/HDM-9561-2022; Moore, Hannah C/G-3690-2011; Moore, Hannah/AHH-1092-2022	Mallal, Simon Alexander/0000-0002-7036-1309; Moore, Hannah/0000-0001-6434-8290				Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505; HAMMOND EL, IN PRESS J CLIN VIRO; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Wang HY, 1996, BBA-MOL BASIS DIS, V1316, P51, DOI 10.1016/0925-4439(96)00015-4; White AJ, 2001, SEX TRANSM INFECT, V77, P158, DOI 10.1136/sti.77.3.158; Witt CS, 2000, TISSUE ANTIGENS, V56, P248, DOI 10.1034/j.1399-0039.2000.560307.x	16	78	85	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					549	560		10.1086/367849	http://dx.doi.org/10.1086/367849			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12587093	Green Published, Bronze			2022-12-18	WOS:000181152600005
J	Dong, CH; Wang, S; Li, WD; Li, D; Zhao, HY; Price, RA				Dong, CH; Wang, S; Li, WD; Li, D; Zhao, HY; Price, RA			Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; LINKAGE ANALYSIS; SCAN; MOUSE; SUSCEPTIBILITY; MARKERS; WEIGHT; REGION; TWINS; FAT	Obesity is a multigenic trait that has a substantial genetic component. Animal models confirm a role for gene-gene interactions, and human studies suggest that as much as one-third of the heritable variance may be due to nonadditive gene effects. To evaluate potential epistatic interactions among five regions, on chromosomes 7, 10, and 20, that have previously been linked to obesity phenotypes, we conducted pairwise correlation analyses based on alleles shared identical by descent (IBD) for independent obese affected sibling pairs (ASPs), and we determined family-specific nonparametric linkage (NPL) scores in 244 families. The correlation analyses were also conducted separately, by race, through use of race-specific allele frequencies. Conditional analyses for a qualitative trait (body mass index [BMI] greater than or equal to27) and hierarchical models for quantitative traits were used to further refine evidence of gene interaction. Both the ASP-specific IBD-sharing probability and the family-specific NPL score revealed that there were strong positive correlations between 10q (88-97 cM) and 20q (65-83 cM), through single-point and multipoint analyses with three obesity thresholds (BMI greater than or equal to27, greater than or equal to30, and greater than or equal to35) across African American and European American samples. Conditional analyses for BMI greater than or equal to27 found that the LOD score at 20q rises from 1.53 in the baseline analysis to 2.80 (empirical P = .012) when families were weighted by evidence for linkage at 10q (D10S1646) through use of zero-one weights (weight(0-1)) and to 3.32 (empirical) when proportional weights (weight(prop)) were used. For percentage fat mass, variance- component analysis based on a two- locus epistatic model yielded significant evidence for interaction between 20q (75 cM) and the chromosome 10 centromere (LOD = 1.74; P = .024), compared with a two- locus additive model (LOD p 0.90). The results from multiple methods and correlated phenotypes are consistent in suggesting that epistatic interactions between loci in these regions play a role in extreme human obesity.	Univ Penn, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	University of Pennsylvania; Pennsylvania Medicine; Yale University	Price, RA (corresponding author), Univ Penn, Ctr Neurobiol & Behav, 415 Curie Blvd,CRB-105, Philadelphia, PA 19104 USA.	arlen@bgl.psycha.upenn.edu		Li, Wei-Dong/0000-0003-0521-7412; Li, Ding/0000-0003-1064-1656	NIDDK NIH HHS [R01DK44073, R01 DK056210, R01DK56210, R01 DK044073, R01DK48095] Funding Source: Medline; NIGMS NIH HHS [R01GM59507, R01 GM059507] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048095, R01DK056210, R01DK044073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059507] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; COLEMAN DL, 1975, ISRAEL J MED SCI, V11, P708; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; GRILO CM, 1991, PSYCHOL BULL, V110, P520; GunayAygun M, 1997, BEHAV GENET, V27, P307, DOI 10.1023/A:1025683829856; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hinney A, 2000, J CLIN ENDOCR METAB, V85, P2962, DOI 10.1210/jc.85.8.2962; Horikawa Y, 2000, NAT GENET, V26, P502; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hunt SC, 2001, HUM GENET, V109, P279, DOI 10.1007/s004390100581; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Li WD, 1999, ANN HUM GENET, V63, P227, DOI 10.1046/j.1469-1809.1999.6330227.x; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Perusse L, 2001, OBES RES, V9, P135, DOI 10.1038/oby.2001.17; PRICE R A, 1987, Annals of Behavioral Medicine, V9, P9, DOI 10.1207/s15324796abm0901_2; Price RA, 2000, OBES RES, V8, P360, DOI 10.1038/oby.2000.43; PRICE RA, 1991, BEHAV GENET, V21, P1, DOI 10.1007/BF01067662; Price RA, 1998, INT J OBESITY, V22, P406, DOI 10.1038/sj.ijo.0800601; Price RA, 2001, DIABETOLOGIA, V44, P363, DOI 10.1007/s001250051627; PRICE RA, 2002, OBESITY THEORY THERA; Rankinen T, 2002, OBES RES, V10, P196, DOI 10.1038/oby.2002.30; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; Shintani M, 1996, DIABETOLOGIA, V39, P1398, DOI 10.1007/s001250050589; Shmulewitz D, 2000, HUM HERED, V51, P8; SORENSEN TIA, 1989, BRIT MED J, V298, P87, DOI 10.1136/bmj.298.6666.87; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	42	78	82	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					115	124		10.1086/345648	http://dx.doi.org/10.1086/345648			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12478478	Green Published, Bronze			2022-12-18	WOS:000180186800011
J	Takahara, K; Schwarze, U; Imamura, Y; Hoffman, GG; Toriello, H; Smith, LT; Byers, PH; Greenspan, DS				Takahara, K; Schwarze, U; Imamura, Y; Hoffman, GG; Toriello, H; Smith, LT; Byers, PH; Greenspan, DS			Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha 1(V) N-propeptides and Ehlers-Danlos syndrome type I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE MORPHOGENETIC PROTEIN-1; AMINO-TERMINAL PROPEPTIDE; TENASCIN-X DEFICIENCY; COLLAGEN GENE COL5A1; V COLLAGEN; NH2-TERMINAL DOMAIN; GRAVIS FORM; CHAIN; PROCOLLAGEN; EXPRESSION	Ehlers-Danlos syndrome (EDS) type I (the classical variety) is a dominantly inherited, genetically heterogeneous connective-tissue disorder. Mutations in the COL5A1 and COL5A2 genes, which encode type V collagen, have been identified in several individuals. Most mutations affect either the triple-helical domain of the protein or the expression of one COL5A1 allele. We identified a novel splice-acceptor mutation (IVS4-2A-->G) in the N-propeptide-encoding region of COL5A1, in one patient with EDS type I. The outcome of this mutation was complex: In the major product, both exons 5 and 6 were skipped; other products included a small amount in which only exon 5 was skipped and an even smaller amount in which cryptic acceptor sites within exon 5 were used. All products were in frame. Pro-alpha1(V) chains with abnormal N-propeptides were secreted and were incorporated into extracellular matrix, and the mutation resulted in dramatic alterations in collagen fibril structure. The two-exon skip occurred in transcripts in which intron 5 was removed rapidly relative to introns 4 and 6, leaving a large (270 nt) composite exon that can be skipped in its entirety. The transcripts in which only exon 5 was skipped were derived from those in which intron 6 was removed prior to intron 5. The use of cryptic acceptor sites in exon 5 occurred in transcripts in which intron 4 was removed subsequent to introns 5 and 6. These findings suggest that the order of intron removal plays an important role in the outcome of splice-site mutations and provide a model that explains why multiple products derive from a mutation at a single splice site.	Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Spectrum Hlth Genet Serv, Grand Rapids, MI USA	University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Greenspan, DS (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 1300 Univ Ave, Madison, WI 53706 USA.	dsgreens@facstaff.wisc.edu	Imamura, Yasutada/AAI-3078-2020	Byers, Peter H./0000-0001-7786-7030; Greenspan, Daniel/0000-0001-8096-7446; Imamura, Yasutada/0000-0001-6264-1709	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043621, P01AR021557] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01 AR021557, AR43621, AR21557] Funding Source: Medline; NIGMS NIH HHS [GM46846] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel F.M., 1987, CURRENT PROTOCOLS MO; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1993, MCKUSICKS HERITABLE; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BORK P, 1992, FEBS LETT, V307, P49, DOI 10.1016/0014-5793(92)80900-2; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Byers PH, 1997, AM J MED GENET, V72, P94, DOI 10.1002/(SICI)1096-8628(19971003)72:1<94::AID-AJMG20>3.0.CO;2-O; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; COLE WG, 1987, J MED GENET, V24, P698, DOI 10.1136/jmg.24.11.698; DePaepe A, 1997, AM J HUM GENET, V60, P547; Fang LJ, 2001, J MOL BIOL, V307, P1261, DOI 10.1006/jmbi.2001.4561; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; GREENAWAY AH, 1991, MEAS SCI TECHNOL, V2, P1, DOI 10.1088/0957-0233/2/1/001; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; Haire RN, 1997, AM J HUM GENET, V60, P798; HATA R, 1988, EUR J BIOCHEM, V174, P231, DOI 10.1111/j.1432-1033.1988.tb14087.x; HAUSSER I, 1994, HUM GENET, V93, P394; HAYASHIDA Y, 1994, BBA-MOL BASIS DIS, V1225, P317, DOI 10.1016/0925-4439(94)90013-2; Hazeki N, 1998, J BIOCHEM-TOKYO, V123, P587; HOLBROOK KA, 1989, AM J MED GENET, V34, P105, DOI 10.1002/ajmg.1320340118; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; Minami N, 1999, J NEUROL SCI, V171, P31, DOI 10.1016/S0022-510X(99)00245-2; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; Nicholls AC, 2001, J MED GENET, V38, P132, DOI 10.1136/jmg.38.2.132; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; Nuytinck L, 2000, AM J HUM GENET, V66, P1398, DOI 10.1086/302859; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; SASAKI T, 1987, ARCH DERMATOL, V123, P76, DOI 10.1001/archderm.123.1.76; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; SCHNEIDER S, 1993, HUM GENET, V91, P599; Schwartz BB, 1999, MEMORY, V7, P1, DOI 10.1080/741943714; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SMITH LT, 1992, AM J HUM GENET, V51, P235; Steinmann Beat, 1993, P351; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; TAKAHARA K, 1991, J BIOL CHEM, V266, P13124; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; TSUMAKI N, 1995, J BIOL CHEM, V270, P2372, DOI 10.1074/jbc.270.5.2372; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VOGEL A, 1979, LAB INVEST, V40, P201; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; ZHIDKOVA NI, 1993, FEBS LETT, V326, P25, DOI 10.1016/0014-5793(93)81753-M	52	78	79	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					451	465		10.1086/342099	http://dx.doi.org/10.1086/342099			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145749	Bronze, Green Published			2022-12-18	WOS:000177489600001
J	Rubio, JP; Bahlo, M; Butzkueven, H; van der Mei, IAF; Sale, MM; Dickinson, JL; Groom, P; Johnson, LJ; Simmons, RD; Tait, B; Varney, M; Taylor, B; Dwyer, T; Williamson, R; Gough, NM; Kilpatrick, TJ; Speed, TP; Foote, SJ				Rubio, JP; Bahlo, M; Butzkueven, H; van der Mei, IAF; Sale, MM; Dickinson, JL; Groom, P; Johnson, LJ; Simmons, RD; Tait, B; Varney, M; Taylor, B; Dwyer, T; Williamson, R; Gough, NM; Kilpatrick, TJ; Speed, TP; Foote, SJ			Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II REGION; LINKAGE DISEQUILIBRIUM; HLA-DR; GENOME SCREEN; SUSCEPTIBILITY; DISEASE; RECOMBINATION; POLYMORPHISM; ASSOCIATION; DQ	Association of multiple sclerosis (MS) with the human leukocyte antigen (HLA) class II haplotype DRB1*1501-DQB1*0602 is the most consistently replicated finding of genetic studies of the disease. However, the high level of linkage disequilibrium (LD) in the HLA region has hindered the identification of other loci that single-marker tests for association are unlikely to resolve. In order to address this issue, we generated haplotypes spanning 14.754 Mb (5 cM) across the entire HLA region. The haplotypes, which were inferred by genotyping relatives of 152 patients with MS and 105 unaffected control subjects of Tasmanian ancestry, define a genomic segment from D6S276 to D6S291, including 13 microsatellite markers integrated with allele-typing data for DRB1 and DQB1. Association to the DRB1*1501-DQB1*0602 haplotype was replicated. In addition, we found that the class I/extended class I region, defined by a genomic segment of similar to400 kb between MOGCA and D6S265, harbors genes that independently increase risk of, or provide protection from, MS. Log-linear modeling analysis of constituent haplotypes that represent genomic regions containing class I (MOGCA-D6S265), class III (TNFa-TNFd-D6S273), and class II (DRB1-DQB1) genes indicated that having class I and class II susceptibility variants on the same haplotype provides an additive effect on risk. Moreover, we found no evidence for a disease locus in the class III region defined by a 150-kb genomic segment containing the TNF locus and 14 other genes. A global overview of LD performed using GOLD identified two discrete blocks of LD in the HLA region that correspond well with previous findings. We propose that the analysis of haplotypes, by use of the types of approaches outlined in the present article, should make it possible to more accurately define the contribution of the HLA to MS.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Cooperat Res Ctr Discovery Genes Common Human Dis, Melbourne, Vic, Australia; Victorian Immunogenet & Transplantat Serv, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Menzies Ctr Populat Hlth Res, Hobart, Tas, Australia; Royal Hobart Hosp, Hobart, Tas, Australia; Canberra Hosp, Australian Natl REgister Multiple Sclerosis Famil, Canberra, ACT, Australia	Walter & Eliza Hall Institute; Murdoch Children's Research Institute; Royal Hobart Hospital; Australian National University; Canberra Hospital	Rubio, JP (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Genet & Bioinformat Div, Melbourne, Vic 3050, Australia.	rubio@wehi.edu.au	van der Mei, Ingrid/J-7457-2014; Foote, Simon J/F-2802-2013; Dickinson, Joanne/J-7728-2014; Speed, Terence P/B-8085-2009; van der Mei, Ingrid/AAI-2566-2020	van der Mei, Ingrid/0000-0001-9009-7472; Speed, Terence P/0000-0002-5403-7998; van der Mei, Ingrid/0000-0001-9009-7472; Foote, Simon/0000-0002-9142-2107; RUBIO, JUSTIN/0000-0003-3750-917X; Butzkueven, Helmut/0000-0003-3940-8727; Bahlo, Melanie/0000-0001-5132-0774; Dickinson, Joanne/0000-0003-4621-1703; Kilpatrick, Trevor/0000-0003-3999-085X				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Allcock RJN, 1999, HUM IMMUNOL, V60, P1266, DOI 10.1016/S0198-8859(99)00127-5; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; Bugawan TL, 2000, TISSUE ANTIGENS, V56, P392, DOI 10.1034/j.1399-0039.2000.560502.x; Celius EG, 2000, J NEUROL SCI, V178, P132, DOI 10.1016/S0022-510X(00)00389-0; Chataway J, 1998, BRAIN, V121, P1869, DOI 10.1093/brain/121.10.1869; Coraddu F, 1998, NEUROGENETICS, V2, P24, DOI 10.1007/s100480050048; Cullen M, 1997, AM J HUM GENET, V60, P397; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fernandez-Arquero M, 1999, NEUROLOGY, V53, P1361, DOI 10.1212/WNL.53.6.1361; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Foissac A, 2000, TISSUE ANTIGENS, V55, P477, DOI 10.1034/j.1399-0039.2000.550601.x; FRANCIS DA, 1991, HUM IMMUNOL, V32, P119, DOI 10.1016/0198-8859(91)90108-L; HEDRICK PW, 1987, GENETICS, V117, P331; HILLERT J, 1993, NEUROLOGY, V43, P163, DOI 10.1212/WNL.43.1_Part_1.163; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; JERSILD C, 1972, LANCET, V1, P1240; JONGENEEL CV, 1991, P NATL ACAD SCI USA, V88, P9717, DOI 10.1073/pnas.88.21.9717; KIMURA A, 1991, 11TH P INT HIST WORK, V1, P397; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KWOK WW, 1993, J IMMUNOL, V150, P2263; Lie BA, 1999, TISSUE ANTIGENS, V54, P162, DOI 10.1034/j.1399-0039.1999.540207.x; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; Martin MP, 1998, IMMUNOGENETICS, V47, P503, DOI 10.1007/s002510050392; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; McDonnell GV, 1999, J NEUROL SCI, V165, P77, DOI 10.1016/S0022-510X(99)00084-2; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Ota M, 1999, AM J HUM GENET, V64, P1406, DOI 10.1086/302364; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; Plackett R. L., 1981, ANAL CATEGORICAL DAT; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; PRIDMORE SA, 1990, MED J AUSTRALIA, V153, P593, DOI 10.5694/j.1326-5377.1990.tb126270.x; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; ROTH MP, 1994, J NEUROIMMUNOL, V51, P93, DOI 10.1016/0165-5728(94)90133-3; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; UDALOVA IA, 1993, GENOMICS, V16, P180, DOI 10.1006/geno.1993.1156	46	78	80	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1125	1137		10.1086/339932	http://dx.doi.org/10.1086/339932			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11923913	Green Published, Bronze			2022-12-18	WOS:000175012400005
J	Puget, N; Gad, S; Perrin-Vidoz, L; Sinilnikova, OM; Stoppa-Layonnet, D; Lenoir, GM; Mazoyer, S				Puget, N; Gad, S; Perrin-Vidoz, L; Sinilnikova, OM; Stoppa-Layonnet, D; Lenoir, GM; Mazoyer, S			Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER FAMILIES; KB DELETION; BREAST; MUTATIONS; GENE; IDENTIFICATION; DNA; DUPLICATION; REGION; GENOME	The 5 end of the breast and ovarian cancer-susceptibility gene BRCA1 has previously been shown to lie within a duplicated region of chromosome band 17q21. The duplicated region contains BRCA1 exons 1A, 1B, and 2 and their surrounding introns; as a result, a BRCA1 pseudogene (PsiBRCA1) lies upstream of BRCA1. However, the sequence of this segment remained essentially unknown. We needed this information to investigate at the nucleotide level the germline deletions comprising BRCA1 exons 1A, 1B, and 2, which we had previously identified in two families with breast and ovarian cancer. We have analyzed the recently deposited nucleotide sequence of the 1.0-Mb region upstream of BRCA1. We found that 14 blocks of homology between the tandemly repeated copies (cumulative length p = 11.5 kb) show similarity of 77%-92%. Gaps between blocks result from insertion or deletion, usually of repetitive elements. BRCA1 exon 1A and PsiBRCA1 exon 1A are 44.5 kb apart. In the two families with breast and ovarian cancer mentioned above, distinct homologous recombination events occurred between intron 2 of BRCA1 and intron 2 of PsiBRCA1, leading to 37-kb deletions. Breakpoint junctions were found to be located at close but distinct sites within segments that are 98% identical. The mutant alleles lack the BRCA1 promoter and harbor a chimeric gene consisting of PsiBRCA1 exons 1A, 1B, and 2, which lacks the initiation codon, fused to BRCA1 exons 3-24. Thus, we report a new mutational mechanism for the BRCA1 gene. The presence of a large region homologous to BRCA1 on the same chromosome appears to constitute a hot spot for recombination.	Univ Lyon 1, Fac Med, Genet Lab, CNRS,Unite Mixte Rech 5641, F-69373 Lyon 08, France; Inst Curie, Serv Genet Oncol, Paris, France; Int Agcy Res Canc, F-69372 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; World Health Organization; International Agency for Research on Cancer (IARC)	Mazoyer, S (corresponding author), Univ Lyon 1, Fac Med, Genet Lab, CNRS,Unite Mixte Rech 5641, 8 Ave Rockefeller, F-69373 Lyon 08, France.		PUGET, Nadine/AAB-9689-2020; Mazoyer, Sylvie/N-7559-2017	Mazoyer, Sylvie/0000-0002-2135-0160; PUGET, Nadine/0000-0003-4046-737X; GAD (LAPITEAU), Sophie/0000-0002-3158-6791				Barker DF, 1996, GENOMICS, V38, P215, DOI 10.1006/geno.1996.0618; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; BROWN HC, 1995, J ORGANOMET CHEM, V500, P1, DOI 10.1016/0022-328X(95)00509-O; Brown MA, 1996, ONCOGENE, V12, P2507; Gad S, 2001, J MED GENET, V38, P388, DOI 10.1136/jmg.38.6.388; Gad S, 2001, GENE CHROMOSOME CANC, V31, P75, DOI 10.1002/gcc.1120; Lahti-Domenici J, 2001, CANCER GENET CYTOGEN, V129, P120, DOI 10.1016/S0165-4608(01)00437-X; Liu JS, 2000, ONCOGENE, V19, P2767, DOI 10.1038/sj.onc.1203599; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Mazoyer S, 2000, AM J HUM GENET, V67, P207, DOI 10.1086/302974; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Montagna M, 1999, ONCOGENE, V18, P4160, DOI 10.1038/sj.onc.1202754; Payne SR, 2000, GENE CHROMOSOME CANC, V29, P58, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1008>3.0.CO;2-F; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; Puget N, 1997, CANCER RES, V57, P828; Puget N, 1999, CANCER RES, V59, P455; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Robinson MD, 2000, GENET TEST, V4, P49, DOI 10.1089/109065700316471; Rohlfs EM, 2000, HUM GENET, V107, P385, DOI 10.1007/s004390000372; Rohlfs EM, 2000, GENE CHROMOSOME CANC, V28, P300, DOI 10.1002/1098-2264(200007)28:3<300::AID-GCC8>3.0.CO;2-1; Serova O, 1996, AM J HUM GENET, V58, P42; Serova OM, 1997, AM J HUM GENET, V60, P486; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Swensen J, 1997, HUM MOL GENET, V6, P1513, DOI 10.1093/hmg/6.9.1513; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Xu CF, 1997, HUM MOL GENET, V6, P1057, DOI 10.1093/hmg/6.7.1057	29	78	84	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					858	865		10.1086/339434	http://dx.doi.org/10.1086/339434			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11880951	Green Published, Bronze			2022-12-18	WOS:000174252100003
J	Goodman, FR; Majewski, F; Collins, AL; Scambler, PJ				Goodman, FR; Majewski, F; Collins, AL; Scambler, PJ			A 117-kb microdeletion removing HOXD9-HOXD13 and EVX2 causes synpolydactyly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2 UNRELATED FAMILIES; INTERSTITIAL DELETION; HOXD COMPLEX; HUMAN GENOME; REGULATORY CONTROLS; FOOT MALFORMATION; LIMB DEVELOPMENT; HOMEOBOX GENES; LONG ARM; EXPRESSION	Studies in mouse and chick have shown that the 5 HoxD genes play major roles in the development of the limbs and genitalia. In humans, mutations in HOXD13 cause the dominantly inherited limb malformation synpolydactyly (SPD). Haploinsufficiency for the 5 HOXD genes has recently been proposed to underlie the monodactyly and penoscrotal hypoplasia in two children with chromosomal deletions encompassing the entire HOXD cluster. Similar deletions, however, have previously been associated with split-hand/foot malformation (SHFM), including monodactyly. Here we report a father and daughter with SPD who carry a 117-kb microdeletion at the 5 end of the HOXD cluster. By sequencing directly across the deletion breakpoint, we show that this microdeletion removes only HOXD9-HOXD13 and EVX2. We also report a girl with bilateral split foot and a chromosomal deletion that includes the entire HOXD cluster and extends similar to5 Mb centromeric to it. Our findings indicate that haploinsufficiency for the 5 HOXD genes causes not SHFM but SPD and point to the presence of a novel locus for SHFM in the interval between EVX2 and D2S294. They also suggest that there is a regulatory region, upstream of the HOXD cluster, that is responsible for activating the cluster as a whole.	Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Dusseldorf, Inst Humangenet, D-4000 Dusseldorf, Germany; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England	University of London; University College London; Heinrich Heine University Dusseldorf	Goodman, FR (corresponding author), Inst Child Hlth, Mol Med Unit, Room 213,30 Guilford St, London WC1N 1EH, England.	fgoodman@hgmp.mrc.ac.uk	Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628				Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; BENSON K, 1986, AM J MED GENET, V25, P405, DOI 10.1002/ajmg.1320250302; BOLES RG, 1995, AM J MED GENET, V55, P155, DOI 10.1002/ajmg.1320550204; Bruneau S, 2001, DEV BIOL, V237, P345, DOI 10.1006/dbio.2001.0382; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; Calabrese Olga, 2000, European Journal of Human Genetics, V8, P140; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; Del Campo M, 1999, AM J HUM GENET, V65, P104, DOI 10.1086/302467; Devriendt K, 1999, AM J HUM GENET, V65, P249, DOI 10.1086/302452; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Drechsler M, 1996, HUM GENET, V98, P297, DOI 10.1007/s004390050210; Goodman F, 1998, AM J HUM GENET, V63, P992, DOI 10.1086/302070; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Goodman FR, 2001, CLIN GENET, V59, P1, DOI 10.1034/j.1399-0004.2001.590101.x; GOODMAN FR, 2001, EUR J HUM GENET, V9, P179; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Limongi MZ, 2000, CYTOGENET CELL GENET, V90, P151, DOI 10.1159/000015651; Maas SM, 2000, CLIN DYSMORPHOL, V9, P47, DOI 10.1097/00019605-200009010-00010; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nagase T, 2000, DNA RES, V7, P347, DOI 10.1093/dnares/7.6.347; Nixon J, 1997, AM J MED GENET, V70, P324; Prieur Marguerite, 2000, European Journal of Human Genetics, V8, P74; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Ramenofsky A.F., 1990, COLUMBIAN CONSEQUENC, V2, P31; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; ROSEN DR, 1993, HUM MOL GENET, V2, P617, DOI 10.1093/hmg/2.5.617; ROSSI E, 1994, GENOMICS, V24, P34, DOI 10.1006/geno.1994.1579; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; Slavotinek A, 1999, AM J MED GENET, V86, P75, DOI 10.1002/(SICI)1096-8628(19990903)86:1<75::AID-AJMG15>3.0.CO;2-J; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	37	78	88	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					547	555		10.1086/338921	http://dx.doi.org/10.1086/338921			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11778160	Green Published, Bronze			2022-12-18	WOS:000173254300027
J	Verhoeven, NM; Huck, JHJ; Roos, B; Struys, EA; Salomons, GS; Douwes, AC; van der Knaap, MS; Jakobs, C				Verhoeven, NM; Huck, JHJ; Roos, B; Struys, EA; Salomons, GS; Douwes, AC; van der Knaap, MS; Jakobs, C			Transaldolase deficiency: Liver cirrhosis associated with a new inborn error in the pentose phosphate pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENE; POLYOLS; EXPRESSION; SEQUENCE; PLASMA	This article describes the first patient with a deficiency of transaldolase (TALDO1 [E.C.2.2.1.2]). Clinically, the patient presented with liver cirrhosis and hepatosplenomegaly during early infancy. In urine and plasma, elevated concentrations of ribitol, D-arabitol, and erythritol were found. By incubating the patient's lymphoblasts and erythrocytes with ribose-5-phosphate and subsequently analyzing phosphate sugar metabolites, we discovered a deficiency of transaldolase. Sequence analysis of the transaldolase gene from this patient showed a homozygous deletion of 3 bp. This deletion results in absence of serine at position 171 of the transaldolase protein. This amino acid is invariable between species and is located in a conserved region, indicating its importance for enzyme activity. The detection of this new inborn error of pentose metabolism has implications for the diagnostic workup of liver problems of unknown etiology.	VU Med Ctr, Dept Clin Chem, Metab Unit, NL-1007 MB Amsterdam, Netherlands; VU Med Ctr, Dept Pediat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Verhoeven, NM (corresponding author), VU Med Ctr, Dept Clin Chem, Metab Unit, POB 7057, NL-1007 MB Amsterdam, Netherlands.		Huck, Jojanneke/B-1534-2013	Huck, Jojanneke/0000-0002-3853-8581				ADAMS MD, 1995, NATURE, V377, P3; BANKI K, 1994, J BIOL CHEM, V269, P2847; BROWNSTONE Y, 1961, CAN J BIOCHEM PHYS, V39, P527, DOI 10.1139/o61-052; Holton J.B., 2000, METABOLIC MOL BASES, P1553; JAKOBS C, 1995, EUR J PEDIATR, V154, pS50, DOI 10.1007/BF02143804; JANSEN G, 1986, CLIN CHIM ACTA, V157, P277, DOI 10.1016/0009-8981(86)90303-7; KUSMIERZ J, 1989, J CHROMATOGR-BIOMED, V497, P39, DOI 10.1016/0378-4347(89)80003-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thorell S, 2000, FEBS LETT, V475, P205, DOI 10.1016/S0014-5793(00)01658-6; van der Knaap MS, 1999, ANN NEUROL, V46, P925, DOI 10.1002/1531-8249(199912)46:6<925::AID-ANA18>3.0.CO;2-J	10	78	82	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1086	1092		10.1086/320108	http://dx.doi.org/10.1086/320108			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283793	Green Published, Bronze			2022-12-18	WOS:000168171200002
J	Grunewald, S; Schollen, E; Van Schaftingen, E; Jaeken, J; Matthijs, G				Grunewald, S; Schollen, E; Van Schaftingen, E; Jaeken, J; Matthijs, G			High residual activity of PMM2 in patients' fibroblasts: Possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBROSPINAL-FLUID TRANSFERRIN; GLYCOPROTEIN SYNDROME TYPE-1; COAGULATION ABNORMALITIES; SERUM; MUTATIONS; FAMILIES; PATTERN; DISEASE	Congenital disorders of glycosylation (CDGs) are a rapidly enlarging group of inherited diseases with abnormal N-glycosylation of glycoconjugates. Most patients have CDG-Ia, which is due to a phosphomannomutase (PMM) deficiency. In this article, we report that a significant portion (9 of 54) of patients with CDG-Ia had a rather high residual PMM activity in fibroblasts included in the normal range (means of the controls +/- 2 SD) and amounting to 35%-70% of the mean control value. The clinical diagnosis of CDG-Ia was made difficult by the fact that most (6 of 9) of these patients belong to a subgroup characterized by a phenotype that is milder than classical CDG-Ia. These patients lack some of the symptoms that are suggestive for the diagnosis, such as inverted nipples and abnormal fat deposition, and, as a mean, had higher residual PMM activities in fibroblasts (2.05 +/- 0.61 mU/mg protein, n = 9; vs. controls 5.34 +/-1.74 mU/mg protein, n = 22), compared with patients with moderate (1.32 +/- 0.86 mU/mg protein, n = 18) or severe (0.63 +/- 0.56 mU/mg protein, n = 27, P< .001) cases. yet they all showed mild mental retardation, hypotonia, cerebellar hypoplasia, and strabismus. All of them had an abnormal serum transferrin pattern and a significantly reduced PMM activity in leukocytes. Six of the nine patients with mild presentations were compound heterozygotes for the C241S mutation, which is known to reduce PMM activity by only <similar to>2-fold. Our results indicate that intermediate PMM values in fibroblasts may mask the diagnosis of CDG-Ia, which is better accomplished by measurement of PMM activity in leukocytes and mutation search in the PMM2 gene. They also indicate that there is some degree of correlation between the residual activity in fibroblasts and the clinical phenotype.	Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Catholic Univ Louvain, Ctr Metab Dis, B-3000 Louvain, Belgium; Inst Cellular Pathol, Physiol Chem Lab, Louvain, Belgium; Univ Louvain, Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Matthijs, G (corresponding author), Catholic Univ Louvain, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium.	Gert.Matthijs@med.kuleuven.ac.be	Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647; Matthijs, Gert/0000-0001-6710-1912				AKABOSHI S, 1995, NEURORADIOLOGY, V37, P491; ANDREASSON S, 1991, AM J OPHTHALMOL, V112, P83, DOI 10.1016/S0002-9394(14)76218-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Barone R, 1999, BRAIN DEV-JPN, V21, P260, DOI 10.1016/S0387-7604(99)00020-0; Bjursell C, 2000, HUM MUTAT, V16, P395, DOI 10.1002/1098-1004(200011)16:5<395::AID-HUMU3>3.0.CO;2-T; Bjursell C, 1997, GENOMICS, V39, P247, DOI 10.1006/geno.1996.4488; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; de Lonlay P, 2001, J MED GENET, V38, P14, DOI 10.1136/jmg.38.1.14; DEJONG G, 1994, ADV EXP MED BIOL, V356, P51; DEZEGHER F, 1995, PEDIATR RES, V37, P395; Di Rocco M, 2000, J INHERIT METAB DIS, V23, P391, DOI 10.1023/A:1005608019977; FIUMARA A, 1994, BRIT J OPHTHALMOL, V78, P845, DOI 10.1136/bjo.78.11.845; Garcia DD, 1996, HRC-J HIGH RES CHROM, V19, P257; HAGBERG BA, 1993, PEDIATR NEUROL, V9, P255, DOI 10.1016/0887-8994(93)90060-P; HUTCHESSON ACJ, 1995, ARCH DIS CHILD, V72, P445, DOI 10.1136/adc.72.5.445; Imtiaz F, 2000, J INHERIT METAB DIS, V23, P162, DOI 10.1023/A:1005669900330; ITOH M, 1993, ACTA PAEDIATR, V82, P607, DOI 10.1111/j.1651-2227.1993.tb12768.x; Jaeken J, 1997, J INHERIT METAB DIS, V20, P447, DOI 10.1023/A:1005331523477; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; JAEKEN J, 1993, J INHERIT METAB DIS, V16, P813, DOI 10.1007/BF00714272; Jaeken J, 1997, J MED GENET, V34, P73, DOI 10.1136/jmg.34.1.73; JENSEN PR, 1995, NEURORADIOLOGY, V37, P328; Kjaergaard S, 1998, EUR J HUM GENET, V6, P331, DOI 10.1038/sj.ejhg.5200194; Kjaergaard S, 1999, EUR J HUM GENET, V7, P884, DOI 10.1038/sj.ejhg.5200398; KRISTIANSSON B, 1995, ACTA PAEDIATR, V84, P655, DOI 10.1111/j.1651-2227.1995.tb13720.x; Kristiansson B, 1998, J INHERIT METAB DIS, V21, P112, DOI 10.1023/A:1005387408009; Matthijs G, 1997, NAT GENET, V16, P316, DOI 10.1038/ng0797-316; Matthijs G, 1998, EUR J HUM GENET, V6, P99, DOI 10.1038/sj.ejhg.5200161; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Matthijs G, 2000, HUM MUTAT, V16, P386, DOI 10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y; Matthijs G, 1999, MOL GENET METAB, V68, P220, DOI 10.1006/mgme.1999.2914; OHZEKI T, 1993, HORM METAB RES, V25, P646, DOI 10.1055/s-2007-1002198; OKAMOTO N, 1993, J INHERIT METAB DIS, V16, P435, DOI 10.1007/BF00710294; PETERSEN MB, 1993, J PEDIATR-US, V122, P66, DOI 10.1016/S0022-3476(05)83488-2; Pirard M, 1999, FEBS LETT, V452, P319, DOI 10.1016/S0014-5793(99)00673-0; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; Stibler H, 1996, BLOOD COAGUL FIBRIN, V7, P118, DOI 10.1097/00001721-199603000-00003; STIBLER H, 1994, J NEUROL NEUROSUR PS, V57, P552, DOI 10.1136/jnnp.57.5.552; STIBLER H, 1990, ARCH DIS CHILD, V65, P107, DOI 10.1136/adc.65.1.107; STIBLER H, 1993, ACTA PAEDIATR, V82, P55, DOI 10.1111/j.1651-2227.1993.tb12517.x; van Ommen CH, 2000, J PEDIATR-US, V136, P400, DOI 10.1067/mpd.2000.103503; VanderKnaap MS, 1996, J INHERIT METAB DIS, V19, P787, DOI 10.1007/BF01799174; VANGEET C, 1993, PEDIATR RES, V33, P540; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Vuillaumier-Barrot S, 2000, J MED GENET, V37, P579, DOI 10.1136/jmg.37.8.579	45	78	79	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					347	354		10.1086/318199	http://dx.doi.org/10.1086/318199			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11156536	Bronze, Green Published			2022-12-18	WOS:000166524800005
J	Richards, AJ; Baguley, DM; Yates, JRW; Lane, C; Nicol, M; Harper, PS; Scott, JD; Snead, MP				Richards, AJ; Baguley, DM; Yates, JRW; Lane, C; Nicol, M; Harper, PS; Scott, JD; Snead, MP			Variation in the vitreous phenotype of stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen Gly-X-Y triple helix	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EHLERS-DANLOS SYNDROME; GENE COL2A1; SPONDYLOEPIPHYSEAL DYSPLASIA; PRECOCIOUS OSTEOARTHRITIS; MILD CHONDRODYSPLASIA; MARFAN-SYNDROME; RNA-METABOLISM; MUTATION; CARTILAGE; FAMILY	Stickler syndrome is a dominantly inherited disorder characterized by arthropathy, midline clefting, hearing loss, midfacial hypoplasia, myopia, and retinal detachment. These features are highly variable both between and within families. Mutations causing the disorder have been found in the COL2A1 and COL11A1 genes. Premature termination codons in COL2A1 that result in haploinsufficiency of type II, collagen are a common finding. These produce a characteristic congenital "membranous" anomaly of the vitreous of all affected individuals. Experience has shown that vitreous slit-lamp biomicroscopy can distinguish between patients with COL2A1 mutations and those with dominant negative mutations in COL11A1, who produce a different "beaded" vitreous phenotype. Here we characterize novel dominant negative mutations in COL2A1 that result in Stickler syndrome. Both alter amino acids in the X position of the Glp-X-Y triple-helical region. A recurrent R365C mutation occurred in two unrelated sporadic cases and resulted in the membranous vitreous anomaly associated with haploinsufficiency. In a large family with linkage to COL2A1, with a LOD score of 2.8, a unique L467F mutation produced a novel "afibrillar" vitreous gel devoid of all normal lamella structure. These data extend the mutation spectrum of the COL2A1 gene and help explain the basis for the different vitreous phenotypes seen in Stickler syndrome.	Addenbrookes Hosp, Vitreoretinal Serv, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Dept Audiol, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Wales Hosp, Cardiff Eye Unit, Cardiff CF4 4XW, S Glam, Wales; Univ Wales Coll Med, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cardiff University; Cardiff University	Snead, MP (corresponding author), Addenbrookes Hosp, Vitreoretinal Serv, Hills Rd,Box 41, Cambridge CB2 2QQ, England.			snead, martin/0000-0003-0042-8659				AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; Anderson D. W., 1994, Matrix Biology, V14, P392, DOI 10.1016/0945-053X(94)90116-3; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Ballo R, 1998, AM J MED GENET, V80, P6, DOI 10.1002/(SICI)1096-8628(19981102)80:1<6::AID-AJMG2>3.0.CO;2-0; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BEIGHTON P, 1993, MCKUSICKS HERITABLE, P199; BROWN DM, 1995, HUM MOL GENET, V4, P141, DOI 10.1093/hmg/4.1.141; BROWN DM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1589, DOI 10.1001/archopht.1992.01080230089027; BRUNNER HG, 1994, HUM MOL GENET, V3, P1561, DOI 10.1093/hmg/3.9.1561; CHAN D, 1993, J BIOL CHEM, V268, P15238; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EYRE DR, 1991, J CLIN INVEST, V87, P357, DOI 10.1172/JCI114994; FRANCOIS I, 1987, PROGR MED, V43, P83; FRYER AE, 1990, J MED GENET, V27, P91, DOI 10.1136/jmg.27.2.91; HALL JG, 1989, HDB NORMAL PHYSICAL; HOLDERBAUM D, 1993, BIOCHEM BIOPH RES CO, V192, P1169, DOI 10.1006/bbrc.1993.1539; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Los LI, 1999, EXP EYE RES, V69, P343, DOI 10.1006/exer.1999.0708; MAQUAT LE, 1995, RNA, V1, P453; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; Martin S, 1999, EUR J HUM GENET, V7, P807, DOI 10.1038/sj.ejhg.5200377; MAYNE R, 1993, J BIOL CHEM, V268, P9381; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; Mundlos S, 1996, AM J MED GENET, V63, P129; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; Nuytinck L, 2000, AM J HUM GENET, V66, P1398, DOI 10.1086/302859; PHILLIPS CL, 1990, J CLIN INVEST, V86, P1723, DOI 10.1172/JCI114897; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; REGINATO AJ, 1994, ARTHRITIS RHEUM, V37, P1078, DOI 10.1002/art.1780370714; Richards AJ, 2000, BRIT J OPHTHALMOL, V84, P364, DOI 10.1136/bjo.84.4.364; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Scott James C., 1998, SURGERY RETINAL VITR, P183; SCOTT JD, 1989, EYE, V3, P491, DOI 10.1038/eye.1989.82; SEERY CM, 1990, AM J OPHTHALMOL, V110, P143, DOI 10.1016/S0002-9394(14)76982-X; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; SNEAD M, 2000, P GREENWOOD GENET CT, V19, P169; SNEAD MP, 1994, EYE, V8, P609, DOI 10.1038/eye.1994.153; Snead MP, 1999, J MED GENET, V36, P353; Superti-Furga A., 1994, Matrix Biology, V14, P385, DOI 10.1016/0945-053X(94)90102-3; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; VINTINER GM, 1991, AM J MED GENET, V41, P44, DOI 10.1002/ajmg.1320410113; WILLIAMS CJ, 1995, HUM MOL GENET, V4, P309, DOI 10.1093/hmg/4.2.309; WILLIAMS CJ, 1993, HUM GENET, V92, P499, DOI 10.1007/BF00216458; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; WU JJ, 1995, J BIOL CHEM, V270, P18865, DOI 10.1074/jbc.270.32.18865	49	78	84	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1083	1094						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11007540				2022-12-18	WOS:000165091600005
J	Green, LD; Derr, JN; Knight, A				Green, LD; Derr, JN; Knight, A			mtDNA affinities of the peoples of north-central Mexico	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; GENE-FREQUENCIES; AFRICAN POPULATIONS; ANALYSIS REVEALS; EVOLUTION; ADMIXTURE; LINEAGES; ANCIENT; AMERICA; ORIGIN	mtDNA haplotypes of representatives of the cosmopolitan peoples of north-central Mexico were studied. Two hundred twenty-three samples from individuals residing in vicinities of two localities in north-central Mexico were analyzed. A combination of strategies was employed to identify the origin of each haplotype, including length variation analysis of the COII and tRNA(LYS) intergenic region, nucleotide sequence analysis of control region hypervariable segment 1, and RFLP analysis of PCR products spanning diagnostic sites. Analysis of these data revealed that the majority of the mtDNA haplotypes were of Native American origin, belonging to one of four primary Native American haplogroups. Others were of European or African origin, and the frequency of African haplotypes was equivalent to that of haplotypes of European derivation. These results provide diagnostic, discrete character, molecular genetic evidence that, together with results of previous studies of classical genetic systems, is informative with regard to both the magnitude of African admixture and the relative maternal contribution of African, European, and Native American peoples to the genetic heritage of Mexico. Phylogenetic analysis revealed that African sequences formed a basal, paraphyletic group.	Sul Ross State Univ, Dept Biol, Alpine, TX USA; Texas A&M Univ, Texas Vet Med Ctr, Dept Vet Pathobiol, College Stn, TX 77843 USA	Texas State University System; Texas A&M University System; Texas A&M University College Station	Green, LD (corresponding author), Los Alamos Natl Lab, Biosci Div, Mail Stop M888, Los Alamos, NM 87545 USA.	green@telomere.lanl.gov						ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BELTRAN AG, 1970, RACE CLASS LATIN AM, P11; BELTRAN AG, 1945, PHYLON, V6, P212; BELTRAN AG, 1944, HISPANIC AM HIST REV, V24, P412; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CERDAFLORES RM, 1989, HUM BIOL, V61, P249; CHEN YS, 1995, AM J HUM GENET, V57, P133; CRAWFORD MH, 1974, AM J PHYS ANTHROPOL, V41, P251, DOI 10.1002/ajpa.1330410208; Crawford MH, 1976, PUBLICATIONS ANTHR, V7, P169; Curtin PD, 1969, ATLANTIC SLAVE TRADE, Vxix; Forster P, 1996, AM J HUM GENET, V59, P935; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HILLIS DM, 1986, EVOLUTION, V40, P1275, DOI 10.1111/j.1558-5646.1986.tb05751.x; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lisker R, 1996, HUM BIOL, V68, P395; LISKER R, 1988, AM J PHYS ANTHROPOL, V76, P331, DOI 10.1002/ajpa.1330760307; LISKER R, 1994, HUM BIOL, V66, P1103; LISKER R, 1986, AM J PHYS ANTHROPOL, V71, P203, DOI 10.1002/ajpa.1330710207; LISKER R, 1995, AM J HUM BIOL, V7, P213, DOI 10.1002/ajhb.1310070210; LISKER R, 1990, HUM BIOL, V62, P791; LISKER R, 1986, REV INVEST CLIN, V38, P145; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Meyer Michael C., 1991, COURSE MEXICAN HIST, V4th; Morner Magnus, 1967, RACE MIXTURE HIST LA; Muhammad Jameelah S., 1995, NO LONGER INVISIBLE, P163; NEI M, 1993, MOL BIOL EVOL, V10, P927; PALMER CA, 1976, SLAVES WHITE GOD; Richards M, 1996, AM J HUM GENET, V59, P185; SCHANFIELD MS, 1978, ANN HUM BIOL, V5, P577, DOI 10.1080/03014467800003261; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Stern P., 1994, COLONIAL LATIN AM HI, V3, P185; Swofford D. L, 2002, PAUP 4 0 PHYLOGENETI; TIBURCIO V, 1978, ANN HUM BIOL, V5, P131, DOI 10.1080/03014467800002721; TJARKS A, 1978, AMERICAS, V35, P45, DOI 10.2307/980925; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P563; VALDES DN, 1987, AMERICAS, V44, P167, DOI 10.2307/1007289; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	47	78	78	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					989	998		10.1086/302801	http://dx.doi.org/10.1086/302801			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712213	Green Published, Bronze			2022-12-18	WOS:000088373200021
J	Lautenberger, JA; Stephens, JC; O'Brien, SJ; Smith, MW				Lautenberger, JA; Stephens, JC; O'Brien, SJ; Smith, MW			Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; DUFFY-NEGATIVE INDIVIDUALS; ADMIXED POPULATIONS; HUMAN GENOME; LENGTH-POLYMORPHISM; CHEMOKINE RECEPTOR; ETHNIC-DIFFERENCES; PLASMODIUM-VIVAX; HOMOSEXUAL MEN; MAPPING GENES	Scientists, to understand the importance of allelic polymorphisms on phenotypes that are quantitative and environmentally interacting, are now turning to population-association screens, especially in instances in which pedigree analysis is difficult. Because association screens require linkage disequilibrium between markers and disease loci, maximizing the degree of linkage disequilibrium increases the chances of discovering functional gene-marker associations. One theoretically valid approach-mapping by admixture linkage disequilibrium (MALD), using recently admired African Americans-is empirically evaluated here by measurement of marker associations with 15 short tandem repeats (STRs) and an insertion/deletion polymorphism of the AT3 locus in a 70-cM segment at 1q22-23, around the FY (Duffy) locus. The FY polymorphism ( - 46T->C) disrupts the GATA promoter motif, specifically blocking FY erythroid expression and has a nearly fixed allele-frequency difference between European Americans and native Africans that is likely a consequence of a selective advantage of EY - / - in malaria infections. Analysis of linkage disequilibrium around the EY gene has indicated that there is strong and consistent linkage disequilibrium between EY and three nanking loci (D1S303, SPTA1, and D1S484) spanning 8 cM. We observed significant linkage-disequilibrium signals over a 30-cM region from -4.4 to 16.3 cM (from D1S2777 to D1S196) for STRs and at 26.4 cM (AT3), which provided quantitative estimates of centimorgan limits, by MALD assessment in African American population-association analyses, of 5-10 cM.	NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, Sci Applicat Int Corp Frederick, Frederick, MD 21702 USA; NCI, Lab Genomic Divers, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, MW (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, Sci Applicat Int Corp Frederick, POB B, Frederick, MD 21702 USA.	Michael_W_Smith@nih.gov	Peng, Bo/A-6920-2009; OBRIEN, STEPHEN/ABD-1346-2020; Smith, Michael/B-5341-2012	Peng, Bo/0000-0001-8225-2284; OBRIEN, STEPHEN/0000-0001-7857-0757	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler D, 1998, NEW ENGL J MED, V338, P1626, DOI 10.1056/NEJM199805283382214; BOCK SC, 1983, NUCLEIC ACIDS RES, V11, P8569, DOI 10.1093/nar/11.24.8569; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; BRISCOE D, 1994, J HERED, V85, P59; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1991, Ethnicity and Disease, V1, P245; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Destro-Bisol G, 1999, HUM GENET, V104, P149, DOI 10.1007/s004390050928; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GINZBURG HM, 1988, J ACQ IMMUN DEF SYND, V1, P2; GOEDERT JJ, 1987, JAMA-J AM MED ASSOC, V257, P331, DOI 10.1001/jama.257.3.331; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; HENTATI A, 1992, HUM MOL GENET, V1, P218, DOI 10.1093/hmg/1.3.218-a; HOLM S, 1979, SCAND J STAT, V6, P65; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Huttley GA, 1999, GENETICS, V152, P1711; Iwamoto S, 1996, BIOCHEM BIOPH RES CO, V222, P852, DOI 10.1006/bbrc.1996.0833; JAFFE HW, 1985, ANN INTERN MED, V103, P210, DOI 10.7326/0003-4819-103-2-210; Kaplan NL, 1998, AM J HUM GENET, V62, P703, DOI 10.1086/301760; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEWONTIN RC, 1964, GENETICS, V49, P49; Lincoln S.E., 1991, PRIMER COMPUTER PROG; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1995, AM J HUM GENET, V56, P799; LOVELAND KA, 1994, J PEDIATR PSYCHOL, V19, P223, DOI 10.1093/jpepsy/19.2.223; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 1997, AM J HUM GENET, V60, P188; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; Shriver MD, 1997, AM J HUM GENET, V60, P957; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sokal R. R., 1995, BIOMETRY PRINCIPLES; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; STEPHENS JC, 1999, MICROSATELLITES EVOL, P211; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Weir B., 1996, GENETIC DATA ANAL; WU S, 1989, NUCLEIC ACIDS RES, V17, P6433, DOI 10.1093/nar/17.15.6433; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	50	78	82	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					969	978		10.1086/302820	http://dx.doi.org/10.1086/302820			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712211	Green Published, Bronze			2022-12-18	WOS:000088373200019
J	Xiong, L; Labuda, M; Li, DS; Hudson, TJ; Desbiens, R; Patry, G; Verret, S; Langevin, P; Mercho, S; Seni, MH; Scheffer, I; Dubeau, F; Berkovic, SF; Andermann, F; Andermann, E; Pandolfo, M				Xiong, L; Labuda, M; Li, DS; Hudson, TJ; Desbiens, R; Patry, G; Verret, S; Langevin, P; Mercho, S; Seni, MH; Scheffer, I; Dubeau, F; Berkovic, SF; Andermann, F; Andermann, E; Pandolfo, M			Mapping of a gene determining familiar partial epilepsy with variable foci to chromosome 22q11-q12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTAL-LOBE EPILEPSY; LINKAGE ANALYSIS; DISORDER; LOCUS; PARAMETERS; MUTATION; TRAITS	We identified two large French-Canadian families segregating a familial partial epilepsy syndrome with variable foci (FPEVF) characterized by mostly nocturnal seizures arising from frontal, temporal, and occasionally occipital epileptic foci. There is no evidence for structural brain damage or permanent neurological dysfunction. The syndrome is inherited as an autosomal dominant trait with incomplete penetrance. We mapped the disease locus to a 3.8-cM interval on chromosome 22q11-q12, between markers D22S1144 and D22S685. Using the most conservative diagnostic scheme, the maximum cumulative LOD score was 6.53 at recombination fraction (theta) 0 with D22S689. The LOD score in the larger family was 5.31 at theta = 0 with the same marker. The two families share an identical linked haplotype for greater than or equal to 10 cM, including the candidate interval, indicating a recent founder effect. A severe phenotype in one of the probands may be caused by homozygosity for the causative mutation, as suggested by extensive homozygosity for the linked haplotype and a bilineal family history of epilepsy. An Australian family with a similar phenotype was not found to link to chromosome 22, indicating genetic heterogeneity of FPEVF.	Univ Montreal, Dept Med, CHU Montreal, Montreal, PQ H3C 3J7, Canada; Montreal Neurol Hosp & Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Montreal Gen Hosp, Res Ctr, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Univ Laval, CHU Quebec, Quebec City, PQ, Canada; Univ Melbourne, Dept Med, Austin & Repatriat Med Ctr, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; Monash Med Ctr, Dept Neurosci, Melbourne, Vic, Australia	Universite de Montreal; McGill University; McGill University; McGill University; Laval University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; Monash University	Pandolfo, M (corresponding author), CHU Montreal, Hop Notre Dame, Y-5608,1560 Rue Sherbrooke Est, Montreal, PQ H2L 4M1, Canada.	massimo.pandolfo@umontreal.ca	Pandolfo, Massimo/B-2853-2010; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Berkovic, Samuel/0000-0003-4580-841X				[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Berkovic SF, 1997, EPILEPSIA, V38, P1; Berkovic SF, 1996, ANN NEUROL, V40, P227, DOI 10.1002/ana.410400214; Berkovic SF, 1997, BRAIN DEV-JPN, V19, P13, DOI 10.1016/S0387-7604(96)00060-5; Berkovic SF, 1997, CURR OPIN NEUROL, V10, P110, DOI 10.1097/00019052-199704000-00007; Cendes F, 1998, NEUROLOGY, V50, P554, DOI 10.1212/WNL.50.2.554; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1985, AM J HUM GENET, V37, P482; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; PANAYIOTOPOULOS CP, 1989, ANN NEUROL, V26, P51, DOI 10.1002/ana.410260108; Phillips HA, 1998, AM J HUM GENET, V63, P1108, DOI 10.1086/302047; PHILLIPS JM, 1995, MRS BULL, V20, P13, DOI 10.1557/S0883769400045036; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; Scheffer IE, 1998, ANN NEUROL, V44, P890, DOI 10.1002/ana.410440607; SCHEFFER IE, 1994, LANCET, V343, P515, DOI 10.1016/S0140-6736(94)91463-X; SCHEFFER IE, 1995, ANN NEUROL, V38, P633, DOI 10.1002/ana.410380412; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Xiong Lan, 1998, Epilepsia, V39, P145; ZIETKIEWICZ E, 1992, HUM GENET, V89, P453	29	78	86	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1698	1710		10.1086/302649	http://dx.doi.org/10.1086/302649			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577924	Bronze, Green Published			2022-12-18	WOS:000084282500025
J	Uhrig, S; Schuffenhauer, S; Fauth, C; Wirtz, A; Daumer-Haas, C; Apacik, C; Cohen, M; Muller-Navia, J; Cremer, T; Murken, J; Speicher, MR				Uhrig, S; Schuffenhauer, S; Fauth, C; Wirtz, A; Daumer-Haas, C; Apacik, C; Cohen, M; Muller-Navia, J; Cremer, T; Murken, J; Speicher, MR			Multiplex-FISH for pre- and postnatal diagnostic applications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; MARKER CHROMOSOMES; CYTOGENETIC ANALYSIS; PAINTING PROBES; YAC CLONES	For >3 decades, Giemsa banding of metaphase chromosomes has been the standard karyotypic analysis for pre- and postnatal diagnostic applications. However, marker chromosomes or structural abnormalities are often encountered that cannot be deciphered by G-banding alone. Here we describe the use of multiplex-FISH (M-FISH), which allows the visualization of the 22 human autosomes and the 2 sex chromosomes, in 24 different colors. By M-FISH, the euchromatin in marker chromosomes could be readily identified. In cases of structural abnormalities, M-FISH identified translocations and insertions or demonstrated that the rearranged chromosome did not contain DNA material from another chromosome. In these cases, deleted or duplicated regions were discerned either by chromosome-specific multicolor bar codes or by comparative genomic hybridization. In addition, M-FISH was able to identify cryptic abnormalities in patients with a normal G-karyotype. In summary, M-FISH is a reliable tool for diagnostic applications, and results can be obtained in less than or equal to 24 h. When M-FISH is combined with G-banding analysis, maximum cytogenetic information is provided.	Univ Munich, Inst Anthropol & Human Genet, D-80336 Munich, Germany; Univ Munich, Abt Med Genet, Kinderklin, D-80336 Munich, Germany; Frauenarzte & Med Genet, Munich, Germany; Kinderzentrum, Munich, Germany; Inst Klin Genet Mainz, Mainz, Germany	University of Munich; University of Munich	Speicher, MR (corresponding author), Univ Munich, Inst Anthropol & Human Genet, Goethestr 31, D-80336 Munich, Germany.		Speicher, Michael R/B-5362-2013	Speicher, Michael R/0000-0003-0105-955X; Cremer, Thomas/0000-0001-7135-7216				BLENNOW E, 1993, AM J HUM GENET, V53, P433; Bolzer A, 1999, CYTOGENET CELL GENET, V84, P233, DOI 10.1159/000015266; BrayWard P, 1996, GENOMICS, V32, P1, DOI 10.1006/geno.1996.0070; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; Carter N. P., 1996, Bioimaging, V4, P41, DOI 10.1002/1361-6374(199606)4:2<41::AID-BIO2>3.3.CO;2-O; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CASPERSSON T, 1968, EXP CELL RES, V49, P219, DOI 10.1016/0014-4827(68)90538-7; Crolla JA, 1997, AM J MED GENET, V72, P440, DOI 10.1002/(SICI)1096-8628(19971112)72:4<440::AID-AJMG13>3.0.CO;2-R; Crolla JA, 1998, AM J MED GENET, V75, P355, DOI 10.1002/(SICI)1096-8628(19980203)75:4<355::AID-AJMG4>3.0.CO;2-P; Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; FRIEDRICH U, 1974, CLIN GENET, V6, P23; GUAN XY, 1995, HUM GENET, V95, P637; Guan XY, 1996, NAT GENET, V12, P10, DOI 10.1038/ng0196-10; JAUCH A, 1990, HUM GENET, V85, P145; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; LENGAUER C, 1993, HUM MOL GENET, V2, P505, DOI 10.1093/hmg/2.5.505; LENGAUER C, 1992, CANCER RES, V52, P2590; Lichter P, 1997, TRENDS GENET, V13, P475, DOI 10.1016/S0168-9525(97)01307-3; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; MULLERNAVIA J, 1995, HUM GENET, V96, P661, DOI 10.1007/BF00210295; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; PLATTNER R, 1993, HUM GENET, V91, P131; RAUCH A, 1992, CLIN GENET, V42, P84; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Schrock E, 1997, HUM GENET, V101, P255, DOI 10.1007/s004390050626; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; SPEICHER MR, 1993, HUM MOL GENET, V2, P1907; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; VoceroAkbani A, 1996, GENOMICS, V36, P492, DOI 10.1006/geno.1996.0495	30	78	82	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					448	462		10.1086/302508	http://dx.doi.org/10.1086/302508			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417288	Green Published, Bronze			2022-12-18	WOS:000081836900021
J	Kluijtmans, LAJ; Boers, GHJ; Kraus, JP; van den Heuvel, LPWJ; Cruysberg, JRM; Trijbels, FJM; Blom, HJ				Kluijtmans, LAJ; Boers, GHJ; Kraus, JP; van den Heuvel, LPWJ; Cruysberg, JRM; Trijbels, FJM; Blom, HJ			The molecular basis of cystathionine beta-synthase deficiency in dutch patients with homocystinuria: Effect of CBS genotype on biochemical and clinical phenotype and on response to treatment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-V-LEIDEN; METHYLENETETRAHYDROFOLATE REDUCTASE; CULTURED FIBROBLASTS; VASCULAR-DISEASE; NATURAL-HISTORY; 3 MUTATIONS; GENE; IDENTIFICATION; THROMBOSIS; YEAST	Homocystinuria due to cystathionine P-synthase (CBS) deficiency, inherited as an autosomal recessive trait, is the most prevalent inborn error of methionine metabolism. Its diverse clinical expression may include ectopia lentis, skeletal abnormalities, mental retardation, and premature arteriosclerosis and thrombosis. This variability is likely caused by considerable genetic heterogeneity. We investigated the molecular basis of CBS deficiency in 29 Dutch patients from 21 unrelated pedigrees and studied the possibility of a genotype-phenotype relationship with regard to biochemical and clinical expression and response to homocysteine-lowering treatment. Clinical symptoms and biochemical parameters were recorded at diagnosis and during long-term followup. Of 10 different mutations detected in the CBS gene, 833T-->C (I278T) was predominant, present in 23 (55%) of 42 independent alleles. At diagnosis, homozygotes for this mutation (n = 12) tended to have higher homocysteine levels than those seen in patients with other genotypes (n = 17), but similar clinical manifestations. During follow-up, I278T homozygotes responded more efficiently to homocysteine-lowering treatment. After 378 patient-years of treatment, only 2 vascular events were recorded; without treatment, at least 30 would have been expected (P < .01). This intervention in Dutch patients significantly reduces the risk of cardiovascular disease and other sequelae of classical homocystinuria syndrome.	Univ Nijmegen Hosp, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Boers, GHJ (corresponding author), Univ Nijmegen Hosp, Dept Internal Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	G.Boers@aig.azn.nl	Kluijtmans, Leo A/L-4437-2015; Cruysberg, Johannes R. M./D-4313-2009; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021	Cruysberg, Johannes R. M./0000-0002-5330-0774; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Blom, Henk/0000-0001-5202-9241				BOERS GH, 1983, J CLIN INVEST, V72, P1971, DOI 10.1172/JCI111161; BOERS GHJ, 1985, HUM GENET, V69, P164, DOI 10.1007/BF00293290; Brenton DP, 1971, INHERITED DISORDERS, P264; CARSON NAJ, 1962, ARCH DIS CHILD, V37, P505, DOI 10.1136/adc.37.195.505; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CRUYSBERG JRM, 1996, THESIS U NIJMEGEN NI; DEFRANCHIS R, 1994, HUM MOL GENET, V3, P1103, DOI 10.1093/hmg/3.7.1103; FINKELSTEIN JD, 1964, SCIENCE, V146, P785, DOI 10.1126/science.146.3645.785; FOWLER B, 1978, J CLIN INVEST, V61, P645, DOI 10.1172/JCI108976; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; GOLDSTEIN JL, 1972, J CLIN INVEST, V51, P1034, DOI 10.1172/JCI106863; Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213; Kluijtmans LAJ, 1998, BLOOD, V91, P2015, DOI 10.1182/blood.V91.6.2015.2015_2015_2018; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; Kluijtmans LAJ, 1996, J CLIN INVEST, V98, P285, DOI 10.1172/JCI118791; Kozich Viktor, 1992, Human Mutation, V1, P113, DOI 10.1002/humu.1380010206; Krans JP, 1998, EUR J PEDIATR, V157, pS50, DOI 10.1007/PL00014304; KRAUS J, 1978, J BIOL CHEM, V253, P6523; KRUGER WD, 1995, HUM MOL GENET, V4, P1155, DOI 10.1093/hmg/4.7.1155; Mandel H, 1996, NEW ENGL J MED, V334, P763, DOI 10.1056/NEJM199603213341204; MARBLE M, 1994, HUM MOL GENET, V3, P1883, DOI 10.1093/hmg/3.10.1883; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; MUDD SH, 1964, SCIENCE, V143, P1443, DOI 10.1126/science.143.3613.1443; MUDD SH, 1985, AM J HUM GENET, V37, P1; MUNKE M, 1988, AM J HUM GENET, V42, P550; POELEPOTHOFF MTWBT, 1995, ANN CLIN BIOCHEM, V32, P218; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324; SHIH VE, 1995, AM J HUM GENET, V57, P34; UHLENDORF BW, 1968, SCIENCE, V160, P1007, DOI 10.1126/science.160.3831.1007; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964	31	78	79	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					59	67		10.1086/302439	http://dx.doi.org/10.1086/302439			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364517	Green Published, Bronze			2022-12-18	WOS:000081224300009
J	Tiziani, V; Reichenberger, E; Buzzo, CL; Niazi, S; Fukai, N; Stiller, M; Peters, H; Salzano, FM; do Amaral, CMR; Olsen, BR				Tiziani, V; Reichenberger, E; Buzzo, CL; Niazi, S; Fukai, N; Stiller, M; Peters, H; Salzano, FM; do Amaral, CMR; Olsen, BR			The gene for cherubism maps to chromosome 4p16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; NOONAN-SYNDROME; BETA-SUBUNIT; MUTATIONS; ACHONDROPLASIA; HYPOCHONDROPLASIA; PHOSPHODIESTERASE; OSTEOPROTEGERIN; LIGAND; DOMAIN	Cherubism is an autosomal dominant disorder that may be related to tooth development and eruption. It is a disorder of age-related bone remodeling, mostly limited to the maxilla and the mandible, with loss of bone in the jaws and its replacement with large amounts of fibrous tissue. We have used a genomewide search with a three-generation family and have established linkage to chromosome 4p16. Three other families affected with cherubism were also genotyped and were mapped to the same locus. The combined LOD score is 4.21 at a recombination fraction of 0, and the locus spans an interval of similar to 22 cM.	Harvard Univ, Sch Dent Med, Harvard Forsyth Dept Oral Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; SOBRAPAR, Inst Cirurgia Plast Craniofacial, Campinas, Brazil; Free Univ Berlin, Klin Polyklin Zahn Mund & Kieferheilkunde, D-1000 Berlin, Germany; Univ Berlin, Inst Med Genet, Berlin, Germany; Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Harvard University; Harvard School of Dental Medicine; Harvard University; Free University of Berlin; Universidade Federal do Rio Grande do Sul	Tiziani, V (corresponding author), 140 Fenway, Boston, MA 02115 USA.	vtiziani@warren.med.harvard.edu	Salzano, Francisco M/L-7916-2015; Tiziani, Valdenize/F-9848-2012	Tiziani, Valdenize/0000-0001-6783-9212	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036819, R37AR036819] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR36819] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson DE, 1962, ORAL SURG ORAL MED O, V15, P5; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; COHEN MM, 1991, AM J MED GENET, V40, P159, DOI 10.1002/ajmg.1320400208; CORNELIU.EA, 1969, AMER J ROENTGENOL RA, V106, P136, DOI 10.2214/ajr.106.1.136; de Pina-Neto JM, 1998, AM J MED GENET, V77, P43, DOI 10.1002/(SICI)1096-8628(19980428)77:1<43::AID-AJMG10>3.0.CO;2-O; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRACOPOLI NC, 1995, CURRENT PROTOCOLS HU; DUNLAP C, 1989, ORAL SURG ORAL MED O, V67, P698, DOI 10.1016/0030-4220(89)90012-1; FAIRCLOTH WJ, 1991, J ORAL MAXIL SURG, V49, P535; GAL A, 1994, HUM MOL GENET, V3, P323, DOI 10.1093/hmg/3.2.323; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; JONES WA, 1965, ORAL SURG ORAL MED O, V20, P648, DOI 10.1016/0030-4220(65)90111-8; Jones WA., 1933, AM J CANC, V17, P946, DOI [10.1158/ajc.1933.946, DOI 10.1158/AJC.1933.946]; KATZ JO, 1992, J ORAL MAXIL SURG, V50, P301, DOI 10.1016/0278-2391(92)90333-U; KAUGARS GE, 1992, ORAL SURG ORAL MED O, V73, P369, DOI 10.1016/0030-4220(92)90137-F; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARCK PA, 1992, J OTOLARYNGOL, V21, P84; McClendon JL, 1962, ORAL SURG         S2, V15, P17; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; MORTON NE, 1955, AM J HUM GENET, V7, P277; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; PINANETO JM, 1986, AM J MED GENET, V25, P433, DOI 10.1002/ajmg.1320250305; QUAN F, 1995, HUM MOL GENET, V4, P1681, DOI 10.1093/hmg/4.9.1681; RAMON Y, 1967, ORAL SURG ORAL MED O, V24, P435, DOI 10.1016/0030-4220(67)90416-1; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SALZANO FM, 1966, ACTA GENET MED GEMEL, V15, P296, DOI 10.1017/S112096230001341X; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; STOILOV I, 1995, AM J MED GENET, V55, P127, DOI 10.1002/ajmg.1320550132; THOMPSON ER, 1962, ORAL SURG ORAL MED O, V15, P69; Timosca G. C., 1996, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V97, P172; WAYMAN JB, 1978, BRIT J ORAL SURG, V16, P47, DOI 10.1016/S0007-117X(78)80055-9; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; ZUO JA, 1993, HUM MOL GENET, V2, P889, DOI 10.1093/hmg/2.7.889	37	78	82	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					158	166		10.1086/302456	http://dx.doi.org/10.1086/302456			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364528	Green Published, Bronze			2022-12-18	WOS:000081224300020
J	Flejter, WL; Fergestad, J; Gorski, J; Varvill, T; Chandrasekharappa, S				Flejter, WL; Fergestad, J; Gorski, J; Varvill, T; Chandrasekharappa, S			A gene involved in XY sex reversal is located on chromosome 9, distal to marker D9S1779	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; MUTATIONAL ANALYSIS; DETERMINING REGION; FEMALE; SOX9; DELETION; MONOSOMY; POLYMORPHISMS; LOCUS	The genetic mechanisms involved in sex differentiation are poorly understood, and progress in identification of the genes involved has been slow The fortuitous finding of chromosomal rearrangements in association with a sex-reversed phenotype has led to the isolation of SRY and SOX9, both shown to be involved in the sex-determining pathway. In addition, duplications of the X chromosome, deletions of chromosomes 9 and 10, and translocations involving chromosome 17 have been reported to be associated with abnormal testicular differentiation, leading to male-to-female sex reversal in 46,XY individuals. We present the cytogenetic and molecular analyses of four sex-reversed XY females, each with gonadal dysgenesis and other variable malformations, and with terminal deletions of distal chromosome 9p, resulting from unbalanced autosomal translocations. PCR amplification and DNA sequence analysis of SRY revealed no mutations in the high-mobility-group domain (i.e., HMG box) in any of the four patients. Conventional and molecular cytogenetic analyses of metaphase chromosomes from each patient suggest that the smallest region of overlap (SRO) of deletions involves a very small region of distal band 9p24. Loss-of-heterozygosity studies using 17 highly polymorphic microsatellite markers, as well as FISH using YAC clones corresponding to the most distal markers on 9p, showed that the SRO lies distal to marker D9S1779. These results significantly narrow the putative sex-determining gene to the very terminal region of the short arm of chromosome 9.	Univ Utah, Dept Pediat, Salt Lake City, UT USA; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; NIH, Bethesda, MD 20892 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA	Flejter, WL (corresponding author), Wake Forest Univ, Sch Med, Dept Pediat, Med Ctr Blvd, Winston Salem, NC 27157 USA.	wflejter@wfubmc.edu			NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000199] Funding Source: NIH RePORTER; NCI NIH HHS [CA42014-10] Funding Source: Medline; NHGRI NIH HHS [P50HG00199-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADAMSON D, 1995, AM J HUM GENET, V57, P619; AFFARA NA, 1993, HUM MOL GENET, V2, P785, DOI 10.1093/hmg/2.6.785; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; BENNETT CP, 1993, J MED GENET, V30, P518, DOI 10.1136/jmg.30.6.518; BERNSTEIN R, 1980, SCIENCE, V207, P768, DOI 10.1126/science.7352285; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Cameron FJ, 1997, HUM MUTAT, V9, P388; CROCKER M, 1988, CLIN GENET, V34, P70; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FLEJTER WL, 1995, GENOMICS, V25, P413, DOI 10.1016/0888-7543(95)80041-J; FLEJTER WL, 1993, GENOMICS, V17, P624, DOI 10.1006/geno.1993.1382; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRYNS JP, 1986, ANN GENET-PARIS, V29, P49; Furlong Robert A., 1992, Human Molecular Genetics, V1, P447, DOI 10.1093/hmg/1.6.447; Guioli S, 1997, ANN HUM GENET, V61, P212; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; HOO J J, 1989, American Journal of Human Genetics, V45, pA78; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; JOTTERAND M, 1976, HUM GENET, V33, P213, DOI 10.1007/BF00286845; KWOK C, 1995, AM J HUM GENET, V57, P1028; Magenis RE, 1990, AM J HUM GENET S, V47, pA33; McDonald MT, 1997, AM J MED GENET, V73, P321; MCELREAVY K, 1992, P NATL ACAD SCI USA, V89, P11016, DOI 10.1073/pnas.89.22.11016; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Ogata T, 1997, J MED GENET, V34, P331, DOI 10.1136/jmg.34.4.331; Povey S, 1997, ANN HUM GENET, V61, P183, DOI 10.1017/S0003480097006106; ROBINSON A, 1993, CLIN GENETICS HDB, P309; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SULTANA R, 1995, GENE CHROMOSOME CANC, V13, P257, DOI 10.1002/gcc.2870130405; TOMMERUP N, 1993, NAT GENET, V4, P170, DOI 10.1038/ng0693-170; Veitia R, 1997, GENOMICS, V41, P271, DOI 10.1006/geno.1997.4648; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILKIE AOM, 1993, AM J MED GENET, V46, P597, DOI 10.1002/ajmg.1320460527; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3	34	78	83	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					794	802		10.1086/302016	http://dx.doi.org/10.1086/302016			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718346	Green Published, Bronze			2022-12-18	WOS:000075919000017
J	Hirano, M; Garcia-de-Yebenes, J; Jones, AC; Nishino, I; DiMauro, S; Carlo, JR; Bender, AN; Hahn, AF; Salberg, LM; Weeks, DE; Nygaard, TG				Hirano, M; Garcia-de-Yebenes, J; Jones, AC; Nishino, I; DiMauro, S; Carlo, JR; Bender, AN; Hahn, AF; Salberg, LM; Weeks, DE; Nygaard, TG			Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; MULTIPLE DELETIONS; AUTO-ANTIGEN; LINKAGE MAP; DNA; DISORDER; REGION; DEFICIENCY; CLONING; MNGIE	Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome is a rare, multisystem disorder characterized clinically by ptosis, progressive external ophthalmoplegia, gastrointestinal dysmotility, leukoencephalopathy, thin body habitus, and myopathy. Laboratory studies reveal defects of oxidative-phosphorylation and multiple mtDNA deletions frequently in skeletal muscle. We studied four ethnically distinct families affected with this apparently autosomal recessive disorder. Probands from each family were shown, by Southern blot, to have multiple mtDNA deletions in skeletal muscle. We mapped the MNGIE locus to 22q13.32-qter, distal to D22S1161, with a maximum two-point LOD score of 6.80 at locus D22S526. Cosegregation of MNGIE with a single chromosomal region in families with diverse ethnic backgrounds suggests that we have mapped an important locus for this disorder. We found no evidence to implicate three candidate genes in this region, by using direct sequence analysis for DNA helicase Il and by assaying enzyme activities for arylsulfatase A and carnitine palmitoyltransferase.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Mt Sinai Sch Med, Dept Neurol, New York, NY USA; Univ Madrid, Dept Neurol, Madrid 3, Spain; Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; Univ Western Ontario, Dept Clin Neurol, London, ON, Canada; Cleveland Clin Fdn, Dept Neurol, Cleveland, OH 44195 USA; Wellcome Trust Ctr Human Genet, Oxford, England; Univ Pittsburgh, Dept Genet, Pittsburgh, PA USA	Columbia University; Icahn School of Medicine at Mount Sinai; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Western University (University of Western Ontario); Cleveland Clinic Foundation; University of Oxford; Wellcome Centre for Human Genetics; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, P&S 4-443,630 W 168th St, New York, NY 10032 USA.		Weeks, Daniel E/B-2995-2012; Nishino, Ichizo/G-2676-2010	Weeks, Daniel E/0000-0001-9410-7228; Nishino, Ichizo/0000-0001-9452-112X; Hirano, Michio/0000-0002-7070-7402	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001617, R29NS032035] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL59657] Funding Source: Medline; NINDS NIH HHS [NS32035, K08-NS01617] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445; BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189; Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Carrozzo R, 1998, NEUROLOGY, V50, P99, DOI 10.1212/WNL.50.1.99; CHAN JYC, 1989, J BIOL CHEM, V264, P3651; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DiMauro S, 1997, MOL GENETIC BASIS NE, P201; HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721; HIRANO M, MOTOR DISORDERS; Kaukonen JA, 1996, AM J HUM GENET, V58, P763; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; REEVES WH, 1989, J BIOL CHEM, V264, P5047; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sobel E, 1996, AM J HUM GENET, V58, P1323; SOBEL E, 1995, GENETIC MAPPING DNA, V81, P89; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; VISHWANATHA JK, 1995, MOL CELL BIOCHEM, V146, P121, DOI 10.1007/BF00944604; WEEKS DE, 1995, GENOMICS, V26, P39, DOI 10.1016/0888-7543(95)80080-6; Yamazaki N, 1996, BBA-GENE STRUCT EXPR, V1307, P157, DOI 10.1016/0167-4781(96)00069-3; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	27	78	82	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					526	533		10.1086/301979	http://dx.doi.org/10.1086/301979			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683610	hybrid, Green Published			2022-12-18	WOS:000075360800028
J	Mooser, V; Scheer, D; Marcovina, SM; Wang, JP; Guerra, R; Cohen, J; Hobbs, HH				Mooser, V; Scheer, D; Marcovina, SM; Wang, JP; Guerra, R; Cohen, J; Hobbs, HH			The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; BLACK-WHITE DIFFERENCES; APOLIPOPROTEIN(A) GENE; LIPOPROTEIN(A) CONCENTRATIONS; GROWTH-HORMONE; SEQUENCE POLYMORPHISMS; SERUM-LIPOPROTEIN; ETHNIC-GROUPS; RISK-FACTORS; PHENOTYPES	The distributions of plasma lipoprotein(a), or Lp(a), levels differ significantly among ethnic groups. Individuals of African descent have a two-to threefold higher mean plasma level of Lp(a) than either Caucasians or Orientals. In Caucasians, variation in the plasma Lp(a) levels has been shown to be largely determined by sequence differences at the apo(a) locus, but little is known about either the genetic architecture of plasma Lp(a) levels in Africans or why they have higher levels of plasma Lp(a). In this paper we analyze the plasma Lp(a) levels of 257 sibling pairs from 49 independent African American families. The plasma Lp(a) levels were much more similar in the sibling pairs who inherited both apo(a) alleles identical by descent (IBD) (r = .85) than in those that shared one (r = .48) or no (r = .22) parental apo(a) alleles in common. On the basis of these findings, it was estimated that 78% of the variation in plasma Lp(a) levels in African Americans is attributable to polymorphism at either the apo(a) locus or sequences closely linked to it. Thus, the apo(a) locus is the major determinant of variation in plasma Lp(a) levels in African Americans, as well as in Caucasians. No molecular evidence was found for a common ''high-expressing'' apo(a) allele in the African Americans, We propose that the higher plasma levels of Lp(a) in Africans are likely due to a yet-to-be-identified trans-acting factor(s) that causes an increase in the rare of secretion of apo(a) or a decrease in its catabolism.	UNIV TEXAS, SW MED CTR, DEPT MOL GENET, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, CTR HUMAN NUTR, DALLAS, TX 75235 USA; SO METHODIST UNIV, DEPT STAT SCI, DALLAS, TX 75275 USA; LOUISIANA STATE UNIV, MED CTR, DEPT PATHOL, NEW ORLEANS, LA USA; UNIV WASHINGTON, NW LIPID RES LABS, DEPT MED, SEATTLE, WA 98195 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Southern Methodist University; Louisiana State University System; University of Washington; University of Washington Seattle					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086, P01HL020948, R01HL047619] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-20948, HL-47619, HL-30086] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1990, CLIN CHEM, V36, P2019; ALBERS JJ, 1974, BIOCHEM GENET, V11, P475, DOI 10.1007/BF00486079; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; AUSTIN MA, 1992, AM J HUM GENET, V51, P829; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; BOOMSMA DI, 1993, ATHEROSCLEROSIS, V99, P23, DOI 10.1016/0021-9150(93)90047-X; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; COBBAERT C, 1992, AM J EPIDEMIOL, V136, P441, DOI 10.1093/oxfordjournals.aje.a116517; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; DECROO S, 1991, HUM HERED, V41, P215, DOI 10.1159/000154004; DEMEESTER CA, 1995, AM J HUM GENET, V56, P287; EDEN S, 1993, ARTERIOSCLER THROMB, V13, P296, DOI 10.1161/01.ATV.13.2.296; Falconer D. S., 1989, Introduction to quantitative genetics.; GAW A, 1994, J CLIN INVEST, V93, P2526, DOI 10.1172/JCI117263; GUYTON JR, 1985, ARTERIOSCLEROSIS, V5, P265, DOI 10.1161/01.ATV.5.3.265; HAFFNER SM, 1992, AM J EPIDEMIOL, V136, P1060, DOI 10.1093/oxfordjournals.aje.a116571; HASEMAN JK, 1972, BEHAV GENET, V2, P2; HEISS G, 1984, AM HEART J, V108, P807, DOI 10.1016/0002-8703(84)90676-8; HELMHOLD M, 1991, J LIPID RES, V32, P1919; Hershkovitz E, 1996, HORM RES, V46, P38, DOI 10.1159/000184975; HEWITT D, 1977, CLIN GENET, V11, P224; JUNGNER I, 1995, CLIN BIOCHEM, V28, P427, DOI 10.1016/0009-9120(95)00009-X; KEIL JE, 1993, NEW ENGL J MED, V329, P73, DOI 10.1056/NEJM199307083290201; KENDALL MG, 1979, ADV THEORY STATISTIC; Kraft HG, 1996, EUR J HUM GENET, V4, P74; KRAFT HG, 1992, HUM GENET, V90, P220; KREMPLER F, 1980, J CLIN INVEST, V65, P1483, DOI 10.1172/JCI109813; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LACKNER C, 1991, J CLIN INVEST, V87, P2077; *LIP RES CLIN PROG, 1982, DEP HLTH ED WELF PUB; MANCINI FP, 1995, HUM MOL GENET, V4, P1535, DOI 10.1093/hmg/4.9.1535; MARCOVINA SM, 1993, BIOCHEM BIOPH RES CO, V191, P1192, DOI 10.1006/bbrc.1993.1343; MARCOVINA SM, 1993, ARTERIOSCLER THROMB, V13, P1037, DOI 10.1161/01.ATV.13.7.1037; Marcovina SM, 1996, J LIPID RES, V37, P2569; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; MOLITERNO DJ, 1995, ARTERIOSCL THROM VAS, V15, P850, DOI 10.1161/01.ATV.15.7.850; MOOSER V, 1995, HUM MOL GENET, V4, P173, DOI 10.1093/hmg/4.2.173; PARRA HJ, 1987, CLIN CHIM ACTA, V167, P27; PEROMBELON YFN, 1994, J CLIN INVEST, V93, P1481, DOI 10.1172/JCI117126; RADER DJ, 1993, J CLIN INVEST, V91, P443, DOI 10.1172/JCI116221; RADER DJ, 1992, JAMA-J AM MED ASSOC, V267, P1109, DOI 10.1001/jama.267.8.1109; SANDHOLZER C, 1991, HUM GENET, V86, P607; SORRENTINO MJ, 1992, AM J MED, V93, P658, DOI 10.1016/0002-9343(92)90199-L; SRINIVASAN SR, 1991, CIRCULATION, V84, P160, DOI 10.1161/01.CIR.84.1.160; STEINBERG AG, 1969, ANNU REV GENET, V3, P25, DOI 10.1146/annurev.ge.03.120169.000325; STOESZ MR, IN PRESS ANN HUM GEN; TROMMSDORFF M, 1995, J CLIN INVEST, V96, P150, DOI 10.1172/JCI118015; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; WADE DP, 1993, P NATL ACAD SCI USA, V90, P1369, DOI 10.1073/pnas.90.4.1369; Wan Y, 1997, ANN HUM GENET, V61, P79; WHITE AL, 1994, J BIOL CHEM, V269, P28716; WRIGHT NM, 1995, J CLIN ENDOCR METAB, V80, P2291, DOI 10.1210/jc.80.8.2291; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014	55	78	79	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					402	417		10.1086/514851	http://dx.doi.org/10.1086/514851			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311746	Green Published, Bronze			2022-12-18	WOS:A1997XX70100019
J	Baysal, BE; Farr, JE; Rubinstein, WS; Galus, RA; Johnson, KA; Aston, CE; Myers, EN; Johnson, JT; Carrau, R; Kirkpatrick, SJ; Myssiorek, D; Singh, D; Saha, S; Gollin, SM; Evans, GA; James, MR; Richard, CW				Baysal, BE; Farr, JE; Rubinstein, WS; Galus, RA; Johnson, KA; Aston, CE; Myers, EN; Johnson, JT; Carrau, R; Kirkpatrick, SJ; Myssiorek, D; Singh, D; Saha, S; Gollin, SM; Evans, GA; James, MR; Richard, CW			Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAROTID-BODY TUMORS; HEREDITARY PARAGANGLIOMAS; COLORECTAL CARCINOMAS; MYOTONIC-DYSTROPHY; MALIGNANT-MELANOMA; GLOMUS TUMORS; WILMS-TUMOR; HETEROZYGOSITY; ANTICIPATION; METHYLATION	Hereditary nonchromaffin paragangliomas (PGL; glomus tumors; MIM 168000) are mostly benign, slow-growing tumors of the head and neck region, inherited from carrier fathers in an autosomal dominant fashion subject to genomic imprinting. Genetic linkage analysis in two large, unrelated Dutch families assigned PGL loci to two regions of chromosome 11, at 11q23 (PGL1) and 11q13.1 (PGL2). We ascertained a total of 11 North American PGL families and confirmed maternal imprinting (inactivation). In three of six families, linkage analysis provided evidence of linkage to the PGL1 locus at 11q23. Recombinants narrowed the critical region to an similar to 4.5-Mb interval flanked by markers D11S1647 and D11S622. Partial allelic loss of strictly maternal origin was detected in 5 of 19 tumors. The greatest degree of imbalance was detected at 11q23, distal to D11S1327 and proximal to CD3D. Age at onset of symptoms was significantly different between fathers and children (Wilcoxon rank-sum test, P < .002). Affected children had an earlier age at onset of symptoms in 39 of 57 father-child pairs (chi(2) = 7.74, P < .006). However, a more conservative comparison of the number of pairs in which a child had greater than or equal to 5 years earlier age at onset (n = 33) vis-a-vis that of complementary pairs (n = 24) revealed no significant difference (chi(2) = 1.42, P > .2). Whether these data represent genetic anticipation or ascertainment bias can be addressed only by analysis of a larger number of father-child pairs.	UNIV PITTSBURGH,WESTERN PSYCHIAT INST & CLIN,MED CTR,DEPT HUMAN GENET,PITTSBURGH,PA 15213; UNIV PITTSBURGH,MED CTR,DEPT PSYCHIAT,PITTSBURGH,PA 15213; UNIV PITTSBURGH,MED CTR,DEPT OTOLARYNGOL,PITTSBURGH,PA 15213; UNIV PITTSBURGH,MED CTR,PITTSBURGH CANC INST,PITTSBURGH,PA 15213; UNIV WISCONSIN,CLIN GENET CTR,DIV MED GENET,MADISON,WI; LONG ISL JEWISH MED CTR,DEPT OTOLARYNGOL & COMMUN DISORDERS,NEW HYDE PK,NY 11042; MEHARRY MED COLL,DIV MED GENET,NASHVILLE,TN 37208; MICHIGAN STATE COLL HUMAN MED,DEPT SURG,E LANSING,MI; UNIV TEXAS,SW MED SCH,EUGENE MCDERMOTT CTR GROWTH & DEV,DALLAS,TX 75230; WELLCOME TRUST CTR HUMAN GENET,OXFORD,ENGLAND	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Wisconsin System; University of Wisconsin Madison; Northwell Health; Meharry Medical College; Michigan State University; Michigan State University College of Human Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oxford; Wellcome Centre for Human Genetics				Gollin, Susanne/0000-0001-5438-6808	NHGRI NIH HHS [HG00202] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ASHIZAWA T, 1992, NEUROLOGY, V42, P1871; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BEECHEY CV, 1995, MOUSE GENOME, V93, P89; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; CHATKUPT S, 1995, J NEUROL SCI, V130, P1, DOI 10.1016/0022-510X(94)00284-U; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; COIA LR, 1981, INT J RADIAT ONCOL, V7, P949, DOI 10.1016/0360-3016(81)90014-6; DEVILEE P, 1994, GENE CHROMOSOME CANC, V11, P71, DOI 10.1002/gcc.2870110202; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FICK GM, 1994, KIDNEY INT, V45, P1153, DOI 10.1038/ki.1994.153; FOULKES WD, 1993, BRIT J CANCER, V67, P268, DOI 10.1038/bjc.1993.51; GRUFFERMAN S, 1980, CANCER, V46, P2116, DOI 10.1002/1097-0142(19801101)46:9<2116::AID-CNCR2820460934>3.0.CO;2-S; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; HAMPTON GM, 1994, CANCER RES, V54, P4586; HAMPTON GM, 1994, P NATL ACAD SCI USA, V91, P6953, DOI 10.1073/pnas.91.15.6953; HERBST RA, 1995, CANCER RES, V55, P2494; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Heutink Peter, 1994, European Journal of Human Genetics, V2, P148; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; HULSEBOS TJM, 1990, LANCET, V335, P660, DOI 10.1016/0140-6736(90)90446-C; IIZUKA M, 1995, GENE CHROMOSOME CANC, V13, P40; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; KELDYSH PL, 1993, GENE CHROMOSOME CANC, V6, P45, DOI 10.1002/gcc.2870060109; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; KROLL AJ, 1964, NEW ENGL J MED, V270, P6, DOI 10.1056/NEJM196401022700102; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; MARIMAN ECM, 1993, HUM GENET, V91, P357, DOI 10.1007/BF00217356; MCCAFFREY TV, 1994, ARCH OTOLARYNGOL, V120, P1211; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; NEGRINI M, 1995, CANCER RES, V55, P3003; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PARRY DM, 1982, J NATL CANCER I, V68, P573; Reid LH, 1996, HUM MOL GENET, V5, P239, DOI 10.1093/hmg/5.2.239; SAPIENZA C, 1994, AM J HUM GENET, V55, P1073; SAPIENZA C, 1995, METABOLIC MOL BASES, P437; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SHAW ME, 1995, GENE CHROMOSOME CANC, V13, P1, DOI 10.1002/gcc.2870130102; SRIVATSAN ES, 1993, GENE CHROMOSOME CANC, V7, P32, DOI 10.1002/gcc.2870070106; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TOMLINSON IPM, 1993, GENE CHROMOSOME CANC, V7, P169, DOI 10.1002/gcc.2870070310; VANDERMEY AGL, 1989, LANCET, V2, P1291; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047	46	78	83	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					121	132						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981955				2022-12-18	WOS:A1997WA81800018
J	KohonenCorish, M; Ross, VL; Doe, WF; Kool, DA; Edkins, E; Faragher, I; Wijnen, J; Khan, PM; Macrae, F; StJohn, DJB				KohonenCorish, M; Ross, VL; Doe, WF; Kool, DA; Edkins, E; Faragher, I; Wijnen, J; Khan, PM; Macrae, F; StJohn, DJB			RNA-based mutation screening in hereditary nonpolyposis colorectal cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLON-CANCER; ADENOMATOUS POLYPOSIS; HMSH2 MUTATIONS; GENE; HOMOLOG; CELLS; KINDREDS; HMLH1; LOCUS; HNPCC	Hereditary nonpolyposis colorectal cancer (HNPCC) is a cancer syndrome inherited in an autosomal dominant fashion. Four susceptibility genes are known, which code for DNA mismatch repair enzymes. The purpose of this study was to identify the HNPCC gene defects in a cohort of Australian HNPCC families and to evaluate the use of RNA-based screening methods. Six mutations were identified, four in the hMLH1 gene and two in hMSH2, by using a combination of DNA-based and RNA-based methods. One of the hMLH1 defects was a missense mutation, and the other five mutations would be expected to result in a shortened protein. These included a rare type of mRNA splicing mutation in hMLH1 exon 17. By use of reverse-transcriptase (RT) PCR, defective transcripts were detectable for three of the hMLH1 mutations but not for the fourth one, which was predicted to cause skipping of exon 15. Furthermore, many more alternative transcripts for the hMLH1 gene were found than previously described, and these were more abundant in the RNA samples prepared from whole blood than from lymphoblastoid cell lines. This confounded RNA-based screening for HNPCC mutations, because it was difficult to determine which aberrant RT-PCR fragment was the real hereditary defect. One of the splice-site mutations reported here causes skipping of exons 9 and 10, which also occurs as an alternative transcript. When the protein-truncation test was used, the results were indistinguishable between the patients in this family and controls. Other aberrant transcripts were also observed that varied in size between individuals but were unrelated to the hereditary defects. This study has important implications for the design of reliable diagnostic tests for HNPCC gene defects.	PRINCESS MARGARET HOSP CHILDREN, GENET SERV WESTERN AUSTRALIA, PERTH, WA, AUSTRALIA; ROYAL MELBOURNE HOSP, LUDWIG INST CANC RES, MELBOURNE, FL USA; ROYAL MELBOURNE HOSP, DEPT GASTROENTEROL, MELBOURNE, FL USA; LEIDEN UNIV, SYLVIUS LAB, DEPT HUMAN GENET, MGC, LEIDEN, NETHERLANDS	University of Western Australia; Ludwig Institute for Cancer Research; Leiden University; Leiden University - Excl LUMC	KohonenCorish, M (corresponding author), AUSTRALIAN NATL UNIV, JOHN CURTIN SCH MED RES, DIV MOL MED, GPO BOX 334, CANBERRA, ACT 2601, AUSTRALIA.		Kohonen-Corish, Maija/Q-9763-2019	Kohonen-Corish, Maija/0000-0002-4073-1479				BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CHARBONNIER F, 1995, CANCER RES, V55, P1839; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; KOHONENCORISH MRJ, 1995, J GASTROEN HEPATOL, V10, P76, DOI 10.1111/j.1440-1746.1995.tb01052.x; KOLODNER RD, 1994, GENOMICS, V24, P516, DOI 10.1006/geno.1994.1661; KOLODNER RD, 1995, CANCER RES, V55, P242; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1994, CANCER RES, V54, P4590; LUCE MC, 1995, GASTROENTEROLOGY, V109, P1368, DOI 10.1016/0016-5085(95)90600-2; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; NAN HJ, 1995, HUM MOL GENET, V4, P237, DOI 10.1093/hmg/4.2.237; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; SAMOWITZ WS, 1995, CANCER RES, V55, P3732; VANDERLUIJT RB, 1995, HUM GENET, V96, P705, DOI 10.1007/BF00210303; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WIJNEN J, 1995, AM J HUM GENET, V56, P1060; Wijnen J, 1996, AM J HUM GENET, V58, P300	26	78	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					818	824						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808596				2022-12-18	WOS:A1996VL28300010
J	Nissinen, M; HelblingLeclerc, A; Zhang, X; Evangelista, T; Topaloglu, H; Cruaud, C; Weissenbach, J; Fardeau, M; Tome, FMS; Schwartz, K; Tryggvason, K; Guicheney, P				Nissinen, M; HelblingLeclerc, A; Zhang, X; Evangelista, T; Topaloglu, H; Cruaud, C; Weissenbach, J; Fardeau, M; Tome, FMS; Schwartz, K; Tryggvason, K; Guicheney, P			Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha 2-chain in congenital muscular dystrophy with partial deficiency of the protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							A-CHAIN; DOMAIN; GENE	Congenital muscular dystrophies (CMDs) are autosomal recessive muscle disorders of early onset. Approximately half of CMD patients present laminin alpha 2-chain (merosin) deficiency in muscle biopsies, and the disease locus has been mapped to the region of the LAMA2 gene (6q22-23) in several families. Recently, two nonsense mutations in the laminin alpha 2-chain gene were identified in CMD patients exhibiting complete deficiency of the laminin alpha 2-chain in muscle biopsies. However, a subset of CMD patients with linkage to LAMA2 show only partial absence of the laminin alpha 2-chain around muscle fibers, by immunocytochemical analysis. In the present study we have identified a homozygous missense mutation in the alpha 2-chain gene of a consanguineous Turkish family with partial laminin alpha 2-chain deficiency. The T-->C transition at position 3035 in the cDNA sequence results in a Cys996-->Arg substitution. The mutation that affects one of the conserved cysteine-rich repeats in the short arm of the laminin alpha 2-chain should result in normal synthesis of the chain and in formation and secretion of a heterotrimeric laminin molecule. Muscular dysfunction is possibly caused either by abnormal disulfide cross-links and folding of the laminin repeat, leading to the disturbance of an as yet unknown binding function of the laminin alpha 2-chain and to shorter half-life of the muscle-specific laminin-2 and laminin-4 isoforms, or by increased proteolytic sensitivity, leading to truncation of the short arm.	KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,DIV MATRIX BIOL,S-17177 STOCKHOLM,SWEDEN; UNIV OULU,BIOCTR OULU,OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,OULU,FINLAND; HOP LA PITIE SALPETRIERE,INSERM,U153,PARIS,FRANCE; HACETTEPE CHILDRENS HOSP MED CTR,DEPT PAEDIAT NEUROL,ANKARA,TURKEY; GENETHON SA,EVRY,FRANCE	Karolinska Institutet; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hacettepe University			TOPALOGLU, HALUK AYDIN/I-9318-2013; de Carvalho, Mamede/I-6295-2019; Evangelista, Teresinha/AAF-3216-2020; Guicheney, Pascale/D-1034-2017	de Carvalho, Mamede/0000-0001-7556-0158; Evangelista, Teresinha/0000-0002-1329-9131; Guicheney, Pascale/0000-0002-7663-2050; Cruaud, Corinne/0000-0002-4752-7278; Nissinen, Marja/0000-0001-9224-1474; HELBLING-LECLERC, Anne/0000-0002-2686-2798				BECK K, 1992, PATTERNS PROTEIN SEQ, P231; BERNIER SM, 1995, MATRIX BIOL, V14, P447, DOI 10.1016/0945-053X(95)90002-0; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; DUBOWITZ V, 1994, NEUROMUSCULAR DISORD, V4, P75, DOI 10.1016/0960-8966(94)90051-5; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P253, DOI 10.1016/0960-8966(95)90011-X; DUBOWITZ V, 1995, MUSCLE DISORDERS CHI, P93; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; Engel J, 1991, CURR OPIN CELL BIOL, V3, P779, DOI 10.1016/0955-0674(91)90050-9; FARDEAU M, 1992, SKELETAL MUSCLE PATH, P237; GARRISON K, 1991, J BIOL CHEM, V266, P22899; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANTAI D, 1985, CONNECT TISSUE RES, V13, P273, DOI 10.3109/03008208509152408; HelblingLeclerc A, 1995, CR ACAD SCI III-VIE, V318, P1245; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NISSINEN M, 1991, BIOCHEM J, V276, P369, DOI 10.1042/bj2760369; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P227, DOI 10.1016/0960-8966(94)00047-D; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; SASAKI M, 1988, J BIOL CHEM, V263, P16536; STEPHENS HR, 1982, J NEUROL SCI, V53, P45, DOI 10.1016/0022-510X(82)90079-X; SUNADA Y, 1995, NEUROLOGY, V45, P2084, DOI 10.1212/WNL.45.11.2084; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; Tryggvason K, 1993, CURR OPIN CELL BIOL, V5, P877, DOI 10.1016/0955-0674(93)90038-R; VUOLTEENAHO R, 1994, J CELL BIOL, V124, P381, DOI 10.1083/jcb.124.3.381; WORTON R, 1995, SCIENCE, V270, P755, DOI 10.1126/science.270.5237.755; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297	42	78	78	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1177	1184						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651294				2022-12-18	WOS:A1996UM27100010
J	Rotter, JI; Bu, XD; Cantor, RM; Warden, CH; Brown, J; Gray, RJ; Blanche, PJ; Krauss, RM; Lusis, AJ				Rotter, JI; Bu, XD; Cantor, RM; Warden, CH; Brown, J; Gray, RJ; Blanche, PJ; Krauss, RM; Lusis, AJ			Multilocus genetic determinants of LDL particle size in coronary artery disease families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; POLYMERASE CHAIN-REACTION; APOLIPOPROTEIN-B; COMBINED HYPERLIPIDEMIA; SUBCLASS PHENOTYPES; HEART-DISEASE; REPEAT POLYMORPHISM; QUANTITATIVE TRAIT; INSULIN-RESISTANCE; LINKAGE ANALYSIS	Recent interest in atherosclerosis has focused on the genetic determinants of low-density lipoprotein (LDL) particle size, because of (i) the association of small dense LDL particles with a three-fold increased risk for coronary artery disease (CAD) and (ii) the recent report of linkage of the trait to the LDL receptor (chromosome 19). By utilizing nonparametric quantitative sib-pair and relative-pair-analysis methods in CAD families, we tested for linkage of a gene or genes controlling LDL particle sizes with the genetic loci for the major apolipoproteins and enzymes participating in lipoprotein metabolism. We confirmed evidence for linkage to the LDL receptor locus (P = .008). For six candidate gene loci, including apolipoprotein(apo)B, apoAII, apo(a), apoE-CI-CII, lipoprotein lipase, and high-density lipoprotein-binding protein, no evidence for linkage was observed by sib-pair linkage analyses (P values ranged from .24 to .81). However, in addition, we did find tentative evidence for linkage with the apoAI-CIII-AIV locus (chromosome 11) (P = .06) and significant evidence for linkage of the cholesteryl ester transfer protein locus (chromosome 16) (P = .01) and the manganese superoxide dismutase locus (chromosome 6) (P = .001), thus indicating multilocus determination of this atherogenic trait.	CEDARS SINAI MED CTR, DIV MED GENET, DEPT PEDIAT, LOS ANGELES, CA 90048 USA; CEDARS SINAI MED CTR, DIV CARDIOL, DEPT PEDIAT, LOS ANGELES, CA 90048 USA; CEDARS SINAI MED CTR, DIV CARDIOL, DEPT MED, LOS ANGELES, CA 90048 USA; UNIV CALIF LOS ANGELES, DEPT MED, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT MICROBIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT MOLEC GENET, LOS ANGELES, CA 90024 USA; UNIV CALIF BERKELEY, LAWRENCE BERKELEY LAB, DIV LIFE SCI, BERKELEY, CA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Rotter, JI (corresponding author), CEDARS SINAI MED CTR, DIV MED GENET, DEPT MED, SSB-3, 8700 BEVERELY BLVD, LOS ANGELES, CA 90048 USA.				NHLBI NIH HHS [HL28481, HL18574] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL018574] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS GH, 1969, ANN NY ACAD SCI, V164, P130, DOI 10.1111/j.1749-6632.1969.tb14036.x; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; AUSTIN M A, 1988, Journal of the American Medical Association, V260, P1917, DOI 10.1001/jama.260.13.1917; AUSTIN MA, 1992, ANN MED, V24, P477, DOI 10.3109/07853899209166999; AUSTIN MA, 1993, ARTERIOSCLER THROMB, V13, P687, DOI 10.1161/01.ATV.13.5.687; AUSTIN MA, 1988, AM J HUM GENET, V43, P838; AUSTIN MA, 1990, ARTERIOSCLEROSIS, V10, P520, DOI 10.1161/01.ATV.10.4.520; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; BARAKAT HA, 1990, DIABETES, V39, P1527, DOI 10.2337/diabetes.39.12.1527; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375; Bu X., 1992, American Journal of Human Genetics, V51, pA336; BU XD, 1994, HUM GENET, V93, P639, DOI 10.1007/BF00201563; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P187, DOI 10.1161/01.ATV.12.2.187; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P1410, DOI 10.1161/01.ATV.12.12.1410; CAMPOS H, 1991, ARTERIOSCLER THROMB, V11, P1089, DOI 10.1161/01.ATV.11.4.1089; CANTOR RM, 1993, GENET EPIDEMIOL, V10, P334; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; DAMMERMAN M, 1993, P NATL ACAD SCI USA, V90, P4562, DOI 10.1073/pnas.90.10.4562; DEGRAAF J, 1992, AM J HUM GENET, V51, P1295; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; DOOLITTLE MH, 1992, MOL GENETICS CORONAR, P172; DRAYNA D, 1987, NUCLEIC ACIDS RES, V15, P4698, DOI 10.1093/nar/15.11.4698; DREON DM, 1994, FASEB J, V8, P121, DOI 10.1096/fasebj.8.1.8299884; FEINGOLD KR, 1992, ARTERIOSCLER THROMB, V12, P1496, DOI 10.1161/01.ATV.12.12.1496; FISHER WR, 1975, P NATL ACAD SCI USA, V72, P2347, DOI 10.1073/pnas.72.6.2347; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HEIBA IM, 1993, AM J MED GENET, V47, P875, DOI 10.1002/ajmg.1320470615; HEINZMANN C, 1988, NUCLEIC ACIDS RES, V16, P4739, DOI 10.1093/nar/16.10.4739; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; JIAO S, 1990, J LIPID RES, V31, P467; KAMBOH MI, 1991, ATHEROSCLEROSIS, V91, P25, DOI 10.1016/0021-9150(91)90184-5; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KODON I, 1989, CLIN GENET, V35, P49; KRAUSS RM, 1983, CLIN RES, V31, pA503; KRAUSS RM, 1987, AM HEART J, V113, P578, DOI 10.1016/0002-8703(87)90636-3; KRAUSS RM, 1982, J LIPID RES, V23, P97; KRAUSS RM, 1973, CIRC RES, V33, P403, DOI 10.1161/01.RES.33.4.403; LABELLE M, 1991, GENET EPIDEMIOL, V8, P269, DOI 10.1002/gepi.1370080407; LACKNER C, 1991, J CLIN INVEST, V87, P2077; LAGROST L, 1993, ARTERIOSCLER THROMB, V13, P815, DOI 10.1161/01.ATV.13.6.815; LAMONFAVA S, 1991, ATHEROSCLEROSIS, V91, P97, DOI 10.1016/0021-9150(91)90191-5; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, P181; Mehrabian M, 1992, MOL GENETICS CORONAR, P363; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NIGON F, 1991, J LIPID RES, V32, P1741; NISHINA PM, 1992, P NATL ACAD SCI USA, V89, P708, DOI 10.1073/pnas.89.2.708; OLSON JM, 1993, GENET EPIDEMIOL, V10, P87, DOI 10.1002/gepi.1370100202; OLSON JM, 1994, GENET EPIDEMIOL, V11, P41, DOI 10.1002/gepi.1370110105; PAULHAYASE H, 1992, HUM GENET, V88, P439, DOI 10.1007/BF00215679; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; Rotter J. I., 1992, American Journal of Human Genetics, V51, pA26; SAKAI N, 1991, ARTERIOSCLER THROMB, V11, P71, DOI 10.1161/01.ATV.11.1.71; SELBY JV, 1993, CIRCULATION, V88, P381, DOI 10.1161/01.CIR.88.2.381; SHEN MMS, 1981, J LIPID RES, V22, P236; TERRY RB, 1989, J CLIN ENDOCR METAB, V68, P191, DOI 10.1210/jcem-68-1-191; TRIBBLE DL, 1992, ATHEROSCLEROSIS, V93, P189, DOI 10.1016/0021-9150(92)90255-F; TRIBBLE DL, 1994, P NATL ACAD SCI USA, V91, P1183, DOI 10.1073/pnas.91.3.1183; TYBJAERGHANSEN A, 1993, ATHEROSCLEROSIS, V100, P157, DOI 10.1016/0021-9150(93)90202-6; WARDEN CH, 1993, P NATL ACAD SCI USA, V90, P10886, DOI 10.1073/pnas.90.22.10886; WEBER JL, 1989, AM J HUM GENET, V44, P388; WINDLER E, 1985, J LIPID RES, V26, P556; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; WOOD S, 1993, HUM GENET, V91, P312; XIA YR, 1993, GENOMICS, V16, P524, DOI 10.1006/geno.1993.1221; XIANG K, 1987, NUCLEIC ACIDS RES, V15, P7654, DOI 10.1093/nar/15.18.7654; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4299; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4300, DOI 10.1093/nar/18.14.4300; 1990, SAS IML SOFTWARE USA; 1992, STATISTICAL ANAL GEN	74	78	79	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					585	594						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644718				2022-12-18	WOS:A1996TV56400017
J	WALLIS, GA; RASH, B; SWEETMAN, WA; THOMAS, JT; SUPER, M; EVANS, G; GRANT, ME; BOOTHANDFORD, RP				WALLIS, GA; RASH, B; SWEETMAN, WA; THOMAS, JT; SUPER, M; EVANS, G; GRANT, ME; BOOTHANDFORD, RP			AMINO-ACID SUBSTITUTIONS OF CONSERVED RESIDUES IN THE CARBOXYL-TERMINAL DOMAIN OF THE ALPHA-L(X) CHAIN OF TYPE-X COLLAGEN OCCUR IN 2 UNRELATED FAMILIES WITH METAPHYSEAL CHONDRODYSPLASIA TYPE SCHMID	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; FRAMESHIFT MUTATION; I COLLAGEN; GENE; LOCALIZATION; CARTILAGE; DNA; AMPLIFICATION; CONFORMATION; ORGANIZATION	Type X collagen is a homotrimeric, short-chain, nonfibrillar extracellular-matrix component that is specifically and transiently synthesized by hypertrophic chondrocytes at the sites of endochondral ossification. The precise function of type X collagen is not known, but its specific pattern of expression suggests that mutations within the encoding gene (COL10A1) that alter the structure or synthesis of the protein may cause heritable forms of chondrodysplasia. We used the PCR and the SSCP techniques to analyze the coding and upstream promoter regions of the COL10A1 gene in a number of individuals with forms of chondrodysplasia. Using this approach, we identified two individuals with metaphyseal chondrodysplasia type Schmid (MCDS) with SSCP changes in the region of the gene encoding the carboxyl-terminal domain. Sequence analysis demonstrated that the individuals were heterozygous for two unique single-base-pair transitions that led to the substitution of the highly conserved amino acid residue tyrosine at position 598 by aspartic acid in one person and of leucine at position 614 by proline in the other. The substitution at residue 598 segregated with the phenotype in a family of eight (five affected and three unaffected) related persons. The substitution at residue 614 occurred in a sporadically affected individual but not in her unaffected mother and brother. Additional members of this family were not available for further study. These results suggest that certain amino acid substitutions within the carboxyl-terminal domain of the chains of the type X collagen molecule cause MCDS. These amino acid substitutions are likely to alter either chain recognition or assembly of the type X collagen molecule, thereby depleting the amount of normal type X collagen deposited in the extracellular matrix, with consequent aberrations in bone growth and development.	ROYAL MANCHESTER CHILDRENS HOSP, PAEDIAT GENET UNIT, MANCHESTER, LANCS, ENGLAND; ROBERT JONES ORTHOPAED HOSP, OSWESTRY, SHROPS, ENGLAND	Royal Manchester Children's Hospital	WALLIS, GA (corresponding author), UNIV MANCHESTER, SCH BIOL SCI, DEPT BIOCHEM & MOLEC BIOL, MANCHESTER M13 9PT, LANCS, ENGLAND.			Boot-Handford, Raymond/0000-0002-6167-8419; Evans, Gareth/0000-0002-8482-5784				APTE S, 1991, FEBS LETT, V282, P393, DOI 10.1016/0014-5793(91)80521-4; BATEMAN JF, 1989, J BIOL CHEM, V264, P10960; BATEMAN JF, 1990, 4TH INT C OST IMP PA; BEIGHTON P, 1988, INHERITED DISORDERS; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BRASS A, 1992, FEBS LETT, V303, P126, DOI 10.1016/0014-5793(92)80503-9; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CHESSLER SD, 1993, J BIOL CHEM, V268, P18218; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; GASPARINI P, 1992, MOL CELL PROBE, V6, P1, DOI 10.1016/0890-8508(92)90064-5; GRANT WT, 1987, J BIOL CHEM, V262, P9844; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; KIRSCH T, 1990, BIOCHEM J, V265, P453, DOI 10.1042/bj2650453; KONG RYC, 1993, EUR J BIOCHEM, V213, P99, DOI 10.1111/j.1432-1033.1993.tb17739.x; KWAN APL, 1989, J CELL BIOL, V109, P1849, DOI 10.1083/jcb.109.4.1849; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; LACHMAN RS, 1988, PEDIATR RADIOL, V18, P93, DOI 10.1007/BF02387549; MARRIOTT A, 1991, J CELL SCI, V99, P641; OKAYAMA H, 1989, J LAB CLIN MED, V114, P105; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RASH B, IN PRESS HUM MOL GEN; REICHENBERGER E, 1992, FEBS LETT, V311, P305, DOI 10.1016/0014-5793(92)81126-7; RIMOIN DL, 1983, PRINCIPLES PRACTICE, P703; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAWADA H, 1990, J CELL BIOL, V110, P219, DOI 10.1083/jcb.110.1.219; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SILLENCE DO, 1979, AM J PATHOL, V96, P813; SPRANGER J, 1974, ADV HUM GENET, V19, P1; STANESCU V, 1984, J BONE JOINT SURG AM, V66A, P817, DOI 10.2106/00004623-198466060-00002; SWEETMAN WA, 1992, AM J HUM GENET, V51, P841; THOMAS JT, 1990, J CELL SCI, V95, P639; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; Wynne-Davies R., 1985, ATLAS SKELETAL DYSPL	36	78	82	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					169	178						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304336				2022-12-18	WOS:A1994MU31500002
J	LOESCH, DZ; HUGGINS, R; HAY, DA; GEDEON, AK; MULLEY, JC; SUTHERLAND, GR				LOESCH, DZ; HUGGINS, R; HAY, DA; GEDEON, AK; MULLEY, JC; SUTHERLAND, GR			GENOTYPE-PHENOTYPE RELATIONSHIPS IN FRAGILE-X SYNDROME - A FAMILY STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARTIN-BELL SYNDROME; PEDIGREE ANALYSIS; MENTAL-RETARDATION; DNA; DIAGNOSIS; MANIFESTATIONS; EXTENSIONS; FEMALES	Relationships between the measures of intellectual and physical status in the fragile X syndrome and the size of amplification of the fragile X-specific fragment, equivalent to the number of CCG repeats within the FMR1 locus, were studied by a maximum-likelihood scoring technique for analysis of pedigree data. This allows for estimation of random effects (genetic and environmental variance) concurrently with other (fixed) effects in a quantitative trait. FMR1 expression is usually shut down in males penetrant for the fragile X syndrome who have hypermethylated CCG amplifications of greater-than-or-equal-to 0.6 kb. The assumption of the step versus curvilinear function representing this relationship was tested by the likelihood-ratio criterion. The maximum-likelihood parameters were based on the most appropriate model for each measure. The results were indicative of the presence of a curvilinear relationship between the amplification size and the two intellectual scores, the Peabody Picture Vocabulary Test and Block Design Test, measuring verbal and spatial abilities, respectively. Reasons for the unexpected curvilinear regression between the amplification size and intellectual scores were explained further by methylation analysis of fragile X males with amplifications of 0.6 < DELTA less-than-or-equal-to 1.2 kb who appeared to be responsible for the curvilinearity of the relationship. Four of these showed unmethylated status of the amplified bands in lymphocytes, which were presumably transcriptionally active. Removal of the aberrant individuals led to the anticipated step function between amplification and intellectual scores. For the combined anthropometric score, as well as for several single physical measures, the step function was the most appropriate model regardless of the inclusion or omission of the aberrant individuals in the pedigree sample.	LA TROBE UNIV,DEPT STAT,BUNDOORA,VIC 3083,AUSTRALIA; WOMENS & CHILDRENS HOSP,CTR MED GENET,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,AUSTRALIA	La Trobe University; Womens & Childrens Hospital Australia	LOESCH, DZ (corresponding author), LA TROBE UNIV,DEPT PSYCHOL,BUNDOORA,VIC 3083,AUSTRALIA.		Gedeon, Agi/G-7890-2011; Sutherland, Grant Robert/D-2606-2012	Loesch, Danuta/0000-0002-2180-2606				BUTLER MG, 1988, AM J MED GENET, V31, P779, DOI 10.1002/ajmg.1320310408; CIANCHETTI C, 1991, AM J MED GENET, V40, P234, DOI 10.1002/ajmg.1320400222; CROWE SF, 1990, NEUROPSYCHOLOGIA, V28, P9, DOI 10.1016/0028-3932(90)90082-Y; DAMATO RC, 1988, J CLIN PSYCHOL, V44, P934, DOI 10.1002/1097-4679(198811)44:6<934::AID-JCLP2270440614>3.0.CO;2-2; Davies KE, 1989, FRAGILE X SYNDROME; DRUDGE JP, 1989, J SOC BEHAV PERS, V4, P145; FRYNS JP, 1989, FRAGILE X SYNDROME, P1; FU YH, 1992, CELL, V57, P1047; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; KEMPER MB, 1986, AM J MED GENET, V23, P139, DOI 10.1002/ajmg.1320230109; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LOESCH DZ, 1988, AM J MED GENET, V30, P149, DOI 10.1002/ajmg.1320300113; LOESCH DZ, 1993, HUM GENET, V91, P469; LOESCH DZ, 1991, AM J MED GENET, V41, P410, DOI 10.1002/ajmg.1320410405; LOESCH DZ, 1992, AM J HUM GENET, V50, P1067; LOESCH DZ, 1987, AM J MED GENET, V27, P401, DOI 10.1002/ajmg.1320270219; LOESCH DZ, 1993, AM J MED GENET, V46, P415, DOI 10.1002/ajmg.1320460414; LOESCH DZ, 1989, CLIN GENET, V36, P145; LOESCH DZ, 1986, ANN HUM GENET, V50, P386; MULLEY JC, 1992, J MED GENET, V29, P368, DOI 10.1136/jmg.29.6.368; OBERLE I, 1991, SCIENCE, V252, P1087; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1991, AM J HUM GENET, V49, P279; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; THEOBALD TM, 1987, AM J MED GENET, V28, P1, DOI 10.1002/ajmg.1320280102; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WHORLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	35	78	79	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1064	1073						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213832				2022-12-18	WOS:A1993MC33300010
J	MUTTER, GL; STEWART, CL; CHAPONOT, ML; POMPONIO, RJ				MUTTER, GL; STEWART, CL; CHAPONOT, ML; POMPONIO, RJ			OPPOSITELY IMPRINTED GENES-H19 AND INSULIN-LIKE GROWTH FACTOR-II ARE COEXPRESSED IN HUMAN ANDROGENETIC TROPHOBLAST	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-II GENE; H19 GENE; HYDATIDIFORM MOLES; METHYLATION; MICE; RNA; HYBRIDIZATION; LINKAGE; ORIGIN; EMBRYO	Human uniparental gestations such as gynogenetic ovarian teratomas and androgenetic complete hydatidiform moles provide a model to evaluate the integrity of parent-specific gene expression-i.e, imprinting-in the absence of a complementary parental genetic contribution. We studied expression, in these tissues, of the oppositely imprinted genes H19, which is an embryonic nontranslated RNA, and insulin-like growth factor type 2 (IGF2). Normal gestations only express H19 from the maternal allele and express IGF2 from the paternal allele, whereas neither is expressed from the maternal genome of gynogenetic gestations, and both are expressed from the paternal genome of androgenetic gestations. Coexpression of H19 and IGF2 in the androgenetic tissues was in a single population of cells, mononuclear trophoblast-the same cell type expressing these genes in biparental placentas. These results demonstrate that a biparental genome may be required for expression of the reciprocal IGF2/H19 imprint. Alternatively, biparental expression may be a normal feature of some imprinted genes in specific cell types. Additional experiments with other imprinted genes will clarify whether this reflects global failure of the imprinting process or a change specific to the IGF2/H19 locus.	ROCHE INST MOLEC BIOL,DEPT CELL & DEV BIOL,NUTLEY,NJ 07110		MUTTER, GL (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,75 FRANCIS ST,BOSTON,MA 02115, USA.		Mutter, George L/C-5819-2009					Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; GLASER A, 1992, MOL REPROD DEV, V33, P77; GRIMES DA, 1984, AM J OBSTET GYNECOL, V150, P309, DOI 10.1016/S0002-9378(84)90370-3; GUNDERSEN G, 1992, GENE, V113, P207, DOI 10.1016/0378-1119(92)90397-8; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; LAWLER SD, 1991, AM J OBSTET GYNECOL, V164, P1270, DOI 10.1016/0002-9378(91)90698-Q; LAWLER SD, 1982, ANN HUM GENET, V46, P209, DOI 10.1111/j.1469-1809.1982.tb00713.x; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; MONK M, 1987, DEVELOPMENT, V99, P371; Mutter G L, 1987, Obstet Gynecol Surv, V42, P661, DOI 10.1097/00006254-198711000-00001; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; POIRIER F, 1991, DEVELOPMENT, V113, P1105; RACHMILEWITZ J, 1992, MOL REPROD DEV, V32, P196, DOI 10.1002/mrd.1080320303; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SCHALLING M, 1987, ACTA PHYSIOL SCAND, V131, P631, DOI 10.1111/j.1748-1716.1987.tb08288.x; SCULLY RE, 1979, TUMORS OVARY MALDEVE, P226; SILVERBERG SG, 1991, TUMORS UTERINE CORPU, P233; SUTCLIFFE J, 1993, HUM MOL GENET, V1, P397; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WEBER JL, 1989, AM J HUM GENET, V44, P388; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	38	78	80	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1096	1102						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	7692725				2022-12-18	WOS:A1993MC33300013
J	CALABRO, V; MASON, PJ; FILOSA, S; CIVITELLI, D; CITTADELLA, R; TAGARELLI, A; MARTINI, G; BRANCATI, C; LUZZATTO, L				CALABRO, V; MASON, PJ; FILOSA, S; CIVITELLI, D; CITTADELLA, R; TAGARELLI, A; MARTINI, G; BRANCATI, C; LUZZATTO, L			GENETIC-HETEROGENEITY OF GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY REVEALED BY SINGLE-STRAND CONFORMATION AND SEQUENCE-ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POINT MUTATIONS; POPULATION; VARIANT; SARDINIA; MUTANT; LOCUS; EAST	We have carried out a systematic study of the molecular basis of glucose-6-phosphate dehydrogenase deficiency on a sample of 53 male subjects from Calabria, in southern Italy. Our sequential approach consisted of the following steps: (1) Partial biochemical characterization was used to pinpoint candidate known variants. The identity of these was then verified by restriction-enzyme or allele-specific oligonucleotide hybridization analysis of the appropriate PCR-amplified fragment. (2) On samples for which there was no obvious candidate mutation, we proceeded to amplify the entire coding region in eight fragments, followed by single-strand conformation polymorphism (SSCP) analysis of each fragment. (3) The next step was M13 phage cloning and sequencing of those individual fragments that were found to be abnormal by SSCP. Through this approach we have identified the molecular lesion in 51 of the 53 samples. In these we found a total of nine different G6PD-deficient variants, five of which (G6PD Mediterranean, G6PD A-, G6PD Coimbra, G6PD Seattle, and G6PD Montalbano) were already known, whereas four are new (G6PD Cassano, G6PD Cosenza, G6PD Sibari, and G6PD Maewo). G6PD Mediterranean is the commonest variant, followed by G6PD Seattle. At least seven of the variants are present, at polymorphic frequencies, in the Calabria region, and some have a nonrandom distribution within the region. This study shows that the genetic heterogeneity of G6PD deficiency in Calabria, when analyzed at the DNA level, is even greater than had been anticipated from biochemical characterization. The sequential approach that we have followed is fast and efficient and could be applied to other populations.	HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT HAEMATOL, DU CANE RD, LONDON W12 0NN, ENGLAND; CNR, IST INT GENET & BIOFIS, NAPLES, ITALY; CNR, IST MALATTIE EREDITARIE & CARENZIALI, COSENZA, ITALY	Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR)			Mason, Philip J/B-1087-2008; Filosa, Stefania/A-4609-2014	Calabro, Viola/0000-0002-6508-8889; Martini, Giuseppe/0000-0003-2871-4243; Filosa, Stefania/0000-0003-2896-3362; CIVITELLI, DONATELLA/0000-0002-5099-9364				BARENGHI L, 1987, CLIN CHEM, V33, P579; BATTISTUZZI G, 1977, AM J HUM GENET, V29, P31; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; BEUTLER E, 1991, J BIOL CHEM, V266, P4145; BRANCATI C, 1982, BIRTH DEFECTS-ORIG, V18, P147; CALABRO V, 1990, HUM GENET, V86, P49; COLONNAROMANO S, 1985, HUM GENET, V69, P228, DOI 10.1007/BF00293030; CORCORAN CM, 1992, HUM GENET, V88, P688, DOI 10.1007/BF02265298; DEVITA G, 1989, AM J HUM GENET, V44, P233; FILOSA S, UNPUB MEDITERRANEAN; KIRKMAN HN, 1965, J LAB CLIN MED, V66, P834; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; Luzzato L, 1989, METABOLIC BASIS INHE, P2237; Maniatis T., 1982, MOL CLONING; NINFALI P, 1991, ENZYME, V45, P180; PERNG LI, 1992, HUM MOL GENET, V1, P205, DOI 10.1093/hmg/1.3.205; POGGI V, 1990, BIOCHEM J, V271, P157, DOI 10.1042/bj2710157; STAMATOYANNOPOULOS G, 1971, J CLIN INVEST, V50, P1253, DOI 10.1172/JCI106603; STEVENS DJ, 1990, NUCLEIC ACIDS RES, V18, P7190, DOI 10.1093/nar/18.23.7190; Tagarelli A, 1991, Gene Geogr, V5, P141; TESTA U, 1980, HUM GENET, V56, P99; THEIN SL, 1986, HUMAN GENETIC DISEAS; Vankampen E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0; VIGLIETTO G, 1990, ANN HUM GENET, V54, P1, DOI 10.1111/j.1469-1809.1990.tb00355.x; VIVESCORRONS JL, 1990, AM J HUM GENET, V47, P575; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171	28	78	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					527	536						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447319				2022-12-18	WOS:A1993KR72000010
J	KETTERLING, RP; VIELHABER, E; BOTTEMA, CDK; SCHAID, DJ; COHEN, MP; SEXAUER, CL; SOMMER, SS				KETTERLING, RP; VIELHABER, E; BOTTEMA, CDK; SCHAID, DJ; COHEN, MP; SEXAUER, CL; SOMMER, SS			GERM-LINE ORIGINS OF MUTATION IN FAMILIES WITH HEMOPHILIA-B - THE SEX-RATIO VARIES WITH THE TYPE OF MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-VIII GENE; DUCHENNE MUSCULAR-DYSTROPHY; FACTOR-IX GENE; SPORADIC HEMOPHILIA; CLINICAL MANIFESTATIONS; RECURRENT MUTATIONS; CARRIER-DETECTION; PARTIAL DELETIONS; HAEMOPHILIA-B; DNA	Previous epidemiological and biochemical studies have generated conflicting estimates of the sex ratio of mutation. Direct genomic sequencing in combination with haplotype analysis extends previous analyses by allowing the precise mutation to be determined in a given family. From analysis of the factor IX gene of 260 consecutive families with hemophilia B, we report the germ-line origin of mutation in 25 families. When combined with 14 origins of mutation reported by others and with 4 origins previously reported by us, a total of 25 occur in the female germ line, and 18 occur in the male germ line. The excess of germ-line origins in females does not imply an overall excess mutation rate per base pair in the female germ line. Bayesian analysis of the data indicates that the sex ratio varies with the type of mutation. The aggregate of single-base substitutions shows a male predominance of germ-line mutations (P < .002). The maximum-likelihood estimate of the male predominance is 3.5-fold. Of the single-base substitutions, transitions at the dinucleotide CpG show the largest male predominance (11-fold). In contrast to single-base substitutions, deletions display a sex ratio of unity. Analysis of the parental age at transmission of a new mutation suggests that germ-line mutations are associated with a small increase in parental age in females but little, if any, increase in males. Although direct genomic sequencing offers a general method for defining the origin of mutation in specific families, accurate estimates of the sex ratios of different mutational classes require large sample sizes and careful correction for multiple biases of ascertainment. The biases in the present data result in an underestimate of the enhancement of mutation in males.	MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT ONCOL,DIV STAT,ROCHESTER,MN 55905; VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,DIV GENET,NASHVILLE,TN 37232; CHILDRENS HOSP,DEPT PEDIAT,DIV GENET,OKLAHOMA CITY,OK	Mayo Clinic; Mayo Clinic; Vanderbilt University				Bottema, Cynthia/0000-0001-6245-0099; Ketterling, Rhett/0000-0001-6479-7897	NHLBI NIH HHS [HL39762] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039762] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; Becker R.A., 1988, NEW S LANGUAGE PROGR; BERNARDI F, 1987, HUM GENET, V76, P253; BOBROW M, 1988, ARCH NEUROL-CHICAGO, V45, P85, DOI 10.1001/archneur.1988.00520250091027; BOTTEMA CDK, 1989, LANCET, V2, P526; BOTTEMA CDK, 1990, AM J HUM GENET, V47, P835; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P839; BROCKERVRIENDS AHJT, 1990, HUM GENET, V85, P288; CASULA L, 1990, BLOOD, V75, P662; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DIEM K, 1970, SCI TABLES, P85; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; GIANNELLI F, 1992, NUCLEIC ACIDS RES, V20, P2027, DOI 10.1093/nar/20.suppl.2027; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1988, AM J HUM GENET, V43, P274; GITSCHIER J, 1988, BLOOD, V72, P1022; GROVER H, 1987, CLIN GENET, V32, P10; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HENDERSON BE, 1988, CANCER RES, V48, P246; HIGUCHI M, 1990, GENOMICS, V6, P65, DOI 10.1016/0888-7543(90)90448-4; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P7405, DOI 10.1073/pnas.88.16.7405; HIGUCHI M, 1989, BLOOD, V74, P1045; HIGUCHI M, 1988, MOL BIOL MED, V5, P23; HOLLOWAY SM, 1973, AM J HUM GENET, V25, P388; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KLING S, 1992, EUR J HAEMATOL, V48, P142; KOEBERL DD, 1990, HUM GENET, V84, P387; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; LEVINSON B, 1990, AM J HUM GENET, V46, P53; LOEB LA, 1989, CANCER RES, V49, P5489; LUDWIG M, 1992, AM J HUM GENET, V50, P164; MILLAR DS, 1990, HUM GENET, V86, P219; MONTANDON AJ, 1990, HUM GENET, V85, P200; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; PAYNTON C, 1991, HUM GENET, V87, P397; RISCH N, 1987, AM J HUM GENET, V41, P218; ROSENDAAL FR, 1990, HUM GENET, V86, P139, DOI 10.1007/BF00197695; SARKAR G, 1991, NUCLEIC ACIDS RES, V19, P631, DOI 10.1093/nar/19.3.631; SCHWAAB R, 1990, AM J HUM GENET, V47, P743; SOMMER SS, 1992, FASEB J, V6, P2767, DOI 10.1096/fasebj.6.10.1634040; SOMMER SS, 1992, HUM GENET, V89, P295; SOMMER SS, 1990, PCR PROTOCOLS GUIDE, P197; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; TANIMOTO M, 1988, J LAB CLIN MED, V112, P307; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; VIDAUD D, 1989, American Journal of Human Genetics, V45, pA226; VIDAUD M, 1986, BLOOD, V68, P961; VOGEL F, 1986, HUMAN GENETICS PROBL, P433; WANG NS, 1990, THROMB HAEMOSTASIS, V63, P24; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WINSHIP PR, 1989, LANCET, V1, P631; WINTER RM, 1980, AM J HUM GENET, V32, P582; WINTER RM, 1983, HUM GENET, V64, P156, DOI 10.1007/BF00327115; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P867; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718; YOUSSOUFIAN H, 1988, HUM GENET, V80, P143, DOI 10.1007/BF00702857; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772; 1918, VITAL STATISTICS US	62	78	78	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					152	166						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434583				2022-12-18	WOS:A1993KK90800018
J	REILLY, SL; FERRELL, RE; KOTTKE, BA; SING, CF				REILLY, SL; FERRELL, RE; KOTTKE, BA; SING, CF			THE GENDER-SPECIFIC APOLIPOPROTEIN-E GENOTYPE INFLUENCE ON THE DISTRIBUTION OF PLASMA-LIPIDS AND APOLIPOPROTEINS IN THE POPULATION OF ROCHESTER, MINNESOTA .2. REGRESSION RELATIONSHIPS WITH CONCOMITANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; HIGH-DENSITY-LIPOPROTEIN; SYSTOLIC BLOOD-PRESSURE; E POLYMORPHISM; MYOCARDIAL-INFARCTION; CHOLESTEROL RESPONSE; QUANTITATIVE TRAITS; HEART-DISEASE; BODY-FAT; GENE	The influence of the apolipoprotein E (Apo E) polymorphism and gender on the regression relationships between each of nine plasma lipid and apolipoprotein traits (total cholesterol; In triglycerides; high-density-lipoprotein cholesterol; apolipoproteins AI, AII, B, and CII; in CIII; and In E) and four concomitants (age, weight, waist-to-hip ratio, and smoking) was studied in 507 unrelated individuals representative of the adult population of Rochester, MN. Analyses are presented separately for females and males. Each lipid and apolipoprotein trait exhibited at least one Apo E genotype-specific regression relationship with the concomitants investigated in this study. In most cases the heterogeneity of regression was associated with differences between the epsilon32 and epsilon33 genotype. This study documents that the influence of Apo E genotype on average levels of plasma lipids and apolipoproteins varies among subdivisions of the population defined by age, body size, and smoking status.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15260; MAYO CLIN & MAYO FDN,DEPT CARDIOL,ROCHESTER,MN 55905	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic	REILLY, SL (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.			Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHS [HL24489, HL30428, HL39107] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489, R01HL030428, R01HL039107] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260; ALBERS JJ, 1976, METABOLISM, V25, P633, DOI 10.1016/0026-0495(76)90060-3; AVOGARO P, 1979, LANCET, V1, P901; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; BROWNLEE KA, 1984, STATISTICAL THEORY M; CARTER CL, 1990, HUM HERED, V40, P235, DOI 10.1159/000153936; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; ENHOLM C, 1986, J LIPID RES, V27, P227; FAGER G, 1981, ARTERIOSCLEROSIS, V1, P273, DOI 10.1161/01.ATV.1.4.273; Falconer D. S., 1989, Introduction to quantitative genetics.; FERRELL RE, 1992, CURR OPIN LIPIDOL, V3, P122; GUEGUEN R, 1989, AM J HUM GENET, V45, P793; HAMSTEN A, 1986, CIRCULATION, V73, P1097, DOI 10.1161/01.CIR.73.6.1097; HANIS CL, 1991, ARTERIOSCLER THROMB, V11, P362, DOI 10.1161/01.ATV.11.2.362; Hartl D. L., 1989, PRINCIPLES POPULATIO; Havekes L M, 1988, Adv Exp Med Biol, V243, P87; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; ISHIKAWA T, 1978, EUR J CLIN INVEST, V8, P179, DOI 10.1111/j.1365-2362.1978.tb00832.x; IZZO C, 1981, CLIN CHEM, V27, P371; JINKS JL, 1988, 2ND P INT C QUANT GE, P505; KAMBOH MI, 1988, J LIPID RES, V29, P1535; KAPRIO J, 1991, ARTERIOSCLER THROMB, V11, P1330, DOI 10.1161/01.ATV.11.5.1330; KAPRIO J, 1989, CLIN GENET, V36, P266; KOTTKE BA, 1991, MAYO CLIN PROC, V66, P1198, DOI 10.1016/S0025-6196(12)62470-7; KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8; KRIEGER H, 1980, HUM GENET, V53, P415, DOI 10.1007/BF00287065; LEIBEL RL, 1989, ANNU REV NUTR, V9, P417, DOI 10.1146/annurev.nu.09.070189.002221; LUSIS AJ, 1988, J LIPID RES, V29, P397; MACCLUER JW, 1992, CURR OPIN LIPIDOL, V3, P114; MAILLY F, UNPUB ESTIMATION FRE; MANTTARI M, 1991, METABOLISM, V40, P217, DOI 10.1016/0026-0495(91)90179-Z; MARAZITA ML, 1987, AM J MED GENET, V26, P511, DOI 10.1002/ajmg.1320260302; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MILLER GJ, 1975, LANCET, V1, P16; MOLL PP, 1989, AM J HUM GENET, V44, P124; MORRISON DF, 1971, MULTIVARIATE STATIST; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1980, HUM GENET, V53, P261; MURPHY EA, 1979, SOC BIOL, V26, P126, DOI 10.1080/19485565.1979.9988371; MURPHY EA, 1986, AM J MED GENET, V24, P159, DOI 10.1002/ajmg.1320240120; NESTRUCK AC, 1987, METABOLISM, V36, P743, DOI 10.1016/0026-0495(87)90110-7; NETER J, 1985, APPLIED LINEAR STATI; ORDOVAS JM, 1987, J LIPID RES, V28, P371; PERUSSE L, 1991, AM J HUM GENET, V49, P94; POULIOT MC, 1990, J LIPID RES, V31, P1023; REILLY SL, 1990, J CLIN EPIDEMIOL, V43, P921, DOI 10.1016/0895-4356(90)90076-2; REILLY SL, 1991, AM J HUM GENET, V49, P1155; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SEDLIS SP, 1986, CIRCULATION, V73, P978, DOI 10.1161/01.CIR.73.5.978; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; Sokal R.R., 1981, BIOMETRY PRINCIPLES; TURNER ST, 1989, HYPERTENSION, V13, P378, DOI 10.1161/01.HYP.13.4.378; Waddington C.H., 1957, STRATEGY GENES; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100; XU CF, 1990, GENET EPIDEMIOL, V7, P261, DOI 10.1002/gepi.1370070405; ZERBA KE, 1991, GENETICS, V129, P525; [No title captured]; 1979, CIRCULATION, V60, P427	61	78	79	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1311	1324						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463013				2022-12-18	WOS:A1992KC99500013
J	DEUFEL, T; GOLLA, A; ILES, D; MEINDL, A; MEITINGER, T; SCHINDELHAUER, D; DEVRIES, A; PONGRATZ, D; MACLENNAN, DH; JOHNSON, KJ; LEHMANNHORN, F				DEUFEL, T; GOLLA, A; ILES, D; MEINDL, A; MEITINGER, T; SCHINDELHAUER, D; DEVRIES, A; PONGRATZ, D; MACLENNAN, DH; JOHNSON, KJ; LEHMANNHORN, F			EVIDENCE FOR GENETIC-HETEROGENEITY OF MALIGNANT HYPERTHERMIA SUSCEPTIBILITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-19 LINKAGE GROUP; MYOTONIC-DYSTROPHY LOCUS; RYANODINE RECEPTOR GENE; CONTRACTURE TEST; DNA; 19Q13.1; REGION; RFLP; 19Q	A locus for malignant hyperthermia susceptibility (MHS) has been localized on chromosome 19q12-13.2, while at the same time the gene encoding the skeletal muscle ryanodine receptor (RYR1) also has been mapped to this region and has been found to be tightly linked to MHS. RYR1 was consequently postulated as the candidate for the molecular defect causing MHS, and a point mutation in the gene has now been identified and is thought to be the cause of MH in at least some MHS patients. Here we report the results of a linkage study done with 19ql2-13.2 markers, including the RYR1 cDNA, in two Bavarian families with MHS. In one of the families, three unambiguous recombination events between MHS and the RYR1 locus were found. In the second family only one informative meiosis was seen with RYR1. However, segregation analysis with markers for D19S75, D19S28, D19S47, CYP2A, BCL3, and APOC2 shows that the crossovers in the first family involve the entire haplotype defined by these markers flanking RYR1 and, furthermore, reveals multiple crossovers between these haplotypes and MHS in the second family. In these families, pairwise and multipoint lod scores below - 2 exclude MHS from an interval spanning more than 26 cM and comprising the RYR1 and the previously described MHS locus. Our findings thus strongly suggest genetic heterogeneity of the MHS trait and prompt the search for another MHS locus.	UNIV MUNICH,DR VONHAUNERSCHEN KINDERSPITAL,KINDERKLIN,W-8000 MUNICH,GERMANY; UNIV MUNICH,KLINIKUM INNENSTADT,KINDERPOLIKLIN,PADIAT GENET ABT,W-8000 MUNICH 2,GERMANY; UNIV MUNICH,KLINIKUM INNENSTADT,MED KLIN,FRIEDRICH BAUER INST,W-8000 MUNICH 2,GERMANY; TECH UNIV MUNICH,KLINIKUM RECHTS ISAR,NEUROL KLIN,W-8000 MUNICH 80,GERMANY; CATHOLIC UNIV NIJMEGEN,DEPT CELL BIOL & HISTOL,NIJMEGEN,NETHERLANDS; UNIV TORONTO,BANTING & BEST DEPT MED RES,TORONTO M5S 1A1,ONTARIO,CANADA; CHARING CROSS & WESTMINSTER MED SCH,DEPT ANAT,LONDON,ENGLAND	University of Munich; University of Munich; University of Munich; Technical University of Munich; Radboud University Nijmegen; University of Toronto; Imperial College London			Meitinger, Thomas/O-1318-2015	johnson, keith/0000-0002-8578-5921; Meitinger, Thomas/0000-0002-8838-8403; Deufel, Thomas/0000-0003-4839-3117				BRITT BA, 1970, CAN ANAESTH SOC J, V17, P293, DOI 10.1007/BF03004694; BRUNNER HG, 1989, GENOMICS, V5, P589, DOI 10.1016/0888-7543(89)90027-X; CAVANNA JS, 1990, GENOMICS, V7, P12, DOI 10.1016/0888-7543(90)90513-T; DEUFEL T, UNPUB CHRONIC MYOPAT; DEUFEL T, 1990, J NEUROL SCI S, V98, P513; ELLIS FR, 1980, BRIT J HOSP MED, V24, P318; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; HAAN EA, 1990, HUM GENET, V86, P187; HEALY JMS, IN PRESS BR MED J; Humphries S E, 1983, Mol Biol Med, V1, P463; JOHNSON K, 1989, GENOMICS, V5, P746, DOI 10.1016/0888-7543(89)90116-X; KALOW W, 1987, MALIGNANT HYPERTHERM, P155; KAUSCH K, 1991, GENOMICS, V10, P765, DOI 10.1016/0888-7543(91)90461-M; KLEIN W, 1987, ANAESTHESIST, V36, P685; KORNELUK RG, 1989, GENOMICS, V5, P596, DOI 10.1016/0888-7543(89)90028-1; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LARACH MG, 1989, ANESTH ANALG, V69, P511; LATHROP GM, 1984, P NATL ACAD SCI USA, V81, P3442; LEHMANNHORN F, 1990, BRIT J ANAESTH, V65, P692, DOI 10.1093/bja/65.5.692; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; MACKENZIE AE, 1989, CYTOGENET CELL GENET, V51, P1036; MACKENZIE AE, 1990, AM J HUM GENET, V46, P1082; MACKENZIE AE, 1991, ANESTHESIOLOGY, V75, P4, DOI 10.1097/00000542-199107000-00002; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MICKELSON JR, 1988, J BIOL CHEM, V263, P9310; ORDING H, 1988, BRIT J ANAESTH, V60, P287, DOI 10.1093/bja/60.3.287; OTSU K, 1991, GENOMICS, V11, P744, DOI 10.1016/0888-7543(91)90083-Q; ROPERS HH, 1991, CYTOGENET CELL GENET, V58, P751, DOI 10.1159/000133179; Sambrook J., 1989, MOL CLONING LAB MANU; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SMEETS H, 1989, NUCLEIC ACIDS RES, V17, P3325, DOI 10.1093/nar/17.8.3325; WAINWRIGHT BJ, 1985, NUCLEIC ACIDS RES, V13, P4610, DOI 10.1093/nar/13.12.4610; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4639, DOI 10.1093/nar/18.15.4639-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; 1984, BRIT J ANAESTH, V56, P1267	38	78	78	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1151	1161						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598899				2022-12-18	WOS:A1992HY65400001
J	WEITZ, CJ; MIYAKE, Y; SHINZATO, K; MONTAG, E; ZRENNER, E; WENT, LN; NATHANS, J				WEITZ, CJ; MIYAKE, Y; SHINZATO, K; MONTAG, E; ZRENNER, E; WENT, LN; NATHANS, J			HUMAN TRITANOPIA ASSOCIATED WITH 2 AMINO-ACID SUBSTITUTIONS IN THE BLUE-SENSITIVE OPSIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUMAN COLOR-VISION; RETINITIS-PIGMENTOSA; MOLECULAR-GENETICS; DNA POLYMORPHISMS; RHODOPSIN GENE; MUTATIONS; FRAGMENTS; DIAGNOSIS; ATROPHY	Tritanopia is an autosomal dominant genetic disorder of human vision characterized by a selective deficiency of blue spectral sensitivity. The defect is manifested within the retina and could be caused by a deficiency in function or numbers (or both) of blue-sensitive cone photoreceptors. We have used PCR, denaturing gradient gel electrophoresis, and DNA sequencing of amplified exons to detect in four of nine unrelated tritanopic subjects two different point mutations in the gene encoding the blue-sensitive opsin, each leading to an amino acid substitution. Segregation analysis within pedigrees and hybridization of oligonucleotides specific for each allele to DNA samples from control subjects support the hypothesis that these mutations cause tritanopia. These results complete the genetic evidence for the trichromatic theory of human color vision.	JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,PCTB 805,725 N WOLFE ST,BALTIMORE,MD 21205; UNIV TUBINGEN,EYE CLIN,TUBINGEN,GERMANY; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; NAGOYA UNIV,DEPT OPHTHALMOL,NAGOYA,AICHI 464,JAPAN; UNIV RYUKYUS,SCH MED,DEPT OPHTHALMOL,NAHA,OKINAWA 903,JAPAN; UNIV CALIF SAN DIEGO,DEPT PSYCHOL,LA JOLLA,CA 92093; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS	Johns Hopkins University; Eberhard Karls University of Tubingen; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Nagoya University; University of the Ryukyus; University of California System; University of California San Diego; Leiden University; Leiden University - Excl LUMC				Nathans, Jeremy/0000-0001-8106-5460				Boynton R. M., 1979, HUMAN COLOR VISION; BOYNTON RM, 1982, J OPT SOC AM, V72, P666, DOI 10.1364/JOSA.72.000666; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; HIGGINS KE, 1983, AM J OPTOM PHYS OPT, V60, P964; KALMUS H, 1955, ANN HUM GENET, V20, P39, DOI 10.1111/j.1469-1809.1955.tb01277.x; KAZAZIAN HH, 1988, MOL GENETICS MED, P43; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; MIYAKE Y, 1985, ARCH OPHTHALMOL-CHIC, V103, P1496; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neuhann T, 1976, Mod Probl Ophthalmol, V17, P135; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PADMOS P, 1978, INVEST OPHTHALMOL VI, V117, P436; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; POKORNY J, 1981, J OPT SOC AM, V71, P1327, DOI 10.1364/JOSA.71.001327; POKORNY J., 1979, CONGENITAL ACQUIRED; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHULZ GE, 1974, NATURE, V250, P120, DOI 10.1038/250120a0; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; VANHEEL L, 1980, COLOR VISION DEFICIE, P256; WEBER JL, 1989, AM J HUM GENET, V44, P388; WENT LN, 1985, HUM GENET, V69, P255, DOI 10.1007/BF00293036; WOOTEN BR, 1973, J GEN PHYSIOL, V61, P125, DOI 10.1085/jgp.61.2.125; WRIGHT WD, 1952, J OPT SOC AM, V42, P509, DOI 10.1364/JOSA.42.000509; Young T., 1802, PHILOS T R SOC LOND, V92, P12, DOI [10.1098/rstl.1802.0004, DOI 10.1098/RSTL.1802.0004]	31	78	80	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					498	507						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1531728				2022-12-18	WOS:A1992HH97400007
J	MACDONALD, ME; LIN, C; SRINIDHI, L; BATES, G; ALTHERR, M; WHALEY, WL; LEHRACH, H; WASMUTH, J; GUSELLA, JF				MACDONALD, ME; LIN, C; SRINIDHI, L; BATES, G; ALTHERR, M; WHALEY, WL; LEHRACH, H; WASMUTH, J; GUSELLA, JF			COMPLEX PATTERNS OF LINKAGE DISEQUILIBRIUM IN THE HUNTINGTON DISEASE REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-RANDOM ASSOCIATION; DNA MARKERS; GENE; LOCALIZATION; CHROMOSOME-4; TELOMERE; LOCUS; MUTATION; SEGMENT; D4S95	The genetic defect causing Huntington disease (HD) has been mapped to 4p16.3 by linkage analysis using DNA markers. Two apparently contradictory classes of recombination events in HD kindreds preclude precise targeting of efforts to clone the disease gene. Here, we report a new recombination event that increases support for an internal candidate region of 2.5 Mb between D4S10 and D4S168. Analysis of 23 DNA polymorphisms in 4p16.3 revealed a complex pattern of association with the disease gene that failed to narrow the size of the candidate region. The degree of linkage disequilibrium did not show a continuous increase across the physical map, nor was a region of extreme disequilibrium identified. Markers displaying no association with the disorder were interspersed with and, in many cases, close to markers displaying significant disequilibrium. Comparison of closely spaced marker pairs on normal and HD chromosomes, as well as analysis of haplotypes across the HD region, suggest that simple recombination subsequent to a single original HD mutation cannot easily explain the pool of HD chromosomes seen today. A number of different mechanisms could contribute to the diversity of haplotypes observed on HD chromosomes, but it is likely that there has been more than one and possibly several independent origins of the HD mutation.	MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cancer Research UK; University of California System; University of California Irvine			Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, R01NS022031, P01NS016367] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00169] Funding Source: Medline; NINDS NIH HHS [NS22031, NS16367] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BATES GP, 1990, AM J HUM GENET, V46, P762; BATES GP, 1991, AM J HUM GENET, V49, P7; BUCAN M, 1990, GENOMICS, V6, P1; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; COX TK, UNPUB MAPPING CYSTIC; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1984, SCIENCE, V225, P1320, DOI 10.1126/science.6089346; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LIN CS, IN PRESS SOMATIC CEL; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4186, DOI 10.1093/nar/16.9.4186; NEI M, 1980, GENET RES, V35, P65, DOI 10.1017/S001667230001394X; ROBBINS C, 1989, AM J HUM GENET, V44, P422; SEIZINGER BR, 1986, NATURE, V322, P664; SHAW M, 1982, J MED GENET, V19, P161, DOI 10.1136/jmg.19.3.161; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; STEVENS D, 1969, J NEUROL NEUROSUR PS, V32, P140, DOI 10.1136/jnnp.32.2.140; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; YOUNGMAN S, 1989, GENOMICS, V5, P802, DOI 10.1016/0888-7543(89)90122-5; YULE GU, 1968, INTRO THEORY STATIST	33	78	83	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					723	734						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1680285				2022-12-18	WOS:A1991GG66500004
J	REICHARDT, JKV; PACKMAN, S; WOO, SLC				REICHARDT, JKV; PACKMAN, S; WOO, SLC			MOLECULAR CHARACTERIZATION OF 2 GALACTOSEMIA MUTATIONS - CORRELATION OF MUTATIONS WITH HIGHLY CONSERVED DOMAINS IN GALACTOSE-I-PHOSPHATE URIDYL TRANSFERASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GALACTOSE-1-PHOSPHATE; PROTEINS; SEQUENCE	Galactosemia is an autosomal recessive disorder of human galactose metabolism caused by deficiency of the enzyme galactose-1-phosphate uridyl transferase (GALT). The molecular basis of this disorder is at present not well understood. We report here two missense mutations which result in low or undetectable enzymatic activity. First, we identified at nucleotide 591 a transition which substitutes glutamine 188 by arginine. The mutated glutamine is not only highly conserved in evolution (conserved also in Escherichia coli and Saccharomyces cerevisiae), but it is also two amino acid residues downstream from the active site histidine-proline-histidine triad and results in about 10% of normal enzymatic activity. The arginine 188 mutation is the most common galactosemia mutation characterized to date. It accounts for one-fourth of the galactosemia alleles studied. Second, we report the substitution of arginine 333 by tryptophan, caused by a transition at nucleotide 1025. The area surrounding this missense mutation is the most highly conserved domain in the homologous enzymes from E. coli, yeast, and humans, and this mutation results in undetectable enzymatic activity, suggesting that this is a severe mutation. This second mutation appears to be rare, since it was found only in the patient we sequenced. Our data provide further evidence for the heterogeneity of galactosemia at the molecular level, heterogeneity which might be related to the variable clinical outcome observed in this disorder.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,DIV GENET,SAN FRANCISCO,CA 94143	Baylor College of Medicine; University of California System; University of California San Francisco	REICHARDT, JKV (corresponding author), BAYLOR COLL MED,TEXAS MED CTR,HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX 77030, USA.			Reichardt, Juergen/0000-0001-6458-2773	NCRR NIH HHS [RR01271] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BOEHLES H, 1986, European Journal of Pediatrics, V145, P413; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DOBBIE JA, 1990, ANN CLIN BIOCHEM, V27, P274, DOI 10.1177/000456329002700317; FIELD TL, 1989, BIOCHEMISTRY-US, V28, P2094, DOI 10.1021/bi00431a019; FLACH JE, 1990, MOL BIOL MED, V7, P365; FRIEDMAN JH, 1989, NEUROLOGY, V39, P741, DOI 10.1212/WNL.39.5.741; KAUFMAN FR, 1988, J PEDIATR-US, V112, P754, DOI 10.1016/S0022-3476(88)80697-8; KELLEY RI, 1989, HUM GENET, V82, P99, DOI 10.1007/BF00284037; LEMAIRE HG, 1986, NUCLEIC ACIDS RES, V14, P7705, DOI 10.1093/nar/14.19.7705; LO W, 1984, PEDIATRICS, V73, P309; NG WG, 1989, J INHERIT METAB DIS, V12, P257, DOI 10.1007/BF01799215; PACKMAN S, 1987, ADV NEONATAL SCREENI, P261; PETRY K, IN PRESS BIOCH MED M; REICHARDT JKV, 1988, NUCLEIC ACIDS RES, V16, P9017, DOI 10.1093/nar/16.18.9017; REICHARDT JKV, 1991, P NATL ACAD SCI USA, V88, P2633, DOI 10.1073/pnas.88.7.2633; REICHARDT JKV, 1989, THESIS STANFORD U ST; ROGERS S, 1970, METABOLIS, V19, P701, DOI 10.1016/0026-0495(70)90067-3; RUSSELL JAMES D., 1967, BIOCHEM GENET, V1, P11, DOI 10.1007/BF00487732; SEGAL S, 1971, J CLIN INVEST, V50, P500, DOI 10.1172/JCI106518; Segal S, 1989, METABOLIC BASIS INHE, P453; STEINMANN B, 1984, ENZYME, V32, P37; Tajima M, 1985, Yeast, V1, P67, DOI 10.1002/yea.320010108; WAISBREN SE, 1983, J PEDIATR-US, V102, P75, DOI 10.1016/S0022-3476(83)80292-3	23	78	81	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					860	867						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897530				2022-12-18	WOS:A1991GG66500018
J	BATES, GP; MACDONALD, ME; BAXENDALE, S; YOUNGMAN, S; LIN, C; WHALEY, WL; WASMUTH, JJ; GUSELLA, JF; LEHRACH, H				BATES, GP; MACDONALD, ME; BAXENDALE, S; YOUNGMAN, S; LIN, C; WHALEY, WL; WASMUTH, JJ; GUSELLA, JF; LEHRACH, H			DEFINED PHYSICAL LIMITS OF THE HUNTINGTON DISEASE GENE CANDIDATE REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CPG ISLANDS; DNA SEGMENT; MARKERS; LOCUS; CHROMOSOME-4; TELOMERE; D4S10; G8; LOCALIZATION; METHYLATION	The Huntington disease (HD) gene has been mapped 4 cM distal to D4S10 within the telomeric chromosome band, 4p16.3. The published physical map of this region extends from D4S10 to the telomere but contains two gaps of unknown size. Recombination events have been used to position the HD mutation with respect to genetic markers within this region, and one such event places the gene proximal to D4S168, excluding the distal gap as a possible location for the defect. One previously published recombination event appeared to have excluded the proximal gap. We have reassessed this event and have moved the proximal boundary for the HD candidate region centromeric to the gap within a "hot spot" for recombination between D4S10 and D4S125. We have closed the proximal gap and report here the complete physical map spanning the HD candidate region from D4S10 to D4S168, the maximum size of which can now be placed accurately at 2.5 Mb.	MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Irvine	BATES, GP (corresponding author), IMPERIAL CANC RES FUND,GENOME ANAL LAB,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305; Baxendale, Sarah/0000-0002-6760-9457	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS016367, R01NS022031] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00169] Funding Source: Medline; NINDS NIH HHS [NS16367, NS22031] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; BATES GP, 1990, AM J HUM GENET, V46, P762; BIRD AP, 1989, NUCLEIC ACIDS RES, V17, P9485, DOI 10.1093/nar/17.22.9485; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUCAN M, 1990, GENOMICS, V6, P1; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4186, DOI 10.1093/nar/16.9.4186; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; PRITCHARD C, 1990, P NATL ACAD SCI USA, V87, P7309, DOI 10.1073/pnas.87.18.7309; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; ROBBINS C, 1989, AM J HUM GENET, V44, P422; SKRAASTAD MI, 1989, AM J HUM GENET, V44, P560; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P8391; YOUNGMAN S, 1989, GENOMICS, V5, P802, DOI 10.1016/0888-7543(89)90122-5	33	78	82	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					7	16						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1829581				2022-12-18	WOS:A1991FW51100002
J	CALLEN, DF; FREEMANTLE, CJ; RINGENBERGS, ML; BAKER, E; EYRE, HJ; ROMAIN, D; HAAN, EA				CALLEN, DF; FREEMANTLE, CJ; RINGENBERGS, ML; BAKER, E; EYRE, HJ; ROMAIN, D; HAAN, EA			THE ISOCHROMOSOME-18P SYNDROME - CONFIRMATION OF CYTOGENETIC DIAGNOSIS IN 9 CASES BY INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET,ADELAIDE,SA 5006,AUSTRALIA; WELLINGTON HOSP,CYTOGENET LAB,WELLINGTON,NEW ZEALAND		CALLEN, DF (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Callen, David F/G-1975-2012; Slagboom, P. Eline/R-4790-2016	Slagboom, P. Eline/0000-0002-2875-4723; Callen, David/0000-0002-6189-9991				BATISTA DAS, 1983, J MED GENET, V20, P144, DOI 10.1136/jmg.20.2.144; CALLEN D F, 1988, Genomics, V2, P144, DOI 10.1016/0888-7543(88)90096-1; CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; DEVILEE P, 1986, CYTOGENET CELL GENET, V41, P193, DOI 10.1159/000132229; FROLAND A, 1963, Cytogenetics, V2, P99, DOI 10.1159/000129771; FRYNS JP, 1985, ANN GENET-PARIS, V28, P111; GOCKE H, 1986, PRENATAL DIAG, V6, P151, DOI 10.1002/pd.1970060211; HARNDEN DG, 1985, ISCN INT SYSTEM HUMA; HOOK EB, 1987, AM J HUM GENET, V40, P83; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; RIVERA H, 1984, ANN GENET-PARIS, V27, P187; Rooney D E, 1986, HUMAN CYTOGENETICS P, VFirst; TAKEDA K, 1989, J MED GENET, V26, P195, DOI 10.1136/jmg.26.3.195; TAYLOR KM, 1975, CLIN GENET, V8, P364; YOSHIHARA S, 1988, Acta Paediatrica Japonica, V30, P635	15	78	81	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					493	498						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393023				2022-12-18	WOS:A1990DX22300014
J	BUTLER, MG				BUTLER, MG			HYPOPIGMENTATION - A COMMON FEATURE OF PRADER-LABHART-WILLI SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BUTLER, MG (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,DIV GENET,T-2404 MED CTR N,NASHVILLE,TN 37232, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM026657] Funding Source: NIH RePORTER; NIADDK NIH HHS [5-P30-AM26657] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUTLER MG, 1987, AM J MED GENET, V28, P839, DOI 10.1002/ajmg.1320280408; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; BUTLER MG, 1989, UNPUB PRADERLABHARTW; CREEL DJ, 1986, NEW ENGL J MED, V314, P1606, DOI 10.1056/NEJM198606193142503; FERNHOFF PM, 1984, FEB NAT NEWB SCREEN; HITTNER HM, 1982, AM J OPHTHALMOL, V94, P328, DOI 10.1016/0002-9394(82)90358-0; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; Massey JY, 1973, J PEDIAT OPHTHALMOL, V10, P282; MATTEI MG, 1984, HUM GENET, V66, P313, DOI 10.1007/BF00287636; NICHOLSON WE, 1984, CLIN CHEM, V30, P259; PATHAK MA, 1987, DERMATOLOGY GENERAL, P1507; PHELAN MC, 1988, P GREENWOOD GENET CT, V7, P27; WENGER SL, 1987, AM J MED GENET, V28, P881, DOI 10.1002/ajmg.1320280413; WIESNER GL, 1987, AM J HUM GENET, V40, P431; WILLEMS PJ, 1987, AM J MED GENET, V27, P773, DOI 10.1002/ajmg.1320270405; WILLIAMS CA, 1982, AM J MED GENET, V11, P453, DOI 10.1002/ajmg.1320110411	17	78	79	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					140	146						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2741944				2022-12-18	WOS:A1989AE77900017
J	LINDLOF, M; KIURU, A; KAARIAINEN, H; KALIMO, H; LANG, H; PIHKO, H; RAPOLA, J; SOMER, H; SOMER, M; SAVONTAUS, ML; DELACHAPELLE, A				LINDLOF, M; KIURU, A; KAARIAINEN, H; KALIMO, H; LANG, H; PIHKO, H; RAPOLA, J; SOMER, H; SOMER, M; SAVONTAUS, ML; DELACHAPELLE, A			GENE DELETIONS IN X-LINKED MUSCULAR-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VAESTOLIITTO,DEPT MED GENET,HELSINKI,FINLAND; UNIV TURKU,DEPT MED GENET,SF-20500 TURKU 50,FINLAND; UNIV TURKU,DEPT PATHOL,SF-20500 TURKU 50,FINLAND; UNIV TURKU,DEPT CLIN NEUROPHYSIOL,SF-20500 TURKU 50,FINLAND; UNIV HELSINKI,DEPT PATHOL,SF-00290 HELSINKI 29,FINLAND; UNIV HELSINKI,DEPT NEUROL,SF-00290 HELSINKI 29,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,SF-00290 HELSINKI 29,FINLAND	University of Turku; University of Turku; University of Turku; University of Helsinki; University of Helsinki; University of Helsinki	LINDLOF, M (corresponding author), UNIV HELSINKI,DEPT MED GENET,HAARTMANINKATU 3,SF-00290 HELSINKI 29,FINLAND.							ARATHA K, 1988, NATURE, V333, P861; BEAM KG, 1988, NATURE, V333, P798, DOI 10.1038/333798a0; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1987, DUCHENNE MUSCULAR DY, P71; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; GARDNERMEDWIN D, 1980, BRIT MED BULL, V36, P109, DOI 10.1093/oxfordjournals.bmb.a071623; HART KA, 1987, HUM GENET, V75, P281, DOI 10.1007/BF00281075; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; HU XY, 1988, J MED GENET, V25, P369, DOI 10.1136/jmg.25.6.369; KALIMO H, 1988, ANN NEUROL, V23, P258, DOI 10.1002/ana.410230308; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LINDLOF M, 1987, ANN HUM GENET, V51, P317, DOI 10.1111/j.1469-1809.1987.tb01066.x; LINDLOF M, 1986, J MED GENET, V23, P560, DOI 10.1136/jmg.23.6.560; LINDLOF M, 1988, CLIN GENET, V33, P131; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; PAGE DC, 1984, AM J HUM GENET, V36, P565; SAVIRANTA P, 1988, AM J HUM GENET, V42, P84; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS NST, 1986, J MED GENET, V23, P509, DOI 10.1136/jmg.23.6.509; THOMAS NST, 1986, J MED GENET, V23, P596, DOI 10.1136/jmg.23.6.596; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; WITKOWSKI JA, 1988, TRENDS GENET, V4, P27; YATES JRW, 1986, J MED GENET, V23, P587, DOI 10.1136/jmg.23.6.587	33	78	79	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					496	503						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2929594				2022-12-18	WOS:A1989T810900008
J	ROMMENS, JM; ZENGERLING, S; BURNS, J; MELMER, G; KEREM, BS; PLAVSIC, N; ZSIGA, M; KENNEDY, D; MARKIEWICZ, D; ROZMAHEL, R; RIORDAN, JR; BUCHWALD, M; TSUI, LC				ROMMENS, JM; ZENGERLING, S; BURNS, J; MELMER, G; KEREM, BS; PLAVSIC, N; ZSIGA, M; KENNEDY, D; MARKIEWICZ, D; ROZMAHEL, R; RIORDAN, JR; BUCHWALD, M; TSUI, LC			IDENTIFICATION AND REGIONAL LOCALIZATION OF DNA MARKERS ON CHROMOSOME-7 FOR THE CLONING OF THE CYSTIC-FIBROSIS GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM & CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET & MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto			Tsui, Lap-chee/A-1081-2010; Rommens, Johanna/AAT-7465-2021	Burns, Julie/0000-0003-1238-8826				ARFIN SM, 1983, SOMAT CELL GENET, V9, P517, DOI 10.1007/BF01574256; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BENITEZ J, 1986, CANCER GENET CYTOGEN, V22, P309, DOI 10.1016/0165-4608(86)90023-3; BENTON WD, 1977, SCIENCE, V196, P190; BERGER W, 1987, HUM GENET, V77, P197, DOI 10.1007/BF00272392; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BUCHWALD M, 1986, CYTOGENET CELL GENET, V41, P234, DOI 10.1159/000132235; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DEAVEN LL, 1986, COLD SPRING HARB SYM, V51, P159, DOI 10.1101/SQB.1986.051.01.019; DELACHAPELLE A, 1984, CYTOGENET CELL GENET, V37, P274, DOI 10.1159/000132012; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; EIBERG H, 1985, CYTOGENET CELL GENET, V40, P623; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LATHROP GM, 1988, AM J HUM GENET, V42, P38; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; MANIATIS T, 1982, MOL CLONING LABORATO; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MICHIELS F, 1987, SCIENCE, V236, P1305, DOI 10.1126/science.3035716; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MORTON NE, 1982, HUM GENET, V62, P266, DOI 10.1007/BF00333534; OCONNELL P, 1988, CYTOGENET CELL GENET, V46, P672; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; OTT J, 1974, AM J HUM GENET, V26, P588; PARK M, 1988, P NATL ACAD SCI USA, V85, P2667, DOI 10.1073/pnas.85.8.2667; POUSTKA A, 1988, CYTOGENET CELL GENET, V46, P677; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; Rowley J D, 1985, Carcinog Compr Surv, V10, P409; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCAMBLER PJ, 1985, LANCET, V2, P1241; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P7159, DOI 10.1093/nar/14.18.7159; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SOUTHERN EM, 1987, NUCLEIC ACIDS RES, V15, P5925, DOI 10.1093/nar/15.15.5925; SPENCE MA, 1988, CYTOGENET CELL GENET, V46, P170; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TSUI LC, 1986, COLD SPRING HARB SYM, V51, P325, DOI 10.1101/SQB.1986.051.01.038; TSUI LC, 1986, AM J HUM GENET, V39, P720; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; TSUI LC, 1987, GENETICS EPITHELIAL, P73; VANOMMEN GJB, 1986, HUMAN GENETIC DISEAS, P113; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WAINWRIGHT BJ, 1987, AM J HUM GENET, V41, P944; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WHITE R, 1986, AM J HUM GENET, V39, P694; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; ZENGERLING S, 1987, AM J HUM GENET, V40, P228	69	78	80	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					645	663						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903665				2022-12-18	WOS:A1988Q933600011
J	KWIATKOWSKI, DJ; WESTBROOK, CA; BRUNS, GAP; MORTON, CC				KWIATKOWSKI, DJ; WESTBROOK, CA; BRUNS, GAP; MORTON, CC			LOCALIZATION OF GELSOLIN PROXIMAL TO ABL ON CHROMOSOME-9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP MED CTR,DIV GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; UNIV CHICAGO,DEPT MED,JOINT SECT HEMATOL ONCOL,CHICAGO,IL 60637	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Chicago	KWIATKOWSKI, DJ (corresponding author), MASSACHUSETTS GEN HOSP,DEPT MED,HEMATOL ONCOL UNIT,COX 6,BOSTON,MA 02114, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R29CA044700] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL001582] Funding Source: NIH RePORTER; NCI NIH HHS [CA44700-01] Funding Source: Medline; NHLBI NIH HHS [HL01582] Funding Source: Medline; NICHD NIH HHS [HD18658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERNARDS A, 1987, MOL CELL BIOL, V7, P3231, DOI 10.1128/MCB.7.9.3231; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRUNS GAP, 1979, BIOCHEM GENET, V17, P1031, DOI 10.1007/BF00504344; BRYAN J, 1984, J BIOL CHEM, V259, P7480; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; CHAPONNIER C, 1979, EXPERIENTIA, V35, P1039, DOI 10.1007/BF01949928; COLLINS SJ, 1983, P NATL ACAD SCI-BIOL, V80, P4813, DOI 10.1073/pnas.80.15.4813; COOK PJL, 1978, ANN HUM GENET, V41, P365, DOI 10.1111/j.1469-1809.1978.tb01904.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HEISTERKAMP N, 1983, Journal of Molecular and Applied Genetics, V2, P57; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; KANDA N, 1983, P NATL ACAD SCI-BIOL, V80, P4069, DOI 10.1073/pnas.80.13.4069; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, IN PRESS J CELL BIOL; LATT SA, 1976, CHROMOSOMA, V57, P135, DOI 10.1007/BF00292912; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MANIATIS T, 1982, MOL CLONING LABORATO; McKusick V.A., 1983, MENDELIAN INHERITANC; MORTON CC, 1984, AM J HUM GENET, V36, P576; NORBERG R, 1979, EUR J BIOCHEM, V100, P575, DOI 10.1111/j.1432-1033.1979.tb04204.x; OHYASHIKI K, 1986, CANCER RES, V46, P3642; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; ROWLEY JD, 1982, ADV CANCER RES, V36, P103, DOI 10.1016/S0065-230X(08)60423-6; SELDEN JR, 1983, P NATL ACAD SCI-BIOL, V80, P7289, DOI 10.1073/pnas.80.23.7289; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SMITH DB, 1987, J LAB CLIN MED, V110, P189; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; WESTBROOK CA, 1987, P NATL ACAD SCI USA, V84, P251, DOI 10.1073/pnas.84.1.251; WESTBROOK CA, IN PRESS BLOOD; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; YIN HL, 1984, J BIOL CHEM, V259, P5271	37	78	81	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1988	42	4					565	572						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6316	2831714				2022-12-18	WOS:A1988M631600006
J	LEPPERT, M; CAVENEE, W; CALLAHAN, P; HOLM, T; OCONNELL, P; THOMPSON, K; LATHROP, GM; LALOUEL, JM; WHITE, R				LEPPERT, M; CAVENEE, W; CALLAHAN, P; HOLM, T; OCONNELL, P; THOMPSON, K; LATHROP, GM; LALOUEL, JM; WHITE, R			A PRIMARY GENETIC-MAP OF CHROMOSOME-13Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CINCINNATI,SCH MED,DEPT MICROBIOL & MOLEC GENET,CINCINNATI,OH 45267; UNIV UTAH,SCH MED,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132	University System of Ohio; University of Cincinnati; Utah System of Higher Education; University of Utah	LEPPERT, M (corresponding author), UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132, USA.							BISHOP D T, 1985, Genetic Epidemiology, V2, P349, DOI 10.1002/gepi.1370020404; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; DRYJA TP, 1985, HUM GENET, V71, P192, DOI 10.1007/BF00284571; DUNN LC, 1967, GENET RES, V9, P211, DOI 10.1017/S0016672300010491; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; JULIER C, 1984, THESIS U PARIS; LALOUEL JM, 1985, CYTOGENET CELL GENET, V40, P676; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1986, GENET EPIDEMIOL; NAYLOR S, 1985, CYTOGENET CELL GENET, V40, P242, DOI 10.1159/000132176; RENWICK JH, 1968, B EUR SOC HUM GENET, V2, P7; SHERMAN SL, 1985, CYTOGENET CELL GENET, V40, P742; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; Thomas J.M., 1984, 8TH P INT C CAT BERL, V1, P31; WALLACE ME, 1972, GENET RES, V20, P257, DOI 10.1017/S0016672300013781; WEITKAMP LR, 1971, AM J HUM GENET, V23, P462; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0	23	78	79	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1986	39	4					425	437						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7063	3464200				2022-12-18	WOS:A1986E706300001
J	LALOUEL, JM; LEMIGNON, L; SIMON, M; FAUCHET, R; BOUREL, M; RAO, DC; MORTON, NE				LALOUEL, JM; LEMIGNON, L; SIMON, M; FAUCHET, R; BOUREL, M; RAO, DC; MORTON, NE			GENETIC-ANALYSIS OF IDIOPATHIC HEMOCHROMATOSIS USING BOTH QUALITATIVE (DISEASE STATUS) AND QUANTITATIVE (SERUM IRON) INFORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP SUD, MED CLIN B, 16 BLVD BULGARIE, F-33022 RENNES, FRANCE; CTR REG TRANSFUS SANGUINE, RENNES, FRANCE; CHU RENNES, MED CLIN A, F-35000 RENNES, FRANCE; UNIV HAWAII, POPULAT GENET LAB, HONOLULU, HI 96822 USA; UNIV PARIS 07, ANTHROPOL BIOL LAB, F-75221 PARIS 05, FRANCE; WASHINGTON UNIV, SCH MED, DIV BIOSTAT, ST LOUIS, MO 63110 USA	CHU Rennes; CHU Rennes; University of Hawaii System; UDICE-French Research Universities; Universite Paris Cite; Washington University (WUSTL)								ADDISON GM, 1972, J CLIN PATHOL, V25, P326, DOI 10.1136/jcp.25.4.326; ALEXANDRE JL, 1975, THESIS FM RENNES REN; BARRY M, 1971, LANCET, V1, P100; Bothwell T.H., 1979, IRON METABOLISM MAN; BOTHWELL TH, 1959, AM J MED, V27, P730, DOI 10.1016/0002-9343(59)90189-5; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FINCH SC, 1955, MEDICINE, V34, P381, DOI 10.1097/00005792-195512000-00001; GOLDIN LR, 1980, AM J MED GENET, V6, P279, DOI 10.1002/ajmg.1320060405; JACOBS A, 1977, IRON METABOLISM THAL, P97; KEATS B, 1982, AM J HUM GENET, V34, P730; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LEMIGNON L, 1983, CLIN GENET, V24, P171; LEMIGNON L, 1982, THESIS FM RENNES REN; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MILDER MS, 1978, ACTA HAEMATOL-BASEL, V60, P65, DOI 10.1159/000207699; MITTAL KK, 1968, TRANSPLANTATION, V6, P913, DOI 10.1097/00007890-196811000-00006; MORTON A, 1976, PLASMA PROTEIN TURNO, P165; MORTON AG, 1977, BRIT J HAEMATOL, V36, P383, DOI 10.1111/j.1365-2141.1977.tb00662.x; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1981, HUM HERED, V31, P3, DOI 10.1159/000153168; NAMBOODIRI KK, 1975, AM J HUM GENET, V27, P454; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; RAMSAY WNM, 1957, CLIN CHIM ACTA, V2, P214, DOI 10.1016/0009-8981(57)90105-5; RAMSAY WNM, 1957, CLIN CHIM ACTA, V2, P221, DOI 10.1016/0009-8981(57)90106-7; Reich T., 1981, Genetic research strategies for psychobiology and psychiatry., P353; Simon M, 1980, Prog Med Genet, V4, P135; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; SIMON M, 1974, NOUV PRESSE MED, V4, P1432; SIMON M, 1977, CLIN GENET, V11, P327; TROUSSEAU A, 1865, CLIN MED HOTEL DIEU, P672; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; [No title captured]	37	78	78	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					700	718						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556659				2022-12-18	WOS:A1985APR1800007
J	WARD, RH; NEEL, JV				WARD, RH; NEEL, JV			GENE FREQUENCIES AND MICRODIFFERENTIATION AMONG MAKIRITARE INDIANS .4. A COMPARISON OF A GENETIC NETWORK WITH ETHNOHISTORY AND MIGRATION MATRICES - A NEW INDEX OF GENETIC ISOLATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1970, AM J HUM GENET, V22, P526; ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; BARANDIARAN DD, 1961, NATURA, V3, P14; BARANDIARAN DD, 1966, ANTROPOLOGICA, P1; BARANDIARAN DD, 1962, ANTROPOLOGICA, V11, P1; BODMER WF, 1968, GENETICS, V59, P565; CAVALLISFORZA L, 1967, AM J HUM GENET, V19, P234; CAVALLISFORZA LL, 1969, AM J HUM GENET, V21, P252; CAVALLISFORZA LL, 1964, GENET TODAY, V3, P923; CHAGNON NA, 1970, AM J PHYS ANTHROPOL, V32, P339, DOI 10.1002/ajpa.1330320304; Edwards A. W. F., 1964, PHENETIC PHYLOGENETI, P67; EVANS C, 1964, PREHISTORIC MAN NEW, P419; FITCH WM, 1969, AM J HUM GENET, V21, P384; FUCHS H, 1964, AM INDIGENA, V24, P171; FUCHS H, 1962, FOLIA ANTROPOLOGICA, P27; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GERSHOWITZ H, 1970, AM J HUM GENET, V22, P515; GILES E, 1966, ANN NY ACAD SCI, V134, P655, DOI 10.1111/j.1749-6632.1966.tb43053.x; HIORNS RW, 1969, ANN HUM GENET, V32, P237, DOI 10.1111/j.1469-1809.1969.tb00073.x; Kendall M. G., 1962, RANK CORRELATION MET; KIDD KK, 1969, THESIS U WISCONSIN; KIMURA M, 1964, GENETICS, V49, P561; KIMURA M, 1954, GENETICS, V39, P280; KOCHGRUNBERG T, 1917, ROROIMA ORINOCO ERGE; Malecot G, 1948, MATH HEREDITE; MODIANO G, 1965, ANN HUM GENET, V29, P19; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JAMES V., 1967, JAP J HUM GENET, V12, P1; NEEL JV, 1970, AM J EPIDEMIOL, V91, P418, DOI 10.1093/oxfordjournals.aje.a121152; NEEL JV, 1967, AM J HUM GENET, V19, P554; NEEL JV, 1964, COLD SPRING HARB SYM, V29, P85, DOI 10.1101/SQB.1964.029.01.014; NEEL JV, 1969, 12 P INT C GEN TOK, V3, P389; NOTHOMB HJF, 1968, ORIENTE MED, V1, P91; REICHELDOLMATO.G, 1961, EVOLUTION HORTICULTU, P84; ROUSE I, 1964, PREHISTORIC MAN NEW, P389; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SANGHVI LD, 1966, BIOL HUM ADAPT, P305; SIMMONS RT, 1961, AM J TROP MED HYG, V10, P639, DOI 10.4269/ajtmh.1961.10.639; SMITH CAB, 1969, ANN HUM GENET, V32, P251, DOI 10.1111/j.1469-1809.1969.tb00074.x; WRIGHT S, 1946, GENETICS, V31, P39; Wright S, 1943, GENETICS, V28, P114	42	78	79	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	5					538	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	H6097	5516237				2022-12-18	WOS:A1970H609700006
J	STEINBERG, A; BLUMBERG, BS; FUDENBERG, H; STAUFFER, R				STEINBERG, A; BLUMBERG, BS; FUDENBERG, H; STAUFFER, R			GM PHENOTYPES AND GENOTYPES IN US WHITES AND NEGROES, IN AMERICAN INDIANS AND ESKIMOS, IN AFRICANS, AND IN MICRONESIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADINOLFI DM, 1960, ACAD NAZION LINCEI, P390; ADINOLFI M, 1959, REND ACCAD NAZ LINCE, V26, P818; ALLISON AC, 1959, NATURE, V183, P118, DOI 10.1038/183118a0; ALLISON AC, 1959, HUM BIOL, V31, P352; BLUMBERG BS, 1959, ANN HUM GENET, V23, P349, DOI 10.1111/j.1469-1809.1959.tb01478.x; BLUMBERG BS, 1959, NATURE, V184, P1990, DOI 10.1038/1841990a0; BLUMBERG BS, 1961, AM J PHYS ANTHROP; CORCORAN PA, 1959, AM J PHYS ANTHROPOL, V17, P187, DOI 10.1002/ajpa.1330170304; GLASS B, 1953, AM J HUM GENET, V5, P1; GRUBB R., 1956, ACTA PATHOL ET MICROBIOL SCAND, V39, P195; GRUBB R., 1956, ACTA PATHOL ET MICROBIOL SCAND, V39, P390; GRUBB R, 1959, BIOCHEMISTRY HUMAN G; HARBOE MORTEN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P191; HARBOE MORTEN, 1959, ACTA PATH ET MICROBIOL SCAND, V45, P357; MOULLEC J, 1959, PROC 7 CONG INT SOC, P881; PODLIACHOUK L, 1960, BULL SOC ANTHROP, V16, P237; ROPARTZ C, 1960, REV FR ETUD CLIN BIO, V5, P814; ROPARTZ C, 1958, REV HEMATOL, V13, P511; ROPARTZ C, 1960, REV FR ETUD CLIN BIO, V5, P933; ROPARTZ C, 1961, NATURE; ROPARTZ C, 1961, SM; ROPATZ C, 1960, REV HEMATOL, V15, P40; STEINBERG AG, 1960, NATURE, V185, P324, DOI 10.1038/185324a0; STEINBERG AG, 1960, NATURE, V188, P169, DOI 10.1038/188169a0; STEINBERG AG, 1960, AM J HUM GENET, V12, P44; VANDEWIEL W, 1959, NED T GENEESK, V103, P2314; YOKOYAMA M, 1961, NATURE, V190, P455, DOI 10.1038/190455a0	27	78	78	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	2					205	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2960A	17948457				2022-12-18	WOS:A19612960A00006
J	SLATIS, HM; REIS, RH; HOENE, RE				SLATIS, HM; REIS, RH; HOENE, RE			CONSANGUINEOUS MARRIAGES IN THE CHICAGO REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMO M, 1952, Atti Accad Fisiocrit Siena Med Fis, V20, P309; BEMISS SM, 1858, T AM MED ASS, V11, P319; BOOK JA, 1957, ANN HUM GENET, V21, P191; GLASS B, 1950, AM J HUM GENET, V2, P269; Mitchell Arthur, 1865, Edinb Med J, V10, P894; Mitchell Arthur, 1865, Edinb Med J, V10, P781; Mitchell Arthur, 1865, Edinb Med J, V10, P1074; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1955, ANN HUM GENET, V20, P116; OREL H, 1935, ARCH RASSENB, V28, P281; PENROSE LS, 1957, ANN HUM GENET, V21, P222, DOI 10.1111/j.1469-1809.1972.tb00283.x; REMLINGER P, 1947, B ACAD NAT MED, V131, P494; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; SLATIS HM, 1954, AM J HUM GENET, V6, P412; SLATIS HM, 1956, 1ST P INT C GEN, V4, P53; Sutter J, 1952, POPULATION, V7, P249, DOI 10.2307/1524207; WOOLF CM, 1956, AM J HUM GENET, V8, P236; 1943, OFFICIAL CATHOLIC DI	18	78	78	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	4					446	464						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA221	13606118				2022-12-18	WOS:A1958WA22100003
J	Fritsche, LG; Gruber, SB; Wu, ZK; Schmidt, EM; Zawistowski, M; Moser, SE; Blanc, VM; Brummett, CM; Kheterpal, S; Abecasis, GR; Mukherjee, B				Fritsche, Lars G.; Gruber, Stephen B.; Wu, Zhenke; Schmidt, Ellen M.; Zawistowski, Matthew; Moser, Stephanie E.; Blanc, Victoria M.; Brummett, Chad M.; Kheterpal, Sachin; Abecasis, Goncalo R.; Mukherjee, Bhramar			Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLORECTAL-CANCER; COMMON VARIANTS; THYROID-CANCER; IDENTIFIES 3; ALLELES; PREDICTION; CATALOG; EMERGE; LOCI	Health systems are stewards of patient electronic health record (EHR) data with extraordinarily rich depth and breadth, reflecting thousands of diagnoses and exposures. Measures of genomic variation integrated with EHRs offer a potential strategy to accurately stratify patients for risk profiling and discover new relationships between diagnoses and genomes. The objective of this study was to evaluate whether polygenic risk scores (PRS) for common cancers are associated with multiple phenotypes in a phenome-wide association study (PheWAS) conducted in 28,260 unrelated, genotyped patients of recent European ancestry who consented to participate in the Michigan Genomics Initiative, a longitudinal biorepository effort within Michigan Medicine. PRS for 12 cancer traits were calculated using summary statistics from the NHGRI-EBI catalog. A total of 1,711 synthetic case-control studies was used for PheWAS analyses. There were 13,490 (47.7%) patients with at least one cancer diagnosis in this study sample. PRS exhibited strong association for several cancer traits they were designed for, including female breast cancer, prostate cancer, melanoma, basal cell carcinoma, squamous cell carcinoma, and thyroid cancer. Phenome-wide significant associations were observed between PRS and many non-cancer diagnoses. To differentiate PRS associations driven by the primary trait from associations arising through shared genetic risk profiles, the idea of "exclusion PRS PheWAS'' was introduced. Further analysis of temporal order of the diagnoses improved our understanding of these secondary associations. This comprehensive PheWAS used PRS instead of a single variant.	[Fritsche, Lars G.; Wu, Zhenke; Schmidt, Ellen M.; Zawistowski, Matthew; Kheterpal, Sachin; Abecasis, Goncalo R.; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.; Zawistowski, Matthew; Abecasis, Goncalo R.; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, KG Jebsen Ctr Genet Epidemiol, N-7491 Trondheim, Sor Trondelag, Norway; [Gruber, Stephen B.] USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Wu, Zhenke; Mukherjee, Bhramar] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA; [Moser, Stephanie E.; Brummett, Chad M.; Kheterpal, Sachin] Univ Michigan, Sch Med, Dept Anesthesiol, Div Pain Med, Ann Arbor, MI 48109 USA; [Blanc, Victoria M.] Univ Michigan, Sch Med, Cent Biorepository, Ann Arbor, MI 48109 USA; [Brummett, Chad M.; Kheterpal, Sachin] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Mukherjee, Bhramar] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Mukherjee, Bhramar] Univ Michigan, Dept Biostat & Epidemiol, Sch Publ Hlth, 1415 Washington Hts,SPH 1 Room 4619, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU); University of Southern California; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mukherjee, B (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA.; Mukherjee, B (corresponding author), Univ Michigan, Dept Biostat & Epidemiol, Sch Publ Hlth, 1415 Washington Hts,SPH 1 Room 4619, Ann Arbor, MI 48109 USA.	bhramar@urnich.edu	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Brummett, Chad/0000-0003-0974-7242; Schmidt, Ellen/0000-0003-1198-7536	National Institutes of Health/NIH [NCI P30CA046592]; National Science Foundation [DMS-1712933]; Michigan Genomics Initiative; University of Michigan Precision Health; University of Michigan Medical School Central Biorepository; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER	National Institutes of Health/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Michigan Genomics Initiative; University of Michigan Precision Health; University of Michigan Medical School Central Biorepository; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors acknowledge the Michigan Genomics Initiative, University of Michigan Precision Health, and the University of Michigan Medical School Central Biorepository for providing the collection, biospecimen storage, management, and distribution services in support of the research reported in this publication. This material is based in part upon work supported by the National Institutes of Health/NIH (NCI P30CA046592) and by the National Science Foundation under grant number DMS-1712933. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ananthakrishnan AN, 2016, CLIN GASTROENTEROL H, V14, P973, DOI 10.1016/j.cgh.2016.02.017; Ananthakrishnan AN, 2016, INFLAMM BOWEL DIS, V22, P151, DOI 10.1097/MIB.0000000000000580; Ananthakrishnan AN, 2015, INFLAMM BOWEL DIS, V21, P2507, DOI 10.1097/MIB.0000000000000524; Asgari MM, 2016, J INVEST DERMATOL, V136, P930, DOI 10.1016/j.jid.2016.01.013; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dey R, 2017, AM J HUM GENET, V101, P37, DOI 10.1016/j.ajhg.2017.05.014; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Frampton M, 2017, GENET MED, V19, P314, DOI 10.1038/gim.2016.101; Garcia-Closas M, 2013, CANCER RES, V73, P2211, DOI 10.1158/0008-5472.CAN-12-2388; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI [10.18637/jss.v042.i08, DOI 10.18637/JSS.V042.I08]; Hsu L, 2015, GASTROENTEROLOGY, V148, P1330, DOI 10.1053/j.gastro.2015.02.010; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lin LI-K, 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Morales J, 2017, BIORXIV, DOI [10.1101/129395, DOI 10.1101/129395]; Nan HM, 2011, HUM MOL GENET, V20, P3718, DOI 10.1093/hmg/ddr287; Rasmussen LV, 2016, APPL CLIN INFORM, V7, P870, DOI 10.4338/ACI-2016-04-RA-0060; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Szulkin R, 2015, PROSTATE, V75, P1467, DOI 10.1002/pros.23037; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Verma A, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0191-8; Wang CL, 2014, NAT GENET, V46, P409, DOI 10.1038/ng.2924; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Werner RN, 2013, BRIT J DERMATOL, V169, P502, DOI 10.1111/bjd.12420; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Witte JS, 2010, ANNU REV PUBL HEALTH, V31, P9, DOI 10.1146/annurev.publhealth.012809.103723	49	77	78	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1048	1061		10.1016/j.ajhg.2018.04.001	http://dx.doi.org/10.1016/j.ajhg.2018.04.001			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29779563	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000434946200004
J	Gabriele, M; Vulto-van Silfhout, AT; Germain, PL; Vitriolo, A; Kumar, R; Douglas, E; Haan, E; Kosaki, K; Takenouchi, T; Rauch, A; Steindl, K; Frengen, E; Misceo, D; Pedurupillay, CRJ; Stromme, P; Rosenfeld, JA; Shao, YR; Craigen, WJ; Schaaf, CP; Rodriguez-Buritica, D; Farach, L; Friedman, J; Thulin, P; McLean, SD; Nugent, KM; Morton, J; Nicholl, J; Andrieux, J; Stray-Pedersen, A; Chambon, P; Patrier, S; Lynch, SA; Kjaergaard, S; Torring, PM; Brasch-Andersen, C; Ronan, A; van Haeringen, A; Anderson, PJ; Powis, Z; Brunner, HG; Pfundt, R; Schuurs-Hoeijmakers, JHM; van Bon, BWM; Lelieveld, S; Gilissen, C; Nillesen, WM; Vissers, LELM; Gecz, J; Koolen, DA; Testa, G; de Vries, BBA				Gabriele, Michele; Vulto-van Silfhout, Anneke T.; Germain, Pierre-Luc; Vitriolo, Alessandro; Kumar, Raman; Douglas, Evelyn; Haan, Eric; Kosaki, Kenjiro; Takenouchi, Toshiki; Rauch, Anita; Steindl, Katharina; Frengen, Eirik; Misceo, Doriana; Pedurupillay, Christeen Ramane J.; Stromme, Petter; Rosenfeld, Jill A.; Shao, Yunru; Craigen, William J.; Schaaf, Christian P.; Rodriguez-Buritica, David; Farach, Laura; Friedman, Jennifer; Thulin, Perla; McLean, Scott D.; Nugent, Kimberly M.; Morton, Jenny; Nicholl, Jillian; Andrieux, Joris; Stray-Pedersen, Asbjorg; Chambon, Pascal; Patrier, Sophie; Lynch, Sally A.; Kjaergaard, Susanne; Torring, Pernille M.; Brasch-Andersen, Charlotte; Ronan, Anne; van Haeringen, Arie; Anderson, Peter J.; Powis, Zoe; Brunner, Han G.; Pfundt, Rolph; Schuurs-Hoeijmakers, Janneke H. M.; van Bon, Bregje W. M.; Lelieveld, Stefan; Gilissen, Christian; Nillesen, Willy M.; Vissers, Lisenka E. L. M.; Gecz, Jozef; Koolen, David A.; Testa, Giuseppe; de Vries, Bert B. A.			YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEMETHYLASE JMJD3; GENE-EXPRESSION; ADENOVIRUS E1A; KANSL1 CAUSE; MUTATIONS; PROTEIN; YANG; YIN; NETWORK; GENOME	Yin and yang 1 (YY1) is a well-known zinc-finger transcription factor with crucial roles in normal development and malignancy. YY1 acts both as a repressor and as an activator of gene expression. We have identified 23 individuals with de novo mutations or deletions of YY1 and phenotypic features that define a syndrome of cognitive impairment, behavioral alterations, intrauterine growth restriction, feeding problems, and various congenital malformations. Our combined clinical and molecular data define "YY1 syndrome" as a haploinsufficiency syndrome. Through immunoprecipitation of YY1-bound chromatin from affected individuals' cells with antibodies recognizing both ends of the protein, we show that YY1 deletions and missense mutations lead to a global loss of YY1 binding with a preferential retention at high-occupancy sites. Finally, we uncover a widespread loss of H3K27 acetylation in particular on the YY1-bound enhancers, underscoring a crucial role for YY1 in enhancer regulation. Collectively, these results define a clinical syndrome caused by haploinsufficiency of YY1 through dysregulation of key transcriptional regulators.	[Gabriele, Michele; Germain, Pierre-Luc; Vitriolo, Alessandro; Testa, Giuseppe] European Inst Oncol, Dept Expt Oncol, Lab Stem Cell Epigenet, I-20139 Milan, Italy; [Vulto-van Silfhout, Anneke T.; Brunner, Han G.; Pfundt, Rolph; Schuurs-Hoeijmakers, Janneke H. M.; van Bon, Bregje W. M.; Lelieveld, Stefan; Gilissen, Christian; Nillesen, Willy M.; Vissers, Lisenka E. L. M.; Koolen, David A.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Kumar, Raman; Douglas, Evelyn; Haan, Eric; Nicholl, Jillian; Gecz, Jozef] Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia; [Kumar, Raman] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5000, Australia; [Douglas, Evelyn; Haan, Eric; Nicholl, Jillian] SA Pathol, SA Clin Genet Serv, Adelaide, SA 5000, Australia; [Kosaki, Kenjiro; Takenouchi, Toshiki] Keio Univ, Ctr Med Genet, Sch Med, Tokyo 1608582, Japan; [Rauch, Anita; Steindl, Katharina] Univ Zurich, Inst Med Genet, CH-8952 Schlieren, Switzerland; [Frengen, Eirik; Misceo, Doriana; Pedurupillay, Christeen Ramane J.] Univ Oslo, Dept Med Genet, N-0315 Oslo, Norway; [Frengen, Eirik; Misceo, Doriana; Pedurupillay, Christeen Ramane J.] Oslo Univ Hosp, N-0315 Oslo, Norway; [Stromme, Petter] Oslo Univ Hosp, Div Paediat & Adolescent Med, N-0313 Oslo, Norway; [Stromme, Petter] Univ Oslo, N-0313 Oslo, Norway; [Rosenfeld, Jill A.; Shao, Yunru; Craigen, William J.; Schaaf, Christian P.] Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA; [Rodriguez-Buritica, David; Farach, Laura] Univ Texas Hlth, Div Genet, Dept Pediat, Houston, TX 77030 USA; [Friedman, Jennifer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92123 USA; [Friedman, Jennifer] Univ Calif San Diego, Dept Pediat, San Diego, CA 92123 USA; [Friedman, Jennifer] Rady Childrens Hosp, San Diego, CA 92123 USA; [Thulin, Perla] Univ Utah, Dept Neurol, San Diego, CA 92123 USA; [McLean, Scott D.; Nugent, Kimberly M.] Childrens Hosp San Antonio, Clin Genet Sect, San Antonio, TX 78207 USA; [Morton, Jenny] Birmingham Womens Hosp, Birmingham B15 2TG, W Midlands, England; [Andrieux, Joris] Hop Jeanne Flandre, Inst Genet Med, F-59000 Lille, France; [Stray-Pedersen, Asbjorg] Baylor Coll Med, Human & Med Genet, Houston, TX 77030 USA; [Chambon, Pascal] Rouen Univ Hosp, Lab Cytogenet, F-76031 Rouen, France; [Patrier, Sophie] Rouen Univ Hosp, Serv Anat Patholog, F-76031 Rouen, France; [Lynch, Sally A.] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin D12 V004, Ireland; [Kjaergaard, Susanne] Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Brasch-Andersen, Charlotte] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Ronan, Anne] Hunter Genet, Waratah, NSW 2298, Australia; [van Haeringen, Arie] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Anderson, Peter J.] Womens & Childrens Hosp, Australian Craniofacial Unit, Adelaide, SA 5006, Australia; [Powis, Zoe] Ambry Genet, Aliso Viejo, CA 92656 USA; [Gecz, Jozef] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia; [Testa, Giuseppe] Univ Milan, Dept Oncol & Hemato Oncol, I-20122 Milan, Italy	IRCCS European Institute of Oncology (IEO); Radboud University Nijmegen; University of Adelaide; Robinson Research Institute; University of Adelaide; SA Pathology; Keio University; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Utah System of Higher Education; University of Utah; Birmingham Women's Hospital; Universite de Lille - ISITE; CHU Lille; Baylor College of Medicine; CHU de Rouen; CHU de Rouen; National Children's Research Centre (NCRC); Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Womens & Childrens Hospital Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Milan	Testa, G (corresponding author), European Inst Oncol, Dept Expt Oncol, Lab Stem Cell Epigenet, I-20139 Milan, Italy.; de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.; Testa, G (corresponding author), Univ Milan, Dept Oncol & Hemato Oncol, I-20122 Milan, Italy.	giuseppe.testa@unimi.it; bert.devries@radboudumc.nl	Schaaf, Christian P/AAJ-7318-2021; Vissers, Lisenka ELM/A-2598-2015; Kumar, Raman/AHE-0538-2022; Vitriolo, Alessandro/R-2118-2017; Germain, Pierre-Luc/K-9326-2016; Koolen, D.A./L-4448-2015; Vitriolo, Alessandro/S-8606-2019; Gecz, Jozef/X-3469-2019; Gilissen, Christian/E-5246-2012; Pfundt, Rolph/L-4576-2015; Misceo, Doriana/AAR-9085-2020; Rauch, Anita/C-5568-2014; van Bon, Bregje/Q-2445-2015; Gabriele, Michele/R-1875-2017; AT, Vulto-van Silfhout/H-4199-2015	Schaaf, Christian P/0000-0002-2148-7490; Vissers, Lisenka ELM/0000-0001-6470-5497; Kumar, Raman/0000-0001-7976-8386; Vitriolo, Alessandro/0000-0002-1462-8064; Germain, Pierre-Luc/0000-0003-3418-4218; Vitriolo, Alessandro/0000-0002-1462-8064; Gecz, Jozef/0000-0002-7884-6861; Gilissen, Christian/0000-0003-1693-9699; Misceo, Doriana/0000-0002-6594-5801; Rauch, Anita/0000-0003-2930-3163; van Bon, Bregje/0000-0003-2234-0105; Gabriele, Michele/0000-0002-5393-9084; Chambon, Pascal/0000-0002-9040-3051; Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Frengen, Eirik/0000-0002-8387-2247; Lynch, Sally Ann/0000-0003-3540-1333; Testa, Giuseppe/0000-0002-9104-0918	European Commission (GENCODYS grant) under FP7 [241995]; European Research Council [DISEASEAVATARS 616441]; Telethon Foundation [GGP13231B, GGP14265]; Associazione Italiana per la Ricerca sul Cancro; Regione Lombardia (Ricerca Indipendente); Umberto Veronesi Foundation; Italian Ministry of Health (ERANET-Neuron grant); Italian Ministry of Health (Ricerca Corrente grant); Japan Agency for Medical Research and Development; Australian National Healthand Medical Research Council [1091593]; Dutch Organization for Health Research and Development (ZON-MW) [917-86-319, 912-12-109]	European Commission (GENCODYS grant) under FP7(European Commission); European Research Council(European Research Council (ERC)European Commission); Telethon Foundation(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Regione Lombardia (Ricerca Indipendente); Umberto Veronesi Foundation(Fondazione Umberto Veronesi); Italian Ministry of Health (ERANET-Neuron grant); Italian Ministry of Health (Ricerca Corrente grant)(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Australian National Healthand Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dutch Organization for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development)	We are grateful to the individuals and their parents for their participation. We thank Lone Laulund (Department of Pediatrics, Odense University Hospital) for additional clinical information about deletion case 263711. We thank Giuseppe D'Agostino from the Testa lab for his help in creating the summary figure. This work was supported by the European Commission (GENCODYS grant 241995 under FP7 to A.T.V.-v.S. and B.B.A.d.V.), the European Research Council (grant DISEASEAVATARS 616441 to G.T.), the Telethon Foundation (grants GGP13231B and GGP14265 to G.T.), the Associazione Italiana per la Ricerca sul Cancro (investigator grant to G.T. and fellowship to M.G.), the Regione Lombardia (Ricerca Indipendente 2012 to G.T.), the Umberto Veronesi Foundation (P.-L.G.), the Italian Ministry of Health (ERANET-Neuron grant to P.-L.G. and Ricerca Corrente grant to G.T.), the Japan Agency for Medical Research and Development (research grant to K.K.), the Australian National Healthand Medical Research Council (grant 1091593 to J.G.), and the Dutch Organization for Health Research and Development (ZON-MW grants 917-86-319 and 912-12-109 to B.B.A.d.V.).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Born Gesche, 2015, Front Synaptic Neurosci, V7, P3, DOI 10.3389/fnsyn.2015.00003; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Castermans D, 2003, J MED GENET, V40, P352, DOI 10.1136/jmg.40.5.352; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Dachtler J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.123; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gerasimova T, 2015, GENE DEV, V29, P1683, DOI 10.1101/gad.263871.115; Germain PL, 2016, NUCLEIC ACIDS RES, V44, P5054, DOI 10.1093/nar/gkw448; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Guo DC, 2017, AM J HUM GENET, V100, P21, DOI 10.1016/j.ajhg.2016.11.008; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Jabbi M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.98; Jolly LA, 2015, HUM MOL GENET, V24, P3335, DOI 10.1093/hmg/ddv083; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kagami M, 2015, EUR J HUM GENET, V23, P1488, DOI 10.1038/ejhg.2015.13; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Severi G, 2016, AM J MED GENET A, V170, P162, DOI 10.1002/ajmg.a.37346; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Testa G, 2011, BIOESSAYS, V33, P519, DOI 10.1002/bies.201100021; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vella P, 2012, NUCLEIC ACIDS RES, V40, P3403, DOI 10.1093/nar/gkr1290; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Vulto-van Silfhout AT, 2013, AM J HUM GENET, V92, P401, DOI 10.1016/j.ajhg.2013.01.007; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu SH, 2008, INT TEST CONF P, P1; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zollino M, 2012, NAT GENET, V44, P636, DOI 10.1038/ng.2257	78	77	78	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					907	925		10.1016/j.ajhg.2017.05.006	http://dx.doi.org/10.1016/j.ajhg.2017.05.006			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28575647	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000402700600007
J	Lo, KK; Karampetsou, E; Boustred, C; Mckay, F; Mason, S; Hi, M; Plagnol, V; Chitty, LS				Lo, Kitty K.; Karampetsou, Evangelia; Boustred, Christopher; Mckay, Fiona; Mason, Sarah; Hi, Melissa; Plagnol, Vincent; Chitty, Lyn S.			Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-FREE DNA; MICROARRAY; DIAGNOSIS; TECHNOLOGIES	The use of massively parallel sequencing of maternal cfDNA for non-invasive prenatal testing (NIPT) of aneuploidy is widely available. Recently, the scope of testing has increased to include selected subchromosomal abnormalities, but the number of samples reported has been small. We developed a calling pipeline based on a segmentation algorithm for the detection of these rearrangements in maternal plasma. The same read depth used in our standard pipeline for aneuploidy NIPT detected 15/18 (83%) samples with pathogenic rearrangements > 6 Mb but only 2/10 samples with rearrangements < 6 Mb, unless they were maternally inherited. There were two false-positive calls in 534 samples with no known subchromosomal abnormalities (specificity 99.6%). Using higher read depths, we detected 29/31 fetal subchromosomal abnormalities, including the three samples with maternally inherited microduplications. We conclude that test sensitivity is a function of the fetal fraction, read depth, and size of the fetal CNV and that at least one of the two false negatives is due to a low fetal fraction. The lack of an independent method for determining fetal fraction, especially for female fetuses, leads to uncertainty in test sensitivity, which currently has implications for this technique's future as a clinical diagnostic test. Furthermore, to be effective, NIPT must be able to detect chromosomal rearrangements across the whole genome for a very low false-positive rate. Because standard NIPT can only detect the majority of larger (>6 Mb) chromosomal rearrangements and requires knowledge of fetal fraction, we consider that it is not yet ready for routine clinical implementation.	[Lo, Kitty K.; Plagnol, Vincent] UCL, UCL Genet Inst, London WC1E 6BT, England; [Karampetsou, Evangelia; Boustred, Christopher; Mckay, Fiona; Mason, Sarah; Hi, Melissa; Chitty, Lyn S.] Great Ormond St Hosp Children NHS Fdn Trust, North East Thames Reg Genet Serv, London WC1N 3BH, England; [Chitty, Lyn S.] UCL, UCL Inst Child Hlth, London WC1N 1EH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Chitty, LS (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, North East Thames Reg Genet Serv, London WC1N 3BH, England.	l.chitty@ucl.ac.uk		chitty, lyn/0000-0002-4857-7138; Plagnol, Vincent/0000-0002-5597-9215	National Institute for Health Research (NIHR) [RP-PG-0707-10107]; New life Foundation for Disabled Children; NIHR Comprehensive Research Network; NIHR Biomedical Research Centre at Great Ormond Street NHS Foundation Trust; UK Medical Research Council [MR/K018523/1]; Medical Research Council [MR/K018523/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10141, RP-PG-0707-10107] Funding Source: researchfish; MRC [MR/K018523/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); New life Foundation for Disabled Children; NIHR Comprehensive Research Network; NIHR Biomedical Research Centre at Great Ormond Street NHS Foundation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under the Programme Grants for Applied Research (RP-PG-0707-10107; the Rapid Accurate Prenatal Non-invasive Diagnosis [RAPID] project), the New life Foundation for Disabled Children, and the NIHR Comprehensive Research Network. The NIHR Biomedical Research Centre at Great Ormond Street NHS Foundation Trust funded K.K.L. and partly funded L.S.C. V.P. is partly funded by a UK Medical Research Council grant MR/K018523/1. V.P. and K.L. are part-time employees and shareholders of Inivata (a company that analyzes circulating tumor DNA). The views expressed herein are those of the authors and not necessarily those of the National Health Service, the NIHR, or the UK Department of Health.	American College of Obstetricians and Gynecologists Committee on Genetics, 2013, Obstet Gynecol, V122, P1374, DOI 10.1097/01.AOG.0000438962.16108.d1; [Anonymous], 2015, Obstet Gynecol, V126, pe31, DOI 10.1097/AOG.0000000000001051; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Callaway JLA, 2013, PRENATAL DIAG, V33, P1119, DOI 10.1002/pd.4209; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Chitty LS, 2006, BMJ-BRIT MED J, V332, P452, DOI 10.1136/bmj.38730.655197.AE; Evans M, 2015, AM J OBSTET GYNECOL, V212, pS403, DOI 10.1016/j.ajog.2014.11.041; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lewis C, 2012, EUR J HUM GENET, V20, P1127, DOI 10.1038/ejhg.2012.50; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; Minear MA, 2015, PRENATAL DIAG, V35, P959, DOI 10.1002/pd.4637; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Petersen OB, 2014, ULTRASOUND OBST GYN, V43, P265, DOI 10.1002/uog.13270; R Development Core Team, 2014, R FDN STAT COMP; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Shaffer LG, 2007, AM J MED GENET C, V145C, P335, DOI 10.1002/ajmg.c.30152; Shaffer LG, 2012, PRENATAL DIAG, V32, P986, DOI 10.1002/pd.3943; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Warsof SL, 2015, PRENATAL DIAG, V35, P972, DOI 10.1002/pd.4601; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111; Yu SCY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060968; Zhao C, 2015, CLIN CHEM, V61, P608, DOI 10.1373/clinchem.2014.233312	27	77	86	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					34	44		10.1016/j.ajhg.2015.11.016	http://dx.doi.org/10.1016/j.ajhg.2015.11.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26708752	Green Published, Bronze			2022-12-18	WOS:000368050800003
J	Niceta, M; Stellacci, E; Gripp, KW; Zampino, G; Kousi, M; Anselmi, M; Traversa, A; Ciolfi, A; Stabley, D; Bruselles, A; Caputo, V; Cecchetti, S; Prudente, S; Fiorenza, MT; Boitani, C; Philip, N; Niyazov, D; Leoni, C; Nakane, T; Keppler-Noreuil, K; Braddock, SR; Gillessen-Kaesbach, G; Palleschi, A; Campeau, PM; Lee, BHL; Pouponnot, C; Stella, L; Bocchinfuso, G; Katsanis, N; Sol-Church, K; Tartaglia, M				Niceta, Marcello; Stellacci, Emilia; Gripp, Karen W.; Zampino, Giuseppe; Kousi, Maria; Anselmi, Massimiliano; Traversa, Alice; Ciolfi, Andrea; Stabley, Deborah; Bruselles, Alessandro; Caputo, Viviana; Cecchetti, Serena; Prudente, Sabrina; Fiorenza, Maria T.; Boitani, Carla; Philip, Nicole; Niyazov, Dmitriy; Leoni, Chiara; Nakane, Takaya; Keppler-Noreuil, Kim; Braddock, Stephen R.; Gillessen-Kaesbach, Gabriele; Palleschi, Antonio; Campeau, Philippe M.; Lee, Brendan H. L.; Pouponnot, Celio; Stella, Lorenzo; Bocchinfuso, Gianfranco; Katsanis, Nicholas; Sol-Church, Katia; Tartaglia, Marco			Mutations Impairing GSK3-Mediated MAF Phosphorylation Cause Cataract, Deafness, Intellectual Disability, Seizures, and a Down Syndrome-like Facies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FINE-LUBINSKY-SYNDROME; BZIP TRANSCRIPTION FACTOR; DNA-BINDING DOMAIN; C-MAF; MENTAL-RETARDATION; CONGENITAL CATARACT; SENSORINEURAL DEAFNESS; SHORT STATURE; DIFFERENTIATION; ACTIVATION	Transcription factors operate in developmental processes to mediate inductive events and cell competence, and perturbation of their function or regulation can dramatically affect morphogenesis, organogenesis, and growth. We report that a narrow spectrum of amino-acid substitutions within the transactivation domain of the v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog (MAF), a leucine zipper-containing transcription factor of the AP1 superfamily, profoundly affect development. Seven different de novo missense mutations involving conserved residues of the four GSK3 phosphorylation motifs were identified in eight unrelated individuals. The distinctive clinical phenotype, for which we propose the eponym Ayme-Gripp syndrome, is not limited to lens and eye defects as previously reported for MAF/Maf loss of function but includes sensorineural deafness, intellectual disability, seizures, brachycephaly, distinctive flat facial appearance, skeletal anomalies, mammary gland hypoplasia, and reduced growth. Disease-causing mutations were demonstrated to impair proper MAF phosphorylation, ubiquitination and proteasomal degradation, perturbed gene expression in primary skin fibroblasts, and induced neurodevelopmental defects in an in vivo model. Our findings nosologically and clinically delineate a previously poorly understood recognizable multisystem disorder, provide evidence for MAF governing a wider range of developmental programs than previously appreciated, and describe a novel instance of protein dosage effect severely perturbing development.	[Niceta, Marcello; Stellacci, Emilia; Traversa, Alice; Ciolfi, Andrea; Bruselles, Alessandro; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Niceta, Marcello; Tartaglia, Marco] Osped Pediat Bambino Gesu IRCSS, Polo Ric Malattie Rare, I-00146 Rome, Italy; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE 19803 USA; [Zampino, Giuseppe; Leoni, Chiara] Univ Cattolica Sacro Cuore, Ist Pediat, I-00168 Rome, Italy; [Kousi, Maria; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Anselmi, Massimiliano; Palleschi, Antonio; Stella, Lorenzo; Bocchinfuso, Gianfranco] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy; [Traversa, Alice; Caputo, Viviana] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00161 Rome, Italy; [Stabley, Deborah; Sol-Church, Katia] Alfred I DuPont Hosp Children, Ctr Pediat Res, Wilmington, DE 19803 USA; [Cecchetti, Serena] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Prudente, Sabrina] IRCCS Casa Sollievo Sofferenza, Mendel Lab, I-00198 Rome, Italy; [Fiorenza, Maria T.] Univ Roma La Sapienza, Sez Neurosci, Dipartimento Psicol, I-00161 Rome, Italy; [Boitani, Carla] Univ Roma La Sapienza, Sez Istol & Embriol Med, Dipartimento Sci Anat Istol Medicolegali & Appara, I-00161 Rome, Italy; [Philip, Nicole] Hop Enfants La Timone, Dept Med Genet, F-13385 Marseille, France; [Niyazov, Dmitriy] Ochsner Hlth Syst, Div Med Genet, New Orleans, LA 70121 USA; [Nakane, Takaya] Univ Yamanashi, Ctr Genet Med, Dept Pediat, Chuo Ku, Yamanashi 4093898, Japan; [Keppler-Noreuil, Kim] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Braddock, Stephen R.] St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA; [Gillessen-Kaesbach, Gabriele] Med Univ Lubeck, Inst Humangenet, D-23538 Lubeck, Germany; [Campeau, Philippe M.] Univ Montreal, St Justine Hosp, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Lee, Brendan H. L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pouponnot, Celio] Univ Paris 11, Inst Curie Ctr Rech, CNRS, INSERM,U1021,UMR 3347, F-91405 Orsay, France	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; Nemours Alfred I. duPont Hospital for Children; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Duke University; University of Rome Tor Vergata; Sapienza University Rome; Nemours Alfred I. duPont Hospital for Children; Istituto Superiore di Sanita (ISS); IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Sapienza University Rome; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Ochsner Health System; University of Yamanashi; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Saint Louis University; University of Lubeck; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Baylor College of Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.tartaglia@iss.it	Cecchetti, Serena/N-1061-2015; Traversa, Alice/AAC-3165-2020; Bocchinfuso, Gianfranco/E-9014-2011; Zampino, Giuseppe/AAC-2152-2019; stellacci, emilia/J-2747-2014; Stella, Lorenzo/A-7996-2010; Niceta, Marcello/V-1557-2019; Campeau, Philippe/J-8614-2015; Braddock, Stephen/AAL-1667-2021; Bruselles, Alessandro/M-7908-2017; Tartaglia, Marco/K-2955-2018; Fiorenza, Maria Teresa/AAC-2181-2019; Anselmi, Massimiliano/H-9950-2014; Bruselles, Alessandro/M-6012-2019; Ciolfi, Andrea/J-4954-2018; Prudente, Sabrina/H-2886-2016; Philip, Nicole/I-2881-2016; leoni, chiara/AAB-5965-2019	Cecchetti, Serena/0000-0002-3601-176X; Bocchinfuso, Gianfranco/0000-0002-5556-7691; stellacci, emilia/0000-0003-0415-3285; Stella, Lorenzo/0000-0002-5489-7381; Niceta, Marcello/0000-0003-4766-7753; Campeau, Philippe/0000-0001-9713-7107; Bruselles, Alessandro/0000-0002-1556-4998; Tartaglia, Marco/0000-0001-7736-9672; Fiorenza, Maria Teresa/0000-0002-5079-4019; Anselmi, Massimiliano/0000-0001-5711-770X; Bruselles, Alessandro/0000-0002-1556-4998; Ciolfi, Andrea/0000-0002-6191-0978; Prudente, Sabrina/0000-0001-9220-8981; leoni, chiara/0000-0002-4089-637X; TRAVERSA, ALICE/0000-0001-6138-6179; Katsanis, Nicholas/0000-0002-2480-0171; Stabley, Deborah/0000-0002-4936-0854	Telethon [GGP13107]; Istituto Superiore di Sanita; Nemours Foundation; NIH [P20GM103464, P20GM103446, P50MH094268]; company BVLGARI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446, P20GM103464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); Istituto Superiore di Sanita; Nemours Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); company BVLGARI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the individuals and their families who contributed to this study. We thank Serenella Venanzi, Chiara Di Claudio, and Francesca Maiorca (ISS, Rome, Italy) for skillful technical assistance. We acknowledge submission of several DNA samples to the Center for Mendelian Genomics (CMG) in Seattle, WA; disease gene identification occurred prior to and without the use of data from the CMG. We thank BGI (Hong Kong) for the high-quality sequencing raw data. M.T., G.B., and L.S. acknowledge CINECA for computational resources (WES data and structural analyses). This work was supported in part by grants from Telethon (GGP13107 to M.T.), Istituto Superiore di Sanita (Ricerca Corrente 2013 to M.T.), Nemours Foundation (to K.S.-C.) and NIH (P20GM103464 and P20GM103446 to K.S.-C.; P50MH094268 to N.K.), and the financial support from the company BVLGARI. This work is dedicated to the memory of Luciano Cianetti (ISS, Rome, Italy).	Ayme S, 1997, AM J MED GENET, V70, P333, DOI 10.1002/(SICI)1096-8628(19970613)70:3<333::AID-AJMG24>3.0.CO;2-L; Ayme S, 1996, CLIN DYSMORPHOL, V5, P55; Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fine B A, 1983, J Clin Dysmorphol, V1, P6; Gilbert S.F., 2008, INBORN ERRORS DEV MO, VSecond, P9; Gripp KW, 1996, AM J MED GENET, V61, P382, DOI 10.1002/(SICI)1096-8628(19960202)61:4<382::AID-AJMG14>3.0.CO;2-O; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hansen L, 2007, MOL VIS, V13, P2019; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Hansson T, 1997, J MOL BIOL, V265, P118, DOI 10.1006/jmbi.1996.0716; Herath NI, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.67; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Holder AM, 2007, AM J MED GENET A, V143A, P2576, DOI 10.1002/ajmg.a.31688; Hu J, 2012, J NEUROSCI, V32, P5362, DOI 10.1523/JNEUROSCI.6239-11.2012; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Keppler-Noreuil K, 2007, AM J MED GENET A, V143A, P2581, DOI 10.1002/ajmg.a.31990; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lyon MF, 2003, HUM MOL GENET, V12, P585, DOI 10.1093/hmg/ddg063; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Nakane T, 2002, CLIN DYSMORPHOL, V11, P195, DOI 10.1097/00019605-200207000-00009; Narumi Y, 2014, AM J MED GENET A, V164, P1272, DOI 10.1002/ajmg.a.36433; Ogata A, 2004, ACTA HISTOCHEM, V106, P65, DOI 10.1016/j.acthis.2003.10.001; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Perveen R, 2007, HUM MOL GENET, V16, P1030, DOI 10.1093/hmg/ddm048; Ring BZ, 2000, DEVELOPMENT, V127, P307; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Corona-Rivera JR, 2009, AM J MED GENET A, V149A, P1070, DOI 10.1002/ajmg.a.32780; Sakai M, 1997, ONCOGENE, V14, P745, DOI 10.1038/sj.onc.1200869; Schoner K, 2008, FETAL DIAGN THER, V23, P228, DOI 10.1159/000116746; Schulte EC, 2014, AM J HUM GENET, V95, P85, DOI 10.1016/j.ajhg.2014.06.005; Vanita V, 2006, AM J MED GENET A, V140A, P558, DOI 10.1002/ajmg.a.31126; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Zankl A, 2012, AM J HUM GENET, V90, P494, DOI 10.1016/j.ajhg.2012.01.003	43	77	81	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					816	825		10.1016/j.ajhg.2015.03.001	http://dx.doi.org/10.1016/j.ajhg.2015.03.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25865493	Green Published, hybrid			2022-12-18	WOS:000354189300012
J	Synofzik, M; Haack, TB; Kopajtich, R; Gorza, M; Rapaport, D; Greiner, M; Schonfeld, C; Freiberg, C; Schorr, S; Holl, RW; Gonzalez, MA; Fritsche, A; Fallier-Becker, P; Zimmermann, R; Strom, TM; Meitinger, T; Zuchner, S; Schule, R; Schols, L; Prokisch, H				Synofzik, Matthis; Haack, Tobias B.; Kopajtich, Robert; Gorza, Matteo; Rapaport, Doron; Greiner, Markus; Schoenfeld, Caroline; Freiberg, Clemens; Schorr, Stefan; Holl, Reinhard W.; Gonzalez, Michael A.; Fritsche, Andreas; Fallier-Becker, Petra; Zimmermann, Richard; Strom, Tim M.; Meitinger, Thomas; Zuechner, Stephan; Schuele, Rebecca; Schoels, Ludger; Prokisch, Holger			Absence of BiP Co-chaperone DNAJC3 Causes Diabetes Mellitus and Multisystemic Neurodegeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARINESCO-SJOGREN-SYNDROME; MUTATIONS; SIL1; ER; CLASSIFICATION; P58(IPK); SPECTRUM; STRESS; KINASE	Diabetes mellitus and neurodegeneration are common diseases for which shared genetic factors are still only partly known. Here, we show that loss of the BiP (immunoglobulin heavy-chain binding protein) co-chaperone DNAJC3 leads to diabetes mellitus and widespread neurodegeneration. We investigated three siblings with juvenile-onset diabetes and central and peripheral neurodegeneration, including ataxia, upper-motor-neuron damage, peripheral neuropathy, hearing loss, and cerebral atrophy. Exome sequencing identified a homozygous stop mutation in DNAIC3. Screening of a diabetes database with 226,194 individuals yielded eight phenotypically similar individuals and one family carrying a homozygous DNAJC3 deletion. DNAJC3 was absent in fibroblasts from all affected subjects in both families. To delineate the phenotypic and mutational spectrum and the genetic variability of DNAJC3, we analyzed 8,603 exomes, including 506 from families affected by diabetes, ataxia, upper-motor-neuron damage, peripheral neuropathy, or hearing loss. This analysis revealed only one further loss-of-function allele in DNAIC3 and no further associations in subjects with only a subset of the features of the main phenotype. Our findings. demonstrate that loss-of-function DNAJC3 mutations lead to a monogenic, recessive form of diabetes mellitus in humans. Moreover, they present a common denominator for diabetes and widespread neurodegeneration. This complements findings from mice in which knockout of Dnajc3 leads to diabetes and modifies disease in a neurodegenerative model of Marinesco-Sjogren syndrome.	[Synofzik, Matthis; Schoenfeld, Caroline; Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Synofzik, Matthis; Schoenfeld, Caroline; Schuele, Rebecca; Schoels, Ludger] Deutsch Zentrum Neurodegenerat Erkrankungen, D-72076 Tubingen, Germany; [Haack, Tobias B.; Kopajtich, Robert; Gorza, Matteo; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Kopajtich, Robert; Gorza, Matteo; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Rapaport, Doron; Schoenfeld, Caroline] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Greiner, Markus; Schorr, Stefan; Zimmermann, Richard] Univ Saarland, D-66421 Homburg, Germany; [Freiberg, Clemens] Univ Gottingen, Univ Med Ctr Gottingen, Dept Pediat & Adolescent Med, D-37075 Gottingen, Germany; [Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89081 Ulm, Germany; [Gonzalez, Michael A.; Zuechner, Stephan; Schuele, Rebecca] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33136 USA; [Gonzalez, Michael A.; Zuechner, Stephan; Schuele, Rebecca] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL 33136 USA; [Fritsche, Andreas] Univ Tubingen, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Dept Internal Med, D-72076 Tubingen, Germany; [Fallier-Becker, Petra] Univ Tubingen, Inst Pathol & Neuropathol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Saarland University; University of Gottingen; Ulm University; University of Miami; University of Miami; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Synofzik, M (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.	matthis.synofzik@uni-tuebingen.de; ludger.schoels@uni-tuebingen.de	Schöls, Ludger/ABB-2482-2021; Schüle, Rebecca/B-5763-2019; Meitinger, Thomas/O-1318-2015	Schöls, Ludger/0000-0001-7774-5025; Schüle, Rebecca/0000-0002-7781-2766; Holl, Reinhard/0000-0003-1395-4842; Meitinger, Thomas/0000-0002-8838-8403; Prokisch, Holger/0000-0003-2379-6286; Synofzik, Matthis/0000-0002-2280-7273	German Federal Ministry of Education and Research (BMBF) [01GM0867, 01GM1113E]; European Union [F5-2012-305121]; HSP/CMT [PIOF-GA-2012-326681]; E-Rare grants [01GM1207]; EUROSCAR [01GM1206]; Interdisciplinary Center for Clinical Research (IZKF) Tubingen [2191-0-0, 1970-0-0]; BMSF Competence Network for diabetes [FKZ 01GI1106]; NIH [5R01NS072248, 1R01NS075764, 5R01NS054132]; BMBF; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054132, R01NS075764, R01NS072248] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); HSP/CMT; E-Rare grants; EUROSCAR; Interdisciplinary Center for Clinical Research (IZKF) Tubingen; BMSF Competence Network for diabetes; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the German Federal Ministry of Education and Research (BMBF) (mitoNET grant 01GM0867 to H.P. and grant 01GM1113E to L.S. and D.R.), the European Union (grant F5-2012-305121 [NEUROMICS] to L.S. and grant PIOF-GA-2012-326681 [HSP/CMT Genetics] to R.S.), E-Rare grants to GENOMIT (01GM1207 to H.P.) and EUROSCAR (01GM1206 to L.S.), the Interdisciplinary Center for Clinical Research (IZKF) Tubingen (grants 2191-0-0 to M.S. and 1970-0-0 to R.S.), the BMSF Competence Network for diabetes (FKZ 01GI1106 to R.H.), and the NIH (grants 5R01NS072248, 1R01NS075764, and 5R01NS054132 to S.Z.). This study was also supported by a grant from the BMBF to the German Center for Diabetes Research (DZD e.V.) in Munich. We are grateful to Professor Hartwig Wolburg (Tubingen) for discussion of the electron-microscopy findings.	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Craig ME, 2014, PEDIATR DIABETES, V15, P4, DOI 10.1111/pedi.12186; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010; Korth MJ, 1996, GENE, V170, P181, DOI 10.1016/0378-1119(95)00883-7; Krieger M, 2013, BRAIN, V136, P3634, DOI 10.1093/brain/awt283; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; Synofzik M, 2010, J NEUROL, V257, P1751, DOI 10.1007/s00415-010-5593-5; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Zhao LH, 2010, HUM MOL GENET, V19, P25, DOI 10.1093/hmg/ddp464	22	77	79	2	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					689	697		10.1016/j.ajhg.2014.10.013	http://dx.doi.org/10.1016/j.ajhg.2014.10.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25466870	Green Published, Bronze			2022-12-18	WOS:000346623100005
J	Clemente, FJ; Cardona, A; Inchley, CE; Peter, BM; Jacobs, G; Pagani, L; Lawson, DJ; Antao, T; Vicente, M; Mitt, M; DeGiorgio, M; Faltyskova, Z; Xue, YL; Ayub, Q; Szpak, M; Magi, R; Eriksson, A; Manica, A; Raghavan, M; Rasmussen, M; Rasmussen, S; Willerslev, E; Vidal-Puig, A; Tyler-Smith, C; Villems, R; Nielsen, R; Metspalu, M; Malyarchuk, B; Derenko, M; Kivisild, T				Clemente, Florian J.; Cardona, Alexia; Inchley, Charlotte E.; Peter, Benjamin M.; Jacobs, Guy; Pagani, Luca; Lawson, Daniel J.; Antao, Tiago; Vicente, Mario; Mitt, Mario; DeGiorgio, Michael; Faltyskova, Zuzana; Xue, Yali; Ayub, Qasim; Szpak, Michal; Maegi, Reedik; Eriksson, Anders; Manica, Andrea; Raghavan, Maanasa; Rasmussen, Morten; Rasmussen, Simon; Willerslev, Eske; Vidal-Puig, Antonio; Tyler-Smith, Chris; Villems, Richard; Nielsen, Rasmus; Metspalu, Mait; Malyarchuk, Boris; Derenko, Miroslava; Kivisild, Toomas			A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENOME; HITCHHIKING; P479L; POLYMORPHISM; EVOLUTION; MAP	Arctic populations live in an environment characterized by extreme cold and the absence of plant foods for much of the year and are likely to have undergone genetic adaptations to these environmental conditions in the time they have been living there. Genome-wide selection scans based on genotype data from native Siberians have previously highlighted a 3 Mb chromosome 11 region containing 79 protein-coding genes as the strongest candidates for positive selection in Northeast Siberians. However, it was not possible to determine which of the genes might be driving the selection signal. Here, using whole-genome high-coverage sequence data, we identified the most likely causative variant as a nonsynonymous G>A transition (rs80356779; c.1436C>T [p.Pro479Leu] on the reverse strand) in CPT1A, a key regulator of mitochondrial long-chain fatty-acid oxidation. Remarkably, the derived allele is associated with hypoketotic hypoglycemia and high infant mortality yet occurs at high frequency in Canadian and Greenland Inuits and was also found at 68% frequency in our. Northeast Siberian sample. We provide evidence of one of the strongest selective sweeps reported in humans; this sweep has driven this variant to high frequency in circum-Arctic populations within the last 6-23 ka despite associated deleterious consequences, possibly as a result of the selective advantage it originally provided to either a high-fat diet or a cold environment.	[Clemente, Florian J.; Cardona, Alexia; Inchley, Charlotte E.; Pagani, Luca; Vicente, Mario; Faltyskova, Zuzana; Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge CB2 3QG, England; [Peter, Benjamin M.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Jacobs, Guy] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Jacobs, Guy] Univ Southampton, Inst Complex Syst Simulat, Southampton SO17 1BJ, Hants, England; [Lawson, Daniel J.] Univ Bristol, Sch Math, Heilbronn Inst, Bristol BS8 1TH, Avon, England; [Antao, Tiago] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Mitt, Mario; Maegi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [DeGiorgio, Michael] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Xue, Yali; Ayub, Qasim; Szpak, Michal; Vidal-Puig, Antonio; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Eriksson, Anders; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Eriksson, Anders] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal 239556900, Saudi Arabia; [Raghavan, Maanasa; Rasmussen, Morten; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Rasmussen, Simon] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Vidal-Puig, Antonio] Univ Cambridge, Dept Clin Biochem, Med Res Council, Metab Dis Unit, Cambridge CB2 2QR, England; [Vidal-Puig, Antonio] Inst Metab Sci, Cambridge CB2 2QR, England; [Villems, Richard; Metspalu, Mait] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Villems, Richard; Metspalu, Mait; Kivisild, Toomas] Estonian Bioctr, EE-51010 Tartu, Estonia; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia; [Malyarchuk, Boris; Derenko, Miroslava] Russian Acad Sci, Inst Biol Problems North, Magadan 685000, Russia	University of Cambridge; University of California System; University of California Berkeley; University of Southampton; University of Southampton; University of Bristol; Liverpool School of Tropical Medicine; University of Liverpool; University of Tartu; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wellcome Trust Sanger Institute; University of Cambridge; King Abdullah University of Science & Technology; University of Copenhagen; Technical University of Denmark; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge; University of Tartu; Estonian Biocentre; Estonian Academy of Sciences; Institute of Biological Problems of the North; Russian Academy of Sciences	Cardona, A (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Cambridge CB2 3QG, England.	ac812@cam.ac.uk; tk331@cam.ac.uk	Rasmussen, Simon/AAA-2308-2020; Eriksson, Anders/C-9767-2010; Mägi, Reedik/AAJ-9679-2021; Manica, Andrea/B-5497-2008; Rasmussen, Simon/G-6258-2016; Malyarchuk, Boris/D-5783-2018; Kivisild, Toomas/P-5889-2017; Pagani, Luca/G-8511-2017; Willerslev, Eske/AAA-5686-2019; Manica, Andrea/N-9013-2019; Derenko, Miroslava/J-1495-2018; Willerslev, Eske/A-9619-2011; Metspalu, Mait/G-8671-2015; Antao, Tiago/C-3615-2009; Nielsen, Rasmus/D-4405-2009; Lawson, Daniel/A-8550-2011	Rasmussen, Simon/0000-0001-6323-9041; Eriksson, Anders/0000-0003-3436-3726; Manica, Andrea/0000-0003-1895-450X; Rasmussen, Simon/0000-0001-6323-9041; Malyarchuk, Boris/0000-0002-0304-0652; Kivisild, Toomas/0000-0002-6297-7808; Pagani, Luca/0000-0002-6639-524X; Manica, Andrea/0000-0003-1895-450X; Derenko, Miroslava/0000-0002-1849-784X; Willerslev, Eske/0000-0002-7081-6748; Metspalu, Mait/0000-0003-3099-9161; Antao, Tiago/0000-0002-7269-5513; Szpak, Michal/0000-0002-9096-852X; Vidal-Puig, Antonio/0000-0003-4220-9577; Gerber, Zuzana/0000-0003-0846-3619; Nielsen, Rasmus/0000-0003-0513-6591; Lawson, Daniel/0000-0002-5311-6213; Cardona, Alexia/0000-0002-7877-5565; Raghavan, Maanasa/0000-0003-1997-0739; Ayub, Qasim/0000-0003-3291-0917; Magi, Reedik/0000-0002-2964-6011; Vicente, Mario/0000-0002-9122-4530	European Research Council [FP7-261213]; Wellcome Trust [098051, WT100066MA]; European Union European Regional Development Fund Centre of Excellence in Genomics; Estonian Institutional Research grant [IUT24-1]; Estonian Science Foundation [8973]; Biotechnology and Biological Sciences Research Council [BB/H002731/1, BB/J009865/1, BB/H005854/1] Funding Source: researchfish; British Heart Foundation [PG/12/53/29714] Funding Source: researchfish; Medical Research Council [MC_UU_12012/2, G0600717, MC_G0802535] Funding Source: researchfish; BBSRC [BB/J009865/1, BB/H002731/1, BB/H005854/1] Funding Source: UKRI; MRC [G0600717, MC_G0802535, MC_UU_12012/2] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); European Union European Regional Development Fund Centre of Excellence in Genomics; Estonian Institutional Research grant; Estonian Science Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by European Research Council Starting Investigator grant FP7-261213 to T.K. C.T.-S., Y.X., Q.A., and M.S. were supported by Wellcome Trust grant 098051, and T.A. was supported by Wellcome Trust grant WT100066MA. M. Metspalu and R.V. received supported from the European Union European Regional Development Fund Centre of Excellence in Genomics to the Estonian Biocentre. T.K, M. Metspalu, and R.V. were supported by Estonian Institutional Research grant IUT24-1, and M. Metspalu received Estonian Science Foundation grant 8973.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cardona A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098076; Collins SA, 2010, MOL GENET METAB, V101, P200, DOI 10.1016/j.ymgme.2010.07.013; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ewens WJ., 2004, MATH POPULATION GENE, DOI DOI 10.1007/978-0-387-21822-9; Fay JC, 2000, GENETICS, V155, P1405; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Greenberg CR, 2009, MOL GENET METAB, V96, P201, DOI 10.1016/j.ymgme.2008.12.018; Khrameeva EE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4584; Kim Y, 2000, GENETICS, V155, P1415; Lemas DJ, 2012, J LIPID RES, V53, P175, DOI 10.1194/jlr.P018952; Leonard WR, 2005, ANNU REV ANTHROPOL, V34, P451, DOI 10.1146/annurev.anthro.34.081804.120558; McEvoy BP, 2011, GENOME RES, V21, P821, DOI 10.1101/gr.119636.110; McVean G, 2007, GENETICS, V175, P1395, DOI 10.1534/genetics.106.062828; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Phinney Stephen D, 2004, Nutr Metab (Lond), V1, P2, DOI 10.1186/1743-7075-1-2; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rajakumar C, 2009, J LIPID RES, V50, P1223, DOI 10.1194/jlr.P900001-JLR200; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Snodgrass JJ, 2008, AM J PHYS ANTHROPOL, V137, P145, DOI 10.1002/ajpa.20851; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; TAJIMA F, 1989, GENETICS, V123, P585; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Westman EC, 2007, AM J CLIN NUTR, V86, P276, DOI 10.1093/ajcn/86.2.276	32	77	88	1	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					584	589		10.1016/j.ajhg.2014.09.016	http://dx.doi.org/10.1016/j.ajhg.2014.09.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25449608	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000344845000009
J	Campbell, IM; Stewart, JR; James, RA; Lupski, JR; Stankiewicz, P; Olofsson, P; Shaw, CA				Campbell, Ian M.; Stewart, Jonathan R.; James, Regis A.; Lupski, James R.; Stankiewicz, Pawel; Olofsson, Peter; Shaw, Chad A.			Parent of Origin, Mosaicism, and Recurrence Risk: Probabilistic Modeling Explains the Broken Symmetry of Transmission Genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION-RATES; MUSCULAR-DYSTROPHY; SOMATIC MOSAICISM; GERM-CELLS; DROSOPHILA; DUCHENNE; DISEASE; MALES; LINE; AGE	Most new mutations are observed to arise in fathers, and increasing paternal age positively correlates with the risk of new variants. Interestingly, new mutations in X-linked recessive disease show elevated familial recurrence rates. In male offspring, these mutations must be inherited from mothers. We previously developed a simulation model to consider parental mosaicism as a source of transmitted mutations. In this paper, we extend and formalize the model to provide analytical results and flexible formulas. The results implicate parent of origin and parental mosaicism as central variables in recurrence risk. Consistent with empirical data, our model predicts that more transmitted mutations arise in fathers and that this tendency increases as fathers' age. Notably, the lack of expansion later in the male germline determines relatively lower variance in the proportion of mutants, which decreases with paternal age. Subsequently, observation of a transmitted mutation has less impact on the expected risk for future offspring. Conversely, for the female germline, which arrests after clonal expansion in early development, variance in the mutant proportion is higher, and observation of a transmitted mutation dramatically increases the expected risk of recurrence in another pregnancy. Parental somatic mosaicism considerably elevates risk for both parents. These findings have important implications for genetic counseling and for understanding patterns of recurrence in transmission genetics. We provide a convenient online tool and source code implementing our analytical results. These tools permit varying the underlying parameters that influence recurrence risk and could be useful for analyzing risk in diverse family structures.	[Campbell, Ian M.; Lupski, James R.; Stankiewicz, Pawel; Shaw, Chad A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stewart, Jonathan R.; Shaw, Chad A.] Rice Univ, Dept Stat, Houston, TX 77005 USA; [James, Regis A.; Shaw, Chad A.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Stankiewicz, Pawel] Inst Mother & Child Hlth, PL-01211 Warsaw, Poland; [Olofsson, Peter] Trinity Univ, Dept Math, San Antonio, TX 78212 USA	Baylor College of Medicine; Rice University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Trinity University	Shaw, CA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	cashaw@bcm.edu	Stankiewicz, Paweł/AAP-7906-2021	Stankiewicz, Paweł/0000-0002-6456-7490; Campbell, Ian/0000-0002-3749-2884; Stewart, Jonathan/0000-0003-3998-4214	Baylor College of Medicine (BCM) Medical Scientist Training Program [T32 GM007330]; National Institute of Neurological Disorders and Stroke (NINDS) [F31 NS083159]; National Heart, Lung, and Blood Institute (NHLBI) [R01 HL101975]; Polish Ministry of Science and Higher Education [R13-0005-04/2008]; NINDS [R01 NS058529]; National Human Genome Research; NHLBI Baylor Hopkins Center for Mendelian Genomics [U54 HG006542]; National Institute of General Medical Sciences [R15 GM093957]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897, R15GM093957, T32GM007330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083159, R01NS058529] Funding Source: NIH RePORTER	Baylor College of Medicine (BCM) Medical Scientist Training Program; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research; NHLBI Baylor Hopkins Center for Mendelian Genomics; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank John Belmont for his insightful suggestions concerning X-linked disease, Arthur Beaudet for his comments about mutational mechanisms that might vary by sex, and Neil Hanchard for his insightful comments concerning locus heterogeneity and recurrence risk. I.M.C. is a fellow of the Baylor College of Medicine (BCM) Medical Scientist Training Program (T32 GM007330) and was supported by a fellowship from the National Institute of Neurological Disorders and Stroke (NINDS; F31 NS083159). This study was supported in part by grants from the National Heart, Lung, and Blood Institute (NHLBI; R01 HL101975) and Polish Ministry of Science and Higher Education (R13-0005-04/2008) to P.S.; grants from the NINDS (R01 NS058529) and the National Human Genome Research and NHLBI Baylor Hopkins Center for Mendelian Genomics (U54 HG006542) to J.R.L.; and a grant from the National Institute of General Medical Sciences (R15 GM093957) to P.O. J.R.L. holds stock ownership in 23andMe Inc. and Ion Torrent Systems Inc. and is a coinventor on multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at BCM derives revenue from molecular genetic testing offered in the Medical Genetics Laboratories (http://www.bcm.edu/geneticlabs/).	Austin Jehannine C, 2008, J Genet Couns, V17, P18, DOI 10.1007/s10897-007-9121-4; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Drake JW, 1998, GENETICS, V148, P1667; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Fu YX, 2003, GENETICS, V164, P797; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; Gao JJ, 2014, G3-GENES GENOM GENET, V4, P1503, DOI 10.1534/g3.114.011056; Gelman A., 2013, BAYESIAN DATA ANAL; Gong Y, 2005, HUM HERED, V60, P150, DOI 10.1159/000089955; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; HARTL DL, 1971, AM J HUM GENET, V23, P124; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Helderman-van den Enden ATJM, 2009, CLIN GENET, V75, P465, DOI 10.1111/j.1399-0004.2009.01173.x; Hurles M, 2012, NAT GENET, V44, P1174, DOI 10.1038/ng.2448; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Leuer M, 2001, AM J HUM GENET, V69, P75, DOI 10.1086/321285; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; Mamsen LS, 2011, HUM REPROD, V26, P2140, DOI 10.1093/humrep/der149; Marques-Mari AI, 2009, HUM REPROD UPDATE, V15, P379, DOI 10.1093/humupd/dmp001; Mettler G, 2000, AM J MED GENET, V90, P250, DOI 10.1002/(SICI)1096-8628(20000131)90:3<250::AID-AJMG13>3.3.CO;2-V; Olofsson P, 2002, J MATH BIOL, V45, P279, DOI 10.1007/s002850200148; Pyott SM, 2011, GENET MED, V13, P125, DOI 10.1097/GIM.0b013e318202e0f6; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Rothlisberger B, 2007, AM J MED GENET A, V143A, P1708, DOI 10.1002/ajmg.a.31826; Woodruff RC, 2009, J HERED, V100, P7, DOI 10.1093/jhered/esn058	29	77	80	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					345	359		10.1016/j.ajhg.2014.08.010	http://dx.doi.org/10.1016/j.ajhg.2014.08.010			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25242496	Bronze, Green Published			2022-12-18	WOS:000342654300001
J	Acuna-Hidalgo, R; Schanze, D; Kariminejad, A; Nordgren, A; Kariminejad, MH; Conner, P; Grigelioniene, G; Nilsson, D; Nordenskjold, M; Wedell, A; Freyer, C; Wredenberg, A; Wieczorek, D; Gillessen-Kaesbach, G; Kayserili, H; Elcioglu, N; Ghaderi-Sohi, S; Goodarzi, P; Setayesh, H; van de Vorst, M; Steehouwer, M; Pfundt, R; Krabichler, B; Curry, C; MacKenzie, MG; Boycott, KM; Gilissen, C; Janecke, AR; Hoischen, A; Zenker, M				Acuna-Hidalgo, Rocio; Schanze, Denny; Kariminejad, Ariana; Nordgren, Ann; Kariminejad, Mohamad Hasan; Conner, Peter; Grigelioniene, Giedre; Nilsson, Daniel; Nordenskjold, Magnus; Wedell, Anna; Freyer, Christoph; Wredenberg, Anna; Wieczorek, Dagmar; Gillessen-Kaesbach, Gabriele; Kayserili, Hulya; Elcioglu, Nursel; Ghaderi-Sohi, Siavash; Goodarzi, Payman; Setayesh, Hamidreza; van de Vorst, Maartje; Steehouwer, Marloes; Pfundt, Rolph; Krabichler, Birgit; Curry, Cynthia; MacKenzie, Malcolm G.; Boycott, Kym M.; Gilissen, Christian; Janecke, Andreas R.; Hoischen, Alexander; Zenker, Martin			Neu-Laxova Syndrome Is a Heterogeneous Metabolic Disorder Caused by Defects in Enzymes of the L-Serine Biosynthesis Pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHOSERINE AMINOTRANSFERASE; CANCER-CELLS; DEFICIENCY DISORDERS; MUTATIONS; GLYCINE; PROTEIN; PHGDH	Neu-Laxova syndrome (NLS) is a rare autosomal-recessive disorder characterized by a recognizable pattern of severe malformations leading to prenatal or early postnatal lethality. Homozygous mutations in PHGDH, a gene involved in the first and limiting step in L-serine biosynthesis, were recently identified as the cause of the disease in three families. By studying a cohort of 12 unrelated families affected by NLS, we provide evidence that NLS is genetically heterogeneous and can be caused by mutations in all three genes encoding enzymes of the L-serine biosynthesis pathway. Consistent with recently reported findings, we could identify PHGDH missense mutations in three unrelated families of our cohort. Furthermore, we mapped an overlapping homozygous chromosome 9 region containing PSAT1 in four consanguineous families. This gene encodes phosphoserine aminotransferase, the enzyme for the second step in L-serine biosynthesis. We identified six families with three different missense and frameshift PSAT1 mutations fully segregating with the disease. In another family, we discovered a homozygous frameshift mutation in PSPH, the gene encoding phosphoserine phosphatase, which catalyzes the last step of L-serine biosynthesis. Interestingly, all three identified genes have been previously implicated in serine-deficiency disorders, characterized by variable neurological manifestations. Our findings expand our understanding of NLS as a disorder of the L-serine biosynthesis pathway and suggest that NLS represents the severe end of serine-deficiency disorders, demonstrating that certain complex syndromes characterized by early lethality could indeed be the extreme end of the phenotypic spectrum of already known disorders.	[Acuna-Hidalgo, Rocio; van de Vorst, Maartje; Steehouwer, Marloes; Pfundt, Rolph; Gilissen, Christian; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Schanze, Denny; Zenker, Martin] Univ Hosp Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany; [Kariminejad, Ariana; Kariminejad, Mohamad Hasan; Ghaderi-Sohi, Siavash; Goodarzi, Payman; Setayesh, Hamidreza] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14667, Iran; [Nordgren, Ann; Grigelioniene, Giedre; Nilsson, Daniel; Nordenskjold, Magnus; Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Nordgren, Ann; Grigelioniene, Giedre; Nilsson, Daniel; Nordenskjold, Magnus] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Conner, Peter] Karolinska Univ Hosp, Dept Obstet & Gynecol, Ctr Fetal Med, S-17176 Stockholm, Sweden; [Wedell, Anna; Freyer, Christoph; Wredenberg, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, S-17176 Stockholm, Sweden; [Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Dept Lab Med, S-17176 Stockholm, Sweden; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Gillessen-Kaesbach, Gabriele] Med Univ Lubeck, Inst Humangenet, D-23562 Lubeck, Germany; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Med Genet Dept, TR-34093 Istanbul, Turkey; [Elcioglu, Nursel] Marmara Univ, Pediat Genet Div, Dept Pediat, Fac Med, TR-34668 Istanbul, Turkey; [Krabichler, Birgit; Janecke, Andreas R.] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Curry, Cynthia] Univ Calif San Francisco, Dept Pediat, Fresno, CA 93701 USA; [MacKenzie, Malcolm G.; Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Janecke, Andreas R.] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria	Radboud University Nijmegen; University Hospital Magdeburg; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Duisburg Essen; University of Lubeck; Istanbul University; Marmara University; Medical University of Innsbruck; University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of Ottawa; Children's Hospital of Eastern Ontario; Medical University of Innsbruck	Janecke, AR (corresponding author), Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria.	andreas.janecke@i-med.ac.at; alexander.hoischen@radboudumc.nl	Gilissen, Christian/E-5246-2012; Janecke, Andreas/AAA-5227-2019; Acuna-Hidalgo, Rocio/D-9607-2016; Grigelioniene, Giedre/AAH-8408-2020; Pfundt, Rolph/L-4576-2015; Hoischen, Alexander/D-1282-2013; Nordgren, Ann/AAQ-9142-2021; Wieczorek, Dagmar/AAU-6008-2021; Grigelioniene, Giedre/N-6599-2013; Kayserili, Hülya/AAA-5593-2021; Hoischen, Alexander/AGF-7293-2022; Conner, Peter/G-1158-2015; Nordgren, Ann C/N-4057-2013; Nilsson, Daniel/B-8365-2009	Gilissen, Christian/0000-0003-1693-9699; Acuna-Hidalgo, Rocio/0000-0001-9413-0348; Grigelioniene, Giedre/0000-0001-9601-3137; Hoischen, Alexander/0000-0002-8072-4476; Nordgren, Ann/0000-0003-3285-4281; Wieczorek, Dagmar/0000-0003-2812-6492; Grigelioniene, Giedre/0000-0001-9601-3137; Kayserili, Hülya/0000-0003-0376-499X; Hoischen, Alexander/0000-0002-8072-4476; Conner, Peter/0000-0002-9246-3277; Nordgren, Ann C/0000-0003-3285-4281; Nilsson, Daniel/0000-0001-5831-385X; Wredenberg, Anna/0000-0002-2500-6121; Freyer, Christoph/0000-0003-0418-1673; Nordenskjold, Magnus/0000-0002-4974-425X; Janecke, Andreas/0000-0001-7155-0315; Setayesh, Hamidreza/0000-0003-1691-0298; Kariminejad, Ariana/0000-0002-8467-4728	Netherlands Organization for Health Research and Development [ZonMW 916-12-095]; Radboudumc PhD grant; Stockholm County Council; Karolinska Institutet; Kronprinsessan Lovisa; Frimurare Barnhuset i Stockholm; Swedish Childhood Cancer Foundation; Care4Rare Canada Consortium; Genome Canada; Canadian Institutes of Health Research	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Radboudumc PhD grant; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Kronprinsessan Lovisa; Frimurare Barnhuset i Stockholm; Swedish Childhood Cancer Foundation(European Commission); Care4Rare Canada Consortium; Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors are grateful to the Radboud Genomics Technology Center, Saskia Velde-Vissers, and all members of the Genomic Disorders Group and Developmental Genomics Group for technical assistance. A.H. was supported by the Netherlands Organization for Health Research and Development (ZonMW 916-12-095). R.A.-H. was supported by a Radboudumc PhD grant. A.N., G.G., M.N., and D.N were supported through the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet by grants from Kronprinsessan Lovisa, Frimurare Barnhuset i Stockholm, Karolinska Institutet, and the Swedish Childhood Cancer Foundation. This work was supported in part by the Care4Rare Canada Consortium with funding from Genome Canada and the Canadian Institutes of Health Research.	Amelio I, 2014, ONCOGENE, V33, P5039, DOI 10.1038/onc.2013.456; Carss KJ, 2014, HUM MOL GENET, V23, P3269, DOI 10.1093/hmg/ddu038; de Koning TJ, 2006, J INHERIT METAB DIS, V29, P347, DOI 10.1007/s10545-006-0269-0; de Koning TJ, 2004, LANCET, V364, P2221, DOI 10.1016/S0140-6736(04)17596-X; Hart CE, 2007, AM J HUM GENET, V80, P931, DOI 10.1086/517888; Hester G, 1999, J MOL BIOL, V286, P829, DOI 10.1006/jmbi.1998.2506; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; LAXOVA R, 1972, J MENT DEFIC RES, V16, P139; Lindy AS, 2014, AM J MED GENET A, V164, P2391, DOI 10.1002/ajmg.a.36647; Manning MA, 2004, AM J MED GENET A, V125A, P240, DOI 10.1002/ajmg.a.20467; NEU RL, 1971, PEDIATRICS, V47, P610; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Quelin C, 2012, EUR J MED GENET, V55, P81, DOI 10.1016/j.ejmg.2011.12.002; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Serra-Juhe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045530; Shaheen R, 2014, AM J HUM GENET, V94, P898, DOI 10.1016/j.ajhg.2014.04.015; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; van der Crabben SN, 2013, J INHERIT METAB DIS, V36, P613, DOI 10.1007/s10545-013-9592-4; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Veiga-da-Cunha M, 2004, EUR J HUM GENET, V12, P163, DOI 10.1038/sj.ejhg.5201083; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14; Yoshida K, 2004, J BIOL CHEM, V279, P3573, DOI 10.1074/jbc.C300507200	25	77	81	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					285	293		10.1016/j.ajhg.2014.07.012	http://dx.doi.org/10.1016/j.ajhg.2014.07.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25152457	Green Published, Bronze			2022-12-18	WOS:000341404100004
J	Tran-Viet, KN; Powell, C; Barathi, VA; Klemm, T; Maurer-Stroh, S; Limviphuvadh, V; Soler, V; Ho, C; Yanovitch, T; Schneider, G; Li, YJ; Nading, E; Metlapally, R; Saw, SM; Goh, L; Rozen, S; Young, TL				Tran-Viet, Khanh-Nhat; Powell, Caldwell; Barathi, Veluchamy A.; Klemm, Thomas; Maurer-Stroh, Sebastian; Limviphuvadh, Vachiranee; Soler, Vincent; Ho, Candice; Yanovitch, Tammy; Schneider, Georg; Li, Yi-Ju; Nading, Erica; Metlapally, Ravikanth; Saw, Seang-Mei; Goh, Liang; Rozen, Steve; Young, Terri L.			Mutations in SCO2 Are Associated with Autosomal-Dominant High-Grade Myopia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLOOD-RETINAL BARRIER; REFRACTIVE ERRORS; PIGMENT-EPITHELIUM; GENE-EXPRESSION; UNITED-STATES; BLUE-LIGHT; PREVALENCE; CARDIOMYOPATHY; PATHOGENESIS; IMPAIRMENT	Myopia, or near-sightedness, is an ocular refractive error of unfocused image quality in front of the retinal plane. Individuals with high-grade myopia (dioptric power greater than -6.00) are predisposed to ocular morbidities such as glaucoma, retinal detachment, and myopic maculopathy. Nonsyndromic, high-grade myopia is highly heritable, and to date multiple gene loci have been reported. We performed exome sequencing in 4 individuals from an 11-member family of European descent from the United States. Affected individuals had a mean dioptric spherical equivalent of -22.00 sphere. A premature stop codon mutation c.157C>T (p.Gln53*) cosegregating with disease was discovered within SCO2 that maps to chromosome 22q13.33. Subsequent analyses identified three additional mutations in three highly myopic unrelated individuals (c.341G>A, c.418G>A, and c.776C>T). To determine differential gene expression in a developmental mouse model, we induced myopia by applying a -15.00D lens over one eye. Messenger RNA levels of SCO2 were significantly downregulated in myopic mouse retinae. Immunohistochemistry in mouse eyes confirmed SCO2 protein localization in retina, retinal pigment epithelium, and sclera. SCO2 encodes for a copper homeostasis protein influential in mitochondrial cytochrome c oxidase activity. Copper deficiencies have been linked with photoreceptor loss and myopia with increased scleral wall elasticity. Retinal thinning has been reported with an SCO2 variant. Human mutation identification with support from an induced myopic animal provides biological insights of myopic development.	[Tran-Viet, Khanh-Nhat; Powell, Caldwell; Li, Yi-Ju; Nading, Erica; Young, Terri L.] Duke Ctr Human Genet, Durham, NC 27710 USA; [Barathi, Veluchamy A.; Klemm, Thomas; Li, Yi-Ju; Goh, Liang; Rozen, Steve; Young, Terri L.] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore; [Barathi, Veluchamy A.; Ho, Candice] Singapore Eye Res Inst, Singapore 168751, Singapore; [Barathi, Veluchamy A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119077, Singapore; [Maurer-Stroh, Sebastian; Limviphuvadh, Vachiranee; Schneider, Georg] Agcy Sci Technol & Res, Bioinformat Inst, Matrix 138671, Singapore; [Maurer-Stroh, Sebastian; Limviphuvadh, Vachiranee] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Soler, Vincent] Univ Toulouse 3, UMRS 563, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France; [Yanovitch, Tammy] Univ Oklahoma, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Schneider, Georg] IST Austria, A-3400 Klosterneuburg, Austria; [Li, Yi-Ju] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Nading, Erica; Young, Terri L.] Duke Univ, Ctr Eye, Dept Ophthalmol, Durham, NC 27710 USA; [Metlapally, Ravikanth] Univ Calif Berkeley, Vis Sci Grp, Sch Optometry & Dept, Berkeley, CA 94720 USA; [Li, Yi-Ju; Saw, Seang-Mei; Goh, Liang; Young, Terri L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	Duke University; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oklahoma System; University of Oklahoma Health Sciences Center; Institute of Science & Technology - Austria; Duke University; Duke University; University of California System; University of California Berkeley; National University of Singapore	Young, TL (corresponding author), Duke Ctr Human Genet, 905 S LaSalle St, Durham, NC 27710 USA.	terri.young@duke.edu	Maurer-Stroh, Sebastian/Q-9476-2019; Limviphuvadh, Vachiranee/J-3713-2019; Rozen, Steven G./J-5939-2013	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Limviphuvadh, Vachiranee/0000-0001-5344-0585; Li, Yi-Ju/0000-0001-6996-4834; Rozen, Steven G./0000-0002-4288-0056	National Institutes of Health [R01 EY014685]; Research to Prevent Blindness (Chicago, IL); Duke-National University of Singapore; Toulouse Hospital Young Researcher Fellowship; Fondation pour la Recherche Medicale; Fondation de France; National Medical Research Council of Singapore [NMRC/IRG/1117/2008, NMRC/CG/T1/2010]; NATIONAL EYE INSTITUTE [R01EY014685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Chicago, IL)(Research to Prevent Blindness (RPB)); Duke-National University of Singapore(National University of Singapore); Toulouse Hospital Young Researcher Fellowship; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); National Medical Research Council of Singapore(National Medical Research Council, Singapore); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was funded by the National Institutes of Health Grant R01 EY014685, the Lew Wasserman Award from Research to Prevent Blindness (Chicago, IL), and a Duke-National University of Singapore core grant to T.L.Y. V.S. was supported by the Toulouse Hospital Young Researcher Fellowship, the Fondation pour la Recherche Medicale, and Fondation de France. The animal model experiments were supported by the National Medical Research Council of Singapore (NMRC/IRG/1117/2008 and NMRC/CG/T1/2010) to V.A.B. The sponsors or funding organizations had no role in the design or conduct of this research. The authors also thank Felicia Hawthorne, Xiaoyan Luo, and Kwan Jia Lin for their helpful insights regarding gene expression and immunohistochemical experiments.	Abbott CJ, 2011, VISION RES, V51, P376, DOI 10.1016/j.visres.2010.12.005; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Amemiya, 2000, Jpn J Ophthalmol, V44, P320, DOI 10.1016/S0021-5155(00)00161-1; Amemiya Tsugio, 1999, Nippon Ganka Gakkai Zasshi, V103, P829; Anderson B Jr, 1968, Trans Am Ophthalmol Soc, V66, P423; AVETISOV ES, 1991, VESTN OFTALMOL, P31; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Beresford JA, 1998, AUST NZ J OPHTHALMOL, V26, pS84, DOI 10.1111/j.1442-9071.1998.tb01383.x; Cai YR, 2011, BIOL TRACE ELEM RES, V144, P469, DOI 10.1007/s12011-011-9145-3; Chui TYP, 2005, VISION RES, V45, P593, DOI 10.1016/j.visres.2004.09.016; CURTIN BJ, 1971, AM J OPHTHALMOL, V71, P42, DOI 10.1016/0002-9394(71)91092-0; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Feldkaemper MP, 2000, INVEST OPHTH VIS SCI, V41, P1623; Frick KD, 2007, ARCH OPHTHALMOL-CHIC, V125, P544, DOI 10.1001/archopht.125.4.544; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; GUO SS, 1995, CURR EYE RES, V14, P385, DOI 10.3109/02713689508999936; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kelly M, 2009, CIRC-CARDIOVASC GENE, V2, P182, DOI 10.1161/CIRCGENETICS.108.836478; Tran-Viet KN, 2012, MOL VIS, V18, P937; Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; NORTON T T, 1991, Society for Neuroscience Abstracts, V17, P558; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Pronicki M, 2010, EUR J PAEDIATR NEURO, V14, P253, DOI 10.1016/j.ejpn.2009.09.008; PUTTING BJ, 1993, GRAEF ARCH CLIN EXP, V231, P600, DOI 10.1007/BF00936526; PUTTING BJ, 1994, EXP EYE RES, V58, P31, DOI 10.1006/exer.1994.1192; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; SILVERSTONE B, 1981, METAB PEDIATR SYST O, V5, P49; Silverstone B.Z., 1990, CIBA F SYMP, V155, P217; SILVERSTONE BZ, 1990, CIBA F SYMP, V155, P210; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Stone RA, 2003, INVEST OPHTH VIS SCI, V44, P3933, DOI 10.1167/iovs.02-0774; Stone RA, 2011, INVEST OPHTH VIS SCI, V52, P5765, DOI 10.1167/iovs.10-6727; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P950, DOI 10.1001/archneur.61.6.950; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Verdijk RM, 2008, AM J MED GENET A, V146A, P2822, DOI 10.1002/ajmg.a.32523; Vesela K, 2008, APMIS, V116, P41, DOI 10.1111/j.1600-0463.2008.00772.x; Vitale S, 2006, OPHTHALMOLOGY, V113, P2163, DOI 10.1016/j.ophtha.2006.06.033; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu PC, 2008, EYE, V22, P551, DOI 10.1038/sj.eye.6702789; Young Terri L, 2004, Trans Am Ophthalmol Soc, V102, P423; Young TL, 2009, OPTOMETRY VISION SCI, V86, P8, DOI 10.1097/OPX.0b013e3181940655; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006	63	77	84	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					820	826		10.1016/j.ajhg.2013.04.005	http://dx.doi.org/10.1016/j.ajhg.2013.04.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643385	Green Published, Bronze			2022-12-18	WOS:000318582800017
J	Jongmans, MCJ; Verwiel, ETP; Heijdra, Y; Vulliamy, T; Kamping, EJ; Hehir-Kwa, JY; Bongers, EMHF; Pfundt, R; van Emst, L; van Leeuwen, FN; van Gassen, KLI; van Kessel, AG; Dokal, I; Hoogerbrugge, N; Ligtenberg, MJL; Kuiper, RP				Jongmans, Marjolijn C. J.; Verwiel, Eugene T. P.; Heijdra, Yvonne; Vulliamy, Tom; Kamping, Eveline J.; Hehir-Kwa, Jayne Y.; Bongers, Ernie M. H. F.; Pfundt, Rolph; van Emst, Liesbeth; van Leeuwen, Frank N.; van Gassen, Koen L. I.; van Kessel, Ad Geurts; Dokal, Inderjeet; Hoogerbrugge, Nicoline; Ligtenberg, Marjolijn J. L.; Kuiper, Roland P.			Revertant Somatic Mosaicism by Mitotic Recombination in Dyskeratosis Congenita	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MARROW FAILURE; TELOMERE LENGTH; CLINICAL PRESENTATION; CONDITIONING REGIMEN; CELL TRANSPLANTATION; PULMONARY-FIBROSIS; APLASTIC-ANEMIA; MUTATIONS; RNA; REVERSION	Revertant mosaicism is an infrequently observed phenomenon caused by spontaneous correction of a pathogenic allele. We have observed such reversions caused by mitotic recombination of mutant TERC (telomerase RNA component) alleles in six patients from four families affected by dyskeratosis congenita (DC). DC is a multisystem disorder characterized by mucocutaneous abnormalities, dystrophic nails, bone-marrow failure, lung fibrosis, liver cirrhosis, and cancer. We identified a 4 nt deletion in TERC in a family with an autosomal-dominant form of DC. In two affected brothers without bone-marrow failure, sequence analysis revealed pronounced overrepresentation of the wild-type allele in blood cells, whereas no such skewing was observed in the other tissues tested. These observations suggest that this mosaic pattern might have resulted from somatic reversion of the mutated allele to the normal allele in blood-forming cells. SNP-microarray analysis on blood DNA from the two brothers indeed showed independent events of acquired segmental isodisomy of chromosome 3q, including TERC, indicating that the reversions must have resulted from mitotic recombination events. Subsequently, after developing a highly sensitive method of detecting mosaic homozygosity, we have found four additional cases with a mosaic-reversion pattern in blood cells; these four cases are part of a cohort of 17 individuals with germline TERC mutations. This shows that revertant mosaicism is a recurrent event in DC. This finding has important implications for improving diagnostic testing and understanding the variable phenotype of DC.	[Jongmans, Marjolijn C. J.; Verwiel, Eugene T. P.; Kamping, Eveline J.; Hehir-Kwa, Jayne Y.; Bongers, Ernie M. H. F.; Pfundt, Rolph; van Gassen, Koen L. I.; van Kessel, Ad Geurts; Hoogerbrugge, Nicoline; Ligtenberg, Marjolijn J. L.; Kuiper, Roland P.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Heijdra, Yvonne] Radboud Univ Nijmegen, Dept Pulmonol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Vulliamy, Tom; Dokal, Inderjeet] Queen Mary Univ London, Ctr Paediat, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London E1 4NS, England; [van Emst, Liesbeth; van Leeuwen, Frank N.] Radboud Univ Nijmegen, Lab Pediat Oncol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Ligtenberg, Marjolijn J. L.] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of London; Queen Mary University London; Radboud University Nijmegen; Radboud University Nijmegen	Jongmans, MCJ (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.	m.jongmans@antrg.umcn.nl; r.kuiper@antrg.umcn.nl	Hehir, g. J.Y./L-4358-2015; Heijdra, Yvonne/N-3585-2014; Kuiper, Roland/A-9646-2014; Ligtenberg, Marjolijn/N-9666-2013; Pfundt, Rolph/L-4576-2015; Kamping, Eveline J/E-9530-2016; Bongers, M.H.F./L-4214-2015; van Kessel, Ad Geurts/A-2810-2010; Hoogerbrugge, Nicoline/O-1016-2013; van Leeuwen, Frank/AAQ-6799-2020	Ligtenberg, Marjolijn/0000-0003-1290-1474; Hoogerbrugge, Nicoline/0000-0003-2393-8141; van Leeuwen, Frank/0000-0003-1107-6513; Hehir-Kwa, Jayne/0000-0003-0837-304X; Dokal, Inderjeet/0000-0003-4462-4782; van Gassen, Koen/0000-0001-7934-0662; Verwiel, Eugene/0000-0001-9663-6780	Netherlands Organization for Health Research and Development	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	We thank the subjects for their cooperation. M.C.J. Jongmans is an MD medical research trainee and is sponsored by The Netherlands Organization for Health Research and Development.	Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Amarasinghe K, 2007, BONE MARROW TRANSPL, V40, P913, DOI 10.1038/sj.bmt.1705839; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brazzola P, 2005, BONE MARROW TRANSPL, V36, P1103, DOI 10.1038/sj.bmt.1705171; Choate KA, 2010, SCIENCE, V330, P94, DOI 10.1126/science.1192280; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dietz AC, 2011, BONE MARROW TRANSPL, V46, P98, DOI 10.1038/bmt.2010.65; DOKAL I, 1992, BLOOD, V80, P3090; Ellis NA, 2001, HUM GENET, V108, P167, DOI 10.1007/s004390000447; Globerson A, 2000, IMMUNOL TODAY, V21, P515, DOI 10.1016/S0167-5699(00)01714-X; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; KEHRER H, 1992, CLIN GENET, V41, P129; Marrone A, 2007, HAEMATOLOGICA, V92, P1013, DOI 10.3324/haematol.11407; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Valera ET, 2010, PEDIATR BLOOD CANCER, V54, P779, DOI 10.1002/pbc.22446; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Yabe M, 1997, BONE MARROW TRANSPL, V19, P389, DOI 10.1038/sj.bmt.1700674; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	33	77	78	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					426	433		10.1016/j.ajhg.2012.01.004	http://dx.doi.org/10.1016/j.ajhg.2012.01.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22341970	Green Published, Bronze			2022-12-18	WOS:000301762800008
J	Akahori, M; Tsunoda, K; Miyake, Y; Fukuda, Y; Lshiura, H; Tsuji, S; Usui, T; Hatase, T; Nakamura, M; Ohde, H; Itabashi, T; Okamoto, H; Takada, Y; Iwata, T				Akahori, Masakazu; Tsunoda, Kazushige; Miyake, Yozo; Fukuda, Yoko; Lshiura, Hiroyuki; Tsuji, Shoji; Usui, Tomoaki; Hatase, Tetsuhisa; Nakamura, Makoto; Ohde, Hisao; Itabashi, Takeshi; Okamoto, Haru; Takada, Yuichiro; Iwata, Takeshi			Dominant Mutations in RP1L1 Are Responsible for Occult Macular Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINITIS-PIGMENTOSA; MULTIFOCAL ELECTRORETINOGRAM; PROTEIN; ABNORMALITY	Occult macular dystrophy (OMD) is an inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. Typical OMD is characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina. Linkage analysis of two OMD families was performed by the SNP High Throughput Linkage analysis system (SNP HiTLink), localizing the disease locus to chromosome 8p22-p23. Among the 128 genes in the linkage region, 22 genes were expressed in the retina, and four candidate genes were selected. No mutations were found in the first three candidate genes, methionine sulfoxide reductase A (MSRA), GATA binding 4 (GATA4), and pericentriolar material 1 (PCM1). However, amino acid substitution of p.Arg45Trp in retinitis pigmentosa 1-like 1 (RP1L1) was found in three OMD families and p.Trp960Arg in a remaining OMD family. These two mutations were detected in all affected individuals but in none of the 876 controls. Immunohistochemistry of RP1L1 in the retina section of cynomolgus monkey revealed expression in the rod and cone photoreceptor, supporting a role of RP1L1 in the photoreceptors that, when disrupted by mutation, leads to OMD. Identification of RP1L1 mutations as causative for OMD has potentially broader implications for understanding the differential cone photoreceptor functions in the fovea and the peripheral retina.	[Akahori, Masakazu; Tsunoda, Kazushige; Miyake, Yozo; Itabashi, Takeshi; Okamoto, Haru; Takada, Yuichiro; Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Meguro Ku, Tokyo 1528902, Japan; [Miyake, Yozo] Aichi Med Univ, Nagakute, Aichi 4891195, Japan; [Fukuda, Yoko; Lshiura, Hiroyuki; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; [Usui, Tomoaki; Hatase, Tetsuhisa] Niigata Univ, Div Ophthalmol & Visual Sci, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Nakamura, Makoto] Nakamura Eye Clin, Nishi Ku, Nagoya, Aichi 4520816, Japan; [Ohde, Hisao] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608582, Japan	Aichi Medical University; University of Tokyo; Niigata University; Keio University	Iwata, T (corresponding author), Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	iwatatakeshi@kankakuki.go.jp		Itabashi, Takeshi/0000-0002-2222-3446; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820; Nakamura, Makoto/0000-0002-6464-4302	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by grants to Takeshi Iwata and Kazushige Tsunoda by the Ministry of Health, Labour, and Welfare of Japan. This work was also supported in part to Shoji Tsuji by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas, Applied Genomics, the Global COE Program, and Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Brockhurst RJ, 2007, AM J OPHTHALMOL, V143, P516, DOI 10.1016/j.ajo.2006.10.025; Browne S, 2003, MOL VIS, V9, P129; Conte I, 2003, EUR J HUM GENET, V11, P155, DOI 10.1038/sj.ejhg.5200942; Fukuda Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-121; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Miyake Y, 1996, AM J OPHTHALMOL, V122, P644, DOI 10.1016/S0002-9394(14)70482-9; MIYAKE Y, 1989, AM J OPHTHALMOL, V108, P292, DOI 10.1016/0002-9394(89)90120-7; Park SJ, 2010, INVEST OPHTH VIS SCI, V51, P3673, DOI 10.1167/iovs.09-4169; Piao CH, 2000, INVEST OPHTH VIS SCI, V41, P513; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; SISK RA, 2010, OPHTHAL SURG LAS IM, V41, P1, DOI DOI 10.3928/15428877-20100215-49; Sullivan LS, 1999, NAT GENET, V22, P255, DOI 10.1038/10314; Wildberger H, 2003, KLIN MONATSBL AUGENH, V220, P111, DOI 10.1055/s-2003-38161; Yamashita T, 2009, J NEUROSCI, V29, P9748, DOI 10.1523/JNEUROSCI.5854-08.2009	18	77	79	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					424	429		10.1016/j.ajhg.2010.08.009	http://dx.doi.org/10.1016/j.ajhg.2010.08.009			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20826268	Green Published, Bronze			2022-12-18	WOS:000281923500013
J	Boon, CJE; Klevering, BJ; Hoyng, CB; Zonneveld-Vrieling, MN; Nabuurs, SB; Blokland, E; Cremers, FPM; den Hollander, AI				Boon, Camiel J. E.; Klevering, B. Jeroen; Hoyng, Carel B.; Zonneveld-Vrieling, Marijke N.; Nabuurs, Sander B.; Blokland, Ellen; Cremers, Frans P. M.; den Hollander, Anneke I.			Basal laminar drusen caused by compound heterozygous variants in the CFH gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; HEMOLYTIC-UREMIC SYNDROME; DENSE DEPOSIT DISEASE; MACULAR DEGENERATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; Y402H POLYMORPHISM; MUTATIONS; COMMON; RISK; UPDATE	Age-related macular degeneration (AMD) is a multifactorial disease that is strongly associated with the Tyr402His variant in the complement factor H (CFH) gene. Drusen are hallmark lesions of AMD and consist of focal-inflammatory and/or immune-mediated depositions of extracellular material at the interface of the retinal pigment epithelium (RPE) and the Bruch membrane. We evaluated the role of CFH in 30 probands with early-onset drusen and identified heterozygous nonsense, missense, and splice variants in five families. The affected individuals all carried the Tyr402His AMD risk variant on the other allele. This supports an autosomal-recessive disease model in which individuals who carry a CFH mutation on one allele and the Tyr402His variant on the other allele develop drusen. Our findings strongly suggest that monogenic inheritance of CFH variants can result in basal laminar drusen in young adults, and this can progress to maculopathy and severe vision loss later in life.	[Zonneveld-Vrieling, Marijke N.; Blokland, Ellen; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Boon, Camiel J. E.; Klevering, B. Jeroen; Hoyng, Carel B.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 GA Nijmegen, Netherlands; [Nabuurs, Sander B.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands.	a.denhollander@antrg.umcn.nl	Klevering, B.J./L-4434-2015; Hollander, Anneke den/N-4911-2014; Hoyng, C.B./H-8050-2014; Boon, Camiel/P-7534-2014; Cremers, Frans/A-5625-2014	Boon, Camiel/0000-0002-6737-7932; Cremers, Frans/0000-0002-4954-5592				Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; GASS JDM, 1985, AM J OPHTHALMOL, V99, P445; Grassi MA, 2007, ARCH OPHTHALMOL-CHIC, V125, P93, DOI 10.1001/archopht.125.1.93; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; LEYS A, 1991, PEDIATR NEPHROL, V5, P189, DOI 10.1007/BF01095950; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; ORMSBY RJ, 2007, MOL IMMUNOL, V44, P224; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Russell SR, 2000, AM J OPHTHALMOL, V129, P205, DOI 10.1016/S0002-9394(99)00345-1; Scholl HPN, 2007, MOL VIS, V13, P196; Sidransky E, 2006, CLIN GENET, V70, P275, DOI 10.1111/j.1399-0004.2006.00688.x; Thompson CL, 2007, HUM MOL GENET, V16, P2135, DOI 10.1093/hmg/ddm164	25	77	80	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					516	523		10.1016/j.ajhg.2007.11.007	http://dx.doi.org/10.1016/j.ajhg.2007.11.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252232	Green Published, Bronze			2022-12-18	WOS:000253223900024
J	Li, MY; Boehnke, M; Abecasis, GR				Li, MY; Boehnke, M; Abecasis, GR			Efficient study designs for test of genetic association using sibship data and unrelated cases and controls	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; LINKAGE DISEQUILIBRIUM; DISEASE; POWER; SUSCEPTIBILITY; ASCERTAINMENT; DETERMINANTS; POLYMORPHISM; STRATEGIES	Linkage mapping of complex diseases is often followed by association studies between phenotypes and marker genotypes through use of case-control or family-based designs. Given fixed genotyping resources, it is important to know which study designs are the most efficient. To address this problem, we extended the likelihood-based method of Li et al., which assesses whether there is linkage disequilibrium between a disease locus and a SNP, to accommodate sibships of arbitrary size and disease-phenotype configuration. A key advantage of our method is the ability to combine data from different family structures. We consider scenarios for which genotypes are available for unrelated cases, affected sib pairs (ASPs), or only one sibling per ASP. We construct designs that use cases only and others that use unaffected siblings or unrelated unaffected individuals as controls. Different combinations of cases and controls result in seven study designs. We compare the efficiency of these designs when the number of individuals to be genotyped is fixed. Our results suggest that (1) when the disease is influenced by a single gene, the one sibling per ASP-control design is the most efficient, followed by the ASP-control design, and familial cases contribute more association information than singleton cases; (2) when the disease is influenced by multiple genes, familial cases provide more association information than singleton cases, unless the effect of the locus being tested is much smaller than at least one other untested disease locus; and (3) the case-control design can be useful for detecting genes with small effect in the presence of genes with much larger effect. Our findings will be helpful for researchers designing and analyzing complex disease-association studies and will facilitate genotyping resource allocation.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, MY (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Blockey Hall Room 624, Philadelphia, PA 19104 USA.	mli@cceb.med.upenn.edu	Abecasis, Goncalo R/B-7840-2010	Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R56HG000376, R29HG000376, R01HG002651, R01HG000376] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012562, EY12562] Funding Source: Medline; NHGRI NIH HHS [R01 HG000376, HG00376, HG02651, R01 HG002651] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baum LE, 1972, INEQUALITIES, V3, P1; CANNINGS C, 1977, CLIN GENET, V12, P208; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Epstein MP, 2002, AM J HUM GENET, V70, P886, DOI 10.1086/339517; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haldane JBS, 1919, J GENET, V8, P299; Howson JMM, 2005, GENET EPIDEMIOL, V29, P51, DOI 10.1002/gepi.20077; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 2001, THEOR POPUL BIOL, V60, P215, DOI 10.1006/tpbi.2001.1538; RISCH N, 1987, AM J HUM GENET, V40, P1; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thompson D, 2004, GENET EPIDEMIOL, V27, P215, DOI 10.1002/gepi.20018; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	30	77	77	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					778	792		10.1086/503711	http://dx.doi.org/10.1086/503711			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642434	Bronze, Green Published			2022-12-18	WOS:000236756200005
J	Puppala, S; Dodd, GD; Fowler, S; Arya, R; Schneider, J; Farook, VS; Granato, R; Dyer, TD; Almasy, L; Jenkinson, CP; Diehl, AK; Stern, MP; Blangero, J; Duggirala, R				Puppala, S; Dodd, GD; Fowler, S; Arya, R; Schneider, J; Farook, VS; Granato, R; Dyer, TD; Almasy, L; Jenkinson, CP; Diehl, AK; Stern, MP; Blangero, J; Duggirala, R			A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CHOLESTEROL GALLSTONE FORMATION; QUANTITATIVE-TRAIT LOCI; BODY-MASS INDEX; FAMILIAL COMBINED HYPERLIPIDEMIA; DENSITY-LIPOPROTEIN-CHOLESTEROL; HETERODIMER PARTNER GENE; LINKAGE ANALYSIS; WIDE SCAN; METABOLIC SYNDROME; INSULIN-RESISTANCE	Gallbladder disease (GBD) is one of the major digestive diseases. Its risk factors include age, sex, obesity, type 2 diabetes, and metabolic syndrome (MS). The prevalence of GBD is high in minority populations, such as Native and Mexican Americans. Ethnic differences, familial aggregation of GBD, and the identification of susceptibility loci for gallstone disease by use of animal models suggest genetic influences on GBD. However, the major susceptibility loci for GBD in human populations have not been identified. Using ultrasound-based information on GBD occurrence and a 10-cM gene map, we performed multipoint variance-components analysis to localize susceptibility loci for GBD. Phenotypic and genotypic data from 715 individuals in 39 low-income Mexican American families participating in the San Antonio Family Diabetes/Gallbladder Study were used. Two GBD phenotypes were defined for the analyses: (1) clinical or symptomatic GBD, the cases of cholecystectomies due to stones confirmed by ultrasound, and (2) total GBD, the clinical GBD cases plus the stone carriers newly diagnosed by ultrasound. With use of the National Cholesterol Education Program/Adult Treatment Panel III criteria, five MS risk factors were defined: increased waist circumference, hypertriglyceredemia, low high-density lipoprotein cholesterol, hypertension, and high fasting glucose. The MS risk-factor score (range 0 - 5) for a given individual was used as a single, composite covariate in the genetic analyses. After accounting for the effects of age, sex, and MS risk-factor score, we found stronger linkage signals for the symptomatic GBD phenotype. The highest LOD scores (3.7 and 3.5) occurred on chromosome 1p between markers D1S1597 and D1S407 (1p36.21) and near marker D1S255 (1p34.3), respectively. Other genetic locations (chromosomes 2p, 3q, 4p, 8p, 9p, 10p, and 16q) across the genome exhibited some evidence of linkage (LOD >= 1.2) to symptomatic GBD. Some of these chromosomal regions corresponded with the genetic locations of Lith loci, which influence gallstone formation in mouse models. In conclusion, we found significant evidence of major genetic determinants of symptomatic GBD on chromosome 1p in Mexican Americans.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Radiol, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Div Clin Epidemiol, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Div Diabet, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Div Gen Med, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX USA	Texas Biomedical Research Institute; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Puppala, S (corresponding author), SW Fdn Biomed Res, Dept Genet, POB 760549, San Antonio, TX 78245 USA.	spuppala@darwin.sfbr.org	Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019	Fowler, Sharon/0000-0003-1117-683X	NIDDK NIH HHS [DK42273, R01 DK053889, DK47482, R01 DK047482, R01 DK079195, DK53889] Funding Source: Medline; NIMH NIH HHS [R37 MH059490, R01 MH059490, MH59490] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079195, R01DK047482, R01DK053889, R01DK042273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Al-Kateb H, 2002, CIRC RES, V90, P951, DOI 10.1161/01.RES.0000018002.43041.08; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Arya R, 2004, AM J HUM GENET, V74, P272, DOI 10.1086/381717; Arya R, 2002, NAT GENET, V30, P102, DOI 10.1038/ng810; Arya R, 2001, GENET EPIDEMIOL, V21, pS774, DOI 10.1002/gepi.2001.21.s1.s774; Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Badzioch MD, 2004, ARTERIOSCL THROM VAS, V24, P1942, DOI 10.1161/01.ATV.0000143499.09575.93; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Bertomeu A, 1996, GASTROENTEROLOGY, V111, P1603, DOI 10.1016/S0016-5085(96)70023-9; Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Boland LL, 2002, ANN EPIDEMIOL, V12, P131, DOI 10.1016/S1047-2797(01)00260-5; BOSSE Y, 2004, THESIS LAVAL U QUEBE; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Burke JP, 2000, HUM GENET, V106, P467, DOI 10.1007/s004390000274; Cai GW, 2004, HUM BIOL, V76, P651, DOI 10.1353/hub.2005.0001; CAREY MC, 1993, AM J SURG, V165, P410, DOI 10.1016/S0002-9610(05)80932-8; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 2002, BEST PRACT RES CL EN, V16, P611, DOI 10.1053/beem.2002.0224; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; Davis RA, 2002, J LIPID RES, V43, P533; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Diehl A K, 1989, Adv Intern Med, V34, P73; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Diehl AK, 2000, HEPATOLOGY, V31, P528, DOI 10.1002/hep.510310238; DIEHL AK, 1994, DIGEST DIS SCI, V39, P2223, DOI 10.1007/BF02090375; Ding Xiong, 2005, Hepatobiliary Pancreat Dis Int, V4, P295; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Duggirala R, 1999, GENET EPIDEMIOL, V16, P191, DOI 10.1002/(SICI)1098-2272(1999)16:2<191::AID-GEPI6>3.0.CO;2-6; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Duggirala R, 2003, AM J HUM GENET, V73, P195; Duggirala R, 2003, GENET EPIDEMIOL, V24, P240, DOI 10.1002/gepi.10233; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Dyke B, 1996, PEDSYS PEDIGREE DATA; Eden ER, 2001, AM J HUM GENET, V68, P653, DOI 10.1086/318795; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Elbein SC, 2002, DIABETES, V51, P528, DOI 10.2337/diabetes.51.2.528; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; EVERHART JE, 1993, ANN INTERN MED, V119, P1029, DOI 10.7326/0003-4819-119-10-199311150-00010; Everhart JE, 2002, HEPATOLOGY, V35, P1507, DOI 10.1053/jhep.2002.33336; EVERHART JE, 1995, NIH PUBLICATION, P457; Fernandez-Real JM, 2000, DIABETES CARE, V23, P831, DOI 10.2337/diacare.23.6.831; Frank C, 2005, J MOL BIOL, V346, P505, DOI 10.1016/j.jmb.2004.12.003; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gavin JR, 1997, DIABETES CARE, V20, P1183; Geurts JMW, 2000, HUM MOL GENET, V9, P2067, DOI 10.1093/hmg/9.14.2067; Glenn CL, 2000, HUM MOL GENET, V9, P1943, DOI 10.1093/hmg/9.13.1943; Grundy SM, 2004, AM J CLIN NUTR, V80, P1; HAFFNER SM, 1993, DIABETES CARE, V16, P1276, DOI 10.2337/diacare.16.9.1276; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; HALL MJ, 1998, AMBULATORY SURG US A; Hanis Craig L., 1993, Ethnicity and Disease, V3, P32; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Heath SC, 1997, J COMPUT BIOL, V4, P505, DOI 10.1089/cmb.1997.4.505; Heijmans BT, 2005, EUR J HUM GENET, V13, P1143, DOI 10.1038/sj.ejhg.5201466; Hillebrandt S, 2003, EUR J CLIN INVEST, V33, P155, DOI 10.1046/j.1365-2362.2003.01089.x; Hinney A, 2000, J CLIN ENDOCR METAB, V85, P2962, DOI 10.1210/jc.85.8.2962; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Hsueh WC, 2001, GENET EPIDEMIOL, V21, pS473, DOI 10.1002/gepi.2001.21.s1.s473; Hsueh WC, 2001, J CLIN ENDOCR METAB, V86, P1199, DOI 10.1210/jc.86.3.1199; Huertas-Vazquez A, 2004, ANN HUM GENET, V68, P419, DOI 10.1046/j.1529-8817.2003.00116.x; Hung CCC, 2003, DIABETES, V52, P1288, DOI 10.2337/diabetes.52.5.1288; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Jiang ZY, 2004, WORLD J GASTROENTERO, V10, P1508; JUVONEN T, 1993, GASTROENTEROLOGY, V104, P1806, DOI 10.1016/0016-5085(93)90662-V; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; KESANIEMI YA, 1989, GUT, V30, P1750, DOI 10.1136/gut.30.12.1750; KHANUJA B, 1995, P NATL ACAD SCI USA, V92, P7729, DOI 10.1073/pnas.92.17.7729; Kosters A, 2003, BBA-MOL BASIS DIS, V1637, P1, DOI 10.1016/S0925-4439(02)00173-4; Lammert F, 2002, HEPATOLOGY, V36, P1145, DOI 10.1053/jhep.2002.36821; Lammert F, 2001, GASTROENTEROLOGY, V120, P221, DOI 10.1053/gast.2001.20878; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Langefeld CD, 2004, DIABETES, V53, P1170, DOI 10.2337/diabetes.53.4.1170; LAWRENCE L, 1999, ADV DATA, V308, P1; Lee S, 2004, NAT CLIN PRACT GASTR, V1, P2, DOI 10.1038/ncpgasthep0017; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Lindsay RS, 2003, DIABETES, V52, P2419, DOI 10.2337/diabetes.52.9.2419; Liu YJ, 2004, J CLIN ENDOCR METAB, V89, P875, DOI 10.1210/jc.2003-030774; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Lyons MA, 2005, MAMM GENOME, V16, P152, DOI 10.1007/s00335-004-2446-5; Lyons MA, 2003, PHYSIOL GENOMICS, V14, P225, DOI 10.1152/physiolgenomics.00073.2003; MACDONALD FR, 1981, GASTROINTEST RADIOL, V6, P39, DOI 10.1007/BF01890219; Mahaney MC, 2003, ARTERIOSCL THROM VAS, V23, P339, DOI 10.1161/01.ATV.0000051406.14162.6A; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; Mendez-Sanchez N, 2004, AM J GASTROENTEROL, V99, P2166, DOI 10.1111/j.1572-0241.2004.40159.x; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; MendezSanchez N, 1996, ARCH MED RES, V27, P433; Misciagna G, 1996, EUR J GASTROEN HEPAT, V8, P585, DOI 10.1097/00042737-199606000-00017; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Nakeeb A, 2002, ANN SURG, V235, P842, DOI 10.1097/00000658-200206000-00012; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Paigen B, 2000, PHYSIOL GENOMICS, V4, P59, DOI 10.1152/physiolgenomics.2000.4.1.59; Paigen B., 2002, GENETIC BASIS COMMON, P298; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Pajukanta P, 2003, AM J HUM GENET, V72, P903, DOI 10.1086/374177; Perusse L, 2001, OBES RES, V9, P135, DOI 10.1038/oby.2001.17; Platte P, 2003, AM J MED GENET C, V121C, P71, DOI 10.1002/ajmg.c.20005; POMERANZ IS, 1985, GASTROENTEROLOGY, V88, P787, DOI 10.1016/0016-5085(85)90152-0; PORTINCASA P, 1995, SCAND J GASTROENTERO, V30, P63, DOI 10.3109/00365529509090303; Portincasa Piero, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P67, DOI 10.2174/1568008033340397; Puga I, 2005, ENDOCRINOLOGY, V146, P2210, DOI 10.1210/en.2004-1366; Reed DR, 2001, J MOL MED-JMM, V79, P262, DOI 10.1007/s001090100212; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; ROSENTHAL TC, 1994, J FAM PRACTICE, V38, P380; Rosmorduc O, 2003, GASTROENTEROLOGY, V125, P452, DOI 10.1016/S0016-5085(03)00898-9; Ruhl CE, 2000, HEPATOLOGY, V31, P299, DOI 10.1002/hep.510310206; Rybicki RJ, 2000, RADIOLOGY, V214, P881, DOI 10.1148/radiology.214.3.r00mr38881; Sahi T, 1998, AM J EPIDEMIOL, V147, P644, DOI 10.1093/oxfordjournals.aje.a009505; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; SARIN SK, 1995, HEPATOLOGY, V22, P138; Schoonjans K, 2002, NAT MED, V8, P789, DOI 10.1038/nm0802-789; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Silva CP, 2003, J CLIN MICROBIOL, V41, P5615, DOI 10.1128/JCM.41.12.5615-5618.2003; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Swidsinski A, 2001, FRONT BIOSCI-LANDMRK, V6, pE93, DOI 10.2741/Swidsinski; Tsai CJ, 2004, AM J CLIN NUTR, V80, P38; Varret M, 1999, AM J HUM GENET, V64, P1378, DOI 10.1086/302370; Wang DQH, 2004, J CLIN INVEST, V114, P521, DOI 10.1172/JCI200416801; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; WEISS KM, 1984, AM J HUM GENET, V36, P1259; Wiltshire S, 2004, DIABETES, V53, P855, DOI 10.2337/diabetes.53.3.855; Wittenburg H, 2003, GASTROENTEROLOGY, V125, P868, DOI 10.1016/S0016-5085(03)01053-9; Xiang KS, 2002, DIABETES, V51, pA262; Yang CC, 2002, J DIABETES COMPLICAT, V16, P347, DOI 10.1016/S1056-8727(01)00218-5; Zhu J, 2005, WORLD J GASTROENTERO, V11, P1685	138	77	83	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					377	392		10.1086/500274	http://dx.doi.org/10.1086/500274			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16400619	Green Published, Bronze			2022-12-18	WOS:000236747500006
J	Chiba-Falek, O; Kowalak, JA; Smulson, ME; Nussbaum, RL				Chiba-Falek, O; Kowalak, JA; Smulson, ME; Nussbaum, RL			Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; PARKINSONS-DISEASE; POLY(ADP-RIBOSE) POLYMERASE; TRANSCRIPTIONAL ACTIVATION; NACP/ALPHA-SYNUCLEIN; SEQUENCE-ANALYSIS; ALLELIC VARIATION; MUTATION; COACTIVATOR; PROMOTER	Alleles at NACP-Rep1, the polymorphic microsatellite repeat located similar to 10 kb upstream of the alpha-synuclein gene ( SNCA), are associated, in some reports, with differing risks of sporadic Parkinson disease (PD). We showed previously that NACP-Rep1 acts as a negative modulator of SNCA transcription, with an effect that varied threefold among different NACP-Rep1 alleles. Given that duplications and triplications of SNCA have been implicated in familial Parkinson disease (PD), even a 1.5 - 2-fold increase in alpha-synuclein expression may, over many decades, contribute to PD. Thus, the association of different NACP-Rep1 alleles with PD may be a consequence of polymorphic differences in transcriptional regulation of SNCA. Here we aimed to identify the factor(s) that bind to NACP-Rep1 and potentially contribute to SNCA transcriptional modulation, by pulling down proteins that bind to NACP- Rep1 and identifying them by mass spectrometry. One of these proteins was poly-(ADP-ribose) transferase/ polymerase-1 (PARP-1), a DNA-binding protein and transcriptional regulator. Electrophoresis mobility shift and chromatin immunoprecipitation assays showed specific binding of PARP-1 to NACP- Rep1. Inhibition of PARP-1's catalytic domain increased the endogenous SNCA mRNA levels in cultured SH-SY5Y cells. Furthermore, PARP-1 binding to NACP- Rep1 specifically reduced the transcriptional activity of the SNCA promoter/enhancer in luciferase reporter assays. This down-regulation effect of PARP-1 depended on NACP- Rep1 being present in the construct and was abrogated by inhibiting PARP-1's catalytic activity with 3-aminobenzamide. The association of different NACP- Rep1 alleles with PD may be mediated, in part, by the effect of PARP-1, as well as other factors, on SNCA expression.	NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; NIMH, Lab Neurotoxicol, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Georgetown University	Nussbaum, RL (corresponding author), NHGRI, Genet Dis Res Branch, NIH, 49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	rlnuss@mail.nih.gov			NCI NIH HHS [P01 CA074175, P01CA-74175] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA074175] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH000274, ZIAMH000274] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Golbe LI, 1999, MOVEMENT DISORD, V14, P6, DOI 10.1002/1531-8257(199901)14:1<6::AID-MDS1004>3.0.CO;2-L; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Izumi Y, 2001, NEUROSCI LETT, V300, P125, DOI 10.1016/S0304-3940(01)01557-9; Johnson J, 2004, NEUROLOGY, V63, P554, DOI 10.1212/01.WNL.0000133401.09043.44; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; Khan N, 2001, ANN NEUROL, V49, P665; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Mizuta I, 2002, J NEUROL NEUROSUR PS, V73, P350, DOI 10.1136/jnnp.73.3.350; Nie J, 1998, FEBS LETT, V424, P27, DOI 10.1016/S0014-5793(98)00131-8; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Parsian A, 1998, NEUROLOGY, V51, P1757, DOI 10.1212/WNL.51.6.1757; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smulson ME, 1998, CANCER RES, V58, P3495; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Spadafora P, 2003, NEUROSCI LETT, V351, P75, DOI 10.1016/S0304-3940(03)00859-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STONE KL, 1993, ENZYMATIC DIGESTION; Tan EK, 2004, NEUROLOGY, V62, P128, DOI 10.1212/01.WNL.0000101721.25345.DC; Tan EK, 2003, NEUROSCI LETT, V336, P70, DOI 10.1016/S0304-3940(02)01178-3; Tan EK, 2000, NEUROLOGY, V54, P1195, DOI 10.1212/WNL.54.5.1195; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WHITACRE CM, 1995, CANCER RES, V55, P3697; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	49	77	81	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					478	492		10.1086/428655	http://dx.doi.org/10.1086/428655			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15672325	Bronze, Green Published			2022-12-18	WOS:000226851900010
J	Donaudy, F; Ferrara, A; Esposito, L; Hertzano, R; Ben-David, O; Bell, RE; Melchionda, S; Zelante, L; Avraham, KB; Gasparini, P				Donaudy, F; Ferrara, A; Esposito, L; Hertzano, R; Ben-David, O; Bell, RE; Melchionda, S; Zelante, L; Avraham, KB; Gasparini, P			Multiple mutations of MYO1A, a cochlear-expressed gene, in sensorineural hearing loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOSIN VIIA GENE; UNCONVENTIONAL MYOSIN; HAIR-CELLS; DEAFNESS; INTESTINE; MICE	Myosin I isozymes have been implicated in various motile processes, including organelle translocation, ion-channel gating, and cytoskeleton reorganization. Unconventional myosins were among the first family of proteins found to be associated with hearing loss in both humans and mice. Here, we report the identification of a nonsense mutation, of a trinucleotide insertion leading to an addition of an amino acid, and of six missense mutations in MYO1A cDNA sequence in a group of hearing-impaired patients from Italy. MYO1A, which is located within the DFNA48 locus, is the first myosin I family member found to be involved in causing deafness and may be a major contributor to autosomal dominant-hearing loss.	Univ Naples 2, Telethon Inst Genet & Med, Dipartimento Patol Gen, Naples, Italy; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Osped Casa Sollievo Sofferenza, Serv Genet Med, Ist Ricovero & Cura & Carattere Sci, San Giovanni Rotondo, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; IRCCS Casa Sollievo Della Sofferenza	Gasparini, P (corresponding author), Univ Naples 2, Telethon Inst Genet & Med, Dipartimento Patol Gen, Naples, Italy.	gasparini@tigem.it	Hertzano, Ronna P/Y-8304-2019	Avraham, Karen B/0000-0002-4913-251X; Gasparini, Paolo/0000-0002-0859-0856	Telethon [TGM06S01, E.0813, TGM03P12] Funding Source: Medline	Telethon(Fondazione Telethon)		Ahituv N, 2000, GENE, V261, P269, DOI 10.1016/S0378-1119(00)00535-7; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; D'Adamo P, 2003, HUM GENET, V112, P319, DOI 10.1007/s00439-002-0880-6; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Petersen MB, 2002, CLIN GENET, V62, P1, DOI 10.1034/j.1399-0004.2002.620101.x; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skowron JF, 1999, J EXP ZOOL, V283, P242, DOI 10.1002/(SICI)1097-010X(19990215)283:3<242::AID-JEZ3>3.3.CO;2-6; Skowron JF, 1998, CELL MOTIL CYTOSKEL, V41, P308, DOI 10.1002/(SICI)1097-0169(1998)41:4<308::AID-CM4>3.3.CO;2-A; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	23	77	82	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1571	1577		10.1086/375654	http://dx.doi.org/10.1086/375654			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12736868	Bronze, Green Published			2022-12-18	WOS:000183275500021
J	Heyer, E; Zietkiewicz, E; Rochowski, A; Yotova, V; Puymirat, J; Labuda, D				Heyer, E; Zietkiewicz, E; Rochowski, A; Yotova, V; Puymirat, J; Labuda, D			Phylogenetic and familial estimates of mitochondrial substitution rates: Study of control region mutations in deep-rooting pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA CONTROL REGION; DNA CONTROL REGION; D-LOOP; EUROPEAN POPULATIONS; NORTH-AMERICA; SEQUENCES; EVOLUTION; LINEAGES; SITES; INDIVIDUALS	We studied mutations in the mtDNA control region (CR) using deep-rooting French-Canadian pedigrees. In 508 maternal transmissions, we observed four substitutions (0.0079 per generation per 673 bp, 95% CI 0.0023-0.186). Combined with other familial studies, our results add up to 18 substitutions in 1,729 transmissions (0.0104), confirming earlier findings of much greater mutation rates in families than those based on phylogenetic comparisons. Only 12 of these mutations occurred at independent sites, whereas three positions mutated twice each, suggesting that pedigree studies preferentially reveal a fraction of highly mutable sites. Fitting the data through use of a nonuniform rate model predicts the presence of 40 (95% CI 27-54) such fast sites in the whole CR, characterized by the mutation rate of 274 per site per million generations (95% CI 138-410). The corresponding values for hypervariable regions I (HVI; 1,729 transmissions) and II (HVII; 1,956 transmissions), are 19 and 22 fast sites, with rates of 224 and 274, respectively. Because of the high probability of recurrent mutations, such sites are expected to be of no or little informativity for the evaluation of mutational distances at the phylogenetic time scale. The analysis of substitution density in the alignment of 973 HVI and 650 HVII unrelated European sequences reveals that the bulk of the sites mutate at relatively moderate and slow rates. Assuming a star-like phylogeny and an average time depth of 250 generations, we estimate the rates for HVI and HVII at 23 and 24 for the moderate sites and 1.3 and 1.0 for the slow sites. The fast, moderate, and slow sites, at the ratio of 1:2:13, respectively, describe the mutation-rate heterogeneity in the CR. Our results reconcile the controversial rate estimates in the phylogenetic and familial studies; the fast sites prevail in the latter, whereas the slow and moderate sites dominate the phylogenetic-rate estimations.	Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; Univ Paris 07, CNRS, MNHN, Musee Homme,Lab Anthropol Biol, Paris, France; Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; PAN, Inst Genet Czlowieka, Poznan, Poland; CHUL, Ctr Rech, St Foy, PQ, Canada	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Laval University	Labuda, D (corresponding author), Hop St Justine, Ctr Rech, 3175 Cote Ste Catherine,Pavillon Videotron,B-4, Montreal, PQ H3T 1C5, Canada.		Zietkiewicz, Ewa/ABP-3539-2022; Heyer, Evelyne/K-9184-2013	Zietkiewicz, Ewa/0000-0003-2437-5088; Heyer, Evelyne/0000-0002-0266-3196				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Baasner A, 1998, FORENSIC SCI INT, V98, P169, DOI 10.1016/S0379-0738(98)00163-7; BANDELT HJ, 1995, GENETICS, V141, P743; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; DEININGER PL, 1993, EVOL BIOL, V27, P157; DERAGON JM, 1994, J MOL EVOL, V39, P378, DOI 10.1007/BF00160270; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; HASEGAWA M, 1991, J MOL EVOL, V32, P37, DOI 10.1007/BF02099927; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1996, AM J HUM GENET, V59, P501; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; LABUDA D, 1991, J MOL EVOL, V32, P405, DOI 10.1007/BF02101280; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Meyer S, 1999, GENETICS, V152, P1103; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; Reynolds R, 2000, J FORENSIC SCI, V45, P1210; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousselet F, 1998, INT J LEGAL MED, V111, P292, DOI 10.1007/s004140050174; SHERRY ST, 1994, HUM BIOL, V66, P761; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Soodyall H, 1997, AM J PHYS ANTHROPOL, V104, P157, DOI 10.1002/(SICI)1096-8644(199710)104:2<157::AID-AJPA2>3.0.CO;2-W; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; TAKAHATA N, 1994, MOL BIOL EVOL, V11, P803; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; ZIETKIEWICZ E, 1994, NUCLEIC ACIDS RES, V22, P5608, DOI 10.1093/nar/22.25.5608; Zietkiewicz E, 1998, J MOL EVOL, V47, P172, DOI 10.1007/PL00006374; [No title captured]	57	77	81	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1113	1126		10.1086/324024	http://dx.doi.org/10.1086/324024			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11582570	Bronze, Green Published			2022-12-18	WOS:000171413400018
J	Reiss, J; Gross-Hardt, S; Christensen, E; Schmidt, P; Mendel, RR; Schwarz, G				Reiss, J; Gross-Hardt, S; Christensen, E; Schmidt, P; Mendel, RR; Schwarz, G			A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLYBDOPTERIN SYNTHASE GENE; ESCHERICHIA-COLI; NITRATE REDUCTASE; GENOMIC STRUCTURE; SULFITE OXIDASE; BIOSYNTHESIS; METABOLISM; IDENTIFICATION; INVOLVEMENT; CINNAMON	Gephyrin was originally identified as a membrane-associated protein that is essential for the postsynaptic localization of receptors for the neurotransmitters glycine and GABA,. A sequence comparison revealed homologies between gephyrin and proteins necessary for the biosynthesis of the universal molybdenum cofactor (MoCo). Because gephyrin expression can rescue a MoCo-deficient mutation in bacteria, plants, and a murine cell line, it became clear that gephyrin also plays a role in MoCo biosynthesis. Human MoCo deficiency is a fatal disease resulting in severe neurological damage and death in early childhood. Most patients harbor MOCS1 mutations, which prohibit formation of a precursor, or carry MOCS2 mutations, which abrogate precursor conversion to molybdopterin. The present report describes the identification of a gephyrin gene (GEPH) deletion in a patient with symptoms typical of MoCo deficiency. Biochemical studies of the patient's fibroblasts demonstrate that gephyrin catalyzes the insertion of molybdenum into molybdopterin and suggest that this novel form of MoCo deficiency might be curable by molybdate supplementation.	Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany; Rigshosp, DK-2100 Copenhagen, Denmark; Tech Univ Braunschweig, Inst Bot, D-3300 Braunschweig, Germany	University of Munster; Rigshospitalet; University of Copenhagen; Braunschweig University of Technology	Reiss, J (corresponding author), Univ Munster, Inst Med Phys & Biophys, Robert Koch Str 31, D-48149 Munster, Germany.		Schwarz, Guenter/ABE-9643-2021	Schwarz, Guenter/0000-0002-2118-9338; Marz, Sigrid/0000-0001-6836-7755				Andrew M, 1997, BRIT J PSYCHIAT, V170, P106, DOI 10.1192/bjp.170.2.106; Appleyard MVCL, 1998, J BIOL CHEM, V273, P14869, DOI 10.1074/jbc.273.24.14869; BAMFORTH FJ, 1990, CLIN BIOCHEM, V23, P537, DOI 10.1016/0009-9120(90)80046-L; Duran M, 1978, J Inherit Metab Dis, V1, P175, DOI 10.1007/BF01805591; ENDRES W, 1988, EUR J PEDIATR, V148, P246, DOI 10.1007/BF00441412; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; FALCIANI F, 1994, BIOCHEM J, V298, P69, DOI 10.1042/bj2980069; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Hasona A, 1998, J BACTERIOL, V180, P1466, DOI 10.1128/JB.180.6.1466-1472.1998; Johnson J.L, 1995, METABOLIC MOL BASES, V7th edition., P2271, DOI [10.1016/0168-9525(96)81407-7, DOI 10.1016/0168-9525(96)81407-7]; JOHNSON JL, 1991, J INHERIT METAB DIS, V14, P932, DOI 10.1007/BF01800477; KAMDAR KP, 1994, GENETICS, V137, P791; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Kuper J, 2000, P NATL ACAD SCI USA, V97, P6475, DOI 10.1073/pnas.110568497; MUNNICH A, 1983, J INHERIT METAB DIS, V6, P95, DOI 10.1007/BF01810344; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Reiss J, 2000, HUM GENET, V106, P157, DOI 10.1007/s004390051023; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Reiss J, 1998, HUM GENET, V103, P639, DOI 10.1007/s004390050884; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Stallmeyer B, 1999, AM J HUM GENET, V64, P698, DOI 10.1086/302295; STALLMEYER B, 1995, PLANT J, V8, P751, DOI 10.1046/j.1365-313X.1995.08050751.x; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; STEWART V, 1988, MICROBIOL REV, V52, P190, DOI 10.1128/MMBR.52.2.190-232.1988	28	77	79	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					208	213		10.1086/316941	http://dx.doi.org/10.1086/316941			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11095995	Green Published, Bronze			2022-12-18	WOS:000166399900019
J	Sasaki, T; Tahira, T; Suzuki, A; Higasa, K; Kukita, Y; Baba, S; Hayashi, K				Sasaki, T; Tahira, T; Suzuki, A; Higasa, K; Kukita, Y; Baba, S; Hayashi, K			Precise estimation of allele frequencies of single-nucleotide polymorphisms by a quantitative SSCP analysis of pooled DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAMPLES	We show that single-nucleotide polymorphisms (SNPs) of moderate to high heterozygosity (minor allele frequencies >10%) can be efficiently detected, and their allele frequencies accurately estimated, by pooling the DNA samples and applying a capillary-based SSCP analysis. In this method, alleles are separated into peaks, and their frequencies can be reliably and accurately quantified from their peak heights (SD <1.8%). We found that as many as 40% of publicly available SNPs that were analyzed by this method have widely differing allele frequency distributions among groups of different ethnicity (parents of Centre d'Etude Polymorphisme Humaine families vs. Japanese individuals), These results demonstrate the effectiveness of the present pooling method in the reevaluation of candidate SNPs that have been collected by examination of limited numbers of individuals. The method should also serve as a robust quantitative technique for studies in which a precise estimate of SNP allele frequencies is essential-for example, in linkage disequilibrium analysis.	Kyushu Univ, Inst Genet Informat, Div Genome Anal, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Hayashi, K (corresponding author), Kyushu Univ, Inst Genet Informat, Div Genome Anal, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	khayashi@gen.kyushu-u.ac.jp	Suzuki, Akari/N-5389-2015	Sasaki, Tomonari/0000-0001-5456-7801; Kukita, Yoji/0000-0003-3523-2816				Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; Barnard R, 1998, BIOTECHNIQUES, V25, P684, DOI 10.2144/98254dt08; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Hayashi K, 1998, PRACT APPROACH SER, P7; Inazuka M, 1996, GENOME RES, V6, P551, DOI 10.1101/gr.6.6.551; Inazuka M, 1997, GENOME RES, V7, P1094, DOI 10.1101/gr.7.11.1094; Kondo H, 2000, BIOTECHNIQUES, V29, P868, DOI 10.2144/00294rr03; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Shaw SH, 1998, GENOME RES, V8, P111, DOI 10.1101/gr.8.2.111; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	17	77	79	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					214	218		10.1086/316928	http://dx.doi.org/10.1086/316928			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11083945	Green Published, Bronze			2022-12-18	WOS:000166399900020
J	Merette, C; Brassard, A; Potvin, A; Bouvier, H; Rousseau, F; Emond, C; Bissonnette, L; Roy, MA; Maziade, M; Ott, J; Caron, C				Merette, C; Brassard, A; Potvin, A; Bouvier, H; Rousseau, F; Emond, C; Bissonnette, L; Roy, MA; Maziade, M; Ott, J; Caron, C			Significant linkage for Tourette syndrome in a large French Canadian family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION; MODELS	Family and twin studies provide strong evidence that genetic factors are involved in the transmission of Gilles de la Tourette syndrome (TS) and related psychiatric disorders. To detect the underlying susceptibility gene(s) for TS, we performed linkage analysis in one large French Canadian family (127 members) from the Charlevoix region, in which 20 family members were definitely affected by TS and 20 others showed related tic disorders. Using model-based linkage analysis, we observed a LOD score of 3.24 on chromosome 11 (11q23). This result was obtained in a multipoint approach involving marker D11S1377, the marker for which significant linkage disequilibrium with TS recently has been detected in an Afrikaner population. Altogether, 25 markers were studied, and, for level of significance, we derived a criterion that took into account the multiple testing arising from the use of three phenotype definitions and three modes of inheritance, a procedure that yielded a LOD score of 3.18. Hence, even after adjustment for multiple testing, the present study shows statistically significant evidence for genetic linkage with TS.	Univ Laval Robert Giffard, Ctr Rech, Beauport, PQ G1J 2G3, Canada; Univ Laval Robert Giffard, Fac Med, Dept Psychiat, Beauport, PQ G1J 2G3, Canada; CHUL, CHUQ, Quebec City, PQ, Canada; Univ Affiliated Ctr, CHSLD, CLSC, Quebec City, PQ, Canada; Rockefeller Univ, New York, NY 10021 USA	Laval University; Laval University; Laval University; Rockefeller University	Merette, C (corresponding author), Univ Laval Robert Giffard, Ctr Rech, 2601 Canardiere, Beauport, PQ G1J 2G3, Canada.	chantal.merette@psa.ulaval.ca			NIMH NIH HHS [MH44292, R37 MH044292, R01 MH044292] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044292, R01MH044292] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Barr CL, 1998, CAN J PSYCHIAT, V43, P351, DOI 10.1177/070674379804300402; Barr CL, 1999, AM J MED GENET, V88, P437, DOI 10.1002/(SICI)1096-8628(19990820)88:4<437::AID-AJMG24>3.0.CO;2-E; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; FAHN S, 1993, ARCH NEUROL-CHICAGO, V50, P1013; GELERNTER J, 1990, ARCH GEN PSYCHIAT, V47, P1073; Halpern J, 1999, HUM HERED, V49, P194, DOI 10.1159/000022874; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Maziade M, 1997, AM J MED GENET, V74, P311, DOI 10.1002/(SICI)1096-8628(19970531)74:3<311::AID-AJMG13>3.3.CO;2-C; MORISSETTE J, 1991, HIST GENOME POPULATI, P107; MORTON NE, 1955, AM J HUM GENET, V7, P277; Ott J., 1991, ANAL HUMAN GENETIC L; Paula D, 1999, AM J HUM GENET, V65, P1428; PAULS DL, 1987, SCHEDULE TOURETTE OT; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Seuchter SA, 2000, GENET EPIDEMIOL, V18, P33, DOI 10.1002/(SICI)1098-2272(200001)18:1<33::AID-GEPI3>3.0.CO;2-2; Simonic I, 1998, AM J HUM GENET, V63, P839, DOI 10.1086/302002	21	77	84	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1008	1013		10.1086/303093	http://dx.doi.org/10.1086/303093			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986045	Green Published, Bronze			2022-12-18	WOS:000089651100026
J	Muntau, AC; Mayerhofer, PU; Paton, BC; Kammerer, S; Roscher, AA				Muntau, AC; Mayerhofer, PU; Paton, BC; Kammerer, S; Roscher, AA			Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIOGENESIS; DISORDERS; GENE; IDENTIFICATION; CLONING	Zellweger cerebro-hepato-renal syndrome is a severe congenital disorder associated with defective peroxisomal biogenesis. At least 23 PEX genes have been reported to be essential for peroxisome biogenesis in various species, indicating the complexity of peroxisomal assembly Cells from patients with peroxisomal biogenesis disorders have previously been shown to segregate into greater than or equal to 12 complementation groups. Two patients assigned to complementation group G who had not been linked previously to a specific gene defect were confirmed as displaying a cellular phenotype characterized by a lack of even residual peroxisomal membrane structures. Here we demonstrate that this complementation group is associated with mutations in the PEX3 gene, encoding an integral peroxisomal membrane protein. Homozygous PEX3 mutations, each leading to C-terminal truncation of PEX3, were identified in the two patients, who both suffered from a severe Zellweger syndrome phenotype. One of the mutations involved a single-nucleotide insertion in exon 7, whereas the other was a single-nucleotide substitution eight nucleotides from the normal splice site in the 3' acceptor site of intron 10, Expression of wild-type PEX3 in the mutant cell lines restored peroxisomal biogenesis, whereas transfection of mutated PEX3 cDNA did not, This confirmed that the causative gene had been identified. The observation of peroxisomal formation in the absence of morphologically recognizable peroxisomal membranes challenges the theory that peroxisomes arise exclusively by growth and division from preexisting peroxisomes and establishes PEX3 as a key factor in early human peroxisome synthesis.	Univ Munich, Dr von Hauner Childrens Hosp, Mol Biol Lab, Munich, Germany; Womens & Childrens Hosp, Dept Chem Pathol, Adelaide, SA, Australia; SEQUENOM Inc, San Diego, CA USA	University of Munich; Womens & Childrens Hospital Australia; Sequenom	Roscher, AA (corresponding author), Lindwurmstr 4, D-80337 Munich, Germany.	Adelbert.Roscher@kk-i.med.uni-muenchen.de						ARIAS JA, 1985, J CELL BIOL, V100, P1789, DOI 10.1083/jcb.100.5.1789; Baerends RJS, 1996, J BIOL CHEM, V271, P8887, DOI 10.1074/jbc.271.15.8887; BELDJORD C, 1988, NUCLEIC ACIDS RES, V16, P4927, DOI 10.1093/nar/16.11.4927; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gotte K, 1998, MOL CELL BIOL, V18, P616; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Kammerer S, 1998, FEBS LETT, V429, P53, DOI 10.1016/S0014-5793(98)00557-2; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kunau WH, 1998, CURR BIOL, V8, pR299, DOI 10.1016/S0960-9822(98)70191-5; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; MUNTAU AC, 2000, BIOCHEM BIOPH RES CO, V268, P225; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; ROSCHER A, 1985, PEDIATR RES, V19, P930, DOI 10.1203/00006450-198509000-00013; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Shimozawa N, 1998, AM J HUM GENET, V63, P1898, DOI 10.1086/302142; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Subramani S, 1997, NAT GENET, V15, P331, DOI 10.1038/ng0497-331; Titorenko VI, 1998, TRENDS BIOCHEM SCI, V23, P231, DOI 10.1016/S0968-0004(98)01226-2; Wanders RJA, 1999, NEUROCHEM RES, V24, P565, DOI 10.1023/A:1022592014988	26	77	78	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					967	975		10.1086/303071	http://dx.doi.org/10.1086/303071			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10958759	Green Published, Bronze			2022-12-18	WOS:000089651100018
J	Kline, J; Kinney, A; Levin, B; Warburton, D				Kline, J; Kinney, A; Levin, B; Warburton, D			Trisomic pregnancy and earlier age at menopause	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOLLICLE-STIMULATING-HORMONE; MATERNAL AGE; LUTEINIZING-HORMONE; CHRONOLOGICAL AGE; REPRODUCTIVE AGE; WOMEN; NONDISJUNCTION; CONFIGURATIONS; CHROMOSOME-21; ESTRADIOL	We tested the hypothesis that the connection between advanced maternal age and autosomal trisomy reflects the diminution of the oocyte pool with age. Because menopause occurs when the number of oocytes falls below some threshold, our hypothesis is that menopause occurs at an earlier age among women with trisomic pregnancies than it does among women with chromosomally normal pregnancies. To determine their menstrual status, we interviewed women from our previous study of karyotyped spontaneous abortions who, in 1993, were age greater than or equal to 44 years. Pre-menopausal women completed interviews every 4-5 mo, until menopause or until the study ended in 1997. The primary analyses compare 111 women whose index pregnancy was a trisomic spontaneous abortion with two groups: women whose index pregnancy was a chromosomally normal loss (n = 157) and women whose index pregnancy was a chromosomally normal birth (n = 226). We used a parametric logistic survival analysis to compare median ages at menopause. The estimated median age at menopause was 0.96 years earlier (95% confidence interval -0.18 to 2.10) among women with trisomic losses than it was among women with chromosomally normal losses and chromosomally normal births combined. Results were unaltered by adjustment for education, ethnicity, and cigarette smoking. Our results support the hypothesis that trisomy risk is increased with decreased numbers of oocytes. Decreased numbers may indicate accelerated oocyte atresia or fewer oocytes formed during fetal development.	New York State Psychiat Inst & Hosp, Epidemiol Dev Brain Disorders Dept, Unit 53, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Res Fdn Mental Hyg, New York, NY 10032 USA; Columbia Univ, Gertrude H Sergievsky Ctr, Div Epidemiol, Joseph L Mailman Sch Publ Hlth, New York, NY 10027 USA; Columbia Univ, Gertrude H Sergievsky Ctr, Div Biostat, Joseph L Mailman Sch Publ Hlth, New York, NY 10027 USA; Columbia Univ, Grad Sch Arts & Sci, New York, NY 10027 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Columbia Univ, Dept Pediat, New York, NY 10027 USA	New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Kline, J (corresponding author), New York State Psychiat Inst & Hosp, Epidemiol Dev Brain Disorders Dept, Unit 53, 1051 Riverside Dr, New York, NY 10032 USA.	jkk3@columbia.edu			NIA NIH HHS [R01 AG015386, R01 AG 15386, R01 AG 10251] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015386, R01AG010251] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Battaglia DE, 1996, HUM REPROD, V11, P2217; BLOCK E, 1952, ACTA ANAT, V14, P108; BRAMBILLA DJ, 1989, J CLIN EPIDEMIOL, V42, P1031, DOI 10.1016/0895-4356(89)90044-9; BROOK JD, 1984, HUM GENET, V66, P41, DOI 10.1007/BF00275184; EichenlaubRitter U, 1996, ENVIRON MOL MUTAGEN, V28, P211, DOI 10.1002/(SICI)1098-2280(1996)28:3<211::AID-EM6>3.0.CO;2-G; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Freeman SB, 2000, AM J HUM GENET, V66, P1680, DOI 10.1086/302907; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; Klein NA, 1996, J CLIN ENDOCR METAB, V81, P2742, DOI 10.1210/jc.81.7.2742; KLINE J, 1995, AM J EPIDEMIOL, V141, P417, DOI 10.1093/oxfordjournals.aje.a117444; Kline J, 1992, Paediatr Perinat Epidemiol, V6, P225, DOI 10.1111/j.1365-3016.1992.tb00763.x; Kline J.S., 1989, CONCEPTION BIRTH EPI; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; LEE SJ, 1988, HUM REPROD, V3, P851, DOI 10.1093/oxfordjournals.humrep.a136796; LENTON EA, 1988, MATURITAS, V10, P35, DOI 10.1016/0378-5122(88)90129-6; MACMAHON B, 1966, US VITAL HLTH STAT 2, V19, P161; MACNAUGHTON J, 1992, CLIN ENDOCRINOL, V36, P339, DOI 10.1111/j.1365-2265.1992.tb01457.x; MCKINLAY SM, 1985, ANN INTERN MED, V103, P350, DOI 10.7326/0003-4819-103-3-350; METCALF MG, 1985, J ENDOCRINOL, V105, P357, DOI 10.1677/joe.0.1050357; OSTER J, 1953, MONGOLISM CLINICOGEN, P96; Peters H., 1980, OVARY; PHILLIPS OP, 1995, HUM GENET, V95, P117; Reuss ML, 1996, AM J OBSTET GYNECOL, V174, P624, DOI 10.1016/S0002-9378(96)70439-8; REYES FI, 1977, AM J OBSTET GYNECOL, V129, P557; RISCH N, 1986, AM J HUM GENET, V39, P68; SIGLER AT, 1967, J PEDIATR-US, V70, P608, DOI 10.1016/S0022-3476(67)80046-5; Smith A, 1955, BRIT J PREV SOC MED, V9, P89; Thomford P J, 1987, Reprod Toxicol, V1, P41, DOI 10.1016/0890-6238(87)90070-0; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154; WARBURTON D, 1986, PERINATAL GENETICS D, P23; [No title captured]	35	77	78	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					395	404		10.1086/303009	http://dx.doi.org/10.1086/303009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10873791	Bronze, Green Published			2022-12-18	WOS:000089357800015
J	Goring, HHH; Terwilliger, JD				Goring, HHH; Terwilliger, JD			Linkage analysis in the presence of errors III: Marker loci and their map as nuisance parameters	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIATION; HUMAN GENOME; GENETIC-MAP; DISEQUILIBRIUM; RECOMBINATION; SEX; CONSTRUCTION; INTERFERENCE; STRATEGIES; DISTANCE	In linkage and linkage disequilibrium (LD) analysis of complex multifactorial phenotypes, various types of errors can greatly reduce the chance of successful gene localization. The power of such studies-even in the absence of errors-is quite low, and, accordingly, their robustness to errors can be poor, especially in multipoint analysis. For this reason, it is important to deal with the ramifications of errors up front, as part of the analytical strategy. In this study, errors in the characterization of marker-locus parameters-including allele frequencies, haplotype frequencies (i.e., LD between marker loci), recombination fractions, and locus order-are dealt with through the use of profile likelihoods maximized over such nuisance parameters. It is shown that the common practice of assuming fixed, erroneous values for such parameters can reduce the power and/or increase the probability of obtaining false positive results in a study. The effects of errors in assumed parameter values are generally more severe when a larger number of less informative marker loci, like the highly-touted single nucleotide polymorphisms (SNPs), are analyzed jointly than when fewer but more informative marker loci, such as microsatellites, are used. Rather than fixing inaccurate values for these parameters a priori, we propose to treat them as nuisance parameters through the use of profile likelihoods. It is demonstrated that the power of linkage and/or LD analysis call be increased through application of this technique in situations where parameter values cannot be specified with a high degree of certainty.	Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; New York State Psychiat Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Terwilliger, JD (corresponding author), Columbia Univ, Dept Psychiat, 1150 St Nicholas Ave,Room 548,Unit 109, New York, NY 10032 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000008, K01HG000008] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG000008, HG00008] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AGARWALA R, IN PRESS DISCRETE AP; Ajioka RS, 1997, AM J HUM GENET, V60, P1439, DOI 10.1086/515466; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRAVARTI A, 1991, GENOMICS, V11, P219, DOI 10.1016/0888-7543(91)90123-V; CHASE GA, 1977, TRANSPLANT P, V9, P167; CHIN DC, 1992, IEEE T AERO ELEC SYS, V28, P884, DOI 10.1109/7.256310; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUPUIS J, 1995, GENETICS, V140, P843; EGUCHI S, 1991, ANN I STAT MATH, V43, P245, DOI 10.1007/BF00118634; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Goring HHH, 1997, AM J HUM GENET, V61, pA277; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; JORDE LB, 1994, AM J HUM GENET, V54, P884; KALBFLEI.JD, 1970, J ROY STAT SOC B, V32, P175; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; LALOUEL JM, 1979, 14 U HAW HON; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1983, AM J HUM GENET, V35, P241; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; MORTON NE, 1990, ANN HUM GENET, V54, P235, DOI 10.1111/j.1469-1809.1990.tb00381.x; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NORDHEIM EV, 1984, BIOMETRICS, V40, P785, DOI 10.2307/2530922; OTT J, 1992, AM J HUM GENET, V51, P283; Ott J, 1999, ANAL HUMAN GENETIC L; Pennisi E, 1998, SCIENCE, V281, P1787, DOI 10.1126/science.281.5384.1787; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Royall R.M., 1997, STAT EVIDENCE LIKELI; SALL T, 1989, GENETICS, V122, P935; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x; Smith HF, 1937, ANN EUGENIC, V8, P94, DOI 10.1111/j.1469-1809.1937.tb02163.x; TAI J J, 1989, Proceedings of the National Science Council Republic of China Part B Life Sciences, V13, P38; TANZI RE, 1992, AM J HUM GENET, V50, P551; Terwilliger JD, 1996, AM J HUM GENET, V58, P1095; TERWILLIGER JD, 1992, GENOMICS, V13, P951, DOI 10.1016/0888-7543(92)90006-E; Terwilliger JD, 2000, HUM BIOL, V72, P63; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1994, 4 WORKSH NORD GEN IN; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; TERWILLIGER JD, IN PRESS EUR J HUM G; TIENARI PJ, 1994, GENOMICS, V19, P320, DOI 10.1006/geno.1994.1064; WEEKS DE, 1991, AM J HUM GENET, V49, P372; Weinberg Wilhelm, 1908, JAHRESHEFTE VEREINS, V64, P368; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; [No title captured]	67	77	78	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1298	1309		10.1086/302846	http://dx.doi.org/10.1086/302846			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10731467	Green Published, Bronze			2022-12-18	WOS:000088373400013
J	Chapman, NH; Wijsman, EM				Chapman, NH; Wijsman, EM			Genome screens using linkage disequilibrium tests: Optimal marker characteristics and feasibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE ALLELES; GENETIC-LINKAGE; ASHKENAZI JEWS; DISEASE GENES; POPULATION; LOCI; POLYMORPHISMS; RESOLUTION; NEUROPATHY; LIKELIHOOD	Linkage disequilibrium (LD) testing has become a popular and effective method of fine-scale disease-gene localization. It has been proposed that LD testing could also be used for genome screening, particularly as dense maps of diallelic markers become available and automation allows inexpensive genotyping of diallelic markers. We compare diallelic markers and multiallelic markers in terms of sample sizes required for detection of LD, by use of a single marker locus in a case-control study, for rare monophyletic diseases with Mendelian inheritance. We extrapolate from our results to discuss the feasibility of single-marker LD screening in more-complex situations. We have used a deterministic population genetic model to calculate the expected power to detect LD as a function of marker density, age of mutation, number of marker alleles, mode-of inheritance of a rare disease, and sample size. Our calculations show that multiallelic markers always have more power to detect LD than do diallelic markers (under otherwise equivalent conditions) and that the ratio of the number of diallelic to the number of multiallelic markers needed for equivalent power increases with mutation age and complexity of mode of inheritance. Power equivalent to that achieved by a multiallelic screen can theoretically be achieved by use of a more dense diallelic screen, but mapping panels of the necessary resolution are not currently available and may be difficult to achieve. Genome screening that uses single-marker LD testing may therefore be feasible only for young (<20 generations), rare, monophyletic Mendelian diseases, such as may be found in rapidly growing genetic isolates.	Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chapman, NH (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.				NIA NIH HHS [AG 14382, AG 12019, AG11762] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG011762, R01AG012019, R01AG011762, P01AG014382] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARNHEIM N, 1991, ANIM GENET, V22, P105, DOI 10.1111/j.1365-2052.1991.tb00652.x; BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; BRISCOE D, 1994, J HERED, V85, P59; Brown PO, 1998, NAT GENET, V18, P91, DOI 10.1038/ng0298-91; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P982; Casaubon LK, 1996, AM J HUM GENET, V58, P28; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; ELLIS NA, 1994, AM J HUM GENET, V55, P453; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; Ewens W.J., 1979, MATH POPULATION GENE; Goddard KAB, 1996, AM J HUM GENET, V58, P1286; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; HOVATTA I, 1997, AM SOC HUM GEN ANN M; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Kaplan NL, 1997, AM J HUM GENET, V60, P691; MacCluer JW, 1997, GENET EPIDEMIOL, V14, P737, DOI 10.1002/(SICI)1098-2272(1997)14:6<737::AID-GEPI29>3.0.CO;2-Q; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; NICKERSON DA, 1992, GENOMICS, V12, P377, DOI 10.1016/0888-7543(92)90388-9; NORIO R, 1991, 8 INT C HUM GEN WASH; OLSON JM, 1994, AM J HUM GENET, V55, P574; Ott J, 1997, GENETICS, V147, P927; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shriver MD, 1997, AM J HUM GENET, V60, P957; SULISALO T, 1994, AM J HUM GENET, V55, P937; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Thompson EA, 1997, AM J HUM GENET, V60, P197; Varilo T, 1996, AM J HUM GENET, V58, P506; Votruba M, 1998, HUM GENET, V102, P79, DOI 10.1007/s004390050657; Votruba M, 1997, J MED GENET, V34, P117, DOI 10.1136/jmg.34.2.117; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEIR BS, 1978, GENETICS, V88, P633; WIJSMAN EM, 1997, HDB PSYCHIAT GENETIC, P7; Yuan B, 1997, AM J HUM GENET, V60, P459	44	77	81	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1872	1885		10.1086/302139	http://dx.doi.org/10.1086/302139			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837839	Bronze, Green Published			2022-12-18	WOS:000077707700032
J	Dahl, HHM				Dahl, HHM			Getting to the nucleus of mitochondrial disorders: Identification of respiratory chain-enzyme genes causing Leigh syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							C-OXIDASE DEFICIENCY; SACCHAROMYCES-CEREVISIAE; COMPLEX-I; DISEASE; MUTATION; FEATURES; COMMON		Royal Childrens Hosp, Murdoch Inst, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Dahl, HHM (corresponding author), Royal Childrens Hosp, Murdoch Inst, Flemington Rd, Parkville, Vic 3052, Australia.							Adams PL, 1997, ANN NEUROL, V41, P268, DOI 10.1002/ana.410410219; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brown RM, 1996, J INHERIT METAB DIS, V19, P752, DOI 10.1007/BF01799168; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chevallet M, 1997, EUR J BIOCHEM, V250, P451, DOI 10.1111/j.1432-1033.1997.0451a.x; DAHL HHM, 1995, AM J HUM GENET, V56, P553; DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S	19	77	77	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1594	1597		10.1086/302169	http://dx.doi.org/10.1086/302169			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837811	Bronze, Green Published			2022-12-18	WOS:000077707700004
J	Richards, M; Oppenheimer, S; Sykes, B				Richards, M; Oppenheimer, S; Sykes, B			MtDNA suggests Polynesian origins in eastern Indonesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL DNAS; POPULATIONS; PACIFIC		Univ Oxford, Inst Mol Med, Dept Cellular Sci, John Radcliffe Hosp, Oxford OX3 9DS, England	University of Oxford	Richards, M (corresponding author), Univ Oxford, Inst Mol Med, Dept Cellular Sci, John Radcliffe Hosp, Oxford OX3 9DS, England.			RICHARDS, MARTIN/0000-0003-3118-0967				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bellwood P., 1997, PREHISTORY INDO MALA, VRevised; BELLWOOD P, 1991, SCI AM, V265, P70; Berger JO., 1985, STAT DECISION THEORY; Bonatto SL, 1996, AM J HUM GENET, V59, P253; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; Forster P, 1996, AM J HUM GENET, V59, P935; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HEYERDAHL T, 1950, KONTIKI PACIFIC RAFT; Irwin G., 1992, PREHISTORIC EXPLORAT; Kolman CJ, 1996, GENETICS, V142, P1321; LUM JK, 1994, HUM BIOL, V66, P567; MEACHAM W, 1984, ASIAN PERSPECT, V26, P89; MELTON T, 1995, AM J HUM GENET, V57, P403; PIETRUSEWSKY M, 1997, INDOPACIFIC PREHISTO, V16, P119; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; SOLHEIM WG, 1994, PREHISTORY BEGINNING, V1, P468; SOODYALL H, 1995, NAT GENET, V10, P377, DOI 10.1038/ng0895-377; SYKES B, 1995, AM J HUM GENET, V57, P1463; Terrell J., 1986, PREHISTORY PACIFIC I	20	77	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1234	1236		10.1086/302043	http://dx.doi.org/10.1086/302043			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758601	Green Published, Bronze			2022-12-18	WOS:000076577800040
J	Howe, JR; Ringold, JC; Summers, RW; Mitros, FA; Nishimura, DY; Stone, EM				Howe, JR; Ringold, JC; Summers, RW; Mitros, FA; Nishimura, DY; Stone, EM			A gene for familial juvenile polyposis maps to chromosome 18q21.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLORECTAL-CANCER; CARCINOMA INSITU; LINKAGE ANALYSIS; DCC GENE; COLON; LOCALIZATION; ENCODES; RISK; DNA	Familial juvenile polyposis (FJP) is a hamartomatous polyposis syndrome in which affected family members develop upper and lower gastrointestinal juvenile polyps and are at increased risk for gastrointestinal cancer. A genetic locus for FJP has not yet been identified by linkage; therefore, the objective of this study was to perform a focused genome screen in a large family segregating FJP. No evidence for linkage was found with markers near MSH2, MLH1, MCC, APC, HMPS, CDLM2A, JP1, PTEN, KRAS2 TP53, or LKB1. Linkage to FJP was established with several markers from chromosome 18q21.1. The maximum LOD score was 5.00, with marker D18S1099 (recombination fraction of .001). Analysis of critical recombinants places the FJP gene in an 11.9-cM interval bounded by D18S1118 and D18S487, a region that also contains the tumor-suppressor genes DCC and DPC4. These data demonstrate localization of a gene for FJP to chromosome 18q21.1 by linkage, and they raise the possibility that either DCC or DPC4 could be responsible for FJP.	Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Howe, JR (corresponding author), Univ Iowa, Coll Med, Dept Surg, 200 Hawkins Dr, Iowa City, IA 52242 USA.	james-howe@uiowa.edu		Howe, James/0000-0001-5312-5972; Stone, Edwin M./0000-0003-3343-4414				BAPTIST SJ, 1985, HUM PATHOL, V16, P1061, DOI 10.1016/S0046-8177(85)80284-7; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BENTLEY E, 1989, AM J GASTROENTEROL, V84, P1456; BRACKWERNER R, 1989, GENOMICS, V4, P68, DOI 10.1016/0888-7543(89)90316-9; BURT RW, 1990, B WORLD HEALTH ORGAN, V68, P655; CHO KR, 1994, GENOMICS, V19, P525, DOI 10.1006/geno.1994.1102; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; GOODMAN ZD, 1979, CANCER, V43, P1906, DOI 10.1002/1097-0142(197905)43:5<1906::AID-CNCR2820430548>3.0.CO;2-O; GROTSKY HW, 1982, GASTROENTEROLOGY, V82, P494; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hahn SA, 1996, CANCER RES, V56, P490; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Jacoby RF, 1997, AM J MED GENET, V70, P361, DOI 10.1002/(SICI)1096-8628(19970627)70:4<361::AID-AJMG6>3.0.CO;2-W; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; JARVINEN H, 1984, GUT, V25, P792, DOI 10.1136/gut.25.7.792; Jass J, 1990, HEREDITARY COLORECTA, P343; JASS JR, 1988, HISTOPATHOLOGY, V13, P619; JONES MA, 1987, ARCH PATHOL LAB MED, V111, P200; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEGGETT BA, 1993, GASTROENTEROLOGY, V105, P1313, DOI 10.1016/0016-5085(93)90134-X; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LIU T-H, 1978, Chinese Medical Journal (English Edition), V4, P434; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Marsh DJ, 1997, CANCER RES, V57, P5017; Mehenni H, 1997, AM J HUM GENET, V61, P1327, DOI 10.1086/301644; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORSON BASIL C., 1962, DIS COLON AND RECTUM, V5, P337, DOI 10.1007/BF02616584; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; NICHOLS BE, 1993, COMPUT APPL BIOSCI, V9, P757; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; RAMASWAMY G, 1984, DIS COLON RECTUM, V27, P393, DOI 10.1007/BF02553009; RIGGINS GJ, 1997, NORMAL PTEN GENE JUV; RISINGER JI, 1992, HUM MOL GENET, V1, P657, DOI 10.1093/hmg/1.8.657-a; ROZEN P, 1982, CANCER, V49, P1500, DOI 10.1002/1097-0142(19820401)49:7<1500::AID-CNCR2820490732>3.0.CO;2-O; SACHATELLO CR, 1970, GASTROENTEROLOGY, V58, P699; SCOTTCONNER CE, 1995, J AM COLL SURGEONS, V181, P407; STEMPER TJ, 1975, ANN INTERN MED, V83, P639, DOI 10.7326/0003-4819-83-5-639; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Thomas HJW, 1996, AM J HUM GENET, V58, P770; VEALE A. M. O., 1966, J MED GENET, V3, P5, DOI 10.1136/jmg.3.1.5; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WALPOLE IR, 1989, AM J MED GENET, V32, P1, DOI 10.1002/ajmg.1320320102; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; WATANABE A, 1979, GASTROENTEROLOGY, V77, P148; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; YOSHIDA T, 1988, ENDOSCOPY, V20, P33, DOI 10.1055/s-2007-1018122	52	77	78	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1129	1136		10.1086/301840	http://dx.doi.org/10.1086/301840			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545410	Green Published, Bronze			2022-12-18	WOS:000073487000019
J	Macek, M; Mackova, A; Hamosh, A; Hilman, BC; Selden, RF; Lucotte, G; Friedman, KJ; Knowles, MR; Rosenstein, BJ; Cutting, GR				Macek, M; Mackova, A; Hamosh, A; Hilman, BC; Selden, RF; Lucotte, G; Friedman, KJ; Knowles, MR; Rosenstein, BJ; Cutting, GR			Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DONOR SPLICE-SITE; REGULATOR CFTR GENE; MESSENGER-RNA; NONSENSE MUTATIONS; MISSENSE MUTATION; EPITHELIAL-CELLS; POPULATION; PROTEIN; DNA; CHROMOSOMES	Cystic fibrosis (CF)-an autosomal recessive disorder caused by mutations in CF transmembrane conductance regulator (CFTR) and characterized by abnormal chloride conduction across epithelial membranes, leading to chronic lung and exocrine pancreatic disease-is less common in African-Americans than in Caucasians. No large-scale studies of mutation identification and screening in African-American CF patients have been reported, to date. In this study, the entire coding and flanking intronic sequence of the CFTR gene was analyzed by denaturing gradient-gel electrophoresis and sequencing in an index group of 82 African-American CF chromosomes to identify mutations. One novel mutation, 312O+1G-->A, occurred with a frequency of 12.3% and was also detected in a native African patient. To establish frequencies, an additional group of 66 African-American CF chromosomes were screened for mutations identified in two or more African-American patients. Screening for 16 ''common Caucasian'' mutations identified 52% of CF alleles in African-Americans, while screening for 8 ''common African'' mutations accounted for an additional 23%. The combined detection rate of 75% was comparable to the sensitivity of mutation analysis in Caucasian CF patients. These results indicate that African-Americans have their own set of ''common'' CF mutations that originate from the native African population. Inclusion of these ''common'' mutations substantially improves CF mutation detection rates in African-Americans.	JOHNS HOPKINS UNIV,SCH MED,CTR GENET MED,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21287; UNIV HOSP MOTOL,DEPT MED GENET 2,PRAGUE,CZECH REPUBLIC; LOUISIANA STATE UNIV,CYST FIBROSIS CTR,SHREVEPORT,LA 71105; UNIV VIRGINIA,HLTH SCI CTR,DEPT PEDIAT,CHARLOTTESVILLE,VA; MAISON BLANCHE HOSP,REG CTR NEUROGENET,REIMS,FRANCE; UNIV N CAROLINA,DEPT MED,DIV PULM DIS,CHAPEL HILL,NC; UNIV N CAROLINA,DEPT PATHOL,CURRICULUM GENET,CHAPEL HILL,NC	Johns Hopkins University; Johns Hopkins University; Motol University Hospital; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Virginia; CHU de Reims; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NIDDK NIH HHS [DK 44003, K08 DK0215] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044003, R37DK044003] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894; Carles S, 1996, J MED GENET, V33, P802, DOI 10.1136/jmg.33.9.802; CHILLON M, 1995, AM J HUM GENET, V56, P623; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1989, AM J HUM GENET, V44, P307; CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; CUTTING GR, 1997, EMERY RIMONS PRINCIP, V2, P26585; *CYST FIBR GEN AN, 1994, HUM MUTAT, V4, P167; DEMAY G, 1984, ARCH FR PEDIATR, V41, P369; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; FRIEDMAN KJ, 1991, CLIN CHEM, V37, P753; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HAMOSH A, IN PRESS J PEDIAT; KAWASAKI E, 1993, METHOD ENZYMOL, V218, P369; KRAWCZAK M, 1992, HUM GENET, V90, P41; Levin S E, 1967, S Afr Med J, V41, P482; Macek M, 1997, HUM MUTAT, V9, P136, DOI 10.1002/(SICI)1098-1004(1997)9:2<136::AID-HUMU6>3.3.CO;2-M; MERCIER B, 1993, HUM MUTAT, V2, P16, DOI 10.1002/humu.1380020104; MERTES G, 1994, GENOMICS, V24, P190, DOI 10.1006/geno.1994.1602; MONTELL C, 1984, NUCLEIC ACIDS RES, V12, P3821, DOI 10.1093/nar/12.9.3821; OBER C, 1992, AM J HUM GENET, V51, P1344; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PHILLIPS OP, 1995, J NATL MED ASSOC, V87, P433; REISS J, 1991, HUM GENET, V87, P457; ROMEY MC, 1995, HUM MUTAT, V6, P190, DOI 10.1002/humu.1380060216; SMIT LS, 1995, HUM MOL GENET, V4, P269, DOI 10.1093/hmg/4.2.269; SMIT LS, 1993, HUM MUTAT, V2, P148, DOI 10.1002/humu.1380020217; WANG CI, 1968, NEW ENGL J MED, V279, P1216, DOI 10.1056/NEJM196811282792209; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; WHITE MB, 1991, GENOMICS, V10, P266, DOI 10.1016/0888-7543(91)90510-L; WILL K, 1995, HUM MUTAT, V5, P210, DOI 10.1002/humu.1380050305; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	35	77	77	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1122	1127						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150159				2022-12-18	WOS:A1997WX76000012
J	Vance, JM; Jonasson, F; Lennon, F; Sarrica, J; Damji, KF; Stauffer, J; PericakVance, MA; Klintworth, GK				Vance, JM; Jonasson, F; Lennon, F; Sarrica, J; Damji, KF; Stauffer, J; PericakVance, MA; Klintworth, GK			Linkage of a gene for macular corneal dystrophy to chromosome 16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KERATAN SULFATE; BLOOD; PROTEOGLYCAN	Autosomal recessive macular corneal dystrophy (MCD) is a heterogeneous disorder leading to visual impairment. Sixteen American and Icelandic families (11 type I and 5 type II) were analyzed for linkage, by use of 208 polymorphic microsatellite markers. A significant maximum LOD score (Z(max)) of 7.82 at a maximum recombination fraction (theta(max)) of .06 was found with the 16q22 locus D16S518 for MCD type I. In addition, a peak LOD score of 2.50 at a recombination fraction of .00 was obtained for the MCD type II families, by use of the identical marker. These findings raise the possibility that MCD type II may be due to the same genetic locus that is involved in MCD type I.	DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT OPHTHALMOL,DURHAM,NC 27710; UNIV ICELAND,LANDAKOT HOSP,DEPT OPHTHALMOL,IS-101 REYKJAVIK,ICELAND	Duke University; Duke University; Duke University; Landspitali National University Hospital; University of Iceland	Vance, JM (corresponding author), DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,POB 2900,DURHAM,NC 27710, USA.		Jonasson, Fridbert/ABA-9889-2021	Vance, Jeffery/0000-0003-3815-8199	NEI NIH HHS [P30-EY05722, EY08249, EY00146] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008249, P30EY005722] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BJARNASO.O, 1973, ANN HUM GENET, V36, P425, DOI 10.1111/j.1469-1809.1973.tb00606.x; CATERSON B, 1983, J BIOL CHEM, V258, P8848; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; DUKEELDER S, 1965, DIS OUTER EYE 2, V8; Eiberg Hans, 1994, European Journal of Human Genetics, V2, P132; GREGORY CY, 1995, J MED GENET, V32, P224, DOI 10.1136/jmg.32.3.224; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASSELL J, 1985, HEREDITY VISUAL DEV, P101; Haynes C., 1995, American Journal of Human Genetics, V57, pA193; JONASSON F, 1989, EYE, V3, P446, DOI 10.1038/eye.1989.66; KLINTWORTH GK, 1986, OPHTHALMIC PAED GEN, V7, P139, DOI 10.3109/13816818609004130; Klintworth Gordon K., 1994, P855; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MIDURA RJ, 1990, J BIOL CHEM, V265, P15947; NAKAZAWA K, 1984, J BIOL CHEM, V259, P3751; OSHIMA E, 1995, INVEST OPHTH VIS SCI, V36, pS1028; Othmane Kamel Ben, 1992, Nature Genetics, V2, P315; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Ott J., 1991, ANAL HUMAN GENETIC L; OTT J, 1985, ANAL HUMAN GENETIC L; SANTO RM, 1995, OPHTHALMOLOGY, V102, P557, DOI 10.1016/S0161-6420(95)30982-7; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47; THONAR EJM, 1986, AM J OPHTHALMOL, V102, P561, DOI 10.1016/0002-9394(86)90525-8; THONAR EJMA, 1985, ARTHRITIS RHEUM, V28, P1367, DOI 10.1002/art.1780281209; YANG CJ, 1988, AM J OPHTHALMOL, V106, P65, DOI 10.1016/S0002-9394(14)76390-1	26	77	79	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					757	762						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644739				2022-12-18	WOS:A1996UA38000013
J	Bykowsky, MJ; Haire, RN; Ohta, Y; Tang, HY; Sung, SSJ; Veksler, ES; Greene, JM; Fu, SM; Litman, GW; Sullivan, KE				Bykowsky, MJ; Haire, RN; Ohta, Y; Tang, HY; Sung, SSJ; Veksler, ES; Greene, JM; Fu, SM; Litman, GW; Sullivan, KE			Discordant phenotype in siblings with X-linked agammaglobulinemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENCY; LYMPHOCYTES; MONOCYTES	X-linked agammaglobulinemia (XLA) is a congenital humoral immunodeficiency caused by a defect in a B-cell-specific signaling molecule, Btk. There has been little concordance of phenotype with genotype in this disorder, and defects in Btk cause immunodeficiencies that range from mild impairment to complete inability to produce antibodies. The factors modifying the phenotype of XLA are not understood. The current study is the first description of two male siblings with identical T-134-->C mutations in the translation initiation ATG of Btk who have different clinical phenotypes as well as different laboratory phenotypes. The proband lacks immunoglobulins and B cells and has recurrent infections, while the elder, affected brother has normal levels of IgG and IgM and very few infections. Both have undetectable levels of Btk kinase activity in circulating mononuclear cells. Complete sequencing of Btk gene transcripts in both brothers revealed no additional mutations to account for the discordant phenotypes. This description provides unequivocal evidence that the phenotype of XLA is influenced by factors additional to the Btk gene.	CHILDRENS HOSP,DEPT PEDIAT,DIV ALLERGY IMMUNOL & INFECT DIS,PHILADELPHIA,PA 19104; UNIV S FLORIDA,COLL MED,DEPT PEDIAT,ST PETERSBURG,FL 33701; UNIV VIRGINIA,HLTH SCI CTR,DEPT INTERNAL MED,CHARLOTTESVILLE,VA 22903	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; State University System of Florida; University of South Florida; University of Virginia				Sullivan, Kathleen/0000-0003-4018-1646; Fu, Shu Man/0000-0001-5158-3494	NCI NIH HHS [R01-CA34546] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034546] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; BRUTON OC, 1952, PEDIATRICS, V9, P722; BUCKLEY RH, 1968, PEDIATR RES, V2, P72, DOI 10.1203/00006450-196803000-00002; CHENG C, 1994, P NATL ACAD SCI USA, V91, P8152; CONLEY ME, 1994, HUM MOL GENET, V3, P1751, DOI 10.1093/hmg/3.10.1751; DEAN M, 1994, HUM GENET, V93, P364; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; GOLDBLUM RM, 1974, J PEDIATR-US, V85, P188, DOI 10.1016/S0022-3476(74)80390-2; GREY HM, 1971, J CLIN INVEST, V50, P2368, DOI 10.1172/JCI106735; GUIOLI S, 1989, HUM GENET, V84, P19, DOI 10.1007/BF00210664; HAIRE RN, 1994, HUM MOL GENET, V3, P897, DOI 10.1093/hmg/3.6.897; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; KORNFELD SJ, 1995, J ALLERGY CLIN IMMUN, V95, P915, DOI 10.1016/S0091-6749(95)70138-9; KORNFELD SJ, 1994, NEW ENGL J MED, V331, P949; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KWAN SP, 1986, J CLIN INVEST, V77, P649, DOI 10.1172/JCI112351; LEDERMAN HM, 1985, MEDICINE, V64, P145, DOI 10.1097/00005792-198505000-00001; LEICKLEY FE, 1986, CLIN EXP IMMUNOL, V65, P90; MENSINK EJBM, 1986, EUR J IMMUNOL, V16, P963, DOI 10.1002/eji.1830160815; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; OHTA Y, 1994, P NATL ACAD SCI USA, V91, P9062, DOI 10.1073/pnas.91.19.9062; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PEARL ER, 1978, J IMMUNOL, V120, P1169; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SAFFRAN DC, 1994, NEW ENGL J MED, V330, P1488, DOI 10.1056/NEJM199405263302104; SMITH CIE, 1994, S IMMUNOLOGY, V3, P61; SUNG SSJ, 1992, J EXP MED, V176, P897, DOI 10.1084/jem.176.3.897; THIELE DL, 1986, J IMMUNOL, V136, P1038; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIBINEN M, 1995, IMMUNOL TODAY, V16, P460; WEDGWOOD RJ, 1980, INSERM S, V16, P69; WILFERT CM, 1977, NEW ENGL J MED, V296, P1485, DOI 10.1056/NEJM197706302962601; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	39	77	78	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					477	483						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644706				2022-12-18	WOS:A1996TV56400005
J	ZATZ, M; MARIE, SK; PASSOSBUENO, MR; VAINZOF, M; CAMPIOTTO, S; CERQUEIRA, A; WIJMENGA, C; PADBERG, G; FRANTS, R				ZATZ, M; MARIE, SK; PASSOSBUENO, MR; VAINZOF, M; CAMPIOTTO, S; CERQUEIRA, A; WIJMENGA, C; PADBERG, G; FRANTS, R			HIGH PROPORTION OF NEW MUTATIONS AND POSSIBLE ANTICIPATION IN BRAZILIAN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 4Q35-QTER; MYOTONIC-DYSTROPHY; GERMINAL MOSAICISM; DNA REARRANGEMENTS; RECURRENCE RISK; CAG REPEAT; GENE; DISEASE	A gene responsible for facioscapulohumeral muscular dystrophy (FSHD) has been localized at 4q35. Subsequently, it was found that probe p13E-11 detects a polymorphic EcoRI fragment, usually >28 kb, in normal individuals, whereas in sporadic and familial FSHD cases, an EcoRI fragment, usually <28 kb, was found. Although these findings have been amply confirmed, several aspects are as yet either controversial or unsolved. In the present investigation, 34 Brazilian FSHD families were studied at the clinical and the molecular level for the following purposes: to assess the frequency of new mutations and their effect on estimates of biological fitness, to characterize FSHD-associated EcoRI fragments detected with probe p13E-11 in familial-as compared with isolated-FSHD cases, and to assess whether anticipation occurs in multigenerational families. Results from our study suggest that new mutations are apparently frequent for FSHD and may account for at least one-third of the cases, that somatic mosaicism may not be rare, and that biological fitness appeared to be reduced in FSHD, ranging from 0.6 to 0.82 by different estimates, with no difference in sexes. Interestingly, the size of the new EcoRI fragment is apparently smaller in more severely affected isolated patients. Moreover, the age at onset of clinical signs, as well as the age at ascertainment, in patients from multigenerational families suggests that anticipation occurs for FSHD in the majority of the families.	UNIV SAO PAULO, FAC MED, DEPT NEUROL, SAO PAULO, BRAZIL; UNIV NIJMEGEN HOSP, DEPT NEUROL, 6500 HB NIJMEGEN, NETHERLANDS; LEIDEN UNIV, DEPT HUMAN GENET, 2300 RA LEIDEN, NETHERLANDS	Universidade de Sao Paulo; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC	ZATZ, M (corresponding author), UNIV SAO PAULO, INST BIOCIENCIAS, DEPT BIOL, CTR MIOPATIAS, RUA MATAO 277, BR-05508900 SAO PAULO, BRAZIL.		Vainzof, Mariz/Q-4787-2019; Marie, Suely Kazue Nagahashi/D-1870-2012; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019; Zatz, Mayana/M-5338-2015; Vainzof, Mariz/J-7150-2012; Padberg, G.W.A.M./H-8079-2014; Passos-Bueno, Maria Rita/I-6796-2016	Vainzof, Mariz/0000-0002-2797-0782; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Wijmenga, Cisca/0000-0002-5635-1614; Zatz, Mayana/0000-0003-3970-8025; Vainzof, Mariz/0000-0002-2797-0782; Passos-Bueno, Maria Rita/0000-0002-9248-3008				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BAKKER E, IN PRESS MUSCLE NERV; BROCKERVRIENDS AHJT, 1990, HUM GENET, V85, P288; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; EGGERS S, 1993, J MED GENET, V30, P589, DOI 10.1136/jmg.30.7.589; EMERY AEH, 1976, METHODOLOGY MED GENE; GILBERT JR, 1993, AM J HUM GENET, V53, P401; GRIGGS RC, 1993, NEUROLOGY, V43, P2369, DOI 10.1212/WNL.43.11.2369; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Iqbal Z., 1992, American Journal of Human Genetics, V51, pA191; LUNT PW, 1989, J MED GENET, V26, P535, DOI 10.1136/jmg.26.8.535; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; MADDALENA A, 1987, American Journal of Human Genetics, V41, pA227; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORTON NE, 1959, AM J HUM GENET, V11, P360; MUNSAT TL, 1986, MYOLOGY BASIC CLIN, P1251; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; Padberg GW, 1982, FACIOSCAPULOHUMERAL; PASSOEBUENO MR, 1993, HUM MOL GENET, V2, P57; PASSOSBUENO MR, 1990, J MED GENET, V27, P727, DOI 10.1136/jmg.27.11.727; PASSOSBUENO MR, 1990, J MED GENET, V27, P145, DOI 10.1136/jmg.27.3.145; PASSOSBUENO MR, 1992, AM J HUM GENET, V51, P1150; PENROSE LS, 1948, ANN EUGENIC, V14, P125; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; TANAKA K, 1974, JPN J HUM GENET, V19, P195; THOMPSON MW, 1986, MYOLOGY, P1151; UPADHYAYA M, 1993, HUM MOL GENET, V2, P981, DOI 10.1093/hmg/2.7.981; VANDEUTEKOM JCT, IN PRESS HUM MOL GEN; WEIFFENBACH B, 1993, NAT GENET, V4, P165, DOI 10.1038/ng0693-165; WIJMENGA C, 1993, NEUROMUSCULAR DISORD, V3, P487, DOI 10.1016/0960-8966(93)90102-P; WIJMENGA C, 1992, AM J HUM GENET, V51, P411; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1994, GENOMICS, V19, P21, DOI 10.1006/geno.1994.1006; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323	41	77	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					99	105						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825608				2022-12-18	WOS:A1995QC10100013
J	MIGEON, BR; LUO, SY; JANI, M; JEPPESEN, P				MIGEON, BR; LUO, SY; JANI, M; JEPPESEN, P			THE SEVERE PHENOTYPE OF FEMALES WITH TINY RING X-CHROMOSOMES IS ASSOCIATED WITH INABILITY OF THESE CHROMOSOMES TO UNDERGO X-INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HISTONE-H4 ACETYLATION; MENTAL-RETARDATION; TURNER SYNDROME; GENE; EXPRESSION; MARKER; MOUSE; RNA; TRANSCRIPTION; CONSERVATION	Mental retardation and a constellation of congenital malformations not usually associated with Turner syndrome are seen in some females with a mosaic 45,X/46,X,r(X) karyotype. Studies of these females show that the XIST locus on their tiny ring X chromosomes is either not present or not expressed. As XIST transcription is well correlated with inactivation of the X chromosome in female somatic cells and spermatogonia, nonexpression of the locus even when it is present suggests that these chromosomes are transcriptionally active. We examined the transcriptional activity of ring X chromosomes lacking XIST expression (XISTE(-)), from three females with severe phenotypes. The two tiny ring X chromosomes studied with an antibody specific for the acetylated isoforms of histone H4 marking transcribed chromatin domains were labeled at a level consistent with their being active. We also examined two of the XISTE(-) ring chromosomes to determine whether genes that are normally silent on an inactive X are expressed from these chromosomes. Analyses of hybrid cells show that TIMP, ZXDA, and ZXDB loci on the proximal short arm, and AR and PHKA1 loci on the long arm, are well expressed from the tiny ring X chromosome lacking XIST DNA. Studies of the ring chromosome that has XIST DNA but does not transcribe it show that its AR allele is transcribed along with the one on the normal X allele. These findings provide compelling evidence that (1) ring X chromosomes associated with severe phenotypes are unable to undergo X chromosome inactivation; (2) they represent chromosomal mutations affecting cis inactivation; and (3) the severe phenotype is due to functional disomy resulting from lack of dosage compensation for genes present within the ring chromosome.	JOHNS HOPKINS UNIV,CTR GENET MED,BALTIMORE,MD; JOHNS HOPKINS UNIV,DEPT PEDIAT,BALTIMORE,MD 21218; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH,MIDLOTHIAN,SCOTLAND	Johns Hopkins University; Johns Hopkins University; University of Edinburgh					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029044] Funding Source: NIH RePORTER; NICHD NIH HHS [HD05465, HD29044] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DENNIS NR, 1993, J MED GENET, V30, P482, DOI 10.1136/jmg.30.6.482; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FILIPPI M, 1990, GENOMICS, V7, P453, DOI 10.1016/0888-7543(90)90184-V; FRASER NJ, 1987, NUCLEIC ACIDS RES, V15, P9616, DOI 10.1093/nar/15.22.9616; GREIG GM, 1993, HUM MOL GENET, V2, P1611; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KUSNICK T, 1987, AM J MED GENET, V28, P567; LAFRENIERE RG, 1993, HUM MOL GENET, V2, P1105, DOI 10.1093/hmg/2.8.1105; LINDGREN V, 1992, HUM GENET, V88, P393, DOI 10.1007/BF00215672; LYON MF, 1972, BIOL REV, V47, P1; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; MIGEON BR, 1993, P NATL ACAD SCI USA, V90, P12025, DOI 10.1073/pnas.90.24.12025; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; SALIDO EC, 1992, NAT GENET, V2, P196, DOI 10.1038/ng1192-196; SCHMUCKER B, 1993, AM J HUM GENET, V53, P600; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; VANDYKE DL, 1992, AM J MED GENET, V43, P996, DOI 10.1002/ajmg.1320430617; VANDYKE DL, 1991, J PEDIATR-US, V118, P415, DOI 10.1016/S0022-3476(05)82159-6; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WARREN AC, 1992, GENOMICS, V14, P818, DOI 10.1016/S0888-7543(05)80198-3; WOLFF DJ, 1993, AM J HUM GENET, V53, P225	31	77	79	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					497	504						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079992				2022-12-18	WOS:A1994PF50900011
J	TITUSTRACHTENBERG, EA; RICKARDS, O; DESTEFANO, GF; ERLICH, HA				TITUSTRACHTENBERG, EA; RICKARDS, O; DESTEFANO, GF; ERLICH, HA			ANALYSIS OF HLA CLASS-II HAPLOTYPES IN THE CAYAPA INDIANS OF ECUADOR - A NOVEL DRB-I ALLELE REVEALS EVIDENCE FOR CONVERGENT EVOLUTION AND BALANCING SELECTION AT POSITION-86	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONRADIOACTIVE OLIGONUCLEOTIDE PROBES; AMPLIFIED DNA; CHAIN-REACTION; B ALLELES; POLYMORPHISM; POLYMERASE; AMERICANS; SEQUENCES; REGION; MHC	PCR amplification, oligonucleotide probe typing, and sequencing were used to analyze the HLA class II loci (DRB1, DQA1, DQB1, and DPB1) of an isolated South Amerindian tribe. Here we report HLA class II variation, including the identification of a new DRB1 allele, several novel DR/DQ haplotypes, and an unusual distribution of DPB1 alleles, among the Cayapa Indians (N=100) of Ecuador. A general reduction of HLA class II allelic variation in the Cayapa is consistent with a population bottleneck during the colonization of the Americas. The new Cayapa DRB1 allele, DRB1*08042, which arose by a G-->T point mutation in the parental DRB1*0802, contains a novel Val codon (GTT) at position 86. The generation of DRB1*08042 (Val-86) from DRB1*0802 (Gly-86) in the Cayapa, by a different mechanism than the (GT-->TG) change in the creation of DRB1*08041 (Val-86) from DRB1*0802 in Africa, implicates selection in the convergent evolution of position 86 DR beta variants. The DRB1*08042 allele has not been found in >1,800 Amerindian haplotypes and thus presumably arose after the Cayapa separated from other South American Amerindians. Selection pressure for increased haplotype diversity can be inferred in the generation and maintenance of three new DRB1*08042 haplotypes and several novel DR/DQ haplotypes in this population. The DPB1 allelic distribution in the Cayapa is also extraordinary, with two alleles, DPB1*1401, a very rare allele in North American Amerindian populations, and DPB1*0402, the most common Amerindian DPB1 allele, constituting 83% of the Cayapa DPB1. These data are consistent with the postulated rapid rate of evolution as noted for the class I HLA-B locus of other South American Indians.	UNIV ROMA TOR VERGATA,DIPARTIMENTO BIOL,I-00173 ROME,ITALY	University of Rome Tor Vergata	TITUSTRACHTENBERG, EA (corresponding author), ROCHE MOLEC SYST,DEPT HUMAN GENET,1145 ATLANTIC AVE,ALAMEDA,CA 94618, USA.		Rickards, Olga/L-7878-2015	Rickards, Olga/0000-0003-2880-7466	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047170] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47170-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		APPLE RJ, 1992, TISSUE ANTIGENS, V40, P69, DOI 10.1111/j.1399-0039.1992.tb01962.x; Barriga Lopez F, 1987, CAYAPAS CHIACHIS, V4; Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231; CERNA M, 1993, HUM IMMUNOL, V37, P213, DOI 10.1016/0198-8859(93)90504-T; EBERLE M, 1992, HUM IMMUNOL, V34, P24, DOI 10.1016/0198-8859(92)90081-W; ERLICH HA, 1991, IMMUNOL TODAY, V12, P411, DOI 10.1016/0167-5699(91)90143-H; ERLICH HA, 1991, HUM IMMUNOL, V30, P110, DOI 10.1016/0198-8859(91)90079-O; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HOWARD J, 1992, NATURE, V357, P284, DOI 10.1038/357284a0; IMANISHI T, 1992, HLA 1991, V1065, P92; KLEIN J, 1991, MOL EVOLUTION MAJOR, P261; KLEIN J, 1993, SCI AM           DEC, P78; MARSH SGE, 1991, IMMUNOGENETICS, V33, P321, DOI 10.1007/BF00216691; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOONSAMY PV, 1992, TISSUE ANTIGENS, V40, P153, DOI 10.1111/j.1399-0039.1992.tb02039.x; MOONSAMY PV, IN PRESS TISSUE ANTI; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEI M, 1991, EVOLUTION OF LIFE, P415; RICKARDS O, 1994, HUM BIOL, V66, P299; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SALZANO FM, 1988, SO AM INDIANS CASE S; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCACCHI R, 1994, ANN HUM BIOL, V21, P67, DOI 10.1080/03014469400003082; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; VERRECK FAW, 1993, EUR J IMMUNOL, V23, P1346, DOI 10.1002/eji.1830230624; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102	34	77	77	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					160	167						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023844				2022-12-18	WOS:A1994NW46100022
J	ELSAS, LJ; DEMBURE, PP; LANGLEY, S; PAULK, EM; HJELM, LN; FRIDOVICHKEIL, J				ELSAS, LJ; DEMBURE, PP; LANGLEY, S; PAULK, EM; HJELM, LN; FRIDOVICHKEIL, J			A COMMON MUTATION ASSOCIATED WITH THE DUARTE GALACTOSEMIA ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE; URIDYLYLTRANSFERASE; URIDYLTRANSFERASE; GENE; MANITOBA; VARIANT	The human cDNA and gene for galactose-1-phosphate uridyl transferase (GALT) have been cloned and sequenced. A prevalent mutation (Q188R) is known to cause classic galactosemia (G/G). G/G galactosemia has an incidence of 1/38,886 in 1,396,766 Georgia live-born infants, but a more common variant of galactosemia, Duarte, has an unknown incidence. The proposed Duarte biochemical phenotypes of GALT are as follows: D/N, D/D, and D/G, which have similar to 75%, 50%, and 25% of normal GALT activity, respectively. In addition, the D allele has isoforms of its enzyme that have more acidic pI than normal. Here we systematically determine (a) the prevalence of an A-to-G transition at base pair 2744 of exon 10 in the GALT gene, a transition that produces a codon change converting asparagine to aspartic acid at position 314 (N314D), and (b) the association of this mutation with the Duarte biochemical phenotype. The 2744G nucleotide change adds an AvaII (SinI) cut site, which was identified in PCR-amplified DNA. In 111 biochemically unphenotyped controls with no history of galactosemia, 13 N314D alleles were identified (prevalence 5.9%). In a prospective study, 40 D alleles were biochemically phenotyped, and 40 N314D alleles were found. By contrast, in 36 individuals known not to have the Duarte biochemical phenotype, no N314D alleles were found. We conclude that the N314D mutation is a common allele that probably causes the Duarte GALT biochemical phenotype and occurs in a predominantly Caucasian, nongalactosemic population, with a prevalence of 5.9%.			ELSAS, LJ (corresponding author), EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,2040 RIDGEWOOD DR,ATLANTA,GA 30322, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD029847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046403] Funding Source: NIH RePORTER; NICHD NIH HHS [NICHD PO-1 HD29847-0] Funding Source: Medline; NIDDK NIH HHS [NIDDK-1R29DK46403-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN MW, 1984, HUM GENET, V65, P287, DOI 10.1007/BF00286519; BEUTLER E, 1965, LANCET, V1, P353; BEUTLER E, 1973, ISRAEL J MED SCI, V9, P1323; BEUTLER E, 1966, J LAB CLIN MED, V64, P646; DONNELL GN, 1961, J PEDIATR-US, V58, P836, DOI 10.1016/S0022-3476(61)80139-X; Elsas LJ, 1993, INT PEDIATR, V8, P101; FLACH JE, 1990, MOL BIOL MED, V7, P365; FOX JG, 1987, CAN MED ASSOC J, V137, P883; FREY PA, 1982, METHOD ENZYMOL, V87, P20; FRIDOVICHKEIL JL, 1993, P NATL ACAD SCI USA, V90, P398, DOI 10.1073/pnas.90.2.398; GITZELMANN R, 1980, NEONATAL SCREENING I, P67; GREENBERG CR, 1989, PEDIATRICS, V84, P331; Henry R.J., 1964, CLIN CHEM PRINCIPLES; IBARRA B, 1979, HUM GENET, V48, P121, DOI 10.1007/BF00273284; KAUFMAN FR, 1981, NEW ENGL J MED, V304, P994, DOI 10.1056/NEJM198104233041702; KELLEY RI, 1983, HUM GENET, V63, P274; KELLEY RI, 1989, J LAB CLIN MED, V114, P152; KOMROWER GM, 1970, ARCH DIS CHILD, V45, P367, DOI 10.1136/adc.45.241.367; KUHNL P, 1974, HUMANGENETIK, V24, P227; LEE JES, 1982, CLIN CHIM ACTA, V124, P351, DOI 10.1016/0009-8981(82)90429-6; LELOIR LF, 1957, ARCH BIOCHEM BIOPHYS, V33, P186; LESLIE ND, 1992, GENOMICS, V14, P474, DOI 10.1016/S0888-7543(05)80244-7; MELLMAN WJ, 1965, J LAB CLIN MED, V66, P980; MELLMAN WJ, 1968, ANN HUM GENET, V32, P1, DOI 10.1111/j.1469-1809.1968.tb00043.x; NG WG, 1967, CLIN CHIM ACTA, V15, P489, DOI 10.1016/0009-8981(67)90014-9; NG WG, 1973, ANN HUM GENET, V37, P1, DOI 10.1111/j.1469-1809.1973.tb01808.x; REICHARDT JKV, 1988, MOL BIOL MED, V5, P107; REICHARDT JKV, 1991, AM J HUM GENET, V49, P860; REICHARDT JKV, 1991, P NATL ACAD SCI USA, V88, P2633, DOI 10.1073/pnas.88.7.2633; REICHARDT JKV, 1993, AM J HUM GENET, V53, P943; Segal S, 1989, METABOLIC BASIS INHE, P453; SHIN YS, 1987, CLIN CHIM ACTA, V166, P27, DOI 10.1016/0009-8981(87)90191-4; SPARKES MC, 1987, HUM GENET, V40, P93; TEDESCO TA, 1972, J BIOL CHEM, V247, P6631; WAGGONER DD, 1990, J INHERIT METAB DIS, V13, P802, DOI 10.1007/BF01800204; WAISBREN SE, 1983, J PEDIATR-US, V102, P75, DOI 10.1016/S0022-3476(83)80292-3	36	77	80	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1030	1036						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198125				2022-12-18	WOS:A1994NP05300011
J	CHENEVIXTRENCH, G; WICKING, C; BERKMAN, J; SHARPE, H; HOCKEY, A; HAAN, E; OLEY, C; RAVINE, D; TURNER, A; GOLDGAR, D; SEARLE, J; WAINWRIGHT, B				CHENEVIXTRENCH, G; WICKING, C; BERKMAN, J; SHARPE, H; HOCKEY, A; HAAN, E; OLEY, C; RAVINE, D; TURNER, A; GOLDGAR, D; SEARLE, J; WAINWRIGHT, B			FURTHER LOCALIZATION OF THE GENE FOR NEVOID BASAL-CELL CARCINOMA SYNDROME (NBCCS) IN 15 AUSTRALASIAN FAMILIES - LINKAGE AND LOSS OF HETEROZYGOSITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; GORLIN SYNDROME; LOCUS; CHROMOSOME-9; D9S12	Nevoid basal cell carcinoma syndrome (NBCCS; basal cell nevus syndrome or Gorlin syndrome) is a cancer-predisposition syndrome characterized by multiple basal cell carcinomas (BCCs) and diverse developmental defects. The gene for NBCCS has been mapped to 9q23.1-q31 in North American and European families. In addition, loss of heterozygosity (LOH) for genetic markers in this region has been detected in sporadic BCCs, indicating that the NBCCS gene is probably a tumor-suppressor gene. In this study we have determined that the NBCCS gene is also linked to this region in Australasian pedigrees and that there is no significant evidence of heterogeneity. We have defined the localization of the gene by multipoint and haplotype analysis of 15 families, using four microsatellite markers. LOH at these loci was detected in 50% of sporadic BCCs, a rate that is significantly higher than that in other skin lesions used as controls.	UNIV QUEENSLAND,CTR MOLEC BIOL & BIOTECHNOL,BRISBANE,QLD 4029,AUSTRALIA; MATER MISERICORDIAE MOTHERS HOSP,BRISBANE,AUSTRALIA; ROYAL BRISBANE HOSP,DEPT PATHOL,BRISBANE,QLD 4029,AUSTRALIA; KING EDWARDS MEM HOSP,PERTH,AUSTRALIA; CHILDRENS HOSP,ADELAIDE,AUSTRALIA; MURDOCH INST,MELBOURNE,AUSTRALIA; PRINCE WALES CHILDRENS HOSP,SYDNEY,AUSTRALIA; UNIV UTAH,DEPT MED INFORMAT,DIV EPIDEMIOL,SALT LAKE CITY,UT 84112	University of Queensland; Royal Brisbane & Women's Hospital; King Edward Memorial Hospital; Murdoch Children's Research Institute; Utah System of Higher Education; University of Utah	CHENEVIXTRENCH, G (corresponding author), UNIV QUEENSLAND,QUEENSLAND INST MED RES,300 HERSTON RD,BRISBANE,QLD 4029,AUSTRALIA.		Chenevix-Trench, Georgia/AAV-2014-2020; Ravine, David/A-6797-2008; Wicking, Carol/J-1814-2014	Chenevix-Trench, Georgia/0000-0002-1878-2587; Wicking, Carol/0000-0002-7225-3803				Bare J. W., 1992, American Journal of Human Genetics, V51, pA57; EVANS DGR, 1991, BRIT J CANCER, V64, P959, DOI 10.1038/bjc.1991.435; FARNDON PA, 1992, LANCET, V339, P581, DOI 10.1016/0140-6736(92)90868-4; FURLONG RA, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925; FUTREAL PA, 1992, CANCER RES, V52, P2624; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GAILANI MR, 1991, AM J HUM GENET S, V49, pA454; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; GREEN A, 1990, INT J CANCER, V46, P356, DOI 10.1002/ijc.2910460303; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVI S, 1991, CANCER RES, V51, P3497; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; MERTENS F, 1991, CANCER RES, V51, P954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; Ott J., 1991, ANAL HUMAN GENETIC L; POVEY S, 1992, ANN HUM GENET, V56, P167, DOI 10.1111/j.1469-1809.1992.tb01145.x; REIS A, 1992, LANCET, V339, P617, DOI 10.1016/0140-6736(92)90903-G; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; Yuille M. A. R., 1992, Human Molecular Genetics, V1, P351, DOI 10.1093/hmg/1.5.351-a; YUILLE MAR, 1991, NUCLEIC ACIDS RES, V19, P5097, DOI 10.1093/nar/19.18.5097-a	21	77	80	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					760	767						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352281				2022-12-18	WOS:A1993LU55900020
J	JACOBSON, DR; GOREVIC, PD; BUXBAUM, JN				JACOBSON, DR; GOREVIC, PD; BUXBAUM, JN			A HOMOZYGOUS TRANSTHYRETIN VARIANT ASSOCIATED WITH SENILE SYSTEMIC AMYLOIDOSIS - EVIDENCE FOR A LATE-ONSET DISEASE OF GENETIC ETIOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NYU,SCH MED,DEPT MED,NEW YORK,NY 10003; SUNY STONY BROOK,DEPT MED,STONY BROOK,NY 11794	New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	JACOBSON, DR (corresponding author), VET ADM MED CTR,RES SERV 151-C,408 1ST AVE,NEW YORK,NY 10010, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM001431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031866] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM01431] Funding Source: Medline; NIGMS NIH HHS [GM31866] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENSON MD, 1987, ARTHRITIS RHEUM, V30, P195, DOI 10.1002/art.1780300210; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CORNWELL GG, 1988, BIOCHEM BIOPH RES CO, V154, P648, DOI 10.1016/0006-291X(88)90188-X; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DWULET FE, 1983, BIOCHEM BIOPH RES CO, V114, P657, DOI 10.1016/0006-291X(83)90831-8; DWULET FE, 1986, J CLIN INVEST, V78, P880, DOI 10.1172/JCI112675; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; FREDERIKSEN T, 1962, AM J MED, V33, P329; GIRVITZ SC, 1980, ANAL BIOCHEM, V106, P492, DOI 10.1016/0003-2697(80)90553-9; GITSCHIER J, 1985, NATURE, V314, P738, DOI 10.1038/314738a0; GOREVIC PD, 1987, OPHTHALMOLOGY, V94, P792; GOREVIC PD, 1989, J CLIN INVEST, V83, P836, DOI 10.1172/JCI113966; GUSELLA JF, 1989, FASEB J, V3, P2036, DOI 10.1096/fasebj.3.9.2568302; HODKINSON HM, 1977, Q J MED, V46, P381; HOLMGREN G, 1988, CLIN GENET, V34, P333; JACOBSON DR, 1987, CLIN RES, V35, pA594; JACOBSON DR, 1988, BIOCHEM BIOPH RES CO, V153, P198, DOI 10.1016/S0006-291X(88)81208-7; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; LIE JT, 1988, MAYO CLIN PROC, V63, P552, DOI 10.1016/S0025-6196(12)64885-X; NORDLIE M, 1988, SCAND J IMMUNOL, V27, P119, DOI 10.1111/j.1365-3083.1988.tb02329.x; OLSON LJ, 1987, NEW ENGL J MED, V317, P738, DOI 10.1056/NEJM198709173171205; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PITKANEN P, 1984, AM J PATHOL, V117, P391; SANDGREN O, 1988, ARCH OPHTHALMOL-CHIC, V106, P790; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; SASAKI H, 1985, GENE, V37, P191; SLETTEN K, 1980, SCAND J IMMUNOL, V12, P503, DOI 10.1111/j.1365-3083.1980.tb00098.x; SMITH RRL, 1979, AM J MED, V66, P96, DOI 10.1016/0002-9343(79)90488-1; SMITH TJ, 1984, MAYO CLIN PROC, V59, P547, DOI 10.1016/S0025-6196(12)61493-1; TAWARA S, 1983, BIOCHEM BIOPH RES CO, V116, P880, DOI 10.1016/S0006-291X(83)80224-1; TSUZUKI T, 1985, J BIOL CHEM, V260, P2224; VANJAARSVELD PP, 1973, J BIOL CHEM, V248, P4698; WALLACE MR, 1986, J CLIN INVEST, V78, P6, DOI 10.1172/JCI112573; WALLACE MR, 1988, J CLIN INVEST, V81, P189, DOI 10.1172/JCI113293; WESTERMARK P, 1979, SCAND J IMMUNOL, V10, P303, DOI 10.1111/j.1365-3083.1979.tb01355.x; WESTERMARK P, 1990, POLYNEUROPATHY, V3, P190; WRIGHT JR, 1969, MEDICINE, V48, P39, DOI 10.1097/00005792-196901000-00002	38	77	79	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					127	136						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349941				2022-12-18	WOS:A1990DK48200018
J	PATEL, PI; FRANCO, B; GARCIA, C; SLAUGENHAUPT, SA; NAKAMURA, Y; LEDBETTER, DH; CHAKRAVARTI, A; LUPSKI, JR				PATEL, PI; FRANCO, B; GARCIA, C; SLAUGENHAUPT, SA; NAKAMURA, Y; LEDBETTER, DH; CHAKRAVARTI, A; LUPSKI, JR			GENETIC-MAPPING OF AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE IN A LARGE FRENCH-ACADIAN KINDRED - IDENTIFICATION OF NEW LINKED MARKERS ON CHROMOSOME-17	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									LOUISIANA STATE UNIV,DEPT NEUROL,NEW ORLEANS,LA; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15260; JAPANESE FDN CANC RES,INST CANC,DIV BIOCHEM,TOKYO 170,JAPAN; BAYLOR UNIV,DEPT PEDIAT,HOUSTON,TX 77030	Louisiana State University System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Japanese Foundation for Cancer Research; Baylor University	PATEL, PI (corresponding author), BAYLOR UNIV,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		Patel, Pragna/H-9129-2017; FRANCO, Brunella/S-2882-2018	Patel, Pragna/0000-0003-3584-1072; FRANCO, Brunella/0000-0001-5588-4569	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064-02, HD20619] Funding Source: Medline; NIGMS NIH HHS [GM33771] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BECKETT J, 1986, J NEUROGENET, V3, P225, DOI 10.3109/01677068609106852; BIRD TD, 1978, CLIN GENET, V14, P43; BIRD TD, 1982, AM J HUM GENET, V34, P388; BIRD TD, 1983, ANN NEUROL, V14, P679, DOI 10.1002/ana.410140612; Charcot JM, 1886, REV MED-PARIS, V6, P97; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; DYCK PJ, 1983, MAYO CLIN PROC, V58, P430; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRIFFITHS LR, 1988, AM J HUM GENET, V42, P756; GUILOFF RJ, 1982, J NEUROL NEUROSUR PS, V45, P669, DOI 10.1136/jnnp.45.8.669; Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MIDDLETONPRICE HR, 1989, GENOMICS, V4, P192, DOI 10.1016/0888-7543(89)90299-1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORTON NE, 1955, AM J HUM GENET, V7, P277; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; OCONNELL P, 1989, AM J HUM GENET, V44, P51; RAEYMAEKERS P, 1988, J NEUROL SCI, V88, P145, DOI 10.1016/0022-510X(88)90212-2; RAO DC, 1978, AM J HUM GENET, V30, P516; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SKRE H, 1974, CLIN GENET, V6, P98; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; STEPHENS K, 1987, Genomics, V1, P353, DOI 10.1016/0888-7543(87)90037-1; SU TS, 1984, AM J HUM GENET, V36, P954; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; WALLACE DM, 1987, METHOD ENZYMOL, V152, P41; WALLACE MR, 1989, NUCLEIC ACIDS RES, V17, P1665, DOI 10.1093/nar/17.4.1665	36	77	79	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					801	809						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2316525				2022-12-18	WOS:A1990CW54900019
J	MOLL, PP; MICHELS, VV; WEIDMAN, WH; KOTTKE, BA				MOLL, PP; MICHELS, VV; WEIDMAN, WH; KOTTKE, BA			GENETIC DETERMINATION OF PLASMA APOLIPOPROTEIN-AL IN A POPULATION-BASED SAMPLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; MAYO CLIN & MAYO FDN, DEPT MED GENET, ROCHESTER, MN 55905 USA; MAYO CLIN & MAYO FDN, DEPT PEDIAT, ROCHESTER, MN 55905 USA; MAYO CLIN & MAYO FDN, DIV CARDIOVASC DIS, ROCHESTER, MN 55905 USA	University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic; Mayo Clinic	MOLL, PP (corresponding author), UNIV MICHIGAN, DEPT EPIDEMIOL, 109 OBSERV, ANN ARBOR, MI 48109 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489, R01HL030428, R01HL039107] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL24489, HL30428, HL39107] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1984, ARTERIOSCLEROSIS, V4, pA555; AMOS CI, 1987, GENET EPIDEMIOL, V4, P115, DOI 10.1002/gepi.1370040206; AU YPT, 1986, CLIN CHEM, V32, P1394; BEATY TH, 1986, AM J MED GENET, V24, P493, DOI 10.1002/ajmg.1320240312; BEATY TH, 1980, AM J MED GENET, V6, P229, DOI 10.1002/ajmg.1320060307; BERG A, 1986, CLIN CHIM ACTA, V161, P165, DOI 10.1016/0009-8981(86)90210-X; BERG K, 1984, ACTA GENET MED GEMEL, V33, P349, DOI 10.1017/S0001566000005808; BLANGERO J, 1987, American Journal of Human Genetics, V41, pA250; BOERWINKLE E, 1987, ANN HUM GENET, V51, P211, DOI 10.1111/j.1469-1809.1987.tb00874.x; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; BRUNS GAP, 1984, ARTERIOSCLEROSIS, V4, P97, DOI 10.1161/01.ATV.4.2.97; BRUNZELL JD, 1984, ARTERIOSCLEROSIS, V4, P79, DOI 10.1161/01.ATV.4.2.79; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CHEUNG P, 1984, P NATL ACAD SCI-BIOL, V81, P508, DOI 10.1073/pnas.81.2.508; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAY NE, 1969, BIOMETRIKA, V56, P463, DOI 10.1093/biomet/56.3.463; DEEB S, 1986, COLD SPRING HARB SYM, V51, P403, DOI 10.1101/SQB.1986.051.01.048; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; Edwards A.W.F, 1972, LIKELIHOOD; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; FREEDMAN DS, 1986, NEW ENGL J MED, V315, P721, DOI 10.1056/NEJM198609183151202; HAFFNER SM, 1985, ARTERIOSCLEROSIS, V5, P169, DOI 10.1161/01.ATV.5.2.169; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; HARTUNG GH, 1986, AM J CARDIOL, V58, P148, DOI 10.1016/0002-9149(86)90259-6; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1984, ATHEROSCLEROSIS, V51, P21, DOI 10.1016/0021-9150(84)90141-2; HASSTEDT SJ, 1979, AM J HUM GENET, V31, pA135; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HEGELE RA, 1987, GENET EPIDEMIOL, V4, P163, DOI 10.1002/gepi.1370040302; KARATHANASIS SK, 1983, NATURE, V301, P718, DOI 10.1038/301718a0; KARATHANASIS SK, 1984, ARTERIOSCLEROSIS, V4, pA562; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KESSLING AM, 1988, AM J HUM GENET, V42, P458; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; KOREN E, 1987, CLIN CHEM, V33, P38; KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8; KUUSI T, 1987, ARTERIOSCLEROSIS, V7, P421, DOI 10.1161/01.ATV.7.4.421; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LUSIS AJ, 1988, J LIPID RES, V29, P397; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MACIEJKO JJ, 1982, CLIN CHEM, V28, P199; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MENZEL HJ, 1984, J BIOL CHEM, V259, P3070; MOLL PP, 1986, AM J HUM GENET, V38, P361; NEEL JV, 1984, AM J HUM GENET, V36, P1135; NIKKILA EA, 1982, METABOLIC RISK FACTO, P205; NIKKILA EA, 1980, ATHEROSCLEROSIS, V5, P387; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; PATSCH JR, 1978, P NATL ACAD SCI USA, V75, P4519, DOI 10.1073/pnas.75.9.4519; POWNALL HJ, 1983, ATHEROSCLEROSIS MECH, P125; SCHONFELD G, 1974, J CLIN INVEST, V53, P1458, DOI 10.1172/JCI107694; SING CF, 1985, AM J HUM GENET, V37, P268; SING CF, 1988, 2ND P INT C QUANT GE, P250; SISTONEN P, 1980, AM J HUM GENET, V32, P1; STEIN O, 1979, BIOCHIM BIOPHYS ACTA, V574, P495, DOI 10.1016/0005-2760(79)90246-7; UTERMANN G, 1982, HUM GENET, V61, P329; WALLACE RB, 1987, EPIDEMIOL REV, V9, P95, DOI 10.1093/oxfordjournals.epirev.a036310; ZANNIS VI, 1985, ADV HUM GENET, V14, P125	65	77	77	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					124	139						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2491774				2022-12-18	WOS:A1989R559600019
J	DEVOR, EJ				DEVOR, EJ			COMPLEX SEGREGATION ANALYSIS OF GILLES-DE-LA-TOURETTE SYNDROME - FURTHER EVIDENCE FOR A MAJOR LOCUS MODE OF TRANSMISSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											DEVOR, EJ (corresponding author), WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63178, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014677] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-14677] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CHAPEL JL, 1964, AM J PSYCHIAT, V121, P608, DOI 10.1176/ajp.121.6.608; COMINGS DE, 1984, AM J HUM GENET, V36, P586; ELDRIDGE R, 1977, NEUROLOGY, V27, P115, DOI 10.1212/WNL.27.2.115; Gilles de la Tourette G, 1885, ARCH NEUROL-CHICAGO, V9, P158; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; Lalouel J. M., 1980, COMPUTER PROGRAM COM; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1977, J MED GENET, V14, P408, DOI 10.1136/jmg.14.6.408; LECKMAN JF, 1983, CHILDHOOD PSYCHOPATH, P211; MOLDOFSKY H, 1974, J NERV MENT DIS, V159, P282, DOI 10.1097/00005053-197410000-00007; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1974, AM J HUM GENET, V26, P318; MORTON NE, 1983, HUMAN POPULATION GEN; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; PAULS DL, 1981, ARCH GEN PSYCHIAT, V38, P1085; WASSMAN ER, 1978, NEUROLOGY, V28, P304, DOI 10.1212/WNL.28.3.304	18	77	77	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					704	709						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6587775				2022-12-18	WOS:A1984SY11900020
J	CONZELMANN, E; KYTZIA, HJ; NAVON, R; SANDHOFF, K				CONZELMANN, E; KYTZIA, HJ; NAVON, R; SANDHOFF, K			GANGLIOSIDE-GM2 N-ACETYL-BETA-D-GALACTOSAMINIDASE ACTIVITY IN CULTURED FIBROBLASTS OF LATE-INFANTILE AND ADULT GM2-GANGLIOSIDOSIS PATIENTS AND OF HEALTHY PROBANDS WITH LOW HEXOSAMINIDASE LEVEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,TEL AVIV,ISRAEL; CHAIM SHEBA MED CTR,TEL HASHOMER,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	CONZELMANN, E (corresponding author), UNIV BONN,INST ORGAN CHEM & BIOCHEM,D-5300 BONN 1,FED REP GER.							CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; CONZELMANN E, 1979, H-S Z PHYSIOL CHEM, V360, P1837, DOI 10.1515/bchm2.1979.360.2.1837; CONZELMANN E, 1982, EUR J BIOCHEM, V123, P455, DOI 10.1111/j.1432-1033.1982.tb19789.x; DREYFUS JC, 1977, AM J HUM GENET, V29, P287; DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; ERZBERGER A, 1980, CLIN CHIM ACTA, V108, P361, DOI 10.1016/0009-8981(80)90342-3; FISCHER G, 1975, H-S Z PHYSIOL CHEM, V356, P605, DOI 10.1515/bchm2.1975.356.1.605; GEIGER B, 1976, BIOCHEMISTRY-US, V15, P3484, DOI 10.1021/bi00661a014; KELLY TE, 1976, CLIN GENET, V9, P540; KYTZIA HJ, 1981, THESIS U BONN; LEE JES, 1976, BIOCHEM J, V159, P535, DOI 10.1042/bj1590535; LI SC, 1981, BIOCHEM BIOPH RES CO, V101, P479, DOI 10.1016/0006-291X(81)91285-7; LI SC, 1976, J BIOL CHEM, V251, P1159; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIETTINEN T, 1959, ACTA CHEM SCAND, V13, P856, DOI 10.3891/acta.chem.scand.13-0856; NAVON R, 1976, AM J HUM GENET, V28, P339; NAVON R, 1973, AM J HUM GENET, V25, P287; NAVON R, 1981, NEUROLOGY, V31, P1397, DOI 10.1212/WNL.31.11.1397; OBRIEN JS, 1978, AM J HUM GENET, V30, P602; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; SANDHOFF K, 1979, HUM GENET, V50, P107, DOI 10.1007/BF00390234; SANDHOFF K, 1977, ANGEW CHEM INT EDIT, V16, P273, DOI 10.1002/anie.197702733; SANDHOFF K, 1977, H-S Z PHYSIOL CHEM, V358, P779, DOI 10.1515/bchm2.1977.358.2.779; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1968, Pathologia Europaea, V3, P278; SANDHOFF K, 1969, FEBS LETT, V4, P351, DOI 10.1016/0014-5793(69)80274-7; SANDHOFF K, 1979, TRENDS BIOCHEM SCI, V4, P231, DOI 10.1016/0968-0004(79)90125-7; SRIVASTAVA SK, 1973, NATURE, V241, P463, DOI 10.1038/241463a0; SUZUKI Y, 1972, J LIPID RES, V13, P687; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; SVENNERHOLM L, 1972, METHODS CARBOHYD CHE, V6, P464; TALLMAN JF, 1974, NATURE, V252, P254, DOI 10.1038/252254a0; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; ZERFOWSKI J, 1974, ACTA NEUROPATHOL, V27, P225, DOI 10.1007/BF00687632	34	77	78	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					900	913						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6614006				2022-12-18	WOS:A1983RK60400010
J	SUTHERLAND, GR; JACKY, PB; BAKER, E; MANUEL, A				SUTHERLAND, GR; JACKY, PB; BAKER, E; MANUEL, A			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .10. NEW FOLATE-SENSITIVE FRAGILE SITES - 6P23, 9P21, 9Q32, AND 11Q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WOMENS HOSP,FDN 41,SYDNEY,NSW 2000,AUSTRALIA		SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,CYTOGENET UNIT,N ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012					GLOVER TW, 1981, AM J HUM GENET, V33, P234; GUICHAOUA M, 1982, J GENET HUM, V30, P183; KOCHEN K, 1981, MAY AM SOC PED RES; MANUEL A, 1981, MAY HUM GEN SOC AUST; PAVEY SM, 1982, MAY HUM GEN SOC AUST; SUTHERLAND GR, 1981, HUM GENET, V57, P217; SUTHERLAND GR, 1983, INT REV CYTOL, V81, P107, DOI 10.1016/S0074-7696(08)62336-0; SUTHERLAND GR, 1982, AM J HUM GENET, V34, P452; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERLAND GR, 1981, AM J HUM GENET, V33, P946; TOMMERUP N, 1981, J MED GENET, V18, P374, DOI 10.1136/jmg.18.5.374	12	77	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					432	437						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6859039				2022-12-18	WOS:A1983QS16000008
J	JUNIEN, C; WEIL, D; MYERS, JC; VANCONG, N; CHU, ML; FOUBERT, C; GROSS, MS; PROCKOP, DJ; KAPLAN, JC; RAMIREZ, F				JUNIEN, C; WEIL, D; MYERS, JC; VANCONG, N; CHU, ML; FOUBERT, C; GROSS, MS; PROCKOP, DJ; KAPLAN, JC; RAMIREZ, F			ASSIGNMENT OF THE HUMAN PRO-ALPHA-2(I) COLLAGEN STRUCTURAL GENE (COLIA2) TO CHROMOSOME-7 BY MOLECULAR HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP ENFANTS MALAD,INSERM,U12 UNITE RECH GENET MED,F-75730 PARIS 15,FRANCE; COLL MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854; COLL MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT OBSTET & GYNECOL,PISCATAWAY,NJ 08854	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	JUNIEN, C (corresponding author), INSERM,U129,INST PATHOL MOLEC,RUE FG ST JACQUES,F-75654 PARIS 14,FRANCE.				NIADDK NIH HHS [AM-16,516] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DEISSEROTH A, 1978, P NATL ACAD SCI USA, V75, P1456, DOI 10.1073/pnas.75.3.1456; DEISSEROTH A, 1977, CELL, V12, P205, DOI 10.1016/0092-8674(77)90198-2; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; KEFALIDES NA, 1979, FED PROC, V38, P816; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; MYERS JC, 1981, P NATL ACAD SCI-BIOL, V78, P3516, DOI 10.1073/pnas.78.6.3516; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P77, DOI 10.1056/NEJM197907123010204; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROBERTS RJ, 1981, NUCLEIC ACIDS RES, V9, P75; SANDERSHAIGH L, 1980, NATURE, V283, P683, DOI 10.1038/283683a0; SOLOMON E, 1980, NATURE, V286, P656, DOI 10.1038/286656a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUNDARRAJ CV, 1977, P NATL ACAD SCI USA, V74, P4444; SYKES B, 1978, NATURE, V272, P548, DOI 10.1038/272548a0; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WEIL D, 1977, HUM GENET, V36, P205, DOI 10.1007/BF00273259; WEIL D, 1980, ANN HUM GENET, V44, P11, DOI 10.1111/j.1469-1809.1980.tb00941.x; WEIL D, 1979, HUM GENET, V52, P249, DOI 10.1007/BF00271580; WEIL D, 1978, HUM GENET, V42, P181, DOI 10.1007/BF00283638; YAMADA Y, 1980, CELL, V22, P887, DOI 10.1016/0092-8674(80)90565-6	25	77	78	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					381	387						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	6282119				2022-12-18	WOS:A1982NR13300002
J	SASAKI, MS; MAKINO, S				SASAKI, MS; MAKINO, S			DEMONSTRATION OF SECONDARY CONSTRICTIONS IN HUMAN CHROMOSOMES BY MEANS OF A NEW TECHNIQUE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Darlington CD, 1938, ANN BOT-LONDON, V2, P615, DOI 10.1093/oxfordjournals.aob.a084022; DELACHAPELLE A, 1961, LANCET, V2, P460; FERGUS.MA, 1961, LANCET, V1, P638, DOI 10.1016/S0140-6736(61)91655-5; GLASS E, 1957, CHROMOSOMA, V8, P468; HAGA T, 1958, S CELL CHEM, V7, P101; HSU TC, 1961, P NATL ACAD SCI USA, V47, P396, DOI 10.1073/pnas.47.3.396; MAKINO S, 1961, AM J HUM GENET, V13, P47; MAKINO S, 1952, STAIN TECHNOL, V27, P1; MCCOY TA, 1956, CANCER RES, V16, P979; MIRSKY AE, 1961, CELL, V2, P677; MULDAL S, 1961, LANCET, V2, P462; OHNO S, 1955, EXP CELL RES, V8, P558, DOI 10.1016/0014-4827(55)90133-6; OHNO S, 1961, LANCET, V2, P123; PATAU K, 1961, CHROMOSOMA, V12, P573, DOI 10.1007/BF00328943; PATAU K, 1961, LANCET, V1, P933; PATAU K, 1960, AM J HUM GENET, V12, P250; ROBINSON A, 1961, AM J DIS CHILD, V101, P379, DOI 10.1001/archpedi.1961.04020040107011; SASAKI MS, 1962, J HERED, V53, P157, DOI 10.1093/oxfordjournals.jhered.a107156; SCHULTZ J, 1949, J HERED, V40, P30; SHAW MW, 1961, LANCET, V1, P1351; TAYLOR JH, 1960, J BIOPHYS BIOCHEM CY, V7, P455, DOI 10.1083/jcb.7.3.455; TOBIAS PV, 1958, LEECH, P1; YERGANIAN G, 1960, CELL PHYSIOLOGY NEOP, P49	23	77	77	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	1					24	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2969A	13986623				2022-12-18	WOS:A19632969A00010
J	TIETZ, W				TIETZ, W			A SYNDROME OF DEAF-MUTISM ASSOCIATED WITH ALBINISM SHOWING DOMINANT AUTOSOMAL INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Cockayne EA, 1933, INHERITED ABNORMALIT; DAHLBERG G, 1931, Z VEREBUNGSL, V15, P492; DIGEORGE AM, 1960, J PEDIATR-US, V57, P649, DOI 10.1016/S0022-3476(60)80159-X; FISH L, 1959, J LARYNGOL OTOL, V73, P355; MARGOLIS E, 1962, ACTA GENET STAT MED, V12, P12; MENDE IRMGARD, 1926, ARCH KINDERHEILK, V79, P214; SANK D, 1962, EXPANDING GOALS GENE, P149; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195	8	77	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					259	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	13985019				2022-12-18	WOS:A19632967A00011
J	BOOK, JA; RAYNER, S				BOOK, JA; RAYNER, S			A CLINICAL AND GENETICAL STUDY OF ANENCEPHALY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Angevine DM, 1938, ARCH PATHOL, V26, P507; BALLANTYNE JW, 1904, MANUAL ANTENATAL PAT, V2, P332; BONNEVIE K, 1940, HDB ERBBIOLOGIE MENS, V1, P73; BONNEVIE K, 1936, SKR NORSKE VIDEN MNV; DODDS, 1937, ANAT RECORD, V67, P499; DUNN HG, 1944, J OBSTET GYN BR COMM, V51, P529; ERNST P, 1909, SCHWALBES MORPHOLO 2; HAMMER E, 1933, ZBL ALLG PATH, V56, P289; Harbeson AE, 1939, AM J OBSTET GYNECOL, V38, P167, DOI 10.1016/S0002-9378(39)90502-8; HIILESMAA V, 1945, ACTA OBSTET GYNEC S2, V25, P27; Josephson JE, 1933, CAN MED ASSOC J, V29, P34; Macklin MT, 1938, J HERED, V29, P295, DOI 10.1093/oxfordjournals.jhered.a104522; Mall FP, 1917, AM J ANAT, V22, P49, DOI 10.1002/aja.1000220104; MALPAS P, 1937, J OBSTET GYN BR COMM, V44, P434; Ossenkopp G, 1932, J PSYCHOL NEUROL, V44, P613; PENROSE LS, 1946, ANN EUGENIC, V13, P73, DOI 10.1111/j.1469-1809.1946.tb02344.x; SCHADE H, 1939, ERBARZT, V7, P116; Snell GD, 1935, J GENET, V31, P213, DOI 10.1007/BF02982341; Stroer WFH, 1939, J ANAT, V73, P441	19	77	77	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	1					61	84						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS388	15425506				2022-12-18	WOS:A1950XS38800005
J	Whitfield, M; Thomas, L; Bequignon, E; Schmitt, A; Stouvenel, L; Montantin, G; Tissier, S; Duquesnoy, P; Copin, B; Chantot, S; Dastot, F; Faucon, C; Barbotin, AL; Loyens, A; Siffroi, JP; Papon, JF; Escudier, E; Amselem, S; Mitchell, V; Toure, A; Legendre, M				Whitfield, Marjorie; Thomas, Lucie; Bequignon, Emilie; Schmitt, Alain; Stouvenel, Laurence; Montantin, Guy; Tissier, Sylvie; Duquesnoy, Philippe; Copin, Bruno; Chantot, Sandra; Dastot, Florence; Faucon, Catherine; Barbotin, Anne Laure; Loyens, Anne; Siffroi, Jean-Pierre; Papon, Jean-Francois; Escudier, Estelle; Amselem, Serge; Mitchell, Valerie; Toure, Aminata; Legendre, Marie			Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CILIARY DYSKINESIA; MULTIPLE MORPHOLOGICAL ABNORMALITIES; FIBROUS SHEATH; PROTEOMIC ANALYSIS; SITUS-INVERSUS; FLAGELLA; RANDOMIZATION; DYSPLASIA; DIAGNOSIS; REVEALS	Motile cilia and sperm flagella share an evolutionarily conserved axonemal structure. Their structural and/or functional defects are associated with primary ciliary dyskinesia (PCD), a genetic disease characterized by chronic respiratory-tract infections and in which most males are infertile due to asthenozoospermia. Among the well-characterized axonemal protein complexes, the outer dynein arms (ODAs), through ATPase activity of their heavy chains (HCs), play a major role for cilia and flagella beating. However, the contribution of the different HCs (gamma-type: DNAH5 and DNAH8 and beta-type: DNAH9, DNAH11, and DNAH17) in ODAs from both organelles is unknown. By analyzing five male individuals who consulted for isolated infertility and displayed a loss of ODAs in their sperm cells but not in their respiratory cells, we identified bi-allelic mutations in DNAH17. The isolated infertility phenotype prompted us to compare the protein composition of ODAs in the sperm and ciliary axonemes from control individuals. We show that DNAH17 and DNAH8, but not DNAH5, DNAH9, or DNAH11, colocalize with alpha-tubulin along the sperm axoneme, whereas the reverse picture is observed in respiratory cilia, thus explaining the phenotype restricted to sperm cells. We also demonstrate the loss of function associated with DNAH17 mutations in two unrelated individuals by performing immunoblot and immunofluorescence analyses on sperm cells; these analyses indicated the absence of DNAH17 and DNAH8, whereas DNAH2 and DNALI, two inner dynein arm components, were present. Overall, this study demonstrates that mutations in DNAH17 are responsible for isolated male infertility and provides information regarding ODA composition in human spermatozoa.	[Whitfield, Marjorie; Schmitt, Alain; Stouvenel, Laurence; Toure, Aminata] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Whitfield, Marjorie; Schmitt, Alain; Stouvenel, Laurence; Toure, Aminata] CNRS, UMR8104, F-75014 Paris, France; [Whitfield, Marjorie; Schmitt, Alain; Stouvenel, Laurence; Toure, Aminata] Univ Paris 05, Fac Med, Sorbonne Paris Cite, F-75014 Paris, France; [Thomas, Lucie; Duquesnoy, Philippe; Siffroi, Jean-Pierre; Escudier, Estelle; Amselem, Serge; Legendre, Marie] Sorbonne Univ, Hop Trousseau, INSERM, U933, F-75012 Paris, France; [Bequignon, Emilie] Hop Henri Mondor, AP HP, F-94000 Creteil, France; [Bequignon, Emilie] Ctr Hosp Intercommunal Creteil, Serv Otorhinolaryngol & Chirurg Cervicofaciale, F-94000 Creteil, France; [Bequignon, Emilie] Univ Paris Est, INSERM, CNRS, Fac Med,U955,Equipe Rech Labellisee 7240, F-94010 Creteil, France; [Montantin, Guy; Tissier, Sylvie; Copin, Bruno; Chantot, Sandra; Dastot, Florence; Siffroi, Jean-Pierre; Escudier, Estelle; Amselem, Serge; Legendre, Marie] Hop Trousseau, AP HP, Dept Med Genet, F-75012 Paris, France; [Faucon, Catherine] Ctr Hosp Intercommunal Creteil, Lab Microscopie Elect, Serv Anatomopathol, F-94010 Creteil, France; [Barbotin, Anne Laure; Mitchell, Valerie] Ctr Hosp Univ Lille, Jeanne de Flandre Hosp, Ctr Etud & Conservat Oeufs & Sperme Inst, Reprod Biol Spermiol, F-59000 Lille, France; [Barbotin, Anne Laure; Mitchell, Valerie] Lille Univ, EA4308 Gametogenesis & Gamete Qual, F-59000 Lille, France; [Loyens, Anne] Lille Univ, Jean Pierre Aubert Res Ctr, Lab Dev & Plast Neuroendocrine Brain, INSERM,U1172, F-59000 Lille, France; [Papon, Jean-Francois] Univ Paris Sud, INSERM, CNRS, Fac Med,U955,Equipe Rech Labellisee 7240, F-94010 Creteil, France; [Papon, Jean-Francois] Hop Bicetre, AP HP, Serv Otorhinolaryngol & Chirurg Cervicofaciale, F-94275 Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Toure, A (corresponding author), Inst Cochin, INSERM, U1016, F-75014 Paris, France.; Toure, A (corresponding author), CNRS, UMR8104, F-75014 Paris, France.; Toure, A (corresponding author), Univ Paris 05, Fac Med, Sorbonne Paris Cite, F-75014 Paris, France.	aminata.toure@inserm.fr	Legendre, Marie/AAD-7018-2021; TOURE, Aminata/B-3236-2018; WHITFIELD, Marjorie/ABH-3433-2021; BEQUIGNON, Emilie/AAO-3221-2020	Legendre, Marie/0000-0003-2178-0846; TOURE, Aminata/0000-0001-5629-849X; WHITFIELD, Marjorie/0000-0001-7956-3436; THOMAS, Lucie/0000-0001-6998-590X	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universite Paris Descartes; Universite Pierre et Marie Curie; French National Research Agency [ANR MASFLAGELLA 14-CE15-0002-03]; Fondation pour la Recherche Medicale [DEQ20120323689]; RaDiCo (French National Research Agency under the specific program "Investments for the Future") [ANR-10-COHO-0003]; Legs Poix grant from the Chancellerie des Universites of Sorbonne Universite; BEAT-PCD (Better Experimental Approaches to Treat Primary Ciliary Dyskinesia) COST (European Collaboration in Science and Technology) action	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Universite Pierre et Marie Curie; French National Research Agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); RaDiCo (French National Research Agency under the specific program "Investments for the Future"); Legs Poix grant from the Chancellerie des Universites of Sorbonne Universite; BEAT-PCD (Better Experimental Approaches to Treat Primary Ciliary Dyskinesia) COST (European Collaboration in Science and Technology) action	We thank all the individuals and their families for their cooperation, as well as all the referring physicians and Denise Escalier for initial TEM analyses. This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Universite Paris Descartes, the Universite Pierre et Marie Curie, the French National Research Agency (grant ANR MASFLAGELLA 14-CE15-0002-03), the Fondation pour la Recherche Medicale (grant DEQ20120323689), RaDiCo (funded by the French National Research Agency under the specific program "Investments for the Future" [cohort grant agreement ANR-10-COHO-0003]), the Legs Poix grant from the Chancellerie des Universites of Sorbonne Universite, and the BEAT-PCD (Better Experimental Approaches to Treat Primary Ciliary Dyskinesia) COST (European Collaboration in Science and Technology) action.	Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; Amiri-Yekta A, 2016, HUM REPROD, V31, P2872, DOI 10.1093/humrep/dew262; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Blackburn K, 2017, J PROTEOME RES, V16, P1579, DOI 10.1021/acs.jproteome.6b00972; CHEMES HE, 1987, FERTIL STERIL, V48, P664; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Coutton C, 2019, AM J HUM GENET, V104, P331, DOI 10.1016/j.ajhg.2018.12.013; Darde T. A, 2019, BIOINFORMATICS; Darde TA, 2015, NUCLEIC ACIDS RES, V43, pW109, DOI 10.1093/nar/gkv345; Dougherty GW, 2016, AM J RESP CELL MOL, V55, P213, DOI 10.1165/rcmb.2015-0353OC; Escalier D, 2006, ANDROLOGIA, V38, P54, DOI 10.1111/j.1439-0272.2006.00711.x; Escalier D, 2006, FERTIL STERIL, V86, DOI 10.1016/j.fertnstert.2005.12.042; Fassad MR, 2018, AM J HUM GENET, V103, P984, DOI 10.1016/j.ajhg.2018.10.016; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Ishikawa T, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028076; Jeanson L, 2016, HUM MUTAT, V37, P776, DOI 10.1002/humu.23005; King SM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028100; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Lhuillier P, 2009, HUM REPROD, V24, P1296, DOI 10.1093/humrep/dep020; Loges NT, 2018, AM J HUM GENET, V103, P995, DOI 10.1016/j.ajhg.2018.10.020; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Mbango JFN, 2019, BASIC CLIN ANDROL, V29, DOI 10.1186/s12610-019-0083-9; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Sha YW, 2017, FERTIL STERIL, V107, P1312, DOI 10.1016/j.fertnstert.2017.04.007; Shapiro AJ, 2016, PEDIATR PULM, V51, P115, DOI 10.1002/ppul.23304; Tamalet A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e86; Vanaken GJ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00314-2017; Viswanadha R, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018325; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wang M, 2018, CELL STEM CELL, V23, P599, DOI 10.1016/j.stem.2018.08.007; Wang X, 2017, CLIN GENET, V91, P313, DOI 10.1111/cge.12857	52	76	81	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 3	2019	105	1					198	212		10.1016/j.ajhg.2019.04.015	http://dx.doi.org/10.1016/j.ajhg.2019.04.015			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG3RM	31178125	Green Published, Bronze			2022-12-18	WOS:000473723000016
J	Alirezaie, N; Kernohan, KD; Hartley, T; Majewski, J; Hocking, TD				Alirezaie, Najmeh; Kernohan, Kristin D.; Hartley, Taila; Majewski, Jacek; Hocking, Toby Dylan			ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNCERTAIN SIGNIFICANCE; MISSENSE VARIANTS; GENETIC-VARIANTS; DATABASE; PATHOGENICITY; MUTATIONS; PRIORITIZATION; GUIDELINES; GENOMICS; IMPACT	Advances in high-throughput DNA sequencing have revolutionized the discovery of variants in the human genome; however, interpreting the phenotypic effects of those variants is still a challenge. While several computational approaches to predict variant impact are available, their accuracy is limited and further improvement is needed. Here, we introduce ClinPred, an efficient tool for identifying disease-relevant nonsynonymous variants. Our predictor incorporates two machine learning algorithms that use existing pathogenicity scores and, notably, benefits from inclusion of normal population allele frequency from the gnomAD database as an input feature. Another major strength of our approach is the use of ClinVar-a rapidly growing database that allows selection of confidently annotated disease-causing variants-as a training set. Compared to other methods, ClinPred showed superior accuracy for predicting pathogenicity, achieving the highest area under the curve (AUC) score and increasing both the specificity and sensitivity in different test datasets. It also obtained the best performance according to various other metrics. Moreover, ClinPred performance remained robust with respect to disease type (cancer or rare disease) and mechanism (gain or loss of function). Importantly, we observed that adding allele frequency as a predictive feature-as opposed to setting fixed allele frequency cutoffs-boosts the performance of prediction. We provide pre-computed ClinPred scores for all possible human missense variants in the exome to facilitate its use by the community.	[Alirezaie, Najmeh; Majewski, Jacek; Hocking, Toby Dylan] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G1, Canada; [Kernohan, Kristin D.; Hartley, Taila] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H 5B2, Canada	McGill University; University of Ottawa; Children's Hospital of Eastern Ontario	Alirezaie, N; Majewski, J (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G1, Canada.	najmeh.alirezaie@mail.mcgill.ca; jacek.majewski@mcgill.ca			Genome Canada	Genome Canada(Genome Canada)	The authors first thank the FORGE Canada, Care4Rare Canada Consortium funded by Genome Canada. We would also like to acknowledge Compute Canada and Calcul Quebec for providing high performance computing infrastructures.	Ainscough BJ, 2016, NAT METHODS, V13, P806, DOI 10.1038/nmeth.4000; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Findlay GM, 2018, 294520 BIORXIV, DOI [10. 1101/294520, DOI 10.1101/294520]; Flygare S, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2056-y; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Harrison SM, 2016, CURR PROTOC HUM GENE, V89, P1; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Kernohan KD, 2018, HUM MUTAT, V39, P197, DOI 10.1002/humu.23374; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kobayashi Y, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0403-7; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Li Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104452; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Liu YN, 2017, J GENET GENOMICS, V44, P119, DOI 10.1016/j.jgg.2016.12.004; Lu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10576; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Niroula A, 2016, HUM MUTAT, V37, P579, DOI 10.1002/humu.22987; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schaafsma GCP, 2015, HUM MUTAT, V36, P161, DOI 10.1002/humu.22727; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Shihab HA, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-11; van der Velde KJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1141-7; Vihinen M, 2013, HUM MUTAT, V34, P275, DOI 10.1002/humu.22253; Zhao M, 2016, NUCLEIC ACIDS RES, V44, pD1023, DOI 10.1093/nar/gkv1268	38	76	77	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					474	483		10.1016/j.ajhg.2018.08.005	http://dx.doi.org/10.1016/j.ajhg.2018.08.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30220433	Bronze, Green Published			2022-12-18	WOS:000446312200002
J	Trynka, G; Westra, HJ; Slowikowski, K; Hu, XL; Xu, H; Stranger, BE; Klein, RJ; Han, B; Raychaudhuri, S				Trynka, Gosia; Westra, Harm-Jan; Slowikowski, Kamil; Hu, Xinli; Xu, Han; Stranger, Barbara E.; Klein, Robert J.; Han, Buhm; Raychaudhuri, Soumya			Disentangling the Effects of Colocalizing Genomic Annotations to Functionally Prioritize Non-coding Variants within Complex-Trait Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE ASSOCIATIONS; SUSCEPTIBILITY LOCI; CELL-TYPES; CHIP-SEQ; EXPRESSION; CANCER; RISK; DNA; IDENTIFICATION	Identifying genomic annotations that differentiate causal from trait-associated variants is essential to fine mapping disease loci. Although many studies have identified non-coding functional annotations that overlap disease-associated variants, these annotations often colocalize, complicating the ability to use these annotations for fine mapping causal variation. We developed a statistical approach (Genomic Annotation Shifter [GoShifter]) to assess whether enriched annotations are able to prioritize causal variation. Go Shifter defines the null distribution of an annotation overlapping an allele by locally shifting annotations; this approach is less sensitive to biases arising from local genomic structure than commonly used enrichment methods that depend on SNP matching. Local shifting also allows Go Shifter to identify independent causal effects from colocalizing annotations. Using Go Shifter, we confirmed that variants in expression quantitative trail loci drive gene-expression changes though DNase-I hypersensitive sites (DHSs) near transcription start sites and independently through 3' UTR regulation. We also showed that (1) 15%-36% of trait-associated loci map to DHSs independently of other annotations; (2) loci associated with breast cancer and rheumatoid arthritis harbor potentially causal variants near the summits of histone marks rather than full peak bodies; (3) variants associated with height are highly enriched in embryonic stem cell DHSs; and (4) we can effectively prioritize causal variation at specific loci.	[Trynka, Gosia; Westra, Harm-Jan; Slowikowski, Kamil; Hu, Xinli; Han, Buhm; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02446 USA; [Trynka, Gosia; Westra, Harm-Jan; Slowikowski, Kamil; Hu, Xinli; Han, Buhm; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02446 USA; [Trynka, Gosia; Westra, Harm-Jan; Slowikowski, Kamil; Hu, Xinli; Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA 02446 USA; [Trynka, Gosia; Westra, Harm-Jan; Slowikowski, Kamil; Hu, Xinli; Han, Buhm; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA 02446 USA; [Trynka, Gosia; Westra, Harm-Jan; Slowikowski, Kamil; Hu, Xinli; Han, Buhm; Raychaudhuri, Soumya] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Trynka, Gosia] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Slowikowski, Kamil] Harvard Univ, Bioinformat & Integrat Genom, Cambridge, MA 02138 USA; [Hu, Xinli] Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Xu, Han] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Xu, Han] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Stranger, Barbara E.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Klein, Robert J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Han, Buhm] Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea; [Han, Buhm] Univ Ulsan, Coll Med, Dept Med, Seoul 138736, South Korea; [Raychaudhuri, Soumya] Univ Manchester, Inst Inflammat & Repair, Manchester M13 9PT, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Chicago; University of Chicago; Icahn School of Medicine at Mount Sinai; University of Ulsan; Asan Medical Center; University of Ulsan; University of Manchester	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02446 USA.	soumya@broadinstitute.org	Slowikowski, Kamil/K-3728-2016; Han, Buhm/AAQ-9672-2020; Klein, Robert/ABI-7857-2020	Slowikowski, Kamil/0000-0002-2843-6370; Klein, Robert/0000-0003-3539-5391; Raychaudhuri, Soumya/0000-0002-1901-8265; Stranger, Barbara/0000-0001-9021-7331	NIH [NIAMS-1R01AR063759, 1UH2AR067677-01, 1U19AI111224-01, NHGRI-1U01HG0070033]; Doris Duke Clinical Scientist Development Award; Rubicon grant from the Netherlands Organization for Scientific Research; Wellcome Trust Sanger Institute [WT098051]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); Rubicon grant from the Netherlands Organization for Scientific Research; Wellcome Trust Sanger Institute(Wellcome Trust); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the GIANT consortium for providing us access to the height SNPs. We also acknowledge Joel Hirschhorn, X. Shirley Liu, Mark Daly, Tonu Esko, Dorothee Diogo, and Joshua Randall for helpful scientific discussions. This work was supported by funding from the NIH (NIAMS-1R01AR063759 [S.R.], 1UH2AR067677-01 [S.R.], 1U19AI111224-01 [S.R.], and NHGRI-1U01HG0070033 [R.J.K.]), a Doris Duke Clinical Scientist Development Award (S.R.), the Rubicon grant from the Netherlands Organization for Scientific Research (G.T.), and the Wellcome Trust Sanger Institute (WT098051 [G.T.]).	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bickel PJ, 2010, ANN APPL STAT, V4, P1660, DOI 10.1214/10-AOAS363; Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Folkerd EJ, 2010, J CLIN ONCOL, V28, P4038, DOI 10.1200/JCO.2009.27.4290; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gerasimova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054359; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hu XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004404; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jordan VC, 2004, CANCER CELL, V5, P207, DOI 10.1016/S1535-6108(04)00059-5; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002998; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McDonald TJ, 2013, ANN CLIN BIOCHEM, V50, P403, DOI 10.1177/0004563213483458; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Paul DS, 2013, GENOME RES, V23, P1130, DOI 10.1101/gr.155127.113; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	76	78	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					139	152		10.1016/j.ajhg.2015.05.016	http://dx.doi.org/10.1016/j.ajhg.2015.05.016			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26140449	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000358189500012
J	Vernot, B; Akey, JM				Vernot, Benjamin; Akey, Joshua M.			Complex History of Admixture between Modern Humans and Neandertals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-POPULATIONS; GENOME SEQUENCE; EAST ASIANS; EUROPEANS; ANCESTRY	Recent analyses have found that a substantial amount of the Neandertal genome persists in the genomes of contemporary non-African individuals. East Asians have, on average, higher levels of Neandertal ancestry than do Europeans, which might be due to differences in the efficiency of purifying selection, an additional pulse of introgression into East Asians, or other unexplored scenarios. To better define the scope of plausible models of archaic admixture between Neandertals and anatomically modern humans, we analyzed patterns of introgressed sequence in whole-genome data of 379 Europeans and 286 East Asians. We found that inferences of demographic history restricted to neutrally evolving genomic regions allowed a simple one-pulse model to be robustly rejected, suggesting that differences in selection cannot explain the differences in Neandertal ancestry. We show that two additional demographic models, involving either a second pulse of Neandertal gene flow into the ancestors of East Asians or a dilution of Neandertal lineages in Europeans by admixture with an unknown ancestral population, are consistent with the data. Thus, the history of admixture between modern humans and Neandertals is most likely more complex than previously thought.	[Vernot, Benjamin; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Vernot, B (corresponding author), Univ Washington, Dept Genome Sci, 3720 15th Ave NE,POB 355065, Seattle, WA 98195 USA.	bvernot@gmail.com; akeyj@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Akey, Joshua/0000-0002-4411-1330	NIH [1R01GM110068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kirk E. Lohmueller and members of the J.M.A. laboratory for helpful discussions related to this manuscript. This work was supported by NIH grant 1R01GM110068 to J.M.A.	Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Csillery K, 2012, METHODS ECOL EVOL, V3, P475, DOI 10.1111/j.2041-210X.2011.00179.x; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wang SG, 2013, GENOME BIOL EVOL, V5, P2075, DOI 10.1093/gbe/evt160	18	76	78	1	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					448	453		10.1016/j.ajhg.2015.01.006	http://dx.doi.org/10.1016/j.ajhg.2015.01.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25683119	Green Published, Bronze			2022-12-18	WOS:000350747800017
J	Borel, C; Ferreira, PG; Santoni, F; Delaneau, O; Fort, A; Popadin, KY; Garieri, M; Falconnet, E; Ribaux, P; Guipponi, M; Padioleau, I; Carninci, P; Dermitzakis, ET; Antonarakis, SE				Borel, Christelle; Ferreira, Pedro G.; Santoni, Federico; Delaneau, Olivier; Fort, Alexandre; Popadin, Konstantin Y.; Garieri, Marco; Falconnet, Emilie; Ribaux, Pascale; Guipponi, Michel; Padioleau, Ismael; Carninci, Piero; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.			Biased Allelic Expression in Human Primary Fibroblast Single Cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; MONOALLELIC EXPRESSION; MAMMALIAN-CELLS; X-CHROMOSOME; IN-VIVO; TRANSCRIPTION; GENOME; DYNAMICS; MOUSE; INACTIVATION	The study of gene expression in mammalian single cells via genomic technologies now provides the possibility to investigate the patterns of allelic gene expression. We used single-cell RNA sequencing to detect the allele-specific mRNA level in 203 single human primary fibroblasts over 133,633 unique heterozygous single-nucleotide variants (hetSNVs). We observed that at the snapshot of analyses, each cell contained mostly transcripts from one allele from the majority of genes; indeed, 76.4% of the hetSNVs displayed stochastic monoallelic expression in single cells. Remarkably, adjacent hetSNVs exhibited a haplotype-consistent allelic ratio; in contrast, distant sites located in two different genes were independent of the haplotype structure. Moreover, the allele-specific expression in single cells correlated with the abundance of the cellular transcript. We observed that genes expressing both alleles in the majority of the single cells at a given time point were rare and enriched with highly expressed genes. The relative abundance of each allele in a cell was controlled by some regulatory mechanisms given that we observed related single-cell allelic profiles according to genes. Overall, these results have direct implications in cellular phenotypic variability.	[Borel, Christelle; Ferreira, Pedro G.; Santoni, Federico; Delaneau, Olivier; Popadin, Konstantin Y.; Garieri, Marco; Falconnet, Emilie; Ribaux, Pascale; Guipponi, Michel; Padioleau, Ismael; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ferreira, Pedro G.; Delaneau, Olivier; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Ferreira, Pedro G.; Delaneau, Olivier; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Fort, Alexandre; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan; [Guipponi, Michel; Antonarakis, Stylianos E.] Univ Hosp Geneva, Serv Genet Med, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia; [Dermitzakis, Emmanouil T.] Biomed Res Fdn Acad Athens, Athens 11527, Greece	University of Geneva; Swiss Institute of Bioinformatics; RIKEN; University of Geneva; King Abdulaziz University; Academy of Athens	Dermitzakis, ET (corresponding author), Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	emmanouil.dermitzakis@unige.ch; stylianos.antonarakis@unige.ch	/AAR-2792-2021; Ferreira, Pedro/HDO-1346-2022; Carninci, Piero/K-1568-2014; Antonarakis, Stylianos E/N-8866-2014; Popadin, Konstantin/L-7459-2017; Ferreira, Pedro G/J-6379-2013; Padioleau, Ismaël/AAE-8927-2019; borel, christelle/AAC-9645-2019	Carninci, Piero/0000-0001-7202-7243; Antonarakis, Stylianos E/0000-0001-8907-5823; Ferreira, Pedro G/0000-0003-3838-8664; Padioleau, Ismaël/0000-0003-4935-3248; Delaneau, Olivier/0000-0002-3906-8446; Santoni, Federico/0000-0002-3258-4747	Swiss National Science Foundation [SNF-144082]; European Research Council [ERC-249968]; ChildCare foundations; Louis-Jeantet Foundation; Swiss National Science Foundation; European Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); ChildCare foundations; Louis-Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank Michel Strubin and David Suter for critical comments on the manuscript, Mark Lynch for helpful technical suggestions, Audrey Letourneau and Cedric Howald for processing raw data, and the Institute of Genetics and Genomics of Geneva genomics platform at the University of Geneva. This work was supported by Swiss National Science Foundation (SNF-144082) and European Research Council (ERC-249968) grants to S.E.A. We thank the ChildCare foundations for supporting the S.E.A. laboratory. This work was also supported by Louis-Jeantet Foundation, Swiss National Science Foundation, and European Research Council grants to E.T.D. The computations were performed at the Vital-IT High Performance Computing Center of the Swiss Institute of Bioinformatics.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Chakalova L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000729; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Dahoun S, 2008, AM J MED GENET A, V146A, P2086, DOI 10.1002/ajmg.a.32431; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Grimaldi Y, 2014, GENOME RES, V24, P117, DOI 10.1101/gr.157792.113; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Levsky JM, 2007, J CELL BIOCHEM, V102, P609, DOI 10.1002/jcb.21495; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Molina N, 2013, P NATL ACAD SCI USA, V110, P20563, DOI 10.1073/pnas.1312310110; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RIMM IJ, 1989, MOL BIOL MED, V6, P355; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Suter DM, 2011, CURR OPIN CELL BIOL, V23, P657, DOI 10.1016/j.ceb.2011.09.004; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694	49	76	77	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					70	80		10.1016/j.ajhg.2014.12.001	http://dx.doi.org/10.1016/j.ajhg.2014.12.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25557783	Bronze, Green Published			2022-12-18	WOS:000347707800005
J	Barbier, M; Gross, MS; Aubart, M; Hanna, N; Kessler, K; Guo, DC; Tosolini, L; Ho-Tin-Noe, B; Regalado, E; Varret, M; Abifadel, M; Milleron, O; Odent, S; Dupuis-Girod, S; Faivre, L; Edouard, T; Dulac, Y; Busa, T; Gouya, L; Milewicz, DM; Jondeau, G; Boileau, C				Barbier, Mathieu; Gross, Marie-Sylvie; Aubart, Melodie; Hanna, Nadine; Kessler, Ketty; Guo, Dong-Chuan; Tosolini, Laurent; Ho-Tin-Noe, Benoit; Regalado, Ellen; Varret, Mathilde; Abifadel, Marianne; Milleron, Olivier; Odent, Sylvie; Dupuis-Girod, Sophie; Faivre, Laurence; Edouard, Thomas; Dulac, Yves; Busa, Tiffany; Gouya, Laurent; Milewicz, Dianna M.; Jondeau, Guillaume; Boileau, Catherine			MFAR5 Loss-of-Function Mutations Underscore the Involvement of Matrix Alteration in the Pathogenesis of Familial Thoracic Aortic Aneurysms and Dissections	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARFAN-SYNDROME; GLYCOPROTEIN 2; MAGP-2; FBN1; FIBRILLIN; GENETICS; TGFBR2; SITE	Thoracic aortic aneurysm and dissection (TAAD) is an autosomal-dominant disorder with major life-threatening complications. The disease displays great genetic heterogeneity with some forms allelic to Marfan and Loeys-Dietz syndrome, and an important number of cases still remain unexplained at the molecular level. Through whole-exome sequencing of affected members in a large TAAD-affected family, we identified the c.472C>T (p.Arg158*) nonsense mutation in MFAP5 encoding the extracellular matrix component MAGP-2. This protein interacts with elastin fibers and the microfibrillar network. Mutation screening of 403 additional probands identified an additional missense mutation of MFAPS (c.62G>T [p.Trp21Leu]) segregating with the disease in a second family. Functional analyses performed on both affected individual's cells and in vitro models showed that these two mutations caused pure or partial haploin-sufficiency. Thus, alteration of MAGP-2, a component of microfibrils and elastic fibers, appears as an initiating mechanism of inherited TAAD.	[Barbier, Mathieu; Gross, Marie-Sylvie; Aubart, Melodie; Hanna, Nadine; Kessler, Ketty; Tosolini, Laurent; Ho-Tin-Noe, Benoit; Varret, Mathilde; Abifadel, Marianne; Jondeau, Guillaume; Boileau, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat, INSERM U1148,Lab Vasc Translat Sci, F-75018 Paris, France; [Hanna, Nadine; Boileau, Catherine] Hop Bichat Claude Bernard, AP HP, Dept Genet, F-75018 Paris, France; [Guo, Dong-Chuan; Regalado, Ellen; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Milleron, Olivier; Gouya, Laurent; Jondeau, Guillaume; Boileau, Catherine] Hop Bichat Claude Bernard, AP HP, Serv Cardiol, Ctr Reference Syndromes Marfan & Apparentes, F-75018 Paris, France; [Milleron, Olivier; Gouya, Laurent; Jondeau, Guillaume; Boileau, Catherine] Univ Paris Diderot, UFR Med, F-75018 Paris, France; [Odent, Sylvie] Hop Sud CHU Rennes, Serv Genet Clin, F-35200 Rennes, France; [Dupuis-Girod, Sophie] CHU Lyon GH Est, Hop Louis Pradel, Serv Genet Clin, F-69677 Bron, France; [Faivre, Laurence] Univ Bourgogne, Equipe GAD, EA 4271, F-21000 Dijon, France; [Faivre, Laurence] Hop Enfants, Ctr Genet, F-21000 Dijon, France; [Faivre, Laurence] Hop Enfants, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21000 Dijon, France; [Edouard, Thomas; Dulac, Yves] CHU Toulouse, Hop Enfants, F-31059 Toulouse, France; [Busa, Tiffany] CHU Marseille, Hop La Timone, Dept Med Genet, F-13005 Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Health Science Center Houston; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; CHU Lyon; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU de Toulouse; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Boileau, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat, INSERM U1148,Lab Vasc Translat Sci, F-75018 Paris, France.	catherine.boileau@bch.aphp.fr	VARRET, Mathilde/C-2279-2016; Dupuis-Girod, Sophie/D-6268-2014; boileau, catherine/M-4482-2017; Aubart, Mélodie/AHA-5006-2022; Abifadel, Marianne/ABH-5370-2020; Edouard, Thomas/M-3155-2014; Dulac, Yves/ABB-1030-2020; Ho-Tin-Noé, Benoit/U-8059-2018	VARRET, Mathilde/0000-0001-9261-1551; boileau, catherine/0000-0002-0371-7539; Aubart, Mélodie/0000-0002-4383-7930; Edouard, Thomas/0000-0002-9222-5009; Dulac, Yves/0000-0002-7027-6358; Ho-Tin-Noé, Benoit/0000-0002-7428-1760; Regalado, Ellen/0000-0002-5859-218X; Gouya, Laurent/0000-0002-1326-7025; ABIFADEL, Marianne/0000-0001-7645-8323; Barbier, Mathieu/0000-0002-5154-2163; Faivre, Laurence/0000-0001-9770-444X; BUSA, Tiffany/0000-0003-4454-1979; HANNA, Nadine/0000-0001-5434-3111; Dupuis-Girod, Sophie/0000-0002-8834-5526	Projet Hospitalier de Recherche Clinique (PHRC) [AOM 10108]; Agence Nationale de Recherche (ANR) [GDPM2]; Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; DHU-FIRE (Assistance Publique-Hopitaux de Paris); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109942] Funding Source: NIH RePORTER	Projet Hospitalier de Recherche Clinique (PHRC); Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; DHU-FIRE (Assistance Publique-Hopitaux de Paris); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are extremely grateful to the families involved in this study and to the medical professionals who aided in the collection of clinical data from the families. We thank Jean-Baptiste Michel and Marie-Paule Jacob for fruitful discussions. We also thank Liliane Louedec, Zoubida Karim, and Narjesse Karboul for technical assistance. The following sources provided funding for this study: Projet Hospitalier de Recherche Clinique (PHRC, AOM 10108), Agence Nationale de Recherche (ANR, GDPM2), Federation Francaise de Cardiologie, Societe Francaise de Cardiologie, and DHU-FIRE (Assistance Publique-Hopitaux de Paris).	Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Aubart M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096387; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Combs MD, 2013, J BIOL CHEM, V288, P28869, DOI 10.1074/jbc.M113.497727; Detaint D, 2010, EUR HEART J, V31, P2223, DOI 10.1093/eurheartj/ehq258; Donovan LJ, 2013, MATRIX BIOL, V32, P117, DOI 10.1016/j.matbio.2012.11.009; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Frederic MY, 2009, HUM MUTAT, V30, P952, DOI 10.1002/humu.20970; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; Gillis E, 2013, CIRC RES, V113, P327, DOI 10.1161/CIRCRESAHA.113.300675; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Jondeau G, 2012, CURR ATHEROSCLER REP, V14, P219, DOI 10.1007/s11883-012-0241-4; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Lemaire R, 2007, J BIOL CHEM, V282, P800, DOI 10.1074/jbc.M609692200; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Miyamoto A., 2014, MATRIX BIOL; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Penner AS, 2002, J BIOL CHEM, V277, P35044, DOI 10.1074/jbc.M206363200; Raghunath M, 1999, J CELL SCI, V112, P1093; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	26	76	82	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					736	743		10.1016/j.ajhg.2014.10.018	http://dx.doi.org/10.1016/j.ajhg.2014.10.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25434006	Bronze, Green Published			2022-12-18	WOS:000346623100010
J	Simino, J; Shi, G; Bis, JC; Chasman, DI; Ehret, GB; Gu, XJ; Guo, XQ; Hwang, SJ; Sijbrands, E; Smith, AV; Verwoert, GC; Bragg-Gresham, JL; Cadby, G; Chen, P; Cheng, CY; Corre, TG; de Boer, RA; Goel, A; Johnson, T; Khor, CC; Lluis-Ganella, C; Luan, J; Lyytikainen, LP; Nolte, IM; Sim, XL; Sober, S; van der Most, PJ; Verweij, N; Zhao, JH; Amin, N; Boerwinkle, E; Bouchard, C; Dehghan, A; Eiriksdottir, G; Elosua, R; Franco, OH; Gieger, C; Harris, TB; Hercberg, S; Hofman, A; James, AL; Johnson, AD; Kahonen, M; Khaw, KT; Kutalik, Z; Larson, MG; Launer, LJ; Li, G; Liu, JJ; Liu, K; Morrison, AC; Navis, G; Ong, RTH; Papanicolau, GJ; Penninx, BW; Psaty, BM; Raffel, LJ; Raitakari, OT; Rice, K; Rivadeneira, F; Rose, LM; Sanna, S; Scott, RA; Siscovick, DS; Stolk, RP; Uitterlinden, AG; Vaidya, D; van der Klauw, MM; Vasan, RS; Vithana, EN; Volker, U; Volzke, H; Watkins, H; Young, TL; Aung, T; Bochud, M; Farrall, M; Hartman, CA; Laan, M; Lakatta, EG; Lehtimaki, T; Loos, RJF; Lucas, G; Meneton, P; Palmer, LJ; Rettig, R; Snieder, H; Tai, ES; Teo, YY; van der Harst, P; Wareham, NJ; Wijmenga, C; Wong, TY; Fornage, M; Gudnason, V; Levy, D; Palmas, W; Ridker, PM; Rotter, JI; van Duijn, CM; Witteman, JCM; Chakravarti, A; Rao, DC				Simino, Jeannette; Shi, Gang; Bis, Joshua C.; Chasman, Daniel I.; Ehret, Georg B.; Gu, Xiangjun; Guo, Xiuqing; Hwang, Shih-Jen; Sijbrands, Eric; Smith, Albert V.; Verwoert, Germaine C.; Bragg-Gresham, Jennifer L.; Cadby, Gemma; Chen, Peng; Cheng, Ching-Yu; Corre, Tanguy; de Boer, Rudolf A.; Goel, Anuj; Johnson, Toby; Khor, Chiea-Chuen; Lluis-Ganella, Carla; Luan, Jian'an; Lyytikainen, Leo-Pekka; Nolte, Ilja M.; Sim, Xueling; Sober, Siim; van der Most, Peter J.; Verweij, Niek; Zhao, Jing Hua; Amin, Najaf; Boerwinkle, Eric; Bouchard, Claude; Dehghan, Abbas; Eiriksdottir, Gudny; Elosua, Roberto; Franco, Oscar H.; Gieger, Christian; Harris, Tamara B.; Hercberg, Serge; Hofman, Albert; James, Alan L.; Johnson, Andrew D.; Kahonen, Mika; Khaw, Kay-Tee; Kutalik, Zoltan; Larson, Martin G.; Launer, Lenore J.; Li, Guo; Liu, Jianjun; Liu, Kiang; Morrison, Alanna C.; Navis, Gerjan; Ong, Rick Twee-Hee; Papanicolau, George J.; Penninx, Brenda W.; Psaty, Bruce M.; Raffel, Leslie J.; Raitakari, Olli T.; Rice, Kenneth; Rivadeneira, Fernando; Rose, Lynda M.; Sanna, Serena; Scott, Robert A.; Siscovick, David S.; Stolk, Ronald P.; Uitterlinden, Andre G.; Vaidya, Dhananjay; van der Klauw, Melanie M.; Vasan, Ramachandran S.; Vithana, Eranga Nishanthie; Voelker, Uwe; Voelzke, Henry; Watkins, Hugh; Young, Terri L.; Aung, Tin; Bochud, Murielle; Farrall, Martin; Hartman, Catharina A.; Laan, Maris; Lakatta, Edward G.; Lehtimaki, Terho; Loos, Ruth J. F.; Lucas, Gavin; Meneton, Pierre; Palmer, Lyle J.; Rettig, Rainer; Snieder, Harold; Tai, E. Shyong; Teo, Yik-Ying; van der Harst, Pim; Wareham, Nicholas J.; Wijmenga, Cisca; Wong, Tien Yin; Fornage, Myriam; Gudnason, Vilmundur; Levy, Daniel; Palmas, Walter; Ridker, Paul M.; Rotter, Jerome I.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.; Chakravarti, Aravinda; Rao, Dabeeru C.		LifeLines Cohort Study	Gene-Age Interactions in Blood Pressure Regulation: A Large-Scale Investigation with the CHARGE, Global BPgen, and ICBP Consortia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTIONS; INTERACTIONS IDENTIFY; SUSCEPTIBILITY LOCI; HYPERTENSION; METAANALYSIS; VARIANTS; DISEASE; POPULATION; FIBRINOGEN	Although age-dependent effects on blood pressure (BP) have been reported, they have not been systematically investigated in large-scale genome-wide association studies (GWASs). We leveraged the infrastructure of three well-established consortia (CHARGE, GBPgen, and ICBP) and a nonstandard approach (age stratification and metaregression) to conduct a genome-wide search of common variants with age-dependent effects on systolic (SBP), diastolic (DBP), mean arterial (MAP), and pulse (PP) pressure. In a two-staged design using 99,241 individuals of European ancestry, we identified 20 genome-wide significant (p <= 5 x 10(-8)) loci by using joint tests of the SNP main effect and SNP-age interaction. Nine of the significant loci demonstrated nominal evidence of age-dependent effects on BP by tests of the interactions alone. Index SNPs in the EHBP1L1 (DBP and MAP), CASZ1 (SBP and MAP), and GOSR2 (PP) loci exhibited the largest age interactions, with opposite directions of effect in the young versus the old. The changes in the genetic effects over time were small but nonnegligible (up to 1.58 mm Hg over 60 years). The EHBP1L1 locus was discovered through gene-age interactions only in whites but had DBP main effects replicated (p = 8.3 x 10(-4)) in 8,682 Asians from Singapore, indicating potential interethnic heterogeneity. A secondary analysis revealed 22 loci with evidence of age-specific effects (e.g., only in 20 to 29-year-olds). Age can be used to select samples with larger genetic effect sizes and more homogenous phenotypes, which may increase statistical power. Age-dependent effects identified through novel statistical approaches can provide insight into the biology and temporal regulation underlying BP associations.	[Simino, Jeannette; Shi, Gang; Rao, Dabeeru C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Bis, Joshua C.; Li, Guo; Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Ehret, Georg B.] Univ Hosp Geneva, Dept Specialties Internal Med, CH-1211 Geneva, Switzerland; [Gu, Xiangjun; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Res Ctr Human Genet, Houston, TX 77030 USA; [Guo, Xiuqing; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Guo, Xiuqing; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Hwang, Shih-Jen; Johnson, Andrew D.; Larson, Martin G.; Vasan, Ramachandran S.; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Hwang, Shih-Jen; Levy, Daniel] NHLBI, Ctr Populat Studies, Framingham, MA 01702 USA; [Sijbrands, Eric; Verwoert, Germaine C.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Smith, Albert V.; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Verwoert, Germaine C.; Amin, Najaf; Dehghan, Abbas; Franco, Oscar H.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Bragg-Gresham, Jennifer L.; Sim, Xueling] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Cadby, Gemma] Univ Western Australia, Ctr Genet Origins Hlth & Dis, Nedlands, WA 6009, Australia; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Genet Epidemiol & Biostat Platform, Toronto, ON M5G 0A3, Canada; [Cadby, Gemma; Palmer, Lyle J.] Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Chen, Peng; Cheng, Ching-Yu; Khor, Chiea-Chuen; Liu, Jianjun; Ong, Rick Twee-Hee; Tai, E. Shyong; Teo, Yik-Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Chen, Peng; Cheng, Ching-Yu; Khor, Chiea-Chuen; Liu, Jianjun; Ong, Rick Twee-Hee; Tai, E. Shyong; Teo, Yik-Ying] Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Cheng, Ching-Yu; Khor, Chiea-Chuen; Vithana, Eranga Nishanthie; Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 119228, Singapore; [Cheng, Ching-Yu; Khor, Chiea-Chuen; Vithana, Eranga Nishanthie; Aung, Tin; Wong, Tien Yin] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore 119228, Singapore; [Cheng, Ching-Yu; Vithana, Eranga Nishanthie; Aung, Tin; Wong, Tien Yin] Singapore Eye Res Inst, Singapore 168751, Singapore; [Cheng, Ching-Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore 169857, Singapore; [Corre, Tanguy; Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Corre, Tanguy; Kutalik, Zoltan] Swiss Inst Bioinforrnat, CH-1015 Lausanne, Switzerland; [de Boer, Rudolf A.; Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Goel, Anuj; Watkins, Hugh; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Goel, Anuj; Watkins, Hugh; Farrall, Martin] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford OX3 9DU, England; [Johnson, Toby] Queen Mary Univ London, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Khor, Chiea-Chuen; Liu, Jianjun] Genome Inst Singapore, Div Human Genet, Singapore 138672, Singapore; [Khor, Chiea-Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore; [Khor, Chiea-Chuen] Natl Univ Hlth Syst, Dept Paediat, Singapore 119074, Singapore; [Lluis-Ganella, Carla; Elosua, Roberto; Lucas, Gavin] IMIM Hosp Mar Med Res Inst, Barcelona 08003, Spain; [Luan, Jian'an; Zhao, Jing Hua; Scott, Robert A.; Loos, Ruth J. F.; Wareham, Nicholas J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere 30101, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, Tampere 33101, Finland; [Nolte, Ilja M.; van der Most, Peter J.; Stolk, Ronald P.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 119260, Singapore; [Sober, Siim; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Grp, EE-51010 Tartu, Estonia; [Boerwinkle, Eric; Morrison, Alanna C.; Fornage, Myriam] Univ Texas Houston, Hlth Sci Ctr, Human Genet Ctr, Houston, TX 77225 USA; [Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Elosua, Roberto] Epidemio1 & Publ Hlth Network CIBERESP, Barcelona 08036, Spain; [Gieger, Christian] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Hercberg, Serge] Univ Paris 13, Inst Natl Rech Agronom, U1125, Inst Natl Sante & Rech Med,U557, F-93000 Bobigny, France; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Nedlands, WA 6009, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Johnson, Andrew D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, NIH, Bethesda, MD 20892 USA; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, Tampere 33521, Finland; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; [Larson, Martin G.] Boston Univ, Dept Math, Boston, MA 02215 USA; [Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Papanicolau, George J.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, EMGO Inst, NL-1081 BT Amsterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2333 ZD Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Raffel, Leslie J.] Pacif Theatres, Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20521, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20521, Finland; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Sanna, Serena] CNR, Ist Ric Genet & Biomed, I-09042 Monserrato, Italy; [Uitterlinden, Andre G.; van Duijn, Cornelia M.] Netherlands Ctr Hlth Aging, Netherland Genom Inititiat, NL-2509 The Hague, Netherlands; [Vaidya, Dhananjay] Johns Hopkins Univ, Dept Med, Baltimore, MD 21202 USA; [van der Klauw, Melanie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Div Epidemiol & Cardiol, Boston, MA 02118 USA; [Vithana, Eranga Nishanthie] Duke NUS Grad Med Sch, Neurosci & Behav Disorders NBD Program, Singapore 169857, Singapore; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Young, Terri L.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Young, Terri L.] Duke Natl Univ Singapore, Div Neurosci, Singapore 169857, Singapore; [Bochud, Murielle] Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Pathol Emot, NL-9700 RB Groningen, Netherlands; [Lakatta, Edward G.] NIA, Lab Cardiovasc Sci, NIH, Bethesda, MD 21224 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Meneton, Pierre] Ctr Rech Cordeliers, Inst Natl Sante & Rech Med, U872, F-75006 Paris, France; [Rettig, Rainer] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, D-17495 Karlsburg, Germany; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Natl Univ Hlth Syst, Singapore 119228, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119228, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Life Sci Inst, Singapore 117456, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117543, Singapore; [Teo, Yik-Ying] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [van der Harst, Pim; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [van der Harst, Pim] Durrer Ctr Cardiogenet Res, NL-3501 DG Utrecht, Netherlands; [Levy, Daniel] Boston Univ, Sch Med, Boston, MA 02118 USA; [Palmas, Walter] Columbia Univ, Dept Med, New York, NY 10032 USA; [van Duijn, Cornelia M.] Ctr Med Syst Biol, Netherland Genom Initiat, NL-2300 RC Leiden, Netherlands; [Rao, Dabeeru C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Rao, Dabeeru C.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Rao, Dabeeru C.] Washington Univ, Sch Med, Dept Math, St Louis, MO 63110 USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; University of Geneva; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; University of Iceland; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Western Australia; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; University of Lausanne; Swiss Institute of Bioinformatics; University of Groningen; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; Queen Mary University London; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Cambridge; Tampere University; University of Groningen; National University of Singapore; University of Tartu; University of Texas System; University of Texas Health Science Center Houston; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; University of Western Australia; University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tampere University; Tampere University Hospital; Tampere University; University of Cambridge; Boston University; Northwestern University; Feinberg School of Medicine; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Cedars Sinai Medical Center; University of Turku; University of Turku; University of Washington; University of Washington Seattle; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Johns Hopkins University; University of Groningen; Boston University; National University of Singapore; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Duke University; National University of Singapore; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Groningen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ernst Moritz Arndt Universitat Greifswald; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Groningen; Boston University; Columbia University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Simino, J (corresponding author), Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA.	jeannette@wubios.wustl.edu; aravinda@jhmi.edu	Sijbrands, Eric/A-1065-2009; Verweij, Niek/ABC-6249-2021; Ramachandran, Vasan/Y-2527-2019; HERCBERG, Serge/B-4429-2008; Lyytikäinen, Leo-Pekka/C-8544-2016; Wong, Tien Yin/AAC-9724-2020; Palmer, Lyle John/N-1948-2019; Dehghan, Abbas/ABE-7377-2020; Loos, Ruth J F/Q-2862-2016; Penninx, Brenda WJH/S-7627-2017; Sim, Xueling/AAZ-6652-2020; Lakatta, Edward G/AAL-1447-2020; Cadby, Gemma/AAE-3849-2022; Khaw, Kay-Tee/AAZ-3209-2021; sanna, serena/H-3009-2019; Wijmenga, Cisca/AAE-7719-2019; Hwang, Shih-Jen/HGU-5826-2022; Serge, Hercberg/F-3038-2017; Rivadeneira, Fernando/O-5385-2015; Chen, Peng/E-5546-2015; Bochud, Murielle/A-3981-2010; Meneton, Pierre/T-1216-2019; Palmer, Lyle John/K-3196-2014; Vaidya, Dhananjay/AAL-5684-2020; Smith, Albert Vernon/K-5150-2015; Johnson, Andrew D/G-6520-2013; Levy, Daniel/ABB-2752-2021; Cheng, Ching-Yu/Y-2229-2019; Verweij, Niek/A-4499-2017; Ormel, Johan/C-6094-2013; Laan, Maris/A-4100-2011; Bouchard, Claude/A-7637-2009; Shi, Gang/D-3301-2016; Raitakari, Olli/AAQ-7389-2021; EHRET, Georg B/A-9532-2009; Wijmenga, Cisca/D-2173-2009; Loos, Ruth/GON-5877-2022; de Boer, Rudolf/ABE-9879-2020; Franco, Óscar H/ABE-2305-2020; Rotter, Jerome/AAY-6598-2021; Bouchard, Claude/AAE-2035-2019; Gudnason, Vilmundur/K-6885-2015; Lehtimäki, Terho/AAD-1094-2022; Gudnason, Vilmundur/AAE-7126-2019; Levy, Daniel/ABF-6873-2021; Colaus, PsyColaus/K-6607-2013; Liu, Jianjun/AAK-4989-2020; Dehghan, Abbas/B-9896-2008; Franke, Lude/P-7036-2016	Sijbrands, Eric/0000-0001-8857-7389; Verweij, Niek/0000-0002-4303-7685; Ramachandran, Vasan/0000-0001-7357-5970; HERCBERG, Serge/0000-0002-3168-1350; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Wong, Tien Yin/0000-0002-8448-1264; Palmer, Lyle John/0000-0002-1628-3055; Loos, Ruth J F/0000-0002-8532-5087; Penninx, Brenda WJH/0000-0001-7779-9672; Sim, Xueling/0000-0002-1233-7642; sanna, serena/0000-0002-3768-1749; Wijmenga, Cisca/0000-0002-5635-1614; Serge, Hercberg/0000-0002-3168-1350; Rivadeneira, Fernando/0000-0001-9435-9441; Chen, Peng/0000-0002-1422-4641; Bochud, Murielle/0000-0002-5727-0218; Palmer, Lyle John/0000-0002-1628-3055; Vaidya, Dhananjay/0000-0002-7164-1601; Smith, Albert Vernon/0000-0003-1942-5845; Johnson, Andrew D/0000-0001-6369-5178; Cheng, Ching-Yu/0000-0003-0655-885X; Laan, Maris/0000-0002-8519-243X; Bouchard, Claude/0000-0002-0048-491X; EHRET, Georg B/0000-0002-5730-0675; Franco, Óscar H/0000-0002-4606-4929; Gudnason, Vilmundur/0000-0001-5696-0084; Lehtimäki, Terho/0000-0002-2555-4427; Gudnason, Vilmundur/0000-0001-5696-0084; Levy, Daniel/0000-0003-1843-8724; Liu, Jianjun/0000-0002-3255-3019; Amin, Najaf/0000-0002-8944-1771; Khor, Chiea Chuen/0000-0002-1128-4729; Kahonen, Mika/0000-0002-4510-7341; Johnson, Toby/0000-0002-5998-3270; Goel, Anuj/0000-0003-2307-4021; Lakatta, Edward/0000-0002-4772-0035; Gieger, Christian/0000-0001-6986-9554; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; Morrison, Alanna/0000-0001-6381-4296; Van Duijn, Cornelia/0000-0002-2374-9204; Dehghan, Abbas/0000-0001-6403-016X; Watkins, Hugh/0000-0002-5287-9016; Stolk, Ronald/0000-0002-0518-1205; ELOSUA, ROBERTO/0000-0001-8235-0095; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Franke, Lude/0000-0002-5159-8802; Tai, E Shyong/0000-0003-2929-8966; Lucas, Gavin/0000-0003-4166-9416; Volker, Uwe/0000-0002-5689-3448; Lluis-Ganella, Carla/0000-0001-7609-5497	Medtronic; Amgen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, ZIAHL006001, R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007380] Funding Source: NIH RePORTER; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0701863, MC_U106179471, MC_UU_12015/1, G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135, NF-SI-0512-10114] Funding Source: researchfish; MRC [G0701863, MC_UU_12015/1] Funding Source: UKRI	Medtronic(Medtronic); Amgen(Amgen); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	B.M.P. served on a data and safety monitoring board for a clinical trial (Zoll LifeCor) and a steering committee for the Yale Open Data Access Project funded by Medtronic. P.M.R. received a grant from Amgen (>$10,000) for genotyping the WGHS. A.C. is on the Science Advisory Board of Affymetrix and Biogen Idec.	Bao XP, 2005, HYPERTENSION, V46, P301, DOI 10.1161/01.HYP.0000175842.19266.95; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Basson J, 2014, AM J HYPERTENS, V27, P431, DOI [10.1093/ajh/hpu149, 10.1093/ajh/hpt283]; Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Bhatnagar V, 2012, AM J HYPERTENS, V25, P1188, DOI 10.1038/ajh.2012.106; BIRKENFELD A, 1984, CLIN EXP IMMUNOL, V55, P651; Boardman JD, 2014, DEMOGRAPHY, V51, P119, DOI 10.1007/s13524-013-0259-4; Bookman EB, 2011, GENET EPIDEMIOL, V35, P217, DOI 10.1002/gepi.20571; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Edwards DRV, 2013, HUM GENET, V132, P323, DOI 10.1007/s00439-012-1246-3; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; FIGUEROA JD, 2014, CARCINOGENESIS; Flynn JT, 2011, CLIN HYPERTENS VASC, P1, DOI 10.1007/978-1-60327-824-9; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Franklin SS, 1997, CIRCULATION, V96, P308; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gauderman WJ, 2013, GENET EPIDEMIOL, V37, P603, DOI 10.1002/gepi.21748; HAVLIK RJ, 1979, AM J EPIDEMIOL, V110, P304, DOI 10.1093/oxfordjournals.aje.a112815; Izzo JL, 2001, HYPERTENSION, V37, P1067, DOI 10.1161/01.HYP.37.4.1067; Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; LANDAHL S, 1986, HYPERTENSION, V8, P1044, DOI 10.1161/01.HYP.8.11.1044; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liao SY, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-101; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Liu ZT, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/490289; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; Oien DB, 2008, FREE RADICAL BIO MED, V45, P193, DOI 10.1016/j.freeradbiomed.2008.04.003; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Pearson JD, 1997, J GERONTOL A-BIOL, V52, pM177, DOI 10.1093/gerona/52A.3.M177; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Shi G, 2009, HYPERTENSION, V53, P35, DOI 10.1161/HYPERTENSIONAHA.108.120071; Siegert S, 2013, HUM GENET, V132, P219, DOI 10.1007/s00439-012-1239-2; Simino Jeannette, 2013, Frontiers in Genetics, V4, P277, DOI 10.3389/fgene.2013.00277; Sohns M, 2013, GENET EPIDEMIOL, V37, P551, DOI 10.1002/gepi.21741; Strazzullo P, 2001, J HYPERTENS, V19, P399, DOI 10.1097/00004872-200103000-00007; Surakka I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002333; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; TAMBS K, 1993, HYPERTENSION, V22, P789, DOI 10.1161/01.HYP.22.5.789; Tang HW, 2014, CANCER EPIDEM BIOMAR, V23, P98, DOI 10.1158/1055-9965.EPI-13-0437-T; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang LY, 2014, ARTERIOSCL THROM VAS, V34, P219, DOI 10.1161/ATVBAHA.113.302706; Wang XL, 2011, CLIN HYPERTENS VASC, P241, DOI 10.1007/978-1-60327-824-9_14; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088088; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459; ZHANG R, 2014, CARCINOGENESIS	56	76	77	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					24	38		10.1016/j.ajhg.2014.05.010	http://dx.doi.org/10.1016/j.ajhg.2014.05.010			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24954895	Bronze, Green Published			2022-12-18	WOS:000338904100002
J	Blumenthal, I; Ragavendran, A; Erdin, S; Klei, L; Sugathan, A; Guide, JR; Manavalan, P; Zhou, JQ; Wheeler, VC; Levin, JZ; Ernst, C; Roeder, K; Devlin, B; Gusella, JF; Talkowski, ME				Blumenthal, Ian; Ragavendran, Ashok; Erdin, Serkan; Klei, Lambertus; Sugathan, Aarathi; Guide, Jolene R.; Manavalan, Poornima; Zhou, Julian Q.; Wheeler, Vanessa C.; Levin, Joshua Z.; Ernst, Carl; Roeder, Kathryn; Devlin, Bernie; Gusella, James F.; Talkowski, Michael E.			Transcriptional Consequences of 16p11.2 Deletion and Duplication in Mouse Cortex and Multiplex Autism Families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; LONG-RANGE INTERACTIONS; COPY NUMBER VARIATION; DE-NOVO MUTATIONS; ENRICHMENT ANALYSIS; FUNCTIONAL IMPACT; SPECTRUM; REVEALS; MODELS; KNOWLEDGEBASE	Reciprocal copy-number variation (CNV) of a 593 kb region of 16p11.2 is a common genetic cause of autism spectrum disorder (ASD), yet it is not completely penetrant and can manifest in a wide array of phenotypes. To explore its molecular consequences, we performed RNA sequencing of cerebral cortex from mouse models with CNV of the syntenic 7qF3 region and lymphoblast lines from 34 members of 7 multiplex ASD-affected families harboring the 16p11.2 CNV. Expression of all genes in the CNV region correlated well with their DNA copy number, with no evidence of dosage compensation. We observed effects on gene expression outside the CNV region, including apparent positional effects in cis and in trans at genomic segments with evidence of physical interaction in Hi-C chromosome conformation data. One of the most significant positional effects was telomeric to the 16p11.2 CNV and includes the previously described "distal" 16p11.2 microdeletion. Overall, 16p11.2 CNV was associated with altered expression of genes and networks that converge on multiple hypotheses of ASD pathogenesis, including synaptic function (e.g., NRXN1, NRXN3), chromatin modification (e.g., CHD8, EHMT1, MECP2), transcriptional regulation (e.g., TCF4, SATB2), and intellectual disability (e.g., FMR1, CEP290). However, there were differences between tissues and species, with the strongest effects being consistently within the CNV region itself. Our analyses suggest that through a combination of indirect regulatory effects and direct effects on nuclear architecture, alteration of 16p11.2 genes disrupts expression networks that involve other genes and pathways known to contribute to ASD, suggesting an overlap in mechanisms of pathogenesis.	[Blumenthal, Ian; Ragavendran, Ashok; Erdin, Serkan; Sugathan, Aarathi; Guide, Jolene R.; Manavalan, Poornima; Wheeler, Vanessa C.; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Blumenthal, Ian; Ragavendran, Ashok; Erdin, Serkan; Sugathan, Aarathi; Guide, Jolene R.; Manavalan, Poornima; Wheeler, Vanessa C.; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Dept Psychiat, Sch Med, Pittsburgh, PA 15213 USA; [Levin, Joshua Z.; Gusella, James F.; Talkowski, Michael E.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Ernst, Carl] McGill Univ, Dept Psychiat, Douglas Hosp, Res Inst, Verdun, PQ H4H 1R3, Canada; [Zhou, Julian Q.; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02141 USA; [Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Genet, Boston, MA 02141 USA; [Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02141 USA; [Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02141 USA; [Gusella, James F.; Talkowski, Michael E.] Harvard Univ, Sch Med, Boston, MA 02141 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; Carnegie Mellon University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA.	talkowski@chgr.mgh.harvard.edu	Erdin, Serkan/AAE-4288-2019; Erdin, Serkan/B-4988-2008	Erdin, Serkan/0000-0001-6587-2625; Talkowski, Michael/0000-0003-2889-0992; Levin, Joshua/0000-0002-0170-3598; Roeder, Kathryn/0000-0002-8869-6254; Zhou, Julian/0000-0001-9602-2092	National Institute of Mental Health [MH095867, R37 MH057881, 1U24MH081810]; Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; Brain and Behavorial Research Foundation (NARSAD); Autism Genetic Resource Exchange (AGRE) and Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, U24MH081810, R00MH095867] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; Brain and Behavorial Research Foundation (NARSAD)(NARSAD); Autism Genetic Resource Exchange (AGRE) and Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Mills for development of the mouse models and AGRE for providing biological materials. These studies were supported by the National Institute of Mental Health (MH095867 to M.E.T., R37 MH057881 to B.D. and K.R.), the Simons Foundation for Autism Research (M.E.T., J.F.G.), the Nancy Lurie Marks Family Foundation (M.E.T., J.F.G.), and the Brain and Behavorial Research Foundation (NARSAD; M.E.T.). We also acknowledge support from the Autism Genetic Resource Exchange (AGRE) and Autism Speaks (to J.F.G.). We gratefully acknowledge the resources provided by the AGRE consortium and the participating AGRE families. The Autism Genetic Resource Exchange (AGRE) is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI).	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Agresti A., 2003, CATEGORICAL DATA ANA; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2011, STAND GUID BEST PRAC; Atkins DC, 2013, PSYCHOL ADDICT BEHAV, V27, P166, DOI 10.1037/a0029508; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Barge-Schaapveld DQCM, 2011, AM J MED GENET A, V155A, P1066, DOI 10.1002/ajmg.a.33991; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Blaker-Lee A, 2012, DIS MODEL MECH, V5, P834, DOI 10.1242/dmm.009944; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Colnaghi R, 2011, SEMIN CELL DEV BIOL, V22, P875, DOI 10.1016/j.semcdb.2011.07.010; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Girirajan S, 2013, HUM MOL GENET, V22, P2870, DOI 10.1093/hmg/ddt136; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Hodge JC, 2014, MOL PSYCHIATR, V19, P368, DOI 10.1038/mp.2013.42; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lintas C, 2012, NEUROBIOL DIS, V45, P57, DOI 10.1016/j.nbd.2010.11.010; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mullegama SV, 2014, EUR J HUM GENET, V22, P57, DOI 10.1038/ejhg.2013.67; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Rosenfeld JA, 2013, GENET MED, V15, P478, DOI 10.1038/gim.2012.164; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Vazquez AI, 2010, J ANIM SCI, V88, P497, DOI 10.2527/jas.2009-1952; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1198/TECH.2003.S33, 10.1007/978-0-387-21706-2]; Voineagu I, 2012, NEUROBIOL DIS, V45, P69, DOI 10.1016/j.nbd.2011.07.017; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams SR, 2010, EUR J HUM GENET, V18, P436, DOI 10.1038/ejhg.2009.199; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Young MD, 2012, BIOINFORMATICS FOR HIGH THROUGHPUT SEQUENCING, P169, DOI 10.1007/978-1-4614-0782-9_10; Zeitz MJ, 2013, NUCLEUS-PHILA, V4, P487, DOI 10.4161/nucl.27364; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	70	76	76	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					870	883		10.1016/j.ajhg.2014.05.004	http://dx.doi.org/10.1016/j.ajhg.2014.05.004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24906019	Bronze, Green Published			2022-12-18	WOS:000337331200007
J	Tuz, K; Bachmann-Gagescu, R; O'Day, DR; Hua, K; Isabella, CR; Phelps, IG; Stolarski, AE; O'Roak, BJ; Dempsey, JC; Lourenco, C; Alswaid, A; Bonnemann, CG; Medne, L; Nampoothiri, S; Stark, Z; Leventer, RJ; Topcu, M; Cansu, A; Jagadeesh, S; Done, S; Ishak, GE; Glass, IA; Shendure, J; Neuhauss, SCF; Haldeman-Englert, CR; Doherty, D; Ferland, RJ				Tuz, Karma; Bachmann-Gagescu, Ruxandra; O'Day, Diana R.; Hua, Kiet; Isabella, Christine R.; Phelps, Ian G.; Stolarski, Allan E.; O'Roak, Brian J.; Dempsey, Jennifer C.; Lourenco, Charles; Alswaid, Abdulrahman; Boennemann, Carsten G.; Medne, Livija; Nampoothiri, Sheela; Stark, Zornitza; Leventer, Richard J.; Topcu, Meral; Cansu, Ali; Jagadeesh, Sujatha; Done, Stephen; Ishak, Gisele E.; Glass, Ian A.; Shendure, Jay; Neuhauss, Stephan C. F.; Haldeman-Englert, Chad R.; Doherty, Dan; Ferland, Russell J.			Mutations in CSPP1 Cause Primary Cilia Abnormalities and Joubert Syndrome with or without Jeune Asphyxiating Thoracic Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; LOCALIZATION; CILIOGENESIS; GENES; CILIOPATHIES; MEMBRANE; SPECTRUM; INSIGHTS; ENCODES; DISEASE	Joubert syndrome (JBTS) is a recessive ciliopathy in which a subset of affected individuals also have the skeletal dysplasia Jeune asphyxiating thoracic dystrophy (JATD). Here, we have identified biallelic truncating CSPP1 (centrosome and spindle pole associated protein 1) mutations in 19 JBTS-affected individuals, four of whom also have features of JATD. CSPP1 mutations explain similar to 5% of JBTS in our cohort, and despite truncating mutations in all affected individuals, the range of phenotypic severity is broad. Morpholino knockdown of cspp1 in zebrafish caused phenotypes reported in other zebrafish models of JBTS (curved body shape, pronephric cysts, and cerebellar abnormalities) and reduced ciliary localization of Arl13b, further supporting loss of CSPP1 function as a cause of JBTS. Fibroblasts from affected individuals with CSPP1 mutations showed reduced numbers of primary cilia and/or short primary cilia, as well as reduced axonemal localization of ciliary proteins ARL13B and adenylyl cyclase III. In summary, CSPP1 mutations are a major cause of the Joubert-Jeune phenotype in humans; however, the mechanism by which these mutations lead to both JBTS and JATD remains unknown.	[Tuz, Karma; Hua, Kiet; Stolarski, Allan E.; Ferland, Russell J.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Bachmann-Gagescu, Ruxandra; Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Bachmann-Gagescu, Ruxandra] Univ Zurich, Inst Med Genet, CH-8603 Zurich, Switzerland; [O'Day, Diana R.; Isabella, Christine R.; Phelps, Ian G.; Dempsey, Jennifer C.; Glass, Ian A.; Doherty, Dan] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [O'Day, Diana R.; Isabella, Christine R.; Phelps, Ian G.; Dempsey, Jennifer C.; Glass, Ian A.; Doherty, Dan] Univ Washington, Dept Pediat, Div Dev Med, Seattle, WA 98195 USA; [O'Roak, Brian J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Lourenco, Charles] Univ Sao Paulo, Sch Med Ribeirao Preto, Clin Hosp, Neurogenet Div, BR-14049900 Sao Paulo, Brazil; [Alswaid, Abdulrahman] King Abdul Aziz Med City, Dept Pediat, Riyadh 11426, Saudi Arabia; [Boennemann, Carsten G.] NIH, Neuromuscular & Neurogenet Disorders Childhood Se, John Edward Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; [Medne, Livija] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Nampoothiri, Sheela] AIMS Ponekkara PO, Amrita Inst Med Sci & Res Ctr, Dept Pediat Genet, Kochi 682041, Kerala, India; [Stark, Zornitza] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [Leventer, Richard J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Neurol, Parkville, Vic 3052, Australia; [Leventer, Richard J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Pediat, Parkville, Vic 3052, Australia; [Leventer, Richard J.] Univ Melbourne, Parkville, Vic 3052, Australia; [Topcu, Meral] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Child Neurol, TR-06100 Ankara, Turkey; [Cansu, Ali] Karadeniz Tech Univ, Pediat Neurol Unit, TR-61080 Trabzon, Turkey; [Jagadeesh, Sujatha] MediScan Syst, Madras 600004, Tamil Nadu, India; [Done, Stephen; Ishak, Gisele E.] Univ Washington, Dept Radiol, Seattle, WA 98105 USA; [Done, Stephen; Ishak, Gisele E.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Glass, Ian A.; Doherty, Dan] Seattle Childrens Hosp, Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Haldeman-Englert, Chad R.] Wake Forest Sch Med, Dept Pediat, Med Genet Sect, Winston Salem, NC 27157 USA; [Ferland, Russell J.] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA	Albany Medical College; University of Zurich; University of Zurich; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University; Universidade de Sao Paulo; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; National Institutes of Health (NIH) - USA; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Murdoch Children's Research Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Hacettepe University; Karadeniz Technical University; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Wake Forest University; Albany Medical College	Doherty, D (corresponding author), Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA.	ddoher@uw.edu; ferlanr@mail.amc.edu	Cansu, Ali/AAL-6667-2021; Neuhauss, Stephan/AAX-9915-2020; Ferland, Russell/Q-6793-2019; Nampoothiri, Sheela/AAQ-4854-2021; Shendure, Jay/AAU-3684-2021; Bachmann-Gagescu, Ruxandra/A-8444-2016	Neuhauss, Stephan/0000-0002-9615-480X; Ferland, Russell/0000-0002-8044-2479; Nampoothiri, Sheela/0000-0002-9575-0722; Bachmann-Gagescu, Ruxandra/0000-0002-3571-5271; Isabella, Christine/0000-0003-0786-7240; Tuz, Karina/0000-0002-1669-4612; Stolarski, Allan/0000-0002-7148-2639; Hua, Kiet/0000-0001-8599-3969; O'Roak, Brian/0000-0002-4141-0095; Shendure, Jay/0000-0002-1516-1865	Swiss National Science Foundation [PZ00P3_142404]; March of Dimes Foundation [5-FY09-29]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS064077]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health (University of Washington Intellectual and Developmental Disabilities Research Center Genetics Core) [P30HD002274, R01NS064283]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064283, ZIANS003129, R01NS064077] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); March of Dimes Foundation(March of Dimes); National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders and Stroke of the National Institutes of Health (University of Washington Intellectual and Developmental Disabilities Research Center Genetics Core); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Our deepest thanks go to all of the individuals with Joubert syndrome and their families. This work was supported in part by the Swiss National Science Foundation (PZ00P3_142404 to R.B.-G.), the March of Dimes Foundation (5-FY09-29 to R.J.F.), and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01NS064077 and University of Washington Intellectual and Developmental Disabilities Research Center Genetics Core P30HD002274 to D.D. and R01NS064283 to R.J.F.). We also acknowledge private donations from the families of children with Joubert syndrome.	Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; JEUNE M, 1955, Arch Fr Pediatr, V12, P886; Keppler-Noreuil KM, 2011, AM J MED GENET A, V155A, P1021, DOI 10.1002/ajmg.a.33892; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Lehman AM, 2010, AM J MED GENET A, V152A, P1411, DOI 10.1002/ajmg.a.33416; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McInerney-Leo AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/j.ajhg.2013.06.022; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; OBERKLAID F, 1977, ARCH DIS CHILD, V52, P758, DOI 10.1136/adc.52.10.758; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Poretti A, 2011, AM J NEURORADIOL, V32, P1459, DOI 10.3174/ajnr.A2517; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sattar S, 2011, DEV MED CHILD NEUROL, V53, P793, DOI 10.1111/j.1469-8749.2011.04021.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tuz K, 2013, J BIOL CHEM, V288, P13676, DOI 10.1074/jbc.M112.420786; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE	34	76	79	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					62	72		10.1016/j.ajhg.2013.11.019	http://dx.doi.org/10.1016/j.ajhg.2013.11.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360808	Bronze, Green Published			2022-12-18	WOS:000329888400006
J	Meyer, KB; O'Reilly, M; Michailidou, K; Carlebur, S; Edwards, SL; French, JD; Prathalingham, R; Dennis, J; Bolla, MK; Wang, Q; de Santiago, I; Hopper, JL; Tsimiklis, H; Apicella, C; Southey, MC; Schmidt, MK; Broeks, A; Van't Veer, LJ; Hogervorst, FB; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Fasching, PA; Lux, MP; Ekici, AB; Beckmann, MW; Peto, J; Silva, ID; Fletcher, O; Johnson, N; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Marme, F; Schneeweiss, A; Sohn, C; Burwinkel, B; Guenel, P; Truong, T; Laurent-Puig, P; Menegaux, F; Bojesen, SE; Nordestgaard, BG; Nielsen, SF; Flyger, H; Milne, RL; Zamora, MP; Arias, JI; Benitez, J; Neuhausen, S; Anton-Culver, H; Ziogas, A; Dur, CC; Brenner, H; Muller, H; Arndt, V; Stegmaier, C; Meindl, A; Schmutzler, RK; Engel, C; Ditsch, N; Brauch, H; Bruning, T; Ko, YD; Nevanlinna, H; Muranen, TA; Aittomaki, K; Blomqvist, C; Matsuo, K; Ito, H; Iwata, H; Yatabe, Y; Dork, T; Helbig, S; Bogdanova, NV; Lindblom, A; Margolin, S; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Chenevix-Trench, G; Wu, AH; Tseng, CC; Van Den Berg, D; Stram, DO; Lambrechts, D; Thienpont, B; Christiaens, MR; Smeets, A; Chang-Claude, J; Rudolph, A; Seibold, P; Flesch-Janys, D; Radice, P; Peterlongo, P; Bonanni, B; Bernard, L; Couch, FJ; Olson, JE; Wang, XS; Purrington, K; Giles, GG; Severi, G; Baglietto, L; McLean, C; Haiman, CA; Henderson, BE; Schumacher, F; Le Marchand, L; Simard, J; Goldberg, MS; Labreche, F; Dumont, M; Teo, SH; Yip, CH; Phuah, SY; Kristensen, V; Alnaes, GG; Borresen-Dale, AL; Zheng, W; Deming-Halverson, S; Shrubsole, M; Long, JR; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Kauppila, S; Andrulis, IL; Knight, JA; Glendon, G; Tchatchou, S; Devilee, P; Tollenaar, RAEM; Seynaeve, CM; Garcia-Closas, M; Figueroa, J; Chanock, SJ; Lissowska, J; Czene, K; Darabi, H; Eriksson, K; Hooning, MJ; Martens, JWM; van den Ouweland, AMW; van Deurzen, CHM; Hall, P; Li, JM; Liu, JJ; Humphreys, K; Shu, XO; Lu, W; Gao, YT; Cai, H; Cox, A; Reed, MWR; Blot, W; Signorello, LB; Cai, QY; Pharoah, PDP; Ghoussaini, M; Harrington, P; Tyrer, J; Kang, D; Choi, JY; Park, SK; Noh, DY; Hartman, M; Hui, M; Lim, WY; Buhari, SA; Hamann, U; Forsti, A; Rudiger, T; Ulmer, HU; Jakubowska, A; Lubinski, J; Jaworska, K; Durda, K; Sangrajrang, S; Gaborieau, V; Brennan, P; Mckay, J; Vachon, C; Slager, S; Fostira, F; Pilarski, R; Shen, CY; Hsiung, CN; Wu, PE; Hou, MF; Swerdlow, A; Ashworth, A; Orr, N; Schoemaker, MJ; Ponder, BAJ; Dunning, AM; Easton, DF				Meyer, Kerstin B.; O'Reilly, Martin; Michailidou, Kyriaki; Carlebur, Saskia; Edwards, Stacey L.; French, Juliet D.; Prathalingham, Radhika; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; de Santiago, Ines; Hopper, John L.; Tsimiklis, Helen; Apicella, Carmel; Southey, Melissa C.; Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Hogervorst, Frans B.; Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pornthep; Fasching, Peter A.; Lux, Michael P.; Ekici, Arif B.; Beckmann, Matthias W.; Peto, Julian; Silva, Isabel dos Santos; Fletcher, Olivia; Johnson, Nichola; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Marme, Federick; Schneeweiss, Andreas; Sohn, Christof; Burwinkel, Barbara; Guenel, Pascal; Truong, Therese; Laurent-Puig, Pierre; Menegaux, Florence; Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.; Flyger, Henrik; Milne, Roger L.; Pilar Zamora, M.; Arias, Jose I.; Benitez, Javier; Neuhausen, Susan; Anton-Culver, Hoda; Ziogas, Argyrios; Dur, Christina C.; Brenner, Hermann; Mueller, Heiko; Arndt, Volker; Stegmaier, Christa; Meindl, Alfons; Schmutzler, Rita K.; Engel, Christoph; Ditsch, Nina; Brauch, Hiltrud; Bruening, Thomas; Ko, Yon-Dschun; Nevanlinna, Heli; Muranen, Taru A.; Aittomaeki, Kristiina; Blomqvist, Carl; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Yatabe, Yasushi; Doerk, Thilo; Helbig, Sonja; Bogdanova, Natalia V.; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Chenevix-Trench, Georgia; Wu, Anna H.; Tseng, Chiu-chen; Van Den Berg, David; Stram, Daniel O.; Lambrechts, Diether; Thienpont, Bernard; Christiaens, Marie-Rose; Smeets, Ann; Chang-Claude, Jenny; Rudolph, Anja; Seibold, Petra; Flesch-Janys, Dieter; Radice, Paolo; Peterlongo, Paolo; Bonanni, Bernardo; Bernard, Loris; Couch, Fergus J.; Olson, Janet E.; Wang, Xianshu; Purrington, Kristen; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; McLean, Catriona; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick; Le Marchand, Loic; Simard, Jacques; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Teo, Soo-Hwang; Yip, Cheng-Har; Phuah, Sze-Yee; Kristensen, Vessela; Alnaes, Grethe Grenaker; Borresen-Dale, Anne-Lise; Zheng, Wei; Deming-Halverson, Sandra; Shrubsole, Martha; Long, Jirong; Winqvist, Robert; Pylkaes, Katri; Jukkola-Vuorinen, Arja; Kauppila, Saila; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Tchatchou, Sandrine; Devilee, Peter; Tollenaar, Robert A. E. M.; Seynaeve, Caroline M.; Garcia-Closas, Montserrat; Figueroa, Jonine; Chanock, Stephen J.; Lissowska, Jolanta; Czene, Kamila; Darabi, Hartef; Eriksson, Kimael; Hooning, Maartje J.; Martens, John W. M.; van den Ouweland, Ans M. W.; van Deurzen, Carolien H. M.; Hall, Per; Li, Jingmei; Liu, Jianjun; Humphreys, Keith; Shu, Xiao-Ou; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Cox, Angela; Reed, Malcolm W. R.; Blot, William; Signorello, Lisa B.; Cai, Qiuyin; Pharoah, Paul D. P.; Ghoussaini, Maya; Harrington, Patricia; Tyrer, Jonathan; Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Noh, Dong-Young; Hartman, Mikael; Hui, Miao; Lim, Wei-Yen; Buhari, Shaik A.; Hamann, Ute; Foersti, Asta; Ruediger, Thomas; Ulmer, Hans-Ulrich; Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Durda, Katarzyna; Sangrajrang, Suleeporn; Gaborieau, Valerie; Brennan, Paul; Mckay, James; Vachon, Celine; Slager, Susan; Fostira, Florentia; Pilarski, Robert; Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei; Hou, Ming-Feng; Swerdlow, Anthony; Ashworth, Alan; Orr, Nick; Schoemaker, Minouk J.; Ponder, Bruce A. J.; Dunning, Alison M.; Easton, Douglas F.		Network, G; Investigators, K; Group, AOCS	Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ESTROGEN-RECEPTOR BINDING; AFRICAN-AMERICAN; EXPRESSION; SUSCEPTIBILITY; TRANSCRIPTION; DETERMINANT; REVEALS	The 10q26 locus in the second intron of FGFR2 is the locus most strongly associated with estrogen-receptor-positive breast cancer in genome-wide association studies. We conducted fine-scale mapping in case-control studies genotyped with a custom chip (iCOGS), comprising 41 studies (n = 89,050) of European ancestry, 9 Asian ancestry studies (n = 13,983), and 2 African ancestry studies (n = 2,028) from the Breast Cancer Association Consortium. We identified three statistically independent risk signals within the locus. Within risk signals 1 and 3, genetic analysis identified five and two variants, respectively, highly correlated with the most strongly associated SNPs. By using a combination of genetic fine mapping, data on DNase hypersensitivity, and electrophoretic mobility shift assays to study protein-DNA binding, we identified rs35054928, rs2981578, and rs45631563 as putative functional SNPs. Chromatin immunoprecipitation showed that FOXA1 preferentially bound to the risk-associated allele (C) of rs2981578 and was able to recruit ER alpha to this site in an allele-specific manner, whereas E2F1 preferentially bound the risk variant of rs35054928. The risk alleles were preferentially found in open chromatin and bound by Ser5 phosphorylated RNA polymerase II, suggesting that the risk alleles are associated with changes in transcription. Chromatin conformation capture demonstrated that the risk region was able to interact with the promoter of FGFR2, the likely target gene of this risk region. A role for FOXA1 in mediating breast cancer susceptibility at this locus is consistent with the finding that the FGFR2 risk locus primarily predisposes to estrogen-receptor-positive disease.	[Meyer, Kerstin B.; O'Reilly, Martin; Carlebur, Saskia; Prathalingham, Radhika; de Santiago, Ines; Ponder, Bruce A. J.] Univ Cambridge, CRUK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England; [Meyer, Kerstin B.; O'Reilly, Martin; Carlebur, Saskia; Prathalingham, Radhika; de Santiago, Ines; Ponder, Bruce A. J.] Univ Cambridge, Dept Oncol, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Michailidou, Kyriaki; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; Pharoah, Paul D. P.; Ghoussaini, Maya; Harrington, Patricia; Tyrer, Jonathan; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Michailidou, Kyriaki; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; Pharoah, Paul D. P.; Ghoussaini, Maya; Harrington, Patricia; Tyrer, Jonathan; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England; [Edwards, Stacey L.; French, Juliet D.; Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld 4029, Australia; [Edwards, Stacey L.; French, Juliet D.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hopper, John L.; Apicella, Carmel; Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Tsimiklis, Helen; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Hogervorst, Frans B.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Muir, Kenneth] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Div Hlth Sci, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Bangkok 10400, Thailand; [Fasching, Peter A.; Lux, Michael P.] Univ Erlangen Nurnberg, Univ Breast Ctr Franconia, Dept Gynecol & Obstet, Univ Hosp Erlangen, D-91054 Erlangen, Germany; [Fasching, Peter A.; Ekici, Arif B.; Beckmann, Matthias W.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Peto, Julian; Silva, Isabel dos Santos] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Fletcher, Olivia; Johnson, Nichola; Garcia-Closas, Montserrat; Ashworth, Alan; Orr, Nick] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Sawyer, Elinor J.] Guys & St Thomas NHS Fdn Trust, Div Canc Studies, NIHR Comprehensive Biomed Res Ctr, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford OX3 7BN, England; [Kerin, Michael J.; Miller, Nicola] Univ Coll Hosp Galway, Inst Clin Sci, Galway, Ireland; [Marme, Federick; Schneeweiss, Andreas; Sohn, Christof; Burwinkel, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, D-69120 Heidelberg, Germany; [Marme, Federick; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, D-69120 Heidelberg, Germany; [Guenel, Pascal; Truong, Therese; Menegaux, Florence] INSERM, CESP, UMRS 1018, F-94807 Villejuif, France; [Guenel, Pascal; Truong, Therese; Menegaux, Florence] Univ Paris Sud, INSERM, UMRS 1018, F-94807 Villejuif, France; [Laurent-Puig, Pierre] Univ Paris Sorbonne Cite, UMR S775 Inserm, F-75270 Paris, France; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Herlev Hosp, Copenhagen Univ Hosp, Copenhagen Gen Populat Stud, DK-2730 Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Herlev Hosp, Copenhagen Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Dept Breast Surg, Herlev Hosp, DK-2730 Herlev, Denmark; [Milne, Roger L.] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Human Canc Genet Program, Madrid 28029, Spain; [Pilar Zamora, M.] Hosp Univ La Paz, Serv Oncol Med, Madrid 28046, Spain; [Arias, Jose I.] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo 33012, Spain; [Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Human Canc Genet Program, Madrid 28029, Spain; [Benitez, Javier] CIBERER, Valencia 46010, Spain; [Neuhausen, Susan] Beckman Res Inst, Duarte, CA 91010 USA; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA; [Dur, Christina C.] Canc Prevent Inst Calif, Fremont, CA 94538 USA; [Brenner, Hermann; Mueller, Heiko; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, D-66024 Saarbrucken, Germany; [Meindl, Alfons] Tech Univ Munich, Div Obstet & Gynecol, D-81675 Munich, Germany; [Schmutzler, Rita K.] Univ Cologne, Div Mol Gynecooncol, Dept Obstet & Gynaecol, D-50931 Cologne, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Statist & Epidemiol, D-04107 Leipzig, Germany; [Ditsch, Nina] Univ Munich, Dept Obstet & Gynaecol, D-80539 Munich, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, D-72074 Tubingen, Germany; [Bruening, Thomas] Ruhr Univ Bochum, Inst Prevent & Occupat Med German Social Accident, D-44789 Bochum, Germany; [Ko, Yon-Dschun] Evangel Klin Bonn gGmbH, Dept Internal Med, D-53113 Bonn, Germany; [Nevanlinna, Heli; Muranen, Taru A.] Univ Helsinki, Dept Obstet & Gynaecol, Helsinki 00029, Finland; [Nevanlinna, Heli; Muranen, Taru A.] Helsinki Univ Cent Hosp, Helsinki 00029, Finland; [Aittomaeki, Kristiina] Helsinki Univ Cent Hosp, Dept Clin Genet, Helsinki 00029, Finland; [Blomqvist, Carl] Helsinki Univ Cent Hosp, Dept Oncol, Helsinki 00029, Finland; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 8128582, Japan; [Ito, Hidemi] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 4648681, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 4648681, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan; [Doerk, Thilo; Helbig, Sonja] Hannover Med Sch, Dept Obstet & Gynaecol, D-30625 Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Sch Med, Inst Clin Med Pathol & Forens Med, Dept Clin Pathol, Kuopio 70211, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Sch Med, Canc Ctr Eastern Finland, Dept Clin Pathol, Kuopio 70211, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Sch Med, Univ Eastern Finland, Dept Clin Pathol, Kuopio 70211, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Sch Med, Imaging Ctr, Dept Clin Pathol, Kuopio 70211, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Sch Med, Inst Clin Med Oncol, Univ Eastern Finland, Kuopio 70211, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Sch Med, Inst Clin Med Oncol, Canc Ctr, Kuopio 70211, Finland; [Wu, Anna H.; Tseng, Chiu-chen; Van Den Berg, David; Stram, Daniel O.; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Lambrechts, Diether; Thienpont, Bernard] VRC, VIB, B-3000 Leuven, Belgium; [Lambrechts, Diether; Thienpont, Bernard] Univ Leuven, B-3000 Leuven, Belgium; [Christiaens, Marie-Rose] Univ Hosp Gasthuisberg, Dept Oncol, B-3000 Leuven, Belgium; [Smeets, Ann] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Chang-Claude, Jenny; Rudolph, Anja; Seibold, Petra] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, D-20246 Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Inst Med Biometr & Epidemiol, D-20246 Hamburg, Germany; [Radice, Paolo] INT, Fdn IRCCS, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent Predict Med, I-20133 Milan, Italy; [Peterlongo, Paolo] IFOM, Fdn Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Bonanni, Bernardo] IEO, Div Canc Prevent & Genet, I-20141 Milan, Italy; [Bernard, Loris] IEO, Dept Expt Oncol, I-20141 Milan, Italy; [Bernard, Loris] Cogentech Canc Genet Test Lab, I-20139 Milan, Italy; [Couch, Fergus J.; Wang, Xianshu] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Olson, Janet E.; Vachon, Celine; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Purrington, Kristen] Karmanos Canc Ctr, Detroit, MI 48201 USA; [Giles, Graham G.; Severi, Gianluca; Baglietto, Laura] Canc Epidemiol Ctr, Canc Council Victoria, Melbourne, Vic 3053, Australia; [McLean, Catriona] Alfred Hosp, Melbourne, Vic 3181, Australia; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Epidemiol Program, Honolulu, HI 96813 USA; [Simard, Jacques; Dumont, Martine] Univ Quebec, Canc Genom Lab, Ctr Hosp, Quebec City, PQ QCG1V4G2, Canada; [Simard, Jacques; Dumont, Martine] Univ Laval, Canc Genom Lab, Quebec City, PQ QCG1V4G2, Canada; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Div Clin Epidemiol, Hlth Ctr, Montreal, PQ H3A 1A1, Canada; [Labreche, France] Univ Montreal, Dept Social & Prevent Med, Dept Sante Environm & Sante Travail, Montreal, PQ H3A 3C2, Canada; [Teo, Soo-Hwang; Phuah, Sze-Yee] Canc Res Initiat Fdn, Sime Darby Med Ctr, Selangor 47500, Malaysia; [Teo, Soo-Hwang; Yip, Cheng-Har; Phuah, Sze-Yee] Univ Malaya, Med Ctr, Breast Canc Res Unit, Univ Malaya Canc Res Inst, Kuala Lumpur 50603, Malaysia; [Kristensen, Vessela; Alnaes, Grethe Grenaker; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Dept Genet, Inst Canc Res, N-0310 Oslo, Norway; [Kristensen, Vessela; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med Fac Div Ahus, N-0318 Oslo, Norway; [Zheng, Wei; Deming-Halverson, Sandra; Shrubsole, Martha; Long, Jirong; Shu, Xiao-Ou; Cai, Hui; Blot, William; Signorello, Lisa B.; Cai, Qiuyin] Vanderbilt Univ, Sch Med,Vanderbilt Ingram Canc Ctr, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr,, Nashville, TN 37203 USA; [Winqvist, Robert; Pylkaes, Katri] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Chem, Oulu Univ Hosp, Oulu 90014, Finland; [Winqvist, Robert; Pylkaes, Katri] Univ Oulu, Lab Canc Genet & Tumor Biol, Bioctr Oulu, Oulu Univ Hosp, Oulu 90014, Finland; [Jukkola-Vuorinen, Arja; Kauppila, Saila] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu 90014, Finland; [Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Tchatchou, Sandrine] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G IX5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S IA8, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A8, Canada; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, NL-2300 RC Leiden, Netherlands; [Seynaeve, Caroline M.; Hooning, Maartje J.; Martens, John W. M.] Erasmus MC Canc Inst, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, Surrey SM2 5NG, England; [Figueroa, Jonine; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Lissowska, Jolanta; Swerdlow, Anthony; Schoemaker, Minouk J.] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, PL-02781 Warsaw, Poland; [Lissowska, Jolanta; Swerdlow, Anthony; Schoemaker, Minouk J.] Inst Oncol, Dept Canc Epidemiol & Prevent, PL-02781 Warsaw, Poland; [Czene, Kamila; Darabi, Hartef; Eriksson, Kimael; Hall, Per; Humphreys, Keith] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [van den Ouweland, Ans M. W.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3008 AE Rotterdam, Netherlands; [van Deurzen, Carolien H. M.] Erasmus Univ, Med Ctr, Dept Pathol, NL-3008 AE Rotterdam, Netherlands; [Li, Jingmei; Liu, Jianjun] Genome Inst Singapore, Div Human Genet, Singapore 138672, Singapore; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai 200336, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China; [Cox, Angela; Reed, Malcolm W. R.; Blot, William] Univ Sheffield, CRUK, YCR Sheffield Canc Res Ctr, Sheffield S10 2RX, S Yorkshire, England; [Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea; [Kang, Daehee; Choi, Ji-Yeob] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul 110799, South Korea; [Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110799, South Korea; [Hartman, Mikael; Hui, Miao; Lim, Wei-Yen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Hartman, Mikael; Hui, Miao; Lim, Wei-Yen] Natl Univ Hlth Syst, Singapore 119228, Singapore; [Buhari, Shaik A.] Natl Univ Hlth Syst, Div Gen Surg, Singapore 119228, Singapore; [Hamann, Ute] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Foersti, Asta] Skanes Univ Sjukhus, Ctr Primary Hlth Care Res, Clin Res Ctr, S-20502 Malmo, Sweden; [Ruediger, Thomas] Stadt Klin Karlsruhe, Inst Pathol, D-76133 Karlsruhe, Germany; [Ulmer, Hans-Ulrich] Frauenklin Stadtklin Baden Baden, D-76532 Baden Baden, Germany; [Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Durda, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [Jaworska, Katarzyna] Med Univ Warsaw, Postgrad Sch Mol Med, PL-02091 Warsaw, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok 10400, Thailand; [Gaborieau, Valerie; Brennan, Paul; Mckay, James] Int Agcy Res Canc, F-69372 Lyon, France; [Fostira, Florentia] NSCR Demokritos, INRASTES, Mol Diagnost Lab, Athens 15310, Greece; [Pilarski, Robert] Ohio State Univ, Dept Internal Med, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Shen, Chen-Yang; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Shen, Chen-Yang; Wu, Pei-Ei] China Med Univ, Coll Publ Hlth, Taichung 40402, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Taiwan Biobank, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Swerdlow, Anthony; Ashworth, Alan; Orr, Nick] Inst Canc Res, Div Breast Canc Res, Surrey SM2 5NG, England	CRUK Cambridge Institute; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Cambridge; QIMR Berghofer Medical Research Institute; University of Queensland; University of Melbourne; University of Melbourne; Netherlands Cancer Institute; University of Warwick; University of Manchester; University of Warwick; Ministry of Public Health - Thailand; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; London School of Hygiene & Tropical Medicine; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario La Paz; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Irvine; Cancer Prevention Institute of California; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Cologne; Leipzig University; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ruhr University Bochum; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Kyushu University; Aichi Cancer Center; Aichi Cancer Center; Aichi Cancer Center; Hannover Medical School; Hannover Medical School; Karolinska Institutet; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Southern California; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); Mayo Clinic; Mayo Clinic; Barbara Ann Karmanos Cancer Institute; Cancer Council Victoria; Florey Institute of Neuroscience & Mental Health; Cancer Research Center of Hawaii; University of Hawaii System; Laval University; University of Quebec; Laval University; McGill University; McGill University; Royal Victoria Hospital; Universite de Montreal; Universiti Malaya; University of Oslo; University of Oslo; Vanderbilt University; University of Oulu; University of Oulu; University of Oulu; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; University of Sheffield; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National University of Singapore; National University of Singapore; National University of Singapore; Helmholtz Association; German Cancer Research Center (DKFZ); Municipal Hospital Karlsruhe; Pomeranian Medical University; Medical University of Warsaw; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); National Centre of Scientific Research "Demokritos"; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Academia Sinica - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of London; Institute of Cancer Research - UK	Meyer, KB (corresponding author), Univ Cambridge, CRUK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.		Flyger, Henrik/AAM-6494-2021; Miller, Nicola/F-4009-2018; Margolin, Sara/AAX-9034-2020; Fasching, Peter A/ABH-9912-2020; Figueroa, Jonine/AFK-2752-2022; Van Den Berg, David J/G-8598-2017; laurent-puig, pierre/B-2226-2013; Gao, Y./GWZ-3665-2022; Teo, Soo-hwang/H-2353-2014; truong, therese/A-2837-2013; Gao, Yu/HGE-1937-2022; smeets, ann/AAP-9191-2020; Knight, Julia/R-5617-2019; Pilarski, Robert/E-3871-2011; Arndt, Volker/B-4999-2014; Andrulis, Irene L./E-7267-2013; Arndt, Volker/AAI-7282-2020; Purrington, Kristen/AAN-6494-2021; Bowtell, David/H-1007-2016; Buhari, Shaik Ahmad/C-7597-2011; Yip, Cheng-Har/B-1909-2010; Guenel, Pascal/AAS-7688-2021; zhang, weihua/GXV-1334-2022; Edwards, Stacey/A-4980-2011; Bernard, Loris/K-5953-2014; Figueroa, Jonine/AAG-1065-2022; Liu, Jianjun/AAK-4989-2020; Dörk, Thilo/J-8620-2012; Schmidt, Marjanka K/G-9058-2011; de Santiago, Ines/AAP-5859-2020; Shrubsole, Martha J/K-5052-2015; Ditsch, Nina/F-6267-2014; Garcia-Closas, Montserrat/F-3871-2015; Hartikainen, Jaana M/E-6256-2015; Guenel, Pascal/H-3728-2018; Bogdanova, Natalia V./Y-2205-2019; Chenevix-Trench, Georgia/AAV-2014-2020; YATABE, Yasushi/J-6461-2014; Reed, Malcolm Walter/AAG-9219-2020; Laurent-Puig, Pierre/K-3641-2019; Zheng, Wei/O-3351-2013; Figueroa, Jonine/GWD-1322-2022; Garcia-Closas, Montserrat/AAZ-6930-2021; Michailidou, Kyriaki/ABD-5122-2020; French, Juliet D/A-4982-2011; Li, Jingmei/I-2904-2012; Matsuo, Keitaro/H-6758-2019; Bonanni, Bernardo/AAM-7928-2020; Knight, Julia/A-6843-2012; Jakubowska, Anna/O-8050-2014; Radice, Paolo/O-3119-2013; Severi, Gianluca/Q-1824-2019; Muranen, Taru/AAC-8418-2019; Menegaux, Florence/H-4261-2018; /AAM-5330-2020; Lambrechts, Diether/AAJ-3167-2020; Baglietto, Laura/AAB-9051-2019; Ekici, Arif B/C-3971-2013; Fostira, Florentia/Z-5730-2019; Pilarski, Robert/X-3256-2019; Lissowska, Jolanta/AAH-3252-2020; Brenner, Hermann/ABE-6383-2020; DEVILEE, PETER/ABR-2140-2022; Severi, Gianluca/H-3774-2018; Noh, Dong-Young/G-5531-2011; Brenner, Hermann/B-4627-2017; Peterlongo, Paolo/Q-4717-2018; gao, yi/HCI-8298-2022; Pharoah, Paul/V-6658-2019; Brüning, Thomas/G-8120-2015; Devilee, Peter/GXV-8005-2022; Schumacher, Fredrick/R-6043-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Thienpont, Bernard/AAG-5423-2019; Lu, Wei/AAE-2921-2022; Hartman, Mikael/B-4324-2011	Miller, Nicola/0000-0002-5416-7047; Fasching, Peter A/0000-0003-4885-8471; Figueroa, Jonine/0000-0002-5100-623X; Van Den Berg, David J/0000-0002-5404-5218; laurent-puig, pierre/0000-0001-8475-5459; truong, therese/0000-0002-2943-6786; Knight, Julia/0000-0002-7610-7635; Arndt, Volker/0000-0001-9320-8684; Arndt, Volker/0000-0001-9320-8684; Purrington, Kristen/0000-0002-5710-1692; Bowtell, David/0000-0001-9089-7525; Guenel, Pascal/0000-0002-8359-518X; Figueroa, Jonine/0000-0002-5100-623X; Liu, Jianjun/0000-0002-3255-3019; Dörk, Thilo/0000-0002-9458-0282; Schmidt, Marjanka K/0000-0002-2228-429X; de Santiago, Ines/0000-0002-8172-1322; Shrubsole, Martha J/0000-0002-5591-7575; Garcia-Closas, Montserrat/0000-0003-1033-2650; Hartikainen, Jaana M/0000-0001-8267-1905; Guenel, Pascal/0000-0002-8359-518X; Chenevix-Trench, Georgia/0000-0002-1878-2587; YATABE, Yasushi/0000-0003-1788-559X; Reed, Malcolm Walter/0000-0001-7442-2132; Laurent-Puig, Pierre/0000-0001-8475-5459; Zheng, Wei/0000-0003-1226-070X; Figueroa, Jonine/0000-0002-5100-623X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Michailidou, Kyriaki/0000-0001-7065-1237; Li, Jingmei/0000-0001-8587-7511; Matsuo, Keitaro/0000-0003-1761-6314; Jakubowska, Anna/0000-0002-5650-0501; Radice, Paolo/0000-0001-6298-4111; Severi, Gianluca/0000-0001-7157-419X; Muranen, Taru/0000-0002-5895-1808; Menegaux, Florence/0000-0003-3363-6411; Lambrechts, Diether/0000-0002-3429-302X; Ekici, Arif B/0000-0001-6099-7066; Lissowska, Jolanta/0000-0003-2695-5799; Brenner, Hermann/0000-0002-6129-1572; Severi, Gianluca/0000-0001-7157-419X; Brenner, Hermann/0000-0002-6129-1572; Peterlongo, Paolo/0000-0001-6951-6855; Pharoah, Paul/0000-0001-8494-732X; Brüning, Thomas/0000-0001-9560-5464; Schumacher, Fredrick/0000-0002-3073-7463; Lu, Wei/0000-0002-4150-8674; Pylkas, Katri/0000-0002-2449-0521; Kang, Daehee/0000-0003-4031-5878; Southey, Melissa/0000-0002-6313-9005; Engel, Christoph/0000-0002-7247-282X; Dunning, Alison Margaret/0000-0001-6651-7166; Swerdlow, Anthony/0000-0001-5550-4159; Fletcher, Olivia/0000-0001-9387-7116; Bojesen, Stig/0000-0002-4061-4133; Giles, Graham/0000-0003-4946-9099; Hartman, Mikael/0000-0001-5726-9965; Long, Jirong/0000-0002-7433-9766; Thienpont, Bernard/0000-0002-8772-6845; French, Juliet/0000-0002-9770-0198; Margolin, Sara/0000-0002-5526-5570; Ito, Hidemi/0000-0002-8023-4581; Durocher, Francine/0000-0001-8012-4641; Lubinski, Jan/0000-0003-2931-3003; Czene, Kamila/0000-0002-3233-5695; Cox, Angela/0000-0002-5138-1099; Winqvist, Robert/0000-0003-0932-9104; Kerin, Michael/0000-0003-4164-5561; McLean, Catriona/0000-0002-0302-5727; Devilee, Peter/0000-0002-8023-2009; Edwards, Stacey/0000-0001-7428-4139; Kataja, Vesa/0000-0003-4846-4843; Lux, Michael Patrick/0000-0002-2781-2178; Hou, Ming-Feng/0000-0001-6030-9702; Baglietto, Laura/0000-0002-8193-7529; Nordestgaard, Borge/0000-0002-1954-7220; Schoemaker, Minouk/0000-0001-8403-2234; Brauch, Hiltrud/0000-0001-7531-2736; Simard, Jacques/0000-0001-6906-3390; Thorne, Heather/0000-0003-3610-2511; Blomqvist, Carl/0000-0003-3041-1938; Nevanlinna, Heli/0000-0002-0916-2976	Cancer Research UK [11022, 10119, 10124, 10118] Funding Source: Medline; NCI NIH HHS [P30 CA015083, R01 CA077398, R01 CA092447] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline; Cancer Research UK [16561, 16563, 19275, 16565] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06, ECF-12-04] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish; The Francis Crick Institute [10124, 10119] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA077398, R01CA092447, P30CA015083] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); National Breast Cancer Foundation; Cancer Foundation Finland sr; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnholtz-Sloan JS, 2010, CARCINOGENESIS, V31, P1417, DOI 10.1093/carcin/bgq128; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferrari N, 2013, J CELL PHYSIOL, V228, P1137, DOI 10.1002/jcp.24285; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Huijts PEA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2917; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liang J, 2008, CARCINOGENESIS, V29, P2341, DOI 10.1093/carcin/bgn235; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nakshatri H, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001008; Odawara J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-516; Orr N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002290; Reintjes N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060264; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sun C, 2010, CANCER GENET CYTOGEN, V197, P193, DOI 10.1016/j.cancergencyto.2009.11.006; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhu XG, 2009, MOL ENDOCRINOL, V23, P1397, DOI 10.1210/me.2009-0071	35	76	76	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1046	1060		10.1016/j.ajhg.2013.10.026	http://dx.doi.org/10.1016/j.ajhg.2013.10.026			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24290378	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000328521300005
J	Yu, HC; Sloan, JL; Scharer, G; Brebner, A; Quintana, AM; Achilly, NP; Manoli, I; Coughlin, CR; Geiger, EA; Schneck, U; Watkins, D; Suormala, T; Van Hove, JLK; Fowler, B; Baumgartner, MR; Rosenblatt, DS; Venditti, CP; Shaikh, TH				Yu, Hung-Chun; Sloan, Jennifer L.; Scharer, Gunter; Brebner, Alison; Quintana, Anita M.; Achilly, Nathan P.; Manoli, Irini; Coughlin, Curtis R., II; Geiger, Elizabeth A.; Schneck, Una; Watkins, David; Suormala, Terttu; Van Hove, Johan L. K.; Fowler, Brian; Baumgartner, Matthias R.; Rosenblatt, David S.; Venditti, Charles P.; Shaikh, Tamim H.			An X-Linked Cobalamin Disorder Caused by Mutations in Transcriptional Coregulator HCFC1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HCF-1; IDENTIFICATION; ASSOCIATION; PROMOTERS; COMPLEX; FAMILY; DEFECT; BINDS; YY1	Derivatives of vitamin B-12 (cobalamin) are essential cofactors for enzymes required in intermediary metabolism. Defects in cobalamin metabolism lead to disorders characterized by the accumulation of methylmalonic acid and/or homocysteine in blood and urine. The most common inborn error of cobalamin metabolism, combined methylmalonic acidemia and hyperhomocysteinemia, cblC type, is caused by mutations in MMACHC. However, several individuals with presumed cblC based on cellular and biochemical analysis do not have mutations in MMACHC. We used exome sequencing to identify the genetic basis of an X-linked form of combined methylmalonic acidemia and hyperhomocysteinemia, designated cblX. A missense mutation in a global transcriptional coregulator, HCFC1, was identified in the index case. Additional male subjects were ascertained through two international diagnostic laboratories, and 13/17 had one of five distinct missense mutations affecting three highly conserved amino acids within the HCFC1 kelch domain. A common phenotype of severe neurological symptoms including intractable epilepsy and profound neurocognitive impairment, along with variable biochemical manifestations, was observed in all affected subjects compared to individuals with early-onset cblC. The severe reduction in MMACHC mRNA and protein within subject fibroblast lines suggested a role for HCFC1 in transcriptional regulation of MMACHC, which was further supported by the identification of consensus HCFC1 binding sites in MMACHC. Furthermore, siRNA-mediated knockdown of HCFC1 expression resulted in the coordinate downregulation of MMACHC mRNA. This X-linked disorder demonstrates a distinct disease mechanism by which transcriptional dysregulation leads to an inborn error of metabolism with a complex clinical phenotype.	[Yu, Hung-Chun; Scharer, Gunter; Quintana, Anita M.; Coughlin, Curtis R., II; Geiger, Elizabeth A.; Schneck, Una; Van Hove, Johan L. K.; Shaikh, Tamim H.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Sloan, Jennifer L.; Achilly, Nathan P.; Manoli, Irini; Venditti, Charles P.] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Scharer, Gunter; Coughlin, Curtis R., II; Van Hove, Johan L. K.; Shaikh, Tamim H.] Univ Colorado, Sch Med, Genet Sect, Aurora, CO 80045 USA; [Scharer, Gunter; Shaikh, Tamim H.] Univ Colorado, Sch Med, Colorado Intellectual & Dev Disabil Res Ctr, Aurora, CO 80045 USA; [Brebner, Alison; Watkins, David; Rosenblatt, David S.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Suormala, Terttu; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, CH-8032 Zurich, Switzerland; [Suormala, Terttu; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland	University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; McGill University; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Shaikh, TH (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	tamim.shaikh@ucdenver.edu	Baumgartner, Matthias R/Q-2855-2017	Baumgartner, Matthias R/0000-0002-9270-0826; Manoli, Irini/0000-0003-1543-2941; Quintana, Anita/0000-0002-3596-1587; Coughlin II, Curtis/0000-0002-3545-7903; Yu, Hung-Chun/0000-0002-4980-8508	National Institutes of Health grant [GM081519]; Colorado Intellectual and Developmental Disabilities Research Center; Pediatrics Student Research Program at Children's Hospital Colorado; Intramural Research Program of the National Human Genome Research Institute; Canadian Institutes of Health Research [CIHR-M08-15078]; Swiss National Science Foundation [31003A_138521];  [T32MH015442]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015442] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Intellectual and Developmental Disabilities Research Center; Pediatrics Student Research Program at Children's Hospital Colorado; Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Renata Gallagher, Janet Thomas, Laura Pickler, and Cynthia Freehauf for their input and advice on the clinical aspects of this project and for their contribution to the care of affected individuals, to Leah Ladores for biochemical and complementation analysis, and to the referring physicians. This work was supported in part by a National Institutes of Health grant (GM081519) to T.H.S. and funds and services from the Colorado Intellectual and Developmental Disabilities Research Center. A.Q. was supported by a grant for postdoctoral research training (T32MH015442), and U.S. was supported by the 2012 Pediatrics Student Research Program at Children's Hospital Colorado. J.L.S., N.P.A., I.M., and C.P.V. were supported by the Intramural Research Program of the National Human Genome Research Institute. D.S.R. was supported by an operating grant from the Canadian Institutes of Health Research (CIHR-M08-15078). M.R.B and B.F. were supported by a grant from the Swiss National Science Foundation (31003A_138521).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Carrillo-Carrasco N, 2012, J INHERIT METAB DIS, V35, P103, DOI 10.1007/s10545-011-9365-x; Carrillo-Carrasco N, 2012, J INHERIT METAB DIS, V35, P91, DOI 10.1007/s10545-011-9364-y; Chandler RJ, 2005, MOL GENET METAB, V86, P34, DOI 10.1016/j.ymgme.2005.07.020; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Knez J, 2006, MOL CELL BIOCHEM, V288, P79, DOI 10.1007/s11010-006-9122-x; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Martinelli D, 2011, J INHERIT METAB DIS, V34, P127, DOI 10.1007/s10545-010-9161-z; Mazars R, 2010, J BIOL CHEM, V285, P13364, DOI 10.1074/jbc.M109.072579; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Parker JB, 2012, MOL CELL BIOL, V32, P1654, DOI 10.1128/MCB.06033-11; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Sloan JL, 2011, NAT GENET, V43, P883, DOI 10.1038/ng.908; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Watkins D, 2011, AM J MED GENET C, V157C, P33, DOI 10.1002/ajmg.c.30288; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	35	76	91	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					506	514		10.1016/j.ajhg.2013.07.022	http://dx.doi.org/10.1016/j.ajhg.2013.07.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	24011988	Green Published, Bronze			2022-12-18	WOS:000330268900009
J	Wiliams, AL; Patterson, N; Glessner, J; Hakonarson, H; Reich, D				Wiliams, Amy L.; Patterson, Nick; Glessner, Joseph; Hakonarson, Hakon; Reich, David			Phasing of Many Thousands of Genotyped Samples	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; HAPLOTYPE INFERENCE; HUMAN-POPULATIONS; IMPUTATION; DISEASES; COMMON; LOCI	Haplotypes are an important resource for a large number of applications in human genetics, but computationally inferred haplotypes are subject to switch errors that decrease their utility. The accuracy of computationally inferred haplotypes increases with sample size, and although ever larger genotypic data sets are being generated, the fact that existing methods require substantial computational resources limits their applicability to data sets containing tens or hundreds of thousands of samples. Here, we present HAPI-UR (haplotype inference for unrelated samples), an algorithm that is designed to handle unrelated and/or trio and duo family data, that has accuracy comparable to or greater than existing methods, and that is computationally efficient and can be applied to 100,000 samples or more. We use HAPI-UR to phase a data set with 58,207 samples and show that it achieves practical runtime and that switch errors decrease with sample size even with the use of samples from multiple ethnicities. Using a data set with 16,353 samples, we compare HAPI-UR to Beagle, MaCH, IMPUTE2, and SHAPEIT and show that HAPI-UR runs 18x faster than all methods and has a lower switch-error rate than do other methods except for Beagle; with the use of consensus phasing, running HAPI-UR three times gives a slightly lower switch-error rate than Beagle does and is more than six times faster. We demonstrate results similar to those from Beagle on another data set with a higher marker density. Lastly, we show that HAPI-UR has better runtime scaling properties than does Beagle so that for larger data sets, HAPI-UR will be practical and will have an even larger runtime advantage. HAPI-UR is available online (see Web Resources).	[Wiliams, Amy L.; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wiliams, Amy L.; Patterson, Nick; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Glessner, Joseph; Hakonarson, Hakon] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wiliams, AL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	alw@genetics.med.harvard.edu		Williams, Amy L./0000-0003-0737-0533; Glessner, Joseph/0000-0001-5131-2811	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service [F32HG005944]; Wellcome Trust [076113, 085475]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG005944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kai Wang for facilitating sharing of the Children's Hospital of Philadelphia dataset and Simon Myers, Alexander Gusev, Swapan Mallick, Christopher Alexander, Jane Morgan, Jennifer Petersen, and Bogdan Pasanuic for helpful discussions. A.L.W. is supported by National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award number F32HG005944; the views in this article are those of the authors and do not necessarily represent those of the NIH. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available at www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jostins L, 2011, EUR J HUM GENET, V19, P662, DOI 10.1038/ejhg.2011.10; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Li N, 2003, GENETICS, V165, P2213; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Pasaniuc B, 2009, LECT N BIOINFORMAT, V5542, P221, DOI 10.1007/978-3-642-01551-9_22; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Risch N., 2011, P 12 INT C HUM GEN 6, P94; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Sundquist A, 2008, GENOME RES, V18, P676, DOI 10.1101/gr.072850.107; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	32	76	82	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					238	251		10.1016/j.ajhg.2012.06.013	http://dx.doi.org/10.1016/j.ajhg.2012.06.013			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22883141	Green Published, Bronze			2022-12-18	WOS:000307608700003
J	Scionti, I; Greco, F; Ricci, G; Govi, M; Arashiro, P; Vercelli, L; Berardinelli, A; Angelini, C; Antonini, G; Cao, M; Di Muzio, A; Moggio, M; Morandi, L; Ricci, E; Rodolico, C; Ruggiero, L; Santoro, L; Siciliano, G; Tomelleri, G; Trevisan, CP; Galluzzi, G; Wright, W; Zatz, M; Tupler, R				Scionti, Isabella; Greco, Francesca; Ricci, Giulia; Govi, Monica; Arashiro, Patricia; Vercelli, Liliana; Berardinelli, Angela; Angelini, Corrado; Antonini, Giovanni; Cao, Michelangelo; Di Muzio, Antonio; Moggio, Maurizio; Morandi, Lucia; Ricci, Enzo; Rodolico, Carmelo; Ruggiero, Lucia; Santoro, Lucio; Siciliano, Gabriele; Tomelleri, Giuliano; Trevisan, Carlo Pietro; Galluzzi, Giuliana; Wright, Woodring; Zatz, Mayana; Tupler, Rossella			Large-Scale Population Analysis Challenges the Current Criteria for the Molecular Diagnosis of Fascioscapulohumeral Muscular Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA REARRANGEMENTS; 4Q35 DELETION; FSHD; PHENOTYPE; LOCUS; D4Z4; CHROMOSOME-4; D4F104S1; FRAGMENT; FAMILY	Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary myopathy causally linked to reduced numbers (<= 8) of 3.3 kilobase D4Z4 tandem repeats at 4q35. However, because individuals carrying D4Z4-reduced alleles and no FSHD and patients with FSHD and no short allele have been observed, additional markers have been proposed to support an FSHD molecular diagnosis. In particular a reduction in the number of D4Z4 elements combined with the 4A(159/161/168)PAS haplotype (which provides the possibility of expressing DUX4) is currently used as the genetic signature uniquely associated with FSHD. Here, we analyzed these DNA elements in more than 800 Italian and Brazilian samples of normal individuals unrelated to any FSHD patients. We find that 3% of healthy subjects carry alleles with a reduced number (4-8) of D4Z4 repeats on chromosome 4q and that one-third of these alleles, 1.3%, occur in combination with the 4A161PAS haplotype. We also systematically characterized the 4q35 haplotype in 253 unrelated FSHD patients. We find that only 127 of them (50.1%) carry alleles with 1-8 D4Z4 repeats associated with 4A161PAS, whereas the remaining FSHD probands carry different haplotypes or alleles with a greater number of D4Z4 repeats. The present study shows that the current genetic signature of FSHD is a common polymorphism and that only half of FSHD probands carry this molecular signature. Our results suggest that the genetic basis of FSHD, which is remarkably heterogeneous, should be revisited, because this has important implications for genetic counseling and prenatal diagnosis of at-risk families.	[Scionti, Isabella; Greco, Francesca; Govi, Monica; Tupler, Rossella] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41125 Modena, Italy; [Ricci, Giulia; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Dept Neurosci, I-56126 Pisa, Italy; [Arashiro, Patricia] Harvard Univ, Sch Med, Childrens Hosp,Howard Hughes Med Inst, Program Genom,Div Genet,Informat Program, Boston, MA 02115 USA; [Vercelli, Liliana] Univ Turin, Dept Neurosci, Ctr Neuromuscular Dis, I-10126 Turin, Italy; [Berardinelli, Angela] Univ Pavia, IRCCS C Modino Fdn, Unit Child Neurol & Psychiat, I-27100 Pavia, Italy; [Angelini, Corrado; Cao, Michelangelo] Univ Padua, Dept Neurosci, I-35129 Padua, Italy; [Antonini, Giovanni] Univ Roma La Sapienza, Dept Neurosci, S Andrea Hosp, I-00189 Rome, Italy; [Di Muzio, Antonio] Univ G DAnnunzio, Ctr Neuromuscular Dis, I-66013 Chieti, Italy; [Moggio, Maurizio] Univ Milan, Dino Ferrari Ctr, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neuromuscular Unit, I-20122 Milan, Italy; [Morandi, Lucia] Neurol Inst Fdn Carlo Besta, Unit Muscular Pathol & Immunol, I-20133 Milan, Italy; [Ricci, Enzo] Univ Cattolica Policlin A Gemelli, Dept Neurosci, I-00168 Rome, Italy; [Ruggiero, Lucia; Santoro, Lucio] Univ Naples Federico II, Dept Neurol Sci, I-80131 Naples, Italy; [Rodolico, Carmelo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, I-98125 Messina, Italy; [Tomelleri, Giuliano] Univ Verona, Dept Neurol Sci & Vis, I-37134 Verona, Italy; [Trevisan, Carlo Pietro] Univ Padua, Dept Neurol & Psychiat Sci, I-35100 Padua, Italy; [Galluzzi, Giuliana] IRCCS Santa Lucia Fdn, Mol Genet Lab UILDM, Lazio Sect, I-00179 Rome, Italy; [Wright, Woodring] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Zatz, Mayana] Univ Sao Paulo, Human Genome Res Ctr, Dept Genet & Evolutionary Biol, Dept Biosci, BR-05508090 Sao Paulo, Brazil; [Tupler, Rossella] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	Universita di Modena e Reggio Emilia; University of Pisa; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Turin; University of Pavia; University of Padua; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; G d'Annunzio University of Chieti-Pescara; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Istituto Neurologico Besta; Catholic University of the Sacred Heart; University of Naples Federico II; University of Messina; University of Verona; University of Padua; IRCCS Santa Lucia; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Sao Paulo; University of Massachusetts System; University of Massachusetts Worcester	Tupler, R (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41125 Modena, Italy.	rossella.tupler@umassmed.edu	Berardinelli, angela/AAA-9496-2019; Cetgen, Inct/I-2412-2013; Ricci, Giulia/K-6731-2016; Zatz, Mayana/M-5338-2015; Angelini, Corrado I/J-3655-2019; Siciliano, Gabriele/K-7259-2016; Antonini, Giovanni/AAC-6698-2022; Ricci, Enzo/AAC-4448-2020; Tupler, Rossella/C-9500-2015	Ricci, Giulia/0000-0002-6612-5995; Zatz, Mayana/0000-0003-3970-8025; Angelini, Corrado I/0000-0002-9554-8794; Siciliano, Gabriele/0000-0002-6142-2384; Tupler, Rossella/0000-0002-3797-1789; Santoro, Lucio/0000-0001-9507-2303; berardinelli, angela/0000-0002-4645-8055; ANTONINI, Giovanni/0000-0002-7519-7739; RODOLICO, Carmelo/0000-0003-2543-6356; RICCI, Enzo/0000-0003-3092-3597	Telethon [GUP08004, GUP11009]; Association Francaise Contre les Myopathies [14339]; National Institute of Health-National Institutes of Neurological Disorders and Stroke [RO1 NS047584]; Centros de Pesquisa, Inovacao e Difusao/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Institutos Nacionais de Ciencia e Tecnologia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047584] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); National Institute of Health-National Institutes of Neurological Disorders and Stroke; Centros de Pesquisa, Inovacao e Difusao/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Institutos Nacionais de Ciencia e Tecnologia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to all FSHD patients and their families for participating in this study. The Associazione Amici del Centro Dino Ferrari-University of Milan is gratefully acknowledged. We thank Paul D. Kaufman and Michael R. Green for their in-depth critique of the manuscript. DNA from Brazilian controls was kindly provided by Naila Lourenco and Antonia Cerqueira (Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of Sao Paulo, Brazil). This work was supported by Telethon GUP08004 and GUP11009, by Association Francaise Contre les Myopathies 14339, by National Institute of Health-National Institutes of Neurological Disorders and Stroke grant RO1 NS047584, by Centros de Pesquisa, Inovacao e Difusao/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, by Institutos Nacionais de Ciencia e Tecnologia, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Butz M, 2003, J NEUROL, V250, P932, DOI 10.1007/s00415-003-1116-y; Casasnovas Carlos, 2008, Foot Ankle Spec, V1, P350, DOI 10.1177/1938640008326247; Chahwan R, 2011, DISCOV MED, V11, P233; Chuenkongkaew WL, 2005, EUR J NEUROL, V12, P388, DOI 10.1111/j.1468-1331.2004.01060.x; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; DEIDDA G, 1995, EUR J HUM GENET, V3, P155; Felice KJ, 2000, NEUROLOGY, V54, P1927, DOI 10.1212/WNL.54.10.1927; Filosto M, 2008, NEUROMUSCULAR DISORD, V18, P204, DOI 10.1016/j.nmd.2007.12.005; Flanigan KM, 2004, MYOLOGY, P1123; GRIGGS RC, 1995, MUSCLE NERVE, pS50; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Jordan B, 2011, J NEUROL, V258, P866, DOI 10.1007/s00415-010-5858-z; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Korngut L, 2008, NEUROMUSCULAR DISORD, V18, P579, DOI 10.1016/j.nmd.2008.03.011; Krasnianski M, 2003, ARCH NEUROL-CHICAGO, V60, P1421, DOI 10.1001/archneur.60.10.1421; Lamperti C, 2010, MUSCLE NERVE, V42, P213, DOI 10.1002/mus.21671; Lecky B R, 1991, Neuromuscul Disord, V1, P275, DOI 10.1016/0960-8966(91)90101-W; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; Matsumura T, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-7; Mostacciuolo ML, 2009, CLIN GENET, V75, P550, DOI 10.1111/j.1399-0004.2009.01158.x; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; Padberg GW, 1982, THESIS LEIDEN U LEID; Reilich P, 2010, J NEUROL, V257, P1108, DOI 10.1007/s00415-010-5471-1; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Ricci G, 2012, NEUROMUSCULAR DISORD, V22, P534, DOI 10.1016/j.nmd.2011.12.001; Rudnik-Schoneborn S, 2008, NEUROMUSCULAR DISORD, V18, P881, DOI 10.1016/j.nmd.2008.06.387; Scionti I, 2012, J MED GENET, V49, P171, DOI 10.1136/jmedgenet-2011-100454; Takahashi M, 1998, RECENT RES CANCER, V154, P229; Tawil Rabi, 2010, Neuromuscul Disord, V20, P471, DOI 10.1016/j.nmd.2010.04.007; Tonini MMO, 2002, NEUROMUSCULAR DISORD, V12, P554, DOI 10.1016/S0960-8966(02)00014-7; Tonini MMO, 2004, NEUROMUSCULAR DISORD, V14, P33, DOI 10.1016/j.nmd.2003.07.001; Tsuji M, 2009, NEUROMUSCULAR DISORD, V19, P140, DOI 10.1016/j.nmd.2008.11.011; Tupler R, 1998, J MED GENET, V35, P778, DOI 10.1136/jmg.35.9.778; van der Kooi AJ, 2000, J NEUROL NEUROSUR PS, V69, P114, DOI 10.1136/jnnp.69.1.114; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; Vitelli F, 1999, MUSCLE NERVE, V22, P1437, DOI 10.1002/(SICI)1097-4598(199910)22:10<1437::AID-MUS15>3.0.CO;2-7; WEIFFENBACH B, 1992, AM J HUM GENET, V51, P416; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wohlgemuth M, 2003, NEUROLOGY, V61, P909, DOI 10.1212/WNL.61.7.909; Zouvelou V, 2009, J CLIN NEUROSCI, V16, P1218, DOI 10.1016/j.jocn.2008.12.004	46	76	79	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					628	635		10.1016/j.ajhg.2012.02.019	http://dx.doi.org/10.1016/j.ajhg.2012.02.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22482803	Bronze, Green Published			2022-12-18	WOS:000302833400005
J	Borck, G; Rehman, AU; Lee, K; Pogoda, HM; Kakar, N; von Ameln, S; Grillet, N; Hildebrand, MS; Ahmed, ZM; Nurnberg, G; Ansar, M; Basit, S; Javed, Q; Morell, RJ; Nasreen, N; Shearer, AE; Ahmad, A; Kahrizi, K; Shaikh, RS; Ali, RA; Khan, SN; Goebel, I; Meyer, NC; Kimberling, WJ; Webster, JA; Stephan, DA; Schiller, MR; Bahlo, M; Najmabadi, H; Gillespie, PG; Nurnberg, P; Wollnik, B; Riazuddin, S; Smith, RJH; Ahmad, W; Muller, U; Hammerschmidt, M; Friedman, TB; Riazuddin, S; Leal, SM; Ahmad, J; Kubisch, C				Borck, Guntram; Rehman, Atteeq Ur; Lee, Kwanghyuk; Pogoda, Hans-Martin; Kakar, Naseebullah; von Ameln, Simon; Grillet, Nicolas; Hildebrand, Michael S.; Ahmed, Zubair M.; Nuernberg, Gudrun; Ansar, Muhammad; Basit, Sulman; Javed, Qamar; Morell, Robert J.; Nasreen, Nabilah; Shearer, A. Eliot; Ahmad, Adeel; Kahrizi, Kimia; Shaikh, Rehan S.; Ali, Rana A.; Khan, Shaheen N.; Goebel, Ingrid; Meyer, Nicole C.; Kimberling, William J.; Webster, Jennifer A.; Stephan, Dietrich A.; Schiller, Martin R.; Bahlo, Melanie; Najmabadi, Hossein; Gillespie, Peter G.; Nuernberg, Peter; Wollnik, Bernd; Riazuddin, Saima; Smith, Richard J. H.; Ahmad, Wasim; Mueller, Ulrich; Hammerschmidt, Matthias; Friedman, Thomas B.; Riazuddin, Sheikh; Leal, Suzanne M.; Ahmad, Jamil; Kubisch, Christian			Loss-of-Function Mutations of ILDR1 Cause Autosomal-Recessive Hearing Impairment DFNB42	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STIMULATED LIPOPROTEIN RECEPTOR; LINKAGE ANALYSIS; MOUSE MODELS; HAIR-CELLS; INNER-EAR; DEAFNESS; ZEBRAFISH; MICE; IDENTIFICATION; HYPERLIPIDEMIA	By using homozygosity mapping in a consanguineous Pakistani family, we detected linkage of nonsyndromic hearing loss to a 7.6 Mb region on chromosome 3q13.31-q21.1 within the previously reported DFNB42 locus. Subsequent candidate gene sequencing identified a homozygous nonsense mutation (c.1135G>T [p.Glu379X]) in ILDR1 as the cause of hearing impairment. By analyzing additional consanguineous families with homozygosity at this locus, we detected ILDR1 mutations in the affected individuals of 10 more families from Pakistan and Iran. The identified ILDR1 variants include missense, nonsense, frameshift, and splice-site mutations as well as a start codon mutation in the family that originally defined the DFNB42 locus. ILDR1 encodes the evolutionarily conserved immunoglobulin-like domain containing receptor 1, a putative transmembrane receptor of unknown function. In situ hybridization detected expression of Ildr1, the murine ortholog, early in development in the vestibule and in hair cells and supporting cells of the cochlea. Expression in hair cell- and supporting cell-containing neurosensory organs is conserved in the zebrafish, in which the ildr1 ortholog is prominently expressed in the developing ear and neuromasts of the lateral line. These data identify loss-of-function mutations of ILDR1, a gene with a conserved expression pattern pointing to a conserved function in hearing in vertebrates, as underlying nonsyndromic prelingual sensorineural hearing impairment.	[Borck, Guntram; von Ameln, Simon; Goebel, Ingrid; Wollnik, Bernd; Kubisch, Christian] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Borck, Guntram; von Ameln, Simon; Nuernberg, Gudrun; Goebel, Ingrid; Nuernberg, Peter; Wollnik, Bernd; Hammerschmidt, Matthias; Kubisch, Christian] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Rehman, Atteeq Ur; Morell, Robert J.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Lab Mol Genet, NIH, Rockville, MD 20850 USA; [Rehman, Atteeq Ur; Shaikh, Rehan S.; Ali, Rana A.; Khan, Shaheen N.] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 54500, Pakistan; [Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pogoda, Hans-Martin; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany; [Kakar, Naseebullah; Nasreen, Nabilah; Ahmad, Jamil] BUITEMS, Dept Biotechnol & Informat, Quetta 78300, Pakistan; [von Ameln, Simon; Goebel, Ingrid; Kubisch, Christian] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; [Grillet, Nicolas; Mueller, Ulrich] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Grillet, Nicolas; Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Hildebrand, Michael S.; Shearer, A. Eliot; Meyer, Nicole C.; Smith, Richard J. H.] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Ahmed, Zubair M.] Univ Cincinnati, Div Pediat Ophthalmol, Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; [Ahmed, Zubair M.] Univ Cincinnati, Dept Ophthalmol, Coll Med, Cincinnati, OH 45229 USA; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Ansar, Muhammad; Basit, Sulman; Javed, Qamar; Ahmad, Wasim] Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad 45320, Pakistan; [Ahmad, Adeel] King Edward Med Univ, Mayo Hosp, Lahore 54000, Pakistan; [Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 19834, Iran; [Shaikh, Rehan S.] Bahauddin Zakariya Univ, Inst Biotechnol, Multan 60800, Pakistan; [Kimberling, William J.] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA; [Webster, Jennifer A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Stephan, Dietrich A.] Inst Individualized Hlth IGNITE, Palo Alto, CA 94301 USA; [Stephan, Dietrich A.] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Stephan, Dietrich A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stephan, Dietrich A.] Fox Chase Canc Ctr, Canc Genome Inst, Philadelphia, PA 19111 USA; [Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89052 USA; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Gillespie, Peter G.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; [Gillespie, Peter G.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Nuernberg, Gudrun; Nuernberg, Peter; Wollnik, Bernd; Hammerschmidt, Matthias; Kubisch, Christian] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Riazuddin, Saima] Univ Cincinnati, Lab Mol Genet, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; [Riazuddin, Saima] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH 45229 USA; [Smith, Richard J. H.] Univ Iowa, Interdept Mental PhD Program Genet, Dept Otolaryngol, Iowa City, IA 52242 USA; [Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Jinnah Hosp Complex, Lahore 54550, Pakistan	University of Cologne; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Baylor College of Medicine; University of Cologne; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; Ulm University; Scripps Research Institute; Scripps Research Institute; University of Iowa; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Cologne; Quaid I Azam University; Bahauddin Zakariya University; Boys Town National Research Hospital; Translational Genomics Research Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Fox Chase Cancer Center; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Walter & Eliza Hall Institute; Oregon Health & Science University; Oregon Health & Science University; University of Cologne; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Iowa; University of Health Science - Pakistan	Borck, G (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	guntram.borck@uk-koeln.de	Ansar, Muhammad/F-4808-2015; Basit, Sulman/AAY-9763-2021; Basit, Sulman/B-2947-2013; Wollnik, Bernd/GRY-6062-2022; Ansar, Muhammad/H-5967-2011; Morell, Robert James/Q-2042-2019; Kahrizi, Kimia/D-7989-2017; Basit, Sulman/F-6395-2015; Ahmad, Wasim/E-9713-2015; Kubisch, Christian/F-1893-2011; Najmabadi, Hossein/P-8182-2017; Basit, Sulman/Q-7939-2018; Borck, Guntram/F-1868-2015; Nasim Khan, Shaheen/F-2135-2015; Ahmad, Wasim/GSD-8904-2022; Rehman, Atteeq/AAG-8342-2020	Basit, Sulman/0000-0003-4294-6825; Wollnik, Bernd/0000-0003-2589-0364; Ansar, Muhammad/0000-0001-5891-7063; Kubisch, Christian/0000-0003-4220-0978; Basit, Sulman/0000-0003-4294-6825; von Ameln, Simon/0000-0002-2242-3165; Morell, Robert/0000-0003-1537-7356; Shearer, Aiden/0000-0002-5324-4805; Barr-Gillespie, Peter/0000-0002-9787-5860; Bahlo, Melanie/0000-0001-5132-0774; Smith, Richard/0000-0003-1201-6731; Lee, Kwanghyuk/0000-0003-1389-1220; Hildebrand, Michael/0000-0003-2739-0515; Najmabadi, Hossein/0000-0002-6084-7778; Grillet, Nicolas/0000-0001-8007-9246; Schiller, Martin R/0000-0003-1671-6823; Lee, Kwanghyuk/0000-0001-7781-9696	Deutsche Forschungsgemeinschaft (DFG) [BO2985/3-1]; European Commission [LSHG-CT-20054-512063]; NIH [RO1 DC002842, DC007704, N01-HG-65403]; NHMRC; Doris Duke Fellowship; Skaggs Institute for Chemical Biology; NIH from NIDCD [DC000039-14]; Higher Education Commission (HEC), Government of Pakistan; NIH-NIDCD [DC03594]; ICGEB, Trieste, Italy; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842, ZIADC000039, R01DC007704, R01DC003594, T32DC000039, R29DC003594, Z01DC000039] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Doris Duke Fellowship(Doris Duke Charitable Foundation (DDCF)); Skaggs Institute for Chemical Biology; NIH from NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Higher Education Commission (HEC), Government of Pakistan(Higher Education Commission of Pakistan); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ICGEB, Trieste, Italy; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We wish to thank the family members for their invaluable participation and cooperation. We thank Dennis Drayna and Changsoo Kang for critically reading the manuscript. This work was funded by the Deutsche Forschungsgemeinschaft (DFG; BO2985/3-1; to GB.), the European Commission FP6 Integrated Project EURO-HEAR, Grant LSHG-CT-20054-512063 (to B.W. and C.K.), NIH RO1 DC002842 (to R.J.H.S), NHMRC Career Development Award (to M.B.), NHMRC Overseas Biomedical Fellowship (to M.S.H.), Doris Duke Fellowship (to A.E.S), NIH DC007704 and Skaggs Institute for Chemical Biology (to U.M.), NIH intramural funds from NIDCD DC000039-14 (to T.B.F.), Higher Education Commission (HEC), Government of Pakistan (to W.A.), NIH-NIDCD grant DC03594 (to S.M.L.), and the ICGEB, Trieste, Italy (to Sheikh R.). J.A. thanks Dost Muhammad Baloch and Ahmed Farooq Bazai, VC, BUITEMS, for faculty funds. Genotyping services were partially provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to The Johns Hopkins University, Contract Number N01-HG-65403 (to S.M.L.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Anwar S, 2009, J HUM GENET, V54, P266, DOI 10.1038/jhg.2009.21; Aslam M, 2005, AM J MED GENET A, V133A, P18, DOI 10.1002/ajmg.a.30508; Brodeur J, 2009, TRAFFIC, V10, P1098, DOI 10.1111/j.1600-0854.2009.00933.x; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Dokmanovic-Chouinard M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000137; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Fagerheim T, 1996, HUM MOL GENET, V5, P1187, DOI 10.1093/hmg/5.8.1187; Fritzsch B, 2000, NEUROREPORT, V11, pR35, DOI 10.1097/00001756-200011270-00013; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hauge H, 2004, BIOCHEM BIOPH RES CO, V323, P970, DOI 10.1016/j.bbrc.2004.08.188; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Narvekar P, 2009, DIABETES, V58, P1040, DOI 10.2337/db08-1184; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Peters LM, 2007, GENOMICS, V89, P197, DOI 10.1016/j.ygeno.2006.09.006; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Santos RLP, 2005, CLIN GENET, V67, P61, DOI 10.1111/j.1399-0004.2005.00379.x; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Vrijens K, 2008, HUM GENET, V124, P325, DOI 10.1007/s00439-008-0556-y; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	37	76	81	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					127	137		10.1016/j.ajhg.2010.12.011	http://dx.doi.org/10.1016/j.ajhg.2010.12.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21255762	Green Published, Bronze			2022-12-18	WOS:000287684100001
J	Li, Y; Byrnes, AE; Li, MY				Li, Yun; Byrnes, Andrea E.; Li, Mingyao			To Identify Associations with Rare Variants, Just WHaIT Weighted Haplotype and Imputation-Based Tests	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DISEASE; COMMON; SUSCEPTIBILITY; HERITABILITY; METAANALYSIS; ALLELES; IFIH1	Empirical evidences suggest that both common and rare variants contribute to complex disease etiology Although the effects of common variants have been thoroughly assessed in recent genome wide association studies (GWAS), our knowledge of the impact of rare variants on complex diseases remains limited A number of methods have been proposed to test for rare variant association in sequencing based studies, a study design that is becoming popular but is still not economically feasible On the contrary, few (if any) methods exist to detect rare variants in GWAS data the data We have collected on thousands of individuals Here we propose two methods, a weighted haplotype based approach and an imputation based approach, to test for the effect of rare variants with GWAS data Both methods can incorporate external sequencing data when available We evaluated our methods and compared them with methods proposed in the sequencing setting through extensive simulations Our methods clearly show enhanced statistical power over existing methods for a wide range of population attributable risk, percentage of disease contributing rare variants, and proportion of rare alleles working in different directions We also applied our methods to the IFIH1 region for the type 1 diabetes GWAS data collected by the Wellcome Trust Case Control Consortium Our methods yield p values in the order of 10(-3), whereas the most significant p value from the existing methods is greater than 0 17 We thus demonstrate that the evaluation of rare variants with GWAS data is possible particularly when public sequencing data are incorporated	[Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Li, Yun; Byrnes, Andrea E.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Li, Mingyao] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania	Li, Y (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.				 [DK078150];  [CA082659];  [R01HG004517];  [R01HG005854]; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004517, R01HG005854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078150] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mike Boehnke, Karen Mohlke, Laura Scott, and Ethan Lange for helpful discussions We also thank the FUSION and WTCCC research teams for providing their GWAS data Y L is partially supported by DK078150 and CA082659 M L is supported by R01HG004517 and R01HG005854	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li QZ, 2010, HUM HERED, V69, P219, DOI 10.1159/000291927; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449	35	76	77	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					728	735		10.1016/j.ajhg.2010.10.014	http://dx.doi.org/10.1016/j.ajhg.2010.10.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21055717	Bronze, Green Published			2022-12-18	WOS:000284668400021
J	Anderson, CA; Pettersson, FH; Barrett, JC; Zhuang, JJ; Ragoussis, J; Cardon, LR; Morris, AP				Anderson, Carl A.; Pettersson, Fredrik H.; Barrett, Jeffrey C.; Zhuang, Joanna J.; Ragoussis, Jiannis; Cardon, Lon R.; Morris, Andrew P.			Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platforms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE MAP; ASSOCIATION	Genotype imputation is potentially a zero-cost method for bridging gaps in coverage and power between genotyping platforms. Here, we quantify these gains in power and coverage by using 1,376 population controls that are from the 1958 British Birth Cohort and were genotyped by the Wellcome Trust Case-Control Consortium with the Illumina HumanHap 550 and Affymetrix SNP Array 5.0 platforms. Approximately 50% of genotypes at single-nucleotide polymorphisms (SNPs) exclusively on the HumanHap 550 can be accurately imputed from direct genotypes on the SNP Array 5.0 or Illumina HumanHap 300. This roughly halves differences in coverage and power between the platforms. When the relative cost of currently available genome-wide SNP platforms is accounted for, and finances are limited but sample size is not, the highest-powered strategy in European populations is to genotype a larger number of individuals with the HumanHap 300 platform and carry out imputation. Platforms consisting of around 1 million SNPs offer poor cost efficiency for SNP association in European populations.	[Anderson, Carl A.; Pettersson, Fredrik H.; Barrett, Jeffrey C.; Zhuang, Joanna J.; Ragoussis, Jiannis; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Cardon, Lon R.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Oxford; Wellcome Centre for Human Genetics; Fred Hutchinson Cancer Center	Anderson, CA (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	carl.anderson@well.ox.ac.uk	Anderson, Carl A/B-8327-2013; Ragoussis, Ioannis/AAD-9790-2022	Anderson, Carl A/0000-0003-1719-7009; Ragoussis, Ioannis/0000-0002-8515-0934; Barrett, Jeffrey/0000-0002-1152-370X	Wellcome Trust [081682, 064890] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; LI C, 2008, GENET EPIDE IN PRESS; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	13	76	78	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					112	119		10.1016/j.ajhg.2008.06.008	http://dx.doi.org/10.1016/j.ajhg.2008.06.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18589396	Green Published, Bronze			2022-12-18	WOS:000257784000014
J	Ionita-Laza, I; McQueen, MB; Laird, NM; Lange, C				Ionita-Laza, Iuliana; McQueen, Matthew B.; Laird, Nan M.; Lange, Christoph			Genomewide weighted hypothesis testing in family-based association studies, with an application to a 100K scan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON GENETIC VARIANT; WIDE ASSOCIATION; DIFFERENTIATION; STRATIFICATION; POLYMORPHISM; LOCI	For genomewide association (GWA) studies in family-based designs, we propose a novel two-stage strategy that weighs the association P values with the use of independently estimated weights. The association information contained in the family sample is partitioned into two orthogonal components - namely, the between-family information and the within-family information. The between-family component is used in the first (i.e., screening) stage to obtain a relative ranking of all the markers. The within-family component is used in the second (i.e., testing) stage in the framework of the standard family-based association test, and the resulting P values are weighted using the estimated marker ranking from the screening step. The approach is appealing, in that it ensures that all the markers are tested in the testing step and, at the same time, also uses information from the screening step. Through simulation studies, we show that testing all the markers is more powerful than testing only the most promising ones from the screening step, which was the method suggested by Van Steen et al. A comparison with a population-based approach shows that the approach achieves comparable power. In the presence of a reasonable level of population stratification, our approach is only slightly affected in terms of power and, since it is a family-based method, is completely robust to spurious effects. An application to a 100K scan in the Framingham Heart Study illustrates the practical advantages of our approach. The proposed method is of general applicability; it extends to any setting in which prior, independent ranking of hypotheses is available.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Genom Med, Boston, MA 02115 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Boulder	Ionita-Laza, I (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 665 Huntington Ave,SPH2,4th Floor, Boston, MA 02115 USA.	iionita@hsph.harvard.edu	McQueen, Matthew/X-5845-2019		NICHD NIH HHS [R01 HD060726] Funding Source: Medline; NIMH NIH HHS [R01-MH063445, R01 MH063445, R01 MH059532, R01-MH59532] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059532, R01MH063445] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; WASSERMAN L, 2006, WEIGHTED HYPOTHESIS	17	76	79	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					607	614		10.1086/519748	http://dx.doi.org/10.1086/519748			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701906	Green Published, Bronze			2022-12-18	WOS:000249128200017
J	Hodgson, U; Pulkkinen, V; Dixon, M; Peyrard-Janvid, M; Rehn, M; Lahermo, P; Ollikainen, V; Salmenkivi, K; Kinnula, V; Kere, J; Tukiainen, P; Laitinen, T				Hodgson, U; Pulkkinen, V; Dixon, M; Peyrard-Janvid, M; Rehn, M; Lahermo, P; Ollikainen, V; Salmenkivi, K; Kinnula, V; Kere, J; Tukiainen, P; Laitinen, T			ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FEATURES; FINLAND	We performed a genomewide scan in six multiplex families with familial idiopathic pulmonary fibrosis ( IPF) who originated from southeastern Finland. The majority of the Finnish multiplex families were clustered in the region, and the population history suggested that the clustering might be explained by an ancestor shared among the patients. The genomewide scan identified five loci of interest. The hierarchical fine mapping in an extended data set with 24 families originating from the same geographic region revealed a shared 110 kb to 13 Mb haplotype on chromosome 4q31, which was significantly more frequent among the patients than in population-based controls ( odds ratio 6.3; 95% CI 2.5 - 15.9; P = .0001). The shared haplotype harbored two functionally uncharacterized genes, ELMOD2 and LOC152586, of which only ELMOD2 was expressed in lung and showed significantly decreased messenger-RNA expression in IPF lung ( n = 6) when compared with that of healthy lung ( n = 7; P = .05). Our results suggest ELMOD2 as a novel candidate gene for susceptibility in familial IPF.	Univ Helsinki, Cent Hosp, Dept Pulm Med, Helsinki 00029, Finland; Univ Helsinki, Cent Hosp, HUSLAB, Helsinki 00029, Finland; Univ Helsinki, Dept Med Genet, Helsinki 00029, Finland; Univ Helsinki, Dept Comp Sci, Helsinki 00029, Finland; Univ Helsinki, Dept Pathol, Helsinki 00029, Finland; Univ Helsinki, Finnish Genome Ctr, Helsinki 00029, Finland; GeneOS, Helsinki, Finland; Karolinska Inst, Novum, Dept Biosci, Stockholm, Sweden	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet	Hodgson, U (corresponding author), Univ Helsinki, Cent Hosp, Dept Pulm Med, Haartmaninkatu 4, Helsinki 00029, Finland.	ulla.hodgson@hus.fi	Kere, Juha/A-9179-2008; Tolvi, Morag/B-9491-2019; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Tolvi, Morag/0000-0002-8794-6661				American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]; BITTERMAN PB, 1986, NEW ENGL J MED, V314, P1343, DOI 10.1056/NEJM198605223142103; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Davies Huw R, 2002, Am J Respir Med, V1, P211; Hodgson U, 2002, THORAX, V57, P338, DOI 10.1136/thorax.57.4.338; HOGLUND P, 1995, AM J HUM GENET, V57, P95; JAVAHERI S, 1980, CHEST, V78, P591, DOI 10.1378/chest.78.4.591; Karlin S, 2002, P NATL ACAD SCI USA, V99, P17008, DOI 10.1073/pnas.262658799; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kere J, 2001, ANNU REV GENOM HUM G, V2, P103, DOI 10.1146/annurev.genom.2.1.103; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lee HL, 2005, CHEST, V127, P2034, DOI 10.1378/chest.127.6.2034; Loyd JE, 2003, AM J RESP CELL MOL, V29, pS47; Marshall RP, 1997, INT J BIOCHEM CELL B, V29, P107, DOI 10.1016/S1357-2725(96)00141-0; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Pagani F, 2003, J BIOL CHEM, V278, P26580, DOI 10.1074/jbc.M212813200; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; PEABODY JW, 1950, DIS CHEST, V18, P330, DOI 10.1016/S0096-0217(15)34710-5; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; TAHVANAINEN E, 1994, P NATL ACAD SCI USA, V91, P7267, DOI 10.1073/pnas.91.15.7267; UCHIYAMA B, 1997, EUR RESPIR J, V10, pS141	25	76	86	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					149	154		10.1086/504639	http://dx.doi.org/10.1086/504639			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773575	Green Published, Bronze			2022-12-18	WOS:000238341200016
J	Aligianis, IA; Morgan, NV; Mione, M; Johnson, CA; Rosser, E; Hennekam, RC; Adams, G; Trembath, RC; Pilz, DT; Stoodley, N; Moore, AT; Wilson, S; Maher, ER				Aligianis, IA; Morgan, NV; Mione, M; Johnson, CA; Rosser, E; Hennekam, RC; Adams, G; Trembath, RC; Pilz, DT; Stoodley, N; Moore, AT; Wilson, S; Maher, ER			Mutation in rab3 GTPase-activating protein (RAB3GAP) noncatalytic subunit in a kindred with Martsolf syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICRO SYNDROME; CONGENITAL CATARACT; MENTAL-RETARDATION; OPTIC ATROPHY; SHORT STATURE; 2ND FAMILY; 2 BROTHERS; SUBFAMILY; HYPOGENITALISM; MICROPHTHALMIA	We identified a homozygous missense mutation in the noncatalytic subunit ( RAB3GAP2) of RAB3GAP that results in abnormal splicing in a family with congenital cataracts, hypogonadism, and mild mental retardation ( Martsolf syndrome). Recently, mutations in the catalytic subunit of RAB3GAP ( RAB3GAP1), a key regulator of calcium-mediated hormone and neurotransmitter exocytosis, were reported in Warburg micro syndrome, a severe neurodevelopmental condition with overlapping clinical features. RAB3GAP is a heterodimeric protein that consists of a catalytic subunit and a noncatalytic subunit encoded by RAB3GAP1 and RAB3GAP2, respectively. We performed messenger RNA-expression studies of RAB3GAP1 and RAB3GAP2 orthologues in Danio rerio embryos and demonstrated that, whereas developmental expression of rab3gap1 was generalized ( similar to that reported elsewhere in mice), rab3gap2 expression was restricted to the central nervous system. These findings are consistent with RAB3GAP2 having a key role in neurodevelopment and may indicate that Warburg micro and Martsolf syndromes represent a spectrum of disorders. However, we did not detect RAB3GAP2 mutations in patients with Warburg micro syndrome. These findings suggest that RAB3GAP dysregulation may result in a spectrum of phenotypes that range from Warburg micro syndrome to Martsolf syndrome.	Univ Birmingham, Biomed Res Inst, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Womens Hosp Med Ctr, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; UCL, Dept Anat & Dev Biol, London, England; UCL, Inst Ophthalmol, London, England; Great Ormond St Hosp Sick Children, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 3JH, England; Great Ormond St Hosp Sick Children, Inst Child Hlth, NE Thames Reg Genet Serv, London WC1N 3JH, England; Moorfields Eye Hosp, Paediat Serv, London, England; Kings Coll London, Div Med & Mol Genet, London WC2R 2LS, England; Inst Fdn Italiana Ric Cancro Oncol Mol, Milan, Italy; Univ Wales Hosp, Inst Med Genet, Cardiff, Wales; Frenchay Hosp, Dept Neuroradiol, Bristol BS16 1LE, Avon, England	University of Birmingham; Birmingham Women's Hospital; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; King's College London; Cardiff University	Maher, ER (corresponding author), Univ Birmingham, Biomed Res Inst, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.	E.R.Maher@bham.ac.uk	Wilson, Stephen W/B-9404-2008; Mione, Maria Caterina/I-3073-2013; Zebrafish, UCL/A-3125-2009; Morgan, Neil V/A-5475-2009; MAHER, EAMONN R/A-9507-2008; Mione, Maria Caterina/ABG-9926-2021	Wilson, Stephen W/0000-0002-8557-5940; Morgan, Neil V/0000-0001-6433-5692; MAHER, EAMONN R/0000-0002-6226-6918; Trembath, Richard/0000-0003-0550-3400; Mione, Maria Caterina/0000-0002-9040-3705	Medical Research Council [G84/6508] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G84/6508] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ainsworth JR, 2001, OPHTHALMOLOGY, V108, P491, DOI 10.1016/S0161-6420(00)00540-6; Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Aligianis IA, 2002, J MED GENET, V39, P656, DOI 10.1136/jmg.39.9.656; Costagli A, 2002, J COMP NEUROL, V450, P73, DOI 10.1002/cne.10292; Criado GR, 1999, CLIN DYSMORPHOL, V8, P241; Derbent M, 2004, AM J MED GENET A, V128A, P232, DOI 10.1002/ajmg.a.30109; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060; HARBORD MG, 1989, J MED GENET, V26, P397, DOI 10.1136/jmg.26.6.397; HENNEKAM RCM, 1988, EUR J PEDIATR, V147, P539, DOI 10.1007/BF00441986; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; MARTSOLF JT, 1978, AM J MED GENET, V1, P291, DOI 10.1002/ajmg.1320010305; Megarbane A, 1999, J MED GENET, V36, P637; Nagano F, 1998, J BIOL CHEM, V273, P24781, DOI 10.1074/jbc.273.38.24781; Nassogne MC, 2000, NEUROPEDIATRICS, V31, P218, DOI 10.1055/s-2000-7463; SANCHEZ JM, 1985, J MED GENET, V22, P308, DOI 10.1136/jmg.22.4.308; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; STRISCIUGLIO P, 1988, J MED GENET, V25, P267, DOI 10.1136/jmg.25.4.267; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takai Y, 1996, GENES CELLS, V1, P615, DOI 10.1046/j.1365-2443.1996.00257.x; Tasaka K, 1998, J ENDOCRINOL, V157, P267, DOI 10.1677/joe.0.1570267; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	25	76	81	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					702	707		10.1086/502681	http://dx.doi.org/10.1086/502681			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532399	Bronze, Green Published			2022-12-18	WOS:000236755900015
J	Samuels, DC; Carothers, AD; Horton, R; Chinnery, PF				Samuels, DC; Carothers, AD; Horton, R; Chinnery, PF			The power to detect disease associations with mitochondrial DNA haplogroups	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MTDNA; RISK; POLYMORPHISMS; POPULATIONS; LONGEVITY; SELECTION; HUMANS	Genetic variation of mitochondrial DNA ( mtDNA) has been linked to a number of multifactorial diseases, but there is currently no tool available to predict the optimal size for these investigations. We used a simulation-based ( Monte Carlo) permutation test to generate power curves for European mtDNA haplogroup studies, to derive a universal equation to enable power calculations for prospective studies across the globe, and to show that very large cohorts are required to reliably detect an association with complex human diseases. In some populations, geographical variation in haplogroup frequencies will prevent the reliable detection of subtle haplogroup associations with uncommon disorders.	Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Newcastle Upon Tyne, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Virginia Polytechnic Institute & State University; University of Edinburgh; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Samuels, David C/A-5393-2008; Samuels, David/C-1365-2012; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617				Armitage P., 2002, STAT METHODS MED RES; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051	17	76	78	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					713	720		10.1086/502682	http://dx.doi.org/10.1086/502682			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532401	Green Published, Bronze			2022-12-18	WOS:000236755900017
J	Riazuddin, S; Khan, SN; Ahmed, ZM; Ghosh, M; Caution, K; Nazli, S; Kabra, M; Zafar, AU; Chen, K; Naz, S; Antonellis, A; Pavan, WJ; Green, ED; Wilcox, ER; Friedman, PL; Morell, RJ; Riazuddin, S; Friedman, TB				Riazuddin, S; Khan, SN; Ahmed, ZM; Ghosh, M; Caution, K; Nazli, S; Kabra, M; Zafar, AU; Chen, K; Naz, S; Antonellis, A; Pavan, WJ; Green, ED; Wilcox, ER; Friedman, PL; Morell, RJ; Riazuddin, S; Friedman, TB			Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELIC MUTATIONS; PCDH15; EAR	In seven families, six different mutant alleles of TRIOBP on chromosome 22q13 cosegregate with autosomal recessive nonsyndromic deafness. These alleles include four nonsense (Q297X, R788X, R1068X, and R1117X) and two frameshift (D1069fsX1082 and R1078fsX1083) mutations, all located in exon 6 of TRIOBP. There are several alternative splice isoforms of this gene, the longest of which, TRIOBP-6, comprises 23 exons. The linkage interval for the deafness segregating in these families includes DFNB28. Genetic heterogeneity at this locus is suggested by three additional families that show significant evidence of linkage of deafness to markers on chromosome 22q13 but that apparently have no mutations in the TRIOBP gene.	Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; All India Inst Med Sci, Dept Pediat, Genet Unit, New Delhi, India; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; NIH, Internal Med Consult Serv, Hatfield Clin Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; All India Institute of Medical Sciences (AIIMS) New Delhi; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA	Friedman, TB (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, 5 Res Court,Room 2A-19, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	naz, sadaf/F-4406-2015; Naz, Sadaf/C-3911-2019; Morell, Robert James/Q-2042-2019; Nasim Khan, Shaheen/F-2135-2015; SHEIKH, RIAZUDDIN/L-2406-2015	Naz, Sadaf/0000-0002-1912-0235; Morell, Robert/0000-0003-1537-7356; Pavan, William/0000-0001-8281-5120	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000136, Z01HG000060, Z01HG000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DC000039] Funding Source: Medline; NIDCD NIH HHS [T32 DC000035, ZO1 DC000035-07, ZO1 DC000039-07] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Morton CC, 2004, AM J MED GENET A, V130A, P26, DOI 10.1002/ajmg.a.30049; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seipel K, 2001, J CELL SCI, V114, P389; Smith RJH, 2004, AM J MED GENET A, V130A, P8, DOI 10.1002/ajmg.a.30053; WALSH TD, 2000, NIDCD HER HEARING IM	14	76	84	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					137	143		10.1086/499164	http://dx.doi.org/10.1086/499164			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385457	Green Published, Bronze			2022-12-18	WOS:000233930400014
J	Fallin, MD; Lasseter, VK; Wolyniec, PS; McGrath, JA; Nestadt, G; Valle, D; Liang, KY; Pulver, AE				Fallin, MD; Lasseter, VK; Wolyniec, PS; McGrath, JA; Nestadt, G; Valle, D; Liang, KY; Pulver, AE			Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; NATIONAL-INSTITUTE; PSYCHOTIC SYMPTOMS; FOUNDER MUTATION; MOOD DISORDERS; POTENTIAL LOCI; DNA MARKERS; WIDE SEARCH; SCHIZOPHRENIA; ASSOCIATION	The relatively short history of linkage studies in bipolar disorders (BPs) has produced inconsistent findings. Implicated regions have been large, with reduced levels of significance and modest effect sizes. Both phenotypic and genetic heterogeneity may have contributed to the failure to define risk loci. BP is part of a spectrum of apparently familial affective disorders, which have been organized by severity. Heterogeneity may arise because of insufficient data to define the spectrum boundaries, and, in general, the less-severe disorders are more difficult to diagnose reliably. To address the inherent complexities in detecting BP susceptibility loci, we have used restricted diagnostic classifications and a genetically more homogeneous (Ashkenazi Jewish) family collection to perform a 9-cM autosomal genomewide linkage scan. Although they are genetically more homogeneous, there are no data to suggest that the rate of illness in the Ashkenazim differs from that in other populations. In a genome scan of 41 Ashkenazi pedigrees with a proband affected with bipolar I disorder (BPI) and at least one other member affected with BPI or bipolar II disorder (BPII), we identified four regions suggestive of linkage on chromosomes 1, 3, 11, and 18. Follow-up genotyping showed that the regions on chromosomes 1, 3, and 18 are also suggestive of linkage in a subset of pedigrees limited to relative pairs affected with BPI. Furthermore, our chromosome 18q22 signal (D18S541 and D18S477) overlaps with previous BP findings. This research is being conducted in parallel with our companion study of schizophrenia, in which, by use of an identical approach, we recently reported significant evidence for a schizophrenia susceptibility locus in the Ashkenazim on chromosome 10q22.	Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21231 USA; Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21231 USA; Johns Hopkins Sch Med, Dept Mol Biol, Baltimore, MD 21231 USA; Johns Hopkins Sch Med, Dept Genet, Baltimore, MD 21231 USA; Johns Hopkins Sch Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21231 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pulver, AE (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, 1820 Lancaster St,Suite 300, Baltimore, MD 21231 USA.	aepulver@jhmi.edu	Liang, Kung-Yee/F-8299-2011	McGrath, John A./0000-0002-9756-7892	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058153] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NIMH NIH HHS [R01 MH058153, R01MH58153] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Akiskal Hagop S, 2002, Curr Psychiatry Rep, V4, P1, DOI 10.1007/s11920-002-0001-1; American Psychiatric Association, 1994, DIAGN STAT MEN MENT; ANDREASEN NC, 1981, ARCH GEN PSYCHIAT, V38, P400; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bassett SS, 2002, AM J MED GENET, V114, P679, DOI 10.1002/ajmg.10648; Benazzi F, 2001, COMPR PSYCHIAT, V42, P461, DOI 10.1053/comp.2001.27901; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 2002, HUM HERED, V54, P199, DOI 10.1159/000070665; Cassano GB, 1999, J AFFECT DISORDERS, V54, P319, DOI 10.1016/S0165-0327(98)00158-X; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Coryell W, 2001, J AFFECT DISORDERS, V67, P79, DOI 10.1016/S0165-0327(99)00024-5; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; Ekholm JM, 2003, HUM MOL GENET, V12, P1907, DOI 10.1093/hmg/ddg199; Escamilla MA, 2001, BIPOLAR DISORD, V3, P299, DOI 10.1034/j.1399-5618.2001.30605.x; Ewald H, 1997, PSYCHIATR GENET, V7, P1, DOI 10.1097/00041444-199700710-00001; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Fanous AH, 2004, AM J MED GENET B, V125B, P69, DOI 10.1002/ajmg.b.20103; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Garner C, 2001, AM J HUM GENET, V68, P1061, DOI 10.1086/319517; Goodwin F.K., 1990, MANIC DEPRESSIVE ILL; Green Elaine, 2003, Curr Psychiatry Rep, V5, P469, DOI 10.1007/s11920-003-0086-1; Grigoroiu-Serbanescu M, 2001, AM J MED GENET, V105, P765, DOI 10.1002/ajmg.10047; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HOLMANS P, 2003, ANN M INT GEN EP SOC; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li FY, 1999, AM J HUM GENET, V65, pA260; Liang KY, 2000, HUM HERED, V51, P64; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; Lynch HT, 2004, JAMA-J AM MED ASSOC, V291, P718, DOI 10.1001/jama.291.6.718; Maziade M, 1995, AM J MED GENET, V60, P522, DOI 10.1002/ajmg.1320600607; Maziade M, 2001, MOL PSYCHIATR, V6, P684, DOI 10.1038/sj.mp.4000915; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; McInnes LA, 2001, P NATL ACAD SCI USA, V98, P11485, DOI 10.1073/pnas.191519098; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; MCKUSICK VA, 1973, ISRAEL J MED SCI, V9, P1276; McMahon FJ, 2001, ARCH GEN PSYCHIAT, V58, P1025, DOI 10.1001/archpsyc.58.11.1025; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; McMahon FJ, 1997, AM J HUM GENET, V61, P1397, DOI 10.1086/301630; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; NANKO S, 1992, JPN J PSYCHIAT NEUR, V46, P155; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; Niell BL, 2003, AM J HUM GENET, V73, P1250, DOI 10.1086/379926; Nothen MM, 1999, MOL PSYCHIATR, V4, P76, DOI 10.1038/sj.mp.4000454; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Potash JB, 2003, AM J MED GENET B, V116B, P90, DOI 10.1002/ajmg.b.10761; Potash JB, 2001, AM J PSYCHIAT, V158, P1258, DOI 10.1176/appi.ajp.158.8.1258; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ritsner M, 2003, PSYCHIAT GENET, V13, P143, DOI 10.1097/00041444-200309000-00002; *SAGE, 2003, STAT SOL; Schulze TG, 2003, BIOL PSYCHIAT, V53, P239, DOI 10.1016/S0006-3223(02)01492-0; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Serretti A, 2000, J AFFECT DISORDERS, V58, P51, DOI 10.1016/S0165-0327(99)00112-3; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Sklar P, 2004, MOL PSYCHIATR, V9, P213, DOI 10.1038/sj.mp.4001418; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Smyth C, 1996, AM J PSYCHIAT, V153, P271; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; STINE OC, 1995, AM J HUM GENET, V57, P1384; STONE K, 1989, BRIT J PSYCHIAT, V155, P220, DOI 10.1192/bjp.155.2.220; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; TIKOCHINSKI Y, 1991, AM J HUM GENET, V48, P129; Todd Richard D, 2002, Curr Psychiatry Rep, V4, P141, DOI 10.1007/s11920-002-0048-z; Tsuang M, 1990, GENETICS MOOD DISORD; WEISSMAN MM, 1984, AM J PSYCHIAT, V141, P892; Zandi PP, 2003, AM J MED GENET B, V119B, P69, DOI 10.1002/ajmg.b.10063	89	76	78	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					204	219		10.1086/422474	http://dx.doi.org/10.1086/422474			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15208783	Green Published, Bronze			2022-12-18	WOS:000222702000005
J	Kamatani, N; Sekine, A; Kitamoto, T; Iida, A; Saito, S; Kogame, A; Inoue, E; Kawamoto, M; Harigai, M; Nakamura, Y				Kamatani, N; Sekine, A; Kitamoto, T; Iida, A; Saito, S; Kogame, A; Inoue, E; Kawamoto, M; Harigai, M; Nakamura, Y			Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DIPLOTYPE CONFIGURATION; RHEUMATOID-ARTHRITIS; JAPANESE POPULATION; CROHNS-DISEASE; HUMAN GENOME; CATALOG; SUSCEPTIBILITY; ALGORITHM; PHARMACOGENOMICS	To optimize the strategies for population-based pharmacogenetic studies, we extensively analyzed single-nucleotide polymorphisms (SNPs) and haplotypes in 199 drug-related genes, through use of 4,190 SNPs in 752 control subjects. Drug-related genes, like other genes, have a haplotype-block structure, and a few haplotype-tagging SNPs (htSNPs) could represent most of the major haplotypes constructed with common SNPs in a block. Because our data included 860 uncommon (frequency <0.1) SNPs with frequencies that were accurately estimated, we analyzed the relationship between haplotypes and uncommon SNPs within the blocks ( 549 SNPs). We inferred haplotype frequencies through use of the data from all htSNPs and one of the uncommon SNPs within a block and calculated four joint probabilities for the haplotypes. We show that, irrespective of the minor-allele frequency of an uncommon SNP, the majority (mean +/- SD frequency 0.943 +/- 0.117) of the minor alleles were assigned to a single haplotype tagged by htSNPs if the uncommon SNP was within the block. These results support the hypothesis that recombinations occur only infrequently within blocks. The proportion of a single haplotype tagged by htSNPs to which the minor alleles of an uncommon SNP were assigned was positively correlated with the minor-allele frequency when the frequency was <0.03 (P < .000001; n = 233 [Spearman's rank correlation coefficient]). The results of simulation studies suggested that haplotype analysis using htSNPs may be useful in the detection of uncommon SNPs associated with phenotypes if the frequencies of the SNPs are higher in affected than in control populations, the SNPs are within the blocks, and the frequencies of the SNPs are >0.03.	Tokyo Womens Med Univ, Inst Rheumatol, Div Stat Genet, Shinjuku Ku, Tokyo 1620054, Japan; Tokyo Womens Med Univ, Dept Adv Biomed Engn & Sci, Div Genom Med, Shinjuku Ku, Tokyo 1620054, Japan; Riken Yokohama Inst, RIKEN SNP Res Ctr, Lab Genotyping, Yokohama, Kanagawa, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; RIKEN	Kamatani, N (corresponding author), Tokyo Womens Med Univ, Inst Rheumatol, Div Stat Genet, Shinjuku Ku, 10-22 Kawado Cho, Tokyo 1620054, Japan.	kamatani@ior.twmu.ac.jp	Iida, Aritoshi/CAA-1373-2022	Iida, Aritoshi/0000-0001-7538-1651; Kitamoto, Takuya/0000-0002-4008-5497				Avi-Itzhak Hadar I, 2003, Pac Symp Biocomput, P466; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Couzin J, 2002, SCIENCE, V298, P941, DOI 10.1126/science.298.5595.941a; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iida A, 2001, J HUM GENET, V46, P668, DOI 10.1007/s100380170019; Iida A, 2002, J HUM GENET, V47, P285, DOI 10.1007/s100380200041; Iida A, 2003, J HUM GENET, V48, P23, DOI 10.1007/s100380300004; Iida A, 2002, J HUM GENET, V47, P505, DOI 10.1007/s100380200075; Iida A, 2001, J HUM GENET, V46, P225, DOI 10.1007/s100380170093; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Judson R, 2001, PHARMACOGENOMICS, V2, P7, DOI 10.1517/14622416.2.1.7; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kitamura Y, 2002, ANN HUM GENET, V66, P183, DOI [10.1046/j.1469-1809.2002.00112.x, 10.1017/S0003480002001124]; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kwiatkowski RW, 1999, MOL DIAGN, V4, P353, DOI 10.1016/S1084-8592(99)80012-5; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LONG JC, 1995, AM J HUM GENET, V56, P799; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Saito S, 2002, J HUM GENET, V47, P576, DOI 10.1007/s100380200088; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tanaka E, 2002, J RHEUMATOL, V29, P2492; Urano W, 2002, PHARMACOGENETICS, V12, P183, DOI 10.1097/00008571-200204000-00002; Zhu XF, 2003, GENOME RES, V13, P173, DOI 10.1101/gr.302003	40	76	77	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					190	203		10.1086/422853	http://dx.doi.org/10.1086/422853			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15202072	Green Published, Bronze			2022-12-18	WOS:000222702000004
J	Schick, JH; Iyengar, SK; Klein, BE; Klein, R; Reading, K; Liptak, R; Millard, C; Lee, KE; Tomany, SC; Moore, EL; Fijal, BA; Elston, RC				Schick, JH; Iyengar, SK; Klein, BE; Klein, R; Reading, K; Liptak, R; Millard, C; Lee, KE; Tomany, SC; Moore, EL; Fijal, BA; Elston, RC			A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MACULAR DEGENERATION; VISUAL-ACUITY; STARGARDT-DISEASE; 5-YEAR INCIDENCE; GRADING SYSTEM; FRAMINGHAM EYE; GENE ABCR; PREVALENCE; POPULATION; APOPTOSIS	Age-related maculopathy (ARM) is a leading cause of visual impairment among the elderly in Western populations. To identify ARM-susceptibility loci, we genotyped a subset of subjects from the Beaver Dam (WI) Eye Study and performed a model-free genomewide linkage analysis for markers linked to a quantitative measure of ARM. We initially genotyped 345 autosomal markers in 325 individuals (N = 263 sib pairs) from 102 pedigrees. Ten regions suggestive of linkage with ARM were observed on chromosomes 3, 5, 6, 12, 15, and 16. Prior to fine mapping, the most significant regions were an 18-cM region on chromosome 12, near D12S1300 (P = .0159); a region on chromosome 3, near D3S1763, with a P value of .0062; and a 6-cM region on chromosome 16, near D16S769, with a P value of .0086. After expanding our analysis to include 25 additional fine-mapping markers, we found that a 14-cM region on chromosome 12, near D12S346 (located at 106.89 cM), showed the strongest indication of linkage, with a P value of .004. Three other regions, on chromosomes 5, 6, and 15, that were nominally significant at P less than or equal to .01 are also appropriate for fine mapping.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Ctr, Cleveland, OH 44109 USA; Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, Madison, WI USA	Case Western Reserve University; MetroHealth System; University of Wisconsin System; University of Wisconsin Madison	Schick, JH (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Ctr, Rammelkamp Bldg,Room 258,2500 Metrohlth Dr, Cleveland, OH 44109 USA.	texilene@darwin.EPBI.cwru.edu	/S-1190-2019	/0000-0001-7488-250X; Klein, Ronald/0000-0002-4428-6237	NCRR NIH HHS [RR03655, P41 RR003655] Funding Source: Medline; NEI NIH HHS [U10-EY06594, EY10605, U10 EY006594] Funding Source: Medline; NHLBI NIH HHS [HL07567, T32 HL007567] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, GM28356, R37 GM028356] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594, R01EY010605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; [Anonymous], [No title captured]; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRESSLER NM, 1995, ARCH OPHTHALMOL-CHIC, V113, P301, DOI 10.1001/archopht.1995.01100030055022; BRESSLER NM, 1989, ARCH OPHTHALMOL-CHIC, V107, P847, DOI 10.1001/archopht.1989.01070010869032; Cruickshanks KJ, 1997, ARCH OPHTHALMOL-CHIC, V115, P242, DOI 10.1001/archopht.1997.01100150244015; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; De La Paz MA, 1999, OPHTHALMOLOGY, V106, P1531, DOI 10.1016/S0161-6420(99)90449-9; DOSSO AA, 1992, OPHTHALMOLOGICA, V205, P24, DOI 10.1159/000310307; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; ELSTON RC, 1979, AM J HUM GENET, V31, P655; ELSTON RC, 1972, GENESCREEN, V1, P63; GIBSON JM, 1985, T OPHTHAL SOC UK, V104, P196; Gomes I, 1999, ANN HUM GENET, V63, P535, DOI 10.1017/S0003480099007824; GOURIEROUX C, 1984, ECONOMETRICA, V52, P681, DOI 10.2307/1913471; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Hoyng CB, 1996, HUM GENET, V98, P500, DOI 10.1007/s004390050247; Huber P. J., 1967, P 5 BERKELEY S MATH, V1, P221; KAHN HA, 1977, AM J EPIDEMIOL, V106, P33, DOI 10.1093/oxfordjournals.aje.a112429; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; KLEIN BE, 1982, ARCH OPHTHALMOL-CHIC, V100, P571; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1203; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 1999, OPHTHALMOLOGY, V106, P1056, DOI 10.1016/S0161-6420(99)90255-5; KLEIN R, 1995, BEAVER DAM EYE STUDY, V2; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514; Meyers S M, 1994, Trans Am Ophthalmol Soc, V92, P775; MEYERS SM, 1995, AM J OPHTHALMOL, V120, P757, DOI 10.1016/S0002-9394(14)72729-1; MEYERS SM, 1988, ARCH OPHTHALMOL-CHIC, V106, P651; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; Putter H, 2002, GENET EPIDEMIOL, V22, P345, DOI 10.1002/gepi.01104; SCHACHAT AP, 1995, ARCH OPHTHALMOL-CHIC, V113, P728, DOI 10.1001/archopht.1995.01100060054032; Schick James H., 2001, International Journal of Human Genetics, V1, P11; SHETE S, IN PRESS HUM HERED; SMALL KW, 1992, GENOMICS, V13, P681, DOI 10.1016/0888-7543(92)90141-E; Small KW, 1999, MOL VIS, V5; Souied EH, 2000, INVEST OPHTH VIS SCI, V41, P244; Sparrow JM, 1997, EYE, V11, P315, DOI 10.1038/eye.1997.67; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Tarttelin EE, 2001, J MED GENET, V38, P381, DOI 10.1136/jmg.38.6.381; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tielsch JA, 1995, VISION PROBLEMS US R, P1; VINGERLING JR, 1995, AM J EPIDEMIOL, V142, P404, DOI 10.1093/oxfordjournals.aje.a117648; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; WILSON AF, 1991, AM J HUM GENET, V48, P862; Yates JRW, 2000, J MED GENET, V37, P83, DOI 10.1136/jmg.37.2.83; YOSHIMURA S, 1994, GENE, V145, P293	64	76	81	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1412	1424		10.1086/375500	http://dx.doi.org/10.1086/375500			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12717633	Green Published, Bronze			2022-12-18	WOS:000183275500005
J	Tsai, HJ; Sun, GY; Weeks, DE; Kaushal, R; Wolujewicz, M; McGarvey, ST; Tufa, J; Viali, S; Deka, R				Tsai, HJ; Sun, GY; Weeks, DE; Kaushal, R; Wolujewicz, M; McGarvey, ST; Tufa, J; Viali, S; Deka, R			Type 2 diabetes and three Calpain-10 gene polymorphisms in Samoans: No evidence of association	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY GENES; WESTERN-SAMOA; PREVALENCE; AMERICAN; MELLITUS; OBESITY; SCAN; LOCI	Although genomewide scans have identified several potential chromosomal susceptibility regions in several human populations, finding a causative gene for type 2 diabetes has remained elusive. Others have reported a novel gene, calpain-10 (CAPN10), located in a previously identified region on chromosome 2q37.3, as a putative susceptibility gene for type 2 diabetes. Three single-nucleotide polymorphisms (SNPs) (UCSNP43, UCSNP19, and UCSNP63) were shown to be involved in increased risk of the disease among Mexican Americans. We have tested the association of these three SNPs with type 2 diabetes among the Samoans of Polynesia, who have a very high prevalence of the disease. In the U.S. territory of American Samoa, prevalence is 25% and 15% in men and women, respectively, whereas, in the independent nation of Samoa, prevalence is 3% and 5% in men and women, respectively. In our study sample, which consisted of 172 unrelated affected case subjects and 96 control subjects, we failed to detect any association between case subjects and control subjects in allele frequencies, haplotype frequencies, or haplotype combinations of UCSNP43, -19, and -63. Also, our data showed no evidence of linkage, among 201 affected sib pairs, in the region of chromosome 2 that contains these SNPs. Three plausible scenarios could explain these observations. (1) CAPN10 is a susceptibility gene only in particular ethnic groups; (2) our study lacks power to detect the effects of CAPN10 polymorphisms (but our sample size is comparable to that of earlier reports); or (3) the underlying biological mechanism is too complex and requires further research.	Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; Brown Univ, Int Hlth Inst, Providence, RI 02912 USA	University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University	Deka, R (corresponding author), Univ Cincinnati, Dept Environm Hlth, 3223 Eden Ave, Cincinnati, OH 45267 USA.	ranjan.deka@uc.edu	McGarvey, Stephen T/I-1788-2014; Weeks, Daniel E/B-2995-2012; Kaushal, Ritesh/ABG-7034-2020; Tsai, Hui-Ju/E-3937-2010	McGarvey, Stephen T/0000-0003-1233-6970; Weeks, Daniel E/0000-0001-9410-7228; 	NHLBI NIH HHS [HL52611, R01 HL052611] Funding Source: Medline; NIA NIH HHS [AG09375, R01 AG009375] Funding Source: Medline; NIDDK NIH HHS [R01 DK059642, DK55406, DK59642] Funding Source: Medline; NIEHS NIH HHS [ES06096, P30 ES006096] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055406, R01DK059642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009375] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; COLLINS VR, 1994, DIABETES CARE, V17, P288, DOI 10.2337/diacare.17.4.288; DEKA R, 1994, HUM BIOL, V66, P805; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Galanis DJ, 1999, J AM DIET ASSOC, V99, P184, DOI 10.1016/S0002-8223(99)00044-9; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HEDRICK PW, 1987, GENETICS, V117, P331; Hegele RA, 1999, J HUM GENET, V44, P10, DOI 10.1007/s100380050097; HODGE AM, 1994, INT J OBESITY, V18, P419; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Malecki MT, 2001, DIABETES, V50, pA243; MCGARVEY ST, 1993, AM J HUM BIOL, V5, P17, DOI 10.1002/ajhb.1310050106; MCGARVEY ST, 1979, HUM BIOL, V51, P461; MCGARVEY ST, 1991, AM J CLIN NUTR, V53, pS1586, DOI 10.1093/ajcn/53.6.1586S; MCGARVEY ST, 2000, 5 INT M DIAB IND PEO; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Ng MCY, 2001, DIABETES, V50, pA234; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Connell JR, 2000, GENET EPIDEMIOL, V19, pS64, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI10>3.0.CO;2-G; ORHOMELANDER M, 2000, 36 ANN M EUR ASS STU; Permutt MA, 2000, J CLIN INVEST, V106, P819, DOI 10.1172/JCI11228; Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681; Schwarz PEH, 2001, DIABETES, V50, pA232; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stumvoll M, 2001, DIABETES, V50, pA239; Terwilliger J., 1994, HDB HUMAN GENETIC LI; *US BUR CENS, 1990, CPH6AS 1990 US BUR C; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; XIE X, 1993, AM J HUM GENET, V53, P1107; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; Zimmet P, 1979, Diabetes Care, V2, P144, DOI 10.2337/diacare.2.2.144	42	76	80	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1236	1244		10.1086/324646	http://dx.doi.org/10.1086/324646			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704924	Green Published, Bronze			2022-12-18	WOS:000172086900008
J	Morris, AP; Whittaker, JC; Balding, DJ				Morris, AP; Whittaker, JC; Balding, DJ			Bayesian fine-scale mapping of disease loci, by hidden Markov models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; POPULATIONS; HUMANS; GENES	We present a new multilocus method for the fine-scale mapping of genes contributing to human diseases. The method is designed for use with multiple biallelic markers-in particular, single-nucleotide polymorphisms for which high-density genetic maps will soon be available. We model disease-marker association in a candidate region via a hidden Markov process and allow for correlation between linked marker loci. Using Markov-chain-Monte Carlo simulation methods, we obtain posterior distributions of model parameter estimates including disease-gene location and the age of the disease-predisposing mutation. In addition, we allow for heterogeneity in recombination rates, across the candidate region, to account for recombination hot and cold spots. We also obtain, for the ancestral marker haplotype, a posterior distribution that is unique to our method and that, unlike maximum-likelihood estimation, can properly account for uncertainty. We apply the method to data for cystic fibrosis and Huntington disease, for which mutations in disease genes have already been identified. The new method performs well compared with existing multi-locus mapping methods.	Univ Reading, Dept Appl Stat, Reading RG6 6FN, Berks, England	University of Reading	Morris, AP (corresponding author), Univ Reading, Dept Appl Stat, POB 240,Earley Gate, Reading RG6 6FN, Berks, England.	sns98am@reading.ac.uk	Whittaker, John C/B-8609-2012; Balding, David/G-9898-2011	Whittaker, John C/0000-0002-3529-2379; Balding, David/0000-0002-1480-6115				Collins A, 1998, P NATL ACAD SCI USA, V95, P1741, DOI 10.1073/pnas.95.4.1741; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Graham J, 1998, AM J HUM GENET, V63, P1517, DOI 10.1086/302102; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1984, SCIENCE, V225, P1320, DOI 10.1126/science.6089346; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lam JC, 2000, AM J HUM GENET, V66, P659, DOI 10.1086/302756; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moran P., 1962, STAT PROCESSES EVOLU; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nielsen R, 2000, GENETICS, V154, P931; Ott J., 1991, ANAL HUMAN GENETIC L; Pennisi E, 1998, SCIENCE, V281, P1787, DOI 10.1126/science.281.5384.1787; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SERRE JL, 1990, HUM GENET, V84, P449; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475	27	76	78	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					155	169		10.1086/302956	http://dx.doi.org/10.1086/302956			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10835299	Bronze, Green Published			2022-12-18	WOS:000088926900018
J	Moynihan, L; Jackson, AP; Roberts, E; Karbani, G; Lewis, I; Corry, P; Turner, G; Mueller, RF; Lench, NJ; Woods, CG				Moynihan, L; Jackson, AP; Roberts, E; Karbani, G; Lewis, I; Corry, P; Turner, G; Mueller, RF; Lench, NJ; Woods, CG			A third novel locus for primary autosomal recessive microcephaly maps to chromosome 9q34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-RELEASING PROTEIN; NORMAL INTELLIGENCE; FAMILY; C3G	Primary autosomal recessive microcephaly is a clinical diagnosis of exclusion in an individual with a head circumference greater than or equal to 4 SDs below the expected age-and-sex mean. There is associated moderate mental retardation, and neuroimaging shows a small but structurally normal cerebral cortex. The inheritance pattern in the majority of cases is considered to be autosomal recessive. Although genetic heterogeneity for this clinical phenotype had been expected, this has only recently been demonstrated, with the mapping of two loci for autosomal recessive primary microcephaly: MCPH1 at 8p and MCPH2 at 19q. We have studied a large multiaffected consanguineous pedigree, using a whole-genome search, and have identified a third locus, MCPH3 at 9q34. The minimal critical region is similar to 12 cM, being defined by the markers cen-D9S1872-D9S159-tel, with a maximum two-point LOD score of 3.76 (recombination fraction 0) observed for the marker D9S290.	St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Paediat Oncol & Haematol, Leeds LS9 7TF, W Yorkshire, England; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England	Saint James's University Hospital; Saint James's University Hospital; University of Leeds; Saint James's University Hospital	Woods, CG (corresponding author), St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England.		woods, christopher g/A-1361-2010; Lench, Nicholas/AAB-1791-2021; Jackson, Andrew P/D-3442-2009	Jackson, Andrew P/0000-0002-8739-2646; Lench, Nicholas/0000-0002-6108-0759				BUNDEY S, 1997, EMERY RIMOINS PRINCI, V1, P725; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; COWIE V, 1960, J MENT DEFIC RES, V4, P42; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; HENEY D, 1992, CANCER, V69, P962, DOI 10.1002/1097-0142(19920215)69:4<962::AID-CNCR2820690421>3.0.CO;2-W; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Knoepfler PS, 1997, MECH DEVELOP, V63, P5, DOI 10.1016/S0925-4773(97)00669-2; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SUJATHA M, 1989, HUM GENET, V81, P388, DOI 10.1007/BF00283699; TAKAI S, 1994, HUM GENET, V94, P549; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; TEEBI AS, 1987, AM J MED GENET, V26, P355, DOI 10.1002/ajmg.1320260214; TOLMIE JL, 1987, AM J MED GENET, V27, P583, DOI 10.1002/ajmg.1320270311; VANDIJK MA, 1995, MECH DEVELOP, V52, P99, DOI 10.1016/0925-4773(95)00394-G	16	76	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					724	727		10.1086/302777	http://dx.doi.org/10.1086/302777			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677332	Green Published, Bronze			2022-12-18	WOS:000088373100039
J	Paula, D				Paula, D		Tourette Syndrome Assoc Int Consor	A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSESSIVE-COMPULSIVE DISORDER; PEDIGREE-MEMBER METHOD; LINKAGE ANALYSIS; RECEPTOR GENE; BILINEAL TRANSMISSION; TIC DISORDERS; FAMILY; TRAITS; HOMOZYGOSITY; ADOLESCENTS	Gilles de la Tourette syndrome is a neuropsychiatric disorder characterized by waxing and waning multiple motor and phonic ties with a complex mode of inheritance. Previous attempts, which used large multigenerational families to localize susceptibility loci, have been unsuccessful. In this report, the results of the first systematic genome scan, using 76 affected-sib-pair families with a total of 110 sib pairs, are summarized. While no results reached acceptable statistical significance, the multipoint maximum-likelihood scores (MLS) for two regions (4q and 8p) were suggestive (MLS > 2.0). Four additional genomic regions also gave multipoint MLS scores between 1.0 and 2.0.			Paula, D (corresponding author), Care Of Pauls D, Yale Univ, Ctr Child Study, Sch Med, 230 S Frontage Rd, New Haven, CT 06520 USA.							APTER A, 1993, ARCH GEN PSYCHIAT, V50, P734; Barr CL, 1998, CAN J PSYCHIAT, V43, P351, DOI 10.1177/070674379804300402; Barr CL, 1999, AM J MED GENET, V88, P437, DOI 10.1002/(SICI)1096-8628(19990820)88:4<437::AID-AJMG24>3.0.CO;2-E; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; COMINGS DE, 1985, AM J HUM GENET, V37, P435; COMINGS DE, 1993, LANCET, V341, P906, DOI 10.1016/0140-6736(93)93123-I; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; Field LL, 1998, AM J HUM GENET, V63, P1448, DOI 10.1086/302107; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Grice DE, 1996, AM J HUM GENET, V59, P644; HASSTEDT SJ, 1995, AM J HUM GENET, V57, P682; Hebebrand J, 1997, J PSYCHIAT RES, V31, P519, DOI 10.1016/S0022-3956(97)00028-9; HEUTINK P, 1995, AM J HUM GENET, V57, P465; HEUTINK P, 1990, J MED GENET, V27, P433, DOI 10.1136/jmg.27.7.433; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; KAUFMAN J, 1995, KIDDIE SADS LIFETIME; KIDD KK, 1993, AM J MED GENET, V48, P71, DOI 10.1002/ajmg.1320480202; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; KURLAN R, 1994, NEUROLOGY, V44, P2336, DOI 10.1212/WNL.44.12.2336; LECKMAN JF, 1994, AM J PSYCHIAT, V151, P675; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Leckman JF, 1997, AM J PSYCHIAT, V154, P911; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; LECKMAN JF, 1993, AM J PSYCHIAT, V150, P98; McMahon WM, 1996, J AM ACAD CHILD PSY, V35, P672, DOI 10.1097/00004583-199605000-00023; MCMAHON WM, 1992, ADV NEUROL, V58, P159; NOTHEN MM, 1994, HUM MOL GENET, V3, P2207, DOI 10.1093/hmg/3.12.2207; NOTHEN MM, 1994, AM J MED GENET, V54, P249, DOI 10.1002/ajmg.1320540311; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; PAULS DL, 1993, NAT GENET, V3, P4, DOI 10.1038/ng0193-4; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1180; PAULS DL, 1990, J AM ACAD CHILD PSY, V29, P195, DOI 10.1097/00004583-199003000-00007; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Robertson MM, 1996, AUST NZ J PSYCHIAT, V30, P749, DOI 10.3109/00048679609065041; Robertson MM, 1998, CURR OPIN NEUROL, V11, P373, DOI 10.1097/00019052-199808000-00014; Simonic I, 1998, AM J HUM GENET, V63, P839, DOI 10.1086/302002; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Walkup JT, 1996, AM J HUM GENET, V59, P684; WARD PJ, 1993, AM J HUM GENET, V52, P1200; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Yuan B, 1997, AM J HUM GENET, V60, P459	46	76	77	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1428	1436						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	252YZ					2022-12-18	WOS:000083531000026
J	Torroni, A; Cruciani, F; Rengo, C; Sellitto, D; Lopez-Bigas, N; Rabionet, R; Govea, N; de Munain, AL; Sarduy, M; Romero, L; Villamar, M; del Castillo, I; Moreno, F; Estivill, X; Scozzari, R				Torroni, A; Cruciani, F; Rengo, C; Sellitto, D; Lopez-Bigas, N; Rabionet, R; Govea, N; de Munain, AL; Sarduy, M; Romero, L; Villamar, M; del Castillo, I; Moreno, F; Estivill, X; Scozzari, R			The A1555G mutation in the 12S rRNA gene of human mtDNA: Recurrent origins and founder events in families affected by sensorineural deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RIBOSOMAL-RNA GENE; HEREDITARY OPTIC NEUROPATHY; NON-SYNDROMIC DEAFNESS; AMINOGLYCOSIDE OTOTOXICITY; HEARING-LOSS; MITOCHONDRIAL; HAPLOGROUPS; POPULATION; IDENTIFICATION; PEDIGREES	The mtDNA variation of 50 Spanish and 4 Cuban families affected by nonsyndromic sensorineural deafness due to the A1555G mutation in the 12S rRNA gene was studied by high-resolution RFLP analysis and sequencing of the control region. Phylogenetic analyses of haplotypes and detailed survey of population controls revealed that the A1555G mutation can be attributed to greater than or equal to 30 independent mutational events among the 50 Spanish families and that it occurs on mtDNA haplogroups that are common in all European populations. This indicates that the relatively high detection rate of this mutation in Spain is not due to sampling biases or to a single major founder event. Moreover, the distribution of these mutational events on different haplogroups is compatible with a random occurrence of the A1555G mutation and tends to support the conclusion that mtDNA backgrounds do not play a significant role in the expression of the mutation. Overall, these findings appear to indicate that the rare detection of this mutation in other populations is most likely due to inadequacy in patient ascertainment and molecular screening. This probable lack of identification of the A1555G mutation in subjects affected by sensorineural hearing loss implies that their maternally related relatives are not benefiting from presymptomatic detection and information concerning their increased risk of ototoxicity due to aminoglycoside treatments.	Univ Urbino, Ist Chim Biol, I-61029 Urbino, Italy; Univ Roma La Sapienza, CNR, Dipartimento Genet & Biol Mol, Rome, Italy; Univ Roma La Sapienza, CNR, Ctr Genet Evoluzionist, Rome, Italy; IRO, Med & Mol Gent Ctr, Barcelona, Spain; Hosp Ntra Sra Aranzazu, Dept Neurol, San Sebastian, Spain; Hosp Ramon & Cajal, Unidad Genet Mol, E-28034 Madrid, Spain	University of Urbino; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Hospital Universitario Ramon y Cajal	Torroni, A (corresponding author), Univ Urbino, Ist Chim Biol, I-61029 Urbino, Italy.	torroni@axcasp.caspur.it	Estivill, Xavier/A-3125-2013; del Castillo, Ignacio/B-4314-2013; Lopez-Bigas, Nuria/F-6193-2011; Rabionet, Raquel/C-8379-2009; Estivill, Xavier/E-2957-2012; Villamar, Manuela/AAD-3842-2020; Cruciani, Fulvio/G-6105-2012; rabionet, raquel/A-7407-2009; Torroni, Antonio/E-1557-2011; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020	Estivill, Xavier/0000-0002-0723-2256; del Castillo, Ignacio/0000-0003-1188-3665; Lopez-Bigas, Nuria/0000-0003-4925-8988; Rabionet, Raquel/0000-0001-5006-8140; Villamar, Manuela/0000-0002-5115-4937; rabionet, raquel/0000-0001-5006-8140; Torroni, Antonio/0000-0002-4163-4478; /0000-0002-9509-4032; ROMERO BARRUETE, LOURDES/0000-0001-7893-5779; Cruciani, Fulvio/0000-0002-6900-024X	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		Abe S, 1998, EUR J HUM GENET, V6, P563, DOI 10.1038/sj.ejhg.5200239; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ArnaizVillena A, 1997, IMMUNOGENETICS, V47, P37, DOI 10.1007/s002510050324; Brown MD, 1997, AM J HUM GENET, V60, P381; Casano RAMS, 1998, AM J MED GENET, V79, P388, DOI 10.1002/(SICI)1096-8628(19981012)79:5<388::AID-AJMG11>3.0.CO;2-N; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHEN YS, 1995, AM J HUM GENET, V57, P133; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; ElSchahawi M, 1997, NEUROLOGY, V48, P453, DOI 10.1212/WNL.48.2.453; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L; Gardner JC, 1997, J MED GENET, V34, P904, DOI 10.1136/jmg.34.11.904; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; HOWELL N, 1995, GENETICS, V140, P285; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; Hutchin T, 1999, ACTA OTO-LARYNGOL, V119, P48, DOI 10.1080/00016489950181927; Hutchin TP, 1997, GENETICS, V145, P771; Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Matthijs G, 1996, EUR J HUM GENET, V4, P46; Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 1996, AM J HUM GENET, V59, P185; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Sarduy M, 1998, DEV GENETIC HEARING, P121; Swofford D, 1993, PHYLOGENETIC ANAL US; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; Usami S, 1997, LARYNGOSCOPE, V107, P483, DOI 10.1097/00005537-199704000-00011	36	76	83	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1349	1358		10.1086/302642	http://dx.doi.org/10.1086/302642			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521300	Bronze, Green Published			2022-12-18	WOS:000083531000016
J	Izagirre, N; de la Rua, C				Izagirre, N; de la Rua, C			An mtDNA analysis in ancient Basque populations: Implications for haplogroup V as a marker for a major paleolithic expansion from southwestern Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA SEQUENCES; RECENT AFRICAN ORIGIN; NEOLITHIC LINEAGES; CONTROL REGION; MODERN HUMANS; GENE POOL; BONE; AMPLIFICATION; FREQUENCIES; REVEALS	mtDNA sequence variation was studied in 121 dental samples from four Basque prehistoric sites, by high-resolution RFLP analysis. The results of this study are corroborated by (1) parallel analysis of 92 bone samples, (2) the use of controls during extraction and amplification, and (3) typing by both positive and negative restriction of the linked sites that characterize each haplogroup. The absence of haplogroup V in the prehistoric samples analyzed conflicts with the hypothesis proposed by Torroni et al., in which haplogroup V is considered as an mtDNA marker for a major Paleolithic population expansion from southwestern Europe, occurring similar to 10,000-15,000 years before the present (YBP). Our samples from the Basque Country provide a valuable tool for checking the previous hypothesis, which is based on genetic data from present-day populations. In light of the available data, the most realistic scenario to explain the origin and distribution of haplogroup V suggests that the mutation defining that haplogroup (4577 NlaIII) appeared at a time when the effective population size was small enough to allow genetic drift to act-and that such drift is responsible for the heterogeneity observed in Basques, with regard to the frequency of haplogroup V (0%-20%), This is compatible with the attributed date for the origin of that mutation (10,000-15,000 YBP), because during the postglacial period (the Mesolithic, similar to 11,000 YBP) there was a major demographic change in the Basque Country, which minimized the effect of genetic drift. This interpretation does not rely on migratory movements to explain the distribution of haplogroup V in present-day Indo-European populations.	EHU, UPV, Zientzi Fak, Bilbao 48080, Spain	University of Basque Country	de la Rua, C (corresponding author), EHU, UPV, Zientzi Fak, POB 644, Bilbao 48080, Spain.			DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825				AGUIRRE A, 1991, AM J HUM GENET, V49, P450; Ammerman A.J., 1984, NEOLITHIC TRANSITION; ARMENDARIZ J, 1995, ARQUITECTURA MUERTE, P1; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; Calderon R, 1998, HUM BIOL, V70, P667; CALDERON R, 1993, ANN HUM BIOL, V20, P109, DOI 10.1080/03014469300002562; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; CLARK GA, 1991, CURR ANTHROPOL, V32, P577, DOI 10.1086/204002; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DeGusta D., 1996, ANCIENT BIOMOL, V1, P89; DELARUA C, 1995, PASSAT PIRINEUS PERS, P301; ETXEBERRIA F, 1988, MUNIBE ANTROPOL ARKE, V6, P105; FOX JC, 1991, J VIROL METHODS, V33, P375, DOI 10.1016/0166-0934(91)90037-Z; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; Hagelberg Erika, 1994, P195; Handt O, 1996, AM J HUM GENET, V59, P368; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1997, AM J HUM GENET, V61, P986; Howell N, 1996, AM J HUM GENET, V59, P501; IRIONDO M, 1998, THESIS UPV EHU BILBA; IZAGIRRE N, 1998, THESIS UPV EHU BILBA; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza C, 1997, HUM MOL GENET, V6, P41, DOI 10.1093/hmg/6.1.41; Manzano C, 1996, AM J PHYS ANTHROPOL, V99, P249, DOI 10.1002/(SICI)1096-8644(199602)99:2<249::AID-AJPA3>3.0.CO;2-U; Mumm S, 1997, AM J HUM GENET, V60, P153; MUNOZ M, 1997, CUADERNOS ARQUEOLOGI, V16; Nei M., 1987, MOL EVOLUTIONARY GEN; OOTA H, 1995, AM J PHYS ANTHROPOL, V98, P133, DOI 10.1002/ajpa.1330980204; Otte M., 1990, WORLD 18000 BP, P54; PAABO S, 1989, J BIOL CHEM, V264, P9709; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Parr RL, 1996, AM J PHYS ANTHROPOL, V99, P507; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PENNY D, 1995, MOL BIOL EVOL, V12, P863; PESOLE G, 1992, MOL BIOL EVOL, V9, P587; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; RibeirodosSantos AKC, 1996, AM J PHYS ANTHROPOL, V101, P29, DOI 10.1002/(SICI)1096-8644(199609)101:1<29::AID-AJPA3>3.0.CO;2-8; Richards M, 1996, AM J HUM GENET, V59, P185; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruvolo M, 1996, MOL PHYLOGENET EVOL, V5, P202, DOI 10.1006/mpev.1996.0014; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SLATKIN M, 1991, GENETICS, V129, P555; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Straus L.G., 1996, HUMANS END ICE AGE; SYKES B, 1996, MOL BIOL HUMAN DIVER, V28, P130; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; WILLS C, 1995, EVOLUTION, V49, P593, DOI 10.1111/j.1558-5646.1995.tb02296.x; Zapata L., 1995, MUNIBE, V47, P35; Zierdt H, 1996, HUM BIOL, V68, P185	58	76	76	1	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					199	207		10.1086/302442	http://dx.doi.org/10.1086/302442			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	212NZ	10364533	Bronze, Green Published			2022-12-18	WOS:000081224300025
J	Mansergh, FC; Millington-Ward, S; Kennan, A; Kiang, AS; Humphries, M; Farrar, GJ; Humphries, P; Kenna, PF				Mansergh, FC; Millington-Ward, S; Kennan, A; Kiang, AS; Humphries, M; Farrar, GJ; Humphries, P; Kenna, PF			Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; SYNDROME TYPE IIA; POINT MUTATION; MOLECULAR-GENETICS; MULTIPLE DELETIONS; LINKAGE ANALYSIS; CELL-DEATH; DISEASE; DNA; DEAFNESS	Family ZMK is a large Irish kindred that segregates progressive sensorineural hearing loss and retinitis pigmentosa. The symptoms in the family are almost identical to those observed in Usher syndrome type III. Unlike that in Usher syndrome type III, the inheritance pattern in this family is compatible with dominant, X-linked dominant, or maternal inheritance. Prior linkage studies had resulted in exclusion of most candidate loci and >90% of the genome. A tentative location for a causative nuclear gene had been established on 9q; however, it is notable that no markers were found at zero recombination with respect to the disease gene. The marked variability in symptoms, together with the observation of subclinical muscle abnormalities in a single muscle biopsy, stimulated sequencing of the entire mtDNA in affected and unaffected individuals. This revealed a number of previously reported polymorphisms and/or silent substitutions. However, a C-->A transversion at position 12258 in the gene encoding the second mitochondrial serine tRNA, MTTS2, was heteroplasmic and was found in family members only. This sequence change was not present in 270 normal individuals from the same ethnic background. The consensus C at this position is highly conserved and is present in species as divergent from Homo sapiens as vulture and platypus. The mutation probably disrupts the amino acid-acceptor stem of the tRNA molecule, affecting aminoacylation of the tRNA and thereby reducing the efficiency and accuracy of mitochondrial translation. In summary, the data presented provide substantial evidence that the C12258A mtDNA mutation is causative of the disease phenotype in family ZMK.	Univ Dublin Trinity Coll, Inst Genet, Wellcome Ocular Genet Unit, Dept Genet, Dublin 2, Ireland; Eye & Ear Hosp, Res Fdn, Dublin, Ireland	Trinity College Dublin	Kenna, PF (corresponding author), Univ Dublin Trinity Coll, Inst Genet, Wellcome Ocular Genet Unit, Dept Genet, Dublin 2, Ireland.	pfkenna@tcd.ie	Farrar, G Jane/B-9832-2011; Bateson, Jane Farrar/AAO-6147-2020	Mansergh, Fiona/0000-0001-7763-0383; Millington-Ward, Sophia/0000-0001-7470-0702	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813; Collins A, 1996, GENOMICS, V36, P157, DOI 10.1006/geno.1996.0436; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DiMauro S, 1998, CURR OPIN CARDIOL, V13, P190; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695; Fischel-Ghodsian N, 1998, MOL GENET METAB, V65, P97, DOI 10.1006/mgme.1998.2751; GROSSMAN LI, 1990, AM J HUM GENET, V46, P415; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HUMPHRIES P, 1990, CLIN GENET, V38, P1; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; Joensuu T, 1996, GENOMICS, V38, P255, DOI 10.1006/geno.1996.0626; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KARJALAINEN S, 1989, ANN OTO RHINOL LARYN, V98, P863, DOI 10.1177/000348948909801106; Kaukonen JA, 1996, AM J HUM GENET, V58, P763; Kenna P, 1997, BRIT J OPHTHALMOL, V81, P207, DOI 10.1136/bjo.81.3.207; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; KIMBERLING WJ, 1995, AM J HUM GENET, V56, P216; Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177; KUMARSINGH R, 1993, HUM MOL GENET, V2, P875, DOI 10.1093/hmg/2.7.875; KUMARSINGH R, 1993, GENOMICS, V15, P212, DOI 10.1006/geno.1993.1038; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Mansergh FC, 1998, HUM MUTAT, V11, P244, DOI 10.1002/(SICI)1098-1004(1998)11:3<244::AID-HUMU10>3.3.CO;2-X; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schapira AHV, 1998, BBA-BIOENERGETICS, V1366, P225, DOI 10.1016/S0005-2728(98)00115-7; SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179; Siregar NC, 1998, MUSCLE NERVE, V21, P599; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Usher C. H., 1914, ROY LOND OPHTHAL HOS, V19, P130; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1995, HUMAN GENE MAPPING 1, P910; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WRIGHT AF, 1992, TRENDS GENET, V8, P85, DOI 10.1016/0168-9525(92)90195-A; ZEVIANI M, 1990, AM J HUM GENET, V47, P904; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80	55	76	85	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					971	985		10.1086/302344	http://dx.doi.org/10.1086/302344			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090882	Green Published, Bronze			2022-12-18	WOS:000079632900008
J	Whittemore, AS; Tu, IP				Whittemore, AS; Tu, IP			Simple, robust linkage tests for affected sibs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE SUSCEPTIBILITY LOCI; ASYMPTOTIC PROPERTIES; GENETIC-LINKAGE; SIBLING METHOD; PAIR; POWER	Parametric-linkage analysis applied to large pedigrees with many affected individuals has helped in the identification of highly penetrant genes; but, for diseases lacking a clear Mendelian inheritance pattern or caused by several genes of low to moderate penetrance, a more robust strategy is nonparametric analysis applied to small sets of affected relatives, such as affected sib pairs. Here we show that the robustness of affected-sib-pair tests is related to the shape of the constraint set for the sibs' identity-by-descent (IBD) probabilities. We also derive a set of constraints for the IBD probabilities of affected sib triples and use common features of the shapes of the two constraint sets to introduce new nonparametric tests (called "minmax" tests) that are more robust than those in current use. Asymptotic-power computations support the robustness of the proposed minmax tests.	Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University	Whittemore, AS (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Redwood Bldg,Room T204, Stanford, CA 94305 USA.	asw@osiris.stanford.edu		Tu, I-Ping/0000-0001-8666-8391	NATIONAL CANCER INSTITUTE [R35CA047448] Funding Source: NIH RePORTER; NCI NIH HHS [CA47448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Cox DR., 1974, THEORETICAL STAT; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P225, DOI 10.1002/gepi.1370100403; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Feingold E, 1997, AM J HUM GENET, V60, P965; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Ott J., 1991, ANAL HUMAN GENETIC L; PENROSE LS, 1953, ANN EUGENIC, V18, P120; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, AM J HUM GENET, V46, P229; SCHAID DJ, 1990, GENET EPIDEMIOL, V7, P359, DOI 10.1002/gepi.1370070506; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SRIBNEY WM, 1992, AM J HUM GENET, V51, P773; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; Teng J, 1997, AM J HUM GENET, V60, P979; TIERNEY C, 1993, HUM HERED, V43, P276, DOI 10.1159/000154145; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Whittemore AS, 1996, AM J HUM GENET, V59, P704	22	76	78	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1228	1242		10.1086/301820	http://dx.doi.org/10.1086/301820			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9599188	Bronze, Green Published			2022-12-18	WOS:000073487000027
J	Kyndt, F; Schott, JJ; Trochu, JN; Baranger, F; Herbert, O; Scott, V; Fressinaud, E; David, A; Moisan, JP; Bouhour, JB; Le Marec, H; Benichou, B				Kyndt, F; Schott, JJ; Trochu, JN; Baranger, F; Herbert, O; Scott, V; Fressinaud, E; David, A; Moisan, JP; Bouhour, JB; Le Marec, H; Benichou, B			Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITRAL-VALVE PROLAPSE; FACTOR-VIII GENE; COLLAGEN GENES; BARTH SYNDROME; SEQUENCE; REGION; SEX	Myxoid heart disease is frequently encountered in the general population. It corresponds to an etiologically heterogeneous group of diseases, idiopathic mitral valve prolapse (IMVP) being the most common form. A rarely observed form of myxoid heart disease, X-linked myxomatous valvular dystrophy (XMVD), is inherited in an X-linked fashion and is characterized by multivalvular myxomatous degeneration; however, the histopathological features of the mitral valve do not differ significantly from the severe form of IMVP. In this article, we describe the genetic analysis of a large family in which XMVD is associated with a mild hemophilia A. The coagulation factor Vm gene position in Xq28 provided a starting point for the genetic study, which was conducted by use of polymorphic markers. Two-point linkage analysis confirmed this localization, and a maximum LOD score of 6.57 was found at theta = 0 for two polymorphic microsatellite markers, INT-3 and DXS1008, the first one being intronic to the factor Vm gene. Haplotype analysis of this chromosomal region allowed the definition of an 8-cM minimal interval containing the gene for XMVD, between DXS8011 and Xqter.	CHU Nantes, INSERM CJF 96 1, Lab Physiol & Pharmacol Cellulaires & Mol, F-44093 Nantes 1, France; CHU Nantes, Serv Genet Med, F-44035 Nantes, France; CHU Nantes, Clin Cardiol, F-44035 Nantes 01, France; CHU Nantes, Serv Hematol, Hotel Dieu, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Le Marec, H (corresponding author), CHU Nantes, INSERM CJF 96 1, Lab Physiol & Pharmacol Cellulaires & Mol, 9 Quai Monousu, F-44093 Nantes 1, France.	herve.lemarec@chu-nantes.fr	Trochu, Jean-Noel/D-6378-2015; Schott, jean-Jacques/F-8842-2013; Le Marec, Hervé/D-2718-2015; KYNDT, Florence/D-6370-2015	Schott, jean-Jacques/0000-0002-9578-9475; Le Marec, Hervé/0000-0002-8288-8693; KYNDT, Florence/0000-0001-6651-1696; BERNARD, BENICHOU/0000-0002-9331-0926				BEIGHTON P, 1969, BRIT HEART J, V31, P227; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; DEVEREUX RB, 1982, ANN INTERN MED, V97, P826, DOI 10.7326/0003-4819-97-6-826; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GEDEON AK, 1995, J MED GENET, V32, P383, DOI 10.1136/jmg.32.5.383; HENNEY AM, 1989, BRIT HEART J, V61, P292; HENRY WL, 1980, CIRCULATION, V62, P212, DOI 10.1161/01.CIR.62.2.212; HUNT D, 1969, AM HEART J, V8, P149; KENWRICK S, 1992, HUM MOL GENET, V1, P179, DOI 10.1093/hmg/1.3.179; KING BD, 1982, CIRCULATION, V66, P288, DOI 10.1161/01.CIR.66.2.288; KRAMER R, 1981, AM J HUM GENET, V33, pA82; LALLOZ MRA, 1994, BRIT J HAEMATOL, V86, P804; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MCKUSICK VA, 1997, MENDELIAN INHERITANC; MONTELEONE PL, 1969, CIRCULATION, V39, P611, DOI 10.1161/01.CIR.39.5.611; MURRU S, 1992, GENOMICS, V23, P352; NEWBURYECOB RA, 1993, J MED GENET, V30, P873, DOI 10.1136/jmg.30.10.873; PYERITZ RE, 1983, AM J MED, V74, P797, DOI 10.1016/0002-9343(83)91070-7; SAVAGE DD, 1983, AM HEART J, V106, P571, DOI 10.1016/0002-8703(83)90704-4; TAMURA K, 1995, AM HEART J, V129, P1149, DOI 10.1016/0002-8703(95)90397-6; TRAUPE H, 1992, GENOMICS, V13, P481, DOI 10.1016/0888-7543(92)90279-2; WEISSMAN NJ, 1994, AM J CARDIOL, V73, P1080, DOI 10.1016/0002-9149(94)90287-9; WORDSWORTH P, 1989, BRIT HEART J, V61, P300	26	76	79	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					627	632		10.1086/301747	http://dx.doi.org/10.1086/301747			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497244	Green Published, Bronze			2022-12-18	WOS:000072894400016
J	Myers, MP; Tonks, NK				Myers, MP; Tonks, NK			PTEN: Sometimes taking it off can be better than putting it on	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							PROTEIN-TYROSINE-PHOSPHATASE; HUMAN GLIOBLASTOMAS; CRYSTAL-STRUCTURE; PHOSPHOTYROSINE; CHROMOSOME-10; KINASE; GENE; SPECIFICITY; DOMAIN; FAMILY		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; BEGUM N, 1991, DIABETES, V40, P1620, DOI 10.2337/diabetes.40.12.1620; CHRZANOWSKAWODNICKA M, 1994, J CELL SCI, V107, P3643; COBB BS, 1993, ONCOGENE, V8, P2897; ENG C, 1994, J MED GENET, V31, P458, DOI 10.1136/jmg.31.6.458; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; GROLIN RJ, 1992, AM J MED GENET, V44, P307; Howell LD, 1996, BIOCHEMISTRY-US, V35, P7566, DOI 10.1021/bi9600409; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; PERSHOUSE MA, 1993, CANCER RES, V53, P5043; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Rhei E, 1997, CANCER RES, V57, P3657; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STECK PA, 1995, GENE CHROMOSOME CANC, V12, P255; Takagi T, 1997, CELL, V89, P867, DOI 10.1016/S0092-8674(00)80272-X; Tashiro H, 1997, CANCER RES, V57, P3935; VANHEYNINGEN V, 1994, NATURE, V367, P319, DOI 10.1038/367319a0; VONDEIMLING A, 1992, J NEUROSURG, V77, P295, DOI 10.3171/jns.1992.77.2.0295; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; ZHANG SH, 1995, J BIOL CHEM, V270, P20067, DOI 10.1074/jbc.270.34.20067	31	76	80	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1234	1238		10.1086/301659	http://dx.doi.org/10.1086/301659			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399917	Bronze, Green Published			2022-12-18	WOS:000071555900004
J	Daniels, R; Zuccotti, M; Kinis, T; Serhal, P; Monk, M				Daniels, R; Zuccotti, M; Kinis, T; Serhal, P; Monk, M			XIST expression in human oocytes and preimplantation embryos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME INACTIVATION; EARLY MOUSE EMBRYOS; GENE; IDENTIFICATION; KANGAROOS; CELLS	During mouse preimplantation development, the exclusive expression of the Xist gene from the paternally inherited allele is thought to play a role in the inactivation of the paternally inherited X chromosome in the extraembryonic cell lineages of the developing female embryo. Recently, inactivation of the paternally inherited X chromosome has also been shown to occur in the extraembryonic cell lineages of the human female conceptus. In this paper, we determine whether the pattern of XIST expression in human preimplantation embryos is similarly correlated with paternal X inactivation. We developed procedures sensitive to the single cell, for the simultaneous analysis of XIST and HPRT expression and of sexing, initially using human fibroblast cells. Application of these procedures to human cleavage-stage embryos derived by in vitro fertilization revealed a pattern of XIST expression different from that in the mouse. Transcripts of the XIST gene were detected as early as the 1-cell zygote and, with increasing efficiency, through to the 8-cell stage of preimplantation development. In addition, transcripts of XIST were detected in both male (hence from the maternally inherited allele) and female preimplantation embryos. This pattern of expression is not consistent with a role for the early expression of the XIST gene in the choice of paternal X inactivation in the extraembryonic cell lineages of the developing human embryo.	INST CHILD HLTH,MOL EMBRYOL UNIT,LONDON WC1N 1EH,ENGLAND; DEPT OBSTET & GYNAECOL,ASSISTED CONCEPT UNIT,LONDON,ENGLAND	University of London; University College London								Ao Asangla, 1994, Zygote, V2, P281; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; DANIELS R, 1995, HUM MOL GENET, V4, P389, DOI 10.1093/hmg/4.3.389; DANIELS R, IN PRESS MOL HUM REP; FIDDLER M, 1995, AM J MED GENET, V55, P80, DOI 10.1002/ajmg.1320550121; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; Goto T, 1997, MOL HUM REPROD, V3, P77, DOI 10.1093/molehr/3.1.77; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; NAKAHORI Y, 1991, AM J MED GENET, V39, P472, DOI 10.1002/ajmg.1320390420; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RAY PF, 1995, J REPROD FERTIL, V104, P165; RICHARDSON BJ, 1971, NATURE-NEW BIOL, V230, P154, DOI 10.1038/newbio230154a0; Rupert JL, 1995, EUR J HUM GENET, V3, P333; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	27	76	77	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					33	39		10.1086/513892	http://dx.doi.org/10.1086/513892			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245982	Green Published, Bronze			2022-12-18	WOS:A1997XM72800009
J	Gao, Q; Neuhausen, S; Cummings, S; Luce, M; Olopade, OI				Gao, Q; Neuhausen, S; Cummings, S; Luce, M; Olopade, OI			Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							OVARIAN-CANCER; SUSCEPTIBILITY GENE; SURVIVAL		UNIV CHICAGO, DEPT MED, HEMATOL ONCOL SECT, CHICAGO, IL 60637 USA; UNIV CHICAGO, COMM GENET, CTR CANC RES, CHICAGO, IL 60637 USA; UNIV UTAH, SCH MED, DEPT MED INFORMAT, GENET EPIDEMIOL GRP, SALT LAKE CITY, UT USA; MYRIAD GENET INC, SALT LAKE CITY, UT USA	University of Chicago; University of Chicago; Utah System of Higher Education; University of Utah; Myriad Genetics, Inc					NATIONAL CANCER INSTITUTE [P30CA014599, R01CA055914] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NCI NIH HHS [CA 14599-21, CA55914] Funding Source: Medline; NCRR NIH HHS [MO1 RR00055] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; GOLDGAR DE, 1995, NAT GENET, V11, P113, DOI 10.1038/ng1095-113; HANKEY BF, 1994, MONOGR NATL CANC I, V16, P7; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; PARKIN DM, 1994, CANCER SURV, V20, P519; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SHIAO YH, 1995, CANCER RES, V55, P1485; SKOLNICK MH, 1992, CANCER, V70, P1747, DOI 10.1002/1097-0142(19920915)70:4+<1747::AID-CNCR2820701616>3.0.CO;2-E; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	16	76	77	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1233	1236						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150171				2022-12-18	WOS:A1997WX76000024
J	Quan, F; Janas, J; TothFejel, S; Johnson, DB; Wolford, JK; Popovich, BW				Quan, F; Janas, J; TothFejel, S; Johnson, DB; Wolford, JK; Popovich, BW			Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; INACTIVATION; GENE; KANGAROOS; ISODISOMY; DELETION; CARRIER; HUMANS; GIRL	Duchenne muscular dystrophy (DMD) is a severe, progressive, X-linked muscle-wasting disorder with an incidence of similar to 1/3,500 male births, Females are also affected, in rare instances, The manifestation of mild to severe symptoms in female carriers of dystrophin mutations is often the result of the preferential inactivation of the X chromosome carrying the normal dystrophin gene, The severity of the symptoms is dependent on the proportion of cells that have inactivated the normal X chromosome, A skewed pattern of X inactivation is also responsible for the clinical manifestation of DMD in females carrying X; autosome translocations, which disrupt the dystrophin gene, DMD may also be observed ill females with Turner syndrome (45,X), if the remaining X chromosome carries a DMD mutation. We report here the case of a karyotypically normal female affected with DMD as a result of homozygosity for a deletion of exon 50 of the dystrophin gene, PCR analysis of microsatellite markers spanning the length of the X chromosome demonstrated that homozygosity for the dystrophin gene mutation was caused by maternal isodisomy for the entire X chromosome, This finding demonstrates that uniparental isodisomy of the X chromosome is an additional mechanism for the expression of X-linked recessive disorders, The proband's clinical presentation is consistent with the absence of imprinted genes (i.e., genes that are selectively expressed based on the parent of origin) on the X chromosome.	OREGON HLTH SCI UNIV,DNA DIAGNOST LAB,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED & MOL GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,RES CYTOGENET LAB,PORTLAND,OR 97201; SHRINERS HOSP CRIPPLED CHILDREN,PORTLAND,OR	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University			DiStefano, Johanna K/V-7801-2019; Quan, Fu-Shi/V-1826-2019	DiStefano, Johanna K/0000-0002-3286-0270; 				BEGGS AH, 1990, HUM GENET, V86, P45; BOYD Y, 1986, J MED GENET, V23, P484, DOI 10.1136/jmg.23.6.484; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHELLY J, 1986, HUM GENET, V74, P193, DOI 10.1007/BF00282093; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; COOPER DW, 1971, NATURE-NEW BIOL, V230, P155, DOI 10.1038/newbio230155a0; ENGEL E, 1993, AM J MED GENET, V46, P670, DOI 10.1002/ajmg.1320460613; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; Migeon BR, 1996, AM J HUM GENET, V58, P161; NANCE WE, 1990, AM J HUM GENET, V46, P646; PEGORARO E, 1994, AM J HUM GENET, V54, P989; PENTAO L, 1992, AM J HUM GENET, V50, P690; QUAN F, 1995, AM J HUM GENET, V56, P1042; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; ROBERTS RG, 1993, GENOMICS, V16, P536, DOI 10.1006/geno.1993.1225; SCHINZEL AA, 1993, HUM GENET, V92, P175; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; SPENCE JE, 1988, AM J HUM GENET, V42, P217; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; VOSS R, 1989, AM J HUM GENET, V45, P373; Willard H, 1995, METABOLIC MOL BASES, P719; WORTON RG, 1995, METABOLIC MOL BASES, P4195; ZNEIMER SM, 1993, AM J MED GENET, V45, P601, DOI 10.1002/ajmg.1320450517	28	76	81	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					160	165						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981959				2022-12-18	WOS:A1997WA81800022
J	Sperandeo, MP; deFranchis, R; Andria, G; Sebastio, G				Sperandeo, MP; deFranchis, R; Andria, G; Sebastio, G			A 68-bp insertion found in a homocystinuric patient is a common variant and is skipped by alternative splicing of the cystathionine beta-synthase mRNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NONSENSE MUTATIONS; VASCULAR-DISEASE; 3 MUTATIONS; RISK FACTOR		UNIV NAPLES FEDERICO II,DEPT PEDIAT,I-80131 NAPLES,ITALY	University of Naples Federico II			Melis, Daniela/AAD-3623-2019; andria, generoso/V-7172-2019	Melis, Daniela/0000-0002-9458-3926; 				CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DeFranchis R, 1996, AM J HUM GENET, V59, P262; DEFRANCHIS R, 1994, HUM MOL GENET, V3, P1103, DOI 10.1093/hmg/3.7.1103; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; MARBLE M, 1994, HUM MOL GENET, V3, P1883, DOI 10.1093/hmg/3.10.1883; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; MUNKE M, 1988, AM J HUM GENET, V42, P550; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324	10	76	78	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1391	1393						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940285				2022-12-18	WOS:A1996VV31500026
J	Bonnefont, JP; Taroni, F; Cavadini, P; Cepanec, C; Brivet, M; Saudubray, JM; Leroux, JP; Demaugre, F				Bonnefont, JP; Taroni, F; Cavadini, P; Cepanec, C; Brivet, M; Saudubray, JM; Leroux, JP; Demaugre, F			Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PALMITYLTRANSFERASE DEFICIENCY; SKELETAL-MUSCLE; MYOGLOBINURIA; FIBROBLASTS; CLONING; ABSENCE; GENE	Carnitine palmitoyltransferase (CPT) II deficiency, an inherited disorder of mitochondrial long-chain fatty-acid (LCFA) oxidation, results in two distinct clinical phenotypes, namely, an adult (muscular) form and an infantile (hepatocardiomuscular) form. The rationale of this phenotypic heterogeneity is poorly understood. The adult form of the disease is commonly ascribed to the Ser-113-Leu substitution in CPT II. Only few data are available regarding the molecular basis of the infantile form of the disease. We report herein a homozygous A-2399-C transversion predicting a Tyr-628-Ser substitution in a CPT II-deficient infant. In vitro expression of mutant cDNA in COS-1 cells demonstrated the responsibility of this mutation for the disease. Metabolic consequences of the Ser-113-Leu and Tyr-628-Ser substitutions were studied in fibroblasts. The Tyr-628-Ser substitution (infantile form) resulted in a 10% CPT II residual activity, markedly impairing LCFA oxidation, whereas the Ser-113-Leu substitution (adult form) resulted in a 20% CPT II residual activity, without consequence on LCFA oxidation. These data show that CPT II activity has to be reduced below a critical threshold in order for LCFA oxidation in fibroblasts to be impaired. The hypothesis that this critical threshold differs among tissues could provide a basis to explain phenotypic heterogeneity of CPT II deficiency.	FAC MED NECKER ENFANTS MALAD,INSERM U75,F-75730 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,DEPT PEDIAT,PARIS,FRANCE; IST NAZL NEUROL CARLO BESTA,DIV BIOCHIM & GENET,MILAN,ITALY; CHU KREMLIN BICETRE,SERV BIOCHIM,LE KREMLIN BICETR,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Istituto Neurologico Besta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP			Taroni, Franco/N-3879-2013	Taroni, Franco/0000-0002-2420-5233; BONNEFONT, Jean-Paul/0000-0002-4235-1197; cavadini, patrizia/0000-0002-1774-5290	Telethon [553] Funding Source: Medline	Telethon(Fondazione Telethon)		BANK WJ, 1975, NEW ENGL J MED, V292, P443, DOI 10.1056/NEJM197502272920902; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BONNEFONT JP, 1990, EUR J PEDIATR, V150, P80, DOI 10.1007/BF02072043; BRITTON CH, 1995, P NATL ACAD SCI USA, V92, P1984, DOI 10.1073/pnas.92.6.1984; BROWN NF, 1994, J BIOL CHEM, V269, P26438; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CORR PB, 1989, J CLIN INVEST, V83, P927, DOI 10.1172/JCI113978; DEMAUGRE F, 1991, J CLIN INVEST, V87, P859, DOI 10.1172/JCI115090; DEMAUGRE F, 1990, PEDIATR RES, V27, P497, DOI 10.1203/00006450-199005000-00016; DIDONATO S, 1978, ANN NEUROL, V4, P465, DOI 10.1002/ana.410040513; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; ESSER V, 1993, J BIOL CHEM, V268, P5817; FELIG P, 1975, NEW ENGL J MED, V293, P1078; FINOCCHIARO G, 1991, P NATL ACAD SCI USA, V88, P661, DOI 10.1073/pnas.88.2.661; FINOCCHIARO G, 1991, P NATL AC SCI US, V10, P981; Gellera C., 1992, American Journal of Human Genetics, V51, pA168; HUG G, 1991, NEW ENGL J MED, V325, P1862, DOI 10.1056/NEJM199112263252607; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MUNNICH A, 1982, PEDIATR RES, V16, P335, DOI 10.1203/00006450-198205000-00001; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; PANDE SV, 1993, J CLIN INVEST, V91, P1247, DOI 10.1172/JCI116288; SCHOLTE HR, 1979, J NEUROL SCI, V40, P39, DOI 10.1016/0022-510X(79)90007-8; SINGH R, 1988, FEBS LETT, V241, P126, DOI 10.1016/0014-5793(88)81044-5; TARONI F, 1992, P NATL ACAD SCI USA, V89, P8429, DOI 10.1073/pnas.89.18.8429; TARONI F, 1993, NAT GENET, V4, P314, DOI 10.1038/ng0793-314; Taroni F., 1994, American Journal of Human Genetics, V55, pA245; TEIN I, 1989, J NEUROL SCI, V92, P229, DOI 10.1016/0022-510X(89)90139-1; TREVISAN CP, 1984, NEUROLOGY, V34, P353, DOI 10.1212/WNL.34.3.353; VERDERIO E, 1995, HUM MOL GENET, V4, P19, DOI 10.1093/hmg/4.1.19; WEIS BC, 1994, J BIOL CHEM, V269, P26443; WOELTJE KF, 1990, J BIOL CHEM, V265, P10720; WOELTJE KF, 1990, J BIOL CHEM, V265, P10714; ZIERZ S, 1994, MYOLOGY, P1577	33	76	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					971	978						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651281				2022-12-18	WOS:A1996UH19200009
J	HASSTEDT, SJ; LEPPERT, M; FILLOUX, F; VANDEWETERING, BJM; MCMAHON, WM				HASSTEDT, SJ; LEPPERT, M; FILLOUX, F; VANDEWETERING, BJM; MCMAHON, WM			INTERMEDIATE INHERITANCE OF TOURETTE SYNDROME, ASSUMING ASSORTATIVE MATING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT TRANSMISSION; FAMILY HISTORY METHOD; LINKAGE ANALYSIS; DISORDERS; PEDIGREE; GENE; RELIABILITY; PREVALENCE; EXPRESSION; PHENOTYPE	Segregation analysis incorporating assortative mating was used to test for major locus inheritance of Tourette syndrome in a single large pedigree containing 182 members. The analysis provided evidence of a major locus with an intermediate inheritance pattern for which the penetrance was estimated from the data as 28% in heterozygotes and 98%-99% in homozygotes. A significant assortative mating correlation was estimated from the data as 70%-79%. In contrast, when assortative mating was not included in the model, intermediate inheritance was not inferred. If, in addition, constancy of the allele frequencies across generations was not assumed, Mendelian transmission was rejected. Each subject, affected or unaffected, was assigned a score reflecting the presence and severity of symptoms. Higher mean scores in affected homozygotes than in affected heterozygotes suggested greater severity in homozygotes: genotype information was obtained from genotype probabilities computed assuming intermediate inheritance.	UNIV UTAH,DEPT NEUROL,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT PSYCHIAT,SALT LAKE CITY,UT 84112; PRIMARY CHILDRENS MED CTR,SALT LAKE CITY,UT; UNIV ROTTERDAM HOSP,DEPT PSYCHIAT,ROTTERDAM,NETHERLANDS	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Erasmus University Rotterdam; Erasmus MC	HASSTEDT, SJ (corresponding author), UNIV UTAH,DEPT HUMAN GENET,2100 ECCLES INST HUMAN GENET,SALT LAKE CITY,UT 84112, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017463, R23HD017463] Funding Source: NIH RePORTER; NICHD NIH HHS [HD17463] Funding Source: Medline; NIMH NIH HHS [MH0098] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; APTER A, 1992, ADV NEUROL, V58, P61; BURD L, 1986, J AM ACAD CHILD PSY, V25, P552, DOI 10.1016/S0002-7138(10)60016-7; BURD L, 1986, AM J PSYCHIAT, V143, P787; CAINE ED, 1988, NEUROLOGY, V38, P472, DOI 10.1212/WNL.38.3.472; COMINGS DE, 1989, AM J MED GENET, V34, P413, DOI 10.1002/ajmg.1320340318; COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P463; COMINGS DE, 1986, P NATL ACAD SCI USA, V83, P2551, DOI 10.1073/pnas.83.8.2551; COMINGS DE, 1987, AM J HUM GENET, V41, P839; COMINGS DE, 1984, AM J HUM GENET, V36, P586; CURTIS D, 1992, BRIT J PSYCHIAT, V160, P845, DOI 10.1192/bjp.160.6.845; DEVOR EJ, 1984, AM J HUM GENET, V36, P704; EAPEN V, 1993, BRIT J PSYCHIAT, V162, P593, DOI 10.1192/bjp.162.5.593; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FURTADO S, 1994, AM J MED GENET, V51, P51, DOI 10.1002/ajmg.1320510112; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; HASSTEDT SJ, 1989, GENET EPIDEMIOL, V6, P319, DOI 10.1002/gepi.1370060203; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; HASSTEDT SJ, 1995, GENET EPIDEMIOL, V12, P109, DOI 10.1002/gepi.1370120202; HASSTEDT SJ, 1994, PAP PEDIGREE ANAL PA; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; KIESSLING LS, 1993, PEDIATRICS, V92, P39; KURLAN R, 1986, NEUROLOGY, V36, P772, DOI 10.1212/WNL.36.6.772; KURLAN R, 1994, NEUROLOGY, V44, P699, DOI 10.1212/WNL.44.4.699; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; LICHTER DG, 1993, NEUROLOGY, V43, pA309; MCMAHON WM, 1992, ADV NEUROL, V58, P159; MERIKANGAS KR, 1982, ARCH GEN PSYCHIAT, V39, P1173; NOTHEN MM, 1994, AM J MED GENET, V54, P249, DOI 10.1002/ajmg.1320540311; ORVASCHEL H, 1982, J AFFECT DISORDERS, V4, P49, DOI 10.1016/0165-0327(82)90019-2; PARNAS J, 1985, BRIT J PSYCHIAT, V146, P490, DOI 10.1192/bjp.146.5.490; PARNAS J, 1988, PSYCHIATRY, V51, P58, DOI 10.1080/00332747.1988.11024380; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1993, J AM ACAD CHILD PSY, V32, P1044, DOI 10.1097/00004583-199309000-00025; PAULS DL, 1992, ADV NEUROL, V58, P151; PAULS DL, 1992, PSYCHIAT CLIN N AM, V15, P759; PAULS DL, 1984, J AM ACAD CHILD PSY, V23, P134, DOI 10.1097/00004583-198403000-00003; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1994, BRIT J PSYCHIAT, V164, P215, DOI 10.1192/bjp.164.2.215; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; PRICE RA, 1988, PSYCHIAT RES, V24, P251; ROBERTSON MM, 1989, BRIT J PSYCHIAT, V154, P147, DOI 10.1192/bjp.154.2.147; ROBERTSON MM, 1994, BRIT J PSYCHIAT, V164, P263, DOI 10.1192/bjp.164.2.263; ROBERTSON MM, 1990, BRIT J PSYCHIAT, V156, P515, DOI 10.1192/bjp.156.4.515; Shapiro A. K., 1978, GILLES TOURETTE SYND; SUCHOWERSKY O, 1994, CAN J NEUROL SCI, V21, P48, DOI 10.1017/S0317167100048769; SWEDO SE, 1993, PEDIATRICS, V91, P706; SWEDO SE, 1980, PEDIATRICS, P363; THOMPSON EA, 1980, GENETIC ANAL COMMON, P363; VANDEWETERING BJM, 1993, J LAB CLIN MED, V121, P638; [No title captured]; 1990, DIAGNOSTIC STATISTIC; 1993, ARCH NEUROL-CHICAGO, V50, P1013	53	76	77	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					682	689						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RR605	7668298				2022-12-18	WOS:A1995RR60500019
J	CRAWFORD, DHG; POWELL, LW; LEGGETT, BA; FRANCIS, JS; FLETCHER, LM; WEBB, SI; HALLIDAY, JW; JAZWINSKA, EC				CRAWFORD, DHG; POWELL, LW; LEGGETT, BA; FRANCIS, JS; FLETCHER, LM; WEBB, SI; HALLIDAY, JW; JAZWINSKA, EC			EVIDENCE THAT THE ANCESTRAL HAPLOTYPE IN AUSTRALIAN HEMOCHROMATOSIS PATIENTS MAY BE ASSOCIATED WITH A COMMON MUTATION IN THE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS; IDIOPATHIC HEMOCHROMATOSIS; DIAGNOSIS; DISEASE; EXPRESSION; POPULATION; FIBROSIS; SIBLINGS	Hemochromatosis (HC) is a common inherited disorder of iron metabolism for which neither the gene nor biochemical defect have yet been identified. The aim of this study was to look for clinical evidence that the predominant ancestral haplotype in Australian patients is associated with a common mutation in the gene. We compared indices of iron metabolism and storage in three groups of HC patients categorized according to the presence of the ancestral haplotype (i.e., patients with two copies, one copy, and no copies of the ancestral. haplotype). We also examined iron indices in two groups of HC heterozygotes (those with the ancestral haplotype and those without) and in age-matched controls. These analyses indicate that (i) HC patients with two copies of the ancestral haplotype show significantly more severe expression of the disorder than those with one copy or those without, (ii) HC heterozygotes have partial clinical expression, which may be influenced by the presence of the ancestral haplotype in females but not in males, and (iii) the high population frequency of the HC gene may be the result of the selective advantage conferred by protecting heterozygotes against iron deficiency.	QUEENSLAND INST MED RES,JOINT LIVER PROGRAM,BRISBANE,QLD,AUSTRALIA; UNIV QUEENSLAND,DEPT MED,BRISBANE,QLD,AUSTRALIA	QIMR Berghofer Medical Research Institute; University of Queensland			Crawford, Darrell HG/F-2157-2010; Fletcher, Linda M/F-8035-2010; Leggett, Barbara A/D-3579-2011	Crawford, Darrell/0000-0001-8480-5954; Leggett, Barbara/0000-0003-2062-7380				ADAMS PC, 1994, AM J HEMATOL, V45, P146, DOI 10.1002/ajh.2830450210; BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; CRAWFORD DHG, 1993, HEPATOLOGY, V17, P833, DOI 10.1016/0270-9139(93)90160-O; DORAN TJ, 1981, HUM IMMUNOL, V2, P191, DOI 10.1016/0198-8859(81)90011-2; EDWARDS CQ, 1977, NEW ENGL J MED, V297, P7, DOI 10.1056/NEJM197707072970102; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; JAZWINSKA EC, 1995, AM J HUM GENET, V56, P428; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; LEGGETT BA, 1990, CLIN CHEM, V36, P1350; MUIR WA, 1984, AM J MED, V76, P806, DOI 10.1016/0002-9343(84)90991-4; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; POWELL LW, 1990, GASTROENTEROLOGY, V98, P1625, DOI 10.1016/0016-5085(90)91100-K; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; SUMMERS KM, 1990, HEPATOLOGY, V12, P20, DOI 10.1002/hep.1840120105; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; YIP R, 1984, AM J CLIN NUTR, V39, P427, DOI 10.1093/ajcn/39.3.427	18	76	82	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					362	367						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668262				2022-12-18	WOS:A1995RL77100019
J	GERSH, M; GOODART, SA; PASZTOR, LM; HARRIS, DJ; WEISS, L; OVERHAUSER, J				GERSH, M; GOODART, SA; PASZTOR, LM; HARRIS, DJ; WEISS, L; OVERHAUSER, J			EVIDENCE FOR A DISTINCT REGION CAUSING A CAT-LIKE CRY IN PATIENTS WITH 5P DELETIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT ARM; CHAT SYNDROME; CHROMOSOME-5; INDIVIDUALS; GENE	The cri-du-chat syndrome is a contiguous gene syndrome that results from a deletion of the short arm of chromosome 5 (5p). Patients present with a cat-like cry at birth, which is usually considered diagnostic of this syndrome. Additional features of the syndrome include failure to thrive, microcephaly, hypertelorism, epicanthal folds, hypotonia, and severe mental retardation. We report on four families in which patients with 5p deletions have only the characteristic cat-like cry, with normal to mildly delayed development. The precise locations of the deletions in each family were determined by FISH using lambda phage and cosmid clones. All of the deletion breakpoints map distal to a chromosomal region that is implicated with the facial features and severe mental and developmental delay in the cri-du-chat syndrome. DNA clones mapping in the chromosomal region associated with the cat-like cry feature will be useful diagnostic tools. They will allow for the distinction between 5p deletions that will result in the severe delay observed in most cri-du-chat syndrome patients and those deletions that result in the isolated cat-like cry feature, which is associated with a better prognosis.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; CHILDRENS MERCY HOSP,GENET SECT,KANSAS CITY,KS; HENRY FORD HOSP,CTR MED GENET BIRTH DEFECTS,DETROIT,MI	Jefferson University; Henry Ford Health System; Henry Ford Hospital					NATIONAL CANCER INSTITUTE [T32CA009678] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000236] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA09678] Funding Source: Medline; NHGRI NIH HHS [HG00236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AQUA MS, 1995, AM J MED GENET, V55, P33, DOI 10.1002/ajmg.1320550111; BACCICHETTI C, 1982, HUM GENET, V60, P389, DOI 10.1007/BF00569228; BACCICHETTI C, 1988, CLIN GENET, V4, P219; Bengtssons U, 1990, AM J HUM GENET S, V47, pA208; CARLIN ME, 1990, 8TH P C INT ASS SCI; Carrozzo R., 1994, American Journal of Human Genetics, V55, pA101; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; Lyons Jones K., 1988, SMITHS RECOGNIZABLE; MEWAR R, 1993, AM J HUM GENET, V53, P1269; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; NIEBUHR E, 1978, HUM GENET, V42, P143, DOI 10.1007/BF00283634; OVERHAUSER J, 1986, AM J HUM GENET, V39, P562; OVERHAUSER J, 1986, AM J HUM GENET, V39, P1; OVERHAUSER J, 1990, AM J MED GENET, V37, P83, DOI 10.1002/ajmg.1320370119; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; WALKER JL, 1984, J MED GENET, V21, P465, DOI 10.1136/jmg.21.6.465	19	76	80	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1404	1410						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762563				2022-12-18	WOS:A1995RA79400019
J	PRAS, E; RABEN, N; GOLOMB, E; ARBER, N; AKSENTIJEVICH, I; SCHAPIRO, JM; HAREL, D; KATZ, G; LIBERMAN, U; PRAS, M; KASTNER, DL				PRAS, E; RABEN, N; GOLOMB, E; ARBER, N; AKSENTIJEVICH, I; SCHAPIRO, JM; HAREL, D; KATZ, G; LIBERMAN, U; PRAS, M; KASTNER, DL			MUTATIONS IN THE SLC3A1 TRANSPORTER GENE IN CYSTINURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID-TRANSPORT; EXPRESSION CLONING; KIDNEY CDNA; SEQUENCE; OOCYTES; SYSTEM	Cystinuria is an autosomal recessive disease characterized by the development of kidney stones. Guided by the identification of the SLC3A1 amino acid-transport gene on chromosome 2, we recently established genetic linkage of cystinuria to chromosome 2p in 17 families, without evidence for locus heterogeneity. Other authors have independently identified missense mutations in SLC3A1 in cystinuria patients. In this report we describe four additional cystinuria-associated mutations in this gene: a frameshift, a deletion, a transversion inducing a critical amino acid change, and a nonsense mutation. The latter stop codon was found in ah of eight Ashkenazi Jewish carrier chromosomes examined, This report brings the number of disease-associated mutations in this gene to 10. We also assess the frequency of these mutations in our 17 cystinuria families.	NIAMSD,ARTHRITIS & RHEUMATISM BRANCH,BETHESDA,MD 20892; NHLBI,HYPERTENS ENDOCRINE BRANCH,BETHESDA,MD 20892; BEILINSON MED CTR,DEPT MED D,IL-49100 PETAH TIQWA,ISRAEL; BEILINSON MED CTR,DEPT METAB,IL-49100 PETAH TIQWA,ISRAEL; BEILINSON MED CTR,DEPT CLIN LABS,IL-49100 PETAH TIQWA,ISRAEL; HADASSAH MED CTR,DEPT UROL,IL-91120 JERUSALEM,ISRAEL; CHAIM SHEBA MED CTR,DEPT MED F,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,HELLER INST MED RES,IL-52621 TEL HASHOMER,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,DEPT PATHOL,IL-69978 TEL AVIV,ISRAEL	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Rabin Medical Center; Rabin Medical Center; Rabin Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine			Aksentijevich, Ivona/AAF-1335-2019	Arber, Nadir/0000-0001-5283-6991				Battey, 1986, BASIC METHODS MOL BI; BERTRAN J, 1993, J BIOL CHEM, V268, P14842; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5606, DOI 10.1073/pnas.89.12.5606; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; DAHLBERG PJ, 1977, MAYO CLIN PROC, V52, P533; DENT CE, 1951, Q J MED, V20, P205; Garrod AE, 1908, LANCET, V2, P1; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; HOFFMAN K, 1994, GENOMICS, V24, P20; KRAFFCZYK F, 1969, Z KLIN CHEM KLIN BIO, V7, P521; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; LEVY HL, 1972, PEDIATRICS, V49, P825; McKusick V.A., 1992, MENDELIAN INHERITANC; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; RABEN N, 1991, DIABETES, V40, P118, DOI 10.2337/diabetes.40.1.118; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Rosenberg L E, 1966, Trans Assoc Am Physicians, V79, P284; ROSENBERG LE, 1966, J CLIN INVEST, V45, P365, DOI 10.1172/JCI105351; WELLS RG, 1992, P NATL ACAD SCI USA, V89, P5596, DOI 10.1073/pnas.89.12.5596; ZHANG XX, 1994, GENOMICS, V24, P413, DOI 10.1006/geno.1994.1644	24	76	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1297	1303						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7539209				2022-12-18	WOS:A1995RA79400006
J	CHURCH, DM; BENGTSSON, U; NIELSEN, KV; WASMUTH, JJ; NIEBUHR, E				CHURCH, DM; BENGTSSON, U; NIELSEN, KV; WASMUTH, JJ; NIEBUHR, E			MOLECULAR DEFINITION OF DELETIONS OF DIFFERENT SEGMENTS OF DISTAL 5P THAT RESULT IN DISTINCT PHENOTYPIC FEATURES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN DOPAMINE TRANSPORTER; CHAT SYNDROME; SHORT ARM; CHROMOSOME-5; CRI; EXPRESSION	Cri du chat syndrome (CDC) is a segmental aneusomy associated with deletions of chromosome 5p15. In an effort to define regions that produce the phenotypes associated with CDC, we have analyzed deletions from 17 patients. The majority of these patients had atypical CDC features or were asymptomatic. Using these patients, we have mapped several phenotypes associated with deletions of 5p, including speech delay, catlike cry, newborn facial dysmorphism, and adult facial dysmorphism. This phenotypic map should provide a framework with which to begin identification of genes associated with various phenotypic features associated with deletions of distal 5p. We have also analyzed the parental origin of the de novo deletions, to determine if genomic imprinting could be occurring in this region. In addition, we have isolated cosmids that could be useful for both prenatal and postnatal assessments of del5(p) individuals.	UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; UNIV CALIF IRVINE,DEPT PEDIAT,IRVINE,CA 92717; UNIV CALIF IRVINE,CTR HUMAN GENOME,IRVINE,CA 92717; UNIV COPENHAGEN,DEPT MED GENET,HUMAN GENOME GRP,COPENHAGEN,DENMARK	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Copenhagen					NHGRI NIH HHS [P01 HG00834-02] Funding Source: Medline; NIGMS NIH HHS [GM07134-0] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000834] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BACCICHETTI C, 1988, CLIN GENET, V34, P219; BERSTEIN R, 1993, AM J MED GENET, V46, P77; BRANT SR, 1993, GENOMICS, V15, P668, DOI 10.1006/geno.1993.1122; BREG WR, 1970, J PEDIATR-US, V77, P782, DOI 10.1016/S0022-3476(70)80236-0; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; GIROS B, 1992, MOL PHARMACOL, V42, P383; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Jones KL, SMITHS RECOGNIZABLE, V9999; KUSHNICK T, 1984, CLIN GENET, V26, P472; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OVERHAUSER J, 1986, AM J HUM GENET, V39, P1; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; OVERHAUSER J, 1990, AM J MED GENET, V37, P83, DOI 10.1002/ajmg.1320370119; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; REED ML, 1994, NAT GENET, V6, P943; RIVIER DH, 1994, CELL, V76, P963, DOI 10.1016/0092-8674(94)90373-5; SHIMADA S, 1992, MOL BRAIN RES, V13, P359, DOI 10.1016/0169-328X(92)90220-6; SMITH A, 1990, J PAEDIATR CHILD H, V26, P152, DOI 10.1111/j.1440-1754.1990.tb02414.x; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; WILKINS LE, 1980, J PEDIATR-US, V97, P401, DOI 10.1016/S0022-3476(80)80189-2; WILKINS LE, 1983, J PEDIATR-US, V102, P528, DOI 10.1016/S0022-3476(83)80179-6; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323	25	76	81	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1162	1172						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726173				2022-12-18	WOS:A1995QU58600020
J	JAZWINSKA, EC; PYPER, WR; BURT, MJ; FRANCIS, JL; GOLDWURM, S; WEBB, SI; LEE, SC; HALLIDAY, JW; POWELL, LW				JAZWINSKA, EC; PYPER, WR; BURT, MJ; FRANCIS, JL; GOLDWURM, S; WEBB, SI; LEE, SC; HALLIDAY, JW; POWELL, LW			HAPLOTYPE ANALYSIS IN AUSTRALIAN HEMOCHROMATOSIS PATIENTS - EVIDENCE FOR A PREDOMINANT ANCESTRAL HAPLOTYPE EXCLUSIVELY ASSOCIATED WITH HEMOCHROMATOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; HLA; LOCALIZATION; MUTATION; MARKERS	Hemochromatosis (HC), an inherited disorder of iron metabolism, shows a very strong founder effect in Australia, with the majority of patients being of Celtic (Scots/Irish) origin. Australian HC patients thus provide an ideal group in which to examine HC-gene-region haplotypes, to analyze the extent of linkage disequilibrium and genetic heterogeneity in HC. We have analyzed chromosomes from 26 multiply affected HC pedigrees, and we were able to assign HC status unambiguously to 107 chromosomes-64 as affected and 43 as unaffected. The haplotypes examined comprise the following highly polymorphic markers: the serological marker HLA-A and the microsatellites D6S248, D6S265, HLA-F, and D6S105. Ah show highly significant allelic association with HC and no evidence of separation from the disease locus by recombination. Analysis identified a predominant ancestral haplotype comprising alleles 5-1-3-2-8 (marker order: D6S248-D6S265-HLA-A-HLA-F-D6S105), present in 21 (33%) of 64 affected chromosomes, and exclusively associated with HC (haplotype relative risk 903). No other common haplotype was significantly associated with HC. Haplotype analysis in Australian HC patients thus provides strong evidence for (a) the introduction of HC into this population on an ancestral haplotype, (b) a common mutation associated with HC in Australian patients, and (c) a candidate HC-gene region extending between and including D6S248 and D6S105.	IST SCI MED,CATTEDRA GASTROENTEROL,MILAN,ITALY		JAZWINSKA, EC (corresponding author), BANCROFT CTR,QUEENSLAND INST MED RES,LIVER UNIT,BRISBANE,QLD 4029,AUSTRALIA.		Goldwurm, Stefano/Q-8978-2016	Goldwurm, Stefano/0000-0002-1651-567X				BACON BR, 1992, NEW ENGL J MED, V326, P126, DOI 10.1056/NEJM199201093260208; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CRAWFORD DHG, 1993, HEPATOLOGY, V17, P833, DOI 10.1016/0270-9139(93)90160-O; DEMENIS E, 1990, ACTA HAEMATOL-BASEL, V83, P113, DOI 10.1159/000205184; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FIGAIRA FA, IN PRESS IMMUNOGENET; GASPARINI P, 1993, HUM MOL GENET, V2, P571, DOI 10.1093/hmg/2.5.571; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P1019; OUDET C, 1993, AM J HUM GENET, V52, P297; POWELL LW, 1990, GASTROENTEROLOGY, V98, P1625, DOI 10.1016/0016-5085(90)91100-K; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; SIMON M, 1975, NOUV PRESSE MED, V4, P1432; SUMMERS KM, 1989, AM J HUM GENET, V45, P41; THOMAS GR, 1994, AM J HUM GENET, V54, P71; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WORWOOD M, 1994, BRIT J HAEMATOL, V86, P833; YAOUANQ J, 1994, AM J HUM GENET, V54, P252	20	76	86	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					428	433						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847378				2022-12-18	WOS:A1995QF42300011
J	GANCZAKOWSKI, M; TOWN, M; BOWDEN, DK; VULLIAMY, TJ; KANEKO, A; CLEGG, JB; WEATHERALL, DJ; LUZZATTO, L				GANCZAKOWSKI, M; TOWN, M; BOWDEN, DK; VULLIAMY, TJ; KANEKO, A; CLEGG, JB; WEATHERALL, DJ; LUZZATTO, L			MULTIPLE GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT VARIANTS CORRELATE WITH MALARIA ENDEMICITY IN THE VANUATU ARCHIPELAGO (SOUTHWESTERN PACIFIC)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE-CHAIN-REACTION; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; G6PD DEFICIENCY; CODING REGION; DNA; HETEROGENEITY; THALASSEMIA; MUTATIONS; CHINESE; CDNA	In studying the relationship between genetic abnormalities of red blood cells and malaria endemicity in the Vanuatu archipelago in the southwestern Pacific, we have found that of 1,442 males tested, 98 (6.8%) were G6PD deficient. The prevalence of GdPD deficiency varied widely (0%-39%), both from one island to another and in different parts of the same island, and generally correlated positively with the degree of malaria transmission. The properties of G6PD from GdPD-deficient subjects were analyzed in a subset of 53 samples. In all cases the residual red-blood-cell activity was <10%. There were three phenotypic patterns. PCR amplification and sequencing of the entire coding region of the G6PD gene showed that the first of these patterns corresponded to G6PD Union (nucleotide 1360C-->T; amino acid 454Arg-->Cys), previously encountered elsewhere. Analysis of samples exhibiting the second pattern revealed two new mutants: G6PD Vanua Lava (nucleotide 383T-->C; amino acid 128Leu--> Pro) and G6PD Namoru (nucleotide 208T-->C; amino acid 70Tyr-->His); in three samples, the underlying mutation has not yet been identified. Analysis of the sample exhibiting the third pattern revealed another new mutant: G6PD Naone (nucleotide 497G-->A; amino acid 166Arg-->His). Of the four mutations, G6PD Union and G6PD Vanua Lava have a polymorphic frequency in more than one island; and G6PD Vanua Lava has also been detected in a sample from Papua New Guinea. G6PD deficiency is of clinical importance in Vanuatu because it is a cause of neonatal jaundice and is responsible for numerous episodes of drug-induced acute hemolytic anemia.	HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON,ENGLAND; MONASH UNIV,DEPT ANAT,VICTORIA,BC,CANADA; WHO,DEPT HLTH,PORT VILA,VANUATU	Imperial College London; World Health Organization	GANCZAKOWSKI, M (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND.			, Akira/0000-0003-2411-3352	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEKTE K, 1967, WHO TECH REP SER, V366, P1; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Beutler E., 1978, HEMOLYTIC ANEMIA DIS, P23; BOWDEN DK, 1985, LANCET, V2, P1025; BUCHANAN JG, 1973, AM J HUM GENET, V25, P36; CALABRO V, 1993, AM J HUM GENET, V52, P527; CHOCKKALINGAM K, 1982, HUM GENET, V60, P189, DOI 10.1007/BF00569710; CHOCKKALINGAM K, 1980, HUM GENET, V56, P209, DOI 10.1007/BF00295696; CORCORAN CM, 1992, HUM GENET, V88, P688, DOI 10.1007/BF02265298; FILOSA S, 1993, GENOMICS, V17, P6, DOI 10.1006/geno.1993.1276; GREENE S, 1993, YB PHYSICAL ANTHR, P153; HILL AVS, 1985, AM J HUM GENET, V37, P571; HILL AVS, 1989, COLONIZATION PACIFIC, P246; HSIA YE, 1993, HUM GENET, V92, P470, DOI 10.1007/BF00216453; Luzzato L, 1989, METABOLIC BASIS INHE, P2237; LUZZATTO L, 1979, BLOOD, V54, P961; LUZZATTO L, 1985, ADV HUM GENET, V14, P217; LUZZATTO L, 1993, HEMATOLOGY INFANCY C, P674; MATTHAY KK, 1981, CLIN HAEMATOL, V10, P31; MELONI T, 1975, ACTA HAEMATOL-BASEL, V54, P284, DOI 10.1159/000208087; NAFA K, 1994, IN PRESS HUM GENET; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PERNG LI, 1992, HUM MOL GENET, V1, P205, DOI 10.1093/hmg/1.3.205; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; POGGI V, 1990, BIOCHEM J, V271, P157, DOI 10.1042/bj2710157; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; REEVE PA, 1992, J TROP MED HYG, V95, P349; ROVIRA A, 1994, HUM MOL GENET, V3, P833; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P286; SYKES BC, 1983, LANCET, V2, P787; TOWN M, 1992, THESIS U LONDON; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; YENCHITSOMANUS P, 1986, PAPUA NEW GUINEA MED, V29, P53; YOSHIDA A, 1970, BLOOD-J HEMATOL, V35, P506, DOI 10.1182/blood.V35.4.506.506	36	76	81	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					294	301						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825590				2022-12-18	WOS:A1995QC10100038
J	CARDON, LR; FULKER, DW				CARDON, LR; FULKER, DW			THE POWER OF INTERVAL MAPPING OF QUANTITATIVE TRAIT LOCI, USING SELECTED SIB PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-REGRESSION ANALYSIS; TWIN DATA; LINKAGE; SAMPLES	The interval-mapping procedure of Fulker and Cardon for analysis of a quantitative-trait loci (QTL) is extended for application to selected samples of sib pairs. Phenotypic selection of sib pairs, which is known to yield striking increases in power when a single marker is used, provides further increases in power when the interval-mapping approach is used. The greatest benefits of the combined approach are apparent with coarse maps, where QTLs of relatively modest (15%-20%) heritability can be detected with widely spaced markers (40-60 cM apart) in reasonably sized sibling samples. Useful information concerning QTL location is afforded by interval mapping in both selected and unselected samples.	SRI INT,HLTH SCI SECT,STANFORD,CA; UNIV COLORADO,INST BEHAV GENET,BOULDER,CO 80309	SRI International; University of Colorado System; University of Colorado Boulder	CARDON, LR (corresponding author), STANFORD UNIV,DEPT MATH,STANFORD,CA 94305, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD011681] Funding Source: NIH RePORTER; NICHD NIH HHS [NICHD HD-27802, NICHD HD-11681] Funding Source: Medline; NIDA NIH HHS [NIDA DA05131] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; CAREY G, 1991, AM J HUM GENET, V49, P786; DEFRIES JC, 1988, ACTA GENET MED GEMEL, V37, P205, DOI 10.1017/S0001566000003810; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; Falconer D. S., 1989, Introduction to quantitative genetics.; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; FULKER DW, 1994, AM J HUM GENET, V54, P1092; FULKER DW, 1994, AM J HUM GENET, V55, P419; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LABUDA MC, 1986, GENET EPIDEMIOL, V3, P425, DOI 10.1002/gepi.1370030607; LANDER ES, 1989, GENETICS, V121, P185; ROBERTSON A, 1973, BEHAV GENET, V3, P389, DOI 10.1007/BF01070222	13	76	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					825	833						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942859				2022-12-18	WOS:A1994PJ02700024
J	DEAN, M; STEPHENS, JC; WINKLER, C; LOMB, DA; RAMSBURG, M; BOAZE, R; STEWART, C; CHARBONNEAU, L; GOLDMAN, D; ALBAUGH, BJ; GOEDERT, JJ; BEASLEY, RP; HWANG, LY; BUCHBINDER, S; WEEDON, M; JOHNSON, PA; EICHELBERGER, M; OBRIEN, SJ				DEAN, M; STEPHENS, JC; WINKLER, C; LOMB, DA; RAMSBURG, M; BOAZE, R; STEWART, C; CHARBONNEAU, L; GOLDMAN, D; ALBAUGH, BJ; GOEDERT, JJ; BEASLEY, RP; HWANG, LY; BUCHBINDER, S; WEEDON, M; JOHNSON, PA; EICHELBERGER, M; OBRIEN, SJ			POLYMORPHIC ADMIXTURE TYPING IN HUMAN ETHNIC POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMERINDIAN MITOCHONDRIAL DNAS; HUMAN GENOME PROJECT; HUMAN-EVOLUTION; LINKAGE MAP; VIRUS; AIDS; RECOMBINATION; SEQUENCES; DIVERSITY; REPEAT	A panel of 257 RFLP loci was selected on the basis of high heterozygosity in Caucasian DNA surveys and equivalent spacing throughout the human genome. Probes from each locus were used in a Southern blot survey of allele frequency distribution for four human ethnic groups: Caucasian, African American, Asian (Chinese), and American Indian (Cheyenne). Nearly all RFLP loci were polymorphic in each group, albeit with a broad range of differing allele frequencies (delta). The distribution of frequency differences (delta values) was used for three purposes: (1) to provide estimates for genetic distance (differentiation) among these ethnic groups, (2) to revisit with a large data set the proportion of human genetic variation attributable to differentiation within ethnic groups, and (3) to identify loci with high delta values between recently admired populations of use in mapping by admixture linkage disequilibrium (MALD). Although most markers display significant allele frequency differences between ethnic groups, the overall genetic distances between ethnic groups were small(.066-.098), and <10% of the measured overall molecular genetic diversity in these human samples can be attributed to ''racial'' differentiation. The median 6 values for pairwise comparisons between groups fell between .15 and .20, permitting identification of highly informative RFLP loci for MALD disease association studies.	NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702; NCI,VIRAL EPIDEMIOL BRANCH,BETHESDA,MD 20892; NIAAA,CLIN STUDIES LAB,BETHESDA,MD 20892; INST BEHAV RES,CLINTON,OK; UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH,HOUSTON,TX; DEPT PUBL HLTH,SAN FRANCISCO CITY CLIN,SAN FRANCISCO,CA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health			Dean, Michael C/G-8172-2012; OBRIEN, STEPHEN/ABD-1346-2020; Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; OBRIEN, STEPHEN/0000-0001-7857-0757				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BEASLEY RP, 1981, LANCET, V2, P1129; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bowcock A M, 1987, Gene Geogr, V1, P47; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1993, GENOME PRIORITY REP, V1, P810; BRISCOE D, 1994, J HERED, V85, P59; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; COLLINS F, 1993, SCIENCE, V262, P43, DOI 10.1126/science.8211127; CUTICCHIA AJ, 1993, SCIENCE, V262, P47, DOI 10.1126/science.8211128; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; GIBBONS A, 1993, SCIENCE, V259, P312, DOI 10.1126/science.8420001; GINZBURG HM, 1988, J ACQ IMMUN DEF SYND, V1, P2; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; KLEIN J, 1993, SCI AM, V269, P78, DOI 10.1038/scientificamerican1293-78; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LITT M, 1989, AM J HUM GENET, V44, P397; MCALPINE PJ, 1993, GENOME PRIORITY REPO, V1, P11; McKusick V. A. E., 1991, MENDELIAN INHERITANC; MURPHY J, 1991, P INT C AIDS, V7, P268; MURRAY JC, 1993, COOPERATIVE HUM LINK, V1, P1; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1982, EVOL BIOL, V14, P1; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, 1971, GENETICS, V68, P47; OBRIEN SJ, 1993, GENETIC MAPS; ROBERTS L, 1992, SCIENCE, V258, P1300, DOI 10.1126/science.1455222; SCHURR TG, 1990, AM J HUM GENET, V46, P613; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; TAJIMA F, 1983, GENETICS, V105, P437; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	43	76	85	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					788	808						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942857				2022-12-18	WOS:A1994PJ02700022
J	BLENNOW, E; TELENIUS, H; DEVOS, D; LARSSON, S; HENRIKSSON, P; JOHANSSON, O; CARTER, NP; NORDENSKJOLD, M				BLENNOW, E; TELENIUS, H; DEVOS, D; LARSSON, S; HENRIKSSON, P; JOHANSSON, O; CARTER, NP; NORDENSKJOLD, M			TETRASOMY 15Q - 2 MARKER CHROMOSOMES WITH NO DETECTABLE ALPHA-SATELLITE DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSITU HYBRIDIZATION; REVERSE; ORIGIN	Two patients with specific and similar phenotypes were both found to have an unusual marker chromosome present in 70%-80% of their lymphocytes at routine cytogenetic examination. The marker chromosomes were isolated by now sorting and were amplified by degenerate oligonucleotide-primed PCR. These libraries and a cosmid probe located at 15q26 were used to characterize the marker chromosomes by FISH. Both marker chromosomes were found to consist of duplicated chromosome material from the distal part of chromosome 15q and were identified as inv dup(15) (qter-->q23::q23-->qter) and inv dup(15) (qter-->q24::q24-->qter), respectively. Hence, the markers did not include any known centromere region, and no alpha-satellite DNA could be detected at the site of the primary constriction. Tetrasomy 15q may be a new syndrome, associated with a specific type of marker chromosome. In addition, further analyses of this type of marker chromosome might give new insight into the structure and function of the mammalian centromere.	UNIV CAMBRIDGE,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,HUMAN MOLEC CYTOGENET GRP,CAMBRIDGE,ENGLAND; CENT HOSP HELSINGBORG,DEPT PEDIAT,HELSINGBORG,SWEDEN	University of Cambridge; University of Cambridge; Helsingborgs Hospital	BLENNOW, E (corresponding author), KAROLINSKA HOSP,DEPT CLIN GENET,S-17176 STOCKHOLM,SWEDEN.			Nordenskjold, Magnus/0000-0002-4974-425X				BERGER SL, 1987, METHOD ENZYMOL, V152, P604; BLENNOW E, 1992, HUM GENET, V90, P371, DOI 10.1007/BF00220461; BLENNOW E, 1993, AM J HUM GENET, V53, P433; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; CARTER NP, 1992, J MED GENET, V29, P299, DOI 10.1136/jmg.29.5.299; COCO R, 1978, J GENET HUM, V26, P203; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FRYNS JP, 1988, ANN GENET-PARIS, V31, P123; FUJIMOTO A, 1974, J MED GENET, V11, P287, DOI 10.1136/jmg.11.3.287; GOLDSTEIN DJ, 1987, J MED GENET, V24, P684, DOI 10.1136/jmg.24.11.684; GREGOIRE MJ, 1981, HUM GENET, V59, P429, DOI 10.1007/BF00295485; HOOK EB, 1987, AM J HUM GENET, V40, P83; KORENBERG JR, 1993, GENOMICS, V16, P546, DOI 10.1006/geno.1993.1228; KRISTOFFERSSON U, 1987, CLIN GENET, V32, P169; KRISTOFFERSSON U, 1984, HEREDITAS, V100, P7, DOI 10.1111/j.1601-5223.1984.tb00097.x; LACRO RV, 1987, AM J MED GENET, V26, P719, DOI 10.1002/ajmg.1320260327; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PLUTA AF, 1990, TRENDS BIOCHEM SCI, V15, P181, DOI 10.1016/0968-0004(90)90158-8; RAUCH A, 1992, CLIN GENET, V42, P84; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; SJOSTEDT AW, 1989, HEREDITAS, V111, P115, DOI 10.1111/j.1601-5223.1989.tb00385.x; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; WISNIEWSKI L, 1979, HUM GENET, V50, P259, DOI 10.1007/BF00399391; YIP MY, 1982, CLIN GENET, V22, P1; ZINN AB, 1993, AM J HUM GENET, V53, P633	29	76	78	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					877	883						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178828				2022-12-18	WOS:A1994NH39400018
J	NIELSEN, DA; DEAN, M; GOLDMAN, D				NIELSEN, DA; DEAN, M; GOLDMAN, D			GENETIC-MAPPING OF THE HUMAN TRYPTOPHAN-HYDROXYLASE GENE ON CHROMOSOME-11, USING AN INTRONIC CONFORMATIONAL POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BECKWITH-WIEDEMANN SYNDROME; HUMAN TYROSINE-HYDROXYLASE; AMINO-ACID HYDROXYLASES; SEROTONERGIC NEURONS; FUNCTIONAL DOMAINS; NERVOUS-SYSTEM; HUMAN GENOME; LOCUS; LOCALIZATION; EVOLUTION	The identification of polymorphic alleles at loci coding for functional genes is crucial for genetic association and linkage studies. Since the tryptophan hydroxylase (TPH) gene codes for the rate-limiting enzyme in the biosynthesis of the neurotransmitter serotonin, it would be advantageous to identify a polymorphism in this gene. By examining introns of the human TPH gene by PCR amplification and analysis by the single-strand conformational polymorphism (SSCP) technique, an SSCP was revealed with two alleles that occur with frequencies of .40 and .60 in unrelated Caucasians. DNAs from 24 informative CEPH families were typed for the TPH intron polymorphism and analyzed with respect to 1 0 linked markers on chromosome 11, between p13 and p15, with the result that TPH was placed between D11S151 and D11S134. This region contains loci for several important genes, including those for Beckwith-Wiedemann syndrome and tyrosine hydroxylase.	NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	NIELSEN, DA (corresponding author), NATL INST ALCOHOL ABUSE & ALCOHOLISM,NEUROGENET LAB,MOLEC GENET SECT,BLDG 10,ROOM 3C102,BETHESDA,MD 20892, USA.		Nielsen, David A/B-4655-2009; Dean, Michael C/G-8172-2012; Goldman, David/F-9772-2010; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; Goldman, David/0000-0002-1724-5405; Nielsen, David/0000-0002-2583-0233				BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; BOULARAND S, 1990, NUCLEIC ACIDS RES, V18, P4257, DOI 10.1093/nar/18.14.4257; CETEIN Y, 1992, LIFE SCI, V50, P1343; CIARANELLO RD, 1991, ANNU REV MED, V42, P151, DOI 10.1146/annurev.me.42.020191.001055; COOPER JR, 1961, J PHARMACOL EXP THER, V132, P265; CRAIG SP, 1991, CYTOGENET CELL GENET, V56, P157, DOI 10.1159/000133075; CRAIG SP, 1986, CYTOGENET CELL GENET, V42, P29, DOI 10.1159/000132246; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; FINOCCHIARO LME, 1991, BIOCHEM J, V280, P727, DOI 10.1042/bj2800727; GERSHON MD, 1981, ANNU REV NEUROSCI, V4, P227, DOI 10.1146/annurev.ne.04.030181.001303; GRAHAMESMITH DG, 1964, BIOCHEM BIOPH RES CO, V16, P586, DOI 10.1016/0006-291X(64)90197-4; GRENETT HE, 1987, P NATL ACAD SCI USA, V84, P5530, DOI 10.1073/pnas.84.16.5530; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; JEQUIER E, 1969, BIOCHEM PHARMACOL, V18, P1071, DOI 10.1016/0006-2952(69)90111-7; JOH TH, 1975, P NATL ACAD SCI USA, V72, P3575, DOI 10.1073/pnas.72.9.3575; JUNIEN C, 1991, CYTOGENET CELL GENET, V58, P459, DOI 10.1159/000133171; KAUFMAN S, 1987, AMINO ACIDS HLTH DIS, P205; KIM KS, 1991, MOL BRAIN RES, V9, P277; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEDLEY FD, 1987, SOMAT CELL MOLEC GEN, V13, P575, DOI 10.1007/BF01534499; LEDLEY FD, 1985, BIOCHEMISTRY-US, V24, P3389, DOI 10.1021/bi00335a001; LIDSKY AS, 1985, P NATL ACAD SCI USA, V82, P6221, DOI 10.1073/pnas.82.18.6221; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; MOSS PAH, 1986, NUCLEIC ACIDS RES, V14, P9927, DOI 10.1093/nar/14.24.9927; OMALLEY KL, 1988, NUCLEIC ACIDS RES, V16, P4437; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAKSTIS AJ, 1991, HUM GENET, V87, P475; PING AJ, 1989, AM J HUM GENET, V44, P720; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHINDLER R, 1958, BIOCHEM PHARMACOL, V1, P323; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; STOLL J, 1990, GENOMICS, V7, P88, DOI 10.1016/0888-7543(90)90522-V; STOLL J, 1991, J NEUROSCI RES, V28, P457, DOI 10.1002/jnr.490280402	37	76	78	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1366	1371						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463016				2022-12-18	WOS:A1992KC99500019
J	WILLING, MC; PRUCHNO, CJ; ATKINSON, M; BYERS, PH				WILLING, MC; PRUCHNO, CJ; ATKINSON, M; BYERS, PH			OSTEOGENESIS IMPERFECTA TYPE-I IS COMMONLY DUE TO A COL1A1 NULL ALLELE OF TYPE-I COLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL DOMINANT FORMS; MESSENGER-RNA; PRO-ALPHA-1(I) CHAINS; DNA FRAGMENTS; GENOMIC DNA; GENE; PROCOLLAGEN; MUTATIONS; CYSTEINE; SEQUENCE	Dermal fibroblasts from most individuals with osteogenesis imperfecta (OI) type I produce about half the normal amount of type I procollagen, as a result of decreased synthesis of one of its constituent chains, pro-alpha(I). To test the hypothesis that decreased synthesis of pro-alpha(I) chains results from mutations in the COL1A1 gene, we used primer extension with nucleotide-specific chain termination to measure the contribution of individual COL1A1 alleles to the mRNA pool in fibroblasts from affected individuals. A polymorphic MnlI restriction endonuclease site in the 3'-untranslated region of COL1A1 was used to distinguish the transcripts of the two alleles in heterozygous individuals. Twenty-three individuals from 21 unrelated families were studied. In each case there was marked diminution in steady-state mRNA levels from one COL1A1 allele. Loss of an allele through deletion or rearrangement was not the cause of the diminished COL1A1 mRNA levels. Primer extension with nucleotide-specific chain termination allows identification of the mutant COL1A1 allele in cell strains that are heterozygous for an expressed polymorphism. It is applicable to sporadic cases, to small families, and to large families in whom key individuals are uninformative at the polymorphic sites used in linkage analysis, making it a useful adjunct to the biochemical screening of collagenous proteins for OI.	UNIV WASHINGTON, CTR INHERITED DIS, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV IOWA, DEPT INTERNAL MED, IOWA CITY, IA 52242 USA; UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Iowa; University of Washington; University of Washington Seattle	WILLING, MC (corresponding author), UNIV IOWA, DEPT PEDIAT, DIV MED GENET 2JCP, IOWA CITY, IA 52242 USA.			Byers, Peter H./0000-0001-7786-7030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R01AR041223] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 21557, AR 41223] Funding Source: Medline; NIDDK NIH HHS [DK 07467] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARSH GS, 1984, J BIOL CHEM, V259, P4906; BARSH GS, 1982, P NATL ACAD SCI-BIOL, V79, P3838, DOI 10.1073/pnas.79.12.3838; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; BYERS PH, 1983, J CLIN INVEST, V71, P689, DOI 10.1172/JCI110815; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHU ML, 1982, NUCLEIC ACIDS RES, V10, P5925, DOI 10.1093/nar/10.19.5925; COHN DH, 1988, J BIOL CHEM, V263, P14605; CONSTANTINOU CD, 1990, NUCLEIC ACIDS RES, V18, P5577, DOI 10.1093/nar/18.18.5577; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; DRISCOLL DM, 1989, CELL, V58, P519, DOI 10.1016/0092-8674(89)90432-7; FALK CT, 1986, AM J HUM GENET, V38, P269; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GENOVESE C, 1987, METHOD ENZYMOL, V145, P223; KUIVANIEMI H, 1988, BIOCHEM J, V252, P633, DOI 10.1042/bj2520633; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; NICHOLLS AC, 1984, BRIT MED J, V288, P112, DOI 10.1136/bmj.288.6411.112; PRUCHNO CJ, 1991, HUM GENET, V87, P33, DOI 10.1007/BF01213088; ROWE DW, 1985, J CLIN INVEST, V76, P604, DOI 10.1172/JCI112012; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; SYKES B, 1990, AM J HUM GENET, V46, P293; SYKES B, 1977, NEW ENGL J MED, V296, P1200, DOI 10.1056/NEJM197705262962104; SYKES B, 1986, LANCET, V2, P69; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; WALLIS G, 1986, J MED GENET, V23, P411, DOI 10.1136/jmg.23.5.411; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; WESTERHAUSEN AI, 1990, NUCLEIC ACIDS RES, V18, P4968, DOI 10.1093/nar/18.16.4968; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; WILLING MC, 1988, J BIOL CHEM, V263, P8398; WILLING MC, 1990, 4TH INT S OST IMP PA	40	76	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					508	515						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1353940				2022-12-18	WOS:A1992JJ82800007
J	JORGENSEN, AL; PHILIP, J; RASKIND, WH; MATSUSHITA, M; CHRISTENSEN, B; DREYER, V; MOTULSKY, AG				JORGENSEN, AL; PHILIP, J; RASKIND, WH; MATSUSHITA, M; CHRISTENSEN, B; DREYER, V; MOTULSKY, AG			DIFFERENT PATTERNS OF X-INACTIVATION IN MZ TWINS DISCORDANT FOR RED-GREEN COLOR-VISION DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CHROMOSOME INACTIVATION; MOLECULAR-GENETICS; MONOZYGOTIC TWINS; METHYLATION; M27-BETA; PAIR; DNA; LYONIZATION; FREQUENCY	Two female identical twins who were clinically normal were obligatory heterozygotes for X-linked deuteranomaly associated with a green-red fusion gene derived from their deuteranomalous father. On anomaloscopy, one of the twins was phenotypically deuteranomalous while the other had normal color vision. The color vision-defective twin had two sons with normal color vision and one deuteranomalous son. X-inactivation analysis was done with the highly informative probe M27-beta. This probe detects a locus (DXS255) which contains a VNTR and which is somewhat differentially methylated on the active and inactive X chromosomes. In skin cells of the color vision-defective twin, almost all paternal X chromosomes with the abnormal color-vision genes were active, thereby explaining her color-vision defect. In contrast, a different pattern was observed in skin cells from the woman with normal color vision; her maternal X chromosome was mostly active. However, in blood lymphocytes, both twins showed identical patterns with mixtures of inactivated maternal and paternal X chromosomes. Deuteranomaly in one of the twins is explained by extremely skewed X inactivation, as shown in skin cells. Failure to find this skewed pattern in blood cells is explained by the sharing of fetal circulation and exchange of hematopoietic precursor cells between twins. These data give evidence for X inactivation of the color-vision locus and add another MZ twin pair with markedly different X-inactivation patterns for X-linked traits.	UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV COPENHAGEN HOSP,DEPT OBSTET & GYNECOL,DK-2100 COPENHAGEN,DENMARK; UNIV COPENHAGEN HOSP,CHROMOSOME LAB,DK-2100 COPENHAGEN,DENMARK; UNIV COPENHAGEN HOSP,DEPT OPHTHALMOL,DK-2100 COPENHAGEN,DENMARK; UNIV COPENHAGEN HOSP,AVIAT MED CLIN,DK-2100 COPENHAGEN,DENMARK	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	JORGENSEN, AL (corresponding author), UNIV AARHUS,HOSP PSYCHIAT,CYTOGENET LAB,DK-8240 RISSKOV,DENMARK.				NATIONAL CANCER INSTITUTE [R01CA016448, R37CA016448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008395] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16448] Funding Source: Medline; NEI NIH HHS [EY08395] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAHAMSON G, 1990, BRIT J HAEMATOL, V74, P371, DOI 10.1111/j.1365-2141.1990.tb02601.x; ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; Benirschke K, 1990, PATHOLOGY HUMAN PLAC; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BORN G, 1976, HUM GENET, V32, P189, DOI 10.1007/BF00291502; BOYD Y, 1987, CLIN GENET, V31, P265; BREWER GEORGE J., 1967, BIOCHEM GENET, V1, P41, DOI 10.1007/BF00487735; BURN J, 1986, J MED GENET, V23, P494, DOI 10.1136/jmg.23.6.494; CHUTKOW JG, 1987, NEUROLOGY, V37, P1147, DOI 10.1212/WNL.37.7.1147; DEEB SS, 1992, IN PRESS AM J HUM GE, V51; DRUMMONDBORG M, 1989, P NATL ACAD SCI USA, V86, P983, DOI 10.1073/pnas.86.3.983; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; FRASER NJ, 1987, NUCLEIC ACIDS RES, V15, P9616, DOI 10.1093/nar/15.22.9616; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GOMEZ MR, 1977, NEUROLOGY, V27, P537, DOI 10.1212/WNL.27.6.537; HANSEN RS, 1990, P NATL ACAD SCI USA, V87, P4174, DOI 10.1073/pnas.87.11.4174; HENDRIKS RW, 1991, HUM GENET, V88, P105, DOI 10.1007/BF00204939; HODGES E, 1991, BRIT J HAEMATOL, V77, P315, DOI 10.1111/j.1365-2141.1991.tb08577.x; INGERSLEV J, 1989, CLIN GENET, V35, P41; JAMES WH, 1988, J MED GENET, V25, P213; JORGENSEN AL, 1990, P NATL ACAD SCI USA, V87, P6512, DOI 10.1073/pnas.87.17.6512; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KITCHENS CS, 1987, AM J HEMATOL, V24, P225, DOI 10.1002/ajh.2830240215; KOURLISCHER L, 1968, 1ER COMPT REND C INT, P242; LASCARI AD, 1969, AM J DIS CHILD, V117, P585, DOI 10.1001/archpedi.1969.02100030587016; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; MASSA G, 1989, ACTA PAEDIATR SCAND, V78, P971, DOI 10.1111/j.1651-2227.1989.tb11189.x; NANCE WE, 1990, AM J HUM GENET, V46, P646; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NETTLESHIP E, 1912, T OPHTHAL SOC UK, V32, P309; NISEN P, 1986, NEW ENGL J MED, V315, P1139, DOI 10.1056/NEJM198610303151806; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; PENA SDJ, 1987, J NEUROL SCI, V79, P337, DOI 10.1016/0022-510X(87)90240-1; PHELAN MC, 1980, AM J HUM GENET, V32, pA123; PHILIP J, 1969, ANN HUM GENET, V33, P185, DOI 10.1111/j.1469-1809.1969.tb01644.x; REVESZ T, 1972, J MED GENET, V9, P396, DOI 10.1136/jmg.9.4.396; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; RICHARDS CS, 1990, AM J HUM GENET S, V47, pA105; STOCKS P, 1933, ANN EUGEN, V5, P17; TUCKERMAN E, 1985, J MED GENET, V22, P85, DOI 10.1136/jmg.22.2.85; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WALLS GL, 1959, ARCH OPTHALMOLOGY, V62, P41; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YOKOTA A, 1990, COLOR VISION DEFECTS	44	76	77	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					291	298						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642230				2022-12-18	WOS:A1992JF77600008
J	ALLSOPP, CEM; HARDING, RM; TAYLOR, C; BUNCE, M; KWIATKOWSKI, D; ANSTEY, N; BREWSTER, D; MCMICHAEL, AJ; GREENWOOD, BM; HILL, AVS				ALLSOPP, CEM; HARDING, RM; TAYLOR, C; BUNCE, M; KWIATKOWSKI, D; ANSTEY, N; BREWSTER, D; MCMICHAEL, AJ; GREENWOOD, BM; HILL, AVS			INTERETHNIC GENETIC DIFFERENTIATION IN AFRICA - HLA CLASS-I ANTIGENS IN THE GAMBIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-EVOLUTION; ORIGIN; POLYMORPHISMS; SELECTION; DNA	A total of 752 individuals from The Gambia, west Africa who are representative of the major ethnic groups in the capital, Banjul, were serologically typed for HLA-A, -B, and -C antigens. Although all were typically "African" in their antigenic profiles, some marked frequency differences were found between the ethnic groups. Genetic distance comparisons with several other African populations showed that, although these west African populations clustered closely together, the positions of the various ethnic groups in The Gambia were consistent with historical and linguistic evidence of their affinities with one another and with other African populations. Despite the potential confounding effects both of selection by infectious diseases and of genetic drift caused by local differences in population structure, HLA frequencies appear to be of value in measuring inter- and intraregional population affinities in sub-Saharan Africa.	UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT SURG,TISSUE TYPING LAB,OXFORD OX3 9DU,ENGLAND; MRC LABS,FAJARA,SENEGAMBIA; ROYAL VICTORIA HOSP,BANJUL,SENEGAMBIA	University of Oxford; University of Oxford			HILL, Adrian V>S>/C-1306-2008	Kwiatkowski, Dominic/0000-0002-5023-0176	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1980, HISTOCOMPATIBILITY T; BLANC M, 1990, AM J HUM GENET, V46, P383; BODMER JG, 1991, TISSUE ANTIGENS, V37, P97, DOI 10.1111/j.1399-0039.1991.tb01853.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CROWDER M, 1977, W AFRICA INTRO ITS H; DAUSSET J, 1972, HISTOCOMPATIBLITY TE; DUTOIT ED, 1990, HUM IMMUNOL, V28, P406, DOI 10.1016/0198-8859(90)90035-N; DUTOIT ED, 1990, TISSUE ANTIGENS, V36, P122, DOI 10.1111/j.1399-0039.1990.tb01812.x; DUTOIT ED, 1987, TISSUE ANTIGENS, V31, P109; EXCOFFIER L, 1991, HUM BIOL, V63, P273; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; GREENBERG JH, 1963, LANGUAGES AFRICA; HEDRICK PW, 1983, GENETICS, V104, P449; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1991, LANCET, V337, P640, DOI 10.1016/0140-6736(91)92452-8; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Johnson A, 1986, HLA ASIA OCEANIA 198, P320; JORDE LB, 1985, ANN REV ANTHR, V24, P343; KALIDI I, 1988, TISSUE ANTIGENS, V31, P98, DOI 10.1111/j.1399-0039.1988.tb02070.x; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; LEE TD, 1991, TISSUE ANTIGENS, V37, P79, DOI 10.1111/j.1399-0039.1991.tb01849.x; LEFEVREWITIER PH, 1985, DISEASES COMPLEX ETI, P365; NEI M, 1989, HUM HERED, V39, P276, DOI 10.1159/000153872; Nurse GT., 1985, PEOPLES SO AFRICA TH; OKOYE RC, 1985, TISSUE ANTIGENS, V25, P142; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Phillipson D. W., 1985, AFRICAN ARCHAEOLOGY; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; Rohlf F.J., 1993, NTSYS PC; SERJEANTSON SW, 1982, AM J HUM GENET, V34, P904; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P120; Sokal R.R., 1981, BIOMETRY, V2nd ed.; SONKO-GODWIN P., 1985, ETHNIC GROUPS SENEGA; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0	36	76	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					411	421						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734720				2022-12-18	WOS:A1992HD00100018
J	SRIVATSAN, ES; MISRA, BC; VENUGOPALAN, M; WILCZYNSKI, SP				SRIVATSAN, ES; MISRA, BC; VENUGOPALAN, M; WILCZYNSKI, SP			LOSS OF HETEROZYGOSITY FOR ALLELES ON CHROMOSOME-II IN CERVICAL-CARCINOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILMS-TUMOR; HUMAN PAPILLOMAVIRUSES; COLORECTAL CARCINOMAS; UTERINE CERVIX; HUMAN CANCER; SHORT ARM; GENE; RETINOBLASTOMA; AMPLIFICATION; EXPRESSION	The HeLa cell (a cervical carcinoma cell line) tumor-suppressor gene has been localized to the long arm of chromosome 11 by molecular genetic studies of nontumorigenic and tumorigenic hybrids derived from normal chromosome 11 x HeLa cell fusions. In the present study, 33 primary cervical carcinoma samples were analyzed using chromosome 11-specific polymorphic DNA markers. The RFLP analysis indicated a somatic loss of chromosome 11 heterozygosity in 10 (30%) of the primary tumors. Preferential loss of the long arm of the chromosome was observed in two of the primary tumors. In addition, at least eight-fold amplification of sequences in the q13 region, including those coding for the fibroblast growth factor-related gene (int-2), was observed in one of the primary tumors. These results suggest a possible role for gene(s) localized to chromosome 11, possibly that localized to the long arm in the development and/or progression of cervical carcinomas.	UNIV SO CALIF,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90033; CITY HOPE NATL MED CTR,DEPT ANAT PATHOL,DUARTE,CA 91010	University of Southern California; City of Hope	SRIVATSAN, ES (corresponding author), CHILDRENS HOSP,DIV HEMATOL ONCOL,4650 SUNSET BLVD,LOS ANGELES,CA 90027, USA.				NATIONAL CANCER INSTITUTE [R29CA047206] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47206, CA 47570] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI IU, 1989, ONCOGENE, V4, P89; ATKIN NB, 1984, CANCER GENET CYTOGEN, V13, P189, DOI 10.1016/0165-4608(84)90043-8; ATKIN NB, 1989, CANCER GENET CYTOGEN, V37, P229, DOI 10.1016/0165-4608(89)90053-8; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CLEWELL DB, 1969, P NATL ACAD SCI USA, V62, P1159, DOI 10.1073/pnas.62.4.1159; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; FEARDON ER, 1990, SCIENCE, V247, P50; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HAUSEN HZ, 1987, CANCER, V59, P1692, DOI 10.1002/1097-0142(19870515)59:10<1692::AID-CNCR2820591003>3.0.CO;2-F; HAUSEN HZ, 1989, CANCER RES, V49, P4677; HECHT F, 1990, CANCER GENET CYTOGEN, V44, P37, DOI 10.1016/0165-4608(90)90195-G; HERTZ F, 1977, CANCER RES, V37, P3209; JAMES GK, 1989, CANCER GENET CYTOGEN, V38, P53, DOI 10.1016/0165-4608(89)90165-9; KNUDSON AG, 1985, CANCER RES, V45, P1437; KOI M, 1989, MOL CARCINOGEN, V2, P12, DOI 10.1002/mc.2940020103; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; LARSEN PM, 1988, CANCER LETT, V41, P123; LAWN RM, 1978, CELL, V15, P1151; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; MISRA BC, 1989, AM J HUM GENET, V45, P565; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; OCADIZ R, 1987, CANCER RES, V47, P4173; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PATER MM, 1986, VIROLOGY, V155, P13, DOI 10.1016/0042-6822(86)90163-7; PFISTER H, 1987, ADV CANCER RES, V48, P113, DOI 10.1016/S0065-230X(08)60691-0; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1980, CANCER GENET CYTOGEN, V2, P131, DOI 10.1016/0165-4608(80)90056-4; RIOU G, 1988, ONCOGENE, V3, P329; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; SILVERBERG E, 1990, CA-CANCER J CLIN, V40, P9, DOI 10.3322/canjclin.40.1.9; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SREEKANTAIAH C, 1988, CANCER, V62, P1317, DOI 10.1002/1097-0142(19881001)62:7<1317::AID-CNCR2820620713>3.0.CO;2-K; SRIVATSAN ES, 1986, CANCER RES, V46, P6174; SRIVATSAN ES, UNPUB MAPPING HELA C, V11; STANBRIDGE EJ, 1981, SOMATIC CELL GENET, V7, P669; SUZUKI T, 1989, CANCER RES, V49, P1095; THEILLET C, 1989, ONCOGENE, V4, P915; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WILCZYNSKI SP, 1988, HUM PATHOL, V19, P697, DOI 10.1016/S0046-8177(88)80176-X; YOKOTA J, 1989, CANCER RES, V49, P3598; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; Yunis J J, 1986, Important Adv Oncol, P93	53	76	77	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					868	877						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1680288				2022-12-18	WOS:A1991GG66500019
J	FAZIO, MJ; MATTEI, MG; PASSAGE, E; CHU, ML; BLACK, D; SOLOMON, E; DAVIDSON, JM; UITTO, J				FAZIO, MJ; MATTEI, MG; PASSAGE, E; CHU, ML; BLACK, D; SOLOMON, E; DAVIDSON, JM; UITTO, J			HUMAN ELASTIN GENE - NEW EVIDENCE FOR LOCALIZATION TO THE LONG ARM OF CHROMOSOME-7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKIN FIBROBLASTS; EXPRESSION; CDNA; HYBRIDIZATION; ASSIGNMENT; SEQUENCE; CLONING; PROTEIN; GENOME; REGION	In this study we have utilized human elastin cDNAs in molecular hybridizations to establish the chromosomal location of the human elastin gene. First, in situ hybridizations were performed with metaphase chromosomes from phytohemagglutinin-stimulated human peripheral blood lymphocytes. In three separate experiments using two different regions of human elastin cDNAs, the distribution of grans was found to be concentrated on the long arm of chromosome 7 within the [q11.1-21.1] region, and the peak number of grains coincided with the locus 7q11.2. Second, hybridizations with a panel of human-rodent cell hybrids showed concordance with human chromosome 7. Third, PCR analyses with elastin-specific primers of DNA from a hybrid cell line containing chromosome 7 as the only human chromosome yielded a product of the expected size, while DNA containing human chromosome 2, but not chromosome 7, did not result in a product. The results indicate that the human elastin gene is located in the proximal region of the long arm of chromosome 7. The precise localization of the elastin gene in the human genome is useful in establishing genetic linkage between inheritance of an allele with a mutated elastin gene and a heritable disorder.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL,1020 LOCUST ST,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM,PHILADELPHIA,PA 19107; VANDERBILT UNIV,DEPT PATHOL,NASHVILLE,TN 37240; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,MOLEC DERMATOL SECT,PHILADELPHIA,PA 19107; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; INSERM,U242,CTR GENET MED,F-13258 MARSEILLE 09,FRANCE; VET ADM MED CTR,NASHVILLE,TN 37203	Jefferson University; Jefferson University; Vanderbilt University; Jefferson University; Cancer Research UK; Institut National de la Sante et de la Recherche Medicale (Inserm); US Department of Veterans Affairs; Veterans Health Administration (VHA)					NIAMS NIH HHS [AR28450, T32AR7561] Funding Source: Medline; NIGMS NIH HHS [GM37387] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007561, R01AR028450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037387] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASHIR MM, 1989, J BIOL CHEM, V264, P8887; BRISSENDEN JE, 1985, CANCER RES, V45, P5593; CICILIA G, 1984, EXTRACELLULAR MATRIX, P333; CROCE CM, 1974, J EXP MED, V140, P1221, DOI 10.1084/jem.140.5.1221; EDWARDS YH, 1989, GENOMICS, V5, P948, DOI 10.1016/0888-7543(89)90140-7; EMANUEL BS, 1985, AM J HUM GENET, V37, P873; FAZIO MJ, 1988, J INVEST DERMATOL, V91, P458, DOI 10.1111/1523-1747.ep12476591; FAZIO MJ, 1988, LAB INVEST, V58, P270; FAZIO MJ, 1990, J INVEST DERMATOL, V94, P191, DOI 10.1111/1523-1747.ep12874495; INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680; JUNIEN C, 1982, AM J HUM GENET, V34, P381; KAHARI VM, 1990, J BIOL CHEM, V265, P9485; KAINULAINEN K, 1990, HUM GENET, V84, P233; Maniatis T, 1989, DECONTAMINATION DILU; MATTEI MG, 1988, HUM GENET, V79, P235, DOI 10.1007/BF00366243; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MYERS JC, 1990, AM J HUM GENET, V46, P1024; OLLIVER L, 1987, COLLAGEN REL RES, V7, P77; OLSEN DR, 1988, J BIOL CHEM, V263, P6465; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; ROSENBLOOM J, 1984, LAB INVEST, V51, P605; SEPHEL GC, 1987, J INVEST DERMATOL, V88, P732, DOI 10.1111/1523-1747.ep12470403; TRACKMAN PC, 1990, BIOCHEMISTRY-US, V29, P4863, DOI 10.1021/bi00472a016; TSUI LC, 1989, CYTOGENET CELL GENET, V51, P166, DOI 10.1159/000132791; UITTO J, IN PRESS BOCH PHYSL; WATKINS PC, 1986, CYTOGENET CELL GENET, V42, P214, DOI 10.1159/000132281	26	76	81	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					696	703						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014796				2022-12-18	WOS:A1991FK47800008
J	RAEYMAEKERS, P; TIMMERMAN, V; DE JONGHE, P; SWERTS, L; GHEUENS, J; MARTIN, JJ; MUYLLE, L; DEWINTER, G; VANDENBERGHE, A; VAN BROECKHOVEN, C				RAEYMAEKERS, P; TIMMERMAN, V; DE JONGHE, P; SWERTS, L; GHEUENS, J; MARTIN, JJ; MUYLLE, L; DEWINTER, G; VANDENBERGHE, A; VAN BROECKHOVEN, C			LOCALIZATION OF THE MUTATION IN AN EXTENDED FAMILY WITH CHARCOT-MARIE-TOOTH NEUROPATHY (HMSN-I)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV INSTELLING ANTWERP, DEPT BIOCHEM, BORN BUNGE FDN, UNIV PLEIN 1, B-2610 WILRIJK, BELGIUM; UNIV INSTELLING ANTWERP, DEPT NEUROL, BORN BUNGE FDN, B-2610 WILRIJK, BELGIUM; UNIV INSTELLING ANTWERP, DEPT HEMATOL, B-2610 WILRIJK, BELGIUM	University of Antwerp; University of Antwerp; University of Antwerp			Timmerman, Vincent/O-7283-2019; Van Broeckhoven, Christine/M-7853-2019	Timmerman, Vincent/0000-0002-2162-0933; Van Broeckhoven, Christine/0000-0003-0183-7665				BIRD TD, 1982, AM J HUM GENET, V34, P388; BIRD TD, 1983, ANN NEUROL, V14, P679, DOI 10.1002/ana.410140612; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CHAMBERLAIN S, 1987, HUM GENET, V76, P186, DOI 10.1007/BF00284919; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COOK PJL, 1980, ANN HUM GENET, V44, P61, DOI 10.1111/j.1469-1809.1980.tb00946.x; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRACOPOLI NC, 1988, AM J HUM GENET, V43, P462; Dyck P.J., 1984, PERIPHERAL NEUROPATH, P1600; DYCK PJ, 1983, MAYO CLIN PROC, V58, P430; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; GRIFFITHS LR, 1988, AM J HUM GENET, V42, P756; GUILOFF RJ, 1982, ANN HUM GENET, V46, P25, DOI 10.1111/j.1469-1809.1982.tb00691.x; Haldane JBS, 1919, J GENET, V8, P299; IONASESCU V, 1987, J NEUROL SCI, V80, P73, DOI 10.1016/0022-510X(87)90222-X; IONASESCU V, 1988, AM J HUM GENET, V42, P74; KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEBO RV, IN PRESS 10TH INT WO; Maniatis T., 1982, MOL CLONING; MIDDLETONPRICE HR, 1989, GENOMICS, V4, P192, DOI 10.1016/0888-7543(89)90299-1; MORTON NE, 1955, AM J HUM GENET, V7, P277; RACE RR, 1975, BLOOD GROUPS MAN, P350; RAEYMAEKERS P, 1989, HUM GENET, V81, P231, DOI 10.1007/BF00278994; RAEYMAEKERS P, 1988, HUM GENET, V78, P76, DOI 10.1007/BF00291239; RAEYMAEKERS P, 1988, J NEUROL SCI, V88, P145, DOI 10.1016/0022-510X(88)90212-2; RAEYMAEKERS P, 1989, NEUROLOGY, V39, P844, DOI 10.1212/WNL.39.6.844; RAEYMAEKERS P, IN PRESS CYTOGENET C; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SARFARAZI M, 1987, J MED GENET, V24, P515, DOI 10.1136/jmg.24.9.515; SHERMAN S L, 1988, Cytogenetics and Cell Genetics, V49, P39, DOI 10.1159/000132646; SKRE H, 1974, CLIN GENET, V6, P98; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; WAINWRIGHT B, 1986, J MED GENET, V23, P417, DOI 10.1136/jmg.23.5.417; WANCE JM, 1989, EXP NEUROL, V104, P186	37	76	80	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					953	958						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2589322				2022-12-18	WOS:A1989CF40300015
J	AMSELEM, S; NUNES, V; VIDAUD, M; ESTIVILL, X; WONG, C; DAURIOL, L; VIDAUD, D; GALIBERT, F; BAIGET, M; GOOSSENS, M				AMSELEM, S; NUNES, V; VIDAUD, M; ESTIVILL, X; WONG, C; DAURIOL, L; VIDAUD, D; GALIBERT, F; BAIGET, M; GOOSSENS, M			DETERMINATION OF THE SPECTRUM OF BETA-THALASSEMIA GENES IN SPAIN BY USE OF DOT-BLOT ANALYSIS OF AMPLIFIED BETA-GLOBIN DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP HENRI MONDOR,INSERM,U91,F-94010 CRETEIL,FRANCE; HOSP SANTA CRUZ & SAN PABLO,HEMATOL SERV,BARCELONA,SPAIN; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,GENET UNIT,BALTIMORE,MD 21205; HOP ST LOUIS,CTR HAYEM,HEMATOL EXPTL LAB,F-75475 PARIS 10,FRANCE	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite			Estivill, Xavier/A-3125-2013; VIDAUD, Dominique/O-7357-2017; Nunes, Virginia/AAD-1014-2019; Vidaud, Michel/O-7346-2017	Estivill, Xavier/0000-0002-0723-2256; Nunes, Virginia/0000-0002-5747-9310; 				ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BAIGET M, 1986, HEMOGLOBIN VARIANTS, P141; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CHANG JC, 1983, NUCLEIC ACIDS RES, V11, P7789, DOI 10.1093/nar/11.22.7789; CHEHAB FF, 1987, BLOOD, V69, P1141; CHIBANI J, 1988, HUM GENET, V78, P190, DOI 10.1007/BF00278196; GOMES MPC, 1988, HUM GENET, V78, P13; Goossens M, 1981, Methods Enzymol, V76, P805; GORSKI J, 1982, J MOL BIOL, V154, P537, DOI 10.1016/S0022-2836(82)80012-0; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PERGOLIZZI R, 1981, NUCLEIC ACIDS RES, V9, P7065, DOI 10.1093/nar/9.24.7065; PIRASTU M, 1987, P NATL ACAD SCI USA, V84, P2882, DOI 10.1073/pnas.84.9.2882; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SPRITZ RA, 1981, P NATL ACAD SCI-BIOL, V78, P2455, DOI 10.1073/pnas.78.4.2455; TAMAGNINI GP, 1983, BRIT J HAEMATOL, V54, P189, DOI 10.1111/j.1365-2141.1983.tb02087.x; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; WAINSCOAT JS, 1983, LANCET, V1, P1235; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WESTAWAY D, 1981, NUCLEIC ACIDS RES, V9, P1777, DOI 10.1093/nar/9.8.1777; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	22	76	76	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					95	100						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	2897787				2022-12-18	WOS:A1988N986300013
J	SATOH, K; NUKIWA, T; BRANTLY, M; GARVER, RI; HOFKER, M; COURTNEY, M; CRYSTAL, RG				SATOH, K; NUKIWA, T; BRANTLY, M; GARVER, RI; HOFKER, M; COURTNEY, M; CRYSTAL, RG			EMPHYSEMA ASSOCIATED WITH COMPLETE ABSENCE OF ALPHA-I-ANTITRYPSIN OF A STOP CODON IN AN ALPHA-I-ANTITRYPSIN-CODING EXON	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NHLBI,PULM BRANCH,BLDG 10,ROOM 6D03,BETHESDA,MD 20892; TRANSGENE SA,STRASBOURG,FRANCE; SYLVIUS LAB,DEPT HUMAN GENET,LEIDEN,NETHERLANDS	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Transgene SA; Leiden University; Leiden University - Excl LUMC			Brantly, Mark/AAH-2922-2020					BIETH JG, 1986, REGULATION MATRIX AC, P248; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CARRELL RW, 1979, ESSAYS MEDICAL BIOCH, V4, P83; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; COURTNEY M, 1984, P NATL ACAD SCI-BIOL, V81, P669, DOI 10.1073/pnas.81.3.669; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; ERRINGTON DM, 1982, FEBS LETT, V148, P83, DOI 10.1016/0014-5793(82)81247-7; Fagerhol M K, 1981, Adv Hum Genet, V11, P1; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; Gadek J., 1982, METABOLIC BASIS INHE, P1450; GADEK JE, 1981, J CLIN INVEST, V68, P889, DOI 10.1172/JCI110344; GARVER RI, 1986, NEW ENGL J MED, V314, P762, DOI 10.1056/NEJM198603203141207; HARDICK C, 1986, American Journal of Human Genetics, V39, pA202; HODGSON I, 1987, J MED GENET, V24, P47, DOI 10.1136/jmg.24.1.47; HUMPHRIES RK, 1984, BLOOD, V64, P23; JANUS ED, 1985, LANCET, V1, P152; JEPPSSON JO, 1978, EUR J BIOCHEM, V83, P143, DOI 10.1111/j.1432-1033.1978.tb12078.x; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; MARTIN JP, 1975, PATHOL BIOL, V23, P521; MORNEX JF, 1986, J CLIN INVEST, V77, P1952, DOI 10.1172/JCI112524; MUENSCH H, 1986, AM J HUM GENET, V38, P898; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; NUKIWA T, 1987, J BIOL CHEM, V262, P11999; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P6918, DOI 10.1073/pnas.82.20.6918; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCHANDEVYL W, 1975, C I NATIONAL SANTE R, V40, P97; SCHROEDER WT, 1985, AM J HUM GENET, V37, P868; TAKESHITA K, 1984, BLOOD, V64, P13; TALAMO RC, 1973, SCIENCE, V181, P70, DOI 10.1126/science.181.4094.70; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEWERS MD, 1987, AM REV RESPIR DIS, V135, P539	37	76	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					77	83						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3257351				2022-12-18	WOS:A1988L869700011
J	WERTZ, DC; SORENSON, JR; HEEREN, TC				WERTZ, DC; SORENSON, JR; HEEREN, TC			CLIENTS INTERPRETATION OF RISKS PROVIDED IN GENETIC-COUNSELING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BOSTON UNIV,SCH PUBL HLTH,BIOSTAT & EPIDEMIOL SECT,BOSTON,MA 02215; UNIV N CAROLINA,SCH PUBL HLTH,DEPT HLTH EDUC,CHAPEL HILL,NC 27514	Boston University; University of North Carolina; University of North Carolina Chapel Hill	WERTZ, DC (corresponding author), BOSTON UNIV,SCH PUBL HLTH,SOCIAL & BEHAV SCI SECT,BOSTON,MA 02215, USA.			Heeren, Timothy/0000-0001-5643-3559				ARROW KJ, 1982, ECON INQ, V20, P1, DOI 10.1111/j.1465-7295.1982.tb01138.x; Black R B, 1979, Birth Defects Orig Artic Ser, V15, P341; BLACK RB, 1981, NOV ANN M AM PUBL HL; BRINGLE RG, 1980, SOC BIOL, V27, P304, DOI 10.1080/19485565.1980.9988433; Douglas M., 1982, RISK CULTURE; FISCHHOFF BV, 1982, POL SCI, V8, P127; HAMMOND PJ, 1982, UTILITARIANISM; Jeffrey R., 1965, LOGIC DECISION; KAHNEMAN D, 1982, SCI AM, V246, P160, DOI 10.1038/scientificamerican0182-160; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lippman-Hand A, 1979, Birth Defects Orig Artic Ser, V15, P325; LIPPMANHAND A, 1979, AM J MED GENET, V4, P51, DOI 10.1002/ajmg.1320040108; LOPES LL, 1984, J EXP PSYCHOL HUMAN, V10, P465, DOI 10.1037/0096-1523.10.4.465; LOPES LL, 1981, J EXP PSYCHOL-HUM L, V7, P377; Lubs M L, 1979, Birth Defects Orig Artic Ser, V15, P355; MACLEAN D, 1983, ENERGY FUTURE; NISBETT RE, 1980, HUMAN INFLUENCE STRA; Pauker S P, 1979, Birth Defects Orig Artic Ser, V15, P289; PEARN JH, 1973, J MED GENET, V10, P129, DOI 10.1136/jmg.10.2.129; Raiffa H., 1997, DECIS ANAL; SLOVIC P, 1974, BEHAV SCI, V19, P368, DOI 10.1002/bs.3830190603; Sorenson J R, 1981, Birth Defects Orig Artic Ser, V17, P215; SORENSON JR, 1981, REPRODUCTIVE PASTS R; SORENSON JR, 1985, UNPUB PROSPECTIVE ST; STARR C, 1969, SCIENCE, V165, P1232, DOI 10.1126/science.165.3899.1232; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WERTZ DC, 1984, AM J MED GENET, V18, P79, DOI 10.1002/ajmg.1320180112	27	76	76	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					253	264						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	E1459	3752089				2022-12-18	WOS:A1986E145900012
J	OBER, CL; MARTIN, AO; SIMPSON, JL; HAUCK, WW; AMOS, DB; KOSTYU, DD; FOTINO, M; ALLEN, FH				OBER, CL; MARTIN, AO; SIMPSON, JL; HAUCK, WW; AMOS, DB; KOSTYU, DD; FOTINO, M; ALLEN, FH			SHARED HLA ANTIGENS AND REPRODUCTIVE-PERFORMANCE AMONG HUTTERITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NORTHWESTERN UNIV,CTR CANC,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT COMMUNITY HLTH & PREVENT MED,CHICAGO,IL 60611; DUKE UNIV,SCH MED,DIV IMMUNOL,DURHAM,NC 27710; NEW YORK BLOOD CTR,NEW YORK,NY 10021	Northwestern University; Northwestern University; Duke University; New York Blood Center	OBER, CL (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT OBSTET & GYNECOL,HUMAN GENET SECT,CHICAGO,IL 60611, USA.				NCI NIH HHS [R01-CA-19822] Funding Source: Medline; NICHD NIH HHS [N01-HD-0-2840] Funding Source: Medline; NIGMS NIH HHS [GM-10356] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD002840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010356] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOS DB, 1980, MANUAL CLIN IMMUNOLO, P978; Beer A. E., 1981, ENDOCRINOLOGY HUMAN, P419; BEER AE, 1980, FOLIA BIOL-PRAGUE, V26, P225; BEER AE, 1981, AM J OBSTET GYNECOL, V141, P987; BEER AE, 1976, IMMUNOLOGY MAMMALIAN; BILLINGTON WD, 1964, NATURE, V202, P317, DOI 10.1038/202317a0; Bleibtreu H., 1964, THESIS HARVARD U CAM; DIXON WJ, 1981, BMDP STATISTICAL SOF; GILL TJ, 1979, AM J PATHOL, V95, P464; Hostetler J, 1974, HUTTERITE SOC; HULL CH, 1979, SPSS; HULL P, 1969, HEREDITY, V24, P203, DOI 10.1038/hdy.1969.26; JAMES DA, 1965, NATURE, V205, P613, DOI 10.1038/205613a0; KIRBY DRS, 1970, P ROY SOC MED, V63, P59, DOI 10.1177/003591577006300126; KOMLOS L, 1977, CLIN IMMUNOL IMMUNOP, V7, P330, DOI 10.1016/0090-1229(77)90066-6; MACCLUER JW, 1979, HUM BIOL, V51, P391; MACCLUER JW, 1978, ANN HUM GENET, V42, P59, DOI 10.1111/j.1469-1809.1978.tb00931.x; MANGE AP, 1964, HUM BIOL, V36, P104; MARTIN AO, 1980, J NATL CANCER I, V5, P235; MARTIN AO, 1980, BANBURY REPORT, V4, P235; MARTIN AO, 1980, GENETIC ENV FACTORS, P291; Olsen C. L., 1976, THESIS U MICHIGAN; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; SCHACTER B, 1979, LANCET          0414; SHEPS MC, 1965, POP STUD-J DEMOG, V19, P65, DOI 10.2307/2173165; Simpson J L, 1981, Birth Defects Orig Artic Ser, V17, P113; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; TAYLOR C, 1981, LANCET          0711	28	76	77	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					994	1004						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6577788				2022-12-18	WOS:A1983RK60400019
J	YOSHIDA, A; MOTULSKY, AG				YOSHIDA, A; MOTULSKY, AG			A PSEUDOCHOLINESTERASE VARIANT (E CYNTHIANA) ASSOCIATED WITH ELEVATED PLASMA ENZYME ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AMES BN, 1963, COLD SPRING HARB SYM, V28, P349, DOI 10.1101/SQB.1963.028.01.049; COHEN JA, 1959, J CELL COMPAR PHYSL, V54, P231, DOI 10.1002/jcp.1030540419; DERN RJ, 1969, J CLIN INVEST, V283, P283; GOEDDE H. W., 1965, BIOCHIM BIOPHYS ACTA, V107, P391, DOI 10.1016/0304-4165(65)90149-2; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HARRIS H, 1963, NATURE, V200, P1185, DOI 10.1038/2001185a0; HARRIS H, 1963, BIOCHIM BIOPHYS ACTA, V73, P649; HARRIS H, 1968, NUCLEUS CYTOPLASM, P72; HAUPT H, 1966, BLUT, V14, P65, DOI 10.1007/BF01633493; HODGKIN WE, 1965, J CLIN INVEST, V44, P486, DOI 10.1172/JCI105162; JANSZ HS, 1959, BIOCHIM BIOPHYS ACTA, V34, P573, DOI 10.1016/0006-3002(59)90320-8; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305; KALOW W, 1959, ANN HUM GENET, V23, P239, DOI 10.1111/j.1469-1809.1959.tb01467.x; KLEIN H, 1967, DEUTSCH Z GES GERICH, V61, P137; LIDDELL J, 1962, NATURE, V193, P561, DOI 10.1038/193561a0; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MITCHELL WM, 1968, P NATL ACAD SCI USA, V61, P742, DOI 10.1073/pnas.61.2.742; MIYAJI TAKAOKI, 1968, SCIENCE, V159, P204, DOI 10.1126/science.159.3811.204; NEITLICH HW, 1966, J CLIN INVEST, V45, P380, DOI 10.1172/JCI105353; POOTRAKUL S, 1967, BRIT J HAEMATOL, V13, P303, DOI 10.1111/j.1365-2141.1967.tb08744.x; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; SHIBATA S, 1964, CLIN CHIM ACTA, V10, P101, DOI 10.1016/0009-8981(64)90153-6; SIROTNAK FM, 1964, J BIOL CHEM, V239, P4298; SMITHIES O, 1962, ARCH BIOCHEM BIOPHYS, P125; STERN J, 1962, J MENT DEFIC RES, V6, P13; TSCHUDY DP, 1965, P NATL ACAD SCI USA, V53, P841, DOI 10.1073/pnas.53.4.841; YOSHIDA A, 1968, 12 P INT C GEN TOK, V2, P192	29	76	76	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	5					486	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7549	5822291				2022-12-18	WOS:A1969E754900007
J	UCHIDA, IA; MILLER, JR; SOLTAN, HC				UCHIDA, IA; MILLER, JR; SOLTAN, HC			DERMATOGLYPHICS ASSOCIATED WITH XXYY CHROMOSOME COMPLEMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARR ML, IN PRESS; BIESELE JJ, 1962, LANCET, V1, P403; BRAY P, 1963, JAMA-J AM MED ASSOC, V184, P179, DOI 10.1001/jama.1963.03700160055007; CARR DH, 1961, CAN MED ASSOC J, V84, P873; DENT T, 1963, LANCET, V2, P484; DUNN HG, 1961, PEDIATRICS, V28, P578; ELLIS JR, 1961, ANN HUM GENET, V25, P145, DOI 10.1111/j.1469-1809.1961.tb01512.x; FITZGERALD PH, 1962, LANCET, V2, P456; HAUSCHKA TS, 1962, AM J HUM GENET, V14, P22; HAYWARD MD, 1960, LANCET, V2, P844; LAURENCE K. M., 1963, CYTOGENETICS [BASEL], V2, P50, DOI 10.1159/000129765; MULDAL S, 1962, ACTA ENDOCRINOL-COP, V39, P183, DOI 10.1530/acta.0.0390183; PENROSE LS, 1963, NATURE, V197, P933, DOI 10.1038/197933a0; ROBINSON GC, SUBMITTED FOR PUBLIC; SANDBERG, 1963, NEW ENGLAND J MEDICI, V268, P585; TURNER B, 1961, LANCET, V2, P49; Uchida I.A., 1963, PEDIATR CLIN N AM, V10, P409; UCHIDA IA, 1962, AM J HUM GENET, V14, P345; VAGUE J, 1961, ANN ENDOCRIN, V22, P987	19	76	76	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	3					284	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2973A	14204778				2022-12-18	WOS:A19642973A00009
J	CATTELL, RB; BLEWETT, DB; BELOFF, JR				CATTELL, RB; BLEWETT, DB; BELOFF, JR			INHERITANCE OF PERSONALITY - MULTIPLE VARIANCE ANALYSIS DETERMINATION OF APPROXIMATE NATURE-NURTURE RATIOS FOR PRIMARY PERSONALITY FACTORS IN Q-DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLEWETT DB, 1953, THESIS U LONDON; Burks B., 1928, YB NATL SOC STUDY ED, V27, P219; Bywaters JH, 1937, GENETICS, V22, P457; Cattell RB, 1950, J SOC PSYCHOL, V31, P243, DOI 10.1080/00224545.1950.9919010; Cattell R.B., 1950, PERSONALITY SYSTEMAT; Cattell RB, 1954, EDUC PSYCHOL MEAS, V14, P50, DOI 10.1177/001316445401400105; CATTELL RB, 1953, AM J HUM GENET, V5, P76; Cattell RB, 1940, PEDAGOG SEMIN J GEN, V57, P31; CATTELL RB, 1951, PROJECTIVE TECHNIQUE, pCH3; CATTELL RB, 1953, J CONSULTING PSYCHOL, V17, P436; CATTELL RB, 1953, 3 U ILL LAB PERS ASS; CATTELL RB, 1940, 39 YB NATL SOC STU 1, P221; CATTELL RB, 1954, OBJECTIVE ANAL PERSO; Cattell RB, 1950, 16 PERSONALITY FACTO; CATTELL RB, 1950, CULTURE FREE INTELLI; CATTELL RB, IN PRESS; CHAPMAN AB, 1946, GENETICS, V31, P494; EYSENCK HJ, 1951, J MENT SCI, V97, P441, DOI 10.1192/bjp.97.408.441; French J. W., 1953, DESCRIPTION PERSONAL; KALLMANN FJ, 1946, AM J PSYCHIAT, V103, P309, DOI 10.1176/ajp.103.3.309; Kretschmer E., 1929, KORPERBAU CHARAKTER; Lush JL, 1934, GENETICS, V19, P0329; MOWRER OH, 1941, T NY ACAD SC       2, V3; Newman HH., 1937, TWINS STUDY HEREDITY; PRICE B, 1950, AM J HUM GENET, V2, P243; ROBINSON HF, 1949, AGRON J, V41, P353, DOI 10.2134/agronj1949.00021962004100080005x; Rosanoff AJ, 1934, AM J PSYCHIAT, V91, P247, DOI 10.1176/ajp.91.2.247; SCHWESINGER GC, 1933, HEREDITY ENV; SCOTT JP, 1950, RES PUBL ASS NEUR ME, V29, P61; Sheldon W. H., 1940, VARIETIES HUMAN PHYS; SLATER E, 1953, MRC278 SPEC REP; STOCKARD CR, 1931, PHYSICAL BASIS PERSO; Thorndike EL, 1944, PEDAGOG SEMIN J GEN, V64, P265; THURSTONE LL, 1941, 2 PSYCH MON; WOODWORTH RS, 1941, SOC SCI RES CO B, V47, P1; YULE FG, 1935, J MENT SCI, V81, P489	36	76	76	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	2					122	146						25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA211	14388001				2022-12-18	WOS:A1955WA21100003
J	Coutton, C; Martinez, G; Kherraf, ZE; Amiri-Yekta, A; Boguenet, M; Saut, A; He, XJ; Zhang, F; Cristou-Kent, M; Escoffier, J; Bidart, M; Satre, V; Conne, B; Ben Mustapha, SF; Halouani, L; Marrakchi, O; Makni, M; Latrous, H; Kharouf, M; Pernet-Gallay, K; Bonhivers, M; Hennebicq, S; Rives, N; Dulioust, E; Toure, A; Gourabi, H; Cao, YX; Zouari, R; Hosseini, SH; Nef, S; Thierry-Mieg, N; Arnoult, C; Ray, PF				Coutton, Charles; Martinez, Guillaume; Kherraf, Zine-Eddine; Amiri-Yekta, Amir; Boguenet, Magalie; Saut, Antoine; He, Xiaojin; Zhang, Feng; Cristou-Kent, Marie; Escoffier, Jessica; Bidart, Marie; Satre, Veronique; Conne, Beatrice; Ben Mustapha, Selima Fourati; Halouani, Lazhar; Marrakchi, Ouafi; Makni, Mounir; Latrous, Habib; Kharouf, Mahmoud; Pernet-Gallay, Karin; Bonhivers, Melanie; Hennebicq, Sylviane; Rives, Nathalie; Dulioust, Emmanuel; Toure, Aminata; Gourabi, Hamid; Cao, Yunxia; Zouari, Raoudha; Hosseini, Seyedeh Hanieh; Nef, Serge; Thierry-Mieg, Nicolas; Arnoult, Christophe; Ray, Pierre F.			Bi-allelic Mutations in ARMC2 Lead to Severe Astheno-Teratozoospermia Due to Sperm Flagellum Malformations in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE MORPHOLOGICAL ABNORMALITIES; PRIMARY CILIARY DYSKINESIA; MALE-INFERTILITY; FRAMESHIFT MUTATION; PROTEINS; DNAH1; TRANSCRIPTOME; ANOMALIES; DEFECTS; DYNEIN	Male infertility is a major health concern. Among its different causes, multiple morphological abnormalities of the flagella (MMAF) induces asthenozoospermia and is one of the most severe forms of qualitative sperm defects. Sperm of affected men display short, coiled, absent, and/or irregular flagella. To date, six genes (DNAH1, CFAP43, CFAP44, CFAP69, FSIP2, and WDR66) have been found to be recurrently associated with MMAF, but more than half of the cases analyzed remain unresolved, suggesting that many yet-uncharacterized gene defects account for this phenotype. Here, whole-exome sequencing (WES) was performed on 168 infertile men who had a typical MMAF phenotype. Five unrelated affected individuals carried a homozygous deleterious mutation in ARMC2, a gene not previously linked to the MMAF phenotype. Using the CRISPR-Cas9 technique, we generated homozygous Armc2 mutant mice, which also presented an MMAF phenotype, thus confirming the involvement of ARMC2 in human MMAF. Immunostaining experiments in AMRC2-mutated individuals and mutant mice evidenced the absence of the axonemal central pair complex (CPC) proteins SPAG6 and SPEF2, whereas the other tested axonemal and peri-axonemal components were present, suggesting that ARMC2 is involved in CPC assembly and/or stability. Overall, we showed that bi-allelic mutations in ARMC2 cause male infertility in humans and mice by inducing a typical MMAF phenotype, indicating that this gene is necessary for sperm flagellum structure and assembly.	[Coutton, Charles; Martinez, Guillaume; Kherraf, Zine-Eddine; Amiri-Yekta, Amir; Boguenet, Magalie; Saut, Antoine; Cristou-Kent, Marie; Escoffier, Jessica; Satre, Veronique; Hennebicq, Sylviane; Arnoult, Christophe; Ray, Pierre F.] Univ Grenoble Alpes, Team Genet Epigenet & Therapies Infertil, Inst Adv Biosci, Inserm,U1209,CNRS,UMR 5309, F-38000 Grenoble, France; [Coutton, Charles; Martinez, Guillaume; Satre, Veronique] Ctr Hosp Univ Grenoble Alpes, Unite Med UM Genet Chromos, F-38000 Grenoble, France; [Kherraf, Zine-Eddine; Amiri-Yekta, Amir; Ray, Pierre F.] Ctr Hosp Univ Grenoble Alpes, Unite Med Genet Infertilite & Diagnost Preimplant, F-38000 Grenoble, France; [Amiri-Yekta, Amir; Gourabi, Hamid] Acad Ctr Educ Culture & Res, Dept Genet, Reprod Biomed Res Ctr, Royan Inst Reprod Biomed, POB 16635-148, Tehran, Iran; [He, Xiaojin; Cao, Yunxia] Anhui Med Univ, Dept Obstet & Gynecol, Reprod Med Ctr, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China; [Zhang, Feng] Fudan Univ, Inst Metab & Integrat Biol, Obstet & Gynecol Hosp, Sch Life Sci, Shanghai 200011, Peoples R China; [Bidart, Marie] Univ Grenoble Alpes, CHU Grenoble, Pole Rech, Clinatec,Inserm,UMR 1205, F-38000 Grenoble, France; [Conne, Beatrice; Nef, Serge] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ben Mustapha, Selima Fourati; Halouani, Lazhar; Marrakchi, Ouafi; Makni, Mounir; Latrous, Habib; Kharouf, Mahmoud; Zouari, Raoudha] Ctr Urbain Nord, Polyclin Jasmins, Ctr Aide Med Procreat, Tunis 1003, Tunisia; [Pernet-Gallay, Karin] Inserm 1216, Grenoble Neurosci Inst, F-38000 Grenoble, France; [Bonhivers, Melanie] Univ Bordeaux, CNRS, Microbiol Fondamentale & Pathogenicite, UMR 5234, F-33000 Bordeaux, France; [Hennebicq, Sylviane] CHU Grenoble, Unite Fonct Biol Procreat, F-38000 Grenoble, France; [Rives, Nathalie] Normandie Univ, EA 4308 Gametogenesis & Gamete Qual, Dept Reprod Biol CECOS, Rouen Univ Hosp,UNIROUEN, F-76000 Rouen, France; [Rives, Nathalie] Univ Rennes 1, INSERM, U1085, Inst Rech Sante Environm & Travail, Rennes, France; [Dulioust, Emmanuel] Grp Hosp Cochin, Lab Histol Embryol & Biol Reprod, F-75014 Broca, France; [Dulioust, Emmanuel] Hop Hotel Dieu, AP HP, F-75014 Broca, France; [Dulioust, Emmanuel; Toure, Aminata] Univ Paris 05, Fac Med, Sorbonne Paris Cite, F-75014 Paris, France; [Toure, Aminata] INSERM, U1016, Inst Cochin, F-75014 Paris, France; [Toure, Aminata] CNRS, UMR 8104, F-75014 Paris, France; [Hosseini, Seyedeh Hanieh] Acad Ctr Educ Culture & Res, Dept Androl, Reprod Biomed Res Ctr, Royan Inst Reprod Biomed, Tehran, Iran; [Thierry-Mieg, Nicolas] Univ Grenoble Alpes, TIMC IMAG, CNRS, BCM, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Academic Center for Education, Culture & Research (ACECR); Anhui Medical University; Fudan University; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Academic Center for Education, Culture & Research (ACECR); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Coutton, C; Ray, PF (corresponding author), Univ Grenoble Alpes, Team Genet Epigenet & Therapies Infertil, Inst Adv Biosci, Inserm,U1209,CNRS,UMR 5309, F-38000 Grenoble, France.; Coutton, C (corresponding author), Ctr Hosp Univ Grenoble Alpes, Unite Med UM Genet Chromos, F-38000 Grenoble, France.; Ray, PF (corresponding author), Ctr Hosp Univ Grenoble Alpes, Unite Med Genet Infertilite & Diagnost Preimplant, F-38000 Grenoble, France.	ccoutton@chu-grenoble.fr; pray@chu-grenoble.fr	TOURE, Aminata/B-3236-2018; Ray, Pierre F/D-7315-2019; Zhang, Feng/C-7735-2009; COUTTON, Charles/G-2859-2014; KHERRAF, Zine-Eddine/F-1585-2019; Escoffier, jessica/T-9857-2019; Escoffier, jessica/E-9498-2017; Nef, Serge/AAV-6445-2020; Amiri-Yekta, Amir/AAF-1062-2020; Thierry-Mieg, Nicolas/M-6007-2014; Christou-Kent, Marie/AAA-4584-2021; HENNEBICQ, Sylviane/A-6564-2012; Martinez, Guillaume/O-3959-2018; ARNOULT, christophe/E-8312-2013; SATRE, Veronique/G-2864-2014	TOURE, Aminata/0000-0001-5629-849X; Ray, Pierre F/0000-0003-1544-7449; Zhang, Feng/0000-0003-4556-8276; KHERRAF, Zine-Eddine/0000-0003-0351-6689; Escoffier, jessica/0000-0001-8166-5845; Nef, Serge/0000-0001-5462-0676; Thierry-Mieg, Nicolas/0000-0002-7667-2853; Christou-Kent, Marie/0000-0002-6008-7350; PERNET GALLAY, Karin/0000-0003-3468-3316; BONHIVERS, Melanie/0000-0001-9179-8473; HENNEBICQ, Sylviane/0000-0002-1851-6932; Coutton, Charles/0000-0002-8873-8098; Martinez, Guillaume/0000-0002-7572-9096; FOURATI BEN MUSTAPHA, Selima/0000-0002-0107-6440; ARNOULT, christophe/0000-0002-3753-5901; SATRE, Veronique/0000-0001-7852-8591	"MAS-Flagella'' project - French Agence Nationale pour la Recherche (ANR); Direction Generale de l'Offre de Soin (DGHOS); Whole genome sequencing of subjects with Flagellar Growth Defects (FGD) - Fondation Maladies Rares (FMR)	"MAS-Flagella'' project - French Agence Nationale pour la Recherche (ANR); Direction Generale de l'Offre de Soin (DGHOS); Whole genome sequencing of subjects with Flagellar Growth Defects (FGD) - Fondation Maladies Rares (FMR)	We thank all individuals for their participation. This work was mainly supported by the following grants: the "MAS-Flagella'' project financed by French Agence Nationale pour la Recherche (ANR) and the Direction Generale de l'Offre de Soin (DGHOS) for the program PRTS 2014 (P.F.R.), the "Whole genome sequencing of subjects with Flagellar Growth Defects (FGD)'' financed by the Fondation Maladies Rares (FMR) for the program Sequencage a haut debit 2012 (P.F.R.).	Amiri-Yekta A, 2016, HUM REPROD, V31, P2872, DOI 10.1093/humrep/dew262; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Auguste Y, 2018, AM J HUM GENET, V103, P413, DOI 10.1016/j.ajhg.2018.07.013; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Dong FN, 2018, AM J HUM GENET, V102, P636, DOI 10.1016/j.ajhg.2018.03.007; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Jan SZ, 2017, DEVELOPMENT, V144, P3659, DOI 10.1242/dev.152413; Kherraf ZE, 2018, AM J HUM GENET, V103, P400, DOI 10.1016/j.ajhg.2018.07.014; Kherraf ZE, 2018, MOL CELL ENDOCRINOL, V468, P70, DOI 10.1016/j.mce.2018.03.002; Krausz C, 2018, NAT REV UROL, V15, P369, DOI 10.1038/s41585-018-0003-3; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; Lores P, 2018, HUM MOL GENET, V27, P1196, DOI 10.1093/hmg/ddy034; Martinez G, 2018, HUM REPROD, V33, P1973, DOI 10.1093/humrep/dey264; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meienberg J, 2016, HUM GENET, V135, P359, DOI 10.1007/s00439-015-1631-9; Onoufriadis A, 2014, J MED GENET, V51, P61, DOI 10.1136/jmedgenet-2013-101938; Pausch H, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0356-7; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Ray PF, 2017, CLIN GENET, V91, P217, DOI 10.1111/cge.12905; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Sha YW, 2017, GENE, V633, P48, DOI 10.1016/j.gene.2017.08.033; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Teves ME, 2016, CYTOSKELETON, V73, P3, DOI 10.1002/cm.21271; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Tuttelmann F, 2018, MED GENET-BERLIN, V30, P12, DOI 10.1007/s11825-018-0181-7; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Wang X, 2017, CLIN GENET, V91, P313, DOI 10.1111/cge.12857; Wang YX, 2014, FERTIL STERIL, V101, P945, DOI 10.1016/j.fertnstert.2013.12.047; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002	36	75	83	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2019	104	2					331	340		10.1016/j.ajhg.2018.12.013	http://dx.doi.org/10.1016/j.ajhg.2018.12.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL2SW	30686508	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000458557800013
